PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Haiden, N; Pimpel, B; Kreissl, A; Jilma, B; Berger, A				Haiden, Nadja; Pimpel, Birgit; Kreissl, Alexandra; Jilma, Bernd; Berger, Angelika			Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?-A Prospective Randomized Controlled Trial	PLOS ONE			English	Article							PRETERM INFANTS; ENTERAL NUTRITION; EVACUATION; GAIN	Background To determine whether the complementary approach of visceral manipulative osteopathic treatment accelerates complete meconium excretion and improves feeding tolerance in very low birth weight infants. Methods This study was a prospective, randomized, controlled trial in premature infants with a birth weight <1500 g and a gestational age <32 weeks who received a visceral osteopathic treatment 3 times during their first week of life or no treatment. Results Passage of the last meconium occurred after a median of 7.5 days (95% confidence interval: 6-9 days, n = 21) in the intervention group and after 6 days (95% confidence interval: 59 days, n = 20,) in the control group (p = 0.11). However, osteopathic treatment was associated with a 8 day longer time to full enteral feedings (p = 0.02), and a 34 day longer hospital stay (Median = 66 vs. 100 days i.e.; p= 0.14). Osteopathic treatment was tolerated well and no adverse events were observed. Conclusions Visceral osteopathic treatment of the abdomen did not accelerate meconium excretion in VLBW (very low birth weight)-infants. However infants in the osteopathic group had a longer time to full enteral feedings and a longer hospital stay, which could represent adverse effects. Based on our trial results, we cannot recommend visceral osteopathic techniques in VLBW-infants.	[Haiden, Nadja; Pimpel, Birgit; Kreissl, Alexandra; Berger, Angelika] Med Univ Vienna, Dept Pediat, Div Neonatol Pediat Intens Care Med & Neuropediat, Vienna, Austria; [Jilma, Bernd] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Haiden, N (corresponding author), Med Univ Vienna, Dept Pediat, Div Neonatol Pediat Intens Care Med & Neuropediat, Vienna, Austria.	nadja.haiden@meduniwien.ac.at	Haiden, Nadja/L-3775-2019	Haiden, Nadja/0000-0003-4806-0312; Berger, Angelika/0000-0001-8775-2405; Thajer, Alexandra/0000-0002-1051-1141; Jilma, Bernd/0000-0001-5652-7977				Agostoni C, 2009, J PEDIAT GASTROENTER, V50, P85, DOI [10.1097/MPG.0b013e3181adaee0, DOI 10.1097/MPG.0B013E3181ADAEE0]; BELL MJ, 1978, NEW ENGL J MED, V298, P281; Educational Council on Osteopathic Principles, 2011, GLOSS OST TERM; Field T, 2006, INFANT BEHAV DEV, V29, P574, DOI 10.1016/j.infbeh.2006.07.011; Field T, 2011, INFANT BEHAV DEV, V34, P383, DOI 10.1016/j.infbeh.2010.12.001; Haiden N, 2007, J PEDIATR GASTR NUTR, V44, P270, DOI 10.1097/MPG.0b013e31802c685a; Haiden N, 2012, PEDIATRICS, V130, pE1600, DOI 10.1542/peds.2011-3634; Hebgen EU., 2011, VISCERAL MANIPULATIO; Klebermass-Schrehof K, 2013, NEONATOLOGY, V103, P252, DOI 10.1159/000346521; McGuire W, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001241.pub2; MEETZE WH, 1993, JPEN-PARENTER ENTER, V17, P537, DOI 10.1177/0148607193017006537; MEETZE WH, 1992, J PEDIATR GASTR NUTR, V15, P163, DOI 10.1097/00005176-199208000-00011; Mihatsch WA, 2001, ACTA PAEDIATR, V90, P196, DOI 10.1080/080352501300049442; Mihatsch WA, 2001, ACTA PAEDIATR, V90, P409, DOI 10.1080/080352501750126276; Moeckel Eva MN, 2008, TXB PEDIAT OSTEOPATH; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; Newell SJ, 2000, CLIN PERINATOL, V27, P221, DOI 10.1016/S0095-5108(05)70015-4; Posadzki P, 2013, PEDIATRICS, V132, P140, DOI 10.1542/peds.2012-3959; STOLLEY PD, 1986, CLIN PHARMACOL THER, V39, P489, DOI 10.1038/clpt.1986.85; Tarsuslu T, 2009, J MANIP PHYSIOL THER, V32, P648, DOI 10.1016/j.jmpt.2009.08.016; Tsang RC., 2005, NUTR PRETERM INFANT; WANG PA, 1994, EUR J PEDIATR, V153, P279, DOI 10.1007/s004310050137; Ward RC, 2003, FDN OSTEOPATHIC MED, V2nd	23	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123530	10.1371/journal.pone.0123530	http://dx.doi.org/10.1371/journal.pone.0123530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875011	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800104
J	Geneva, AJ; Muirhead, CA; Kingan, SB; Garrigan, D				Geneva, Anthony J.; Muirhead, Christina A.; Kingan, Sarah B.; Garrigan, Daniel			A New Method to Scan Genomes for Introgression in a Secondary Contact Model	PLOS ONE			English	Article							GENETIC-VARIATION; SPECIATION; DROSOPHILA; HYBRIDIZATION; POPULATIONS; SELECTION; DIVERSITY; FLOW	Secondary contact between divergent populations or incipient species may result in the exchange and introgression of genomic material. We develop a simple DNA sequence measure, called G(min), which is designed to identify genomic regions experiencing introgression in a secondary contact model. Gmin is defined as the ratio of the minimum between-population number of nucleotide differences in a genomic window to the average number of between- population differences. Although it is conceptually simple, one advantage of Gmin is that it is computationally inexpensive relative to model-based methods for detecting gene flow and it scales easily to the level of whole-genome analysis. We compare the sensitivity and specificity of Gmin to those of the widely used index of population differentiation, F-ST, and suggest a simple statistical test for identifying genomic outliers. Extensive computer simulations demonstrate that Gmin has both greater sensitivity and specificity for detecting recent introgression than does FST. Furthermore, we find that the sensitivity of Gmin is robust with respect to both the population mutation and recombination rates. Finally, a scan of Gmin across the X chromosome of Drosophila melanogaster identifies candidate regions of introgression between sub-Saharan African and cosmopolitan populations that were previously missed by other methods. These results show that Gmin is a biologically straightforward, yet powerful, alternative to FST, as well as to more computationally intensive model-based methods for detecting gene flow.	[Geneva, Anthony J.; Muirhead, Christina A.; Kingan, Sarah B.; Garrigan, Daniel] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Muirhead, Christina A.] Ronin Inst, Montclair, NJ USA	University of Rochester	Garrigan, D (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dgarriga@ur.rochester.edu	Geneva, Anthony J/H-2471-2011; Garrigan, Daniel/N-6587-2013	Geneva, Anthony J/0000-0001-8253-6527; Garrigan, Daniel/0000-0002-7000-6788	National Institutes of Health [R01-ODO1054801]; University of Rochester River Campus Libraries	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester River Campus Libraries	This work was made possible by a grant from the National Institutes of Health to DG (R01-ODO1054801). Funds for data deposition were provided by the University of Rochester River Campus Libraries. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Brand CL, 2013, MOL BIOL EVOL, V30, P2177, DOI 10.1093/molbev/mst123; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Garrigan D, 2014, MSMOVE A MODIFIED VE, DOI [10.6084/m9.figshare.1060474, DOI 10.6084/M9.FIGSHARE.1060474]; Garrigan D, 2013, EVOL BIOINFORM, V9, P343, DOI 10.4137/EBO.S12751; Geneva A, 2010, GENES-BASEL, V1, P124, DOI 10.3390/genes1010124; Gompert Z, 2012, PHILOS T R SOC B, V367, P439, DOI 10.1098/rstb.2011.0196; Gompert Z, 2011, MOL ECOL, V20, P2111, DOI 10.1111/j.1365-294X.2011.05074.x; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Langley CH, 2011, GENETICS, V188, P239, DOI 10.1534/genetics.111.127530; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Murray MC, 2006, MOL ECOL, V15, P4229, DOI 10.1111/j.1365-294X.2006.03060.x; Nadachowska-Brzyska K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003942; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Smith Joel, 2013, Biol Lett, V9, P20130503, DOI 10.1098/rsbl.2013.0503; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; TAKAHATA N, 1990, THEOR POPUL BIOL, V38, P331, DOI 10.1016/0040-5809(90)90018-Q; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yukilevich R, 2012, EVOLUTION, V66, P1430, DOI 10.1111/j.1558-5646.2011.01534.x	40	27	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0118621	10.1371/journal.pone.0118621	http://dx.doi.org/10.1371/journal.pone.0118621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874895	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700002
J	Pernus, A; Langowski, J				Pernus, Agata; Langowski, Joerg			Imaging Fos-Jun Transcription Factor Mobility and Interaction in Live Cells by Single Plane Illumination-Fluorescence Cross Correlation Spectroscopy	PLOS ONE			English	Article							AP-1 SITE; C-FOS; BINDING; PROTEIN; DIFFUSION; RECEPTOR; DYNAMICS; COMPLEX; PRODUCT; GENE	We collected mobility and interaction maps of c-Fos-eGFP and c-Jun-mRFP1 transcription factors within living cell nuclei. c-Fos dimerizes with c-Jun to form the transcription activator protein-1 (AP-1) which binds to the specific recognition site. To monitor this process, we used fluorescence cross-correlation spectroscopy on a single plane illumination microscope (SPIM-FCCS), which provides diffusion coefficient and protein-protein interaction data in the whole image plane simultaneously, instead of just one point on conventional confocal FCS. We find a strong correlation between diffusional mobility and interaction: regions of strong interaction show slow mobility. Controls containing either an eGFP-mRFP dimer, separately expressing eGFP and mRPF, or c-Fos-eGFP and c-Jun-mRFP1 mutants lacking dimerization and DNA-binding domains, showed no such correlation. These results extend our earlier findings from confocal FCCS to include spatial information.	[Pernus, Agata; Langowski, Joerg] DKFZ, Div Biophys Macromol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Langowski, J (corresponding author), DKFZ, Div Biophys Macromol, Heidelberg, Germany.	jl@dkfz.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666	NUS-BW (National University of Singapore/Baden Wurttemberg) grant	NUS-BW (National University of Singapore/Baden Wurttemberg) grant	This study was funded by a NUS-BW (National University of Singapore/Baden Wurttemberg) grant to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRETTO EA, 1990, J CELL BIOCHEM, V42, P193, DOI 10.1002/jcb.240420403; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bacia Kirsten, 2007, V398, P73, DOI 10.1007/978-1-59745-513-8_7; Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bestvater F, 2010, OPT EXPRESS, V18, P23818, DOI 10.1364/OE.18.023818; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Brazda P, 2014, MOL CELL BIOL, V34, P1234, DOI 10.1128/MCB.01097-13; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Burkhardt M, 2006, OPT EXPRESS, V14, P5013, DOI 10.1364/OE.14.005013; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; Glauner H, 2010, BRIT J PHARMACOL, V160, P958, DOI 10.1111/j.1476-5381.2010.00732.x; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Greger K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2428277; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Hwang LC, 2007, CELL BIOCHEM BIOPHYS, V49, P1, DOI 10.1007/s12013-007-0042-5; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Krieger JW, 2014, OPT EXPRESS, V22, P2358, DOI 10.1364/OE.22.002358; Krieger JW, 2014, QUICKFIT 3 0 BETA SV; Krieger JW, 2014, THESIS U HEIDELBERG; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Langowski J, 2008, METHOD CELL BIOL, V85, P471; Lee W, 2010, ANAL CHEM, V82, P1401, DOI 10.1021/ac9024768; Ma Xiaoxiao, 2011, Front Biosci (Elite Ed), V3, P22, DOI 10.2741/e216; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; McBride K, 1998, MOL CELL BIOL, V18, P5073, DOI 10.1128/MCB.18.9.5073; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Ries J, 2009, BIOPHYS J, V96, P1999, DOI 10.1016/j.bpj.2008.12.3888; Sadamoto Hisayo, 2013, Methods Mol Biol, V977, P229, DOI 10.1007/978-1-62703-284-1_18; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; Sankaran J, 2009, BIOPHYS J, V97, P2630, DOI 10.1016/j.bpj.2009.08.025; Singh AP, 2014, CURR OPIN CHEM BIOL, V20, P29, DOI 10.1016/j.cbpa.2014.04.006; Singh AP, 2013, OPT EXPRESS, V21, P8652, DOI 10.1364/OE.21.008652; TEWES M, 2001, Patent No. 0941470; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vamosi G, 2009, CURR PROTOC CYTOM, V2, P1; Vamosi G, 2008, BIOPHYS J, V94, P2859, DOI 10.1529/biophysj.107.120766; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wachsmuth M, 2001, THESIS U HEIDELBERG; Weidemann T, 2014, CURR OPIN STRUC BIOL, V28, P69, DOI 10.1016/j.sbi.2014.07.008; Wohland T, 2010, OPT EXPRESS, V18, P10627, DOI 10.1364/OE.18.010627; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123070	10.1371/journal.pone.0123070	http://dx.doi.org/10.1371/journal.pone.0123070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875593	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700026
J	Seto, KKY; Andrulis, IL				Seto, Kelly K. Y.; Andrulis, Irene L.			Atypical Protein Kinase C Zeta: Potential Player in Cell Survival and Cell Migration of Ovarian Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; PKC-ZETA; PANCREATIC-CANCER; EXPRESSION; INSULIN; RECEPTOR; ALPHA; PROLIFERATION; ISOFORMS; RHOA	Ovarian cancer is one of the most aggressive gynaecological cancers, thus understanding the different biological pathways involved in ovarian cancer progression is important in identifying potential therapeutic targets for the disease. The aim of this study was to investigate the potential roles of Protein Kinase C Zeta (PRKCZ) in ovarian cancer. The atypical protein kinase C isoform, PRKCZ, is involved in the control of various signalling processes including cell proliferation, cell survival, and cell motility, all of which are important for cancer development and progression. Herein, we observe a significant increase in cell survival upon PRKCZ over-expression in SKOV3 ovarian cancer cells; additionally, when the cells are treated with small interference RNA (siRNA) targeting PRKCZ, the motility of SKOV3 cells decreased. Furthermore, we demonstrate that over-expression of PRKCZ results in gene and/or protein expression alterations of insulin-like growth factor 1 receptor (IGF1R) and integrin beta 3 (ITGB3) in SKOV3 and OVCAR3 cells. Collectively, our study describes PRKCZ as a potential regulatory component of the IGF1R and ITGB3 pathways and suggests that it may play critical roles in ovarian tumourigenesis.	[Seto, Kelly K. Y.; Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Seto, Kelly K. Y.; Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Andrulis, IL (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	andrulis@lunenfeld.ca	Andrulis, Irene L./E-7267-2013		Canadian Institutes of Health Research; CIHR Collaborative Training Program in Molecular Medicine (KKYS); Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS); Toronto Ovarian Cancer Research Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Collaborative Training Program in Molecular Medicine (KKYS); Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS); Toronto Ovarian Cancer Research Network	This work was supported by the Canadian Institutes of Health Research (ILA;http://www.cihrirsc. gc.ca), the CIHR Collaborative Training Program in Molecular Medicine (KKYS), the Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS) and Toronto Ovarian Cancer Research Network (KKYS;http://www.uhnres.utoronto.ca/ programs/tocrn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, ONKOLOGIE, V32, P638, DOI 10.1159/000242253; Baldwin RM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-233; BECK EP, 1994, GYNECOL ONCOL, V53, P196, DOI 10.1006/gyno.1994.1115; Chang WW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3423; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Donson AM, 2000, J NEURO-ONCOL, V47, P109, DOI 10.1023/A:1006406208376; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gest C, 2012, CANCER LETT, V317, P207, DOI 10.1016/j.canlet.2011.11.026; Ghosh PM, 2002, CANCER RES, V62, P2630; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Inoue T, 2006, MOL ENDOCRINOL, V20, P3053, DOI 10.1210/me.2006-0033; Joung I, 2005, BIOCHEM BIOPH RES CO, V334, P654, DOI 10.1016/j.bbrc.2005.06.138; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Kim DS, 2008, BIOCHEM BIOPH RES CO, V377, P479, DOI 10.1016/j.bbrc.2008.10.010; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2001, ADV ENZYME REGUL, V41, P99, DOI 10.1016/S0065-2571(00)00009-1; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Partheen K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-336; Rodriguez EM, 2009, J CELL PHYSIOL, V221, P171, DOI 10.1002/jcp.21841; Sarkissyan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103534; Spentzos D, 2007, ENDOCR-RELAT CANCER, V14, P781, DOI 10.1677/ERC-06-0073; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tian XD, 2013, DIGEST DIS SCI, V58, P2705, DOI 10.1007/s10620-013-2673-2; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; Win HY, 2009, CELL PROLIFERAT, V42, P182, DOI 10.1111/j.1365-2184.2009.00582.x; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; YEE D, 1991, CANCER RES, V51, P5107; Yu LR, 2011, NEOPLASMA, V58, P491, DOI 10.4149/neo_2011_06_491; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	45	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123528	10.1371/journal.pone.0123528	http://dx.doi.org/10.1371/journal.pone.0123528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874946	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700033
J	Findling, O; Baltisberger, M; Jung, SM; Kamm, CP; Mattle, HP; Sellner, J				Findling, Oliver; Baltisberger, Magdalena; Jung, Simon; Kamm, Christian P.; Mattle, Heinrich P.; Sellner, Johann			Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study	PLOS ONE			English	Article							EMPLOYMENT STATUS; UNEMPLOYMENT; FATIGUE	Introduction Reduced working capability is one of the most devastating consequences of multiple sclerosis (MS). We aimed to study working capability and related variables in Swiss MS patients. Materials and Methods A cross-sectional analysis of employment status and risk factors for reduced working capability among MS patients treated at our outpatient clinic. A questionnaire was mailed to 644 MS patients and returned by 69.7%. 405 patients (66% female, mean age 44.2 years (SD +/- 10.2), median EDSS 3.0 (SD +/- 1.8))were eligible for subsequent analysis. Results After a mean disease duration of 12.3 years (SD +/- 8.25), full or part time employment was declared by 26.7% and 25.7%, respectively. Incapacity to work was reported by 27.1%. A total of 52.8% specified MS as the cause for altered working capability, whereas 20.5% cited reasons unrelated to the disorder. Even with minimal disability (EDSS< 3) a significant proportion of patients (24%) reported reduced working capability. Among the MS-specific restricting factors were fatigue (47.6%), sensorimotor deficits (31.1%), impaired vision (3.3%) and pain (2.8%). Conclusion MS continues to takes its toll on the professional life of the patients early in the course. While complete incapacity becomes relevant with moderate to severe disability, many patients scale down to part-time even with minimal impairment.	[Findling, Oliver; Baltisberger, Magdalena; Jung, Simon; Kamm, Christian P.; Mattle, Heinrich P.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Sellner, Johann] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria	University of Bern; University Hospital of Bern; Paracelsus Private Medical University	Findling, O (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland.	oliver.findling@gmail.com	Findling, Oliver/AAE-3815-2019; Selllner, Johann/AAB-1263-2019					Bishop M, 2009, J VOCAT REHABIL, V31, P119, DOI 10.3233/JVR-2009-0480; Busche KD, 2003, CAN J NEUROL SCI, V30, P137, DOI 10.1017/S0317167100053403; Cote I, 2013, MULT SCLER J, V19, P480, DOI 10.1177/1352458512455958; DOOLEY D, 1994, AM J COMMUN PSYCHOL, V22, P745, DOI 10.1007/BF02521557; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; Glad SB, 2011, J NEUROL NEUROSUR PS, V82, P78, DOI 10.1136/jnnp.2010.210732; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Kern S, 2013, FORTSCHR NEUROL PSYC, V81, P95, DOI 10.1055/s-0032-1330286; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS86; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lange R, 2009, J NEUROL, V256, P645, DOI 10.1007/s00415-009-0152-7; LAROCCA N, 1985, J CHRON DIS, V38, P203, DOI 10.1016/0021-9681(85)90093-1; Multiple Sclerosis International Federation, 2010, MSIF SURV EMPL MS; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Polman CH, 2010, NEUROLOGY, V74, pS8, DOI 10.1212/WNL.0b013e3181dbb571; Roessler Richard T, 2003, Work, V21, P17; Rumrill PD, 2009, J VOCAT REHABIL, V31, P83, DOI 10.3233/JVR-2009-0477; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Strober LB, 2012, MULT SCLER J, V18, P647, DOI 10.1177/1352458511426735; Swiss Federal Statistical Office, UN STAT BAS ILO DEF; Van der Hiele K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105673; Veauthier C, 2011, MULT SCLER J, V17, P613, DOI 10.1177/1352458510393772; Weinges-Evers N, 2010, MULT SCLER J, V16, P1134, DOI 10.1177/1352458510374202	26	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121856	10.1371/journal.pone.0121856	http://dx.doi.org/10.1371/journal.pone.0121856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867208	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100050
J	Sesen, J; Dahan, P; Scotland, SJ; Saland, E; Dang, VT; Lemarie, A; Tyler, BM; Brem, H; Toulas, C; Moyal, ECJ; Sarry, JE; Skuli, N				Sesen, Julie; Dahan, Perrine; Scotland, Sarah J.; Saland, Estelle; Van-Thi Dang; Lemarie, Anthony; Tyler, Betty M.; Brem, Henry; Toulas, Christine; Moyal, Elizabeth Cohen-Jonathan; Sarry, Jean-Emmanuel; Skuli, Nicolas			Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANTIGLIOMA ACTION; FEEDBACK-CONTROL; CYCLE ARREST; IN-VITRO; TEMOZOLOMIDE; APOPTOSIS; AMPK; METABOLISM; MTOR	High-grade gliomas, glioblastomas (GB), are refractory to conventional treatment combining surgery, chemotherapy, mainly temozolomide, and radiotherapy. This highlights an urgent need to develop novel therapies and increase the efficacy of radio/chemotherapy for these very aggressive and malignant brain tumors. Recently, tumor metabolism became an interesting potential therapeutic target in various cancers. Accordingly, combining drugs targeting cell metabolism with appropriate chemotherapeutic agents or radiotherapy has become attractive. In light of these perspectives, we were particularly interested in the anticancer properties of a biguanide molecule used for type 2 diabetes treatment, metformin. In our present work, we demonstrate that metformin decreases mitochondrial-dependent ATP production and oxygen consumption and increases lactate and glycolytic ATP production. We show that metformin induces decreased proliferation, cell cycle arrest, autophagy, apoptosis and cell death in vitro with a concomitant activation of AMPK, Redd1 and inhibition of the mTOR pathway. Cell sensitivity to metformin also depends on the genetic and mutational backgrounds of the different GB cells used in this study, particularly their PTEN status. Interestingly, knockdown of AMPK and Redd1 with siRNA partially, but incompletely, abrogates the induction of apoptosis by metformin suggesting both AMPK/Redd1-dependent and-independent effects. However, the primary determinant of the effect of metformin on cell growth is the genetic and mutational backgrounds of the glioma cells. We further demonstrate that metformin treatment in combination with temozolomide and/or irradiation induces a synergistic anti-tumoral response in glioma cell lines. Xenografts performed in nude mice demonstrate in vivo that metformin delays tumor growth. As current treatments for GB commonly fail to cure, the need for more effective therapeutic options is overwhelming. Based on these results, metformin could represent a potential enhancer of the cytotoxic effects of temozolomide and/or radiotherapy.	[Sesen, Julie; Dahan, Perrine; Scotland, Sarah J.; Saland, Estelle; Van-Thi Dang; Lemarie, Anthony; Toulas, Christine; Moyal, Elizabeth Cohen-Jonathan; Sarry, Jean-Emmanuel; Skuli, Nicolas] Ctr Rech Cancerol Toulouse, INSERM, U1037, Toulouse, France; [Scotland, Sarah J.; Tyler, Betty M.; Brem, Henry] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Johns Hopkins University	Skuli, N (corresponding author), Ctr Rech Cancerol Toulouse, INSERM, U1037, Toulouse, France.	nicolas.skuli@inserm.fr	Sarry, Jean-Emmanuel/P-1633-2014; Sarry, Jean-Emmanuel/AAC-3664-2020; Moyal, Elizabeth/A-9802-2015; SALAND, Estelle/W-7996-2019; LEMARIE, Anthony/G-4018-2017	Sarry, Jean-Emmanuel/0000-0002-6704-2032; Sarry, Jean-Emmanuel/0000-0002-6704-2032; Moyal, Elizabeth/0000-0002-6593-9276; LEMARIE, Anthony/0000-0002-6523-4962; Skuli, Sarah/0000-0001-7711-0732; Dang, Van Thi/0000-0003-2259-6266; Dahan, Perrine/0000-0003-4738-8893	Institut Nationale de la Sante et de la Recherche Medicale [U1037SPDOTSKULI]; Ligue Contre le Cancer [GB/MA/VSP-10443]	Institut Nationale de la Sante et de la Recherche Medicale; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by Institut Nationale de la Sante et de la Recherche Medicale to JS, PD, SJS, AL, CT, ECJM, JES, NS, Grant number: U1037SPDOTSKULI, URL: http://www.inserm.fr; and Ligue Contre le Cancer to JS, CT, ECJM, NS, Grant number: GB/MA/VSP-10443, URL: http://www.liguecancer.net. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, J BUON, V16, P409; Aldea MD, 2014, J BUON, V19, P502; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Carmignani M, 2014, J BIOL REG HOMEOS AG, V28, P1; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Gao LB, 2013, NEUROREPORT, V24, P504, DOI 10.1097/WNR.0b013e32836277fb; Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Icard P, 2012, BBA-REV CANCER, V1826, P423, DOI 10.1016/j.bbcan.2012.07.001; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Janjetovic K, 2010, EUR J PHARMACOL, V651, P41, DOI [10.1016/j.ejphar.2010.11.012, DOI 10.1016/J.EJPHAR.2010.11.012]; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kast RE, 2011, BRIT J PHARMACOL, V164, P1393, DOI 10.1111/j.1476-5381.2011.01320.x; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lemarie A, 2009, MITOCHONDRION, V9, P254, DOI 10.1016/j.mito.2009.03.004; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Najbauer J, 2014, PATHOL ONCOL RES; Pajonk F, 2013, SEMIN RADIAT ONCOL, V23, P237, DOI 10.1016/j.semradonc.2013.05.007; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sato A, 2012, STEM CELL TRANSL MED, V1, P811, DOI 10.5966/sctm.2012-0058; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Schiff D, 2009, NAT REV CLIN ONCOL, V6, P596, DOI 10.1038/nrclinonc.2009.128; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sesen J, 2014, INT J MOL SCI, V15, P2172, DOI 10.3390/ijms15022172; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Ucbek A, 2014, EXP THER MED, V7, P1285, DOI 10.3892/etm.2014.1597; Vadysirisack DD, 2011, MOL CELL BIOL, V31, P4356, DOI 10.1128/MCB.05541-11; Valle G, 2011, J BUON, V16, P787; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vucicevic L, 2009, BIOCHEM PHARMACOL, V77, P1684, DOI 10.1016/j.bcp.2009.03.005; Wick W, 2014, CANCER DISCOV, V4, P1120, DOI 10.1158/2159-8290.CD-14-0918; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wurth R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/126586; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264	61	119	125	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123721	10.1371/journal.pone.0123721	http://dx.doi.org/10.1371/journal.pone.0123721			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867026	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100202
J	Svensson, A; Ozen, I; Genove, G; Paul, G; Bengzon, J				Svensson, Andreas; Ozen, Ilknur; Genove, Guillem; Paul, Gesine; Bengzon, Johan			Endogenous Brain Pericytes Are Widely Activated and Contribute to Mouse Glioma Microvasculature	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSELS; DETAILED CHARACTERIZATION; MURAL CELLS; STEM-CELLS; GLIOBLASTOMA; TUMORS; MODEL; ANGIOGENESIS; SURVIVAL	Glioblastoma multiforme (GBM) is the most common brain tumor in adults. It presents an extremely challenging clinical problem, and treatment very frequently fails due to the infiltrative growth, facilitated by extensive angiogenesis and neovascularization. Pericytes constitute an important part of the GBM microvasculature. The contribution of endogenous brain pericytes to the tumor vasculature in GBM is, however, unclear. In this study, we determine the site of activation and the extent of contribution of endogenous brain pericytes to the GBM vasculature. GL261 mouse glioma was orthotopically implanted in mice expressing green fluorescent protein (GFP) under the pericyte marker regulator of G protein signaling 5 (RGS5). Host pericytes were not only activated within the glioma, but also in cortical areas overlying the tumor, the ipsilateral subventricular zone and within the hemisphere contralateral to the tumor. The host-derived activated pericytes that infiltrated the glioma were mainly localized to the tumor vessel wall. Infiltrating GFP positive pericytes co-expressed the pericyte markers platelet-derived growth factor receptor-beta (PDGFR-beta) and neuron-glial antigen 2. Interestingly, more than half of all PDGFR-beta positive pericytes within the tumor were contributed by the host brain. We did not find any evidence that RGS5 positive pericytes adopt another phenotype within glioma in this paradigm. We conclude that endogenous pericytes become activated in widespread areas of the brain in response to an orthotopic mouse glioma. Host pericytes are recruited into the tumor and constitute a major part of the tumor pericyte population.	[Svensson, Andreas; Bengzon, Johan] Skane Univ Hosp, Lund Stem Cell Ctr, BMC B10, Lund, Sweden; [Svensson, Andreas; Bengzon, Johan] Skane Univ Hosp, Dept Clin Sci, Div Neurosurg, Lund, Sweden; [Ozen, Ilknur] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurol,Translat Neurol Grp, Lund, Sweden; [Genove, Guillem] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Karolinska Institutet	Svensson, A (corresponding author), Skane Univ Hosp, Lund Stem Cell Ctr, BMC B10, Lund, Sweden.	andreas.svensson@med.lu.se		Genove, Guillem/0000-0002-8558-3107	Faculty of Medicine at Lund University [13404]; Swedish Cancer Society [2012/451, 2013-0782]; Gunnar Nilsson Cancer Foundation [35541]; Swedish Research Council [K2012-61X-22095-01-4]; Region Skane [13461]	Faculty of Medicine at Lund University; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane	This work was supported by a donation from Viveca Jeppsson (JB), grants from Region Skane (grant number 13461, JB), ALF grants from the Faculty of Medicine at Lund University (grant number 13404, JB), grants from the Swedish Cancer Society (grant number 2012/451, JB and grant number 2013-0782, GG; http://www.cancerfonden.se), the Gunnar Nilsson Cancer Foundation (grant number 35541, JB; http://www.cancerstiftelsen.com) and the Swedish Research Council (grant number K2012-61X-22095-01-4, GP; http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Airley R, 2001, CLIN CANCER RES, V7, P928; AUSMAN JI, 1970, CANCER RES, V30, P2394; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bexell D, 2007, NEUROSCIENCE, V147, P824, DOI 10.1016/j.neuroscience.2007.04.058; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Crisan M, 2008, METHOD CELL BIOL, V86, P295, DOI 10.1016/S0091-679X(08)00013-7; Diaz-Flores L, 2009, FRONT BIOSCI-LANDMRK, V14, P1433, DOI 10.2741/3317; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Newcomb EW, 2009, CNS CANC MODELS MARK, V12, P227, DOI DOI 10.1007/978-1-60327-553-8; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Ochs K, 2013, J NEUROIMMUNOL, V265, P106, DOI 10.1016/j.jneuroim.2013.09.011; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Ozen I, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-30; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Scully S, 2012, J NEUROSCI, V32, P12950, DOI 10.1523/JNEUROSCI.2017-12.2012; Sharma V, 2012, J CEREBR BLOOD F MET, V32, P2055, DOI 10.1038/jcbfm.2012.107; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yi L, 2013, INT J ONCOL, V43, P477, DOI 10.3892/ijo.2013.1962	38	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123553	10.1371/journal.pone.0123553	http://dx.doi.org/10.1371/journal.pone.0123553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875288	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100186
J	Tang, YY; Li, Y; Zhuo, KM; Wang, Y; Liao, LW; Song, ZH; Li, H; Fan, XD; Goff, DC; Wang, JJ; Xu, YF; Liu, DT				Tang, Yingying; Li, Yan; Zhuo, Kaiming; Wang, Yan; Liao, Liwei; Song, Zhenhua; Li, Hui; Fan, Xiaoduo; Goff, Donald C.; Wang, Jijun; Xu, Yifeng; Liu, Dengtang			Neural Correlates of the Preserved Inhibition of Return in Schizophrenia	PLOS ONE			English	Article							NEGATIVE SYNDROME SCALE; ATTENTIONAL ASYMMETRY; VISUOSPATIAL ATTENTION; DEFICIENT INHIBITION; BLUNTED INHIBITION; NEUROCOGNITION; INFORMATION	Inhibition of return (IOR) is an attentional mechanism that previously has been reported to be either intact or blunted in subjects with schizophrenia (SCZ). In the present study, we explored the neural mechanism of IOR in SCZ by comparing the target-locked N1 and P1 activity evoked by valid-cued trials with that evoked by invalid-cued trials. Twenty-seven schizophrenia patients and nineteen healthy controls participated in a task involving covert orienting of attention with two stimulus onset asynchronies (SOAs: 700 ms and 1200 ms) during which 64-channel EEG data were recorded. Behavioral reaction times (RTs) were longer in response to valid-cued trials than to invalid-cued ones, suggesting an intact IOR in SCZ. However, reduced N1 amplitude elicited by valid-cued trials suggested a stronger inhibition of attention from being oriented to a previously cued location, and therefore a relative inhibition of perceptual processing at that location in SCZ. These results indicate that altered N1 activity is associated with the preservation of IOR in SCZ and could be a sensitive marker to track the IOR effect.	[Tang, Yingying; Li, Yan; Zhuo, Kaiming; Liao, Liwei; Song, Zhenhua; Li, Hui; Wang, Jijun; Xu, Yifeng; Liu, Dengtang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr,Div Psychot Disorders, Episode Schizophrenia & Early Psychosis Program 1, Shanghai 200030, Peoples R China; [Tang, Yingying; Zhuo, Kaiming; Wang, Jijun; Xu, Yifeng; Liu, Dengtang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Wang, Yan] E China Normal Univ, Dept Psychol, Shanghai 200062, Peoples R China; [Goff, Donald C.] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Psychot Disorders Program, Worcester, MA USA; [Fan, Xiaoduo] NYU, Med Ctr, Nathan Kline Inst Psychiat Res, New York, NY 10016 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester; Nathan Kline Institute for Psychiatric Research; New York University	Xu, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr,Div Psychot Disorders, Episode Schizophrenia & Early Psychosis Program 1, Shanghai 200030, Peoples R China.	hyyyyb@gmail.com; erliu110@126.com	Fan, Xiaoduo/AAV-1268-2020; Xu, Yifeng/AAA-2064-2021	Fan, Xiaoduo/0000-0003-4299-8924; Xu, Yifeng/0000-0002-0403-1141	National Natural Science Foundation of China [81371479, 81171267, 61102020]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500, 14K03]; Shanghai Municipal Natural Science Foundation [07ZR14093, 11ZR1431600, 134119b0300]; Shanghai Municipal Health Bureau Foundation [024036]; Shanghai Clinical Center for Mental Disorders; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health) [2011-873]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]; Early Psychosis Program of Shanghai Mental Health Center [2013-YJTSZK-05]; Shanghai Mental Health Center [2014-FX-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Psychotic Disorders; Shanghai Municipal Natural Science Foundation; Shanghai Municipal Health Bureau Foundation; Shanghai Clinical Center for Mental Disorders; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health); National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH); Early Psychosis Program of Shanghai Mental Health Center; Shanghai Mental Health Center	This work was supported by National Natural Science Foundation of China (81371479, 81171267, 61102020), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500, 14K03), Shanghai Municipal Natural Science Foundation (07ZR14093, 11ZR1431600, 134119b0300), Shanghai Municipal Health Bureau Foundation (024036), Shanghai Clinical Center for Mental Disorders (2014), National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health, 2011-873; OMA-MH, 2011-873) and Early Psychosis Program of Shanghai Mental Health Center (2013-YJTSZK-05). Yingying Tang is supported by Shanghai Mental Health Center (2014-FX-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; CARTER CS, 1994, PROG NEURO-PSYCHOPH, V18, P661, DOI 10.1016/0278-5846(94)90075-2; CARTER CS, 1992, BIOL PSYCHIAT, V31, P909, DOI 10.1016/0006-3223(92)90117-I; Carter JD, 2010, SCHIZOPHR RES, V122, P104, DOI 10.1016/j.schres.2010.03.019; Fuentes LJ, 1999, SCHIZOPHR RES, V40, P75, DOI 10.1016/S0920-9964(99)00044-4; Fuentes LJ, 1999, NEUROPSYCHOLOGY, V13, P259, DOI 10.1037/0894-4105.13.2.259; Giuliano AJ, 2012, CURR PHARM DESIGN, V18, P399; Gouzoulis-Mayfrank E, 2006, PROG NEURO-PSYCHOPH, V30, P42, DOI 10.1016/j.pnpbp.2005.06.016; Gouzoulis-Mayfrank E, 2004, PROG NEURO-PSYCHOPH, V28, P389, DOI 10.1016/j.pnpbp.2003.11.010; Gouzoulis-Mayfrank E, 2007, SCHIZOPHR RES, V97, P35, DOI 10.1016/j.schres.2007.06.028; GUY W, 1976, MANUAL EDCEU ASSESSM; Hahn B, 2012, J ABNORM PSYCHOL, V121, P119, DOI 10.1037/a0023938; Hu FK, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00007; HUEY ED, 1994, SCHIZOPHR RES, V14, P57, DOI 10.1016/0920-9964(94)90009-4; KAY S R, 1989, British Journal of Psychiatry, V155, P59; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kebir O, 2010, PSYCHIAT RES, V176, P17, DOI 10.1016/j.psychres.2008.10.010; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lalanne L, 2012, BIOL PSYCHIAT, V71, P162, DOI 10.1016/j.biopsych.2011.09.018; Larrison-Faucher A, 2002, PROG NEURO-PSYCHOPH, V26, P505, DOI 10.1016/S0278-5846(01)00298-6; Liu DT, 2010, PROG NEURO-PSYCHOPH, V34, P961, DOI 10.1016/j.pnpbp.2010.05.002; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Lupianez J, 1999, J GEN PSYCHOL, V126, P392, DOI 10.1080/00221309909595373; Lupianez J, 2006, COGN NEUROPSYCHOL, V23, P1003, DOI 10.1080/02643290600588095; MARUFF P, 1995, NEUROPSYCHOLOGIA, V33, P1205, DOI 10.1016/0028-3932(95)00037-4; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; MILLER GA, 1988, PSYCHOPHYSIOLOGY, V25, P241, DOI 10.1111/j.1469-8986.1988.tb00999.x; Moritz Steffen, 2007, Cogn Neuropsychiatry, V12, P381, DOI 10.1080/13546800601119982; Mushquash AR, 2012, SCHIZOPHR RES, V135, P55, DOI 10.1016/j.schres.2011.11.034; Nestor PG, 2010, J CLIN EXP NEUROPSYC, V32, P281, DOI 10.1080/13803390902984472; Nuechterlein KH, 2006, DEV PSYCHOPATHOL, V18, P831; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; Prime DJ, 2004, PSYCHOL SCI, V15, P272, DOI 10.1111/j.0956-7976.2004.00665.x; Sapir A, 2001, NEUROPSYCHOLOGY, V15, P361, DOI 10.1037//0894-4105.15.3.361; Sapir A, 2007, NEUROPSYCHOLOGIA, V45, P3263, DOI 10.1016/j.neuropsychologia.2007.06.007; Satel J, 2013, ATTEN PERCEPT PSYCHO, V75, P29, DOI 10.3758/s13414-012-0381-1; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sostaric M, 2011, PSYCHIAT DANUB, V23, P251; Tassinari G, 2002, EXP BRAIN RES, V146, P523, DOI 10.1007/s00221-002-1192-8; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Tian Y, 2008, BIOL PSYCHOL, V79, P171, DOI 10.1016/j.biopsycho.2008.04.006; Vlcek P, 2014, NEUROPSYCH DIS TREAT, V10, P1309, DOI 10.2147/NDT.S64219; Zhou XL, 2008, NEUROPSYCHOLOGIA, V46, P2766, DOI 10.1016/j.neuropsychologia.2008.05.017	48	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							0119521	10.1371/journal.pone.0119521	http://dx.doi.org/10.1371/journal.pone.0119521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875486	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100015
J	Zhang, XW; Wang, JR; Ji, MF; Milne, RI; Wang, MH; Liu, JQ; Shi, S; Yang, SL; Zhao, CM				Zhang, Xiao Wei; Wang, Jing Ru; Ji, Ming Fei; Milne, Richard Ian; Wang, Ming Hao; Liu, Jian-Quan; Shi, Sheng; Yang, Shu-Li; Zhao, Chang-Ming			Higher Thermal Acclimation Potential of Respiration but Not Photosynthesis in Two Alpine Picea Taxa in Contrast to Two Lowland Congeners	PLOS ONE			English	Article							PLANT RESPIRATION; TEMPERATURE-DEPENDENCE; NET PHOTOSYNTHESIS; LEAF RESPIRATION; RESPONSES; GROWTH; NORTHERN; SEEDLINGS; TREES; ADAPTATION	The members of the genus Picea form a dominant component in many alpine and boreal forests which are the major sink for atmospheric CO2. However, little is known about the growth response and acclimation of CO2 exchange characteristics to high temperature stress in Picea taxa from different altitudes. Gas exchange parameters and growth characteristics were recorded from four year old seedlings of two alpine (Picea likiangensis vars. rubescens and linzhiensis) and two lowland (P. koraiensis and P. meyeri) taxa. Seedlings were grown at moderate (25 degrees C/15 degrees C) and high (35 degrees C/25 degrees C) day/night temperatures, for four months. The approximated biomass increment (Delta(DH)-H-2) for all taxa decreased under high temperature stress, associated with decreased photosynthesis and increased respiration. However, the two alpine taxa exhibited lower photosynthetic acclimation and higher respiratory acclimation than either lowland taxon. Moreover, higher leaf dry mass per unit area (LMA) and leaf nitrogen content per unit area (N-area), and a smaller change in the nitrogen use efficiency of photosynthesis (PNUE) for lowland taxa indicated that these maintained higher homeostasis of photosynthesis than alpine taxa. The higher respiration rates produced more energy for repair and maintenance biomass, especially for higher photosynthetic activity for lowland taxa, which causes lower respiratory acclimation. Thus, the changes of Delta(DH)-H-2 for alpine spruces were larger than that for lowland spruces. These results indicate that long term heat stress negatively impact on the growth of Picea seedlings, and alpine taxa are more affected than low altitude ones by high temperature stress. Hence the altitude ranges of Picea taxa should be taken into account when predicting changes to carbon fluxes in warmer conditions.	[Zhang, Xiao Wei; Wang, Jing Ru; Ji, Ming Fei; Wang, Ming Hao; Liu, Jian-Quan; Shi, Sheng; Yang, Shu-Li; Zhao, Chang-Ming] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Sch Life Sci, Lanzhou 730000, Peoples R China; [Milne, Richard Ian] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland	Lanzhou University; University of Edinburgh	Zhao, CM (corresponding author), Lanzhou Univ, State Key Lab Grassland Agroecosyst, Sch Life Sci, Lanzhou 730000, Peoples R China.	zhaochm@lzu.edu.cn			National Science Foundation of China [30930072, 31170571, 31370603]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Science Foundation of China (30930072, 31170571 and 31370603).	[Anonymous], 2007, CONTRIBUTION WORKING; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Atkin OK, 2005, ADV PHOTO RESPIRAT, V18, P95; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BILLINGS W D, 1971, Arctic and Alpine Research, V3, P277; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cunningham S, 2003, J BIOGEOGR, V30, P143, DOI 10.1046/j.1365-2699.2003.00811.x; Cunningham SC, 2002, OECOLOGIA, V133, P112, DOI 10.1007/s00442-002-1034-1; Danby RK, 2007, GLOBAL CHANGE BIOL, V13, P437, DOI 10.1111/j.1365-2486.2006.01302.x; Day ME, 2000, TREE PHYSIOL, V20, P57; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Du FK, 2011, NEW PHYTOL, V192, P1024, DOI 10.1111/j.1469-8137.2011.03853.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Farjon A, 2001, WORLD CHECKLIST BIBL; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fu L, 1999, FLORA CHINA, P25; Ghannoum O, 2011, TREE PHYSIOL, V31, P1273, DOI 10.1093/treephys/tpr115; Gratani L, 2012, PHOTOSYNTHETICA, V50, P15, DOI 10.1007/s11099-012-0006-x; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; Hikosaka K, 2009, OECOLOGIA, V160, P443, DOI 10.1007/s00442-009-1315-z; HILL RS, 1988, J BIOGEOGR, V15, P431, DOI 10.2307/2845274; LARIGAUDERIE A, 1995, ANN BOT-LONDON, V76, P245, DOI 10.1006/anbo.1995.1093; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Miehe G, 2007, MT RES DEV, V27, P169, DOI 10.1659/mrd.0792; MOONEY HA, 1978, PLANT PHYSIOL, V61, P406, DOI 10.1104/pp.61.3.406; Nedlo JE, 2009, TREES-STRUCT FUNCT, V23, P751, DOI 10.1007/s00468-009-0317-0; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Ow LF, 2010, GLOBAL CHANGE BIOL, V16, P288, DOI 10.1111/j.1365-2486.2009.01892.x; Pontailler JY, 1997, ANN SCI FOREST, V54, P335, DOI 10.1051/forest:19970402; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Ryan MG, 2010, TREE PHYSIOL, V30, P667, DOI 10.1093/treephys/tpq033; Smith NG, 2013, GLOBAL CHANGE BIOL, V19, P45, DOI 10.1111/j.1365-2486.2012.02797.x; Tjoelker MG, 2009, NEW PHYTOL, V181, P218, DOI 10.1111/j.1469-8137.2008.02624.x; Tjoelker MG, 1999, GLOB CHANGE BIOL, V5, P679, DOI 10.1046/j.1365-2486.1999.00257.x; Turnbull MH, 2001, TREE PHYSIOL, V21, P571, DOI 10.1093/treephys/21.9.571; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Wertin TM, 2011, TREE PHYSIOL, V31, P1277, DOI 10.1093/treephys/tpr091; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yamori W, 2009, PLANT CELL PHYSIOL, V50, P203, DOI 10.1093/pcp/pcn189; Zhou XH, 2007, J INTEGR PLANT BIOL, V49, P270, DOI 10.1111/j.1744-7909.2007.00374.x; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	53	19	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123248	10.1371/journal.pone.0123248	http://dx.doi.org/10.1371/journal.pone.0123248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874631	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100155
J	Zhao, DY; Qiu, G; Luo, ZC; Zhang, YJ				Zhao, Dongying; Qiu, Gang; Luo, Zhongcheng; Zhang, Yongjun			Platelet Parameters and (1,3)-beta-D-Glucan as a Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BIRTH-WEIGHT INFANTS; MYCOSES STUDY-GROUP; ASPERGILLUS-FUMIGATUS; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; CANDIDIASIS; INFECTIONS; BACTEREMIA; ACTIVATION	The diagnosis of neonatal invasive fungal disease (IFD) is difficult and often delayed. The platelet parameters and (1, 3)-beta-D-Glucan (BG) may be useful for diagnosing IFD, but their diagnostic performance are not well characterized in neonates. We studied 63 preterm infants with IFD, 160 preterm infants without sepsis (preterm control), and 41 preterm infants with bacterial sepsis. Platelet parameters at the first day of onset of IFD and at the fourteenth day after antifungal treatment were evaluated. Serum BG was measured. Platelet count (PC), plateletcrit (PCT), and platelet distribution width (PDW) values were significantly lower, and mean platelet volume (MPV) values significantly higher in the IFD versus preterm control infants. PC and PCT values were much lower in infants with IFD versus bacterial sepsis, and there were significant differences in BG value between the two groups. After 14 days of antifungal treatment, significant elevations in PC, PCT, PDW and reductions in MPV levels in IFD group were observed. Receiver operating characteristic (ROC) curves showed that PC and PCT were strong predictors of IFD. The PC and PCT cut-offs for predicting IFD were 119.5 (sensitivity 78%, specificity 95%) and 0.21 (sensitivity 83%, specificity 85%), respectively. There were significant differences in PC and PCT levels between deceased and survived patients. The PC and PCT cut-offs for predicting deceased IFD were 39 (sensitivity 62%, specificity 86%) and 0.04 (sensitivity 50%, specificity 95%), respectively. The sensitivity in diagnosing IFD by a BG cutoff of >= 10 pg/ml was 68.3% and specificity was 75.6%. PC and PCT levels in the BG >= 400 pg/ml group were significantly lower compared to the BG<400 pg/ml group. Platelet parameters and BG could be useful biomarkers for the diagnosis and prognosis of neonatal IFD.	[Zhao, Dongying; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China; [Luo, Zhongcheng; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, MOE, Shanghai 200030, Peoples R China; [Luo, Zhongcheng; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Qiu, Gang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn	Zhao, Doreen/HHN-5678-2022; Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	This work was supported by the Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert O, 2011, EUR J CLIN MICROBIOL, V30, P1453, DOI 10.1007/s10096-011-1244-8; Becchi C, 2006, MINERVA ANESTESIOL, V72, P749; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Benjamin DK, 2003, PEDIATRICS, V112, P543, DOI 10.1542/peds.112.3.543; Brus F, 1997, PEDIATRICS, V99, P672, DOI 10.1542/peds.99.5.672; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; De Vlieger G, 2011, J CLIN MICROBIOL, V49, P3783, DOI 10.1128/JCM.00879-11; Ellepola ANB, 2005, J MICROBIOL, V43, P65; Fernandes G, 2012, JPEN-PARENTER ENTER, V36, P407, DOI 10.1177/0148607111434599; Gao YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103761; Goudjil S, 2013, J MATERN-FETAL NEO M, V26, P44, DOI 10.3109/14767058.2012.722716; Greenberg RG, 2012, J PEDIATR-US, V161, P264, DOI 10.1016/j.jpeds.2012.01.053; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Gunnink SF, 2014, EXPERT REV HEMATOL, V7, P387, DOI 10.1586/17474086.2014.902301; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Jaijakul S, 2012, CLIN INFECT DIS, V55, P521, DOI 10.1093/cid/cis456; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Koyama K, 2013, J CRIT CARE, V28, P556, DOI 10.1016/j.jcrc.2012.10.069; Lee JH, 2006, PEDIATR INFECT DIS J, V32, P222; Manzoni P, 2011, EARLY HUM DEV, V87, pS59, DOI 10.1016/j.earlhumdev.2011.01.013; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Metan G, 2012, REV IBEROAM MICOL, V29, P169, DOI 10.1016/j.riam.2011.07.003; Mohr JF, 2011, J CLIN MICROBIOL, V49, P58, DOI 10.1128/JCM.01240-10; Oeser C, 2013, J ANTIMICROB CHEMOTH, V68, P2733, DOI 10.1093/jac/dkt297; Osselaer JC, 1997, CLIN CHEM, V43, P1072; PATRICK CH, 1990, AM J CLIN PATHOL, V93, P391, DOI 10.1093/ajcp/93.3.391; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Prina E, 2013, CHEST, V143, P767, DOI 10.1378/chest.12-1235; Racil Z, 2013, MYCOSES, V56, P101, DOI 10.1111/j.1439-0507.2012.02210.x; Rodland EK, 2010, INFECT IMMUN, V78, P1269, DOI 10.1128/IAI.01091-09; Rodriguez D, 2006, PEDIATR INFECT DIS J, V25, P224, DOI 10.1097/01.inf.0000202127.43695.06; Segal BH, 2008, CLIN INFECT DIS, V47, P674, DOI 10.1086/590566; Speth C, 2013, FUTURE MICROBIOL, V8, P1431, DOI 10.2217/fmb.13.104; Speth C, 2013, J INFECT DIS, V207, P823, DOI 10.1093/infdis/jis743	35	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123907	10.1371/journal.pone.0123907	http://dx.doi.org/10.1371/journal.pone.0123907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874376	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100223
J	Chu, ML; Chang, YL; Guo, YJ; Wang, NT; Cui, J; Gao, WQ				Chu, Mingliang; Chang, Yunli; Guo, Yanjing; Wang, Naitao; Cui, Jian; Gao, Wei-Qiang			Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; MICRORNA GENES; EXPRESSION; MARKERS; METASTASIS; SITES	Prostate cancer (PCa) is the most frequently diagnosed cancer for men in the developed world. Androgen receptor signaling pathway plays an important role in prostate cancer progression. Recent studies show that microRNA miR-124 exerts a tumor suppressive function in prostate cancer. However, the relationship between AR and miR-124 is unclear. In the present study, we found a negative feedback loop between AR and miR-124 expression. On one hand, miR-124 was a positively regulated target gene of the AR, on the other hand, overexpression of miR-124 inhibited the expression of AR. In addition, we found that miR124- 2 and miR-124-3 promoters were hypermethylated in AR-negative PCa cells. Furthermore, overexpression of miR-124 inhibited proliferation rates and invasiveness capacity of PCa cells in vitro, and suppressed xenograft tumor growth in vivo. Taken together, our results support a negative feedback loop between AR and miR-124 expression. Methylation of miR-124-2 and miR-124-3 may serve as a biomarker for AR-negative PCa cells, and overexpression of miR-124 might be of potential therapeutic value for the treatment of PCa.	[Chu, Mingliang; Chang, Yunli; Guo, Yanjing; Wang, Naitao; Cui, Jian; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med,State Key Lab Oncogenes & Related Genes, Ren Ji Med X Clin Stem Cell Res Ctr,Med X Res Ins, Shanghai 200127, Peoples R China; [Chu, Mingliang] Guiyang Med Univ, Affiliated Peoples Hosp, Guizhou Prov Peoples Hosp, Dept Pathol, Guiyang 550002, Peoples R China; [Wang, Naitao; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Wang, Naitao; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Guizhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med,State Key Lab Oncogenes & Related Genes, Ren Ji Med X Clin Stem Cell Res Ctr,Med X Res Ins, Shanghai 200127, Peoples R China.	gao.weiqiang@sjtu.edu.cn	Gao, Wei/GXH-0380-2022	Chu, Mingliang/0000-0003-0559-8921	Chinese Ministry of Science and Technology [2012CB966800, 2013CB945600, 2012CB967900]; National Natural Science Foundation of China [81130038, 81372189]; Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Education Committee Key Discipline and Specialty Foundation [J50208]; Key Discipline and Specialty Foundation of Shanghai Health Bureau; KC Wong foundation; Shanghai Postdoctoral Scientific Program of China [12R21415100]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Education Committee Key Discipline and Specialty Foundation; Key Discipline and Specialty Foundation of Shanghai Health Bureau; KC Wong foundation; Shanghai Postdoctoral Scientific Program of China	The study is supported by funds to W.-Q. Gao from the Chinese Ministry of Science and Technology (2012CB966800; 2013CB945600 and 2012CB967900), the National Natural Science Foundation of China (81130038 and 81372189), Science and Technology Commission of Shanghai Municipality (Pujiang program), Shanghai Education Committee Key Discipline and Specialty Foundation (J50208), Key Discipline and Specialty Foundation of Shanghai Health Bureau and KC Wong foundation, and to M. Chu from Shanghai Postdoctoral Scientific Program of China (12R21415100).	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Baldi E, 2003, ENDOCRINOLOGY, V144, P1653, DOI 10.1210/en.2003-0234; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chu ML, 2014, ONCOL REP, V31, P34, DOI 10.3892/or.2013.2810; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Dai JL, 1996, STEROIDS, V61, P531; Dean L, 1999, PTEN TUMOR SUPPRESSO; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Mao HL, 2009, ASIAN J ANDROL, V11, P68, DOI 10.1038/aja.2008.14; Marsit C, 2013, ADV EXP MED BIOL, V754, P233, DOI 10.1007/978-1-4419-9967-2_12; Raynal NJM, 2012, CANCER RES, V72, P1170, DOI 10.1158/0008-5472.CAN-11-3248; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Yamashita R, 2005, GENE, V350, P129, DOI 10.1016/j.gene.2005.01.012; Zhao GS, 2005, FORENSIC SCI INT, V154, P122, DOI 10.1016/j.forsciint.2004.09.123	29	65	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0116197	10.1371/journal.pone.0116197	http://dx.doi.org/10.1371/journal.pone.0116197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860954	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300001
J	Raza, SEA; Prince, G; Clarkson, JP; Rajpoot, NM				Raza, Shan-e-Ahmed; Prince, Gillian; Clarkson, John P.; Rajpoot, Nasir M.			Automatic Detection of Diseased Tomato Plants Using Thermal and Stereo Visible Light Images	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; DOWNY MILDEW	Accurate and timely detection of plant diseases can help mitigate the worldwide losses experienced by the horticulture and agriculture industries each year. Thermal imaging provides a fast and non-destructive way of scanning plants for diseased regions and has been used by various researchers to study the effect of disease on the thermal profile of a plant. However, thermal image of a plant affected by disease has been known to be affected by environmental conditions which include leaf angles and depth of the canopy areas accessible to the thermal imaging camera. In this paper, we combine thermal and visible light image data with depth information and develop a machine learning system to remotely detect plants infected with the tomato powdery mildew fungus Oidium neolycopersici. We extract a novel feature set from the image data using local and global statistics and show that by combining these with the depth information, we can considerably improve the accuracy of detection of the diseased plants. In addition, we show that our novel feature set is capable of identifying plants which were not originally inoculated with the fungus at the start of the experiment but which subsequently developed disease through natural transmission.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Prince, Gillian; Clarkson, John P.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Warwick; Qatar University	Raza, SEA (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	S.E.A.Raza@warwick.ac.uk; Nasir.Rajpoot@ieee.org		Raza, Shan E Ahmed/0000-0002-1097-1738; Rajpoot, Nasir/0000-0002-4706-1308; Clarkson, John/0000-0001-5931-933X	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick [CP60a]	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick	The authors would like to thank Horticultural Development Company (HDC) and the Department of Computer Science, University of Warwick to fund the project (CP60a). The authors would also like to thank the Engineering and Physical Sciences Research Council (EPSRC) for providing the thermal imaging camera Cedip Titanium via their loan pool scheme. The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.	Andersen HJ, 2005, COMPUT ELECTRON AGR, V49, P219, DOI 10.1016/j.compag.2005.02.015; Belin E, 2013, COMPUT ELECTRON AGR, V90, P159, DOI 10.1016/j.compag.2012.09.014; Birchfield S, 1999, INT J COMPUT VISION, V35, P269, DOI 10.1023/A:1008160311296; Biskup B, 2007, PLANT CELL ENVIRON, V30, P1299, DOI 10.1111/j.1365-3040.2007.01702.x; Chaerle L, 1999, NAT BIOTECHNOL, V17, P813, DOI 10.1038/11765; Chaerle L, 2007, J EXP BOT, V58, P773, DOI 10.1093/jxb/erl257; Han J, 2007, PATTERN RECOGN, V40, P1771, DOI 10.1016/j.patcog.2006.11.010; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; IVANOV N, 1995, AGR FOREST METEOROL, V75, P85, DOI 10.1016/0168-1923(94)02204-W; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Kolmogorov V, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P508, DOI 10.1109/ICCV.2001.937668; Konolige K., 1998, SMALL VISION SYSTEMS; Lenthe JH, 2007, PRECIS AGRIC, V8, P15, DOI 10.1007/s11119-006-9025-6; Lindenthal M, 2005, PHYTOPATHOLOGY, V95, P233, DOI 10.1094/PHYTO-95-0233; Mahlein AK, 2012, EUR J PLANT PATHOL, V133, P197, DOI 10.1007/s10658-011-9878-z; Naidu RA, 2009, COMPUT ELECTRON AGR, V66, P38, DOI 10.1016/j.compag.2008.11.007; Oerke EC, 2006, J EXP BOT, V57, P2121, DOI 10.1093/jxb/erj170; Oerke EC, 2011, PRECIS AGRIC, V12, P699, DOI 10.1007/s11119-010-9212-3; Oerke EC, 2010, PRECISION CROP PROTECTION - THE CHALLENGE AND USE OF HETEROGENEITY, P167, DOI 10.1007/978-90-481-9277-9_11; Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142; Raza SEA, 2015, PATTERN RECOGNITION; Raza SEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097612; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Song Y, 2007, SIXTH INTERNATIONAL; Stoll M, 2008, VITIS, V47, P133; Sun HJ, 2014, EUR J PLANT PATHOL, V139, P125, DOI 10.1007/s10658-013-0371-8; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Verstockt S, 2012, MACH VISION APPL, V23, P1243, DOI 10.1007/s00138-011-0359-3; Yang QX, 2012, PROC CVPR IEEE, P1402, DOI 10.1109/CVPR.2012.6247827; Yang QX, 2010, PROC CVPR IEEE, P1458, DOI 10.1109/CVPR.2010.5539797	32	85	92	11	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123262	10.1371/journal.pone.0123262	http://dx.doi.org/10.1371/journal.pone.0123262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861025	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300087
J	Akin, EJ; Sole, L; Dib-Hajj, SD; Waxman, SG; Tamkun, MM				Akin, Elizabeth J.; Sole, Laura; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Tamkun, Michael M.			Preferential Targeting of Na(v)1.6 Voltage-Gated Na+ Channels to the Axon Initial Segment during Development	PLOS ONE			English	Article							SODIUM-CHANNEL; ANKYRIN-G; PERIMETER FENCE; BETA-1 SUBUNITS; BINDING MOTIF; MEMBRANE; PROTEINS; IDENTIFICATION; ESTABLISHMENT; ORGANIZATION	During axonal maturation, voltage-gated sodium (Na-v) channels accumulate at the axon initial segment (AIS) at high concentrations. This localization is necessary for the efficient initiation of action potentials. The mechanisms underlying channel trafficking to the AIS during axonal development have remained elusive due to a lack of Na-v reagents suitable for high resolution imaging of channels located specifically on the cell surface. Using an optical pulse-chase approach in combination with a novel Na(v)1.6 construct containing an extracellular biotinylation domain we demonstrate that Na(v)1.6 channels are preferentially inserted into the AIS membrane during neuronal development via direct vesicular trafficking. Singlemolecule tracking illustrates that axonal channels are immediately immobilized following delivery, while channels delivered to the soma are often mobile. Neither a Na(v)1.6 channel lacking the ankyrin-binding motif nor a chimeric K(v)2.1 channel containing the Na-v ankyrinGbinding domain show preferential AIS insertion. Together these data support a model where ankyrinG-binding is required for preferential Na(v)1.6 insertion into the AIS plasma membrane. In contrast, ankyrinG-binding alone does not confer the preferential delivery of proteins to the AIS.	[Akin, Elizabeth J.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Sole, Laura; Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Tamkun, Michael M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Akin, Elizabeth J.; Tamkun, Michael M.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Adm Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; Yale University	Tamkun, MM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	michael.tamkun@colostate.edu	Waxman, Stephen/Z-2507-2019; Akin, Elizabeth/P-1182-2019; Sole, Laura/AAT-7332-2020	Waxman, Stephen/0000-0001-5718-7177; 	National Science Foundation Graduate Research Fellowship [DGE-1321845]; National Institutes of Health [RO1 NS085142]; Rehabilitation Research Service, the Veterans Administration, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085142] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000605] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rehabilitation Research Service, the Veterans Administration, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Science Foundation Graduate Research Fellowship award DGE-1321845 (http://www.nsfgrfp.org/) to EJA, National Institutes of Health RO1 NS085142 (http://grants.nih.gov/grants/guide/pa-files/PA-13-302.html) to MMT and Rehabilitation Research Service, the Veterans Administration, USA (http://www.rehab.research.va.gov/) to SDH and SGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Boiko T, 2003, J NEUROSCI, V23, P2306; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Gasser A, 2010, J BIOL CHEM, V285, P26149, DOI 10.1074/jbc.M109.098681; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lee A, 2009, CHANNELS, V3, P171, DOI 10.4161/chan.3.3.8854; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Leterrier C, 2014, SEMIN CELL DEV BIOL, V27, P44, DOI 10.1016/j.semcdb.2013.11.001; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Smith MR, 1998, J NEUROSCI, V18, P6093; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742	36	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124397	10.1371/journal.pone.0124397	http://dx.doi.org/10.1371/journal.pone.0124397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874799	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800141
J	Chuang, YC; Huang, YL; Tseng, KC; Yen, CH; Yang, LH				Chuang, Ying-Chih; Huang, Ya-Li; Tseng, Kuo-Chien; Yen, Chia-Hsin; Yang, Lin-hui			Social Capital and Health-Protective Behavior Intentions in an Influenza Pandemic	PLOS ONE			English	Article							SELF-RATED HEALTH; POLITICAL-ECONOMY; AVIAN INFLUENZA; TRUST; VACCINATION; COMMUNICATION; ASSOCIATIONS	Health-protective behaviors, such as receiving a vaccine, wearing a face mask, and washing hands frequently, can reduce the risk of contracting influenza. However, little is known about how social capital may influence health-protective behavior in the general population. This study examined whether each of the social capital dimensions (bonding, bridging, and linking) contributed to the intention to adopt any of the health-protective behaviors in an influenza pandemic. The data of this study were from the 2014 Taiwan Social Change Survey. A stratified, three-stage probability proportional-to-size sampling from across the nation, was conducted to select adults aged 20 years and older (N = 1,745). Bonding social capital was measured by the frequency of neighborly contact and support. Bridging social capital was measured based on association membership. Linking social capital was measured according to general government trust and trust in the government's capacity to counter an influenza pandemic. Binary logistic regressions were used to assess the multivariate associations between social capital and behavioral intention. The study results indicate that social capital may influence the response to influenza pandemic. Specifically, the intention to receive a vaccine and to wash hands more frequently were associated with the linking dimension and the bonding dimension of social capital, while the intention to wear a face mask was associated with all forms of social capital. The findings of this study suggest that government credibility and interpersonal networks may play a crucial role in health-protective behavior. This study provides new insights into how to improve the effectiveness of influenza prevention campaigns.	[Chuang, Ying-Chih; Tseng, Kuo-Chien; Yen, Chia-Hsin] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Huang, Ya-Li] Taipei Med Univ, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Yang, Lin-hui] Natl Taiwan Univ, Dept Anthropol, Taipei 10764, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University	Chuang, YC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	yingchih@tmu.edu.tw			Ministry of Science and Technology in Taiwan	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	The data presented in this study were collected by the "2014 Taiwan Social Change Survey" research project, sponsored by the Ministry of Science and Technology in Taiwan. The Taiwan Social Change Survey was administered by the Institute of Sociology, Academia Sinica. The Center for Survey Research of Academia Sinica is responsible for the data distribution. The authors appreciate the assistance of these institutes and individuals in providing these data.	[Anonymous], 1984, DISTINCTION SOCIAL C; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Cadigan R., 2008, SOCIAL CAPITAL HLTH, P273, DOI DOI 10.1007/978-0-387-71311-3_13; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101083; Cheng H-L, 2002, TAIWAN J PUBLIC HLTH, V21, P289; Cheung Chau-Kiu, 2008, Soc Work Public Health, V23, P41, DOI 10.1080/19371910802053224; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Chuang YC, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-87; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Derose KP, 2009, MED CARE RES REV, V66, P272, DOI 10.1177/1077558708330428; Earle TC, 2010, RISK ANAL, V30, P541, DOI 10.1111/j.1539-6924.2010.01398.x; Fang D, 2012, INT J ENV RES PUB HE, V9, P2742, DOI 10.3390/ijerph9082742; Fu Y-C, 2014, TAIWAN SOCIAL CHANGE; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Jung M, 2013, VACCINE, V31, P4860, DOI 10.1016/j.vaccine.2013.07.068; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kobayashi T, 2013, SOC SCI MED, V85, P32, DOI 10.1016/j.socscimed.2013.02.027; Kok G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-174; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; Lin N., 2001, SOCIAL CAPITAL THEOR, P57, DOI DOI 10.1017/CBO9780511815447; Liu BM, 2014, SURV METHODOL, V40, P1; Miao YY, 2012, TROP MED INT HEALTH, V17, P604, DOI 10.1111/j.1365-3156.2012.02966.x; Poortinga W, 2003, RISK ANAL, V23, P961, DOI 10.1111/1539-6924.00373; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; PUTNAM RD, 1995, J DEMOCRACY, V0006; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Rojas Y, 2006, SOC SCI MED, V62, P2732, DOI 10.1016/j.socscimed.2005.11.007; Ronnerstrand B, 2013, SCAND J PUBLIC HEALT, V41, P853, DOI 10.1177/1403494813494975; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Sundquist K, 2014, EXP GERONTOL, V55, P29, DOI 10.1016/j.exger.2014.03.007; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Tsai MC, 2006, J SOC PERS RELAT, V23, P151, DOI 10.1177/0265407506060184; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Waisbord S R, 2008, Glob Public Health, V3, P197, DOI 10.1080/17441690801887620; WHO WHO WHO WHO, 2011, PAND INFL A H1N1	40	80	80	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122970	10.1371/journal.pone.0122970	http://dx.doi.org/10.1371/journal.pone.0122970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874625	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800084
J	Kristoufek, L				Kristoufek, Ladislav			What Are the Main Drivers of the Bitcoin Price? Evidence from Wavelet Coherence Analysis	PLOS ONE			English	Article								The Bitcoin has emerged as a fascinating phenomenon in the Financial markets. Without any central authority issuing the currency, the Bitcoin has been associated with controversy ever since its popularity, accompanied by increased public interest, reached high levels. Here, we contribute to the discussion by examining the potential drivers of Bitcoin prices, ranging from fundamental sources to speculative and technical ones, and we further study the potential influence of the Chinese market. The evolution of relationships is examined in both time and frequency domains utilizing the continuous wavelets framework, so that we not only comment on the development of the interconnections in time but also distinguish between short-term and long-term connections. We find that the Bitcoin forms a unique asset possessing properties of both a standard financial asset and a speculative one.	[Kristoufek, Ladislav] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Kristoufek, Ladislav] Acad Sci Czech Republ, Inst Informat Theory & Automat, CR-18208 Prague 8, Czech Republic; [Kristoufek, Ladislav] Charles Univ Prague, Inst Econ Studies, Prague 11000, Czech Republic	University of Warwick; Czech Academy of Sciences; Institute of Information Theory & Automation of the Czech Academy of Sciences; Charles University Prague	Kristoufek, L (corresponding author), Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.	kristouf@utia.cas.cz	Kristoufek, Ladislav/H-3568-2014; Kristoufek, Ladislav/GOV-5386-2022	Kristoufek, Ladislav/0000-0003-4843-9373; Kristoufek, Ladislav/0000-0003-4843-9373	European Union [FP7-SSH-612955]; Czech Science Foundation [P402/12/G097]; Research Councils United Kingdom [EP/K039830/1]; EPSRC [EP/K039830/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039830/1] Funding Source: researchfish	European Union(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); Research Councils United Kingdom; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. FP7-SSH-612955 Czech Science Foundation project No. P402/12/G097 "DYME - Dynamic Models in Economics" The Research Councils United Kingdom via Grant EP/K039830/1.	Aguiar-Conraria L, 2008, PHYSICA A, V387, P2863, DOI 10.1016/j.physa.2008.01.063; [Anonymous], [No title captured]; Barber S., 2012, FINANCIAL CRYPTOGRAP, P399, DOI [DOI 10.1007/978-3-642-32946-3, 10.1007/978-3-642-32946-3_29]; Barratt MJ, 2012, ADDICTION, V107, P683, DOI 10.1111/j.1360-0443.2011.03709.x; Bornholdt S., 2014, ARXIV14036378, P1; Clark J., 2012, LNCS, P390, DOI DOI 10.1007/978-3-642-32946-3; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Jacobs E., 2011, BANKING COMMERCE, V16, P1; Kondor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086197; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Mihanovic H, 2009, J MARINE SYST, V78, pS157, DOI 10.1016/j.jmarsys.2009.01.021; Ng EKW, 2012, J ATMOS OCEAN TECH, V29, P1845, DOI 10.1175/JTECH-D-12-00056.1; Reid F., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P1318, DOI 10.1109/PASSAT/SocialCom.2011.79; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1998, Q J ROY METEOR SOC, V124, P1985, DOI 10.1256/smsqj.55009	18	365	368	7	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123923	10.1371/journal.pone.0123923	http://dx.doi.org/10.1371/journal.pone.0123923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874694	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800124
J	Ossiboff, RJ; Raphael, BL; Ammazzalorso, AD; Seimon, TA; Newton, AL; Chang, TY; Zarate, B; Whitlock, AL; McAloose, D				Ossiboff, Robert J.; Raphael, Bonnie L.; Ammazzalorso, Alyssa D.; Seimon, Tracie A.; Newton, Alisa L.; Chang, Tylis Y.; Zarate, Brian; Whitlock, Alison L.; McAloose, Denise			Three Novel Herpesviruses of Endangered Clemmys and Glyptemys Turtles	PLOS ONE			English	Article							SEA-TURTLES; B-VIRUS; INFECTION; TORTOISES; DISEASE; SEQUENCES; REPTILES; MONKEYS	The rich diversity of the world's reptiles is at risk due to significant population declines of broad taxonomic and geographic scope. Significant factors attributed to these declines include habitat loss, pollution, unsustainable collection and infectious disease. To investigate the presence and significance of a potential pathogen on populations of critically endangered bog turtles (Glyptemys muhlenbergii) as well sympatric endangered wood (G. insculpta) and endangered spotted (Clemmys guttata) turtles in the northeastern United States, choanal and cloacal swabs collected from 230 turtles from 19 sites in 5 states were screened for herpesvirus by polymerase chain reaction. We found a high incidence of herpesvirus infection in bog turtles (51.5%; 105/204) and smaller numbers of positive wood (5) and spotted (1) turtles. Sequence and phylogenetic analysis revealed three previously uncharacterized alphaherpesviruses. Glyptemys herpesvirus 1 was the predominant herpesvirus detected and was found exclusively in bog turtles in all states sampled. Glyptemys herpesvirus 2 was found only in wood turtles. Emydid herpesvirus 2 was found in a small number of bog turtles and a single spotted turtle from one state. Based on these findings, Glyptemys herpesvirus 1 appears to be a common infection in the study population, whereas Glyptemys herpesvirus 2 and Emydid herpesvirus 2 were not as frequently detected. Emydid herpesvirus 2 was the only virus detected in more than one species. Herpesviruses are most often associated with subclinical or mild infections in their natural hosts, and no sampled turtles showed overt signs of disease at sampling. However, infection of host-adapted viruses in closely related species can result in significant disease. The pathogenic potential of these viruses, particularly Emydid herpesvirus 2, in sympatric chelonians warrants additional study in order to better understand the relationship of these viruses with their endangered hosts.	[Ossiboff, Robert J.; Raphael, Bonnie L.; Ammazzalorso, Alyssa D.; Seimon, Tracie A.; Newton, Alisa L.; McAloose, Denise] Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY USA; [Ammazzalorso, Alyssa D.] Fordham Univ, Bronx, NY 10458 USA; [Chang, Tylis Y.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; [Zarate, Brian] New Jersey Div Fish & Wildlife, Endangered & Nongame Species Program, Clinton, NJ USA; [Whitlock, Alison L.] US Fish & Wildlife Serv, Hadley, MA USA	Wildlife Conservation Society; Fordham University; Yeshiva University; Albert Einstein College of Medicine; United States Department of the Interior; US Fish & Wildlife Service	Ossiboff, RJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rjo23@cornell.edu	Ossiboff, Robert/AAB-8732-2019	Ossiboff, Robert/0000-0001-6951-6070	United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs; Delaware Division of Fish and Wildlife; New Jersey Division of Fish, Game and Wildlife	United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs; Delaware Division of Fish and Wildlife; New Jersey Division of Fish, Game and Wildlife	This study was funded in part by the United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs, the Delaware Division of Fish and Wildlife, the New Jersey Division of Fish, Game and Wildlife, and gifts from several private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barragan AR, 1994, MAR TURT NEWSL, V67; Bicknese EJ, 2010, J ZOO WILDLIFE MED, V41, P353, DOI 10.1638/2009-0214R.1; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; CHELLMAN GJ, 1992, LAB ANIM SCI, V42, P146; COX WR, 1980, J WILDLIFE DIS, V16, P445, DOI 10.7589/0090-3558-16.3.445; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Dunowska M, 2001, J GEN VIROL, V82, P2785, DOI 10.1099/0022-1317-82-11-2785; Fonnesbeck CJ, 2003, J HERPETOL, V37, P602, DOI 10.1670/37-02N; FRYE FL, 1977, J AM VET MED ASSOC, V171, P882; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huerta P., 2002, P 20 ANN S SEA TURTL, P193; Jacobson Elliott R., 2007, P395, DOI 10.1201/9781420004038.ch9; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1020; JACOBSON ER, 1985, J AM VET MED ASSOC, V187, P1227; JACOBSON ER, 1982, J AM VET MED ASSOC, V181, P1322; Jungwirth N, 2014, VET MICROBIOL, V170, P403, DOI 10.1016/j.vetmic.2014.02.029; Landolfi JA, 2005, J VET DIAGN INVEST, V17, P369, DOI 10.1177/104063870501700412; Marschang RE, 2006, VET MICROBIOL, V117, P258, DOI 10.1016/j.vetmic.2006.06.009; McGeoch DJ, 2005, J VIROL, V79, P725, DOI 10.1128/JVI.79.2.725-731.2005; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Ostrowski SR, 1998, EMERG INFECT DIS, V4, P117, DOI 10.3201/eid0401.980117; PettanBrewer KCB, 1996, J WILDLIFE DIS, V32, P521, DOI 10.7589/0090-3558-32.3.521; Pinkerton ME, 2008, J WILDLIFE DIS, V44, P622, DOI 10.7589/0090-3558-44.3.622; Seigel RA, 2003, J HERPETOL, V37, P137, DOI 10.1670/0022-1511(2003)037[0137:SFOPUR]2.0.CO;2; Seminoff J. A., 2004, IUCN 2014 IUCN RED L; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; Sutherland WJ, 2014, TRENDS ECOL EVOL, V29, P15, DOI 10.1016/j.tree.2013.11.004; Todd BD, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P47, DOI 10.1201/EBK1420064162-c3; Uetz P, 2014, REPTILE DATABASE; Van Dijk PP, 2013, IUCN 2014 IUCN RED L; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Williams EH, 2006, J VIROL, V80, P4643, DOI 10.1128/JVI.80.9.4643-4644.2006	39	20	21	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122901	10.1371/journal.pone.0122901	http://dx.doi.org/10.1371/journal.pone.0122901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875510	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800082
J	Wong, P; Kosik, I; Raess, A; Carson, JJL				Wong, Philip; Kosik, Ivan; Raess, Avery; Carson, Jeffrey J. L.			Objective Assessment and Design Improvement of a Staring, Sparse Transducer Array by the Spatial Crosstalk Matrix for 3D Photoacoustic Tomography	PLOS ONE			English	Article							FOURIER CROSSTALK; IMAGING-SYSTEM; POINT-SOURCE; ANGIOGRAPHY; QUALITY	Accurate reconstruction of 3D photoacoustic (PA) images requires detection of photoacoustic signals from many angles. Several groups have adopted staring ultrasound arrays, but assessment of array performance has been limited. We previously reported on a method to calibrate a 3D PA tomography (PAT) staring array system and analyze system performance using singular value decomposition (SVD). The developed SVD metric, however, was impractical for large system matrices, which are typical of 3D PAT problems. The present study consisted of two main objectives. The first objective aimed to introduce the crosstalk matrix concept to the field of PAT for system design. Figures-of-merit utilized in this study were root mean square error, peak signal-to-noise ratio, mean absolute error, and a three dimensional structural similarity index, which were derived between the normalized spatial crosstalk matrix and the identity matrix. The applicability of this approach for 3D PAT was validated by observing the response of the figures-of-merit in relation to well-understood PAT sampling characteristics (i.e. spatial and temporal sampling rate). The second objective aimed to utilize the figures-of-merit to characterize and improve the performance of a near-spherical staring array design. Transducer arrangement, array radius, and array angular coverage were the design parameters examined. We observed that the performance of a 129-element staring transducer array for 3D PAT could be improved by selection of optimal values of the design parameters. The results suggested that this formulation could be used to objectively characterize 3D PAT system performance and would enable the development of efficient strategies for system design optimization.	[Wong, Philip; Kosik, Ivan; Raess, Avery; Carson, Jeffrey J. L.] St Josephs Hlth Care, Lawson Hlth Res Inst, Imaging Program, London, ON, Canada; [Wong, Philip; Kosik, Ivan; Raess, Avery; Carson, Jeffrey J. L.] Univ Western Ontario, Dept Med Biophys, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Carson, JJL (corresponding author), St Josephs Hlth Care, Lawson Hlth Res Inst, Imaging Program, London, ON, Canada.	jcarson@lawsonimaging.ca	Carson, Jeffrey JL/C-7785-2014	Carson, Jeffrey JL/0000-0003-0683-6004	Translational Breast Cancer Research Unit; University of Western Ontario (WGRS); Ontario Graduate Scholarship; WGRS; Canadian Institute of Health Research (CIHR); CIHR strategic training program in Cancer Research and Technology Transfer; Canada Foundation for Innovation [29864]; Natural Sciences and Engineering Research Council [312232-2009]; Canadian Institute of Health Research [220298]; Ontario Ministry of Research and Innovation's Ontario Research Fund through the Ontario Preclinical Imaging Consortium (OPIC) [RE-03-051]; Lawson Health Research Institute (LHRI)	Translational Breast Cancer Research Unit; University of Western Ontario (WGRS); Ontario Graduate Scholarship(Ontario Graduate Scholarship); WGRS; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR strategic training program in Cancer Research and Technology Transfer(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation's Ontario Research Fund through the Ontario Preclinical Imaging Consortium (OPIC); Lawson Health Research Institute (LHRI)	PW and IK were supported by the Translational Breast Cancer Research Unit (http://www.lhsc.on.ca/Research_Training/LRCP/Research_Groups/TranslationalBreastCancerResearch.htm) as well as The University of Western Ontario (WGRS) (http://grad.uwo.ca/current_students/student_finances/wgrs.html). PW was also supported by the Ontario Graduate Scholarship (https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRD19842319.html). AR was supported by WGRS, the Canadian Institute of Health Research (CIHR)(http://www.cihr-irsc.gc.ca/e/193.html), and the CIHR strategic training program in Cancer Research and Technology Transfer (http://www.uwo.ca/oncology/CIHR/STP/). Research funding was provided by the Canada Foundation for Innovation (ID#: 29864), the Natural Sciences and Engineering Research Council (ID#: 312232-2009) (http://www.nserc-crsng.gc.ca/index_eng.asp), the Canadian Institute of Health Research (ID#: 220298) (http://www.innovation.ca/), The Ontario Ministry of Research and Innovation's Ontario Research Fund (ID#: RE-03-051)(https://www.ontario.ca/businessand-economy/ontario-research-fund-research-excellence) through the Ontario Preclinical Imaging Consortium (OPIC), and the Lawson Health Research Institute (LHRI). MultiMagnetics Inc. provided matching funds with respect to ORF-OPIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT HH, 1994, PHYS MED BIOL, V39, P451, DOI 10.1088/0031-9155/39/3/012; BARRETT HH, 1995, J OPT SOC AM A, V12, P834, DOI 10.1364/JOSAA.12.000834; Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028; Bolanos JG, 2013, J ACOUST SOC AM, V133, pEL221, DOI 10.1121/1.4793566; Brecht HP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259361; Brunet D, 2012, IEEE T IMAGE PROCESS, V21, P1488, DOI 10.1109/TIP.2011.2173206; Bu SH, 2012, IEEE T BIO-MED ENG, V59, P1354, DOI 10.1109/TBME.2012.2187649; Buehler A, 2012, OPT EXPRESS, V20, P22712, DOI 10.1364/OE.20.022712; Dean-Ben XL, 2013, IEEE T MED IMAGING, V32, P2050, DOI 10.1109/TMI.2013.2272079; Dima A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036021; Ephrat P, 2008, OPT EXPRESS, V16, P21570, DOI 10.1364/OE.16.021570; Erber T, 1991, J PHYS A, V24; Ermilov SA, 2012, J BIOMED OPT, V14; Fronheiser MP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3370336; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Lin WS, 2011, J VIS COMMUN IMAGE R, V22, P297, DOI 10.1016/j.jvcir.2011.01.005; Lu W, 2011, BIOMATERIALS, V31, P1; Lutzweiler C, 2013, SENSORS-BASEL, V13, P7345, DOI 10.3390/s130607345; Mallidi S, 2011, TRENDS BIOTECHNOL, V29, P213, DOI 10.1016/j.tibtech.2011.01.006; Qi JY, 2004, IEEE T NUCL SCI, V51, P123, DOI 10.1109/TNS.2003.822997; Roumeliotis M, 2010, OPT EXPRESS, V18, P11406, DOI 10.1364/OE.18.011406; Roumeliotis M, 2009, OPT EXPRESS, V17, P15228, DOI 10.1364/OE.17.015228; Roumeliotis MB, 2011, OPT EXPRESS, V19, P13405, DOI 10.1364/OE.19.013405; Scholl J. F., 2010, DESIGN ANAL COMPUTED; Shao M, 1996, SPHERICAL SAMPLING A; Stodilka RZ, 2002, IEEE T MED IMAGING, V21, P1468, DOI 10.1109/TMI.2002.806595; Wang SH, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074303; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu D, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3669512; Xiang LZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01113; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Xu MH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016706; Zeng K, 2012, IND MINERALS PROCESS, P1	34	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124759	10.1371/journal.pone.0124759	http://dx.doi.org/10.1371/journal.pone.0124759			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875177	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800151
J	Yu, YS; Wang, JP; Liu, JH; Ling, DS; Xia, J				Yu, Yongsheng; Wang, Jianpeng; Liu, Jiahui; Ling, Daishun; Xia, Jiang			Functional Assembly of Protein Fragments Induced by Spatial Confinement	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; FIREFLY LUCIFERASE; FOLDING LANDSCAPE; MESOPOROUS SILICA; ENZYME; CORONA; CELLS; RED; BIOLUMINESCENCE; IMMOBILIZATION	Natural proteins are often confined within their local microenvironments, such as three-dimensional confinement in organelles or two-dimensional confinement in lipid rafts on cytoplasmic membrane. Spatial confinement restricts proteins' entropic freedom, forces their lateral interaction, and induces new properties that the same proteins lack at the soluble state. So far, the phenomenon of environment-induced protein functional alteration still lacks a full illustration. We demonstrate here that engineered protein fragments, although being non-functional in solution, can be re-assembled within the nanometer space to give the full activity of the whole protein. Specific interaction between hexahistidine-tag (His-tag) and NiO surface immobilizes protein fragments on NiO nanoparticles to form a self-assembled protein "corona" on the particles inside the nanopores of mesoporous silica. Site-specific assembly forces a shoulder-by-shoulder orientation and promotes fragment-fragment interaction; this interaction together with spatial confinement of the mesopores results in functional re-assembly of the protein half fragments. To our surprise, a single half fragment of luciferase (non-catalytic in solution) exhibited luciferase activity when immobilized on NiO in the mesopores, in the absence of the complimentary half. This shows for the first time that spatial confinement can induce the folding of a half fragment, reconstitute the enzyme active site, and re-gain the catalytic capability of the whole protein. Our work thereby highlights the under-documented notion that aside from the chemical composition such as primary sequence, physical environment of a protein also determines its function.	[Yu, Yongsheng; Wang, Jianpeng; Liu, Jiahui; Xia, Jiang] Chinese Univ Hong Kong, Ctr Novel Biomat, Dept Chem, Shatin, Hong Kong, Peoples R China; [Ling, Daishun] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China	Chinese University of Hong Kong; Zhejiang University	Ling, DS (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	lingds@zju.edu.cn; jiangxia@cuhk.edu.hk	Xia, Jiang/AAT-2366-2020; Ling, Daishun/AAH-6088-2021; Ling, Daishun/J-4736-2014; YU, Yongsheng/O-6211-2015	Ling, Daishun/0000-0002-6814-7370; Xia, Jiang/0000-0001-8112-7625; YU, Yongsheng/0000-0001-5139-3439	University Grants Committee of Hong Kong [CUHK 404812, 403711, 404413, AoE/M-09/12]	University Grants Committee of Hong Kong	Financial support for this work came from the University Grants Committee of Hong Kong (ECS grant CUHK 404812, GRF grants 403711 and 404413, and AoE/M-09/12).	Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bhattacharya A, 2012, BIOPHYS J, V103, P596, DOI 10.1016/j.bpj.2012.07.005; Branchini BR, 2001, BIOCHEMISTRY-US, V40, P2410, DOI 10.1021/bi002246m; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Foffi G, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/040301; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Gursoy G, 2014, NUCLEIC ACIDS RES, V42, P8223, DOI 10.1093/nar/gku462; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Guo ZF, 2010, BIOORG MED CHEM LETT, V20, P3855, DOI 10.1016/j.bmcl.2010.05.051; Hancock R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036045; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Javidpour L, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3641482; Jedlovszky-Hajdu A, 2012, LANGMUIR, V28, P14983, DOI 10.1021/la302446h; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Kao KC, 2014, J PHYS CHEM C, V118, P6734, DOI 10.1021/jp4112684; Koutsioubas A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4723871; Latour RA, 2008, INFORM HEALTHCARE, V1, P270, DOI [10.3171/PED/2008/1/4/270, DOI 10.3171/PED/2008/1/4/270]; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Ling DS, 2014, CHEM-EUR J, V20, P7916, DOI 10.1002/chem.201403071; Liu J, 2013, CHEM-EUR J, V19, P2711, DOI 10.1002/chem.201203833; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Marino KA, 2012, J PHYS CHEM B, V116, P11872, DOI 10.1021/jp306727r; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2003, CURR OPIN BIOTECH, V14, P610, DOI 10.1016/j.copbio.2003.10.014; Minh DDL, 2006, J AM CHEM SOC, V128, P6006, DOI 10.1021/ja060483s; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Saha R, 2013, J MOL RECOGNIT, V26, P59, DOI 10.1002/jmr.2246; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Tan ZJ, 2012, BIOPHYS J, V103, P827, DOI 10.1016/j.bpj.2012.06.048; Wang W, 2009, P NATL ACAD SCI USA, V106, P5517, DOI 10.1073/pnas.0809649106; Warkentin PH, 1995, PROTEINS INTERFACES, P163; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	42	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122101	10.1371/journal.pone.0122101	http://dx.doi.org/10.1371/journal.pone.0122101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875003	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800039
J	Klarenbeek, J; Goedhart, J; van Batenburg, A; Groenewald, D; Jalink, K				Klarenbeek, Jeffrey; Goedhart, Joachim; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees			Fourth-Generation Epac-Based FRET Sensors for cAMP Feature Exceptional Brightness, Photostability and Dynamic Range: Characterization of Dedicated Sensors for FLIM, for Ratiometry and with High Affinity	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; YELLOW FLUORESCENT PROTEIN; ACTIVATION; INDICATORS; GFP	Epac-based FRET sensors have been widely used for the detection of cAMP concentrations in living cells. Originally developed by us as well as others, we have since then reported several important optimizations that make these sensors favourite among many cell biologists. We here report cloning and characterization of our fourth generation of cAMP sensors, which feature outstanding photostability, dynamic range and signal-to-noise ratio. The design is based on mTurquoise2, currently the brightest and most bleaching-resistant donor, and a new acceptor cassette that consists of a tandem of two cp(173)Venus fluorophores. We also report variants with a single point mutation, Q270E, in the Epac moiety, which decreases the dissociation constant of cAMP from 9.5 to 4 mu M, and thus increases the affinity similar to 2.5-fold. Finally, we also prepared and characterized dedicated variants with non-emitting (dark) acceptors for single-wavelength FLIM acquisition that display an exceptional near-doubling of fluorescence lifetime upon saturation of cAMP levels. We believe this generation of cAMP outperforms all other sensors and therefore recommend these sensors for all future studies.	[Klarenbeek, Jeffrey; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Goedhart, Joachim] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, NL-1012 WX Amsterdam, Netherlands; [Klarenbeek, Jeffrey; Goedhart, Joachim; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees] van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	k.jalink@nki.nl		Jalink, Kees/0000-0001-7019-3440; Goedhart, Joachim/0000-0002-0630-3825	NanoNextNL; KWF [NKI 2010-4626]; Stichting Technische Wetenschappen	NanoNextNL; KWF; Stichting Technische Wetenschappen	JG is supported by NanoNextNL. KJ is supported by grants from KWF (NKI 2010-4626) and the Stichting Technische Wetenschappen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Polito M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00211; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916	19	164	164	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122513	10.1371/journal.pone.0122513	http://dx.doi.org/10.1371/journal.pone.0122513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875503	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700017
J	Luta, X; Maessen, M; Egger, M; Stuck, AE; Goodman, D; Clough-Gorr, KM				Luta, Xhyljeta; Maessen, Maud; Egger, Matthias; Stuck, Andreas E.; Goodman, David; Clough-Gorr, Kerri M.			Measuring Intensity of End of Life Care: A Systematic Review	PLOS ONE			English	Review							LAST 6 MONTHS; OBSTRUCTIVE PULMONARY-DISEASE; INPATIENT TREATMENT INTENSITY; LUNG-CANCER PATIENTS; QUALITY-OF-CARE; MEDICARE BENEFICIARIES; PALLIATIVE CARE; REGIONAL-VARIATIONS; CHEMOTHERAPY USE; UNITED-STATES	Background Many studies have measured the intensity of end of life care. However, no summary of the measures used in the field is currently available. Objectives To summarise features, characteristics of use and reported validity of measures used for evaluating intensity of end of life care. Methods This was a systematic review according to PRISMA guidelines. We performed a comprehensive literature search in Ovid Medline, Embase, The Cochrane Library of Systematic Reviews and reference lists published between 1990-2014. Two reviewers independently screened titles, abstracts, full texts and extracted data. Studies were eligible if they used a measure of end of life care intensity, defined as all quantifiable measures describing the type and intensity of medical care administered during the last year of life. Results A total of 58 of 1590 potentially eligible studies met our inclusion criteria and were included. The most commonly reported measures were hospitalizations (n = 44), intensive care unit admissions (n = 39) and chemotherapy use (n = 27). Studies measured intensity of care in different timeframes ranging from 48 hours to 12 months. The majority of studies were conducted in cancer patients (n = 31). Only 4 studies included information on validation of the measures used. None evaluated construct validity, while 3 studies considered criterion and 1 study reported both content and criterion validity. Conclusions This review provides a synthesis to aid in choosing intensity of end of life care measures based on their previous use but simultaneously highlights the crucial need for more validation studies and consensus in the field.	[Luta, Xhyljeta; Maessen, Maud; Egger, Matthias; Stuck, Andreas E.; Clough-Gorr, Kerri M.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Stuck, Andreas E.] Univ Dept Geriatr, Inselspital Bern, Bern, Switzerland; [Goodman, David] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Clough-Gorr, Kerri M.] Boston Univ, Med Ctr, Sect Geriatr, Boston, MA USA	University of Bern; Dartmouth College; Boston University	Clough-Gorr, KM (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	kclough@ispm.unibe.ch	Goodman, David/AAG-7497-2020	Egger, Matthias/0000-0001-7462-5132; Maessen, Maud/0000-0002-5439-9948	Swiss National Science Foundation [16-803]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant number 16-803) (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Alonso-Babarro A, 2013, PALLIATIVE MED, V27, P68, DOI 10.1177/0269216312442973; Alturki A, 2014, J NEURO-ONCOL, V117, P103, DOI 10.1007/s11060-014-1360-2; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Au DH, 2006, ARCH INTERN MED, V166, P326, DOI 10.1001/archinte.166.3.326; Axelsson B, 1997, EUR J SURG ONCOL, V23, P145, DOI 10.1016/S0748-7983(97)80009-1; Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barbera L, 2006, J PALLIATIVE CARE, V22, P12, DOI 10.1177/082585970602200103; Barbera L, 2008, J PAIN SYMPTOM MANAG, V35, P267, DOI 10.1016/j.jpainsymman.2007.04.019; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2006, HEALTH SERV RES, V41, P2219, DOI 10.1111/j.1475-6773.2006.00598.x; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Barnet CS, 2013, ANESTHESIOLOGY, V119, P796, DOI 10.1097/ALN.0b013e31829c2db0; Bergman J, 2011, ARCH INTERN MED, V171, P204, DOI 10.1001/archinternmed.2010.394; Bergman J, 2010, CANCER-AM CANCER SOC, V116, P2126, DOI [10.1002/cncr25039, 10.1002/cncr.25039]; Braga S, 2007, PSYCHO-ONCOL, V16, P863, DOI 10.1002/pon.1140; Bukki J, 2013, SUPPORT CARE CANCER, V21, P1743, DOI 10.1007/s00520-013-1721-y; Chan KW, 2012, J ASIAN PUBLIC POLIC, V5, P71, DOI 10.1080/17516234.2012.662358; Cintron Alexie, 2003, J Palliat Med, V6, P757, DOI 10.1089/109662103322515266; Cooper Z, 2012, J HEALTH CARE POOR U, V23, P857, DOI 10.1353/hpu.2012.0064; Cowall DE, 2012, J ONCOL PRACT, V8, pE40, DOI 10.1200/JOP.2011.000451; Curtis JR, 2012, AM J RESP CRIT CARE, V186, P587, DOI 10.1164/rccm.201206-1020CP; Da Silva Roxane Borges, 2011, Healthc Policy, V6, pe106; Earle CC, 2006, J CLIN ONCOL, V24, P838, DOI 10.1200/JCO.2005.03.9388; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, ANN INTERN MED, V138, P136; Forero R, 2012, LIT REV CARE END OF; Gagnon B, 2006, J CLIN ONCOL, V24, P856, DOI 10.1200/JCO.2005.02.1790; George Linda K, 2002, Gerontologist, V42 Spec No 3, P86; Gielen B, 2010, HEALTH POLICY, V97, P53, DOI 10.1016/j.healthpol.2010.03.002; Giovanis P, 2010, TUMORI J, V96, P443, DOI 10.1177/030089161009600311; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Gonsalves WI, 2011, J PALLIAT MED, V14, P1231, DOI 10.1089/jpm.2011.0131; Goodman D, 2010, DARTMOUTH ATLAS OF H; Goodman D, 2011, DARTMOUTH ATLAS OF H; Goodridge D, 2010, RURAL REMOTE HEALTH, V10; Goodridge D, 2008, RESP MED, V102, P885, DOI 10.1016/j.rmed.2008.01.007; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Hearn J, 1997, J PUBLIC HEALTH MED, V19, P193, DOI 10.1093/oxfordjournals.pubmed.a024608; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; HENDERSON J, 1990, BRIT MED J, V301, P17, DOI 10.1136/bmj.301.6742.17; HENDERSON J, 1992, J PUBLIC HEALTH MED, V14, P39; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Izumi S, 2012, NURS ETHICS, V19, P608, DOI 10.1177/0969733011436205; Keam B, 2008, JPN J CLIN ONCOL, V38, P381, DOI 10.1093/jjco/hyn031; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P3732, DOI 10.1002/cncr.25077; Kelley AS, 2011, LANCET, V378, P1364, DOI 10.1016/S0140-6736(11)61420-7; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Langton JM, 2014, PALLIATIVE MED, V28, P1167, DOI 10.1177/0269216314533813; Le Conte P, 2004, INTENS CARE MED, V30, P2216, DOI 10.1007/s00134-004-2475-2; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; Miesfeldt S, 2012, J PALLIAT MED, V15, P548, DOI 10.1089/jpm.2011.0310; Morden NE, 2012, HEALTH AFFAIR, V31, P786, DOI 10.1377/hlthaff.2011.0650; Mularski RA, 2007, HEALTH SERV RES, V42, P1848, DOI 10.1111/j.1475-6773.2007.00721.x; O'Hare AM, 2010, JAMA-J AM MED ASSOC, V304, P180, DOI 10.1001/jama.2010.924; Ohta B, 2011, J PALLIAT MED, V14, P722, DOI 10.1089/jpm.2010.0360; Raijmakers NJH, 2011, ANN ONCOL, V22, P1478, DOI 10.1093/annonc/mdq620; Ramroth H, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-70; Reed SD, 2012, AM J CARDIOL, V110, P1150, DOI 10.1016/j.amjcard.2012.05.059; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Rosenwax LK, 2011, MED J AUSTRALIA, V194, P570, DOI 10.5694/j.1326-5377.2011.tb03106.x; Sampson EL, 2006, AGE AGEING, V35, P187, DOI 10.1093/ageing/afj025; Sato K, 2008, SUPPORT CARE CANCER, V16, P113, DOI 10.1007/s00520-007-0332-x; Seow H, 2010, MED CARE, V48, P118, DOI 10.1097/MLR.0b013e3181c162ef; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Sheffield KM, 2011, CANCER-AM CANCER SOC, V117, P5003, DOI 10.1002/cncr.26115; Smith AK, 2009, J AM GERIATR SOC, V57, P153, DOI 10.1111/j.1532-5415.2008.02081.x; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Temel JS, 2008, CANCER-AM CANCER SOC, V113, P826, DOI 10.1002/cncr.23620; Teno JM, 1999, J PAIN SYMPTOM MANAG, V17, P109, DOI 10.1016/S0885-3924(98)00132-8; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Toole M, 2012, J AM COLL RADIOL, V9, P199, DOI 10.1016/j.jacr.2011.11.006; Unroe KT, 2011, ARCH INTERN MED, V171, P196, DOI 10.1001/archinternmed.2010.371; van der Steen JT, 2008, PALLIATIVE MED, V22, P750, DOI 10.1177/0269216308094102; van Walraven C, 2001, JAMA-J AM MED ASSOC, V285, P1602, DOI 10.1001/jama.285.12.1602; Warren JL, 2011, J NATL CANCER I, V103, P853, DOI 10.1093/jnci/djr145; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wentlandt K, 2012, AGGRESSIVE TREATMENT; Wong SPY, 2012, ARCH INTERN MED, V172, P661, DOI 10.1001/archinternmed.2012.268; Yabroff KR, 2007, NAT CLIN PRACT ONCOL, V4, P643, DOI 10.1038/ncponc0978	91	47	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123764	10.1371/journal.pone.0123764	http://dx.doi.org/10.1371/journal.pone.0123764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EB	25875471	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700041
J	Mihelich, BL; Maranville, JC; Nolley, R; Peehl, DM; Nonn, L				Mihelich, Brittany L.; Maranville, Joseph C.; Nolley, Rosalie; Peehl, Donna M.; Nonn, Larisa			Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort	PLOS ONE			English	Article							CIRCULATING MICRORNAS; TUMOR-SUPPRESSOR; PROGRESSION; CLUSTER; CELLS; RECURRENCE; EXPRESSION; BIOMARKERS; BIOPSY; ORIGIN	To reduce treatment of indolent prostate cancer (PCa), biomarkers are needed to improve identification of patients with a low-risk of having aggressive disease. Over-treatment of these patients occurs because of uncertainty in the aggressiveness of the entire tumor based on the biopsies, which do not accurately sample multifocal tumors. Circulating microRNAs (miRNAs) are stable serum markers and differential miRNA levels occur in men with PCa. The goal of this study was to identify circulating miRNAs that were associated with aggressive or indolent PCa. We measured circulating miRNAs in 150 patients prior to surgery and compared the miRNA levels to the pathology of the entire radical prostatectomy specimen. For this study we used an exceptionally well-characterized cohort of patients who had benign prostatic hyperplasia (BPH), low-grade or high-grade PCa. Low-grade was defined as patients with 100% Gleason grade 3 tumor as determined by step-wise sectioning. High-grade PCa patients had 30-90% Gleason grade 4+5 in the tumor. BPH patients had at least two biopsies negative for PCa. Twenty one miRNAs were selected for analysis. The miRNAs were quantified by RT-qPCR and analyzed by logistic regression. High levels of 14 miRNAs were exclusively present in the serum from patients with low-grade PCa or BPH, compared to men with high-grade PCa who had consistently low levels. The expression levels of the 14 miRNAs were combined into a "miR Score" which had a negative predictive value (NPV) of 0.939 to predict absence of high-grade PCa among PCa and BPH patients. Biochemical recurrence (BCR) was known for the PCa patients and a combined "miR Risk Score" accurately classified a subset of patients with low risk of BCR (NPV 0.941). In summary, measurement of serum miRNAs may have pre-surgical utility in combination with clinical risk calculators to identify patients with low risk of harboring aggressive PCa.	[Mihelich, Brittany L.; Nonn, Larisa] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Maranville, Joseph C.] Univ Chicago, Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Nolley, Rosalie; Peehl, Donna M.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Stanford University	Nonn, L (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60612 USA.	lnonn@uic.edu		Maranville, Joseph/0000-0002-1688-1573	National Institutes of Health [R01 CA121460, R01 CA166588]; NATIONAL CANCER INSTITUTE [R01CA121460, R01CA166588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, http://www.nih.gov, R01 CA121460, PI Peehl and National Institutes of Health, http://www.nih.gov, R01 CA166588, PI Nonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen Q, 2015, MOL CARCINOGEN, V54, P1292, DOI 10.1002/mc.22204; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Giangreco AA, 2013, CANCER PREV RES, V6, P483, DOI 10.1158/1940-6207.CAPR-12-0253; Goto Y, 2014, ONCOTARGET, V5, P7748, DOI 10.18632/oncotarget.2294; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Kachakova D, 2015, DNA CELL BIOL, V34, P189, DOI 10.1089/dna.2014.2663; Kan CWS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-627; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; McCann MJ, 2014, NUTRIENTS, V6, P4839, DOI 10.3390/nu6114839; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh PK, 2014, ONCOTARGET, V5, P824, DOI 10.18632/oncotarget.1776; Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Thompson IM, 2013, NEW ENGL J MED, V369, P603, DOI 10.1056/NEJMoa1215932; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098597; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Westermann AM, 2014, ANTICANCER RES, V34, P665	39	56	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124245	10.1371/journal.pone.0124245	http://dx.doi.org/10.1371/journal.pone.0124245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874774	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700061
J	Wong, MCS; Ching, JYL; Chan, VCW; Bruggemann, R; Lam, TYT; Luk, AKC; Wu, JCY; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Bruggemann, Renee; Lam, Thomas Y. T.; Luk, Arthur K. C.; Wu, Justin C. Y.; Chan, Francis K. L.; Sung, Joseph J. Y.			Regret on Choice of Colorectal Cancer Screening Modality Was Associated with Poorer Screening Compliance: A 4-Year Prospective Cohort Study	PLOS ONE			English	Article							TESTS; ASIA; DECISIONS; MORTALITY; BARRIERS; BEHAVIOR	Purpose Very few studies examined the issue of regret on choosing colorectal cancer (CRC) screening tests. We evaluated the determinants of regret and tested the hypothesis that regret over screening choices was associated with poorer screening compliance. Methods A bowel cancer screening centre invited all Hong Kong citizens aged 50-70 years who were asymptomatic of CRC to participate in free-of-charge screening programmes. Upon attendance they attended health seminars on CRC and its screening, and were offered an option to choose yearly faecal immunochemical test (FIT) for up to four years vs. one direct colonoscopy. They were not allowed to switch the screening option after decision. A self-administered, four-item validated survey was used to assess whether they regretted over their choice (> 2 = regretful from a scale of 0 [no regret]-5 [extreme regret]). A binary logistic regression model evaluated if initial regret over their choice was associated with poorer programme compliance. Results From 4,341 screening participants who have chosen FIT or colonoscopy, 120 (2.8%) regretted over their decision and 1,029 (23.7%) were non-compliant with the screening programme. Younger subjects and people who felt pressure when making their decision were associated with regret. People who regretted their decision were 2.189 (95% C. I. 1.3613.521, p = 0.001) times more likely to be non-compliant with the programme.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Bruggemann, Renee; Lam, Thomas Y. T.; Luk, Arthur K. C.; Wu, Justin C. Y.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Wong, Martin C. S.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Sung, Joseph J. Y./R-3203-2018; Chan, Francis K. L./F-4851-2010	Wong, Martin/0000-0001-7706-9370; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Francis K. L./0000-0001-7388-2436; Chan, Victor/0000-0001-9178-5031	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The authors are grateful for the full funding support by the Hong Kong Jockey Club Charities Trust for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG 2011; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Clark JA, 2001, J CLIN ONCOL, V19, P72, DOI 10.1200/JCO.2001.19.1.72; Connolly T, 2002, CURR DIR PSYCHOL SCI, V11, P212, DOI 10.1111/1467-8721.00203; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Koo JH, 2012, GASTROINTEST ENDOSC, V76, P126, DOI 10.1016/j.gie.2012.03.168; Koo JH, 2010, CANCER EPIDEMIOL, V34, P604, DOI 10.1016/j.canep.2010.05.013; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; O'Connor AM., 1996, USER MANUAL DECISION; Pieters R, 2005, ORGAN BEHAV HUM DEC, V97, P18, DOI 10.1016/j.obhdp.2005.01.003; Sandberg T, 2008, BRIT J SOC PSYCHOL, V47, P589, DOI 10.1348/014466607X258704; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Walsh JME, 2004, J GEN INTERN MED, V19, P156, DOI 10.1111/j.1525-1497.2004.30263.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2014, GUT, V63, P1130, DOI 10.1136/gutjnl-2013-305639; Wong MCS, 2013, PREV MED, V57, P227, DOI 10.1016/j.ypmed.2013.05.017; Wong MCS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070209, 10.1371/journal.pone.0084321]; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060366; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	28	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125782	10.1371/journal.pone.0125782	http://dx.doi.org/10.1371/journal.pone.0125782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875160	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700077
J	Xu, CJ; Zeng, BY; Huang, JM; Huang, W; Liu, YM				Xu, Chuanjun; Zeng, Biyu; Huang, Junmei; Huang, Wen; Liu, Yumei			Genome-Wide Transcriptome and Expression Profile Analysis of Phalaenopsis during Explant Browning	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; CUT LETTUCE; POLYPHENOL; ANTHOCYANINS; PEROXIDASE; DISORDERS; FRUIT	Background Explant browning presents a major problem for in vitro culture, and can lead to the death of the explant and failure of regeneration. Considerable work has examined the physiological mechanisms underlying Phalaenopsis leaf explant browning, but the molecular mechanisms of browning remain elusive. In this study, we used whole genome RNA sequencing to examine Phalaenopsis leaf explant browning at genome-wide level. Methodology/Principal Findings We first used Illumina high-throughput technology to sequence the transcriptome of Phalaenopsis and then performed de novo transcriptome assembly. We assembled 79,434,350 clean reads into 31,708 isogenes and generated 26,565 annotated unigenes. We assigned Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations, and potential Pfam domains to each transcript. Using the transcriptome data as a reference, we next analyzed the differential gene expression of explants cultured for 0, 3, and 6 d, respectively. We then identified differentially expressed genes (DEGs) before and after Phalaenopsis explant browning. We also performed GO, KEGG functional enrichment and Pfam analysis of all DEGs. Finally, we selected 11 genes for quantitative real-time PCR (qPCR) analysis to confirm the expression profile analysis. Conclusions/Significance Here, we report the first comprehensive analysis of transcriptome and expression profiles during Phalaenopsis explant browning. Our results suggest that Phalaenopsis explant browning may be due in part to gene expression changes that affect the secondary metabolism, such as: phenylpropanoid pathway and flavonoid biosynthesis. Genes involved in photosynthesis and ATPase activity have been found to be changed at transcription level; these changes may perturb energy metabolism and thus lead to the decay of plant cells and tissues. This study provides comprehensive gene expression data for Phalaenopsis browning. Our data constitute an important resource for further functional studies to prevent explant browning.	[Xu, Chuanjun; Zeng, Biyu; Huang, Junmei; Huang, Wen; Liu, Yumei] Fujian Inst Subtrop Bot, Fujian Key Lab Physiol & Biochem Subtrop Plants, Xiamen 361006, Peoples R China; [Liu, Yumei] Fujian Inst Subtrop Bot, Xiamen Overseas Chinese Subtrop Plant Intro Garde, Xiamen 361002, Peoples R China		Xu, CJ (corresponding author), Fujian Inst Subtrop Bot, Fujian Key Lab Physiol & Biochem Subtrop Plants, Xiamen 361006, Peoples R China.	xcj7099@aliyun.com			Natural Science Foundation in China [31070618]	Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation in China (31070618), http://www.nsfc.gov.cn/(CJX).	Andersen M, 2010, ENCY LIFE SCI, P1; BHAT SR, 1991, PLANT CELL REP, V10, P358, DOI 10.1007/BF00193159; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cascia G, 2013, PHYSIOL PLANTARUM, V147, P121, DOI 10.1111/j.1399-3054.2012.01641.x; [陈冬茵 CHEN Dong-yin], 2009, [亚热带植物科学, Subtropical Plant Science], V38, P15; Chen G, 2012, SCI HORTIC-AMSTERDAM, V141, P17, DOI 10.1016/j.scienta.2012.03.027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franck C, 2007, POSTHARVEST BIOL TEC, V43, P1, DOI 10.1016/j.postharvbio.2006.08.008; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Gould K., 2009, ANTHOCYANINS BIOSYNT; Hisaminato H, 2001, BIOSCI BIOTECH BIOCH, V65, P1016, DOI 10.1271/bbb.65.1016; Hong MJ, 2014, INT J RADIAT BIOL, V17, P1; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Jiang J, 2012, J AGR FOOD CHEM, V60, P3955, DOI 10.1021/jf205303y; Jiang YM, 2000, J SCI FOOD AGR, V80, P305, DOI 10.1002/1097-0010(200002)80:3&lt;305::AID-JSFA518&gt;3.0.CO;2-H; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071713; Krishna H, 2008, SCI HORTIC-AMSTERDAM, V118, P132, DOI 10.1016/j.scienta.2008.05.040; Laukkanen H, 1999, PHYSIOL PLANTARUM, V106, P337, DOI 10.1034/j.1399-3054.1999.106312.x; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074217; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; Mellidou I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0328-x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oliveros JC., 2007, INTERACTIVE TOOL COM; PARKIN KL, 1989, J FOOD BIOCHEM, V13, P127, DOI 10.1111/j.1745-4514.1989.tb00389.x; Ru ZhiWei, 2013, Journal of Agricultural Science (Toronto), V5, P57; Ruenroengklin N, 2009, FOOD CHEM, V115, P1253, DOI 10.1016/j.foodchem.2009.01.040; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Tanaka E, 2011, J AGR FOOD CHEM, V59, P6705, DOI 10.1021/jf200382e; Veltman RH, 2003, POSTHARVEST BIOL TEC, V28, P295, DOI 10.1016/S0925-5214(02)00198-9; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Xu CJ, 2011, PAK J BOT, V43, P2161; Xu ChuanJun, 2006, Acta Horticulturae Sinica, V33, P671; Xu ChuanJun, 2005, Acta Horticulturae Sinica, V32, P1111; Xu CJ, 2007, J TROP SUBTROP BOT, V5, P50; Xu CJ, 2010, N HORTIC, V21, P90; Ye M, 2004, LETT BIOTEC, V15, P426; YU JJ, 1990, PLANT CELL, V2, P315; Zhou WL., 2009, GENES GENOM GENOMICS, V3, P68	42	16	20	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123356	10.1371/journal.pone.0123356	http://dx.doi.org/10.1371/journal.pone.0123356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874455	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700029
J	Chan, DC; Yang, RS; Ho, CH; Tsai, YS; Wang, JJ; Tsai, KT				Chan, Ding-Cheng; Yang, Rong-Sen; Ho, Chung-Han; Tsai, Yau-Sheng; Wang, Jhi-Joung; Tsai, Kang-Ting			The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus-A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; UNDERCARBOXYLATED OSTEOCALCIN; OLDER MEN; MARKERS; SUPPLEMENTATION; OSTEOPOROSIS; PREVALENCE; TURNOVER; THERAPY	Purpose Bone remodeling has been linked to glucose metabolism in animal studies, but the results of human trials were inconclusive. Bisphosphonates may play a role in glucose metabolism through their impacts on bone remodeling enzymes. In this study, we aimed to examine the influence of alendronate usage on the incidence of type 2 diabetes mellitus (DM) among osteoporotic patients. Methods A retrospective cohort study was designed to include osteoporotic patients without DM from a population-based cohort containing 1,000,000 subjects. Patients treated with alendronate (exposed group, N=1,011) were compared with those who received no treatment (age and gender matched non-exposed group, N=3,033). Newly diagnosed DM was identified from medical records by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM) code. The incidence of DM in both groups was calculated for comparison. Results The non-exposed group had a significantly higher incidence of DM (Odds ratio 1.21, 95% confidence interval 1.03 similar to 1.41) when compared with the exposed group. In subgroup analysis, the DM risk reduction in exposed group was only significant among those younger than 65 years and those without hypertension or dyslipidemia. Patients who were prescribed alendronate more than or equal to 3 times had demonstrated a significant reduction in DM risk. Conclusions Our study showed alendronate might yield a protective effect for incident DM. This effect became insignificant in patients with older age, dyslipidemia or hypertension. The underlying mechanism needs further exploration with prospective data for confirmation of the observed findings.	[Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Gerontol & Geriatr, Taipei, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Superintendent Off, JinShan Branch, New Taipei City, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung] Chi Mei Med Ctr, Inst Med Res, Tainan, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 70101, Taiwan; [Tsai, Kang-Ting] Chi Mei Med Ctr, Dept Geriatr, Tainan, Taiwan; [Tsai, Kang-Ting] Chi Mei Med Ctr, Dept Family Med, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital	Tsai, KT (corresponding author), Chi Mei Med Ctr, Dept Geriatr, Tainan, Taiwan.	irised57@yahoo.com.tw	Ting, Tsai Kang/J-1468-2019	CHAN, DING-CHENG/0000-0003-2215-2243; Yang, Rong-Sen/0000-0002-0553-4779; Ho, Chung-Han/0000-0001-5925-8477				Abdelazim IA, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0189-9; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Chan WP, 2004, ACTA RADIOL, V45, P59, DOI 10.1080/02841850310003221; Chang CH, 2010, DIABETIC MED, V27, P636, DOI 10.1111/j.1464-5491.2010.03007.x; Choi HJ, 2008, MATURITAS, V60, P170, DOI 10.1016/j.maturitas.2008.05.003; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hirao M, 2008, J BONE MINER METAB, V26, P260, DOI 10.1007/s00774-007-0823-3; Kumar R, 2010, AM J CLIN NUTR, V92, P1528, DOI 10.3945/ajcn.2010.30108; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Maugeri D, 2002, ARCH GERONTOL GERIAT, V34, P117, DOI 10.1016/S0167-4943(01)00202-3; Perifanis V, 2007, ANN HEMATOL, V86, P23, DOI 10.1007/s00277-006-0180-7; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Schafer AL, 2011, J CLIN ENDOCR METAB, V96, pE1982, DOI 10.1210/jc.2011-0587; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P265, DOI 10.1007/s00223-011-9515-z; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009; Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414; Yoshida M, 2008, DIABETES CARE, V31, P2092, DOI 10.2337/dc08-1204	20	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123279	10.1371/journal.pone.0123279	http://dx.doi.org/10.1371/journal.pone.0123279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874962	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100159
J	Chuan, FN; Tang, K; Jiang, P; Zhou, B; He, XQ				Chuan, Fengning; Tang, Kang; Jiang, Peng; Zhou, Bo; He, Xiaoqun			Reliability and Validity of the Perfusion, Extent, Depth, Infection and Sensation (PEDIS) Classification System and Score in Patients with Diabetic Foot Ulcer	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; VALIDATION; RISK; MANAGEMENT; DISEASE	Aims To validate the perfusion, extent, depth, infection and sensation (PEDIS) classification system and to make the clinical practice easier, we created a score system and compared this system with two previously published common score systems. Methods A retrospective cohort study was conducted on patients with diabetic foot ulcer (DFU) attending our hospital (n=364) from May 2007 to September 2013. Participants' characteristics and all variables composing the PEDIS classification system were assessed. Results During a median follow-up of 25 months (range 6-82), ulcers healed in 217 of the 364 patients (59.6%), remained unhealed in 37 patients (10.2%), and were resolved by amputation in 62 patients (17.0%); 48 patients (13.2%) died. When measured using the PEDIS classification system, the outcome of DFU deteriorated with increasing severity of each subcategory. Additionally, longer ulcer history, worse perfusion of lower limb, a larger extent of the ulcer, a deeper wound, more severe infection, and loss of protective sensation were independent predictors of adverse outcome. More importantly, the new PEDIS score system showed good diagnostic accuracy, especially when compared with the SINBAD and Wagner score systems. Conclusions The PEDIS classification system, which encompasses relevant variables that contribute to the outcome of DFU and has excellent capacity for predicting the ulcer outcome, demonstrated acceptable accuracy. The PEDIS classification system might be useful in clinical practice and research both for the anticipation of health care costs and for comparing patient subgroups.	[Chuan, Fengning; Tang, Kang; Jiang, Peng; Zhou, Bo; He, Xiaoqun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Zhou, B (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	zhoubo915@126.com			National Key Clinical Department Construction Project	National Key Clinical Department Construction Project	This study was funded by the National Key Clinical Department Construction Project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.06.055; Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Chu Y.-J., 2014, INT WOUND J; Donnelly R, 2000, BRIT MED J, V320, P1062, DOI 10.1136/bmj.320.7241.1062; Ince P, 2008, DIABETES CARE, V31, P964, DOI 10.2337/dc07-2367; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Karthikesalingam A, 2010, DIABETIC MED, V27, P544, DOI 10.1111/j.1464-5491.2010.02989.x; Lavery LA, 2007, CLIN INFECT DIS, V44, P562, DOI 10.1086/511036; Lee JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086515; Lipsky BA, 2011, DIABETES CARE, V34, P1695, DOI 10.2337/dc11-0331; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Monteiro-Soares M, 2012, EUR J ENDOCRINOL, V167, P401, DOI 10.1530/EJE-12-0279; Monteiro-Soares M, 2011, DIABETOLOGIA, V54, P1190, DOI 10.1007/s00125-010-2030-3; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Oyibo SO, 2001, DIABETES CARE, V24, P84, DOI 10.2337/diacare.24.1.84; Reynolds T, 2001, ANN INTERN MED, V135, P637, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00023; Schaper NC, 2004, DIABETES-METAB RES, V20, pS90, DOI 10.1002/dmrr.464; Shahbazian H, 2013, PAK J MED SCI, V29, P730, DOI 10.12669/pjms.293.3473; Smith Robert G, 2003, Ostomy Wound Manage, V49, P54; Treece KA, 2004, DIABETIC MED, V21, P987, DOI 10.1111/j.1464-5491.2004.01275.x; Trignano E, 2015, MICROSURGERY; Wang Ai-hong, 2012, Zhonghua Yi Xue Za Zhi, V92, P224; Younes Nidal A, 2004, J Foot Ankle Surg, V43, P209, DOI 10.1053/j.jfas.2004.05.003	24	47	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124739	10.1371/journal.pone.0124739	http://dx.doi.org/10.1371/journal.pone.0124739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875097	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100270
J	Helmbrecht, MS; Soellner, H; Castiblanco-Urbina, MA; Winzeck, S; Sundermeier, J; Theis, FJ; Fouad, K; Huber, AB				Helmbrecht, Michaela S.; Soellner, Heidi; Castiblanco-Urbina, Maria A.; Winzeck, Stefan; Sundermeier, Julia; Theis, Fabian J.; Fouad, Karim; Huber, Andrea B.			A Critical Period for Postnatal Adaptive Plasticity in a Model of Motor Axon Miswiring	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SEMAPHORIN 3F; ENRICHMENT; EXPERIENCE; CIRCUITRY; NEURONS; CORTEX; EPH	The correct wiring of neuronal circuits is of crucial importance for precise neuromuscular functionality. Therefore, guidance cues provide tight spatiotemporal control of axon growth and guidance. Mice lacking the guidance cue Semaphorin 3F (Sema3F) display very specific axon wiring deficits of motor neurons in the medial aspect of the lateral motor column (LMCm). While these deficits have been investigated extensively during embryonic development, it remained unclear how Sema3F mutant mice cope with these errors postnatally. We therefore investigated whether these animals provide a suitable model for the exploration of adaptive plasticity in a system of miswired neuronal circuitry. We show that the embryonically developed wiring deficits in Sema3F mutants persist until adulthood. As a consequence, these mutants display impairments in motor coordination that improve during normal postnatal development, but never reach wildtype levels. These improvements in motor coordination were boosted to wildtype levels by housing the animals in an enriched environment starting at birth. In contrast, a delayed start of enriched environment housing, at 4 weeks after birth, did not similarly affect motor performance of Sema3F mutants. These results, which are corroborated by neuroanatomical analyses, suggest a critical period for adaptive plasticity in neuromuscular circuitry. Interestingly, the formation of perineuronal nets, which are known to close the critical period for plastic changes in other systems, was not altered between the different housing groups. However, we found significant changes in the number of excitatory synapses on limb innervating motor neurons. Thus, we propose that during the early postnatal phase, when perineuronal nets have not yet been formed around spinal motor neurons, housing in enriched environment conditions induces adaptive plasticity in the motor system by the formation of additional synaptic contacts, in order to compensate for coordination deficits.	[Helmbrecht, Michaela S.; Soellner, Heidi; Castiblanco-Urbina, Maria A.; Winzeck, Stefan; Sundermeier, Julia; Huber, Andrea B.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Theis, Fabian J.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany; [Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Alberta	Huber, AB (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	andrea.huber@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021	Theis, Fabian J/0000-0002-2419-1943; Fouad, Karim/0000-0003-3654-7852	International Foundation for Research in Paraplegia (AHB); German Science Foundation Collaborative Research Centre (CRC) [870]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; European Research Council (starting grant LatentCauses); Deutsche Forschungsgemeinschaft [SPP 1356]	International Foundation for Research in Paraplegia (AHB); German Science Foundation Collaborative Research Centre (CRC); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; European Research Council (starting grant LatentCauses); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge the support by the International Foundation for Research in Paraplegia (AHB), the German Science Foundation Collaborative Research Centre (CRC)870 and the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. F.J.T. was supported by the European Research Council (starting grant LatentCauses) and the Deutsche Forschungsgemeinschaft (SPP 1356 Pluripotency and Cellular Reprogramming). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bengoetxea H, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/305693; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Berrocal Y, 2007, J NEUROTRAUM, V24, P1761, DOI 10.1089/neu.2007.0327; Claudepierre T, 2008, DEV DYNAM, V237, P3394, DOI 10.1002/dvdy.21759; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Glasl L, 2012, EXP NEUROL, V235, P214, DOI 10.1016/j.expneurol.2012.01.002; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Heyser Charles J, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0818s25; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kao TJ, 2012, SEMIN CELL DEV BIOL, V23, P83, DOI 10.1016/j.semcdb.2011.10.016; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Maya-Vetencourt JF, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/631965; Murphy KM, 2005, DEV PSYCHOBIOL, V46, P209, DOI 10.1002/dev.20053; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Parker D, 2000, MOL NEUROBIOL, V22, P55, DOI 10.1385/MN:22:1-3:055; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Sahay A, 2003, J NEUROSCI, V23, P6671; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Simonetti T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006780; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; THOMPSON WJ, 1985, CELL MOL NEUROBIOL, V5, P167, DOI 10.1007/BF00711091; Tognini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034815; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Zadicario P, 2005, BEHAV BRAIN RES, V159, P27, DOI 10.1016/j.bbr.2004.09.022	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123643	10.1371/journal.pone.0123643	http://dx.doi.org/10.1371/journal.pone.0123643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874621	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100193
J	Kasonga, AE; Deepak, V; Kruger, MC; Coetzee, M				Kasonga, Abe E.; Deepak, Vishwa; Kruger, Marlena C.; Coetzee, Magdalena			Arachidonic Acid and Docosahexaenoic Acid Suppress Osteoclast Formation and Activity in Human CD14+Monocytes, In vitro	PLOS ONE			English	Article							N-3 FATTY-ACIDS; BONE-MINERAL DENSITY; EICOSAPENTAENOIC ACID; GENE-EXPRESSION; PHOSPHATASE 5B; HIP FRACTURE; CATHEPSIN K; RISK; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION	An unbalanced diet can have adverse effects on health. Long chain polyunsaturated fatty acids (LCPUFAs) have been the focus of research owing to their necessity of inclusion in a healthy diet. However, the effects of LCPUFAs on human osteoclast formation and function have not been explored before. A human CD14+ monocyte differentiation model was used to elucidate the effects of an omega-3 LCPUFA, docosahexaenoic acid (DHA), and an omega-6 LCPUFA, arachidonic acid (AA), on osteoclast formation and activity. CD14+ monocytes were isolated from peripheral blood of healthy donors and stimulated with macrophage colony stimulating factor and receptor activator of nuclear factor kappa-B ligand to generate osteoclasts. Data from this study revealed that both the LCPUFAs decreased osteoclast formation potential of CD14+ monocytes in a dose-dependent manner when treated at an early stage of differentiation. Moreover, when exposed at a late stage of osteoclast differentiation AA and DHA impaired the bone resorptive potential of mature osteoclasts without affecting osteoclast numbers. AA and DHA abrogated vitronectin receptor expression in differentiating as well as mature osteoclasts. In contrast, the degree of inhibition for calcitonin receptor expression varied between the LCPUFAs with only AA causing inhibition during osteoclast differentiation. Furthermore, AA and DHA down regulated the expression of key osteoclast-specific genes in differentiating as well as mature osteoclasts. This study demonstrates for the first time that LCPUFAs can modulate osteoclast formation and function in a human primary osteoclast cell line.	[Kasonga, Abe E.; Deepak, Vishwa; Coetzee, Magdalena] Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0002 Pretoria, South Africa; [Kruger, Marlena C.] Massey Univ, Massey Inst Food Sci & Technol, Sch Food & Nutr, Palmerston North, New Zealand; [Kruger, Marlena C.] Univ Pretoria, Dept Human Nutr, Nutr & Well Being, ZA-0002 Pretoria, South Africa; [Kruger, Marlena C.] Univ Pretoria, Associate Inst Food, Nutr & Well Being, ZA-0002 Pretoria, South Africa	University of Pretoria; Massey University; University of Pretoria; University of Pretoria	Coetzee, M (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0002 Pretoria, South Africa.	magdalena.coetzee@up.ac.za	Kasonga, Abe/I-4548-2019	Kasonga, Abe/0000-0001-7379-6044; Coetzee, Magdalena/0000-0002-5815-9247	South African Medical Research Council (MRC); University of Pretoria School of Medicine Research Committee (RESCOM); University of Pretoria Postgraduate Study Abroad Programme	South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Pretoria School of Medicine Research Committee (RESCOM); University of Pretoria Postgraduate Study Abroad Programme	This work was supported by grants from the South African Medical Research Council (MRC), the University of Pretoria School of Medicine Research Committee (RESCOM) and the University of Pretoria Postgraduate Study Abroad Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed are those of the authors of the manuscript.	Agrawal A, 2012, METHODS MOL BIOL, V806, P357, DOI 10.1007/978-1-61779-367-7_23; Agrawal A, 2010, PURINERG SIGNAL, V6, P307, DOI 10.1007/s11302-010-9181-z; Al-Nouri DM, 2012, J FUNCT FOODS, V4, P584, DOI 10.1016/j.jff.2012.03.004; Allard-Chamard H, 2014, PROSTAG LEUKOTR ESS, V90, P117, DOI 10.1016/j.plefa.2013.12.009; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bassey EJ, 2000, BRIT J NUTR, V83, P629, DOI 10.1017/S0007114500000805; Boeyens JCA, 2014, NUTRIENTS, V6, P2584, DOI 10.3390/nu6072584; Bonnet N, 2011, J NUTR BIOCHEM, V22, P665, DOI 10.1016/j.jnutbio.2010.05.006; Choi HK, 2011, CELL SIGNAL, V23, P1633, DOI 10.1016/j.cellsig.2011.05.017; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Corwin RL, 2003, PROSTAG LEUKOTR ESS, V68, P379, DOI 10.1016/S0952-3278(03)00062-0; Costa-Rodrigues J, 2010, J CELL BIOCHEM, V109, P205, DOI 10.1002/jcb.22398; Deepak V, 2014, CONNECT TISSUE RES, DOI [10.3109/03008207.03002014.03989320, DOI 10.3109/03008207.03002014.03989320]; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Faccio R, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P141, DOI 10.1016/B978-0-12-375670-1.10006-8; Farina EK, 2011, J NUTR, V141, P1146, DOI 10.3945/jn.110.133728; Farina EK, 2011, AM J CLIN NUTR, V93, P1142, DOI 10.3945/ajcn.110.005926; Ferlin A, 2010, BONE, V46, P504, DOI 10.1016/j.bone.2009.10.007; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Goto T, 2003, J ELECTRON MICROSC, V52, P551, DOI 10.1093/jmicro/52.6.551; Halleen JM, 2006, CLIN LAB, V52, P499; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482; Hogstrom M, 2007, AM J CLIN NUTR, V85, P803; Hutchins-Wiese HL, 2014, NUTR CANCER, V66, P68, DOI 10.1080/01635581.2014.847964; Johnson MR, 1996, GENOME RES, V6, P1050, DOI 10.1101/gr.6.11.1050; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Kurlak LO, 1999, ARCH DIS CHILD-FETAL, V80, pF148, DOI 10.1136/fn.80.2.F148; Lepidi S, 2001, J VASC SURG, V34, P1111, DOI 10.1067/mva.2001.119401; McLaughlin V, 2013, NUTR REV, V71, P600, DOI 10.1111/nure.12043; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Rahman M, 2008, J CELL PHYSIOL, V214, P201, DOI 10.1002/jcp.21188; Rasband WS, 2014, IMAGEJ; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Sharif PS, 2010, AGE, V32, P179, DOI 10.1007/s11357-009-9122-3; Shomali T, 2009, BASIC CLIN PHARMACOL, V105, P46, DOI 10.1111/j.1742-7843.2009.00393.x; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tartibian B, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-71; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Vaananen HK, 2000, J CELL SCI, V113, P377; Virtanen JK, 2012, OSTEOPOROSIS INT, V23, P2615, DOI 10.1007/s00198-012-1903-3; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WALSH CA, 1991, J BONE MINER RES, V6, P661; Xing LP, 2013, BONE RES, V1, P336, DOI 10.4248/BR201304004; Yuan JZ, 2010, PROSTAG OTH LIPID M, V92, P85, DOI 10.1016/j.prostaglandins.2010.04.001	54	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125145	10.1371/journal.pone.0125145	http://dx.doi.org/10.1371/journal.pone.0125145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867515	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100292
J	Kosik, I; Praznovska, M; Kosikova, M; Bobisova, Z; Holly, J; Vareckova, E; Kostolansky, F; Russ, G				Kosik, Ivan; Praznovska, Margareta; Kosikova, Martina; Bobisova, Zuzana; Holly, Jaroslav; Vareckova, Eva; Kostolansky, Frantisek; Russ, Gustav			The Ubiquitination of the Influenza A Virus PB1-F2 Protein Is Crucial for Its Biological Function	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE; LYSINE RESIDUES; EXPRESSION; DEGRADATION; CONTRIBUTES; INDUCTION; RNA; PATHOGENICITY; LOCALIZATION; PATHOGENESIS	The aim of the present study was to identify what influences the short half-life of the influenza A virus PB1-F2 protein and whether a prolonged half-life affects the properties of this molecule. We hypothesized that the short half-life of PB1-F2 could conceal the phenotype of the protein. Because proteasome degradation might be involved in PB1-F2 degradation, we focused on ubiquitination, a common label for proteasome targeting. A cluster of lysine residues was demonstrated as an ubiquitination acceptor site in evolutionary and functionally distinct proteins. The PB1-F2 sequence alignment revealed a cluster of lysines on the carboxy terminal end of PB1-F2 in almost all of the GenBank sequences available to date. Using a proximity ligation assay, we identified ubiquitination as a novel posttranslational modification of PB1-F2. Changing the lysines at positions 73, 78, and 85 to arginines suppressed the ubiquitination of A/Puerto Rico/8/1934 (H1N1)-derived PB1-F2. The mutation of the C-terminal lysine residue cluster positively affected the overall expression levels of avian A/Honk Kong/156/1997 (H5N1)- and mammalian A/Puerto Rico/8/1934 (H1N1)derived PB1-F2. Moreover, increased PB1-F2 copy numbers strengthened the functions of this virus in the infected cells. The results of a minigenome luciferase reporter assay revealed an enhancement of viral RNA-dependent RNA polymerase activity in the presence of stabilized PB1-F2, regardless of viral origin. IFN beta antagonism was enhanced in 293T cells transfected with a plasmid expressing stabilized K -> R mutant variants of PB1-F2. Compared with PB1-F2 wt, the loss of ubiquitination enhanced the antibody response after DNA vaccination. In summary, we revealed that PB1-F2 is an ubiquitinated IAV protein, and this posttranslational modification plays a central role in the regulation of the biological functions of this protein.	[Kosik, Ivan; Praznovska, Margareta; Kosikova, Martina; Bobisova, Zuzana; Holly, Jaroslav; Vareckova, Eva; Kostolansky, Frantisek; Russ, Gustav] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia	Slovak Academy of Sciences	Kosik, I (corresponding author), Slovak Acad Sci, Inst Virol, Dubravska Cesta 9, Bratislava 84505, Slovakia.	virukosi@savba.sk	Kostolansky, Frantisek/HHS-1115-2022	Kosik, Ivan/0000-0001-5756-5182	Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences [2/0085/10, 2/0124/11 KP, 2/0176/12 EV, 2/0100/13 FK, 02/152/14 IK, 02/153/14 ZB]; Slovak Research and Development Agency [APVV-0250-10 EV, DO7RP-0025-10 EV]	Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency)	This work was supported through 2/0085/10, 2/0124/11 KP, 2/0176/12 EV, 2/0100/13 FK, 02/152/14 IK and 02/153/14 ZB grants from the Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences, https://www.minedu.sk/vedecka-grantova-agentura-msvvas-sr-a-sav-vega/. This study was also supported through grants no. APVV-0250-10 EV and DO7RP-0025-10 EV from the Slovak Research and Development Agency, http://www.apvv.sk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Belicha-Villanueva A, 2012, J VIROL, V86, P5926, DOI 10.1128/JVI.06384-11; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Buehler J, 2013, J VIROL, V87, P10687, DOI 10.1128/JVI.01520-13; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen JH, 2011, HEPAT MON, V11, P620, DOI 10.5812/kowsar.1735143X.689; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Fu F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-264; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Kosik I, 2013, VIROLOGY, V447, P1, DOI 10.1016/j.virol.2013.08.022; Kosik I, 2013, ACTA VIROL, V57, P138, DOI 10.4149/av_2013_02_138; Kosik I, 2011, ACTA VIROL, V55, P45, DOI 10.4149/av_2011_01_45; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Krejnusova I, 2009, ARCH VIROL, V154, P1599, DOI 10.1007/s00705-009-0479-5; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee JC, 2005, APOPTOSIS, V10, P1483, DOI 10.1007/s10495-005-1833-z; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Meunier I, 2012, J VIROL, V86, P4271, DOI 10.1128/JVI.07243-11; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Pancucharova H, 2006, ACTA VIROL, V50, P269; Pena L, 2012, J VIROL, V86, P5523, DOI 10.1128/JVI.00134-12; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reis AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063852; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Sumita K, 2014, J BIOL CHEM, V289, P3950, DOI 10.1074/jbc.M113.531178; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Trovato R, 1999, J VIROL, V73, P6460, DOI 10.1128/JVI.73.8.6460-6467.1999; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	59	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118477	10.1371/journal.pone.0118477	http://dx.doi.org/10.1371/journal.pone.0118477			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866881	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100007
J	Qu, YJ; Zhuo, L; Li, N; Hu, YQ; Chen, WH; Zhou, Y; Wang, JW; Tao, QM; Hu, J; Nie, XL; Zhan, SY				Qu, Yanji; Zhuo, Lin; Li, Na; Hu, Yiqing; Chen, Weihua; Zhou, Yun; Wang, Jinwei; Tao, Qingmei; Hu, Jing; Nie, Xiaolu; Zhan, Siyan			Prevalence of Post-Stroke Cognitive Impairment in China: A Community-Based, Cross-Sectional Study	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; CLINICAL DETERMINANTS; 1ST-EVER STROKE; DEMENTIA; HEMORRHAGE; FREQUENCY; SURVIVORS; COHORT	International hospital-based studies have indicated a high risk of cognitive impairment after stroke, evidence from community-based studies in China is scarce. To determine the prevalence of post-stroke cognitive impairment (PSCI) and its subtypes in stroke survivors residing in selected rural and urban Chinese communities, we conducted a community-based, cross-sectional study in 599 patients accounting for 48% of all stroke survivors registered in the 4 communities, who had suffered confirmed strokes and had undergone cognitive assessments via the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Hachinski Ischemia Scale (HIS). Detection of PSCI was based on scores in these neuropsychological scales. Factors potentially impacting on occurrence of PSCI were explored by comparing demographic characteristics, stroke features, and cardiovascular risk factors between patients with and without PSCI. The overall prevalence of PSCI was 80.97% (95% CI: 77.82%-84.11%), while that of non-dementia PSCI (PSCI-ND) and post-stroke vascular dementia (PSD) was 48.91% (95% CI: 44.91%-52.92%) and 32.05% (95% CI: 28.32%-35.79%), respectively. Prior stroke and complications during the acute phase were independent risk factors for PSCI. The risk of recurrent stroke survivors having PSCI was 2.7 times higher than for first-episode survivors, and it was 3 times higher for those with complications during the acute phase than for those without. The higher prevalence of PSCI in this study compared with previous Chinese studies was possibly due to the combined effects of including rural stroke survivors, a longer period from stroke onset, and different assessment methods. There is an urgent need to recognize and prevent PSCI in stroke patients, especially those with recurrent stroke and complications during the acute phase.	[Qu, Yanji] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Qu, Yanji; Zhuo, Lin; Wang, Jinwei; Tao, Qingmei; Hu, Jing; Nie, Xiaolu; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Li, Na] Fangshan Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Hu, Yiqing] Bansongyuan Ctr Community Hlth Serv, Shanghai, Peoples R China; [Chen, Weihua] East Nanjing Rd Ctr Community Hlth Serv, Shanghai, Peoples R China; [Zhou, Yun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Peking University; Capital Medical University	Zhan, SY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing, Peoples R China.	siyan-zhan@bjmu.edu.cn	Qu, Yanji/GSN-4453-2022	Nie, Xiaolu/0000-0001-8026-7845; Zhuo, Lin/0000-0001-9188-702X	Bayer HealthCare, China Ltd; National Twelve-Fifth Scientific Research Project [2011BAI08B01]	Bayer HealthCare, China Ltd; National Twelve-Fifth Scientific Research Project	Financial support for the study was provided by Bayer HealthCare, China Ltd and the National Twelve-Fifth Scientific Research Project (Grant No. 2011BAI08B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Fan B, 1989, SHANGHAI ARCH PSYCHI, V3, P131; Garcia PY, 2013, J STROKE CEREBROVASC, V22, P80, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.013; Gong-wei J, 2008, NEURAL INJURY FUNCTI, V3, P41; Ihle-Hansen H, 2011, DEMENT GERIATR COGN, V32, P401, DOI 10.1159/000335361; Jacquin A, 2014, J ALZHEIMERS DIS, V40, P1029, DOI 10.3233/JAD-131580; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Li JC, 2005, CHINESE J CLIN REHAB, V9, P156; Liu HJ, 2009, CHINESE J CEREBROVAS, V6, P514; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Merino JG, 2002, STROKE, V33, P2261; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Mukhopadhyay Amita, 2012, J Assoc Physicians India, V60, P29; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pasi M, 2012, FRONT NEUROL NEUROSC, V30, P65, DOI 10.1159/000333412; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Qu YJ, 2013, CHIN J GERIATR HEART, V15, P1294; Royal College of Physicians, NAT CLIN GUID STROK; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434; Srikanth VK, 2003, STROKE, V34, P1136, DOI 10.1161/01.STR.0000069161.35736.39; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Tang X, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-60; TATEMICHI TK, 1990, STROKE, V21, P858, DOI 10.1161/01.STR.21.6.858; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; [王海波 Wang Haibo], 2014, [中国全科医学, Chinese General Practice], V17, P4374; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Qun, 2008, Zhonghua Nei Ke Za Zhi, V47, P981; [张立秀 Zhang Lixiu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P123; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhang Y, 2012, J HUAZHONG U SCI-MED, V32, P906, DOI 10.1007/s11596-012-1056-9; Zhou DHD, 2005, NEUROEPIDEMIOLOGY, V24, P87, DOI 10.1159/000081055; Zhou JJ, 2011, SHANGHAI J PREVENTIV, V23, P224; 涂秋云, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P3576	41	59	80	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122864	10.1371/journal.pone.0122864	http://dx.doi.org/10.1371/journal.pone.0122864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874998	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100112
J	Yu, DN; Zhang, JY; Li, P; Zheng, RQ; Shao, C				Yu, Danna; Zhang, Jiayong; Li, Peng; Zheng, Rongquan; Shao, Chen			Do Cryptic Species Exist in Hoplobatrachus rugulosus? An Examination Using Four Nuclear Genes, the Cyt b Gene and the Complete MT Genome	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; COMPLETE NUCLEOTIDE-SEQUENCE; DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; 3-DIMENSIONAL STRUCTURES; FROGS; ANURA; EVOLUTION; AMPHIBIA; WEB	he Chinese tiger frog Hoplobatrachus rugulosus is widely distributed in southern China, Malaysia, Myanmar, Thailand, and Vietnam. It is listed in Appendix II of CITES as the only Class II nationally-protected frog in China. The bred tiger frog known as the Thailand tiger frog, is also identified as H. rugulosus. Our analysis of the Cyt b gene showed high genetic divergence (13.8%) between wild and bred samples of tiger frog. Unexpected genetic divergence of the complete mt genome (14.0%) was also observed between wild and bred samples of tiger frog. Yet, the nuclear genes (NCX1, Rag1, Rhod, Tyr) showed little divergence between them. Despite this and their very similar morphology, the features of the mitochondrial genome including genetic divergence of other genes, different three-dimensional structures of ND5 proteins, and gene rearrangements indicate that H. rugulosus may be a cryptic species complex. Using Bayesian inference, maximum likelihood, and maximum parsimony analyses, Hoplobatrachus was resolved as a sister clade to Euphlyctis, and H. rugulosus (BT) as a sister clade to H. rugulosus (WT). We suggest that we should prevent Thailand tiger frogs (bred type) from escaping into wild environments lest they produce hybrids with Chinese tiger frogs (wild type).	[Yu, Danna; Zhang, Jiayong; Zheng, Rongquan] Zhejiang Normal Univ, Inst Ecol, Jinhua 321004, Zhejiang, Peoples R China; [Zhang, Jiayong; Shao, Chen] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Zhejiang, Peoples R China; [Yu, Danna; Li, Peng] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Zheng, Rongquan] Zhejiang Normal Univ, Inst Special Aquaculture Source, Jinhua 321004, Zhejiang, Peoples R China	Zhejiang Normal University; Zhejiang Normal University; Nanjing Normal University; Zhejiang Normal University	Zhang, JY (corresponding author), Zhejiang Normal Univ, Inst Ecol, Jinhua 321004, Zhejiang, Peoples R China.	zhang3599533@163.com	Li, Peng/GYD-6748-2022; Zheng, Rongquan/AAR-5372-2021		Science Technology Commission of Zhejiang Province of China [2014C32068, 2011C22006, 2012R10026-07, 2013R404019]; National Natural Science Foundation of China [31172116, 31472015]	Science Technology Commission of Zhejiang Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Special thanks go to the Committee of Forest Administrative Bureau of Jinhua for samples. This research was supported by the Science Technology Commission of Zhejiang Province of China (No. 2014C32068, 2011C22006, 2012R10026-07 and 2013R404019) and the National Natural Science Foundation of China (No. 31172116 and 31472015).	Alam MS, 2008, MOL PHYLOGENET EVOL, V48, P515, DOI 10.1016/j.ympev.2008.04.020; Alam MS, 2010, GENES GENET SYST, V85, P219, DOI 10.1266/ggs.85.219; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avise John C., 1994, pi; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BOORE JL, 1994, NAUTILUS, V108, P61; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brown W.M., 1983, P62; Burland T G, 2000, Methods Mol Biol, V132, P71; Cannatella DC, 1998, SYST BIOL, V47, P311, DOI 10.1080/106351598260932; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Channing A, 1999, T ROY SOC S AFR, V54, P121, DOI 10.1080/00359199909520407; Che J, 2007, MOL PHYLOGENET EVOL, V43, P1, DOI 10.1016/j.ympev.2006.11.032; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chen GY, 2011, CURR ZOOL, V57, P785, DOI 10.1093/czoolo/57.6.785; Chen LQ, 2005, HERPETOL J, V15, P231; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Dubois Alain, 2005, Alytes (Paris), V23, P1; Dubois Alain, 1992, Bulletin Mensuel de la Societe Linneenne de Lyon, V61, P305; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Fei L, 2010, COLORED ATLAS CHINES, P1; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; HAY JM, 1995, MOL BIOL EVOL, V12, P928; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P2621, DOI 10.1073/pnas.91.7.2621; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Jia WZ, 2012, ACTA TROP, V123, P154, DOI 10.1016/j.actatropica.2012.04.006; Kosuch J, 2001, MOL PHYLOGENET EVOL, V21, P398, DOI 10.1006/mpev.2001.1034; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kurabayashi A, 2010, MOL PHYLOGENET EVOL, V56, P543, DOI 10.1016/j.ympev.2010.01.022; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Macey JR, 2000, SYST BIOL, V49, P257, DOI 10.1093/sysbio/49.2.257; Matsui M, 2005, MOL PHYLOGENET EVOL, V37, P733, DOI 10.1016/j.ympev.2005.04.030; Pansook A, 2012, ZOOL SCI, V29, P54, DOI 10.2108/zsj.29.54; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ren ZM, 2009, GENE, V441, P148, DOI 10.1016/j.gene.2008.09.010; Sambrook J., 2001, MOL CLONING LAB MANU; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Su X, 2007, GENE, V394, P25, DOI 10.1016/j.gene.2007.01.022; Sumida M, 2001, GENES GENET SYST, V76, P311, DOI 10.1266/ggs.76.311; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-691; Yu DN, 2012, MITOCHONDR DNA, V23, P336, DOI 10.3109/19401736.2012.690748; Zhang JY, 2008, GENE, V424, P18, DOI 10.1016/j.gene.2008.07.037; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	63	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124825	10.1371/journal.pone.0124825	http://dx.doi.org/10.1371/journal.pone.0124825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875761	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100275
J	Anund, A; Lahti, E; Fors, C; Genell, A				Anund, Anna; Lahti, Eva; Fors, Carina; Genell, Anders			The Effect of Low-Frequency Road Noise on Driver Sleepiness and Performance	PLOS ONE			English	Article							DRIVING SIMULATOR; RISK; FATIGUE	It is a well-known fact today that driver sleepiness is a contributory factor in crashes. Factors considered as sleepiness contributor are mostly related to time of the day, hours being awake and hours slept. Factors contributing to active and passive fatigue are mostly focusing on the level of cognitive load. Less is known what role external factors, e.g. type of road, sound/noise, vibrations etc., have on the ability to stay awake both under conditions of sleepiness and under active or passive fatigue. The aim of this moving base driving simulator study with 19 drivers participating in a random order day and night time, was to evaluate the effect of low-frequency road noise on driver sleepiness and performance, including both long-term and short-term effects. The results support to some extent the hypothesis that road-induced interior vehicle sound affects driving performance and driver sleepiness. Increased low-frequency noise helps to reduce speed during both day-and night time driving, but also contributes to increase the number of lane crossings during night time.	[Anund, Anna; Fors, Carina; Genell, Anders] Swedish Natl Rd & Transport Res Inst, Linkoping, Sweden; [Anund, Anna] Linkoping Univ, Rehabil Med, Linkoping, Sweden; [Lahti, Eva] Volvo Car Cooperat, Gothenburg, Sweden	VTI; Linkoping University; Volvo	Anund, A (corresponding author), Swedish Natl Rd & Transport Res Inst, Linkoping, Sweden.	anna.anund@vti.se		Anund, Anna/0000-0002-4790-7094	competence centre ViP (Virtual Prototyping and Assessment by Simulation); VINNOVA (the Swedish Governmental Agency for Innovation Systems) [2007-03083]; ViP; Volvo Car Cooperation	competence centre ViP (Virtual Prototyping and Assessment by Simulation); VINNOVA (the Swedish Governmental Agency for Innovation Systems)(Vinnova); ViP; Volvo Car Cooperation	This work was supported by the competence centre ViP (Virtual Prototyping and Assessment by Simulation, www.vipsimulation.se), co-financed by VINNOVA (the Swedish Governmental Agency for Innovation Systems; grant number 2007-03083) and the ViP partners. Volvo Car Cooperation provided support in the form of salaries for author Eva Lahti, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; Akerstedt T, 2001, J SLEEP RES, V10, P105, DOI 10.1046/j.1365-2869.2001.00248.x; [Anonymous], 2004, CONSUMER REPORTS, V69, P23; Anund A, 2009, IND HEALTH, V47, P393, DOI 10.2486/indhealth.47.393; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Filtness AJ, 2012, BIOL PSYCHOL, V89, P580, DOI 10.1016/j.biopsycho.2012.01.002; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Hanowski RJ, 2007, ACCIDENT ANAL PREV, V39, P169, DOI 10.1016/j.aap.2006.06.016; Hanowski RJ, 2003, ACCIDENT ANAL PREV, V35, P153, DOI 10.1016/S0001-4575(01)00098-7; Hartleip L.G., 2005, SAE TECHNICAL PAPERS; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; Horne JA, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00222.x; Ihs A, 2010, 6692010 VTI; James B, 2008, SOMNOLOGIE, V12, P227; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; Kjellberg A, 1997, ARBETE HALSA, V1; Klauer S.G., 2006, IMPACT DRIVER INATTE, DOI [10.1037/e729262011-001, DOI 10.1037/E729262011-001]; Landstrom U., 1987, Journal of Low Frequency Noise & Vibration, V6, P29; Lathi E, DRIV SIM C 2014 PAR, P21; Lofstedt P, 1988, ARBETSMILJOINSTITUTE, P15; Lowden A, 2009, ACCIDENT ANAL PREV, V41, P1001, DOI 10.1016/j.aap.2009.05.014; May JF, 2009, TRANSPORT RES F-TRAF, V12, P218, DOI 10.1016/j.trf.2008.11.005; Moren B, 1989, INVERKAN INFRALJUD B, P340; Philip P, 2009, SLEEP, V32, pA248; Soderberg L, 1988, ARBETSMILJOINSTITUTE, P25; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6	27	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123835	10.1371/journal.pone.0123835	http://dx.doi.org/10.1371/journal.pone.0123835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874883	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800118
J	Kayina, V; Kyobe, S; Katabazi, FA; Kigozi, E; Okee, M; Odongkara, B; Babikako, HM; Whalen, CC; Joloba, ML; Musoke, PM; Mupere, E				Kayina, Vincent; Kyobe, Samuel; Katabazi, Fred A.; Kigozi, Edgar; Okee, Moses; Odongkara, Beatrice; Babikako, Harriet M.; Whalen, Christopher C.; Joloba, Moses L.; Musoke, Philippa M.; Mupere, Ezekiel			Pertussis Prevalence and Its Determinants among Children with Persistent Cough in Urban Uganda	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; YOUNG INFANTS; DIAGNOSIS; EPIDEMIOLOGY; RESURGENCE; INFECTION; OUTBREAK; PROTECT; DISEASE; BURDEN	Background We determined prevalence of pertussis infection and its associated host and environmental factors to generate information that would guide strategies for disease control. Methods In a cross-sectional study, 449 children aged 3 months to 12 years with persistent cough lasting >= 14 days were enrolled and evaluated for pertussis using DNA polymerase chain reaction (PCR) and ELISA serology tests. Results Pertussis prevalence was 67 (15% (95% Confidence Interval (CI): 12-18)) and 81 (20% (95% CI: 16-24)) by PCR and ELISA, respectively among 449 participating children. The prevalence was highest in children with >59 months of age despite high vaccination coverage of 94% in this age group. Study demographic and clinical characteristics were similar between pertussis and non-pertussis cases. Of the 449 children, 133 (30%) had a coughing household member and 316 (70%) did not. Among 133 children that had a coughing household member, sex of child, sharing bed with a coughing household member and having a coughing individual in the neighborhood were factors associated with pertussis. Children that had shared a bed with a coughing household individual had seven-fold likelihood of having pertussis compared to children that did not (odds ratio (OR) 7.16 (95% CI: 1.24-41.44)). Among the 316 children that did not have a coughing household member, age <23 months, having or contact with a coughing individual in neighborhood, a residence with one room, and having a caretaker with >40 years of age were the factors associated with pertussis. Age <23 months was three times more likely to be associated with pertussis compared to age 24-59 months (OR 2.97 (95% CI: 1.07-8.28)). Conclusion Findings suggest high prevalence of pertussis among children with persistent cough at a health facility and it was marked in children >59 months of age, suggesting the possibility of waning immunity. The factors associated with pertussis varied by presence or absence of a coughing household member.	[Kayina, Vincent; Musoke, Philippa M.; Mupere, Ezekiel] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Kyobe, Samuel; Katabazi, Fred A.; Kigozi, Edgar; Okee, Moses; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Odongkara, Beatrice] Gulu Univ, Sch Med, Dept Paediat, Gulu, Uganda; [Babikako, Harriet M.] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Whalen, Christopher C.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	Makerere University; Makerere University; Makerere University; University System of Georgia; University of Georgia	Mupere, E (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda.	mupez@yahoo.com		Joloba, Moses/0000-0002-0334-9983; Mupere, Ezekiel/0000-0002-8746-9009	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust [087540]	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust	This work was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices.	BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Burns DL, 2014, J INFECT DIS, V209, pS32, DOI 10.1093/infdis/jit491; Cherry JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003418; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; Chuk LMR, 2008, COMMUN DIS INTELL, V32, P449; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Elliott E, 2004, PEDIATR INFECT DIS J, V23, P246, DOI 10.1097/01.inf.0000116023.56344.46; Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684; Hallander HO, 1999, CLIN INFECT DIS, V28, pS99, DOI 10.1086/515056; Hallbauer UM, 2011, S AFR FAM PRACT, V53, P495, DOI 10.1080/20786204.2011.10874140; HALPERIN SA, 1989, J PEDIATR-US, V115, P686, DOI 10.1016/S0022-3476(89)80643-2; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; Reizenstein E, 1996, J CLIN MICROBIOL, V34, P810, DOI 10.1128/JCM.34.4.810-815.1996; STREBEL P, 1991, J TROP PEDIATRICS, V37, P71, DOI 10.1093/tropej/37.2.71; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Uganda Bureau of Statistics [UBOS] ICF International, 2012, UG DEM HLTH SURV; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wiley KE, 2013, VACCINE, V31, P618, DOI 10.1016/j.vaccine.2012.11.052; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; Zouari A, 2012, DIAGN MICR INFEC DIS, V72, P303, DOI 10.1016/j.diagmicrobio.2012.01.002	27	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123240	10.1371/journal.pone.0123240	http://dx.doi.org/10.1371/journal.pone.0123240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874411	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800089
J	Raymond, AA; Benhamouche, S; Neaud, V; Di Martino, J; Javary, J; Rosenbaum, J				Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean			Reptin Regulates DNA Double Strand Breaks Repair in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; CELL-CYCLE; DAMAGE; SENESCENCE; STABILITY; APOPTOSIS; PROTEINS; CANCER; HSP90; PHOSPHORYLATION	Reptin/RUVBL2 is overexpressed in most hepatocellular carcinomas and is required for the growth and viability of HCC cells. Reptin is involved in several chromatin remodeling complexes, some of which are involved in the detection and repair of DNA damage, but data on Reptin involvement in the repair of DNA damage are scarce and contradictory. Our objective was to study the effects of Reptin silencing on the repair of DNA double-strand breaks (DSB) in HCC cells. Treatment of HuH7 cells with etoposide (25 mu M, 30 min) or. irradiation (4 Gy) increased the phosphorylation of H2AX by 1.94 +/- 0.13 and 2.0 +/- 0.02 fold, respectively. These values were significantly reduced by 35 and 65% after Reptin silencing with inducible shRNA. Irradiation increased the number of BRCA1 (3-fold) and 53BP1 foci (7.5 fold). Depletion of Reptin reduced these values by 62 and 48%, respectively. These defects in activation and/or recruitment of repair proteins were not due to a decreased number of DSBs as measured by the COMET assay. All these results were confirmed in the Hep3B cell line. Protein expression of ATM and DNA-PKcs, the major H2AX kinases, was significantly reduced by 52 and 61% after Reptin depletion whereas their mRNA level remained unchanged. Phosphorylation of Chk2, another ATM target, was not significantly altered. Using co-immunoprecipitation, we showed an interaction between Reptin and DNA-PKcs. The half-life of newly-synthesized DNA-PKcs was reduced when Reptin was silenced. Finally, depletion of Reptin was synergistic with etoposide or. irradiation to reduce cell growth and colony formation. In conclusion, Reptin is an important cofactor for the repair of DSBs. Our data, combined with those of the literature suggests that it operates at least in part by regulating the expression of DNA-PKcs by a stabilization mechanism. Overexpression of Reptin in HCC could be a factor of resistance to treatment, consistent with the observed overexpression of Reptin in subgroups of chemo-resistant breast and ovarian cancers.	[Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean] INSERM, U1053, F-33076 Bordeaux, France; [Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean] Univ Bordeaux 2, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rosenbaum, J (corresponding author), INSERM, U1053, F-33076 Bordeaux, France.	jean.rosenbaum@inserm.fr	Rosenbaum, Jean/F-5547-2013; Javary, Joaquim/AAR-5177-2021; di Martino, Julie Sandra/AAD-1430-2020	Rosenbaum, Jean/0000-0001-8585-5152; Javary, Joaquim/0000-0001-5423-6332; di Martino, Julie Sandra/0000-0002-2163-0736; RAYMOND, Anne-Aurelie/0000-0003-2697-9352	Equipe Labelisee Ligue Contre le Cancer; Institut National du Cancer [PLBIO10-155]; Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046"; Institut National du Cancer; Fondation pour la Recherche Medicale; Ligue Nationale Contre le Cancer	Equipe Labelisee Ligue Contre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046"; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The study was supported by grants from Equipe Labelisee Ligue Contre le Cancer 2011 to Jean Rosenbaum (http://www.ligue-cancer.net/), Institut National du Cancer grant PLBIO10-155 to JR (http://www.e-cancer.fr/), and Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046" to JR (http://www.e-cancer.fr/). AAR was supported by a fellowship from Institut National du Cancer (http://www.e-cancer.fr/), SB by a fellowship from Fondation pour la Recherche Medicale (http://www.frm.org/) and JJ by a fellowship from Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net/).	Ahmad Moaz, 2013, Communicative & Integrative Biology, V6, pe26005, DOI 10.4161/cib.26005; AJMANI AK, 1995, J EXP MED, V181, P2049, DOI 10.1084/jem.181.6.2049; Aoyama M, 2001, BIOCHEM PHARMACOL, V61, P49, DOI 10.1016/S0006-2952(00)00539-6; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Gospodinov A, 2009, INT J BIOCHEM CELL B, V41, P925, DOI 10.1016/j.biocel.2008.09.004; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Grigoletto A, 2011, BIOCHIM BIOPHYS ACTA, V31, P91; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huber O, 2008, CANCER RES, V68, P6873, DOI 10.1158/0008-5472.CAN-08-0547; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Izumi N, 2012, CANCER SCI, V103, P50, DOI 10.1111/j.1349-7006.2011.02112.x; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kubicka S, 1997, HEPATOLOGY, V25, P867, DOI 10.1002/hep.510250414; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Osaki H, 2013, LEUKEMIA, V27, P1461, DOI 10.1038/leu.2013.42; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Potter AJ, 2005, MUTAT RES-FUND MOL M, V572, P27, DOI 10.1016/j.mrfmmm.2004.11.018; Ren JC, 2013, UROL ONCOL-SEMIN ORI, V31, P1358, DOI 10.1016/j.urolonc.2012.01.004; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yang WS, 2012, J PROTEOME RES, V11, P1078, DOI 10.1021/pr2008187; Zhao L, 2013, P NATL ACAD SCI USA, V110, P12697, DOI 10.1073/pnas.1300968110; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	43	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123333	10.1371/journal.pone.0123333	http://dx.doi.org/10.1371/journal.pone.0123333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875766	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800092
J	Yang, JM; Favazza, C; Yao, JJ; Chen, RM; Zhou, QF; Shung, KK; Wang, LHV				Yang, Joon Mo; Favazza, Christopher; Yao, Junjie; Chen, Ruimin; Zhou, Qifa; Shung, K. Kirk; Wang, Lihong V.			Three-Dimensional Photoacoustic Endoscopic Imaging of the Rabbit Esophagus	PLOS ONE			English	Article							MINIMALLY INVASIVE ESOPHAGECTOMY; OPTICAL COHERENCE TOMOGRAPHY; BARRETTS-ESOPHAGUS; MUCOSAL MORPHOLOGY; MICROSCOPY; DYSPLASIA; PATTERNS; RISK	We report photoacoustic and ultrasonic endoscopic images of two intact rabbit esophagi. To investigate the esophageal lumen structure and microvasculature, we performed in vivo and ex vivo imaging studies using a 3.8-mm diameter photoacoustic endoscope and correlated the images with histology. Several interesting anatomic structures were newly found in both the in vivo and ex vivo images, which demonstrates the potential clinical utility of this endoscopic imaging modality. In the ex vivo imaging experiment, we acquired high-resolution motion-artifact-free three-dimensional photoacoustic images of the vasculatures distributed in the walls of the esophagi and extending to the neighboring mediastinal regions. Blood vessels with apparent diameters as small as 190 mu m were resolved. Moreover, by taking advantage of the dual-mode high-resolution photoacoustic and ultrasound endoscopy, we could better identify and characterize the anatomic structures of the esophageal lumen, such as the mucosal and submucosal layers in the esophageal wall, and an esophageal branch of the thoracic aorta. In this paper, we present the first photoacoustic images showing the vasculature of a vertebrate esophagus and discuss the potential clinical applications and future development of photoacoustic endoscopy.	[Yang, Joon Mo; Favazza, Christopher; Yao, Junjie; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA; [Chen, Ruimin; Zhou, Qifa; Shung, K. Kirk] Univ So Calif, Dept Biomed Engn, Natl Inst Hlth Ultrason Transducer Resource Ctr, Los Angeles, CA 90089 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; University of Southern California	Wang, LHV (corresponding author), Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA.	lhwang@biomed.wustl.edu	Chen, Ruimin/K-2854-2018; yao, junjie/G-9226-2014; Yang, Joon-Mo/X-5629-2018	Chen, Ruimin/0000-0002-5338-359X; yao, junjie/0000-0002-2847-5839; 	National Institutes of Health [R01 CA157277, EB016986, R01 CA186567, R01 CA159959]; NATIONAL CANCER INSTITUTE [R01CA159959, R01CA186567, R01CA157277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP1EB016986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health through the following grants: R01 CA157277, EB016986 (NIH Director's Pioneer Award), R01 CA186567 (NIH Director's Transformative Research Award), and R01 CA159959. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Becker V, 2008, ENDOSCOPY, V40, P888, DOI 10.1055/s-2008-1077718; Cai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043999; Chen Y, 2007, ENDOSCOPY, V39, P599, DOI 10.1055/s-2007-966648; Cobb MJ, 2010, GASTROINTEST ENDOSC, V71, P223, DOI 10.1016/j.gie.2009.07.005; Dietrich C, 2011, ENDOSCOPIC ULTRASOUN; Evans JA, 2006, CLIN GASTROENTEROL H, V4, P38, DOI 10.1016/S1542-3565(05)00746-9; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245; Hammoud GM, 2014, WORLD J GASTROENTERO, V20, P14230, DOI 10.3748/wjg.v20.i39.14230; Hawes RH, 2006, ENDOSONOGRAPHY; Kang D, 2010, GASTROINTEST ENDOSC, V71, P35, DOI 10.1016/j.gie.2009.08.026; Kara MA, 2006, GASTROINTEST ENDOSC, V64, P155, DOI 10.1016/j.gie.2005.11.049; Kiesslich R, 2007, NAT CLIN PRACT ONCOL, V4, P480, DOI 10.1038/ncponc0881; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Lee MM, 2009, CAN J GASTROENTEROL, V23, P84, DOI 10.1155/2009/732481; LIEBERMANNMEFFERT DMI, 1987, ANN SURG, V206, P184; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Sato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001890; Shami VM, 2010, CLIN GASTROENT-SER, P1, DOI 10.1007/978-1-60327-480-7; Singh R, 2008, ENDOSCOPY, V40, P457, DOI 10.1055/s-2007-995741; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Suter MJ, 2008, GASTROINTEST ENDOSC, V68, P745, DOI 10.1016/j.gie.2008.05.014; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; Thekkek N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026007; Vakoc BJ, 2007, GASTROINTEST ENDOSC, V65, P898, DOI 10.1016/j.gie.2006.08.009; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wilson BC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795688; Yang JM, 2012, OPT EXPRESS, V20, P23944, DOI 10.1364/OE.20.023944; Yang JM, 2012, NAT MED, V18, P1297, DOI 10.1038/nm.2823; Yang JM, 2009, OPT LETT, V34, P1591, DOI 10.1364/OL.34.001591; Yao JJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.080505; Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	39	29	33	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120269	10.1371/journal.pone.0120269	http://dx.doi.org/10.1371/journal.pone.0120269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874640	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353015800010
J	Minarik, J; Pavlicek, P; Pour, L; Pika, T; Maisnar, V; Spicka, I; Jarkovsky, J; Krejci, M; Bacovsky, J; Radocha, J; Straub, J; Kessler, P; Wrobel, M; Walterova, L; Sykora, M; Obernauerova, J; Brozova, L; Gregora, E; Adamova, D; Gumulec, J; Adam, Z; Scudla, V; Hajek, R				Minarik, Jiri; Pavlicek, Petr; Pour, Ludek; Pika, Tomas; Maisnar, Vladimir; Spicka, Ivan; Jarkovsky, Jiri; Krejci, Marta; Bacovsky, Jaroslav; Radocha, Jakub; Straub, Jan; Kessler, Petr; Wrobel, Marek; Walterova, Lenka; Sykora, Michal; Obernauerova, Jarmila; Brozova, Lucie; Gregora, Evzen; Adamova, Dagmar; Gumulec, Jaromir; Adam, Zdenek; Scudla, Vlastimil; Hajek, Roman		Czech Myeloma Grp	Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy	PLOS ONE			English	Article							INITIAL TREATMENT; PHASE-III; IMPACT; REVERSIBILITY; PREDNISONE; MELPHALAN; SURVIVAL; EFFICACY; TRIAL	Objective Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) patients treated using either intravenous (IV) or subcutaneous (SC) route of administration. Patients and methods During January 2012 through December 2013, we performed a retrospective analysis of 446 patients with MM treated with bortezomib-based regimens (either once weekly -63% or twice weekly -27%) in both, the first line setting, and in relapse, with separate analysis of patients undergoing autologous stem cell transplantation. We assessed the response rates and toxicity profiles in both, IV and SC route of bortezomib administration. Results The response rates in both IV and SC arm were similar with overall response rate 71.7% vs 70.7%, complete remissions in 13.9% vs 8.6%, very good partial remissions in 30.8% vs 34.5% and partial remissions in 27% vs 27.6%. The most frequent grade >= 3 toxicities were anemia, thrombocytopenia and neutropenia, with no significant differences between IV and SC group. There were no significant differences in the rate of peripheral neuropathy (PN). PN of any grade was present in 48% in the IV arm and in 41% in the SC arm. PN grade >= 2 was present in 20% vs 18% and PN grade >= 3 was present in 6% vs 4%. Conclusions We conclude that subcutaneous application of bortezomib has similar therapeutic outcomes and toxicity profile as intravenous route of application. In our cohort there was no difference in the incidence of PN, suggesting that PN is dose dependent and might be reduced by lower intensity schemes rather than by the route of administration.	[Minarik, Jiri; Pika, Tomas; Bacovsky, Jaroslav; Scudla, Vlastimil] Palacky Univ, Univ Hosp Olomouc, Dept Hematooncol, CR-77147 Olomouc, Czech Republic; [Minarik, Jiri; Pika, Tomas; Bacovsky, Jaroslav; Scudla, Vlastimil] Palacky Univ, Fac Med, CR-77147 Olomouc, Czech Republic; [Pavlicek, Petr; Gregora, Evzen] Univ Hosp Kralovske Vinohrady, Dept Clin Hematol, Prague, Czech Republic; [Pour, Ludek; Krejci, Marta; Adam, Zdenek] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Maisnar, Vladimir; Radocha, Jakub] Univ Hosp, Dept Clin Hematol, Hradec Kralove, Czech Republic; [Spicka, Ivan; Straub, Jan] Univ Hosp, Dept Internal Med, Prague, Czech Republic; [Jarkovsky, Jiri; Brozova, Lucie] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Kessler, Petr] Gen Hosp, Dept Hematol & Transfus, Pelhrimov, Czech Republic; [Wrobel, Marek] Hosp Novy Jicin, Dept Oncol, Novy Jicin, Czech Republic; [Walterova, Lenka] Gen Hosp Liberec, Dept Clin Hematol, Liberec, Czech Republic; [Sykora, Michal] Gen Hosp, Dept Clin Hematol, Ceske Budejovice, Czech Republic; [Obernauerova, Jarmila] Claudian Hosp, Dept Hematol & Transfus, Mlada Boleslav, Czech Republic; [Adamova, Dagmar] Silesian Hosp, Dept Hematol & Transfusiol, Opava, Czech Republic; [Gumulec, Jaromir; Hajek, Roman] Univ Ostrava, Univ Hosp Ostrava, Dept Haematooncol, CZ-70103 Ostrava, Czech Republic; [Gumulec, Jaromir; Hajek, Roman] Univ Ostrava, Fac Med, CZ-70103 Ostrava, Czech Republic	Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; University Hospital Vinohrady; University Hospital Brno; University Hospital Hradec Kralove; General University Hospital Prague; Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Ostrava; University of Ostrava; University of Ostrava	Minarik, J (corresponding author), Palacky Univ, Univ Hosp Olomouc, Dept Hematooncol, CR-77147 Olomouc, Czech Republic.	abretina@email.cz	Radocha, Jakub/AAK-4080-2021; Krejci, Marta/ABE-2414-2020; Maisnar, Vladimir/Q-8579-2017; Hajek, Roman/I-6639-2017; Radocha, Jakub/S-3708-2016; Minarik, Jiri/GWR-0249-2022; Jarkovsky, Jiri/G-5494-2017	Radocha, Jakub/0000-0002-5384-8238; Krejci, Marta/0000-0001-5216-8778; Maisnar, Vladimir/0000-0003-1738-4920; Hajek, Roman/0000-0001-6955-6267; Radocha, Jakub/0000-0002-5384-8238; Minarik, Jiri/0000-0003-0513-326X; Spicka, Ivan/0000-0002-5451-5283	Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR) [IGA MZ CR NT 14393, IGA MZ CR NT 12215-4/2011, IGA MZ CR NT 14400, IGA MZ CR NT12451-5, MSM0021622434]	Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR)	The paper was supported by the grant of Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR) - IGA MZ CR NT 14393, IGA MZ CR NT 12215-4/2011, IGA MZ CR NT 14400, IGA MZ CR NT12451-5, and the grant MSM0021622434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-149385; Arnulf B, 2012, HAEMATOL-HEMATOL J, V97, P1925, DOI 10.3324/haematol.2012.067793; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Horvath N, EHA 2014 MIL IT; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kumar SK, 2012, COMMUN ONCOL, V9, P272; Kurtin Sandra, 2012, J Adv Pract Oncol, V3, P406; Larocca A, ASH 2013 NEW ORL LA; Maisnar V, 2011, ONKOLOGIE, V3, P138; Manochakian R, 2007, ONCOLOGIST, V12, P978, DOI 10.1634/theoncologist.12-8-978; Mateos MV, 2009, CLIN LYMPHOMA MYELOM, V9, pS30, DOI 10.1016/S1557-9190(11)70492-9; Mateos MV, 2012, THER ADV HEMATOL, V3, P117, DOI 10.1177/2040620711432020; Millennium Pharmaceuticals Inc, 2012, VELC BORT INJ PRESCR; Moreau P, 2012, CLIN PHARMACOKINET, V51, P823, DOI 10.1007/s40262-012-0010-0; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Moreau P, 2008, HAEMATOL-HEMATOL J, V93, P1908, DOI 10.3324/haematol.13285; National Cancer Institute, NAT CANC I CANC THER; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rifkin R, ASH 2013 NEW ORL LA; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sidana S, 1975, ASH 2013 NEW ORL LA	26	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123866	10.1371/journal.pone.0123866	http://dx.doi.org/10.1371/journal.pone.0123866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875484	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700049
J	Chin, CY; Weng, MY; Lin, TC; Cheng, SY; Yang, YHK; Tseng, VS				Chin, Chu Yu; Weng, Meng Yu; Lin, Tzu Chieh; Cheng, Shyr Yuan; Yang, Yea Huei Kao; Tseng, Vincent S.			Mining Disease Risk Patterns from Nationwide Clinical Databases for the Assessment of Early Rheumatoid Arthritis Risk	PLOS ONE			English	Article							ASSOCIATION; PREVALENCE; PREDICTION	Rheumatoid arthritis (RA) is a chronic autoimmune rheumatic disease that can cause painful swelling in the joint lining, morning stiffness, and joint deformation/destruction. These symptoms decrease both quality of life and life expectancy. However, if RA can be diagnosed in the early stages, it can be controlled with pharmacotherapy. Although many studies have examined the possibility of early assessment and diagnosis, few have considered the relationship between significant risk factors and the early assessment of RA. In this paper, we present a novel framework for early RA assessment that utilizes data preprocessing, risk pattern mining, validation, and analysis. Under our proposed framework, two risk patterns can be discovered. Type I refers to well-known risk patterns that have been identified by existing studies, whereas Type II denotes unknown relationship risk patterns that have rarely or never been reported in the literature. These Type II patterns are very valuable in supporting novel hypotheses in clinical trials of RA, and constitute the main contribution of this work. To ensure the robustness of our experimental evaluation, we use a nationwide clinical database containing information on 1,314 RA-diagnosed patients over a 12-year follow-up period (1997-2008) and 965,279 non-RA patients. Our proposed framework is employed on this large-scale population-based dataset, and is shown to effectively discover rich RA risk patterns. These patterns may assist physicians in patient assessment, and enhance opportunities for early detection of RA. The proposed framework is broadly applicable to the mining of risk patterns for major disease assessments. This enables the identification of early risk patterns that are significantly associated with a target disease.	[Chin, Chu Yu; Tseng, Vincent S.] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Weng, Meng Yu] Natl Cheng Kung Univ, Med Coll & Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Tainan 70101, Taiwan; [Lin, Tzu Chieh; Yang, Yea Huei Kao] Natl Cheng Kung Univ Hosp, Hlth Outcome Res Ctr, Tainan 70428, Taiwan; [Yang, Yea Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Tseng, Vincent S.] Natl Cheng Kung Univ, Inst Med Informat, Tainan 70101, Taiwan; [Chin, Chu Yu; Cheng, Shyr Yuan] Chunghwa Telecom Co Ltd, Telecommun Labs, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; Chunghwa Telecom	Tseng, VS (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	tsengsm@mail.ncku.edu.tw			National Science Council of Taiwan [101-3114-Y-006-001, 101-2221-E-006-255-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council of Taiwan (Grant No. 101-3114-Y-006-001 and 101-2221-E-006-255-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Telecommunication Laboratories, Chunghwa Telecom Co., Ltd. provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Bedran Z, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/548502; Bing Liu, 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P80; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Chen HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/125943; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cruz VA, 2012, REV BRAS REUMATOL, V52, P645, DOI 10.1590/S0482-50042012000400014; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Ebringer A, 2014, APMIS, V122, P363, DOI 10.1111/apm.12154; Fischer TW, 2003, DERMATOLOGY, V207, P386, DOI 10.1159/000074120; Fraser Kathleen, 2013, Skin Therapy Lett, V18, P5; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Haikola B, 2013, ACTA ODONTOL SCAND, V71, P498, DOI 10.3109/00016357.2012.696692; Huizinga T. W. J., 2007, Rev.Colomb.Reumatol., V14, P106; Jaimes-Hernandez J, 2012, REUMATOL CLIN, V8, P145, DOI 10.1016/j.reuma.2011.09.005; Kapoor S, 2015, NEUROUROL URODYNAM, V34, P101, DOI 10.1002/nau.22500; Karadag O, 2012, RHEUMATOL INT, V32, P2313, DOI 10.1007/s00296-011-1957-0; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; LAWRY GV, 1984, ARTHRITIS RHEUM, V27, P873, DOI 10.1002/art.1780270806; Lee LY, 2012, BMJ CASE REPORTS; Li WM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P369, DOI 10.1109/ICDM.2001.989541; Mathias JS, 2013, J AM MED INFORM ASSN, V20, pE118, DOI 10.1136/amiajnl-2012-001360; Matsuura E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-47; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McNally E, 2014, SEMIN ARTHRITIS RHEU, V43, P498, DOI 10.1016/j.semarthrit.2013.08.005; Monsarrat P, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-253; Ng T, 2012, J PALLIAT MED, V15, P863, DOI 10.1089/jpm.2011.0417; Nyirjesy Paul, 1994, Obstetrics and Gynecology, V84, P710; O'Connor PJ, 2013, SEMIN MUSCULOSKEL R, V17, P74, DOI 10.1055/s-0033-1333940; Quinlan JR, 1993, PROGRAMS MACHINE LEA; Sayers E., 2008, E UTILITIES QUICK ST; Shadick NA, 2006, ARCH INTERN MED, V166, P2490, DOI 10.1001/archinte.166.22.2490; Shang GF, 2013, J MED VIROL, V85, P1334, DOI 10.1002/jmv.23609; Skare TL, 2013, CLIN RHEUMATOL, V32, P1065, DOI 10.1007/s10067-013-2213-7; Smolik Irene, 2009, Compend Contin Educ Dent, V30, P188; Tai YM, 2009, INT J MED INFORM, V78, pE75, DOI 10.1016/j.ijmedinf.2009.09.005; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; Vapnik V., 2013, NATURE STAT LAERNING; Verweij KE, 2012, CASE REP MED, V2012, DOI 10.1155/2012/523218; Yin XX, 2003, SIAM PROC S, P331	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122508	10.1371/journal.pone.0122508	http://dx.doi.org/10.1371/journal.pone.0122508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875441	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100079
J	Farrar, EJ; Huntley, GD; Butcher, J				Farrar, Emily J.; Huntley, Geoffrey D.; Butcher, Jonathan			Endothelial-Derived Oxidative Stress Drives Myofibroblastic Activation and Calcification of the Aortic Valve	PLOS ONE			English	Article							VALVULAR INTERSTITIAL-CELLS; SUPEROXIDE-DISMUTASE; DEPENDENT REGULATION; ADHESION MOLECULES; DISEASE; STENOSIS; GENERATION; EXPRESSION; HEART; PROGRESSION	Aims Oxidative stress is present in and contributes to calcification of the aortic valve, but the driving factors behind the initiation of valve oxidative stress are not well understood. We tested whether the valve endothelium acts as an initiator and propagator of oxidative stress in aortic valve disease. Methods and Results Calcified human aortic valves showed side-specific elevation of superoxide in the endothelium, co-localized with high VCAM1 expression, linking oxidative stress, inflammation, and valve degeneration. Treatment with inflammatory cytokine TNF alpha increased superoxide and oxidative stress and decreased eNOS and VE-cadherin acutely over 48 hours in aortic valve endothelial cells (VEC) and chronically over 21 days in ex vivo AV leaflets. Co-treatment of VEC with tetrahydrobiopterin (BH4) but not apocynin mitigated TNF alpha-driven VEC oxidative stress. Co-treatment of ex vivo AV leaflets with TNF alpha+BH4 or TNF alpha+peg-SOD rescued endothelial function and mitigated inflammatory responses. Both BH4 and peg-SOD rescued valve leaflets from the pro-osteogenic effects of TNF alpha treatment, but only peg-SOD was able to mitigate the fibrogenic effects, including increased collagen and alpha SMA expression. Conclusions Aortic valve endothelial cells are a novel source of oxidative stress in aortic valve disease. TNF alpha-driven VEC oxidative stress causes loss of endothelial protective function, chronic inflammation, and fibrogenic and osteogenic activation, mitigated differentially by BH4 and peg-SOD. These mechanisms identify new targets for tailored antioxidant therapy focused on mitigation of oxidative stress and restoration of endothelial protection.	[Farrar, Emily J.; Butcher, Jonathan] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Huntley, Geoffrey D.] Mayo Clin, Mayo Med Sch, Rochester, MN USA	Cornell University; Mayo Clinic	Butcher, J (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	jtb47@cornell.edu	Butcher, Jonathan T/D-2280-2012; Butcher, Jonathan/AAE-8239-2020	Butcher, Jonathan T/0000-0002-9309-6296; Butcher, Jonathan/0000-0002-9309-6296; Huntley, Geoffrey/0000-0001-7681-1107; Farrar, Emily/0000-0003-4968-0038	National Science Foundation [CBET-0955172, MRSEC DMR-1120296]; National Institutes of Health [HL110328, HL118672]; National Science Foundation graduate research fellowship; National Science Foundation Research Experience for Undergraduates Site program [DMR-1063059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110328, R21HL118672] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); National Science Foundation Research Experience for Undergraduates Site program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation (nsf.gov, CBET-0955172 and MRSEC DMR-1120296 to JTB), and by the National Institutes of Health (nih.gov, HL110328 and HL118672 to JTB). EJF was supported by a National Science Foundation graduate research fellowship. GDH was supported by the National Science Foundation Research Experience for Undergraduates Site program (DMR-1063059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200; Bischoff J, 2011, J CARDIOVASC TRANSL, V4, P710, DOI 10.1007/s12265-011-9312-0; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795; Branchetti E, 2013, ARTERIOSCL THROM VAS, V33, pE66, DOI 10.1161/ATVBAHA.112.300177; Butcher JT, 2007, PHILOS T R SOC B, V362, P1445, DOI 10.1098/rstb.2007.2127; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Ciprian AB, 2012, CIRC RES, V111, P1157, DOI [10.1161/CIRCRESAHA.111.261750, DOI 10.1161/CIRCRESAHA.111.261750]; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Farivar RS, 2003, EUR J CARDIO-THORAC, V24, P527, DOI 10.1016/S1010-7940(03)00408-1; Farrar EJ, 2014, ANN BIOMED ENG, V42, P149, DOI 10.1007/s10439-013-0894-3; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Ghaisas NK, 2000, J AM COLL CARDIOL, V36, P2257, DOI 10.1016/S0735-1097(00)00998-0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154; Guerraty MA, 2010, ARTERIOSCL THROM VAS, V30, P225, DOI 10.1161/ATVBAHA.109.198549; Heistad DD, 2009, CIRC J, V73, P201, DOI 10.1253/circj.CJ-08-1082; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Kar S, 2012, FREE RADICAL RES, V46, P1496, DOI 10.3109/10715762.2012.731052; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; Mahler GJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/721419; Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; Mele J, 2006, ANTIOXID REDOX SIGN, V8, P628, DOI 10.1089/ars.2006.8.628; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Poggianti E, 2003, J AM COLL CARDIOL, V41, P136, DOI 10.1016/S0735-1097(02)02622-0; Pompilio G, 1998, ANN THORAC SURG, V65, P986, DOI 10.1016/S0003-4975(98)00075-7; Rajamannan N., 2013, OXIDATIVE STRESS AND, P265, DOI [10.5772/52275, DOI 10.5772/52275]; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2011, CARDIOVASC PATHOL, V20, P168, DOI 10.1016/j.carpath.2010.11.007; Rajamannan NM, 2005, HEART, V91, P806, DOI 10.1136/hrt.2003.029785; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Shavelle DM, 2002, LANCET, V359, P1125, DOI 10.1016/S0140-6736(02)08161-8; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915	57	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123257	10.1371/journal.pone.0123257	http://dx.doi.org/10.1371/journal.pone.0123257			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874717	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100156
J	Forsblom, E; Ruotsalainen, E; Jarvinen, A				Forsblom, Erik; Ruotsalainen, Eeva; Jarvinen, Asko			Improved Outcome with Early Rifampicin Combination Treatment in Methicillin-Sensitive Staphylococcus aureus Bacteraemia with a Deep Infection Focus - A Retrospective Cohort Study	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTIONS; RANDOMIZED CLINICAL-TRIAL; ANTIBIOTIC-TREATMENT; DRUG-USERS; ENDOCARDITIS; RESISTANT; THERAPY; VANCOMYCIN; MORTALITY; OSTEOMYELITIS	Introduction Rifampicin has been used as adjunctive therapy in Staphylococcus aureus bacteraemia (SAB) with a deep infection focus. However, data for prognostic impact of rifampicin therapy is unestablished including the optimal initiation time point. We studied the impact of rifampicin therapy and the optimal initiation time for rifampicin treatment on prognosis in methicillin-sensitive S. aureus bacteraemia with a deep infection. Methods Retrospective, multicentre study in Finland including 357 SAB patients with a deep infection focus. Patients with alcoholism, liver disease or patients who died within 3 days were excluded. Patients were categorised according to duration of rifampicin therapy and according to whether rifampicin was initiated early (within 7 days) or late (7 days after) after the positive blood cultures. Primary end point was 90 days mortality. Results Twenty-seven percent of patients received no rifampicin therapy, 14% received rifampicin for 1-13 days whereas 59% received rifampicin >= 14 days. The 90 day mortality was; 26% for patients treated without rifampicin, 16% for rifampicin therapy of any length and 10% for early onset rifampicin therapy >= 14 days. Lack of rifampicin therapy increased (OR 1.89, p=0.026), rifampicin of any duration decreased (OR 0.53, p=0.026) and rifampicin therapy >= 14 days with early onset lowered the risk for a fatal outcome (OR 0.33, p<0.01) during 90 days follow-up. Conclusion Rifampicin adjunctive therapy for at least 14 days and initiated within 7 days of positive blood culture associated with improved outcome among SAB patients with a deep infection.	[Forsblom, Erik; Ruotsalainen, Eeva; Jarvinen, Asko] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Forsblom, E (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland.	erik.forsblom@helsinki.fi			Medical Society of Finland; Medicinska Understodsforeningen Liv och Halsa; SSAC-foundation; Maud Kuistila Memorial Foundation; Suomen Infektiolaakarit r.y. foundation; Swedish Cultural Foundation in Finland	Medical Society of Finland; Medicinska Understodsforeningen Liv och Halsa; SSAC-foundation; Maud Kuistila Memorial Foundation; Suomen Infektiolaakarit r.y. foundation; Swedish Cultural Foundation in Finland	This study was financially supported by grants from: The Medical Society of Finland, The Medicinska Understodsforeningen Liv och Halsa, The SSAC-foundation, The Maud Kuistila Memorial Foundation, The Suomen Infektiolaakarit r.y. foundation and The Swedish Cultural Foundation in Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703; Berdal JE, 2005, CLIN MICROBIOL INFEC, V11, P843, DOI 10.1111/j.1469-0691.2005.01230.x; Calfee DP, 2005, PRINCIPLES PRACTICE, V1, P374; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Craig WA, 2004, INFECT DIS, P277; DWORKIN RJ, 1989, LANCET, V2, P1071; Finnish National Institute for Health and Welfare, 172011 FINN NAT I HL, P28; Forsblom E, 2013, CLIN INFECT DIS, V56, P527, DOI 10.1093/cid/cis889; Forsblom E, 2011, J HOSP INFECT, V78, P102, DOI 10.1016/j.jhin.2011.03.010; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Lai CC, 2010, J AM GERIATR SOC, V58, P1001, DOI 10.1111/j.1532-5415.2010.02842.x; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; NORDEN CW, 1986, SOUTHERN MED J, V79, P947, DOI 10.1097/00007611-198608000-00008; NORDEN CW, 1983, REV INFECT DIS, V5, pS495; Riedel DJ, 2008, ANTIMICROB AGENTS CH, V52, P2463, DOI 10.1128/AAC.00300-08; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Ringberg H, 2000, INFECTION, V28, P132, DOI 10.1007/s150100050065; Ruotsalainen E, 2006, J INTERN MED, V259, P179, DOI 10.1111/j.1365-2796.2005.01598.x; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schrenzel J, 2004, CLIN INFECT DIS, V39, P1285, DOI 10.1086/424506; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Senneville E, 2011, CLIN INFECT DIS, V53, P334, DOI 10.1093/cid/cir402; Siegman-Igra Y, 2005, SCAND J INFECT DIS, V37, P572, DOI 10.1080/00365540510038488; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; Thwaites G, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-241; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Tice AD, 2003, J ANTIMICROB CHEMOTH, V51, P1261, DOI 10.1093/jac/dkg186; VANDERAUWERA P, 1985, ANTIMICROB AGENTS CH, V28, P467, DOI 10.1128/AAC.28.4.467; VANDERAUWERA P, 1983, REV INFECT DIS, V5, pS515; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537; ZIMMERLI W, 1994, J ANTIMICROB CHEMOTH, V33, P959	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122824	10.1371/journal.pone.0122824	http://dx.doi.org/10.1371/journal.pone.0122824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874546	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100106
J	Fuentes-Claramonte, P; Avila, C; Rodriguez-Pujadas, A; Ventura-Campos, N; Bustamante, JC; Costumero, V; Rosell-Negre, P; Barros-Loscertales, A				Fuentes-Claramonte, Paola; Avila, Cesar; Rodriguez-Pujadas, Aina; Ventura-Campos, Noelia; Bustamante, Juan C.; Costumero, Victor; Rosell-Negre, Patricia; Barros-Loscertales, Alfonso			Reward Sensitivity Modulates Brain Activity in the Prefrontal Cortex, ACC and Striatum during Task Switching	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BEHAVIORAL ACTIVATION; ANTERIOR CINGULATE; COGNITIVE CONTROL; INHIBITORY CONTROL; NEURAL MECHANISMS; DOPAMINE; PERSONALITY; PUNISHMENT; MOTIVATION	Current perspectives on cognitive control acknowledge that individual differences in motivational dispositions may modulate cognitive processes in the absence of reward contingencies. This work aimed to study the relationship between individual differences in Behavioral Activation System (BAS) sensitivity and the neural underpinnings involved in processing a switching cue in a task-switching paradigm. BAS sensitivity was hypothesized to modulate brain activity in frontal regions, ACC and the striatum. Twenty-eight healthy participants underwent fMRI while performing a switching task, which elicited activity in fronto-striatal regions during the processing of the switch cue. BAS sensitivity was negatively associated with activity in the lateral prefrontal cortex, anterior cingulate cortex and the ventral striatum. Combined with previous results, our data indicate that BAS sensitivity modulates the neurocognitive processes involved in task switching in a complex manner depending on task demands. Therefore, individual differences in motivational dispositions may influence cognitive processing in the absence of reward contingencies.	[Fuentes-Claramonte, Paola; Avila, Cesar; Rodriguez-Pujadas, Aina; Ventura-Campos, Noelia; Costumero, Victor; Rosell-Negre, Patricia; Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain; [Bustamante, Juan C.] Univ Zaragoza, Fac Educ, Dept Psicol & Sociol, Zaragoza, Spain	Universitat Jaume I; University of Zaragoza	Barros-Loscertales, A (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain.	barros@uji.es	Costumero, Víctor/A-5784-2019; Campos, Noelia Ventura/L-4877-2014; Avila, Cesar/B-4370-2011; Barros-Loscertales, Alfonso/D-7069-2013; Fuentes-Claramonte, Paola/AAC-1196-2021; Bustamante, Juan Carlos/J-7534-2015; Barrós-Loscertales, Alfonso/AAA-5611-2019	Costumero, Víctor/0000-0002-8743-5239; Campos, Noelia Ventura/0000-0002-0443-8048; Avila, Cesar/0000-0002-5840-605X; Fuentes-Claramonte, Paola/0000-0002-1428-7976; Bustamante, Juan Carlos/0000-0002-8201-0469; Barrós-Loscertales, Alfonso/0000-0002-2456-6653; Rosell Negre, Patricia/0000-0002-2440-8495	Brainglot Project of the CONSOLIDER-INGENIO Program [CSD2007-00012]; MINECO [PSI2012-33054]; Spanish National Drug Strategy [4623/2011]; Spanish Ministry of Health and Consumption; Generalitat Valenciana [GV/2012/042]; Universitat Jaume I [P1-1A2010-01]	Brainglot Project of the CONSOLIDER-INGENIO Program; MINECO(Spanish Government); Spanish National Drug Strategy; Spanish Ministry of Health and Consumption(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat Jaume I	This research was supported by the Brainglot Project of the 2010 CONSOLIDER-INGENIO Program (CSD2007-00012). The project was also supported by grants from MINECO (PSI2012-33054), the Spanish National Drug Strategy (4623/2011), the Spanish Ministry of Health and Consumption, the Generalitat Valenciana (GV/2012/042) and Universitat Jaume I (P1-1A2010-01) to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Armbruster DJN, 2012, J COGNITIVE NEUROSCI, V24, P2385, DOI 10.1162/jocn_a_00286; Avila C, 2003, COGNITION EMOTION, V17, P951, DOI 10.1080/02699930341000031; Avila C, 2002, PERS INDIV DIFFER, V33, P979, DOI 10.1016/S0191-8869(01)00207-0; Avila C, 2008, NEUROTOX RES, V14, P191, DOI 10.1007/BF03033810; AVILA C, 1995, PERS INDIV DIFFER, V18, P503, DOI 10.1016/0191-8869(94)00184-T; Avila C, 1997, PERS INDIV DIFFER, V23, P1055, DOI 10.1016/S0191-8869(97)00124-4; Avila C, 2001, J PERS SOC PSYCHOL, V80, P311, DOI 10.1037//0022-3514.80.2.311; Avila C, 2012, SOC COGN AFFECT NEUR, V7, P423, DOI 10.1093/scan/nsr028; Barcelo F, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.013.2007; Barros-Loscertales A, 2006, EUR J NEUROSCI, V24, P2071, DOI 10.1111/j.1460-9568.2006.05084.x; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Caseras X, 2003, PERS INDIV DIFFER, V34, P999, DOI 10.1016/S0191-8869(02)00084-3; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costumero V, 2013, EUR J NEUROSCI, V38, P2399, DOI 10.1111/ejn.12234; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Cubillo A, 2014, CEREB CORTEX, V24, P174, DOI 10.1093/cercor/bhs296; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; De Baene W, 2013, NEUROIMAGE, V77, P207, DOI 10.1016/j.neuroimage.2013.03.057; de Ruiter MB, 2012, DRUG ALCOHOL DEPEN, V121, P81, DOI 10.1016/j.drugalcdep.2011.08.010; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; FOWLES DC, 1980, PSYCHOPHYSIOLOGY, V17, P87, DOI 10.1111/j.1469-8986.1980.tb00117.x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gable SL, 2000, J PERS SOC PSYCHOL, V78, P1135, DOI 10.1037//0022-3514.78.6.1135; Grange JA, 2010, PSYCHOL RES-PSYCH FO, V74, P481, DOI 10.1007/s00426-009-0270-y; Gray JA, 1987, PSYCHOL FEAR STRESS, P241; Gray JA, 2000, THE NEUROPSYCHOLOGY; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Gruber O, 2006, NEUROIMAGE, V31, P887, DOI 10.1016/j.neuroimage.2005.12.043; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Hajek T, 2013, J PSYCHIATR RES, V47, P1955, DOI 10.1016/j.jpsychires.2013.08.015; Hakuri JG, 2012, BRAIN RES, V1451, P53, DOI 10.1016/j.brainres.2012.02.046; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Jost K, 2008, COGN AFFECT BEHAV NE, V8, P74, DOI 10.3758/CABN.8.1.74; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kim C, 2012, BRAIN RES, P1; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Lieberman MD, 2001, J PERS SOC PSYCHOL, V80, P294, DOI 10.1037//0022-3514.80.2.294; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luijten M, 2014, J PSYCHIATR NEUROSCI, V39, P149, DOI 10.1503/jpn.130052; Matuskey D, 2013, PSYCHIAT RES-NEUROIM, V214, P116, DOI 10.1016/j.pscychresns.2013.06.009; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; PATTERSON CM, 1987, J PERS SOC PSYCHOL, V52, P565, DOI 10.1037/0022-3514.52.3.565; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Pickering AD., 1997, HDB PERS THEORY RES, P277; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Torrubia R, 2008, THE REINFORCEMENT SE; van Holstein M, 2011, PSYCHOPHARMACOLOGY, V218, P567, DOI 10.1007/s00213-011-2340-2; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Woodward TS, 2006, BRAIN RES, V1068, P161, DOI 10.1016/j.brainres.2005.10.094; Yehene E, 2008, J COGNITIVE NEUROSCI, V20, P1079, DOI 10.1162/jocn.2008.20077	71	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123073	10.1371/journal.pone.0123073	http://dx.doi.org/10.1371/journal.pone.0123073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875640	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100132
J	Gage, SH; Hickman, M; Heron, J; Munafo, MR; Lewis, G; Macleod, J; Zammit, S				Gage, Suzanne H.; Hickman, Matthew; Heron, Jon; Munafo, Marcus R.; Lewis, Glyn; Macleod, John; Zammit, Stanley			Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							USE DISORDERS; SHORT QUESTIONNAIRE; SUBSTANCE USE; ALCOHOL; ADOLESCENTS; SYMPTOMS; EPIDEMIOLOGY; DEPENDENCE; COMMUNITY; RECEPTOR	Introduction Substance use is associated with common mental health disorders, but the causal effect of specific substances is uncertain. We investigate whether adolescent cannabis and cigarette use is associated with incident depression and anxiety, while attempting to account for confounding and reverse causation. Methods We used data from ALSPAC, a UK birth cohort study, to investigate associations between cannabis or cigarettes (measured at age 16) and depression or anxiety (measured at age 18), before and after adjustment for pre-birth, childhood and adolescent confounders. Our imputed sample size was 4561 participants. Results Both cannabis (unadjusted OR 1.50, 95% CI 1.26, 1.80) and cigarette use (OR 1.37, 95% CI 1.16, 1.61) increased the odds of developing depression. Adjustment for pre-birth and childhood confounders partly attenuated these relationships though strong evidence of association persisted for cannabis use. There was weak evidence of association for cannabis (fully adjusted OR 1.30, 95% CI 0.98, 1.72) and insufficient evidence for association for cigarette use (fully adjusted OR = 0.97, 95% CI 0.75, 1.24) after mutually adjusting for each other, or for alcohol or other substance use. Neither cannabis nor cigarette use were associated with anxiety after adjustment for pre-birth and childhood confounders. Conclusions Whilst evidence of association between cannabis use and depression persisted after adjusting for pre-term and childhood confounders, our results highlight the difficulties in trying to estimate and interpret independent effects of cannabis and tobacco on psychopathology. Complementary methods are required to robustly examine effects of cannabis and tobacco on psychopathology.	[Gage, Suzanne H.; Hickman, Matthew; Heron, Jon; Macleod, John; Zammit, Stanley] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Gage, Suzanne H.; Munafo, Marcus R.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Gage, Suzanne H.; Munafo, Marcus R.] Univ Bristol, United Kingdom Ctr Tobacco Control Studies, Bristol, Avon, England; [Lewis, Glyn] UCL, Mental Hlth Sci Unit, London, England; [Zammit, Stanley] Cardiff Univ, Ctr Neuropsychiat Genet & Genom, MRC, Cardiff CF10 3AX, S Glam, Wales	University of Bristol; University of Bristol; University of Bristol; University of London; University College London; Cardiff University	Gage, SH (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	suzi.gage@bristol.ac.uk	Heron, Jon/D-5884-2011; Lewis, Glyn/E-9944-2012; Munafo, Marcus/AAE-2306-2020; Hickman, Matthew/Y-2400-2019	Heron, Jon/0000-0001-6199-5644; Lewis, Glyn/0000-0001-5205-8245; Munafo, Marcus/0000-0002-4049-993X; Hickman, Matthew/0000-0001-9864-459X; Zammit, Stanley/0000-0002-2647-9211; Macleod, John/0000-0001-8202-1144	UK Medical Research Council [74882, G0800612, G0802736]; Wellcome Trust [076467, 084268/Z/07/Z]; University of Bristol provide core support for ALSPAC; MRC grant [G0701503]; MRC [MR/K023233/1, MC_UU_12013/6, G0801418, G0802736, G0800612, G0701503] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6, MR/K023233/1, MR/K023195/1B, G0701503, 1046634, MR/K023195/1, G0802736, MR/L010305/1, G0800612, G0801418] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol provide core support for ALSPAC; MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (Grant: 74882) the Wellcome Trust (Grant: 076467) and the University of Bristol provide core support for ALSPAC. Suzanne Gage and Marcus Munafo are members of the UK Centre for Tobacco and Alcohol Studies. This publication is the work of the authors and Suzanne Gage, Matt Hickman, and Stan Zammit serve as guarantors for the contents of this paper. JH is supported by the UK Medical Research Council (Grants G0800612 and G0802736) and this work was also supported by MRC grant G0701503 and Wellcome Trust grant 084268/Z/07/Z. The funders were not involved in the design, data collection, analysis or write up of the study. All authors are independent of the funders.	Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Baer RA, 2012, CLIN PSYCHOL REV, V32, P359, DOI 10.1016/j.cpr.2012.03.002; Bambico FR, 2010, NEUROBIOL DIS, V37, P641, DOI 10.1016/j.nbd.2009.11.020; Barker ED, 2009, AM J PSYCHIAT, V166, P900, DOI 10.1176/appi.ajp.2009.08121770; Barrera M, 2002, J COMMUNITY PSYCHOL, V30, P135, DOI 10.1002/jcop.10000; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.41596.6f; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; Degenhardt L, 2001, ADDICTION, V96, P1603, DOI 10.1046/j.1360-0443.2001.961116037.x; EDWARDS G, 1976, BRIT MED J, V1, P1058, DOI 10.1136/bmj.1.6017.1058; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Gage SH, 2014, PSYCHOL MED; Gage SH, 2013, DEPRESS ANXIETY, V30, P1185, DOI 10.1002/da.22150; Goldman S, 2012, CHILD ADOL PSYCH CL, V21, P217, DOI 10.1016/j.chc.2011.12.002; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Gruber SA, 2009, DRUG ALCOHOL DEPEN, V105, P139, DOI 10.1016/j.drugalcdep.2009.06.019; Hamet P, 2005, METABOLISM, V54, P10, DOI 10.1016/j.metabol.2005.01.006; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hill MN, 2006, INT J NEUROPSYCHOPH, V9, P277, DOI 10.1017/S1461145705005651; Kaltiala-Heino R, 2011, ADOLESC HEALTH MED T, V2, P37, DOI 10.2147/AHMT.S11554; Kedzior KK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-136; Koethe D, 2007, J NEURAL TRANSM, V114, P1055, DOI 10.1007/s00702-007-0660-5; Laje R P, 2001, Curr Psychiatry Rep, V3, P470, DOI 10.1007/s11920-001-0040-z; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Leventhal AM, 2013, DRUG ALCOHOL DEPEN, V133, P324, DOI 10.1016/j.drugalcdep.2013.06.015; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lewis SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021689; Loeber R, 2001, CLIN CHILD FAM PSYCH, V4, P273, DOI 10.1023/A:1013574903810; Marco EM, 2012, J PSYCHOPHARMACOL, V26, P150, DOI 10.1177/0269881111408459; Mars B, CLIN SOCIAL OUTCOMES; Mazza JJ, 2009, J EARLY ADOLESCENCE, V29, P664, DOI 10.1177/0272431608324193; Mesman J, 2000, J AM ACAD CHILD PSY, V39, P1371, DOI 10.1097/00004583-200011000-00011; Messer SC, 1995, INT J METH PSYCH RES, V5, P251; Meyer JS, 2013, SUBST ABUSE REHABIL, V4, P83, DOI 10.2147/SAR.S37258; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan CJA, 2012, PSYCHOL MED, V42, P391, DOI 10.1017/S0033291711001322; Rao U, 2006, AM J PREV MED, V31, pS161, DOI 10.1016/j.amepre.2006.07.002; Rossler W, 2012, ADDICTION, V107, P1174, DOI 10.1111/j.1360-0443.2011.03760.x; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Rubino T, 2012, J PSYCHOPHARMACOL, V26, P177, DOI 10.1177/0269881111405362; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Wechsler D., 1992, WECHSLER INTELLIGENC; Zammit S., 2013, AM J PSYCHIAT	49	55	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122896	10.1371/journal.pone.0122896	http://dx.doi.org/10.1371/journal.pone.0122896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875443	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000352845100115
J	Jin, JK; Jang, B; Jin, HT; Choi, EK; Jung, CG; Akatsu, H; Kim, JI; Carp, RI; Kim, YS				Jin, Jae-Kwang; Jang, Byungki; Jin, Hyoung Tae; Choi, Eun-Kyoung; Jung, Cha-Gyun; Akatsu, Hiroyasu; Kim, Jae-Il; Carp, Richard I.; Kim, Yong-Sun			Phosphatidylinositol-Glycan-Phospholipase D Is Involved in Neurodegeneration in Prion Disease	PLOS ONE			English	Article							SCRAPIE-INFECTED MICE; NEUROBLASTOMA-CELLS; PHOSPHATIDIC-ACID; OXIDATIVE STRESS; PROTEIN; EXPRESSION; BRAINS; INHIBITION; CONVERSION; COMPLEXES	PrPSc is formed from a normal glycosylphosphatidylinositol (GPI)-anchored prion protein (PrPC) by a posttranslational modification. Most GPI-anchored proteins have been shown to be cleaved by GPI phospholipases. Recently, GPI-phospholipase D (GPI-PLD) was shown to be a strictly specific enzyme for GPI anchors. To investigate the involvement of GPI-PLD in the processes of neurodegeneration in prion diseases, we examined the mRNA and protein expression levels of GPI-PLD in the brains of a prion animal model (scrapie), and in both the brains and cerebrospinal fluids (CSF) of sporadic and familial Creutzfeldt-Jakob disease (CJD) patients. We found that compared with controls, the expression of GPI-PLD was dramatically down-regulated in the brains of scrapie-infected mice, especially in the caveolinenriched membrane fractions. Interestingly, the observed decrease in GPI-PLD expression levels began at the same time that PrPSc began to accumulate in the infected brains and this decrease was also observed in both the brain and CSF of CJD patients; however, no differences in expression were observed in either the brains or CSF specimens from Alzheimer's disease patients. Taken together, these results suggest that the down-regulation of GPI-PLD protein may be involved in prion propagation in the brains of prion diseases.	[Jin, Jae-Kwang; Jang, Byungki; Jin, Hyoung Tae; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Gyeonggi Do, South Korea; [Jung, Cha-Gyun] Nagoya City Univ Grad, Dept Neurophysiol & Brain Sci, Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Kim, Jae-Il] Pukyong Natl Univ, Dept Food Sci & Nutr, Busan 608737, South Korea; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Dept Virol, Staten Isl, NY 10314 USA	Hallym University; Pukyong National University; Institute for Basic Research in Developmental Disabilities	Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Gyeonggi Do, South Korea.	yskim@hallym.ac.kr		Jung, Cha-Gyun/0000-0002-0225-0658	Korea Research Foundation Grant - Korean Government [KRF-2008-313-E00110, KRF-2011-619-E0001]	Korea Research Foundation Grant - Korean Government(National Research Foundation of KoreaKorean Government)	The present study was supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2008-313-E00110, KRF-2011-619-E0001).	Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bernasconi E, 1996, J CELL SCI, V109, P1195; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRUNNER G, 1994, BLOOD, V83, P2115; CARP RI, 1991, J GEN VIROL, V72, P293, DOI 10.1099/0022-1317-72-2-293; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Deeg MA, 2001, J LIPID RES, V42, P442; Du XH, 2001, INFECT IMMUN, V69, P3214, DOI 10.1128/IAI.69.5.3214-3223.2001; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; HARMEY JH, 1995, BIOCHEM BIOPH RES CO, V210, P753, DOI 10.1006/bbrc.1995.1723; Jin JK, 2005, J NEUROCHEM, V92, P452, DOI 10.1111/j.1471-4159.2004.02881.x; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Low MG, 1999, ARCH BIOCHEM BIOPHYS, V371, P332, DOI 10.1006/abbi.1999.1436; LOW MG, 1993, J BIOL CHEM, V268, P8480; LOW MG, 2000, PNH GPI LINKED PROTE, P239; MAGUIRE GA, 1995, ANN CLIN BIOCHEM, V32, P74, DOI 10.1177/000456329503200107; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; METZ CN, 1994, EMBO J, V13, P1741, DOI 10.1002/j.1460-2075.1994.tb06438.x; METZ CN, 1991, J BIOL CHEM, V266, P17733; Nakashima S, 1999, CHEM PHYS LIPIDS, V98, P153, DOI 10.1016/S0009-3084(99)00027-4; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945	34	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122120	10.1371/journal.pone.0122120	http://dx.doi.org/10.1371/journal.pone.0122120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867459	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100059
J	Sato, APS; Antunes, JLF; Moura, RF; de Andrade, FB; Duarte, YAO; Lebrao, ML				Sayuri Sato, Ana Paula; Ferreira Antunes, Jose Leopoldo; Moura, Roudom Ferreira; de Andrade, Fabiola Bof; Oliveira Duarte, Yeda Aparecida; Lebrao, Maria Lucia			Factors Associated to Vaccination against Influenza among Elderly in a Large Brazilian Metropolis	PLOS ONE			English	Article							OLDER-ADULTS; PNEUMOCOCCAL VACCINATION; SELF-REPORT; A H1N1; HEALTH; PREVALENCE; PEOPLE; STATE	Background This study aimed to estimate coverage and identify factors associated to vaccination against influenza in the elderly population. Methods The study design was cross-sectional and population based. Data was collected in 2010 by the Health, Well-Being and Aging Study. Sample consisted of 1,341 community-dwelling elderly, in Sao Paulo, Brazil. Association between vaccination and covariates was evaluated by means of prevalence ratios estimated by Poisson regression models. Results Self-reported vaccination coverage was 74.2% (95% confidence interval: 71.3-76.9). Remaining physically active and having had recent interaction with health services, mainly with public units of healthcare, were the main incentives to increase vaccination coverage among the elderly; whereas lower age, living alone and absent interaction with health services were the main constraints to influenza vaccination at the community level. These covariates had already been reported to influence influenza vaccination of elders in previous years. Conclusion Previous knowledge already available on the main constraints to influenza vaccination has not allowed to remove them. Influenza campaigns should be strengthened to increase vaccination coverage, especially in the group more reticent to vaccination. Instructing healthcare providers to recommend vaccine uptake is an important piece of this puzzle.	[Sayuri Sato, Ana Paula; Ferreira Antunes, Jose Leopoldo; Lebrao, Maria Lucia] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Moura, Roudom Ferreira] Ctr Epidemiol Surveillance Prof Alexandre Vranjac, Sao Paulo, Brazil; [de Andrade, Fabiola Bof] Fundacao Oswaldo Cruz, Rene Rachou Res Inst, Ctr Studies Publ Hlth & Aging, Belo Horizonte, MG, Brazil; [Oliveira Duarte, Yeda Aparecida] Univ Sao Paulo, Sch Nursing, Dept Med Surg Nursing, Sao Paulo, Brazil	Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Sato, APS (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.	sah@usp.br	Sato, Ana Paula Sayuri/D-4111-2016; Duarte, Yeda/AAT-8935-2020; Antunes, Jose Leopoldo Ferreira/F-6969-2010; Moura, Roudom/AFL-9925-2022; de Andrade, Fabiola Bof/AAT-2885-2020; de Andrade, Fabiola Bof/D-8922-2012	Sato, Ana Paula Sayuri/0000-0001-8601-5884; Antunes, Jose Leopoldo Ferreira/0000-0003-3972-9723; de Andrade, Fabiola Bof/0000-0002-3467-3989; 	Sao Paulo Research Foundation - FAPESP [99/05125-7, 2005/54947-2, 2009/53778-3]; Ministry of Health, Brazil	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Health, Brazil	The Health, Wellbeing and Aging Study (SABE) was funded by the Sao Paulo Research Foundation - FAPESP (99/05125-7; 2005/54947-2; 2009/53778-3) - URL: http://www.fapesp.br and Ministry of Health, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew MK, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-36; [Anonymous], 2012, WKLY EPIDEMIOL REC; Antunes JLF, 2007, INT J EPIDEMIOL, V36, P1319, DOI 10.1093/ije/dym208; Ashbaugh AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058852; Avelino-Silva VI, 2011, CLINICS, V66, P2031, DOI 10.1590/S1807-59322011001200006; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brasil. Ministerio da Saude, PROGR NAC IM SIST IN; Brasil. Ministerio da Saude, 2011, PROGR NAC IM INF TEC; Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007; Chang YC, 2013, VACCINE, V31, P410, DOI 10.1016/j.vaccine.2012.10.086; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; de Andrade FB, 2013, J AM GERIATR SOC, V61, P809, DOI 10.1111/jgs.12221; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Donalisio MR, 2006, REV SAUDE PUBL, V40, P115, DOI 10.1590/S0034-89102006000100018; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Heo JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064230; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; LEBRAO ML, 2003, SABE SAUDE BEM ESTAR; Lima-Costa MF, 2008, REV SAUDE PUBL, V42, P100, DOI 10.1590/S0034-89102008000100013; Lu PJ, 2013, AM J INFECT CONTROL, V41, P702, DOI 10.1016/j.ajic.2012.10.027; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-249; Martinez-Baz I, 2012, PREV MED, V55, P246, DOI 10.1016/j.ypmed.2012.06.020; McIntyre A, 2014, CAN J AGING, V33, P92, DOI 10.1017/S0714980813000640; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; Moura RF., 2013, THESIS U SAO PAULO; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Paulo Sao, 2005, DROP; Peng Y, 2013, PUBLIC HEALTH, V127, P930, DOI 10.1016/j.puhe.2013.06.007; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Rolnick SJ, 2013, VACCINE, V31, P3928, DOI 10.1016/j.vaccine.2013.06.041; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Francisco PMSB, 2011, CAD SAUDE PUBLICA, V27, P417, DOI 10.1590/S0102-311X2011000300003; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Victor JF, 2014, REV ESC ENFERM USP, V48, P57, DOI 10.1590/S0080-623420140000100007; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wu SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-636; Zheng Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003662; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123840	10.1371/journal.pone.0123840	http://dx.doi.org/10.1371/journal.pone.0123840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874953	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100218
J	Song, N; Choi, JY; Sung, H; Jeon, S; Chung, S; Park, SK; Han, W; Lee, JW; Kim, MK; Lee, JY; Yoo, KY; Han, BG; Ahn, SH; Noh, DY; Kang, D				Song, Nan; Choi, Ji-Yeob; Sung, Hyuna; Jeon, Sujee; Chung, Seokang; Park, Sue K.; Han, Wonshik; Lee, Jong Won; Kim, Mi Kyung; Lee, Ji-Young; Yoo, Keun-Young; Han, Bok-Ghee; Ahn, Sei-Hyun; Noh, Dong-Young; Kang, Daehee			Prediction of Breast Cancer Survival Using Clinical and Genetic Markers by Tumor Subtypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ONE-CARBON METABOLISM; POLYMORPHISMS; PROGNOSIS; WOMEN; SUSCEPTIBILITY; HETEROGENEITY; CHEMOTHERAPY; THERAPY; STAGE	Purpose To identify the genetic variants associated with breast cancer survival, a genome-wide association study (GWAS) was conducted of Korean breast cancer patients. Methods From the Seoul Breast Cancer Study (SEBCS), 3,226 patients with breast cancer (1,732 in the discovery and 1,494 in the replication set) were included in a two-stage GWAS on disease- free survival (DFS) by tumor subtypes based on hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2). The associations of the re-classified combined prognostic markers through recursive partitioning analysis (RPA) of DFS for breast cancer were assessed with the Cox proportional hazard model. The prognostic predictive values of the clinical and genetic models were evaluated by Harrell's C. Results In the two-stage GWAS stratified by tumor subtypes, rs166870 and rs10825036 were consistently associated with DFS in the HR+ HER2-and HR-HER2-breast cancer subtypes, respectively (P-rs166870= 2.88x10(-7) and P-rs10825036= 3.54x10(-7) in the combined set). When patients were classified by the RPA in each subtype, genetic factors contributed significantly to differentiating the high risk group associated with DFS inbreast cancer, specifically the HR+ HER2-(P-discovery= 1.18x10(-8) and P-replication= 2.08x10(-5)) and HR-HRE2-subtypes (P-discovery= 2.35x10(-4) and P-replication= 2.60x10(-2)). The inclusion of the SNPs tended to improve the performance of the prognostic models consisting of age, TNM stage and tumor subtypes based on ER, PR, and HER2 status. Conclusion Combined prognostic markers that include clinical and genetic factors by tumor subtypes could improve the prediction of survival in breast cancer.	[Song, Nan; Choi, Ji-Yeob; Park, Sue K.; Han, Wonshik; Noh, Dong-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Ji-Yeob; Sung, Hyuna; Chung, Seokang; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Choi, Ji-Yeob; Jeon, Sujee; Park, Sue K.; Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Sung, Hyuna] Natl Canc Inst, Div Epidemiol & Genet, Rockville, MD USA; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won; Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won; Ahn, Sei-Hyun] ASAN Med Ctr, Seoul, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Management, Goyang Si, Gyeonggi Do, South Korea; [Lee, Ji-Young] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Ji-Young] Yonsei Univ Hlth Syst, Cardiovasc Genome Ctr, Seoul, South Korea; [Han, Bok-Ghee] Korea Natl Inst Hlth, Ctr Genome Sci, Osong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); University of Ulsan; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Kang, D (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	dhkang@snu.ac.kr	Han, Wonshik/B-3699-2008; Song, Nan/F-5774-2019	Han, Wonshik/0000-0001-7310-0764; Song, Nan/0000-0002-9182-1060; Kang, Daehee/0000-0003-4031-5878; Lee, Ji-Young/0000-0002-7784-1401	BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-0000347]; Seoul National University Hospital	BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Seoul National University Hospital	This research was supported by the BRL (Basic Research Laboratory) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0000347) and by the Seoul National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Azzato EM, 2010, J NATL CANCER I, V102, P650, DOI 10.1093/jnci/djq057; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Boyapati SM, 2005, CLIN CANCER RES, V11, P1093; Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Chung SY, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3475; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Clark, 1995, Breast Cancer, V2, P79, DOI 10.1007/BF02966945; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dumenil G, 1997, BIOCHEM BIOPH RES CO, V234, P748, DOI 10.1006/bbrc.1997.6702; Eroglu A, 2012, ANN SURG ONCOL, V19, P1365, DOI 10.1245/s10434-011-1969-8; Falck AK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-558; Fasching PA, 2012, HUM MOL GENET, V21, P3926, DOI 10.1093/hmg/dds159; Figueroa JD, 2011, HUM MOL GENET, V20, P4693, DOI 10.1093/hmg/ddr368; Fu FM, 2013, DNA CELL BIOL, V32, P274, DOI 10.1089/dna.2012.1928; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Horner MJ, 2009, SEER CANCER STATISTI, DOI 10.1016/j.healun.2014.01.862; Hsieh SM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2412; Huang ZY, 2011, STAT INTERFACE, V4, P359; Huertas-Vazquez A, 2010, HUM GENET, V127, P83, DOI 10.1007/s00439-009-0749-z; Ishitobi M, 2003, CLIN CANCER RES, V9, P1376; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Kang HS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-465; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kiyotani K, 2012, HUM MOL GENET, V21, P1665, DOI 10.1093/hmg/ddr597; Kurebayashi J, 2007, BREAST, V16, pS72, DOI 10.1016/j.breast.2007.07.017; Ladoire S, 2012, ANN ONCOL, V23, P2552, DOI 10.1093/annonc/mds028; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; LANE DM, 1995, BREAST CANCER RES TR, V34, P161, DOI 10.1007/BF00665788; LEE YS, 2012, J INEQUAL APPL, DOI DOI 10.1186/1475-2891-11-59; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; MARNETT LJ, 1980, CANCER RES, V40, P276; Martin DN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-257; Matakidou A, 2007, BRIT J CANCER, V97, P247, DOI 10.1038/sj.bjc.6603830; Mook S, 2009, LANCET ONCOL, V10, P1070, DOI 10.1016/S1470-2045(09)70254-2; Muendlein A, 2013, J CANCER RES CLIN, V139, P491, DOI 10.1007/s00432-012-1355-3; Naushad SM, 2012, MOL CELL BIOCHEM, V361, P189, DOI 10.1007/s11010-011-1103-z; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Puig-Vives M, 2013, GYNECOL ONCOL, V130, P609, DOI 10.1016/j.ygyno.2013.05.039; Rafiq S, 2013, CANCER RES, V73, P1883, DOI 10.1158/0008-5472.CAN-12-3377; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Roberts MR, 2013, BREAST CANCER RES TR, V139, P873, DOI 10.1007/s10549-013-2601-3; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Shrubsole MJ, 2005, BREAST CANCER RES TR, V91, P73, DOI 10.1007/s10549-004-7265-6; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Song N, 2014, INT J CANCER, V135, P669, DOI 10.1002/ijc.28685; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Xu XR, 2008, CANCER EPIDEM BIOMAR, V17, P2109, DOI 10.1158/1055-9965.EPI-07-2900; Xu XR, 2009, J GENET GENOMICS, V36, P203, DOI 10.1016/S1673-8527(08)60108-3; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8; Zhao J, 2009, J SURG ONCOL, V100, P89, DOI 10.1002/jso.21307	59	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122413	10.1371/journal.pone.0122413	http://dx.doi.org/10.1371/journal.pone.0122413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867717	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100072
J	Weinberg, A; Muresan, P; Richardson, KM; Fenton, T; Dominguez, T; Bloom, A; Watts, DH; Abzug, MJ; Nachman, SA; Levin, MJ				Weinberg, Adriana; Muresan, Petronella; Richardson, Kelly M.; Fenton, Terence; Dominguez, Teresa; Bloom, Anthony; Watts, D. Heather; Abzug, Mark J.; Nachman, Sharon A.; Levin, Myron J.		P1086 Team	Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMAGGLUTINATION-INHIBITING ANTIBODY; MATERNAL INFLUENZA VACCINATION; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; YOUNG INFANTS; RESPIRATORY ILLNESS; IMMUNE ACTIVATION; UNITED-STATES; A H1N1	Influenza infections have high frequency and morbidity in HIV-infected pregnant women, underscoring the importance of vaccine-conferred protection. To identify the factors that determine vaccine immunogenicity in this group, we characterized the relationship of B-and T-cell responses to pandemic H1N1 (pH1N1) vaccine with HIV-associated immunologic and virologic characteristics. pH1N1 and seasonal-H1N1 (sH1N1) antibodies were measured in 119 HIV-infected pregnant women after two double-strength pH1N1 vaccine doses. pH1N1-IgG and IgA B-cell FluoroSpot, pH1N1-and sH1N1-interferon gamma (IFN gamma) and granzyme B (GrB) T-cell FluoroSpot, and flow cytometric characterization of B-and T-cell subsets were performed in 57 subjects. pH1N1-antibodies increased after vaccination, but less than previously described in healthy adults. pH1N1-IgG memory B cells (Bmem) increased, IFN gamma-effector T-cells (Teff) decreased, and IgA Bmem and GrB Teff did not change. pH1N1-antibodies and Teff were significantly correlated with each other and with sH1N1-HAI and Teff, respectively, before and after vaccination. pH1N1-antibody responses to the vaccine significantly increased with high proportions of CD4+, low CD8+ and low CD8+ HLADR+ CD38+ activated (Tact) cells. pH1N1-IgG Bmem responses increased with high proportions of CD19+ CD27+ CD21-activated B cells (Bact), high CD8+ CD39+ regulatory T cells (Treg), and low CD19+ CD27-CD21-exhausted B cells (Bexhaust). IFN gamma-Teff responses increased with low HIV plasma RNA, CD8+ HLADR+ CD38+ Tact, CD4+ FoxP3+ Treg and CD19+ IL10+ Breg. In conclusion, pre-existing antibody and Teff responses to sH1N1 were associated with increased responses to pH1N1 vaccination in HIV-infected pregnant women suggesting an important role for heterosubtypic immunologic memory. High CD4+% T cells were associated with increased, whereas high HIV replication, Tact and Bexhaust were associated with decreased vaccine immunogenicity. High Treg increased antibody responses but decreased Teff responses to the vaccine. The proportions of immature and transitional B cells did not affect the responses to vaccine. Increased Bact were associated with high Bmem responses to the vaccine.	[Weinberg, Adriana; Richardson, Kelly M.; Dominguez, Teresa; Abzug, Mark J.; Levin, Myron J.] Univ Colorado, Anschutz Med Ctr, Aurora, CO 80045 USA; [Muresan, Petronella; Fenton, Terence] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Stat & Data Anal Ctr, Boston, MA 02115 USA; [Bloom, Anthony] Frontier Sci & Technol Res Fdn Inc, Buffalo, NY USA; [Watts, D. Heather] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, Bethesda, MD USA; [Nachman, Sharon A.] SUNY Hlth Sci Ctr, Stony Brook, NY USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System	Weinberg, A (corresponding author), Univ Colorado, Anschutz Med Ctr, Aurora, CO 80045 USA.	adriana.weinberg@ucdenver.edu		Logan, Latania/0000-0002-3883-2043	National Institute of Allergy and Infectious Diseases [U01 AI068632, U01 AI41110, U01 AI068616]; National Institute of Child Health and Human Development; National Institute of Mental Health [AI068632, N01-DK-9-001/HHSN267200800001C, N01HD33162 (97-07)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, UM1AI068616, U01AI068632, U01AI041110, U01AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institute of Allergy and Infectious Diseases, grant number U01 AI068632 & U01 AI41110 & U01 AI068616, http://www.niaid.nih.gov/Pages/default.aspx; and National Institute of Child Health and Human Development and the National Institute of Mental Health, grant number AI068632 & N01-DK-9-001/HHSN267200800001C & N01HD33162 (97-07), https://www.nichd.nih.gov/ Pages/index.aspx and http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzug MJ, 2013, CLIN INFECT DIS, V56, P1488, DOI 10.1093/cid/cit057; Adedinsewo DA, 2013, VACCINE, V31, P5827, DOI 10.1016/j.vaccine.2013.09.071; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Benne CA, 1998, CLIN DIAGN LAB IMMUN, V5, P114, DOI 10.1128/CDLI.5.1.114-117.1998; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; BLACK SC, 2011, AM POETRY REV, V40, P30, DOI DOI 10.1097/INF.0B013E3182367662; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; Chougnet CA, 2007, AIDS RES HUM RETROV, V23, P945, DOI 10.1089/aid.2006.0259; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cooper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017758; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Dolan GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041638; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; El Sahly HM, 2012, J INFECT DIS, V205, P703, DOI 10.1093/infdis/jir837; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Flynn PM, 2012, J INFECT DIS, V206, P421, DOI 10.1093/infdis/jis360; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fukushima W, 2012, VACCINE, V30, P7630, DOI 10.1016/j.vaccine.2012.10.027; Fuller JD, 1999, CLIN INFECT DIS, V28, P541, DOI 10.1086/515170; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hammitt LL, 2009, VACCINE, V27, P7359, DOI 10.1016/j.vaccine.2009.09.041; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Lagler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036773; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Madhi SA, 2014, PEDIATR INFECT DIS J, V33, P174, DOI 10.1097/INF.0b013e3182a73ebb; Maltezou HC, 2013, CLIN INFECT DIS, V57, P1520, DOI 10.1093/cid/cit599; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez E, 2011, HIV MED, V12, P236, DOI 10.1111/j.1468-1293.2010.00905.x; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Muyanja E, 2014, J CLIN INVEST, V124, P1, DOI [10.1172/JCI72323, DOI 10.1172/JCI72323]; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Noguera-Julian A, 2011, PEDIATR INFECT DIS J, V30, P173, DOI 10.1097/INF.0b013e3181f5358b; Omer SB, 2013, J INFECT DIS, V207, P1144, DOI 10.1093/infdis/jit003; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Peters PJ, 2011, CLIN INFECT DIS, V52, pS183, DOI 10.1093/cid/ciq036; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Richardson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028172; Richardson K, 2011, AIDS, V25, P595, DOI 10.1097/QAD.0b013e32834411a8; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Viau M, 2007, MOL IMMUNOL, V44, P2124, DOI 10.1016/j.molimm.2006.07.302; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; Weinberg A, 2004, CLIN INFECT DIS, V39, P107, DOI 10.1086/420931; Weinberg A, 2013, HUM VACC IMMUNOTHER, V9, P957, DOI 10.4161/hv.23774; Weinberg A, 2010, J IMMUNOL METHODS, V363, P42, DOI 10.1016/j.jim.2010.09.032; Weinberg A, 2010, JAIDS-J ACQ IMM DEF, V55, P189, DOI 10.1097/QAI.0b013e3181e46308; Weinberg A, 2010, AIDS RES HUM RETROV, V26, P51, DOI 10.1089/aid.2009.0163; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	86	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122431	10.1371/journal.pone.0122431	http://dx.doi.org/10.1371/journal.pone.0122431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874544	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100073
J	Garczyk, S; von Stillfried, S; Antonopoulos, W; Hartmann, A; Schrauder, MG; Fasching, PA; Anzeneder, T; Tannapfel, A; Ergonenc, Y; Knuchel, R; Rose, M; Dahl, E				Garczyk, Stefan; von Stillfried, Saskia; Antonopoulos, Wiebke; Hartmann, Arndt; Schrauder, Michael G.; Fasching, Peter A.; Anzeneder, Tobias; Tannapfel, Andrea; Ergoenenc, Yavuz; Knuechel, Ruth; Rose, Michael; Dahl, Edgar			AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection	PLOS ONE			English	Article							MONITORING TREATMENT RESPONSES; XENOPUS CEMENT GLAND; ANTERIOR GRADIENT-2; ESTROGEN-RECEPTOR; OVARIAN-CANCER; HUMAN HOMOLOG; PROTEIN; TUMOR; MAMMOGRAPHY; GENE	Blood-based early detection of breast cancer has recently gained novel momentum, as liquid biopsy diagnostics is a fast emerging field. In this study, we aimed to identify secreted proteins which are up-regulated both in tumour tissue and serum samples of breast cancer patients compared to normal tissue and sera. Based on two independent tissue cohorts (n = 75 and n = 229) and one serum cohort (n = 80) of human breast cancer and healthy serum samples, we characterised AGR3 as a novel potential biomarker both for breast cancer prognosis and early breast cancer detection from blood. AGR3 expression in breast tumours is significantly associated with oestrogen receptor a (P<0.001) and lower tumour grade (P<0.01). Interestingly, AGR3 protein expression correlates with unfavourable outcome in low (G1) and intermediate (G2) grade breast tumours (multivariate hazard ratio: 2.186, 95% CI: 1.008-4.740, P<0.05) indicating an independent prognostic impact. In sera analysed by ELISA technique, AGR3 protein concentration was significantly (P<0.001) elevated in samples from breast cancer patients (n = 40, mainly low stage tumours) compared to healthy controls (n = 40). To develop a suitable biomarker panel for early breast cancer detection, we measured AGR2 protein in human serum samples in parallel. The combined AGR3/AGR2 biomarker panel achieved a sensitivity of 64.5% and a specificity of 89.5% as shown by receiver operating characteristic (ROC) curve statistics. Thus our data clearly show the potential usability of AGR3 and AGR2 as biomarkers for blood-based early detection of human breast cancer.	[Garczyk, Stefan; von Stillfried, Saskia; Antonopoulos, Wiebke; Knuechel, Ruth; Rose, Michael; Dahl, Edgar] Rhein Westfal TH Aachen, Inst Pathol, Fac Med, Mol Oncol Grp, Aachen, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Schrauder, Michael G.; Fasching, Peter A.] Univ Hosp Erlangen, Dept Obstet & Gynaecol, Erlangen, Germany; [Anzeneder, Tobias] Patients Tumor Bank Hope PATH Fdn, Munich, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany; [Ergoenenc, Yavuz] St Anna Hosp, Dept Senol, Herne, Germany	RWTH Aachen University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruhr University Bochum; Saint Anna Hospital	Dahl, E (corresponding author), Rhein Westfal TH Aachen, Inst Pathol, Fac Med, Mol Oncol Grp, Aachen, Germany.	edahl@ukaachen.de	Garczyk, Stefan/AAD-3755-2019; Fasching, Peter A/ABH-9912-2020	Fasching, Peter A/0000-0003-4885-8471; von Stillfried, Saskia/0000-0002-5260-8494	INTERREG IV-A MicroBioMed [EMR. INT4-1.2.-2009-11/058]	INTERREG IV-A MicroBioMed	Funding provided by INTERREG IV-A MicroBioMed EMR. INT4-1.2.-2009-11/058 (ED), http://www.interregemr.eu/, http://www.microbiomed.ulg.ac.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Bradley L, 1996, DEVELOPMENT, V122, P2739; Brychtova V, 2014, EXP MOL PATHOL, V96, P375, DOI 10.1016/j.yexmp.2014.04.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Chikkaveeraiah BV, 2012, ACS NANO, V6, P6546, DOI 10.1021/nn3023969; Chung K, 2011, CANCER BIOMARK, V10, P101, DOI 10.3233/CBM-2012-0234; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; DERSHAW DD, 1995, AM J ROENTGENOL, V164, P309, DOI 10.2214/ajr.164.2.7839960; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Graham LJ, 2014, J CANCER, V5, P58, DOI 10.7150/jca.7047; Gray TA, 2012, J IMMUNOL METHODS, V378, P20, DOI 10.1016/j.jim.2012.01.013; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hooley RJ, 2011, ULTRASOUND Q, V27, P23, DOI 10.1097/RUQ.0b013e31820e15ac; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Innes HE, 2006, BRIT J CANCER, V94, P1057, DOI 10.1038/sj.bjc.6603065; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kani K, 2013, PROSTATE, V73, P306, DOI 10.1002/pros.22569; King ER, 2011, AM J SURG PATHOL, V35, P904, DOI 10.1097/PAS.0b013e318212ae22; Kloten V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3375; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Makawita S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-404; Otieno BA, 2014, BIOSENS BIOELECTRON, V53, P268, DOI 10.1016/j.bios.2013.09.054; Park K, 2011, EXP MOL MED, V43, P91, DOI 10.3858/emm.2011.43.2.011; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-452; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; REMMELE W, 1987, PATHOLOGE, V8, P138; Shupe MP, 2014, J CANCER, V5, P69, DOI 10.7150/jca.7048; Sive H, 1996, DEV DYNAM, V205, P265, DOI 10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G; Sobin L. H., 1997, TNM CLASSIFICATION M; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Thuma F, 2013, MOL ONCOL, V7, P917, DOI 10.1016/j.molonc.2013.05.002; Waldmann A, 2014, GEBURTSH FRAUENHEILK, V74, P361, DOI 10.1055/s-0033-1360263; Ying L, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-76; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang PJ, 2014, INT J CANCER, V134, P2646, DOI 10.1002/ijc.28584	58	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122106	10.1371/journal.pone.0122106	http://dx.doi.org/10.1371/journal.pone.0122106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875093	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800040
J	Gervasoni, C; Meraviglia, P; Minisci, D; Ferraris, L; Riva, A; Landonio, S; Cozzi, V; Charbe, N; Molinari, L; Rizzardini, G; Clementi, E; Galli, M; Cattaneo, D				Gervasoni, Cristina; Meraviglia, Paola; Minisci, Davide; Ferraris, Laurenzia; Riva, Agostino; Landonio, Simona; Cozzi, Valeria; Charbe, Nitin; Molinari, Lara; Rizzardini, Giuliano; Clementi, Emilio; Galli, Massimo; Cattaneo, Dario			Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?	PLOS ONE			English	Article							RITONAVIR-BOOSTED ATAZANAVIR; UNBOOSTED ATAZANAVIR; ANTIRETROVIRAL THERAPY; RENAL STONES; EFFICACY; PHARMACOKINETICS; HYPERBILIRUBINEMIA; TOLERABILITY; POLYMORPHISM; BILIRUBIN	Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia, dyslipidemia, nephrolithiasis and cholelithiasis have been reported in the medium and long term. Unboosted ATV may be selected for some patients because it has fewer gastrointestinal adverse effects, less hyperbilirubinemia and less impact on lipid profiles. Methods We investigated the distribution of ATV plasma trough concentrations according to drug dosage and the potential relationship between ATV plasma trough concentrations and drug-related adverse events in a consecutive series of 240 HIV-infected patients treated with ATV/r 300/100 mg (68%) or ATV 400 mg (32%). Results 43.9% of patients treated with ATV/r 300/100 mg had ATV concentrations exceeding the upper therapeutic threshold. A significant and direct association has been observed between the severity of hyperbilirubinemia and ATV plasma trough concentrations (ATV concentrations: 271 [77-555], 548 [206-902], 793 [440-1164], 768 [494-1527] and 1491 [1122-1798] ng/mL in patients with grade 0, 1, 2, 3 and 4 hyperbilirubinemia, respectively). In an exploratory analysis we found that patients with dyslipidemia or nephrolitiasis had ATV concentrations significantly higher (582 [266-1148], and 1098 [631-1238] ng/mL, respectively) (p<0.001), as compared with patients with no ATV-related complications (218 [77-541] ng/mL). Conclusions A significant proportion of patients treated with the conventional dosage of ATV (300/100) had plasma concentrations exceeding the upper therapeutic threshold. These patients that are at high risk to experience ATV-related complications may benefit from TDM-driven adjustments in ATV dosage with potential advantages in terms of costs and toxicity.	[Gervasoni, Cristina; Meraviglia, Paola; Minisci, Davide; Ferraris, Laurenzia; Riva, Agostino; Landonio, Simona; Molinari, Lara; Rizzardini, Giuliano; Galli, Massimo] L Sacco Univ Hosp, Dept Infect Dis, Milan, Italy; [Cozzi, Valeria; Charbe, Nitin; Cattaneo, Dario] L Sacco Univ Hosp, Clin Pharmacol Unit, Milan, Italy; [Clementi, Emilio] Univ Milan, L Sacco Univ Hosp, Dept Biomed & Clin Sci, Clin Pharmacol Unit,Consiglio Nazl Ric,Inst Neuro, Milan, Italy; [Clementi, Emilio] E Medea Sci Inst, Bosisio Parini, Italy; [Rizzardini, Giuliano] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; University of Witwatersrand	Gervasoni, C (corresponding author), L Sacco Univ Hosp, Dept Infect Dis, Milan, Italy.	cristina.gervasoni@unimi.it	Cattaneo, Dario/J-9265-2016; charbe, nitin/ABH-3390-2020; GALLI, MASSIMO/L-7282-2017	charbe, nitin/0000-0001-6959-2305; FERRARIS, LAURENZIA/0000-0003-0721-512X; GALLI, MASSIMO/0000-0001-8887-6215; Riva, Agostino/0000-0003-3171-3049; meraviglia, paola/0000-0002-3356-7199				Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; Anderson PL, 2009, J ANTIMICROB CHEMOTH, V64, P1071, DOI 10.1093/jac/dkp317; Carey D, 2010, J ANTIMICROB CHEMOTH, V65, P1878, DOI 10.1093/jac/dkq231; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chang HR, 2006, NEW ENGL J MED, V355, P2158, DOI 10.1056/NEJMc061892; Cleijsen RMM, 2007, J ANTIMICROB CHEMOTH, V60, P897, DOI 10.1093/jac/dkm298; De Nicolo A, 2014, ANTIMICROB AGENTS CH, V58, P4042, DOI 10.1128/AAC.00104-14; European AIDS Clinical Society, 2013, GUID VERS OCT 2013; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fayet A, 2009, J CHROMATOGR B, V877, P1057, DOI 10.1016/j.jchromb.2009.02.057; FDA guidance for industry-Bioanalytical methdod validation, 2001, FDA GUID IND BIOAN M; Ferraris L, 2012, J ANTIMICROB CHEMOTH, V67, P2236, DOI 10.1093/jac/dks175; Foca E, 2012, DRUGS, V72, P1161, DOI 10.2165/11631070-000000000-00000; Gianotti N, 2005, NEW MICROBIOL, V28, P119; Gonzalez de Requena D, 2005, 12 C RETR OPP INF BO; Hamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069845; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Jansen K, 2013, AIDS RES HUM RETROV, V29, P564, DOI [10.1089/aid.2012.0092, 10.1089/AID.2012.0092]; Laprise C, 2013, AIDS PATIENT CARE ST, V27, P378, DOI 10.1089/apc.2013.0009; Le Tiec C, 2005, CLIN PHARMACOKINET, V44, P1035, DOI 10.2165/00003088-200544100-00003; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Nishijima T, 2013, J ANTIMICROB CHEMOTH; Pacanowski J, 2006, AIDS, V20, P2131, DOI 10.1097/01.aids.0000247571.88256.90; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Podzamczer D, 2011, HIV MED, V12, P374, DOI 10.1111/j.1468-1293.2011.00917.x; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; Schipani A, 2010, ANTIMICROB AGENTS CH, V54, P5242, DOI 10.1128/AAC.00781-10; Smith DE, 2006, HIV CLIN TRIALS, V7, P34, DOI 10.1310/0KX0-H9VH-99EE-5D0L; Solas C, 2008, THER DRUG MONIT, V30, P670, DOI 10.1097/FTD.0b013e3181897bff; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Wempe MF, 2011, DRUG METAB DISPOS, V39, P522, DOI 10.1124/dmd.110.036178	32	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123670	10.1371/journal.pone.0123670	http://dx.doi.org/10.1371/journal.pone.0123670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875091	gold, Green Published			2022-12-27	WOS:000353015800109
J	Kamboj, SK; Krol, KM; Curran, HV				Kamboj, Sunjeev K.; Krol, Kathleen M.; Curran, H. Valerie			A Specific Association between Facial Disgust Recognition and Estradiol Levels in Naturally Cycling Women	PLOS ONE			English	Article							MENSTRUAL-CYCLE; EMOTION RECOGNITION; SEX-DIFFERENCES; PROGESTERONE; EXPRESSIONS; SENSITIVITY; DISCRIMINATION; ACCURACY; DISPLAYS; HORMONES	Subtle changes in social cognition are associated with naturalistic fluctuations in estrogens and progesterone over the course of the menstrual cycle. Using a dynamic emotion recognition task we aimed to provide a comprehensive description of the association between ovarian hormone levels and emotion recognition performance using a variety of performance metrics. Naturally cycling, psychiatrically healthy women attended a single experimental session during a follicular (days 7-13; n = 16), early luteal (days 15-19; n = 14) or late luteal phase (days 22-27; n = 14) of their menstrual cycle. Correct responses and reaction times to dynamic facial expressions were recorded and a two-high threshold analysis was used to assess discrimination and response bias. Salivary progesterone and estradiol were assayed and subjective measures of premenstrual symptoms, anxiety and positive and negative affect assessed. There was no interaction between cycle phase (follicular, early luteal, late luteal) and facial expression (sad, happy, fearful, angry, neutral and disgusted) on any of the recognition performance metrics. However, across the sample as a whole, progesterone levels were positively correlated with reaction times to a variety of facial expressions (anger, happiness, sadness and neutral expressions). In contrast, estradiol levels were specifically correlated with disgust processing on three performance indices (correct responses, response bias and discrimination). Premenstrual symptoms, anxiety and positive and negative affect were not associated with emotion recognition indices or hormone levels. The study highlights the role of naturalistic variations in ovarian hormone levels in modulating emotion recognition. In particular, progesterone seems to have a general slowing effect on facial expression processing. Our findings also provide the first behavioural evidence of a specific role for estrogens in the processing of disgust in humans.	[Kamboj, Sunjeev K.; Krol, Kathleen M.; Curran, H. Valerie] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London	Kamboj, SK (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	sunjeev.kamboj@ucl.ac.uk	Krol, Kathleen/L-1817-2019	Krol, Kathleen/0000-0002-8098-3195; Kamboj, Sunjeev/0000-0003-2197-0826	UCL	UCL	The study was funded entirely by UCL. UCL had no role in study design data collection, analysis, decision to publish or preparation of the manuscript	Bao AM, 2003, EUR J ENDOCRINOL, V148, P227, DOI 10.1530/eje.0.1480227; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Choleris E, 2012, FRONT NEUROENDOCRIN, V33, P140, DOI 10.1016/j.yfrne.2012.02.001; Conway CA, 2007, HORM BEHAV, V51, P202, DOI 10.1016/j.yhbeh.2006.10.002; Derntl B, 2008, PSYCHONEUROENDOCRINO, V33, P1031, DOI 10.1016/j.psyneuen.2008.04.014; Derntl B, 2008, HORM BEHAV, V53, P90, DOI 10.1016/j.yhbeh.2007.09.006; Derntl B, 2013, HORM BEHAV, V63, P97, DOI 10.1016/j.yhbeh.2012.10.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fleischman DS, 2011, HORM BEHAV, V59, P271, DOI 10.1016/j.yhbeh.2010.11.014; Guapo VG, 2009, PSYCHONEUROENDOCRINO, V34, P1087, DOI 10.1016/j.psyneuen.2009.02.007; Harmer CJ, 2011, J PSYCHOPHARMACOL, V25, P1148, DOI 10.1177/0269881110367722; Kamboj SK, 2013, PSYCHOPHARMACOLOGY, V227, P31, DOI 10.1007/s00213-012-2940-5; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Lee NC, 2013, EMOTION, V13, P1030, DOI 10.1037/a0033560; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Little AC, 2013, FRONT NEUROENDOCRIN, V34, P315, DOI 10.1016/j.yfrne.2013.07.009; Lynn SK, 2014, PSYCHOL SCI; Maner JK, 2014, EVOL HUM BEHAV, V35, P9, DOI 10.1016/j.evolhumbehav.2013.09.001; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Pearson R, 2005, HORM BEHAV, V47, P267, DOI 10.1016/j.yhbeh.2004.11.003; Platt B, 2010, DRUG ALCOHOL DEPEN, V112, P27, DOI 10.1016/j.drugalcdep.2010.05.004; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Puts DA, 2006, HUM NATURE-INT BIOS, V17, P114, DOI 10.1007/s12110-006-1023-x; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rubinow DR, 2007, J AFFECT DISORDERS, V104, P37, DOI 10.1016/j.jad.2007.01.031; Soni M, 2013, NEUROBIOL LEARN MEM, V104, P32, DOI 10.1016/j.nlm.2013.04.003; Spielberger C, 1983, STAI MANUAL STATE TR; Steiner M, 1997, ANNU REV MED, V48, P447, DOI 10.1146/annurev.med.48.1.447; Steiner M, 2011, J AFFECT DISORDERS, V135, P82, DOI 10.1016/j.jad.2011.06.058; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Toffoletto S, 2014, PSYCHONEUROENDOCRINO, V50, P28, DOI 10.1016/j.psyneuen.2014.07.025; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Wingen G, 2007, J NEUROSCI, V27, P11416, DOI 10.1523/JNEUROSCI.1715-07.2007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	38	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122311	10.1371/journal.pone.0122311	http://dx.doi.org/10.1371/journal.pone.0122311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874795	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800050
J	Senetta, R; Duregon, E; Sonetto, C; Spadi, R; Mistrangelo, M; Racca, P; Chiusa, L; Munoz, FH; Ricardi, U; Arezzo, A; Cassenti, A; Castellano, I; Papotti, M; Morino, M; Risio, M; Cassoni, P				Senetta, Rebecca; Duregon, Eleonora; Sonetto, Cristina; Spadi, Rossella; Mistrangelo, Massimiliano; Racca, Patrizia; Chiusa, Luigi; Munoz, Fernando H.; Ricardi, Umberto; Arezzo, Alberto; Cassenti, Adele; Castellano, Isabella; Papotti, Mauro; Morino, Mario; Risio, Mauro; Cassoni, Paola			YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; C-MET; COLORECTAL-CANCER; COMPLETE RESPONSE; IONIZING-RADIATION; INVASIVE GROWTH; BETA-CATENIN; ADENOCARCINOMA; RADIOTHERAPY; CARCINOMA	Background Neoadjuvant chemo-radiotherapy (CRT) followed by surgical resection is the standard treatment for locally advanced rectal cancer, although complete tumor pathological regression is achieved in only up to 30% of cases. A clinicopathological and molecular predictive stratification of patients with advanced rectal cancer is still lacking. Here, c-Met and YKL-40 have been studied as putative predictors of CRT response in rectal cancer, due to their reported involvement in chemoradioresistance in various solid tumors. Material and Methods A multicentric study was designed to assess the role of c-Met and YKL-40 expression in predicting chemoradioresistance and to correlate clinical and pathological features with CRT response. Immunohistochemistry and fluorescent in situ hybridization for c-Met were performed on 81 rectal cancer biopsies from patients with locally advanced rectal adenocarcinoma. All patients underwent standard (50.4 gy in 28 fractions + concurrent capecitabine 825 mg/m(2)) neoadjuvant CRT or the XELOXART protocol. CRT response was documented on surgical resection specimens and recorded as tumor regression grade (TRG) according to the Mandard criteria. Results A significant correlation between c-Met and YKL-40 expression was observed (R = 0.43). The expressions of c-Met and YKL-40 were both significantly associated with a lack of complete response (86% and 87% of c-Met and YKL-40 positive cases, p<0.01 and p = 0.006, respectively). Thirty of the 32 biopsies co-expressing both markers had partial or absent tumor response (TRG 2-5), strengthening their positive predictive value (94%). The exclusive predictive role of YKL-40 and c-Met was confirmed using a multivariate analysis (p = 0.004 and p = 0.007 for YKL-40 and c-Met, respectively). TRG was the sole morphological parameter associated with poor outcome. Conclusion c-Met and YKL-40 expression is a reliable predictor of partial/absent response to neoadjuvant CRT in rectal cancer. Targeted therapy protocols could take advantage of prior evaluations of c-MET and YKL-40 expression levels to increase therapeutic efficacy.	[Senetta, Rebecca; Chiusa, Luigi; Cassenti, Adele; Castellano, Isabella; Cassoni, Paola] Univ Turin, Dept Med Sci, Turin, Italy; [Duregon, Eleonora; Munoz, Fernando H.; Ricardi, Umberto; Papotti, Mauro] Univ Turin, Dept Oncol, Turin, Italy; [Sonetto, Cristina; Spadi, Rossella; Racca, Patrizia] City Hlth & Sci Hosp Turin, SSCVD Colorectal Canc Unit, Turin, Italy; [Mistrangelo, Massimiliano; Arezzo, Alberto; Morino, Mario] Univ Turin, Ctr Minimal Invas Surg, Digest & Colorectal Surg, Turin, Italy; [Risio, Mauro] IRCCS, FPO, Candiolo Canc Inst, Turin, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Cassoni, P (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	paola.cassoni@unito.it	Duregon, Eleonora/L-9509-2019; Castellano, Isabella/K-1888-2018; Arezzo, Alberto/AAB-6552-2020; Mistrangelo, Massimiliano/AAK-4428-2020; Cassoni, Paola/I-8544-2018; Morino, Mario/AAI-6437-2020	Duregon, Eleonora/0000-0003-4018-3983; Arezzo, Alberto/0000-0002-2110-4082; Mistrangelo, Massimiliano/0000-0001-8506-6794; Morino, Mario/0000-0003-4540-1409; Castellano, isabella/0000-0002-9072-1615	FIRC (Fondazione Italiana per la Ricerca sul Cancro); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	RS has received fellowships from FIRC (Fondazione Italiana per la Ricerca sul Cancro). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Bakr A A, 2013, Gulf J Oncolog, V1, P28; Akiyoshi T, 2012, SURG TODAY, V42, P713, DOI 10.1007/s00595-012-0223-8; An X, 2014, CANCER-AM CANCER SOC, V120, P675, DOI 10.1002/cncr.28454; Avoranta ST, 2013, HUM PATHOL, V44, P966, DOI 10.1016/j.humpath.2012.10.003; Bhardwaj V, 2013, CANCER-AM CANCER SOC, V119, P1768, DOI 10.1002/cncr.27965; Borst P, 2010, CELL CYCLE, V9, P4836, DOI 10.4161/cc.9.24.14326; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Bouzourene H, 2002, CANCER-AM CANCER SOC, V94, P1121, DOI 10.1002/cncr.10327; Braendengen M, 2008, J CLIN ONCOL, V26, P3687, DOI 10.1200/JCO.2007.15.3858; Brettingham-Moore KH, 2011, CLIN CANCER RES, V17, P3039, DOI 10.1158/1078-0432.CCR-10-2915; Buchanan IM, 2011, J CELL MOL MED, V15, P1999, DOI 10.1111/j.1582-4934.2010.01122.x; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Casado E, 2011, CLIN CANCER RES, V17, P4145, DOI 10.1158/1078-0432.CCR-10-2257; Chang HJ, 2005, HUM PATHOL, V36, P364, DOI 10.1016/j.humpath.2005.01.018; Chen HJ, 2013, INT J ONCOL, V43, P141, DOI 10.3892/ijo.2013.1941; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Duldulao MP, 2013, DIS COLON RECTUM, V56, P142, DOI 10.1097/DCR.0b013e31827541e2; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Fokas E, 2014, J CLIN ONCOL, V32, P1554, DOI 10.1200/JCO.2013.54.3769; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Frykholm GJ, 2001, INT J RADIAT ONCOL, V50, P427, DOI 10.1016/S0360-3016(01)01479-1; Gao W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0546-3; Garouniatis A, 2013, INT J COLORECTAL DIS, V28, P9, DOI 10.1007/s00384-012-1520-9; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Grade M, 2012, LANGENBECK ARCH SURG, V397, P543, DOI 10.1007/s00423-012-0929-5; Guo BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099399; Hermanek P, 2013, ANTICANCER RES, V33, P559; Hiotis SP, 2002, J AM COLL SURGEONS, V194, P131, DOI 10.1016/S1072-7515(01)01159-0; Huh JW, 2013, DIS COLON RECTUM, V56, P698, DOI 10.1097/DCR.0b013e3182837e5b; Jakob C, 2008, WORLD J GASTROENTERO, V14, P1060, DOI 10.3748/wjg.14.1060; Janjan NA, 1999, INT J RADIAT ONCOL, V44, P1027, DOI 10.1016/S0360-3016(99)00099-1; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Kawamura M, 2012, ANTICANCER RES, V32, P1527; Kim IJ, 2007, DIS COLON RECTUM, V50, P1342, DOI 10.1007/s10350-007-277-7; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; Lin AY, 2008, INT J COLORECTAL DIS, V23, P243, DOI 10.1007/s00384-007-0406-8; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Medich D, 2001, DIS COLON RECTUM, V44, P1123, DOI 10.1007/BF02234632; Moussata D, 2012, AM J PATHOL, V181, P1271, DOI 10.1016/j.ajpath.2012.06.029; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Ricardi U, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0581-0; Rodel F, 2002, STRAHLENTHER ONKOL, V178, P426, DOI 10.1007/s00066-002-1003-y; Rosenthal DI, 2008, INT J RADIAT ONCOL, V72, P108, DOI 10.1016/j.ijrobp.2008.05.054; Schultz Nicolai A, 2010, Cancers (Basel), V2, P1453, DOI 10.3390/cancers2031453; Shao R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00122; Shao R, 2014, CARCINOGENESIS, V35, P373, DOI 10.1093/carcin/bgt380; Siemens H, 2013, CLIN CANCER RES, V19, P710, DOI 10.1158/1078-0432.CCR-12-1703; Smith FM, 2006, EJSO-EUR J SURG ONC, V32, P55, DOI 10.1016/j.ejso.2005.09.010; Stella GM, 2011, HUM MUTAT, V32, P44, DOI 10.1002/humu.21374; Valentini V, 2014, J CLIN ONCOL, V32, P1534, DOI 10.1200/JCO.2014.55.4766; Vigna E, 2015, ONCOGENE, V34, P1883, DOI 10.1038/onc.2014.142; Voutsina A, 2013, MODERN PATHOL, V26, P302, DOI 10.1038/modpathol.2012.150; Wang L, 2013, WORLD J GASTROENTERO, V19, P6876, DOI 10.3748/wjg.v19.i40.6876; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; Wheeler JMD, 2004, DIS COLON RECTUM, V47, P2025, DOI 10.1007/s10350-004-0713-x; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Yang H, 2013, LAB INVEST, V93, P344, DOI 10.1038/labinvest.2012.180; Yu HL, 2012, BIOCHEM BIOPH RES CO, V427, P659, DOI 10.1016/j.bbrc.2012.09.117	63	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123759	10.1371/journal.pone.0123759	http://dx.doi.org/10.1371/journal.pone.0123759			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875173	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800114
J	Swiatek-Polatynska, MA; Bucca, G; Laing, E; Gubbens, J; Titgemeyer, F; Smith, CP; Rigali, S; van Wezel, GP				Swiatek-Polatynska, Magdalena A.; Bucca, Giselda; Laing, Emma; Gubbens, Jacob; Titgemeyer, Fritz; Smith, Colin P.; Rigali, Sebastien; van Wezel, Gilles P.			Genome-Wide Analysis of In Vivo Binding of the Master Regulator DasR in Streptomyces coelicolor Identifies Novel Non-Canonical Targets	PLOS ONE			English	Article							AERIAL MYCELIUM FORMATION; N-ACETYLGLUCOSAMINE METABOLISM; CARBON CATABOLITE REPRESSION; AMP RECEPTOR PROTEIN; ANTIBIOTIC PRODUCTION; ESCHERICHIA-COLI; MORPHOLOGICAL-DIFFERENTIATION; PHOSPHOTRANSFERASE SYSTEM; BACILLUS-SUBTILIS; GLUCOSE KINASE	Streptomycetes produce a wealth of natural products, including over half of all known antibiotics. It was previously demonstrated that N-acetylglucosamine and secondary metabolism are closely entwined in streptomycetes. Here we show that DNA recognition by the N-acetylglucosamine-responsive regulator DasR is growth-phase dependent, and that DasR can bind to sites in the S. coelicolor genome that have no obvious resemblance to previously identified DasR-responsive elements. Thus, the regulon of DasR extends well beyond what was previously predicted and includes a large number of genes with functions far removed from N-acetylglucosamine metabolism, such as genes for small RNAs and DNA transposases. Conversely, the DasR regulon during vegetative growth largely correlates to the presence of canonical DasR-responsive elements. The changes in DasR binding in vivo following N-acetylglucosamine induction were studied in detail and a possible molecular mechanism by which the influence of DasR is extended is discussed. Discussion of DasR binding was further informed by a parallel transcriptome analysis of the respective cultures. Evidence is provided that DasR binds directly to the promoters of all genes encoding pathway-specific regulators of antibiotic production in S. coelicolor, thereby providing an exquisitely simple link between nutritional control and secondary metabolism.	[Swiatek-Polatynska, Magdalena A.; Gubbens, Jacob; van Wezel, Gilles P.] Leiden Univ, Inst Biol Leiden, Mol Biotechnol, NL-2300 RA Leiden, Netherlands; [Bucca, Giselda; Laing, Emma; Smith, Colin P.] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England; [Titgemeyer, Fritz] Munster Univ Appl Sci, Dept Oecotrophol, D-48149 Munster, Germany; [Rigali, Sebastien] Univ Liege, Ctr Prot Engn, Inst Chim B6A, B-4000 Liege, Belgium	Leiden University; Leiden University - Excl LUMC; University of Surrey; University of Applied Sciences, Muenster; University of Liege	van Wezel, GP (corresponding author), Leiden Univ, Inst Biol Leiden, Mol Biotechnol, POB 9502, NL-2300 RA Leiden, Netherlands.	g.wezel@biology.leidenuniv.nl	Smith, Colin/AAL-4507-2021; van Wezel, Gilles/ABC-7854-2021	van Wezel, Gilles/0000-0003-0341-1561; Rigali, Sebastien/0000-0003-4022-7325; Bucca, Giselda/0000-0001-5286-7771; Smith, Colin/0000-0001-9042-2263	VENI grant of the Netherlands Technology Foundation STW; VICI grant of the Netherlands Technology Foundation STW; Belgian program of Interuniversity Attraction Poles; Federal Office for Scientific Technical and Cultural Affairs (PAI) [P7/44]; Biotechnology and Biological Sciences Research Council (UK) [BB/D011582]	VENI grant of the Netherlands Technology Foundation STW; VICI grant of the Netherlands Technology Foundation STW; Belgian program of Interuniversity Attraction Poles; Federal Office for Scientific Technical and Cultural Affairs (PAI); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by VENI and VICI grants of the Netherlands Technology Foundation STW to JG and GPvW, respectively, by the Belgian program of Interuniversity Attraction Poles initiated by the Federal Office for Scientific Technical and Cultural Affairs (PAI no. P7/44) and by the Biotechnology and Biological Sciences Research Council (UK) (BB/D011582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2012, NUCLEIC ACIDS RES, V40, P9543, DOI 10.1093/nar/gks766; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; ANGELL S, 1994, MOL GEN GENET, V244, P135, DOI 10.1007/BF00283514; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bertram R, 2011, J BACTERIOL, V193, P3525, DOI 10.1128/JB.00264-11; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; Bibb MJ, 2000, J BACTERIOL, V182, P4606, DOI 10.1128/JB.182.16.4606-4616.2000; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Bucca G, 2003, MOL MICROBIOL, V50, P153, DOI 10.1046/j.1365-2958.2003.03696.x; Bucca G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r5; Chakraburtty R, 1997, J BACTERIOL, V179, P5854, DOI 10.1128/jb.179.18.5854-5861.1997; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chater K. F., 1997, BACTERIA MULTICELLUL, P149; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; Colson S, 2008, MICROBIOL-SGM, V154, P373, DOI 10.1099/mic.0.2007/011940-0; Colson S, 2007, J MOL MICROB BIOTECH, V12, P60, DOI 10.1159/000096460; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Craig M, 2012, ENV MICROBIOL REP; Cruz-Morales P, 2013, GENOME BIOL EVOL, V5, P1165, DOI 10.1093/gbe/evt082; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Derouaux A, 2004, J BACTERIOL, V186, P1893, DOI 10.1128/JB.186.6.1893-1897.2004; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Gao C, 2012, MBIO, V3, DOI 10.1128/mBio.00407-12; Gao ZY, 2012, INT J BIOL MACROMOL, V50, P1, DOI 10.1016/j.ijbiomac.2011.08.016; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hopwood DA, 2007, STREPTOMYCES NATURE; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Mahr K, 2000, ANTON LEEUW INT J G, V78, P253, DOI 10.1023/A:1010234916745; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Nazari B, 2013, APPL ENVIRON MICROB, V79, P707, DOI 10.1128/AEM.02217-12; Nazari B, 2011, FEMS MICROBIOL ECOL, V77, P623, DOI 10.1111/j.1574-6941.2011.01143.x; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Nodwell JR, 1998, J BACTERIOL, V180, P1334, DOI 10.1128/JB.180.5.1334-1337.1998; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Nothaft H, 2003, J BACTERIOL, V185, P7019, DOI 10.1128/JB.185.23.7019-7023.2003; Nothaft H, 2010, MOL MICROBIOL, V75, P1133, DOI 10.1111/j.1365-2958.2009.07020.x; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Piette A, 2005, J PROTEOME RES, V4, P1699, DOI 10.1021/pr050155b; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Saito A, 2007, APPL ENVIRON MICROB, V73, P3000, DOI 10.1128/AEM.02612-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Swiatek MA, 2012, J BACTERIOL, V194, P1136, DOI 10.1128/JB.06370-11; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; van Wezel GP, 2007, J MOL MICROB BIOTECH, V12, P67, DOI 10.1159/000096461; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; van Wezel GP, 2009, METHOD ENZYMOL, V458, P117, DOI 10.1016/S0076-6879(09)04805-8; van Wezel GP, 2005, MOL MICROBIOL, V55, P624, DOI 10.1111/j.1365-2958.2004.04413.x; VANWEZEL GP, 1991, NUCLEIC ACIDS RES, V19, P4399, DOI 10.1093/nar/19.16.4399; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wade JT, 2001, EMBO J, V20, P7160, DOI 10.1093/emboj/20.24.7160; Wang F, 2002, MOL GENET GENOMICS, V268, P344, DOI 10.1007/s00438-002-0749-3; Wang LY, 2003, FEMS MICROBIOL LETT, V220, P21, DOI 10.1016/S0378-1097(03)00044-2; WILLEY J, 1991, CELL, V65, P641, DOI 10.1016/0092-8674(91)90096-H; Wosten HAB, 2000, MICROBIOL-UK, V146, P767, DOI 10.1099/00221287-146-4-767; Zhang Li, 2007, Weishengwu Xuebao, V47, P849; Zhu H, 2014, J IND MICROBIOL BIOT, V41, P371, DOI 10.1007/s10295-013-1309-z	90	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122479	10.1371/journal.pone.0122479	http://dx.doi.org/10.1371/journal.pone.0122479			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875084	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800061
J	Becares, J; Garcia-Tarrason, M; Villero, D; Bateman, S; Jover, L; Garcia-Matarranz, V; Sanpera, C; Arcos, JM				Becares, Juan; Garcia-Tarrason, Manuel; Villero, Dani; Bateman, Santiago; Jover, Llus; Garcia-Matarranz, Victor; Sanpera, Carolina; Arcos, Jose Manuel			Modelling Terrestrial and Marine Foraging Habitats in Breeding Audouin's Gulls Larus audouinii: Timing Matters	PLOS ONE			English	Article							EBRO DELTA; SPATIAL AUTOCORRELATION; COMMERCIAL FISHERIES; FEEDING ECOLOGY; SEABIRDS; MANAGEMENT; PERFORMANCE; ALBATROSSES; COMMUNITY; COLONIES	Although the breeding ecology of Audouin's gull has been widely studied, its spatial distribution patterns have received little attention. We assessed the foraging movements of 36 GPS-tracked adult Audouin's gulls breeding at the Ebro Delta (NW Mediterranean), coinciding with the incubation period (May 2011). This also coincided with a trawling moratorium northwards from the colony. We modelled the distribution of the gulls by combining these tracking data with environmental variables (including fishing activities from Vessel Monitoring System, VMS), using Maxent. The modelling range included both marine and terrestrial areas. Models were produced separately for every 2h time interval across the day, and for 2 fishing activity scenarios (workdays vs. weekends), allowing to assess the spatio-temporal distribution patterns of the gulls and the degree of association with fisheries. During workdays, gull distribution at sea fully matched with fishing activities, both trawling (daylight) and purse-seining (nightime). Gulls tended to avoid the area under trawling moratorium, confirming the high influence of fisheries on the distribution patterns of this species. On weekends, gulls made lesser use of the sea and tended to increase the use of rice fields. Overall, Audouin's gull activity was more intense during dailight hours, although birds also showed nocturnal activity, on both workdays and weekends. Nocturnal patterns at sea were more disperse during the latter, probably because these gulls are able to capture small pelagic fish at night in natural conditions, but tend to congregate around purse-seiners (which would enhance their foraging efficiency) in workdays. These results provide important insight for the management of this species. This is of particular relevance under the current scenario of European fisheries policies, since new regulations are aimed at eliminating discards, and this would likely influence Audouin's gull populations.	[Becares, Juan; Arcos, Jose Manuel] SEO BirdLife, Programa Marino, Delegacio Catalunya, Barcelona, Spain; [Garcia-Tarrason, Manuel; Bateman, Santiago; Sanpera, Carolina] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Villero, Dani] Ctr Tecnol Forestal Catalunya, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Spain; [Jover, Llus] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona, Spain; [Garcia-Matarranz, Victor] MAGRAMA, Direcc Gen Med Nat & Polit Forestal, Madrid, Spain; [Jover, Llus; Sanpera, Carolina] Univ Barcelona, IRBio Res Inst Biodivers, Barcelona, Spain	University of Barcelona; Centre Tecnologic Forestal de Catalunya (CTFC); University of Barcelona; University of Barcelona	Becares, J (corresponding author), Grp Invest Cetaceos, San Cristobal la Laguna, SC De Tenerife, Spain.	juanbecares@gmail.com	Villero, Dani/E-1761-2014; Arcos, Jose Manuel/GRJ-0631-2022; sanpera, carolina/B-5461-2013; Jover, Lluís/D-2192-2011	Villero, Dani/0000-0002-5562-3809; Arcos, Jose Manuel/0000-0001-7486-4475; sanpera, carolina/0000-0002-5198-6514; Jover, Lluís/0000-0003-0631-1398	LIFE+INDEMARES [LIFE 07 NAT/E/00732]; MCyI project [CGL2008-05448-C02/BOS]; University of Barcelona	LIFE+INDEMARES; MCyI project; University of Barcelona	This research was funded under the LIFE+INDEMARES, LIFE 07 NAT/E/00732 (JB JMA) and MCyI project CGL2008-05448-C02/BOS (MG CSLJ). We also thank the financial support from the University of Barcelona to cover publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], 2005, DISCARDS WORLDS MARI; Arcos j.M., 2009, LIFE04NAT000049 SEO; Arcos JM, 2002, MAR ECOL PROG SER, V232, P281, DOI 10.3354/meps232281; Arcos JM, 2002, MAR BIOL, V141, P277, DOI 10.1007/s00227-002-0828-3; Arcos JM, 2001, MAR BIOL, V139, P807; Arcos JM, 1996, COLON WATERBIRD, V19, P128, DOI 10.2307/1521817; Arcos JM, 2001, THESIS U BARCELONA; Arcos JM, 2008, AM FISH S S, V49, P1471; Becares J., 2010, REV ANILLAMIENTO, V25, P29; Bertolero A, 2008, GAVIOTA CABECINEGRA; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; BirdLife International, 2004, RES GLOB PROC TRACK; Bossard M., 2000, 40 EUR ENV AG; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bub H, 1991, BIRD TRAPPING BIRD B; Burger J, 1996, HDB BIRDS WORLD; Cama A, 2013, MAR ECOL PROG SER, V484, P279, DOI 10.3354/meps10312; Cama A, 2012, ECOGRAPHY, V35, P912, DOI 10.1111/j.1600-0587.2011.06756.x; Canicio A, 2008, CULTIVO ECOLOGICO AR; Christel I, 2012, ESTUAR COAST SHELF S, V96, P257, DOI 10.1016/j.ecss.2011.11.019; Coll M, 2006, J MARINE SYST, V59, P63, DOI 10.1016/j.jmarsys.2005.09.001; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estrada M, 1996, SCI MAR, V60, P55; FASOLA M, 1990, COLON WATERBIRD, V13, P72, DOI 10.2307/1521424; Feldman GC, 2012, OCEAN COLOR WEB; Furness R.W., 1987, SEABIRD ECOLOGY; Garcia-Tarrason M, 2014, J EXP MAR BIOL ECOL, V453, P116, DOI 10.1016/j.jembe.2014.01.012; Garcia-Tarrason M, 2013, MAR POLLUT BULL, V74, P285, DOI 10.1016/j.marpolbul.2013.06.043; Gonzalez-Solis J, 2003, SCI MAR, V67, P83, DOI 10.3989/scimar.2003.67s283; Gonzalez-Solis J, 1998, VOGELWARTE, V40, P52; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Gutierrez-Yurrita PJ, 1999, CRAYFISH EUROPE ALIE; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Longoni V, 2010, WATERBIRDS, V33, P83, DOI 10.1675/063.033.s106; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Louzao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035728; Lowry E, 2013, ECOL EVOL, V3, P182, DOI 10.1002/ece3.431; Madrono A., 2004, LIBRO ROJO AVES ESPA; Manosa S, 2004, SCI MAR, V68, P605; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Martinez-Abrain A, 2003, SCI MAR, V67, P89, DOI 10.3989/scimar.2003.67s289; METI and NASA, 2009, ASTER GLOB DIG EL MO; Ministerio de Agricultura alimentacion y Medio Ambiente (MAGRAMA), 2012, ESTR MAR DEM LEV B 2; Montevecchi William A., 2002, P527; Navarro J, 2010, MAR BIOL, V157, P2453, DOI 10.1007/s00227-010-1509-2; Oro D, 1997, IBIS, V139, P631, DOI 10.1111/j.1474-919X.1997.tb04685.x; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1996, MAR ECOL PROG SER, V139, P19, DOI 10.3354/meps139019; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Oro D, 2001, J ANIM ECOL, V70, P527, DOI 10.1046/j.1365-2656.2001.00511.x; Oro D, 1995, ORNIS FENNICA, V72, P154; Oro D, 1999, P 22 INT ORN C DURB, P717; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Oro D, 2009, BIOL CONSERV, V142, P1830, DOI 10.1016/j.biocon.2009.03.023; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Penas E, 2007, ICES J MAR SCI, V64, P588, DOI 10.1093/icesjms/fsm053; Perthold J, 2011, CATTRACK1 USER MANUA; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ruiz X, 1996, COLON WATERBIRD, V19, P68, DOI 10.2307/1521947; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Salat J, 1996, SCI MAR, V60, P21; Suarez-Serrano A, 2010, ECOTOX ENVIRON SAFE, V73, P280, DOI 10.1016/j.ecoenv.2009.11.001; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Symes D, 2009, FISH RES, V100, P99, DOI 10.1016/j.fishres.2009.06.012; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Thaxter CB, 2012, BIOL CONSERV, V156, P53, DOI 10.1016/j.biocon.2011.12.009; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wagner EL, 2011, REV FISH SCI, V19, P157, DOI 10.1080/10641262.2011.562568; WALLACE D I M, 1969, British Birds, V62, P223; Wanless S, 2005, MARINE ECOLOGY PROGR, V294, P8; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wildlife telemetry fr: SD Schemnitz, 1980, WILDLIFE MANAGEMENT, V4a, p5O7; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; WITT HH, 1981, IBIS, V123, P519, DOI 10.1111/j.1474-919X.1981.tb04058.x	89	20	22	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120799	10.1371/journal.pone.0120799	http://dx.doi.org/10.1371/journal.pone.0120799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875597	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700006
J	Pai, HC; Kumar, S; Shen, CC; Liou, JP; Pan, SL; Teng, CM				Pai, Hui Chen; Kumar, Sunil; Shen, Chien Chang; Liou, Jing Ping; Pan, Shiow Lin; Teng, Che Ming			MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ACTIVATION; APOPTOSIS; HEAT-SHOCK-PROTEIN-27; CELLS; EXPRESSION; TUMOR; PACLITAXEL	Objective In this study, the anticancer mechanisms of MT-4 were examined in A2780 and multidrug-resistant NCI-ADR/res human ovarian cancer cell lines. Methods To evaluate the activity of MT-4, we performed in vitro cell viability and cell cycle assays and in vivo xenograft assays. Immunoblotting analysis was carried out to evaluate the effect of MT-4 on ovarian cancer. Tubulin polymerization was determined using a tubulin binding assay. Results MT-4 (2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-phenol), a derivative of moscatilin, can inhibit both sensitive A2780 and multidrug-resistant NCI-ADR/res cell growth and viability. MT-4 inhibited tubulin polymerization to induce G2/M arrest followed by caspase-mediated apoptosis. Further studies indicated that MT-4 is not a substrate of P-glycoprotein (pgp). MT-4 also caused G2/M cell cycle arrest, accompanied by the upregulation of cyclin B, p-Thr161 Cdc2/p34, polo-like kinase 1 (PLK1), Aurora kinase B, and phospho-Ser10-histone H3 protein levels. In addition, we found that p38 MAPK pathway activation was involved in MT-4-induced apoptosis. Most importantly, MT-4 also decreased heat shock protein 27 expression and reduced its interaction with caspase-3, which inured cancer cells to chemotherapy resistance. Treatment of cells with SB203580 or overexpression of dominant negative (DN)-p38 or wild-type HSP27 reduced PARP cleavage caused by MT-4. MT4 induced apoptosis through regulation of p38 and HSP27. Our xenograft models also show the in vivo efficacy of MT-4. MT-4 inhibited both A2780 and NCI-ADR/res cell growth in vitro and in vivo. Conclusion These findings indicate that MT-4 could be a potential lead compound for the treatment of multidrug-resistant ovarian cancer.	[Pai, Hui Chen; Teng, Che Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei 10764, Taiwan; [Kumar, Sunil; Liou, Jing Ping] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Shen, Chien Chang] Natl Res Inst Chinese Med, Taipei, Taiwan; [Pan, Shiow Lin] Coll Med Sci & Technol, Canc Biol & Drug Discovery, Taipei, Taiwan	National Taiwan University; Taipei Medical University; National Research Institute of Chinese Medicine	Pan, SL (corresponding author), Coll Med Sci & Technol, Canc Biol & Drug Discovery, Taipei, Taiwan.	sipan@tmu.edu.tw; cmteng@ntu.edu.tw		Kumar, Sunil/0000-0001-7627-3740	National Science Council of Taiwan [NSC99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC99-2628- B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Elpek GO, 2003, APMIS, V111, P523, DOI 10.1034/j.1600-0463.2003.1110411.x; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Langdon SP, 1995, CLIN CANCER RES, V1, P1603; Liu YN, 2010, SHOCK, V33, P70, DOI 10.1097/SHK.0b013e3181a7ff4a; Ma WB, 2013, FEBS J, V280, P4612, DOI 10.1111/febs.12432; Pai HC, 2013, J MOL MED, V91, P347, DOI 10.1007/s00109-012-0945-5; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Song TF, 2009, J INT MED RES, V37, P1375, DOI 10.1177/147323000903700512; Tanaka Y, 2004, INT J GYNECOL CANCER, V14, P616, DOI 10.1111/j.1048-891X.2004.14409.x; Tsai AC, 2010, CANCER LETT, V292, P163, DOI 10.1016/j.canlet.2009.11.020; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Yamamoto K, 2001, CANCER LETT, V168, P173, DOI 10.1016/S0304-3835(01)00532-8; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	26	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123819	10.1371/journal.pone.0123819	http://dx.doi.org/10.1371/journal.pone.0123819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874627	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700045
J	Senthil, K; Thirugnanasambantham, P; Oh, TJ; Kim, SH; Choi, HK				Senthil, Kalaiselvi; Thirugnanasambantham, Pankajavalli; Oh, Taek Joo; Kim, So Hyun; Choi, Hyung Kyoon			Free Radical Scavenging Activity and Comparative Metabolic Profiling of In Vitro Cultured and Field Grown Withania somnifera Roots	PLOS ONE			English	Article							WITHANOLIDE PRODUCTION; NATURAL-PRODUCT; PROLINE; PLANT; MS	Free radical scavenging activity (FRSA), total phenolic content (TPC), and total flavonoid content (TFC) of in vitro cultured and field grown Withania somnifera (Ashwagandha) roots were investigated. Withanolides analysis and comprehensive metabolic profiling between 100% methanol extracts of in vitro and field grown root tissues was performed using high performance thin layer chromatography (HPTLC) and gas chromatography-mass spectrometry (GC-MS), respectively. Significantly higher levels of FRSA, TPC, and TFC were observed in in-vitro cultured roots compared with field grown samples. In addition, 30 day-cultured in vitro root samples (1MIR) exhibited a significantly higher FRSA (IC50 81.01 mu g/mL), TPC (118.91 mg GAE/g), and TFC (32.68 mg CE/g) compared with those in 45 day-cultured samples (1.5MIR). Total of 29 metabolites were identified in in vitro cultured and field grown roots by GC-MS analysis. The metabolites included alcohols, organic acids, purine, pyrimidine, sugars, and putrescine. Vanillic acid was only observed in the in vitro cultured root samples, and higher level of the vanillic acid was observed in 1MIR when compared to 1.5MIR. Therefore, it is suggested that 1MIR might serve as an alternative to field grown roots for the development of medicinal and functional food products.	[Senthil, Kalaiselvi; Thirugnanasambantham, Pankajavalli] Avinashilingam Univ Women, Dept Biochem Biotechnol & Bioinformat, Coimbatore 641043, Tamil Nadu, India; [Oh, Taek Joo; Kim, So Hyun; Choi, Hyung Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Avinashilingam University for Women; Chung Ang University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hykychoi@cau.ac.kr	Senthil, kalaiselvi/AAQ-3730-2020	Senthil, kalaiselvi/0000-0002-8276-4607; k, selvi/0000-0002-9912-8586	Mid-career Researcher Program through NRF grant - MSIP of Republic of Korea [NRF-2012R1A2A2A02011748]; Major Research Project by University Grants Commission Government of India [34-278/2008]	Mid-career Researcher Program through NRF grant - MSIP of Republic of Korea; Major Research Project by University Grants Commission Government of India	This work was supported by Mid-career Researcher Program (NRF-2012R1A2A2A02011748) through NRF grant funded by the MSIP of Republic of Korea and Major Research Project by University Grants Commission Government of India (F.No. 34-278/2008 (SR)).	Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Cho SK, 2009, J PHARMACEUT BIOMED, V49, P567, DOI 10.1016/j.jpba.2008.11.037; Cox DG, 2014, BBA-GEN SUBJECTS, V1840, P3460, DOI 10.1016/j.bbagen.2014.08.007; Davis L, 2001, J ETHNOPHARMACOL, V75, P165, DOI 10.1016/S0378-8741(00)00404-9; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Demiray S., 2009, WORLD ACAD SCI ENG T, V3, P312; Dewir YH, 2010, BIOL PLANTARUM, V54, P357, DOI 10.1007/s10535-010-0063-6; Frederich M, 2011, PLANTA MED, V77, P81, DOI 10.1055/s-0030-1250132; Gupta G. L., 2007, Pharmacognosy Reviews, V1, P129; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Hithamani G, 2014, FOOD CHEM, V164, P55, DOI 10.1016/j.foodchem.2014.04.107; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim Y, 2012, PROCESS BIOCHEM, V47, P62, DOI 10.1016/j.procbio.2011.10.010; Kumar A, 2007, GENET RESOUR CROP EV, V54, P655, DOI 10.1007/s10722-006-9129-x; Lahouar L, 2014, FOOD CHEM, V145, P578, DOI 10.1016/j.foodchem.2013.08.102; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Li XG, 2013, INT J BIOL SCI, V9, P164, DOI 10.7150/ijbs.5579; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Murch SJ, 2004, PLANT CELL REP, V23, P419, DOI 10.1007/s00299-004-0862-3; Murthy HN, 2008, J INTEGR PLANT BIOL, V50, P975, DOI 10.1111/j.1744-7909.2008.00680.x; Praveen N., 2010, International Journal of Pharma and Bio Sciences, V1, pBS26; Praveen N, 2010, ACTA PHYSIOL PLANT, V32, P1017, DOI 10.1007/s11738-010-0489-7; RAJENDRAKUMAR CSV, 1994, BIOCHEM BIOPH RES CO, V201, P957, DOI 10.1006/bbrc.1994.1795; Ray A B, 1994, Fortschr Chem Org Naturst, V63, P1; Sabir F, 2008, Z NATURFORSCH C, V63, P409; Sang SM, 2002, J AGR FOOD CHEM, V50, P2459, DOI 10.1021/jf011533+; Sapropoulou V, 2013, TURK J AGRIC FOR, V37, P688; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Satyapal Singh, 2011, Advances in Applied Science Research, V2, P47; Sharada M, 2007, BIOL PLANTARUM, V51, P161, DOI 10.1007/s10535-007-0031-y; Sharma S., 1985, INDIAN DRUGS, V22, P133; Shetty K, 1997, Asia Pac J Clin Nutr, V6, P162; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sumner LW, 2015, NAT PROD REP, V32, P212, DOI 10.1039/c4np00072b; Tai A, 2012, BIOSCI BIOTECH BIOCH, V76, P314, DOI 10.1271/bbb.110700; Tarachiwin L, 2008, J PHARMACEUT BIOMED, V48, P42, DOI 10.1016/j.jpba.2008.04.025; van der Kooy F, 2009, PLANTA MED, V75, P763, DOI 10.1055/s-0029-1185450; Vaz JA, 2011, FOOD CHEM, V126, P610, DOI 10.1016/j.foodchem.2010.11.063; VERNON DM, 1992, EMBO J, V11, P2077, DOI 10.1002/j.1460-2075.1992.tb05266.x; Visweswari G, 2013, INT J PHARM SCI RES, V4, P2770, DOI 10.13040/IJPSR.0975-8232.4(7).2770-76; Wasnik Neha G., 2009, [Korean Journal of Plant Reources., 한국자원식물학회지], V22, P584; Wolfender JL, 2009, NAT PROD COMMUN, V4, P1417; Yadava S. A., 2011, Journal of Pharmacy Research, V4, P1428	48	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123360	10.1371/journal.pone.0123360	http://dx.doi.org/10.1371/journal.pone.0123360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874568	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700030
J	Avila, ML; Ward, LC; Feldman, BM; Montoya, MI; Stinson, J; Kiss, A; Brandao, LR				Avila, Maria Laura; Ward, Leigh C.; Feldman, Brian M.; Montoya, Madeline I.; Stinson, Jennifer; Kiss, Alex; Brandao, Leonardo R.			Normal Values for Segmental Bioimpedance Spectroscopy in Pediatric Patients (vol )	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE SPECTROSCOPY; POSTTHROMBOTIC SYNDROME; DIRECTIONAL ASYMMETRY; BILATERAL ASYMMETRY; UPPER-LIMB; VEIN THROMBOSIS; EARLY-DIAGNOSIS; LEG VOLUME; LYMPHEDEMA; CHILDREN	Introduction Localized limb edema is a clinically relevant sign in diseases such as post-thrombotic syndrome and lymphedema. Quantitative evaluation of localized edema in children is mainly done by measuring the absolute difference in limb circumference, which includes fat and fat-free mass. Bioimpedance spectroscopy (BIS) provides information on the fluid volume of a body segment. Our objective was to determine normal ranges for segmental (arm and leg) BIS measurements in healthy children. Additionally, we determined the normal ranges for the difference in arm and ankle circumference and explored the influence of handedness and the correlation between techniques. Methods Healthy children aged 1-18 years were recruited. The ratio of extracellular fluid content between contralateral limbs (estimated as the inter-arm and inter-leg extracellular impedance ratio), and the ratio of extracellular to intracellular fluid content for each limb (estimated as the intracellular to extracellular impedance ratio) were determined with a bioimpedance spectrometer. Arm and ankle circumference was determined with a Gulick II tape. Results We recruited 223 healthy children (48 infants, 54 preschoolers, 66 school-aged children, and 55 teenagers). Normal values for arm and leg BIS measurements, and for the difference in arm and ankle circumference were estimated for each age category. No influence of handedness was found. We found a statistically significant correlation between extracellular impedance ratio and circumference difference for arms among teenagers. Conclusion We determined normal BIS ranges for arms and legs and for the difference in circumference between arms and between ankles in children. There was no statistically significant correlation between extracellular impedance ratio and difference in circumference, except in the case of arms in adolescents. This may indicate that limb circumference measures quantities other than fluid, challenging the adequacy of this technique to determine the presence of localized edema in most age groups.	[Avila, Maria Laura; Feldman, Brian M.; Montoya, Madeline I.; Brandao, Leonardo R.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Ward, Leigh C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Feldman, Brian M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5G 1X8, Canada; [Kiss, Alex] Sunnybrook Hlth Sci Ctr, Dept Res Design & Biostat, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Queensland; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brandao, LR (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.	leonardo.brandao@sickkids.ca	Ward, Leigh C/L-4461-2019; Ward, Leigh C/A-4834-2010	Ward, Leigh C/0000-0003-2378-279X; Avila, Laura/0000-0002-4340-9645	Physicians' Services Incorporated (PSI) Foundation	Physicians' Services Incorporated (PSI) Foundation	This study was supported by a Health Research Grant from the Physicians' Services Incorporated (PSI) Foundation. The funding institution had no role in the design of the study, data collection or analysis, or manuscript preparation.	Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Beebe HG, 1996, EUR J VASC ENDOVASC, V12, P487, DOI 10.1016/S1078-5884(96)80019-0; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; Boulden BM, 2007, J THROMB HAEMOST, V5, P1077, DOI 10.1111/j.1538-7836.2007.02445.x; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; CDC, SAS PROG CDC GROWTH; Cornish BH, 2002, ANGIOLOGY, V53, P41, DOI 10.1177/000331970205300106; Cornish BH, 2001, LYMPHOLOGY, V34, P2; Cornish BH, 1999, PHYSIOL MEAS, V20, P241, DOI 10.1088/0967-3334/20/3/302; Cornish Bruce, 2006, Lymphatic Research and Biology, V4, P47, DOI 10.1089/lrb.2006.4.47; DARGENTPARE C, 1992, CORTEX, V28, P343, DOI 10.1016/S0010-9452(13)80144-X; Eberley C, FIGURE 8 METHOD MEAS; Edelstein S, 2009, LIFE CYCLE NUTR EVID, Vxxv; FAULKNER RA, 1993, CALCIFIED TISSUE INT, V53, P7, DOI 10.1007/BF01352007; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Ginsberg JS, 2000, ARCH INTERN MED, V160, P669, DOI 10.1001/archinte.160.5.669; Goldenberg NA, 2007, BLOOD, V110, P45, DOI 10.1182/blood-2006-12-061234; Goldenberg NA, 2010, J PEDIATR-US, V157, P852, DOI 10.1016/j.jpeds.2010.07.003; Kuhle S, 2003, THROMB RES, V111, P227, DOI 10.1016/j.thromres.2003.09.008; Lee BB, 2011, LYMPHEDEMA: A CONCISE COMPENDIUM OF THEORY AND PRACTICE, P1, DOI 10.1007/978-0-85729-567-5; Lohman TG, 1992, ADV BODY COMPOSITION, Vviii; Manco-Johnson MJ, 2003, BLOOD, V102, p553A; Neumann Susanne, 1992, Zeitschrift fuer Morphologie und Anthropologie, V79, P183; Ozener B, 2007, COLLEGIUM ANTROPOL, V31, P693; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; PARKER DF, 1990, ANN HUM BIOL, V17, P199, DOI 10.1080/03014469000000962; Perrin M, 2000, ANGIOLOGY, V51, P9, DOI 10.1177/000331970005100103; Pesavento R, 2010, INTERN EMERG MED, V5, P185, DOI 10.1007/s11739-009-0336-2; PLATO CC, 1985, HUM BIOL, V57, P327; Ridner SH, 2007, LYMPHOLOGY, V40, P35; Ridner Sheila H., 2009, Lymphatic Research and Biology, V7, P11, DOI 10.1089/lrb.2008.1003; Round JM, 1999, ANN HUM BIOL, V26, P49, DOI 10.1080/030144699282976; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; Sabharwal S, 2008, CLIN ORTHOP RELAT R, V466, P2910, DOI 10.1007/s11999-008-0524-9; Sander AP, 2002, PHYS THER, V82, P1201, DOI 10.1093/ptj/82.12.1201; SCHELL LM, 1985, AM J PHYS ANTHROPOL, V67, P317, DOI 10.1002/ajpa.1330670404; STEELE J, 1995, INT J OSTEOARCHAEOL, V5, P39, DOI 10.1002/oa.1390050105; SUKUL DMKSK, 1993, J BIOMED ENG, V15, P477, DOI 10.1016/0141-5425(93)90062-4; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Villalta S, 1994, HAEMOSTASIS, V24, p57a; WAKI M, 1991, AM J PHYSIOL, V261, pE199, DOI 10.1152/ajpendo.1991.261.2.E199; Ward LC, 2011, LYMPHAT RES BIOL, V9, P43, DOI 10.1089/lrb.2010.0024; Ward LC, 2011, LYMPHAT RES BIOL, V9, P47, DOI 10.1089/lrb.2010.0014; Ward L, 2011, INT J GYNECOL CANCER, V21, P409, DOI 10.1097/IGC.0b013e31820866e1; Ward Leigh C., 2009, Lymphatic Research and Biology, V7, P81, DOI 10.1089/lrb.2008.1027; Winters RW, 1973, BODY FLUIDS PEDIAT L	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0126268	10.1371/journal.pone.0126268	http://dx.doi.org/10.1371/journal.pone.0126268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875618	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100304
J	Cao, HL; He, NN; Song, SL; Xu, MQ; Piao, MY; Yan, F; Wang, BM				Cao, Hailong; He, Nana; Song, Shuli; Xu, Mengque; Piao, Meiyu; Yan, Fang; Wang, Bangmao			Is Surveillance Colonoscopy Necessary for Patients with Sporadic Gastric Hyperplastic Polyps?	PLOS ONE			English	Article							HELICOBACTER-PYLORI; COLORECTAL NEOPLASIA; DISTRIBUTION TRENDS; EPITHELIAL POLYPS; DATABASE ANALYSIS; CANCER; RISK; ADENOMAS; SEROPREVALENCE; MULTICENTER	Background Gastric polyps, such as adenomas and hyperplastic polyps, can be found in various colonic polyposis syndromes. Unlike in sporadic gastric adenomas, in which the increased risk of colorectal neoplasia has been well characterized, information in sporadic gastric hyperplastic polyps was limited. Aim To evaluate the association of sporadic gastric hyperplastic polyps with synchronous colorectal neoplasia in a large cohort. Methods Patients with sporadic gastric hyperplastic polyps who underwent colonoscopy simultaneously or within six months were consecutively enrolled. Each patient was compared with two randomly selected age and sex matched controls without gastric polyps who also underwent colonoscopy in the same period. Data of patients' demographics and characteristics of the gastrointestinal polyps were documented. Results A total of 261 cases in 118,576 patients who underwent esophagogastroduodenoscopy were diagnosed as sporadic gastric hyperplastic polyps, and 192 of 261 (73.6%) patients underwent colonoscopy. Colorectal neoplasias were identified in 46 (24.0%) of 192 cases and in 40 (10.4%) of 384 controls (P<0.001). The mean size and distribution of colorectal neoplasias were not significantly different between the two groups. There was a significantly higher rate of colorectal adenoma (odds ratio [OR] 3.2, 95% confidence interval [CI] 1.9-5.3) in the gastric hyperplastic polyps group than in the control group, while the prevalence of colorectal cancer was similar in the two groups. Logistic regression analysis also suggested that the presence of gastric hyperplastic polyps (OR 2.5, 95% CI 1.5-4.0) was an independent risk factor for colorectal neoplasias. Conclusion The risk of colorectal adenoma increases in patients with sporadic gastric hyperplastic polyps, and surveillance colonoscopy for these patients should be considered.	[Cao, Hailong; He, Nana; Song, Shuli; Xu, Mengque; Piao, Meiyu; Yan, Fang; Wang, Bangmao] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China; [Cao, Hailong; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Tianjin Medical University; Vanderbilt University	Wang, BM (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China.	tjmughgi@hotmail.com	song, sl/GRS-1884-2022		National Natural Science Foundation of China [81300272, 81470796]; Research Fund for the Doctoral Program of Higher Education of China [20121202110018]; Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Research Program of Application Foundation and Advanced Technology of China	This study is supported by grants (81300272 to H.L.C. and 81470796 to F.Y.) from the National Natural Science Foundation of China, a grant (20121202110018 to B.M.W.) from Research Fund for the Doctoral Program of Higher Education of China, and a grant (13JCQNJC10600 to H.L.C.) from Tianjin Research Program of Application Foundation and Advanced Technology of China.	Abraham SC, 2003, MODERN PATHOL, V16, P786, DOI 10.1097/01.MP.0000080349.37658.5E; Archimandritis A, 1996, ITAL J GASTROENTEROL, V28, P387; Attard TM, 2004, AM J GASTROENTEROL, V99, P681, DOI 10.1111/j.1572-0241.2004.04115.x; Bai Y, 2010, J GASTROEN HEPATOL, V25, P1668, DOI 10.1111/j.1440-1746.2010.06414.x; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Cao HL, 2012, J GASTROEN HEPATOL, V27, P1175, DOI 10.1111/j.1440-1746.2012.07116.x; CAPPELL MS, 1995, J CLIN GASTROENTEROL, V21, P198, DOI 10.1097/00004836-199510000-00006; Carmack SW, 2009, NAT REV GASTRO HEPAT, V6, P331, DOI 10.1038/nrgastro.2009.70; Carmack SW, 2009, AM J GASTROENTEROL, V104, P1524, DOI 10.1038/ajg.2009.139; Chung WC, 2011, GUT LIVER, V5, P432, DOI 10.5009/gnl.2011.5.4.432; DEPPISCH LM, 1989, J CLIN GASTROENTEROL, V11, P110, DOI 10.1097/00004836-198902000-00028; Goddard AF, 2010, GUT, V59, P1270, DOI 10.1136/gut.2009.182089; Kang Hwa Mi, 2011, Korean J Gastroenterol, V58, P184; Lahner E, 2012, DIGEST LIVER DIS, V44, P793, DOI 10.1016/j.dld.2012.04.012; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Morais Drausio Jefferson, 2007, Arq. Gastroenterol., V44, P14; MOSS SF, 1995, J NATL CANCER I, V87, P762, DOI 10.1093/jnci/87.10.762; Murray MA, 2004, GUT, V53, P261, DOI 10.1136/gut.2003.025320; Niv Y, 2003, EUR J GASTROEN HEPAT, V15, P1361, DOI 10.1097/00042737-200312000-00016; Oberhuber G, 2000, VIRCHOWS ARCH, V437, P581, DOI 10.1007/s004280000330; Okamoto K, 2008, DIGESTION, V78, P82, DOI 10.1159/000165354; ORLOWSKA J, 1995, AM J GASTROENTEROL, V90, P2152; Park DI, 2010, J CLIN GASTROENTEROL, V44, P102, DOI 10.1097/MCG.0b013e3181a15849; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Rokkas T, 2013, EUR J GASTROEN HEPAT, V25, P1286, DOI 10.1097/MEG.0b013e328363d3cd; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406; Siddheshwar RK, 2001, AM J GASTROENTEROL, V96, P84, DOI 10.1111/j.1572-0241.2001.03355.x; STOLTE M, 1994, ENDOSCOPY, V26, P659, DOI 10.1055/s-2007-1009061; Udd L, 2010, AM J PATHOL, V176, P2467, DOI 10.2353/ajpath.2010.090519; Wang FL, 2014, IEEE T SEMICONDUCT M, V27, P246, DOI 10.1109/TSM.2014.2309591; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Wu ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091810; Yang MH, 2010, GASTROINTEST ENDOSC, V71, P774, DOI 10.1016/j.gie.2009.11.042; ZeaIriarte WL, 1996, DIGEST DIS SCI, V41, P377, DOI 10.1007/BF02093832	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122996	10.1371/journal.pone.0122996	http://dx.doi.org/10.1371/journal.pone.0122996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874940	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100125
J	Dave, P; Vadera, B; Kumar, AMV; Chinnakali, P; Modi, B; Solanki, R; Patel, P; Patel, P; Pujara, K; Nimavat, P; Shah, A; Bharaswadkar, S; Rade, K; Parmar, M; Nair, SA				Dave, Paresh; Vadera, Bhavin; Kumar, Ajay M. V.; Chinnakali, Palanivel; Modi, Bhavesh; Solanki, Rajesh; Patel, Pranav; Patel, Prakash; Pujara, Kirit; Nimavat, Pankaj; Shah, Amar; Bharaswadkar, Sandeep; Rade, Kiran; Parmar, Malik; Nair, Sreenivas Achuthan			Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; PROGRAM	Background Revised National TB Control Programme (RNTCP) in India recommends that all previouslytreated TB (PT) patients are offered drug susceptibility testing (DST) at diagnosis, using rapid diagnostics and screened out for rifampicin resistance before being treated with standardized, eight-month, retreatment regimen. This is intended to improve the early diagnosis of rifampicin resistance and its appropriate management and improve the treatment outcomes among the rest of the patients. In this state-wide study from Gujarat, India, we assess proportion of PT patients underwent rapid DST at diagnosis and the impact of this intervention on their treatment outcomes. Methods This is a retrospective cohort study involving review of electronic patient-records maintained routinely under RNTCP. All PT patients registered for treatment in Gujarat during January-June 2013 were included. Information on DST and treatment outcomes were extracted from 'presumptive DR-TB patient register' and TB treatment register respectively. We performed a multivariate analysis to assess if getting tested is independently associated with unfavourable outcomes (death, loss-to-follow-up, failure, transfer out). Results Of 5,829 PT patients, 5306(91%) were tested for drug susceptibility with rapid diagnostics. Overall, 71% (4,113) TB patients were successfully treated - 72% among tested versus 60% among non-tested. Patients who did not get tested at diagnosis had a 34% higher risk of unsuccessful outcomes as compared to those who got tested (aRR - 1.34; 95% CI 1.20-1.50) after adjusting for age, sex, HIV status and type of TB. Unfavourable outcomes (particularly failure and switched to category IV) were higher among INH-resistant patients (39%) as compared to INH-sensitive (29%). Conclusion Offering DST at diagnosis improved the treatment outcomes among PT patients. However, even among tested, treatment outcomes remained suboptimal and were related to INH resistance and high loss-to-follow-up. These need to be addressed urgently for further progress.	[Dave, Paresh; Patel, Pranav; Patel, Prakash; Pujara, Kirit; Nimavat, Pankaj] Minist Hlth & FamilyWelfare, State TB Cell Commissionerate Hlth, Med Serv & Med Educ, Gandhinagar, Gujarat, India; [Vadera, Bhavin; Shah, Amar; Bharaswadkar, Sandeep; Rade, Kiran; Parmar, Malik; Nair, Sreenivas Achuthan] WHO, Country Off India, New Delhi, India; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Modi, Bhavesh] GMERS Med Coll, Dept Community Med, Gandhinagar, Gujarat, India; [Solanki, Rajesh] BJ Med Coll, Dept Pulm Med, Ahmadabad, Gujarat, India; [Chinnakali, Palanivel] Jawaharlal Inst Postgraduate Med Educ & Res, Dept Prevent & Social Med, Pondicherry, India; [Vadera, Bhavin] Civil Hosp Campus, Near TB & Chest Dept, State TB Training & Demonstrat Ctr, Ahmadabad, Gujarat, India	World Health Organization; B. J. Medical College & Civil Hospital, Ahmedabad; Jawaharlal Institute of Postgraduate Medical Education & Research	Vadera, B (corresponding author), WHO, Country Off India, New Delhi, India.	dr.vadera@gmail.com	Rade, Kiran/AAU-9564-2020; Chinnakali, Palanivel/AAV-7708-2020	Rade, Kiran/0000-0001-7601-0780; Chinnakali, Palanivel/0000-0001-8320-1016; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797	American People through United States Agency for International Development (USAID)	American People through United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: the The Union South-East Asia Regional Office, New Delhi, India, the Centre for Operational Research, The Union, Paris, France and Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, India. Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript.	Abeygunawardena SC, 2014, PUBLIC HEALTH ACTION, V4, P105, DOI 10.5588/pha.13.0111; Central TB Division, 2013, TB IND 2013 REV NAT; Central TB Division, 2012, NAT STRAT PLAN TUB C, DOI [10.1097/QAI.0b013e31825f313b, DOI 10.1097/QAI.0B013E31825F313B]; Central TB Division, 2012, GUID PROGR MAN DRUG; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Deepa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076189; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden TR, 2014, GLOBAL TUBERCULOSIS, P30333, DOI [10.1001/jama.2014.11450.Conflict, DOI 10.1001/JAMA.2014.11450.CONFLICT]; Furin J, 2012, B WORLD HEALTH ORGAN, V90, P63, DOI 10.2471/BLT.11.092320; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Joseph P., 2006, Indian Journal of Tuberculosis, V53, P141; Khann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059903; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Paramasivan C. N., 2000, Indian Journal of Tuberculosis, V47, P27; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P7; Santha T, 2006, INT J TUBERC LUNG D, V10, P52; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; State TB Cell Gujarat, 2014, REV NAT TB CONTR PRO; State TB Cell Gujarat, 2013, REV NAT TB CONTR PRO; State TB Cell Gujarat, 2013, TB GUJ 2013 REV NAT; Stop TB Partnership World Health Organization, 2006, GLOB PLAN STOP TB 20; Vijay S, 2002, RETREATMENT OUTCOME; World Health Organization, 2009, TREATM TIB GUID	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121996	10.1371/journal.pone.0121996	http://dx.doi.org/10.1371/journal.pone.0121996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874545	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100055
J	Helland, T; Gjerde, J; Dankel, S; Fenne, IS; Skartveit, L; Drangevag, A; Bozickovic, O; Flageng, MH; Soiland, H; Mellgren, G; Lien, EA				Helland, Thomas; Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Soiland, Havard; Mellgren, Gunnar; Lien, Ernst A.			The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; SERUM CONCENTRATIONS; EXPRESSION; QUANTIFICATION; COACTIVATOR; PROLIFERATION; METASTASIS; CARCINOMA; KERATIN-6; BINDING	Introduction Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positive breast cancer. Effects and side effects of tamoxifen is the sum of tamoxifen and all its metabolites. 4-Hydroxytamoxifen (4OHtam) and 4-hydroxy-N-demethyltamoxifen (4OHNDtam, endoxifen) both have ER affinity exceeding that of the parent drug tamoxifen. 4OHNDtam is considered the main active metabolite of tamoxifen. Ndesmethyltamoxifen (NDtam) is the major tamoxifen metabolite. It has low affinity to the ER and is not believed to influence tumor growth. However, NDtam might mediate adverse effects of tamoxifen treatment. In this study we investigated the gene regulatory effects of the three metabolites of tamoxifen in MCF-7 breast cancer cells. Material and Methods Using concentrations that mimic the clinical situation we examined effects of 4OHtam, 4OHNDtam and NDtam on global gene expression in 17 beta-estradiol (E-2) treated MCF-7 cells. Transcriptomic responses were assessed by correspondence analysis, differential expression, gene ontology analysis and quantitative real time PCR (Q-rt-PCR). E-2 deprivation and knockdown of Steroid Receptor Coactivator-3 (SRC-3)/Amplified in Breast Cancer 1 (AIB1) mRNA in MCF-7 cells were performed to further characterize specific effects on gene expression. Results 4OHNDtam and 4OHtam caused major changes in gene expression compared to treatment with E-2 alone, with a stronger effect of 4OHNDtam. NDtam had nearly no effect on the global gene expression profile. Treatment of MCF-7 cells with 4OHNDtam led to a strong down-regulation of the CytoKeratin 6 isoforms (KRT6A, KRT6B and KRT6C). The CytoKeratin 6 mRNAs were also down-regulated in MCF-7 cells after E-2 deprivation and after SRC-3/AIB1 knockdown. Conclusion Using concentrations that mimic the clinical situation we report global gene expression changes that were most pronounced with 4OHNDtam and minimal with NDtam. Genes encoding CytoKeratin 6, were highly down-regulated by 4OHNDtam, as well as after E-2 deprivation and knockdown of SRC-3/AIB1, indicating an estrogen receptor-dependent regulation.	[Helland, Thomas; Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Mellgren, Gunnar; Lien, Ernst A.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Soiland, Havard; Mellgren, Gunnar; Lien, Ernst A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Soiland, Havard] Stavanger Univ Hosp, Sect Breast & Endocrine Surg, Stavanger, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Stavanger University Hospital	Lien, EA (corresponding author), Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway.	Ernst.Lien@k2.uib.no	Mellgren, Gunnar/AAG-6573-2020; Gjerde, Jennifer/AAZ-5811-2021	Mellgren, Gunnar/0000-0001-6282-4986; Dankel, Simon/0000-0001-6972-1824; Gjerde, Jennifer/0000-0001-5329-2666	Western Norway Regional Health Authority; Norwegian Cancer Society; University of Bergen	Western Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); University of Bergen	This study has received support from The Western Norway Regional Health Authority (http://www.helse-vest.no/fagfolk/forskning/det-regionalesamarbeidsorganet/Sider/helse-vests-forskingsmidlar.aspx), the Norwegian Cancer Society (www.kreftforeningen.no) and the University of Bergen (www.uib.no). Authors who recieved funding are EAL, GM, JG and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P579, DOI 10.1007/s10549-009-0704-7; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonanni B, 2009, CLIN CANCER RES, V15, P7053, DOI 10.1158/1078-0432.CCR-09-1354; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Casetta B, 2010, EUR J MASS SPECTROM, V16, P81, DOI 10.1255/ejms.1024; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Endo T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001211; Fabian CJ, 2004, CLIN CANCER RES, V10, P5403, DOI 10.1158/1078-0432.CCR-04-0171; Fadare O, 2008, HUM PATHOL, V39, P331, DOI 10.1016/j.humpath.2007.07.014; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fenne IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070096; Gallicchio L, 2004, BREAST CANCER RES TR, V85, P89, DOI 10.1023/B:BREA.0000021050.92539.b0; Gjerde J, 2005, J CHROMATOGR A, V1082, P6, DOI 10.1016/j.chroma.2005.01.004; Gjerde J, 2008, THESIS; Gjerde J, 2012, BREAST CANCER RES TR, V134, P693, DOI 10.1007/s10549-012-2074-9; Gong IY, 2013, BREAST CANCER RES TR, V139, P61, DOI 10.1007/s10549-013-2530-1; Grimm SL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1504; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawse JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054613; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Jaremko M, 2010, ANAL CHEM, V82, P10186, DOI 10.1021/ac102337d; JORDAN VC, 1982, ENDOCRINOLOGY, V110, P1281, DOI 10.1210/endo-110-4-1281; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; KATZENELLENBOGEN JA, 1985, J STEROID BIOCHEM, V22, P589, DOI 10.1016/0022-4731(85)90210-9; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; Klinke DJ, 2014, BIOTECHNOL BIOENG, V111, P1853, DOI 10.1002/bit.25238; LIEN EA, 1989, CANCER RES, V49, P2175; LIEN EA, 1991, CANCER RES, V51, P4837; LIEN EA, 1990, CANCER RES, V50, P5851; Lien EA, 2013, BREAST CANCER RES TR, V141, P243, DOI 10.1007/s10549-013-2677-9; Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lorizio W, 2012, BREAST CANCER RES TR, V132, P1107, DOI 10.1007/s10549-011-1893-4; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; MacGregor JI, 1998, PHARMACOL REV, V50, P151; McGowan K, 1998, Subcell Biochem, V31, P173; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nayfield SG, 1996, J CLIN ONCOL, V14, P1018, DOI 10.1200/JCO.1996.14.3.1018; Paganini-Hill A, 2000, BREAST CANCER RES TR, V60, P167, DOI 10.1023/A:1006342300291; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peyrade F, 1996, CLIN PHARMACOL THER, V59, P401, DOI 10.1016/S0009-9236(96)90108-3; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; REDDEL RR, 1983, EUR J CANCER CLIN ON, V19, P1179, DOI 10.1016/0277-5379(83)90047-0; ROBERTSON DW, 1982, J MED CHEM, V25, P167, DOI 10.1021/jm00344a015; Romano S, 2010, CELL DEATH DIFFER, V17, P145, DOI 10.1038/cdd.2009.115; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Sun GG, 2014, TUMOR BIOL, V35, P3455, DOI 10.1007/s13277-013-1456-x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656	52	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122339	10.1371/journal.pone.0122339	http://dx.doi.org/10.1371/journal.pone.0122339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867603	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100064
J	Le, Y; Ren, J; Shen, J; Li, T; Zhang, CF				Le, Yan; Ren, Jie; Shen, Jie; Li, Tong; Zhang, Cheng-Feng			The Changing Gender Differences in Life Expectancy in Chinese Cities 2005-2010	PLOS ONE			English	Article							MORTALITY; PATTERN; TRENDS; STATES	Objectives To analyze the gender difference in life expectancy in Chinese urban people and explore the age-specific and cause-specific contributions to the changing gender differences in life expectancy. Methods Data of life expectancy and mortality were obtained from "Annual statistics of public health in China." The gender difference was analyzed by decomposition method, including age-specific decomposition and cause-specific decomposition. Results Women lived much longer than men in Chinese urban areas, with remarkable gains in life expectancy since 2005, respectively. The gender difference reached a peak in 2007. Mortality difference between men and women in the 60-79 age group made the largest contributions to the gender gap in life expectancy in all 6 years. Among causes of death, cancers, circulatory diseases and respiratory diseases made the largest contributions to the gender gap. 33-38% of the gender gap were caused by cancers, among which lung cancer contributed 0.6 years of the overall gap. The contribution of cancers to the gender gap reduced over time, mostly influenced by the narrowing effect of liver cancer on gender gap. Traffic accidents and suicide were the external causes influencing the gender gap, contributing 10-16% of the overall difference. Conclusion Public health efforts to reduce excess mortalities for cancers, circulatory disease, respiratory diseases, and suicide among men in particular might further narrow the gender gap in life expectancy in Chinese cities.	[Le, Yan; Ren, Jie; Li, Tong; Zhang, Cheng-Feng] Fu Dan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China; [Shen, Jie] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Dept Epidemiol,Publ Hlth, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, CF (corresponding author), Fu Dan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China.	e3dangdang@hotmail.com						ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; Jacobsen R, 2008, EUR J EPIDEMIOL, V23, P723, DOI 10.1007/s10654-008-9288-5; Karanikolos M, 2012, J EPIDEMIOL COMMUN H, V66, P1043, DOI 10.1136/jech-2011-200879; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Lopez AD, 1983, SEX DIFFERENTIALS MO, P53; Ma GuanSheng, 2005, Acta Nutrimenta Sinica, V27, P362; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; Ministry of health of the people's republic of China, 2006, ANNUAL STATISTICS ON; Ministry of health of the people's republic of China, 2009, ANNUAL STATISTICS ON; Ministry of health of the people's republic of China, 2007, ANNUAL STATISTICS ON; Ministry of health of the people's republic of China, 2010, ANNUAL STATISTICS ON; Ministry of health of the people's republic of China, 2008, ANNUAL STATISTICS ON; Ministry of health of the people's republic of China, 2011, ANNUAL STATISTICS ON; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pampel FC, 2002, POPUL DEV REV, V28, P77, DOI 10.1111/j.1728-4457.2002.00077.x; Pampel F, 2005, DEMOGR RES, V13, P455, DOI 10.4054/DemRes.2005.13.18; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Preston SH, 2006, DEMOGRAPHY, V43, P631, DOI 10.1353/dem.2006.0037; Spijker J., 2007, VIENNA YB POPUL RES, V2007, P61, DOI [DOI 10.1553/POPULATIONYEARBOOK2007S61, 10.1553/populationyearbook2007s61]; Tabutin D., 1998, TOO YOUNG DIE GENES, P17; Trovato F, 2006, J BIOSOC SCI, V38, P391, DOI 10.1017/S0021932005007212; Trovato F, 2003, SOC BIOL, V50, P238; Trovato F, 2007, CAN REV SOC ANTHROP, V44, P101; Van Oyen H, 2013, INT J PUBLIC HEALTH, V58, P143, DOI 10.1007/s00038-012-0361-1; Wang Yan-Hong, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P262; Yang SM, 2012, SOC SCI MED, V75, P1280, DOI 10.1016/j.socscimed.2012.04.026	27	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123320	10.1371/journal.pone.0123320	http://dx.doi.org/10.1371/journal.pone.0123320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875494	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100163
J	Sreenivasa, M; Mombaur, K; Laumond, JP				Sreenivasa, Manish; Mombaur, Katja; Laumond, Jean-Paul			Walking Paths to and from a Goal Differ: On the Role of Bearing Angle in the Formation of Human Locomotion Paths	PLOS ONE			English	Article							OBSTACLE AVOIDANCE; TRAJECTORY FORMATION; ORIENTED LOCOMOTION; CURVED PATHS; HEAD; BODY; DIRECTION	The path that humans take while walking to a goal is the result of a cognitive process modulated by the perception of the environment and physiological constraints. The path shape and timing implicitly embeds aspects of the architecture behind this process. Here, locomotion paths were investigated during a simple task of walking to and from a goal, by looking at the evolution of the position of the human on a horizontal (x,y) plane. We found that the path while walking to a goal was not the same as that while returning from it. Forward-return paths were systematically separated by 0.5-1.9m, or about 5% of the goal distance. We show that this path separation occurs as a consequence of anticipating the desired body orientation at the goal while keeping the target in view. The magnitude of this separation was strongly influenced by the bearing angle (difference between body orientation and angle to goal) and the final orientation imposed at the goal. This phenomenon highlights the impact of a trade-off between a directional perceptual apparatus-eyes in the head on the shoulders-and and physiological limitations, in the formation of human locomotion paths. Our results give an insight into the influence of environmental and perceptual variables on human locomotion and provide a basis for further mathematical study of these mechanisms.	[Sreenivasa, Manish; Mombaur, Katja] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Optimizat Robot & Biomech, Heidelberg, Germany; [Laumond, Jean-Paul] Univ Toulouse, LAAS CNRS, Toulouse, France	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Sreenivasa, M (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Optimizat Robot & Biomech, Heidelberg, Germany.	manish.sreenivasa@iwr.uni-heidelberg.de	Sreenivasa, Manish/P-6311-2018	Sreenivasa, Manish/0000-0002-0979-5706	European Union within the KoroiBot project [GA 611909]; Alexander von Humboldt foundation [3.3-FRA/1152261 STP]; European Research Council [ERC-ADG 340050]; German Universities Excellence Initiative	European Union within the KoroiBot project; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); German Universities Excellence Initiative	This research was supported by the European Union within the KoroiBot project (GA 611909, cordis.europa.eu). MS was funded by a postdoctoral fellowship from the Alexander von Humboldt foundation (3.3-FRA/1152261 STP, www.humboldt-foundation.de). JPL received funding from the European Research Council for the project Actanthrope (ERC-ADG 340050, erc.europa.eu). KM received funding from the 3rd line of the German Universities Excellence Initiative (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta G, 2008, AUTON ROBOT, V25, P25, DOI 10.1007/s10514-007-9075-2; Belmonti V, 2013, EXP BRAIN RES, V227, P131, DOI 10.1007/s00221-013-3495-3; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Brogan DC, 2003, COMP ANIM CONF PROC, P94, DOI 10.1109/CASA.2003.1199309; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; CRATTY BJ, 1967, AM FDN BLIND RES B, V14, P31; Fajen BR, 2003, INT J COMPUT VISION, V54, P13, DOI 10.1023/A:1023701300169; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Frissen Ilja, 2013, HUMAN WALKING VIRTUA, P113; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2005, NEUROSCI LETT, V383, P87, DOI 10.1016/j.neulet.2005.03.046; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Huang WH, 2006, ROBOT AUTON SYST, V54, P288, DOI 10.1016/j.robot.2005.11.004; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Laumond JP, 1998, LECT NOTES CONTROL I, V229; Luo N, 1999, P 55 ANN M I NAV CAM; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mombaur K, 2010, AUTON ROBOT, V28, P369, DOI 10.1007/s10514-009-9170-7; Olivier AH, 2007, NEUROSCI LETT, V412, P148, DOI 10.1016/j.neulet.2006.11.005; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Prevost P, 2003, NEUROSCI LETT, V339, P243, DOI 10.1016/S0304-3940(02)01390-3; Rushton SK, 2013, DISPLAYS, V34, P105, DOI 10.1016/j.displa.2012.10.006; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Sreenivasa MN, 2008, EXP BRAIN RES, V191, P313, DOI 10.1007/s00221-008-1525-3; Steinicke F, 2013, HUMAN WALKING IN VIR; Terrier P, 2000, J BIOMECH, V33, P1717, DOI 10.1016/S0021-9290(00)00133-0; Vielledent S, 2001, NEUROSCI LETT, V305, P65, DOI 10.1016/S0304-3940(01)01798-0; Wilkie RM, 2010, EXP BRAIN RES, V204, P539, DOI 10.1007/s00221-010-2321-4	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121714	10.1371/journal.pone.0121714	http://dx.doi.org/10.1371/journal.pone.0121714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860941	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300029
J	Bai, PY; Wittert, GA; Taylor, AW; Martin, SA; Milne, RW; Shi, ZM				Bai, Peter Y.; Wittert, Gary A.; Taylor, Anne W.; Martin, Sean A.; Milne, Robert W.; Shi, Zumin			The Association of Socio-Demographic Status, Lifestyle Factors and Dietary Patterns with Total Urinary Phthalates in Australian Men	PLOS ONE			English	Article							BISPHENOL-A; METABOLITE CONCENTRATIONS; PREGNANT-WOMEN; US POPULATION; UNITED-STATES; ACID ESTERS; EXPOSURE; MEDICATIONS; DIESTERS; OUTCOMES	Objective To investigate the associations between socio-demographic status, lifestyle factors, dietary patterns and urinary total phthalate concentration in a cohort of South Australian men. Method We randomly selected 1527 males aged 39 to 84 from wave two of the Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) study. Total phthalate concentration was examined in fasting morning urine samples. Socio-demographic and lifestyle factors were assessed by questionnaire. Food intake was assessed by food frequency questionnaire (FFQ). Dietary patterns were constructed using factor analysis. Results Total phthalates were detected in 99.6% of the urine samples. The overall geometric mean (95% CI) of total phthalate concentration was 112.4 (107.5-117.5) ng/mL. The least square geometric means (LSGMs) of total phthalate concentration were significantly higher among people who were obese (127.8 ng/mL), consuming less than two serves fruit per day (125.7 ng/mL) and drinking more than one can (375mL) of carbonated soft drink per day (131.9 ng/mL). Two dietary patterns were identified: a prudent dietary pattern and a western dietary pattern. Both the western dietary pattern (p = 0.002) and multiple lifestyle risk factors including smoking, obesity, insufficient physical activity and the highest quartile of the western dietary pattern (p<0.001), were positively associated with total phthalate levels. There was no significant relationship between total phthalate concentration and sociodemographic status. Conclusion Phthalate exposure is ubiquitous and positively associated with lifestyle risk factors in urban dwelling Australian men.	[Bai, Peter Y.; Wittert, Gary A.; Taylor, Anne W.; Martin, Sean A.; Shi, Zumin] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Milne, Robert W.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Bai, PY (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	peter.bai@adelaide.edu.au	Shi, Zumin/A-1093-2009; Milne, Robert/C-6890-2009; wittert, gary/AAE-2398-2019; Taylor, Anne w/F-5708-2010	Shi, Zumin/0000-0002-3099-3299; Milne, Robert/0000-0002-4554-8366; Taylor, Anne w/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065	National Health and Medical Research Council (NHMRC) [627227]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by National Health and Medical Research Council (NHMRC), grant number #627227, to the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001; AIHW, 2012, 15613 AIHW AUS; Australian Institute of Health and Wellfare (AIHW), 2003, ACT AUSTR SURV GUID; Bradley EL, 2013, FOOD ADDIT CONTAM A, V30, P735, DOI 10.1080/19440049.2013.781684; Bradley EL, 2013, FOOD ADDIT CONTAM A, V30, P722, DOI 10.1080/19440049.2013.781683; Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012; Chen L, 2012, SCI TOTAL ENVIRON, V427, P60, DOI 10.1016/j.scitotenv.2012.03.090; Feng XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072643; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Genuis SJ, 2012, SCI WORLD J, V2012, DOI [DOI 10.1100/2012/615068, 10.1100/2012/615068]; Goodman M, 2014, CRIT REV TOXICOL, V44, P151, DOI 10.3109/10408444.2013.860076; Grant JF, 2013, INT J EPIDEMIOL; Guo Y, 2012, J AGR FOOD CHEM; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Guo ZY, 2010, J CHROMATOGR SCI, V48, P760, DOI 10.1093/chromsci/48.9.760; Heinemeyer G, 2013, INT J HYGIENE ENV HL; Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Kappenstein Oliver, 2012, Exp Suppl, V101, P87, DOI 10.1007/978-3-7643-8340-4_4; Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998; Khedr A, 2013, J CHROMATOGR B, V930, P98, DOI 10.1016/j.jchromb.2013.04.040; Kobrosly RW, 2012, ENVIRON RES, V115, P11, DOI 10.1016/j.envres.2012.03.008; Koch HM, 2013, INT J HYGIENE ENV HL; Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405, DOI 10.1289/ehp.02110405; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Mohr P, 2007, PUBLIC HEALTH NUTR, V10, P1456, DOI 10.1017/S1368980007000109; National Industrial Chemicals Notification and Assessment Scheme (NICNAS), 2008, EX CHEM HAZ ASS REP, DOI [10.1002/etc.2672, DOI 10.1002/ETC.2672]; Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X; Olsen L, 2012, ECOTOX ENVIRON SAFE, V75, P242, DOI 10.1016/j.ecoenv.2011.09.004; Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4; PETERSEN SB, 2012, PUBLIC HLTH NUT 0912; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Saravanabhavan G, 2013, INT J HYGIENE ENV HL; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Schoenaker DAJM, 2013, J NUTR, V143, P392, DOI 10.3945/jn.112.169011; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; StataCorp, 2013, STAT REF MAN; Toxicity and Exposure Assessment for Children's Health (TEACH), 2006, TEACH CHEM SUMM PHTH; Tranfo G, 2012, INT J HYGIENE ENV HL; U.S. CDC, 2013, CHEM FACT SHEET PHTH; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zeng Q, 2013, FOOD CHEM TOXICOL, V56, P18, DOI 10.1016/j.fct.2013.01.045; Zota A. R., 2014, ENV HLTH PERSPECT	49	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122140	10.1371/journal.pone.0122140	http://dx.doi.org/10.1371/journal.pone.0122140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875472	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353015800042
J	Coles, CA; Wadeson, J; Leyton, CP; Siddell, JP; Greenwood, PL; White, JD; McDonagh, MB				Coles, Chantal A.; Wadeson, Jenny; Leyton, Carolina P.; Siddell, Jason P.; Greenwood, Paul L.; White, Jason D.; McDonagh, Matthew B.			Proliferation Rates of Bovine Primary Muscle Cells Relate to Liveweight and Carcase Weight in Cattle	PLOS ONE			English	Article							ADULT SKELETAL-MUSCLE; SATELLITE CELLS; GENE MYF-5; MYOD; MICE; DIFFERENTIATION; INACTIVATION; MYOGENESIS	Muscling in cattle is largely influenced by genetic background, ultimately affecting beef yield and is of major interest to the beef industry. This investigation aimed to determine whether primary skeletal muscle cells isolated from different breeds of cattle with a varying genetic potential for muscling differ in their myogenic proliferative capacity. Primary skeletal muscle cells were isolated and cultured from the Longissimus muscle (LM) of 6 month old Angus, Hereford and Wagyu X Angus cattle. Cells were assessed for rate of proliferation and gene expression of PAX7, MYOD, MYF5, and MYOG. Proliferation rates were found to differ between breeds of cattle whereby myoblasts from Angus cattle were found to proliferate at a greater rate than those of Hereford and Wagyu X Angus during early stages of growth (5-20 hours in culture) in vitro (P < 0.05). The proliferation rates of myoblasts during early stages of culture in vitro were also found to be positively related to the liveweight and carcase weight of cattle (P < 0.05). Gene expression of MYF5 was also found to be significantly down-regulated in WagyuX compared with Angus cattle (P < 0.05). These findings suggest that early events during myogenesis are important for determining liveweight and caracase weights in cattle.	[Coles, Chantal A.; Wadeson, Jenny; Leyton, Carolina P.; McDonagh, Matthew B.] Discovery Technol, Biosci Res Div, Dept Primary Ind Victoria, Melbourne, Vic 3083, Australia; [Coles, Chantal A.; White, Jason D.] Univ Melbourne, Dept Vet Sci, Melbourne, Vic 3010, Australia; [Siddell, Jason P.; Greenwood, Paul L.; McDonagh, Matthew B.] Univ New England, Cooperat Res Ctr Cattle & Beef Qual, Armidale, NSW 2351, Australia; [Siddell, Jason P.; Greenwood, Paul L.; McDonagh, Matthew B.] Beef Ind Ctr Excellence, New South Wales Dept Primary Ind, Armidale, NSW 2351, Australia	Victorian Department of Environment & Primary Industries; University of Melbourne; University of New England; NSW Department of Primary Industries	Coles, CA (corresponding author), Discovery Technol, Biosci Res Div, Dept Primary Ind Victoria, Melbourne, Vic 3083, Australia.	chantal.coles@mcri.edu.au	Greenwood, Paul L/G-9747-2013; White, Jason/AAF-8712-2020	Greenwood, Paul L/0000-0002-7719-8233; White, Jason/0000-0002-0557-392X	Cooperative Research Centre for Beef Technologies Australia [1.1.3]; Victorian Government's Operational Infrastructure Support Program	Cooperative Research Centre for Beef Technologies Australia; Victorian Government's Operational Infrastructure Support Program	This work was supported by Cooperative Research Centre for Beef Technologies Australia Project Number: 1.1.3, Project Name: Biological validation and gene expression underpinning gene discovery (Proof of concept), Project Leader: Dr. Paul Greenwood; and Sub-Program 1.1 Full utilisation of genetic markers for improved beef quality, Start Date: 01/07/2005, End Date: 30/06/2012. Sponsors were involved in large scale coordination of cattle including management and finances in housing cattle up to slaughter date and coordination of cattle into abbattoirs for sample collection. The funders also financed laboratory reagents and labour for data analysis and preparation of the manuscript. This work was also supported in part by the Victorian Government's Operational Infrastructure Support Program.	Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kook SH, 2006, MOL CELLS, V22, P239; Lavulo LT, 2008, CELLS TISSUES ORGANS, V187, P141, DOI 10.1159/000110080; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	15	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124468	10.1371/journal.pone.0124468	http://dx.doi.org/10.1371/journal.pone.0124468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875203	Green Published, gold			2022-12-27	WOS:000353015800142
J	Crawford, GL; Boldison, J; Copland, DA; Adamson, P; Gale, D; Brandt, M; Nicholson, LB; Dick, AD				Crawford, G. L.; Boldison, J.; Copland, D. A.; Adamson, P.; Gale, D.; Brandt, M.; Nicholson, L. B.; Dick, A. D.			The Role of Lipoprotein-Associated Phospholipase A(2) in a Murine Model of Experimental Autoimmune Uveoretinitis	PLOS ONE			English	Article							CELLULAR INFILTRATE; UVEITIS; OXLDL; CLASSIFICATION; INFLAMMATION; MACROPHAGES; INHIBITION; ACTIVATION; DARAPLADIB; RESPONSES	Macrophage activation is, in part, regulated via hydrolysis of oxidised low density lipoproteins by Lipoprotein-Associated phospholipase A(2) (Lp-PLA(2)), resulting in increased macrophage migration, pro-inflammatory cytokine release and chemokine expression. In uveitis, tissue damage is mediated as a result of macrophage activation; hence inhibition of LpPLA(2) may limit macrophage activation and protect the tissue. Utilising Lp-PLA(2) gene-deficient (KO) mice and a pharmacological inhibitor of Lp-PLA(2) (SB-435495) we aimed to determine the effect of Lp-PLA(2) suppression in mediating retinal protection in a model of autoimmune retinal inflammation, experimental autoimmune uveoretinitis (EAU). Following immunisation with RBP-3 (IRBP) 1-20 or 161-180 peptides, clinical disease was monitored and severity assessed, infiltrating leukocytes were enumerated by flow cytometry and tissue destruction quantified by histology. Despite ablation of Lp-PLA(2) enzyme activity in LpPLA(2) KO mice or wild-type mice treated with SB-435495, the number of infiltrating CD45(+) cells in the retina was equivalent to control EAU animals, and there was no reduction in disease severity. Thus, despite the reported beneficial effects of therapeutic Lp-PLA(2) depletion in a variety of vascular inflammatory conditions, we were unable to attenuate disease, show delayed disease onset or prevent progression of EAU in Lp-PLA(2) KO mice. Although EAU exhibits inflammatory vasculopathy there is no overt defect in lipid metabolism and given the lack of effect following Lp-PLA(2) suppression, these data support the hypothesis that sub-acute autoimmune inflammatory disease progresses independently of Lp-PLA(2) activity.	[Crawford, G. L.; Copland, D. A.; Nicholson, L. B.; Dick, A. D.] Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol, Avon, England; [Boldison, J.; Nicholson, L. B.; Dick, A. D.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Adamson, P.] GlaxoSmithKline, Ophthiris Discovery Performance Unit, Stevenage, Herts, England; [Gale, D.] GlaxoSmithKline, Ophthiris Discovery Performance Unit, King Of Prussia, PA USA; [Brandt, M.] Platform Technol Sci, King Of Prussia, PA USA	University of Bristol; University of Bristol; GlaxoSmithKline; GlaxoSmithKline	Dick, AD (corresponding author), Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol, Avon, England.	a.dick@bristol.ac.uk	Copland, David/AAE-5334-2020; Copland, David/AAG-2368-2019	Copland, David/0000-0002-2257-4270; Dick, Andrew/0000-0002-0742-3159	Biotechnology and biological sciences research council [BB/J500197/1]; GlaxoSmithKline [STU100020289]; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [1135012] Funding Source: researchfish	Biotechnology and biological sciences research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	http://www.bbsrc.ac.uk/home/home.aspx, Biotechnology and biological sciences research council: BB/J500197/1, received by GLC (nee Gemma Beers) and http://www.gsk.com/ GlaxoSmithKline: STU100020289, received by GLC (nee Gemma Beers). The funder GlaxoSmithKline provided support in the form of salaries for authors PA, DG & MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson P, 2013, US Patent, Patent No. [20,130,267,544, 20130267544]; Arai H, 2002, PROSTAG OTH LIPID M, V68-9, P83, DOI 10.1016/S0090-6980(02)00023-0; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Brilakis ES, 2005, EUR HEART J, V26, P137, DOI 10.1093/eurheartj/ehi010; Calder CJ, 2005, J IMMUNOL, V175, P6286, DOI 10.4049/jimmunol.175.10.6286; Chung Y, 2013, J IMMUNOL, V190; Copland DA, 2007, AM J PATHOL, V171, P580, DOI 10.2353/ajpath.2007.070272; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Dick AD, 1996, EUR J IMMUNOL, V26, P1018, DOI 10.1002/eji.1830260510; Forrester JV, 2013, INT REV IMMUNOL, V32, P76, DOI 10.3109/08830185.2012.747524; Forrester JV, 1997, EYE, V11, P162, DOI 10.1038/eye.1997.45; Forrester JV, 1998, CURR EYE RES, V17, P426, DOI 10.1080/02713689808951224; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Jiang ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-100; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Kotosai M, 2013, LIPIDS, V48, P569, DOI 10.1007/s11745-013-3779-1; Lee RWJ, 2012, EYE, V26, P17, DOI 10.1038/eye.2011.255; Lee RW, 2014, AUTOIMMUNE AND AUTOI; Lee RH, 2011, ARCHIT DIGEST, V68, P26; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Sanchez-Quesada JL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-112; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Raveney BJE, 2010, IMMUNOLOGY, V131, P340, DOI 10.1111/j.1365-2567.2010.03305.x; Raveney BJE, 2009, J IMMUNOL, V183, P2321, DOI 10.4049/jimmunol.0901340; Schewitz-Bowers LP, 2010, EXPERT REV OPHTHALMO, V5, P43, DOI 10.1586/EOP.09.68; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Selmi C, 2014, AUTOIMMUN REV, V13, P591, DOI 10.1016/j.autrev.2014.01.006; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Wang WD, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-6; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; (WHO) WHO, GLOB DAT VIS IMP; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Xu HP, 2003, INVEST OPHTH VIS SCI, V44, P226, DOI 10.1167/iovs.01-1202; Yeo TK, 2013, OCUL IMMUNOL INFLAMM, V21, P264, DOI 10.3109/09273948.2013.774424; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122093	10.1371/journal.pone.0122093	http://dx.doi.org/10.1371/journal.pone.0122093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874928	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800038
J	Masukume, G; Khashan, AS; Kenny, LC; Baker, PN; Nelson, G				Masukume, Gwinyai; Khashan, Ali S.; Kenny, Louise C.; Baker, Philip N.; Nelson, Gill		SCOPE Consortium	Risk Factors and Birth Outcomes of Anaemia in Early Pregnancy in a Nulliparous Cohort	PLOS ONE			English	Article							MATERNAL ANEMIA; IRON; SMOKING; WOMEN	Background Anaemia in pregnancy is a major public health and economic problem worldwide, that contributes to both maternal and fetal morbidity and mortality. Objective The aim of the study was to calculate the prevalence of anaemia in early pregnancy in a cohort of 'low risk' women participating in a large international multicentre prospective study (n = 5 609), to identify the modifiable risk factors for anaemia in pregnancy in this cohort, and to compare the birth outcomes between pregnancies with and without anaemia in early gestation. Methods The study is an analysis of data that were collected prospectively during the Screening for Pregnancy Endpoints study. Anaemia was defined according to the World Health Organization's definition of anaemia in pregnancy (haemoglobin <11g/dL). Binary logistic regression with adjustment for potential confounders (country, maternal age, having a marital partner, ethnic origin, years of schooling, and having paid work) was the main method of analysis. Results The hallmark findings were the low prevalence of anaemia (2.2%), that having no marital partner was an independent risk factor for having anaemia (OR 1.34, 95% CI 1.01-1.78), and that there was no statistically significant effect of anaemia on adverse pregnancy outcomes (small for gestational age, pre-tem birth, mode of delivery, low birth weight, APGAR score < 7 at one and five minutes). Adverse pregnancy outcomes were however more common in those with anaemia than in those without. Conclusion In this low risk healthy pregnant population we found a low anaemia rate. The absence of a marital partner was a non-modifiable factor, albeit one which may reflect a variety of confounding factors, that should be considered for addition to anaemia's conceptual framework of determinants. Although not statistically significant, clinically, a trend towards a higher risk of adverse pregnancy outcomes was observed in women that were anaemic in early pregnancy.	[Masukume, Gwinyai; Nelson, Gill] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Khashan, Ali S.; Kenny, Louise C.] Natl Univ Ireland Univ Coll Cork, Dept Obstet & Gynaecol, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland; [Khashan, Ali S.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Baker, Philip N.] Univ Auckland, Liggins Inst, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand	University of Witwatersrand; University College Cork; University College Cork; University of Auckland	Masukume, G (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	parturitions@gmail.com	Kenny, Louise C/G-1112-2011; Kenny, Louise/X-6329-2019; Nelson, Gill/AAC-3074-2020	Kenny, Louise C/0000-0002-9011-759X; Kenny, Louise/0000-0002-9011-759X; Nelson, Gill/0000-0001-7815-3718; Masukume, Gwinyai/0000-0002-9251-0264; Baker, Philip/0000-0002-4592-6427	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council [04/198]; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity; Biotechnology and Biological Sciences Research Council [GT084]; UK National Health Services (NEAT) [FSD025]; University of Manchester Proof of Concept Funding; National Institute for Health Research (NIHR); Cerebra, UK; Health Research Board, Ireland [CSA/2007/2]; Tommy's the baby Charity	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK National Health Services (NEAT); University of Manchester Proof of Concept Funding; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cerebra, UK; Health Research Board, Ireland; Tommy's the baby Charity	The SCOPE study was funded by the New Enterprise Research Fund, Foundation for Research Science and Technology; the Health Research Council (04/198); the Evelyn Bond Fund, Auckland District Health Board Charitable Trust; The Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity, Tommy's the baby Charity; the Biotechnology and Biological Sciences Research Council (GT084), UK National Health Services (NEAT grant FSD025), University of Manchester Proof of Concept Funding, National Institute for Health Research (NIHR); Cerebra, UK; and the Health Research Board, Ireland (CSA/2007/2). The study sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present study received no specific funding for this work.	Alio AP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-60; Annals of Internal Medicine, 2014, ANN INTERNAL MED; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Besingi W, 2014, HUM MOL GENET, V23, P2290, DOI 10.1093/hmg/ddt621; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Gonzales Gustavo F, 2012, ISRN Obstet Gynecol, V2012, P368571, DOI 10.5402/2012/368571; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Goonewardene M, 2012, BEST PRACT RES CL OB, V26, P3, DOI 10.1016/j.bpobgyn.2011.10.010; Goshtasebi A, 2013, J HEALTH POPUL NUTR, V31, P398; Grewal A, 2010, INDIAN J ANAESTH, V54, P380, DOI 10.4103/0019-5049.71026; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hare GMT, 2013, CAN J ANESTH, V60, P168, DOI 10.1007/s12630-012-9861-y; Harm Sarah K, 2012, Korean J Hematol, V47, P136, DOI 10.5045/kjh.2012.47.2.136; Hebert PC, 2014, NEW ENGL J MED, V371, P1459, DOI 10.1056/NEJMe1408976; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lazarou Chrystalleni, 2010, Complement Ther Clin Pract, V16, P161, DOI 10.1016/j.ctcp.2010.01.003; Lee AI, 2011, HEMATOL ONCOL CLIN N, V25, P241, DOI 10.1016/j.hoc.2011.02.001; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCarthy FP, 2013, HUM REPROD, V28, P3197, DOI 10.1093/humrep/det332; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; New Zealand Ministry of Health-Manat Hauora, 2014, FOL FOL AC QUEST ANS; Noronha JA, 2012, J SAFOG, V4, P64, DOI [10.5005/jp-journals-10006-1177, DOI 10.5005/JP-JOURNALS-10006-1177, DOI 10.5005/JPJOURNALS-10006-1177]; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Raatikainen K, 2005, BJOG-INT J OBSTET GY, V112, P1411, DOI 10.1111/j.1471-0528.2005.00667.x; Sagili H, 2012, ARCH GYNECOL OBSTET, V285, P573, DOI 10.1007/s00404-011-1987-6; Saunders AV, 2013, MED J AUSTRALIA, V199, P11, DOI 10.5694/mjao11.11494; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Van Tiel ED, 2002, ANN EPIDEMIOL, V12, P378, DOI 10.1016/S1047-2797(01)00282-4; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, SER FERR CONC ASS IR	37	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122729	10.1371/journal.pone.0122729	http://dx.doi.org/10.1371/journal.pone.0122729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875012	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353015800074
J	Cardoso, CW; Ribeiro, GS; Reis, MG; Flannery, B; Reis, JN				Cardoso, Cristiane Wanderley; Ribeiro, Guilherme Sousa; Reis, Mitermayer Galvao; Flannery, Brendan; Reis, Joice Neves			Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; DISEASE; EPIDEMIC; IMPACT; TEENAGERS; RISK; AGE	Background During a citywide epidemic of serogroup C meningococcal disease in Salvador in 2010, Brazil, the state government initiated mass vaccination targeting two age groups with high attack rates: individuals aged < 5 years and 10-24 years. More than 600,000 doses of meningococcal serogroup C conjugate vaccines were administered. We performed a casecontrol study to evaluate vaccine uptake, document vaccine effectiveness and identify reasons for non-vaccination. Methods and Findings Population-based surveillance identified patients with laboratory-confirmed invasive meningococcal C MenC) disease during 2010. Information on MenC vaccination was obtained from case patients and age-matched individuals from the same neighborhoods. MenC vaccine effectiveness was estimated based on the exact odds ratios obtained by conditional logistic regression analysis. Of 51 laboratory-confirmed cases of serogroup C meningococcal disease among patients < 5 and 10-24 years of age 50 were included in the study and matched with 240 controls. Overall case-fatality was 25%. MenC vaccine coverage among controls increased from 7.1% to 70.2% after initiation of the vaccination campaign. None of the 50 case patients but 70 (29.2%) of the 240 control individuals, including 59 (70.2%) of 84 matched with cases from the period afterMenC vaccination, had received at least one MenC vaccine dose. Overall effectiveness of MenC was 98% with a lower 95% exact confidence limit of 89%. Conclusions MenC vaccines administered during the meningococcal epidemic were highly effective, suggesting that rapid vaccine uptake through campaigns contributed to control of meningococcal disease.	[Cardoso, Cristiane Wanderley; Ribeiro, Guilherme Sousa; Reis, Mitermayer Galvao; Reis, Joice Neves] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Reis, Joice Neves] Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Pan American Health Organization; Universidade Federal da Bahia	Reis, JN (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.	joice@ufba.br	Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008; Reis, Joice N/H-9227-2013; Cardoso, Cristiane W/U-3350-2019; Pedreira, Joice Neves Reis/AAO-3536-2021; Cardoso, Cristiane W/Y-8510-2018	Reis, Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059; Pedreira, Joice Neves Reis/0000-0001-5273-2658; Cardoso, Cristiane/0000-0001-5432-1174	Bahia State Foundation [PP-SUS0001/2009]; Secretary of Health Surveillance [SVS/MS - 284/2013]	Bahia State Foundation; Secretary of Health Surveillance	This work was supported by the grants from the Bahia State Foundation (PP-SUS0001/2009) and Secretary of Health Surveillance (SVS/MS - 284/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P521; [Anonymous], 2013, NATL IMMUNIZATION PR; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Bose A, 2003, LANCET, V361, P675, DOI 10.1016/S0140-6736(03)12563-9; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044; Center for Disease Control and Prevention, 2013, MEN DIS SIGNS SYMPT; Coen PG, 2006, INT J EPIDEMIOL, V35, P330, DOI 10.1093/ije/dyi295; Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012; Teixeira AMD, 2011, REV PANAM SALUD PUBL, V30, P7; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; Moraes José Cássio de, 2005, Cad. Saúde Pública, V21, P1458, DOI 10.1590/S0102-311X2005000500019; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Murray RL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1062; PELTOLA H, 1982, LANCET, V2, P595; Azevedo LCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064524; Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689; Secretaria de Saude do Estado de Sao Paulo, IM ESP SUAS IND 2013; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195	24	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123734	10.1371/journal.pone.0123734	http://dx.doi.org/10.1371/journal.pone.0123734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874777	Green Published, gold			2022-12-27	WOS:000352845100206
J	Cheyuo, C; Aziz, M; Yang, WL; Jacob, A; Zhou, M; Wang, P				Cheyuo, Cletus; Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping			Milk Fat Globule-EGF Factor VIII Attenuates CNS Injury by Promoting Neural Stem Cell Proliferation and Migration after Cerebral Ischemia	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; CYCLIN D2; RAT; NEUROGENESIS; PHAGOCYTOSIS; INFLAMMATION; OSTEOPONTIN; LACTADHERIN; STRIATUM; NEURONS	The mediators in activating neural stem cells during the regenerative process of neurogenesis following stroke have not been fully identified. Milk fat globule-EGF Factor VIII (MFGE8), a secreted glycoprotein serves several cellular functions by binding to its receptor, alpha(v)beta(3)-integrin. However, its role in regulating neural stem cells after stroke has not been determined yet. We therefore, aim to reveal whether MFG-E8 promotes neural stem cell proliferation and migration during stroke. Stroke was induced in wild-type (Wt) and MFG-E8-deficinet (Mfge8(-/-)) mice by transient middle cerebral artery occlusion (tMCAO). Commercially available recombinant mouse MFG-E8 (rmMFG-E8) was used for mechanistic assays in neural stem cell line, while the in house prepared recombinant human MFG-E8 (rhMFG-E8) was used for in vivo administration into rats with tMCAO. The in vitro effects of recombinant rmMFG-E8 for the neural stem cell proliferation and migration were determined by BrdU and transwell migration assay, respectively. The expression of cyclin D2, p53 and netrin-1, was analyzed by qPCR. We report that the treatment of rhMFG-E8 significantly improved the neurological deficit score, body weight lost and neural stem cell proliferation in a rat model of tMCAO. Conversely, decreased neural stem cell proliferation was observed in Mfge8(-/-) mice in comparison with the Wt counterparts underwent tMCAO. rmMFG-E8 stimulated the proliferation of mouse embryonic neural stem cells via upregulation of cyclin D2 and downregulation of p53, which is mediated by alpha(v)beta(3)- integrin. rmMFG-E8 also promoted mouse embryonic neural stem cell migration via alpha(v)beta(3)-integrin dependent manner in upregulating netrin-1. Our findings suggest MFG-E8 to promote neural stem cell proliferation and migration, which therefore establishes a promising therapeutic strategy for cerebral ischemia.	[Cheyuo, Cletus; Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA; [Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping] Hofstra North Shore Long Isl Jewish Sch Med, Dept Surg, Manhasset, NY USA	Northwell Health; Hofstra University	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA.	pwang@nshs.edu	Cheyuo, Cletus/AAM-5785-2021; Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394; Cheyuo, Cletus/0000-0002-9717-3738	National Institutes of Health (NIH) [R01 GM 057468, R01 HL076179, R01 GM 053008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468, R01GM053008] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH) grants, R01 GM 057468, R01 HL076179 and R01 GM 053008 (PW). PW is co-founder of TheraSource LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046540; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2012, J IMMUNOL, V189, P393, DOI 10.4049/jimmunol.1200262; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018; Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jiang P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3196; Kerever A, 2014, STEM CELL RES, V12, P492, DOI 10.1016/j.scr.2013.12.009; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P356, DOI 10.1038/jcbfm.2012.166; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Shah KG, 2012, INTENS CARE MED, V38, P128, DOI 10.1007/s00134-011-2353-7; SHIOIDE M, 1993, J CELL BIOCHEM, V53, P176, DOI 10.1002/jcb.240530211; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Vande Velde G, 2012, NEUROIMAGE, V62, P367, DOI 10.1016/j.neuroimage.2012.04.040; Wang P., 2014, MFG E8 INFLAMMATION, Vxv; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	40	14	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122833	10.1371/journal.pone.0122833	http://dx.doi.org/10.1371/journal.pone.0122833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867181	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100107
J	Ding, H; Hu, GL; Zheng, XY; Chen, Q; Threapleton, DE; Zhou, ZH				Ding, Hong; Hu, Guang Li; Zheng, Xue Yan; Chen, Qing; Threapleton, Diane Erin; Zhou, Zeng Huan			The Method Quality of Cross-Over Studies Involved in Cochrane Systematic Reviews	PLOS ONE			English	Article								Background It is possible that cross-over studies included in current systematic reviews are being inadequately assessed, because the current risk of bias tools do not consider possible biases specific to cross-over design. We performed this study to evaluate whether this was being done in cross-over studies included in Cochrane Systematic Reviews (CSRs). Methods We searched the Cochrane Library (up to 2013 issue 5) for CSRs that included at least one cross-over trial. Two authors independently undertook the study selection and data extraction. A random sample of the CSRs was selected and we evaluated whether the cross-over trials in these CSRs were assessed according to criteria suggested by the Cochrane handbook. In addition we reassessed the risk of bias of these cross-over trials by a checklist developed form the Cochrane handbook. Results We identified 688 CSRs that included one or more cross-over studies. We chose a random sample of 60 CSRs and these included 139 cross-over studies. None of these CSRs undertook a risk of bias assessment specific for cross-over studies. In fact items specific for cross-over studies were seldom considered anywhere in quality assessment of these CSRs. When we reassessed the risk of bias, including the 3 items specific to cross-over trials, of these 139 studies, a low risk of bias was judged for appropriate cross-over design in 110(79%), carry-over effects in 48(34%) and for reporting data in all stages of the trial in 114 (82%). Assessment of biases in cross-over trials could affect the GRADE assessment of a review's findings. Conclusion The current Cochrane risk of bias tool is not adequate to assess cross-over studies. Items specific to cross-over trials leading to potential risk of bias are generally neglected in CSRs. A proposed check list for the evaluation of cross-over trials is provided.	[Ding, Hong; Hu, Guang Li; Zheng, Xue Yan; Chen, Qing; Zhou, Zeng Huan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Threapleton, Diane Erin] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Chinese University of Hong Kong	Zhou, ZH (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	zhouzenghuan@163.com	Threapleton, Diane/AAP-8205-2021	Threapleton, Diane/0000-0002-5884-3372				[Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Blackhall K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002986; BROWN BW, 1980, BIOMETRICS, V36, P69, DOI 10.2307/2530496; Clarke M, 2007, BRIT J SURG, V94, P391, DOI 10.1002/bjs.5812; CLEOPHAS TJM, 1990, J CLIN PHARMACOL, V30, P1036, DOI 10.1002/j.1552-4604.1990.tb03591.x; Cleophas TJM, 1998, PHARM WORLD SCI, V20, P113, DOI 10.1023/A:1008626002664; Collaboration C, 2008, COCHRANE HDB SYSTEMA; Davies AN, 2007, COCHRANE DB SYST REV, V18; de Paoli A.G., 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002272, DOI 10.1002/14651858.CD002272]; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; FREEMAN PR, 1989, STAT MED, V8, P1421, DOI 10.1002/sim.4780081202; French SD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004750.pub2; Herbert R. D., 2007, COCHRANE DB SYST REV, V17; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; Mills EJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-27; Moja PL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002919.pub2; Pringsheim T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006996.pub2; Senn S., 2002, CROSS TRIALS CLIN RE CROSS TRIALS CLIN RE, V2nd, P1; Senn SJ, 1993, STAT ISSUES DRUG DEV, Vxx, P273; VIRGILI G, 2006, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD003303.PUB2	22	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120519	10.1371/journal.pone.0120519	http://dx.doi.org/10.1371/journal.pone.0120519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867772	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100024
J	Ignacio, DL; Silvestre, DHD; Cavalcanti-de-Albuquerque, JPA; Louzada, RA; Carvalho, DP; Werneck-de-Castro, JP				Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Carvalho, Denise P.; Werneck-de-Castro, Joao Pedro			Thyroid Hormone and Estrogen Regulate Exercise-Induced Growth Hormone Release	PLOS ONE			English	Article							OBESITY; GENDER; INTENSITY; SECRETION; AXIS; SEX; PATHOPHYSIOLOGY; REPLACEMENT; DEIODINASE; METABOLISM	Growth hormone (GH) regulates whole body metabolism, and physical exercise is the most potent stimulus to induce its secretion in humans. The mechanisms underlying GH secretion after exercise remain to be defined. The aim of this study was to elucidate the role of estrogen and pituitary type 1 deiodinase (D1) activation on exercise-induced GH secretion. Ten days after bilateral ovariectomy, animals were submitted to 20 min of treadmill exercise at 75% of maximum aerobic capacity and tissues were harvested immediately or 30 min after exercise. Non-exercised animals were used as controls. A significant increase in D1 activity occurred immediately after exercise (similar to 60%) in sham-operated animals and GH was higher (similar to 6-fold) 30 min after exercise. Estrogen deficient rats exhibited basal levels of GH and D1 activity comparable to those found in control rats. However, after exercise both D1 activity and serum GH levels were blunted compared to sedentary rats. To understand the potential cause-effect of D1 activation in exercise-induced GH release, we pharmacologically blocked D1 activity by propylthiouracil (PTU) injection into intact rats and submitted them to the acute exercise session. D1 inhibition blocked exercise-induced GH secretion, although basal levels were unaltered. In conclusion, estrogen deficiency impairs the induction of thyroid hormone activating enzyme D1 in the pituitary, and GH release by acute exercise. Also, acute D1 activation is essential for exercise-induced GH response.	[Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Carvalho, Denise P.; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, Rio De Janeiro, Brazil; [Werneck-de-Castro, Joao Pedro] Rush Univ, Med Ctr, Dept Endocrinol & Metab, Chicago, IL 60612 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Rush University	Werneck-de-Castro, JP (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.	joaopedrowerneck@yahoo.com.br	Louzada, Ruy Andrade AN/T-2494-2017; de Albuquerque, João Paulo Cavalcanti/B-4097-2017; Carvalho, Denise P/H-6306-2012; Cavalcanti-de-Albuquerque, João Paulo A/B-4753-2017	Louzada, Ruy Andrade AN/0000-0003-1789-4234; Carvalho, Denise P/0000-0001-6933-6424; Cavalcanti-de-Albuquerque, Joao Paulo/0000-0002-1894-9658; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by research grants from CNPq, FAPERJ and CAPES. Daniele Leao Ignacio is recipient of a fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur A, 1999, EUR J ENDOCRINOL, V140, P367, DOI 10.1530/eje.0.1400367; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Birzniece V, 2012, J CLIN ENDOCR METAB, V97, pE521, DOI 10.1210/jc.2011-3347; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRILLON D, 1986, ENDOCR RES, V12, P137, DOI 10.1080/07435808609035433; BUTKUS JA, 1995, ENDOCRINOLOGY, V136, P2664, DOI 10.1210/en.136.6.2664; Cavalcanti-de-Albuquerque JPA, 2014, J APPL PHYSIOL, V116, P779, DOI 10.1152/japplphysiol.00121.2013; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Fanciulli G, 2009, HUM REPROD UPDATE, V15, P341, DOI 10.1093/humupd/dmp005; FELSING NE, 1992, J CLIN ENDOCR METAB, V75, P157, DOI 10.1210/jcem.75.1.1619005; Fortunato RS, 2008, J ENDOCRINOL, V198, P347, DOI 10.1677/JOE-08-0174; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; GORDON SE, 1994, J APPL PHYSIOL, V76, P821, DOI 10.1152/jappl.1994.76.2.821; HERVAS F, 1975, ENDOCRINOLOGY, V97, P91, DOI 10.1210/endo-97-1-91; Ignacio DL, 2012, HORM METAB RES, V44, P797, DOI 10.1055/s-0032-1314875; Ippoliti F, 2013, J NEUROIMMUNE PHARM, V8, P212, DOI 10.1007/s11481-012-9432-6; Jorgensen JOL, 2010, PEDIATR NEPHROL, V25, P705, DOI 10.1007/s00467-009-1334-3; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kanaley JA, 1999, J CLIN ENDOCR METAB, V84, P3156, DOI 10.1210/jc.84.9.3156; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Moreno M, 2002, ENDOCRINOLOGY, V143, P504, DOI 10.1210/en.143.2.504; Nappi RE, 2012, CLIMACTERIC, V15, P36, DOI 10.3109/13697137.2011.647840; Percegoni N, 2009, HORM METAB RES, V41, P50, DOI 10.1055/s-0028-1087173; Poehlman ET, 2002, ACTA OBSTET GYNECOL, V84, P1131; Pritzlaff-Roy CJ, 2002, J APPL PHYSIOL, V92, P2053, DOI 10.1152/japplphysiol.01018.2001; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; RUSSELLJONES DL, 1993, CLIN ENDOCRINOL, V38, P427, DOI 10.1111/j.1365-2265.1993.tb00525.x; SNEL YEM, 1995, AM J CLIN NUTR, V61, P1290, DOI 10.1093/ajcn/61.6.1290; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; Veldhuis JD, 1997, J CLIN ENDOCR METAB, V82, P3414, DOI 10.1210/jc.82.10.3414; Weltman A, 1997, MED SCI SPORT EXER, V29, P669, DOI 10.1097/00005768-199705000-00013; Weltman A, 2008, J CLIN ENDOCR METAB, V93, P4711, DOI 10.1210/jc.2008-0998; Werneck-De-Castro JPS, 2006, BASIC RES CARDIOL, V101, P494, DOI 10.1007/s00395-006-0605-4; Wheldon A, 2006, GROWTH HORM IGF RES, V16, P125, DOI 10.1016/j.ghir.2006.02.005; Wideman L, 1999, J APPL PHYSIOL, V87, P1154, DOI 10.1152/jappl.1999.87.3.1154; Wideman L, 2006, J APPL PHYSIOL, V101, P1641, DOI 10.1152/japplphysiol.00518.2006	37	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122556	10.1371/journal.pone.0122556	http://dx.doi.org/10.1371/journal.pone.0122556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874614	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100083
J	Jia, XY; Cui, Z; Li, JN; Hu, SY; Zhao, MH				Jia, Xiao-yu; Cui, Zhao; Li, Jian-nan; Hu, Shui-yi; Zhao, Ming-hui			Identification of Critical Residues of Linear B Cell Epitope on Goodpasture Autoantigen	PLOS ONE			English	Article							BASEMENT-MEMBRANE ANTIBODY; CD4(+) T-CELLS; ANTIGEN; MODULATION; DISEASE; COMPLEX; GLOMERULONEPHRITIS; SUSCEPTIBILITY; IMMUNITY; COLLAGEN	Background The autoantigen of anti-glomerular basement membrane (GBM) disease has been identified as the non-collagenous domain 1 of alpha 3 chain of type IV collagen, alpha 3(IV)NC1. Our previous study revealed a peptide on alpha 3(IV) NC1 as a major linear epitope for B cells and potentially nephrogenic, designated as P14 (alpha 3129-150). This peptide has also been proven to be the epitope of auto-reactive T cells in anti-GBM patients. This study was aimed to further characterize the critical motif of P14. Methods 16 patients with anti-GBMdisease and positive anti-P14 antibodies were enrolled. A set of truncated and alanine substituted peptides derived from P14 were synthesized. Circulating antibodies against the peptides were detected by enzyme linked immunosorbent assay (ELISA). Results We found that all sera with anti-P14 antibodies reacted with the 13-mer sequence in the C-terminus of P14 (P14c) exclusively. The level of antibodies against P14 was highly correlated with the level of antibodies against P14c (r=0.970, P<0.001). P14c was the core immunogenic region and the amino acid sequence (ISLWKGFSFIMFT) was highly hydrophobic. Each amino acid residue in P14c was sequentially replaced by alanine. Three residues of glycine142, phenylalanine143, and phenylalanine145 were identified crucial for antibody binding based on the remarkable decline (P<0.001) of antibody reaction after each residue replacement. Conclusions We defined GFxF (alpha 3142, 143,145) as the critical motif of P14. It may provide some clues for understanding the etiology of anti-GBM disease.	[Jia, Xiao-yu; Cui, Zhao; Li, Jian-nan; Hu, Shui-yi; Zhao, Ming-hui] Peking Univ, Div Renal, Dept Med,Key Lab CKD Prevent & Treatment,Minist E, Hosp 1,Inst Nephrol,Key Lab Renal Dis,Minist Hlth, Beijing, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University	Cui, Z (corresponding author), Peking Univ, Div Renal, Dept Med,Key Lab CKD Prevent & Treatment,Minist E, Hosp 1,Inst Nephrol,Key Lab Renal Dis,Minist Hlth, Beijing, Peoples R China.	cuizhao@bjmu.edu.cn	Li, Jiannan/AAD-2792-2022; Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926; Hu, Shui-Yi/0000-0003-2036-0866; Li, Jiannan/0000-0003-4023-690X	Chinese 973 project [2012CB517702]; Natural Science Fund of China to the Innovation Research Group [81321064]; National Natural Science Fund of China [81170645, 81370801, 81330020, 81400703]	Chinese 973 project(National Basic Research Program of China); Natural Science Fund of China to the Innovation Research Group; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of Chinese 973 project (No. 2012CB517702), a grant from Natural Science Fund of China to the Innovation Research Group (81321064) and grants of National Natural Science Fund of China (81170645, 81370801, 81330020, 81400703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Arends J, 2006, J IMMUNOL, V176, P1252, DOI 10.4049/jimmunol.176.2.1252; Berg M, 1997, EUR J IMMUNOL, V27, P1022, DOI 10.1002/eji.1830270432; BOLTON WK, 1984, J CLIN INVEST, V73, P1263, DOI 10.1172/JCI111328; Bolton WK, 2005, J AM SOC NEPHROL, V16, P2657, DOI 10.1681/ASN.2004100823; Cairns LS, 2003, J AM SOC NEPHROL, V14, P2801, DOI 10.1097/01.ASN.0000091588.80007.0E; Chen JL, 2013, CLIN J AM SOC NEPHRO, V8, P51, DOI 10.2215/CJN.05140512; David M, 2001, J BIOL CHEM, V276, P6370, DOI 10.1074/jbc.M008956200; Goodpasture EW, 2009, AM J MED SCI, V338, P148, DOI 10.1097/MAJ.0b013e31818fff94; Gozalbo-Rovira R, 2013, KIDNEY INT, V83, P438, DOI 10.1038/ki.2012.399; Jia XY, 2012, CLIN J AM SOC NEPHRO, V7, P926, DOI 10.2215/CJN.09930911; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; Kitagawa W, 2008, NEPHROL DIAL TRANSPL, V23, P3126, DOI 10.1093/ndt/gfn179; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Macaulay AE, 1997, J IMMUNOL, V158, P4171; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Quaratino S, 2005, J IMMUNOL, V174, P557, DOI 10.4049/jimmunol.174.1.557; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reynolds J, 2000, J CLIN INVEST, V105, P643, DOI 10.1172/JCI6710; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; Salama AD, 2001, J AM SOC NEPHROL, V12, P1908, DOI 10.1681/ASN.V1291908; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; STOCKINGER B, 1992, EUR J IMMUNOL, V22, P1271, DOI 10.1002/eji.1830220523; VOGT AB, 1994, J IMMUNOL, V153, P1665; Watts C, 1998, IMMUNOL REV, V164, P11, DOI 10.1111/j.1600-065X.1998.tb01203.x; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Wu J, 2004, J IMMUNOL, V172, P4567, DOI 10.4049/jimmunol.172.7.4567; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Yang R, 2009, CLIN IMMUNOL, V133, P245, DOI 10.1016/j.clim.2009.07.005; Zou J, 2007, J AM SOC NEPHROL, V18, P771, DOI 10.1681/ASN.2006091056	34	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123277	10.1371/journal.pone.0123277	http://dx.doi.org/10.1371/journal.pone.0123277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874890	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100158
J	Lanzi, S; Codecasa, F; Cornacchia, M; Maestrini, S; Capodaglio, P; Brunani, A; Fanari, P; Salvadori, A; Malatesta, D				Lanzi, Stefano; Codecasa, Franco; Cornacchia, Mauro; Maestrini, Sabrina; Capodaglio, Paolo; Brunani, Amelia; Fanari, Paolo; Salvadori, Alberto; Malatesta, Davide			Long Maximal Incremental Tests Accurately Assess Aerobic Fitness in Class II and III Obese Men	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; ANAEROBIC THRESHOLD; LIPID OXIDATION; EXERCISE; METABOLISM; OVERWEIGHT; VO(2)PEAK; CAPACITY; DURATION; PROTOCOL	This study aimed to compare two different maximal incremental tests with different time durations [a maximal incremental ramp test with a short time duration (8-12 min) (S-Test) and a maximal incremental test with a longer time duration (20-25 min) (L-Test)] to investigate whether an L-Test accurately assesses aerobic fitness in class II and III obese men. Twenty obese men (BMI >= 35 kg.m-2) without secondary pathologies (mean +/- SE; 36.7 +/- 1.9 yr; 41.8 +/- 0.7 kg*m(-2)) completed an STest (warm-up: 40 W; increment: 20W*min(-1)) and an LTest [warm-up: 20% of the peak power output (PPO) reached during the STest; increment: 10% PPO every 5 min until 70% PPO was reached or until the respiratory exchange ratio reached 1.0, followed by 15 W.min(-1) until exhaustion] on a cycle-ergometer to assess the peak oxygen uptake <(V)over dot>O-2peak and peak heart rate (HRpeak) of each test. There were no significant differences in <(V)over dot>O-2peak (S-Test: 3.1 +/- 0.1 L*min(-1); L-Test: 3.0 +/- 0.1 L*min(-1)) and HRpeak (S-Test: 174 +/- 4 bpm; L-Test: 173 +/- 4 bpm) between the two tests. Bland-Altman plot analyses showed good agreement and Pearson product-moment and intra-class correlation coefficients showed a strong correlation between <(V)over dot>O-2peak (r=0.81 for both; p <= 0.001) and HRpeak (r=0.95 for both; p <= 0.001) during both tests. <(V)over dot>O-2peak and HRpeak assessments were not compromised by test duration in class II and III obese men. Therefore, we suggest that the L-Test is a feasible test that accurately assesses aerobic fitness and may allow for the exercise intensity prescription and individualization that will lead to improved therapeutic approaches in treating obesity and severe obesity.	[Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, Inst Sport Sci Univ Lausanne, Lausanne, Switzerland; [Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Codecasa, Franco; Cornacchia, Mauro; Fanari, Paolo; Salvadori, Alberto] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Pulm Rehabil Dept, Verbania, Italy; [Maestrini, Sabrina] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Mol Biol Lab, Verbania, Italy; [Capodaglio, Paolo] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Orthopaed Rehabil Unit, Verbania, Italy; [Capodaglio, Paolo] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Clin Lab Gait & Posture Anal, Verbania, Italy; [Brunani, Amelia] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Dept Rehabil Med, Verbania, Italy	University of Lausanne; University of Lausanne; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Lanzi, S (corresponding author), Univ Lausanne, Inst Sport Sci Univ Lausanne, Lausanne, Switzerland.	lanziste@bluwein.ch	Fanari, Paolo/AAA-2489-2020; Paolo, Capodaglio/AAB-7795-2019; Malatesta, Davide/G-5812-2012	Fanari, Paolo/0000-0001-6544-8509; Paolo, Capodaglio/0000-0003-3719-8789; Malatesta, Davide/0000-0003-3905-5642; Amelia, Brunani/0000-0003-3059-544X; Lanzi, Stefano/0000-0003-1089-6309				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Ara I, 2011, INT J OBESITY, V35, P99, DOI 10.1038/ijo.2010.123; Astorino T.A., 2004, J EXERC PHYSL, V7, P1; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Aucouturier J, 2009, EUR J APPL PHYSIOL, V105, P325, DOI 10.1007/s00421-008-0907-3; Baillot A, 2014, OBES REV, V15, P721, DOI 10.1111/obr.12171; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bentley DJ, 2003, J SCI MED SPORT, V6, P422, DOI 10.1016/S1440-2440(03)80268-2; Bishop D, 1998, J Sci Med Sport, V1, P171; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bordenave S, 2008, DIABETES METAB, V34, P162, DOI 10.1016/j.diabet.2007.11.006; Brun JF, 2012, J ENDOCRINOL INVEST, V35, P686, DOI 10.3275/8466; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Castres I, 2011, J SPORT MED PHYS FIT, V51, P283; Cheneviere X, 2009, MED SCI SPORT EXER, V41, P1615, DOI 10.1249/MSS.0b013e31819e2f91; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; De Glisezinski I, 1998, AM J PHYSIOL-ENDOC M, V275, pE951, DOI 10.1152/ajpendo.1998.275.6.E951; Deriaz O, 2001, INT J OBESITY, V25, P1579, DOI 10.1038/sj.ijo.0801809; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1998, DIABETES CARE S1, V21, pS5; FROELICHER VF, 1974, J APPL PHYSIOL, V36, P720, DOI 10.1152/jappl.1974.36.6.720; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Houmard JA, 2012, EXERC SPORT SCI REV, V40, P204, DOI 10.1097/JES.0b013e31825d53fc; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kang J, 2001, EUR J APPL PHYSIOL, V84, P291, DOI 10.1007/s004210000366; Kuipers H, 2003, INT J SPORTS MED, V24, P486; Lanzi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088707; Larsen S, 2009, DIABETOLOGIA, V52, P1400, DOI 10.1007/s00125-009-1353-4; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; McCole SD, 2001, MED SCI SPORT EXER, V33, P1265, DOI 10.1097/00005768-200108000-00004; McConnell T R, 1988, Br J Sports Med, V22, P3; Midgley AW, 2008, SPORTS MED, V38, P441, DOI 10.2165/00007256-200838060-00001; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Nordby P, 2006, SCAND J MED SCI SPOR, V16, P209, DOI 10.1111/j.1600-0838.2005.00480.x; Ozyener F, 2011, J SPORT SCI MED, V10, P584; Pierce S J, 1999, J Sci Med Sport, V2, P356, DOI 10.1016/S1440-2440(99)80008-5; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Venables MC, 2008, MED SCI SPORT EXER, V40, P495, DOI 10.1249/MSS.0b013e31815f256f; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Weston SB, 2002, INT J SPORTS MED, V23, P22, DOI 10.1055/s-2002-19267; Wood RE, 2010, MED SCI SPORT EXER, V42, P470, DOI 10.1249/MSS.0b013e3181b666ad; Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b13e318054e304; ZOLADZ JA, 1995, J PHYSIOL-LONDON, V488, P211, DOI 10.1113/jphysiol.1995.sp020959	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124180	10.1371/journal.pone.0124180	http://dx.doi.org/10.1371/journal.pone.0124180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875746	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100243
J	Stein, JD; Talwar, N; Kang, JH; Okereke, OI; Wiggs, JL; Pasquale, LR				Stein, Joshua D.; Talwar, Nidhi; Kang, Jae H.; Okereke, Olivia I.; Wiggs, Janey L.; Pasquale, Louis R.			Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large US Managed Care Network	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MOUSE MODEL; GENE-EXPRESSION; TNF-ALPHA; PREVENTS; DISEASES; SMOKING; CELLS	Objective Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of developing open-angle glaucoma (OAG) in humans. The purpose of this study is to determine whether bupropion use alters the risk of developing OAG. Methods Claims data for beneficiaries age >= 35 years with no pre-existing OAG enrolled in a large nationwide U.S. managed care network continuously for >= 4 years between 2001-2011 was analyzed to identify patients who had been newly-diagnosed with OAG. The amount of bupropion use as captured from outpatient pharmacy claims over a four-year period was also quantified for each beneficiary. Multivariable Cox regression modeling assessed the impact of bupropion and other antidepressant medications on the risk of developing OAG with adjustment for sociodemographic characteristics of the enrollees along with medical and ocular comorbidities. Results Of 638,481 eligible enrollees, 15,292 (2.4%) developed OAG. After adjustment for confounding factors including use of other antidepressant medication classes, each additional month of bupropion use was associated with a 0.6% reduced risk of OAG (HR = 0.994, (95% CI: 0.989-0.998), p = 0.007). Compared to nonusers, those with 24-48 months of bupropion use had a 21% reduced hazard (HR=0.79, (CI: 0.65-0.94), p = 0.0099) of OAG. This association did not differ among persons taking bupropion for depression or for other reasons (p-interaction = 0.82). There was no significant association between use of tricyclic antidepressants (HR = 1.000, (CI: 0.997-1.004), p = 0.95) or selective serotonin reuptake in-hibitors (HR = 0.999, (CI: 0.997-1.001), p = 0.39) and development of OAG. Conclusion These findings suggest bupropion use may be beneficial in reducing the risk of OAG. If prospective studies confirm the findings of this analysis, this may identify a novel therapeutic target for OAG.	[Stein, Joshua D.; Talwar, Nidhi] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Kang, Jae H.; Okereke, Olivia I.; Pasquale, Louis R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [Okereke, Olivia I.] Harvard Univ, Sch Publ Hlth, Sch Med, Boston, MA 02115 USA; [Okereke, Olivia I.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Okereke, Olivia I.] Harvard Univ, Sch Med, Boston, MA USA; [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stein, JD (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	jdstein@med.umich.edu	Okereke, Olivia I/R-9934-2016; Okereke, Olivia/AAF-7031-2021	Stein, Joshua/0000-0003-2937-6987	National Eye Institute [1K23EY019511, EY00703, RO1 EY015473]; American Glaucoma Society; Research to Prevent Blindness; Harvard Glaucoma Center of Excellence; Margolis Fund; Arthur Ashley Foundation; NATIONAL EYE INSTITUTE [K23EY019511, R01EY015473] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Glaucoma Society; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; Margolis Fund; Arthur Ashley Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute K23 Mentored Clinician Scientist Award (JDS:1K23EY019511); American Glaucoma Society Young Clinician Scientist Grant (JDS), Research to Prevent Blindness "Physician Scientist Award" (JDS); National Eye Institute Core Grant EY00703; National Eye Institute RO1 EY015473 (LRP); Harvard Glaucoma Center of Excellence (LRP, JLW); the Margolis Fund (LRP); and the Arthur Ashley Foundation (LRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Byrne AM, 2012, CLIN EXP ALLERGY, V42, P550, DOI 10.1111/j.1365-2222.2012.03956.x; Camara-Lemarroy CR, 2013, TRANSPL P, V45, P2502, DOI 10.1016/j.transproceed.2013.04.010; Edwards R, 2008, J GLAUCOMA, V17, P558, DOI 10.1097/IJG.0b013e31815f530c; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Jain R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/278392; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kast RE, 2001, GASTROENTEROLOGY, V121, P1260; Manosso LM, 2013, PROG NEURO-PSYCHOPH, V46, P48, DOI 10.1016/j.pnpbp.2013.06.012; Modell JG, 2002, PSYCHOSOM MED, V64, P835, DOI 10.1097/01.PSY.0000021954.59258.9B; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Newman-Casey PA, 2014, JAMA OPHTHALMOL, V132, P298, DOI 10.1001/jamaophthalmol.2013.7618; Peake STC, 2013, INFLAMM BOWEL DIS, V19, P1546, DOI 10.1097/MIB.0b013e318281333b; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; RUDORFER MV, 1994, DRUG SAFETY, V10, P18, DOI 10.2165/00002018-199410010-00003; Stein JD, 2013, AM J OPHTHALMOL, V156, P1169, DOI 10.1016/j.ajo.2013.06.035; Stein JD, 2012, OPHTHALMOLOGY, V119, P2074, DOI 10.1016/j.ophtha.2012.04.029; Stein JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1053, DOI 10.1001/archophthalmol.2011.191; Takusagawa HL, 2012, ARCH OPHTHALMOL-CHIC, V130, P120, DOI 10.1001/archopht.130.1.120; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Wise LA, 2011, ANN EPIDEMIOL, V21, P430, DOI 10.1016/j.annepidem.2011.03.006; Wu J, 2012, INVEST OPHTH VIS SCI, V53, P7142, DOI 10.1167/iovs.12-9968; Xin XY, 2013, MOL VIS, V19, P526; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123682	10.1371/journal.pone.0123682	http://dx.doi.org/10.1371/journal.pone.0123682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875446	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100198
J	Tietze, A; Mouridsen, K; Lassen-Ramshad, Y; Ostergaard, L				Tietze, Anna; Mouridsen, Kim; Lassen-Ramshad, Yasmin; Ostergaard, Leif			Perfusion MRI Derived Indices of Microvascular Shunting and Flow Control Correlate with Tumor Grade and Outcome in Patients with Cerebral Glioma	PLOS ONE			English	Article							BLOOD-VOLUME MEASUREMENTS; STEM-CELLS; BRAIN-TUMORS; ENHANCED MR; DSC-MRI; HYPOXIA; GLIOBLASTOMA; ANGIOGENESIS; VASCULATURE; CANCER	Objectives Deficient microvascular blood flow control is thought to cause tumor hypoxia and increase resistance to therapy. In glioma patients, we tested whether perfusion-weighted MRI (PWI) based indices of microvascular flow control provide more information on tumor grade and patient outcome than does the established PWI angiogenesis marker, cerebral blood volume (CBV). Material and Methods Seventy-two glioma patients (sixty high-grade, twelve low-grade gliomas) were included. Capillary transit time heterogeneity (CTH) and the coefficient of variation (COV), its ratio to blood mean transit time, provide indices of microvascular flow control and the extent to which oxygen can be extracted by tumor tissue. The ability of these parameters and CBV to differentiate tumor grade were assessed by receiver operating characteristic curves and logistic regression. Their ability to predict time to progression and overall survival was examined by the Cox proportional-hazards regression model, and by survival curves using log-rank tests. Results The best prediction of grade (AUC = 0.876; p < 0.05) was achieved by combining knowledge of CBV and CTH in the enhancing tumor and peri-focal edema, and patients with glioblastoma multiforme were identified best by CTH (AUC = 0.763; p<0.001). CTH outperformed CBV and COV in predicting time to progression and survival in all gliomas and in a subgroup consisting of only high-grade gliomas. Conclusion Our study confirms the importance of microvascular flow control in tumor growth by demonstrating that determining CTH improves tumor grading and outcome prediction in glioma patients compared to CBV alone.	[Tietze, Anna; Mouridsen, Kim; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark; [Tietze, Anna; Ostergaard, Leif] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Lassen-Ramshad, Yasmin] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Tietze, A (corresponding author), Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark.	annatietze@gmail.com	Østergaard, Leif/A-9281-2008; Ostergaard, Lars/AAA-3020-2020; Tietze, Anna/H-3333-2018	Østergaard, Leif/0000-0003-2930-6997; Ostergaard, Lars/0000-0003-2459-0511; Tietze, Anna/0000-0002-2601-9055; Ostergaard, Lars/0000-0002-7619-605X	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab) [902063]; Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat; Harboefonden	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat; Harboefonden	Support was provided by the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab; AT, LO, KM; http://ufm.dk/en; grant number: 902063), "Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat" (AT, LO; http://www.jeppe-juhls-legater.dk/), and "Harboefonden" (AT; http://www.harboefonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Asgari S, 2003, ACTA NEUROCHIR, V145, P453, DOI 10.1007/s00701-003-0035-0; Bar EE, 2011, BRAIN PATHOL, V21, P119, DOI 10.1111/j.1750-3639.2010.00460.x; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bisdas S, 2009, AM J NEURORADIOL, V30, P681, DOI 10.3174/ajnr.A1465; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caseiras GB, 2010, EUR J RADIOL, V73, P215, DOI 10.1016/j.ejrad.2008.11.005; Cher LM, 2006, J NUCL MED, V47, P410; Danchaivijitr N, 2008, RADIOLOGY, V247, P170, DOI 10.1148/radiol.2471062089; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen RL, 2014, NEURO-ONCOLOGY, V16, P280, DOI 10.1093/neuonc/not148; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kawai N, 2014, EUR J NUCL MED MOL I, V41, P1870, DOI 10.1007/s00259-014-2776-9; Law M, 2006, NEUROSURGERY, V58, P1099, DOI 10.1227/01.NEU.0000215944.81730.18; Lemasson B, 2012, RADIOLOGY, V265, P743, DOI 10.1148/radiol.12112621; Lev MH, 2004, AM J NEURORADIOL, V25, P214; Mouridsen K, 2006, MAGN RESON MED, V55, P524, DOI 10.1002/mrm.20759; Mouridsen K, 2006, NEUROIMAGE, V33, P570, DOI 10.1016/j.neuroimage.2006.06.015; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; RENKIN EM, 1985, MICROVASC RES, V30, P251, DOI 10.1016/0026-2862(85)90057-3; Schabel MC, 2012, MAGN RESON MED, V68, P1632, DOI 10.1002/mrm.24162; Secomb TW, 2012, BASIC CLIN PHARMACOL, V110, P63, DOI 10.1111/j.1742-7843.2011.00815.x; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toth V, 2013, J NEURO-ONCOL, V115, P197, DOI 10.1007/s11060-013-1210-7; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014	42	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123044	10.1371/journal.pone.0123044	http://dx.doi.org/10.1371/journal.pone.0123044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875182	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100128
J	Zha, C; Jiang, XH; Peng, SF				Zha, Cong; Jiang, Xue Hua; Peng, Shi Fang			iTRAQ-Based Quantitative Proteomic Analysis on S100 Calcium Binding Protein A2 in Metastasis of Laryngeal Cancer	PLOS ONE			English	Article							BASAL CYTOKERATIN EXPRESSION; PUTATIVE TUMOR-SUPPRESSOR; NECK-CANCER; IN-VITRO; TRANSCRIPTIONAL ACTIVATION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; MESSENGER-RNA; CELL; GROWTH	Laryngeal cancer is the most frequent neoplasm in the head and neck region, with the vast majority of tumors originating from squamous cells. The survival rate of patients with laryngeal cancer has not improved substantially over the past 25 years. To acquire further knowledge regarding the molecules responsible for laryngeal cancer oncogenesis and, in turn, to improve target therapy iTRAQ and mass spectrometry analysis were utilized to detect differences in protein expression from 15 paired laryngeal cancer and adjacent non-cancerous tissue samples. Using mass spectrometry analysis, the expression levels of 100 proteins in laryngeal cancer samples were distinct from the non-tumor, non-cancerous samples. Further validation of the differentially expressed proteins S100A2, KRT16, FGB and HSPB1 were carried out using quantitative real-time RT-PCR, immunoblot and immunohistochemistry. Functional analysis of one of the highly expressed proteins, S100 calcium binding protein A2 (S100A2), was performed using RNA interference. As a consequence, attenuated S100A2 expression enhanced the ability of HEp-2 cell lines to migrate and invade in vitro. Our investigation complements the current understanding of laryngeal cancer progression. Furthermore, this study supports the concept that enhanced expression of S100A2 may be a promising strategy in developing novel cancer therapeutic drugs.	[Zha, Cong; Jiang, Xue Hua] Sichuan Univ, West China Sch Pharm, Chengdu 610064, Sichuan, Peoples R China; [Peng, Shi Fang] Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Peng, Shi Fang] Cent South Univ, Dept Hlth Management Ctr, Changsha, Hunan, Peoples R China	Sichuan University; Central South University; Central South University	Jiang, XH (corresponding author), Sichuan Univ, West China Sch Pharm, Chengdu 610064, Sichuan, Peoples R China.	jxh1013@vip.163.com; sfp1988@gmail.com			Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; Startup Fund of Xiangya Hospital, Central South University, Hunan, China	Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; Startup Fund of Xiangya Hospital, Central South University, Hunan, China	This research was supported by the Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; the Startup Fund of Xiangya Hospital, Central South University, Hunan, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Chang T, 2011, EXP DERMATOL, V20, P555, DOI 10.1111/j.1600-0625.2010.01235.x; Chatterji B, 2009, PROTEOMICS, V9, P1044, DOI 10.1002/pmic.200701135; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2010, J PROTEOMICS, V73, P1632, DOI 10.1016/j.jprot.2010.04.005; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Feng G, 2001, CANCER RES, V61, P7999; Franz C, 1998, J BIOL CHEM, V273, P18826, DOI 10.1074/jbc.273.30.18826; Fujii K, 2005, PROTEOMICS, V5, P1411, DOI 10.1002/pmic.200401004; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jagadeeshan S, 2015, ONCOGENE, V34, P455, DOI 10.1038/onc.2013.576; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lauriola L, 2000, INT J CANCER, V89, P345, DOI 10.1002/1097-0215(20000720)89:4<345::AID-IJC5>3.0.CO;2-T; Lefebvre JL, 2006, LANCET ONCOL, V7, P747, DOI 10.1016/S1470-2045(06)70860-9; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090181; Liu JS, 2010, CANCER BIOTHER RADIO, V25, P29, DOI 10.1089/cbr.2009.0706; Liu ZB, 2009, TUMORI J, V95, P53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2011, DIAGN CYTOPATHOL, V39, P752, DOI 10.1002/dc.21461; Ma YL, 2009, MOL CELL PROTEOMICS, V8, P1878, DOI 10.1074/mcp.M800541-MCP200; Martens JE, 2004, ANTICANCER RES, V24, P771; Medina JE, 2011, HEAD NECK-J SCI SPEC, V33, P746, DOI 10.1002/hed.21453; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nagy N, 2002, HISTOL HISTOPATHOL, V17, P123, DOI 10.14670/HH-17.123; Nagy N, 2001, LAB INVEST, V81, P599, DOI 10.1038/labinvest.3780269; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Potemski P, 2005, ONCOLOGY-BASEL, V69, P478, DOI 10.1159/000090986; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sengupta S, 2010, NEOPLASIA, V12, P837, DOI 10.1593/neo.10662; Sewell DA, 2007, ORL-J OTO-RHIN-LARYN, V69, P77, DOI 10.1159/000097406; Shibata K, 1998, CANCER RES, V58, P900; Shibata K, 1997, CLIN EXP METASTAS, V15, P612, DOI 10.1023/A:1018495414975; Solassol J, 2010, BRIT J CANCER, V102, P181, DOI 10.1038/sj.bjc.6605470; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Sun Y, 1999, MOL CARCINOGEN, V24, P25, DOI 10.1002/(SICI)1098-2744(199901)24:1<25::AID-MC4>3.3.CO;2-J; Tan MJ, 1999, FEBS LETT, V445, P265, DOI 10.1016/S0014-5793(99)00135-0; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Torbenson M, 2002, MODERN PATHOL, V15, P826, DOI 10.1097/01.MP.0000024257.83046.7C; Toyoshima T, 2009, J ORAL PATHOL MED, V38, P530, DOI 10.1111/j.1600-0714.2009.00748.x; Tsai WC, 2006, MOL CANCER RES, V4, P539, DOI 10.1158/1541-7786.MCR-05-0266; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Warawdekar UM, 2006, CLIN CHIM ACTA, V372, P83, DOI 10.1016/j.cca.2006.03.023; Wei KJ, 2009, ORAL DIS, V15, P111, DOI 10.1111/j.1601-0825.2008.01501.x; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang YX, 2012, J PROTEOME RES, V11, P5736, DOI 10.1021/pr300555y; Zvrko E, 2012, COLLEGIUM ANTROPOL, V36, P119	53	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122322	10.1371/journal.pone.0122322	http://dx.doi.org/10.1371/journal.pone.0122322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874882	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100062
J	Castellani, J; Mihaylova, B; Evers, SMAA; Paulus, ATG; Mrango, ZE; Kimbute, O; Shishira, JP; Mulokozi, F; Petzold, M; Singlovic, J; Gomes, M				Castellani, Joelle; Mihaylova, Borislava; Evers, Silvia M. A. A.; Paulus, Aggie T. G.; Mrango, Zakayo E.; Kimbute, Omari; Shishira, Joseph P.; Mulokozi, Francis; Petzold, Max; Singlovic, Jan; Gomes, Melba			Out-of-Pocket Costs and Other Determinants of Access to Healthcare for Children with Febrile Illnesses: A Case-Control Study in Rural Tanzania	PLOS ONE			English	Article							MALARIA; DISTRICT	Objectives To study private costs and other determinants of access to healthcare for childhood fevers in rural Tanzania. Methods A case-control study was conducted in Tanzania to establish factors that determine access to a health facility in acute febrile illnesses in children less than 5 years of age. Carers of eligible children were interviewed in the community; cases were represented by patients who went to a facility and controls by those who did not. A Household Wealth Index was estimated using principal components analysis. A multivariable logistic regression analysis was performed to understand the factors which influenced attendance of healthcare facility including severity of the illness and household wealth/socio-demographic indicators. To complement the data on costs from community interviews, a hospital-based study obtained details of private expenditures for hospitalised children under the age of 5. Results Severe febrile illness is strongly associated with health facility attendance (OR: 35.76, 95% CI: 3.68-347.43, p = 0.002 compared with less severe febrile illness). Overall, the private costs of an illness for patients who went to a hospital were six times larger than private costs of controls ($5.68 vs. $0.90, p<0.0001). Household wealth was not significantly correlated with total costs incurred. The separate hospital based cost study indicated that private costs were three times greater for admissions at the mission versus public hospital: $13.68 mission vs. $4.47 public hospital (difference $9.21 (95% CI: 7.89 - 10.52), p<0.0001). In both locations, approximately 50% of the cost was determined by the duration of admission, with each day in hospital increasing private costs by about 12% (95% CI: 5% - 21%). Conclusion The more severely ill a child, the higher the probability of attending hospital. We did not find association between household wealth and attending a health facility; nor was there an association between household wealth and private cost.	[Castellani, Joelle; Evers, Silvia M. A. A.; Paulus, Aggie T. G.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands; [Mihaylova, Borislava] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Mrango, Zakayo E.; Kimbute, Omari; Shishira, Joseph P.; Mulokozi, Francis] Natl Inst Med Res, Kilosa Stn, Kilosa, Tanzania; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Singlovic, Jan] World Hlth Org Consultant, Libochovany, Czech Republic; [Gomes, Melba] WHO, UNICEF UNDP World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Maastricht University; University of Oxford; University of Gothenburg; World Health Organization; The World Bank; World Health Organization	Castellani, J (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands.	j.castellani@maastrichtuniversity.nl	Evers, Silvia/ABG-2128-2020; Evers, Silvia MAA/K-9720-2015	Evers, Silvia/0000-0003-1026-570X; Evers, Silvia MAA/0000-0003-1026-570X; Kimbute, Omari/0000-0002-0067-5783; Castellani, Joelle/0000-0002-8176-0903; Mihaylova, Borislava/0000-0002-0951-1304	Pan American Health and Education Foundation through EUROHEALTH	Pan American Health and Education Foundation through EUROHEALTH	This work was supported by the Pan American Health and Education Foundation through EUROHEALTH. URL: http://www.pahef.org/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikaeli J, 2010, 104 RES POV ALL; Alilio MS, 2004, AM J TROP MED HYG, V71, P205, DOI 10.4269/ajtmh.2004.71.205; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Jowett M, 2000, MALARIA EXPENDITURE; Kalyango JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060481; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Mboera LEG, 2010, GEOSPATIAL HEALTH, V4, P167, DOI 10.4081/gh.2010.198; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Ministry of Health and AMMP team, 1997, POL IMPL AD MORB MOR; Mubyazi G. M., 2004, East African Journal of Public Health, V1, P11; Muela SH, 2000, HEALTH POLICY PLANN, V15, P296, DOI 10.1093/heapol/15.3.296; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Saksena P, 2010, HEALTH POLICY PLANN, V25, P328, DOI 10.1093/heapol/czq003; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Tanzania Turiani-Hospital Foundation, 2007, TUR HOSP HLTH ALL MV; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2008, INT MAN CHILDH ILLN	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122386	10.1371/journal.pone.0122386	http://dx.doi.org/10.1371/journal.pone.0122386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25861012	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300044
J	Hunter, ME; Oyler-McCance, SJ; Dorazio, RM; Fike, JA; Smith, BJ; Hunter, CT; Reed, RN; Hart, KM				Hunter, Margaret E.; Oyler-McCance, Sara J.; Dorazio, Robert M.; Fike, Jennifer A.; Smith, Brian J.; Hunter, Charles T.; Reed, Robert N.; Hart, Kristen M.			Environmental DNA (eDNA) Sampling Improves Occurrence and Detection Estimates of Invasive Burmese Pythons	PLOS ONE			English	Article							EVERGLADES NATIONAL-PARK; MOLURUS-BIVITTATUS; FLORIDA; OCCUPANCY; RATES	Environmental DNA (eDNA) methods are used to detect DNA that is shed into the aquatic environment by cryptic or low density species. Applied in eDNA studies, occupancy models can be used to estimate occurrence and detection probabilities and thereby account for imperfect detection. However, occupancy terminology has been applied inconsistently in eDNA studies, and many have calculated occurrence probabilities while not considering the effects of imperfect detection. Low detection of invasive giant constrictors using visual surveys and traps has hampered the estimation of occupancy and detection estimates needed for population management in southern Florida, USA. Giant constrictor snakes pose a threat to native species and the ecological restoration of the Florida Everglades. To assist with detection, we developed species-specific eDNA assays using quantitative PCR (qPCR) for the Burmese python (Python molurus bivittatus), Northern African python (P. sebae), boa constrictor (Boa constrictor), and the green (Eunectes murinus) and yellow anaconda (E. notaeus). Burmese pythons, Northern African pythons, and boa constrictors are established and reproducing, while the green and yellow anaconda have the potential to become established. We validated the python and boa constrictor assays using laboratory trials and tested all species in 21 field locations distributed in eight southern Florida regions. Burmese python eDNA was detected in 37 of 63 field sampling events; however, the other species were not detected. Although eDNA was heterogeneously distributed in the environment, occupancy models were able to provide the first estimates of detection probabilities, which were greater than 91%. Burmese python eDNA was detected along the leading northern edge of the known population boundary. The development of informative detection tools and eDNA occupancy models can improve conservation efforts in southern Florida and support more extensive studies of invasive constrictors. Generic sampling design and terminology are proposed to standardize and clarify interpretations of eDNA-based occupancy models.	[Hunter, Margaret E.; Dorazio, Robert M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA; [Oyler-McCance, Sara J.; Fike, Jennifer A.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Smith, Brian J.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Hunter, Charles T.] Univ Florida, Inst Food & Agr Sci, Hort Sci, Gainesville, FL 32611 USA; [Hart, Kristen M.] US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey	Hunter, ME (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA.	mhunter@usgs.gov	Smith, Brian J./AAV-7609-2020	Smith, Brian J./0000-0002-0531-0492; Oyler-McCance, Sara/0000-0003-1599-8769	U.S. Geological Survey, Priority Ecosystems Science Program; U.S. Geological Survey, Southeast Ecological Science Center	U.S. Geological Survey, Priority Ecosystems Science Program; U.S. Geological Survey, Southeast Ecological Science Center	This work was funded through the U.S. Geological Survey, Priority Ecosystems Science Program and the U.S. Geological Survey, Southeast Ecological Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Dorcas ME, 2011, BIOL INVASIONS, V13, P793, DOI 10.1007/s10530-010-9869-6; Dove CJ, 2011, WILSON J ORNITHOL, V123, P126, DOI 10.1676/10-092.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Greene Daniel U., 2007, Herpetological Review, V38, P355; Hunter ME, 2012, CONSERV GENET, V13, P1623, DOI 10.1007/s10592-012-0414-2; Hyatt A, 2007, DIS AQUAT ORGAN, V73; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kolar CS, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P213; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mazzotti FJ, 2011, BIOL INVASIONS, V13, P143, DOI 10.1007/s10530-010-9797-5; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Phalen D., 2011, DEV VALIDATION RAPID; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Reed RN, 2010, IRCF REPTILES AMPHIB, V17, P52; Reed RN, 2011, WILDLIFE RES, V38, P114, DOI 10.1071/WR10202; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Snow Ray W., 2007, P416; Snow Ray W., 2007, Herpetological Bulletin, P5; Stuart B., 2012, IUCN RED LIST THREAT; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	37	149	155	6	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121655	10.1371/journal.pone.0121655	http://dx.doi.org/10.1371/journal.pone.0121655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874630	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800027
J	Mishra, EK; Corcoran, JP; Hallifax, RJ; Stradling, J; Maskell, NA; Rahman, NM				Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Maskell, Nicholas A.; Rahman, Najib M.			Defining the Minimal Important Difference for the Visual Analogue Scale Assessing Dyspnea in Patients with Malignant Pleural Effusions	PLOS ONE			English	Article								Background The minimal important difference (MID) is essential for interpreting the results of randomised controlled trials (RCTs). Despite a number of RCTs in patients with malignant pleural effusions (MPEs) which use the visual analogue scale for dyspnea (VASD) as an outcome measure, the MID has not been established. Methods Patients with suspected MPE undergoing a pleural procedure recorded their baseline VASD and their post-procedure VASD (24 hours after the pleural drainage), and in parallel assessed their breathlessness on a 7 point Likert scale. Findings The mean decrease in VASD in patients with a MPE reporting a 'small but just worthwhile decrease' in their dyspnea (i.e. equivalent to the MID) was 19mm (95% CI 14-24mm). The mean drainage volume required to produce a change in VASD of 19mm was 760ml. Interpretation The mean MID for the VASD in patients with a MPE undergoing a pleural procedure is 19mm (95% CI 14-24mm). Thus choosing an improvement of 19mm in the VASD would be justifiable in the design and analysis of future MPE studies.	[Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Rahman, Najib M.] Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; [Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Rahman, Najib M.] Churchill Hosp, Oxford Biomed Res Ctr, Oxford Resp Trials Unit, Oxford OX3 7LJ, England; [Maskell, Nicholas A.] Univ Bristol, Bristol, Avon, England	University of Oxford; University of Oxford; University of Bristol	Mishra, EK (corresponding author), Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England.	eleanor.mishra@gmail.com		maskell, nick/0000-0002-1276-6500; Rahman, Najib M/0000-0003-1195-1680; Stradling, John/0000-0003-4971-5018; Mishra, Eleanor/0000-0002-5903-3005; Hallifax, Rob/0000-0002-9467-668X	National Cancer Research Institute; Marie Curie [MCCC-RP-14-A17178] Funding Source: researchfish	National Cancer Research Institute; Marie Curie(European Commission)	This research was funded by a grant from the National Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ander Douglas S, 2004, Congest Heart Fail, V10, P188, DOI 10.1111/j.1527-5299.2004.03475.x; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; de Torres JP, 2002, CHEST, V121, P1092, DOI 10.1378/chest.121.4.1092; GUYATT GH, 1989, J CLIN EPIDEMIOL, V42, P913, DOI 10.1016/0895-4356(89)90105-4; Karras DJ, 2000, ACAD EMERG MED, V7, P327, DOI 10.1111/j.1553-2712.2000.tb02231.x; Paul-Dauphin A, 1999, AM J EPIDEMIOL, V150, P1117, DOI 10.1093/oxfordjournals.aje.a009937; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Ries Andrew L, 2005, COPD, V2, P105; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; RODRIGUEZPANADERO F, 1989, EUR RESPIR J, V2, P366; Schunemann Holger J, 2005, COPD, V2, P81; Sloan J A, 2004, J Biopharm Stat, V14, P73, DOI 10.1081/BIP-120028507; Tu YK, 2007, STAT MED, V26, P443, DOI 10.1002/sim.2538; Yost KJ, 2005, J CLIN EPIDEMIOL, V58, P1241, DOI 10.1016/j.jclinepi.2005.07.008	14	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123798	10.1371/journal.pone.0123798	http://dx.doi.org/10.1371/journal.pone.0123798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874452	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000353015800116
J	Chen, JN; Li, SH; Sun, WS; Li, JR				Chen, Jinan; Li, Shenghua; Sun, Wenshan; Li, Junrong			Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; ACTIN POLYMERIZATION; S-NITROSYLATION; TAU PATHOLOGY; LONG-TERM; CDK5; PHOSPHORYLATION; PEPTIDE; ACTIVATOR	Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is activated by the neuron specific activators p35/p39 and plays many important roles in neuronal development. However, aberrant activation of Cdk5 is believed to be associated with the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Here in the present study, enhanced Cdk5 activity was observed in mouse models of AD; whereas soluble amyloid-beta oligomers (A beta), which contribute to synaptic failures during AD pathogenesis, induced Cdk5 hyperactivation in cultured hippocampal neurons. Inhibition of Cdk5 activity by pharmacological or genetic approaches reversed dendritic spine loss caused by soluble amyloid-beta oligomers (A beta) treatment. Interestingly, we found that the anti-diabetes drug pioglitazone could inhibit Cdk5 activity by decreasing p35 protein level. More importantly, pioglitazone treatment corrected long-term potentiation (LTP) deficit caused by A beta exposure in cultured slices and pioglitazone administration rescued impaired LTP and spatial memory in AD mouse models. Taken together, our study describes an unanticipated role of pioglitazone in alleviating AD and reveals a potential therapeutic drug for AD curing.	[Chen, Jinan; Li, Shenghua; Sun, Wenshan; Li, Junrong] Nanjing Med Univ, Jiangning Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Chen, JN (corresponding author), Nanjing Med Univ, Jiangning Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	cjn1523@yahoo.com; Ljry612@163.com						Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Cho DH, 2013, J NEUROCHEM, V126, P685, DOI 10.1111/jnc.12264; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Derosa Giuseppe, 2012, Curr Mol Pharmacol, V5, P272; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gupta R, 2012, PHARMACOL BIOCHEM BE, V102, P184, DOI 10.1016/j.pbb.2012.03.028; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Lavelle L, 2010, NEW ENGL J MED, V363, P1772, DOI 10.1056/NEJMc1008660; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Miller BW, 2011, ANN PHARMACOTHER, V45, P1416, DOI 10.1345/aph.1Q238; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Qu J, 2012, PRION, V6, P364, DOI 10.4161/pri.21250; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; Stevens J, 2009, FASEB J, V23; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Xiang GQ, 2012, J PHARM PHARMACOL, V64, P589, DOI 10.1111/j.2042-7158.2011.01432.x; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zheng YL, 2010, J BIOL CHEM, V285, P34202, DOI 10.1074/jbc.M110.134643	32	32	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123864	10.1371/journal.pone.0123864	http://dx.doi.org/10.1371/journal.pone.0123864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875370	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700048
J	Lagenaur, LA; Swedek, I; Lee, PP; Parks, TP				Lagenaur, Laurel A.; Swedek, Iwona; Lee, Peter P.; Parks, Thomas P.			Robust Vaginal Colonization of Macaques with a Novel Vaginally Disintegrating Tablet Containing a Live Biotherapeutic Product to Prevent HIV Infection in Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYANOVIRIN-N; BACTERIAL VAGINOSIS; PREEXPOSURE PROPHYLAXIS; MICROBICIDE DEVELOPMENT; MACACA-MULATTA; TENOFOVIR GEL; AFRICAN WOMEN; LACTOBACILLUS; ACQUISITION	MucoCept is a biotherapeutic for prevention of HIV-1 infection in women and contains a human, vaginal Lactobacillus jensenii that has been genetically enhanced to express the HIV-1 entry inhibitor, modified cyanovirin-N (mCV-N). The objective of this study was to develop a solid vaginal dosage form that supports sustained vaginal colonization of the MucoCept Lactobacillus at levels previously shown, with freshly prepared cultures, to protect macaques from SHIV infection and to test this formulation in a macaque vaginal colonization model. Vaginally disintegrating tablets were prepared by lyophilizing the formulated bacteria in tablet-shaped molds, then packaging in foil pouches with desiccant. Disintegration time, potency and stability of the tablets were assessed. For colonization, non-synchronized macaques were dosed vaginally with either one tablet or five tablets delivered over five days. Vaginal samples were obtained at three, 14, and 21 days post-dosing and cultured to determine Lactobacillus colonization levels. To confirm identity of the MucoCept Lactobacillus strain, genomic DNA was extracted from samples on days 14 and 21 and a strain-specific PCR was performed. Supernatants from bacteria were tested for the presence of the mCV-N protein by Western blot. The tablets were easy to handle, disintegrated within two minutes, potent (5.7x10(11) CFU/g), and stable at 4 degrees C and 25 degrees C. Vaginal administration of the tablets to macaques resulted in colonization of the MucoCept Lactobacillus in 66% of macaques at 14 days post-dosing and 83% after 21 days. There was no significant difference in colonization levels for the one or five tablet dosing regimens (p=0.88 Day 14, p=0.99 Day 21). Strain-specific PCR confirmed the presence of the bacteria even in culture-negative macaques. Finally, the presence of mCV-N protein was confirmed by Western blot analysis using a specific anti-mCV-N antibody.	[Lagenaur, Laurel A.; Swedek, Iwona; Lee, Peter P.; Parks, Thomas P.] Osel Inc, Mountain View, CA 94043 USA; [Lagenaur, Laurel A.] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lagenaur, LA (corresponding author), Osel Inc, Mountain View, CA 94043 USA.	llagenaur@mail.nih.gov		Lee, Peter P./0000-0002-2660-4377	National Institutes of Health (NIH) research grant [5R33AI071978]; Bill and Melinda Gates Foundation; Osel Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI071978, R44AI100753] Funding Source: NIH RePORTER	National Institutes of Health (NIH) research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Osel Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) research grant 5R33AI071978 and Phase 1 and Phase 2 Grand Challenges Explorations grants through the Bill and Melinda Gates Foundation (www.grandchallenges.org/). Osel Inc. played an indirect role through the participation of the co-authors and provided support in the form of salaries for authors LAL, TPP and IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Badgujar BP, 2011, ACTA PHARMACEUT, V61, P117, DOI 10.2478/v10007-011-0020-8; Basu B, 2011, J ADV PHARM TECHNOL, V2, P266, DOI 10.4103/2231-4040.90885; Benning L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096844; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Brichacek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078817; Brotman RM, 2014, MENOPAUSE, V21, P450, DOI 10.1097/GME.0b013e3182a4690b; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Damelin LH, 2011, J MED MICROBIOL, V60, P180, DOI 10.1099/jmm.0.024463-0; Dey B, 2000, J VIROL, V74, P4562, DOI 10.1128/JVI.74.10.4562-4569.2000; Fiereck K, 2013, DEV WORLD BIOETHICS; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; GIORGI A, 1987, MICROBIOLOGICA, V10, P377; Gravett MG, 2012, J MED PRIMATOL, V41, P183, DOI 10.1111/j.1600-0684.2012.00537.x; Hemalatha R, 2012, EUR J CLIN MICROBIOL, V31, P3097, DOI 10.1007/s10096-012-1671-1; Hemmerling A, 2010, SEXUALLY TRANSMITTED; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; Lagenaur L, 2011, MUCOSAL IMMUNOL; Liegler T, 2014, J INFECT DIS; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; MacQueen KM, 2014, AIDS BEHAV, V18, P826, DOI 10.1007/s10461-014-0753-8; Maggi L, 2000, EUR J PHARM BIOPHARM, V50, P389, DOI 10.1016/S0939-6411(00)00121-1; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Ngugi BM, 2011, SEX TRANSM DIS, V38, P1020, DOI 10.1097/OLQ.0b013e3182267ac4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; RAVEL J, 2010, P NATL ACAD SCI US; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Yu RR, 2009, J MED PRIMATOL, V38, P125, DOI 10.1111/j.1600-0684.2008.00316.x	48	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122730	10.1371/journal.pone.0122730	http://dx.doi.org/10.1371/journal.pone.0122730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875100	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700023
J	Ballak, DB; van Asseldonk, EJP; van Diepen, JA; Jansen, H; Hijmans, A; Joosten, LAB; Tack, CJ; Netea, MG; Stienstra, R				Ballak, Dov B.; van Asseldonk, Edwin J. P.; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Joosten, Leo A. B.; Tack, Cees J.; Netea, Mihai G.; Stienstra, Rinke			TLR-3 is Present in Human Adipocytes, but Its Signalling is Not Required for Obesity-Induced Inflammation in Adipose Tissue In Vivo	PLOS ONE			English	Article							INSULIN-RESISTANCE; FATTY-ACIDS; RECOGNITION; MACROPHAGES; INHIBITION; STEATOSIS; INDUCTION; CELLS; RNA	Innate immunity plays a pivotal role in obesity-induced low-grade inflammation originating from adipose tissue. Key receptors of the innate immune system including Toll-like receptors- 2 and -4 (TLRs) are triggered by nutrient excess to promote inflammation. The role of other TLRs in this process is largely unknown. In addition to double-stranded viral mRNA, TLR-3 can also recognize mRNA from dying endogenous cells, a process that is frequently observed within obese adipose tissue. Here, we identified profound expression of TLR-3 in adipocytes and investigated its role during diet-induced obesity. Human adipose tissue biopsies (n=80) and an adipocyte cell-line were used to study TLR-3 expression and function. TLR-3-/- and WT animals were exposed to a high-fat diet (HFD) for 16 weeks to induce obesity. Expression of TLR-3 was significantly higher in human adipocytes compared to the non-adipocyte cells part of the adipose tissue. In vitro, TLR-3 expression was induced during differentiation of adipocytes and stimulation of the receptor led to elevated expression of pro-inflammatory cytokines. In vivo, TLR-3 deficiency did not significantly influence HFD-induced obesity, insulin sensitivity or inflammation. In humans, TLR-3 expression in adipose tissue did not correlate with BMI or insulin sensitivity (HOMA-IR). Together, our results demonstrate that TLR-3 is highly expressed in adipocytes and functionally active. However, TLR-3 appears to play a redundant role in obesity-induced inflammation and insulin resistance.	[Ballak, Dov B.; van Asseldonk, Edwin J. P.; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Joosten, Leo A. B.; Tack, Cees J.; Netea, Mihai G.; Stienstra, Rinke] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Stienstra, Rinke] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research	Ballak, DB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	duby.ballak@radboudumc.nl	Joosten, Leo AB/H-3138-2015; van Diepen, Janna/E-9485-2010; Tack, Cees J/A-2368-2014; Netea, Mihai/N-5155-2014; Stienstra, Rinke/A-4763-2015; Ballak, Dov B/E-1188-2017	Joosten, Leo AB/0000-0001-6166-9830; van Diepen, Janna/0000-0001-9091-1075; Stienstra, Rinke/0000-0001-6729-7193; 	Ruby Grant of the Dutch Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO)	Ruby Grant of the Dutch Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	RS was supported by a Ruby Grant of the Dutch Diabetes Research Foundation (http://www.diabetesfonds.nl). MN was supported by a Vici Grant from the Netherlands Organization for Scientific Research (NWO) (http://www.nwo.nl/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vici/index.html) (http://www.nwo.nl/onderzoek-en-resultaten/programmas/vernieuwingsimpuls/toekenningen/alle+vici+toekenningen/Toekenningen+ Vici+2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; Brenner C, 2012, SCAND J IMMUNOL, V76, P359, DOI 10.1111/j.1365-3083.2012.02744.x; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Franchini M, 2010, HORM METAB RES, V42, P703, DOI 10.1055/s-0030-1261872; Gregor MF, 2011, ANN REV IMMUNOL; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jansen HJ, 2012, CLIN ENDOCRINOL OXF; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Joosten LA, 2010, ARTHRITIS RHEUM; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2010, WHO FACT FIL 10 FACT; Wu LDH, 2012, METABOLISM, V61, P1633, DOI 10.1016/j.metabol.2012.04.015; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu LL, 2014, IMMUNOL CELL BIOL, V92, P105, DOI 10.1038/icb.2013.66	29	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123152	10.1371/journal.pone.0123152	http://dx.doi.org/10.1371/journal.pone.0123152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867514	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100140
J	Eberson, LS; Sanchez, PA; Majeed, BA; Tawinwung, S; Secomb, TW; Larson, DF				Eberson, Lance S.; Sanchez, Pablo A.; Majeed, Beenish A.; Tawinwung, Supannikar; Secomb, Timothy W.; Larson, Douglas F.			Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ABDOMINAL AORTIC-ANEURYSMS; GROWTH-FACTOR-BETA; CROSS-LINKING; COLLAGEN-SYNTHESIS; BLOOD-PRESSURE; ELASTIN; MICE; CELLS; DYSFUNCTION	It is well accepted that angiotensin II (Ang II) induces altered vascular stiffness through responses including both structural and material remodeling. Concurrent with remodeling is the induction of the enzyme lysyl oxidase (LOX) through which ECM proteins are crosslinked. The study objective was to determine the effect of LOX mediated cross-linking on vascular mechanical properties. Three-month old mice were chronically treated with Ang II with or without the LOX blocker, beta-aminopropionitrile (BAPN), for 14 days. Pulse wave velocity (PWV) from Doppler measurements of the aortic flow wave was used to quantify in vivo vascular stiffness in terms of an effective Young's modulus. The increase in effective Young's modulus with Ang II administration was abolished with the addition of BAPN, suggesting that the material properties are a major controlling element in vascular stiffness. BAPN inhibited the Ang II induced collagen cross-link formation by 2-fold and PWV by 44% (P<0.05). Consistent with this observation, morphometric analysis showed that BAPN did not affect the Ang II mediated increase in medial thickness but significantly reduced the adventitial thickness. Since the hypertensive state contributes to the measured in vivo PWV stiffness, we removed the Ang II infusion pumps on Day 14 and achieved normal arterial blood pressures. With pump removal we observed a decrease of the PWV in the Ang II group to 25% above that of the control values (P=0.002), with a complete return to control values in the Ang II plus BAPN group. In conclusion, we have shown that the increase in vascular stiffness with 14 day Ang II administration results from a combination of hypertension- induced wall strain, adventitial wall thickening and Ang II mediated LOX ECM cross-linking, which is a major material source of vascular stiffening, and that the increased PWV was significantly inhibited with co-administration of BAPN.	[Eberson, Lance S.; Sanchez, Pablo A.; Secomb, Timothy W.; Larson, Douglas F.] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [Majeed, Beenish A.; Tawinwung, Supannikar; Larson, Douglas F.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Eberson, Lance S.; Sanchez, Pablo A.; Majeed, Beenish A.; Tawinwung, Supannikar; Larson, Douglas F.] Univ Arizona, Coll Med, Sarver Heart Ctr, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Larson, DF (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.	dflarson@u.arizona.edu		Tawinwung, Supannikar/0000-0003-2151-4580; Secomb, Timothy/0000-0002-0176-5502	NIH [R01HL105280]; Steinbronn Heart Failure Research Award through the Sarver Heart Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steinbronn Heart Failure Research Award through the Sarver Heart Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH R01HL105280, Steinbronn Heart Failure Research Award to DFL through the Sarver Heart Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2004, BRIT J PHARMACOL, V142, P1055, DOI 10.1038/sj.bjp.0705832; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Che ZQ, 2008, HYPERTENS RES, V31, P1233, DOI 10.1291/hypres.31.1233; Chow MJ, 2014, BIOPHYS J, V106, P2684, DOI 10.1016/j.bpj.2014.05.014; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Fitch RM, 2006, AM J PHYSIOL-HEART C, V290, pH1190, DOI 10.1152/ajpheart.00327.2005; Ford CM, 1999, ARTERIOSCL THROM VAS, V19, P1843, DOI 10.1161/01.ATV.19.8.1843; Greenwald SE, 1997, J BIOMECH ENG-T ASME, V119, P438, DOI 10.1115/1.2798291; Gulan U, 2014, IEEE J BIOMED HEALTH; Guo XM, 2003, AM J PHYSIOL-HEART C, V285, pH2614, DOI 10.1152/ajpheart.00567.2003; Haidet GC, 1996, AM HEART J, V132, P319, DOI 10.1016/S0002-8703(96)90428-7; Hametner B, 2014, INT J CARDIOL, V171, P31, DOI 10.1016/j.ijcard.2013.11.039; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Humphrey JD, 2008, HYPERTENSION, V52, P195, DOI 10.1161/HYPERTENSIONAHA.107.103440; IWATSUKI K, 1977, P NATL ACAD SCI USA, V74, P360, DOI 10.1073/pnas.74.1.360; Jiang B, 2008, ULTRASOUND MED BIOL, V34, P509, DOI 10.1016/j.ultrasmedbio.2007.09.008; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Majeed B, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/126365; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Remus EW, 2012, AM J PHYSIOL-HEART C, V303, pH1067, DOI 10.1152/ajpheart.00217.2012; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Saphirstein RJ, 2014, MICROCIRCULATION, V21, P201, DOI 10.1111/micc.12101; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Weber T, 2012, HYPERTENSION, V60, P534, DOI 10.1161/HYPERTENSIONAHA.112.194571; Woodiwiss AJ, 2001, CIRCULATION, V103, P155; Yu QL, 2010, MATRIX BIOL, V29, P511, DOI 10.1016/j.matbio.2010.06.003; Zhang L, 2012, ANN VASC SURG, V26, P996, DOI 10.1016/j.avsg.2012.02.004	39	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124013	10.1371/journal.pone.0124013	http://dx.doi.org/10.1371/journal.pone.0124013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875748	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100233
J	Grantham, NS; Reich, BJ; Pacifici, K; Laber, EB; Menninger, HL; Henley, JB; Barberan, A; Leff, JW; Fierer, N; Dunn, RR				Grantham, Neal S.; Reich, Brian J.; Pacifici, Krishna; Laber, Eric B.; Menninger, Holly L.; Henley, Jessica B.; Barberan, Albert; Leff, Jonathan W.; Fierer, Noah; Dunn, Robert R.			Fungi Identify the Geographic Origin of Dust Samples	PLOS ONE			English	Article							POLLEN ANALYSIS; BOOTSTRAP; BACTERIAL; SEQUENCES	There is a long history of archaeologists and forensic scientists using pollen found in a dust sample to identify its geographic origin or history. Such palynological approaches have important limitations as they require time-consuming identification of pollen grains, a priori knowledge of plant species distributions, and a sufficient diversity of pollen types to permit spatial or temporal identification. We demonstrate an alternative approach based on DNA sequencing analyses of the fungal diversity found in dust samples. Using nearly 1,000 dust samples collected from across the continental U.S., our analyses identify up to 40,000 fungal taxa from these samples, many of which exhibit a high degree of geographic endemism. We develop a statistical learning algorithm via discriminant analysis that exploits this geographic endemicity in the fungal diversity to correctly identify samples to within a few hundred kilometers of their geographic origin with high probability. In addition, our statistical approach provides a measure of certainty for each prediction, in contrast with current palynology methods that are almost always based on expert opinion and devoid of statistical inference. Fungal taxa found in dust samples can therefore be used to identify the origin of that dust and, more importantly, we can quantify our degree of certainty that a sample originated in a particular place. This work opens up a new approach to forensic biology that could be used by scientists to identify the origin of dust or soil samples found on objects, clothing, or archaeological artifacts.	[Grantham, Neal S.; Reich, Brian J.; Laber, Eric B.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Pacifici, Krishna] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Menninger, Holly L.; Dunn, Robert R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Henley, Jessica B.; Barberan, Albert; Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Dunn, RR (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	Rob_Dunn@ncsu.edu	Barberan, Albert/A-5319-2013; Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020; Pacifici, Krishna/AAF-5171-2020	Dunn, Robert/0000-0002-6030-4837; Pacifici, Krishna/0000-0002-7518-7186; BARBERAN, ALBERT/0000-0002-3066-7530; FIERER, NOAH/0000-0002-6432-4261; Reich, Brian/0000-0002-5473-120X	A. P. Sloan Microbiology of the Built Environment Program	A. P. Sloan Microbiology of the Built Environment Program	Funding for this work was provided by a grant from the A. P. Sloan Microbiology of the Built Environment Program (http://www.sloan.org/major-program-areas/basic-research/microbiology-of-thebuilt-environment/) to NF and RRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; [Anonymous], 1992, HDB PALYNOLOGY MORPH; Araujo R, 2009, FORENS SCI INT-GEN S, V2, P297, DOI 10.1016/j.fsigss.2009.08.145; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blanco-Ulate B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00228-13; Bock JH, 1997, J FORENSIC SCI, V42, P364; Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BRYANT V M JR, 1990, Palynology, V14, P193; Bryant VA, 2006, FORENSIC SCI INT, V163, P183, DOI 10.1016/j.forsciint.2005.11.021; Coyle HM, 2001, CROAT MED J, V42, P340; DICICCIO TJ, 1992, BIOMETRIKA, V79, P285, DOI 10.2307/2336840; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Flores GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044563; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Giampaoli S, 2014, FORENSIC SCI INT, V240, P41, DOI 10.1016/j.forsciint.2014.02.028; HALL P, 1986, ANN STAT, V14, P1431, DOI 10.1214/aos/1176350168; Hastie T., 2009, UNSUPERVISED LEARNIN; Hawksworth DL, 2011, FORENSIC SCI INT, V206, P1, DOI 10.1016/j.forsciint.2010.06.012; Hwang GM, 2013, AASP PALYNOLOGICAL S; Locard, 1930, AM J POLICE SCI, P276, DOI [10.2307/1147154, DOI 10.2307/1147154]; MARTIN MA, 1990, J AM STAT ASSOC, V85, P1105, DOI 10.2307/2289608; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Montali E, 2006, FORENSIC SCI INT, V163, P211, DOI 10.1016/j.forsciint.2005.11.020; Morgan RM, 2013, SCI JUSTICE, V53, P375, DOI 10.1016/j.scijus.2013.03.004; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; PYE K., 2004, FORENSIC GEOSCIENCE, V232, P1, DOI [10.1144/gsl.sp.2004.232.01.01, DOI 10.1144/GSL.SP.2004.232.01.01, 10.1144/GSL.SP.2004.232.01.01]; Pye K, 2007, FORENSIC SCI INT, V165, P52, DOI 10.1016/j.forsciint.2006.03.001; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; STONEY D. A., 2011, J AM SOC TRACE EVIDE, V2, P13; Szibor R, 1998, NATURE, V395, P449, DOI 10.1038/26646; Talbot JM, 2014, P NATL ACAD SCI; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warny S, 2013, AASP PALYNOLOGICAL S, V46; Warny S, 2013, SCIENCE, V339, P1149, DOI 10.1126/science.339.6124.1149-a	37	42	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122605	10.1371/journal.pone.0122605	http://dx.doi.org/10.1371/journal.pone.0122605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875229	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100087
J	Koribanics, NM; Tuorto, SJ; Lopez-Chiaffarelli, N; McGuinness, LR; Haggblom, MM; Williams, KH; Long, PE; Kerkhof, LJ				Koribanics, Nicole M.; Tuorto, Steven J.; Lopez-Chiaffarelli, Nora; McGuinness, Lora R.; Haeggblom, Max M.; Williams, Kenneth H.; Long, Philip E.; Kerkhof, Lee J.			Spatial Distribution of an Uranium-Respiring Betaproteobacterium at the Rifle, CO Field Research Site	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MICROBIAL REDUCTION; SUBSURFACE SEDIMENT; U(VI) REDUCTION; SP-NOV.; BIOREMEDIATION; NITRATE; ACETATE; FE(III); GROWTH	The Department of Energy's Integrated Field-Scale Subsurface Research Challenge Site (IFRC) at Rifle, Colorado was created to address the gaps in knowledge on the mechanisms and rates of U(VI) bioreduction in alluvial sediments. Previous studies at the Rifle IFRC have linked microbial processes to uranium immobilization during acetate amendment. Several key bacteria believed to be involved in radionuclide containment have been described; however, most of the evidence implicating uranium reduction with specific microbiota has been indirect. Here, we report on the cultivation of a microorganism from the Rifle IFRC that reduces uranium and appears to utilize it as a terminal electron acceptor for respiration with acetate as electron donor. Furthermore, this bacterium constitutes a significant proportion of the subsurface sediment community prior to biostimulation based on TRFLP profiling of 16S rRNA genes. 16S rRNA gene sequence analysis indicates that the microorganism is a betaproteobacterium with a high similarity to Burkholderia fungorum. This is, to our knowledge, the first report of a betaproteobacterium capable of uranium respiration. Our results indicate that this microorganism occurs commonly in alluvial sediments located between 3-6 m below ground surface at Rifle and may play a role in the initial reduction of uranium at the site.	[Koribanics, Nicole M.; Tuorto, Steven J.; Lopez-Chiaffarelli, Nora; McGuinness, Lora R.; Kerkhof, Lee J.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Lopez-Chiaffarelli, Nora; Haeggblom, Max M.] Rutgers State Univ, Cook Coll, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Williams, Kenneth H.; Long, Philip E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kerkhof, LJ (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	lkerkhof@rutgers.edu	Williams, Kenneth Hurst/O-5181-2014; Long, Philip E/F-5728-2013; Haggblom, Max M/E-7597-2010	Williams, Kenneth Hurst/0000-0002-3568-1155; Long, Philip E/0000-0003-4152-5682; Haggblom, Max M/0000-0001-6307-7863; Kerkhof, Lee/0000-0001-9107-8695	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy [DE-AC0676RLO-1830]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	The Rifle IFC is funded by the Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy (Contract Number DE-AC0676RLO-1830; managed by the Pacific Northwest National Laboratory and Battelle Memorial Institute). Currently, the Rifle IFC is managed by the Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231 to the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SW, 2012, WORLD J MICROB BIOT, V28, P39, DOI 10.1007/s11274-011-0790-7; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Andreolli M, 2011, FEMS MICROBIOL LETT, V319, P11, DOI 10.1111/j.1574-6968.2011.02259.x; Bargar JR, 2013, P NATL ACAD SCI USA, V110, P4506, DOI 10.1073/pnas.1219198110; Blakeney MD, 2000, MICROBIOL RES, V155, P87; Boonchayaanant B, 2008, BIOTECHNOL BIOENG, V99, P1107, DOI 10.1002/bit.21670; Brooks SC, 2003, ENVIRON SCI TECHNOL, V37, P1850, DOI 10.1021/es0210042; Campbell KM, 2011, APPL GEOCHEM, V26, pS167, DOI 10.1016/j.apgeochem.2011.03.094; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chang YJ, 2005, ENVIRON SCI TECHNOL, V39, P9039, DOI 10.1021/es051218u; Chaudhary HJ, 2012, MICROB ECOL, V63, P813, DOI 10.1007/s00248-011-9978-5; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1099, DOI 10.1099/00207713-51-3-1099; Corredor Jorge E., 2004, Applied and Environmental Microbiology, V70, P5559; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Fennell DE, 2004, APPL ENVIRON MICROB, V70, P1169, DOI 10.1128/AEM.70.2.1169-1175.2004; Finneran KT, 2002, ENVIRON MICROBIOL, V4, P510, DOI 10.1046/j.1462-2920.2002.00317.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Kerkhof LJ, 2011, ENVIRON SCI TECHNOL, V45, P1250, DOI 10.1021/es102893r; Khijniak TV, 2005, APPL ENVIRON MICROB, V71, P6423, DOI 10.1128/AEM.71.10.6423-6426.2005; King GM, 2006, FEMS MICROBIOL ECOL, V56, P1, DOI 10.1111/j.1574-6941.2006.00065.x; Knight VK, 2002, GEOMICROBIOL J, V19, P77, DOI 10.1080/014904502317246183; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kotik M, 2013, SCI TOTAL ENVIRON, V454, P517, DOI 10.1016/j.scitotenv.2013.02.082; Long PE, 2015, GEOCHIM COSMOCHIM AC, V150, P106, DOI 10.1016/j.gca.2014.11.013; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850, DOI 10.1128/AEM.58.3.850-856.1992; McGuinness LM, 2006, ENVIRON SCI TECHNOL, V40, P509, DOI 10.1021/es050900l; Moon HS, 2010, WATER RES, V44, P4015, DOI 10.1016/j.watres.2010.05.003; Moreels D, 2008, ENVIRON SCI POLLUT R, V15, P481, DOI 10.1007/s11356-008-0034-z; Mueller JG, 1997, ANTON LEEUW INT J G, V71, P329, DOI 10.1023/A:1000277008064; Nevin KP, 2005, INT J SYST EVOL MICR, V55, P1667, DOI 10.1099/ijs.0.63417-0; Newsome L, 2014, CHEM GEOL, V363, P164, DOI 10.1016/j.chemgeo.2013.10.034; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Peacock AD, 2004, MICROBIAL ECOL, V47, P284, DOI 10.1007/s00248-003-1024-9; Plangklang P, 2013, CHEM ECOL, V29, P44, DOI 10.1080/02757540.2012.686609; Prakash O, 2010, INT J SYST EVOL MICR, V60, P546, DOI 10.1099/ijs.0.010843-0; Qafoku NP, 2014, APPL GEOCHEM, V42, P77, DOI 10.1016/j.apgeochem.2013.12.001; Sakano Y, 1998, APPL ENVIRON MICROB, V64, P4877; Sanford RA, 2007, ENVIRON MICROBIOL, V9, P2885, DOI 10.1111/j.1462-2920.2007.01405.x; Senko JM, 2002, ENVIRON SCI TECHNOL, V36, P1491, DOI 10.1021/es011240x; Shelobolina ES, 2008, INT J SYST EVOL MICR, V58, P1075, DOI 10.1099/ijs.0.65377-0; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Smith WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062423; Spear JR, 2000, APPL ENVIRON MICROB, V66, P3711, DOI 10.1128/AEM.66.9.3711-3721.2000; Tanase AM, 2013, INT BIODETER BIODEGR, V84, P150, DOI 10.1016/j.ibiod.2012.05.022; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; Vishnivetskaya TA, 2010, APPL ENVIRON MICROB, V76, P5728, DOI 10.1128/AEM.00308-10; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Wang JL, 2001, CHEMOSPHERE, V44, P1041, DOI 10.1016/S0045-6535(00)00469-0; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Williams KH, 2010, ENVIRON SCI TECHNOL, V44, P47, DOI 10.1021/es9017464	56	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123378	10.1371/journal.pone.0123378	http://dx.doi.org/10.1371/journal.pone.0123378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874721	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100168
J	Liu, CC; Hsieh, HM; Wu, CF; Hsieh, TJ; Huang, SP; Chou, YH; Huang, CN; Wu, WJ; Wu, MT				Liu, Chia-Chu; Hsieh, Hui-Min; Wu, Chia-Fang; Hsieh, Tusty-Jiuan; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng; Wu, Ming-Tsang			Long-Term Prescription of a-Blockers Decrease the Risk of Recurrent Urolithiasis Needed for Surgical Intervention-A Nationwide Population-Based Study	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; STONE CLEARANCE; RENAL STONES; SUBTYPES; NEPHROLITHIASIS; TAMSULOSIN; UPDATE	Purpose a1 receptors and subtypes have been confirmed to distribute in human pelvis and calyces recently. As used in ureteral stones, a-blocker treatment may facilitate kidney stone passage and long-term prescription of a-blocker may decrease the risk of recurrent urolithiasis. The aim of this study is to determine if use of a-blockers 180 days or more can decrease the risk of recurrent urolithiasis needed for surgical intervention. Materials and Methods A representative database of 1,000,000 patients from Taiwan's National Health Insurance was analyzed. Eligible patients were those who had received the first-time procedure for upper urinary stone removal, including extracorporeal shock-wave lithotripsy, ureterorenoscopic lithotripsy, or both, between 2000 and 2010. After completing a 180-day treatment for first event, patients were prospectively followed-up until a second set of stone procedures was performed (proxy of stone recurrence), loss to follow-up, or end of study. The effect of percentage of total number of days of a-blocker use on need for second set of stone procedures within a post treatment 180-day follow-up period was analyzed by quartile. A nested case-control study was also performed. Results 1,259 patients were eligible for final analyses. During 3,980 person-years follow-up, 167 patients had recurrent urolithiasis needed for surgical intervention. From first to fourth quartile of drug exposure, recurrence rates were 45.64, 47.19, 43.11, and 18.52 per 1,000 person-years. The adjusted hazard ratio was 0.46 (95% CI = 0.24 to 0.89) for the fourth quartile (vs. quartile 1). In the nested case-control study, adjusted ORs was 0.23 (95% CI = 0.10 to 0.53) in the fourth quartile (vs. quartile 1). The results remained similar even in patients categorized by cumulative defined daily dose (cDDD) quartiles and average cDDD per day quartiles. Conclusion Use of a-blockers for 180 days or more decrease the risk of recurrent urolithiasis needed for surgical intervention. In patients at higher risk of recurrent urolithiasis, long term prescription of a-blockers might help them prevent further surgical intervention.	[Liu, Chia-Chu; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng] Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan; [Liu, Chia-Chu; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Liu, Chia-Chu] Pingtung Hosp, Dept Urol, Minist Hlth & Welf, Execut Yuan, Pingtung, Taiwan; [Hsieh, Hui-Min; Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw	LIU, CHIA CHU/T-2880-2019; Wu, Ming-Tsang/G-5637-2012	Wu, Ming-Tsang/0000-0001-7307-7816; wu, wen jeng/0000-0002-9691-7416; Hsieh, Tusty-Jiuan/0000-0001-5387-6522	Kaohsiung Medical University [KMU-DT103004]; Kaohsiung Medical University Hospital [KMUH101-1I04, KMUH102-2R58, KMUH102-2M40, KMUH103-3R44]; National Science Council [NSC 101-2314-B-037-037-MY3]; Ministry of Science and Technology [MOST 103-2314-B-037-066-MY2]; Taiwan's National Health Research Institutes [NHRI-EX102-10209PI]	Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan's National Health Research Institutes	This work was supported by Kaohsiung Medical University (KMU-DT103004), Kaohsiung Medical University Hospital (KMUH101-1I04; KMUH102-2R58; KMUH102-2M40; KMUH103-3R44), the National Science Council (NSC 101-2314-B-037-037-MY3), Ministry of Science and Technology (MOST 103-2314-B-037-066-MY2), and Taiwan's National Health Research Institutes (NHRI-EX102-10209PI), none of which had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, THE INTERNATIONAL CL; Brown J, 2006, INT UROL NEPHROL, V38, P87, DOI 10.1007/s11255-005-3622-6; Cupisti A, 2011, J NEPHROL, V24, pS25, DOI 10.5301/JN.2011.7766; Heran BS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004643.pub3; Huang CY, 2009, UROL INT, V83, P410, DOI 10.1159/000251180; Hussein MM, 2010, SCAND J UROL NEPHROL, V44, P27, DOI 10.3109/00365590903359916; John TT, 2010, UROLOGY, V75, P1040, DOI 10.1016/j.urology.2009.07.1257; Karabacak OR, 2013, UROLITHIASIS, V41, P385, DOI 10.1007/s00240-013-0592-5; Lee YH, 2006, UROLOGY, V67, P480, DOI 10.1016/j.urology.2005.09.067; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006; Milani S, 2005, BJU INT, V95, P29, DOI 10.1111/j.1464-410X.2005.05485.x; Moe OW, 2011, KIDNEY INT, V79, P385, DOI 10.1038/ki.2010.389; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; MORITA T, 1987, TOHOKU J EXP MED, V152, P111, DOI 10.1620/tjem.152.111; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Romero Victoriano, 2010, Rev Urol, V12, pe86; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Sigala S, 2005, NEUROUROL URODYNAM, V24, P142, DOI 10.1002/nau.20097; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Tomiyama Y, 2007, EUR J PHARMACOL, V573, P201, DOI 10.1016/j.ejphar.2007.06.056; Vicentini FC, 2011, UROLOGY, V78, P1016, DOI 10.1016/j.urology.2011.04.062; WHO, 2003, WHO COLLABORATING CE; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; Zhu YF, 2010, BJU INT, V106, P256, DOI 10.1111/j.1464-410X.2009.09014.x	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122494	10.1371/journal.pone.0122494	http://dx.doi.org/10.1371/journal.pone.0122494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875226	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100077
J	de Paz, AM; Sanchez-Mut, JV; Samitier-Marti, M; Petazzi, P; Saez, M; Szczesna, K; Huertas, D; Esteller, M; Ausio, J				Martinez de Paz, Alexia; Vicente Sanchez-Mut, Jose; Samitier-Marti, Mireia; Petazzi, Paolo; Saez, Mauricio; Szczesna, Karolina; Huertas, Dori; Esteller, Manel; Ausio, Juan			Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes	PLOS ONE			English	Article							BINDING-PROTEIN 2; BDNF TRANSCRIPTION; MOUSE-BRAIN; CLOCK; EXPRESSION; SLEEP; PHOSPHORYLATION; DISEASE; ACETYLATION; PATTERNS	Methyl CpG binding protein 2 (MeCP2) is a chromosomal protein of the brain, very abundant especially in neurons, where it plays an important role in the regulation of gene expression. Hence it has the potential to be affected by the mammalian circadian cycle. We performed expression analyses of mice brain frontal cortices obtained at different time points and we found that the levels of MeCP2 are altered circadianly, affecting overall organization of brain chromatin and resulting in a circadian-dependent regulation of well-stablished MeCP2 target genes. Furthermore, this data suggests that alterations of MeCP2 can be responsible for the sleeping disorders arising from pathological stages, such as in autism and Rett syndrome.	[Martinez de Paz, Alexia; Vicente Sanchez-Mut, Jose; Samitier-Marti, Mireia; Petazzi, Paolo; Saez, Mauricio; Szczesna, Karolina; Huertas, Dori; Esteller, Manel; Ausio, Juan] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain; [Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; University of Victoria	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain.	emesteller@idibell.cat; jausio@uvic.ca	Petazzi, Paolo/H-7707-2013; Esteller, Manel/L-5956-2014; Saez, Mauricio/AAN-6750-2021; Sanchez-Mut, Jose V./A-8651-2019	Esteller, Manel/0000-0003-4490-6093; Sanchez-Mut, Jose V./0000-0002-9292-8521; Martinez de Paz, Alexia/0000-0003-0808-1389; Saez Venegas, Mauricio Alejandro/0000-0002-3355-7628; Petazzi, Paolo/0000-0002-1036-2895; Samitier Marti, Mireia/0000-0002-3771-7991	European Community [PITN-GA2009-238242]; European Research Council [268626]; E-RARE EuroRETT network (Carlos III Health Institute) [PI071327]; Foundation Lejeune; MINECO [SAF2011 22803]; Catalan Association of Rett Syndrome; Health and Science Department of the Catalan Government (Generalitat de Catalunya); Canadian Institutes of Health Research (CIHR) [MOP-97878]; Catalan Institution for Research and Advanced Studies; ICREA Funding Source: Custom	European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); E-RARE EuroRETT network (Carlos III Health Institute); Foundation Lejeune; MINECO(Spanish Government); Catalan Association of Rett Syndrome; Health and Science Department of the Catalan Government (Generalitat de Catalunya); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Catalan Institution for Research and Advanced Studies(ICREA); ICREA(ICREA)	Funding was provided by the European Community's Seven Framework Programme (FP7/2007-2013) under grant agreement no PITN-GA2009-238242 DISCHROM project and by the European Research Council under grant agreement no. 268626 EPINORC project, E-RARE EuroRETT network (Carlos III Health Institute Project no PI071327), the Foundation Lejeune, MINECO Project no SAF2011 22803, the Catalan Association of Rett Syndrome, and the Health and Science Department of the Catalan Government (Generalitat de Catalunya) (M.E.). Canadian Institutes of Health Research (CIHR) [MOP-97878] grant (J.A.). M.E. is supported as a Catalan Institution for Research and Advanced Studies Research Professor.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Albrecht A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084668; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Ausio J, 2014, TRENDS MOL MED; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; de Leon-Guerrero SD, 2011, EUR J NEUROSCI, V33, P1563, DOI 10.1111/j.1460-9568.2011.07658.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2014, NAT STRUCT MOL BIOL, V21, P126, DOI 10.1038/nsmb.2746; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Ko Y, 2013, P NATL ACAD SCI USA, V110, P3095, DOI 10.1073/pnas.1222897110; Lim ASP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004792; Malow BA, 2012, PEDIATRICS, V130, pS106, DOI 10.1542/peds.2012-0900I; Martin-Fairey CA, 2014, BRAIN RES; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Muller D, 2014, SCIENCE, V343, P1264, DOI 10.1126/science.1246448; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nomura Y, 2005, BRAIN DEV-JPN, V27, pS35, DOI 10.1016/j.braindev.2005.03.017; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stengel A, 2013, PEPTIDES, V42, P70, DOI 10.1016/j.peptides.2012.12.022; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Wither RG, 2013, EXP NEUROL, V239, P49, DOI 10.1016/j.expneurol.2012.09.005; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Young D, 2007, BRAIN DEV-JPN, V29, P609, DOI 10.1016/j.braindev.2007.04.001; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123693	10.1371/journal.pone.0123693	http://dx.doi.org/10.1371/journal.pone.0123693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875630	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100199
J	Nathan, G; Kredo-Russo, S; Geiger, T; Lenz, A; Kaspi, H; Hornstein, E; Efrat, S				Nathan, Gili; Kredo-Russo, Sharon; Geiger, Tamar; Lenz, Ayelet; Kaspi, Haggai; Hornstein, Eran; Efrat, Shimon			MiR-375 Promotes Redifferentiation of Adult Human beta Cells Expanded In Vitro	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; INSULIN; PROTEIN; PHOSPHORYLATION; GLUCOSE; PROLIFERATION; STABILITY; ABLATION	In-vitro expansion of beta cells from adult human pancreatic islets could provide abundant cells for cell replacement therapy of diabetes. However, proliferation of beta-cell-derived (BCD) cells is associated with dedifferentiation. Here we analyzed changes inmicroRNAs (miRNAs) during BCD cell dedifferentiation and identified miR-375 as one of the miRNAs greatly downregulated. We hypothesized that restoration of miR-375 expression in expanded BCD cells may contribute to their redifferentiation. Our findings demonstrate that overexpression of miR-375 alone leads to activation of beta-cell gene expression, reduced cell proliferation, and a switch from N-cadherin to E-cadherin expression, which characterizes mesenchymal-epithelial transition. These effects, which are reproducible in cells derived from multiple human donors, are likely mediated by repression of PDPK1 transcripts and indirect downregulation of GSK3 activity. These findings support an important role of miR-375 in regulation of human beta-cell phenotype, and suggest that miR-375 upregulation may facilitate the generation of functional insulin-producing cells following ex-vivo expansion of human islet cells.	[Nathan, Gili; Geiger, Tamar; Lenz, Ayelet; Efrat, Shimon] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Kredo-Russo, Sharon; Kaspi, Haggai; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Efrat, S (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X; Geiger, Tamar/0000-0002-9526-197X	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was funded by a grant from the Israel Science Foundation to SE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hong S, 2014, NEOPLASIA, V16, P279, DOI 10.1016/j.neo.2014.03.010; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kredo-Russo S, 2012, DEVELOPMENT, V139, P3021, DOI 10.1242/dev.080127; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Patel S, 2008, CANCER CELL, V14, P351, DOI 10.1016/j.ccr.2008.10.013; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519	38	46	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122108	10.1371/journal.pone.0122108	http://dx.doi.org/10.1371/journal.pone.0122108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875172	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100058
J	Wang, L; Zhang, Y; Asakawa, T; Li, W; Han, S; Li, QY; Xiao, BG; Namba, H; Lu, CZ; Dong, Q				Wang, Liang; Zhang, Yang; Asakawa, Tetsuya; Li, Wei; Han, Sha; Li, Qinying; Xiao, Baoguo; Namba, Hiroki; Lu, Chuanzhen; Dong, Qiang			Neuroprotective Effect of Neuroserpin in Oxygen-Glucose Deprivation- and Reoxygenation-Treated Rat Astrocytes In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; TISSUE-PLASMINOGEN ACTIVATOR; PROTECTS NEURONS; INHIBITOR NEUROSERPIN; DUAL ROLE; APOPTOSIS; INFLAMMATION; EXPRESSION; PATHWAY; DYSFUNCTION	Neuroserpin (NSP) reportedly exerts neuroprotective effects in cerebral ischemic animal models and patients; however, the mechanism of protection is poorly understood. We thus attempted to confirm neuroprotective effects of NSP on astrocytes in the ischemic state and then explored the relative mechanisms. Astrocytes from neonatal rats were treated with oxygen-glucose deprivation (OGD) followed by reoxygenation (OGD/R). To confirm the neuroprotective effects of NSP, we measured the cell survival rate, relative lactate dehydrogenase (LDH) release; we also performed morphological methods, namely Hoechst 33342 staining and Annexin V assay. To explore the potential mechanisms of NSP, the release of nitric oxide (NO) and TNF-alpha related to NSP administration were measured by enzymelinked immunosorbent assay. The proteins related to the NF-kappa B, ERK1/2, and PI3K/Akt pathways were investigated by Western blotting. To verify the cause-and-effect relationship between neuroprotection and the NF-kappa B pathway, a NF-kappa B pathway inhibitor sc3060 was employed to observe the effects of NSP-induced neuroprotection. We found that NSP significantly increased the cell survival rate and reduced LDH release in OGD/R-treated astrocytes. It also reduced NO/TNF-alpha release. Western blotting showed that the protein levels of p-IKKB alpha/beta and P65 were upregulated by the OGD/R treatment and such effects were significantly inhibited by NSP administration. The NSP-induced inhibition could be significantly reversed by administration of the NF-kappa B pathway inhibitor sc3060, whereas, expressions of p-ERK1, p-ERK2, and p-AKT were upregulated by the OGD/R treatment; however, their levels were unchanged by NSP administration. Our results thus verified the neuroprotective effects of NSP in ischemic astrocytes. The potential mechanisms include inhibition of the release of NO/TNF-alpha and repression of the NF-kappa B signaling pathways. Our data also indicated that NSP has little influence on the MAPK and PI3K/Akt pathways.	[Wang, Liang; Zhang, Yang; Han, Sha; Lu, Chuanzhen; Dong, Qiang] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Liang; Li, Qinying; Xiao, Baoguo; Lu, Chuanzhen; Dong, Qiang] Fudan Univ, Inst Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Zhang, Yang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Asakawa, Tetsuya; Namba, Hiroki] Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan; [Asakawa, Tetsuya] Hamamatsu Univ, Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4312102, Japan; [Li, Wei] Fudan Univ, Dept Neurol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nanjing University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Fudan University	Wang, L (corresponding author), Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China.	ianliangwang@yahoo.com; asakawat1971@gmail.com	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	Science and Technology Commission of Shanghai Municipality [13441902600]; Clinical Medical Research Grant of Chinese medical Association [09010180173]; Japan Society for the Promotion of Science [20791025, 24592157]; Grants-in-Aid for Scientific Research [24592157] Funding Source: KAKEN	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Clinical Medical Research Grant of Chinese medical Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	LW was supported by the Grant from Science and Technology Commission of Shanghai Municipality (No. 13441902600) and Clinical Medical Research Grant of Chinese medical Association (No. 09010180173). TA was supported by grants from the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists, Type B, No. 20791025 and Grant-in-Aid for Scientific Research C, General, No. 24592157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Docagne F, 1999, FASEB J, V13, P1315, DOI 10.1096/fasebj.13.11.1315; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P385, DOI 10.1016/S0161-813X(02)00084-0; Gelderblom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063118; Gouix E, 2014, PHARMACOL RES, V87, P8, DOI 10.1016/j.phrs.2014.06.002; Graham LS, 2009, CLIN IMMUNOL, V133, P265, DOI 10.1016/j.clim.2009.07.011; Hanzel CE, 2014, J ALZHEIMERS DIS, V40, P667, DOI 10.3233/JAD-132282; Jiang ZJ, 2003, NEUROCHEM RES, V28, P831, DOI 10.1023/A:1023206906164; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lasierra-Cirujeda J, 2013, J BLOOD MED, V4, P31, DOI 10.2147/JBM.S35496; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lebeurrier N, 2005, MOL CELL NEUROSCI, V30, P552, DOI 10.1016/j.mcn.2005.09.005; Lebeurrier N, 2008, J CELL SCI, V121, P3357, DOI 10.1242/jcs.031872; Lee TW, 2012, J NEUROCHEM, V121, P561, DOI 10.1111/j.1471-4159.2011.07639.x; Ma J, 2012, BIOL RES, V45, P357, DOI 10.4067/S0716-97602012000400005; Man HY, 2012, J NEUROCHEM, V121, P495, DOI 10.1111/j.1471-4159.2012.07655.x; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Navarrete M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00033; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Noto R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032444; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Rodriguez-Gonzalez R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-58; Rodriguez-Gonzalez R, 2011, THROMB HAEMOSTASIS, V105, P421, DOI 10.1160/TH10-09-0621; Rodriguez-Gonzalez R, 2011, NEUROCHEM INT, V58, P337, DOI 10.1016/j.neuint.2010.12.006; Rogove AD, 1999, J CELL SCI, V112, P4007; Tung WH, 2010, J CELL PHYSIOL, V224, P376, DOI 10.1002/jcp.22133; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wan SC, 2012, CLIN LAB, V58, P891, DOI 10.7754/Clin.Lab.2011.110527; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Wang L, 2004, BRAIN RES, V1015, P175, DOI 10.1016/j.brainres.2004.04.053; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yepes M, 2000, BLOOD, V96, P569; Zhang AL, 2010, NEUROSCI LETT, V478, P32, DOI 10.1016/j.neulet.2010.04.062; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036	40	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123932	10.1371/journal.pone.0123932	http://dx.doi.org/10.1371/journal.pone.0123932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874935	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100225
J	Welinder, C; Pawlowski, K; Sugihara, Y; Yakovleva, M; Jonsson, G; Ingvar, C; Lundgren, L; Baldetorp, B; Olsson, H; Rezeli, M; Jansson, B; Laurell, T; Fehniger, T; Dome, B; Malm, J; Wieslander, E; Nishimura, T; Marko-Varga, G				Welinder, Charlotte; Pawlowski, Krzysztof; Sugihara, Yutaka; Yakovleva, Maria; Jonsson, Goran; Ingvar, Christian; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Rezeli, Melinda; Jansson, Bo; Laurell, Thomas; Fehniger, Thomas; Dome, Balazs; Malm, Johan; Wieslander, Elisabet; Nishimura, Toshihide; Marko-Varga, Gyorgy			A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; EXPRESSION; IDENTIFICATION; CLASSIFICATION; RESISTANCE; PROTEOMICS; PEPTIDES; DEPTH	Malignant melanoma has the highest increase of incidence of malignancies in the western world. In early stages, front line therapy is surgical excision of the primary tumor. Metastatic disease has very limited possibilities for cure. Recently, several protein kinase inhibitors and immune modifiers have shown promising clinical results but drug resistance in metastasized melanoma remains a major problem. The need for routine clinical biomarkers to follow disease progression and treatment efficacy is high. The aim of the present study was to build a protein sequence database in metastatic melanoma, searching for novel, relevant biomarkers. Ten lymph node metastases (South-Swedish Malignant Melanoma Biobank) were subjected to global protein expression analysis using two proteomics approaches (with/without orthogonal fractionation). Fractionation produced higher numbers of protein identifications (4284). Combining both methods, 5326 unique proteins were identified (2641 proteins overlapping). Deep mining proteomics may contribute to the discovery of novel biomarkers for metastatic melanoma, for example dividing the samples into two metastatic melanoma "genomic subtypes", ("pigmentation" and "high immune") revealed several proteins showing differential levels of expression. In conclusion, the present study provides an initial version of a metastatic melanoma protein sequence database producing a total of more than 5000 unique protein identifications. The raw data have been deposited to the ProteomeXchange with identifiers PXD001724 and PXD001725.	[Welinder, Charlotte; Sugihara, Yutaka; Jonsson, Goran; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Jansson, Bo; Fehniger, Thomas; Wieslander, Elisabet; Nishimura, Toshihide; Marko-Varga, Gyorgy] Lund Univ, Dept Clin Sci, Oncol & Pathol, Lund, Sweden; [Welinder, Charlotte; Laurell, Thomas; Fehniger, Thomas; Nishimura, Toshihide; Marko-Varga, Gyorgy] Lund Univ, CEBMMS, Biomed Ctr D13, Lund, Sweden; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland; [Yakovleva, Maria; Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Yakovleva, Maria; Rezeli, Melinda; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Biomed Ctr, Dept Biomed Engn, Clin Prot Sci & Imaging, Lund, Sweden; [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Surg, Lund, Sweden; [Lundgren, Lotta; Olsson, Hakan] Skane Univ Hosp, Lund, Sweden; [Olsson, Hakan] Lund Univ, Dept Clin Sci, Canc Epidemiol, Lund, Sweden; [Dome, Balazs] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Malm, Johan] Lund Univ, Skane Univ Hosp Malmo, Dept Lab Med, Sect Clin Chem, Malmo, Sweden; [Nishimura, Toshihide; Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Tokyo 1608402, Japan	Lund University; Lund University; Warsaw University of Life Sciences; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Medical University of Vienna; Lund University; Skane University Hospital; Tokyo Medical University	Marko-Varga, G (corresponding author), Lund Univ, CEBMMS, Biomed Ctr D13, Lund, Sweden.	Gyorgy.Marko-Varga@bme.lth.se	Baldetorp, Bo/HDM-9924-2022; Laurell, Thomas/B-5524-2013; Ingvar, Christian/AAE-9841-2019; Welinder, Charlotte/G-1144-2014; Pawłowski, Krzysztof/C-2949-2013	Laurell, Thomas/0000-0002-2486-3607; Welinder, Charlotte/0000-0001-9626-0576; Pawłowski, Krzysztof/0000-0002-5367-0935; Olsson, Hakan/0000-0002-8794-9635; Dome, Balazs/0000-0001-8799-8624	Mrs. Berta Kamprad Foundation; Swedish Academy of Pharmaceutical Sciences; Swedish Research Council; Swedish Foundation for Strategic Research; Vinnova; Crafoord Foundation; European Research Council [ERC-2011-294576]; Ingabritt & Arne Lundbergs forskningsstiftelse	Mrs. Berta Kamprad Foundation; Swedish Academy of Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Vinnova(Vinnova); Crafoord Foundation; European Research Council(European Research Council (ERC)European Commission); Ingabritt & Arne Lundbergs forskningsstiftelse	This work was supported by grants from Mrs. Berta Kamprad Foundation, Swedish Academy of Pharmaceutical Sciences, Swedish Research Council, the Swedish Foundation for Strategic Research, Vinnova, Ingabritt & Arne Lundbergs forskningsstiftelse, the Crafoord Foundation and European Research Council Advanced Grant ERC-2011-294576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Avwioro G, 2011, J PHARMACY AND CLINI, V1; Azimi A, 2014, BRIT J CANCER, V110, P2489, DOI 10.1038/bjc.2014.169; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baldetorp B., 2013, PUBLIC SERVICE REVIE; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Byrum Stephanie D, 2013, J Proteomics Bioinform, V6, P43; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cirenajwis H, 2015, MOLECULAR STRATIFICA; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Harbst K, 2014, J PATHOL, V233, P39, DOI 10.1002/path.4318; Harbst K, 2012, CLIN CANCER RES, V18, P4026, DOI 10.1158/1078-0432.CCR-12-0343; Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Levine D, 2014, METHODS MOL BIOL, V1102, P177, DOI 10.1007/978-1-62703-727-3_11; Lillie RD, 1965, HISTOPATHOLOGIC TECH; Machtejevas E, 2004, J CHROMATOGR B, V803, P121, DOI 10.1016/j.jchromb.2003.07.015; Machtejevas E, 2009, J SEP SCI, V32, P2223, DOI 10.1002/jssc.200900058; Mactier S, 2014, PIGMENT MELANOMA RES; Matsuo Y, 2010, PMID, V5, DOI [10.1371/journal.pone.0010481, DOI 10.1371/J0URNAL.P0NE.0010481]; Nading MA, 2010, SEMIN CUTAN MED SURG, V29, P142, DOI 10.1016/j.sder.2010.06.004; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Sabel Michael S, 2011, Int J Proteomics, V2011, P181890, DOI 10.1155/2011/181890; Srinivas PR, 2001, CLIN CHEM, V47, P1901; Sugihara Y, 2014, PROTEOMICS, V14, P1963, DOI 10.1002/pmic.201300476; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner K, 2002, ANAL CHEM, V74, P809, DOI 10.1021/ac010627f; Welinder C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110804; Welinder C, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-7; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zarei M, 2012, J PROTEOME RES, V11, P4269, DOI 10.1021/pr300375d	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123661	10.1371/journal.pone.0123661	http://dx.doi.org/10.1371/journal.pone.0123661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874936	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100196
J	Yan, HF; Liu, YJ; Xie, XF; Zhang, CY; Hu, CM; Hao, G; Ge, XJ				Yan, Hai-Fei; Liu, Yun-Jiao; Xie, Xiu-Feng; Zhang, Cai-Yun; Hu, Chi-Ming; Hao, Gang; Ge, Xue-Jun			DNA Barcoding Evaluation and Its Taxonomic Implications in the Species-Rich Genus Primula L. in China	PLOS ONE			English	Article							HYBRID ORIGIN; IDENTIFICATION; YUNNAN; HYBRIDIZATION; FAILURE; SPACER; PLANTS; LOCI	The genus Primula is extremely diverse in the east Himalaya-Hengduan Mountains (HHM) in China as a result of rapid radiation. In order to overcome the difficulty of morphological classification of this genus, we surveyed three plastid regions (rbcL, matK, and trnH-psbA) and two nuclear markers (ITS and ITS2) from 227 accessions representing 66 Primula species across 18 sections, to assess their discriminatory power as barcodes. We found that ITS alone or combined with plastid regions showed the best discrimination across different infrageneric ranks and at species level. We suggest rbcL + matK + ITS as the first choice at present to barcode Primula plants. Although the present barcoding combination performed poorly in many closely related species of Primula, it still provided many new insights into current Primula taxonomy, such as the underlying presence of cryptic species, and several potential improper taxonomic treatments. DNA barcoding is one useful technique in the integrative taxonomy of the genus Primula, but it still requires further efforts to improve its effectiveness in some taxonomically challenging groups.	[Yan, Hai-Fei; Hu, Chi-Ming; Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Liu, Yun-Jiao; Zhang, Cai-Yun; Hao, Gang] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Xie, Xiu-Feng] Guangdong Agr Ind Business Polytech Coll, Trop Agr Dept, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; South China Agricultural University	Hao, G (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn; xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475	National Natural Science Foundation of China [31270009, 31170205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (grant nos. 31270009, 31170205) [http://www.nsfc.gov.cn/].	Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Cianchi R, 2015, PLANT BIOSYST, V149, P229, DOI 10.1080/11263504.2013.826745; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gong X, 2003, NOVON, V13, P193, DOI 10.2307/3393517; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hu C. M., 2011, Edinburgh Journal of Botany, V68, P297, DOI 10.1017/S096042861100014X; HU CM, 1990, NORD J BOT, V10, P399, DOI 10.1111/j.1756-1051.1990.tb01779.x; Hu CM, 1996, PRIMULACEAE; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, PRIMULACEAE; Huang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082400, 10.1371/journal.pone.0068688]; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019874; Kane NC, 2008, MOL ECOL, V17, P5175, DOI 10.1111/j.1365-294X.2008.03972.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li R, 2009, ANN BOT FENN, V46, P130, DOI 10.5735/085.046.0208; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu BB, 2014, MOL ECOL, V23, P3013, DOI 10.1111/mec.12783; Ma YP, 2014, ANN BOT-LONDON, V113, P763, DOI 10.1093/aob/mct312; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Ming HC, 2003, NOVON, V13, P196, DOI 10.2307/3393518; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Rambaut A, 2002, SE AL VERSION2 0A11; Richards J, 2003, PRIMULA; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Saitoh T, 2015, MOL ECOL RESOUR, V15, P177, DOI 10.1111/1755-0998.12282; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Smith WW, 1977, PLANT MONOGRAPH REPR; Smith WW, 1942, GENUS PRIMULA SECTIO, P227; Smith WW, 1941, GENUS PRIMULA SECTIO, P122; Sun YS, 2014, MOL ECOL, V23, P343, DOI 10.1111/mec.12599; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Trift I, 2002, SYST BOT, V27, P396; Twyford AD, 2014, MOL ECOL, V23, P4674, DOI 10.1111/mec.12892; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu X, 2013, PHYTOTAXA, V131, P49, DOI 10.11646/phytotaxa.131.1.9; Xie XF, 2012, J SYST EVOL, V50, P284, DOI 10.1111/j.1759-6831.2012.00204.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhu XF, 2009, ACTA BIOL CRACOV BOT, V51, P29	75	30	33	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122903	10.1371/journal.pone.0122903	http://dx.doi.org/10.1371/journal.pone.0122903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875620	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100116
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Induced Sporicidal Activity of Chlorhexidine against Clostridium difficile Spores under Altered Physical and Chemical Conditions	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTIONS; WORKERS HANDS; GLUCONATE; RESISTANCE; ENVIRONMENT; REDUCE; UNIT	Background Chlorhexidine is a broad-spectrum antimicrobial commonly used to disinfect the skin of patients to reduce the risk of healthcare-associated infections. Because chlorhexidine is not sporicidal, it is not anticipated that it would have an impact on skin contamination with Clostridium difficile, the most important cause of healthcare-associated diarrhea. However, although chlorhexidine is not sporicidal as it is used in healthcare settings, it has been reported to kill spores of Bacillus species under altered physical and chemical conditions that disrupt the spore's protective barriers (e.g., heat, ultrasonication, alcohol, or elevated pH). Here, we tested the hypothesis that similarly altered physical and chemical conditions result in enhanced sporicidal activity of chlorhexidine against C. difficile spores. Principal Findings C. difficile spores became susceptible to heat killing at 80 degrees C within 15 minutes in the presence of chlorhexidine, as opposed to spores suspended in water which remained viable. The extent to which the spores were reduced was directly proportional to the concentration of chlorhexidine in solution, with no viable spores recovered after 15 minutes of incubation in 0.04%-0.0004% w/v chlorhexidine solutions at 80 degrees C. Reduction of spores exposed to 4% w/v chlorhexidine solutions at moderate temperatures (37 degrees C and 55 degrees C) was enhanced by the presence of 70% ethanol. However, complete elimination of spores was not achieved until 3 hours of incubation at 55 degrees C. Elevating the pH to >= 9.5 significantly enhanced the killing of spores in either aqueous or alcoholic chlorhexidine solutions. Conclusions Physical and chemical conditions that alter the protective barriers of C. difficile spores convey sporicidal activity to chlorhexidine. Further studies are necessary to identify additional agents that may allow chlorhexidine to reach its target within the spore.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.	michellenerandzi@aim.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review grant from the Department of Veterans Affairs to CJD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 2008, E105408 AM SOC TEST; Beausoleil CM, 2012, J HOSP INFECT, V81, P283, DOI 10.1016/j.jhin.2012.05.003; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; DAVIES GE, 1954, BRIT J PHARM CHEMOTH, V9, P192, DOI 10.1111/j.1476-5381.1954.tb00840.x; Denton GW, 2001, DISINFECTION STERILI, P321; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P240, DOI 10.1001/archsurg.2010.5; Gardner JF, 1983, DISINFECTION STERILI, P251; GORMAN SP, 1990, INT J PHARM, V65, P127, DOI 10.1016/0378-5173(90)90017-X; GORMAN SP, 1987, J APPL BACTERIOL, V63, P183, DOI 10.1111/j.1365-2672.1987.tb02701.x; Gorman SP, 1987, J APPL BACTERIOL, V63, P193; HUGO WB, 1964, J PHARM PHARMACOL, V16, P655, DOI 10.1111/j.2042-7158.1964.tb07384.x; JONES DS, 1995, INT J PHARM, V119, P247, DOI 10.1016/0378-5173(94)00409-X; Jury LA, 2011, INFECT CONT HOSP EP, V32, P181, DOI 10.1086/657911; Landelle C, 2014, INFECT CONT HOSP EP, V35, P10, DOI 10.1086/674396; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MACHEBOEUF M, 1953, B SOC CHIM BIOL, V35, P399; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Nishihara Y, 2012, J INFUS MURS, V35, P44, DOI 10.1097/NAN.0b013e31823d79ba; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Pop-Vicas A, 2014, INFECT CONT HOSP EP, V35, P16, DOI 10.1086/674397; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Rodriguez-Palacios A, 2011, APPL ENVIRON MICROB, V77, P3085, DOI 10.1128/AEM.01589-10; Rupp ME, 2012, INFECT CONT HOSP EP, V33, P1094, DOI 10.1086/668024; RUSSELL AD, 1986, INFECTION, V14, P212, DOI 10.1007/BF01644264; SCHINDLER PRG, 1978, J BACTERIOL, V135, P198, DOI 10.1128/JB.135.1.198-206.1978; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123809	10.1371/journal.pone.0123809	http://dx.doi.org/10.1371/journal.pone.0123809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861057	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300115
J	Long, NM; Rule, DC; Tuersunjiang, N; Nathanielsz, PW; Ford, SP				Long, Nathan M.; Rule, Daniel C.; Tuersunjiang, Nuermaimaiti; Nathanielsz, Peter W.; Ford, Stephen P.			Maternal Obesity in Sheep Increases Fatty Acid Synthesis, Upregulates Nutrient Transporters, and Increases Adiposity in Adult Male Offspring after a Feeding Challenge	PLOS ONE			English	Article							DIET-INDUCED OBESITY; NERVOUS-SYSTEM CONTROL; INSULIN-RESISTANCE; LEPTIN RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; GENE-EXPRESSION; ALTERED GROWTH; ADIPOCYTE SIZE	Maternal obesity in women is increasing worldwide. The objective of this study was to evaluate differences in adipose tissue metabolism and function in adult male offspring from obese and control fed mothers subjected to an ad libitum feeding challenge. We developed a model in which obese ewes were fed 150% of feed provided for controls from 60 days before mating to term. All ewes were fed to requirements during lactation. After weaning, F1 male offspring were fed only to maintenance requirements until adulthood (control = 7, obese = 6), when they were fed ad libitum for 12 weeks with intake monitored. At the end of the feeding challenge offspring were given an intravenous glucose tolerance test (IVGTT), necropsied, and adipose tissue collected. During the feeding trial F1obese males consumed more (P < 0.01), gained more weight (P < 0.01) and became heavier (P < 0.05) than F1control males. During IVGTT, Obese F1 offspring were hyperglycemic and hypoinsulinemic (P < 0.01) compared to F1 control F1. At necropsy perirenal and omental adipose depots weights were 47% and 58% greater respectively and subcutaneous fat thickness 41% greater in F1obese vs F1control males (P < 0.05). Adipocyte diameters were greater (P <= 0.04) in perirenal, omental and subcutaneous adipose depots in F1obese males (11, 8 and 7% increase vs. control, respectively). When adipose tissue was incubated for 2 hrs with C-14 labeled acetate, subcutaneous, perirenal, and omental adipose tissue of F1 obese males exhibited greater incorporation (290, 83, and 90% increase vs. control, respectively P < 0.05) of acetate into lipids. Expression of fatty acid transporting, binding, and syntheses mRNA and protein was increased (P < 0.05) compared to F1 control offspring. Maternal obesity increased appetite and adiposity associated with increased adipocyte diameters and increased fatty acid synthesis in over-nourished adult male offspring.	[Long, Nathan M.; Tuersunjiang, Nuermaimaiti; Nathanielsz, Peter W.; Ford, Stephen P.] Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Long, Nathan M.] Clemson Univ, Dept Anim & Vet Sci, Clemson, SC USA; [Rule, Daniel C.; Tuersunjiang, Nuermaimaiti; Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Nathanielsz, Peter W.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78284 USA	University of Wyoming; Clemson University; University of Wyoming; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio	Ford, SP (corresponding author), Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	spford@uwyo.edu		Nathanielsz, Peter/0000-0001-8410-6280	University of Wyoming National Institute of Health [INBRE P20-RR-16474-04, HD 21350]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	University of Wyoming National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the University of Wyoming National Institute of Health Grant INBRE P20-RR-16474-04 and HD 21350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P671; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Budge H, 2003, PEDIATR RES, V53, P302, DOI [10.1203/00006450-200302000-00016, 10.1203/01.PDR.0000047653.73271.C4]; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Caluwaerts S, 2007, METABOLISM, V56, P1431, DOI 10.1016/j.metabol.2007.06.007; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Duckett SK, 2009, J ANIM SCI, V87, P1120, DOI 10.2527/jas.2008-1420; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; FASS, 2010, GUID CAR US AGR AN A; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Long NM, 2012, J ANIM SCI, V90, P197, DOI 10.2527/jas.2011-4237; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Long NM, 2010, J ANIM SCI, V88, P3251, DOI 10.2527/jas.2009-2512; Long NM, 2011, J PHYSIOL-LONDON, V589, P1455, DOI 10.1113/jphysiol.2010.201681; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Murrieta CM, 2003, MEAT SCI, V65, P523, DOI 10.1016/S0309-1740(02)00244-9; National Research Council, 1985, NUTR REQ SHEEP; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Proulx K, 2001, ENDOCRINOLOGY, V142, P4607, DOI 10.1210/en.142.11.4607; RULE DC, 1987, ANIM PROD, V44, P454, DOI 10.1017/S0003356100012411; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SANSON DW, 1993, J ANIM SCI, V71, P1112, DOI 10.2527/1993.7151112x; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang L, 2011, DOMEST ANIM ENDOCRIN, V40, P30, DOI 10.1016/j.domaniend.2010.08.004; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	49	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122152	10.1371/journal.pone.0122152	http://dx.doi.org/10.1371/journal.pone.0122152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875659	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800043
J	Black, AP; Vilivong, K; Nouanthong, P; Souvannaso, C; Hubschen, JM; Muller, CP				Black, Antony P.; Vilivong, Keooudomphone; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Huebschen, Judith M.; Muller, Claude P.			Serosurveillance of Vaccine Preventable Diseases and Hepatitis C in Healthcare Workers from Lao PDR	PLOS ONE			English	Article							SELF-REPORTED HISTORY; B-VIRUS; MEDICAL-STUDENTS; ANTI-HBC; INFECTIONS; RISK; RECOMMENDATIONS; IMMUNIZATION; MANAGEMENT; IMMUNITY	Background and Aims Healthcare workers (HCW) have an increased risk of exposure to infectious diseases and are a potential source of infections for their patients. The Lao People's Democratic Republic (Lao PDR) has no national policy regarding HCW vaccinations and routine vaccination coverage is low within the general population. This cross-sectional serostudy determines the level of exposure and risk of infection in Lao HCW against 6 vaccine preventable diseases and hepatitis C. Methods 1128 HCW were recruited from 3 central, 2 provincial and 8 district hospitals. Sera were tested by ELISA for the presence of antibodies and antigens to hepatitis B, hepatitis C, measles, rubella, varicella zoster, tetanus and diphtheria. Results Only 53.1% of the HCW had protective anti-hepatitis B surface antigen antibodies (anti-HBs) with 48.8% having anti- hepatitis B core antibodies (anti-HBc), indicating previous exposure and 8.0% were hepatitis B surface antigen carriers. 3.9% were hepatitis C seropositive. Measles and rubella antibodies were detected in 95.4% and 86.2% of the HCW, with 11.9% of females being unprotected against rubella. Antibodies against varicella zoster, tetanus and diphtheria were detected in 95%, 78.8% and 55.3%, respectively. Seroprevalence varied according to age, gender and number of children. Conclusion An unacceptably high proportion of Lao HCW remain susceptible to infection with hepatitis B, diphtheria, tetanus and rubella. Furthermore, a high number of healthcare workers are chronically infected with hepatitis B and C viruses. These data emphasize the need for a robust HCW vaccination policy in addition to increased awareness within this subpopulation.	[Black, Antony P.; Huebschen, Judith M.; Muller, Claude P.] Luxembourg Inst Hlth, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg; [Black, Antony P.; Vilivong, Keooudomphone; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Huebschen, Judith M.; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos	Luxembourg Institute of Health	Muller, CP (corresponding author), Luxembourg Inst Hlth, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg.	Claude.Muller@LiH.lu	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; 	Ministry of Cooperation [5-BI-2010-1071]; Centre de Recherche Public de la Sante in Luxembourg	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	This study was funded by the Ministry of Cooperation (n<SUP>o</SUP>5-BI-2010-1071) and the Centre de Recherche Public de la Sante in Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT HLTH STAT REP FY; [Anonymous], 2007, COMPR MULT PLAN 2007; Baldo V, 2002, INFECT CONT HOSP EP, V23, P325, DOI 10.1086/502059; Black AP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-457; De Juanes JR, 2005, VACCINE, V23, P1434, DOI 10.1016/j.vaccine.2004.10.003; Fitzsimons D, 2008, OCCUP ENVIRON MED, V65, P446, DOI 10.1136/oem.2006.032334; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Kabir A, 2008, HUM VACCINES, V4, P379, DOI 10.4161/hv.4.5.6010; Kaltsas A, 2013, CURR OPIN INFECT DIS, V26, P366, DOI 10.1097/QCO.0b013e3283630ee5; Leung V, 2014, AUST NZ J PUBL HEAL, V38, P83, DOI 10.1111/1753-6405.12163; Mele A, 2001, DIGEST LIVER DIS, V33, P795, DOI 10.1016/S1590-8658(01)80698-8; Nanthavong N, DIPHTHERIA LAO UNPUB; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Pathoumthong K, 2014, VACCINE, V32, P4993, DOI 10.1016/j.vaccine.2014.07.022; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Pruss-Ustun AR E, 2003, WHO ENV BURDEN DIS S, P3; Rose VL, 1998, AM FAM PHYSICIAN, V57, P1426; Shefer A, 2011, MMWR-MORBID MORTAL W, P60; Shefer A, 2012, INFECT CONT HOSP EP, V33, P71, DOI 10.1086/662715; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Srichomkwun P, 2009, INFECT CONT HOSP EP, V30, P585, DOI 10.1086/597508; Sukriti, 2008, J GASTROEN HEPATOL, V23, P1710, DOI 10.1111/j.1440-1746.2008.05483.x; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Sunbul M, 2000, SCAND J INFECT DIS, V32, P315, DOI 10.1080/00365540050165983; Sydnor E, 2014, VACCINE, V32, P4814, DOI 10.1016/j.vaccine.2014.03.097; Trevisan A, 2007, INFECT CONT HOSP EP, V28, P564, DOI 10.1086/516657; WHO, 2012, INT REV EXP PROGR IM; WHO, 2011, COUNTRY HLTH INFORM, P162; Wicker S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-121; Wiwanitkit V, 2002, ANN TROP MED PARASIT, V96, P627, DOI 10.1179/000349802125001672; Yen YH, 2005, LIVER INT, V25, P1162, DOI 10.1111/j.1478-3231.2005.01157.x	32	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123647	10.1371/journal.pone.0123647	http://dx.doi.org/10.1371/journal.pone.0123647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874696	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700035
J	Davis, JA; Burgoon, LD				Davis, J. Allen; Burgoon, Lyle D.			Can Data Science Inform Environmental Justice and Community Risk Screening for Type 2 Diabetes?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SLC30A8 RS13266634; COMMON VARIANTS; POLYMORPHISMS; IGF2BP2; CDKAL1; CHINESE; SUSCEPTIBILITY; LOCI	Background Having the ability to scan the entire country for potential "hotspots" with increased risk of developing chronic diseases due to various environmental, demographic, and genetic susceptibility factors may inform risk management decisions and enable better environmental public health policies. Objectives Develop an approach for community-level risk screening focused on identifying potential genetic susceptibility hotpots. Methods Our approach combines analyses of phenotype-genotype data, genetic prevalence of single nucleotide polymorphisms, and census/geographic information to estimate census tract-level population attributable risks among various ethnicities and total population for the state of California. Results We estimate that the rs13266634 single nucleotide polymorphism, a type 2 diabetes susceptibility genotype, has a genetic prevalence of 56.3%, 47.4% and 37.0% in Mexican Mestizo, Caucasian, and Asian populations. Looking at the top quintile for total population attributable risk, 16 California counties have greater than 25% of their population living in hotspots of genetic susceptibility for developing type 2 diabetes due to this single genotypic susceptibility factor. Conclusions This study identified counties in California where large portions of the population may bear additional type 2 diabetes risk due to increased genetic prevalence of a susceptibility genotype. This type of screening can easily be extended to include information on environmental contaminants of interest and other related diseases, and potentially enables the rapid identification of potential environmental justice communities. Other potential uses of this approach include problem formulation in support of risk assessments, land use planning, and prioritization of site cleanup and remediation actions.	[Davis, J. Allen; Burgoon, Lyle D.] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Davis, JA (corresponding author), US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	davis.allen@epa.gov	Burgoon, Lyle D./I-2894-2019	Burgoon, Lyle D./0000-0003-4977-5352				Gamboa-Melendez MA, 2012, DIABETES, V61, P3314, DOI 10.2337/db11-0550; [Anonymous], UNITED STATES CENSUS; [Anonymous], CENTERS FOR DISEASE; [Anonymous], 2013, DATABASE OF SINGLE N; Astell-Burt T., 2013, DIABETES CARE; Bronstein M, 2008, HUM GENET, V124, P101, DOI 10.1007/s00439-008-0520-x; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Gaskin DJ, 2013, AM J PUBLIC HEALTH; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Huang QO, 2010, EUR J CLIN PHARMACOL, V66, P1207, DOI 10.1007/s00228-010-0882-6; Kuo CC, 2013, CURR DIABETES REP, V13, P831, DOI 10.1007/s11892-013-0432-6; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Luna MTT, 2005, ARCH MED RES, V36, P210, DOI 10.1016/j.arcmed.2005.03.004; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Miao X, 2013, FRONT MED-PRC, V7, P31, DOI 10.1007/s11684-013-0251-9; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000312; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; United States Environmental Protection Agency, 2013, NEXT GENERATION RISK, DOI [10.1016/j.yrtph.2013.12.002, DOI 10.1016/J.YRTPH.2013.12.002]; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Xu KF, 2011, DIABETES RES CLIN PR, V91, P195, DOI 10.1016/j.diabres.2010.11.012; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0121855	10.1371/journal.pone.0121855	http://dx.doi.org/10.1371/journal.pone.0121855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875676	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700011
J	Ravinet, M; Hynes, R; Poole, R; Cross, TF; McGinnity, P; Harrod, C; Prodohl, PA				Ravinet, Mark; Hynes, Rosaleen; Poole, Russell; Cross, Tom F.; McGinnity, Phil; Harrod, Chris; Prodoehl, Paulo A.			Where the Lake Meets the Sea: Strong Reproductive Isolation Is Associated with Adaptive Divergence between Lake Resident and Anadromous Three-Spined Sticklebacks	PLOS ONE			English	Article							LATERAL-PLATE REDUCTION; THREESPINE STICKLEBACK; GASTEROSTEUS-ACULEATUS; GENETIC-DIVERGENCE; ECOLOGICAL SPECIATION; CONTRASTING PATTERNS; POPULATION-STRUCTURE; PARALLEL EVOLUTION; STREAM STICKLEBACK; SYMPATRIC FORMS	Contact zones between divergent forms of the same species are often characterised by high levels of phenotypic diversity over small geographic distances. What processes are involved in generating such high phenotypic diversity? One possibility is that introgression and recombination between divergent forms in contact zones results in greater phenotypic and genetic polymorphism. Alternatively, strong reproductive isolation between forms may maintain distinct phenotypes, preventing homogenisation by gene flow. Contact zones between divergent freshwater-resident and anadromous stickleback (Gasterosteus aculeatus L.) forms are numerous and common throughout the species distribution, offering an opportunity to examine these contrasting hypotheses in greater detail. This study reports on an interesting new contact zone located in a tidally influenced lake catchment in western Ireland, characterised by high polymorphism for lateral plate phenotypes. Using neutral and QTL-linked microsatellite markers, we tested whether the high diversity observed in this contact zone arose as a result of introgression or reproductive isolation between divergent forms: we found strong support for the latter hypothesis. Three phenotypic and genetic clusters were identified, consistent with two divergent resident forms and a distinct anadromous completely plated population that migrates in and out of the system. Given the strong neutral differentiation detected between all three morphotypes (mean F-ST = 0.12), we hypothesised that divergent selection between forms maintains reproductive isolation. We found a correlation between neutral genetic and adaptive genetic differentiation that support this. While strong associations between QTL linked markers and phenotypes were also observed in this wild population, our results support the suggestion that such associations may be more complex in some Atlantic populations compared to those in the Pacific. These findings provide an important foundation for future work investigating the dynamics of gene flow and adaptive divergence in this newly discovered stickleback contact zone.	[Ravinet, Mark; Hynes, Rosaleen; Harrod, Chris; Prodoehl, Paulo A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Hynes, Rosaleen; Prodoehl, Paulo A.] Queens Univ Belfast, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Poole, Russell] Inst Marine, Newport, County Mayo, Ireland; [Cross, Tom F.; McGinnity, Phil] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Aquaculture Fisheries & Dev Ctr, Cork, Ireland	Queens University Belfast; Queens University Belfast; Marine Institute Ireland; University College Cork	Prodohl, PA (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	p.prodohl@qub.ac.uk	Harrod, Chris/A-8830-2008; McGinnity, Philip/P-6781-2015	Harrod, Chris/0000-0002-5353-1556; Ravinet, Mark/0000-0002-2841-1798; McGinnity, Philip/0000-0001-5199-5632; Prodohl, Paulo/0000-0001-8570-9964	Department for Employment and Learning of Northern Ireland; Beaufort Marine Research Award in Fish Population Genetics	Department for Employment and Learning of Northern Ireland; Beaufort Marine Research Award in Fish Population Genetics	This study was supported by Department for Employment and Learning of Northern Ireland (http://www.delni.gov.uk/) and the Beaufort Marine Research Award in Fish Population Genetics (http://www.marine.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Anderson EC, 2002, GENETICS, V160, P1217; Ballantyne CK, 2008, QUATERNARY SCI REV, V27, P185, DOI 10.1016/j.quascirev.2007.10.019; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barrett RDH, 2009, EVOLUTION, V63, P2831, DOI 10.1111/j.1558-5646.2009.00762.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bell Michael A., 1994, P1; Bell MA, 2010, ENVIRON BIOL FISH, V89, P189, DOI 10.1007/s10641-010-9712-z; Berner D, 2014, EVOLUTION, V68, P1792, DOI 10.1111/evo.12390; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Berner D, 2010, EVOLUTION, V64, P2265, DOI 10.1111/j.1558-5646.2010.00982.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Brooks AJ, 2008, J QUATERNARY SCI, V23, P175, DOI 10.1002/jqs.1119; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Cassina F, 2013, PALAEOGEOGR PALAEOCL, V383, P1, DOI 10.1016/j.palaeo.2013.04.016; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; DeFaveri J, 2013, J EVOLUTION BIOL, V26, P1700, DOI 10.1111/jeb.12168; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Endler J.A., 1986, Monographs in Population Biology, pviii; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galindo J, 2013, J EVOLUTION BIOL, V26, P1472, DOI 10.1111/jeb.12152; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2004, EVOLUTION, V58, P2319; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones FC, 2008, BEHAVIOUR, V145, P463, DOI 10.1163/156853908792451520; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kahilainen KK, 2011, MOL ECOL, V20, P3838, DOI 10.1111/j.1365-294X.2011.05209.x; Kalbe M, 2009, P ROY SOC B-BIOL SCI, V276, P925, DOI 10.1098/rspb.2008.1466; Karve AD, 2008, ENVIRON BIOL FISH, V81, P287, DOI 10.1007/s10641-007-9200-2; Keenan K, 2013, METHODS ECOL EVOL, pn/a; Kitano J, 2008, CURR BIOL, V18, P769, DOI 10.1016/j.cub.2008.04.027; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Lambeck K, 2001, J QUATERNARY SCI, V16, P497, DOI 10.1002/jqs.638.abs; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2012, EVOLUTION, V66, P3866, DOI 10.1111/j.1558-5646.2012.01724.x; Lucek K, 2012, J HERED, V103, P579, DOI 10.1093/jhered/ess021; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Marchinko KB, 2007, EVOLUTION, V61, P1084, DOI 10.1111/j.1558-5646.2007.00103.x; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; McCabe AM, 2007, GEOLOGY, V35, P147, DOI 10.1130/G23167A.1; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McPhail J.D., 1994, P399; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; MORI S, 1990, ENVIRON BIOL FISH, V27, P21, DOI 10.1007/BF00004901; Myhre F, 2009, J FISH BIOL, V75, P2062, DOI 10.1111/j.1095-8649.2009.02404.x; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Payseur BA, 2010, MOL ECOL RESOUR, V10, P806, DOI 10.1111/j.1755-0998.2010.02883.x; Pirhonen J, 2003, AQUACULTURE, V220, P507, DOI 10.1016/S0044-8486(02)00624-5; Poole WR, 2006, RESTOR EUR EEL POPUL, V14; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Raeymaekers JAM, 2007, MOL ECOL, V16, P891, DOI 10.1111/j.1365-294X.2006.03190.x; Raeymaekers JAM, 2014, MOL ECOL, V23, P162, DOI 10.1111/mec.12582; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Ravinet M, 2014, ECOL EVOL, V4, P2488, DOI 10.1002/ece3.853; Ravinet M, 2013, EVOL ECOL RES, V15, P271; Reimchen TE, 1994, EVOLUTIONARY BIOL TH, P241; REIST JD, 1986, CAN J ZOOL, V64, P1363, DOI 10.1139/z86-203; Renaut S, 2012, PHILOS T R SOC B, V367, P354, DOI 10.1098/rstb.2011.0197; Roesti M, 2014, MOL ECOL; Rohlf F. J., 2010, TPSDIG 2 16; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Schwartz TS, 2008, J FISH BIOL, V72, P435, DOI 10.1111/j.1095-8649.2007.01734.x; SPITZE K, 1993, GENETICS, V135, P367; Storz JF, 2002, MOL ECOL, V11, P2537, DOI 10.1046/j.1365-294X.2002.01636.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valentin AE, 2008, J FISH BIOL, V73, P623, DOI 10.1111/j.1095-8649.2008.01961.x; Von Hippel FA, 2004, BEHAVIOUR, V141, P1441, DOI 10.1163/1568539042948259; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; ZIUGANOV VV, 1987, ENVIRON BIOL FISH, V18, P241, DOI 10.1007/BF00004877	97	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122825	10.1371/journal.pone.0122825	http://dx.doi.org/10.1371/journal.pone.0122825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874617	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700025
J	Solis, MY; Cooper, S; Hobson, RM; Artioli, GG; Otaduy, MC; Roschel, H; Robertson, J; Martin, D; Painelli, VS; Harris, RC; Gualano, B; Sale, C				Solis, Marina Yazigi; Cooper, Simon; Hobson, Ruth M.; Artioli, Guilherme G.; Otaduy, Maria C.; Roschel, Hamilton; Robertson, Jacques; Martin, Daniel; Painelli, Vitor S.; Harris, Roger C.; Gualano, Bruno; Sale, Craig			Effects of Beta-Alanine Supplementation on Brain Homocarnosine/Carnosine Signal and Cognitive Function: An Exploratory Study	PLOS ONE			English	Article							PEPT2 NULL MICE; CARNOSINE SYNTHETASE; EXERCISE PERFORMANCE; AMINO ACIDS; MUSCLE; HISTIDINE; ABSORPTION; TRANSPORT; PROTECTS; CULTURES	Objectives Two independent studies were conducted to examine the effects of 28 d of beta-alanine supplementation at 6.4 g d(-1) on brain homocarnosine/carnosine signal in omnivores and vegetarians (Study 1) and on cognitive function before and after exercise in trained cyclists (Study 2). Methods In Study 1, seven healthy vegetarians (3 women and 4 men) and seven age-and sex-matched omnivores undertook a brain 1H-MRS exam at baseline and after beta-alanine supplementation. In study 2, nineteen trained male cyclists completed four 20-Km cycling time trials (two pre supplementation and two post supplementation), with a battery of cognitive function tests (Stroop test, Sternberg paradigm, Rapid Visual Information Processing task) being performed before and after exercise on each occasion. Results In Study 1, there were no within-group effects of beta-alanine supplementation on brain homocarnosine/carnosine signal in either vegetarians (p = 0.99) or omnivores (p = 0.27); nor was there any effect when data from both groups were pooled (p = 0.19). Similarly, there was no group by time interaction for brain homocarnosine/ carnosine signal (p = 0.27). In study 2, exercise improved cognitive function across all tests (P<0.05), although there was no effect (P>0.05) of beta-alanine supplementation on response times or accuracy for the Stroop test, Sternberg paradigm or RVIP task at rest or after exercise. Conclusion 28 d of beta-alanine supplementation at 6.4g d(-1) appeared not to influence brain homocarnosine/carnosine signal in either omnivores or vegetarians; nor did it influence cognitive function before or after exercise in trained cyclists.	[Solis, Marina Yazigi; Artioli, Guilherme G.; Roschel, Hamilton; Painelli, Vitor S.; Gualano, Bruno] Univ Sao Paulo, Sch Phys Educ & Sport, BR-05508030 Sao Paulo, SP, Brazil; [Cooper, Simon; Hobson, Ruth M.; Robertson, Jacques; Martin, Daniel; Sale, Craig] Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Nottingham NG11 8NS, England; [Otaduy, Maria C.] Univ Sao Paulo, Fac Med, LIM44, BR-05403900 Sao Paulo, SP, Brazil; [Harris, Roger C.] Junipa Ltd, Newmarket, Suffolk, England	Universidade de Sao Paulo; Nottingham Trent University; Universidade de Sao Paulo	Sale, C (corresponding author), Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Nottingham NG11 8NS, England.	craig.sale@ntu.ac.uk	Gualano, Bruno/ABA-9571-2020; Otaduy, Maria/AAV-6070-2020; Painelli, Vitor/AAB-6925-2020; Roschel, Hamilton/D-4353-2012; Otaduy, Maria/C-1316-2012; Gualano, Bruno/C-7190-2012; Artioli, Guilherme Giannini/K-5925-2013	Gualano, Bruno/0000-0001-7100-8681; Otaduy, Maria/0000-0003-2515-1131; Painelli, Vitor/0000-0001-5828-9669; Roschel, Hamilton/0000-0002-9513-6132; Otaduy, Maria/0000-0003-2515-1131; Gualano, Bruno/0000-0001-7100-8681; Artioli, Guilherme Giannini/0000-0001-8463-2213; Cooper, Simon/0000-0001-5219-5020; Sale, Craig/0000-0002-5816-4169	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11221-0, 2011/17059/2, 2013/04806-0]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #2010/11221-0, #2011/17059/2 and #2013/04806-0). In addition, the authors are thankful to Natural Alternatives International (NAI) for providing the supplements for Study 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Aldini G, 2004, J MASS SPECTROM, V39, P1417, DOI 10.1002/jms.696; Altman DG, 1996, BRIT MED J, V313, P570; ASATOOR AM, 1970, GUT, V11, P250, DOI 10.1136/gut.11.3.250; Baraniuk James Nicholas, 2013, Glob J Health Sci, V5, P69, DOI 10.5539/gjhs.v5n3p69; BAUER K, 1994, EUR J BIOCHEM, V219, P43, DOI 10.1111/j.1432-1033.1994.tb19912.x; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Boldyrev AA, 2008, REJUV RES, V13, P156; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; BRUUN A, 1974, EXP EYE RES, V19, P435, DOI 10.1016/0014-4835(74)90052-9; Chengappa KNR, 2012, SCHIZOPHR RES, V142, P145, DOI 10.1016/j.schres.2012.10.001; Cooper SB, 2012, BRIT J NUTR, V107, P1823, DOI 10.1017/S0007114511005022; Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7; Dunnett M, 1999, Equine Vet J Suppl, P499; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Fedorova TN, 2009, BIOCHEM MOSC SUPPL S, V3, P62, DOI 10.1134/S1990747809010085; Gross M, 2014, EUR J APPL PHYSIOL, V114, P221, DOI 10.1007/s00421-013-2767-8; HARDING JW, 1979, BRAIN RES, V173, P99, DOI 10.1016/0006-8993(79)91099-0; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; Hobson R, J SPOR IN PRESS 0717, P1; Hoffman JR, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-15; Hoffmann AM, 1996, NEUROSCI LETT, V215, P29, DOI 10.1016/S0304-3940(96)12937-2; Hogervorst E, 2008, MED SCI SPORT EXER, V40, P1841, DOI 10.1249/MSS.0b013e31817bb8b7; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Kamal MA, 2009, AM J PHYSIOL-REG I, V296, pR986, DOI 10.1152/ajpregu.90744.2008; KISH SJ, 1979, J NEUROCHEM, V32, P1629, DOI 10.1111/j.1471-4159.1979.tb02272.x; Komura J, 1997, FEBS LETT, V400, P131, DOI 10.1016/S0014-5793(96)01366-X; Leech R, BRAIN IN PRESS  0718; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Ozdemir MSR, 2007, PHYS MED BIOL, V52, P6781, DOI 10.1088/0031-9155/52/23/001; PARROTT AC, 1991, HUM PSYCHOPHARM CLIN, V6, P1, DOI 10.1002/hup.470060102; PERRY TL, 1971, J NEUROCHEM, V18, P521, DOI 10.1111/j.1471-4159.1971.tb11980.x; Petroff OAC, 1998, ANN NEUROL, V44, P948, DOI 10.1002/ana.410440614; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Rothman DL, 1997, MAGN RESON MED, V38, P924, DOI 10.1002/mrm.1910380611; Rothman DL, 2001, NMR BIOMED, V14, P149, DOI 10.1002/nbm.692; Sale C, 2013, AMINO ACIDS, V44, P1477, DOI 10.1007/s00726-013-1476-2; Solis MY, 2014, BRIT J NUTR, V111, P1272, DOI 10.1017/S0007114513003802; Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4; STERNBERG S, 1969, AM SCI, V57, P421; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stvolinsky S, 2000, BRAIN RES BULL, V53, P445, DOI 10.1016/S0361-9230(00)00366-X; Teuscher NS, 2004, J NEUROCHEM, V89, P375, DOI 10.1111/j.1471-4159.2004.02333.x; Vermathen P, 2000, MAGN RESON MED, V43, P665, DOI 10.1002/(SICI)1522-2594(200005)43:5<665::AID-MRM8>3.0.CO;2-3; Weinsier R, 2000, AM J CLIN NUTR, V71, P1211	50	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123857	10.1371/journal.pone.0123857	http://dx.doi.org/10.1371/journal.pone.0123857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875297	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000353014700047
J	Aguirre-Rueda, D; Guerra-Ojeda, S; Aldasoro, M; Iradi, A; Obrador, E; Mauricio, MD; Vila, JM; Marchio, P; Valles, SL				Aguirre-Rueda, Diana; Guerra-Ojeda, Sol; Aldasoro, Martin; Iradi, Antonio; Obrador, Elena; Mauricio, Maria D.; Vila, Jose Ma; Marchio, Patricia; Valles, Soraya L.			WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid beta(1-42) Effects on Astrocytes in Primary Culture	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PPAR-GAMMA; OXIDATIVE STRESS; IN-VITRO; ENDOCANNABINOID SYSTEM; INDUCED NEUROINFLAMMATION; LIPID-PEROXIDATION; CELL-DEATH	Alzheimer's disease (AD), a neurodegenerative illness involving synaptic dysfunction with extracellular accumulation of A beta(1-42) toxic peptide, glial activation, inflammatory response and oxidative stress, can lead to neuronal death. Endogenous cannabinoid system is implicated in physiological and physiopathological events in central nervous system (CNS), and changes in this system are related to many human diseases, including AD. However, studies on the effects of cannabinoids on astrocytes functions are scarce. In primary cultured astrocytes we studied cellular viability using MTT assay. Inflammatory and oxidative stress mediators were determined by ELISA and Western-blot techniques both in the presence and absence of A beta(1-42) peptide. Effects of WIN 55,212-2 (a synthetic cannabinoid) on cell viability, inflammatory mediators and oxidative stress were also determined. A beta(1-42) diminished astrocytes viability, increased TNF-alpha and IL-1 beta levels and p-65, COX-2 and iNOS protein expression while decreased PPAR-gamma and antioxidant enzyme Cu/Zn SOD. WIN 55,212-2 pretreatment prevents all effects elicited by A beta(1-42). Furthermore, cannabinoid WIN 55,212-2 also increased cell viability and PPAR-gamma expression in control astrocytes. In conclusion cannabinoid WIN 55,212-2 increases cell viability and anti-inflammatory response in cultured astrocytes. Moreover, WIN 55,212-2 increases expression of anti-oxidant Cu/Zn SOD and is able to prevent inflammation induced by A beta(1-42) in cultured astrocytes. Further studies would be needed to assess the possible beneficial effects of cannabinoids in Alzheimer's disease patients.	[Aguirre-Rueda, Diana; Guerra-Ojeda, Sol; Aldasoro, Martin; Iradi, Antonio; Obrador, Elena; Mauricio, Maria D.; Vila, Jose Ma; Marchio, Patricia; Valles, Soraya L.] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain	University of Valencia	Valles, SL (corresponding author), Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain.	lilian.valles@uv.es	Guerra, Solanye/AAX-2891-2021; Guerra, Solanye/GXH-1600-2022; Mauricio, Maria D/AAN-7412-2020; OBRADOR, ELENA/H-4069-2015; ALDASORO, MARTIN/AAB-3344-2019; Valles, Soraya L./H-9320-2019	Mauricio, Maria D/0000-0002-7695-2898; OBRADOR, ELENA/0000-0002-5934-5543; ALDASORO, MARTIN/0000-0001-6630-0493; Valles, Soraya L./0000-0003-4861-4266; Aguirre Rueda, Diana/0000-0003-2019-0457; Guerra, Solanye/0000-0003-3018-4683; Estan Capell, Nuria/0000-0001-8768-3139; Vila Salinas/0000-0001-8589-9307; Aguirre Rueda, Diana/0000-0003-1166-5780	Generalitat Valenciana [AP-073/09]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Generalitat Valenciana AP-073/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2012, NEUROCHEM RES, V37, P2589, DOI 10.1007/s11064-012-0895-x; Aguirre-Rueda D, 2015, INT J MED SCI, V12, P48, DOI 10.7150/ijms.10035; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Bondareff W, 2013, J ALZHEIMERS DIS, V35, P1, DOI 10.3233/JAD-122305; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; De Petrocellis L, 2013, BRIT J PHARMACOL, V168, P79, DOI 10.1111/j.1476-5381.2012.02027.x; del Pulgar TG, 2002, J BIOL CHEM, V277, P36527, DOI 10.1074/jbc.M205797200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Esposito G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028668; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fakhfouri G, 2012, NEUROPHARMACOLOGY, V63, P653, DOI 10.1016/j.neuropharm.2012.05.013; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Inestrosa NC, 2005, NEUROBIOL AGING, V26, P1023, DOI 10.1016/j.neurobiolaging.2004.09.016; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jimenez-Jimenez FJ, 2006, REV NEUROLOGIA, V42, P419, DOI 10.33588/rn.4207.2005225; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Keller JN, 1998, J NEUROSCI, V18, P687; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Krishnan S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007204.pub2; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li CH, 2011, CELL MOL IMMUNOL, V8, P67, DOI 10.1038/cmi.2010.55; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Rocha FCM, 2014, J NEURO-ONCOL, V116, P11, DOI 10.1007/s11060-013-1277-1; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Pacher P, 2013, FEBS J, V280, P1918, DOI 10.1111/febs.12260; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Palanca JM, 2013, INT J MED SCI, V10, P1278, DOI 10.7150/ijms.6254; Palmer SL, 2002, CHEM PHYS LIPIDS, V121, P3, DOI 10.1016/S0009-3084(02)00143-3; Pappolla MA, 1998, AM J PATHOL, V152, P871; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pourkhalili N, 2013, TOXICOL MECH METHOD, V23, P120, DOI 10.3109/15376516.2012.730559; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Quintanilla RA, 2012, ARCH MED RES, V43, P632, DOI 10.1016/j.arcmed.2012.10.016; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Strohmeyer R, 2001, J ALZHEIMERS DIS, V3, P131, DOI 10.3233/JAD-2001-3118; Sun Y, 2007, PPAR RES, V2007, DOI 10.1155/2007/23513; Valles S, 1999, J BIOL CHEM, V274, P20103, DOI 10.1074/jbc.274.29.20103; Valles SL, 2008, AGING CELL, V7, P112, DOI 10.1111/j.1474-9726.2007.00356.x; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Walther S, 2006, PSYCHOPHARMACOLOGY, V185, P524, DOI 10.1007/s00213-006-0343-1; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611	92	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122843	10.1371/journal.pone.0122843	http://dx.doi.org/10.1371/journal.pone.0122843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874692	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100108
J	Chen, XB; Di, PP; Wang, HM; Li, BL; Pan, YJ; Yan, SL; Wang, YJ				Chen, Xiaobing; Di, Panpan; Wang, Hongming; Li, Bailin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie			Bacterial Community Associated with the Intestinal Tract of Chinese Mitten Crab (Eriocheir sinensis) Farmed in Lake Tai, China	PLOS ONE			English	Article							STALK-FORMING LINEAGE; MICROBIAL DIVERSITY; GUT MICROBIOTA; MIDGUT GLANDS; SP NOV.; MOLLICUTES; MORPHOLOGY; GENES	Chinese mitten crab (CMC, Eriocheir sinensis) is an economically valuable species in South-East Asia that has been widely farmed in China. Characterization of the intestinal bacterial diversity of CMC will provide insights into the aquaculturing of CMCs. Based on the analysis of cloned 16S rRNA genes from culture-independent CMC gut bacteria, 124 out of 128 different clones reveal > 95% nucleotide similarity to the species belonging to the four phyla of Tenericutes, Bacteroidetes, Firmicutes and Proteobacteria; one clone shows 91% sequence similarity to themember of TM7 (a candidate phylum without cultured representatives). Fluorescent in situ hybridization also reveals the abundance of Bacteroidetes in crab intestine. Electron micrographs show that spherical and filamentous bacteria are closely associated with themicrovillus brush border of the midgut epithelium and are often inserted into the space between the microvilli using a stalk-like cell appendage. In contrast, the predominant rod-shaped bacteria in the hindgut are tightly attached to the epithelium surface by an unusual pili-like structure. Both 16S rRNA gene denaturing gel gradient electrophoresis and metagenome library indicate that the CMC Mollicutes group 2 appears to be present in both the midgut and hindgut with no significant difference in abundance. The CMC Mollicutes group 1, however, was found mostly in the midgut of CMCs. The CMC gut Mollicutes phylotypes appear to be most closely related to Mollicutes symbionts detected in the gut of isopods (Crustacea: Isopoda). Overall, the results suggest that CMCs harbor diverse, novel and specific gut bacteria, which are likely to live in close relationships with the CMC host.	[Chen, Xiaobing; Di, Panpan; Wang, Hongming; Pan, Yingjie; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Pan, Yingjie; Wang, Yongjie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai, Peoples R China; [Chen, Xiaobing; Di, Panpan; Wang, Hongming; Li, Bailin; Pan, Yingjie; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Yan, Shuling] Univ Goettingen, Inst Biochem & Mol Cell Biol, Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn	li, bai/GRJ-4913-2022; li, bz/GVR-7133-2022	Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Doctoral Fund of Ministry of Education of China [20133104110006]; Innovation Program of Shanghai Municipal Education Commission, China [14ZZ144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Innovation Program of Shanghai Municipal Education Commission, China(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Natural Science Foundation of China (No. 41376135), Doctoral Fund of Ministry of Education of China (20133104110006), Innovation Program of Shanghai Municipal Education Commission (14ZZ144), China, to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Chinese Fishery Bureau, 2013, CHIN FISH YB, P23; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Collado L, 2009, INT J SYST EVOL MICR, V59, P1391, DOI 10.1099/ijs.0.003749-0; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; Foster HA, 2010, METHODS MOL BIOL, V659, P427, DOI 10.1007/978-1-60761-789-1_33; Fraune S, 2008, ENVIRON MICROBIOL, V10, P2497, DOI 10.1111/j.1462-2920.2008.01672.x; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; Ke Li, 2007, Weishengwu Xuebao, V47, P649; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larsen AM, 2014, J APPL MICROBIOL, V116, P1396, DOI 10.1111/jam.12475; Li K, 2007, J APPL MICROBIOL, V103, P675, DOI 10.1111/j.1365-2672.2007.03295.x; Liu HD, 2011, AQUACULTURE, V317, P32, DOI 10.1016/j.aquaculture.2011.04.008; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Na H, 2009, INT J SYST EVOL MICR, V59, P2241, DOI 10.1099/ijs.0.009027-0; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; NELSON ET, 1976, INFECT IMMUN, V14, P527, DOI 10.1128/IAI.14.2.527-547.1976; Olmos J, 2011, MAR DRUGS, V9, P1119, DOI 10.3390/md9061119; Ravi AV, 2007, LETT APPL MICROBIOL, V45, P219, DOI 10.1111/j.1472-765X.2007.02180.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SANFORD SE, 1991, J VET DIAGN INVEST, V3, P328, DOI 10.1177/104063879100300410; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Verna C, 2010, ENVIRON MICROBIOL, V12, P2355, DOI 10.1111/j.1462-2920.2010.02299.x; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; Wang YJ, 2004, APPL ENVIRON MICROB, V70, P6166, DOI 10.1128/AEM.70.10.6166-6172.2004; Wang YJ, 2004, ARCH MICROBIOL, V181, P299, DOI 10.1007/s00203-004-0655-7; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu SG, 2012, WORLD J MICROB BIOT, V28, P2165, DOI 10.1007/s11274-012-1022-5; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Yu Z, 2014, J EUKARYOT MICROBIOL, V61, P126, DOI 10.1111/jeu.12090	36	51	57	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123990	10.1371/journal.pone.0123990	http://dx.doi.org/10.1371/journal.pone.0123990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875449	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100230
J	Greene, E				Greene, Ernest			Evaluating Letter Recognition, Flicker Fusion, and the Talbot-Plateau Law using Microsecond-Duration Flashes	PLOS ONE			English	Article							CONE PHOTORECEPTORS; LUMINOUS SENSATION; PHOTIC-STIMULATION; RETINAL RODS; BRIGHTNESS; LIGHT; PHOTOCURRENT; SENSITIVITY; KINETICS; DISCRIMINATION	Four experiments examined the ability of respondents to identify letters that were displayed on an LED array with flashes lasting little more than a microsecond. The first experiment displayed each letter with a single, simultaneous flash of all the dots forming the letter and established the relation of flash intensity to the probability of letter identification. The second experiment displayed the letters with multiple flashes at different frequencies to determine the probability that the sequence of flashes would be perceived as fused. The third experiment displayed the letters at a frequency that was above the flicker-fusion frequency, varying flash intensity to establish the amount needed to elicit a given probability of letter identification. The fourth experiment displayed each letter twice, once at a frequency where no flicker was perceived and also with steady light emission. The intensity of each flash was fixed and the steady intensity was varied; respondents were asked to judge whether the fused-flicker display and the steady display appeared to be the same brightness. Steady intensity was about double the average flash intensity where the two conditions were perceived as being equal in brightness. This is at odds with Talbot-Plateau law, which predicts that these two values should be equal. The law was formulated relative to a flash lasting half of each period, so it is surprising that it comes this close to being correct where the flash occupies only a millionth of the total period.	Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA	University of Southern California	Greene, E (corresponding author), Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA.	egreene@usc.edu			Neuropsychology Foundation; Quest for Truth Foundation	Neuropsychology Foundation; Quest for Truth Foundation	Funds were provided by the Neuropsychology Foundation and the Quest for Truth Foundation, as described in Acknowledgments. These organizations have no vested interest in the results of the investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA TS, 1964, VISION RES, V4, P391, DOI 10.1016/0042-6989(64)90011-2; ANDERSON DA, 1966, J OPT SOC AM, V56, P1607, DOI 10.1364/JOSA.56.001607; Arnold W, 1934, J GEN PHYSIOL, V18, P97, DOI 10.1085/jgp.18.1.97; Bartley SH, 1951, J PSYCHOL, V32, P57, DOI 10.1080/00223980.1951.9916083; Bartley SH, 1939, J EXP PSYCHOL, V25, P462, DOI 10.1037/h0053866; Bartley SH, 1938, P SOC EXP BIOL MED, V38, P535; Bartley SH, 1951, J PSYCHOL, V34, P165; BATTERSBY WS, 1953, J EXP PSYCHOL, V46, P154, DOI 10.1037/h0062884; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BERMAN SM, 1979, BIOL CYBERN, V34, P171, DOI 10.1007/BF00336968; Brecher A, 1935, Z VERGL PHYSIOL, V22, P539; Brewster D., 1838, PHILOS MAG, V4, P241; Broca A, 1902, CR HEBD ACAD SCI, V134, P831; COBBS WH, 1987, J PHYSIOL-LONDON, V394, P529, DOI 10.1113/jphysiol.1987.sp016884; Corwin TR, 1974, VISION RES, V14, P1675; Crozier WJ, 1941, J GEN PHYSIOL, V24, P635, DOI 10.1085/jgp.24.5.635; Crozier WJ, 1941, J GEN PHYSIOL, V25, P89, DOI 10.1085/jgp.25.1.89; Crozier WJ, 1941, J GEN PHYSIOL, V24, P505, DOI 10.1085/jgp.24.4.505; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Greene E, 2014, I-PERCEPTION, V5, P87, DOI 10.1068/i0639rep; Greene E, 2013, I-PERCEPTION, V4, P429, DOI 10.1068/i0602; HAMER RD, 1992, J OPT SOC AM A, V9, P1889, DOI 10.1364/JOSAA.9.001889; Hecht S, 1933, J GEN PHYSIOL, V17, P269, DOI 10.1085/jgp.17.2.269; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; Kleitman N, 1924, CR SOC BIOL, V91, P453; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; MATTHEWS G, 1987, P NATL ACAD SCI USA, V84, P299, DOI 10.1073/pnas.84.1.299; NELSON TM, 1964, VISION RES, V4, P403, DOI 10.1016/0042-6989(64)90012-4; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; OSAKA N, 1977, PERCEPT PSYCHOPHYS, V22, P63, DOI 10.3758/BF03206081; PENN RD, 1972, BIOPHYS J, V12, P1073, DOI 10.1016/S0006-3495(72)86145-9; Petrova D, 2013, J VISION, V13, DOI 10.1167/13.7.15; PINNEO LR, 1967, J NEUROL SCI, V5, P303, DOI 10.1016/0022-510X(67)90138-4; Plateau J. A. F., 1830, ANN PHYS-LEIPZIG, P304; Pokorny J, 2001, COLOR RES APPL, V26, pS140, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL31>3.0.CO;2-N; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Smith VC, 2000, COLOR RES APPL, V25, P105, DOI 10.1002/(SICI)1520-6378(200004)25:2<105::AID-COL5>3.0.CO;2-G; Stockman A, 2000, METHOD ENZYMOL, V316, P626; Talbot H.F., 1834, LOND EDINB PHIL MAG, V29, P321, DOI DOI 10.1080/14786443408648474; van Hateren JH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-34; Walker AE, 1943, J NEUROPHYSIOL, V6, P213, DOI 10.1152/jn.1943.6.3.213	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123458	10.1371/journal.pone.0123458	http://dx.doi.org/10.1371/journal.pone.0123458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875652	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100177
J	Kuo, CH; Hsieh, TC; Wang, CH; Chou, CL; Lai, YH; Chen, YY; Lin, YL; Wu, ST; Fang, TC				Kuo, Chiu-Huang; Hsieh, Tsung-Cheng; Wang, Chih-Hsien; Chou, Chu-Lin; Lai, Yu-Hsien; Chen, Yi-Ya; Lin, Yu-Li; Wu, Sheng-Teng; Fang, Te-Chao			Increased Risks of Mortality and Atherosclerotic Complications in Incident Hemodialysis Patients Subsequently with Bone Fractures: A Nationwide Case-Matched Cohort Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; CHRONIC KIDNEY-DISEASE; HIP FRACTURE; DIALYSIS PATIENTS; TEMPORAL TRENDS; OUTCOMES; ASSOCIATION; CHOLESTEROL; IMPACT; RATES	Background Hemodialysis (HD) patients with bone fractures have an increased risk for death. However, the risks for mortality and atherosclerotic complications in incident HD patients subsequently with bone fractures are unknown. Methods Data derived from the Taiwan National Health Institute Research Database between January 1997 and December 2008 was analyzed. The enrolled patients included 3,008 incident HD patients subsequently with a single long bone fracture (LB Fx) and 2,070 incident HD patients subsequently with a single non-long bone fracture (NLB Fx). These patients were matched (1:5 ratio) for age, sex, and same duration of HD with incident HD patients who had no fractures and outcomes were measured over a 3-year follow-up. Results After demographic and co-morbidity adjustment, LB Fx increased the risk for overall mortality (HR = 1.59, p < 0.001) and stroke (HR = 1.09, p = 0.028) in incident HD patients. NLB Fx increased the risk for overall mortality (HR = 1.52, p < 0.001), stroke (HR = 1.19, p < 0.001), coronary artery disease (CAD), (HR = 1.13, p = 0.003), and peripheral arterial occlusive disease (PAOD), (HR = 1.41, p < 0.001) in incident HD patients. Moreover, incident patients subsequently with NLB Fx had significantly higher risks of CAD and PAOD than those subsequently with LB Fx. Conclusions The rates of mortality and stroke were significantly higher in incident HD patients subsequently with bone fractures than in matched patients without bone fractures. Incident HD patients subsequently with NLB Fx had significantly higher risks of CAD and PAOD than those subsequently with LB Fx and without bone fractures. Thus, incident HD patients subsequently with bone fractures should be closely followed for a higher mortality and possible development of atherosclerotic complications.	[Kuo, Chiu-Huang; Wang, Chih-Hsien; Lai, Yu-Hsien; Chen, Yi-Ya; Lin, Yu-Li; Wu, Sheng-Teng] Buddhist Tzu Chi Gen Hosp, Div Nephrol, Dept Internal Med, Hualien, Taiwan; [Hsieh, Tsung-Cheng; Chou, Chu-Lin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	fangtechao@yahoo.com.tw		Chou, Chu-Lin/0000-0002-9695-1067; Lai, Yu-Hsien/0000-0002-6687-1058; Hsieh, Tsung-Cheng/0000-0003-3024-8675	Tzu Chi General Hospital (Hualien, Taiwan) [TCRD 100-56]	Tzu Chi General Hospital (Hualien, Taiwan)	This study was supported by a grant (TCRD 100-56) from Tzu Chi General Hospital (Hualien, Taiwan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Beaubrun AC, 2013, J AM SOC NEPHROL, V24, P1461, DOI 10.1681/ASN.2012090916; Berry SD, 2007, ARCH INTERN MED, V167, P1971, DOI 10.1001/archinte.167.18.1971; Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Chen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065077; Chou CL, 2014, ARCH MED RES, V45, P188, DOI 10.1016/j.arcmed.2014.01.009; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fusaro M, 2014, KIDNEY INT, V85, P20, DOI 10.1038/ki.2013.302; Hung HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054304; Hung TH, 2014, HEPATOL RES, V44, P863, DOI 10.1111/hepr.12190; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Li WH, 2012, NEPHROL DIAL TRANSPL, V27, P833, DOI 10.1093/ndt/gfr277; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Mittalhenkle A, 2004, AM J KIDNEY DIS, V44, P672, DOI 10.1053/j.ajkd.2004.07.001; Nair SS, 2013, CLIN J AM SOC NEPHRO, V8, P1336, DOI 10.2215/CJN.10901012; Robbins JA, 2006, J AM GERIATR SOC, V54, P1885, DOI 10.1111/j.1532-5415.2006.00985.x; Rodriguez-Garcia M, 2009, NEPHROL DIAL TRANSPL, V24, P239, DOI 10.1093/ndt/gfn466; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	24	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121705	10.1371/journal.pone.0121705	http://dx.doi.org/10.1371/journal.pone.0121705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874794	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100045
J	Nielsen, MH; Irvine, H; Vedel, S; Raungaard, B; Beck-Nielsen, H; Handberg, A				Nielsen, Morten Hjuler; Irvine, Helle; Vedel, Simon; Raungaard, Bent; Beck-Nielsen, Henning; Handberg, Aase			Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACHILLES-TENDON THICKNESS; C-REACTIVE PROTEIN; OXIDIZED LDL; DENDRITIC CELLS; MACROPHAGES; PATHOGENESIS; CHOLESTEROL; GAMMA; CD36	Objective Animal and in vitro studies have suggested that hypercholesterolemia and increased oxidative stress predisposes to monocyte activation and enhanced accumulation of oxidized LDL cholesterol (oxLDL-C) through a CD36-dependent mechanism. The aim of this study was to investigate the hypothesis that elevated oxLDL-C induce proinflammatory monocytes and increased release of monocyte-derived microparticles (MMPs), as well as up-regulation of CD36, chemokine receptors and proinflammatory factors through CD36-dependent pathways and that this is associated with accelerated atherosclerosis in subjects with heterozygous familial hypercholesterolemia (FH), in particular in the presence of Achilles tendon xanthomas (ATX). Approach and Results We studied thirty FH subjects with and without ATX and twenty-three healthy control subjects. Intima-media thickness (IMT) and Achilles tendon (AT) thickness were measured by ultrasonography. Monocyte classification and MMP analysis were performed by flow cytometry. Monocyte expression of genes involved in atherosclerosis was determined by quantitative PCR. IMT and oxLDL-C were increased in FH subjects, especially in the presence of ATX. In addition, FH subjects had elevated proportions of intermediate CD14++CD16+monocytes and higher circulating MMP levels. Stepwise linear regression identified oxLDLC, gender and intermediate monocytes as predictors of MMPs. Monocyte expression of pro-atherogenic and pro-inflammatory genes regulated by oxLDL-C-CD36 interaction was increased in FH, especially in ATX+ subjects. Monocyte chemokine receptor CX(3)CR1 was identified as an independent contributor to IMT. Conclusions Our data support that lipoprotein-associated oxidative stress is involved in accelerated atherosclerosis in FH, particularly in the presence of ATX, by inducing pro-inflammatory monocytes and increased release of MMPs along with elevated monocyte expression of oxLDLC-induced atherosclerosis-related genes.	[Nielsen, Morten Hjuler] Univ Southern Denmark, Danish PhD Sch Mol Metab, Odense, Denmark; [Irvine, Helle] Aarhus Univ Hosp, Dept Med & Cardiol A, DK-8000 Aarhus, Denmark; [Vedel, Simon] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark; [Raungaard, Bent] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol M, DK-5000 Odense, Denmark; [Nielsen, Morten Hjuler; Handberg, Aase] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	University of Southern Denmark; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital	Nielsen, MH (corresponding author), Univ Southern Denmark, Danish PhD Sch Mol Metab, Odense, Denmark.	mohn@rn.dk		Handberg, Aase/0000-0001-5719-203X	Danish Heart Association; Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism	Danish Heart Association; Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism	This work was supported by The Danish Heart Association and the Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artieda M, 2005, FEBS LETT, V579, P4503, DOI 10.1016/j.febslet.2005.06.087; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Caparevic Z, 2009, SRP ARK CELOK LEK, V137, P140, DOI 10.2298/SARH0904140C; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Civeira F, 2005, ARTERIOSCL THROM VAS, V25, P1960, DOI 10.1161/01.ATV.0000177811.14176.2b; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; de Groot E, 2008, NAT CLIN PRACT CARD, V5, P280, DOI 10.1038/ncpcardio1163; Descamps OS, 2001, ATHEROSCLEROSIS, V157, P514, DOI 10.1016/S0021-9150(01)00533-0; Dzik WH, 2010, CYTOM PART B-CLIN CY, V78B, P81, DOI 10.1002/cyto.b.20504; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Frankenberger M, 1996, BLOOD, V87, P373; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Huh HY, 1996, BLOOD, V87, P2020; Jarauta E, 2008, ATHEROSCLEROSIS; Kiortsis DN, 2006, ATHEROSCLEROSIS, V186, P228, DOI 10.1016/j.atherosclerosis.2006.02.002; Leroyer AS, 2008, J INTERN MED, V263, P528, DOI 10.1111/j.1365-2796.2008.01957.x; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Liu ML, 2007, ARTERIOSCL THROM VAS, V27, P430, DOI 10.1161/01.ATV.0000254674.47693.e8; Matsumoto N, 2004, THROMB HAEMOSTASIS, V91, P146, DOI 10.1160/TH03-04-0247; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosig S, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-60; Mosig S, 2009, FASEB J, V23, P866, DOI 10.1096/fj.08-118240; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Le NA, 2015, INT J MOL SCI, V16, P401, DOI 10.3390/ijms16010401; Nielsen MH, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.20795; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rothe G, 1996, ARTERIOSCL THROM VAS, V16, P1437, DOI 10.1161/01.ATV.16.12.1437; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stein Evan A, 2002, Curr Atheroscler Rep, V4, P14, DOI 10.1007/s11883-002-0057-8; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Tsouli SG, 2005, EUR J CLIN INVEST, V35, P236, DOI 10.1111/j.1365-2362.2005.01484.x; Tsouli SG, 2006, J LIPID RES, V47, P2208, DOI 10.1194/jlr.M600109-JLR200; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wegner M, 2012, CLIN BIOCHEM, V45, P1620, DOI 10.1016/j.clinbiochem.2012.08.019; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	49	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121516	10.1371/journal.pone.0121516	http://dx.doi.org/10.1371/journal.pone.0121516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875611	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100042
J	Petrides, KV; Furnham, A				Petrides, K. V.; Furnham, Adrian			Further Tests of Belief-Importance Theory	PLOS ONE			English	Article							TRAIT EMOTIONAL INTELLIGENCE; BIG 5; PERSONALITY; QUESTIONNAIRE; PSYCHOLOGY; MODEL	Belief-importance (belimp) theory hypothesizes that personality traits confer a propensity to perceive convergences or divergences between the belief that we can attain certain goals and the importance that we place on these goals. Belief and importance are conceptualized as two coordinates, together defining the belimp plane. We tested fundamental aspects of the theory using four different planes based on the life domains of appearance, family, financial security, and friendship as well as a global plane combining these four domains. The criteria were from the areas of personality (Big Five and trait emotional intelligence) and learning styles. Two hundred and fifty eight participants were allocated into the four quadrants of the belimp plane (Hubris, Motivation, Depression, and Apathy) according to their scores on four reliable instruments. Most hypotheses were supported by the data. Results are discussed with reference to the stability of the belimp classifications under different life domains and the relationship of the quadrants with the personality traits that are hypothesized to underpin them.	[Petrides, K. V.] UCL, London Psychometr Lab, London WC1H 0AP, England; [Furnham, Adrian] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London	Petrides, KV (corresponding author), UCL, London Psychometr Lab, 26 Bedford Way, London WC1H 0AP, England.	k.petrides@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Ashton MC, 1998, J ORGAN BEHAV, V19, P289, DOI 10.1002/(SICI)1099-1379(199805)19:3<289::AID-JOB841>3.3.CO;2-3; Bandura A, 1997, SELF EFFICACY EXERCI, DOI [10.1080/08870440802254597, DOI 10.1080/08870440802254597]; Barrett PT, 1998, PERS INDIV DIFFER, V25, P805, DOI 10.1016/S0191-8869(98)00026-9; Biggs JB, 1987, STUDY PROCESS QUESTI; Chamorro-Premuzic T, 2009, LEARN INDIVID DIFFER, V19, P524, DOI 10.1016/j.lindif.2009.06.004; Cooper A, 2010, J PERS ASSESS, V92, P449, DOI 10.1080/00223891.2010.497426; COSTA PT, 1986, CLIN PSYCHOL REV, V6, P407, DOI 10.1016/0272-7358(86)90029-2; Costa PT, 2007, REVISED NEO PERSONAL; Epstein S, 2010, PSYCHOL INQ, V21, P34, DOI 10.1080/10478401003648682; FISHBEIN M, 1963, HUM RELAT, V16, P233, DOI 10.1177/001872676301600302; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; Levine SZ, 2004, LEGAL CRIMINOL PSYCH, V9, P135, DOI 10.1348/135532504322776906; Magidson JF, 2014, DEV PSYCHOL, V50, P1442, DOI 10.1037/a0030583; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Ormel J, 2004, SOC PSYCH PSYCH EPID, V39, P906, DOI 10.1007/s00127-004-0873-y; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Petrides KV, 2011, SCAND J PSYCHOL, V52, P161, DOI 10.1111/j.1467-9450.2010.00832.x; Petrides KV, 2011, TWIN RES HUM GENET, V14, P35, DOI 10.1375/twin.14.1.35; Petrides KV, 2011, BRIT J EDUC PSYCHOL, V81, P97, DOI 10.1111/j.2044-8279.2010.02010.x; Petrides KV, 2010, SOC BEHAV PERSONAL, V38, P697, DOI 10.2224/sbp.2010.38.5.697; Petrides KV, 2011, NEW IDEAS PSYCHOL, V29, P64, DOI 10.1016/j.newideapsych.2010.02.001; Petrides KV, 2006, J APPL SOC PSYCHOL, V36, P552, DOI 10.1111/j.0021-9029.2006.00019.x; Rogers W.L., 1976, QUALITY AM LIFE PERC; Saucier G, 1998, J PERS ASSESS, V70, P263, DOI 10.1207/s15327752jpa7002_6; TWENGE JEAN M., 2009, NARCISSISM EPIDEMIC; Uher J, 2013, INTEGR PSYCHOL BEHAV, V47, P1, DOI 10.1007/s12124-013-9230-6; Van Gestel S, 2003, MOL PSYCHIATR, V8, P840, DOI 10.1038/sj.mp.4001367	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121978	10.1371/journal.pone.0121978	http://dx.doi.org/10.1371/journal.pone.0121978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874374	Green Published, gold			2022-12-27	WOS:000352845100054
J	Stinglhamber, F; Marique, G; Caesens, G; Desmette, D; Hansez, I; Hanin, D; Bertrand, F				Stinglhamber, Florence; Marique, Geraldine; Caesens, Gaetane; Desmette, Donatienne; Hansez, Isabelle; Hanin, Dorothee; Bertrand, Francoise			Employees' Organizational Identification and Affective Organizational Commitment: An Integrative Approach	PLOS ONE			English	Article							LEADER-MEMBER EXCHANGE; PERCEIVED EXTERNAL PRESTIGE; SOCIAL IDENTITY; MEDIATING ROLE; PSYCHOLOGICAL EMPOWERMENT; SELF-CATEGORIZATION; VOLUNTARY TURNOVER; JOB-SATISFACTION; SUPPORT; WORK	Although several studies have empirically supported the distinction between organizational identification (OI) and affective commitment (AC), there is still disagreement regarding how they are related. Precisely, little attention has been given to the direction of causality between these two constructs and as to why they have common antecedents and outcomes. This research was designed to fill these gaps. Using a cross-lagged panel design with two measurement times, Study 1 examined the directionality of the relationship between OI and AC, and showed that OI is positively related to temporal change in AC, confirming the antecedence of OI on AC. Using a cross-sectional design, Study 2 investigated the mediating role of OI in the relationship between three work experiences (i.e., perceived organizational support, leader-member exchange, and job autonomy) and AC, and found that OI partially mediates the influence of work experiences on AC. Finally, Study 3 examined longitudinally how OI and AC combine in the prediction of actual turnover, and showed that AC totally mediates the relationship between OI and turnover. Overall, these findings suggest that favorable work experiences operate via OI to increase employees' AC that, in turn, decreases employee turnover.	[Stinglhamber, Florence; Marique, Geraldine; Caesens, Gaetane; Desmette, Donatienne; Hanin, Dorothee] Catholic Univ Louvain, Dept Psychol, Louvain, Belgium; [Hansez, Isabelle] Univ Liege, Dept Psychol, Liege, Belgium; [Bertrand, Francoise] Belgian Def, DGHR Sect Recrutement & Select Res & Dev, Brussels, Belgium	Universite Catholique Louvain; University of Liege	Stinglhamber, F (corresponding author), Catholic Univ Louvain, Dept Psychol, Louvain, Belgium.	florence.stinglhamber@uclouvain.be		HANSEZ, Isabelle/0000-0002-6014-9849	Fonds National de la Recherche Scientifique de Belgique (FRS-FNRS) [1141212F, 1137015F]	Fonds National de la Recherche Scientifique de Belgique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS)	Geraldine Marique was supported by grant 1141212F from the Fonds National de la Recherche Scientifique de Belgique (FRS-FNRS, www.frs-fnrs.be). Gaetane Caesens was supported by grant 1137015F from the Fonds National de la Recherche Scientifique de Belgique (FRS-FNRS, www.frs-fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D., 2001, SOCIAL IDENTITY PROC, P115; Amiot CE, 2007, PERS SOC PSYCHOL REV, V11, P364, DOI 10.1177/1088868307304091; [Anonymous], 2004, INT REV IND ORG PSYC, V19, P171, DOI DOI 10.1002/0470013311.CH6; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Apker Julie, 2003, Nurs Econ, V21, P226; Aryee S, 2006, J BUS RES, V59, P793, DOI 10.1016/j.jbusres.2005.03.003; Ashforth B. E., 2007, INT REV IND ORG PSYC, V22, P1, DOI [10.1002/9780470753378.ch1, DOI 10.1002/9780470753378.CH1]; ASHFORTH BE, 1989, ACAD MANAGE REV, V14, P20, DOI 10.2307/258189; Ashforth BE, 2008, J MANAGE, V34, P325, DOI 10.1177/0149206308316059; Bamber EM, 2002, AUDITING-J PRACT TH, V21, P21, DOI 10.2308/aud.2002.21.2.21; BECKER TE, 1992, ACAD MANAGE J, V35, P232, DOI 10.2307/256481; Becker TE, 2005, ORGAN RES METHODS, V8, P274, DOI 10.1177/1094428105278021; Bell SJ, 2002, J RETAILING, V78, P131, DOI 10.1016/S0022-4359(02)00069-6; Bergami M, 2000, BRIT J SOC PSYCHOL, V39, P555, DOI 10.1348/014466600164633; BILLIG M, 1973, EUR J SOC PSYCHOL, V3, P27, DOI 10.1002/ejsp.2420030103; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Brislin R.W., 1980, HDB CROSSCULTURAL PS, P398; Carmeli A, 2006, CORP REPUT REV, V9, P92, DOI 10.1057/palgrave.crr.1550014; CARSTEN JM, 1987, J APPL PSYCHOL, V72, P374, DOI 10.1037/0021-9010.72.3.374; Conway JM, 2010, J BUS PSYCHOL, V25, P325, DOI 10.1007/s10869-010-9181-6; Cooper D, 2010, ACAD MANAGE REV, V35, P516, DOI 10.5465/AMR.2010.53502693; Dess GG, 2001, ACAD MANAGE REV, V26, P446, DOI 10.2307/259187; Dovidio J, 1996, STEREOTYPES STEREOTY, P276, DOI DOI 10.1177/1368430204046142; DUNHAM RB, 1994, J APPL PSYCHOL, V79, P370, DOI 10.1037/0021-9010.79.3.370; Edwards MR, 2007, EUR J WORK ORGAN PSY, V16, P25, DOI 10.1080/13594320601088195; Edwards MR, 2010, J PERS PSYCHOL, V9, P17, DOI 10.1027/1866-5888/a000007; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; Eisenberger R, 2002, J APPL PSYCHOL, V87, P565, DOI 10.1037//0021-9010.87.3.565; Eisenberger R., 2011, PERCEIVED ORGANIZATI; Eisenberger R, 2014, J ORGAN BEHAV, V35, P635, DOI 10.1002/job.1877; Eisenberger R, 2010, J APPL PSYCHOL, V95, P1085, DOI 10.1037/a0020858; Ellemers N, 1997, J PERS SOC PSYCHOL, V72, P617, DOI 10.1037/0022-3514.72.3.617; Ellemers N, 2004, ACAD MANAGE REV, V29, P459, DOI 10.2307/20159054; Finkel SE, 1995, CAUSAL ANALYSIS WITH; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fuller JB, 2006, J ORGAN BEHAV, V27, P1089, DOI 10.1002/job.408; Fuller JB, 2006, HUM RELAT, V59, P815, DOI 10.1177/0018726706067148; Goodman JS, 1996, J MANAGE, V22, P627, DOI 10.1177/014920639602200405; GRAEN GB, 1995, LEADERSHIP QUART, V6, P219, DOI 10.1016/1048-9843(95)90036-5; Griffeth RW, 2000, J MANAGE, V26, P463, DOI 10.1177/014920630002600304; HACKMAN JR, 1975, J APPL PSYCHOL, V60, P159, DOI 10.1037/h0076546; Hayes A. F., 2013, INTRODUCTION TO MEDI; Hogg MA, 2000, ACAD MANAGE REV, V25, P121, DOI 10.1093/cdj/bsi087; Humphrey SE, 2007, J APPL PSYCHOL, V92, P1332, DOI 10.1037/0021-9010.92.5.1332; Jackson JW, 2002, SELF IDENTITY, V1, P11, DOI 10.1080/152988602317232777; Jû┬reskog KG., 1993, LISREL 8 USERS REFER; Kacmar KM, 2006, ACAD MANAGE J, V49, P133, DOI 10.2307/20159750; Kaplan D., 2000, STRUCTURAL EQUATION, DOI [10.1111/j.1745-3984.2002.tb01142, DOI 10.1111/J.1745-3984.2002.TB01142]; Kenny D.A., 1998, HDB SOCIAL PSYCHOL, V4th ed., P233; Kim J, 2013, SOC BEHAV PERSONAL, V41, P1019, DOI 10.2224/sbp.2013.41.6.1019; Klein HJ, 2009, COMMITMENT IN ORGANI; Lang J, 2011, J APPL PSYCHOL, V96, P602, DOI 10.1037/a0022463; Lavelle JJ, 2007, J MANAGE, V33, P841, DOI 10.1177/0149206307307635; Lee J, 2007, J ORGAN BEHAV, V28, P661, DOI 10.1002/job.431; LEVINSON H, 1965, ADMIN SCI QUART, V9, P370, DOI 10.2307/2391032; Liden RC, 1997, RES PERS H, V15, P47; Liden RC, 2000, J APPL PSYCHOL, V85, P407, DOI 10.1037//0021-9010.85.3.407; Lievens F, 2007, BRIT J MANAGE, V18, pS45, DOI 10.1111/j.1467-8551.2007.00525.x; Mackie DM, 1998, PSYCHOL REV, V105, P499, DOI 10.1037/0033-295X.105.3.499; MacKinnon D P, 1994, NIDA Res Monogr, V139, P127; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MACKINNON DP, 2000, MULT APPL BK SER, P141; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Maertz CP, 2004, J MANAGE, V30, P667, DOI 10.1016/j.jm.2004.04.001; Marique G, 2013, GROUP ORGAN MANAGE, V38, P68, DOI 10.1177/1059601112457200; Marique G, 2011, J PERS PSYCHOL, V10, P107, DOI 10.1027/1866-5888/a000040; Maruyama GM, 1998, BASICS OF STRUCTURAL; Meyer J. P., 2001, HUM RESOUR MANAGE R, V11, P299, DOI [10.1016/S1053-4822(00)00053-X, 10.1016/S1053-4822%2800%2900053-X, DOI 10.1016/S1053-4822(00)00053-X]; Meyer J.P., 1991, HUM RESOUR MANAGE R, V1, P61, DOI [10.1016/1053-4822(91)90011-Z, DOI 10.1016/1053-4822(91)90011-Z]; Meyer J. P., 1997, COMMITMENT IN THE WO; Meyer JP, 2006, J ORGAN BEHAV, V27, P665, DOI 10.1002/job.383; MEYER JP, 1993, J APPL PSYCHOL, V78, P538, DOI 10.1037/0021-9010.78.4.538; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; Meyer JP, 2004, J APPL PSYCHOL, V89, P991, DOI 10.1037/0021-9010.89.6.991; Northouse PG, 2010, LEADERSHIP THEORY AN; OREILLY C, 1986, J APPL PSYCHOL, V71, P492, DOI 10.1037/0021-9010.71.3.492; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pratt M. G., 2012, SOCIAL IDENTITY PROC, P13; Pratt M.G., 1998, IDENTITY ORGAN, V24, P171; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rhoades L, 2001, J APPL PSYCHOL, V86, P825, DOI 10.1037//0021-9010.86.5.825; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Riketta M, 2005, J VOCAT BEHAV, V66, P358, DOI 10.1016/j.jvb.2004.05.005; Riketta M., 2009, COMMITMENT ORG ACCUM, P69; Saks AM, 1997, J VOCAT BEHAV, V51, P234, DOI 10.1006/jvbe.1997.1614; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sluss DM, 2008, J VOCAT BEHAV, V73, P457, DOI 10.1016/j.jvb.2008.09.001; Smith LGE, 2012, BRIT J MANAGE, V23, P45, DOI 10.1111/J.1467-8551.2010.00728.X; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tangirala S, 2007, J APPL PSYCHOL, V92, P309, DOI 10.1037/0021-9010.92.2.309; TETT RP, 1993, PERS PSYCHOL, V46, P259, DOI 10.1111/j.1744-6570.1993.tb00874.x; Turner J. C., 1985, ADV GROUP PROCESSES, V2, P77; Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07; Van Dick R, 2004, BRIT J MANAGE, V15, P351, DOI 10.1111/j.1467-8551.2004.00424.x; van Dick R, 2001, INT J MANAG REV, V3, P265, DOI 10.1111/1468-2370.00068; van Knippenberg D, 2006, J ORGAN BEHAV, V27, P571, DOI 10.1002/job.359; Vandenberg R.J., 2009, COMMITMENT ORG ACCUM, P383; Wayne S. J, 2009, COMMITMENT ORG ACCUM, P253; Wayne SJ, 1997, ACAD MANAGE J, V40, P82, DOI 10.2307/257021	102	41	41	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123955	10.1371/journal.pone.0123955	http://dx.doi.org/10.1371/journal.pone.0123955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875086	Green Published, gold			2022-12-27	WOS:000352845100227
J	Tankwanchi, ABS; Vermund, SH; Perkins, DD				Tankwanchi, Akhenaten Benjamin Siankam; Vermund, Sten H.; Perkins, Douglas D.			Monitoring Sub-Saharan African Physician Migration and Recruitment Post-Adoption of the WHO Code of Practice: Temporal and Geographic Patterns in the United States	PLOS ONE			English	Article							INTERNATIONAL RECRUITMENT; GLOBAL CODE; HEALTH PERSONNEL; BRAIN WASTE; EDUCATION; DRAIN; CONSORTIUM; NETWORKS; FOREIGN; WORKERS	Data monitoring is a key recommendation of the WHO Global Code of Practice on the International Recruitment of Health Personnel, a global framework adopted in May 2010 to address health workforce retention in resource-limited countries and the ethics of international migration. Using data on African-born and African-educated physicians in the 2013 American Medical Association Physician Masterfile (AMA Masterfile), we monitored Sub-Saharan African (SSA) physician recruitment into the physician workforce of the United States (US) post-adoption of the WHO Code of Practice. From the observed data, we projected to 2015 with linear regression, and we mapped migrant physicians' locations using GPS Visualizer and ArcGIS. The 2013 AMA Masterfile identified 11,787 active SSA-origin physicians, representing barely 1.3% (11,787/940,456) of the 2013 US physician workforce, but exceeding the total number of physicians reported by WHO in 34 SSA countries (N = 11,519). We estimated that 15.7%(1,849/11,787) entered the US physician workforce after the Code of Practice was adopted. Compared to pre-Code estimates from 2002 (N = 7,830) and 2010 (N = 9,938), the annual admission rate of SSA emigres into the US physician workforce is increasing. This increase is due in large part to the growing number of SSA-born physicians attending medical schools outside SSA, representing a trend towards younger migrants. Projection estimates suggest that there will be 12,846 SSA migrant physicians in the US physician workforce in 2015, and over 2,900 of them will be post-Code recruits. Most SSA migrant physicians are locating to large urban US areas where physician densities are already the highest. The Code of Practice has not slowed the SSA-to-US physician migration. To stem the physician "brain drain", it is essential to incentivize professional practice in SSA and diminish the appeal of US migration with bolder interventions targeting primarily earlycareer (age <= 35) SSA physicians.	[Tankwanchi, Akhenaten Benjamin Siankam; Perkins, Douglas D.] Vanderbilt Univ, Program Community Res & Act, Dept Human & Org Dev, Peabody Coll Educ & Human Dev, Nashville, TN 37235 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University Peabody College; Vanderbilt University; Vanderbilt University	Tankwanchi, ABS (corresponding author), Vanderbilt Univ, Program Community Res & Act, Dept Human & Org Dev, Peabody Coll Educ & Human Dev, 221 Kirkland Hall, Nashville, TN 37235 USA.	akhenaton.tankwanchi@gmail.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Tankwanchi, Akhenaten/0000-0002-6051-3292	Fogarty International Center [R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grant R24TW007988 to SHV from the Fogarty International Center [http://www.fic.nih.gov/Pages/Default.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association's website, DAT EL AMA PHYS MAST; [Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; [Anonymous], 2006, WORK TOG HLTH; [Anonymous], RES 2012 MED SCH ENR; [Anonymous], COMMUNICATION; [Anonymous], 2013, 3 GLOB FOR HUM RES H; April MD, 2014, J INFECT DIS, V209, P491, DOI 10.1093/infdis/jit584; Association of American Medical Colleges Center for Workforce Study, 2014, 2013 STAT PHYS WORKF; Awases M., 2004, MIGRATION HLTH PROFE; Baker D., 2012, DOCTOR SHORTAGE NYT; Baubock R, 2010, IMISCOE RES, P295; Braichet JM, 2010, SANTE PUBLIQUE, V22, P599, DOI 10.3917/spub.106.0599; Clemens MA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-1; Cometto G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001514; Committee on the US Commitment to Global Health, 2009, US COMM GLOB HLTH RE; Cooke M, 2015, COMMUNICATION; Cooper RA, 2015, HEARING DELIVERY REF; de Haas H, 2010, J ETHN MIGR STUD, V36, P1587, DOI 10.1080/1369183X.2010.489361; Dowling PT, 2012, PRIMARY CARE, V39, P643, DOI 10.1016/j.pop.2012.08.002; Dumont JC, 2007, INT MIGRATION OUTLOO, P162; Edge JS, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-60; Educational Commission for Foreign Medical Graduates, IMG PERF 2011 MATCH; Educational Commission for Foreign Medical Graduates, IMG PERF 2014 MATCH; Educational Commission for Foreign Medical Graduates' website, ECFMG CERT; Eichbaum Q, 2014, ACAD MED, V89, pS108, DOI 10.1097/ACM.0000000000000340; Eichbaum Q, 2012, JAIDS-J ACQ IMM DEF, V61, P263, DOI 10.1097/QAI.0b013e31826bf957; Eyal N, 2012, AM J BIOETHICS, V12, P23, DOI 10.1080/15265161.2012.665134; First National Bank, U BOTSW GRAD 1 BOTSW; Frehywot S, 2014, ACAD MED S, V89, pS1, DOI [10.1097/ACM.0000000000000357, DOI 10.1097/ACM.0000000000000357]; Global Health Workforce Alliance World Health Organization, 2013, UN TRUTH NO HLTH WOR; Gostin LO, LANCET; Hagopian A, 2005, SOC SCI MED, V61, P1750, DOI 10.1016/j.socscimed.2005.03.027; Hagopian A, 2003, HEALTH AFFAIR, V22, P241, DOI 10.1377/hlthaff.22.5.241; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Hart LG, 2007, HEALTH AFFAIR, V26, P1159, DOI 10.1377/hlthaff.26.4.1159; Haug S, 2008, J ETHN MIGR STUD, V34, P585, DOI 10.1080/13691830801961605; Hoyt DB, 2015, COMMUNICATION; Iglehart JK, 2013, NEW ENGL J MED, V369, P297, DOI 10.1056/NEJMp1306445; Iglehart JK, 2011, NEW ENGL J MED, V365, P1340, DOI 10.1056/NEJMhpr1107519; IHS, COMPL PHYS SUPPL DEM; International Monetary Fund, FACTSH DEBT REL HEAV; Johnson K, 2006, ACAD MED, V81, P179, DOI 10.1097/00001888-200602000-00019; Kahn TR, 2010, ACAD MED, V85, P614, DOI 10.1097/ACM.0b013e3181d2ad1d; Kirch D, 1979, AAMC ENDORSES CONRAD; Ley D, 2003, ANN ASSOC AM GEOGR, V93, P426, DOI 10.1111/1467-8306.9302010; Lofters A, 2014, RISK MANAG HEALTHC P, V7, P81, DOI 10.2147/RMHP.S60708; Madara LJ, 2013, CONRAD STATE 30 PHYS; Mandala WL, 2014, LANCET GLOB HEALTH, V2, pE691, DOI 10.1016/S2214-109X(14)70321-3; Mattoo A, 2008, J DEV ECON, V87, P255, DOI 10.1016/j.jdeveco.2007.05.001; McGroarty P., 2014, WALL STREET J; Mick SS, 2000, SOC SCI MED, V50, P185, DOI 10.1016/S0277-9536(99)00183-5; Mmegi, 1 MDS GRAD UB; Moore J, 2014, BUZZFEED NEWS   0911; Morgan A, 2015, NRHA SUPPORTS CONRAD; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2013, HEALTH AFFAIR, V32, P1914, DOI 10.1377/hlthaff.2013.0545; Mullan F, 2012, HEALTH AFFAIR, V31, P1561, DOI 10.1377/hlthaff.2012.0219; National Resident Matching Program, ADV DAT TABL 2014 MA; O'Rourke K, 2014, JAMA-J AM MED ASSOC, V312, P880, DOI 10.1001/jama.2014.10664; Ohlheiser A., 2014, WASHINGTON POST; Organization for Economic Co-operation and Development, DEV AID INCR WORR TR; Polsky D, 2002, HEALTH SERV RES, V37, P907, DOI 10.1034/j.1600-0560.2002.58.x; Ratha D, 2011, LEVERAGING MIGRATION FOR AFRICA: REMITTANCES, SKILLS, AND INVESTMENTS, P1, DOI 10.1596/978-0-8213-8257-8; Reddi A, 2012, AIDS, V26, P1979, DOI 10.1097/QAD.0b013e32835857d4; Save GME's website, PROT FED FUND GRAD M; Saxton JF, 2009, JAMA-J AM MED ASSOC, V301, P1925, DOI 10.1001/jama.2009.660; SCHILLER NG, 1992, ANN NY ACAD SCI, V645, P1; Sheikh A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-43; Shipman SA, 2013, ACAD MED, V88, P1904, DOI 10.1097/ACM.0000000000000040; Siankam Benjamin, 2011, Psychosocial Intervention, V20, P295, DOI 10.5093/in2011v20n3a6; Siskind Susser PC's, AM HOSP ASS END CONR; Siyam A, 2013, B WORLD HEALTH ORGAN, V91, P816, DOI 10.2471/BLT.13.118778; Stilwell B, 2004, B WORLD HEALTH ORGAN, V82, P595; Tankwanchi ABS, 2014, LANCET GLOB HEALTH, V2, pE390, DOI 10.1016/S2214-109X(14)70240-2; Tankwanchi ABS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001513; Tankwanchi S, 2012, THESIS VANDERBILT U; Taylor AL, 2011, NEW ENGL J MED, V365, P2348, DOI 10.1056/NEJMp1108658; The White House's website, FACT SHEET GLOB HLTH; Thompson MJ, 2009, J RURAL HEALTH, V25, P2; U.S. Department of State Bureau of Consular Affairs, VIS WAIV PROGR; United States Citizenship and Immigration Services', CONR 30 WAIV PROGR; University of Namibia School of Medicine's, SCH OV; Vujicic Marko, 2004, Hum Resour Health, V2, P3, DOI 10.1186/1478-4491-2-3; WHO [World Health Organization], 2013, WHO GLOB HLTH WORKF; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization, EB SIT REP; World Health Organization, 2010, WHO GLOB COD PRACT I; World Health Organization Global Health Workforce Alliance, 2008, SCAL SAV LIV TASK FO, DOI 10.1016/S0140-6736 (08)60309-8	88	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124734	10.1371/journal.pone.0124734	http://dx.doi.org/10.1371/journal.pone.0124734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875010	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100269
J	Hu, MB; Bai, PD; Wu, YS; Zhang, LM; Xu, H; Na, R; Jiang, HW; Ding, Q				Hu, Meng-Bo; Bai, Pei-De; Wu, Yi-Shuo; Zhang, Li-Min; Xu, Hua; Na, Rong; Jiang, Hao-Wen; Ding, Qiang			Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; OBESITY; ANTIGEN; TESTOSTERONE; ASSOCIATION; POPULATION; IMPACT; SIZE; PSA	Objective To investigate the relationship between body mass index (BMI) and prostate cancer (PCa) risk at biopsy in Chinese men. Patients and Methods We retrospectively reviewed the records of 1,807 consecutive men who underwent initial multicore (>= 10) prostate biopsy under transrectal ultrasound guidance between Dec 2004 and Feb 2014. BMI was categorised based on the Asian classification of obesity as follows: <18.5 (underweight), 18.5-22.9 (normal weight), 23-24.9 (overweight), 25-29.9 (moderately obese), and >= 30 kg/m2 (severely obese). The odds ratios (OR) of each BMI category for risk of PCa and high-grade prostate cancer (HGPCa, Gleason score >= 4+ 3) detection were estimated in crude, age-adjusted and multivariate-adjusted models. Prevalence ratios and accuracies of PSA predicted PCa were also estimated across BMI groups. Results In total, PCa was detected by biopsy in 750 (45.4%) men, and HGPCa was detected in 419 (25.4%) men. Compared with men of normal weight, underweight men and obese men were older and had higher prostate specific antigen levels. The risk of overall PCa detection via biopsy presented an obvious U-shaped relationship with BMI in crude analysis. Overall, 50.0%, 37.4%, 45.6% 54.4% and 74.1% of the men in the underweight, normal weight, overweight, moderately obese and severely obese groups, respectively, were diagnosed with PCa via biopsy. In multivariate analysis, obesity was significantly correlated with a higher risk of PCa detection (OR = 1.17, 95% CI 1.10-1.25, P<0.001). However, higher BMI was not correlated with HGPCa detection (OR = 1.03, 95% CI 0.97-1.09, P = 0.29). There were no significant differences in the accuracy of using PSA to predict PCa or HGPCa detection across different BMI categories. Conclusion Obesity was associated with higher risk of PCa detection in the present Chinese biopsy population. No significant association was detected between obesity and HGPCa.	[Hu, Meng-Bo; Bai, Pei-De; Wu, Yi-Shuo; Zhang, Li-Min; Xu, Hua; Na, Rong; Jiang, Hao-Wen; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	haowenj@gmail.com; qiangd_urol@126.com	Na, Rong/AAN-8655-2021; Xu, Hua/AAH-2453-2019; Hu, Meng-Bo/HDL-7502-2022	Na, Rong/0000-0001-7470-5108; 	National Natural Science Foundation of China [81272835]; Program for New Century Excellent Talents in University, China [NCET-13-0136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, China(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Natural Science Foundation of China (Grant No. 81272835, received by HWJ, www.nsfc.gov.cn) and Program for New Century Excellent Talents in University, China (NCET-13-0136, received by HWJ, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banez LL, 2007, JAMA-J AM MED ASSOC, V298, P2275, DOI 10.1001/jama.298.19.2275; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Chen WQ, 2014, CHINESE J CANCER RES, V26, P48, DOI 10.3978/j.issn.1000-9604.2014.01.08; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fowke JH, 2007, PROSTATE CANCER P D, V10, P137, DOI 10.1038/sj.pcan.4500924; Freedland SJ, 2009, PROSTATE CANCER P D, V12, P259, DOI 10.1038/pcan.2009.11; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Hisasue S, 2008, JPN J CLIN ONCOL, V38, P129, DOI 10.1093/jjco/hym162; Hu MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106677; Hu MB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0829-8; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaks R, 2014, NAT REV ENDOCRINOL, V10, P644, DOI 10.1038/nrendo.2014.168; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Kim YJ, 2007, INT J UROL, V14, P1009, DOI 10.1111/j.1442-2042.2007.01879.x; Kobayashi T, 2005, UROLOGY, V66, P130, DOI 10.1016/j.urology.2005.01.041; Lee SE, 2011, BJU INT, V107, P1250, DOI 10.1111/j.1464-410X.2010.09592.x; Lee SE, 2010, UROLOGY, V76, P1063, DOI 10.1016/j.urology.2010.03.069; Lovasi Gina S, 2012, Open Epidemiol J, V5, P13; Masuda H, 2013, INT J UROL, V20, P701, DOI 10.1111/iju.12023; Nandeesha H, 2009, INT UROL NEPHROL, V41, P267, DOI 10.1007/s11255-008-9440-x; Narita S, 2013, PROSTATE CANCER P D, V16, P271, DOI 10.1038/pcan.2013.16; Oh JJ, 2013, BJU INT, V112, pE265, DOI 10.1111/j.1464-410X.2012.11766.x; Park JH, 2009, J UROLOGY, V182, P106, DOI 10.1016/j.juro.2009.02.130; Park J, 2014, BJU INT, V114, P891, DOI 10.1111/bju.12600; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Price RS, 2012, PROSTATE CANCER P D, V15, P135, DOI 10.1038/pcan.2011.54; Qu YY, 2013, ASIAN J ANDROL, V15, P747, DOI 10.1038/aja.2013.104; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; Yang Chao-Yang, 2011, Chang Gung Med J, V34, P1	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124668	10.1371/journal.pone.0124668	http://dx.doi.org/10.1371/journal.pone.0124668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861033	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300143
J	Sadasivan, S; Zanin, M; O'Brien, K; Schultz-Cherry, S; Smeyne, RJ				Sadasivan, Shankar; Zanin, Mark; O'Brien, Kevin; Schultz-Cherry, Stacey; Smeyne, Richard J.			Induction of Microglia Activation after Infection with the Non-Neurotropic A/CA/04/2009 H1N1 Influenza Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; UP-REGULATION; CELLS; NEUROINFLAMMATION; MACROPHAGES; SURVIVAL; MODEL; CNS; ENCEPHALOPATHY; INFLAMMATION	Although influenza is primarily a respiratory disease, it has been shown, in some cases, to induce encephalitis, including people acutely infected with the pandemic A/California/04/ 2009 (CA/09) H1N1 virus. Based on previous studies showing that the highly pathogenic avian influenza (HPAI) A/Vietnam/1203/2004 H5N1 virus was neurotropic, induced CNS inflammation and a transient parkinsonism, we examined the neurotropic and inflammatory potential of the CA/09 H1N1 virus in mice. Following intranasal inoculation, we found no evidence for CA/09 H1N1 virus neurotropism in the enteric, peripheral or central nervous systems. We did, however, observe a robust increase in microglial activity in the brain characterized by an increase in the number of activated Iba-1-positive microglia in the substantia nigra (SN) and the hippocampus, despite the absence of virus in the brain. qPCR analysis in SN tissue showed that the induction of microgliosis was preceded by reduced gene expression of the neurotrophic factors bdnf, and gdnf and increases in the immune modulatory chemokine chemokine (C-C motif) ligand 4 (ccl4). We also noted changes in the expression of transforming growth factor-1 (tgf beta 1) in the SN starting at 7 days post-infection (dpi) that was sustained through 21 dpi, coupled with increases in arginase-1 (arg1) and csf1, M2 markers for microglia. Given that neuroinflammation contributes to generation and progression of a number of neurodegenerative disorders, these findings have significant implications as they highlight the possibility that influenza and perhaps other non-neurotropic viruses can initiate inflammatory signals via microglia activation in the brain and contribute to, but not necessarily be the primary cause of, neurodegenerative disorders.	[Sadasivan, Shankar; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zanin, Mark; O'Brien, Kevin; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Smeyne, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA.	Richard.smeyne@stjude.org	Schultz-Cherry, Stacey/N-2506-2018	Smeyne, Richard/0000-0002-8459-5472; Zanin, Mark/0000-0003-3158-1744	National Institute of Health [NS075840-01]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075840] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Health NS075840-01 and American Lebanese Syrian Associated Charities (www.stjude.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Chen XX, 2014, VET MICROBIOL, V170, P48, DOI 10.1016/j.vetmic.2014.01.031; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004; Frisullo G, 2011, HUM IMMUNOL, V72, P632, DOI 10.1016/j.humimm.2011.04.006; Fuchigami T, 2012, PEDIATR EMERG CARE, V28, P998, DOI 10.1097/PEC.0b013e31826ca999; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Hayakawa K, 2014, J NEUROSCI RES; Henry J, 2010, PARKINSONISM RELAT D; Jang H, 2012, J NEUROSCI, V32, P1545, DOI 10.1523/JNEUROSCI.5123-11.2012; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; KIEFER R, 1993, J NEUROSCI RES, V36, P391, DOI 10.1002/jnr.490360405; KLEMPT ND, 1992, MOL BRAIN RES, V13, P93, DOI 10.1016/0169-328X(92)90048-G; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Louboutin JP, 2013, CNS NEUROL DISORD-DR, V12, P815, DOI 10.2174/18715273113126660173; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Lyck R, 2012, J VASC RES, V49, P497, DOI 10.1159/000341232; Madore C, 2013, BRAIN BEHAV IMMUN, V34, P151, DOI 10.1016/j.bbi.2013.08.008; Maeda K, 2012, INTERNAL MED, V51, P1931, DOI 10.2169/internalmedicine.51.7487; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Manes TD, 2008, J IMMUNOL, V180, P8386, DOI 10.4049/jimmunol.180.12.8386; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Canabal A, 2014, INT J NEUROSCI; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mitchell K, 2014, J NEUROCHEM, V129, P155, DOI 10.1111/jnc.12612; Mizoguchi Y, 2014, J BIOL CHEM, V289, P18549, DOI 10.1074/jbc.M114.555334; Moehle MS, 2014, NEUROSCIENCE; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muhammad Ismail HI, 2014, BRAIN DEV; Mukherjee A, 2011, ACTA NEUROPATHOL, V122, P371, DOI 10.1007/s00401-011-0854-7; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980; Nakajima K, 2001, BRAIN RES, V916, P76, DOI 10.1016/S0006-8993(01)02866-9; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sadasivan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033693; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Studahl M, 2003, J CLIN VIROL, V28, P225, DOI 10.1016/S1386-6532(03)00119-7; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Thomas PG, 2010, J IMMUNOL, V184, P1721, DOI 10.4049/jimmunol.0901427; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xue QS, 2010, BRAIN RES, V1319, P131, DOI 10.1016/j.brainres.2009.12.089; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396	65	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124047	10.1371/journal.pone.0124047	http://dx.doi.org/10.1371/journal.pone.0124047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861024	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300129
J	De Spiegelaere, W; Philippe, J; Vervisch, K; Verhofstede, C; Malatinkova, E; Kiselinova, M; Trypsteen, W; Bonczkowski, P; Vogelaers, D; Callens, S; Ruelle, J; Kabeya, K; De Wit, S; Van Acker, P; Van Sandt, V; Emonds, MP; Coucke, P; Sermijn, E; Vandekerckhove, L				De Spiegelaere, Ward; Philippe, Jan; Vervisch, Karen; Verhofstede, Chris; Malatinkova, Eva; Kiselinova, Maja; Trypsteen, Wim; Bonczkowski, Pawel; Vogelaers, Dirk; Callens, Steven; Ruelle, Jean; Kabeya, Kabamba; De Wit, Stephane; Van Acker, Petra; Van Sandt, Vicky; Emonds, Marie-Paule; Coucke, Paul; Sermijn, Erica; Vandekerckhove, Linos			Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care	PLOS ONE			English	Article								Abacavir is a nucleoside reverse transcriptase inhibitor used as part of combination antiretroviral therapy in HIV-1-infected patients. Because this drug can cause a hypersensitivity reaction that is correlated with the presence of the HLA-B*57:01 allotype, screening for the presence of HLA-B*57:01 is recommended before abacavir initiation. Different genetic assays have been developed for HLA-B*57:01 screening, each with specific sensitivity, turnaround time and assay costs. Here, a new real-time PCR (qPCR) based analysis is described and compared to sequence specific primer PCR with capillary electrophoresis (SSP PCR CE) on 149 patient-derived samples, using sequence specific oligonucleotide hybridization combined with high resolution SSP PCR as gold standard. In addition to these PCR based methods, a complementary approach was developed using flow cytometry with an HLA-B17 specific monoclonal antibody as a pre-screening assay to diminish the number of samples for genetic testing. All three assays had a maximum sensitivity of >99. However, differences in specificity were recorded, i.e. 84.3%, 97.2% and >99% for flow cytometry, qPCR and SSP PCR CE respectively. Our data indicate that the most specific and sensitive of the compared methods is the SSP PCR CE. Flow cytometry pre-screening can substantially decrease the number of genetic tests for HLA-B*57:01 typing in a clinical setting.	[De Spiegelaere, Ward; Vervisch, Karen; Malatinkova, Eva; Kiselinova, Maja; Trypsteen, Wim; Bonczkowski, Pawel; Vogelaers, Dirk; Callens, Steven; Sermijn, Erica; Vandekerckhove, Linos] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Philippe, Jan; Verhofstede, Chris] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Ruelle, Jean] Catholic Univ Louvain, IREC, AIDS Reference Lab, B-1200 Brussels, Belgium; [Kabeya, Kabamba; De Wit, Stephane] St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium; [Van Acker, Petra; Coucke, Paul] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Van Sandt, Vicky; Emonds, Marie-Paule] HILA, Lab Histocompatibil & Immunogenet Red Cross Fland, Mechelen, Belgium	Ghent University; Ghent University; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University	De Spiegelaere, W (corresponding author), Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium.	Ward.DeSpiegelaere@ugent.be	Vandekerckhove, Linos/J-6420-2013; philippé, jan/AAG-8964-2019; Emonds, Marie-Paule/B-5354-2018; De Spiegelaere, Ward/C-6245-2008; Coucke, Paul J/AAO-2954-2020; Malatinkova, Eva/ABA-7405-2020	Vandekerckhove, Linos/0000-0002-8600-1631; philippé, jan/0000-0003-4857-5746; Emonds, Marie-Paule/0000-0002-2653-8656; De Spiegelaere, Ward/0000-0003-2097-8439; Coucke, Paul J/0000-0001-7119-586X; Van sandt, Vicky/0000-0002-9748-4069; Callens, Steven/0000-0002-7245-527X	Research Fund - Flanders (FWO) [1.8.020.09.N.00]; Agency for Innovation by Science and Technology in Flanders (IWT) [111286, 111393]; Special Research Grant of Ghent University (BOF) [01N02712]; Viiv Healthcare; Beckton Dickinson	Research Fund - Flanders (FWO)(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Special Research Grant of Ghent University (BOF); Viiv Healthcare; Beckton Dickinson	This work was supported by the Research Fund - Flanders (FWO, 1.8.020.09.N.00 to Linos Vandekerckhove), by the Agency for Innovation by Science and Technology in Flanders (IWT, Grant nr: 111286 and 111393 to Eva Malatinkova and Pawel Bonczkowski), and by the Special Research Grant of Ghent University (BOF, 01N02712 to Maja Kiselinova). Viiv Healthcare and Beckton Dickinson provided financial support for sampling and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutrell AG, 2004, ANN PHARMACOTHER, V38, P2171, DOI 10.1345/aph.1E202; Darke C, 2014, INT J IMMUNOGENET, V41, P277, DOI 10.1111/iji.12122; Dello Russo C, 2011, PHARMACOGENOMICS, V12, P567, DOI [10.2217/PGS.10.208, 10.2217/pgs.10.208]; Frissen PHJ, 2001, AIDS, V15, P289, DOI 10.1097/00002030-200101260-00027; Giardina E, 2010, ELECTROPHORESIS, V31, P3525, DOI 10.1002/elps.201000283; Hammond E, 2007, TISSUE ANTIGENS, V70, P58, DOI 10.1111/j.1399-0039.2007.00840.x; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hewitt RG, 2002, CLIN INFECT DIS, V34, P1137, DOI 10.1086/339751; Hughes S, 2008, PHARM STAT, V7, P121, DOI 10.1002/pst.286; Kostenko L, 2011, TISSUE ANTIGENS, V78, P11, DOI 10.1111/j.1399-0039.2011.01649.x; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Martin AM, 2005, TISSUE ANTIGENS, V65, P571, DOI 10.1111/j.1399-0039.2005.00401.x; Martin MA, 2013, PHARMACOTHERAPY, V33, P765, DOI 10.1002/phar.1278; NG J, 1993, TISSUE ANTIGENS, V42, P473, DOI 10.1111/j.1399-0039.1993.tb02191.x; Pozzi S, 1999, TISSUE ANTIGENS, V53, P275, DOI 10.1034/j.1399-0039.1999.530308.x; Rodriguez-Sainz C, 2013, HIV CLIN TRIALS, V14, P160, DOI 10.1310/hct1404-160; Rowley CF, 2014, CLIN INFECT DIS, V58, P407, DOI 10.1093/cid/cit733; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Shapiro M, 2001, AIDS Read, V11, P222; Stevens R, 2013, INT J IMMUNOGENET, V40, P311, DOI 10.1111/iji.12025; Stocchi L, 2012, CURR GENOMICS, V13, P314, DOI 10.2174/138920212800793311	22	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123525	10.1371/journal.pone.0123525	http://dx.doi.org/10.1371/journal.pone.0123525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874872	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800103
J	Gaibelet, G; Allart, S; Terce, F; Azalbert, V; Bertrand-Michel, J; Hamdi, S; Collet, X; Orlowski, S				Gaibelet, Gerald; Allart, Sophie; Terce, Francois; Azalbert, Vincent; Bertrand-Michel, Justine; Hamdi, Safouane; Collet, Xavier; Orlowski, Stephane			Specific Cellular Incorporation of a Pyrene-Labelled Cholesterol: Lipoprotein-Mediated Delivery toward Ordered Intracellular Membranes	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; PROSTATE-CANCER CELLS; I SR-BI; LIPID DROPLETS; PLASMA-LIPOPROTEINS; MIXED MICELLES; LIVING CELLS; LDL RECEPTOR; HDL RECEPTOR	In the aim of testing tools for tracing cell trafficking of exogenous cholesterol, two fluorescent derivatives of cholesterol, 22-nitrobenzoxadiazole-cholesterol (NBD-Chol) and 21-methylpyrenyl-cholesterol (Pyr-met-Chol), with distinctive chemico-physical characteristics, have been compared for their cell incorporation properties, using two cell models differently handling cholesterol, with two incorporation routes. In the Caco-2 cell model, the cholesterol probes were delivered in bile salt micelles, as a model of intestinal absorption. The two probes displayed contrasting behaviors for cell uptake characteristics, cell staining, and efflux kinetics. In particular, Pyr-met-Chol cell incorporation involved SR-BI, while that of NBD-Chol appeared purely passive. In the PC-3 cell model, which overexpresses lipoprotein receptors, the cholesterol probes were delivered via the serum components, as a model of systemic delivery. We showed that Pyr-met-Chol-labelled purified LDL or HDL were able to specifically deliver Pyr-met-Chol to the PC-3 cells, while NBD-Chol incorporation was independent of lipoproteins. Observations by fluorescence microscopy evidenced that, while NBD-Chol readily stained the cytosolic lipid droplets, Pyr-met-Chol labelling led to the intense staining of intracellular structures of membranous nature, in agreement with the absence of detectable esterification of Pyr-met-Chol. A 48 h incubation of PC-3 cells with either Pyr-met-Chol-labelled LDL or HDL gave same staining patterns, mainly colocalizing with Lamp1, caveolin-1 and CD63. These data indicated convergent trafficking downwards their respective receptors, LDL-R and SR-BI, toward the cholesterolrich internal membrane compartments, late endosomes and multivesicular bodies. Interestingly, Pyr-met-Chol staining of these structures exhibited a high excimer fluorescence emission, revealing their ordered membrane environment, and indicating that Pyr-met-Chol behaves as a fair cholesterol tracer regarding its preferential incorporation into cholesterolrich domains. We conclude that, while NBD-Chol is a valuable marker of cholesterol esterification, Pyr-met-Chol is a reliable new lipoprotein fluorescent marker which allows to probe specific intracellular trafficking of cholesterol-rich membranes.	[Gaibelet, Gerald; Hamdi, Safouane; Orlowski, Stephane] CHU Purpan, INSERM U563 1048, F-31024 Toulouse 3, France; [Gaibelet, Gerald; Orlowski, Stephane] IBiTec Saclay, I2BC, SB2SM, CEA, F-91191 Gif Sur Yvette, France; [Gaibelet, Gerald; Orlowski, Stephane] IBiTec Saclay, I2BC, CNRS UMR8221 UMR9198, F-91191 Gif Sur Yvette, France; [Gaibelet, Gerald; Allart, Sophie; Terce, Francois; Azalbert, Vincent; Bertrand-Michel, Justine; Collet, Xavier] Univ Toulouse 3, UMR 1048, F-31000 Toulouse, France; [Allart, Sophie] INSERM U1043, Plateau Tech Imagerie Cellulaire, F-31300 Toulouse, France; [Terce, Francois; Azalbert, Vincent; Collet, Xavier] INSERM U1048, F-31400 Toulouse, France; [Bertrand-Michel, Justine] INSERM U1048, Lipid Platform Metatoul, F-31400 Toulouse, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Orlowski, S (corresponding author), CHU Purpan, INSERM U563 1048, F-31024 Toulouse 3, France.	stephane.orlowski@cea.fr	HAMDI, Safouane/AAC-4205-2019; Blasco Baque, Vincent/AHA-9524-2022; Collet, Xavier/M-6938-2017; Tercé, François/M-5863-2018	Tercé, François/0000-0003-4488-2167; /0000-0002-2434-3441; Sophie, Allart/0000-0001-7447-2471	Institut National de la Sante Et de la Recherche Medicale; Agence Nationale de la Recherche [06-PNRA 5.34]; Vaincre La Mucoviscidose [FC0906]; "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; Societe Francaise de Nutrition	Institut National de la Sante Et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Vaincre La Mucoviscidose; "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; Societe Francaise de Nutrition	This work was supported by grants from Institut National de la Sante Et de la Recherche Medicale, from Agence Nationale de la Recherche (06-PNRA 5.34 "Absinte"), and from Vaincre La Mucoviscidose (FC0906). XC was a recipient of a "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; GG was a recipient of a "Prix de Recherche 2008" from Societe Francaise de Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2002, BBA-MOL CELL BIOL L, V1580, P77, DOI 10.1016/S1388-1981(01)00190-1; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Andrieux K, 2004, PHARM RES-DORDR, V21, P1505, DOI 10.1023/B:PHAM.0000036927.37888.93; Aumuller G, 1999, ANN ANAT, V181, P437, DOI 10.1016/S0940-9602(99)80020-X; BAUCHART D, 1985, REPROD NUTR DEV, V25, P243, DOI 10.1051/rnd:19850214; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cai XH, 1997, J PHARM SCI, V86, P372, DOI 10.1021/js9602148; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; CHIJIIWA K, 1989, BIOCHIM BIOPHYS ACTA, V1001, P111; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Gaibelet G, 2013, BIOCHEM BIOPH RES CO, V440, P533, DOI 10.1016/j.bbrc.2013.09.101; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Haikal Z, 2008, LIPIDS, V43, P401, DOI 10.1007/s11745-008-3172-7; Harwood HJ, 1997, BIOCHEM J, V323, P649, DOI 10.1042/bj3230649; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; KAO YJ, 1986, J LIPID RES, V27, P781; KASURINEN J, 1995, BIOCHEMISTRY-US, V34, P2049, DOI 10.1021/bi00006a027; Koivusalo M, 2004, BIOPHYS J, V86, P923, DOI 10.1016/S0006-3495(04)74168-5; Kravets FG, 2000, PROSTATE, V43, P169, DOI 10.1002/(SICI)1097-0045(20000515)43:3<169::AID-PROS2>3.0.CO;2-D; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Le Guyader L, 2007, BIOPHYS J, V93, P4462, DOI 10.1529/biophysj.107.112821; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Li H, 2004, ACAD RADIOL, V11, P669, DOI 10.1016/j.acra.2004.01.016; Lin DS, 2010, ATHEROSCLEROSIS, V208, P155, DOI 10.1016/j.atherosclerosis.2009.07.031; Llorente A, 2007, EUR J CELL BIOL, V86, P405, DOI 10.1016/j.ejcb.2007.05.001; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; Loura LMS, 2001, BBA-BIOMEMBRANES, V1511, P236, DOI 10.1016/S0005-2736(01)00269-3; Lusa S, 1998, BIOCHEM J, V332, P451, DOI 10.1042/bj3320451; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; Marrink SJ, 2002, BIOCHEMISTRY-US, V41, P5375, DOI 10.1021/bi015613i; Matsuoka K, 2006, CHEM PHYS LIPIDS, V139, P1, DOI 10.1016/j.chemphyslip.2005.08.006; Mazeres S, 2001, SPECTROCHIM ACTA A, V57, P2297, DOI 10.1016/S1386-1425(01)00486-3; Mobius W, 2003, TRAFFIC, V4, P222; Morel E, 2004, MOL BIOL CELL, V15, P132, DOI 10.1091/mbc.E03-04-0215; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SATO Y, 1995, BBA-LIPID LIPID MET, V1257, P38, DOI 10.1016/0005-2760(95)00053-F; Scheidt HA, 2003, J BIOL CHEM, V278, P45563, DOI 10.1074/jbc.M303567200; SCHUBERT R, 1988, BIOCHEMISTRY-US, V27, P8787, DOI 10.1021/bi00424a015; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sparrow CP, 1999, J LIPID RES, V40, P1747; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; STEPHAN ZF, 1993, J LIPID RES, V34, P325; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; Tesseromatis C, 2008, EUR J DRUG METAB PH, V33, P225, DOI 10.1007/BF03190876; Webber MM, 1997, PROSTATE, V30, P58; Wiedmann TS, 2002, PHARMACEUT RES, V19, P1203, DOI 10.1023/A:1019858428449; Wustner D, 2004, J LIPID RES, V45, P427, DOI 10.1194/jlr.M300440-JLR200; Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004	70	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121563	10.1371/journal.pone.0121563	http://dx.doi.org/10.1371/journal.pone.0121563			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875769	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800023
J	Hirota, Y; Nakagawa, K; Sawada, N; Okuda, N; Suhara, Y; Uchino, Y; Kimoto, T; Funahashi, N; Kamao, M; Tsugawa, N; Okano, T				Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natsumi; Okuda, Naoko; Suhara, Yoshitomo; Uchino, Yuri; Kimoto, Takashi; Funahashi, Nobuaki; Kamao, Maya; Tsugawa, Naoko; Okano, Toshio			Functional Characterization of the Vitamin K-2 Biosynthetic Enzyme UBIAD1	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; CRYSTAL-STRUCTURE; TARGET GENES; PRENYLTRANSFERASE; TERE1; CHOLESTEROL; EXPRESSION; PHYTYLTRANSFERASE	UbiA prenyltransferase domain-containing protein 1 (UBIAD1) plays a significant role in vitamin K-2 (MK-4) synthesis. We investigated the enzymological properties of UBIAD1 using microsomal fractions from Sf9 cells expressing UBIAD1 by analysing MK-4 biosynthetic activity. With regard to UBIAD1 enzyme reaction conditions, highest MK-4 synthetic activity was demonstrated under basic conditions at a pH between 8.5 and 9.0, with a DTT >= 0.1 mM. In addition, we found that geranyl pyrophosphate and farnesyl pyrophosphate were also recognized as a side-chain source and served as a substrate for prenylation. Furthermore, lipophilic statins were found to directly inhibit the enzymatic activity of UBIAD1. We analysed the aminoacid sequences homologies across the menA and UbiA families to identify conserved structural features of UBIAD1 proteins and focused on four highly conserved domains. We prepared protein mutants deficient in the four conserved domains to evaluate enzyme activity. Because no enzyme activity was detected in the mutants deficient in the UBIAD1 conserved domains, these four domains were considered to play an essential role in enzymatic activity. We also measured enzyme activities using point mutants of the highly conserved aminoacids in these domains to elucidate their respective functions. We found that the conserved domain I is a substrate recognition site that undergoes a structural change after substrate binding. The conserved domain II is a redox domain site containing a CxxC motif. The conserved domain III is a hinge region important as a catalytic site for the UBIAD1 enzyme. The conserved domain IV is a binding site for Mg2+/isoprenyl side-chain. In this study, we provide a molecular mapping of the enzymological properties of UBIAD1.	[Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natsumi; Okuda, Naoko; Uchino, Yuri; Kimoto, Takashi; Funahashi, Nobuaki; Kamao, Maya; Tsugawa, Naoko; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan; [Hirota, Yoshihisa] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan	Kobe Pharmaceutical University; Shibaura Institute of Technology	Hirota, Y (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan.	hirota@suzuka-u.ac.jp; t-okano@kobepharma-u.ac.jp	Funahashi, Nobuaki/ABF-1529-2021; Hirota, Yoshihisa/R-6741-2019	Funahashi, Nobuaki/0000-0003-0888-1060; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [23390022, 2379110, 26860047, 24-7941]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-aid for Scientific Research (B) (grant number 23390022 to TO: https://kaken.nii.ac.jp/d/r/20131542.en.html) from JSPS, a Grant-in-aid for Scientific Research (Young Scientists-B) (grant number 2379110 to KN: https://kaken.nii.ac.jp/d/r/90309435.en.html and 26860047 to YH: https://kaken.nii.ac.jp/d/r/70724277.en.html) from JSPS, and a Grant-in-aid for JSPS Fellows (grant number 24-7941 to YH: https://kaken.nii.ac.jp/d/p/12J07941.ja.html) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, MED HYPOTHESES, V57, P151, DOI 10.1054/mehy.2001.1307; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Brandt W, 2009, PHYTOCHEMISTRY, V70, P1758, DOI 10.1016/j.phytochem.2009.09.001; Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hemmi H, 2004, J BIOL CHEM, V279, P50197, DOI 10.1074/jbc.M409207200; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Huang H, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001911; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104078; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAIKI K, 1993, J BIOL CHEM, V268, P26041; Schledz M, 2001, FEBS LETT, V499, P15, DOI 10.1016/S0014-5793(01)02508-X; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Suhara Y, 2012, YAKUGAKU ZASSHI, V132, P881, DOI 10.1248/yakushi.132.881; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Xia Y, 2015, DEV BIOL, V398, P218, DOI 10.1016/j.ydbio.2014.12.001; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zu YG, 2006, J SEP SCI, V29, P1607, DOI 10.1002/jssc.200600047	48	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125737	10.1371/journal.pone.0125737	http://dx.doi.org/10.1371/journal.pone.0125737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874989	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800159
J	Jiang, HB; He, CG; Sheng, LX; Tang, ZH; Wen, Y; Yan, TT; Zou, CL				Jiang, Haibo; He, Chunguang; Sheng, Lianxi; Tang, Zhanhui; Wen, Yang; Yan, Tingting; Zou, Changlin			Hydrological Modelling for Siberian Crane Grus Leucogeranus Stopover Sites in Northeast China	PLOS ONE			English	Article							HABITAT SUITABILITY; FOREST RESTORATION; MOMOGE WETLAND; RIVER ESTUARY; CONSERVATION; POPULATION; TRENDS; BIRDS; BASIN; LAKE	Habitat loss is one of the key factors underlying the decline of many waterbird species, including Siberian Crane (Grus leucogeranus), a threatened species worldwide. Wetlands are the primary stopover for many waterbirds and restoration of these wetlands involves both hydrological restoration and water resource management. To protect the stopover sites of Siberian Cranes, we collected Siberian Crane stopover numbers, meteorological and hydrological data, and remote sensing data from 2008 to 2011 in Momoge National Nature Reserve, one of the largest wetlands in northeastern China. A model was developed to estimate the suitability of Siberian Crane stopover sites. According to our results, the most suitable daily water level for Siberian Cranes between 2008 and 2012 occurred in the spring of 2008 and in the Scirpus planiculmis growing season and autumn of 2010. We suggest a season-dependent water management strategy in order to provide suitable conditions at Siberian Crane stopover sites.	[Jiang, Haibo; He, Chunguang; Sheng, Lianxi; Tang, Zhanhui; Wen, Yang; Yan, Tingting] NE Normal Univ, Sch Environm, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China; [Zou, Changlin] Momoge Natl Nat Reserve Jilin, Zhenlai, Peoples R China	Northeast Normal University - China	He, CG (corresponding author), NE Normal Univ, Sch Environm, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China.	he-cg@nenu.edu.cn; shenglx@nenu.edu.cn			China National special funds of science and technology for control and remediation of water pollution [2012ZX07201-001-03]; Scientific Research Project - Special Funds of the State Environmental Protection Public Welfare Industry [2011467032]	China National special funds of science and technology for control and remediation of water pollution; Scientific Research Project - Special Funds of the State Environmental Protection Public Welfare Industry	This study was supported by the China National special funds of science and technology for control and remediation of water pollution (Project NO. 2012ZX07201-001-03) and the Scientific Research Project Sponsored by Special Funds of the State Environmental Protection Public Welfare Industry (Project NO. 2011467032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BirdLife International, IUCN RED LIST THREAT; Bysykatova IP, 2010, CONTEMP PROBL ECOL, V3, P86, DOI 10.1134/S1995425510010145; Cai TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089913; Convertino M, 2011, ECOL ENG, V37, P1184, DOI 10.1016/j.ecoleng.2011.02.019; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Cui BS, 2009, J NAT CONSERV, V17, P129, DOI 10.1016/j.jnc.2009.01.003; Debeljak M, 2001, ECOL MODEL, V138, P321, DOI 10.1016/S0304-3800(00)00411-7; Desgranges JL, 2006, ENVIRON MONIT ASSESS, V113, P329, DOI 10.1007/s10661-005-9087-3; Dong ZY, 2013, ECOL ENG, V55, P94, DOI 10.1016/j.ecoleng.2013.02.006; Gabbe AP, 2002, CONSERV BIOL, V16, P462, DOI 10.1046/j.1523-1739.2002.00460.x; Gaines WL, 2007, RESTOR ECOL, V15, P670, DOI 10.1111/j.1526-100X.2007.00279.x; Gilbert AJ, 2004, REG ENVIRON CHANGE, V4, P118, DOI 10.1007/s10113-004-0071-1; Gray A, 2002, RESTOR ECOL, V10, P514, DOI 10.1046/j.1526-100X.2002.01039.x; Hamel PB, 2003, FORESTRY, V76, P189, DOI 10.1093/forestry/76.2.189; He CG, 2002, BIO SCI, V3, P286; He CG, 2009, HYDROL PROCESS, V23, P612, DOI 10.1002/hyp.7189; Jia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065843; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; Kang XG, 1993, CHIN B BOT, V35, P466; Khan MA, 2004, RESTOR ECOL, V9, P125; Konisky RA, 2006, RESTOR ECOL, V14, P516, DOI 10.1111/j.1526-100X.2006.00163.x; Li Fengshan, 2012, Chinese Birds, V3, P180; Liu Chun-Yue, 2013, Chinese Journal of Zoology, V48, P382; Ma ZJ, 2009, ENVIRON MANAGE, V43, P1187, DOI 10.1007/s00267-008-9247-7; MacGregor-Fors I, 2010, ECOL ENG, V36, P1492, DOI 10.1016/j.ecoleng.2010.06.001; Majer JD, 2009, RESTOR ECOL, V17, P315, DOI 10.1111/j.1526-100X.2009.00528.x; Min Q, 2005, ADV SCI TEC WAT RESO, V25, P17; Mitsch WJ, 2005, ECOL ENG, V24, P243, DOI 10.1016/j.ecoleng.2005.02.006; Mitsch WJ, 2006, ECOL ENG, V26, P55, DOI 10.1016/j.ecoleng.2005.09.005; Ortega-Alvarez R, 2013, ECOL ENG, V53, P275, DOI 10.1016/j.ecoleng.2012.12.058; Passell HD, 2000, RESTOR ECOL, V8, P112, DOI 10.1046/j.1526-100x.2000.80017.x; Phurba L, 2009, FORKTAIL, V25, P125; Shokoohi A, 2011, HYDROL PROCESS, V25, P3490, DOI 10.1002/hyp.8076; Sun YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098690; Twedt DJ, 2006, CONSERV BIOL, V20, P100, DOI 10.1111/j.1523-1739.2005.00303.x; Wang XY, 2010, ENVIRON MONIT ASSESS, V161, P271, DOI 10.1007/s10661-008-0744-1; Wang Y, 2013, CHINESE GEOGR SCI, V23, P708, DOI 10.1007/s11769-013-0641-6; Xiang Gui-quang, 2010, Dongbei Shida Xuebao (Ziran Kexue Ban), V42, P126; Yan DH, 2012, HYDROL EARTH SYST SC, V16, P2469, DOI 10.5194/hess-16-2469-2012	39	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122687	10.1371/journal.pone.0122687	http://dx.doi.org/10.1371/journal.pone.0122687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874552	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800071
J	Parsons, WL; Parsons, KM				Parsons, William L.; Parsons, Kristen M.			Morphological Variations within the Ontogeny of Deinonychus antirrhopus (Theropoda, Dromaeosauridae)	PLOS ONE			English	Article							ASSESSING GROWTH; PERIOSTEAL BONE; BODY-SIZE; DINOSAUR; EVOLUTION; TYRANNOSAURIDAE; HETEROCHRONY; LOCOMOTION; OSTEOLOGY; HISTOLOGY	This research resulted from the determination that MCZ 8791 is a specimen of Deinonychus antirrhopus between one and two years of age and that the morphological variations within particular growth stages of this taxon have yet to be described. The primary goal of the research is to identify ontogenetic variations in this taxon. Histological analyses determined that the Deinonychus specimens AMNH 3015 and MOR 1178 were adults. Comparisons are made between MCZ 8791 and these adult specimens. The holotype, YPM 5205, and the other associated specimens of this taxon within the YPM collection are similar in size and morphology to AMNH 3015. Further comparisons were made with the three partial specimens OMNH 50268, MCZ 4371, and MOR 1182. Although these specimens represent only a partial ontogenetic series, a number of morphological variations can be described. One secondary goal of this research is to compare the known pattern of variable, informative, ontogenetic characters in MCZ 8791 to a similar pattern of morphological characters in the sub-adult dromaeosaurid specimen Bambiraptor feinbergorum, AMNH FR: 30556. If the characters that have been determined to represent variable juvenile morphology in the ontogeny of Deinonychus are exhibited in Bambiraptor, this study will begin the process of determining whether a similar, conservative, ontogenetic pattern exists throughout the rest of Dromaeosauridae. If defensible, it may reduce the number of sympatric taxa within this clade. The other secondary goal relates to the forelimb function. The approximate body size, forelimb length, wrist development, and the presence of a more prominent olecranon on the ulna of MCZ 8791 support the hypothesis that juveniles of this taxon possessed some form of flight capability.	[Parsons, William L.; Parsons, Kristen M.] Buffalo Museum Sci, Dept Geol, Buffalo, NY 14211 USA		Parsons, WL (corresponding author), Buffalo Museum Sci, Dept Geol, 1020 Humboldt Pkwy, Buffalo, NY 14211 USA.	bparsons@gow.org						[Anonymous], 1998, RAILS GUIDE RAILS CR; [Anonymous], 1980, COLD LOOK WARM BLOOD; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Brinkman Daniel L., 1998, Oklahoma Geological Survey Bulletin, V146, P1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; BROCHU CA, 1995, J HERPETOL, V29, P464, DOI 10.2307/1565002; Burnham DA, 2004, LIFE O PAST, P67; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CAMPBELL KE, 1983, AUK, V100, P390, DOI 10.1093/auk/100.2.390; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; Chiappe LM, 1996, MUNCHER GEOWEISS, V30, ps203; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Goloboff PJ, 2013, TREE ANAL USING NEW; Guenther MF, 2009, ANAT REC, V292, P1427, DOI 10.1002/ar.20988; Han G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5382; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Kirkland JI, 1993, HUNTERIA, V2, P116; Lee AH, 2013, J VERTEBR PALEONTOL, V33, P865, DOI 10.1080/02724634.2013.743898; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Matthew WD, 1922, B AM MUS NAT HIST, V56, P367; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; Osborne T., 1998, ECOLOGY KORI BUSTARD; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ostrom J.H., 1974, Postilla, VNo. 165, P1; Ostrom J.H., 1976, BREVIORA, V439, P1; Parsons William L., 2009, Bulletin of the Buffalo Society of Natural Sciences, V38, P43; Paul G.S., 2010, PRINCETON FIELD GUID; Reid R.E.H., 1990, Modern Geology, V15, P19; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Sampson SD, 1993, THESIS U TORONTO TOR; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; SUES HD, 1978, ZOOL J LINN SOC-LOND, V62, P381, DOI 10.1111/j.1096-3642.1978.tb01049.x; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2012, B AM MUS NAT HIST, P5; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; Woolley JD, 2000, J EXP BIOL, V203, P1767; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	61	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121476	10.1371/journal.pone.0121476	http://dx.doi.org/10.1371/journal.pone.0121476			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875499	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800021
J	Phan, MD; Forde, BM; Peters, KM; Sarkar, S; Hancock, S; Stanton-Cook, M; Ben Zakour, NL; Upton, M; Beatson, SA; Schembri, MA				Phan, Minh Duy; Forde, Brian M.; Peters, Kate M.; Sarkar, Sohinee; Hancock, Steven; Stanton-Cook, Mitchell; Ben Zakour, Nouri L.; Upton, Mathew; Beatson, Scott A.; Schembri, Mark A.			Molecular Characterization of a Multidrug Resistance IncF Plasmid from the Globally Disseminated Escherichia coli ST131 Clone	PLOS ONE			English	Article							SEQUENCE TYPE 131; F-PLASMID; BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; STABLE MAINTENANCE; DNA GYRASE; REPA1 GENE; REPLICATION; NR1; CTX-M-15	Escherichia coli sequence type 131 (E. coli ST131) is a recently emerged and globally disseminated multidrug resistant clone associated with urinary tract and bloodstream infections. Plasmids represent a major vehicle for the carriage of antibiotic resistance genes in E. coli ST131. In this study, we determined the complete sequence and performed a comprehensive annotation of pEC958, an IncF plasmid from the E. coli ST131 reference strain EC958. Plasmid pEC958 is 135.6 kb in size, harbours two replicons (RepFIA and RepFII) and contains 12 antibiotic resistance genes (including the bla(CTX-M-15) gene). We also carried out hyper-saturated transposon mutagenesis and multiplexed transposon directed insertion- site sequencing (TraDIS) to investigate the biology of pEC958. TraDIS data showed that while only the RepFII replicon was required for pEC958 replication, the RepFIA replicon contains genes essential for its partitioning. Thus, our data provides direct evidence that the RepFIA and RepFII replicons in pEC958 cooperate to ensure their stable inheritance. The gene encoding the antitoxin component (ccdA) of the post-segregational killing system CcdAB was also protected from mutagenesis, demonstrating this system is active. Sequence comparison with a global collection of ST131 strains suggest that IncF represents the most common type of plasmid in this clone, and underscores the need to understand its evolution and contribution to the spread of antibiotic resistance genes in E. coli ST131.	[Phan, Minh Duy; Forde, Brian M.; Peters, Kate M.; Sarkar, Sohinee; Hancock, Steven; Stanton-Cook, Mitchell; Ben Zakour, Nouri L.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Upton, Mathew] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Upton, Mathew] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England	University of Queensland; University of Plymouth; University of Plymouth	Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au	Upton, Mathew/J-7514-2019; ZAKOUR, Nouri L BEN/B-9338-2011; Beatson, Scott/B-6985-2013; Forde, Brian/GLQ-9491-2022; Hancock, Steven/AAJ-5231-2021; Phan, Minh-Duy/I-9147-2012; Schembri, Mark A/C-7262-2009	Upton, Mathew/0000-0003-4287-6396; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Beatson, Scott/0000-0002-1806-3283; Forde, Brian/0000-0002-2264-4785; Hancock, Steven/0000-0001-7203-2640; Phan, Minh-Duy/0000-0002-3426-1044; Schembri, Mark A/0000-0003-4863-9260; Sarkar, Sohinee/0000-0001-9364-1920	Australian National Health and Medical Research Council (NHMRC) [APP1012076, APP1067455]; Australian Research Council [FT100100662]; NHMRC [APP1090456]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) (http://www.nhmrc.gov.au/) to MAS and SAB (APP1012076 and APP1067455). MAS is supported by an Australian Research Council (http://www.arc.gov.au/) Future Fellowship (FT100100662). SAB is supported by an NHMRC Career Development Fellowship (APP1090456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; AUSTIN S, 1983, PLASMID, V10, P73, DOI 10.1016/0147-619X(83)90059-8; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2422, DOI 10.1128/AAC.02587-13; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P1005, DOI 10.1093/jac/dkr041; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Fiett J, 2014, ANTIMICROB AGENTS CH, V58, P1203, DOI 10.1128/AAC.01197-13; Floyd RV, 2012, J INFECT DIS, V206, P1589, DOI 10.1093/infdis/jis554; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; JIANG T, 1993, J BACTERIOL, V175, P5350, DOI 10.1128/JB.175.17.5350-5358.1993; Johnson JR, 2010, ANTIMICROB AGENTS CH, V54, P546, DOI 10.1128/AAC.01089-09; KLINE BC, 1985, PLASMID, V14, P1, DOI 10.1016/0147-619X(85)90027-7; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LANE D, 1986, NUCLEIC ACIDS RES, V14, P9713; LANE HED, 1981, PLASMID, V5, P100, DOI 10.1016/0147-619X(81)90079-2; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lanza VF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004766; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lou ZQ, 2014, CHINESE MED J-PEKING, V127, P528, DOI 10.3760/cma.j.issn.0366-6999.20130253; MAAS R, 1989, MOL GEN GENET, V218, P190, DOI 10.1007/BF00331268; MANEEWANNAKUL S, 1992, J BACTERIOL, V174, P5567, DOI 10.1128/JB.174.17.5567-5574.1992; MASAI H, 1983, P NATL ACAD SCI-BIOL, V80, P6814, DOI 10.1073/pnas.80.22.6814; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; MIKI T, 1980, J BACTERIOL, V141, P87, DOI 10.1128/JB.141.1.87-99.1980; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Montesinos I, 2010, J ANTIMICROB CHEMOTH, V65, P1828, DOI 10.1093/jac/dkq208; MOORE D, 1990, J BACTERIOL, V172, P4263, DOI 10.1128/jb.172.8.4263-4270.1990; MORI H, 1986, J MOL BIOL, V192, P1, DOI 10.1016/0022-2836(86)90459-6; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; O'Hara JA, 2014, ANTIMICROB AGENTS CH, V58, P4234, DOI 10.1128/AAC.02182-13; OHTSUBO E, 1977, PLASMID, V1, P8, DOI 10.1016/0147-619X(77)90004-X; Ohtsubo H, 1986, Adv Biophys, V21, P115, DOI 10.1016/0065-227X(86)90018-3; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; SILVER L, 1977, J BACTERIOL, V131, P929, DOI 10.1128/JB.131.3.929-942.1977; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; SYKORA P, 1992, J THEOR BIOL, V159, P53, DOI 10.1016/S0022-5193(05)80767-2; TABUCHI A, 1988, J MOL BIOL, V202, P511, DOI 10.1016/0022-2836(88)90282-3; TANIMOTO K, 1985, MOL GEN GENET, V198, P356, DOI 10.1007/BF00383019; Totsika M, 2013, J INFECT DIS; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Tripathi A, 2012, P NATL ACAD SCI USA, V109, P12497, DOI 10.1073/pnas.1121217109; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; TSUCHIMOTO S, 1988, J BACTERIOL, V170, P1461, DOI 10.1128/jb.170.4.1461-1466.1988; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; WOMBLE DD, 1988, MICROBIOL REV, V52, P433, DOI 10.1128/MMBR.52.4.433-451.1988; WOMBLE DD, 1986, J MOL BIOL, V192, P529, DOI 10.1016/0022-2836(86)90274-3; Woodford N, 2004, J ANTIMICROB CHEMOTH, V54, P735, DOI 10.1093/jac/dkh424; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; WU RP, 1992, J BACTERIOL, V174, P7620, DOI 10.1128/JB.174.23.7620-7628.1992; WU RP, 1993, J BACTERIOL, V175, P3161, DOI 10.1128/JB.175.10.3161-3173.1993; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zong ZY, 2013, ANTIMICROB AGENTS CH, V57, P597, DOI 10.1128/AAC.01081-12	86	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122369	10.1371/journal.pone.0122369	http://dx.doi.org/10.1371/journal.pone.0122369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875675	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800055
J	Zou, C; Yang, LH; Wu, YC; Su, GB; Chen, SH; Guo, XF; Wu, XQ; Liu, XS; Lin, QZ				Zou, Chuan; Yang, Lihong; Wu, Yuchi; Su, Guobin; Chen, Shuhui; Guo, Xinfeng; Wu, Xiuqing; Liu, Xusheng; Lin, Qizhan			Auricular Acupressure on Specific Points for Hemodialysis Patients with Insomnia: A Pilot Randomized Controlled Trial	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; SLEEP QUALITY INDEX; DIALYSIS PATIENTS; KIDNEY-DISEASE; OF-LIFE; DISORDERS; RISK	Objectives To assess the feasibility and acceptability of a randomized controlled trial compared auricular acupressure (AA) on specific acupoints with AA on non-specific acupoints for treating maintenance hemodialysis (MHD) patients with insomnia. Methods Sixty three (63) eligible subjects were randomly assigned into either AA group received AA on specific acupoints (n=32), or sham AA (SAA) group received AA on points irrelevant to insomnia treatment (n=31) for eight weeks. All participants were followed up for 12 weeks after treatments. The primary outcome was clinical response at eight weeks after randomization, defined as a reduction of Pittsburgh Sleep Quality Index (PSQI) global score by 3 points and more. Results Fifty-eight (58) participants completed the trial and five dropped out. Twenty participants in AA group (62.5%) and ten in SAA group (32.3%) responded to the eight-week interventions (chi(2) = 5.77, P = 0.02). PSQI global score declined 3.75 +/- 4.36 (95% CI -5.32, -2.18) and 2.26 +/- 3.89 (95% CI -3.68, -0.83) in AA group and SAA group respectively. Three participants died during the follow-up period. No evidence supported their deaths were related to the AA intervention. No other adverse event was observed. Conclusion Feasibility and logistics of patient recruitment, randomization procedure, blinding approach, interventions application and outcome assessment had been tested in this pilot trial. The preliminary data appeared to show a favorable result on AA treatment. A full-scale trial is warranted.	[Zou, Chuan; Wu, Yuchi; Su, Guobin; Wu, Xiuqing; Liu, Xusheng; Lin, Qizhan] Guangdong Prov Hosp Chinese Med, Nephrol Ctr, Guangzhou, Guangdong, Peoples R China; [Yang, Lihong; Chen, Shuhui; Guo, Xinfeng] Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangdong Prov Hosp Chinese Med,Clin Coll,Affilia, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, QZ (corresponding author), Guangdong Prov Hosp Chinese Med, Nephrol Ctr, Guangzhou, Guangdong, Peoples R China.	linqizhan656635@163.com	Guo, Xinfeng/AAG-6818-2019; GUO, Xinfeng/AAM-6850-2021; Su, Guobin/AAD-8807-2020	Guo, Xinfeng/0000-0003-2699-9740; Su, Guobin/0000-0001-5073-9848; Yang, Lihong/0000-0001-6497-1680	Project of Research Studio of Famous Old TCM Practitioners Experience Heritage, State Administration of Traditional Chinese Medicine [2012KT1301]; Research Project for Practice Development of National TCM Clinical Research Bases, P.R. China [201007005]	Project of Research Studio of Famous Old TCM Practitioners Experience Heritage, State Administration of Traditional Chinese Medicine; Research Project for Practice Development of National TCM Clinical Research Bases, P.R. China	This work was supported by the Project of Research Studio of Famous Old TCM Practitioners Experience Heritage, State Administration of Traditional Chinese Medicine (Grant No. 2012KT1301); and Research Project for Practice Development of National TCM Clinical Research Bases, P.R. China (Grant No. 201007005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate S, 2003, CHINESE AURICULAR AC; American Psychiatric Association, DIAGN STAT MAN MENT; Anand S, 2013, HEMODIAL INT, V17, P50, DOI 10.1111/j.1542-4758.2012.00726.x; [Anonymous], 2011, J MED SCI, DOI DOI 10.3923/JMS.2011.236.240; Bonnet M H, 1997, Sleep Med Rev, V1, P97, DOI 10.1016/S1087-0792(97)90012-5; Bornivelli C, 2008, J NEPHROL, V21, pS78; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cengic B, 2012, INT UROL NEPHROL, V44, P557, DOI 10.1007/s11255-010-9881-x; Chiu YL, 2009, NEPHROL DIAL TRANSPL, V24, P247, DOI 10.1093/ndt/gfn439; Elder SJ, 2008, NEPHROL DIAL TRANSPL, V23, P998, DOI 10.1093/ndt/gfm630; Erden I, 2010, BLOOD PRESS MONIT, V15, P184, DOI 10.1097/MBP.0b013e32833a23a0; Esposito MG, 2008, J NEPHROL, V21, pS92; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; He W, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-85; Huang YL, 2011, BLOOD PRESS MONIT, V16, P117, DOI [10.1097/MBP.0b013e328346a8b4, 10.1097/MBP.0b013e32834c672d]; Liu X., 1996, CHIN J PSYCHIAT, V29, P103; Malaki M, 2012, SAUDI J KIDNEY DIS T, V23, P15; Merlino G, 2008, J NEPHROL, V21, pS66; Molnar MZ, 2005, AM J KIDNEY DIS, V45, P388, DOI 10.1053/j.ajkd.2004.10.007; Morin CM, 2013, SLEEP MED CLIN, V8, P281, DOI 10.1016/j.jsmc.2013.05.002; National Institutes of Health, 2005, Sleep, V28, P1049; Novak M, 2006, SEMIN DIALYSIS, V19, P25, DOI 10.1111/j.1525-139X.2006.00116.x; Ramos RW, 2013, SLEEP MED S1, V14, pe240; Razeghi E, 2012, ACTA NEUROL BELG, V112, P45, DOI 10.1007/s13760-012-0003-7; Roumelioti ME, 2010, NEPHROL DIAL TRANSPL, V25, P3733, DOI 10.1093/ndt/gfq234; Suen LKP, 2003, COMPLEMENT THER MED, V11, P85, DOI 10.1016/S0965-2299(03)00041-4; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Ueno N, 1993, Nihon Jibiinkoka Gakkai Kaiho, V96, P212; Unruh ML, 2006, CLIN J AM SOC NEPHRO, V1, P802, DOI 10.2215/CJN.00710206; Winkelmann J, 2002, MOVEMENT DISORD, V17, P1072, DOI 10.1002/mds.10231; Wu YC, 2014, J ALTERN COMPLEM MED, V20, P356, DOI 10.1089/acm.2013.0319; Yan J., 2006, SKILLS ILLUSTRATIONS; Yeung WF, 2012, SLEEP MED, V13, P971, DOI 10.1016/j.sleep.2012.06.003; Zhang CS, 2014, J ALTERN COMPLEM MED, V20, P147, DOI 10.1089/acm.2013.0238; Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1	37	18	20	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122724	10.1371/journal.pone.0122724	http://dx.doi.org/10.1371/journal.pone.0122724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874938	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800073
J	Ogembo, RK; Gona, PN; Seymour, AJ; Park, HSM; Bain, PA; Maranda, L; Ogembo, JG				Ogembo, Rebecca Kemunto; Gona, Philimon Nyakauru; Seymour, Alaina J.; Park, Henry Soo-Min; Bain, Paul A.; Maranda, Louise; Ogembo, Javier Gordon			Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; RISK HUMAN-PAPILLOMAVIRUS; HIV-INFECTED WOMEN; HPV TYPE-DISTRIBUTION; CANCER PREVENTION; NEGATIVE WOMEN; COTE-DIVOIRE; POPULATION; VACCINE	Background Several meta-analyses confirmed the five most prevalent human papillomavirus (HPV) strains in women with and without cervical neoplastic diseases are HPV16, 18, 31, 52, and 58. HPV16/18 are the predominant oncogenic genotypes, causing approximately 70% of global cervical cancer cases. The vast majority of the women studied in previous analyses were from Europe, North America, Asia, and most recently Latin America and the Caribbean. Despite the high burden of cervical cancer morbidity and mortality in Africa, a robust meta-analysis of HPV genotype prevalence and distribution in African women is lacking. Methods and Findings We systematically searched 14 major databases from inception to August 2013 without language restriction, following the Meta-Analysis of Observational Studies in Epidemiology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Seventy-one studies from 23 African countries were identified after screening 1162 citations and data abstracted and study quality appraised from 195 articles. HPV type-specific prevalence and distribution was estimated from 17,273 cases of women with normal cervical cytology; 1019 women with atypical squamous cells of undetermined significance (ASCUS); 1444 women with low-grade squamous intraepithelial lesion (LSIL); 1571 women with high-grade squamous intraepithelial lesion (HSIL); and 4,067 cases of invasive cervical carcinoma (ICC). Overall prevalence of HPV16/18 were 4.4% and 2.8% of women with normal cytology, 12.0% and 4.4% with ASCUS, 14.5% and 10.0% with LSIL, 31.2% and 13.9% with HSIL, and 49.7% and 18.0% with ICC, respectively. Study limitations include the lack of adequate data from Middle and Northern African regions, and variations in the HPV type-specific sensitivity of different genotyping protocols. Conclusions To our knowledge, this study is the most comprehensive assessment of the overall prevalence and distribution of HPV genotypes in African women with and without different cervical neoplasias. We have established that HPV16/18 account for 67.7% of ICC cases among African women. Based on our findings, we highly recommend the administration of existing prophylactic vaccines to younger women not infected with HPV16/18 and an increase in HPV screening efforts for high-risk genotypes to prevent cervical cancer.	[Ogembo, Rebecca Kemunto; Seymour, Alaina J.] Northeastern Univ, Boston, MA 02115 USA; [Ogembo, Rebecca Kemunto; Maranda, Louise; Ogembo, Javier Gordon] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Gona, Philimon Nyakauru] Univ Massachusetts, Boston, MA 02125 USA; [Park, Henry Soo-Min] Yale Univ, Sch Med, New Haven, CT USA; [Bain, Paul A.] Harvard Univ, Sch Med, Countway Lib, Boston, MA USA	Northeastern University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Boston; Yale University; Harvard University; Harvard Medical School	Ogembo, JG (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	javier.ogembo@umassmed.edu	Gona, Philimon/K-1477-2019; Bain, Paul A./P-3641-2016	Bain, Paul A./0000-0002-4257-2467; Park, Henry/0000-0002-9366-8514; Ogembo, Javier Gordon/0000-0001-6949-8693				Abate E, 2013, J MED VIROL, V85, P282, DOI 10.1002/jmv.23437; Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Alhamany Z, 2010, J INFECT DEV COUNTR, V4, P732, DOI 10.3855/jidc.781; Allan B, 2008, J CLIN MICROBIOL, V46, P740, DOI 10.1128/JCM.01981-07; [Anonymous], 2013, LANCET, V381, P1688, DOI 10.1016/S0140-6736(13)61058-2; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Astori G, 1999, INTERVIROLOGY, V42, P221, DOI 10.1159/000024981; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; Bekele A, 2010, TROP MED INT HEALTH, V15, P890, DOI 10.1111/j.1365-3156.2010.02552.x; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Blossom DB, 2007, J MED VIROL, V79, P758, DOI 10.1002/jmv.20817; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Broutet N, 2006, PREPARING INTRO HPV, P21; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Castellsague X, 2008, INT J CANCER, V122, P1901, DOI 10.1002/ijc.23292; Chabaud M, 1996, J MED VIROL, V49, P259, DOI 10.1002/(SICI)1096-9071(199608)49:4&lt;259::AID-JMV1&gt;3.0.CO;2-2; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; COOPER K, 1991, J CLIN PATHOL, V44, P406, DOI 10.1136/jcp.44.5.406; CZEGLEDY J, 1992, MED MICROBIOL IMMUN, V180, P321, DOI 10.1007/BF00191552; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; De Vuyst H, 2011, INT J CANC; De Vuyst H, 2012, INFECT AGENTS CANC, V7; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; De Vuyst H, 2010, CANCER CAUSE CONTROL, V21, P2309, DOI 10.1007/s10552-010-9645-z; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Denny L, 2010, JNCI-J NATL CANCER I, V102, P1557, DOI 10.1093/jnci/djq342; Denny LA, 2013, VACCINE, V31, pF73, DOI 10.1016/j.vaccine.2012.11.077; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dols Joke A M, 2012, ISRN Obstet Gynecol, V2012, P514146, DOI 10.5402/2012/514146; el Khair MM, 2009, J MED VIROL, V81, P678, DOI 10.1002/jmv.21279; Fanta BE, 2005, ETHIOPIAN MED J, V43, P151; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Firnhaber C, 2009, ACTA CYTOL, V53, P10, DOI 10.1159/000325079; Gage JC, 2012, INT J CANCER, V130, P2111, DOI 10.1002/ijc.26211; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Garcia-Espinosa B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-31; GAVI, 2014, 206000 MOR GIRL BEN; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Gravitt PE, 2002, INT J CANCER, V100, P729, DOI 10.1002/ijc.10538; Guan Peng, 2012, Int J Cancer, V131, P2349, DOI 10.1002/ijc.27485; Hammouda D, 2005, INT J CANCER, V113, P483, DOI 10.1002/ijc.20600; Hammouda D, 2011, INT J CANCER, V128, P2224, DOI 10.1002/ijc.25539; ICENOGLE JP, 1992, J INFECT DIS, V166, P1210, DOI 10.1093/infdis/166.6.1210; Jaquet A, 2012, BRIT J CANCER, V107, P556, DOI 10.1038/bjc.2012.299; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06; Kay P, 2003, J MED VIROL, V71, P265, DOI 10.1002/jmv.10479; Keita N, 2009, BRIT J CANCER, V101, P202, DOI 10.1038/sj.bjc.6605140; La Ruche G, 1998, INT J CANCER, V76, P480, DOI 10.1002/(SICI)1097-0215(19980518)76:4&lt;480::AID-IJC6&gt;3.0.CO;2-N; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178; Marais DJ, 2008, J MED VIROL, V80, P953, DOI 10.1002/jmv.21166; Marais DJ, 2000, J MED VIROL, V60, P403, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;403::AID-JMV7&gt;3.0.CO;2-6; Maranga Innocent O, 2013, Open Virol J, V7, P19, DOI 10.2174/1874357901307010019; Mayaud P, 2003, J CLIN MICROBIOL, V41, P4451, DOI 10.1128/JCM.41.9.4451-4453.2003; McDonald AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044332; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moodley JR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-275; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naucler P, 2004, J GEN VIROL, V85, P2189, DOI 10.1099/vir.0.80001-0; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Ndiaye C, 2012, TROP MED INT HLTH; Ng'andwe C, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-77; Odida M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-8; Odida Michael, 2010, Infect Agent Cancer, V5, P15, DOI 10.1186/1750-9378-5-15; Odida M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-85; Ogembo JG, 2014, VACCINE, V32, P4399, DOI 10.1016/j.vaccine.2014.06.064; Ogembo JG, 2013, HUMAN PAPILLOMAVIRUS; Okolo Clement, 2010, Infect Agent Cancer, V5, P24, DOI 10.1186/1750-9378-5-24; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peres J, 2011, J NATL CANCER I, V103, P360, DOI 10.1093/jnci/djr053; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Piras F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-514; Rahman M, 2011, J MED VIROL, V83, P1988, DOI 10.1002/jmv.22203; Ramesar JE, 1996, S AFR MED J, V86, P1402; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Richter KL, 2008, J ORAL PATHOL MED, V37, P555, DOI 10.1111/j.1600-0714.2008.00670.x; Rogo K, 1990, HUMAN PAPILLOMAVIRUS; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Said HM, 2009, J CLIN VIROL, V44, P318, DOI 10.1016/j.jcv.2009.02.001; Sankaranarayanan R, 2013, VACCINE, V31, pF47, DOI 10.1016/j.vaccine.2012.06.066; Schiffman M, 2013, NEW ENGL J MED, V369, P2324, DOI 10.1056/NEJMcp1210379; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Sitas F, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P289; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon N, 2004, BETHESDA SYSTEM REPO; Stanczuk GA, 2003, J MED VIROL, V71, P110, DOI 10.1002/jmv.10456; Stanczuk GA, 2003, ACTA OBSTET GYN SCAN, V82, P762, DOI 10.1034/j.1600-0412.2003.00245.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; STUART A, 1994, KENDALLS ADV THEORY, VI; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Tricco AC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-235; UNAIDS, 2013, GLOB REP 2013 UNAIDS; Vaccarella S, 2013, VACCINE, V31, pG32, DOI 10.1016/j.vaccine.2012.06.098; Vidal AC, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-20; Wall SR, 2005, BRIT J CANCER, V93, P1068, DOI 10.1038/sj.bjc.6602736; WHO, 2013, GUID SCREEN TREAT PR; WILLIAMSON AL, 1994, J MED VIROL, V43, P231, DOI 10.1002/jmv.1890430307; WILLIAMSON AL, 1989, J MED VIROL, V28, P146, DOI 10.1002/jmv.1890280307; World Health Organization, 2013, COMPR CERV CANC PREV; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876	120	71	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122488	10.1371/journal.pone.0122488	http://dx.doi.org/10.1371/journal.pone.0122488			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875167	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700016
J	Yang, WH; Heine, O; Pauly, S; Kim, P; Bloch, W; Mester, J; Grau, M				Yang, Woo Hwi; Heine, Oliver; Pauly, Sebastian; Kim, Pilsang; Bloch, Wilhelm; Mester, Joachim; Grau, Marijke			Rapid Rather than Gradual Weight Reduction Impairs Hemorheological Parameters of Taekwondo Athletes through Reduction in RBC-NOS Activation	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; PLASMA NITRITE; EXERCISE; DEFORMABILITY; ERYTHROCYTES; RHEOLOGY; AGGREGATION; REHYDRATION; DEHYDRATION	Purpose Rapid weight reduction is part of the pre-competition routine and has been shown to negatively affect psychological and physiological performance of Taekwondo (TKD) athletes. This is caused by a reduction of the body water and an electrolyte imbalance. So far, it is unknown whether weight reduction also affects hemorheological properties and hemorheology- influencing nitric oxide (NO) signaling, important for oxygen supply to the muscles and organs. Methods For this purpose, ten male TKD athletes reduced their body weight by 5% within four days (rapid weight reduction, RWR). After a recovery phase, athletes reduced body weight by 5% within four weeks (gradual weight reduction, GWR). Each intervention was preceded by two baseline measurements and followed by a simulated competition. Basal blood parameters (red blood cell (RBC) count, hemoglobin concentration, hematocrit, mean corpuscular volume, mean cellular hemoglobin and mean cellular hemoglobin concentration), RBC-NO synthase activation, RBC nitrite as marker for NO synthesis, RBC deformability and aggregation parameters were determined on a total of eight investigation days. Results Basal blood parameters were not affected by the two interventions. In contrast to GWR, RWR decreased activation of RBC-NO synthase, RBC nitrite, respective NO concentration and RBC deformability. Additionally, RWR increased RBC aggregation and disaggregation threshold. Conclusion The results point out that a rapid weight reduction negatively affects hemorheological parameters and NO signaling in RBC which might limit performance capacity. Thus, GWR should be preferred to achieve the desired weight prior to a competition to avoid these negative effects.	[Pauly, Sebastian; Kim, Pilsang; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Inst Cardiovasc Res & Sport Med, Cologne, Germany; [Yang, Woo Hwi; Mester, Joachim] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany; [Bloch, Wilhelm; Mester, Joachim; Grau, Marijke] German Sport Univ Cologne, German Res Ctr Elite Sports, Cologne, Germany; [Yang, Woo Hwi; Heine, Oliver] Olymp Training Ctr Rhineland, Cologne, Germany	German Sport University Cologne; German Sport University Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Inst Cardiovasc Res & Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Yang, Woo-Hwi/O-6393-2016; Grau, Marijke/AAM-7025-2020; Yang, Woo-Hwi/ABF-6255-2020	Yang, Woo-Hwi/0000-0001-6618-1834; Yang, Woo-Hwi/0000-0001-6618-1834; Grau, Dr. Marijke/0000-0003-1980-9195	German Sport University Cologne	German Sport University Cologne	This study was supported by the grant funding of the German Sport University Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadizad S, 2006, CLIN HEMORHEOL MICRO, V35, P317; ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Baskurt O, 2012, RED BLOOD CELL AGGRE, P1; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 1998, FREE RADICAL BIO MED, V24, P102, DOI 10.1016/S0891-5849(97)00169-X; BEUTLER E, 1988, TRANSFUSION, V28, P353, DOI 10.1046/j.1537-2995.1988.28488265266.x; BEUTLER E, 1969, TRANSFUSION, V9, P109, DOI 10.1111/j.1537-2995.1969.tb05527.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Brito CJ, 2012, INT J SPORT NUTR EXE, V22, P89, DOI 10.1123/ijsnem.22.2.89; Brun JF, 2012, CLIN HEMORHEOL MICRO, V51, P29, DOI 10.3233/CH-2011-1426; Brun JF, 2010, BIORHEOLOGY, V47, P95, DOI 10.3233/BIR-2010-0563; Brun JF, 2000, CLIN HEMORHEOL MICRO, V22, P287; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Bull BS, 1996, 26TH WORLD CONGRESS; CARD RT, 1982, TRANSFUSION, V22, P96, DOI 10.1046/j.1537-2995.1982.22282177134.x; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; DERN RJ, 1967, J LAB CLIN MED, V69, P968; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; ERNST E, 1991, CLIN HEMORHEOL, V11, P429; FRANCESCONI RP, 1987, J APPL PHYSIOL, V62, P1271, DOI 10.1152/jappl.1987.62.3.1271; Gaudard A, 2004, CLIN HEMORHEOL MICRO, V30, P1; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Grau M, 2015, CLIN HEMORHEOL MICRO, V60, P215, DOI 10.3233/CH-141850; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; HARADIN AR, 1969, TRANSFUSION, V9, P229; HARDEMAN MR, 1987, CLIN CHIM ACTA, V165, P227, DOI 10.1016/0009-8981(87)90166-5; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Henkelman S, 2010, TRANSFUSION, V50, P941, DOI 10.1111/j.1537-2995.2009.02521.x; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kilic-Toprak E, 2012, MED SCI MONITOR, V18, pCR351, DOI 10.12659/MSM.882878; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koral J, 2009, J SPORT SCI, V27, P115, DOI 10.1080/02640410802413214; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; LIPOWSKY HH, 1993, MICROVASC RES, V46, P43, DOI 10.1006/mvre.1993.1034; Lundberg JO, 2010, BIOCHEM BIOPH RES CO, V396, P39, DOI 10.1016/j.bbrc.2010.02.136; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P40, DOI 10.1111/j.1600-0838.2010.01207.x; McArdle W, 1986, EXERCISE PHYSIOLOGY; MCMURRAY RG, 1991, INT J SPORTS MED, V12, P167, DOI 10.1055/s-2007-1024662; Michalska-Malecka K, 2012, CLIN HEMORHEOL MICRO, V51, P277, DOI 10.3233/CH-2012-1533; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Oppliger RA, 1996, MED SCI SPORT EXER, V28, pR9; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Rampling MW, 2004, BIORHEOLOGY, V41, P91; RIBISL PM, 1970, RES QUART, V41, P536, DOI 10.1080/10671188.1970.10615013; ROBINSON S, 1954, PHYSIOL REV, V34, P202, DOI 10.1152/physrev.1954.34.2.202; Roemmich JN, 1996, INT J SPORTS MED, V17, P92, DOI 10.1055/s-2007-972814; SALTIN B, 1964, J APPL PHYSIOL, V19, P1125, DOI 10.1152/jappl.1964.19.6.1125; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; SOMER T, 1993, ANN MED, V25, P31, DOI 10.3109/07853899309147854; SOPKO G, 1985, METABOLISM, V34, P227, DOI 10.1016/0026-0495(85)90005-8; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Tikhomirova IA, 2002, CLIN HEMORHEOL MICRO, V26, P85; Tripette J, 2010, AM J PHYSIOL-HEART C, V299, pH908, DOI 10.1152/ajpheart.00298.2010; Ulker P, 2009, BIORHEOLOGY, V46, P121, DOI 10.3233/BIR-2009-0532; VICAUT E, 1995, J CARDIOVASC SURG, V36, P361; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; Yalcin O, 2003, J APPL PHYSIOL, V94, P997, DOI 10.1152/japplphysiol.00368.2002; Yang WH, 2014, ARCH BUDO, V10, P169	63	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123767	10.1371/journal.pone.0123767	http://dx.doi.org/10.1371/journal.pone.0123767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875585	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700042
J	Baiamonte, M; Brennan, CH; Vinson, GP				Baiamonte, Matteo; Brennan, Caroline H.; Vinson, Gavin P.			Sustained Action of Developmental Ethanol Exposure on the Cortisol Response to Stress in Zebrafish Larvae and Adults	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-INTERRENAL AXIS; PRENATAL EXPOSURE; BETA-ENDORPHIN; ALCOHOL DEPENDENCE; ADRENAL RESPONSES; CORTICOSTERONE; BRAIN; MODEL; RAT	Background Ethanol exposure during pregnancy is one of the leading causes of preventable birth defects, leading to a range of symptoms collectively known as fetal alcohol spectrum disorder. More moderate levels of prenatal ethanol exposure lead to a range of behavioural deficits including aggression, poor social interaction, poor cognitive performance and increased likelihood of addiction in later life. Current theories suggest that adaptation in the hypothalamo-pituitary-adrenal (HPA) axis and neuroendocrine systems contributes to mood alterations underlying behavioural deficits and vulnerability to addiction. In using zebrafish (Danio rerio), the aim is to determine whether developmental ethanol exposure provokes changes in the hypothalamo-pituitary-interrenal (HPI) axis (the teleost equivalent of the HPA), as it does in mammalian models, therefore opening the possibilities of using zebrafish to elucidate the mechanisms involved, and to test novel therapeutics to alleviate deleterious symptoms. Results and Conclusions The results showed that developmental exposure to ambient ethanol, 20mM-50mM 1-9 days post fertilisation, had immediate effects on the HPI, markedly reducing the cortisol response to air exposure stress, as measured by whole body cortisol content. This effect was sustained in adults 6 months later. Morphology, growth and locomotor activity of the animals were unaffected, suggesting a specific action of ethanol on the HPI. In this respect the data are consistent with mammalian results, although they contrast with the higher corticosteroid stress response reported in rats after developmental ethanol exposure. The mechanisms that underlie the specific sensitivity of the HPI to ethanol require elucidation.	[Baiamonte, Matteo; Brennan, Caroline H.; Vinson, Gavin P.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Vinson, GP (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	G.P.Vinson@qmul.ac.uk			National Centre for the replacement, refinement and reduction of animals in research; Biotechnology and Biological Sciences Research Council [976807] Funding Source: researchfish; National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the replacement, refinement and reduction of animals in research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	This study was supported by the National Centre for the replacement, refinement and reduction of animals in research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2003, ALCOHOL CLIN EXP RES, V27, P1420, DOI 10.1097/01.ALC.0000087581.13912.64; Alderman SL, 2012, J ENDOCRINOL, V215, P393, DOI 10.1530/JOE-12-0379; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; ANGELOGIANNI P, 1989, ALCOHOL CLIN EXP RES, V13, P564, DOI 10.1111/j.1530-0277.1989.tb00379.x; Bailey JM, 2015, NEUROTOXICOL TERATOL, V48, P1, DOI 10.1016/j.ntt.2015.01.005; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Brennan CH, 2011, NEUROMETHODS, V52, P163, DOI 10.1007/978.1.60761.922.2_7; Collier AD, 2014, PROG NEURO-PSYCHOPH, V55, P16, DOI 10.1016/j.pnpbp.2014.05.014; de Jong IEM, 2009, PSYCHOPHARMACOLOGY, V204, P693, DOI 10.1007/s00213-009-1498-3; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Kammerer BD, 2010, COMP BIOCHEM PHYS A, V157, P260, DOI 10.1016/j.cbpa.2010.07.009; Keedwell PA, 2001, ADDICT BIOL, V6, P247, DOI 10.1080/13556210120056580; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P301, DOI 10.1097/00000374-199902000-00016; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P52; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lopez-Olmeda JF, 2013, CHRONOBIOL INT, V30, P530, DOI 10.3109/07420528.2012.754448; Marchesi C, 1997, PSYCHIAT RES, V72, P187, DOI 10.1016/S0165-1781(97)00101-7; NELSON LR, 1986, ALCOHOL CLIN EXP RES, V10, P397, DOI 10.1111/j.1530-0277.1986.tb05112.x; Osborn JA, 1996, PSYCHONEUROENDOCRINO, V21, P127, DOI 10.1016/0306-4530(95)00037-2; Paintner A, 2012, J CHILD NEUROL, V27, P258, DOI 10.1177/0883073811428376; Park E, 2004, NEUROSCI LETT, V368, P345, DOI 10.1016/j.neulet.2004.08.001; Parker MO, 2014, PROG NEURO-PSYCHOPH, V55, P94, DOI 10.1016/j.pnpbp.2014.03.011; PIAZZA PV, 1994, BRAIN RES, V658, P259, DOI 10.1016/S0006-8993(09)90034-8; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Rivier C, 1996, ALCOHOL CLIN EXP RES, V20, P240, DOI 10.1111/j.1530-0277.1996.tb01636.x; RIVIER C, 1984, J PHARMACOL EXP THER, V229, P127; Rivier C, 1996, BRAIN RES, V726, P1, DOI 10.1016/0006-8993(96)00301-0; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Spanagel R, 2014, TRENDS NEUROSCI, V37, P219, DOI 10.1016/j.tins.2014.02.006; Taves MD, 2015, ENDOCRINOLOGY, V156, P511, DOI 10.1210/en.2013-1606; Tran S, 2014, PROG NEURO-PSYCHOPH, V55, P87, DOI 10.1016/j.pnpbp.2014.02.008; Vinson GP, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0028; Vinson GP, 1992, THE ADRENAL CORTEX; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; Weinberg J, 1996, ALCOHOL CLIN EXP RES, V20, P122, DOI 10.1111/j.1530-0277.1996.tb01054.x; Xia LP, 2014, TOXICOL LETT, V226, P98, DOI 10.1016/j.toxlet.2014.01.023	44	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124488	10.1371/journal.pone.0124488	http://dx.doi.org/10.1371/journal.pone.0124488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875496	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100263
J	Bennion, BJ; Essiz, SG; Lau, EY; Fattebert, JL; Emigh, A; Lightstone, FC				Bennion, Brian J.; Essiz, Sebnem G.; Lau, Edmond Y.; Fattebert, Jean-Luc; Emigh, Aiyana; Lightstone, Felice C.			A Wrench in the Works of Human Acetylcholinesterase: Soman Induced Conformational Changes Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							ACTIVE-SITE GORGE; X-RAY CRYSTALLOGRAPHY; BACK DOOR HYPOTHESIS; CRYSTAL-STRUCTURES; TORPEDO-CALIFORNICA; PRODUCT CLEARANCE; SUBSTRATE; MECHANISM; BINDING; PROTEIN	Irreversible inactivation of human acetylcholinesterase (hAChE) by organophosphorous pesticides (OPs) and chemical weapon agents (CWA) has severe morbidity and mortality consequences. We present data from quantum mechanics/molecular mechanics (QM/MM) and 80 classical molecular dynamics (MD) simulations of the apo and soman-adducted forms of hAChE to investigate the effects on the dynamics and protein structure when the catalytic Serine 203 is phosphonylated. We find that the soman phosphonylation of the active site Ser203 follows a water assisted addition-elimination mechanism with the elimination of the fluoride ion being the highest energy barrier at 6.5 kcal/mole. We observe soman-dependent changes in backbone and sidechain motions compared to the apo form of the protein. These alterations restrict the soman-adducted hAChE to a structural state that is primed for the soman adduct to be cleaved and removed from the active site. The altered motions and resulting structures provide alternative pathways into and out of the hAChE active site. In the soman-adducted protein both side and back door pathways are viable for soman adduct access. Correlation analysis of the apo and soman adducted MD trajectories shows that the correlation of gorge entrance and back door motion is disrupted when hAChE is adducted. This supports the hypothesis that substrate and product can use two different pathways as entry and exit sites in the apo form of the protein. These alternative pathways have important implications for the rational design of medical countermeasures.	[Bennion, Brian J.; Lau, Edmond Y.; Emigh, Aiyana; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Essiz, Sebnem G.] Kadir Has Univ, Fac Engn & Nat Sci, Bioinformat & Genet Dept, Istanbul 34083, Turkey; [Fattebert, Jean-Luc] Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Kadir Has University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, 7000 East Ave, Livermore, CA 94550 USA.	Lightstone@llnl.gov	Emigh, Aiyana/AAD-2851-2019	Lau, Edmond/0000-0003-0619-7249; Essiz, Sebnem/0000-0002-5476-4722; Fattebert, Jean-Luc/0000-0002-1455-6160	United States Army Medical Research Institute of Chemical Defense [MIPR1AAAM10158]; Department of Energy STEM Teacher and Researcher program AE	United States Army Medical Research Institute of Chemical Defense; Department of Energy STEM Teacher and Researcher program AE(United States Department of Energy (DOE))	United States Army Medical Research Institute of Chemical Defense (MIPR1AAAM10158) BJB, SGE, JLF, EL, and FCL, and Department of Energy STEM Teacher and Researcher program AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisaraie L, 2006, J MOL MODEL, V12, P348, DOI 10.1007/s00894-005-0051-5; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Ariel N, 1998, BIOCHEM J, V335, P95, DOI 10.1042/bj3350095; Artursson E, 2013, BIOCHEM PHARMACOL, V85, P1389, DOI 10.1016/j.bcp.2013.01.016; Bai F, 2013, P NATL ACAD SCI USA, V110, P4273, DOI 10.1073/pnas.1301814110; Bartolucci C, 1999, BIOCHEMISTRY-US, V38, P5714, DOI 10.1021/bi982723p; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; Beck JM, 2010, CHEM-BIOL INTERACT, V187, P220, DOI 10.1016/j.cbi.2010.02.012; Bennion B.J., 2013, MIL MED SCI LETT, V8, P102, DOI [10.31482/mmsl.2013.015, DOI 10.31482/MMSL.2013.015]; Bennion BJ, 2004, BIOCHEMISTRY-US, V43, P12955, DOI 10.1021/bi0486379; Bennion BJ, 2004, P NATL ACAD SCI USA, V101, P6433, DOI 10.1073/pnas.0308633101; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Boyd AE, 2004, J BIOL CHEM, V279, P26612, DOI 10.1074/jbc.M401482200; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bui JM, 2003, BIOPHYS J, V85, P2267, DOI 10.1016/S0006-3495(03)74651-7; Carletti E, 2008, J AM CHEM SOC, V130, P16011, DOI 10.1021/ja804941z; Case DA, 2012, AMBER12 AND AMBER TO; Colletier JP, 2007, ACTA CRYSTALLOGR D, V63, P1115, DOI 10.1107/S0907444907044472; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Dolgin E, 2013, NAT MED, V19, P1194, DOI 10.1038/nm1013-1194; Dvir H, 2002, BIOCHEMISTRY-US, V41, P10810, DOI 10.1021/bi020151+; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; Faerman C, 1996, FEBS LETT, V386, P65, DOI 10.1016/0014-5793(96)00374-2; Fang L, 2011, J PHYS CHEM B, V115, P8797, DOI 10.1021/jp112030p; Fattebert JL, 2009, J CHEM THEORY COMPUT, V5, P2257, DOI 10.1021/ct900209y; Fattebert JL, 2004, COMPUT PHYS COMMUN, V162, P24, DOI 10.1016/j.cpc.2004.06.068; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fuxreiter M, 1998, J AM CHEM SOC, V120, P183, DOI 10.1021/ja972326m; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Greenblatt HM, 2004, J AM CHEM SOC, V126, P15405, DOI 10.1021/ja0466154; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Habtemariam B, 2005, NUCLEIC ACIDS RES, V33, P4212, DOI 10.1093/nar/gki724; Hornberg A, 2010, BIOCHEM PHARMACOL, V79, P507, DOI 10.1016/j.bcp.2009.08.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kovach IM, 2004, J PHYS ORG CHEM, V17, P602, DOI 10.1002/poc.778; Kovarik Z, 1999, BBA-PROTEIN STRUCT M, V1433, P261, DOI 10.1016/S0167-4838(99)00124-7; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; KRONMAN C, 1994, J BIOL CHEM, V269, P27819; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; LARSSON L, 1957, ACTA CHEM SCAND, V11, P1131, DOI 10.3891/acta.chem.scand.11-1131; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Liu JJ, 2009, J PHYS CHEM B, V113, P16226, DOI 10.1021/jp9055335; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Masson P, 2011, TOXICOL LETT, V206, P5, DOI 10.1016/j.toxlet.2011.04.006; McCammon JA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-4; MICHEL HO, 1967, ARCH BIOCHEM BIOPHYS, V121, P29, DOI 10.1016/0003-9861(67)90006-9; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Munoz FJ, 1999, NEUROREPORT, V10, P3621, DOI 10.1097/00001756-199911260-00029; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Niu CY, 2005, J PHYS CHEM B, V109, P23730, DOI 10.1021/jp0552877; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Peters J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4825199; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porschke D, 1996, BIOPHYS J, V70, P1603, DOI 10.1016/S0006-3495(96)79759-X; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1994, EMBO J, V13, P3448, DOI 10.1002/j.1460-2075.1994.tb06650.x; Silva GR, 2012, QUIM NOVA, V35, P2083, DOI 10.1590/S0100-40422012001000033; Sirin GS, 2014, THE JOURNAL OF PHYSI; Sirin GS, 2012, J PHYS CHEM B, V116, P12199, DOI 10.1021/jp307790v; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stone J, 1998, EFFICIENT LIBRARY FO; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; TAN RC, 1993, BIOCHEMISTRY-US, V32, P401, DOI 10.1021/bi00053a003; Trapp M, 2012, THE JOURNAL OF PHYSI; Van Belle D, 2000, J MOL BIOL, V298, P705, DOI 10.1006/jmbi.2000.3698; Viragh C, 1999, BIOCHEMISTRY-US, V38, P9557, DOI 10.1021/bi991112+; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILSON IB, 1961, J BIOL CHEM, V236, P2292; Wlodek ST, 2000, BIOPOLYMERS, V53, P265, DOI 10.1002/(SICI)1097-0282(200003)53:3<265::AID-BIP6>3.3.CO;2-E; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Worek F, 2013, PHARMACOL THERAPEUT, V139, P249, DOI 10.1016/j.pharmthera.2013.04.009; Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t; Xu YC, 2008, BIOPHYS J, V95, P2500, DOI 10.1529/biophysj.108.129601; Xu YC, 2008, PROTEIN SCI, V17, P601, DOI 10.1110/ps.083453808; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047; Zhao Y, 2005, J PHYS CHEM A, V109, P2012, DOI 10.1021/jp045141s; Zhou HX, 1998, P NATL ACAD SCI USA, V95, P9280, DOI 10.1073/pnas.95.16.9280; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	93	25	26	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121092	10.1371/journal.pone.0121092	http://dx.doi.org/10.1371/journal.pone.0121092			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874456	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100035
J	Chiba, H; Nishide, H; Uchiyama, I				Chiba, Hirokazu; Nishide, Hiroyo; Uchiyama, Ikuo			Construction of an Ortholog Database Using the Semantic Web Technology for Integrative Analysis of Genomic Data	PLOS ONE			English	Article							ONTOLOGY; GENE; INFORMATION; UNIFICATION; ANNOTATION; DIVERSITY; RESOURCE; SEQUENCE; UNIPROT; BIOLOGY	Recently, various types of biological data, including genomic sequences, have been rapidly accumulating. To discover biological knowledge from such growing heterogeneous data, a flexible framework for data integration is necessary. Ortholog information is a central resource for interlinking corresponding genes among different organisms, and the Semantic Web provides a key technology for the flexible integration of heterogeneous data. We have constructed an ortholog database using the Semantic Web technology, aiming at the integration of numerous genomic data and various types of biological information. To formalize the structure of the ortholog information in the Semantic Web, we have constructed the Ortholog Ontology (OrthO). While the OrthO is a compact ontology for general use, it is designed to be extended to the description of database-specific concepts. On the basis of OrthO, we described the ortholog information from our Microbial Genome Database for Comparative Analysis (MBGD) in the form of Resource Description Framework (RDF) and made it available through the SPARQL endpoint, which accepts arbitrary queries specified by users. In this framework based on the OrthO, the biological data of different organisms can be integrated using the ortholog information as a hub. Besides, the ortholog information from different data sources can be compared with each other using the OrthO as a shared ontology. Here we show some examples demonstrating that the ortholog information described in RDF can be used to link various biological data such as taxonomy information and Gene Ontology. Thus, the ortholog database using the Semantic Web technology can contribute to biological knowledge discovery through integrative data analysis.	[Chiba, Hirokazu; Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi 4448585, Japan; [Nishide, Hiroyo; Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Data Integrat & Anal Facil, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Uchiyama, I (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	uchiyama@nibb.ac.jp		Uchiyama, Ikuo/0000-0002-9197-5000	National Bioscience Database Center, Japan Science Technology Agency	National Bioscience Database Center, Japan Science Technology Agency	This work was supported by the National Bioscience Database Center, Japan Science Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Minarro-Gimenez JA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S13; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Chen HJ, 2013, BRIEF BIOINFORM, V14, P109, DOI 10.1093/bib/bbs014; Chiba H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-148; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dumontier M, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-14; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Erling Orri, 2007, CSSW, V113, P59; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Katayama T, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-5; Katayama T, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-6; Kim JF, 2001, TRENDS GENET, V17, P65, DOI 10.1016/S0168-9525(00)02175-2; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Schmitt T, 2011, BRIEF BIOINFORM, V12, P485, DOI 10.1093/bib/bbr025; Sonnhammer ELL, 2014, BIOINFORMATICS, V30, P2993, DOI 10.1093/bioinformatics/btu492; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2013, NUCLEIC ACIDS RES, V41, pD631, DOI 10.1093/nar/gks1006; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83	29	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122802	10.1371/journal.pone.0122802	http://dx.doi.org/10.1371/journal.pone.0122802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875762	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100103
J	Pierre, PV; Johnson, AC; Fridberger, A				Pierre, Pernilla Videhult; Johnson, Ann-Christin; Fridberger, Anders			Subjective and Clinically Assessed Hearing Loss; A Cross-Sectional Register-Based Study on a Swedish Population Aged 18 through 50 Years	PLOS ONE			English	Article							GENERATIONAL-DIFFERENCES; OTOACOUSTIC EMISSIONS; PREVALENCE; IMPAIRMENT; AUDIOMETRY; HEALTH; NOISE; ACCURACY; EXPOSURE; EAR	Objectives Questionnaire studies suggest that hearing is declining among young adults. However, few studies have examined the reliability of hearing questionnaires among young adult subjects. This study examined the associations between pure tone audiometrically assessed (PTA) hearing loss and questionnaire responses in young to middle aged adults. Materials and Methods A cross-sectional study using questionnaire and screening PTA (500 through 6000 Hz) data from 15322 Swedish subjects (62% women) aged 18 through 50 years. PTA hearing loss was defined as a hearing threshold above 20 dB in both ears at one or more frequencies. Data were analysed with chi-square tests, nonlinear regression, binary logistic regression, and the generalized estimating equation (GEE) approach. Results The prevalence of PTA hearing loss was 6.0% in men and 2.9% in women (p < 0.001). Slight hearing impairment was reported by 18.5% of the men and 14.8% of the women (p < 0.001), whereas 0.5% of men and women reported very impaired hearing. Using multivariate GEE modelling, the odds ratio of PTA hearing loss was 30.4 (95% CI, 12.7-72.9) in men and 36.5 (17.2-77.3) in women reporting very impaired hearing. The corresponding figures in those reporting slightly impaired hearing were 7.06 (5.25-9.49) in men and 8.99 (6.38-12.7) in women. These values depended on the sound stimulus frequency (p = 0.001). The area under the ROC curve was 0.904 (0.892-0.915) in men and 0.886 (0.872-0.900) in women. Conclusions Subjective hearing impairment predicted clinically assessed hearing loss, suggesting that there is cause for concern as regards the future development of hearing in young to middle-aged people.	[Pierre, Pernilla Videhult; Johnson, Ann-Christin] Karolinska Inst, Div Audiol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Pierre, Pernilla Videhult] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Fridberger, Anders] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden	Karolinska Institutet; Uppsala University; Linkoping University	Pierre, PV (corresponding author), Karolinska Inst, Div Audiol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	pernilla.videhult-pierre@ki.se	Fridberger, Anders/E-8977-2010	Fridberger, Anders/0000-0002-7960-1559; Videhult Pierre, Pernilla/0000-0002-2623-4660	Swedish Research Council for Health, Working Life, and Welfare [2006-1526]	Swedish Research Council for Health, Working Life, and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Swedish Research Council for Health, Working Life, and Welfare (http://www.forte.se) financially supported the study (2006-1526; PVP, A-CJ, AF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baker M, 2004, J HUM RESOUR, V39, P1067, DOI 10.2307/3559039; Bardel A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-37; Bhagat SP, 2008, INT J AUDIOL, V47, P751, DOI 10.1080/14992020802310879; Borchgrevink H M, 2005, Noise Health, V7, P1; Chang HP, 2009, EAR HEARING, V30, P576, DOI 10.1097/AUD.0b013e3181ac127a; Engdahl B, 2013, INT J AUDIOL, V52, P74, DOI 10.3109/14992027.2012.733423; Hoffman HJ, 2010, EAR HEARING, V31, P725, DOI 10.1097/AUD.0b013e3181e9770e; Johansson MSK, 2003, INT J AUDIOL, V42, P18, DOI 10.3109/14992020309056081; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Middendorf PJ, 2004, AM J IND MED, V46, P492, DOI 10.1002/ajim.20092; Muhr P, 2007, SCAND J PUBLIC HEALT, V35, P524, DOI 10.1080/14034940701281477; Muhr P, 2010, INT J AUDIOL, V49, P317, DOI 10.3109/14992020903431280; Nondahl DM, 2012, EAR HEARING, V33, P640, DOI 10.1097/AUD.0b013e31825069e8; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Okamoto M, 2005, CLIN OTOLARYNGOL, V30, P16, DOI 10.1111/j.1365-2273.2004.00904.x; PERSSON BO, 1993, SCAND AUDIOL, V22, P141, DOI 10.3109/01050399309046030; Picavet HSJ, 1996, J EPIDEMIOL COMMUN H, V50, P86, DOI 10.1136/jech.50.1.86; Pierre PV, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-874; Ramkissoon Ishara, 2011, J Clin Med Res, V3, P183, DOI 10.4021/jocmr611w; Salonen J, 2011, INT J AUDIOL, V50, P297, DOI 10.3109/14992027.2010.549517; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Statistics Sweden, 2011, MIS 2011 1; Sulaiman AH, 2014, EUR ARCH OTO-RHINO-L, V271, P1463, DOI 10.1007/s00405-013-2612-z; Swanepoel D, 2013, J AM ACAD AUDIOL, V24, P514, DOI 10.3766/jaaa.24.6.7; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Widen SE, 2009, INT J AUDIOL, V48, P537, DOI 10.1080/14992020902894541; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Zhan WH, 2010, AM J EPIDEMIOL, V171, P260, DOI 10.1093/aje/kwp370	36	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123290	10.1371/journal.pone.0123290	http://dx.doi.org/10.1371/journal.pone.0123290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875116	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100160
J	Rubinstein, M; Katzenellenbogen, M; Eshed, R; Rozen, A; Katzir, N; Colle, M; Yang, LM; Grumet, R; Weng, YQ; Sherman, A; Ophir, R				Rubinstein, Mor; Katzenellenbogen, Mark; Eshed, Ravit; Rozen, Ada; Katzir, Nurit; Colle, Marivi; Yang, Luming; Grumet, Rebecca; Weng, Yiqun; Sherman, Amir; Ophir, Ron			Ultrahigh-Density Linkage Map for Cultivated Cucumber (Cucumis sativus L.) Using a Single-Nucleotide Polymorphism Genotyping Array	PLOS ONE			English	Article							SEGREGATION DISTORTION; GENE CONVERSION; QTL ANALYSIS; GENOME; RECOMBINATION; TRAITS; EVOLUTION; FRUIT; DOMESTICATION; CONSTRUCTION	Genotyping arrays are tools for high-throughput genotyping, which is beneficial in constructing saturated genetic maps and therefore high-resolution mapping of complex traits. Since the report of the first cucumber genome draft, genetic maps have been constructed mainly based on simple-sequence repeats (SSRs) or on combinations of SSRs and sequence-related amplified polymorphism (SRAP). In this study, we developed the first cucumber genotyping array consisting of 32,864 single-nucleotide polymorphisms (SNPs). These markers cover the cucumber genome with a median interval of similar to 2 Kb and have expected genotype calls in parents/F-1 hybridizations as a training set. The training set was validated with Fluidigm technology and showed 96% concordance with the genotype calls in the parents/F-1 hybridizations. Application of the genotyping array was illustrated by constructing a 598.7 cM genetic map based on a '9930' x 'Gy14' recombinant inbred line (RIL) population comprised of 11,156 SNPs. Marker collinearity between the genetic map and reference genomes of the two parents was estimated at R-2 = 0.97. We also used the array-derived genetic map to investigate chromosomal rearrangements, regional recombination rate, and specific regions with segregation distortions. Finally, 82% of the linkage-map bins were polymorphic in other cucumber variants, suggesting that the array can be applied for genotyping in other lines. The genotyping array presented here, together with the genotype calls of the parents/F-1 hybridizations as a training set, should be a powerful tool in future studies with high-throughput cucumber genotyping. An ultrahigh-density linkage map constructed	[Rubinstein, Mor; Katzenellenbogen, Mark; Eshed, Ravit; Rozen, Ada; Sherman, Amir; Ophir, Ron] Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Volcani Ctr, Rishon Leziyyon, Israel; [Katzir, Nurit] Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Newe Yaar Ctr, Ramat Yishai, Israel; [Katzenellenbogen, Mark] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Colle, Marivi; Grumet, Rebecca] Michigan State Univ, Dept Hort, Plant Breeding Genet Genom & Biotechnol, E Lansing, MI 48824 USA; [Yang, Luming; Weng, Yiqun] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Weng, Yiqun] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Ophir, R (corresponding author), Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Volcani Ctr, Rishon Leziyyon, Israel.	ron@agri.gov.il	Yang, Luming/K-3222-2019	Ophir, Ron/0000-0002-7951-6661	U.S.-Israel Binational Agricultural Research and Development (BARD) fund [IS-4341-10]; U.S. Department of Agriculture Specialty Crop Research Initiative grant [2011-51181-30661]; ARS [ARS-0425034] Funding Source: Federal RePORTER	U.S.-Israel Binational Agricultural Research and Development (BARD) fund(US-Israel Binational Science Foundation); U.S. Department of Agriculture Specialty Crop Research Initiative grant; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was jointly funded by a U.S.-Israel Binational Agricultural Research and Development (BARD) fund (grant no. IS-4341-10). Work in Yiqun Weng's lab was partially supported by a U.S. Department of Agriculture Specialty Crop Research Initiative grant (project no. 2011-51181-30661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chai HS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-356; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dijkhuizen A, 1996, EUPHYTICA, V90, P79; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Farkhari M, 2011, PLANT BREEDING, V130, P533, DOI 10.1111/j.1439-0523.2011.01866.x; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Galtier N, 2001, GENETICS, V159, P907; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Han YH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-18; He XM, 2013, THEOR APPL GENET, V126, P2149, DOI 10.1007/s00122-013-2125-6; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; KNERR LD, 1989, THEOR APPL GENET, V78, P119, DOI 10.1007/BF00299764; Kumar S, 2007, MOL GENET GENOMICS, V278, P187, DOI 10.1007/s00438-007-0248-7; Li DW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-396; Li YH, 2011, THEOR APPL GENET, V123, P973, DOI 10.1007/s00122-011-1640-6; Lin, 2008, VALIDATION AND EXTEN; Lin S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r63; Liu X, 2010, RES J AGRON, V4, P78, DOI [10.3923/rjagr.2010.78.83, DOI 10.3923/RJAGR.2010.78.83]; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; Miller AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078680; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang LM, 2014, PLANT J, V77, P16, DOI 10.1111/tpj.12355; Yang LM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-53; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x; Yuan XJ, 2008, EUPHYTICA, V164, P473, DOI 10.1007/s10681-008-9722-5; Yuan XJ, 2008, PLANT BREEDING, V127, P180, DOI 10.1111/j.1439-0523.2007.01426.x; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang WW, 2012, THEOR APPL GENET, V124, P249, DOI 10.1007/s00122-011-1701-x; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu CS, 2007, THEOR APPL GENET, V114, P295, DOI 10.1007/s00122-006-0432-x	62	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124101	10.1371/journal.pone.0124101	http://dx.doi.org/10.1371/journal.pone.0124101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874931	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100239
J	Stonko, DP; Manning, L; Starz-Gaiano, M; Peercy, BE				Stonko, David P.; Manning, Lathiena; Starz-Gaiano, Michelle; Peercy, Bradford E.			A Mathematical Model of Collective Cell Migration in a Three-Dimensional, Heterogeneous Environment	PLOS ONE			English	Article							COMPUTATIONAL-MODEL; MOTILITY; ADHESION; CADHERIN; GUIDANCE; MECHANISMS; COOPERATE; FEEDBACK	Cell migration is essential in animal development, homeostasis, and disease progression, but many questions remain unanswered about how this process is controlled. While many kinds of individual cell movements have been characterized, less effort has been directed towards understanding how clusters of cells migrate collectively through heterogeneous, cellular environments. To explore this, we have focused on the migration of the border cells during Drosophila egg development. In this case, a cluster of different cell types coalesce and traverse as a group between large cells, called nurse cells, in the center of the egg chamber. We have developed a new model for this collective cell migration based on the forces of adhesion, repulsion, migration and stochastic fluctuation to generate the movement of discrete cells. We implement the model using Identical Math Cells, or IMCs. IMCs can each represent one biological cell of the system, or can be aggregated using increased adhesion forces to model the dynamics of larger biological cells. The domain of interest is filled with IMCs, each assigned specific biophysical properties to mimic a diversity of cell types. Using this system, we have successfully simulated the migration of the border cell cluster through an environment filled with larger cells, which represent nurse cells. Interestingly, our simulations suggest that the forces utilized in this model are sufficient to produce behaviors of the cluster that are observed in vivo, such as rotation. Our framework was developed to capture a heterogeneous cell population, and our implementation strategy allows for diverse, but precise, initial position specification over a three-dimensional domain. Therefore, we believe that this model will be useful for not only examining aspects of Drosophila oogenesis, but also for modeling other two or three-dimensional systems that have multiple cell types and where investigating the forces between cells is of interest.	[Stonko, David P.; Peercy, Bradford E.] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA; [Manning, Lathiena; Starz-Gaiano, Michelle] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Peercy, BE (corresponding author), Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA.	bpeercy@umbc.edu	Starz-Gaiano, Michelle/AAJ-1810-2021	Stonko, David/0000-0002-2804-2857	National Science Foundation (NSF) [CNS-0821258, CNS-1228778, DMS-0821311]; NSF-UBM Training program [DBI-1031420]; NSF [IOS-1054422]; University of Maryland Baltimore/Baltimore County Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1228778] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1031420] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-UBM Training program; NSF(National Science Foundation (NSF)); University of Maryland Baltimore/Baltimore County Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded in part by grants CNS-0821258, CNS-1228778, DMS-0821311 from the National Science Foundation (NSF) for the UMBC High Performance Computing Facility. DPS, MSG, and BEP were funded in part by a NSF-UBM Training program grant: DBI-1031420, LM and MSG were funded in part by NSF grant IOS-1054422; DS and BEP were funded in part by a University of Maryland Baltimore/Baltimore County Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Arciero J, 2013, COMPLEX SYSTEMS COMP, P185; Ashburner M., 1989, DROSOPHILA LAB HDB; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Danuser G, 2013, ANNU REV CELL DEV BI, V29, P501, DOI 10.1146/annurev-cellbio-101512-122308; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Etienne-Manneville S, 2014, CURR OPIN CELL BIOL, V30, P51, DOI 10.1016/j.ceb.2014.06.004; Fletcher AG, 2014, BIOPHYS J, V106, P2291, DOI 10.1016/j.bpj.2013.11.4498; Frascoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059249; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Groen CM, 2012, MOL BIOL CELL, V23, P4567, DOI 10.1091/mbc.E12-05-0417; Hudson AM, 2014, METHODS, V68, P207, DOI 10.1016/j.ymeth.2014.01.005; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Kraning-Rush CM, 2012, METHOD CELL BIOL, V110, P139, DOI 10.1016/B978-0-12-388403-9.00006-0; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Monahan AJ, 2013, DEV BIOL, V379, P152, DOI 10.1016/j.ydbio.2013.03.022; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nogare DD, 2014, DEVELOPMENT, V141, P3188, DOI 10.1242/dev.106690; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Rangarajan R, 2008, CELL ADHES MIGR, V2, P106, DOI 10.4161/cam.2.2.6211; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Stonko D, 2014, TECHNICAL REPORT; Stonko DP, 2013, THESIS; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Thompson RN, 2012, B MATH BIOL, V74, P2793, DOI 10.1007/s11538-012-9779-0; Van de Bor V, 2011, DEVELOPMENT, V138, P1383, DOI 10.1242/dev.056184; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vargas DA, 2011, ANN BIOMED ENG, V39, P2068, DOI 10.1007/s10439-011-0290-9; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Yamao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027950; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	51	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122799	10.1371/journal.pone.0122799	http://dx.doi.org/10.1371/journal.pone.0122799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875645	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100102
J	Wang, Q; Zhao, DY; Xu, H; Zhou, H; Yang, QY; Liu, F; Zhou, GP				Wang, Quan; Zhao, De-Yu; Xu, Hong; Zhou, Hui; Yang, Qian-Yuan; Liu, Feng; Zhou, Guo-Ping			Down-Regulation of MicroRNA-223 Promotes Degranulation via the PI3K/Akt Pathway by Targeting IGF-1R in Mast Cells	PLOS ONE			English	Article							IGE; INFLAMMATION; ACTIVATION; APOPTOSIS; MIR-223	Background Mast cells play a central role in allergic and inflammatory disorders by inducing degranulation and inflammatory mediator release. Recent reports have shown that miRNAs play an important role in inflammatory response regulation. Therefore, the role of miR-223 in mast cells was investigated. Methods The expression of miR-223 was quantified by quantitative real-time polymerase chain reaction (qRT-PCR) in immunoglobulin E (IgE)-mediated mast cells. After successful miR-223 inhibition by transfection, degranulation was detected in IgE-mediated mast cells. The phosphorylation of I kappa B-alpha and Akt were examined using western blotting. NF-kappa B was tested using electrophoretic mobility shift assay. PI3K-inhibitor (LY294002) was used to investigate whether the PI3K/Akt pathway was essential for mast cell activation. The TargetScan database and a luciferase reporter system were used to identify whether insulin-like growth factor 1 receptor (IGF-1R) is a direct target of miR-223. Results MiR-223 expression was up-regulated in IgE-mediated mast cells, whereas its down-regulation promoted mast cell degranulation. Levels of I kappa B-alpha and Akt phosphorylation as well as NF-kappa B were increased in miR-223 inhibitor cells. LY294002 could block the PI3K/Akt signaling pathway and rescue the promotion caused by suppressing miR-223 in mast cells. IGF-1R was identified as a direct target of miR-223. Conclusions These findings suggest that down-regulation of miR-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells.	[Wang, Quan; Zhao, De-Yu; Xu, Hong; Yang, Qian-Yuan; Liu, Feng] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Hui] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Zhou, Guo-Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, F (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	axsliu@163.com; gpzhou@aliyun.com			National Natural Science Foundation of China [81200012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was supported by the National Natural Science Foundation of China (81200012; Feng Liu).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biethahn K, 2014, ALLERGY, V69, P752, DOI 10.1111/all.12407; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Pan Y, 2014, J IMMUNOL, V192, P437, DOI 10.4049/jimmunol.1301790; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Peschke K, 2014, CELL REP, V8, P1300, DOI 10.1016/j.celrep.2014.07.046; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Yu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078769; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	19	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123575	10.1371/journal.pone.0123575	http://dx.doi.org/10.1371/journal.pone.0123575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875646	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100189
J	Zheng, YZ; Cao, X; Wen, J; Yang, H; Luo, KJ; Liu, QW; Huang, QY; Chen, JY; Fu, JH				Zheng, Yuzhen; Cao, Xun; Wen, Jing; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua			Smoking Affects Treatment Outcome in Patients with Resected Esophageal Squamous Cell Carcinoma Who Received Chemotherapy	PLOS ONE			English	Article							EPIDEMIOLOGIC EVIDENCE; CIGARETTE-SMOKING; ALCOHOL-DRINKING; CANCER PROGNOSIS; TOBACCO SMOKING; GASTRIC-CANCER; SURVIVAL; NICOTINE; RISK; CHEMORADIOTHERAPY	Background Cigarette smoking is reported to decrease survival and induce chemotherapy resistance in patients with various cancers. However, the impact of cigarette smoking on patients with esophageal squamous cell carcinoma (ESCC) remains unknown. Methods A total of 1,084 ESCC patients were retrospectively enrolled from a southern Chinese institution. Patients were divided into two groups according to their treatment modalities: the SC group (surgery with chemotherapy) (n = 306) and the S group (surgery without chemotherapy) (n = 778). Smoking status was quantified as smoking history (non-smoker, ex-smoker, and current smoker) and cumulative smoking (0, between 0 and 20, and greater than 20 pack-years). The association between cigarette smoking and overall survival (OS) was evaluated using the Kaplan-Meier method and univariate/multivariate regression analysis. Results Among 1,084 patients, 702 (64.8%) reported a cigarette smoking history, and the 5-year OS for non-smokers and smokers was 45.8% and 37.3%, respectively. In the SC group, compared with non-smoker, the adjusted HRs of ex-smoker and current smoker were 1.540 (95% CI, 1.1-2.2) and 2.110 (95% CI, 1.4-3.1), respectively; there is a correlative trend of decreased OS with increased cigarette smoking (P-trend = 0.001). These associations were insignificant in the S group. In subgroup analysis of the SC group, the lower OS conferred by smoking was not significantly modified by age, gender, body mass index, alcohol drinking, or chemotherapy method (chemotherapy and chemoradiotherapy). Conclusion Our results suggest that smoking may affect treatment outcome in patients with resected ESCC who received chemotherapy.	[Zheng, Yuzhen; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Xun] Sun Yat Sen Univ, Ctr Canc, Dept Intens Care Unit, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Jing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yuzhen; Wen, Jing; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Fu, JH (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Thorac Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China.	fu_jianhua@126.com	wen, jing/HDM-2205-2022		Chinese Ministry of Health Key Program [179]; National Natural Science Foundation of China [81272635]	Chinese Ministry of Health Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Chinese Ministry of Health Key Program (grant number 179) and National Natural Science Foundation of China General Program (grant number 81272635).	Aksoy S, 2007, BREAST J, V13, P431, DOI 10.1111/j.1524-4741.2007.00459.x; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Chen RJ, 2010, TOXICOL SCI, V115, P118, DOI 10.1093/toxsci/kfq028; Cooke JP, 2004, ANN MED, V36, P33, DOI 10.1080/07853890310017576; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Edge SB, 2010, AJCC CANC STAGING MA, P67; FOUNTZILAS G, 1992, ANN ONCOL, V3, P553, DOI 10.1093/oxfordjournals.annonc.a058260; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Han MA, 2013, CANCER EPIDEM BIOMAR, V22, P1805, DOI 10.1158/1055-9965.EPI-13-0385; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Jiang JM, 2006, INT J CANCER, V119, P1427, DOI 10.1002/ijc.21887; JOHNSTONEARLY A, 1980, JAMA-J AM MED ASSOC, V244, P2175, DOI 10.1001/jama.244.19.2175; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Kofoed SC, 2012, SCAND J SURG, V101, P26, DOI 10.1177/145749691210100106; Liu JG, 2012, ANN THORAC SURG, V93, P423, DOI 10.1016/j.athoracsur.2011.10.011; Liu Y, 2011, WORLD J GASTROENTERO, V17, P2674, DOI 10.3748/wjg.v17.i21.2674; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Mariette C, 2014, J CLIN ONCOL; Oze I, 2012, JPN J CLIN ONCOL, V42, P63, DOI 10.1093/jjco/hyr170; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Seibold P, 2014, CANCER EPIDEMIOL, V38, P419, DOI 10.1016/j.canep.2014.05.006; Sharp L, 2014, CANCER EPIDEMIOL BIO; Shitara K, 2010, CANCER SCI, V101, P1001, DOI 10.1111/j.1349-7006.2009.01466.x; Tsao AS, 2006, CANCER, V106, P2428, DOI 10.1002/cncr.21884; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wakai K, 2006, JPN J CLIN ONCOL, V36, P309, DOI 10.1093/jjco/hyl025; Walter V, 2014, ANN ONCOL, V25, P1517, DOI 10.1093/annonc/mdu040; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Wang ZW, 2014, NEOPLASMA, V61, P732, DOI 10.4149/neo_2014_089; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yaegashi Y, 2014, ASIAN PAC J CANCER P, V15, P1023, DOI 10.7314/APJCP.2014.15.2.1023; Yoshioka A, 2008, ONCOL REP, V19, P1099; Zhang F, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-249; Zhang SS, 2013, DIS ESOPHAGUS	37	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123246	10.1371/journal.pone.0123246	http://dx.doi.org/10.1371/journal.pone.0123246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874561	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100154
J	Fleet, R; Pelletier, C; Marcoux, J; Maltais-Giguere, J; Archambault, P; Audette, LD; Plant, J; Begin, F; Tounkara, FK; Poitras, J				Fleet, Richard F; Pelletier, Christina; Marcoux, Jeremie; Maltais-Giguere, Julie; Archambault, Patrick; Audette, Louis David; Plant, Jeff; Begin, Francois; Tounkara, Fatoumata Korika; Poitras, Julien			Differences in Access to Services in Rural Emergency Departments of Quebec and Ontario	PLOS ONE			English	Article							HOSPITALS; CANADA; CARE; MORTALITY; QUALITY; RATES	Introduction Rural emergency departments (EDs) are important safety nets for the 20% of Canadians who live there. A serious problem in access to health care services in these regions has emerged. However, there are considerable geographic disparities in access to trauma center in Canada. The main objective of this project was to compare access to local 24/7 support services in rural EDs in Quebec and Ontario as well as distances to Levels 1 and 2 trauma centers. Materials and Methods Rural EDs were identified through the Canadian Healthcare Association's Guide to Canadian Healthcare Facilities. We selected hospitals with 24/7 ED physician coverage and hospitalization beds that were located in rural communities. There were 26 rural EDs in Quebec and 62 in Ontario meeting these criteria. Data were collected from ministries of health, local health authorities, and ED statistics. Fisher's exact test, the t-test or Wilcoxon-Mann-Whitney test, were performed to compare rural EDs of Quebec and Ontario. Results All selected EDs of Quebec and Ontario agreed to participate in the study. The number of EDs visits was higher in Quebec than in Ontario (19 322 +/- 6 275 vs 13 446 +/- 8 056, p = 0.0013). There were no significant differences between Quebec and Ontario's local population and small town population density. Quebec's EDs have better access to advance imaging services such as CT scanner (77% vs 15%, p < .0001) and most the consultant support and ICU (92% vs 31%, p < .0001). Finally, more than 40% of rural EDs in Quebec and Ontario are more than 300 km away from Levels 1 and 2 trauma centers. Conclusions Considering that Canada has a Universal health care system, the discrepancies between Quebec and Ontario in access to support services are intriguing. A nationwide study is justified to address this issue.	[Fleet, Richard F; Pelletier, Christina; Marcoux, Jeremie; Archambault, Patrick; Audette, Louis David; Begin, Francois; Poitras, Julien] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Fleet, Richard F; Maltais-Giguere, Julie; Archambault, Patrick; Tounkara, Fatoumata Korika] Univ Laval, CHAU Hotel Dieu Levis Hosp, Res Chair Emergency Med, Levis City, PQ, Canada; [Plant, Jeff] Univ British Columbia, Fac Med, Penticton, BC, Canada; [Plant, Jeff] Penticton Reg Hosp, Dept Emergency Med, Penticton, BC, Canada; [Poitras, Julien] Hotel Dieu Levis Hosp, CSSS Alphonse Desjardins, Dept Emergency Med, Levis, PQ, Canada	Laval University; Laval University; University of British Columbia; Laval University	Fleet, R (corresponding author), Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada.	rfleet@videotron.ca			Junior 1 Clinician -Scientist award from the FRQS; Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital research fund	Junior 1 Clinician -Scientist award from the FRQS; Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital research fund	The research project was supported in part by a Junior 1 Clinician -Scientist award from the FRQS (RF), the Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital and the Hotel-Dieu de Levis Hospital research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GL, 2006, AM J CARDIOL, V98, P1160, DOI 10.1016/j.amjcard.2006.05.042; Alexandrescu R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-80; Barua B, 2011, HOSP REPORT CARD BRI; Barua B, 2013, STUDIES HLTH POLICY; Canadian Healthcare Association, 2009, GUID CAN HEALTHC FAC; Canadian Institute for Health I, 2006, HLTH AR RUR CAN ASS; Collier R, 2010, CAN MED ASSOC J, V182, P331, DOI 10.1503/cmaj.109-3167; du Plessis V., 2001, RURAL SMALL TOWN CAN, V3, P1; Ellehoj E, 2006, CAN J RURAL MED, V11, P187; Fleet R, 2013, BMJ OPEN, V3; Fleet R, 2013, CJEM, V15, P1; Fleet R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003876; Fleet R, 2013, CAN J EMERG MED, V15, P191; Gilmour SJ, 2010, HEALTH SERV RES, V45, P497, DOI 10.1111/j.1475-6773.2009.01069.x; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Grzybowski S, 2013, CAN J RURAL MED, V18, P123; Haggerty Jeannie L, 2007, Healthc Policy, V3, P72; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Hu WW, 2007, BIOTECHNOL PROGR, V23, P1355, DOI 10.1021/bp070306a; Institut canadien d'information sur la sante, 2012, TEND DEP NAT SANT 19; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P1379, DOI 10.1001/jama.2013.2366; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Kobayashi S, 2010, J MED SYST, V34, P1157, DOI 10.1007/s10916-009-9335-0; Kornelsen J, 2013, RURAL REMOTE HEALTH, V13; Lefer TB, 2008, PUBLIC HEALTH REP, V123, P474, DOI 10.1177/003335490812300408; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Lizotte A, 2013, COMMUNICATION; Masino C, 2010, TELEMED J E-HEALTH, V16, P273, DOI 10.1089/tmj.2010.0057; Merkens BJ, 2006, CAN ASSOC RADIOL J, V57, P224; Ministere de la Sante et des Services sociaux du Quebec, 2006, GUID GEST URG; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Nivala AM, 2008, CARTOGR J, V45, P129, DOI 10.1179/174327708X305120; Rourke J T, 2001, CJEM, V3, P296; Rourke JTB, 1998, CAN FAM PHYSICIAN, V44, P2107; Rural Committee of the Canadien Association of Emergency Physicians, 1997, J EMERGENCY MED, V15, P741; Soles TML, 2005, CAN J RURAL MED, V10, P107; Statistics Canada, POP YEAR PROV TERR 2; Statistics Canada, POP URB RUR PROV TER; Statistics Canada, 2006, COMM PROF 2006; Statistics Canada, 2005, LAND FRESHW AR PROV; Thompson J M, 1995, J Emerg Med, V13, P415, DOI 10.1016/0736-4679(95)00014-2; Wu Jiyi, 2013, COMMUNICATION	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123746	10.1371/journal.pone.0123746	http://dx.doi.org/10.1371/journal.pone.0123746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874948	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800113
J	Stout, D; Hecht, E; Khreisheh, N; Bradley, B; Chaminade, T				Stout, Dietrich; Hecht, Erin; Khreisheh, Nada; Bradley, Bruce; Chaminade, Thierry			Cognitive Demands of Lower Paleolithic Toolmaking	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; SUPERIOR FRONTAL GYRUS; STONE TOOL TECHNOLOGY; HUMAN-EVOLUTION; WORKING-MEMORY; HUMAN BRAIN; CORTEX; ORGANIZATION; ATTENTION; NETWORKS	Stone tools provide some of the most abundant, continuous, and high resolution evidence of behavioral change over human evolution, but their implications for cognitive evolution have remained unclear. We investigated the neurophysiological demands of stone toolmaking by training modern subjects in known Paleolithic methods ("Oldowan", "Acheulean") and collecting structural and functional brain imaging data as they made technical judgments (outcome prediction, strategic appropriateness) about planned actions on partially completed tools. Results show that this task affected neural activity and functional connectivity in dorsal prefrontal cortex, that effect magnitude correlated with the frequency of correct strategic judgments, and that the frequency of correct strategic judgments was predictive of success in Acheulean, but not Oldowan, toolmaking. This corroborates hypothesized cognitive control demands of Acheulean toolmaking, specifically including information monitoring and manipulation functions attributed to the "central executive" of working memory. More broadly, it develops empirical methods for assessing the differential cognitive demands of Paleolithic technologies, and expands the scope of evolutionary hypotheses that can be tested using the available archaeological record.	[Stout, Dietrich; Khreisheh, Nada] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Hecht, Erin] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Bradley, Bruce] Univ Exeter, Dept Archaeol, Exeter, Devon, England; [Chaminade, Thierry] Aix Marseille Univ, Inst Neurosci Timone, Marseille, France	Emory University; University System of Georgia; Georgia State University; University of Exeter; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Stout, D (corresponding author), Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA.	dwstout@emory.edu	Chaminade, Thierry/F-8367-2010; Chaminade, Thierry/AAF-6072-2020	Chaminade, Thierry/0000-0003-4952-1467; Chaminade, Thierry/0000-0003-4952-1467; Hecht, Erin/0000-0003-1247-0432; Khreisheh, Nada/0000-0002-3002-4228; Stout, Dietrich/0000-0003-3555-7637	Leverhulme Trust [F/00144/BP]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a grant from the Leverhulme Trust (http://www.leverhulme.ac.uk/), "Learning to Be Human: Skill Acquisition and the Development of the Human Brain," F/00144/BP to BB and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati D, 2007, COGNITION, V103, P358, DOI 10.1016/j.cognition.2006.04.002; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Carmel D, 2008, NEURON, V57, P799, DOI 10.1016/j.neuron.2008.03.009; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Deacon T., 1997, SYMBOLIC SPECIES COE; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Engels F., 1873, PHILOS TECHNOLOGY, P71; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Falquez R, 2014, FRONT BEHAV NEUROSCI, P8, DOI [10. 3389/ fnbeh. 2014. 00008, DOI 10.3389/FNBEH.2014.00008]; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Gerlach KD, 2014, SOCIAL COGNITIVE AFF; Gowlett J, 2012, CURR ANTHROPOL, V53, P693, DOI 10.1086/667994; Hecht E. E., 2014, BRAIN STRUCTURE FUNC, P1, DOI [10.1007/s00429-013-0527-5, DOI 10.1007/S00429-013-0527-5]; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kelly R.L., 2013, ARCHAEOLOGY, V6th Edn; Khreisheh N., 2013, THESIS EXETER U; Khreisheh NN, 2013, ADV ARCHAEOL PRACT, V1, P37, DOI 10.7183/2326-3768.1.1.37; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Mithen S, 1996, PREHISTORY MIND COGN; Moore MW, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P13; Mruczek REB, 2013, J NEUROPHYSIOL, V109, P2883, DOI 10.1152/jn.00658.2012; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Oakley KP, 1954, HIST TECHNOLOGY, P1; Pelegrin J, 1990, ARCHAEOLOGICAL REV C, V9, P116; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Schiffer M., 2013, MANUALS ARCHAEOLOGIC, V9, P43; Shea JJ, 2013, J ARCHAEOL METHOD TH, V20, P151, DOI 10.1007/s10816-012-9128-5; Shea JJ, 2011, EVOL ANTHROPOL, V20, P48, DOI 10.1002/evan.20290; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shultz S, 2012, PHILOS T R SOC B, V367, P2130, DOI 10.1098/rstb.2012.0115; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, EUR J NEUROSCI, V33, P1328, DOI 10.1111/j.1460-9568.2011.07619.x; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2010, TOP COGN SCI, V2, P614, DOI 10.1111/j.1756-8765.2009.01078.x; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanLehn K, 1996, ANNU REV PSYCHOL, V47, P513, DOI 10.1146/annurev.psych.47.1.513; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whittaker J.C., 1994, FLINTKNAPPING MAKING; Williams E, 2014, J HUMAN EVOLUTION; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	70	91	95	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121804	10.1371/journal.pone.0121804	http://dx.doi.org/10.1371/journal.pone.0121804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CG1EL	25875283	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800032
J	Yan, L; Lai, XJ; Li, XD; Wei, CH; Tan, XM; Zhang, YZ				Yan, Lang; Lai, Xianjun; Li, Xuedan; Wei, Changhe; Tan, Xuemei; Zhang, Yizheng			Analyses of the Complete Genome and Gene Expression of Chloroplast of Sweet Potato [Ipomoea batata]	PLOS ONE			English	Article							REAL-TIME PCR; DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; PLASTID GENOMES; HIGH-THROUGHPUT; ORGANIZATION; DIVERSIFICATION; TRANSCRIPTION; ANGIOSPERMS; ANNOTATION	Sweet potato [Ipomoea batatas (L.) Lam] ranks among the top seven most important food crops cultivated worldwide and is hexaploid plant (2n=6x=90) in the Convolvulaceae family with a genome size between 2,200 to 3,000 Mb. The genomic resources for this crop are deficient due to its complicated genetic structure. Here, we report the complete nucleotide sequence of the chloroplast (cp) genome of sweet potato, which is a circular molecule of 161,303 bp in the typical quadripartite structure with large (LSC) and small (SSC) single-copy regions separated by a pair of inverted repeats (IRs). The chloroplast DNA contains a total of 145 genes, including 94 protein-encoding genes of which there are 72 single-copy and 11 double-copy genes. The organization and structure of the chloroplast genome (gene content and order, IR expansion/contraction, random repeating sequences, structural rearrangement) of sweet potato were compared with those of Ipomoea (L.) species and some basal important angiosperms, respectively. Some boundary gene-flow and gene gain-and-loss events were identified at intra-and inter-species levels. In addition, by comparing with the transcriptome sequences of sweet potato, the RNA editing events and differential expressions of the chloroplast functional-genes were detected. Moreover, phylogenetic analysis was conducted based on 77 protein-coding genes from 33 taxa and the result may contribute to a better understanding of the evolution progress of the genus Ipomoea (L.), including phylogenetic relationships, intraspecific differentiation and interspecific introgression.	[Yan, Lang; Li, Xuedan; Wei, Changhe; Tan, Xuemei; Zhang, Yizheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China; [Lai, Xianjun] Sichuan Agr Univ, Maize Res Inst, Key Lab Crop Genet Resource & Improvement, Minist Educ, Chengdu, Peoples R China	Sichuan University; Sichuan Agricultural University	Tan, XM (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China.	txmyyf@scu.edu.cn; yizzhang@scu.edu.cn			National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five" Key Project of Sichuan Province, China [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleventh-Five" Key Project of Sichuan Province, China	This work is supported by grants from the National Science & Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five" Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Berg S, 2004, PLANTA, V219, P541, DOI 10.1007/s00425-004-1260-3; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DeCoste NJ, 2011, APPL ENVIRON MICROB, V77, P41, DOI 10.1128/AEM.01387-10; del Campo EM, 2009, GENE REGUL SYST BIO, V3, P31; Dixit R, 1999, CURR GENET, V36, P165, DOI 10.1007/s002940050487; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eserman LA, 2014, AM J BOT, V101, P92, DOI 10.3732/ajb.1300207; Favory JJ, 2005, NUCLEIC ACIDS RES, V33, P5991, DOI 10.1093/nar/gki908; Firon LD, 2009, BOT PHYSL STORAGE RO, P13; Gaba V., 2009, P65, DOI 10.1007/978-1-4020-9475-0_6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He XJ ZT, 2010, CHINESE J TROPICAL A, P-10; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenz H, 2010, CURR GENET, V56, P189, DOI 10.1007/s00294-009-0283-5; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma J, 2013, GENE, V528, P120, DOI 10.1016/j.gene.2013.07.037; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Naito K, 2013, BREEDING SCI, V63, P176, DOI 10.1270/jsbbs.63.176; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shiina T, 1998, PLANT CELL, V10, P1713, DOI 10.1105/tpc.10.10.1713; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Thottappilly G., 2009, P3, DOI 10.1007/978-1-4020-9475-0_1; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073946; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	29	36	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124083	10.1371/journal.pone.0124083	http://dx.doi.org/10.1371/journal.pone.0124083			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874767	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800132
J	Vedder, A; Smigielski, L; Gutyrchik, E; Bao, Y; Blautzik, J; Poppel, E; Zaytseva, Y; Russell, E				Vedder, Aline; Smigielski, Lukasz; Gutyrchik, Evgeny; Bao, Yan; Blautzik, Janusch; Poeppel, Ernst; Zaytseva, Yuliya; Russell, Edmund			Neurofunctional Correlates of Environmental Cognition: An fMRI Study with Images from Episodic Memory	PLOS ONE			English	Article							MENTAL-IMAGERY; CORTEX; REPRESENTATIONS; PERCEPTION; MECHANISMS; EXPOSURE; RECOVERY	This study capitalizes on individual episodic memories to investigate the question, how different environments affect us on a neural level. Instead of using predefined environmental stimuli, this study relied on individual representations of beauty and pleasure. Drawing upon episodic memories we conducted two experiments. Healthy subjects imagined pleasant and non-pleasant environments, as well as beautiful and non-beautiful environments while neural activity was measured by using functional Magnetic Resonance Imaging. Although subjects found the different conditions equally simple to visualize, our results revealed more distribut-ed brain activations for non-pleasant and non-beautiful environments than for pleasant and beautiful environments. The additional regions activated in non-pleasant (left lateral prefrontal cortex) and non-beautiful environments (supplementary motor area, anterior cortical midline structures) are involved in self-regulation and top-down cognitive control. Taken together, the results show that perceptual experiences and emotional evaluations of environments within a positive and a negative frame of reference are based on distinct patterns of neural activity. We interpret the data in terms of a different cognitive and processing load placed by exposure to different environments. The results hint at the efficiency of subject-generated representations as stimulus material.	[Vedder, Aline; Smigielski, Lukasz; Gutyrchik, Evgeny; Poeppel, Ernst; Zaytseva, Yuliya; Russell, Edmund] LMU, Human Sci Ctr, Munich, Germany; [Vedder, Aline] LMU, Inst Sociol, Munich, Germany; [Vedder, Aline; Gutyrchik, Evgeny; Poeppel, Ernst; Zaytseva, Yuliya] LMU, Inst Med Psychol, Munich, Germany; [Vedder, Aline; Gutyrchik, Evgeny; Bao, Yan; Poeppel, Ernst; Zaytseva, Yuliya] Parmenides Ctr Art & Sci, Pullach, Germany; [Blautzik, Janusch] LMU, Inst Clin Radiol, Munich, Germany; [Bao, Yan; Poeppel, Ernst] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Bao, Yan] Peking Univ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Zaytseva, Yuliya] Moscow Res Inst Psychiat, Moscow, Russia; [Zaytseva, Yuliya] Univ Kansas, Dept Hist, Lawrence, KS USA	University of Munich; University of Munich; University of Munich; University of Munich; Peking University; Peking University; University of Kansas	Gutyrchik, E (corresponding author), LMU, Human Sci Ctr, Munich, Germany.	evgeny.gutyrchik@med.uni-muenchen.de		Zaytseva, Yuliya/0000-0002-6560-8127; Gutyrchik, Evgeny/0000-0003-0550-2547; Smigielski, Lukasz/0000-0002-7428-7644	Munich Center for Neuroscience; Bavarian State Ministry of Education, Science and the Arts; Hanns-Seidel-Foundation; Parmenides Center for Art and Science; Andrea von Braun Foundation; Bavarian Research Foundation; National Natural Science Foundation of China	Munich Center for Neuroscience; Bavarian State Ministry of Education, Science and the Arts; Hanns-Seidel-Foundation; Parmenides Center for Art and Science; Andrea von Braun Foundation; Bavarian Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the Munich Center for Neuroscience (www.mcn.uni-muenchen.de) to the Rachel Carson Center, the Bavarian State Ministry of Education, Science and the Arts (www.stmwfk.bayern.de), the Hanns-Seidel-Foundation (www.hss.de), the Parmenides Center for Art and Science (www.parmenides-foundation.org), the Andrea von Braun Foundation (www.avbstiftung.de), the Bavarian Research Foundation (www.forschungsstiftung.de), and the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram M, 2013, NEUROSCI LETT, V534, P128, DOI 10.1016/j.neulet.2012.11.053; Bao Y, 2012, NEUROSCI BIOBEHAV R, V36, P2143, DOI 10.1016/j.neubiorev.2012.06.008; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Borst G, 2008, MEM COGNITION, V36, P849, DOI 10.3758/MC.36.4.849; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Buijs AE, 2009, LANDSCAPE URBAN PLAN, V91, P113, DOI 10.1016/j.landurbplan.2008.12.003; Cichy RM, 2012, CEREB CORTEX, V22, P372, DOI 10.1093/cercor/bhr106; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; FINKE RA, 1985, PSYCHOL BULL, V98, P236, DOI 10.1037/0033-2909.98.2.236; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kellert SR, 2013, THE BIOPHILIA HYPOTH; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 1999, MEM COGNITION, V27, P276, DOI 10.3758/BF03211412; Laumann K, 2001, J ENVIRON PSYCHOL, V21, P31, DOI 10.1006/jevp.2000.0179; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lutz A, 2013, NEUROIMAGE, V66, P288, DOI 10.1016/j.neuroimage.2012.10.067; Martinez-Soto J, 2013, INTELL BUILD INT, V5, P10, DOI 10.1080/17508975.2013.807765; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Park M, 2013, BRAIN RES, V1523, P68, DOI 10.1016/j.brainres.2013.05.042; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Poppel E., 2014, SUBJECTIVE TIME PHIL, P241, DOI DOI 10.7551/MITPRESS/8516.003.0020; Poppel E., 2011, CULTURE NEURAL FRAME, P215, DOI DOI 10.1007/978-3-642-15423-2_14; Sapolsky RM, 2004, THE ACCLAIMED GUIDE; Schweitzer M, 2004, J ALTERN COMPLEM MED, V10, pS71, DOI 10.1089/acm.2004.10.S-71; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; Silveira S, 2012, PERCEPTION, V41, P569, DOI 10.1068/p7191; Staricoff RL, 2003, HEALING ENV, P63; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulrich R.S., 1993, 33 M SOC PSYCH RES R; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Weidner R, 2002, CEREB CORTEX, V12, P318, DOI 10.1093/cercor/12.3.318; Wells NM, 2010, J ARCHIT PLAN RES, V27, P124	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122470	10.1371/journal.pone.0122470	http://dx.doi.org/10.1371/journal.pone.0122470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875000	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700015
J	Bien, CH; Muessig, KE; Lee, R; Lo, EJ; Yang, LG; Yang, B; Peeling, RW; Tucker, JD				Bien, Cedric H.; Muessig, Kathryn E.; Lee, Ramon; Lo, Elaine J.; Yang, Li Gang; Yang, Bin; Peeling, Rosanna W.; Tucker, Joseph D.			HIV and Syphilis Testing Preferences among Men Who Have Sex with Men in South China: A Qualitative Analysis to Inform Sexual Health Services	PLOS ONE			English	Article							RISK; MSM; INFECTION; HIV/AIDS; CARE; INTERVENTION; EPIDEMIOLOGY; METAANALYSIS; POPULATIONS; PREVALENCE	Background Health services for men who have sex with men (MSM) are inadequate in many areas around the world. HIV and syphilis test uptake remain suboptimal among MSM in China and many other regions. To inform the development of more comprehensive sexually transmitted disease (STD) testing programs among MSM, we collected descriptive data on MSM testing practices and preferences. Methods MSM in two large urban Chinese cities were recruited through community-based organizations and clinics to participate in semi-structured interviews. We purposively sampled MSM across a range of sociodemographic characteristics and testing history, and assessed preferences for HIV and syphilis testing in the context of facilitators and barriers to testing and previous testing experiences. Each interview transcript was coded and thematically analyzed using Atlas.ti 7.0. Results 35 MSM were interviewed. Confidentiality and privacy were the most important factors influencing participants' decisions about whether and where to get tested. Men preferred rapid testing (results available within 30 minutes) compared to conventional tests where results take several hours or days to return. Participants described concerns about quality and accuracy of rapid tests offered in non-clinical settings such as community-based organizations. Men preferred testing service providers who were MSM-friendly, non-discriminatory, and medically trained. Preferred service center environments included: convenient but discrete location, MSM-friendly atmosphere, and clean/standard medical facilities. Conclusion Our data highlight the need for HIV/syphilis testing services that are confidential and inclusive of MSM. Rapid testing in decentralized (i.e. peripheral health facilities and community-level, non-clinical venues) settings provides an opportunity to reach individuals who have not been tested before, but must be accompanied by quality assurance systems and technical competence. Implementation research could further evaluate HIV/syphilis testing programs responsive to MSM preferences. Short Summary A qualitative study of MSM in South China found thatmen preferred rapid STD testing at MSM-focused test centers, but were concerned about test quality assurance and confidentiality.	[Bien, Cedric H.; Muessig, Kathryn E.; Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Bien, Cedric H.] Mt Sinai Sch Med, New York, NY USA; [Muessig, Kathryn E.; Lo, Elaine J.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Lee, Ramon] Harvard Univ, Sch Med, Boston, MA USA; [Yang, Li Gang; Yang, Bin] Guangdong Prov STD Control Ctr, Guangzhou, Guangdong, Peoples R China; [Peeling, Rosanna W.; Tucker, Joseph D.] London Sch Hyg & Trop Med, London WC1, England; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tucker, JD (corresponding author), Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China.	jdtucker@med.unc.edu	Muessig, Kate/P-1242-2018	Tucker, Joseph/0000-0003-2804-1181	NIAID [1R01AI114310-01]; NIH Fogarty Career Development Award (US NIH) [1K01TW008200-01A1]; NIH institutional training grant [5T32AI007001-35]; UNC Center for AIDS Research [NIAID 5P30AI050410-13]; Partnership for Social Science Research on HIV/AIDS in China [NICHD 1R24 HD056670-04]; American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund; Columbia University College of Physicians and Surgeons Dean's International Grant; Harvard Medical School; IDSA Medical Scholars Program; Doris Duke Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056670] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, R01AI114310, P30AI050410] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Fogarty Career Development Award (US NIH); NIH institutional training grant; UNC Center for AIDS Research; Partnership for Social Science Research on HIV/AIDS in China; American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund; Columbia University College of Physicians and Surgeons Dean's International Grant; Harvard Medical School; IDSA Medical Scholars Program; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the NIAID (1R01AI114310-01), an NIH Fogarty Career Development Award (US NIH 1K01TW008200-01A1), an NIH institutional training grant (5T32AI007001-35), the UNC Center for AIDS Research (NIAID 5P30AI050410-13), the Partnership for Social Science Research on HIV/AIDS in China (NICHD 1R24 HD056670-04), a junior faculty award from the American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund, Columbia University College of Physicians and Surgeons Dean's International Grant, Harvard Medical School, IDSA Medical Scholars Program, and a grant from the Doris Duke Charitable Foundation to UNC-Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Chai J, 2012, AIDS CARE, V24, P424, DOI 10.1080/09540121.2011.613907; Chiu YHC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018294; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cochran SD, 2011, AM J PUBLIC HEALTH, V101, P1133, DOI 10.2105/AJPH.2010.300013; Cohall A, 2010, AM J PUBLIC HEALTH, V100, P1961, DOI 10.2105/AJPH.2008.140632; Dixon-Woods M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-39; Fan EL, 2014, GLOB PUBLIC HEALTH, V9, P85, DOI 10.1080/17441692.2014.881520; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Huang ZH, 2013, AIDS RES HUM RETROV, V29, P441, DOI [10.1089/aid.2012.0151, 10.1089/AID.2012.0151]; Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Lambdin B, 2012, 19 INT AIDS C WASH D; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Lee D, 2010, SEX TRANSM DIS, V37, P557, DOI 10.1097/OLQ.0b013e3181d707de; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Lorente N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061225; Marley G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-422; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Prost A, 2007, SEX TRANSM INFECT, V83, P547, DOI 10.1136/sti.2007.027110; Prost A, 2007, SEX TRANSM INFECT, V83, P185, DOI 10.1136/sti.2006.023341; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Tao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102812; Tucker JD, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0601-5; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Tucker JD, 2011, SEX TRANSM INFECT, V87, pII16, DOI 10.1136/sti.2010.048314; Wei CY, 2014, SEX TRANSM INFECT, V90, P469, DOI 10.1136/sextrans-2013-051460; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; Wu ZY, 2011, B WORLD HEALTH ORGAN, V89, P227, DOI 10.2471/BLT.10.082552; Xu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064652; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397; Yang L, 2012, INT UN SEX TRANSM IN; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0; Zeng Gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P977; Zhang D, 2011, INT J STD AIDS; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; Zhang DP, 2014, AIDS CARE, V26, P1118, DOI 10.1080/09540121.2014.902420; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	47	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124161	10.1371/journal.pone.0124161	http://dx.doi.org/10.1371/journal.pone.0124161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875336	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100242
J	Favero, M; Cangiano, A; Busetto, G				Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe			Adult Rat Motor Neurons Do Not Re-Establish Electrical Coupling during Axonal Regeneration and Muscle Reinnervation	PLOS ONE			English	Article							MAMMALIAN SPINAL-CORD; SYNAPSE ELIMINATION; GAP-JUNCTIONS; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; IN-VIVO; NEONATAL-RAT; NEWBORN RAT; MOTONEURONS; TRANSMISSION	Gap junctions (GJs) between neurons are present in both the newborn and the adult nervous system, and although important roles have been suggested or demonstrated in a number of instances, in many other cases a full understanding of their physiological role is still missing. GJs are expressed in the rodent lumbar cord at birth and mediate both dye and electrical coupling between motor neurons. This expression has been proposed to mediate: (i) fast synchronization of motoneuronal spike activity, in turn linked to the process of refinement of neuromuscular connections, and (ii) slow synchronization of locomotor-like oscillatory activity. Soon after birth this coupling disappears. Since in the adult rat regeneration of motor fibers after peripheral nerve injury leads to a recapitulation of synaptic refinement at the target muscles, we tested whether GJs between motor neurons are transiently re-expressed. We found that in conditions of maximal responsiveness of lumbar motor neurons (such as no depression by anesthetics, decerebrate release of activity of subsets of motor neurons, use of temporal and spatial summation by antidromic and orthodromic stimulations, testing of large ensembles of motor neurons) no firing is observed in ventral root axons in response to antidromic spike invasion of nearby counterparts. We conclude that junctional coupling between motor neurons is not required for the refinement of neuromuscular innervation in the adult.	[Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe] Univ Verona, Dept Neurol & Movement Sci, Sect Physiol & Psychol, I-37134 Verona, Italy; [Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe] Natl Inst Neurosci, I-37134 Verona, Italy	University of Verona	Busetto, G (corresponding author), Univ Verona, Dept Neurol & Movement Sci, Sect Physiol & Psychol, I-37134 Verona, Italy.	giuseppe.busetto@univr.it			Italian Ministry of Education, Universities and Research; Research Projects of National Interest, Italy [2006055835]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Research Projects of National Interest, Italy	This work was supported by Italian Ministry of Education, Universities and Research (to A.C.), Research Projects of National Interest 2006 Grant 2006055835, Italy (to G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Brunton L., 2011, GOODMAN GILMANS PHAR; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Buffelli M, 1997, J MUSCLE RES CELL M, V18, P683, DOI 10.1023/A:1018687923929; Burke RE, 1994, MYOLOGY, P464; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; CZEH G, 1990, BRAIN RES, V527, P224, DOI 10.1016/0006-8993(90)91141-3; Favero M, 2010, NEUROSCIENCE, V167, P343, DOI 10.1016/j.neuroscience.2010.01.055; Favero M, 2014, NEUROSCIENTIST, V20, P8, DOI 10.1177/1073858413491148; Favero M, 2012, P NATL ACAD SCI USA, V109, pE1667, DOI 10.1073/pnas.1201147109; FULTON BP, 1980, PROC R SOC SER B-BIO, V208, P115, DOI 10.1098/rspb.1980.0045; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Hansen NL, 2001, J NEUROPHYSIOL, V86, P1266, DOI 10.1152/jn.2001.86.3.1266; Hedo G, 1999, NEUROSCIENCE, V92, P309, DOI 10.1016/S0306-4522(98)00734-9; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kiehn O, 2002, TRENDS NEUROSCI, V25, P108, DOI 10.1016/S0166-2236(02)02038-6; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUNO M, 1970, J PHYSIOL-LONDON, V210, P807, DOI 10.1113/jphysiol.1970.sp009243; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; MAGLADERY JW, 1950, B JOHNS HOPKINS HOSP, V86, P265; MATSUMOTO A, 1988, J NEUROSCI, V8, P4177; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mazo I, 2015, EUR J PAIN, V19, P1012, DOI 10.1002/ejp.629; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; NICHOLSON GM, 1988, NEUROPHARMACOLOGY, V27, P459, DOI 10.1016/0028-3908(88)90127-X; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Personius KE, 2008, J NEUROSCI, V28, P8983, DOI 10.1523/JNEUROSCI.5226-07.2008; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; PIERAU FK, 1969, FED PROC, V28, P1006; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; REES D, 1978, J PHYSIOL-LONDON, V278, pP8; RIBCHESTER RR, 1993, J PHYSIOL-LONDON, V466, P421; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Rothwell J., 1994, CONTROL HUMAN VOLUNT, V2nd ed.; SALA C, 1995, J NEUROSCI, V15, P520; Sherrington C S, 1898, J Physiol, V22, P319; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Tapia J.C., 2012, FUNDAMENTAL NEUROSCI, P437; Tresch MC, 2002, J NEUROSCI, V22, P9997; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; van der Want JJL, 1998, BRAIN RES, V779, P342, DOI 10.1016/S0006-8993(97)01238-9; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426	49	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123576	10.1371/journal.pone.0123576	http://dx.doi.org/10.1371/journal.pone.0123576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875765	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100190
J	Ku, HY; Su, PH; Wen, HJ; Sun, HL; Wang, CJ; Chen, HY; Jaakkola, JJK; Wang, SL				Ku, Hsiu Ying; Su, Pen Hua; Wen, Hui Ju; Sun, Hai Lun; Wang, Chien Jen; Chen, Hsiao Yen; Jaakkola, Jouni J. K.; Wang, Shu-Li		TMICS Grp	Prenatal and Postnatal Exposure to Phthalate Esters and Asthma: A 9-Year Follow-Up Study of a Taiwanese Birth Cohort	PLOS ONE			English	Article							CHILDREN; ASSOCIATION; SYMPTOMS; HEALTH; YOUNG; METABOLITES; PREVALENCE; BIPHENYLS; ALLERGIES; DIOXINS	Previous studies have shown that phthalate exposure in childhood is associated with the development of respiratory problems. However, few studies have assessed the relative impact of prenatal and postnatal exposure to phthalates on the development of asthma later in childhood. Therefore, we assessed the impact of prenatal and postnatal phthalate exposure on the development of asthma and wheezing using a Taiwanese birth cohort. A total of 430 pregnant women were recruited, and 171 (39.8%) of them had their children followed when they were aged 2, 5, and 8 years. The International Study of Asthma and Allergies in Childhood questionnaire was used to assess asthma and wheezing symptoms and serumtotal immunoglobulin E levels were measured at 8 years of age. Urine samples were obtained from 136 women during their third trimester of pregnancy, 99 children at 2 years of age, and 110 children at 5 years. Four common phthalate monoester metabolites inmaternal and children's urine were measured using liquid chromatography-electrospray ionization-tandem mass spectrometry. Maternal urinary mono-benzyl phthalate [MBzP] concentrations were associated with an increased occurrence of wheezing in boys at 8 years of age (odds ratio [OR] = 4.95 (95% CI 1.08-22.63)), for upper quintile compared to the others) after controlling for parental allergies and family members' smoking status. Urinary mono-2-ethylhexyl phthalate [MEHP] levels over the quintile at 2-year-old were associated with increased asthma occurrence (adjusted OR = 6.14 (1.17-32.13)) in boys. Similarly, the sum of di-2-ethyl-hexyl phthalate [DEHP] metabolites at 5 years was associated with asthma in boys (adjusted OR = 4.36 (1.01-18.86)). Urinary MEHP inmaternal and 5-year-old children urine were significantly associated with increased IgE in allergic children at 8 years. Prenatal and postnatal exposure to phthalate was associated with the occurrence of asthma in children, particularly for boys.	[Ku, Hsiu Ying; Wang, Shu-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Ku, Hsiu Ying; Wen, Hui Ju; Wang, Chien Jen; Chen, Hsiao Yen; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Miaoli, Taiwan; [Su, Pen Hua] Chung Shan Med Univ Hosp, Dept Pediat, Div Genet, Taichung 40201, Taiwan; [Sun, Hai Lun] Chung Shan Med Univ Hosp, Dept Pediat, Taichung 40201, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Jouni J. K.] Med Res Ctr, Oulu, Finland; [Wang, Shu-Li] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; University of Oulu; China Medical University Taiwan; National Defense Medical Center	Wang, SL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	slwang@nhri.org.tw	Jaakkola, Jouni J.K./G-4314-2012	Wang, Shu-Li/0000-0002-0686-4729; Wen, Hui-Ju/0000-0003-1268-3120; Jaakkola, Jouni/0000-0003-4168-4683	Department of National Health Research Institutes, Taiwan [EH-102-SP-02, EO-103-PP-05, EH-103-SP-02, EO-104-PP-05, EO-090-PP-03]; Ministry of Science and Technology (MOST) [103-2314-B-400006]	Department of National Health Research Institutes, Taiwan; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	Financial support received from the Department of National Health Research Institutes, Taiwan, is gratefully acknowledged: EH-102-SP-02, EO-103-PP-05, EH-103-SP-02, EO-104-PP-05, EO-090-PP-03 and also Ministry of Science and Technology (MOST 103-2314-B-400006). The funding agents had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bertelsen RJ, 2013, ENVIRON HEALTH PERSP, V121, P251, DOI 10.1289/ehp.1205256; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Bolling AK, 2012, TOXICOL LETT, V209, P43, DOI 10.1016/j.toxlet.2011.11.016; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Chen YC, 2014, AM J RESP CRIT CARE, V189, P1194, DOI 10.1164/rccm.201401-0097OC; Chiang LC, 2007, ASIAN PAC J ALLERGY, V25, P1; Delacourt C, 2002, REV FR ALLERGOL, V42, P267, DOI 10.1016/S0335-7457(02)00148-X; Dietert RR, 2008, BIRTH DEFECTS RES B, V83, P547, DOI 10.1002/bdrb.20170; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039008; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797; Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC; Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kuo CH, 2013, ALLERGY, V68, P870, DOI 10.1111/all.12162; Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x; Li LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062526; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663; Moral R, 2011, ENV HLTH, V10, pe5; Osman MF, 2009, PAEDIATR PERINAT EP, V23, P567, DOI 10.1111/j.1365-3016.2009.01064.x; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6; Su PH, 2012, ENVIRON INT, V39, P181, DOI 10.1016/j.envint.2011.09.009; Wang IJ, 2013, ENV INT C, V62C, P48; Wang SL, 2004, CHEMOSPHERE, V54, P1459, DOI 10.1016/j.chemosphere.2003.08.012; Whyatt RM, 2014, ENVIRON HEALTH PERSP, V122, P1141, DOI 10.1289/ehp.1307670; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014	38	66	67	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123309	10.1371/journal.pone.0123309	http://dx.doi.org/10.1371/journal.pone.0123309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875379	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100162
J	Lam, V; Takechi, R; Pallabage-Gamarallage, M; Giles, C; Mamo, JCL				Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.			The Vitamin D, Ionised Calcium and Parathyroid Hormone Axis of Cerebral Capillary Function: Therapeutic Considerations for Vascular-Based Neurodegenerative Disorders	PLOS ONE			English	Article							CEREBROSPINAL-FLUID CALCIUM; 25-HYDROXYVITAMIN D CONCENTRATIONS; ALZHEIMERS-DISEASE; D-RECEPTOR; COGNITIVE FUNCTION; OLDER-ADULTS; CHRONIC HYPOCALCEMIA; LESION VOLUMES; SATURATED FAT; SERUM-CALCIUM	Blood-brain barrier dysfunction characterised by brain parenchymal extravasation of plasma proteins may contribute to risk of neurodegenerative disorders, however the mechanisms for increased capillary permeability are not understood. Increasing evidence suggests vitamin D confers central nervous system benefits and there is increasing demand for vitamin D supplementation. Vitamin D may influence the CNS via modulation of capillary function, however such effects may be indirect as it has a central role in maintaining calcium homeostasis, in concert with calcium regulatory hormones. This study utilised an integrated approach and investigated the effects of vitamin D supplementation, parathyroid tissue ablation (PTX), or exogenous infusion of parathyroid hormone (PTH) on cerebral capillary integrity. Parenchymal extravasation of immunoglobulin G (IgG) was used as a marker of cerebral capillary permeability. In C57BL/6J mice and Sprague Dawley rats, dietary vitamin D was associated with exaggerated abundance of IgG within cerebral cortex (CTX) and hippocampal formation (HPF). Vitamin D was also associated with increased plasma ionised calcium (iCa) and decreased PTH. A response to dose was suggested and parenchymal effects persisted for up to 24 weeks. Ablation of parathyroid glands increased CTX- and HPF-IgG abundance concomitant with a reduction in plasma iCa. With the provision of PTH, iCa levels increased, however the PTH treated animals did not show increased cerebral permeability. Vitamin D supplemented groups and rats with PTH-tissue ablation showed modestly increased parenchymal abundance of glial-fibrillary acidic protein (GFAP), a marker of astroglial activation. PTH infusion attenuated GFAP abundance. The findings suggest that vitamin D can compromise capillary integrity via a mechanism that is independent of calcium homeostasis. The effects of exogenous vitamin D supplementation on capillary function and in the context of prevention of vascular neurodegenerative conditions should be considered in the context of synergistic effects with calcium modulating hormones.	[Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia; [Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.] Curtin Univ, Curtin Hlth Innovat Res Inst Ageing & Chron Dis, Perth, WA 6845, Australia	Curtin University; Curtin University	Mamo, JCL (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia.	J.Mamo@Curtin.edu.au	Takechi, Ryusuke/D-3692-2012; Takechi, Ryu/T-9970-2019; Giles, Corey/AAM-9003-2020	Takechi, Ryusuke/0000-0001-6359-3382; Takechi, Ryu/0000-0001-6359-3382; Giles, Corey/0000-0002-6050-1259; Mamo, John/0000-0002-5741-7849; Lam, Virginie/0000-0001-8463-645X	Australian National Health and Medical Research Council [1064567]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Research was supported by the Australian National Health and Medical Research Council www.nhmrc.gov.au. Project grant 1064567. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Afzal S, 2014, ALZHEIMERS DEMENT, V10, P296, DOI 10.1016/j.jalz.2013.05.1765; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Batista DG, 2010, CALCIFIED TISSUE INT, V87, P60, DOI 10.1007/s00223-010-9367-y; Berdud I, 1998, CALCIFIED TISSUE INT, V62, P457, DOI 10.1007/s002239900460; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bjorkman MP, 2008, EUR J ENDOCRINOL, V158, P749, DOI 10.1530/EJE-07-0849; Bollerslev J, 2011, IBMS BONEKEY, V8, P342; Braverman ER, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-21; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; de Groot JC, 2000, ANN NEUROL, V47, P145; Durk MR, 2012, J NEUROCHEM, V123, P944, DOI 10.1111/jnc.12041; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Eyles DW, 2014, NEUROSCIENCE, V268, P1, DOI 10.1016/j.neuroscience.2014.02.042; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Farid K, 2012, NUCL MED COMMUN, V33, P1048, DOI 10.1097/MNM.0b013e32835674c4; Feldman D, 2011, TWO VOLUME SET; Feldman F, 2014, J AM GERIATR SOC, V62, P1546, DOI 10.1111/jgs.12927; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; GASCONBARRE M, 1983, AM J PHYSIOL, V244, pE266, DOI 10.1152/ajpendo.1983.244.3.E266; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; Goodman WG, 2002, NEPHROL DIAL TRANSPL, V17, P1731, DOI 10.1093/ndt/17.10.1731; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hirasawa T, 2000, BRIT J PHARMACOL, V129, P21, DOI 10.1038/sj.bjp.0702949; JOBORN C, 1991, PSYCHONEUROENDOCRINO, V16, P311, DOI 10.1016/0306-4530(91)90017-N; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Khudaverian D N, 1996, Biull Eksp Biol Med, V122, P484; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; MURPHY VA, 1986, J NEUROCHEM, V47, P1735, DOI 10.1111/j.1471-4159.1986.tb13082.x; MURPHY VA, 1988, J NEUROCHEM, V51, P1777, DOI 10.1111/j.1471-4159.1988.tb01159.x; Payne ME, 2008, NUTR RES, V28, P285, DOI 10.1016/j.nutres.2008.02.013; Payne ME, 2014, BRIT J NUTR, V112, P220, DOI 10.1017/S0007114514000828; Payne ME, 2013, NUTRIENTS, V5, P2192, DOI 10.3390/nu5062192; Rashid G, 2008, EUR J CLIN INVEST, V38, P798, DOI 10.1111/j.1365-2362.2008.02033.x; Rashid G, 2007, NEPHROL DIAL TRANSPL, V22, P2831, DOI 10.1093/ndt/gfm269; Rezic-Muzinic N, 2013, J PHYSIOL BIOCHEM, V69, P199, DOI 10.1007/s13105-012-0202-y; SAPORITO MS, 1994, BRAIN RES, V633, P189, DOI 10.1016/0006-8993(94)91539-3; Schlogl M, 2014, CLIN INTERV AGING, V9, P559, DOI 10.2147/CIA.S51785; Schram MT, 2007, J AM GERIATR SOC, V55, P1786, DOI 10.1111/j.1532-5415.2007.01418.x; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; TAI CY, 1986, BRAIN RES, V385, P227, DOI 10.1016/0006-8993(86)91068-1; Takechi R, 2013, NEURODEGENER DIS, V12, P125, DOI 10.1159/000343211; Takechi R, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-91; Takechi R, 2013, CLIN EXP PHARMACOL P, V40, P45, DOI 10.1111/1440-1681.12032; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Throckmorton D, 2002, PEPTIDES, V23, P79, DOI 10.1016/S0196-9781(01)00582-4; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; TOVERUD SU, 1986, BONE MINER, V1, P145; Tuohimaa P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS278, DOI 10.1016/j.psyneuen.2009.07.003; van Vliet P, 2009, NEUROLOGY, V72, P821, DOI 10.1212/01.wnl.0000343852.10018.24; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Walker MD, 2009, J CLIN ENDOCR METAB, V94, P1951, DOI 10.1210/jc.2008-2574; Wang-Fischer Y, 2009, MANUAL STROKE MODELS, P315; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	64	9	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125504	10.1371/journal.pone.0125504	http://dx.doi.org/10.1371/journal.pone.0125504			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874538	gold, Green Published			2022-12-27	WOS:000352845100297
J	Nunez, J; Rabinovich, GA; Sandino, J; Mainar, L; Palau, P; Santas, E; Villanueva, MP; Nunez, E; Bodi, V; Chorro, FJ; Minana, G; Sanchis, J				Nunez, Julio; Rabinovich, Gabriel A.; Sandino, Justo; Mainar, Luis; Palau, Patricia; Santas, Enrique; Pilar Villanueva, Maria; Nunez, Eduardo; Bodi, Vicent; Chorro, Francisco J.; Minana, Gema; Sanchis, Juan			Prognostic Value of the Interaction between Galectin-3 and Antigen Carbohydrate 125 in Acute Heart Failure	PLOS ONE			English	Article							STATIN THERAPY; ASSOCIATION; SURFACE; CA125; CELLS; INFLAMMATION; CONTRIBUTES	Aims Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have emerged as robust prognostic biomarkers in heart failure. Experimental data have also suggested a potential molecular interaction between CA125 and Gal-3; however, the biological and clinical relevance of this interaction is still uncertain. We sought to evaluate, in patients admitted for acute heart failure, the association between plasma Gal-3 with all-cause mortality and the risk for rehospitalizations among high and low levels of CA125. Methods and Results We included 264 consecutive patients admitted for acute heart failure to the Cardiology Department in a third-level center. Both biomarkers were measured on admission. Negative binomial and Cox regression models were used to evaluate the prognostic effect of the interaction between Gal-3 and CA125 (dichotomized by its median) with hospital readmission and all-cause mortality, respectively. During a median follow-up of 2 years (IQR = 1-2.8), 108 (40.9%) patients deaths and 365 rehospitalizations in 171 (69.5%) patients were registered. In a multivariable setting, the effect of Gal-3 on mortality and rehospitalization was differentially mediated by CA125 (p = 0.007 and p< 0.001, respectively). Indeed, in patients with CA125 above median (> 67 U/ml), values across the continuum of Gal-3 showed a positive and almost linear relationship with either the risk of death or rehospitalization. Conversely, when CA125 was below median (<= 67 U/ml), Gal-3 lacked any prognostic effect on both endpoints. Conclusion In patients with acute heart failure, Gal-3 was strongly associated with higher risk of longterm mortality and repeated rehospitalizations, but only in those patients exhibiting higher values of CA125 (above 67 U/ml).	[Nunez, Julio; Sandino, Justo; Mainar, Luis; Santas, Enrique; Nunez, Eduardo; Bodi, Vicent; Chorro, Francisco J.; Sanchis, Juan] Univ Valencia, Hosp Clin, Serv Cardiol, Valencia, Spain; [Rabinovich, Gabriel A.] Univ Buenos Aires, CONICET, Inst Biol & Med Expt IBYME, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Palau, Patricia] Hosp Plana, Serv Cardiol, Villa Real, Spain; [Pilar Villanueva, Maria] Univ Valencia, Hosp Clin, Serv Bioquim Clin, Valencia, Spain; [Minana, Gema] Hosp Manises, Serv Cardiol, Manises, Spain	University of Valencia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires; University of Valencia	Nunez, J (corresponding author), Univ Valencia, Hosp Clin, Serv Cardiol, Valencia, Spain.	yulnunez@gmail.com	Palau, Patricia/AGR-8555-2022; Palau, Patricia/T-1027-2017; Chorro, Francisco J/AAB-6766-2020	Palau, Patricia/0000-0001-5040-0924; Palau, Patricia/0000-0001-5040-0924; Nunez, Julio/0000-0003-1672-7119	Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia [EC10-108]	Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia	This work was supported in part by grants from Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia EC10-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; D'Aloia A, 2003, J AM COLL CARDIOL, V41, P1805, DOI 10.1016/S0735-1097(03)00311-5; de Boer RA, 2014, CARDIOVASC DRUG THER, V28, P237, DOI 10.1007/s10557-014-6520-2; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Felder M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-129; Forsman H, 2011, ARTHRITIS RHEUM-US, V63, P445, DOI 10.1002/art.30118; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gonzalez GE, 2014, INT J CARDIOL, V176, P1423, DOI 10.1016/j.ijcard.2014.08.011; Gullestad L, 2012, EUR HEART J, V33, P2290, DOI 10.1093/eurheartj/ehs077; Jiang WW, 2009, J IMMUNOL, V182; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meijers WC, 2014, AM HEART J, V167, P853, DOI 10.1016/j.ahj.2014.02.011; Minana G, 2010, INT J CARDIOL, V145, P547, DOI 10.1016/j.ijcard.2010.04.081; Mitic N, 2010, ARCH BIOL SCI, V62, P271, DOI 10.2298/ABS1002271M; Motiwala SR, 2013, EUR J HEART FAIL, V15, P1157, DOI 10.1093/eurjhf/hft075; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nunez J, 2014, HEART FAIL REV, V19, P575, DOI 10.1007/s10741-013-9402-y; Nunez J, 2012, EUR J HEART FAIL, V14, P974, DOI 10.1093/eurjhf/hfs090; Nunez J, 2011, REV ESP CARDIOL, V64, P1100, DOI [10.1016/j.rec.2011.05.033, 10.1016/j.recesp.2011.05.029]; Nunez J, 2012, INT J CARDIOL, V159, P21, DOI 10.1016/j.ijcard.2011.02.001; Nunez J, 2011, INT J CARDIOL, V146, P473, DOI 10.1016/j.ijcard.2010.12.027; Nunez J, 2010, EUR HEART J, V31, P1752, DOI 10.1093/eurheartj/ehq142; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Rogers JK, 2014, EUR J HEART FAIL, V16, P33, DOI 10.1002/ejhf.29; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Seropian IM, 2013, AM J PATHOL, V182, P29, DOI 10.1016/j.ajpath.2012.09.022; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; ZEILLEMAKER AM, 1994, J CLIN PATHOL, V47, P263, DOI 10.1136/jcp.47.3.263	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122360	10.1371/journal.pone.0122360	http://dx.doi.org/10.1371/journal.pone.0122360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875367	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100067
J	Ramadas, GCV; Rocha, AMAC; Fernandes, EMGP				Ramadas, Gisela C. V.; Rocha, Ana Maria A. C.; Fernandes, Edite M. G. P.			Testing Nelder-Mead Based Repulsion Algorithms for Multiple Roots of Nonlinear Systems via a Two-Level Factorial Design of Experiments	PLOS ONE			English	Article							SIMPLEX-METHOD; SOLVING SYSTEMS; EQUATIONS; CONVERGENCE; VARIANT	This paper addresses the challenging task of computing multiple roots of a system of nonlinear equations. A repulsion algorithm that invokes the Nelder-Mead (N-M) local search method and uses a penalty-type merit function based on the error function, known as 'erf', is presented. In the N-M algorithm context, different strategies are proposed to enhance the quality of the solutions and improve the overall efficiency. The main goal of this paper is to use a two-level factorial design of experiments to analyze the statistical significance of the observed differences in selected performance criteria produced when testing different strategies in the N-M based repulsion algorithm. The main goal of this paper is to use a two-level factorial design of experiments to analyze the statistical significance of the observed differences in selected performance criteria produced when testing different strategies in the N-M based repulsion algorithm.	[Ramadas, Gisela C. V.] Polytech Porto, Sch Engn, Dept Math, P-4200072 Porto, Portugal; [Rocha, Ana Maria A. C.; Fernandes, Edite M. G. P.] Univ Minho, ALGORITMI Res Ctr, P-4710057 Braga, Portugal	Polytechnic Institute of Porto; Universidade do Minho	Ramadas, GCV (corresponding author), Polytech Porto, Sch Engn, Dept Math, P-4200072 Porto, Portugal.	gcv@isep.ipp.pt	Fernandes, Edite/B-7116-2008; Rocha, Ana Maria A. C./N-2995-2013	Fernandes, Edite/0000-0003-0722-9361; Rocha, Ana Maria A. C./0000-0001-8679-2886; Goncalves Vieira Ramadas, Gisela Cristina/0000-0003-3883-2964	CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal); FCT (Fundacao para a Ciencia e Tecnologia) [PEst-OE/EME/UI0615/2014, PEst-OE/EEI/UI0319/2014]	CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal); FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work has been supported by CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal) and FCT (Fundacao para a Ciencia e Tecnologia) within the Projects Scope: PEst-OE/EME/UI0615/2014 and PEst-OE/EEI/UI0319/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2007, DOE SIMPLIFIED PRACT; Gao FC, 2012, COMPUT OPTIM APPL, V51, P259, DOI 10.1007/s10589-010-9329-3; Grosan C, 2008, IEEE T SYST MAN CY A, V38, P698, DOI 10.1109/TSMCA.2008.918599; Hirsch MJ, 2009, NONLINEAR ANAL-REAL, V10, P2000, DOI 10.1016/j.nonrwa.2008.03.006; Jaberipour M, 2011, COMPUT MATH APPL, V62, P566, DOI 10.1016/j.camwa.2011.05.031; Kelley CT, 1999, SIAM J OPTIMIZ, V10, P43, DOI 10.1137/S1052623497315203; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; MARANAS CD, 1995, J GLOBAL OPTIM, V7, P143, DOI 10.1007/BF01097059; Mckinnon KIM, 1998, SIAM J OPTIMIZ, V9, P148, DOI 10.1137/S1052623496303482; Montgomery D.C., 2012, DESIGN ANAL EXPT; MORGAN AP, 1983, ACM T MATH SOFTWARE, V9, P1, DOI 10.1145/356022.356023; Nazareth L, 2002, COMPUT OPTIM APPL, V22, P133, DOI 10.1023/A:1014842520519; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nie JW, 2008, SIAM J OPTIMIZ, V19, P1534, DOI 10.1137/060668791; Parsopoulos KE, 2004, IEEE T EVOLUT COMPUT, V8, P211, DOI 10.1109/tevc.2004.826076; Pourjafari E, 2012, SWARM EVOL COMPUT, V4, P33, DOI 10.1016/j.swevo.2011.12.001; Price CJ, 2002, J OPTIMIZ THEORY APP, V113, P5, DOI 10.1023/A:1014849028575; Ramadas GCV, 2014, LECT NOTES COMPUT SC, V8580, P126, DOI 10.1007/978-3-319-09129-7_10; Silva RMA, 2014, J GLOBAL OPTIM, V60, P289, DOI 10.1007/s10898-013-0105-7; SPENDLEY W, 1962, TECHNOMETRICS, V4, P441, DOI 10.2307/1266283; Tsoulos IG, 2010, NONLINEAR ANAL-REAL, V11, P2465, DOI 10.1016/j.nonrwa.2009.08.003; VanHentenryck P, 1997, SIAM J NUMER ANAL, V34, P797, DOI 10.1137/S0036142995281504; Voglis C, 2009, APPL MATH COMPUT, V213, P216, DOI 10.1016/j.amc.2009.03.012; Yamamura K, 2003, J COMPUT APPL MATH, V152, P587, DOI 10.1016/S0377-0427(02)00731-8; Yamamura K, 2009, APPL MATH COMPUT, V215, P405, DOI 10.1016/j.amc.2009.05.017	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121844	10.1371/journal.pone.0121844	http://dx.doi.org/10.1371/journal.pone.0121844			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875591	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100049
J	Yamamoto, S; Kido, R; Onishi, Y; Fukuma, S; Akizawa, T; Fukagawa, M; Kazama, JJ; Narita, I; Fukuhara, S				Yamamoto, Suguru; Kido, Ryo; Onishi, Yoshihiro; Fukuma, Shingo; Akizawa, Tadao; Fukagawa, Masafumi; Kazama, Junichiro J.; Narita, Ichiei; Fukuhara, Shunichi			Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CONVERTING ENZYME-INHIBITOR; CARDIOVASCULAR EVENTS; MAINTENANCE HEMODIALYSIS; PARATHYROID-HORMONE; MINERAL METABOLISM; DIALYSIS OUTCOMES; PRACTICE PATTERNS; SERUM-CALCIUM; HIP	Background Patients with chronic kidney disease, especially those undergoing dialysis treatment and having secondary hyperparathyroidism, have a high risk of bone fracture. The renin-angiotensin system (RAS) is associated with osteoclastic bone resorption. We aimed to examine whether the use of RAS inhibitors reduces the incidence of fracture in hemodialysis patients. Methods and Findings This was a multicenter, 3-year, prospective, observational study. From 2008 to 2011, maintenance hemodialysis patients with secondary hyperparathyroidism (N = 3,276) treated with angiotensin converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) at baseline were followed for a mean of 2.7 years. The association between the use of ACEI/ARB and hospitalization rate owing to fracture was examined by using Cox regression models. Effect modifications by the severity of secondary hyperparathyroidism (intact parathyroid hormone [iPTH] level), sex, and systolic blood pressure were also examined. The incidence proportion of fracture-related hospitalization was 5.42% throughout the observation period. ACEI/ARB use was associated with a lower rate of fracture-related hospitalization (adjusted hazard ratio, 0.65; 95% confidence interval [CI], 0.45-0.92). This association was not significantly affected by sex (P = 0.56) or systolic blood pressure levels (P = 0.87). The hazard ratios adjusted by iPTH levels were qualitatively different, but not statistically significant (P = 0.11): 0.77 (95% CI, 0.42-1.39), 0.38 (95% CI, 0.20-0.73), 0.59 (95% CI, 0.29-1.21), and 1.29 (95% CI, 0.58-2.42) for the first, second, third and fourth quartiles of iPTH, respectively. Conclusions Use of RAS inhibitors is associated with a lower rate of fracture-related hospitalization in hemodialysis patients with secondary hyperparathyroidism.	[Yamamoto, Suguru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Nephrosci, Niigata, Japan; [Yamamoto, Suguru; Kazama, Junichiro J.; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Kido, Ryo; Onishi, Yoshihiro; Fukuma, Shingo] IHope Int, Inst Hlth Outcomes & Proc Evaluat Res, Kyoto, Japan; [Kido, Ryo] Inagi Municipal Hosp, Med Examinat Ctr, Tokyo, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Sch Med, Grad Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto 606, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 25911, Japan; [Kazama, Junichiro J.] Niigata Univ, Med & Dent Hosp, Blood Purificat Ctr, Niigata, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Japan	Niigata University; Niigata University; Kyoto University; Showa University; Tokai University; Niigata University; Fukushima Medical University	Yamamoto, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Nephrosci, Niigata, Japan.	yamamots@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096; Fukagawa, Masafumi/0000-0002-7832-2339; Fukagawa, Misato/0000-0003-1117-9213; Fukuma, Shingo/0000-0002-8379-8761	Kyowa Hakko Kirin; Grants-in-Aid for Scientific Research [15K09249] Funding Source: KAKEN	Kyowa Hakko Kirin(Kyowa Kirin Ltd); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The MBD-5D study was supported by research grants from Kyowa Hakko Kirin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; [Anonymous], 2003, AM J KIDNEY DIS S3, V42, pS1; [Anonymous], 2009, KIDNEY INT S, V113, pS1, DOI [10.1038/ki.2009.188, DOI 10.1038/KI.2009.188]; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Danese MD, 2006, AM J KIDNEY DIS, V47, P149, DOI 10.1053/j.ajkd.2005.09.024; Ensrud KE, 2007, ARCH INTERN MED, V167, P133, DOI 10.1001/archinte.167.2.133; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Fukagawa M, 2012, CLIN J AM SOC NEPHRO, V7, P1473, DOI 10.2215/CJN.13081211; Fukagawa M, 2011, AM J NEPHROL, V33, P427, DOI 10.1159/000327654; Fukuhara S, 2011, THER APHER DIAL, V15, P169, DOI 10.1111/j.1744-9987.2010.00906.x; Garcia P, 2010, BRIT J PHARMACOL, V159, P1672, DOI 10.1111/j.1476-5381.2010.00651.x; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sj.ki.5001754; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kaneko K, 2011, J BONE MINER RES, V26, P2959, DOI 10.1002/jbmr.501; Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x; Kovarik JJ, 2015, NEPHROL DIAL TRANSPL, V30, P115, DOI 10.1093/ndt/gfu265; Kwok T, 2012, OSTEOPOROSIS INT, V23, P2159, DOI 10.1007/s00198-011-1831-7; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Masunari Naomi, 2008, Hiroshima Journal of Medical Sciences, V57, P17; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657; Zhang YF, 2012, J BONE MINER METAB, V30, P666, DOI 10.1007/s00774-012-0363-3	33	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122691	10.1371/journal.pone.0122691	http://dx.doi.org/10.1371/journal.pone.0122691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874620	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100094
J	Yoshihara, N; Sakamoto, T; Yamashita, T; Yamashita, T; Yamakiri, K; Sonoda, S; Ishibashi, T				Yoshihara, Naoya; Sakamoto, Taiji; Yamashita, Takehiro; Yamashita, Toshifumi; Yamakiri, Keita; Sonoda, Shozo; Ishibashi, Tatsuro			Wider Retinal Artery Trajectories in Eyes with Macular Hole Than in Fellow Eyes of Patients with Unilateral Idiopathic Macular Hole	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; NERVE-FIBER; AXIAL LENGTH	Purpose To determine whether the width of the retinal artery (RA) trajectory was associated with the presence of a macular hole (MH). Methods A retrospective cross sectional case-control study was performed. The fundus photographs were rotated 90 degrees, and the coordinates of the best fit curve of the RA trajectory were determined automatically based on these plots using the ImageJ program. The converted coordinates were fit to a second degree polynomial (ax(2)/100 + bx + c) equation. The width and steepness of the RA trajectory, "a", of the eyes with a MH eye were compared to that of the fellow eyes. Results One hundred and ten eyes of 55 consecutive patients (30 women) with a unilateral MH and healthy fellow eyes were analyzed. The mean age was 64.9 years (range 47-81 years). The constant 'a' was significantly smaller in eyes with a MH than that of the fellow eyes (0.379 +/- 0.094 vs 0.416 +/- 0.121, P = 0.001, paired t test), indicating that the RA trajectory was wider in the MH eyes than in the fellow eyes. There was a significant correlation between the axial length and 'a' of the RA trajectory in the MH eyes (R = 0.273, P = 0.044) and in the fellow eyes (R = 0.356, P = 0.008; Spearman's rank correlation coefficient). Conclusions Because eyes with a MH have a significantly wider and flatter RA trajectory, there may be greater traction on the fovea which is located between the RA arches. The causative role of this finding is still unclear.	[Yoshihara, Naoya; Sakamoto, Taiji; Yamashita, Takehiro; Yamashita, Toshifumi; Yamakiri, Keita; Sonoda, Shozo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan; [Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Fukuoka 812, Japan	Kagoshima University; Kyushu University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Grants-in-Aid for Scientific Research [26462643] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BENGTSSON B, 1980, ACTA OPHTHALMOL, V58, P726; BRONSTEIN MA, 1981, AM J OPHTHALMOL, V92, P757, DOI 10.1016/S0002-9394(14)75625-9; Chew EY, 1999, ARCH OPHTHALMOL-CHIC, V117, P242, DOI 10.1001/archopht.117.2.242; Ezra E, 1998, OPHTHALMOLOGY, V105, P353, DOI 10.1016/S0161-6420(98)93562-X; GASS JDM, 1988, ARCH OPHTHALMOL-CHIC, V106, P629, DOI 10.1001/archopht.1988.01060130683026; GASS JDM, 1995, AM J OPHTHALMOL, V119, P752, DOI 10.1016/S0002-9394(14)72781-3; Gaudric A, 1999, ARCH OPHTHALMOL-CHIC, V117, P744; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Hoh ST, 2006, OPHTHALMOLOGY, V113, P773, DOI 10.1016/j.ophtha.2006.01.058; Hong SW, 2012, INVEST OPHTH VIS SCI, V51, P3515; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson MW, 2001, ARCH OPHTHALMOL-CHIC, V119, P215; Kishi S, 2000, AM J OPHTHALMOL, V130, P65, DOI 10.1016/S0002-9394(00)00383-4; Kishi S, 1996, AM J OPHTHALMOL, V122, P622, DOI 10.1016/S0002-9394(14)70480-5; Kumagai K, 2013, AM J OPHTHALMOL, V156, P140, DOI 10.1016/j.ajo.2012.11.029; Kumagai K, 2012, ARCH OPHTHALMOL-CHIC, V130, P393, DOI 10.1001/archopthalmol.2011.1427; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Lewis ML, 1996, GRAEF ARCH CLIN EXP, V234, P241, DOI 10.1007/BF00430416; Ryan SJ, 2001, RETINA, V3, P1882; Singh A. J., 2012, International Ophthalmology, V32, P393, DOI 10.1007/s10792-012-9568-7; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Spaide RF, 2002, AM J OPHTHALMOL, V133, P226, DOI 10.1016/S0002-9394(01)01377-0; Steel DHW, 2013, EYE, V27, pS1, DOI 10.1038/eye.2013.212; Takahashi A, 2011, AM J OPHTHALMOL, V151, P981, DOI 10.1016/j.ajo.2011.01.011; Uchino E, 2001, ARCH OPHTHALMOL-CHIC, V119, P1475; Yamashita T, 2014, INVEST OPHTH VIS SCI, V55, P5176, DOI 10.1167/iovs.14-14105; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836; YANNUZZI LA, 1994, AM J OPHTHALMOL, V118, P754; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008; Zangwill LM, 2000, OPHTHALMOLOGY, V107, P1309, DOI 10.1016/S0161-6420(00)00168-8	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122876	10.1371/journal.pone.0122876	http://dx.doi.org/10.1371/journal.pone.0122876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867212	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100113
J	Calderaro, A; Piergianni, M; Buttrini, M; Montecchini, S; Piccolo, G; Gorrini, C; Rossi, S; Chezzi, C; Arcangeletti, MC; Medici, MC; De Conto, F				Calderaro, Adriana; Piergianni, Maddalena; Buttrini, Mirko; Montecchini, Sara; Piccolo, Giovanna; Gorrini, Chiara; Rossi, Sabina; Chezzi, Carlo; Arcangeletti, Maria Cristina; Medici, Maria Cristina; De Conto, Flora			MALDI-TOF Mass Spectrometry for the Detection and Differentiation of Entamoeba histolytica and Entamoeba dispar	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CRYPTOSPORIDIUM-PARVUM; GIARDIA-LAMBLIA; BRUMPT 1925; DIAGNOSIS; PCR; CULTIVATION; SCHAUDINN; SAMPLES; DNA	Detection of Entamoeba histolytica and its differentiation from Entamoeba dispar is an important goal of the clinical parasitology laboratory. The aim of this study was the identification and differentiation of E. histolytica and E. dispar by MALDI-TOF MS, in order to evaluate the application of this technique in routine diagnostic practice. MALDI-TOF MS was applied to 3 amebic reference strains and to 14 strains isolated from feces that had been differentiated by molecular methods in our laboratory. Protein extracts from cultures of these strains (axenic cultures for the 3 reference strains and monoxenic cultures for the 14 field isolates) were analyzed by MALDI-TOF MS and the spectra obtained were analyzed by statistical software. Five peaks discriminating between E. histolytica and E. dispar reference strains were found by protein profile analysis: 2 peaks (8,246 and 8,303 Da) specific for E. histolytica and 3 (4,714; 5,541; 8,207 Da) for E. dispar. All clinical isolates except one showed the discriminating peaks expected for the appropriate species. For 2 fecal samples from which 2 strains (1 E. histolytica and 1 E. dispar) out of the 14 included in this study were isolated, the same discriminating peaks found in the corresponding isolated amebic strains were detected after only 12h (E. histolytica) and 24h (E. dispar) of incubation of the fecal samples in Robinson's medium without serum. Our study shows that MALDI-TOF MS can be used to discriminate between E. histolytica and E. dispar using in vitro xenic cultures and it also could have potential for the detection of these species in clinical samples.	[Calderaro, Adriana; Piergianni, Maddalena; Buttrini, Mirko; Montecchini, Sara; Piccolo, Giovanna; Gorrini, Chiara; Rossi, Sabina; Chezzi, Carlo; Arcangeletti, Maria Cristina; Medici, Maria Cristina; De Conto, Flora] Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy	University of Parma; University Hospital of Parma	Calderaro, A (corresponding author), Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy.	adriana.calderaro@unipr.it	De Conto, Flora/H-9760-2019; piccolo, giovanna/HHZ-8454-2022; ROSSI, Sabina/ABD-2601-2020	De Conto, Flora/0000-0002-0493-2353; 	Ministry of University and Scientific Research Grant FIL, Parma, Italy	Ministry of University and Scientific Research Grant FIL, Parma, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of University and Scientific Research Grant FIL, Parma, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IKM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000219; Ali IKM, 2008, INFECT GENET EVOL, V8, P698, DOI 10.1016/j.meegid.2008.05.004; Ali IKM, 2003, EMERG INFECT DIS, V9, P580, DOI 10.3201/eid0905.020548; Blessmann J, 2002, J CLIN MICROBIOL, V40, P4413, DOI 10.1128/JCM.40.12.4413-4417.2002; Calderaro A, 2006, T ROY SOC TROP MED H, V100, P450, DOI 10.1016/j.trstmh.2005.07.015; Calderaro A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06803; Calderaro Adriana, 2014, BMC Res Notes, V7, P330, DOI 10.1186/1756-0500-7-330; Calderaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088895; Calderaro A, 2013, J PROTEOMICS, V78, P273, DOI 10.1016/j.jprot.2012.09.027; Cassagne C, 2014, CLIN MICROBIOL INFEC, V20, P551, DOI 10.1111/1469-0691.12387; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; CLARK CG, 1995, J EUKARYOT MICROBIOL, V42, P590, DOI 10.1111/j.1550-7408.1995.tb05912.x; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Heredia RD, 2012, ACTA TROP, V123, P139, DOI 10.1016/j.actatropica.2012.05.012; DIAMOND LS, 1993, J EUKARYOT MICROBIOL, V40, P340, DOI 10.1111/j.1550-7408.1993.tb04926.x; Gitau EN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-205; Gonin P, 2003, J CLIN MICROBIOL, V41, P237, DOI 10.1128/JCM.41.1.237-241.2003; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Magnuson ML, 2000, APPL ENVIRON MICROB, V66, P4720, DOI 10.1128/AEM.66.11.4720-4724.2000; Makioka A, 2007, PARASITOL RES, V102, P103, DOI 10.1007/s00436-007-0736-z; Martiny D, 2014, EUR J CLIN MICROBIOL, V33, P529, DOI 10.1007/s10096-013-1980-z; Moura H, 2003, J EUKARYOT MICROBIOL, V50, P156, DOI 10.1111/j.1550-7408.2003.tb00110.x; Nunez YO, 2001, AM J TROP MED HYG, V64, P293, DOI 10.4269/ajtmh.2001.64.293; PETITHORY JC, 1994, B SOC PATHOL EXOT, V87, P231; Sedo O, 2011, SYST APPL MICROBIOL, V34, P30, DOI 10.1016/j.syapm.2010.11.008; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Villegas EN, 2006, J EUKARYOT MICROBIOL, V53, pS179, DOI 10.1111/j.1550-7408.2006.00223.x; Wang YH, 2009, EXP PARASITOL, V123, P162, DOI 10.1016/j.exppara.2009.06.014; WHO: World Health Organization/ Pan American Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P97	31	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122448	10.1371/journal.pone.0122448	http://dx.doi.org/10.1371/journal.pone.0122448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874612	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800057
J	Flores-Felix, JD; Silva, LR; Rivera, LP; Marcos-Garcia, M; Garcia-Fraile, P; Martinez-Molina, E; Mateos, PF; Velazquez, E; Andrade, P; Rivas, R				David Flores-Felix, Jose; Silva, Luis R.; Rivera, Lina P.; Marcos-Garcia, Marta; Garcia-Fraile, Paula; Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Andrade, Paula; Rivas, Raul			Plants Probiotics as a Tool to Produce Highly Functional Fruits: The Case of Phyllobacterium and Vitamin C in Strawberries	PLOS ONE			English	Article							GROWTH PROMOTION; ORGANIC-ACIDS; SP-NOV; ERYTHROCYTE; ENDOPHYTES; NODULES; STRAIN; L.	The increasing interest in the preservation of the environment and the health of consumers is changing production methods and food consumption habits. Functional foods are increasingly demanded by consumers because they contain bioactive compounds involved in health protection. In this sense biofertilization using plant probiotics is a reliable alternative to the use of chemical fertilizers, but there are few studies about the effects of plant probiotics on the yield of functional fruits and, especially, on the content of bioactive compounds. In the present work we reported that a strain of genus Phyllobacterium able to produce biofilms and to colonize strawberry roots is able to increase the yield and quality of strawberry plants. In addition, the fruits from plants inoculated with this strain have significantly higher content in vitamin C, one of the most interesting bioactive compounds in strawberries. Therefore the use of selected plant probiotics benefits the environment and human health without agronomical losses, allowing the production of highly functional foods.	[David Flores-Felix, Jose; Rivera, Lina P.; Marcos-Garcia, Marta; Garcia-Fraile, Paula; Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Rivas, Raul] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Silva, Luis R.; Andrade, Paula] Univ Porto, Fac Farm, Dept Quim, REQUIMTE,Lab Farmacognosia, P-4100 Porto, Portugal; [Rivera, Lina P.; Martinez-Molina, Eustoquio; Mateos, Pedro F.] Univ Salamanca, Ctr Hispano Luso Invest Agr CIALE, E-37008 Salamanca, Spain; [Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Rivas, Raul] Unidad Asociada Univ Salamanca CSIC IRNASA, Salamanca, Spain	University of Salamanca; Universidade do Porto; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA)	Rivas, R (corresponding author), Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	raulrg@usal.es	Silva, Luís R./D-5485-2013; Mateos, Pedro/L-6001-2014; Velázquez, Encarna/B-3669-2017; Flores-Félix, Jose David/B-2082-2017; Rivas, Raúl/B-1869-2017; Fraile, Paula Garcia/N-8193-2014; Andrade, Paula/A-5900-2008	Silva, Luís R./0000-0001-5264-3516; Mateos, Pedro/0000-0003-1628-598X; Velázquez, Encarna/0000-0002-5946-7241; Flores-Félix, Jose David/0000-0003-2200-4400; Rivas, Raúl/0000-0003-2202-1470; Fraile, Paula Garcia/0000-0002-9576-2184; Andrade, Paula/0000-0002-9764-3920; Martinez-Molina, Eustoquio/0000-0002-0983-9780; Marcos Garcia, Marta/0000-0002-6791-9893	"Junta de Castilla y Leon" (Regional Government) [SA183A11-2]; MINECO (Central Government) [AGL2011-29227]; Academy of Sciences of the Czech Republic; Salamanca University; Fundacion Miguel Casado San Jose; European Union (FEDER funds through COMPETE); FCT, Fundacao para a Ciencia e Tecnologia [Pest-C/EQB/LA0006/2013]; European Union (FEDER funds) under the framework of QREN [NORTE-07-0124-FEDER-000069]	"Junta de Castilla y Leon" (Regional Government)(Junta de Castilla y Leon); MINECO (Central Government); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Salamanca University; Fundacion Miguel Casado San Jose; European Union (FEDER funds through COMPETE); FCT, Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Union (FEDER funds) under the framework of QREN	This work was granted by "Junta de Castilla y Leon" (Regional Government, Grant SA183A11-2) and MINECO (Central Government, Grant AGL2011-29227). Paula Garcia-Fraile is recipient of a postdoctoral researcher contract from Academy of Sciences of the Czech Republic. Jose David Flores-Felix was supported by a fellowship of Salamanca University. Marta Marcos Garcia was supported by a fellowship of Fundacion Miguel Casado San Jose. Luis R. Silva is grateful to the financial support from the European Union (FEDER funds through COMPETE) and National Funds (FCT, Fundacao para a Ciencia e Tecnologia) through project Pest-C/EQB/LA0006/2013 and from the European Union (FEDER funds) under the framework of QREN through Project NORTE-07-0124-FEDER-000069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Azzini E, 2010, BRIT J NUTR, V104, P1165, DOI 10.1017/S000711451000187X; Basu A, 2014, CRIT REV FOOD SCI, V54, P790, DOI 10.1080/10408398.2011.608174; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Berlec A, 2012, PLANT SCI, V193, P96, DOI 10.1016/j.plantsci.2012.05.010; Bertrand H, 2001, BIOL FERT SOILS, V33, P152, DOI 10.1007/s003740000305; Bona E, 2015, MYCORRHIZA, V25, P181, DOI 10.1007/s00572-014-0599-y; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Contesto C, 2010, PLANTA, V232, P1455, DOI 10.1007/s00425-010-1264-0; Dopico-Garcia MS, 2007, ANAL CHIM ACTA, V583, P15, DOI 10.1016/j.aca.2006.09.056; Esitken A, 2010, SCI HORTIC-AMSTERDAM, V124, P62, DOI 10.1016/j.scienta.2009.12.012; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flores-Felix JD, 2013, INT J SYST EVOL MICR, V63, P821, DOI 10.1099/ijs.0.038497-0; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; Garcia-Fraile P, 2013, FOOD CHEM, V139, P31, DOI 10.1016/j.foodchem.2012.12.043; Garcia-Fraile P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038122; Giampieri F, 2012, NUTRITION, V28, P9, DOI 10.1016/j.nut.2011.08.009; Kechid M, 2013, NEW PHYTOL, V198, P514, DOI 10.1111/nph.12158; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; KNOSEL D, 1984, BERGEYS MANUAL SYSTE, V1, P254; Larcher M, 2003, NEW PHYTOL, V160, P119, DOI 10.1046/j.1469-8137.2003.00862.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; OGARA F, 1976, BIOCHIM BIOPHYS ACTA, V451, P342, DOI 10.1016/0304-4165(76)90129-X; OHARA GW, 1989, APPL ENVIRON MICROB, V55, P1870, DOI 10.1128/AEM.55.8.1870-1876.1989; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Robledo M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-125; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Rojas A, 2001, FEMS MICROBIOL ECOL, V35, P181, DOI 10.1111/j.1574-6941.2001.tb00802.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Sanchez M, 2014, INT J SYST EVOL MICR, V64, P781, DOI 10.1099/ijs.0.052993-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silva LR, 2014, J AGR FOOD CHEM, V62, P557, DOI 10.1021/jf4046649; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Spence C, 2012, BACTERIA AGROBIOLOGY, P1; Sun-Waterhouse D, 2011, INT J FOOD SCI TECH, V46, P899, DOI 10.1111/j.1365-2621.2010.02499.x; Tulipani S, 2014, FOOD CHEM, V156, P87, DOI 10.1016/j.foodchem.2014.01.098; Tulipani S, 2011, FOOD CHEM, V128, P180, DOI 10.1016/j.foodchem.2011.03.025; VINCENT J. M., 1970, A manual for the practical study of the root-nodule bacteria.; Wang H, 2004, ARCH MICROBIOL, V182, P520, DOI 10.1007/s00203-004-0735-8; Wentland EJ, 1996, BIOTECHNOL PROGR, V12, P316, DOI 10.1021/bp9600243	42	68	70	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122281	10.1371/journal.pone.0122281	http://dx.doi.org/10.1371/journal.pone.0122281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874563	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800049
J	Frings, A; Richard, G; Steinberg, J; Skevas, C; Druchkiv, V; Katz, T; Linke, SJ				Frings, Andreas; Richard, Gisbert; Steinberg, Johannes; Skevas, Christos; Druchkiv, Vasyl; Katz, Toam; Linke, Stephan J.			LASIK for Spherical Refractive Myopia: Effect of Topographic Astigmatism (Ocular Residual Astigmatism, ORA) on Refractive Outcome	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CORNEAL ASTIGMATISM; EYES; EFFICACY; VECTORS	Purpose In eyes with a preoperative plano refractive cylinder, it would appear that there is no rationale for astigmatic treatment. The aim of this retrospective, cross-sectional data analysis was to determine the amount of topographic astigmatism in refractive plano eyes that results in reduced efficacy after myopic laser in situ keratomileusis (LASIK). Methods This study included 267 eyes from 267 consecutive myopic patients with a refractive plano cylinder. Receiver operating characteristic analysis was used to find the cut-off values of preoperative ocular residual astigmatism (=topographic astigmatism) that can best discriminate between groups of efficacy and safety indices in preoperative plano refractive cylinder eyes. Results Preoperative ocular residual astigmatism (ORA) (or topographic astigmatism) of <= 0.9 diopters (D) resulted in an efficacy index of at least 0.8 statistically significantly more frequently than eyes with a preoperative ORA of >0.9 D. Eyes with a high ORA preoperatively also had a high ORA postoperatively. Regression analysis showed that each diopter of preoperative ORA reduced efficacy by 0.07. Conclusion A preoperative corneal astigmatism of >= 0.9 D could (partially) be taken into account in the LASIK design, even if the subjective refractive astigmatism is neutral.	[Frings, Andreas; Richard, Gisbert; Steinberg, Johannes; Skevas, Christos; Druchkiv, Vasyl; Katz, Toam; Linke, Stephan J.] Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Frings, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Hamburg, Germany.	a.frings@uke.de		Druchkiv, Vasyl/0000-0002-6344-4480				Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; ALPINS NA, 1993, J CATARACT REFR SURG, V19, P524, DOI 10.1016/S0886-3350(13)80617-7; Alpins NA, 1997, J CATARACT REFR SURG, V23, P65, DOI 10.1016/S0886-3350(97)80153-8; Alpins NA, 1998, J CATARACT REFR SURG, V24, P634, DOI 10.1016/S0886-3350(98)80258-7; Alpins N, 2008, J CATARACT REFR SURG, V34, P1250, DOI 10.1016/j.jcrs.2008.03.028; Alpins N, 2007, J CATARACT REFR SURG, V33, P591, DOI 10.1016/j.jcrs.2006.12.014; Alpins N, 2012, J CATARACT REFR SURG, V38, P1978, DOI 10.1016/j.jcrs.2012.07.026; Artal P, 2001, J VISION, V1, DOI 10.1167/1.1.1; Frings A, 2014, J CATARACT REFR SURG, V40, P232, DOI 10.1016/j.jcrs.2013.11.015; Frings A, 2013, J CATARACT REFR SURG, V39, P366, DOI 10.1016/j.jcrs.2012.09.024; Kamiya K, 2012, BRIT J OPHTHALMOL, V96, P267, DOI 10.1136/bjo.2011.202481; Kugler L, 2010, J CATARACT REFR SURG, V36, P1745, DOI 10.1016/j.jcrs.2010.05.014; Mrochen M, 2004, J CATARACT REFR SURG, V30, P775, DOI 10.1016/j.jcrs.2004.01.026; Tejedor J, 2013, CORNEA, V32, P783, DOI 10.1097/ICO.0b013e31826dd44b	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124313	10.1371/journal.pone.0124313	http://dx.doi.org/10.1371/journal.pone.0124313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875476	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800137
J	Stemig, M; Astelford, K; Emery, A; Cho, JJ; Allen, B; Huang, TH; Gopalakrishnan, R; Mansky, KC; Jensen, ED				Stemig, Melissa; Astelford, Kristina; Emery, Ann; Cho, Jangyeun J.; Allen, Ben; Huang, Tsang-hai; Gopalakrishnan, Rajaram; Mansky, Kim C.; Jensen, Eric D.			Deletion of Histone Deacetylase 7 in Osteoclasts Decreases Bone Mass in Mice by Interactions with MITF	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; ACID-PHOSPHATASE GENE; RECEPTOR ACTIVATOR; MINERAL DENSITY; NUCLEAR DOMAIN; P38 MAPK; EXPRESSION; DIFFERENTIATION; PU.1; IDENTIFICATION	Molecular regulators of osteoclast formation and function are an important area of research due to the central role of osteoclasts in bone resorption. Transcription factors such as MITF are essential for osteoclast generation by regulating expression of the genes required for cellular differentiation and resorptive function. We recently reported that histone deacetylase 7 (HDAC7) binds to and represses the transcriptional activity of MITF in osteoclasts, and that loss of HDAC7 in vitro accelerated osteoclastogenesis. In the current study, we extend this initial observation by showing that conditional deletion of HDAC7 in osteoclasts of mice leads to an in vivo enhancement in osteoclast formation, associated with increased bone resorption and lower bone mass. Expression of multiple MITF target genes is increased in bone marrow derived osteoclast cultures from the HDAC7 knockout mice. Interestingly, multiple regions of the HDAC7 amino-terminus can bind to MITF or exert repressive activity. Moreover, mutation or deletion of the HDAC7 conserved deacetylase catalytic domain had little effect on repressive function. These observations identify HDAC7 in osteoclasts as an important molecular regulator of MITF activity and bone homeostasis, but also highlight a gap in our understanding of exactly how HDAC7 functions as a corepressor.	[Stemig, Melissa; Emery, Ann; Gopalakrishnan, Rajaram; Jensen, Eric D.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA; [Astelford, Kristina; Cho, Jangyeun J.; Allen, Ben; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Huang, Tsang-hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Cheng Kung University	Mansky, KC (corresponding author), Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA.	kmansky@umn.edu; jens0709@umn.edu		Mansky, Kim/0000-0002-2826-5030	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR061352, R01AR056642]; University of Minnesota Office of the Vice-President for Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, R01AR056642] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota Office of the Vice-President for Research(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grant number R01AR061352 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to EDJ and KCM, http://www.niams.nih.gov; grant number R01AR056642 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to RG, http://www.niams.nih.gov; Grant-in-Aid of Research, Artistry, and Scholarship from the University of Minnesota Office of the Vice-President for Research to EDJ, http://www.research.umn.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boluk A, 2004, PHARMACOL RES, V50, P93, DOI 10.1016/j.phrs.2003.11.011; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Cantley MD, 2012, J PHARM PHARMACOL, V64, P763, DOI 10.1111/j.2042-7158.2011.01421.x; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Ecevit CG, 2004, PEDIATR NEUROL, V31, P279, DOI 10.1016/j.pediatrneurol.2004.03.021; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kim HN, 2012, EUR J PHARMACOL, V691, P69, DOI 10.1016/j.ejphar.2012.07.034; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P304; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Williams PJ, 2011, ANN NY ACAD SCI, V1240, P18, DOI 10.1111/j.1749-6632.2011.06286.x	37	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123843	10.1371/journal.pone.0123843	http://dx.doi.org/10.1371/journal.pone.0123843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875108	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800120
J	Weng, TC; Chan, TC; Lin, HT; Chang, CKJ; Wang, WW; Li, ZRT; Cheng, HY; Chu, YR; Chiu, AWH; Yen, MY; King, CC				Weng, Ting Chia; Chan, Ta Chien; Lin, Hsien Tang; Chang, Chia Kun Jasper; Wang, Wen Wen; Li, Zheng Rong Tiger; Cheng, Hao-Yuan; Chu, Yu-Roo; Chiu, Allen Wen-Hsiang; Yen, Muh-Yong; King, Chwan-Chuen			Early Detection for Cases of Enterovirus- and Influenza-Like Illness through a Newly Established School-Based Syndromic Surveillance System in Taipei, January 2010 similar to August 2011	PLOS ONE			English	Article							ASTHMA SURVEILLANCE; EPIDEMIC; CHILDREN; DISEASE; TAIWAN; HOUSEHOLD; INFECTION; VIRUS; FRANCE; NUMBER	School children may transmit pathogens with cluster cases occurring on campuses and in families. In response to the 2009 influenza A (H1N1) pandemic, Taipei City Government officials developed a School-based Infectious Disease Syndromic Surveillance System (SIDSSS). Teachers and nurses from preschools to universities in all 12 districts within Taipei are required to daily report cases of symptomatic children or sick leave requests through the SID-SSS. The pre-diagnosis at schools is submitted firstly as common pediatric disease syndrome-groups and re-submitted after confirmation by physicians. We retrieved these data from January 2010 to August 2011 for spatio-temporal analysis and evaluated the temporal trends with cases obtained from both the Emergency Department-based Syndromic Surveillance System (ED-SSS) and the Longitudinal Health Insurance Database 2005 (LHID2005). Through the SID-SSS, enterovirus-like illness (EVI) and influenza-like illness (ILI) were the two most reported syndrome groups (77.6% and 15.8% among a total of 19,334 cases, respectively). The pre-diagnosis judgments made by school teachers and nurses showed high consistency with physicians' clinical diagnoses for EVI (97.8%) and ILI (98.9%). Most importantly, the SID-SSS had better timeliness with earlier peaks of EVI and ILI than those in the ED-SSS. Furthermore, both of the syndrome groups in these two surveillance systems had the best correlation reaching 0.98 and 0.95, respectively (p<0.01). Spatio-temporal analysis observed the patterns of EVI and ILI both diffuse from the northern suburban districts to central Taipei, with ILI spreading faster. This novel system can identify early suspected cases of two important pediatric infections occurring at schools, and clusters from schools/families. It was also cost-effective (95.5% of the operation cost reduced and 59.7% processing time saved). The timely surveillance of mild EVI and ILI cases integrated with spatial analysis may help public health decision-makers with where to target for enhancing surveillance and prevention measures to minimize severe cases.	[Weng, Ting Chia] NTU, Coll Med, Dept Med, Taipei, Taiwan; [Chan, Ta Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Lin, Hsien Tang; Chu, Yu-Roo] Taipei City Govt, Dept Hlth, Taipei, Taiwan; [Chang, Chia Kun Jasper; Wang, Wen Wen; Li, Zheng Rong Tiger; King, Chwan-Chuen] NTU, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Cheng, Hao-Yuan] NTU Hosp, Dept Pediat, Taipei, Taiwan; [Chiu, Allen Wen-Hsiang; Yen, Muh-Yong] Taipei City Govt, Dept Hlth, Taipei City Hosp, Taipei, Taiwan; [Chiu, Allen Wen-Hsiang; Yen, Muh-Yong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Taipei City Hospital; National Yang Ming Chiao Tung University	Yen, MY (corresponding author), Taipei City Govt, Dept Hlth, Taipei City Hosp, Taipei, Taiwan.	myyen1121@gmail.com; chwanchuen@gmail.com		King, Chwan-Chuen/0000-0002-6078-2601	National Science Council, Executive Yuan of Taiwan [NSC 102-2815-C-002 -182-B, NSC 102-2621-M-002-002]; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Health Sciences; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Science Council, Executive Yuan of Taiwan(Ministry of Science and Technology, Taiwan); Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Health Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was financially supported by a grant from the National Science Council, Executive Yuan of Taiwan [NSC 102-2815-C-002 -182-B] and [NSC 102-2621-M-002-002] and the student scholarships from the Medical Foundation in Memory of Dr. Deh-Lin Cheng and the Foundation of Health Sciences to cultivate young infectious disease researchers. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bailey-Davis L, 2012, PEDIATRICS, V130, P1102, DOI 10.1542/peds.2012-0192; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chao A, 1996, STAT SINICA, V6, P403; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; Crawford GB, 2011, PUBLIC HEALTH REP, V126, P591; Department of Budget TaipeiCityGovernment, 2019, REP FAM INC EXP SURV; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.1093/biomet/63.3.435; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fujii H, 2002, JPN J INFECT DIS, V55, P97; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050228, DOI 10.1371/JOURNAL.PONE.0050228]; Huang YC, 2013, BMC INFECT DIS, P13; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Lawson AB, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, P1, DOI 10.1002/0470092505.ch1; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Magzamen S, 2005, PEDIAT ALLERG IMM-UK, V16, P669, DOI 10.1111/j.1399-3038.2005.00304.x; Medaglia F, 2013, J SCHOOL HEALTH, V83, P907, DOI 10.1111/josh.12109; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; Ohta A, 2007, J EPIDEMIOL, V17, pS14, DOI 10.2188/jea.17.S14; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schmidt WP, 2010, EURO SURVEILL, V15; Short VL, 2011, AM J PUBLIC HEALTH, V101, P2178, DOI 10.2105/AJPH.2011.300132; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Thibaut HJ, 2012, BIOCHEM PHARMACOL, V83, P185, DOI 10.1016/j.bcp.2011.08.016; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; Witt CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S10; World Health Organization, 2014, CUM NUMB CONF HUM CA; Wu HS, 2014, EMERG INFECT DIS, V20, P857, DOI 10.3201/eid2005.131393; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yen MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007962; Zhang DM, 2010, INT J INFECT DIS, V14, pE739, DOI 10.1016/j.ijid.2009.12.002	44	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122865	10.1371/journal.pone.0122865	http://dx.doi.org/10.1371/journal.pone.0122865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875080	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800079
J	Williams, PA; Stilhano, RS; To, VP; Tran, L; Wong, K; Silva, EA				Williams, Priscilla A.; Stilhano, Roberta S.; To, Vivian P.; Tran, Lyndon; Wong, Kevin; Silva, Eduardo A.			Hypoxia Augments Outgrowth Endothelial Cell (OEC) Sprouting and Directed Migration in Response to Sphingosine-1-Phosphate (S1P)	PLOS ONE			English	Article							COLONY-FORMING CELLS; PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTORS; CORD-BLOOD; IN-VITRO; THERAPEUTIC ANGIOGENESIS; CROSS-TALK; DELIVERY	Therapeutic angiogenesis provides a promising approach to treat ischemic cardiovascular diseases through the delivery of proangiogenic cells and/or molecules. Outgrowth endothelial cells (OECs) are vascular progenitor cells that are especially suited for therapeutic strategies given their ease of noninvasive isolation from umbilical cord or adult peripheral blood and their potent ability to enhance tissue neovascularization. These cells are recruited to sites of vascular injury or tissue ischemia and directly incorporate within native vascular endothelium to participate in neovessel formation. A better understanding of how OEC activity may be boosted under hypoxia with external stimulation by proangiogenic molecules remains a challenge to improving their therapeutic potential. While vascular endothelial growth factor (VEGF) is widely established as a critical factor for initiating angiogenesis, sphingosine-1-phosphate (S1P), a bioactive lysophospholipid, has recently gained great enthusiasm as a potential mediator in neovascularization strategies. This study tests the hypothesis that hypoxia and the presence of VEGF impact the angiogenic response of OECs to S1P stimulation in vitro. We found that hypoxia altered the dynamically regulated S1P receptor 1 (S1PR1) expression on OECs in the presence of S1P (1.0 mu M) and/or VEGF (1.3 nM). The combined stimuli of S1P and VEGF together promoted OEC angiogenic activity as assessed by proliferation, wound healing, 3D sprouting, and directed migration under both normoxia and hypoxia. Hypoxia substantially augmented the response to S1P alone, resulting in similar to 6.5-fold and similar to 25-fold increases in sprouting and directed migration, respectively. Overall, this report highlights the importance of establishing hypoxic conditions in vitro when studying ischemia-related angiogenic strategies employing vascular progenitor cells.	[Williams, Priscilla A.; To, Vivian P.; Wong, Kevin; Silva, Eduardo A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Stilhano, Roberta S.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Tran, Lyndon] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Davis	Silva, EA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	esilva@ucdavis.edu	Silva, Eduardo A./M-2711-2015; STILHANO, roberta/F-6923-2015	Silva, Eduardo A./0000-0003-3173-7622; STILHANO, roberta/0000-0002-0653-5968	University of California, Davis; American Heart Association (AHA) [15PRE22930044]	University of California, Davis(University of California System); American Heart Association (AHA)(American Heart Association)	This work was supported by start-up funds provided by the University of California, Davis. PAW was supported by the American Heart Association Western States Affiliate 2014 Predoctoral Fellowship (AHA Award Number 15PRE22930044; (http://my.americanheart.org/)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Anderson EM, 2014, TISSUE EN A IN PRESS; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Capitani N, 2012, BLOOD, V120, P4391, DOI 10.1182/blood-2012-04-425959; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Ikeda T, 2011, BIOCHEM J, V436, P399, DOI 10.1042/BJ20101490; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292; Kuiper C, 2014, FREE RADICAL BIO MED, V69, P308, DOI 10.1016/j.freeradbiomed.2014.01.033; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu Jingjing, 2011, World J Biol Chem, V2, P1, DOI 10.4331/wjbc.v2.i1.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HW, 2012, MOL CELL BIOCHEM, V363, P217, DOI 10.1007/s11010-011-1173-y; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mier-y-Teran-Romero L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000726; Mikhaylova M, 2008, NEOPLASIA, V10, P380, DOI 10.1593/neo.07854; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007; Ouma GO, 2012, VASC MED, V17, P174, DOI 10.1177/1358863X12438270; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Silva EA, 2014, ANGIOGENESIS; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Takuwa Yoh, 2010, World J Biol Chem, V1, P298, DOI 10.4331/wjbc.v1.i10.298; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Williamson KA, 2013, AGING CELL, V12, P139, DOI 10.1111/acel.12031; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203	59	57	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123437	10.1371/journal.pone.0123437	http://dx.doi.org/10.1371/journal.pone.0123437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875493	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800098
J	Xia, Y; Lian, S; Khoi, PN; Yoon, HJ; Joo, YE; Chay, KO; Kim, KK; Do Jung, Y				Xia, Yong; Lian, Sen; Khoi, Pham Ngoc; Yoon, Hyun Joong; Joo, Young Eun; Chay, Kee Oh; Kim, Kyung Keun; Do Jung, Young			Chrysin Inhibits Tumor Promoter-Induced MMP-9 Expression by Blocking AP-1 via Suppression of ERK and JNK Pathways in Gastric Cancer Cells	PLOS ONE			English	Article							INDUCED MATRIX-METALLOPROTEINASE-9 EXPRESSION; NF-KAPPA-B; MATRIX METALLOPROTEINASES; C-JUN; CYCLOOXYGENASE-2 EXPRESSION; NUCLEAR-FACTOR; PHOSPHORYLATION; ANGIOGENESIS; FOS; PROLIFERATION	Cell invasion is a crucial mechanism of cancer metastasis and malignancy. Matrix metallo-proteinase-9 (MMP-9) is an important proteolytic enzyme involved in the cancer cell invasion process. High expression levels of MMP-9 in gastric cancer positively correlate with tumor aggressiveness and have a significant negative correlation with patients' survival times. Recently, mechanisms suppressing MMP-9 by phytochemicals have become increasingly investigated. Chrysin, a naturally occurring chemical in plants, has been reported to suppress tumor metastasis. However, the effects of chrysin on MMP-9 expression in gastric cancer have not been well studied. In the present study, we tested the effects of chrysin on MMP-9 expression in gastric cancer cells, and determined its underlying mechanism. We examined the effects of chrysin on MMP-9 expression and activity via RT-PCR, zymography, promoter study, and western blotting in human gastric cancer AGS cells. Chrysin inhibited phorbol-12-myristate 13-acetate (PMA)-induced MMP-9 expression in a dose-dependent manner. Using AP-1 decoy oligodeoxynucleotides, we confirmed that AP-1 was the crucial transcriptional factor for MMP-9 expression. Chrysin blocked AP-1 via suppression of the phosphorylation of c-Jun and c-Fos through blocking the JNK1/2 and ERK1/2 pathways. Furthermore, AGS cells pretreated with PMA showed markedly enhanced invasiveness, which was partially abrogated by chrysin and MMP-9 antibody. Our results suggest that chrysin may exert at least part of its anticancer effect by controlling MMP-9 expression through suppression of AP-1 activity via a block of the JNK1/2 and ERK1/2 signaling pathways in gastric cancer AGS cells.	[Xia, Yong; Lian, Sen; Khoi, Pham Ngoc; Yoon, Hyun Joong; Joo, Young Eun; Chay, Kee Oh; Kim, Kyung Keun; Do Jung, Young] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju, South Korea	Chonnam National University	Do Jung, Y (corresponding author), Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju, South Korea.	ydjung@chonnam.ac.kr	Xia, Yong/AAX-2206-2021; Xia, Yong/L-1618-2019		National Cancer Center [0720570]; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2010-0009910]; Medical Research Center from the Korean Science and Engineering Foundation [2012-000-9442]	National Cancer Center; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Medical Research Center from the Korean Science and Engineering Foundation	This work was supported by a Research grant (0720570) from the National Cancer Center (www.ncc.re.kr), Basic Science Research Program grant through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0009910, www.moe.go.kr), and a Medical Research Center (2012-000-9442) grant from the Korean Science and Engineering Foundation (www.nrf.re.kr). All above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Chen CC, 2004, MOL PHARMACOL, V66, P683; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen RH, 1996, ONCOGENE, V12, P1493; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Harris GK, 2006, J NUTR, V136, P1517, DOI 10.1093/jn/136.6.1517; Hwang YP, 2010, BIOCHEM PHARMACOL, V79, P1714, DOI 10.1016/j.bcp.2010.02.003; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin XH, 2014, B CANCER, V101, pE1, DOI 10.1684/bdc.2013.1882; Kim S, 2009, PHYTOMEDICINE, V16, P573, DOI 10.1016/j.phymed.2008.11.006; Li X, 2011, TOXICOL IN VITRO, V25, P630, DOI 10.1016/j.tiv.2010.12.013; Lin CM, 2010, J AGR FOOD CHEM, V58, P7082, DOI 10.1021/jf100421w; Lin CM, 2006, PLANTA MED, V72, P708, DOI 10.1055/s-2006-931602; Lirdprapamongkol K, 2013, ONCOL REP, V30, P2357, DOI 10.3892/or.2013.2667; Liu QX, 2011, BIOCELL, V35, P71; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Khoi PN, 2013, INT J ONCOL, V43, P868, DOI 10.3892/ijo.2013.2006; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Song Dong Up, 2014, Chonnam Med J, V50, P6, DOI 10.4068/cmj.2014.50.1.6; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Velinov N, 2010, Khirurgiia (Sofiia), P44; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048; Yang B, 2014, J APPL TOXICOL, V34, P105, DOI 10.1002/jat.2941; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013	38	47	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124007	10.1371/journal.pone.0124007	http://dx.doi.org/10.1371/journal.pone.0124007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875631	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800127
J	Ponsuksili, S; Siengdee, P; Du, Y; Trakooljul, N; Murani, E; Schwerin, M; Wimmers, K				Ponsuksili, Siriluck; Siengdee, Puntita; Du, Yang; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus			Identification of Common Regulators of Genes in Co-Expression Networks Affecting Muscle and Meat Properties	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOBLAST DIFFERENTIATION; THIAMINE-DEFICIENCY; GLUCOSE-UPTAKE; EXPRESSION; MOUSE; PIGS; QUALITY; CXCR7; DEGENERATION	Understanding the genetic contributions behind skeletal muscle composition and metabolism is of great interest in medicine and agriculture. Attempts to dissect these complex traits combine genome-wide genotyping, expression data analyses and network analyses. Weighted gene co-expression network analysis (WGCNA) groups genes into modules based on patterns of co-expression, which can be linked to phenotypes by correlation analysis of trait values and the module eigengenes, i.e. the first principal component of a given module. Network hub genes and regulators of the genes in the modules are likely to play an important role in the emergence of respective traits. In order to detect common regulators of genes in modules showing association with meat quality traits, we identified eQTL for each of these genes, including the highly connected hub genes. Additionally, the module eigengene values were used for association analyses in order to derive a joint eQTL for the respective module. Thereby major sites of orchestrated regulation of genes within trait-associated modules were detected as hotspots of eQTL of many genes of a module and of its eigengene. These sites harbor likely common regulators of genes in the modules. We exemplarily showed the consistent impact of candidate common regulators on the expression of members of respective modules by RNAI knockdown experiments. In fact, Cxcr7 was identified and validated as a regulator of genes in a module, which is involved in the function of defense response in muscle cells. Zfp3612 was confirmed as a regulator of genes of a module related to cell death or apoptosis pathways. The integration of eQTL in module networks enabled to interpret the differentially-regulated genes from a systems perspective. By integrating genome-wide genomic and transcriptomic data, employing co-expression and eQTL analyses, the study revealed likely regulators that are involved in the fine-tuning and synchronization of genes with trait-associated expression.	[Ponsuksili, Siriluck; Siengdee, Puntita; Du, Yang; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummertorf.de	Siengdee, Puntita/AAF-4813-2019; Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790; Trakooljul, Nares/0000-0002-3214-2498; Du, Yang/0000-0002-5707-513X; Siengdee, Puntita/0000-0003-0665-0912	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [PO753/6-1, WI1754/14-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; PO753/6-1 and WI1754/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berdanier CD, 1997, ADVANCED NUTRITION M; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; Calingasan NY, 1996, AM J PATHOL, V149, P1063; Davis RC, 2012, PHYSIOL GENOMICS, V44, P1, DOI 10.1152/physiolgenomics.00003.2011; ESTRADE M, 1993, COMP BIOCHEM PHYS B, V104, P321, DOI 10.1016/0305-0491(93)90375-F; Evangelisti C, 2009, CELL SIGNAL, V21, P801, DOI 10.1016/j.cellsig.2009.01.027; Fan YY, 2013, J MOL HISTOL, V44, P75, DOI 10.1007/s10735-012-9445-8; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Farber CR, 2009, J BONE MINER RES, V24, P1937, DOI [10.1359/jbmr.091101, 10.1359/JBMR.091101]; Farber CR, 2009, PHYSIOL GENOMICS, V37, P294, DOI 10.1152/physiolgenomics.90245.2008; Feng Z, 2007, GENE, V403, P170, DOI 10.1016/j.gene.2007.08.009; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; Frederikse PH, 1999, BIOCHEM BIOPH RES CO, V258, P703, DOI 10.1006/bbrc.1999.0560; Ge YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068068; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; GUNTERT M, 1993, PROGRESS IN FLAVOUR PRECURSOR STUDIES, P361; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; MA JT, 1994, BIOCHEM BIOPH RES CO, V200, P1742, DOI 10.1006/bbrc.1994.1654; Meinert L, 2009, MEAT SCI, V81, P255, DOI 10.1016/j.meatsci.2008.07.031; Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Mo XY, 2011, MOL BIOL REP, V38, P4389, DOI 10.1007/s11033-010-0566-4; Moreno-Sanchez N, 2010, FUNCT INTEGR GENOMIC, V10, P609, DOI 10.1007/s10142-010-0175-2; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Ponsuksili S, 2012, GENETICS, V192, P1109, DOI 10.1534/genetics.112.143081; Ponsuksili S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-572; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; Ramos SBV, 2012, J BIOL CHEM, V287, P13116, DOI 10.1074/jbc.M111.330837; Reiner G, 2002, ANIM GENET, V33, P49, DOI 10.1046/j.1365-2052.2002.00805.x; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stratz P, 2014, ANIM GENET, V45, P350, DOI 10.1111/age.12133; Stumpo DJ, 2010, WIRES RNA, V1, P60, DOI 10.1002/wrna.1; Tao G, 2012, J MOL CELL CARDIOL, V53, P626, DOI 10.1016/j.yjmcc.2012.08.002; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; TonoOka S, 1996, J HISTOCHEM CYTOCHEM, V44, P907, DOI 10.1177/44.8.8756762; TROUCHE D, 1995, FEBS LETT, V361, P140, DOI 10.1016/0014-5793(95)00140-5; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	63	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123678	10.1371/journal.pone.0123678	http://dx.doi.org/10.1371/journal.pone.0123678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875247	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700037
J	Ullah, H; Islam, S; Khan, I; Shafie, S; Fiza, M				Ullah, Hakeem; Islam, Saeed; Khan, Ilyas; Shafie, Sharidan; Fiza, Mehreen			Formulation and Application of Optimal Homotopty Asymptotic Method to Coupled Differential - Difference Equations	PLOS ONE			English	Article							SYMMETRIES; FLOW	In this paper we applied a new analytic approximate technique Optimal Homotopy Asymptotic Method (OHAM) for treatment of coupled differential-difference equations (DDEs). To see the efficiency and reliability of the method, we consider Relativistic Toda coupled nonlinear differential-difference equation. It provides us a convenient way to control the convergence of approximate solutions when it is compared with other methods of solution found in the literature. The obtained solutions show that OHAM is effective, simpler, easier and explicit.	[Ullah, Hakeem; Islam, Saeed; Fiza, Mehreen] Abdul Wali Khan Univ Mardan, Dept Math, Mardan 23200, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Shafie, Sharidan] Univ Teknol Malayisa, Fac Sci, Dept Math Sci, Johar Bohru 81310, Johor, Malaysia	Majmaah University	Shafie, S (corresponding author), Univ Teknol Malayisa, Fac Sci, Dept Math Sci, Johar Bohru 81310, Johor, Malaysia.	sharidan@utm.my	Khan, Ilyas/C-8770-2019; Saeed, Islam/AAD-6067-2020	Khan, Ilyas/0000-0002-2056-9371; Saeed, Islam/0000-0001-5263-4871				Abdou M.A., 2011, INT J NONLINEAR SCI, V12, P29; Baldwin D, 2004, COMPUT PHYS COMMUN, V162, P203, DOI 10.1016/j.cpc.2004.07.002; CHERDANTSEV IY, 1995, PHYSICA D, V87, P140, DOI 10.1016/0167-2789(95)00167-3; Herisanu N, 2010, MECCANICA, V45, P847, DOI 10.1007/s11012-010-9293-0; Idrees M, 2010, COMPUT MATH APPL, V59, P3858, DOI 10.1016/j.camwa.2010.04.023; Idrees M., 2012, COMPUT MATH APPL, V63, P695; Levi D, 1997, J MATH PHYS, V38, P6648, DOI 10.1063/1.532230; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2010, J SOUND VIB, V329, P1450, DOI 10.1016/j.jsv.2009.11.005; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; NARITA K, 1993, CHAOS SOLITON FRACT, V3, P279, DOI 10.1016/0960-0779(93)90011-O; Nawaz R, 2013, J APPL MATH, DOI 10.1155/2013/387478; Shabat A. B., 1991, LENINGRAD MATH J, V2, P377; Ullah H, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/520467; Ullah H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/362816; Ullah H, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/324869; Ullah H., 2014, SCI INT, V26, P567; Ullah H, 2014, INT J DIFFER EQUAT, V2014, DOI 10.1155/2014/106934; Wang Z, 2007, PHYS LETT A, V369, P77, DOI 10.1016/j.physleta.2007.04.070; Wang Z, 2006, CHINESE PHYS, V15, P2210, DOI 10.1088/1009-1963/15/10/004; Wang Z, 2011, APPL MATH COMPUT, V218, P1371, DOI 10.1016/j.amc.2011.06.019; YAMILOV RI, 1994, J PHYS A-MATH GEN, V27, P6839, DOI 10.1088/0305-4470/27/20/020; Zhang DJ, 2005, CHAOS SOLITON FRACT, V23, P1333, DOI 10.1016/j.chaos.2004.06.034; Zhen W, 2006, APPL MATH COMPUT, V178, P431, DOI 10.1016/j.amc.2005.11.060; Zou L, 2008, COMPUT MATH APPL, V56, P2289, DOI 10.1016/j.camwa.2008.03.052	25	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120127	10.1371/journal.pone.0120127	http://dx.doi.org/10.1371/journal.pone.0120127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874457	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700003
J	Beziau, DM; Toussaint, F; Blanchette, A; Dayeh, NR; Charbel, C; Tardif, JC; Dupuis, J; Ledoux, J				Beziau, Delphine M.; Toussaint, Fanny; Blanchette, Alexandre; Dayeh, Nour R.; Charbel, Chimene; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan			Expression of Phosphoinositide-Specific Phospholipase C Isoforms in Native Endothelial Cells	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; CA2+ SIGNALS; CALCIUM; ACTIVATION; CHANNELS; ROLES; PHOSPHORYLATION; GROWTH	Phospholipase C (PLC) comprises a superfamily of enzymes that play a key role in a wide array of intracellular signalling pathways, including protein kinase C and intracellular calcium. Thirteen different mammalian PLC isoforms have been identified and classified into 6 families (PLC-beta, gamma, delta, epsilon, zeta and eta) based on their biochemical properties. Although the expression of PLC isoforms is tissue-specific, concomitant expression of different PLC has been reported, suggesting that PLC family is involved in multiple cellular functions. Despite their critical role, the PLC isoforms expressed in native endothelial cells (ECs) remains undetermined. A conventional PCR approach was initially used to elucidate the mRNA expression pattern of PLC isoforms in 3 distinct murine vascular beds: mesenteric (MA), pulmonary (PA) and middle cerebral arteries (MCA). mRNA encoding for most PLC isoforms was detected in MA, MCA and PA with the exception of eta 2 and beta 2 (only expressed in PA), delta 4 (only expressed in MCA), eta 1 (expressed in all but MA) and zeta (not detected in any vascular beds tested). The endothelial-specific PLC expression was then sought in freshly isolated ECs. Interestingly, the PLC expression profile appears to differ across the investigated arterial beds. While mRNA for 8 of the 13 PLC isoforms was detected in ECs from MA, two additional PLC isoforms were detected in ECs from PA and MCA. Co-expression of multiple PLC isoforms in ECs suggests an elaborate network of signalling pathways: PLC isoforms may contribute to the complexity or diversity of signalling by their selective localization in cellular microdomains. However in situ immunofluorescence revealed a homogeneous distribution for all PLC isoforms probed (beta 3, gamma 2 and delta 1) in intact endothelium. Although PLC isoforms play a crucial role in endothelial signal transduction, subcellular localization alone does not appear to be sufficient to determine the role of PLC in the signalling microdomains found in the native endothelium.	[Beziau, Delphine M.; Toussaint, Fanny; Blanchette, Alexandre; Dayeh, Nour R.; Charbel, Chimene; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Beziau, Delphine M.; Toussaint, Fanny; Ledoux, Jonathan] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ, Canada; [Charbel, Chimene; Ledoux, Jonathan] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Dayeh, Nour R.; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Ledoux, J (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	jonathan.ledoux@umontreal.ca	Dupuis, Jocelyn/C-6613-2013; Ledoux, Jonathan/D-2945-2012	Dupuis, Jocelyn/0000-0002-3193-1014; Ledoux, Jonathan/0000-0001-8540-7763	Universite de Montreal; Societe Quebecois d'Hypertension Arterielle (SQHA); Fonds de Recherche du Quebec - Sante (FRQS); Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI); Heart and Stroke Foundation of Canada (HSFC)	Universite de Montreal; Societe Quebecois d'Hypertension Arterielle (SQHA); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This study was support through studentship and salary grants: Universite de Montreal - Fanny Toussaint, Nour R. Dayeh; Societe Quebecois d'Hypertension Arterielle (SQHA) - Delphine M. Beziau and Fanny Toussaint; Fonds de Recherche du Quebec - Sante (FRQS) - Jonathan Ledoux; Canadian Institutes of Health Research (CIHR) - Jonathan Ledoux; The Canada Foundation for Innovation (CFI) - Jonathan Ledoux; Heart and Stroke Foundation of Canada (HSFC) - Jonathan Ledoux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Cines DB, 1998, BLOOD, V91, P3527; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Crljen V, 2004, FEBS LETT, V571, P35, DOI 10.1016/j.febslet.2004.06.051; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; FU YG, 1994, THROMB RES, V73, P405, DOI 10.1016/0049-3848(94)90042-6; Fujii M, 2009, J CELL BIOCHEM, V108, P638, DOI 10.1002/jcb.22297; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Gonzales AL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004732; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Hoeppner LH, 2012, BLOOD, V120, P2167, DOI 10.1182/blood-2012-03-417824; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Ishida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086410; Jang Hyun-Jun, 2013, Advances in Biological Regulation, V53, P51, DOI 10.1016/j.jbior.2012.09.008; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Johnson RP, 2009, J PHYSIOL-LONDON, V587, P2537, DOI 10.1113/jphysiol.2008.168252; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; KIBRIA G, 1980, THORAX, V35, P186, DOI 10.1136/thx.35.3.186; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Kirby BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054849; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Lo Vasco VR, 2011, J CLIN PATHOL, V64, P911, DOI 10.1136/jclinpath-2011-200096; Mao GF, 2000, BRIT J HAEMATOL, V110, P402, DOI 10.1046/j.1365-2141.2000.02201.x; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Socha MJ, 2011, AM J PHYSIOL-HEART C, V301, pH773, DOI 10.1152/ajpheart.00214.2011; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sullivan MN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005659; Sun LS, 2007, PLATELETS, V18, P217, DOI 10.1080/09537100601016133; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; Vines CM, 2012, ADV EXP MED BIOL, V740, P235, DOI 10.1007/978-94-007-2888-2_10; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003	56	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123769	10.1371/journal.pone.0123769	http://dx.doi.org/10.1371/journal.pone.0123769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875657	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100211
J	Chen, HY; Cui, SH; Zhao, YA; Zhang, CM; Zhang, SB; Peng, XJ				Chen, Huiying; Cui, Shaohui; Zhao, Yinan; Zhang, Chuanmin; Zhang, Shubiao; Peng, Xiaojun			Grafting Chitosan with Polyethylenimine in an Ionic Liquid for Efficient Gene Delivery	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENIMINE; TRANSFECTION EFFICIENCY; IN-VITRO; NONVIRAL VECTOR; SIRNA DELIVERY; NANOPARTICLES; COPOLYMER; TOXICITY; CARRIERS; POLYMER	Modifying chitosan (CS) with polyethylenimine (PEI) grafts is an effective way to improve its gene transfection performance. However, it is still a challenge to conduct the grafting with fine control and high efficiency, particularly for the modification of water-insoluble CS. Herein, a novel method to graft CS with PEI (1.8 kDa, PEI-1.8) was developed by using ionic liquid 1-butyl-3-methyl imidazolium acetate ([ BMIM] Ac) as a reaction solvent, water-insoluble CS as a reaction substrate and 1,1-carbonyldiimidazole (CDI) as a linking agent. The grafting reaction was greatly accelerated and the reaction time was largely shortened to 4 h by taking advantages of the good solubility of CS, the enhanced nucleophilicity of amino groups and the preferential stability of the activated complexes in the ionic liquid. The chitosan-graft-polyethylenimine (CS-g-PEI) products were characterized by H-1 NMR, FTIR and GPC. PEI1.8 was quantitatively grafted to CS through urea linkages, and the grafting degree (GD) was conveniently tuned by varying the molar ratios of PEI-1.8 to D-glucosamine units of CS in the range of 9.0 x 10(-3) to 9.0 x 10(-2). Compared with CS, the synthesized CS-g-PEI copolymers showed higher pDNA-binding affinity, which increased with the GD as shown in Agarose gel electrophoresis. The dynamic light scattering (DLS) experiment demonstrated that the CS-g-PEI/pDNA polyplexes had suitable particle sizes and proper zeta-potentials for cell transfection. The CS-g-PEI copolymer with a medium GD of 4.5% conferred the best gene transfection, with the efficiency 44 times of CS and 38 times of PEI-1.8 in HEp-2 cells. The cytotoxicity of CS-g-PEI was tested and found nearly as low as that of CS and much lower than that of PEI.	[Chen, Huiying; Zhao, Yinan; Zhang, Chuanmin; Peng, Xiaojun] Dalian Univ Technol, State Key Lab Fine Chem, Fac Chem Environm & Biol Sci & Technol, Dalian, Liaoning, Peoples R China; [Chen, Huiying; Cui, Shaohui; Zhao, Yinan; Zhang, Shubiao] Dalian Nationalities Univ, Coll Life Sci, Key Lab Biotechnol & Bioresources Utilizat, State Ethn Affairs Commiss,Minist Educ, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian Minzu University	Zhang, SB (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Key Lab Biotechnol & Bioresources Utilizat, State Ethn Affairs Commiss,Minist Educ, Dalian, Liaoning, Peoples R China.	zsb@dlnu.edu.cn	zhang, chuanmin/AAV-9453-2020		National High Technology Research and Development Program of China (863 Program) [2014AA020707]; Natural Science Foundation of China [21176046]; Fundamental Research Funds for the Dalian Nationalities University	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Dalian Nationalities University	This work was supported by National High Technology Research and Development Program of China (863 Program, 2014AA020707) http://www.863.gov.cn/, National Natural Science Foundation of China (21176046) http://www.nsfc.gov.cn/, and Fundamental Research Funds for the Dalian Nationalities University, http://kjc.dlnu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre M, 2014, POLYMERS-BASEL, V6, P1727, DOI 10.3390/polym6061727; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Benns JM, 2002, J CONTROL RELEASE, V79, P255, DOI 10.1016/S0168-3659(01)00513-2; BOTTEGA R, 1992, BIOCHEMISTRY-US, V31, P9025, DOI 10.1021/bi00152a045; Chang KL, 2011, J CONTROL RELEASE, V156, P195, DOI 10.1016/j.jconrel.2011.07.021; Chen HY, 2014, ACTA POLYM SIN, P1089; Crowhurst L, 2004, J AM CHEM SOC, V126, P11549, DOI 10.1021/ja046757y; Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g; El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Hiemenz P. C., 1997, PRINCIPLES COLLOID S, V3rd; Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.jconrel.2005.05.004; Jain A, 2013, CRIT REV THER DRUG, V30, P91; Jere D, 2009, INT J PHARMACEUT, V378, P194, DOI 10.1016/j.ijpharm.2009.05.046; Jia LJ, 2013, POLYM CHEM-UK, V4, P156, DOI 10.1039/c2py20781h; Jiang HL, 2008, J CONTROL RELEASE, V131, P150, DOI 10.1016/j.jconrel.2008.07.029; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Jiang HL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025013; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li ZT, 2010, CARBOHYD POLYM, V80, P254, DOI 10.1016/j.carbpol.2009.11.021; Liu CC, 2012, INT J NANOMED, V7, P5339, DOI 10.2147/IJN.S36179; Liu WG, 2002, J CONTROL RELEASE, V83, P1; Lu B, 2008, BIOMACROMOLECULES, V9, P2594, DOI 10.1021/bm8004676; Lu B, 2009, MOL BIOSYST, V5, P629, DOI 10.1039/b822505b; Lu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084703; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2; Malmo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054182; Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8; Murata J, 1996, CARBOHYD POLYM, V29, P69, DOI 10.1016/0144-8617(95)00144-1; Pei LJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40052; Pezzoli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034711; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Ragelle H, 2013, J CONTROL RELEASE, V172, P207, DOI 10.1016/j.jconrel.2013.08.005; Rajesh R, 2012, PROCESS BIOCHEM, V47, P1079, DOI 10.1016/j.procbio.2012.03.014; Ranieri G, 2008, IND ENG CHEM RES, V47, P638, DOI 10.1021/ie070632v; Sarkar K, 2013, CARBOHYD POLYM, V92, P2048, DOI 10.1016/j.carbpol.2012.11.067; Sezer AD, 2012, EXPERT OPIN DRUG DEL, V9, P1129, DOI 10.1517/17425247.2012.702752; Shi BY, 2013, POLYM CHEM-UK, V4, P840, DOI 10.1039/c2py20494k; Singh B, 2014, J NANOSCI NANOTECHNO, V14, P564, DOI 10.1166/jnn.2014.9079; Stefanescu C, 2012, CARBOHYD POLYM, V87, P435, DOI 10.1016/j.carbpol.2011.08.003; SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Tran CD, 2013, J BIOMED MATER RES A, V101, P2248, DOI 10.1002/jbm.a.34520; Tripathi SK, 2012, NANOMED-NANOTECHNOL, V8, P337, DOI 10.1016/j.nano.2011.06.022; Wang B, 2012, BIOTECHNOL LETT, V34, P19, DOI 10.1007/s10529-011-0748-8; Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597; Zhao H, 2006, TETRAHEDRON-ASYMMETR, V17, P377, DOI 10.1016/j.tetasy.2006.01.015	50	18	20	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121817	10.1371/journal.pone.0121817	http://dx.doi.org/10.1371/journal.pone.0121817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875475	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100048
J	Chen, LX; Li, YL; Ning, GZ; Li, Y; Wu, QL; Guo, JX; Shi, HY; Wang, XB; Zhou, Y; Feng, SQ				Chen, Ling-Xiao; Li, Yu-Lin; Ning, Guang-Zhi; Li, Yan; Wu, Qiu-Li; Guo, Jin-Xiu; Shi, Hong-Yu; Wang, Xiao-Bo; Zhou, Yong; Feng, Shi-Qing			Comparative Efficacy and Tolerability of Three Treatments in Old People with Osteoporotic Vertebral Compression Fracture: A Network Meta-Analysis and Systematic Review	PLOS ONE			English	Article							PERCUTANEOUS VERTEBROPLASTY; BALLOON KYPHOPLASTY; RANDOMIZED-TRIAL; PAIN RELIEF; FOLLOW-UP; SCHIZOPHRENIA; ANTIPSYCHOTICS; TECHNOLOGIES	Purpose The question which kind of methods is most suitable for treating the old people for osteoporotic vertebral compression fracture is still discussed and pairwise meta-analyses cannot get hierarchies of these treatments. Our aim is to integrate the evidence to provide hierarchies of the comparative efficacy measured by the change of VAS (Visual Analogue Scale) and tolerability measured by incidence of new fractures and risk of all-cause discontinuation on three treatments (percutaneous vertebroplasty (PVP). balloon kyphoplasty (BK) and conservative treatment(CT)). Methods We performed a Bayesian-framework network meta-analysis of randomized controlled trials (RCTs) to compare three treatments for the old people with osteoporotic vertebral compression fracture. The eligible RCTs were identified by searching Amed, British Nursing Index, Embase, Pubmed, the Cochrane Central Register of Controlled Trials (CENTRAL), Google scholar, SIGLE, the National Technical Information Service, the National Research Register (UK) and the Current Controlled Trials databases. Data from three outcomes (e.g. VAS, risk of all-cause discontinuation and incidence of new fractures) were independently extracted by two authors. Results A total of five RCTs were finally included into this article. PVP and BK significantly decreased VAS when compared with CT. BK had a significantly lower risk of all-cause discontinuation contrast to CT. Three treatments (BK, PVP and CT) had no significant differences in the incidence of new fractures. Conclusions PVP may be the best way to relieve pain, CT might lead to the lowest incidence of new fractures and BK might had the lowest risk of all-cause discontinuation in old people with osteoporotic vertebral compression fracture. More large-scale and longer duration of follow-up studies are needed.	[Chen, Ling-Xiao; Li, Yu-Lin; Ning, Guang-Zhi; Li, Yan; Wu, Qiu-Li; Guo, Jin-Xiu; Shi, Hong-Yu; Wang, Xiao-Bo; Zhou, Yong; Feng, Shi-Qing] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Heping, Peoples R China	Tianjin Medical University	Feng, SQ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthopaed, 154 Anshan Rd, Heping, Peoples R China.	fengsq321@gmail.com	Chen, Lingxiao/M-7806-2019	Chen, Lingxiao/0000-0001-7721-0493	Applied Basic Research Programs of Science and Technology Commission of Tianjin [13JCQNJC11100]; National Natural Science Funds of China [81201400, 81330042]; NSFC-RFBR [2014DFR31210]; Sino-australian cooperation projects [13RCGFSY19000]	Applied Basic Research Programs of Science and Technology Commission of Tianjin; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); NSFC-RFBR; Sino-australian cooperation projects	This work is sponsored by the Applied Basic Research Programs of Science and Technology Commission of Tianjin (Grant No. 13JCQNJC11100), National Natural Science Funds of China (Grant No. 81201400), National Natural Science Funds of China (Grant No. 81330042), NSFC-RFBR (Grant No. 2014DFR31210) and Sino-australian cooperation projects (Grant No. 13RCGFSY19000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVALUATION OF OUTCOM; [Anonymous], SAFETY AND EFFICACY; [Anonymous], VERTEBROPLASTY COMPA; [Anonymous], TRIAL VERTEBROPLASTY; Anselmetti GC, 2007, CARDIOVASC INTER RAD, V30, P441, DOI 10.1007/s00270-006-0146-0; Beasley CM, 2007, J CLIN PSYCHOPHARM, V27, P252, DOI 10.1097/JCP.0b013e3180582426; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Boonen S, 2011, J BONE MINER RES, V26, P1627, DOI 10.1002/jbmr.364; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Diamond TH, 2006, MED J AUSTRALIA, V184, P113, DOI 10.5694/j.1326-5377.2006.tb00148.x; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Folman Y, 2011, ISR MED ASSOC J, V13, P394; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Grohs JG, 2005, J SPINAL DISORD TECH, V18, P238; Higgins J., 2011, COCHRANE HDB SYST RE; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Kumar K, 2010, NEUROSURGERY, V67, P171, DOI 10.1227/01.NEU.0000380936.00143.11; Lamy O, 2014, OSTEOPOROSIS INT, V25, P807, DOI 10.1007/s00198-013-2574-4; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Liu JT, 2010, OSTEOPOROSIS INT, V21, P359, DOI 10.1007/s00198-009-0952-8; Liu JT, 2013, PAIN PHYSICIAN, V16, P455; Lovi A, 2009, EUR SPINE J, V18, pS95, DOI 10.1007/s00586-009-0986-9; Ma XL, 2012, EUR SPINE J, V21, P1844, DOI 10.1007/s00586-012-2441-6; Movrin I, 2010, ARCH ORTHOP TRAUM SU, V130, P1157, DOI 10.1007/s00402-010-1106-3; Rollinghoff M, 2009, MINIM INVAS NEUROSUR, V52, P233, DOI 10.1055/s-0029-1243631; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Rousing Rikke, 2009, Spine (Phila Pa 1976), V34, P1349, DOI 10.1097/BRS.0b013e3181a4e628; Santiago FR, 2010, EUR J RADIOL, V75, pE108, DOI 10.1016/j.ejrad.2010.01.010; Schofer MD, 2009, ARCH ORTHOP TRAUM SU, V129, P1391, DOI 10.1007/s00402-009-0901-1; Stevenson M, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18170; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Xing D, 2013, J CLIN NEUROSCI, V20, P795, DOI 10.1016/j.jocn.2012.05.038; Zhou JL, 2008, CHIN J TRAUMATOL, V11, P42, DOI 10.1016/S1008-1275(08)60009-7	43	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123153	10.1371/journal.pone.0123153	http://dx.doi.org/10.1371/journal.pone.0123153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874802	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100141
J	Li, XM; Zhong, L; Xue, FZ; Zhang, AG				Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo			A Priori Data-Driven Multi-Clustered Reservoir Generation Algorithm for Echo State Network	PLOS ONE			English	Article							PSEUDOPERIODIC TIME-SERIES; COMPLEX NETWORK; SPATIAL GROWTH; WORLD NETWORKS; BEHAVIOR; SYSTEMS; WINDOWS	Echo state networks (ESNs) with multi-clustered reservoir topology perform better in reservoir computing and robustness than those with random reservoir topology. However, these ESNs have a complex reservoir topology, which leads to difficulties in reservoir generation. This study focuses on the reservoir generation problem when ESN is used in environments with sufficient priori data available. Accordingly, a priori data-driven multi-cluster reservoir generation algorithm is proposed. The priori data in the proposed algorithm are used to evaluate reservoirs by calculating the precision and standard deviation of ESNs. The reservoirs are produced using the clustering method; only the reservoir with a better evaluation performance takes the place of a previous one. The final reservoir is obtained when its evaluation score reaches the preset requirement. The prediction experiment results obtained using the Mackey-Glass chaotic time series show that the proposed reservoir generation algorithm provides ESNs with extra prediction precision and increases the structure complexity of the network. Further experiments also reveal the appropriate values of the number of clusters and time window size to obtain optimal performance. The information entropy of the reservoir reaches the maximum when ESN gains the greatest precision.	[Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo] Chongqing Univ, Key Lab Dependable Serv Comp Cyber Phys Soc, Minist Educ, Chongqing 400044, Peoples R China; [Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo] Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China	Chongqing University; Chongqing University	Xue, FZ (corresponding author), Chongqing Univ, Key Lab Dependable Serv Comp Cyber Phys Soc, Minist Educ, Chongqing 400044, Peoples R China.	xuefangzheng@cqu.edu.cn	Li, Xiumin/ABA-5948-2020; Zhang, Anguo/K-3723-2019; Zhang, Anguo/AAF-4985-2019	Li, Xiumin/0000-0002-2398-4757; Zhang, Anguo/0000-0002-4825-7054	National Natural Science Foundation of China [61473051, 61304165]; Fundamental Research Funds for the Central Universities [CDJZR11170006, CDJZR12170008, CDJZR12170018]; Chongqing Natural Science Foundation [2011BB0081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work is supported by the National Natural Science Foundation of China (Nos. 61473051 and 61304165), the Fundamental Research Funds for the Central Universities (Nos. CDJZR11170006, CDJZR12170008 and CDJZR12170018) and Chongqing Natural Science Foundation (No. 2011BB0081).	Boccato L, 2014, NEUROCOMPUTING, V138, P297, DOI 10.1016/j.neucom.2014.01.036; Cui Hong-yan, 2013, Journal of China Universities of Posts and Telecommunications, V20, P59, DOI 10.1016/S1005-8885(13)60070-9; Deng ZD, 2007, IEEE T NEURAL NETWOR, V18, P1364, DOI 10.1109/TNN.2007.894082; Ding HY, 2005, IEEE INT WORKSH VLSI; Gallicchio C, 2013, NEUROCOMPUTING, V101, P319, DOI 10.1016/j.neucom.2012.08.017; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ihara S, 1993, INFORM THEORY CONTIN, V2; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2001, 148 GMD; Jaeger H., 2002, 159 GMD; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Kaiser M, 2007, NEUROCOMPUTING, V70, P1829, DOI 10.1016/j.neucom.2006.10.060; Li DC, 2012, IEEE T NEUR NET LEAR, V23, P787, DOI 10.1109/TNNLS.2012.2188414; Ma QL, 2013, NEUROCOMPUTING, V122, P406, DOI 10.1016/j.neucom.2013.06.012; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Skowronski MD, 2007, NEURAL NETWORKS, V20, P414, DOI 10.1016/j.neunet.2007.04.006; Song QS, 2010, NEUROCOMPUTING, V73, P2177, DOI 10.1016/j.neucom.2010.01.015; Venayagamoorthy GK, 2009, NEURAL NETWORKS, V22, P861, DOI 10.1016/j.neunet.2009.03.021; Wiener N, 1965, 2 EDITION CONTROL CO; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008	27	7	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120750	10.1371/journal.pone.0120750	http://dx.doi.org/10.1371/journal.pone.0120750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875296	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100026
J	Ren, J; Huang, SC; Zhang, JC; Zhu, Q; Wilson, AD; Snapp-Childs, W; Bingham, GP				Ren, Jie; Huang, Shaochen; Zhang, Jiancheng; Zhu, Qin; Wilson, Andrew D.; Snapp-Childs, Winona; Bingham, Geoffrey P.			The 50s Cliff: A Decline in Perceptuo-Motor Learning, Not a Deficit in Visual Motion Perception	PLOS ONE			English	Article							RHYTHMIC MOVEMENT COORDINATION; PHASE-TRANSITIONS; 3-D SHAPE; AGE; STABILITY; FEEDBACK; SYSTEM; SPEED; DEPTH	Previously, we measured perceptuo-motor learning rates across the lifespan and found a sudden drop in learning rates between ages 50 and 60, called the "50s cliff." The task was a unimanual visual rhythmic coordination task in which participants used a joystick to oscillate one dot in a display in coordination with another dot oscillated by a computer. Participants learned to produce a coordination with a 90 degrees relative phase relation between the dots. Learning rates for participants over 60 were half those of younger participants. Given existing evidence for visual motion perception deficits in people over 60 and the role of visual motion perception in the coordination task, it remained unclear whether the 50s cliff reflected onset of this deficit or a genuine decline in perceptuo-motor learning. The current work addressed this question. Two groups of 12 participants in each of four age ranges (20s, 50s, 60s, 70s) learned to perform a bimanual coordination of 90 degrees relative phase. One group trained with only haptic information and the other group with both haptic and visual information about relative phase. Both groups were tested in both information conditions at baseline and post-test. If the 50s cliff was caused by an age dependent deficit in visual motion perception, then older participants in the visual group should have exhibited less learning than those in the haptic group, which should not exhibit the 50s cliff, and older participants in both groups should have performed less well when tested with visual information. Neither of these expectations was confirmed by the results, so we concluded that the 50s cliff reflects a genuine decline in perceptuo-motor learning with aging, not the onset of a deficit in visual motion perception.	[Ren, Jie; Huang, Shaochen; Zhang, Jiancheng; Zhu, Qin; Bingham, Geoffrey P.] Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China; [Zhu, Qin] Univ Wyoming, Kinesiol & Hlth, Laramie, WY 82071 USA; [Wilson, Andrew D.] Leeds Metropolitan Univ, Social Psychol & Commun Sci, Leeds LS1 3HE, W Yorkshire, England; [Snapp-Childs, Winona; Bingham, Geoffrey P.] Indiana Univ, Psychol & Brain Sci, Bloomington, IN USA	Shanghai University of Sport; University of Wyoming; Leeds Beckett University; Indiana University System; Indiana University Bloomington	Bingham, GP (corresponding author), Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China.	gbingham@indiana.edu	; Zhu, Qin "Arthur"/C-8732-2009; Wilson, Andrew/A-7891-2008	Snapp-Childs, Winona/0000-0003-4354-7092; Zhu, Qin "Arthur"/0000-0002-2088-6043; Wilson, Andrew/0000-0002-0459-0728	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	This study was supported by the First-class Disciplines of Shanghai Colleges and Universities (Psychology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Andersen GJ, 2012, WIRES COGN SCI, V3, P403, DOI 10.1002/wcs.1167; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; Bingham GP, 2004, THEORIES TIME TO CON; Coats RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085758; Coats RO, 2013, EXP BRAIN RES, V225, P75, DOI 10.1007/s00221-012-3349-4; Ghisletta P, 2010, J GERONTOL B-PSYCHOL, V65, P163, DOI 10.1093/geronb/gbp126; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kelso S., 1995, DYNAMIC PATTERNS SEL; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Norman JF, 2004, PSYCHOL AGING, V19, P506, DOI 10.1037/0882-7974.19.3.506; Norman JF, 2003, PERCEPTION, V32, P85, DOI 10.1068/p3478; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; Panzer S, 2011, HUM MOVEMENT SCI, V30, P459, DOI 10.1016/j.humov.2010.11.003; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Serrien DJ, 2000, J GERONTOL B-PSYCHOL, V55, pP295, DOI 10.1093/geronb/55.5.P295; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; Stratford, 2001, PHYSIOTHER CAN, V53, P259; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2003, J EXP PSYCHOL HUMAN, V29, P1179, DOI 10.1037/0096-1523.29.6.1179; Wilson AD, 2011, BEHAV RES METHODS, V43, P210, DOI 10.3758/s13428-010-0034-z; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wishart LR, 2002, ACTA PSYCHOL, V110, P247, DOI 10.1016/S0001-6918(02)00036-7; Zaal FTJM, 2000, J EXP PSYCHOL HUMAN, V26, P1209, DOI 10.1037//0096-1523.26.3.1209; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	35	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121708	10.1371/journal.pone.0121708	http://dx.doi.org/10.1371/journal.pone.0121708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874880	Green Published, gold			2022-12-27	WOS:000352845100046
J	Kapheim, KM; Rao, VD; Yeoman, CJ; Wilson, BA; White, BA; Goldenfeld, N; Robinson, GE				Kapheim, Karen M.; Rao, Vikyath D.; Yeoman, Carl J.; Wilson, Brenda A.; White, Bryan A.; Goldenfeld, Nigel; Robinson, Gene E.			Caste-Specific Differences in Hindgut Microbial Communities of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOTA; POLLEN CONSUMPTION; ANIMAL BEHAVIOR; DIVERSITY; BACTERIA; CHIMPANZEES; DIGESTION; CARNICA; SEARCH	Host-symbiont dynamics are known to influence host phenotype, but their role in social behavior has yet to be investigated. Variation in life history across honey bee (Apis mellifera) castes may influence community composition of gut symbionts, which may in turn influence caste phenotypes. We investigated the relationship between host-symbiont dynamics and social behavior by characterizing the hindgut microbiome among distinct honey bee castes: queens, males and two types of workers, nurses and foragers. Despite a shared hive environment and mouth-to-mouth food transfer among nestmates, we detected separation among gut microbiomes of queens, workers, and males. Gut microbiomes of nurses and foragers were similar to previously characterized honey bee worker microbiomes and to each other, despite differences in diet, activity, and exposure to the external environment. Queen microbiomes were enriched for bacteria that may enhance metabolic conversion of energy from food to egg production. We propose that the two types of workers, which have the highest diversity of operational taxonomic units (OTUs) of bacteria, are central to the maintenance of the colony microbiome. Foragers may introduce new strains of bacteria to the colony from the environment and transfer them to nurses, who filter and distribute them to the rest of the colony. Our results support the idea that host-symbiont dynamics influence microbiome composition and, reciprocally, host social behavior.	[Kapheim, Karen M.; Rao, Vikyath D.; Yeoman, Carl J.; Wilson, Brenda A.; White, Bryan A.; Goldenfeld, Nigel; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kapheim, Karen M.; Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Kapheim, Karen M.] Utah State Univ, Dept Biol, Logan, UT 84341 USA; [Rao, Vikyath D.; Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; Utah State University; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kapheim, KM (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	karen.kapheim@usu.edu	Yeoman, Carl/ABA-1906-2021; Kapheim, Karen Marie/AAA-6124-2019	Yeoman, Carl/0000-0002-8775-7879; Kapheim, Karen Marie/0000-0002-8140-7712	NIH [1DP1OD006416]; UIUC Institute for Genomic Biology Post-doctoral Fellowship; UIUC Sociogenomics Initiative Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006416] Funding Source: NIH RePORTER; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UIUC Institute for Genomic Biology Post-doctoral Fellowship; UIUC Sociogenomics Initiative Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	NIH Director's Pioneer Award (http://commonfund.nih.gov/pioneer/index) #1DP1OD006416 to GER, UIUC Institute for Genomic Biology Post-doctoral Fellowship to CJY (http://www.igb.illinois.edu/content/postdoctoral-fellowships-genomic-biology), and UIUC Sociogenomics Initiative Award to VDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Anderson MJ, 2008, PERMANOVA PRIMER GUI; [Anonymous], 1971, INSECT SOC; Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Dillon RJ, 2010, ANTON LEEUW INT J G, V97, P69, DOI 10.1007/s10482-009-9389-5; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2013, GUT MICROBES, V4, P60, DOI 10.4161/gmic.22517; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; Moeller AH, 2013, GENOME RES, V23, P1715, DOI 10.1101/gr.154773.113; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; NIXON HL, 1952, PROC R SOC SER B-BIO, V140, P43, DOI 10.1098/rspb.1952.0042; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Schachtschneider KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053969; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; SZOLDERITS MJ, 1993, J INSECT PHYSIOL, V39, P877, DOI 10.1016/0022-1910(93)90120-G; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Winston M., 1987, The biology of the honey bee.; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86	60	64	72	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123911	10.1371/journal.pone.0123911	http://dx.doi.org/10.1371/journal.pone.0123911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874551	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800123
J	Nikolopoulos, GK; Fotiou, A; Kanavou, E; Richardson, C; Detsis, M; Pharris, A; Suk, JE; Semenza, JC; Costa-Storti, C; Paraskevis, D; Sypsa, V; Malliori, MM; Friedman, SR; Hatzakis, A				Nikolopoulos, Georgios K.; Fotiou, Anastasios; Kanavou, Eleftheria; Richardson, Clive; Detsis, Marios; Pharris, Anastasia; Suk, Jonathan E.; Semenza, Jan C.; Costa-Storti, Claudia; Paraskevis, Dimitrios; Sypsa, Vana; Malliori, Melpomeni-Minerva; Friedman, Samuel R.; Hatzakis, Angelos			National Income Inequality and Declining GDP Growth Rates Are Associated with Increases in HIV Diagnoses among People Who Inject Drugs in Europe: A Panel Data Analysis	PLOS ONE			English	Article							POPULATION HEALTH; POVERTY	Background There is sparse evidence that demonstrates the association between macro-environmental processes and drug-related HIV epidemics. The present study explores the relationship between economic, socio-economic, policy and structural indicators, and increases in reported HIV infections among people who inject drugs (PWID) in the European Economic Area (EEA). Methods We used panel data (2003-2012) for 30 EEA countries. Statistical analyses included logistic regression models. The dependent variable was taking value 1 if there was an outbreak (significant increase in the national rate of HIV diagnoses in PWID) and 0 otherwise. Explanatory variables included the growth rate of Gross Domestic Product (GDP), the share of the population that is at risk for poverty, the unemployment rate, the Eurostat S80/S20 ratio, the Gini coefficient, the per capita government expenditure on health and social protection, and variables on drug control policy and drug-using population sizes. Lags of one to three years were investigated. Findings In multivariable analyses, using two-year lagged values, we found that a 1% increase of GDP was associated with approximately 30% reduction in the odds of an HIV outbreak. In GDP-adjusted analyses with three-year lagged values, the effect of the national income inequality on the likelihood of an HIV outbreak was significant [ S80/S20 Odds Ratio (OR) = 3.89; 95% Confidence Interval (CI): 1.15 to 13.13]. Generally, the multivariable analyses produced similar results across three time lags tested. Interpretation Given the limitations of ecological research, we found that declining economic growth and increasing national income inequality were associated with an elevated probability of a large increase in the number of HIV diagnoses among PWID in EEA countries during the last decade. HIV prevention may be more effective if developed within national and European-level policy contexts that promote income equality, especially among vulnerable groups.	[Nikolopoulos, Georgios K.; Detsis, Marios; Paraskevis, Dimitrios; Sypsa, Vana; Hatzakis, Angelos] Athens Univ Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Nikolopoulos, Georgios K.] Hellen Ctr Dis Control & Prevent, Amarousio, Greece; [Fotiou, Anastasios; Kanavou, Eleftheria; Richardson, Clive] Univ Mental Hlth Res Inst, Greek Reitox Focal Point EMCDDA, Athens, Greece; [Fotiou, Anastasios; Malliori, Melpomeni-Minerva] Athens Univ Med Sch, Dept Psychiat, Athens, Greece; [Richardson, Clive] Pante Univ Social & Polit Sci, Athens, Greece; [Pharris, Anastasia; Suk, Jonathan E.; Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden; [Costa-Storti, Claudia] EMCDDA, Lisbon, Portugal; [Friedman, Samuel R.] Natl Dev & Res Inst, New York, NY USA	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Panteion University; European Centre for Disease Prevention & Control; National Development & Research Institutes, Inc	Nikolopoulos, GK (corresponding author), Athens Univ Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece.	gknikolopoulos@gmail.com	Suk, Jonathan/L-2300-2017; Nikolopoulos, Georgios/H-5698-2011; Paraskevis, Dimitrios/H-5835-2019; Fotiou, Anastasios/X-2091-2019	Suk, Jonathan/0000-0003-4689-4583; Nikolopoulos, Georgios/0000-0002-3307-0246; Paraskevis, Dimitrios/0000-0001-6167-7152; Fotiou, Anastasios/0000-0001-7905-3241; Detsis, Marios/0000-0003-1907-845X; Friedman, Sam/0000-0003-2083-1226; SYPSA, VANA/0000-0002-9430-7614	European Centre for Disease Prevention and Control (ECDC) [ECD.4167]; Hellenic Scientific Society [ECD.4167]; International AIDS Society; US National Institute on Drug Abuse; National Institute on Drug Abuse (NIDA) (Center for Drug Use and HIV Research) [P30 DA11041]; National Institute on Drug Abuse (NIDA) (Preventing HIV Transmission by Recently-Infected Drug Users) [DP1 DA034989];  [T32 DA007233]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, T32DA007233, DP1DA034989] Funding Source: NIH RePORTER	European Centre for Disease Prevention and Control (ECDC); Hellenic Scientific Society; International AIDS Society; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Drug Abuse (NIDA) (Center for Drug Use and HIV Research); National Institute on Drug Abuse (NIDA) (Preventing HIV Transmission by Recently-Infected Drug Users); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was undertaken under service contract ECD.4167 with funding provided by the European Centre for Disease Prevention and Control (ECDC). AF, EK and CR report personal fees from the Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases related to the ECDC grant ECD.4167. GKN and SF also declare that: (1) the International AIDS Society and the US National Institute on Drug Abuse have supported the post-doc fellowship of GKN; (2) SF and GKN are involved in the Transmission Reduction Intervention Project (TRIP) and they acknowledge support from National Institute on Drug Abuse (NIDA) (grants P30 DA11041-Center for Drug Use and HIV Research, DP1 DA034989-Preventing HIV Transmission by Recently-Infected Drug Users, and T32 DA007233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; Bonovas S, 2012, J Prev Med Hyg, V53, P169; Botescu A, 2012, HIV AIDS INJECTING D; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; European Centre for Disease Prevention and Control, 2011, PEOPL WHO INJ DRUGS; European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; European Monitoring Centre for Drugs and Drug Addiction, 2013, EUR DRUG REP 2013 TR; Fotiou A., 2012, HIV OUTBREAK INJECTI; Friedman SR, 2014, ANN EPIDEMIOL, V24, P304, DOI 10.1016/j.annepidem.2014.01.008; Friedman SR, 2009, INT J DRUG POLICY, V20, P283, DOI 10.1016/j.drugpo.2008.10.006; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, 2000 GLOB RES NETW M, P147; Holmqvist G., 2009, WORKING PAPER; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Lin CC, 2003, ETHNIC DIS, V13, P240; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Paraskevis D, 2011, EUROSURVEILLANCE, V16, P2; Paraskevis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078941; Pharris A, 2011, EURO SURVEILL, V16; Pickett KE, 2010, BRIT J PSYCHIAT, V197, P426, DOI 10.1192/bjp.bp.109.072066; Platt L., 2013, HIV EPIDEMICS EUROPE; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, VII; Ram R, 2005, SOC SCI MED, V61, P2568, DOI 10.1016/j.socscimed.2005.04.038; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916; Sypsa V, 2015, AM J PUBLIC HEALTH, V105, P196, DOI 10.2105/AJPH.2013.301656; Tsafack-Temah C, 2008, THESIS U AUVERGNE CL; Wiessing L, 2011, EURO SURVEILL, V16	33	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122367	10.1371/journal.pone.0122367	http://dx.doi.org/10.1371/journal.pone.0122367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875598	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800054
J	Pan, H; Chen, J; Shen, KZ; Wang, XP; Wang, P; Fu, GH; Meng, HZ; Wang, YM; Jin, BY				Pan, Hao; Chen, Jun; Shen, Kezhen; Wang, Xueping; Wang, Ping; Fu, Guanghou; Meng, Hongzhou; Wang, Yimin; Jin, Baiye			Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury through Decreasing Oxidative/Nitrative Stress, Inflammation and NF-kB in Mice	PLOS ONE			English	Article							GREEN TEA CATECHINS; RAT-KIDNEY MITOCHONDRIA; REDOX STATE UNBALANCE; INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; CANCER CHEMOPREVENTION; SUPEROXIDE-PRODUCTION; ENERGETIC METABOLISM; CELL-PROLIFERATION; PROSTATE-CANCER	Cancer chemotherapy drug cisplatin is known for its nephrotoxicity. The aim of this study is to investigate whether Epigallocatechin 3-Gallate (EGCG) can reduce cisplatin mediated side effect in kidney and to understand its mechanism of protection against tissue injury. We used a well-established 3-day cisplatin induced nephrotoxicity mice model where EGCG were administered. EGCG is a major active compound in Green Tea and have strong anti-oxidant and anti-inflammatory properties. EGCG protected against cisplatin induced renal dysfunction as measured by serum creatinine and blood urea nitrogen (BUN). EGCG improved cisplatin induced kidney structural damages such as tubular dilatation, cast formation, granulovaculoar degeneration and tubular cell necrosis as evident by PAS staining. Cisplatin induced kidney specific mitochondrial oxidative stress, impaired activities of mitochondrial electron transport chain enzyme complexes, impaired anti-oxidant defense enzyme activities such as glutathione peroxidase (GPX) and manganese superoxide dismutase (MnSOD) in mitochondria, inflammation (tumor necrosis factor a and interleukin 1 beta), increased accumulation of NF-kappa B in nuclear fraction, p53 induction, and apoptotic cell death (caspase 3 activity and DNA fragmentation). Treatment of mice with EGCG markedly attenuated cisplatin induced mitochondrial oxidative/nitrative stress, mitochondrial damages to electron transport chain activities and antioxidant defense enzyme activities in mitochondria. These mitochondrial modulations by EGCG led to protection mechanism against cisplatin induced inflammation and apoptotic cell death in mice kidney. As a result, EGCG improved renal function in cisplatin mediated kidney damage. In addition to that, EGCG attenuated cisplatin induced apoptotic cell death and mitochondrial reactive oxygen species (ROS) generation in human kidney tubular cell line HK-2. Thus, our data suggest that EGCG may represent new promising adjunct candidate for cisplatin.	[Pan, Hao; Chen, Jun; Wang, Xueping; Wang, Ping; Fu, Guanghou; Meng, Hongzhou; Wang, Yimin; Jin, Baiye] Zhejiang Univ, Coll Med, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun] First Peoples Hosp Wenling City, Dept Urol, Wenling, Zhejiang, Peoples R China; [Shen, Kezhen] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Jin, BY (corresponding author), Zhejiang Univ, Coll Med, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	jinbaiye1964@aliyun.com		Pan, Hao/0000-0001-9925-0752	National Natural Science Foundation of China [81000302]; Science and Technology Department of Zhejiang Province [2013C37053, 2014C33200]; Natural Science Foundation of Zhejiang Province [LY14H050001]; Zhejiang medical and health science and technology plan project [201461868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang medical and health science and technology plan project	This work was supported by grants from National Natural Science Foundation of China (no. 81000302), Science and Technology Department of Zhejiang Province (no. 2013C37053, 2014C33200), Natural Science Foundation of Zhejiang Province (no. LY14H050001), Zhejiang medical and health science and technology plan project (201461868). The funding agency has no role in study design or conclusion.	Ahn WS, 2003, DNA CELL BIOL, V22, P217, DOI 10.1089/104454903321655846; Al-Majed AA, 2003, J BIOCHEM MOL TOXIC, V17, P146, DOI 10.1002/jbt.10072; Albrecht DS, 2008, CHEM-BIOL INTERACT, V171, P89, DOI 10.1016/j.cbi.2007.09.001; Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Braicu C, 2013, J NANOSCI NANOTECHNO, V13, P632, DOI 10.1166/jnn.2013.6882; Cavet ME, 2011, MOL VIS, V17, P533; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Connors SK, 2012, NUTR CANCER, V64, P4, DOI 10.1080/01635581.2012.630158; DAUGAARD G, 1987, INT J ANDROL, V10, P347, DOI 10.1111/j.1365-2605.1987.tb00201.x; DAUGAARD G, 1989, CANCER CHEMOTH PHARM, V25, P1, DOI 10.1007/BF00694330; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Guerrero-Beltran CE, 2010, TOXICOL LETT, V199, P80, DOI 10.1016/j.toxlet.2010.08.009; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Jung SH, 2014, MOL CELLS, V37, P234, DOI 10.14348/molcells.2014.2322; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Kursunluoglu G, 2014, CELL BIOCH BIOPHYS; Lambert JD, 2006, DRUG METAB DISPOS, V34, P8, DOI 10.1124/dmd.104.003434; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Meng QY, 2008, FREE RADICAL BIO MED, V44, P1032, DOI 10.1016/j.freeradbiomed.2007.11.023; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nasri H, 2014, J RENAL INJ PREV, V3, P47, DOI 10.12861/jrip.2014.16; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086057; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Santos NAG, 2008, CANCER CHEMOTH PHARM, V61, P145, DOI 10.1007/s00280-007-0459-y; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Shimizu M, 2011, MOL NUTR FOOD RES, V55, P832, DOI 10.1002/mnfr.201000622; Shirakami Y, 2012, CURR DRUG TARGETS, V13, P1842, DOI 10.2174/138945012804545506; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Wang Y, 2015, BASIC CLIN PHARM TOX; Waseem M, 2013, CELL BIOCHEM FUNCT, V31, P678, DOI 10.1002/cbf.2955; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zhong Y, 2012, FOOD CHEM, V134, P742, DOI 10.1016/j.foodchem.2012.02.172; Zhou H, 2004, TOXICOL APPL PHARM, V200, P111, DOI 10.1016/j.taap.2004.04.003; Zhou P, 2013, MOL MED REP, V7, P1096, DOI 10.3892/mmr.2013.1296; Zou PM, 2014, INT J CLIN EXP PATHO, V7, P4607	64	62	63	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124775	10.1371/journal.pone.0124775	http://dx.doi.org/10.1371/journal.pone.0124775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875356	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800152
J	Jardine, CB; Bond, AL; Davidson, PJA; Butler, RW; Kuwae, T				Jardine, Catherine B.; Bond, Alexander L.; Davidson, Peter J. A.; Butler, Robert W.; Kuwae, Tomohiro			Biofilm Consumption and Variable Diet Composition of Western Sandpipers (Calidris mauri) during Migratory Stopover	PLOS ONE			English	Article							FRASER-RIVER ESTUARY; SEMIPALMATED SANDPIPERS; BILL LENGTH; DIFFERENTIAL MIGRATION; INTERTIDAL MUDFLAT; LATITUDINAL CLINES; DISTANCE MEASURES; BRITISH-COLUMBIA; SITE SELECTION; PREY ABUNDANCE	Many shorebird species undertake long-distance migrations punctuated by brief stays at food-rich, estuarine stopover locations. Understanding use of these food resources helps guide conservation and responsible development decisions. We determined the extent and degree to which Western Sandpiper (Calidris mauri) utilized biofilm as a food resource across a large and variable stopover location during northward (spring) migration. We investigated the spatial heterogeneity in diet composition, to determine whether shorebirds were consistently feeding on biofilm or whether diet varied between naturally and anthropogenically delineated sites. We used stable isotope analysis to estimate that biofilm conservatively comprised 22% to 53% of Western Sandpiper droppings across all sampling sites and that prey composition differed significantly between areas within the stopover location. Widespread biofilm consumption demonstrates the importance of biofilm as a dietary component. Variable diet composition suggests that habitat heterogeneity may be an important component of high quality stopover locations in the context of "state-dependant trade-offs" of Western Sandpiper population sub-groups. Future management decisions must consider and address potential impacts on the biofilm community throughout a stopover location, as single site studies of diet composition may not be adequate to develop effective management strategies for entire stopover sites.	[Jardine, Catherine B.; Davidson, Peter J. A.; Butler, Robert W.] Pacific Wildlife Res Ctr, Bird Studies Canada, Delta, BC, Canada; [Bond, Alexander L.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Kuwae, Tomohiro] Port & Airport Res Inst, Coastal & Estuarine Environm Res Grp, Yokosuka, Kanagawa, Japan	Environment & Climate Change Canada; Canadian Wildlife Service; Pacific Wildlife Research Centre; University of Saskatchewan; Port & Airport Research Institute	Jardine, CB (corresponding author), Pacific Wildlife Res Ctr, Bird Studies Canada, Delta, BC, Canada.	cjardine@bsc-eoc.org		Bond, Alexander/0000-0003-2125-7238	Vancouver Airport Fuel Facilities Corporation	Vancouver Airport Fuel Facilities Corporation	Bird Studies Canada was commissioned to conduct this work by Coastal and Ocean Resources Inc., as part of a wider study of biofilm in the Fraser Estuary funded by Vancouver Airport Fuel Facilities Corporation, which contributed to the environmental review process for the facility development proposal. The funders provided direction on the research question that was pursued but did not participate in study design, data collection and analysis, or preparation of the manuscript. The funders have granted permission for the results of the study to be submitted for publication.	Beninger PG, 2011, MAR ECOL PROG SER, V428, P259, DOI 10.3354/meps09050; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bond AL, 2012, J ORNITHOL, V153, P115, DOI 10.1007/s10336-011-0704-3; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Boundary Bay Wildlife Management Area, 2014, BOUND BAY WILDL MAN; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Butler RW, 2002, WILSON BULL, V114, P485, DOI 10.1676/0043-5643(2002)114[0485:SFALMO]2.0.CO;2; Butler RW, 1994, 83 CAN WILDL SERV; CARTAR RV, 1984, WILSON BULL, V96, P277; Catry T, 2009, MAR ECOL PROG SER, V374, P259, DOI 10.3354/meps07713; Characklis W. G., 1990, BIOFILMS; Clark CW, 1999, EVOL ECOL RES, V1, P443; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; de Brouwer JFC, 2001, MAR ECOL PROG SER, V218, P33, DOI 10.3354/meps218033; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Delany S, 2006, WATERBIRD POPULATION; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Drever MC, 2014, J FIELD ORNITHOL, V85, P10, DOI 10.1111/jofo.12045; Elner Robert W., 2003, Wader Study Group Bulletin, V100, P30; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Fernandez G, 2012, J FIELD ORNITHOL, V83, P272, DOI 10.1111/j.1557-9263.2012.00375.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Guglielmo CG, 2003, PHYSIOL BIOCHEM ZOOL, V76, P84, DOI 10.1086/367942; Herlory O, 2004, MAR ECOL PROG SER, V282, P33, DOI 10.3354/meps282033; HICKLIN PW, 1984, CAN J ZOOL, V62, P2201, DOI 10.1139/z84-321; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hoskins DL, 2003, MAR ECOL PROG SER, V247, P93, DOI 10.3354/meps247093; Iverson GC, 1996, CONDOR, V98, P10, DOI 10.2307/1369502; Jimenez Reyes A., 2013, THESIS S FRASER U; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Kuwae T, 2010, MAR ECOL PROG SER, V406, P281, DOI 10.3354/meps08519; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; Mathot KJ, 2007, ECOLOGY, V88, P781, DOI 10.1890/06-1225; Mathot KJ, 2010, WATERBIRDS, V33, P300, DOI 10.1675/063.033.0305; Mathot KJ, 2004, CAN J ZOOL, V82, P1035, DOI 10.1139/Z04-080; Mehlman DW, 2005, AUK, V122, P1281, DOI 10.1642/0004-8038(2005)122[1281:CSSFFM]2.0.CO;2; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; Myers J.P., 1987, American Scientist, V75, P18; Nebel S, 2005, ACTA OECOL, V28, P33, DOI 10.1016/j.actao.2005.02.002; Nebel S, 2002, AUK, V119, P922, DOI 10.1642/0004-8038(2002)119[0922:WSCMDT]2.0.CO;2; Nebel Silke, 2003, Wader Study Group Bulletin, V100, P118; O'Hara PD, 2006, CONDOR, V108, P225, DOI 10.1650/0010-5422(2006)108[0225:DMIWSW]2.0.CO;2; O'Hara PD, 2005, J AVIAN BIOL, V36, P191, DOI 10.1111/j.0908-8857.2005.03368.x; OREILLY KM, 1995, AM ZOOL, V35, P222; PAGE G, 1971, BIRD BANDING, V42, P297, DOI 10.2307/4511799; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Placyk JS, 2004, J FIELD ORNITHOL, V75, P223, DOI 10.1648/0273-8570-75.3.223; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2008, AVIAN CONSERV ECOL, V3; Quinn JT, 2012, CAN J ZOOL, V90, P1181, DOI 10.1139/Z2012-086; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauber TW, 2008, PATTERN RECOGN, V41, P637, DOI 10.1016/j.patcog.2007.06.023; Roberts Bank Wildlife Management Area, 2014, ROB BANK WILDL MAN A; Seaman DAA, 2006, AUK, V123, P563, DOI 10.1642/0004-8038(2006)123[563:LPSDIR]2.0.CO;2; Sewell MA, 1996, MAR ECOL PROG SER, V144, P23, DOI 10.3354/meps144023; Skagen SK, 1996, CAN FIELD NAT, V110, P419; Stein RW, 2008, CAN J ZOOL, V86, P601, DOI 10.1139/Z08-033; Stein RW, 2006, FUNCT ECOL, V20, P142, DOI 10.1111/j.1365-2435.2006.01065.x; Stein RW, 2005, PHYSIOL BIOCHEM ZOOL, V78, P434, DOI 10.1086/430038; Sturgeon Bank Wildlife Management Area, 2014, STURG BANK WILDL MAN; Sutherland TF, 2000, MAR BIOL, V137, P983, DOI 10.1007/s002270000406; Taylor IS, 1999, BIOGEOCHEMISTRY, V45, P303, DOI 10.1023/A:1026433702118; Underwood GJC, 2005, LIMNOL OCEANOGR, V50, P755, DOI 10.4319/lo.2005.50.3.0755; Warnock N, 1998, CONDOR, V100, P456, DOI 10.2307/1369711; Warnock N. D., 1996, BIRDS N AM ONLINE; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Ydenberg RC, 2002, J AVIAN BIOL, V33, P47, DOI 10.1034/j.1600-048X.2002.330108.x	71	23	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124164	10.1371/journal.pone.0124164	http://dx.doi.org/10.1371/journal.pone.0124164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875528	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700057
J	Mattenberger, Y; Silva, F; Belin, D				Mattenberger, Yves; Silva, Filo; Belin, Dominique			55.2, a Phage T4 ORFan Gene, Encodes an Inhibitor of Escherichia coli Topoisomerase I and Increases Phage Fitness	PLOS ONE			English	Article							R-LOOP FORMATION; DNA TOPOISOMERASES; BACTERIOPHAGE-T4 DNA; TN5 TRANSPOSASE; REPLICATION; BACTERIAL; MUTANTS; GYRASE; ROLES; PROTEIN	Topoisomerases are enzymes that alter the topological properties of DNA. Phage T4 encodes its own topoisomerase but it can also utilize host-encoded topoisomerases. Here we characterized 55.2, a phage T4 predicted ORF of unknown function. High levels of expression of the cloned 55.2 gene are toxic in E. coli. This toxicity is suppressed either by increased topoisomerase I expression or by partial inactivation of the ATPase subunit of the DNA gyrase. Interestingly, very low-level expression of 55.2, which is non-lethal to wild type E. coli, prevents the growth of a deletion mutant of the topoisomerase I (topA) gene. In vitro, gp55.2 binds DNA and blocks specifically the relaxation of negatively supercoiled DNA by topoisomerase I. In vivo, expression of gp55.2 at low non-toxic levels alters the steady state DNA supercoiling of a reporter plasmid. Although 55.2 is not an essential gene, competition experiments indicate that it is required for optimal phage growth. We propose that the role of gp55.2 is to subtly modulate host topoisomerase I activity during infection to insure optimal T4 phage yield.	[Mattenberger, Yves; Silva, Filo; Belin, Dominique] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	University of Geneva	Mattenberger, Y (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	yves.mattenberger@unige.ch		Mattenberger, Yves/0000-0002-1651-7691	Fondation Schmidheiny DB Geneva Department of Education	Fondation Schmidheiny DB Geneva Department of Education	Fondation Schmidheiny DB Geneva Department of Education The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ang D, 2012, GENETICS, V190, P989, DOI 10.1534/genetics.111.135640; ARMSTRONG KA, 1984, J MOL BIOL, V175, P331, DOI 10.1016/0022-2836(84)90352-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bieler S, 2006, J BACTERIOL, V188, P7049, DOI 10.1128/JB.00688-06; Bost S, 1999, J BACTERIOL, V181, P2185, DOI 10.1128/JB.181.7.2185-2191.1999; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHURCHWARD G, 1983, NUCLEIC ACIDS RES, V11, P5645, DOI 10.1093/nar/11.16.5645; Clark DJ, 2009, METHODS MOL BIOL, V543, P523, DOI 10.1007/978-1-60327-015-1_30; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Comeau AM, 2008, RES MICROBIOL, V159, P306, DOI 10.1016/j.resmic.2008.05.001; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; DINARDO S, 1982, CELL, V31, P43, DOI 10.1016/0092-8674(82)90403-2; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; DRLICA K, 1978, J MOL BIOL, V120, P145, DOI 10.1016/0022-2836(78)90061-X; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; Epstein RH, 2012, GENETICS, V190, P833, DOI 10.1534/genetics.112.138438; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Ghosh S, 2014, NUCLEIC ACIDS RES, V42, P11156, DOI 10.1093/nar/gku804; Gormley NA, 1996, BIOCHEMISTRY-US, V35, P5083, DOI 10.1021/bi952888n; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hardy CD, 2003, ANTIMICROB AGENTS CH, V47, P941, DOI 10.1128/AAC.47.3.941-947.2003; Higgins N. Patrick, 2005, P133; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Jeong KS, 2006, PLOS GENET, V2, P1464, DOI 10.1371/journal.pgen.0020152; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Kreuzer KN, 1998, BBA-GENE STRUCT EXPR, V1400, P339, DOI 10.1016/S0167-4781(98)00145-6; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; Luke K, 2002, VIROLOGY, V299, P182, DOI 10.1006/viro.2002.1409; Masse E, 1999, J BIOL CHEM, V274, P16654, DOI 10.1074/jbc.274.23.16654; Mattenberger Y, 2011, MOL MICROBIOL, V82, P1406, DOI 10.1111/j.1365-2958.2011.07897.x; MCCARTHY D, 1976, J MOL BIOL, V106, P963, DOI 10.1016/0022-2836(76)90346-6; MCCARTHY D, 1979, J MOL BIOL, V127, P265, DOI 10.1016/0022-2836(79)90329-2; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mosig G, 2001, P NATL ACAD SCI USA, V98, P8306, DOI 10.1073/pnas.131007398; Mosig G, 1983, MECHANISMS DNA REPLI, P173; Mosig Gisela, 1994, P54; MUFTI S, 1974, J VIROL, V14, P860, DOI 10.1128/JVI.14.4.860-871.1974; Otsuka Y, 2012, MOL MICROBIOL, V83, P669, DOI 10.1111/j.1365-2958.2012.07975.x; Perez-Cheeks BA, 2012, MOL MICROBIOL, V86, P1007, DOI 10.1111/mmi.12039; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; PRUSS GJ, 1982, CELL, V31, P35, DOI 10.1016/0092-8674(82)90402-0; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; SELICK HE, 1988, J BIOL CHEM, V263, P11336; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0; SHURE M, 1977, NUCLEIC ACIDS RES, V4, P1183, DOI 10.1093/nar/4.5.1183; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; SINDEN RR, 1982, J MOL BIOL, V162, P659, DOI 10.1016/0022-2836(82)90394-1; Stavans J, 2006, PHYS BIOL, V3, pR1, DOI 10.1088/1478-3975/3/4/R01; STETLER GL, 1979, P NATL ACAD SCI USA, V76, P3737, DOI 10.1073/pnas.76.8.3737; Stockum A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-26; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TSEDINH YC, 1988, J MOL BIOL, V202, P735, DOI 10.1016/0022-2836(88)90554-2; Vetcher AA, 2010, BIOPHYS CHEM, V148, P104, DOI 10.1016/j.bpc.2010.02.016; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yigit H, 1998, J BACTERIOL, V180, P5866, DOI 10.1128/JB.180.22.5866-5874.1998; Yigit H, 1999, J BACTERIOL, V181, P3185, DOI 10.1128/JB.181.10.3185-3192.1999; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103; ZHU CX, 1995, J MOL BIOL, V250, P609, DOI 10.1006/jmbi.1995.0402; Zhu Q, 2001, P NATL ACAD SCI USA, V98, P9766, DOI 10.1073/pnas.171579898	84	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124309	10.1371/journal.pone.0124309	http://dx.doi.org/10.1371/journal.pone.0124309			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875362	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700066
J	Osborne, AJ; Pearson, J; Chilvers, BL; Kennedy, MA; Gemmell, NJ				Osborne, Amy J.; Pearson, John; Chilvers, B. Louise; Kennedy, Martin A.; Gemmell, Neil J.			Examining the Role of Components of Slc11a1 (Nramp1) in the Susceptibility of New Zealand Sea Lions (Phocarctos hookeri) to Disease	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; KLEBSIELLA-PNEUMONIAE EPIDEMICS; NATURAL-RESISTANCE; INNATE RESISTANCE; BRUCELLA-ABORTUS; MASS MORTALITY; INTRACELLULAR PARASITES; GENETIC-RESISTANCE; HARBOR SEALS; CLASS-I	The New Zealand sea lion (NZSL, Phocarctos hookeri) is a Threatened marine mammal with a restricted distribution and a small, declining, population size. The species is susceptible to bacterial pathogens, having suffered three mass mortality events since 1998. Understanding the genetic factors linked to this susceptibility is important in mitigating population decline. The gene solute carrier family 11 member a1 (Slc11a1) plays an important role in mammalian resistance or susceptibility to a wide range of bacterial pathogens. At present, Slc11a1 has not been characterised in many taxa, and despite its known roles in mediating the effects of infectious disease agents, has not been examined as a candidate gene in susceptibility or resistance in any wild population of conservation concern. Here we examine components of Slc11a1 in NZSLs and identify: i) a polymorphic nucleotide in the promoter region; ii) putative shared transcription factor binding motifs between canids and NZSLs; and iii) a conserved polymorphic microsatellite in the first intron of Slc11a1, which together suggest conservation of Slc11a1 gene structure in otariids. At the promoter polymorphism, we demonstrate a shift away from normal allele frequency distributions and an increased likelihood of death from infectious causes with one allelic variant. While this increased likelihood is not statistically significant, lack of significance is potentially due to the complexity of genetic susceptibility to disease in wild populations. Our preliminary data highlight the potential significance of this gene in disease resistance in wild populations; further exploration of Slc11a1 will aid the understanding of susceptibility to infection in mammalian species of conservation significance.	[Osborne, Amy J.; Gemmell, Neil J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Osborne, Amy J.; Kennedy, Martin A.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Pearson, John] Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; [Chilvers, B. Louise] Dept Conservat, Marine Species & Threats Team, Wellington, New Zealand; [Gemmell, Neil J.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Osborne, AJ (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	amy.osborne@otago.ac.nz	Kennedy, Martin A/A-4942-2008; Pearson, John F/D-7428-2012; Chilvers, B. Louise/AAV-1965-2021; Gemmell, Neil J/C-6774-2009; Kennedy, Martin/O-4540-2019	Kennedy, Martin A/0000-0002-6445-8526; Pearson, John F/0000-0001-5607-4517; Chilvers, B. Louise/0000-0002-7657-4217; Gemmell, Neil J/0000-0003-0671-3637; Kennedy, Martin/0000-0002-6445-8526	University of Otago; Landcare Research's FRST OBI "Sustaining and Restoring Biodiversity" [C09X0503]; University of Otago Department of Anatomy PhD Scholarship	University of Otago; Landcare Research's FRST OBI "Sustaining and Restoring Biodiversity"; University of Otago Department of Anatomy PhD Scholarship	Funding was provided by the University of Otago; subcontract to NJG from Landcare Research's FRST OBI "Sustaining and Restoring Biodiversity" contract #C09X0503; and University of Otago Department of Anatomy PhD Scholarship to AJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Adams LG, 1998, REV SCI TECH OIE, V17, P200, DOI 10.20506/rst.17.1.1085; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; Altet L, 2002, INFECT IMMUN, V70, P2763, DOI 10.1128/IAI.70.6.2763-2771.2002; Aragon T., 2010, EPITOOLS R PACKAGE E; Baker A., 1998, UNUSUAL MORTALITY NZ; BANCROFT GJ, 1987, J IMMUNOL, V139, P1104; Barribeau SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002692; Barthel R, 2001, INFECT IMMUN, V69, P3110, DOI 10.1128/IAI.69.5.3110-3119.2001; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; BLACKWELL JM, 1994, IMMUNOL LETT, V43, P99, DOI 10.1016/0165-2478(94)00161-8; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; BORST GHA, 1986, J WILDLIFE DIS, V22, P1; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Capparelli R, 2007, INFECT IMMUN, V75, P988, DOI 10.1128/IAI.00948-06; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Castinel A, 2007, VET MICROBIOL, V125, P388, DOI 10.1016/j.vetmic.2007.08.009; Cellier M, 1996, TRENDS GENET, V12, P201, DOI 10.1016/0168-9525(96)30042-5; Cellier M, 1997, J LEUKOCYTE BIOL, V61, P96, DOI 10.1002/jlb.61.1.96; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Chilvers BL, 2012, POLAR BIOL, V35, P1607, DOI 10.1007/s00300-011-1143-6; Chilvers B. Louise, 2008, Endangered Species Research, V5, P193, DOI 10.3354/esr00086; Chilvers BL, 2009, DEMOGRAPHIC PARAMETE; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drummond AJ, 2010, GENEIOUS; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Evans ML, 2009, MOL ECOL, V18, P4716, DOI 10.1111/j.1365-294X.2009.04374.x; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Feng JW, 1996, GENOME RES, V6, P956, DOI 10.1101/gr.6.10.956; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; GERACI JR, 1982, SCIENCE, V215, P1129; Giacani L, 2007, FEMS IMMUNOL MED MIC, V51, P289, DOI 10.1111/j.1574-695X.2007.00303.x; Gomes MS, 1998, IMMUNOLOGY, V95, P165; GOVONI G, 1995, GENOMICS, V27, P9, DOI 10.1006/geno.1995.1002; Govoni G, 1997, J LEUKOCYTE BIOL, V62, P277, DOI 10.1002/jlb.62.2.277; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GROS P, 1981, J IMMUNOL, V127, P2417; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HARWOOD J, 1990, TRENDS ECOL EVOL, V5, P254, DOI 10.1016/0169-5347(90)90066-M; Hu JX, 1997, GENOME RES, V7, P693, DOI 10.1101/gr.7.7.693; Hughes AM, 2010, TISSUE ANTIGENS, V75, P684, DOI 10.1111/j.1399-0039.2010.01440.x; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Larruskain A, 2010, IMMUNOGENETICS, V62, P75, DOI 10.1007/s00251-009-0419-2; LISSNER CR, 1983, J IMMUNOL, V131, P3006; LIU J, 1995, AM J HUM GENET, V56, P845; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Osborne AJ, 2013, HEREDITY, V111, P44, DOI 10.1038/hdy.2013.18; Osborne AJ, 2011, MOL ECOL RESOUR, V11, P503, DOI 10.1111/j.1755-0998.2010.02962.x; Osterhaus A, 1998, VACCINE, V16, P979, DOI 10.1016/S0264-410X(98)00006-1; OSTERHAUS A, 1989, VACCINE, V7, P483, DOI 10.1016/0264-410X(89)90265-X; OSTERHAUS ADME, 1988, NATURE, V335, P403, DOI 10.1038/335403a0; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; R Core Development Team, 2010, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddacliff LA, 2005, AUST VET J, V83, P435, DOI 10.1111/j.1751-0813.2005.tb13087.x; Roberts RL, 2008, PHARMACOGENET GENOM, V18, P434, DOI 10.1097/FPC.0b013e3282f85e47; Robertson BC, 2011, MAMMAL REV, V41, P253, DOI 10.1111/j.1365-2907.2011.00186.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez-Robert E, 2005, J HERED, V96, P755, DOI 10.1093/jhered/esi111; Sanchez-Robert E, 2008, VET RES, V39, DOI 10.1051/vetres:2008013; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawaya SM, 2012, GENOME BIOL EVOL, V4, P748, DOI 10.1093/gbe/evs050; Searle S, 1999, J MED GENET, V36, P295; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; VEDROS NA, 1971, SCIENCE, V172, P1250, DOI 10.1126/science.172.3989.1250; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wilkinson IS, 2006, LOW WAKE FI, P385; Wittkopp PJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000342	86	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122703	10.1371/journal.pone.0122703	http://dx.doi.org/10.1371/journal.pone.0122703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874773	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700022
J	Yoda, K; Inaba, M; Hamamoto, K; Yoda, M; Tsuda, A; Mori, K; Imanishi, Y; Emoto, M; Yamada, S				Yoda, Koichiro; Inaba, Masaaki; Hamamoto, Kae; Yoda, Maki; Tsuda, Akihiro; Mori, Katsuhito; Imanishi, Yasuo; Emoto, Masanori; Yamada, Shinsuke			Association between Poor Glycemic Control, Impaired Sleep Quality, and Increased Arterial Thickening in Type 2 Diabetic Patients	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTOR; INSOMNIA; EEG; DISEASE; JAPAN; ATHEROSCLEROSIS; DEPRIVATION; HEMOGLOBIN; COMPLAINTS	Objective Poor sleep quality is an independent predictor of cardiovascular events. However, little is known about the association between glycemic control and objective sleep architecture and its influence on arteriosclerosis in patients with type-2 diabetes mellitus (DM). The present study examined the association of objective sleep architecture with both glycemic control and arteriosclerosis in type-2 DM patients. Design Cross-sectional study in vascular laboratory. Methods The subjects were 63 type-2 DM inpatients (M/F, 32/31; age, 57.5 +/- 13.1) without taking any sleeping promoting drug and chronic kidney disease. We examined objective sleep architecture by single-channel electroencephalography and arteriosclerosis by carotid-artery intima-media thickness (CA-IMT). Results HbA1c was associated significantly in a negative manner with REM sleep latency (interval between sleep-onset and the first REM period) (beta=-0.280, p=0.033), but not with other measurements of sleep quality. REM sleep latency associated significantly in a positive manner with log delta power (the marker of deep sleep) during that period (beta=0.544, p=0.001). In the model including variables univariately correlated with CA-IMT (REM sleep latency, age, DM duration, systolic blood pressure, and HbA1c) as independent variables, REM sleep latency (beta=-0.232, p=0.038), but not HbA1c were significantly associated with CA-IMT. When log delta power was included in place of REM sleep latency, log delta power (beta=-0.257, p=0.023) emerged as a significant factor associated with CA-IMT. Conclusions In type-2 DM patients, poor glycemic control was independently associated with poor quality of sleep as represented by decrease of REM sleep latency which might be responsible for increased CA-IMT, a relevant marker for arterial wall thickening.	[Yoda, Koichiro; Inaba, Masaaki; Hamamoto, Kae; Yoda, Maki; Tsuda, Akihiro; Mori, Katsuhito; Imanishi, Yasuo; Emoto, Masanori; Yamada, Shinsuke] Osaka City Univ, Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 545, Japan	Osaka Metropolitan University	Yoda, K (corresponding author), Osaka City Univ, Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 545, Japan.	y45162001@yahoo.co.jp						AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Armitage R, 2013, SLEEP MED, V14, P257, DOI 10.1016/j.sleep.2012.11.012; Bruehl H, 2007, J CLIN ENDOCR METAB, V92, P2439, DOI 10.1210/jc.2006-2540; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Flexer A, 2005, ARTIF INTELL MED, V33, P199, DOI 10.1016/j.artmed.2004.04.004; Fujishima M, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.3.S14; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Geyer J. D., 2009, CLIN SLEEP DISORDERS, P265; Iber C., 2007, AASM MANUAL SCORING; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Javaheri S, 2012, CURR HYPERTENS REP, V14, P442, DOI 10.1007/s11906-012-0289-0; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; KOSTIC VS, 1989, J NEUROL, V236, P421, DOI 10.1007/BF00314903; Krystal AD, 2002, SLEEP, V25, P630; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakazaki C, 2012, AM J HYPERTENS, V25, P1149, DOI 10.1038/ajh.2012.107; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pallayova Maria, 2010, J Diabetes Sci Technol, V4, P344; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; Poland, 1992, J Sleep Res, V1, P54; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1; Takahashi H, 2013, J ORAL REHABIL, V40, P892, DOI 10.1111/joor.12110; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Tribl GG, 2013, SLEEP MED REV, V17, P133, DOI 10.1016/j.smrv.2012.05.001; Unosawa S, 2012, J CARDIOL, V60, P61, DOI 10.1016/j.jjcc.2012.01.012; Yanase T, 2006, AM J HYPERTENS, V19, P1206, DOI 10.1016/j.amjhyper.2006.05.010; Yoda K, 2014, DIABETES CARE, V37, P644, DOI 10.2337/dc13-1102	32	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122521	10.1371/journal.pone.0122521	http://dx.doi.org/10.1371/journal.pone.0122521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875738	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700018
J	Chen, LQ; Wu, SJ; Lu, HF; Huang, K; Zhao, LJ				Chen, Liqiong; Wu, Shijuan; Lu, Hongfang; Huang, Kun; Zhao, Lijie			Numerical Simulation and Structural Optimization of the Inclined Oil/Water Separator	PLOS ONE			English	Article								Improving the separation efficiency of the inclined oil/water separator, a new type of gravity separation equipment, is of great importance. In order to obtain a comprehensive understanding of the internal flow field of the separation process of oil and water within this separator, a numerical simulation based on Euler multiphase flow analysis and the realizable k-epsilon two equation turbulence model was executed using Fluent software. The optimal value ranges of the separator's various structural parameters used in the numerical simulation were selected through orthogonal array experiments. A field experiment on the separator was conducted with optimized structural parameters in order to validate the reliability of the numerical simulation results. The research results indicated that the horizontal position of the dispenser, the hole number, and the diameter had significant effects on the oil/water separation efficiency, and that the longitudinal position of the dispenser and the position of the weir plate had insignificant effects on the oil/water separation efficiency. The optimal structural parameters obtained through the orthogonal array experiments resulted in an oil/water separation efficiency of up to 95%, which was 4.996% greater than that realized by the original structural parameters.	[Chen, Liqiong; Wu, Shijuan; Lu, Hongfang; Huang, Kun] Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China; [Zhao, Lijie] China Univ Petr, Coll Geosci, State Key Lab Petr Resources & Prospecting, Beijing, Peoples R China	Southwest Petroleum University; China University of Petroleum	Lu, HF (corresponding author), Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China.	luhongfang_sci@126.com	Lu, Hongfang/T-1016-2019	Lu, Hongfang/0000-0002-5172-9008	Science and Technology Innovation Foundation of CNPC [2012D-5006-0602]; Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU)	Science and Technology Innovation Foundation of CNPC; Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU)	This research is supported by Science and Technology Innovation Foundation of CNPC (2012D-5006-0602) and Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen PAK, 2000, COLLOID SURFACE A, V170, P33, DOI 10.1016/S0927-7757(99)00518-X; Deng ZA, 2006, CHINA PETROL MACH, V34, P18; Frising T, 2006, J DISPER SCI TECHNOL, V27, P1035, DOI 10.1080/01932690600767098; [高雄发 Gao Xiongfa], 2014, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V45, P101; Hou XR, 2011, THESIS DALIAN MARITI; [黄坤 Huang Kun], 2014, [石油与天然气化工, Chemical Engineering of Oil and Gas], V43, P241; Jia C, 2014, ROCK SOIL MECH, V35, P1718; Klasson KT, 2005, SEP SCI TECHNOL, V40, P453, DOI 10.1081/SS-200042503; [刘苏 Liu Su], 2012, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University], V34, P147; [刘晓敏 LIU Xiaomin], 2006, [流体机械, Fluid Machinery], V34, P13; Liu Y.H, 2009, THESIS TIANJIN U; Lu YJ, 1999, ACTA PETROLEI SINICA, P34; Lv YL, 2008, CHINA PETROL MACH, V36, P12; Wang GD, ACTA PETROLEI SINICA, V27, P112; Wang HM, CHEM ENG MACH, V36, P13; Zhang L., 2005, THESIS TIANJIN U	16	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124095	10.1371/journal.pone.0124095	http://dx.doi.org/10.1371/journal.pone.0124095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874861	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100238
J	Chen, YY; Lin, YJ; Chong, E; Chen, PC; Chao, TF; Chen, SA; Chien, KL				Chen, Yun-Yu; Lin, Yenn-Jiang; Chong, Eric; Chen, Pei-Chun; Chao, Taz-Fan; Chen, Shih-Ann; Chien, Kuo-Liong			The Impact of Diabetes Mellitus and Corresponding HbA1c Levels on the Future Risks of Cardiovascular Disease and Mortality: A Representative Cohort Study in Taiwan	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; GLYCATED HEMOGLOBIN; TASK-FORCE; ASSOCIATION; GUIDELINES; HBA(1C); EVENTS; ESC	Background This study explored the relationship between the glycated hemoglobin (HbA1c) level in patients with or without diabetes mellitus and future risks of cardiovascular disease and death. Methods Based on a national representative cohort, a total of 5277 participants (7% with diabetes) were selected from Taiwan's Triple High Survey in 2002. The comorbidities, medication usages, and outcomes of cardiovascular disease and death, were extracted from the Taiwan's National Health Insurance Research Database and National Death Registry. Results After a median follow-up of 9.7 years, participants with diabetes had higher incidence of new onset cardiovascular disease (17.9 versus 3.16 cases per 1000 person-years) and death (20.1 versus 4.96 cases per 1000 person-years) than those without diabetes (all P < 0.001). Diabetes showed increased risk of all-cause death after adjusting for all con-founders (adjusted hazard ratio [HR]: 2.29, 95% confidence interval [CI]: 1.52-3.45). Every 1% increment of HbA1c was positively associated with the risk of total cardiovascular disease (HR: 1.2, 95% CI: 1.08-1.34) and the risk of death (HR: 1.14, 95% CI: 1.03-1.26) for all participants. As compared to the reference group with HbA1c below 5.5%, participants with HbA1c levels >= 7.5% had significantly elevated future risks of total cardiovascular disease (HR: 1.82, 95% CI: 1.01-3.26) and all-cause death (HR: 2.45, 95% CI: 1.45-4.14). Conclusions/Interpretation Elevated HbA1C levels were associated with increased risks of cardiovascular disease and death, the suboptimal glycemic control with HbA1c level over 7.5% (58.5 mmol/mol) was strongly associated with increased risks of cardiovascular disease and all-cause death.	[Chen, Yun-Yu; Lin, Yenn-Jiang; Chong, Eric; Chao, Taz-Fan; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chen, Yun-Yu; Chen, Pei-Chun; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Yenn-Jiang; Chao, Taz-Fan; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Lin, Yenn-Jiang; Chao, Taz-Fan; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chong, Eric] Jurong Hlth Private Ltd, Dept Cardiol, Singapore, Singapore	Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw		Chen, Pei-Chun/0000-0002-8713-8816; CHIEN, KUO-LIONG/0000-0003-4979-8351	Ministry of Science and Technology [NSC102-2314-B-010-056-MY2]; Taipei Veterans General Hospital [V102E7-001]; Jurong Health Private Limited	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Jurong Health Private Limited	The authors appreciate the financial support from Ministry of Science and Technology (NSC102-2314-B-010-056-MY2), and Taipei Veterans General Hospital (V102E7-001). Jurong Health Private Limited provided support in the form of a salary for author E.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Cannon CP, 2008, AM J CARDIOL, V102, p5L, DOI 10.1016/j.amjcard.2008.09.067; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348; Cosentino F, 1997, CIRCULATION, V96, P25; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Deo R K, 2008, Kathmandu Univ Med J (KUMJ), V6, P476; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Oh HG, 2011, DIABETES METAB J, V35, P551, DOI 10.4093/dmj.2011.35.5.551; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sakurai M, 2013, DIABETES CARE, V36, P3759, DOI 10.2337/dc12-2412; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Su TC, 2008, J HYPERTENS, V26, P600, DOI 10.1097/HJH.0b013e3282f3b352; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0	24	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123116	10.1371/journal.pone.0123116	http://dx.doi.org/10.1371/journal.pone.0123116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874454	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100137
J	Jensen, TB; Cheema, MU; Szymiczek, A; Damkier, HH; Praetorius, J				Jensen, Thomas Buus; Cheema, Muhammad Umar; Szymiczek, Agata; Damkier, Helle Hasager; Praetorius, Jeppe			Renal Type A Intercalated Cells Contain Albumin in Organelles with Aldosterone-Regulated Abundance	PLOS ONE			English	Article							ALPHA-FETOPROTEIN; KIDNEY; RAT; EXPRESSION; TRANSPORT; SUBTYPES; SUBUNIT; BINDING; MODEL; WATER	Albumin has been identified in preparations of renal distal tubules and collecting ducts by mass spectrometry. This study aimed to establish whether albumin was a contaminant in those studies or actually present in the tubular cells, and if so, identify the albumin containing cells and commence exploration of the origin of the intracellular albumin. In addition to the expected proximal tubular albumin immunoreactivity, albumin was localized to mouse renal type-A intercalated cells and cells in the interstitium by three anti-albumin antibodies. Albumin did not colocalize with markers for early endosomes (EEA1), late endosomes/lysosomes (cathepsin D) or recycling endosomes (Rab11). Immuno-gold electron microscopy confirmed the presence of albumin-containing large spherical membrane associated bodies in the basal parts of intercalated cells. Message for albumin was detected in mouse renal cortex as well as in a wide variety of other tissues by RT-PCR, but was absent from isolated connecting tubules and cortical collecting ducts. Wild type I MDCK cells showed robust uptake of fluorescein-albumin from the basolateral side but not from the apical side when grown on permeable support. Only a subset of cells with low peanut agglutinin binding took up albumin. Albumin-aldosterone conjugates were also internalized from the basolateral side by MDCK cells. Aldosterone administration for 24 and 48 hours decreased albumin abundance in connecting tubules and cortical collecting ducts from mouse kidneys. We suggest that albumin is produced within the renal interstitium and taken up from the basolateral side by type-A intercalated cells by clathrin and dynamin independent pathways and speculate that the protein might act as a carrier of less water-soluble substances across the renal interstitium from the capillaries to the tubular cells.	[Jensen, Thomas Buus; Cheema, Muhammad Umar; Szymiczek, Agata; Damkier, Helle Hasager; Praetorius, Jeppe] Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark	Aarhus University	Praetorius, J (corresponding author), Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark.	jp@ana.au.dk	Praetorius, Jeppe/AAU-7893-2020; Buus, Thomas Winther/AAE-2028-2019	Praetorius, Jeppe/0000-0001-6109-247X; Buus, Thomas Winther/0000-0003-4801-6389; Damkier, Helle/0000-0001-7518-4017	Danish Council for Independent Research | Medical Sciences; Lundbeck Foundation; Danish Heart Association	Danish Council for Independent Research | Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Heart Association	Thomas B Jensen was supported by a scholar stipend from The Danish Council for Independent Research | Medical Sciences. Running expences were covered by the Lundbeck Foundation and the Danish Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biner HL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134836; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Boron W, 2009, MED PHYSL; BRENNER BM, 1976, PHYSIOL REV, V56, P502, DOI 10.1152/physrev.1976.56.3.502; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; CHRISTENSEN EI, 1991, SEMIN NEPHROL, V11, P414; CLAPP WL, 1988, LAB INVEST, V58, P549; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Da Silva N, 2010, AM J PHYSIOL-CELL PH, V298, pC1326, DOI 10.1152/ajpcell.00552.2009; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jensen TB, 2012, NEPHRON PHYSIOL, V121, P9; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MAUNSBAC.AB, 1966, NATURE, V212, P546, DOI 10.1038/212546a0; MOORMAN AFM, 1990, HISTOCHEM J, V22, P653, DOI 10.1007/BF01047449; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; POLIARD A, 1988, DIFFERENTIATION, V39, P59, DOI 10.1111/j.1432-0436.1988.tb00081.x; Rosenbaek LL, 2014, J BIOL CHEM, V289, P13347, DOI 10.1074/jbc.M113.543710; SCHWEGLER JS, 1991, PFLUG ARCH EUR J PHY, V418, P383, DOI 10.1007/BF00550876; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van der Lubbe N, 2012, PFLUG ARCH EUR J PHY, V463, P853, DOI 10.1007/s00424-012-1104-0; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; WEISBERG HF, 1978, ANN CLIN LAB SCI, V8, P155; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; WUNSCH S, 1995, J CELL PHYSIOL, V164, P164, DOI 10.1002/jcp.1041640121	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124902	10.1371/journal.pone.0124902	http://dx.doi.org/10.1371/journal.pone.0124902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874770	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100283
J	Li, FG; Wang, LX; Lan, QJ; Yang, H; Li, Y; Liu, XL; Yang, ZX				Li, Fenggang; Wang, Lixin; Lan, Qingjing; Yang, Hui; Li, Yang; Liu, Xiaolin; Yang, Zhaoxia			RNA-Seq Analysis and Gene Discovery of Andrias davidianus Using Illumina Short Read Sequencing	PLOS ONE			English	Article							LYMPHOTOXIN-BETA; TRANSCRIPTOME; EXPRESSION; PEPTIDES; GENOME; GALECTIN-3; TOOL	The Chinese giant salamander, Andrias davidianus, is an important species in the course of evolution; however, there is insufficient genomic data in public databases for understanding its immunologic mechanisms. High-throughput transcriptome sequencing is necessary to generate an enormous number of transcript sequences from A. davidianus for gene discovery. In this study, we generated more than 40 million reads from samples of spleen and skin tissue using the Illumina paired-end sequencing technology. De novo assembly yielded 87,297 transcripts with a mean length of 734 base pairs (bp). Based on the sequence similarities, searching with known proteins, 38,916 genes were identified. Gene enrichment analysis determined that 981 transcripts were assigned to the immune system. Tissue-specific expression analysis indicated that 443 of transcripts were specifically expressed in the spleen and skin. Among these transcripts, 147 transcripts were found to be involved in immune responses and inflammatory reactions, such as fucolectin, beta-defensins and lymphotoxin beta. Eight tissue-specific genes were selected for validation using real time reverse transcription quantitative PCR (qRT-PCR). The results showed that these genes were significantly more expressed in spleen and skin than in other tissues, suggesting that these genes have vital roles in the immune response. This work provides a comprehensive genomic sequence resource for A. davidianus and lays the foundation for future research on the immunologic and disease resistance mechanisms of A. davidianus and other amphibians.	[Li, Fenggang; Wang, Lixin; Lan, Qingjing; Yang, Hui; Li, Yang; Liu, Xiaolin; Yang, Zhaoxia] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China; [Li, Fenggang] Chinese Acad Fishery Sci, Yellow River Fisheries Res Inst, Xian 710086, Peoples R China	Northwest A&F University - China; Chinese Academy of Fishery Sciences	Li, FG (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China.	lifenggang.123@163.com			Agricultural science and technology research project [2012K01-18]; Houji Scholar Project of Northwest AF University [Z11021007]	Agricultural science and technology research project; Houji Scholar Project of Northwest AF University	Agricultural science and technology research project (2012K01-18) Houji Scholar Project of Northwest A&F University (Z11021007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyekum S, 2003, J PATHOL, V199, P115, DOI 10.1002/path.1249; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Das S, 2008, P NATL ACAD SCI USA, V105, P16647, DOI 10.1073/pnas.0808800105; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoyer KK, 2004, AM J PATHOL, V164, P893, DOI 10.1016/S0002-9440(10)63177-X; KELLY C, 1984, BIOCHEM J, V220, P221, DOI 10.1042/bj2200221; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LICHTENSTEIN A, 1991, J CLIN INVEST, V88, P93, DOI 10.1172/JCI115310; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu YH, 2009, AM J PHYSIOL-HEART C, V296, pH404, DOI 10.1152/ajpheart.00747.2008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Mizukawa N, 1999, ANTICANCER RES, V19, P2969; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy RW, 2000, MOL ECOL, V9, P1539, DOI 10.1046/j.1365-294x.2000.01036.x; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Sun LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069441; UHLENBRUCK G, 1982, IMMUNOBIOLOGY, V163, P36, DOI 10.1016/S0171-2985(82)80104-6; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004	46	22	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123730	10.1371/journal.pone.0123730	http://dx.doi.org/10.1371/journal.pone.0123730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874626	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100204
J	Lin, MY; Kuo, MC; Hung, CC; Wu, WJ; Chen, LT; Yu, ML; Hsu, CC; Lee, CH; Chen, HC; Hwang, SJ				Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Wu, Wen Jeng; Chen, Li Tzong; Yu, Ming Lung; Hsu, Chih Cheng; Lee, Chien Hung; Chen, Hung Chun; Hwang, Shang Jyh			Association of Dialysis with the Risks of Cancers	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TRANSITIONAL-CELL CARCINOMA; ARISTOLOCHIC ACID; URINARY-TRACT; POPULATION; KIDNEY; NEPHROPATHY; DIAGNOSIS; TAIWAN	Background To increase the survival span after dialysis in patients with end-stage renal disease (ESRD), identifying specific cancer risks is crucial in the cancer screening of these patients. The aim of this study was to investigate the risks of various cancers in an incident dialysis group in comparison with a non-dialysis group. Method We conducted a nationwide cohort study by using data from the Taiwan National Health Insurance Research Database. Patients who initially received long-term dialysis between January 1997 and December 2004, were selected and defined as the dialysis group and were matched with the non-dialysis patients (control group) according to age, sex, and index year. Competing risk analysis was used to estimate cumulative incidence and subdistribution hazard ratios (SHRs) of the first cancer occurrence. Results After consideration for the competing risk of mortality, the dialysis group showed a significantly higher 7-year cancer incidence rate than did the control group (6.4%; 95% confidence interval [CI], 6.0%-6.7% vs 1.7%; 95% CI, 1.4%-2.1%; P <0.001). The modified Cox proportional hazard model revealed that the dialysis group had significantly association with increased risks for all cancers (SHR, 3.43; 95% CI, 3.02-3.88). The risk of cancers was dominated in younger and female patients. Specific cancer risks were significantly higher in the dialysis group particularly in the development of oral, colorectal, liver, blood, breast, renal, upper urinary tract, and bladder cancer than in the control group. Multivariable stratified analyses confirmed the association between long-term dialysis and cancer in all subgroups of patients. Conclusions Dialysis is associated with a higher risk of cancer in patients with ESRD. However, cancer screening in ESRD population should be a selective approach, based on individual patient health condition and life expectancy.	[Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Chen, Hung Chun; Hwang, Shang Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Chen, Hung Chun; Hwang, Shang Jyh] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Lin, Ming Yen] Natl Appl Res Labs, Instrument Technol Res Ctr, Hsinchu, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Wen Jeng; Yu, Ming Lung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Chen, Li Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Li Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Yu, Ming Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hepatobiliary, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Chih Cheng; Hwang, Shang Jyh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Lee, Chien Hung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Applied Research Laboratories - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Lee, Chien-Hung/D-4437-2009; Lin, Ming Yen/A-8637-2010	Yu, Ming-Lung/0000-0001-8145-1900; Lee, Chien-Hung/0000-0002-0988-264X; Lin, Ming Yen/0000-0002-8194-4833; wu, wen jeng/0000-0002-9691-7416	National Science Council, Taiwan [NSC 102-3114-Y-492-076-023]; Ministry of Health and Welfare [MOHW103-TD-B-111-05]; Kaohsiung Medical University [QP094005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Kaohsiung Medical University	The authors would like to thank the National Science Council, Taiwan (NSC 102-3114-Y-492-076-023), the Ministry of Health and Welfare (MOHW103-TD-B-111-05), and Kaohsiung Medical University (QP094005) for supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CH, 2001, AM J NEPHROL, V21, P441, DOI 10.1159/000046647; Chang CH, 2007, CANCER-AM CANCER SOC, V109, P1487, DOI 10.1002/cncr.22557; Chen CH, 2013, INT J CANCER, V133, P14, DOI 10.1002/ijc.28013; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien IC, 2009, SCHIZOPHR RES, V111, P17, DOI 10.1016/j.schres.2009.04.003; Chung CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044675; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Grandits G, 2018, USING SAS PERFORM IN, V2010; Gray B., CMPRSK SUBDISTRIBUTI; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hsieh CY, 2013, J FORMOSAN MED ASS; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin MY, 2012, SCI C ANN M 2012 TAI, P308; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Satoh S, 2005, J UROLOGY, V174, P1749, DOI 10.1097/01.ju.0000177489.98031.54; Shebl FM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-65; Skov Dalgaard L, 2013, BMC NEPHROL, V14, P137, DOI [10.1186/1471-2369-14-137, DOI 10.1186/1471-2369-14-137]; Stefanovic V, 2008, NAT CLIN PRACT UROL, V5, P105, DOI 10.1038/ncpuro1019; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Stewart JH, 2009, NEPHROL DIAL TRANSPL, V24, P3225, DOI 10.1093/ndt/gfp331; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Wang SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/149750; Yang CS, 2000, AM J KIDNEY DIS, V35, P313, DOI 10.1016/S0272-6386(00)70343-X; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	33	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122856	10.1371/journal.pone.0122856	http://dx.doi.org/10.1371/journal.pone.0122856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874862	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100110
J	Liu, QH; Wu, X; Ma, JQ; Chen, BC; Xin, CY				Liu, Qihua; Wu, Xiu; Ma, Jiaqing; Chen, Bocong; Xin, Caiyun			Effects of Delaying Transplanting on Agronomic Traits and Grain Yield of Rice under Mechanical Transplantation Pattern	PLOS ONE			English	Article							SEEDLING AGE; WATER PRODUCTIVITY; DRY-MATTER; ACCUMULATION; ATTRIBUTES; NITROGEN	A delay in the mechanical transplantation (MT) of rice seedlings frequently occurs in Huanghuai wheat-rice rotation cropping districts of China, due to the late harvest of wheat, the poor weather conditions and the insufficiency of transplanters, missing the optimum transplanting time and causing seedlings to age. To identify how delaying transplanting rice affects the agronomic characteristics including the growth duration, photosynthetic productivity and dry matter remobilization efficiency and the grain yield under mechanical transplanting pattern, an experiment with a split-plot design was conducted over two consecutive years. The main plot includes two types of cultivation: mechanical transplanting and artificial transplanting (AT). The subplot comprises four japonica rice cultivars. The results indicate that the rice jointing, booting, heading and maturity stages were postponed under MT when using AT as a control. The tiller occurrence number, dry matter weight per tiller, accumulative dry matter for the population, leaf area index, crop growth rate, photosynthetic potential, and dry matter remobilization efficiency of the leaf under MT significantly decreased compared to those under AT. In contrast, the reduction rate of the leaf area during the heading-maturity stage was markedly enhanced under MT. The numbers of effective panicles and filled grains per panicle and the grain yield significantly decreased under MT. A significant correlation was observed between the dry matter production, remobilization and distribution characteristics and the grain yield. We infer that, as with rice from old seedlings, the decrease in the tiller occurrence, the photosynthetic productivity and the assimilate remobilization efficiency may be important agronomic traits that are responsible for the reduced grain yield under MT.	[Liu, Qihua; Wu, Xiu; Ma, Jiaqing; Chen, Bocong; Xin, Caiyun] Shandong Acad Agr Sci, Rice Res Inst, Jinan 250100, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Liu, QH (corresponding author), Shandong Acad Agr Sci, Rice Res Inst, Jinan 250100, Shandong, Peoples R China.	zxbsds@163.com; mjq1961sd@163.com						Adhikari B. B., 2013, American Journal of Plant Sciences, V4, P146; Brar SK, 2012, AGR WATER MANAGE, V115, P217, DOI 10.1016/j.agwat.2012.09.001; Chahal GBS, 2007, AGR WATER MANAGE, V88, P14, DOI 10.1016/j.agwat.2006.08.007; Cheng SH, 2012, REPORT RICE IND DEV, P149; Choi WeonYoung, 2006, Korean Journal of Crop Science, V51, P379; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Han X, 2011, NO EC TRADE, V3, P38; Hemmat A, 2003, SOIL TILL RES, V70, P65, DOI 10.1016/S0167-1987(02)00119-8; Huo ZhongYang, 2012, Acta Agronomica Sinica, V38, P1908; Ito T, 2009, J DEV ECON, V88, P292, DOI 10.1016/j.jdeveco.2008.06.002; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Knight J, 2011, CHINA ECON REV, V22, P585, DOI 10.1016/j.chieco.2011.01.006; Kobayashi K., 2009, Japanese Journal of Crop Science, V78, P17, DOI 10.1626/jcs.78.17; Laszlo S, 2008, WORLD DEV, V36, P2421, DOI 10.1016/j.worlddev.2008.04.001; Li Jie, 2011, Acta Agronomica Sinica, V37, P1235; Li Jie, 2011, Acta Agronomica Sinica, V37, P309, DOI 10.3724/SP.J.1006.2011.00309; Mobasser Hamid Reza, 2007, Asian Journal of Plant Sciences, V6, P438; Ntanos DA, 2002, FIELD CROP RES, V74, P93, DOI 10.1016/S0378-4290(01)00203-9; Park HK, 2002, KOREAN J CROP SCI, V47, P167; Ranamukhaarachchi S., 2011, RECENT RES SCI TECHN, V3, P76; Sarwa N, 2011, CHIL J AGR RES, V71, P343, DOI 10.4067/S0718-58392011000300001; Shafiq MN, 2007, J ASIAN ECON, V18, P946, DOI 10.1016/j.asieco.2007.07.003; Takahashi Y., 2007, Japanese Journal of Crop Science, V76, P355, DOI 10.1626/jcs.76.355; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Thanunathan K., 2002, CROP RES, V24, P421; Thomas EV, 2002, MECH MACH THEORY, V37, P395; Wang XB, 2007, CHINA ECON REV, V18, P287, DOI 10.1016/j.chieco.2007.02.004; Xiong J, 2013, AGRON J, V105, P1142, DOI 10.2134/agronj2012.0297; Yu LY, 2006, SCANNING, V28, P73; Zhang ZuJian, 2008, Acta Agronomica Sinica, V34, P297, DOI 10.3724/SP.J.1006.2008.00297	30	26	28	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123330	10.1371/journal.pone.0123330	http://dx.doi.org/10.1371/journal.pone.0123330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875607	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100164
J	Petzold, K; Poster, D; Krauer, F; Spanaus, K; Andreisek, G; Nguyen-Kim, TDL; Pavik, I; Ho, TA; Serra, AL; Rotar, L				Petzold, Katja; Poster, Diane; Krauer, Fabienne; Spanaus, Katharina; Andreisek, Gustav; Thi Dan Linh Nguyen-Kim; Pavik, Ivana; Thien Anh Ho; Serra, Andreas L.; Rotar, Laura			Urinary Biomarkers at Early ADPKD Disease Stage	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; TAMM-HORSFALL PROTEIN; GELATINASE-ASSOCIATED LIPOCALIN; INJURY; UROMODULIN; EXPRESSION; FAILURE; GROWTH; DAMAGE	Background Autosomal dominant polycystic kidney disease ( ADPKD) is characterized by a decline in renal function at late disease stage when the majority of functional renal parenchyma is replaced by cystic tissue. Thus, kidney function, assessed by estimated glomerular filtration rate (eGFR) does not well represent disease burden in early disease. Here, we investigated various urinary markers for tubular injury and their association with disease burden in ADPKD patients at early disease course. Methods ADPKD patients between 18 and 40 years with an eGFR greater or equal to 70 ml per min per 1.73m(2) were eligible for this cross-sectional study. Urinary Neutrophil Gelatinase- Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), and Uromodulin (UMOD) were investigated by Enzyme-Linked Immunosorbent Assay. Clara Cell Protein 16 (CC16) was investigated by Latex Immuno Assay. Cryoscopy was performed to assess urine osmolality and Urinary Albumin-to-Creatinine Ratio (UACR) was calculated. The association and the predictive properties of the markers on eGFR and height adjusted total kidney volume (htTKV) was evaluated using multiple regression analysis, incorporating different control variables for adjustment. Internal bootstrapping validated the obtained results. Results In 139 ADPKD patients (age 31 +/- 7 years, mean eGFR of 93 +/- 19 ml per min per 1.73m(2)) the total kidney volume was negatively correlated with eGFR and UMOD and positive associated with age, UACR, KIM-1 and urine osmolality after adjustment for possible confounders. Urine osmolality and htTKV were also associated with eGFR, whereas no association of CC16, NGAL and UMOD with eGFR or htTKV was found. Conclusion UACR and urinary KIM-1 are independently associated with kidney size but not with renal function in our study population. Urine osmolality was associated with eGFR and kidney volume following adjustment for multiple confounders. Despite statistical significance, the clinical value of our results is not yet conceivable. Further studies are needed to evaluate the property of the aforementioned biomarkers to assess disease state at early ADPKD stage.	[Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Inst Physiol, Zurich, Switzerland; [Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Poster, Diane; Krauer, Fabienne; Serra, Andreas L.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Spanaus, Katharina] Univ & Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland; [Andreisek, Gustav; Thi Dan Linh Nguyen-Kim] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Serra, Andreas L.; Rotar, Laura] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Univ Zurich, Coordinat Ctr, EuroCYST Initiat, Zurich, Switzerland; [Thien Anh Ho] Catholic Univ Louvain, Clin Univ St Luc, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Serra, Andreas L.; Rotar, Laura] Univ Zurich, Trancyst PEOPLE MCA ITN FP7, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Zurich	Serra, AL (corresponding author), Inst Physiol, Zurich, Switzerland.	andreas.serra@uzh.ch	Nguyen-Kim, PD Dr. Thi Dan Linh/AAD-7478-2019	Nguyen-Kim, Thi Dan Linh/0000-0001-9888-0453; Krauer, Fabienne/0000-0001-8341-4011	EuroCYST Initiative (ERA EDTA); TransCYST (FP7-PEOPLE-MCA-ITN) [317246]; European Community's 7th Framework Program (FP7) (EURenOmics) [305608]; Action de Recherche Concertee (Communaute Francaise de Belgique) [ARC10/15-029]; Inter-University Attraction Pole (IUAP, Belgium Federal Government); NCCR Kidney. CH program (Swiss National Science Foundation); Swiss National Science Foundation [310030-146490]	EuroCYST Initiative (ERA EDTA); TransCYST (FP7-PEOPLE-MCA-ITN); European Community's 7th Framework Program (FP7) (EURenOmics); Action de Recherche Concertee (Communaute Francaise de Belgique); Inter-University Attraction Pole (IUAP, Belgium Federal Government); NCCR Kidney. CH program (Swiss National Science Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the EuroCYST Initiative (ERA EDTA), TransCYST (FP7-PEOPLE-MCA-ITN no. 317246), European Community's 7th Framework Program (FP7/2007-2013) under grant n degrees 305608 (EURenOmics); Action de Recherche Concertee (ARC10/15-029, Communaute Francaise de Belgique); Inter-University Attraction Pole (IUAP, Belgium Federal Government); the NCCR Kidney. CH program (Swiss National Science Foundation); and the Swiss National Science Foundation 310030-146490.	Aberg F, 2014, CLIN TRANSPLANT, V28, P869, DOI 10.1111/ctr.12394; Arthur JM, 2014, KIDNEY INT, V85, P431, DOI 10.1038/ki.2013.333; Bachhaus K, 2000, BACHHAUS MULTIVARIAT; BERNARD A, 1991, CLIN CHIM ACTA, V201, P231, DOI 10.1016/0009-8981(91)90374-L; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; BERNARD AM, 1994, KIDNEY INT, pS34; Blanco G, 2013, AM J PHYSIOL-RENAL, V305, pF797, DOI 10.1152/ajprenal.00248.2013; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Briggs JP, 2008, KIDNEY INT, V74, P987, DOI 10.1038/ki.2008.426; CARONE FA, 1988, KIDNEY INT, V33, P8, DOI 10.1038/ki.1988.2; Chakraborty J, 2004, UROL RES, V32, P79, DOI 10.1007/s00240-003-0374-6; Chao YCE, 2008, J OCCUP ENVIRON HYG, V5, P519, DOI 10.1080/15459620802225481; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Damman K, 2010, HEART, V96, P1297, DOI 10.1136/hrt.2010.194878; Devuyst O, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-28; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Kuehn EW, 2007, BIOCHEM BIOPH RES CO, V364, P861, DOI 10.1016/j.bbrc.2007.10.103; Kuehn EW, 2002, AM J PHYSIOL-RENAL, V283, pF1326, DOI 10.1152/ajprenal.00166.2002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lohninger H., 2007, LOHNINGER GRUNDLAGEN; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Meijer E, 2010, CLIN J AM SOC NEPHRO, V5, P1091, DOI 10.2215/CJN.00360110; Mollsten A, 2010, SCAND J UROL NEPHROL, V44, P438, DOI 10.3109/00365599.2010.504190; Nisula S, 2014, ANESTH ANALG, V119, P95, DOI 10.1213/ANE.0000000000000243; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Tesch GH, 2010, NEPHROLOGY, V15, P609, DOI 10.1111/j.1440-1797.2010.01361.x; Ho TA, 2012, KIDNEY INT, V82, P1121, DOI 10.1038/ki.2012.225; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, KIDNEY INT, V81, P577, DOI 10.1038/ki.2011.411; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Youhanna S, 2014, NEPHROL DIAL TRANSPL, V29, P136, DOI 10.1093/ndt/gft345; Zhou JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071023	45	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123555	10.1371/journal.pone.0123555	http://dx.doi.org/10.1371/journal.pone.0123555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875363	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000352845100187
J	Real, J; Galindo, G; Galvan, L; Lafarga, MA; Rodrigo, MD; Ortega, M				Real, Jordi; Galindo, Gisela; Galvan, Leonardo; Antonia Lafarga, Maria; Dolors Rodrigo, Maria; Ortega, Marta			Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURE; VERTEBRAL FRACTURES; RISK; MANAGEMENT; INITIATION; DENSITY; MEN	Oral bisphosphonates are first-line drugs in the treatment of osteoporosis under most guidelines, and have been shown to decrease risk of first fracture only in asymptomatic vertebral fractures and in clinical trial populations that are generally very different from the general population. Objective To compare incidence of first osteoporotic fracture in two cohorts of postmenopausal women, one treated with bisphosphonates and the other only with calcium and vitamin D. Design Retrospective population cohort study with paired matching based on data from electronic health records. Setting Women aged 60 years and older in 2005, from 21 primary care centers in a healthcare region of Spain. Participants Two groups of women aged 60 years and older (n = 1208), prescribed either calcium and vitamin D (CalVitD) or bisphosphonates (BIPHOS) with or without calcium and vitamin D, were compared for the end point of first recorded osteoporotic-related fracture, with 5-years follow-up. Main Outcome Measure Incidence of first fracture: Vertebral fracture, osteoporosis with pathological fracture, fracture of the upper humeral epiphysis, fracture of the lower radial epiphysis, or femur fracture. Results Estimated 10-year risk of fracture was 11.4% (95% confidence interval: 9.6 to 13.2), 11.8% (9.2 to 14.3) in the BIPHOS group and 11.1%(8.6 to 13.6) in the CalVitD group. No significant differences were found between groups in total fractures (Hazard ratio = 0.934 (0.67 to 1.31)) or location (vertebral, femoral, radial or humeral). Conclusions In postmenopausal women, bisphosphonates have not been shown to better decrease risk of first fracture compared with calcium and vitamin D therapy alone.	[Real, Jordi; Galindo, Gisela] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Lleida, Spain; [Real, Jordi] Univ Int Catalunya, Sch Med & Hlth Sci, Sant Cugat Del Valles, Spain; [Galindo, Gisela] Inst Catala Salut, Primer Maig Ctr, Lleida, Spain; [Galvan, Leonardo] Catalan Hlth Dept, Lleida, Spain; [Antonia Lafarga, Maria; Dolors Rodrigo, Maria] Inst Catala Salut, Bordeta Magraners Ctr, Lleida, Spain; [Ortega, Marta] Inst Catala Salut, Cappont Ctr, Lleida, Spain	Universitat Internacional de Catalunya (UIC)	Real, J (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Lleida, Spain.	jreal.lleida.ics@gencat.cat		Lafarga, Maria Antonia/0000-0001-8402-3186; Real, Jordi/0000-0002-5979-8948				Agirrezabala J, 2006, INFAC, V14, P43; Alvarez Rodriguez E, 2009, IMPROVEMENT TREATMEN; American Academy of Family Physicians, 2014, 15 THINGS PHYS PAT S; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Arnold BF, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-94; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Azagra R, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-204; Barry P, 2014, DO NOT DO RECOMMENDA; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Brotons Munto F, 2014, WORKING GROUP RECOMM; Butt DA, 2013, OSTEOPOROSIS INT, V24, P2649, DOI 10.1007/s00198-013-2369-7; Burgos EC, 2011, REUMATOL CLIN, V7, pS28, DOI 10.1016/j.reuma.2011.06.002; Casado E, 2011, REUMATOL CLIN, V7, P305, DOI 10.1016/j.reuma.2010.12.008; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Departament de Salut de la Generalitat de Catalunya, 2013, BISPH POSTM WOM LOW; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Giannini S, 2009, Reumatismo, V61 Suppl 2, P2; Lopez-Valcarcel BG, 2013, MED CLIN-BARCELONA, V140, P104, DOI 10.1016/j.medcli.2011.11.030; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imaz I, 2010, OSTEOPOROSIS INT, V21, P1943, DOI 10.1007/s00198-009-1134-4; Imaz Iglesia I, 2010, COST UTILITY ANAL PR; Jamart Sancheza L, 2011, FMC, V18, P317; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Arias LHM, 2013, EUR J CLIN PHARMACOL, V69, P559, DOI 10.1007/s00228-012-1337-z; Guerra-Garcia MM, 2011, ATEN PRIM, V43, P82, DOI 10.1016/j.aprim.2010.04.010; Migliore A, 2013, EUR REV MED PHARMACO, V17, P658; Pages-Castella A, 2013, MED CLIN-BARCELONA, V141, P217, DOI 10.1016/j.medcli.2013.01.036; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Pressman A, 2001, OSTEOPOROSIS INT, V12, P337, DOI 10.1007/s001980170099; Richards M., 2010, REPORT SECRETARY STA; Sanfelix-Genoves J, 2014, MED CLIN-BARCELONA, V142, P15, DOI 10.1016/j.medcli.2012.10.025; Sanfelix-Gimeno G, 2013, MED CLIN-BARCELONA, V141, P527, DOI 10.1016/j.medcli.2013.09.013; Vazquez M, 2010, MED CLIN-BARCELONA, V134, P206, DOI 10.1016/j.medcli.2009.10.009; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003376.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0118178	10.1371/journal.pone.0118178	http://dx.doi.org/10.1371/journal.pone.0118178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861000	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300002
J	Gaffin, DD; Dewar, A; Graham, P; Philippides, A				Gaffin, Douglas D.; Dewar, Alexander; Graham, Paul; Philippides, Andrew			Insect-Inspired Navigation Algorithm for an Aerial Agent Using Satellite Imagery	PLOS ONE			English	Article							AUSTRALIAN DESERT ANT; PATH-INTEGRATION; HONEY-BEES; SNAPSHOTS; MAP	Humans have long marveled at the ability of animals to navigate swiftly, accurately, and across long distances. Many mechanisms have been proposed for how animals acquire, store, and retrace learned routes, yet many of these hypotheses appear incongruent with behavioral observations and the animals' neural constraints. The "Navigation by Scene Familiarity Hypothesis" proposed originally for insect navigation offers an elegantly simple solution for retracing previously experienced routes without the need for complex neural architectures and memory retrieval mechanisms. This hypothesis proposes that an animal can return to a target location by simply moving toward the most familiar scene at any given point. Proof of concept simulations have used computer-generated ant's-eye views of the world, but here we test the ability of scene familiarity algorithms to navigate training routes across satellite images extracted from Google Maps. We find that Google satellite images are so rich in visual information that familiarity algorithms can be used to retrace even tortuous routes with low-resolution sensors. We discuss the implications of these findings not only for animal navigation but also for the potential development of visual augmentation systems and robot guidance algorithms.	[Gaffin, Douglas D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Dewar, Alexander; Graham, Paul] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Philippides, Andrew] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Oklahoma System; University of Oklahoma - Norman; University of Sussex; University of Sussex	Gaffin, DD (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	ddgaffin@ou.edu	Philippides, Andrew/E-7240-2010	Philippides, Andrew/0000-0001-5503-0467; Graham, Paul/0000-0002-3745-0940; Gaffin, Douglas/0000-0003-3340-9147	Research Council of the University of Oklahoma Norman Campus; Biotechnology and Biological Sciences Research Council [BB/F015925/1, BB/H013644]; Engineering and Physical Sciences Research Council [EP/I031758/1]; EU [ICT 308943]; EPSRC [EP/I031758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1090672] Funding Source: researchfish	Research Council of the University of Oklahoma Norman Campus; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DG was supported by a grant from the Research Council of the University of Oklahoma Norman Campus. AD and PG are both funded by the Biotechnology and Biological Sciences Research Council (grant codes: BB/F015925/1 and BB/H013644). AP is funded by the Engineering and Physical Sciences Research Council (EP/I031758/1) and an EU FP7 grant (ICT 308943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; CARTWRIGHT BA, 1987, BIOL CYBERN, V57, P85, DOI 10.1007/BF00318718; Chittka L, 2012, PHILOS T R SOC B, V367, P2677, DOI 10.1098/rstb.2012.0215; Collett TS, 2003, CURR OPIN NEUROBIOL, V13, P718, DOI 10.1016/j.conb.2003.10.004; GOULD JL, 1986, SCIENCE, V232, P861, DOI 10.1126/science.232.4752.861; Graham P, 2012, ENCY NANOTECHNOLOGY, P1122; Hentschel M, 2010, IEEE INT C INT TRANS, DOI [10.1109/ITSC.2010.5625092, DOI 10.1109/ITSC.2010.5625092]; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Majdik AL, 2013, IEEE INT C INT ROBOT, P3979, DOI 10.1109/IROS.2013.6696925; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Muser B, 2005, AUST J ZOOL, V53, P301, DOI 10.1071/ZO05023; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Santschi F., 1911, Revue Suisse de Zoologie, V19; Senlet T, 2012, IEEE INT CONF ROBOT, P2647, DOI 10.1109/ICRA.2012.6225352; Smith L, 2007, ADAPT BEHAV, V15, P257, DOI 10.1177/1059712307082091; Sommer S, 2008, P NATL ACAD SCI USA, V105, P317, DOI 10.1073/pnas.0710157104; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Sturzl W, 2006, ROBOT AUTON SYST, V54, P300, DOI 10.1016/j.robot.2005.12.001; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wehner R, 2004, ECOL ENTOMOL, V29, P240, DOI 10.1111/j.0307-6946.2004.00591.x; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; Wystrach A, 2014, J COMP PHYSIOL A, V200, P615, DOI 10.1007/s00359-014-0900-8; Wystrach A, 2014, CURR BIOL, V24, pR78, DOI 10.1016/j.cub.2013.11.054; Wystrach A, 2013, J EXP BIOL, V216, P1766, DOI 10.1242/jeb.082941; Wystrach A, 2012, ANIM BEHAV, V84, P13, DOI 10.1016/j.anbehav.2012.04.017; Zeil J, 1996, J EXP BIOL, V199, P245; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450	31	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122077	10.1371/journal.pone.0122077	http://dx.doi.org/10.1371/journal.pone.0122077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874764	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800036
J	Hsu, JF; Chu, SM; Lee, CW; Yang, PH; Lien, RY; Chiang, MC; Fu, RH; Huang, HR; Tsai, MH				Hsu, Jen-Fu; Chu, Shih-Ming; Lee, Chiang-Wen; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong; Tsai, Ming-Horng			Incidence, Clinical Characteristics and Attributable Mortality of Persistent Bloodstream Infection in the Neonatal Intensive Care Unit	PLOS ONE			English	Article							LATE-ONSET SEPSIS; COAGULASE-NEGATIVE STAPHYLOCOCCI; RISK-FACTORS; BACTEREMIA; THERAPY; EPIDEMIOLOGY; CANDIDIASIS; CANDIDEMIA; INFANTS	Background An atypical pattern of neonatal sepsis, characterized by persistent positive blood culture despite effective antimicrobial therapy, has been correlated with adverse outcomes. However, previous studies focused only on coagulate-negative staphylococcus infection. Methods All episodes of persistent bloodstream infection (BSI), defined as 3 or more consecutive positive blood cultures with the same bacterial species, at least two of them 48 hours apart, during a single sepsis episode, were enrolled over an 8-year period in a tertiary level neonatal intensive care unit. These cases were compared with all non-persistent BSI during the same period. Results We identified 81 episodes of persistent BSI (8.5% of all neonatal late-onset sepsis) in 74 infants, caused by gram-positive pathogens (n=38, 46.9%), gram-negative pathogens (n=21, 25.9%), fungus (n=20, 24.7%) and polymicrobial bacteremia (n=2, 2.5%). Persistent BSI does not differ from non-persistent BSI in most clinical characteristics and patient demo-graphics, but tends to have a prolonged septic course, longer duration of feeding intolerance and more frequent requirement of blood transfusions. No difference was observed for death attributable to infection (9.8% vs. 6.5%), but neonates with persistent BSI had significantly higher rates of infectious complications (29.6% vs. 9.2%, P<0.001), death from all causes (21.6% vs. 11.7%, P=0.025), and duration of hospitalization among survivors [median (interquartile range): 80.0 (52.5-117.5) vs. 64.0 (40.0-96.0) days, P = 0.005] than those without persistent BSI. Conclusions Although persistent BSI does not contribute directly to increased mortality, the associated morbidities, infectious complications and prolonged septic courses highlight the importance of aggressive treatment to optimize outcomes.	[Hsu, Jen-Fu; Chu, Shih-Ming; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Taoyuan, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Div Neonatol & Pediat Hematol Oncol, Dept Pediat, Yunlin, Taiwan; [Hsu, Jen-Fu; Chu, Shih-Ming; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong; Tsai, Ming-Horng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Div Basic Med Sci, Dept Nursing, Chiayi, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Div Neonatol & Pediat Hematol Oncol, Dept Pediat, Yunlin, Taiwan.	mingmin.tw@yahoo.com.tw			Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG340599]	Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital	All authors thank Mrs. Chiao-Ching Chiang for keeping the database of our NICU, and all nursing staff working in our NICUs for keeping extremely detailed patient records, which contributed greatly to the completion of this research. We want to thank Miss Chun-Chun Cheng and Mr. Yu-Jr Lin for statistical consultation, who was supported by grants from Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (CLRPG340599).	Anderson-Berry A, 2011, NEONATOLOGY, V99, P23, DOI 10.1159/000292567; Apisarnthanarak A, 2003, PEDIATRICS, V112, P1283, DOI 10.1542/peds.112.6.1283; Benjamin DK, 2010, PEDIATRICS, V126, pE865, DOI 10.1542/peds.2009-3412; Benjamin DK, 2000, PEDIATRICS, V106, P712, DOI 10.1542/peds.106.4.712; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; Chapman RL, 2000, PEDIATR INFECT DIS J, V19, P822, DOI 10.1097/00006454-200009000-00003; Chapman RL, 2003, PEDIATR INFECT DIS J, V22, P17, DOI 10.1097/00006454-200301000-00008; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI S; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Dimitriou G, 2011, CLIN MICROBIOL INFEC, V17, P1684, DOI 10.1111/j.1469-0691.2011.03489.x; DOBSON SRM, 1990, PEDIATRICS, V85, P165; Gleason CA, 2011, AVERYS DIS NEWBORN; Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e; GRAY JE, 1992, PEDIATRICS, V90, P561; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Karlowicz MG, 2002, PEDIATR INFECT DIS J, V21, P22, DOI 10.1097/00006454-200201000-00005; Karlowicz MG, 2000, PEDIATRICS, V106, P1387, DOI 10.1542/peds.106.6.1387; Khashu M, 2006, PEDIATRICS, V117, P340, DOI 10.1542/peds.2005-0333; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Lemonovich TL, 2011, INFECTION, V39, P549, DOI 10.1007/s15010-011-0189-2; Linder N, 2011, EUR J PEDIATR, V170, P989, DOI 10.1007/s00431-010-1387-0; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; Odio CM, 2004, PEDIATR INFECT DIS J, V23, P1093, DOI 10.1097/01.inf.0000145408.51526.0a; Oeser C, 2013, PEDIATR INFECT DIS J, V32, P23, DOI 10.1097/INF.0b013e318275612e; PATRICK CC, 1989, PEDIATRICS, V84, P977; Robinson JA, 2012, J PERINATOL, V32, P621, DOI 10.1038/jp.2011.162; Sutter D, 2008, PEDIATR INFECT DIS J, V27, P400, DOI 10.1097/INF.0b013e31816591be; Tsai MH, 2014, CLIN MICROBIOL INFEC, V20, pO928, DOI 10.1111/1469-0691.12661; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Tsai MH, 2012, AM J INFECT CONTROL, V40, P59, DOI 10.1016/j.ajic.2011.04.051; Tsai MH, 2009, PEDIATR INFECT DIS J, V28, P966, DOI 10.1097/INF.0b013e3181aa3a29; Uckay I, 2012, ANTIMICROB AGENTS CH, V56, P1258, DOI 10.1128/AAC.05808-11; van der Lugt NM, 2010, BMC PEDIATR, V19, P10; Xia HP, 2014, PEDIATR INFECT DIS J, V33, P106, DOI 10.1097/INF.0000000000000009	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124567	10.1371/journal.pone.0124567	http://dx.doi.org/10.1371/journal.pone.0124567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875677	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800143
J	Jiang, JJ; Lee, CL; Fang, MD; Boyd, KG; Gibb, SW				Jiang, Jheng Jie; Lee, Chon Lin; Fang, Meng Der; Boyd, Kenneth G.; Gibb, Stuart W.			Source Apportionment and Risk Assessment of Emerging Contaminants: An Approach of Pharmaco-Signature in Water Systems	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; POLYCYCLIC AROMATIC-HYDROCARBONS; WASTE-WATER; SURFACE WATERS; ILLICIT DRUGS; RIVER-BASIN; PHARMACEUTICAL RESIDUES; ENVIRONMENTAL RELEASE; ENDOCRINE DISRUPTORS; URBAN ATMOSPHERE	This paper presents a methodology based on multivariate data analysis for characterizing potential source contributions of emerging contaminants (ECs) detected in 26 river water samples across multi-scape regions during dry and wet seasons. Based on this methodology, we unveil an approach toward potential source contributions of ECs, a concept we refer to as the "Pharmaco-signature." Exploratory analysis of data points has been carried out by unsupervised pattern recognition (hierarchical cluster analysis, HCA) and receptor model (principal component analysis-multiple linear regression, PCA-MLR) in an attempt to demonstrate significant source contributions of ECs in different land-use zone. Robust cluster solutions grouped the database according to different EC profiles. PCA-MLR identified that 58.9% of the mean summed ECs were contributed by domestic impact, 9.7% by antibiotics application, and 31.4% by drug abuse. Diclofenac, ibuprofen, codeine, ampicillin, tetracycline, and erythromycin-H2O have significant pollution risk quotients (RQ>1), indicating potentially high risk to aquatic organisms in Taiwan.	[Jiang, Jheng Jie; Lee, Chon Lin] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan; [Lee, Chon Lin] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Lee, Chon Lin] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan; [Lee, Chon Lin] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Fang, Meng Der] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Boyd, Kenneth G.; Gibb, Stuart W.] Univ Highlands & Isl, North Highland Coll, ERI, Thurso, Caithness, Scotland	National Sun Yat Sen University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Industrial Technology Research Institute - Taiwan; UHI Millennium Institute	Lee, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan.	linnohc@mail.nsysu.edu.tw	Jiang, Jheng-Jie/H-6031-2016; PRAZERES, KELLY C/O-7715-2015	Jiang, Jheng-Jie/0000-0002-2887-723X; Lee, Chon-Lin/0000-0003-0521-1440; Gibb, Stuart/0000-0003-3882-338X; Boyd, Kenneth/0000-0002-6501-6324	Ministry of Science and Technology (MOST) [NSC 97-2911-I-110-012, NSC 99-2611-M-110-004]; Ministry of Education of Taiwan, R.O.C. [DOE 98C030219, DOE 01C030703]; Kaohsiung Medical University "Aim for the Top University Grant [KMU-TP103A27]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education of Taiwan, R.O.C.; Kaohsiung Medical University "Aim for the Top University Grant	This study was funded by the Ministry of Science and Technology (MOST), Grant NSC 97-2911-I-110-012 and NSC 99-2611-M-110-004, and by the Ministry of Education of Taiwan, R.O.C., project DOE 98C030219 and DOE 01C030703. This study was also supported partially by Kaohsiung Medical University "Aim for the Top University Grant (Grant No. KMU-TP103A27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DR, 2011, J CHROMATOGR A, V1218, P1620, DOI 10.1016/j.chroma.2011.01.060; Bartelt-Hunt SL, 2009, ENVIRON POLLUT, V157, P786, DOI 10.1016/j.envpol.2008.11.025; Cao JL, 2010, CHINESE SCI BULL, V55, P3138, DOI 10.1007/s11434-010-3158-8; Chang H, 2009, ENVIRON SCI TECHNOL, V43, P7691, DOI 10.1021/es803653j; Chang SCCM, 2003, INFECT CONTROL J, V13, P334; Daneshvar A, 2012, CHEMOSPHERE, V88, P131, DOI 10.1016/j.chemosphere.2012.03.016; Daughton CG, 2004, ENVIRON IMPACT ASSES, V24, P711, DOI 10.1016/j.eiar.2004.06.003; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Duan YP, 2013, ENVIRON SCI POLLUT R, V20, P108, DOI 10.1007/s11356-012-1000-3; EMEA, 2005, CPMPSEP444700 EMEA; Fernandez C, 2010, SCI TOTAL ENVIRON, V408, P543, DOI 10.1016/j.scitotenv.2009.10.009; da Silva BF, 2011, CHEMOSPHERE, V85, P1331, DOI 10.1016/j.chemosphere.2011.07.051; Gobel A, 2005, ENVIRON SCI TECHNOL, V39, P3981, DOI 10.1021/es048550a; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Heeb F, 2012, ENVIRON SCI TECHNOL, V46, P8680, DOI 10.1021/es301912q; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Hollender J, 2009, ENVIRON SCI TECHNOL, V43, P7862, DOI 10.1021/es9014629; Hopke PK, 2003, J CHEMOMETR, V17, P255, DOI 10.1002/cem.796; Jiang JJ, 2014, MAR POLLUT BULL, V85, P391, DOI 10.1016/j.marpolbul.2013.12.045; Jones-Lepp TL, 2012, SCI TOTAL ENVIRON, V430, P237, DOI 10.1016/j.scitotenv.2012.04.053; Joss A, 2005, WATER RES, V39, P3139, DOI 10.1016/j.watres.2005.05.031; Kasprzyk-Hordern B, 2008, WATER RES, V42, P3498, DOI 10.1016/j.watres.2008.04.026; Kim SD, 2007, WATER RES, V41, P1013, DOI 10.1016/j.watres.2006.06.034; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184; Li WH, 2012, CHEMOSPHERE, V89, P1307, DOI 10.1016/j.chemosphere.2012.05.079; Lin AYC, 2009, SCI TOTAL ENVIRON, V407, P3793, DOI 10.1016/j.scitotenv.2009.03.009; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Nakada N, 2007, WATER SCI TECHNOL, V56, P133, DOI 10.2166/wst.2007.801; Pal A, 2014, ENVIRON INT, V71, P46, DOI 10.1016/j.envint.2014.05.025; Postigo C, 2010, ENVIRON INT, V36, P75, DOI 10.1016/j.envint.2009.10.004; Santos JL, 2007, ENVIRON INT, V33, P596, DOI 10.1016/j.envint.2006.09.014; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Diaz-Cruz MS, 2012, ANAL BIOANAL CHEM, V402, P2325, DOI 10.1007/s00216-011-5560-8; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; Singh KP, 2008, ENVIRON MONIT ASSESS, V136, P183, DOI 10.1007/s10661-007-9674-6; Spongberg AL, 2008, SCI TOTAL ENVIRON, V397, P148, DOI 10.1016/j.scitotenv.2008.02.042; Stout SA, 2010, ENVIRON SCI TECHNOL, V44, P2932, DOI 10.1021/es903353z; Stuart M, 2012, SCI TOTAL ENVIRON, V416, P1, DOI 10.1016/j.scitotenv.2011.11.072; Thomaidis NS, 2012, GLOBAL NEST J, V14, P72; Thomas KV, 2012, SCI TOTAL ENVIRON, V432, P432, DOI 10.1016/j.scitotenv.2012.06.069; van der Aa M, 2013, WATER RES, V47, P1848, DOI 10.1016/j.watres.2013.01.013; Vazquez-Roig P, 2010, ANAL BIOANAL CHEM, V397, P2851, DOI 10.1007/s00216-010-3720-x; Vazquez-Roig P, 2012, ENVIRON SCI POLLUT R, V19, P971, DOI 10.1007/s11356-011-0617-y; Vidal-Dorsch DE, 2012, ENVIRON TOXICOL CHEM, V31, P2674, DOI 10.1002/etc.2004; Wick A, 2009, WATER RES, V43, P1060, DOI 10.1016/j.watres.2008.11.031; Yoon Y, 2010, SCI TOTAL ENVIRON, V408, P636, DOI 10.1016/j.scitotenv.2009.10.049; Yu Y, 2013, SCI TOTAL ENVIRON, V442, P310, DOI 10.1016/j.scitotenv.2012.10.001; Zhang SY, 2007, CHEMOSPHERE, V66, P1057, DOI 10.1016/j.chemosphere.2006.06.067	51	17	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122813	10.1371/journal.pone.0122813	http://dx.doi.org/10.1371/journal.pone.0122813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874375	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800078
J	Avanzi, MP; Izak, M; Oluwadara, OE; Mitchell, WB				Avanzi, Mauro P.; Izak, Marina; Oluwadara, Oluwasijibomi E.; Mitchell, William Beau			Actin Inhibition Increases Megakaryocyte Proplatelet Formation through an Apoptosis Dependent Mechanism	PLOS ONE			English	Article							CELL-DEATH; CASPASE ACTIVATION; PLATELET FORMATION; BCL-X; DIFFERENTIATION; MITOCHONDRIA; SENESCENCE; EXPRESSION; MATURATION; PROTEINS	Background Megakaryocytes assemble and release platelets through the extension of proplatelet processes, which are cytoplasmic extensions that extrude from the megakaryocyte and form platelets at their tips. Proplatelet formation and platelet release are complex processes that require a combination of structural rearrangements. While the signals that trigger the initiation of proplatelet formation process are not completely understood, it has been shown that inhibition of cytoskeletal signaling in mature megakaryocytes induces proplatelet formation. Megakaryocyte apoptosis may also be involved in initiation of proplatelet extension, although this is controversial. This study inquires whether the proplatelet production induced by cytoskeletal signaling inhibition is dependent on activation of apoptosis. Methods Megakaryocytes derived from human umbilical cord blood CD34+ cells were treated with the actin polymerization inhibitor latrunculin and their ploidy and proplatelet formation were quantitated. Apoptosis activation was analyzed by flow cytometry and luminescence assays. Caspase activity was inhibited by two compounds, ZVAD and QVD. Expression levels of pro-survival and pro-apoptosis genes were measured by quantitative RT-PCR. Protein levels of Bcl-XL, Bax and Bak were measured by western blot. Cell ultrastructure was analyzed by electron microscopy. Results Actin inhibition resulted in increased ploidy and increased proplatelet formation in cultured umbilical cord blood-derived megakaryocytes. Actin inhibition activated apoptosis in the cultured cells. The effects of actin inhibition on proplatelet formation were blocked by caspase inhibition. Increased expression of both pro-apoptotic and pro-survival genes was observed. Pro-survival protein (Bcl-xL) levels were increased compared to levels of proapoptotic proteins Bak and Bax. Despite apoptosis being activated, the megakaryocytes underwent minimal ultrastructural changes during actin inhibition.	[Avanzi, Mauro P.; Izak, Marina; Oluwadara, Oluwasijibomi E.; Mitchell, William Beau] New York Blood Ctr, Platelet Biol Lab, New York, NY 10021 USA	New York Blood Center	Mitchell, WB (corresponding author), New York Blood Ctr, Platelet Biol Lab, New York, NY 10021 USA.	bmitchell@nybloodcenter.org						Avanzi MP, 2014, BRIT J HAEMATOL, V164, P867, DOI 10.1111/bjh.12709; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Battinelli E, 2000, BLOOD, V95, P3451, DOI 10.1182/blood.V95.11.3451.011k34_3451_3459; Battinelli E, 2001, P NATL ACAD SCI USA, V98, P14458, DOI 10.1073/pnas.241427398; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falcieri E, 2000, ANAT RECORD, V258, P90, DOI 10.1002/(SICI)1097-0185(20000101)258:1<90::AID-AR10>3.0.CO;2-G; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Josefsson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4455; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Kaluzhny Y, 2003, ACTA HAEMATOL-BASEL, V111, P67, DOI 10.1159/000074487; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Konishi H, 2009, ANTICANCER RES, V29, P2091; Kozuma Y, 2007, J THROMB HAEMOST, V5, P1274, DOI 10.1111/j.1538-7836.2007.02546.x; Kozuma Y, 2009, LEUKEMIA, V23, P1080, DOI 10.1038/leu.2009.7; Kren BT, 1996, CELL GROWTH DIFFER, V7, P1633; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Martin S, 2001, TELECONNECT, V19, P10; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; RADLEY JM, 1983, BRIT J HAEMATOL, V53, P277, DOI 10.1111/j.1365-2141.1983.tb02022.x; Sanz C, 2001, EXP HEMATOL, V29, P728, DOI 10.1016/S0301-472X(01)00635-X; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069315; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Terui Y, 1998, EXP HEMATOL, V26, P236; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; White MJ, 2010, SEMIN HEMATOL, V47, P227, DOI 10.1053/j.seminhematol.2010.03.006; Yang L, 2010, BLOOD, V116, P4307, DOI 10.1182/blood-2010-02-267435; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Zauli G, 1997, BLOOD, V90, P2234	39	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125057	10.1371/journal.pone.0125057	http://dx.doi.org/10.1371/journal.pone.0125057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875470	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700074
J	Witowski, N; Lusczek, E; Determan, C; Lexcen, D; Mulier, K; Ostrowski, B; Beilman, G				Witowski, Nancy; Lusczek, Elizabeth; Determan, Charles, Jr.; Lexcen, Daniel; Mulier, Kristine; Ostrowski, Beverly; Beilman, Greg			A Four-Compartment Metabolomics Analysis of the Liver, Muscle, Serum, and Urine Response to Polytrauma with Hemorrhagic Shock following Carbohydrate Prefeed	PLOS ONE			English	Article							SKELETAL-MUSCLE; MITOCHONDRIAL MEGACHANNEL; NETWORK ANALYSIS; ACID CYCLE; RESUSCITATION; METABOLISM; MODULATION; GLUCOSE; TRAUMA; PLASMA	Objective Hemorrhagic shock accompanied by injury represents a major physiologic stress. Fasted animals are often used to study hemorrhagic shock (with injury). A fasted state is not guaranteed in the general human population. The objective of this study was to determine if fed animals would exhibit a different metabolic profile in response to hemorrhagic shock with trauma when compared to fasted animals. Methods Proton (1H) NMR spectroscopy was used to determine concentrations of metabolites from four different compartments (liver, muscle, serum, urine) taken at defined time points throughout shock/injury and resuscitation. PLS-DA was performed and VIP lists established for baseline, shock and resuscitation (10 metabolites for each compartment at each time interval) on metabolomics data from surviving animals. Results Fed status prior to the occurrence of hemorrhagic shock with injury alters the metabolic course of this trauma and potentially affects mortality. The death rate for CPF animals is higher than FS animals (47 vs 28%). The majority of deaths occur post-resuscitation suggesting reperfusion injury. The metabolomics response to shock reflects priorities evident at baseline. FS animals raise the baseline degree of proteolysis to provide additional amino acids for energy production while CPF animals rely on both glucose and, to a lesser extent, amino acids. During early resuscitation levels of metabolites associated with energy production drop, suggesting diminished demand. Conclusions Feeding status prior to the occurrence of hemorrhagic shock with injury alters the metabolic course of this trauma and potentially affects mortality. The response to shock reflects metabolic priorities at baseline.	[Witowski, Nancy; Lusczek, Elizabeth; Determan, Charles, Jr.; Lexcen, Daniel; Mulier, Kristine; Beilman, Greg] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Ostrowski, Beverly] Univ Minnesota, Minnesota NMR Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Witowski, N (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	witow001@umn.edu		Beilman, Gregory/0000-0001-5036-3027; Lusczek, Elizabeth/0000-0003-4680-965X	Office of Naval Research [N00014-09-0323]; University of Minnesota; North Memorial Center; Office of the Vice President for Research; Medical School; College of Biological Science; National Institutes of Health; NSF; Minnesota Medical Foundation	Office of Naval Research(Office of Naval Research); University of Minnesota(University of Minnesota System); North Memorial Center; Office of the Vice President for Research; Medical School; College of Biological Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Minnesota Medical Foundation	Funding was provided by Office of Naval Research - N00014-09-0323, University of Minnesota, and North Memorial Center. Funding for NMR instrumentation was provided by the Office of the Vice President for Research, the Medical School, the College of Biological Science, National Institutes of Health, NSF, and the Minnesota Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Argiles JM, 2001, LIFE SCI, V69, P1345, DOI 10.1016/S0024-3205(01)01238-3; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Colling KP, 2015, SHOCK, V44, P103, DOI 10.1097/SHK.0000000000000324; de Lange P, 2006, FASEB J, V20, DOI 10.1096/fj.06-6025fje; Determan CE, 2014, METABOLOMICS, V10, P950, DOI 10.1007/s11306-014-0621-6; Deussen A, 2012, J MOL CELL CARDIOL, V52, P794, DOI 10.1016/j.yjmcc.2011.10.001; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; FRIEDMAN SG, 1982, J TRAUMA, V22, P86, DOI 10.1097/00005373-198202000-00002; Frizzell N, 2012, BIOCHEM J, V445, P247, DOI 10.1042/BJ20112142; GRANGER DN, 1986, GASTROENTEROLOGY, V90, P80, DOI 10.1016/0016-5085(86)90078-8; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heininger K, 2002, INT REV NEUROBIOL, V51, P103, DOI 10.1016/S0074-7742(02)51004-7; Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Liland KH, 2011, TRAC-TREND ANAL CHEM, V30, P827, DOI 10.1016/j.trac.2011.02.007; LJUNGQVIST O, 1990, AM J PHYSIOL, V259, pE692, DOI 10.1152/ajpendo.1990.259.5.E692; LJUNGQVIST O, 1987, CIRC SHOCK, V22, P251; Lusczek E. R., 2011, J BIOANAL BIOMED, V3, P38, DOI DOI 10.4172/1948-593X.1000041; Lusczek ER, 2013, METABOLOMICS, V9, P223, DOI 10.1007/s11306-012-0441-5; MATEOS FA, 1987, J CLIN INVEST, V79, P847, DOI 10.1172/JCI112893; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; Mulier KE, 2012, J SURG RES, V174, pE31, DOI 10.1016/j.jss.2011.10.005; Naimi M, 2010, TRENDS ENDOCRIN MET, V21, P75, DOI 10.1016/j.tem.2009.09.003; Orman MA, 2012, J THEOR BIOL, V293, P101, DOI 10.1016/j.jtbi.2011.10.019; R Core Team, 2013, R LANG ENV STAT COMP; Ruilope L M, 2001, Curr Hypertens Rep, V3, P197, DOI 10.1007/s11906-001-0038-2; Sanchez G, 2013, DISCRIMINER TOOLS TR; Simpson GL, 2014, PERMUTE FUNCTIONS GE; Sonanez-Organis JG, 2012, J EXP BIOL, V215, P1448, DOI 10.1242/jeb.067173; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; VIANT MA, 2007, METHOD MOL BIOL, P229; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wishart DS, 2006, CURR OPIN NEPHROL HY, V15, P637, DOI 10.1097/01.mnh.0000247499.64291.52	40	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124467	10.1371/journal.pone.0124467	http://dx.doi.org/10.1371/journal.pone.0124467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875111	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700069
J	Ahmadiafshar, A; Mohsenifard, MR; Mazloomzadeh, S				Ahmadiafshar, Akefeh; Mohsenifard, Mahmood Reza; Mazloomzadeh, Saeideh			Evaluation of Serum & Salivary IgA in Patients with Type 1 Diabetes	PLOS ONE			English	Article							IMMUNOGLOBULIN-A DEFICIENCY; BLOOD-DONORS; PREVALENCE; CHILDREN	Background Diabetes mellitus is a common immune mediated disorder. The aim of the present study is to evaluate the level of serum and salivary IgA levels in patients with Type 1 diabetes. Material and Method In this case control study, serum and salivary IgA levels of patients with diabetes type 1 and similar non diabetes subjects were measured. Age, gender, duration of diabetes and the last HbA1c level of diabetic patients were also studied. Data was analyzed by SPSS software. Results Two hundred and fifty subjects (126 diabetics and 124 non diabetics) were enrolled in the study. The mean value of serum IgA in patients with Type 1 Diabetes and controls was 1.77 +/- 1.55 g/lit and 2.39 +/- 1.52 g/lit, respectively. The mean salivary IgA level in diabetics and controls was 276 +/- 162.5 40 mu g/ml and 129 +/- 112.2 40 mu g/ml, respectively. Selective IgA deficiency was detected in two (1.6%) and three(2.4%) cases of diabetic and control group; respectively (p=0.68). We found low salivary IgA level in 44.4% diabetic and 33.9% control (p=0.08). There was no significant correlation between serum and salivary IgA level. There was also significant association between serum IgA levels with age. Salivary IgA was significantly correlated with HbA1c level. But considering gender, duration of diabetes we didn't find any association. Conclusion We didn't find any significant difference in serum and salivary IgA level among diabetic and non diabetics and also, no association between serum and salivary IgA levels.	[Ahmadiafshar, Akefeh; Mohsenifard, Mahmood Reza] Zanjan Univ Med Sci, Metab Dis Res Ctr, Zanjan, Iran; [Ahmadiafshar, Akefeh; Mazloomzadeh, Saeideh] Zanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Zanjan, Iran; [Mohsenifard, Mahmood Reza] Zanjan Univ Med Sci, Mousavi Hosp, Zanjan, Iran		Ahmadiafshar, A (corresponding author), Zanjan Univ Med Sci, Metab Dis Res Ctr, Zanjan, Iran.	akefeh45@zums.ac.ir	Ahmadiafshar, Akefeh/M-8150-2019; Ahmadiafshar, a/L-1879-2016; Mazloomzadeh, Saeideh/H-4062-2016; Vazirinejad, Reza/Q-9333-2017	Ahmadiafshar, a/0000-0002-9202-6915; Mazloomzadeh, Saeideh/0000-0001-6325-0662; Vazirinejad, Reza/0000-0002-1967-7631	Zanjan University of Medical Sciences	Zanjan University of Medical Sciences	This study was supported by (Zanjan University of Medical Sciences) after being approved by the research council of ZUMS and permission of the ethic committee of ZUMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bakianian Vaziri P, 2010, J Dent (Tehran), V7, P13; Basturk B, 2011, TURKISH J PEDIATR, V53, P364; Belazi M A, 1998, Int J Paediatr Dent, V8, P29, DOI 10.1046/j.1365-263X.1998.00057.x; Bhuyan SK, 2011, J INDIAN ACAD ORAL M, V23, P548, DOI DOI 10.5005/jp-journals-10011-1220; Bokor-Bratic M, MED PREGL, V53, P164; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Branco-de-Almeida LS, 2011, BRAZ ORAL RES, V25, P550, DOI 10.1590/S1806-83242011000600013; Chandran S, 2006, INDIAN J MED RES, V123, P653; Dunne JL, 2014, CLIN EXP IMMUNOL, V177, P30, DOI 10.1111/cei.12321; Fageras M, 2011, PEDIATR RES, V70, P572, DOI 10.1203/PDR.0b013e318232169e; Feng ML, 2011, TRANSFUSION MED, V21, P338, DOI 10.1111/j.1365-3148.2011.01082.x; Jafarzadeh Abdollah, 2010, Braz. oral res., V24, P21, DOI 10.1590/S1806-83242010000100004; Lamb MM, 2015, PEDIATR DIABETES, V16, P31, DOI 10.1111/pedi.12115; Moazezi Z, 2014, IRAN J ALLERGY ASTHM, V13, P110; Moise Ana, 2010, J Med Life, V3, P60; Moradinejad MH, 2011, IRAN J ALLERGY ASTHM, V10, P35, DOI 010.01/ijaai.3540; OHMURO H, 1993, NEPHRON, V63, P355, DOI 10.1159/000187224; Palmer DS, 2010, TRANSFUSION, V50, P1524, DOI 10.1111/j.1537-2995.2010.02588.x; Peng J, 2014, J AUTOIMMUN, V53, P85, DOI 10.1016/j.jaut.2014.03.005; Rashkova M, 2009, OHDMBSC, V8, P16; RodriguezSegade S, 1996, CLIN CHEM, V42, P1064; Saghafi S, 2008, IRAN J ALLERGY ASTHM, V7, P157, DOI 07.03/ijaai.157162; Sakowicz-Burkiewicz M, 2013, IMMUNOBIOLOGY, V218, P591, DOI 10.1016/j.imbio.2012.07.010; Sayarifard F, 2012, ACTA DIABETOL, V49, P131, DOI 10.1007/s00592-010-0183-7; Svensson J, 2012, HUM IMMUNOL, V73, P17, DOI 10.1016/j.humimm.2011.10.019; Teeuw W, 2004, BIOL CHEM, V385, P1137, DOI 10.1515/BC.2004.147; Wang N, 2012, CURR OPIN ALLERGY CL, V12, P602, DOI 10.1097/ACI.0b013e3283594219; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zipris D, 2013, CURR OPIN ENDOCRINOL, V20, P265, DOI 10.1097/MED.0b013e3283628569	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122757	10.1371/journal.pone.0122757	http://dx.doi.org/10.1371/journal.pone.0122757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875365	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100098
J	Fujita, T; Yuno, M; Okuzaki, D; Ohki, R; Fujii, H				Fujita, Toshitsugu; Yuno, Miyuki; Okuzaki, Daisuke; Ohki, Rieko; Fujii, Hodaka			Identification of Non-Coding RNAs Associated with Telomeres Using a Combination of enChIP and RNA Sequencing	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CHROMATIN IMMUNOPRECIPITATION; EFFICIENT ISOLATION; GENOMIC REGIONS; HUMAN-DISEASE; NUCLEAR; MUTATIONS; COMPONENT; UNVEILS	Accumulating evidence suggests that RNAs interacting with genomic regions play important roles in the regulation of genome functions, including X chromosome inactivation and gene expression. However, to our knowledge, no non-biased methods of identifying RNAs that interact with a specific genomic region have been reported. Here, we used enChIP-RNA-Seq, a combination of engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) and RNA sequencing (RNA-Seq), to perform a non-biased search for RNAs interacting with telomeres. In enChIP-RNA-Seq, the target genomic regions are captured using an engineered DNA-binding molecule such as a transcription activator-like protein. Subsequently, RNAs that interact with the target genomic regions are purified and sequenced. The RNAs detected by enChIP-RNA-Seq contained known telomere-binding RNAs, including the telomerase RNA component (Terc), the RNA component of mitochondrial RNA processing endoribonuclease (Rmrp), and Cajal body-specific RNAs. In addition, a number of novel telomere-binding non-coding RNAs were also identified. Binding of two candidate non-coding RNAs to telomeres was confirmed by immunofluorescence microscopy and RNA fluorescence in situ hybridization (RNA-FISH) analyses. The novel telomerebinding non-coding RNAs identified here may play important roles in telomere functions. To our knowledge, this study is the first non-biased identification of RNAs associated with specific genomic regions. The results presented here suggest that enChIP-RNA-Seq analyses are useful for the identification of RNAs interacting with specific genomic regions, and may help to contribute to current understanding of the regulation of genome functions.	[Fujita, Toshitsugu; Yuno, Miyuki; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan; [Ohki, Rieko] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Tokyo 104, Japan	Osaka University; Osaka University; National Cancer Center - Japan	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/N-9792-2019; Fujita, Toshitsugu/AAB-4964-2022; FUJITA, Toshitsugu/ABH-5101-2020; Okuzaki, Daisuke/AAN-5641-2020; Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; Okuzaki, Daisuke/0000-0002-4552-783X; Fujii, Hodaka/0000-0003-1296-4256	Takeda Science Foundation; Asahi Glass Foundation; Uehara Memorial Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [25830131, 26430133, 23118516, 25118512, 221S0002]; Ministry of Health, Labour and Welfare	Takeda Science Foundation(Takeda Science Foundation (TSF)); Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Takeda Science Foundation (T. F.), the Asahi Glass Foundation, the Uehara Memorial Foundation (H. F.), the Kurata Memorial Hitachi Science and Technology Foundation (T. F. and H. F.), Grant-in-Aid for Young Scientists (B) (#25830131) (T. F.), Grant-in-Aid for Scientific Research (C) (#26430133) (R. O.), Grant-in- Aid for Scientific Research on Innovative Areas "Cell Fate" (#23118516) (T. F.), "Transcription Cycle" (#25118512), "Genome Support" (#221S0002) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (R. O.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI [10.4236/abb.2012.35081., DOI 10.4236/ABB.2012.35081]; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116579; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita Toshitsugu, 2013, ISRN Biochem, V2013, P913273, DOI 10.1155/2013/913273; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Gendrel AV, 2014, ANNU REV CELL DEV BI; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; de Silanes IL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5723; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Naganuma T, 2013, RNA BIOL, V10, P456, DOI 10.4161/rna.23547; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Uziel O, 2005, BRIT J CANCER, V92, P1881, DOI 10.1038/sj.bjc.6602592; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002	39	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123387	10.1371/journal.pone.0123387	http://dx.doi.org/10.1371/journal.pone.0123387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874893	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100170
J	Gadhoumi, K; Gotman, J; Lina, JM				Gadhoumi, Kais; Gotman, Jean; Lina, Jean Marc			Scale Invariance Properties of Intracerebral EEG Improve Seizure Prediction in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							PREICTAL DISCHARGES; DYNAMICAL DISEASES; INTRACRANIAL EEG; WAVELET ANALYSIS; BRAIN SYSTEMS; LONG; SIGNALS; REST; CONNECTIVITY; TRANSITION	Although treatment for epilepsy is available and effective for nearly 70 percent of patients, many remain in need of new therapeutic approaches. Predicting the impending seizures in these patients could significantly enhance their quality of life if the prediction performance is clinically practical. In this study, we investigate the improvement of the performance of a seizure prediction algorithm in 17 patients with mesial temporal lobe epilepsy by means of a novel measure. Scale-free dynamics of the intracerebral EEG are quantified through robust estimates of the scaling exponents-the first cumulants-derived from a wavelet leader and bootstrap based multifractal analysis. The cumulants are investigated for the discriminability between preictal and interictal epochs. The performance of our recently published patient-specific seizure prediction algorithm is then out-of-sample tested on long-lasting data using combinations of cumulants and state similarity measures previously introduced. By using the first cumulant in combination with state similarity measures, up to 13 of 17 patients had seizures predicted above chance with clinically practical levels of sensitivity (80.5%) and specificity (25.1% of total time under warning) for prediction horizons above 25 min. These results indicate that the scale-free dynamics of the preictal state are different from those of the interictal state. Quantifiers of these dynamics may carry a predictive power that can be used to improve seizure prediction performance.	[Gadhoumi, Kais; Gotman, Jean] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Lina, Jean Marc] Ecole Technol Super, Dept Genie Elect, Montreal, PQ, Canada; [Lina, Jean Marc] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	McGill University; University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal	Gadhoumi, K (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	kais.gadhoumi@mail.mcgill.ca	Gadhoumi, Kais/AAG-2184-2020	Gadhoumi, Kais/0000-0003-4148-6118	Canadian Institutes of Health Research (CIHR) [MOP-10189/102710]; Royal Society of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [CHRPJ 323490-06]; joint NSERC/CIHR grant [CHRP-CPG-80098]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Royal Society of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); joint NSERC/CIHR grant	This work was supported by the Canadian Institutes of Health Research (CIHR) grants MOP-10189/102710 (http://www.cihr-irsc.gc.ca), by the Royal Society of Canada and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant CHRPJ 323490-06 (http://www.nserc-crsng.gc.ca), and by the joint NSERC/CIHR grant CHRP-CPG-80098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2011, IEEE ENG MED BIO, P2566, DOI 10.1109/IEMBS.2011.6090709; Abry P, 2002, IEEE SIGNAL PROC MAG, V19, P28, DOI 10.1109/79.998080; Abry P., 2000, SELF SIMILAR NETWORK; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Aschenbrenner-Scheibe R, 2003, BRAIN, V126, P2616, DOI 10.1093/brain/awg265; BACRY E, 1993, J STAT PHYS, V70, P635, DOI 10.1007/BF01053588; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beran J., 1994, STAT LONG MEMORY PRO; Brodu N, 2012, NEUROCOMPUTING, V79, P87, DOI 10.1016/j.neucom.2011.10.010; Buzsaki G., 2006, RHYTHMS BRAIN, P111; Cai SM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061903; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Ciuciu P, 2014, NEUROIMAGE, V95, P248, DOI 10.1016/j.neuroimage.2014.03.047; Ciuciu P, 2008, IEEE J-STSP, V2, P929, DOI 10.1109/JSTSP.2008.2006663; D'Alessandro M, 2005, CLIN NEUROPHYSIOL, V116, P506, DOI 10.1016/j.clinph.2004.11.014; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Falconer K., 2014, FRACTAL GEOMETRY MAT; Feldwisch-Drentrup H, 2010, EPILEPSIA, V51, P1598, DOI 10.1111/j.1528-1167.2009.02497.x; Gadhoumi K, 2013, CLIN NEUROPHYSIOL, V124, P1745, DOI 10.1016/j.clinph.2013.04.006; Gadhoumi K, 2012, CLIN NEUROPHYSIOL, V123, P1906, DOI 10.1016/j.clinph.2012.03.001; Haut SR, 2002, EPILEPSIA, V43, P711, DOI 10.1046/j.1528-1157.2002.26401.x; He BYJ, 2014, TRENDS COGN SCI, V18, P480, DOI 10.1016/j.tics.2014.04.003; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Jaffard S., 2006, WAVELET ANAL APPL, P219, DOI DOI 10.1007/978-3-7643-7778-6; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Lashermes B, 2005, INT CONF ACOUST SPEE, P161; Le Van Quyen M, 2005, CLIN NEUROPHYSIOL, V116, P559, DOI 10.1016/j.clinph.2004.10.014; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mandelbrot B. B., 1999, MULTIFRACTALS NOISE, P317, DOI 10.1371/journal.pone.0024791; Martis RJ, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500238; Mirowski P, 2009, CLIN NEUROPHYSIOL, V120, P1927, DOI 10.1016/j.clinph.2009.09.002; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Perucca P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080972; Poupard L, 2001, BIOL CYBERN, V85, P19, DOI 10.1007/PL00007993; RIEDI R, 1995, J MATH ANAL APPL, V189, P462, DOI 10.1006/jmaa.1995.1030; Samorodnitsky G., 1994, STABLE NONGAUSSIAN R; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stafstrom CE, 2011, EPILEPSY CURR, V11, P200, DOI 10.5698/1535-7511-11.6.200; Valderrama M, 2010, 12 MED C MED BIOL EN, P77; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Varsavsky A, 2011, EPILEPTIC SEIZURES E, P263; Wendt H, 2009, INT CONF ACOUST SPEE, P2913, DOI 10.1109/ICASSP.2009.4960233; Wendt H, 2007, IEEE T SIGNAL PROCES, V55, P4811, DOI 10.1109/TSP.2007.896269; Wendt H, 2007, IEEE SIGNAL PROC MAG, V24, P38, DOI 10.1109/MSP.2007.4286563; Winterhalder M, 2003, EPILEPSY BEHAV, V4, P318, DOI 10.1016/S1525-5050(03)00105-7; Zilber N, 2013, I S BIOMED IMAGING, P998; Zilber N, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1531, DOI 10.1109/ISBI.2012.6235864	53	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121182	10.1371/journal.pone.0121182	http://dx.doi.org/10.1371/journal.pone.0121182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867083	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100037
J	Marti-Fabregas, J; Delgado-Mederos, R; Crespo, J; Pena, E; Marin, R; Jimenez-Xarrie, E; Fernandez-Arcos, A; Perez-Perez, J; Martinez-Domeno, A; Camps-Renom, P; Prats-Sanchez, L; Casoni, F; Badimon, L				Marti-Fabregas, Joan; Delgado-Mederos, Raquel; Crespo, Javier; Pena, Esther; Marin, Rebeca; Jimenez-Xarrie, Elena; Fernandez-Arcos, Ana; Perez-Perez, Jesus; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Prats-Sanchez, Luis; Casoni, Francesca; Badimon, Lina			Circulating Endothelial Progenitor Cells and the Risk of Vascular Events after Ischemic Stroke	PLOS ONE			English	Article							PLATELET ACTIVATION; DYSFUNCTION; MARKERS; DISEASE	Background and Purpose We evaluated the hypothesis that the number of circulating EPC could be associated with the risk of stroke recurrence (SR) or vascular events (VE) after an ischemic stroke. Methods We studied prospectively consecutive patients with cerebral infarction within the first 48 hours after the onset. We recorded demographic factors, vascular risk factors, previous Rankin scale (RS) score, and etiology. We analyzed EPC counts by flow cytometry in blood collected at day 7 and defined EPC as CD34+/CD133+/KDR+ cells. Mean follow-up was 29.3 +/- 16 months. We evaluated SR as well as VE. Patients were classified as to the presence or absence of EPC in the circulation (either EPC+ or EPC-). Bivariate analyses, Kaplan-Meier survival curves and Cox regression models were used. Results We included 121 patients (mean age 70.1 +/- 12.6 years; 65% were men). The percentage of EPC+ patients was 47.1%. SR occurred in 12 (9.9%) and VE in 18 (14.9%) patients. SR was associated significantly with a worse prior RS score, previous stroke and etiology, but not with EPC count. VE were associated significantly with EPC-, worse prior RS score, previous stroke, high age, peripheral artery disease and etiology. Cox regression model showed that EPC-(HR 7.07, p=0.003), age (HR 1.08, p=0.004) and a worse prior RS score (HR 5.8, p=0.004) were associated significantly with an increased risk of VE. Conclusions The absence of circulating EPC is not associated with the risk of stroke recurrence, but is associated with an increased risk of future vascular events.	[Marti-Fabregas, Joan; Delgado-Mederos, Raquel; Marin, Rebeca; Jimenez-Xarrie, Elena; Fernandez-Arcos, Ana; Perez-Perez, Jesus; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Prats-Sanchez, Luis; Casoni, Francesca] Hosp Santa Creu & Sant Pau, Dept Neurol, IIB St Pau, Barcelona, Spain; [Crespo, Javier; Pena, Esther; Badimon, Lina] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, IIB St Pau, Barcelona, Spain	Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Marti-Fabregas, J (corresponding author), Hosp Santa Creu & Sant Pau, Dept Neurol, IIB St Pau, Barcelona, Spain.	jmarti@santpau.cat	BADIMON, LINA/S-2950-2019; Peña, Esther/AAB-8217-2019; Martí-Fàbregas, Joan/I-5933-2019; Badimon, Lina/O-4711-2014	Martí-Fàbregas, Joan/0000-0001-9229-8649; Perez-Perez, Jesus/0000-0002-9835-0484; CAMPS-RENOM, POL/0000-0001-6587-6271; Martinez-Domeno, Alejandro/0000-0002-9933-3192; Crespo, Javier/0000-0001-8248-0172; Pena, Esther/0000-0003-2750-0614; Badimon, Lina/0000-0002-9162-2459	Spanish Ministery of Health - Instituto Carlos III; Fondo de Investigaciones Sanitarias [PI071062]; Redes Tematicas de Investigacion Cooperativa [RETICS-RENEVAS RD06/0026/0019, RETICS-INVICTUS RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Spanish Ministery of Health - Instituto Carlos III; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Redes Tematicas de Investigacion Cooperativa(Instituto de Salud Carlos III); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This study was funded by the Spanish Ministery of Health - Instituto Carlos III, Fondo de Investigaciones Sanitarias PI071062, Redes Tematicas de Investigacion Cooperativa (RETICS-RENEVAS RD06/0026/0019 and RETICS-INVICTUS RD012/0014). The study also received funding from FEDER (Fondo Europeo de Desarrollo Regional). JM-F received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Cherian P, 2003, STROKE, V34, P2132, DOI 10.1161/01.STR.0000086466.32421.F4; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Du FY, 2012, FRONT BIOSCI-LANDMRK, V17, P2327, DOI 10.2741/4055; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Freestone B, 2005, THROMB HAEMOSTASIS, V94, P702, DOI 10.1160/TH05-02-0093; Fuentes B, 2014, NEUROLOGIA, V29, P168, DOI 10.1016/j.nrl.2011.06.003; Fuentes B, 2012, NEUROLOGIA, V27, P560, DOI 10.1016/j.nrl.2011.06.002; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Hassan A, 2003, BRAIN, V126, P424, DOI 10.1093/brain/awg040; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Jung KH, 2008, J CLIN NEUROL, V4, P139, DOI 10.3988/jcn.2008.4.4.139; Lambiase PD, 2004, CIRCULATION, V109, P2986, DOI 10.1161/01.CIR.0000130639.97284.EC; Lapergue B, 2007, PROG NEUROBIOL, V83, P349, DOI 10.1016/j.pneurobio.2007.08.001; Lavallee PC, 2013, CEREBROVASC DIS, V36, P131, DOI 10.1159/000353671; Marti-Fabregas J, 2013, BRAIN BEHAV, V3, P649, DOI 10.1002/brb3.175; Mohammad A, 2010, NEUROLOGY, V75, P2050, DOI 10.1212/WNL.0b013e318200d822; Roquer J, 2009, CEREBROVASC DIS, V27, P25, DOI 10.1159/000200439; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Rustemeyer P, 2006, J IMMUNOASS IMMUNOCH, V27, P77, DOI 10.1080/15321810500403789; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Taguchi A, 2009, J CEREBR BLOOD F MET, V29, P34, DOI 10.1038/jcbfm.2008.92; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	31	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124895	10.1371/journal.pone.0124895	http://dx.doi.org/10.1371/journal.pone.0124895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874380	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100280
J	Xue, Y; Zhao, A; Cai, L; Yang, B; Szeto, IMY; Ma, DF; Zhang, YM; Wang, PY				Xue, Yong; Zhao, Ai; Cai, Li; Yang, Baoru; Szeto, Ignatius M. Y.; Ma, Defu; Zhang, Yumei; Wang, Peiyu			Growth and Development in Chinese Pre-Schoolers with Picky Eating Behaviour: A Cross-Sectional Study	PLOS ONE			English	Article							EARLY FEEDING PROBLEMS; COGNITIVE-DEVELOPMENT; AFFLUENT SOCIETY; SENSITIVE PERIOD; FOOD NEOPHOBIA; CHILDREN; PATTERNS; FRUIT; CHILDHOOD; GIRLS	Objective To explore the associations between picky eating behaviour and pre-schoolers' growth and development. Corresponding potential mechanisms, such as nutrient and food subgroup intake, as well as micronutrients in the blood, will be considered. Methods Picky eating behaviour was present if it was reported by parents. From various areas of China, 937 healthy children of 3-7 years old were recruited using a multi-stage stratified cluster sampling method. Children and their mothers' socio-demographic information and children's anthropometry, intelligence, blood samples, one 24-hour dietary intake record and food frequency questionnaire were collected. Z-scores and intelligence tests were used to evaluate growth and development (cognitive development). Multilevel models were employed to verify the associations between picky eating behaviour and growth and development. Results The prevalence of picky eating as reported by parents was 54% in pre-schoolers. Compared with the non-picky eaters, weight for age in picky eaters was 0.14 z-score (95% CI: -0.25, -0.02; p = 0.017) lower while no significant difference was found in intelligence (p > 0.05). Picky eating behaviour lasting over two years was associated with lower weight for age, as was nit-picking meat (the prevalence from parents' perception was 23% in picky eaters) (p < 0.05). Picky eaters consumed fewer cereals, vegetables, and fish (p < 0.05), and had a lower dietary intake of protein, dietary fibre, iron, and zinc (p < 0.05). There were no differences in the concentrations of essential minerals in whole blood (p > 0.05). Conclusions Picky eating behaviour is reported by parents in half of the Chinese pre-schoolers, which is negatively associated with growth (weight for age). Lower protein and dietary fibre as well as lower iron and zinc intakes were associated with picky eating as were lower intakes of vegetables, fish and cereals.	[Xue, Yong; Cai, Li; Yang, Baoru; Szeto, Ignatius M. Y.; Zhang, Yumei; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Zhao, Ai; Ma, Defu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, YM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China.	zhangyumei@bjmu.edu.cn; wpeiyu@bjmu.edu.cn	Yang, Baoru/AAD-6221-2019	Yang, Baoru/0000-0001-5561-514X	China Mengniu Dairy Stock Company Ltd.	China Mengniu Dairy Stock Company Ltd.	The investigation was supported by China Mengniu Dairy Stock Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ARCH DIS CHILD, V99, DOI 10.1136/archdischild-2013-305833; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bhutia Dechenla Tshering, 2014, J Family Med Prim Care, V3, P63, DOI 10.4103/2249-4863.130279; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Carruth BR, 1998, J AM COLL NUTR, V17, P180, DOI 10.1080/07315724.1998.10718744; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; Carruth BR, 2000, J AM COLL NUTR, V19, P771, DOI 10.1080/07315724.2000.10718077; CASHDAN E, 1994, HUM NATURE-INT BIOS, V5, P279, DOI 10.1007/BF02692155; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; DAHL M, 1987, ACTA PAEDIATR SCAND, V76, P881, DOI 10.1111/j.1651-2227.1987.tb17258.x; DAHL M, 1987, ACTA PAEDIATR SCAND, V76, P872, DOI 10.1111/j.1651-2227.1987.tb17257.x; de Moura JE, 2013, BIOL TRACE ELEM RES, V155, P23, DOI 10.1007/s12011-013-9766-9; Dennison BA, 1998, J AM COLL NUTR, V17, P371, DOI 10.1080/07315724.1998.10718778; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Dubois L, 2007, EUR J CLIN NUTR, V61, P846, DOI 10.1038/sj.ejcn.1602586; Dubois L, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-9; Ekstein S, 2010, CLIN PEDIATR, V49, P217, DOI 10.1177/0009922809337331; Fisher JO, 2002, J AM DIET ASSOC, V102, P58, DOI 10.1016/S0002-8223(02)90017-9; Fortunato JE, 2008, CLIN PEDIATR, V47, P496, DOI 10.1177/0009922807310937; Galloway AT, 2003, J AM DIET ASSOC, V103, P692, DOI 10.1053/jada.2003.50134; Galloway AT, 2005, J AM DIET ASSOC, V105, P541, DOI 10.1016/j.jada.2005.01.029; Goh Daniel Yt, 2012, Asia Pac Fam Med, V11, P5, DOI 10.1186/1447-056X-11-5; Jacobi C, 2003, J AM ACAD CHILD PSY, V42, P76, DOI 10.1097/00004583-200301000-00013; Jacobi C, 2008, INT J EAT DISORDER, V41, P626, DOI 10.1002/eat.20545; Kotler LA, 2001, J AM ACAD CHILD PSY, V40, P1434, DOI 10.1097/00004583-200112000-00014; Lassen A, 2004, PUBLIC HEALTH NUTR, V7, P263, DOI 10.1079/PHN2003532; Lewinsohn PM, 2005, INT J EAT DISORDER, V38, P208, DOI 10.1002/eat.20175; LI D, 1990, PSYCHOL REP, V67, P531; Liu Yuxin, 2002, Zhonghua Yi Xue Za Zhi, V82, P389; MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017; Mascola AJ, 2010, EAT BEHAV, V11, P253, DOI 10.1016/j.eatbeh.2010.05.006; McAfee AJ, 2012, PUBLIC HEALTH NUTR, V15, P1670, DOI 10.1017/S136898001200016X; McDermott BM, 2010, ACTA PAEDIATR, V99, P68, DOI 10.1111/j.1651-2227.2009.01517.x; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 2008, PHYSIOL BEHAV, V94, P29, DOI 10.1016/j.physbeh.2007.11.014; Mennella JA, 2012, CLIN NUTR, V31, P1022, DOI 10.1016/j.clnu.2012.05.005; Meshram II, 2013, ASIA PAC J PUBLIC HL; Micali N, 2011, J DEV BEHAV PEDIATR, V32, P572, DOI 10.1097/DBP.0b013e31822bc7b7; Morrison H, 2013, APPETITE, V63, P77, DOI 10.1016/j.appet.2012.12.017; Mukhopadhyay K, 2013, ACTA PAEDIATR, V102, P278, DOI 10.1111/apa.12113; Munoz KA, 1997, PEDIATRICS, V100, P323, DOI 10.1542/peds.100.3.323; Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006; RYDELL AM, 1995, J GENET PSYCHOL, V156, P217, DOI 10.1080/00221325.1995.9914818; Scaglioni S, 2008, BRIT J NUTR, V99, pS22, DOI 10.1017/S0007114508892471; Schulze KJ, 2014, J NUTR, V144, P979, DOI 10.3945/jn.114.192336; Shim JE, 2011, J AM DIET ASSOC, V111, P1363, DOI 10.1016/j.jada.2011.06.410; STARK LJ, 1986, J APPL BEHAV ANAL, V19, P367, DOI 10.1901/jaba.1986.19-367; TODD KS, 1983, AM J CLIN NUTR, V37, P139, DOI 10.1093/ajcn/37.1.139; Wright CM, 2007, PEDIATRICS, V120, pe1069, DOI 10.1542/peds.2006-2961; Xing LF, 2014, J ZHEJIANG UNIV-SC B, V15, P51, DOI 10.1631/jzus.B1300229; Yang L L, 1994, Int J Neurosci, V74, P109; Yang Y.X., 2005, CHINA FOOD COMPOSITI	55	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123664	10.1371/journal.pone.0123664	http://dx.doi.org/10.1371/journal.pone.0123664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875004	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100197
J	Albatsh, FM; Ahmad, S; Mekhilef, S; Mokhlis, H; Hassan, MA				Albatsh, Fadi M.; Ahmad, Shameem; Mekhilef, Saad; Mokhlis, Hazlie; Hassan, M. A.			Optimal Placement of Unified Power Flow Controllers to Improve Dynamic Voltage Stability Using Power System Variable Based Voltage Stability Indices	PLOS ONE			English	Article							ALLOCATION; UPFC; GA	This study examines a new approach to selecting the locations of unified power flow controllers (UPFCs) in power system networks based on a dynamic analysis of voltage stability. Power system voltage stability indices (VSIs) including the line stability index (LQP), the voltage collapse proximity indicator (VCPI), and the line stability index (L-mn) are employed to identify the most suitable locations in the system for UPFCs. In this study, the locations of the UPFCs are identified by dynamically varying the loads across all of the load buses to represent actual power system conditions. Simulations were conducted in a power system computer-aided design (PSCAD) software using the IEEE 14-bus and 39-bus benchmark power system models. The simulation results demonstrate the effectiveness of the proposed method. When the UPFCs are placed in the locations obtained with the new approach, the voltage stability improves. A comparison of the steady-state VSIs resulting from the UPFCs placed in the locations obtained with the new approach and with particle swarm optimization (PSO) and differential evolution (DE), which are static methods, is presented. In all cases, the UPFC locations given by the proposed approach result in better voltage stability than those obtained with the other approaches.	[Albatsh, Fadi M.; Ahmad, Shameem; Mekhilef, Saad] Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia; [Mokhlis, Hazlie] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia; [Hassan, M. A.] Univ Malaya, Dept Engn Design & Mfg, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Albatsh, FM (corresponding author), Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia.	fbatsh83@yahoo.com	MOKHLIS, HAZLIE/B-8616-2010; Abu Bakar, Ab Halim/B-8085-2010; Albatsh, Fadi M./I-9249-2017; Hassan, Mohsen A./J-9534-2012; Saad, Mekhilef/B-9652-2010; Ahmad, Shameem/ABI-3356-2020	MOKHLIS, HAZLIE/0000-0002-1166-1934; Abu Bakar, Ab Halim/0000-0001-8390-0204; Albatsh, Fadi M./0000-0002-2999-9458; Hassan, Mohsen A./0000-0001-8599-7732; Saad, Mekhilef/0000-0001-8544-8995; 	Ministry of Higher Education of Malaysia [UM.C/HIR/MOHE/ENG/16001-00-D000024]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	The authors would like to thank the Ministry of Higher Education of Malaysia for providing financial support under the research grant No. UM.C/HIR/MOHE/ENG/16001-00-D000024.	Ahmad S., 2014, P 2014 IEEE 6 INDIA, P1, DOI [DOI 10.1109/IICPE.2014.7145018, DOI 10.1109/EPE.2014.6910863]; Ahmad S., 2014, P SAUD AR SMART GRID, P1; Ahmad S, 2014, 2014 IEEE INNOVATIVE SMART GRID TECHNOLOGIES - ASIA (ISGT ASIA), P249, DOI 10.1109/ISGT-Asia.2014.6873798; Ahmad S, 2014, ENERG CONVERS MANAGE, V79, P652, DOI 10.1016/j.enconman.2013.12.042; Albatsh F.M., 2014, P 7 IET INT C POW EL, P5, DOI DOI 10.1049/CP.2014.0397; Albatsh F M, 2015, APPL MATH I IN PRESS; Ameli M. T., 2010, 2010 Second Pacific-Asia Conference on Circuits,Communications and System (PACCS 2010), P429, DOI 10.1109/PACCS.2010.5626960; Arya LD, 2008, ENERG CONVERS MANAGE, V49, P267, DOI 10.1016/j.enconman.2007.06.018; Baghace HR, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT, VOL I, P209; Banu RN, 2012, APPL SOFT COMPUT, V12, P2756, DOI 10.1016/j.asoc.2012.03.057; Benabid R, 2009, ELECTR POW SYST RES, V79, P1668, DOI 10.1016/j.epsr.2009.07.004; Cupelli M., 2012, P1; Ghahremani E, 2013, IEEE T POWER SYST, V28, P764, DOI 10.1109/TPWRS.2012.2210253; Hingorani N.G., 2000, UNDERSTANDING FACTS; Islam M., 2014, 7 IET INT C POW EL M; Jafarzadeh J., 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P345, DOI 10.1109/ICCRD.2011.5764210; Jazebi S, 2011, ENERG CONVERS MANAGE, V52, P2777, DOI 10.1016/j.enconman.2011.01.006; Kumar BK, 2007, IET GENER TRANSM DIS, V1, P209, DOI 10.1049/iet-gtd:20050529; Laifa A., 2010, 2010 IEEE International Energy Conference (ENERGYCON 2010), P205, DOI 10.1109/ENERGYCON.2010.5771677; Lee D, 2008, GLOB TELECOMM CONF, DOI 10.1109/GLOCOM.2008.ECP.462; Lim JU, 2002, 2002 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, VOLS 1-3, CONFERENCE PROCEEDINGS, P610, DOI 10.1109/PESS.2002.1043312; Made Wartana I., 2011, INT C UT EXH POW EN, P1, DOI 10.1109/ICUEPES.2011.6497710; Messina AR, 2003, INT J ELEC POWER, V25, P259, DOI 10.1016/S0142-0615(02)00093-5; Nireekshana T, 2011, 3 INT C EL COMP TECH, P209; Phadke AR, 2012, INT J ELEC POWER, V40, P46, DOI 10.1016/j.ijepes.2012.02.004; Rabiee A, 2012, ENERG CONVERS MANAGE, V59, P66, DOI 10.1016/j.enconman.2012.02.017; Rajani B., 2012, J THEORETICAL APPL I, V41, P192; Rezazad M., 2005, INT J COLORECTAL DIS; Shaheen HI, 2010, ENG APPL ARTIF INTEL, V23, P203, DOI 10.1016/j.engappai.2009.12.002; Shaheen HI, 2011, INT J ELEC POWER, V33, P94, DOI 10.1016/j.ijepes.2010.06.023; Shayeghi H, 2010, ENERG CONVERS MANAGE, V51, P2299, DOI 10.1016/j.enconman.2010.04.002; Shayeghi H, 2009, ENERG CONVERS MANAGE, V50, P2554, DOI 10.1016/j.enconman.2009.06.005; Sirjani R, 2012, INT J ELEC POWER, V43, P562, DOI 10.1016/j.ijepes.2012.05.068; Taher SA, 2012, INT J ELEC POWER, V43, P899, DOI 10.1016/j.ijepes.2012.05.064; Visakha K, 2004, ELECTR POW SYST RES, V70, P46, DOI 10.1016/j.epsr.2003.11.011; Wang KY, 2010, IEEE T POWER SYST, V25, P1892, DOI 10.1109/TPWRS.2010.2045664; Wibowo RS, 2011, IEEE T POWER SYST, V26, P2302, DOI 10.1109/TPWRS.2011.2106806; Ya-Chin Chang, 2009, 2009 4th IEEE Conference on Industrial Electronics and Applications, P2661, DOI 10.1109/ICIEA.2009.5138690; Zeraatzade Mahbube, 2010, THESIS BRUNEL U UK; Zhang Y, 2006, ELECTR POW SYST RES, V76, P1003, DOI 10.1016/j.epsr.2005.12.005; Zhang YJ, 2010, ELECTR POW SYST RES, V80, P1520, DOI 10.1016/j.epsr.2010.06.016	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123802	10.1371/journal.pone.0123802	http://dx.doi.org/10.1371/journal.pone.0123802			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874560	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800117
J	Noguchi, S; Mukae, H; Kawanami, T; Yamasaki, K; Fukuda, K; Akata, K; Ishimoto, H; Taniguchi, H; Yatera, K				Noguchi, Shingo; Mukae, Hiroshi; Kawanami, Toshinori; Yamasaki, Kei; Fukuda, Kazumasa; Akata, Kentarou; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Yatera, Kazuhiro			Bacteriological Assessment of Healthcare-Associated Pneumonia Using a Clone Library Analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITALIZED-PATIENTS; ASPIRATION PNEUMONIA; ANTIBIOTIC-THERAPY; CLINICAL-OUTCOMES; LUNG-DISEASE; RISK-FACTORS; PATHOGENS; EPIDEMIOLOGY	Background The causative pathogens of healthcare-associated pneumonia (HCAP) remain controversial, and the use of conventional cultivation of sputum samples is occasionally inappropriate due to the potential for oral bacterial contamination. It is also sometimes difficult to determine whether methicillin-resistant Staphylococcus aureus (MRSA) is a true causative pathogen of HCAP. Methods We evaluated the bacterial diversity in bronchoalveolar lavage fluid (BALF) using molecular and cultivation methods in 82 HCAP patients. BALF specimens were obtained from the lesions of pneumonia using bronchoscopy. The bacterial flora was analyzed according to the clone library method using amplified fragments of the 16S ribosomal RNA gene with universal primers. In addition, sputum cultures and the above specimens were assessed. Results Eighty (97.6%) of the 82 BALF samples obtained from the patients with HCAP showed positive polymerase chain reaction results. The predominant phylotypes detected in the BALF in this study included bacteria common in cases of community-and hospital-acquired pneumonia. In addition, the phylotypes of streptococci and anaerobes were detected in 19 (23.2%) and 8 (9.8%) cases, respectively. In particular, phylotypes of streptococci were highly detected among the patients 75 of age or older. Staphylococcus aureus was cultured in 23 (28.0%) cases using conventional cultivation methods and detected in only 6 (7.3%) cases as predominant phylotypes according to the clone library method. Conclusions The clone library analysis of BALF in the HCAP patients detected heterogeneous bacteria and a high incidence of streptococci compared with that observed using cultivation methods. In addition, the results of our study may indicate a lower incidence of MRSA than previously expected in HCAP patients.	[Noguchi, Shingo; Mukae, Hiroshi; Kawanami, Toshinori; Yamasaki, Kei; Akata, Kentarou; Ishimoto, Hiroshi; Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan; [Fukuda, Kazumasa; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Mukae, H (corresponding author), Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan.	hmukae@med.uoeh-u.ac.jp		Ishimoto, Hiroshi/0000-0002-4374-2894	High Altitude Research Grant from the University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture [23591173]	High Altitude Research Grant from the University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by a High Altitude Research Grant from the University of Occupational and Environmental Health, Japan, and a Research Grant from the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 23591173, 2011.	Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; Akiyama T, 2010, ORAL SURG ORAL MED O, V109, P669, DOI 10.1016/j.tripleo.2009.10.045; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Aoki R, 2013, OPHTHALMOLOGY, V120, P668, DOI 10.1016/j.ophtha.2012.10.001; Attridge RT, 2011, EUR RESPIR J, V38, P878, DOI 10.1183/09031936.00141110; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Carrabba M, 2012, EUR RESPIR J, V40, P1201, DOI 10.1183/09031936.00187811; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Chalmers JD, 2014, CLIN INFECT DIS, V58, P330, DOI 10.1093/cid/cit734; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cilloniz C, 2013, CHEST, V144, P999, DOI 10.1378/chest.13-0062; El-Solh AA, 2003, AM J RESP CRIT CARE, V167, P1650, DOI 10.1164/rccm.200212-1543OC; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Garcia-Vidal C, 2011, CLIN MICROBIOL INFEC, V17, P1659, DOI 10.1111/j.1469-0691.2011.03484.x; Garzoni C, 2013, THORAX, V68, P1150, DOI 10.1136/thoraxjnl-2012-202917; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Jeong BH, 2013, CLIN INFECT DIS, V56, P625, DOI 10.1093/cid/cis970; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; Kishimoto T, 2009, JPN J INFECT DIS, V62, P260; Kohno S, 2013, RESPIR INVESTIG, V51, P103, DOI 10.1016/j.resinv.2012.11.001; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Leone Marc, 2013, Crit Care, V17, pR170, DOI 10.1186/cc12849; Lescure FX, 2006, INFECT CONT HOSP EP, V27, P1213, DOI 10.1086/507920; Lim WS, 2001, EUR RESPIR J, V18, P362, DOI 10.1183/09031936.01.00204401; Madison JM, 2004, ARCH INTERN MED, V164, P1725, DOI 10.1001/archinte.164.16.1725; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Oshitani Y, 2013, J INFECT CHEMOTHER, V19, P579, DOI 10.1007/s10156-012-0517-1; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Sugisaki M, 2012, J INFECT CHEMOTHER, V18, P352, DOI 10.1007/s10156-011-0344-9; Takayanagi N, 2010, RESPIRATION, V80, P98, DOI 10.1159/000312404; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Yamasaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063103	40	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124697	10.1371/journal.pone.0124697	http://dx.doi.org/10.1371/journal.pone.0124697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874715	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800148
J	Salillas, E; Barraza, P; Carreiras, M				Salillas, Elena; Barraza, Paulo; Carreiras, Manuel			Oscillatory Brain Activity Reveals Linguistic Prints in the Quantity Code	PLOS ONE			English	Article							NUMBER REPRESENTATIONS; SYNCHRONIZATION; NETWORKS; CHILDREN; DYSCALCULIA; PERCEPTION; MECHANISMS; DYNAMICS; ORIGINS; ADULTS	Number representations change through education, although it is currently unclear whether and how language could impact the magnitude representation that we share with other species. The most prominent view is that language does not play any role in modulating the core numeric representation involved in the contrast of quantities. Nevertheless, possible cultural hints on the numerical magnitude representation are currently on discussion focus. In fact, the acquisition of number words provides linguistic input that the quantity system may not ignore. Bilingualism offers a window to the study of this question, especially in bilinguals where the two number wording systems imply also two different numerical systems, such as in Basque-Spanish bilinguals. The present study evidences linguistic prints in the core number representational system through the analysis of EEG oscillatory activity during a simple number comparison task. Gamma band synchronization appears when Basque-Spanish bilinguals compare pairs of Arabic numbers linked through the Basque base-20 wording system, but it does not if the pairs are related through the base-10 system. Crucially, this gamma activity, originated in a left fronto-parietal network, only appears in bilinguals who learned math in Basque and not in equivalent proficiency bilinguals who learned math in Spanish. Thus, this neural index reflected in gamma band synchrony appears to be triggered by early learning experience with the base-20 numerical associations in Basque number words.	[Salillas, Elena; Carreiras, Manuel] BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Barraza, Paulo] Univ Chile, Ctr Invest Avanzada Educ, Santiago, Chile; [Carreiras, Manuel] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Universidad de Chile; Basque Foundation for Science	Salillas, E (corresponding author), BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain.	e.salillas@bcbl.eu	Carreiras, Manuel/D-5267-2009; , CIAE/R-5423-2017; Salillas, Elena/E-1262-2015	Carreiras, Manuel/0000-0001-6726-7613; Salillas, Elena/0000-0002-0873-5357; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	Marie Curie grant FP7-PEOPLE-IEF; Ministry of Science and Innovation [PSI2011-23995]; Basal Funds for Centers of Excellence; Associative Research Program of CONICYT [FB 0003]; Initial Teacher Training of MECESUP3 [UCH1201]; Spanish Ministry of Economy and Competitiveness [CSD2008-00048]; European Research Council [ERC-2011-ADG-295362]	Marie Curie grant FP7-PEOPLE-IEF; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basal Funds for Centers of Excellence(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Associative Research Program of CONICYT; Initial Teacher Training of MECESUP3; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Marie Curie grant FP7-PEOPLE-2010-IEF and the Ministry of Science and Innovation grant PSI2011-23995 awarded to ES. PB was supported by the Basal Funds for Centers of Excellence, Project FB 0003 from the Associative Research Program of CONICYT and the Project UCH1201 from Initial Teacher Training of MECESUP3. This research was partially supported by the CONSOLIDER-INGENIO2010 CSD2008-00048 grant from the Spanish Ministry of Economy and Competitiveness, and the ERC-2011-ADG-295362 grant from the European Research Council awarded to MC.	Ansari D, 2005, NEUROREPORT, V16, P1769, DOI 10.1097/01.wnr.0000183905.23396.f1; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Barraza P, 2014, NEUROSCI LETT, V567, P40, DOI 10.1016/j.neulet.2014.03.021; BURGESS AP, 1999, HANDB EL CL, V6, P139; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Campbell JID, 2009, EUR J COGN PSYCHOL, V21, P686, DOI 10.1080/09541440802214846; CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Goodglass H., 1983, BOSTON NAMING TEST; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hsu YF, 2012, NEUROIMAGE, V59, P3103, DOI 10.1016/j.neuroimage.2011.11.017; Kaufmann L, 2006, NEUROREPORT, V17, P587, DOI 10.1097/00001756-200604240-00007; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Libertus ME, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-1; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Micheloyannis S, 2005, NEUROSCI LETT, V373, P212, DOI 10.1016/j.neulet.2004.10.005; Miller KF, 2005, HDB MATH COGNITION; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Perez A, 2012, NEUROPSYCHOLOGIA, V50, P2584, DOI 10.1016/j.neuropsychologia.2012.07.009; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salillas E, 2014, CORTEX, V52, P1, DOI 10.1016/j.cortex.2013.12.009; Salillas E, 2012, PSYCHOL SCI, V23, P745, DOI 10.1177/0956797612446347; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121434	10.1371/journal.pone.0121434	http://dx.doi.org/10.1371/journal.pone.0121434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875210	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800020
J	Joachim, A; Nilsson, C; Aboud, S; Bakari, M; Lyamuya, EF; Robb, ML; Marovich, MA; Earl, P; Moss, B; Ochsenbauer, C; Wahren, B; Mhalu, F; Sandstrom, E; Biberfeld, G; Ferrari, G; Polonis, VR				Joachim, Agricola; Nilsson, Charlotta; Aboud, Said; Bakari, Muhammad; Lyamuya, Eligius F.; Robb, Merlin L.; Marovich, Mary A.; Earl, Patricia; Moss, Bernard; Ochsenbauer, Christina; Wahren, Britta; Mhalu, Fred; Sandstrom, Eric; Biberfeld, Gunnel; Ferrari, Guido; Polonis, Victoria R.			Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults	PLOS ONE			English	Article							CELL-MEDIATED CYTOTOXICITY; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; RHESUS MACAQUES; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; VACCINE; VIRUS; INFECTION; CHALLENGE	Vaccine-induced HIV antibodies were evaluated in serum samples collected from healthy Tanzanian volunteers participating in a phase I/II placebo-controlled double blind trial using multi-clade, multigene HIV-DNA priming and recombinant modified vaccinia Ankara (HIV-MVA) virus boosting (HIVIS03). The HIV-DNA vaccine contained plasmids expressing HIV-1 gp160 subtypes A, B, C, Rev B, Gag A, B and RTmut B, and the recombinant HIV-MVA boost expressed CRF01_AE HIV-1 Env subtype E and Gag-Pol subtype A. While no neutralizing antibodies were detected using pseudoviruses in the TZM-bl cell assay, this prime-boost vaccination induced neutralizing antibodies in 83% of HIVIS03 vaccinees when a peripheral blood mononuclear cell (PBMC) assay using luciferase reporter-infectious molecular clones (LucR-IMC) was employed. The serum neutralizing activity was significantly (but not completely) reduced upon depletion of natural killer (NK) cells from PBMC (p= 0.006), indicating a role for antibody-mediated Fcy-receptor function. High levels of antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies against CRF01_AE and/or subtype B were subsequently demonstrated in 97% of the sera of vaccinees. The magnitude of ADCC-mediating antibodies against CM235 CRF01_AE IMC-infected cells correlated with neutralizing antibodies against CM235 in the IMC/PBMC assay. In conclusion, HIV-DNA priming, followed by two HIV-MVA boosts elicited potent ADCC responses in a high proportion of Tanzanian vaccinees. Our findings highlight the potential of HIV-DNA prime HIV-MVA boost vaccines for induction of functional antibody responses and suggest this vaccine regimen and ADCC studies as potentially important new avenues in HIV vaccine development.	[Joachim, Agricola; Aboud, Said; Lyamuya, Eligius F.; Mhalu, Fred] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Joachim, Agricola; Nilsson, Charlotta; Wahren, Britta; Biberfeld, Gunnel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Nilsson, Charlotta; Biberfeld, Gunnel] Publ Hlth Agcy Sweden, Solna, Sweden; [Nilsson, Charlotta] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med, Mil HIV Res Program, Bethesda, MD USA; [Marovich, Mary A.; Polonis, Victoria R.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Earl, Patricia; Moss, Bernard] NIAID, NIH, Bethesda, MD 20892 USA; [Ochsenbauer, Christina] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Sandstrom, Eric] Karolinska Inst Sodersjukhuset, Venhalsan, Stockholm, Sweden; [Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Public Health Agency of Sweden; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham; Karolinska Institutet; Duke University	Joachim, A (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania.	agricolaj@muhas.ac.tz	Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015	Ferrari, Guido/0000-0001-7747-3349; Moss, Bernard/0000-0002-2154-8564	European Union; Swedish International Development Cooperation Agency (Sida); Swedish Embassy Tanzania; European & Developing Countries Clinical Trials Partnership (EDCTP) [CT.2006.33111.007]; Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka [2150012801]; Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation [1032144]; Duke University Center for AIDS Research (CFAR) [P30 AI64518]; US Military HIV Research program; Walter Reed Army Institute of Research (WRAIR); Division of Intramural Research, NIAD, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416, P30AI064518, P30AI027767] Funding Source: NIH RePORTER	European Union(European Commission); Swedish International Development Cooperation Agency (Sida); Swedish Embassy Tanzania; European & Developing Countries Clinical Trials Partnership (EDCTP); Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka; Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation; Duke University Center for AIDS Research (CFAR); US Military HIV Research program; Walter Reed Army Institute of Research (WRAIR); Division of Intramural Research, NIAD, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the European Union, the Swedish International Development Cooperation Agency (Sida),Swedish Embassy Tanzania, the European & Developing Countries Clinical Trials Partnership (EDCTP, project code CT.2006.33111.007), and The Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka, jointly funded by Sweden and Norway (Sida contribution number 2150012801). Additional support was provided by the Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation (Grant ID: 1032144), Duke University Center for AIDS Research (CFAR, grant P30 AI64518), the US Military HIV Research program, Walter Reed Army Institute of Research (WRAIR) and the Division of Intramural Research, NIAD, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Baum LL, 1996, J IMMUNOL, V157, P2168; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BROWN B, 2012, DES ISSUES, V28, P1, DOI DOI 10.1371/J0URNAL.P0NE.0029454.PUBMED:22509241; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Ferrantelli F, 2002, CURR OPIN IMMUNOL, V14, P495, DOI 10.1016/S0952-7915(02)00362-X; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Lambotte O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074855; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; LJUNGGREN K, 1990, J INFECT DIS, V161, P198, DOI 10.1093/infdis/161.2.198; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Nilsson C, 2014, AIDS RES HUM RETROV, V30, P299, DOI [10.1089/aid.2013.0149, 10.1089/AID.2013.0149]; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2013, EXPERT OPIN BIOL TH, V13, P197, DOI 10.1517/14712598.2012.743527; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2010, CURR OPIN HIV AIDS, V5, P421, DOI 10.1097/COH.0b013e32833d2d45; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	40	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0118486	10.1371/journal.pone.0118486	http://dx.doi.org/10.1371/journal.pone.0118486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874723	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700001
J	Panagopoulos, I; Gorunova, L; Bjerkehagen, B; Heim, S				Panagopoulos, Ioannis; Gorunova, Ludmila; Bjerkehagen, Bodil; Heim, Sverre			Fusion of the Genes EWSR1 and PBX3 in Retroperitoneal Leiomyoma with t(9;22)(q33;q12)	PLOS ONE			English	Article							DNA-BINDING DOMAIN; SOFT-TISSUE; CHROMOSOME-TRANSLOCATION; TUMORS; HOMEODOMAIN; CARCINOMA; CANCER; BONE	Retroperitoneal leiomyoma is a rare benign smooth muscle tumor almost exclusively found in women and with histopathological features similar to uterine leiomyomas. The pathogenesis of retroperitoneal leiomyoma is unclear and next to nothing is known about the cytogenetics and molecular genetics of the tumor. We present here a retroperitoneal leiomyoma with a t(9;22)(q33;q12) as the sole karyotypic aberration. The translocation resulted in an EWSR1-PBX3 fusion gene in which exon 9 of EWSR1 (nucleotide 1320 accession number NM_013986 version 3) was in-frame fused to exon 5 of PBX3 (nucleotide 824 accession number NM_006195 version 5). The EWSR1-PBX3 fusion transcript codes for a 529 amino acids long chimeric EWSR1-PBX3 protein which contains the N-terminal transactivation part of EWSR1 and the homeodomain of PBX3. The present study, together with our previous finding of a retroperitoneal leiomyoma with t(10;17)(q22;q21) as the sole karyotypic aberration and a KAT6B-KANSL1 fusion gene, indicates that retroperitoneal leiomyomas may be characterized by fusion genes coding for chimeric proteins. However, cytogenetic and molecular heterogeneity exists in these tumors and it is too early to tell how many and which different pathways lead to retroperitoneal leiomyomagenesis.	[Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no			Norwegian Cancer Society; Norwegian Radium Hospital Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Radium Hospital Foundation	This study was supported by grants from the Norwegian Cancer Society and the Norwegian Radium Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2015, GENE CHROMOSOME CANC, V54, P63, DOI 10.1002/gcc.22216; Antonescu CR, 2010, GENE CHROMOSOME CANC, V49, P1114, DOI 10.1002/gcc.20819; Arbajian E, 2013, AM J SURG PATHOL, V37, P613, DOI 10.1097/PAS.0b013e31827ae13b; Billings SD, 2001, AM J SURG PATHOL, V25, P1134, DOI 10.1097/00000478-200109000-00003; Brandal P, 2008, GENE CHROMOSOME CANC, V47, P558, DOI 10.1002/gcc.20559; Brandal P, 2009, GENE CHROMOSOME CANC, V48, P1051, DOI 10.1002/gcc.20706; Chang CP, 1996, MOL CELL BIOL, V16, P1734; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fisher C, 2014, HISTOPATHOLOGY, V64, P134, DOI 10.1111/his.12269; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Han HB, 2012, J PATHOL, V226, P544, DOI 10.1002/path.3014; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; LABELLE Y, 1995, HUM MOL GENET, V4, P2219, DOI 10.1093/hmg/4.12.2219; LADANYI M, 1994, CANCER RES, V54, P2837; Laurent A, 2008, INT J DEV BIOL, V52, P9, DOI 10.1387/ijdb.072304al; Li YK, 2014, TUMOR BIOL, V35, P4363, DOI [10.1007/s13277-013-1573-6, 10.1007/s13277-014-1777-4]; Li ZJ, 2013, BLOOD, V121, P1422, DOI 10.1182/blood-2012-07-442004; Moller E, 2008, J PATHOL, V215, P78, DOI 10.1002/path.2327; MONICA K, 1994, MOL CELL BIOL, V14, P8304, DOI 10.1128/MCB.14.12.8304; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Paal E, 2001, AM J SURG PATHOL, V25, P1355, DOI 10.1097/00000478-200111000-00002; Panagopoulos I, 2002, INT J CANCER, V99, P560, DOI 10.1002/ijc.10404; Panagopoulos I, 1996, ONCOGENE, V12, P489; Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117010; PLOUGASTEL B, 1993, GENOMICS, V18, P609, DOI 10.1016/S0888-7543(05)80363-5; Poliquin V, 2008, J MINIM INVAS GYN, V15, P152, DOI 10.1016/j.jmig.2007.12.009; Ramberg H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-50; Schaffer LG, 2009, ISCN 2009 INT SYSTEM; Wagner K, 2001, MECH DEVELOP, V103, P127, DOI 10.1016/S0925-4773(01)00349-5	30	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124288	10.1371/journal.pone.0124288	http://dx.doi.org/10.1371/journal.pone.0124288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875009	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700063
J	Chin, MP; Patrick, HWC; Cheong, AMY; Chan, HHL				Chin, Man Pan; Chu, Patrick H. W.; Cheong, Allen M. Y.; Chan, Henry H. L.			Human Electroretinal Responses to Grating Patterns and Defocus Changes by Global Flash Multifocal Electroretinogram	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; SPATIAL-FREQUENCY; EYE GROWTH; REFRACTIVE ERROR; OPTICAL DEFOCUS; DEPENDENT CHANGES; GANGLION-CELLS; AMACRINE CELLS; AXIAL LENGTH; LENS	The electrical response of the retina was examined as a function of retinal region, using stimuli of various spatial frequencies in the first experiment. In the second experiment, the regional response of the retina to defocus at high and low spatial frequencies was investigated. Twenty three subjects were recruited for global flash multifocal electroretinogram (mfERG) in experiment 1. Black and white gratings (printed on plastic transparent sheets) of four spatial frequencies (SF), 0.24, 1.2, 2.4 and 4.8 cycle per degree were presented in front of the mfERG stimulation. The amplitudes and implicit times of the direct (DC) and induced (IC) components of mfERG responses were pooled into six concentric rings for analysis. There was low amplitude DC at low SF, which increased with increasing SF, and which decreased with increasing eccentricity. The IC was high in amplitude at all SF and reduced in amplitude with increasing eccentricity. Our findings suggested that outer and inner retina had different characteristics in processing spatial details. In experiment 2, Twenty-three young adults were recruited for mfERG measurement. The retinal electrical responses for low (0.24cpd) and high (4.8cpd) SF under fully corrected conditions of shortterm negative defocus (-2D) and short term positive defocus (+2D) conditions were measured. There was a sign-dependent response to defocus in the DC response, mainly in peripheral regions. The sign dependent response at low SF was more obvious than that at high SF, and was located more peripherally. The IC response showed no clear trends for either defocus condition. The human retina seems to have a decoding system for optical defocus, which was tuned for low spatial frequency, and was located in the retinal near periphery.	[Chin, Man Pan; Chu, Patrick H. W.; Cheong, Allen M. Y.; Chan, Henry H. L.] Hong Kong Polytech Univ, Sch Optometry, Lab Expt Optometry Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Chan, HHL (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Lab Expt Optometry Neurosci, Hong Kong, Hong Kong, Peoples R China.	henryhl.chan@polyu.edu.hk	Chu, Patrick HW/H-5532-2011; Cheong, Allen Ming Yan/L-9008-2013	Chu, Patrick HW/0000-0003-0547-2675; Cheong, Allen Ming Yan/0000-0002-6746-3902; CHAN, Henry HL/0000-0002-8516-4711	General Research Fund from Research Grants Committee of the Hong Kong SAR [PolyU 5605/13M]; associated fund (Research Postgraduate) from Hong Kong Polytechnic University	General Research Fund from Research Grants Committee of the Hong Kong SAR; associated fund (Research Postgraduate) from Hong Kong Polytechnic University	This study was supported by the General Research Fund (PolyU 5605/13M) from The Research Grants Committee of the Hong Kong SAR and the associated fund (Research Postgraduate) from The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SJ, 1991, J PHYSIOL-LONDON, V442, P47, DOI 10.1113/jphysiol.1991.sp018781; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; BERNINGER T, 1985, DOC OPHTHALMOL, V61, P17, DOI 10.1007/BF00143211; Brown B, 1996, OPHTHAL PHYSL OPT, V16, P42, DOI 10.1016/0275-5408(95)00043-7; Buck C, 2004, INVEST OPHTH VIS SCI, V45, P402, DOI 10.1167/iovs.03-0789; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chen JC, 2006, VISION RES, V46, P4096, DOI 10.1016/j.visres.2006.07.033; Chen JC, 2006, VISION RES, V46, P3413, DOI 10.1016/j.visres.2006.03.013; Chen X, 2010, VISION RES, V50, P31, DOI 10.1016/j.visres.2009.10.004; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Chu PHW, 2008, VISION RES, V48, P1726, DOI 10.1016/j.visres.2008.05.006; Chu PHW, 2007, INVEST OPHTH VIS SCI, V48, P2626, DOI 10.1167/iovs.06-0962; Chu PH, 2011, CLIN EXP OPTOM, V94, P259, DOI 10.1111/j.1444-0938.2011.00583.x; Chu PHW, 2006, INVEST OPHTH VIS SCI, V47, P929, DOI 10.1167/iovs.05-0891; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Day M, 2011, SCANDINAVIAN J OPTOM, V4, P1; Diether S, 2005, INVEST OPHTH VIS SCI, V46, P2242, DOI 10.1167/iovs.04-1200; Diether S, 1997, VISION RES, V37, P659, DOI 10.1016/S0042-6989(96)00224-6; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FALSINI B, 1991, GRAEF ARCH CLIN EXP, V229, P262, DOI 10.1007/BF00167881; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; Fortune B, 2002, INVEST OPHTH VIS SCI, V43, P2638; GREEN DG, 1965, J OPT SOC AM, V55, P1154, DOI 10.1364/JOSA.55.001154; Grosvenor Theodore, 2003, Clin Exp Optom, V86, P273; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; Hess RF, 2006, CURR BIOL, V16, P687, DOI 10.1016/j.cub.2006.02.065; Ho WC, 2012, INVEST OPHTH VIS SCI, V53, P5320, DOI 10.1167/iovs.12-10185; Ho WC, 2012, VISION RES, V52, P47, DOI 10.1016/j.visres.2011.10.017; Ho WC, 2011, VISION RES, V51, P367, DOI 10.1016/j.visres.2010.12.001; HODOS W, 1984, INVEST OPHTH VIS SCI, V25, P652; Howlett MHC, 2006, VISION RES, V46, P267, DOI 10.1016/j.visres.2005.06.036; Liu Y, 2012, INVEST OPHTH VIS SCI, V53, P5085, DOI 10.1167/iovs.12-9628; Lung JCY, 2010, GRAEF ARCH CLIN EXP, V248, P1117, DOI 10.1007/s00417-010-1346-5; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Mok AKH, 2011, CLIN OPTOM, V3, P1, DOI 10.2147/OPTO.S16599; NORTON TT, 1994, VISUAL NEUROSCI, V11, P143, DOI 10.1017/S0952523800011184; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Park TW, 2003, VISION RES, V43, P1519, DOI 10.1016/S0042-6989(03)00180-9; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SACHS MB, 1971, J OPT SOC AM, V61, P1176, DOI 10.1364/JOSA.61.001176; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schaeffel F, 2004, OPTOMETRY VISION SCI, V81, P99, DOI 10.1097/00006324-200402000-00008; Schaeffel F, 1999, VISION RES, V39, P1585, DOI 10.1016/S0042-6989(98)00304-6; Schmid KL, 1997, VISION RES, V37, P2011, DOI 10.1016/S0042-6989(97)00014-X; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; Shen W, 2005, INVEST OPHTH VIS SCI, V46, P1797, DOI 10.1167/iovs.04-1318; Shimada Y, 2005, GRAEF ARCH CLIN EXP, V243, P132, DOI 10.1007/s00417-004-1072-y; Shimada Y, 2001, BRIT J OPHTHALMOL, V85, P414, DOI 10.1136/bjo.85.4.414; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Smith EL, 2010, INVEST OPHTH VIS SCI, V51, P3864, DOI 10.1167/iovs.09-4969; Smith EL, 2009, VISION RES, V49, P2386, DOI 10.1016/j.visres.2009.07.011; Smith EL, 1998, OPTOMETRY VISION SCI, V75, P388, DOI 10.1097/00006324-199806000-00023; Smith EL, 1999, OPTOMETRY VISION SCI, V76, P428, DOI 10.1097/00006324-199906000-00023; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; Sutter EE, 1999, OSA TECHNICAL DIGEST, P52; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; Tran N, 2008, VISION RES, V48, P1655, DOI 10.1016/j.visres.2008.03.022; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; VAEGAN, 1987, VISION RES, V27, P883, DOI 10.1016/0042-6989(87)90004-6; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Walker L, 1978, SCIENCE, V201, P29; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Wang YZ, 1997, INVEST OPHTH VIS SCI, V38, P2134; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Winawer J, 2005, VISION RES, V45, P1667, DOI 10.1016/j.visres.2004.12.013; Winawer J, 2002, VISION RES, V42, P2651, DOI 10.1016/S0042-6989(02)00300-0; Yamada K, 2006, DOC OPHTHALMOL, V113, P83, DOI 10.1007/s10633-006-9017-x; Zhang Z, 1996, Yan Ke Xue Bao, V12, P135; Zhi ZN, 2013, INVEST OPHTH VIS SCI, V54, P890, DOI 10.1167/iovs.11-8064; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046; Zhu XY, 2003, INVEST OPHTH VIS SCI, V44, P2818, DOI 10.1167/iovs.02-0606	80	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123480	10.1371/journal.pone.0123480	http://dx.doi.org/10.1371/journal.pone.0123480			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874564	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100181
J	Cook, JA; Razzano, LA; Swarbrick, MA; Jonikas, JA; Yost, C; Burke, L; Steigman, PJ; Santos, A				Cook, Judith A.; Razzano, Lisa A.; Swarbrick, Margaret A.; Jonikas, Jessica A.; Yost, Chantelle; Burke, Larisa; Steigman, Pamela J.; Santos, Alberto			Health Risks and Changes in Self-Efficacy Following Community Health Screening of Adults with Serious Mental Illnesses	PLOS ONE			English	Article							PHYSICAL HEALTH; LIFE-STYLE; PRIMARY-CARE; US ADULTS; PEOPLE; INTERVENTION; MANAGEMENT; SERVICES; QUALITY; DISCRIMINATION	Physical health screenings were conducted by researchers and peer wellness specialists for adults attending publicly-funded community mental health programs. A total of 457 adults with serious mental illnesses attended health fairs in 4 U.S. states and were screened for 8 common medical co-morbidities and health risk factors. Also assessed were self-reported health competencies, medical conditions, and health service utilization. Compared to non-institutionalized U.S. adults, markedly higher proportions screened positive for obesity (60%), hypertension (32%), diabetes (14%), smoking (44%), nicotine dependence (62%), alcohol abuse (17%), drug abuse (11%), and coronary heart disease (10%). A lower proportion screened positive for hyperlipidemia (7%). Multivariable random regression analysis found significant pre- to post-screening increases in participants' self-rated abilities for health practices, competence for health maintenance, and health locus of control. Screening identified 82 instances of undiagnosed diabetes, hypertension or hyperlipidemia, and 76 instances where these disorders were treated but uncontrolled. These results are discussed in the context of how this global public health approach holds promise for furthering the goal of integrating health and mental health care.	[Cook, Judith A.; Razzano, Lisa A.; Jonikas, Jessica A.; Yost, Chantelle; Burke, Larisa; Steigman, Pamela J.] Univ Illinois, Dept Psychiat, Chicago, IL 60607 USA; [Swarbrick, Margaret A.] Rutgers State Univ, Freehold, NJ USA; [Swarbrick, Margaret A.] Collaborat Support Programs New Jersey, Freehold, NJ USA; [Santos, Alberto] Georgia Regents Univ, Dept Psychiat, Augusta, GA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; University System of Georgia; Augusta University	Cook, JA (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60607 USA.	jcook@uic.edu			U.S. Department of Education, National Institute on Disability and Rehabilitation Research; Substance Abuse & Mental Health Services Administration, Center for Mental Health Services [H133B100028]	U.S. Department of Education, National Institute on Disability and Rehabilitation Research(US Department of Education); Substance Abuse & Mental Health Services Administration, Center for Mental Health Services	This work was funded by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research; and the Substance Abuse & Mental Health Services Administration, Center for Mental Health Services, Cooperative Agreement #H133B100028. The views expressed herein are those of the authors and do not necessarily reflect the policy or position of any Federal agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2011, J EPIDEMIOL COMMUN H, V65, pA19, DOI 10.1136/jech.2011.143586.42; Gutierrez-Padilla JA, 2010, AM J KIDNEY DIS, V55, P474, DOI 10.1053/j.ajkd.2009.07.023; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ancelin ML, 2010, BIOL PSYCHIAT, V68, P125, DOI 10.1016/j.biopsych.2010.04.011; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baig AA, 2010, J GEN INTERN MED, V25, P701, DOI 10.1007/s11606-010-1326-9; Barnard K, 2013, DIABETES CARE, V36, P3337, DOI 10.2337/dc13-0560; Barr O, 1999, J ADV NURS, V29, P1482, DOI 10.1046/j.1365-2648.1999.01036.x; Boyd JL, 2002, J CLIN DENSITOM, V5, P375, DOI 10.1385/JCD:5:4:375; Bressington D, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-57; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Casey Daniel E, 2005, Am J Med, V118 Suppl 2, p15S; Centers for Disease Control and Prevention, 2010, 2011 NAT DIAB FACT S; Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V61, P889, DOI DOI 10.1001/JAMA.2012.114523; Centers for Disease Control and Prevention, NHANES 3 SER 11 DAT; Centers for Disease Control and Prevention, 2005, QUICKST PREV SEL UNH; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Colton CW, 2006, PREV CHRONIC DIS; Cook JA, 2012, SCHIZOPHR RES, V136, P36, DOI 10.1016/j.schres.2011.10.016; Cook JA, 2012, SCHIZOPHRENIA BULL, V38, P881, DOI 10.1093/schbul/sbr012; Correll Christoph U, 2010, Psychiatr Serv, V61, P892, DOI 10.1176/ps.2010.61.9.892; Davidson L, 2012, WORLD PSYCHIATRY, V11, P123, DOI 10.1016/j.wpsyc.2012.05.009; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dillon D L, 1997, J Community Health Nurs, V14, P1, DOI 10.1207/s15327655jchn1401_1; Druss BG, 2010, SCHIZOPHR RES, V118, P264, DOI 10.1016/j.schres.2010.01.026; Druss BG, 2002, MED CARE, V40, P129, DOI 10.1097/00005650-200202000-00007; Dulin MK, 1996, J HLTH CARE POOR, V17, P821; Epstein J, 2002, DHHS PUBLICATION A24, DOI [10. 1176/ appi. ps. 201300172. A, DOI 10.1176/APPI.PS.201300172.A]; Fagerstrom K.O., 1991, ENT-EAR NOSE THROAT, V69, P763; Farag NH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-313; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Francisco V T, 1994, Arch Fam Med, V3, P246, DOI 10.1001/archfami.3.3.246; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Ghouri N, 2005, PUBLIC HEALTH, V119, P197, DOI 10.1016/j.puhe.2004.05.009; Goldberg RW, 2013, PSYCHIAT SERV, V64, P51, DOI 10.1176/appi.ps.201200034; Griswold KS, 2010, PRIMARY PSYCHIAT, V17, P42, DOI DOI 10.1007/S10597-010-9300-X; Hamilton R, 2009, PSYCHIATR BULL, V33, P445, DOI 10.1192/pb.bp.107.019265; Hedeker D, 2008, SUPERMIX PROGRAM MIX, DOI [10.1021/pr5008224, DOI 10.1021/PR5008224]; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Kelly E, 2014, COMMUNITY MENT HLT J, V50, P435, DOI 10.1007/s10597-013-9616-4; Lester HE, 2005, BMJ-BRIT MED J, V330, P1122, DOI 10.1136/bmj.38440.418426.8F; Macias EP, 2000, J COMMUN HEALTH, V25, P35, DOI 10.1023/A:1005188801228; Mangurian C, 2010, PSYCHIAT SERV, V61, P346, DOI 10.1176/ps.2010.61.4.346; Marshall SE, 2013, AM J PUBLIC HEALTH, V103, P1022, DOI 10.2105/AJPH.2013.301259; Maurana CA, 1996, ACAD MED, V71, P425, DOI 10.1097/00001888-199605000-00009; McIntosh S, 2000, Nicotine Tob Res, V2, P281; Mess SE, 2000, J COMMUN HEALTH, V25, P315, DOI 10.1023/A:1005164427176; Ness KK, 2003, PHYS THER, V83, P631, DOI 10.1093/ptj/83.7.631; Nosek MA, 1997, ARCH PHYS MED REHAB, V78, pS39, DOI 10.1016/S0003-9993(97)90220-3; Pappa E, 2009, INT J ENV RES PUB HE, V6, P2712, DOI 10.3390/ijerph6102712; Pastakia SD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-21; Phelan M, 2001, BRIT MED J, V322, P443, DOI 10.1136/bmj.322.7284.443; Ploylearmsang C, 2013, AM J PHARM EDUC, V77, DOI 10.5688/ajpe77356; Razzano LA, 2015, SCHIZOPHR RES, V161, P458, DOI 10.1016/j.schres.2014.11.021; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Richardson CR, 2005, PSYCHIAT SERV, V56, P324, DOI 10.1176/appi.ps.56.3.324; Rodriguez-Artalejo F, 2003, PREV MED, V37, P82, DOI 10.1016/S0091-7435(03)00086-0; Rydholm L, 2005, J AGRIC SAF HEALTH, V11, P441, DOI 10.13031/2013.19723; Sabin JE, 2003, PSYCHIAT SERV, V54, P497, DOI 10.1176/appi.ps.54.4.497; Schmutte T, 2009, PSYCHIAT QUART, V80, P1, DOI 10.1007/s11126-008-9088-9; Scott David, 2011, Issues Ment Health Nurs, V32, P589, DOI 10.3109/01612840.2011.569846; Scott KM, 2009, PSYCHOL MED, V39, P33, DOI 10.1017/S0033291708003188; Seo DC, 2011, J NATL MED ASSOC, V103, P897, DOI 10.1016/S0027-9684(15)30445-4; Sokal J, 2004, J NERV MENT DIS, V192, P421, DOI 10.1097/01.nmd.0000130135.78017.96; Sorel E, 2010, AM J PSYCHIAT, V167, P354, DOI 10.1176/appi.ajp.2009.09081218; Strassnig M, 2005, SCHIZOPHR RES, V75, P425, DOI 10.1016/j.schres.2004.04.007; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; Substance Abuse and Mental Health Services Administration, 2008, NAT SURV DRUG US HLT; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2010, CTR BEH HLTH STAT QU; Swarbrick MA, 2013, J PSYCHOSOC NURS MEN, V51, P22, DOI 10.3928/02793695-20130930-02; Swarbrick MA, 2013, PSYCHIAT SERV, V64, P723, DOI 10.1176/appi.ps.201300144; Thornicroft G, 2007, INT REV PSYCHIATR, V19, P113, DOI 10.1080/09540260701278937; Vauth R, 2007, PSYCHIAT RES, V150, P71, DOI 10.1016/j.psychres.2006.07.005; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wallace JE, 2012, HEALTH-LONDON, V16, P3, DOI 10.1177/1363459310371080; Waller PR, 1998, AM J HLTH PROMOT, V3, P17; WALLSTON BS, 1976, J CONSULT CLIN PSYCH, V44, P580, DOI 10.1037/0022-006X.44.4.580; Wee LE, 2011, PREV MED, V53, P64, DOI 10.1016/j.ypmed.2011.05.005; Wells K, 2004, AM J PSYCHIAT, V161, P955, DOI 10.1176/appi.ajp.161.6.955; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; WILSON DN, 1990, BRIT MED J, V301, P1379, DOI 10.1136/bmj.301.6765.1379	86	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123552	10.1371/journal.pone.0123552	http://dx.doi.org/10.1371/journal.pone.0123552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875181	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100185
J	Gu, HG; Zhao, ZG; Jia, B; Chen, SG				Gu Huaguang; Zhao Zhiguo; Jia Bing; Chen Shenggen			Dynamics of On-Off Neural Firing Patterns and Stochastic Effects near a Sub-Critical Hopf Bifurcation	PLOS ONE			English	Article							SUBTHRESHOLD MEMBRANE OSCILLATIONS; MESENCEPHALIC-V NEURONS; PHASE-RESETTING CURVES; ROOT GANGLION NEURONS; COHERENCE RESONANCE; PYRAMIDAL NEURONS; CORTICAL-NEURONS; IN-VITRO; NOISE; RAT	On-off firing patterns, in which repetition of clusters of spikes are interspersed with epochs of subthreshold oscillations or quiescent states, have been observed in various nervous systems, but the dynamics of this event remain unclear. Here, we report that on-off firing patterns observed in three experimental models (rat sciatic nerve subject to chronic constrictive injury, rat CA1 pyramidal neuron, and rabbit blood pressure baroreceptor) appeared as an alternation between quiescent state and burst containing multiple period-1 spikes over time. Burst and quiescent state had various durations. The interspike interval (ISI) series of on-off firing pattern was suggested as stochastic using nonlinear prediction and autocorrelation function. The resting state was changed to a period-1 firing pattern via on-off firing pattern as the potassium concentration, static pressure, or depolarization current was changed. During the changing process, the burst duration of on-off firing pattern increased and the duration of the quiescent state decreased. Bistability of a limit cycle corresponding to period-1 firing and a focus corresponding to resting state was simulated near a sub-critical Hopf bifurcation point in the deterministic Morris-Lecar (ML) model. In the stochastic ML model, noise-induced transitions between the coexisting regimes formed an on-off firing pattern, which closely matched that observed in the experiment. In addition, noise-induced exponential change in the escape rate from the focus, and noise-induced coherence resonance were identified. The distinctions between the on-off firing pattern and stochastic firing patterns generated near three other types of bifurcations of equilibrium points, as well as other viewpoints on the dynamics of on-off firing pattern, are discussed. The results not only identify the on-off firing pattern as noise-induced stochastic firing pattern near a sub-critical Hopf bifurcation point, but also offer practical indicators to discriminate bifurcation types and neural excitability types.	[Gu Huaguang; Zhao Zhiguo; Chen Shenggen] Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China; [Jia Bing] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Gu, HG (corresponding author), Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China.	guhuaguang@tongji.edu.cn	Zhiguo, Zhao/Q-8480-2018; Gu, Huaguang/E-3562-2013; Gu, Huaguang/ABA-5898-2020	Zhiguo, Zhao/0000-0002-0041-724X; Gu, Huaguang/0000-0003-0815-1447; Gu, Huaguang/0000-0003-0815-1447; Jia, Bing/0000-0003-4266-7228	National Natural Science Foundation of China [11372224, 11072135, 10772101]; Fundamental Research Funds for Central Universities [1330219127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China under grant Nos. 11372224, 11072135 and 10772101 and the Fundamental Research Funds for Central Universities under grant No. 1330219127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; Amir R, 2005, J NEUROSCI, V25, P2576, DOI 10.1523/JNEUROSCI.4118-04.2005; Amir R, 2002, J NEUROSCI, V22, P1187, DOI 10.1523/JNEUROSCI.22-03-01187.2002; Amir R, 2002, BRAIN, V125, P421, DOI 10.1093/brain/awf037; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berglund N, 2006, PROB APPL S; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; BRAUN HA, 1994, NATURE, V367, P270, DOI 10.1038/367270a0; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Chacron MJ, 2000, PHYS REV LETT, V85, P1576, DOI 10.1103/PhysRevLett.85.1576; Chacron MJ, 2001, PHYS REV LETT, V92; Clay JR, 2002, J MEMBRANE BIOL, V187, P213, DOI 10.1007/s00232-001-0165-3; Del Negro CA, 1998, BIOPHYS J, V75, P174, DOI 10.1016/S0006-3495(98)77504-6; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Feng JF, 1999, BIOL CYBERN, V80, P291, DOI 10.1007/s004220050526; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066204; Gao JB, 1999, PHYS REV LETT, V83, P3178, DOI 10.1103/PhysRevLett.83.3178; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; Greenwood PE, 2000, PHYS REV LETT, V84, P4773, DOI 10.1103/PhysRevLett.84.4773; Gu HG, 2001, PHYS LETT A, V285, P63, DOI 10.1016/S0375-9601(01)00278-X; Gu HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081759; Gu HG, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501952; Gu HG, 2013, CHAOS, V23, DOI 10.1063/1.4810932; Gu HG, 2011, INT J MOD PHYS B, V25, P3977, DOI 10.1142/S0217979211101673; Gu HG, 2011, COGN NEURODYNAMICS, V5, P87, DOI 10.1007/s11571-010-9145-6; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; Gutkin BS, 1998, NEURAL COMPUT, V10, P1047, DOI 10.1162/089976698300017331; HAYASHI H, 1982, PHYS LETT A, V88, P435, DOI 10.1016/0375-9601(82)90674-0; HAYASHI H, 1983, PHYS LETT A, V98, P474, DOI 10.1016/0375-9601(83)90267-0; Hirata Y, 2012, CHAOS, V22, DOI 10.1063/1.4738191; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Izhikevich E. M, 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jia B, 2012, COGN NEURODYNAMICS, V6, P485, DOI 10.1007/s11571-012-9209-x; Jia B, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/9/090507; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Lee SG, 1998, PHYS REV E, V57, P3292, DOI 10.1103/PhysRevE.57.3292; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Ma C, 2007, J NEUROSCI, V27, P14059, DOI 10.1523/JNEUROSCI.3699-07.2007; MANNELLA R, 1989, PHYS REV A, V40, P3381, DOI 10.1103/PhysRevA.40.3381; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/20007; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; Pedroarena CM, 1999, J NEUROPHYSIOL, V82, P1465, DOI 10.1152/jn.1999.82.3.1465; Phoka E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000768; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Reboreda A, 2003, J PHYSIOL-LONDON, V551, P191, DOI 10.1113/jphysiol.2003.039917; RINZEL J., 1987, P INT C MATHEMATICIA, P1578; Rinzel J., 1989, METHODS NEURONAL MOD, P135; SAUER T, 1994, PHYS REV LETT, V72, P3811, DOI 10.1103/PhysRevLett.72.3811; SEJNOWSKI TJ, 1995, NATURE, V376, P21, DOI 10.1038/376021a0; Serafin M, 1996, NEUROSCIENCE, V75, P671, DOI 10.1016/0306-4522(96)00349-1; Song Y, 2012, PAIN, V153, P657, DOI 10.1016/j.pain.2011.11.030; Sun W, 2012, BRAIN, V135, P359, DOI 10.1093/brain/awr345; Suzuki H, 2000, BIOL CYBERN, V82, P305, DOI 10.1007/s004220050584; Tal M, 1996, PAIN, V64, P511, DOI 10.1016/0304-3959(95)00175-1; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Tateno T, 2004, CHAOS, V14, P511, DOI 10.1063/1.1756118; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x; Tsumoto K, 2006, NEUROCOMPUTING, V69, P293, DOI 10.1016/j.neucom.2005.03.006; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang YY, 2011, NEUROSIGNALS, V19, P54, DOI 10.1159/000324519; Wu NP, 2005, J NEUROPHYSIOL, V93, P2710, DOI 10.1152/jn.00636.2004; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Xie RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018681; Xie WR, 2005, PAIN, V116, P243, DOI 10.1016/j.pain.2005.04.017; Xing JL, 2003, PAIN, V105, P177, DOI 10.1016/S0304-3959(03)00200-8; Xing JL, 2001, NEUROREPORT, V12, P1311, DOI 10.1097/00001756-200105080-00051; Xing JL, 2001, BRAIN RES, V901, P128, DOI 10.1016/S0006-8993(01)02329-0; Yang H, 2014, CHAOS, V24, DOI 10.1063/1.4869306; Yang MH, 2006, NEUROREPORT, V17, P995, DOI 10.1097/01.wnr.0000224770.74528.d6; Yang MH, 2009, INT J BIFURCAT CHAOS, V19, P453, DOI 10.1142/S0218127409023135; Yang RH, 2009, PAIN, V143, P48, DOI 10.1016/j.pain.2009.01.020; Zhu ZR, 2009, NEUROSIGNALS, V17, P181, DOI 10.1159/000209279	94	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121028	10.1371/journal.pone.0121028	http://dx.doi.org/10.1371/journal.pone.0121028			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867027	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100033
J	Jayathunge, PHM; McBride, WJH; MacLaren, D; Browne, K				Jayathunge, Parana Hewage Mangalasiri; McBride, William John Hannan; MacLaren, David; Browne, Kelwyn			Men in Papua New Guinea Accurately Report Their Circumcision Status	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV-INFECTION; ACCEPTABILITY	Background Male circumcision (MC) is a well-established component of HIV prevention in countries with high HIV prevalence and heterosexually driven epidemics. Delivery and monitoring of MC programs are reliant on good quality MC data. Such data are often generated through self-reported MC status surveys. This study examined self-reported MC status in comparison with genital photographs from men in Papua New Guinea (PNG). Methods This retrospective non-interventional study collated self-reported MC status data from the 'acceptability and feasibility of MC' study at 4 sites in PNG during 2010-2011. Participants reported their MC status based on an 8-category photographic classification covering the range of foreskin cutting practices in PNG. Genital photographs of 222 participants from this study were independently classified by 2 investigators. The 8-category photographic classification was simplified into a 3 category classification of 'no cut', 'straight cut' and 'round cut' before comparing for agreement between self-reporting and investigator assessment using Cohen's Kappa measure. Results Using the 3-category classification, there was 90.6% (201/222) agreement between self-assessment and investigator classification (K value 0.805). Of the discordant 9.4% (21/222), 3.6% (8/222) self-classified as having a cut foreskin (5 straight cut; 3 round cut) while investigators classified as having no cut; 4.1% (9/222) self-classified as having no cut while investigators classified them as having had a cut (6 straight cut; 3 round cut) and 1.8% (4/222) self-classified as having a round cut while investigators classified as having a straight cut. Given the great variety of foreskin cutting practices and appearances, feasible explanations are suggested for two-thirds (13/21) of these discordant results. Conclusions This study demonstrates a high level of agreement between self-reporting and investigator assessment of MC status in PNG and suggests self-reporting of MC status to be highly reliable among men in PNG.	[Jayathunge, Parana Hewage Mangalasiri; McBride, William John Hannan] James Cook Univ, Coll Med & Dent, Cairns Clin Sch, Cairns, Qld 4870, Australia; [MacLaren, David] James Cook Univ, Coll Med & Dent, Cairns, Qld 4870, Australia; [Browne, Kelwyn] Natl Dept Hlth, Rural Primary Hlth Serv Delivery Project, Port Moresby, Papua N Guinea	James Cook University; James Cook University	Jayathunge, PHM (corresponding author), James Cook Univ, Coll Med & Dent, Cairns Clin Sch, Cairns, Qld 4870, Australia.	mangalasiri.paranahewage@jcu.edu.au	McBride, William John Hannan/B-9145-2008	McBride, William John Hannan/0000-0001-8894-533X				[Anonymous], NAT RES AG HIV AIDS; Bell K, 2005, MED ANTHROPOL Q, V19, P125, DOI 10.1525/maq.2005.19.2.125; Caldwell JC, 2002, J HEALTH POPUL NUTR, V20, P104; Gray RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104531; Hewett PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036251; Hill PS, 2012, AIDS CARE, V24, P77, DOI 10.1080/09540121.2011.592812; Hull TH, 2001, REPROD HEALTH MATTER, V9, P60, DOI 10.1016/S0968-8080(01)90091-6; Jenkins C., HIV AIDS CULTURE SEX, P1; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Kempf W, 2002, OCEANIA, V73, P56, DOI 10.1002/j.1834-4461.2002.tb02806.x; Kupe F, 2011, BEHAV SURVEILLANCE R; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Ledikwe JH, 2014, HIV AIDS-RES PALLIAT, V6, P139, DOI 10.2147/HIV.S65354; MacLaren D, 2011, AUSTR HIV AIDS C 201, P1; MacLaren D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-818; Millan J, 2007, HIV AIDS BEHAV SURVE; Risser JMH, 2004, AM J EPIDEMIOL, V159, P1095, DOI 10.1093/aje/kwh149; SCHLOSSBERGER NM, 1992, J ADOLESCENT HEALTH, V13, P293, DOI 10.1016/1054-139X(92)90162-5; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Skolnik L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1119; Templeton DJ, 2008, SEX TRANSM INFECT, V84, P187, DOI 10.1136/sti.2007.029645; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; Tommbe R, 2012, RES REPORT; *UNAIDS WHO, 2008, OC AIDS EP UPD REG S; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Williamson MH, 1990, GENDER COSMOS KWORNA, P385	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123429	10.1371/journal.pone.0123429	http://dx.doi.org/10.1371/journal.pone.0123429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25866957	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000352845100175
J	Saxena, R; Gupta, S; Singh, K; Mitra, K; Tripathi, AK; Tripathi, RK				Saxena, Reshu; Gupta, Sudipti; Singh, Kavita; Mitra, Kalyan; Tripathi, Anil Kumar; Tripathi, Raj Kamal			Proteomic Profiling of SupT1 Cells Reveal Modulation of Host Proteins by HIV-1 Nef Variants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOWN-REGULATION; REPLICATION; CYCLOPHILIN; MOLECULES; INFECTION; GENE; ENDOCYTOSIS; PROGRESSION; INTERFERES	Nef is an accessory viral protein that promotes HIV-1 replication, facilitating alterations in cellular pathways via multiple protein-protein interactions. The advent of proteomics has expanded the focus on better identification of novel molecular pathways regulating disease progression. In this study, nef was sequenced from randomly selected patients, however, sequence variability identified did not elicited any specific mutation that could have segregated HIV-1 patients in different stages of disease progression. To explore the difference in Nef functionality based on sequence variability we used proteomics approach. Proteomic profiling was done to compare the effect of Nef variants in host cell protein expression. 2DGE in control and Nef transfected SupT1 cells demonstrated several differentially expressed proteins. Fourteen protein spots were detected with more than 1.5 fold difference. Significant down regulation was seen in six unique protein spots in the Nef treated cells. Proteins were identified as Cyclophilin A, EIF5A-1 isoform B, Rho GDI 1 isoform a, VDAC1, OTUB1 and alpha-enolase isoform 1 (ENO1) through LC-MS/MS. The differential expression of the 6 proteins was analyzed by Real time PCR, Western blotting and Immunofluorescence studies with two Nef variants (RP14 and RP01) in SupT1 cells. There was contrasting difference between the effect of these Nef variants upon the expression of these six proteins. Downregulation of alpha-enolase (ENO1), VDAC1 and OTUB1 was more significant by Nef RP01 whereas Cyclophilin A and RhoGDI were found to be more downregulated by Nef RP14. This difference in Nef variants upon host protein expression was also studied through a site directed mutant of Nef RP01 ((55AAAAAAA61)) and the effect was found to be reversed. Deciphering the role of these proteins mediated by Nef variants will open a new avenue of research in understanding Nef mediated pathogenesis. Overall study determines modulation of cellular protein expression in T cells by HIV-1 Nef variants.	[Saxena, Reshu; Gupta, Sudipti; Tripathi, Raj Kamal] Cent Drug Res Inst, CSIR, Div Toxicol, Lucknow 226001, Uttar Pradesh, India; [Singh, Kavita; Mitra, Kalyan] Cent Drug Res Inst, CSIR, Sophisticated Analyt Instrument Facil, Elect Microscopy Lab, Lucknow 226001, Uttar Pradesh, India; [Tripathi, Anil Kumar] King Georges Med Univ, Dept Med, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Tripathi, RK (corresponding author), Cent Drug Res Inst, CSIR, Div Toxicol, Sect 10,Janakipuram Extens,Sitapur Rd, Lucknow 226001, Uttar Pradesh, India.	rajkamalcdri@gmail.com	Saxena, Reshu/AAU-3178-2021	Tripathi, Anil/0000-0001-9139-8701; Saxena, Reshu/0000-0001-7252-4688	Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI); CSIR [BSC0111]; ICMR	Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	The authors thank "Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI)" for providing the institutional Funding and CSIR Network Project-'Indepth' (BSC0111) for providing financial support. RS acknowledges fellowship support from ICMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Audoly G, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-48; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bell I, 1998, J GEN VIROL, V79, P2717, DOI 10.1099/0022-1317-79-11-2717; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bregnard C, 2011, RETROVIROLOGY S2, V8, pP3; Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Carl S, 2000, J INFECT DIS, V181, P132, DOI 10.1086/315187; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Catucci M, 2000, J MED VIROL, V60, P294, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;294::AID-JMV8&gt;3.0.CO;2-1; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Das SR, 2005, INDIAN J MED RES, V121, P315; Fackler OT, 2006, J VIROLOGY; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; HA HJ, 1993, J BIOL CHEM, V268, P12143; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hanna Z, 2004, VIROLOGY, V327, P273, DOI 10.1016/j.virol.2004.06.028; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kumar B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067586; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; Lin YL, 2005, J VIROL, V79, P7938, DOI 10.1128/JVI.79.12.7938-7941.2005; Liu K.-J., 2007, J CANC MOL, V3, P45; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Lutz NW, 1997, AIDS, V11, P147, DOI 10.1097/00002030-199702000-00003; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Nazir A, 2010, PLOS ONE, V13, P5; O'Neill E, 2006, J VIROL, V80, P1311, DOI 10.1128/JVI.80.3.1311-1320.2006; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Rasola A, 2001, J IMMUNOL, V166, P81, DOI 10.4049/jimmunol.166.1.81; Ratner L, 1996, VIROLOGY, V223, P245, DOI 10.1006/viro.1996.0474; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Saphire ACS, 2000, IMMUNOL RES, V21, P211, DOI 10.1385/IR:21:2-3:211; Saxena SK, 2012, FUTURE VIROL, V7, P609, DOI 10.2217/FVL.12.42; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shi XP, 1996, EXP CELL RES, V225, P348, DOI 10.1006/excr.1996.0185; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SINGH P, 2011, PLOS ONE, V6; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Van Duyne R, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-21; Vignoli AL, 2000, MOL CELL BIOCHEM, V215, P73, DOI 10.1023/A:1026590916661; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045	77	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122994	10.1371/journal.pone.0122994	http://dx.doi.org/10.1371/journal.pone.0122994			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874870	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100124
J	Tang, LQ; Hu, DP; Chen, QY; Zhang, L; Lai, XP; He, Y; Xu, YXX; Wen, SH; Peng, YT; Chen, WH; Guo, SS; Liu, LT; Qian, CN; Guo, X; Zeng, MS; Mai, HQ				Tang, Lin Quan; Hu, Dong Peng; Chen, Qiu Yan; Zhang, Lu; Lai, Xiao Ping; He, Yun; Xu, Yun-Xiu-Xiu; Wen, Shi-Hua; Peng, Yu-Tuan; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang			Elevated High-Sensitivity C-Reactive Protein Levels Predict Decreased Survival for Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era	PLOS ONE			English	Article							BARR-VIRUS DNA; CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; VIRAL-DNA; EBV DNA; PLASMA; DIAGNOSIS; SERUM; CHEMORADIOTHERAPY; QUANTITATION; METASTASIS	Purpose This study aimed to clarify the prognostic utility of high-sensitivity C-reactive protein (hs-CRP) in nasopharyngeal carcinoma (NPC) patients in the Intensity-Modulated Radiotherapy (IMRT) era. Patients and Methods In this observational study, 1,589 non-metastatic NPC patients treated with IMRT were recruited. Blood samples were collected before treatment for examination of hs-CRP levels. We evaluated the association of pretreatment hs-CRP levels with overall survival rate (OS), progression free survival rate (PFS), locoregional relapse free survival rate (LRFS) and distant metastasis free survival rate (DMFS). Results Baseline hs-CRP levels were correlated with sex, clinical stage, body mass index, smoking status, and EBV DNA level. Multivariate analysis showed that hs-CRP had significant association with OS (HR:1.723; 95% CI:1.238-2.398; p = 0.001), PFS (HR:1.621; 95% CI:1.273-2.064; p < 0.001) and DMFS (HR: 1.879; 95% CI: 1.394-2.531; p < 0.001). In subgroups such as advanced-stage group, low EBV DNA group and high EBV DNA group, elevated hs-CRP levels still predicted poor clinical outcomes. Furthermore, in patients with chronic HBV infection, decreased 4-year survival was observed in the cohort of high hs-CRP levels, with 87.4% vs. 94.9% (p = 0.023) for OS, 65.2% vs. 90.8% (p < 0.001) for PFS, and 67.6% vs. 95.0% (p < 0.001) for DMFS. A similar finding was observed for patients with cardiovascular disease, with 79.1% vs. 90.2% (p = 0.020) for PFS, and 71.4% vs. 97.6% (p = 0.002) for DMFS. Conclusion Elevated serum hs-CRP levels were correlated with poor survival for NPC patients in the IMRT era, playing a complementary role to TNM stage and EBV DNA. In addition, elevated hs-CRP level was still an effective indicator for patients with chronic HBV infection and cardiovascular disease.	[Tang, Lin Quan; Chen, Qiu Yan; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Dong Peng; Lai, Xiao Ping; He, Yun; Xu, Yun-Xiu-Xiu; Wen, Shi-Hua; Peng, Yu-Tuan] Sun Yat Sen Univ, ZhongShan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zeng, MS (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zengmsh@mail.sysu.edu.cn; maihq@mail.sysu.edu.cn			National Natural Science Foundation of China [81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034, 2011B031800161]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Sun Yatsen University Clinical Research 5010 Program; Fundamental Research Funds for the central universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Sun Yatsen University Clinical Research 5010 Program; Fundamental Research Funds for the central universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Natural Science Foundation of China (No: 81072226, http://www.nsfc.gov.cn), the 863 Project (No: 2012AA02A501, http://www.863.gov.cn/), the National Key Basic Research Program of China (No: 2013CB910304, http://www.973.gov.cn), the Sci-Tech Project Foundation of Guangdong Province (No: 2011B080701034, and 2011B031800161, http://www.gdstc.gov.cn/), the Sci-Tech Project Foundation of Guangzhou City (No: 2011J4300100, http://www.gzsi.gov.cn), the Sun Yatsen University Clinical Research 5010 Program, and the Fundamental Research Funds for the central universities (http://www.sysu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; ATONO Y, 1989, Gastroenterologia Japonica, V24, P655; Boncler M, 2009, ACTA BIOCHIM POL, V56, P17; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2003, CANCER RES, V63, P2028; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Hu QF, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.07.016; Huang PY, 2013, EUR J CANCER, V49, P1923, DOI 10.1016/j.ejca.2013.01.027; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee NY, 2008, J SURG ONCOL, V97, P691, DOI 10.1002/jso.21014; Leung SF, 2014, ANN ONCOL, V25, P1204, DOI 10.1093/annonc/mdu117; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Liu X, 2014, CANCER-AM CANCER SOC, V120, P68, DOI 10.1002/cncr.28377; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Liu ZQ, 2014, ASIAN J ANDROL, V16, P467, DOI 10.4103/1008-682X.123686; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Lo YMD, 2000, ANN NY ACAD SCI, V906, P99; Ma BBY, 2006, INT J RADIAT ONCOL, V66, P714, DOI 10.1016/j.ijrobp.2006.05.064; Mutirangura A, 1998, CLIN CANCER RES, V4, P665; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Salazar J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/605810; Shibutani M, 2015, SURG TODAY, V45, P315, DOI 10.1007/s00595-014-0909-1; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Song CX, 2013, PAK J MED SCI, V29, P885, DOI 10.12669/pjms.293.2907; Strang F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/757123; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Xia WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076958; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Yi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094632; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122965	10.1371/journal.pone.0122965	http://dx.doi.org/10.1371/journal.pone.0122965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874450	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100121
J	Thoma, V; White, E; Panigrahi, A; Strowger, V; Anderson, I				Thoma, Volker; White, Elliott; Panigrahi, Asha; Strowger, Vanessa; Anderson, Irina			Good Thinking or Gut Feeling? Cognitive Reflection and Intuition in Traders, Bankers and Financial Non-Experts	PLOS ONE			English	Article							DECISION-MAKING; INDIVIDUAL-DIFFERENCES; PROCESSING STYLES; RISK PERCEPTION; OVERCONFIDENCE; PERSONALITY; HEURISTICS; JUDGMENT; BIAS; INTELLIGENCE	The current study investigated differences in decision-making style and risk-taking between financial traders, non-trading bank employees, and people not working in finance. Traders scored significantly higher than participants in the other two groups on the cognitive reflection test (CRT) which measures the tendency to inhibit automatic but frequently false responses in reasoning tasks. Scores for traders compared to people outside the banking sector were also higher on a self-rated scale for reflective thinking in decision-making, but there were no differences in self-rated intuitive thinking between groups. Financial risk-taking correlated with cognitive reflection scores and was significantly lower in the nonexpert group compared to the other groups working in financial services. Traders in the current study showed no elevated preference to use 'intuition' in their decision-making compared to other groups. Overall, these results indicate that compared to non-expert participants financial traders have a higher self-rated tendency for reflective thinking and a greater propensity to inhibit the use of mental shortcuts (heuristics) in decision-making.	[Thoma, Volker; Anderson, Irina] Univ E London, London E15 4LZ, England; [White, Elliott] Canterbury Christ Church Univ, Canterbury, Kent, England; [Panigrahi, Asha] Univ Glasgow, Glasgow, Lanark, Scotland; [Strowger, Vanessa] Eclipse Energy Grp, London, England	University of East London; Canterbury Christ Church University; University of Glasgow	Thoma, V (corresponding author), Univ E London, London E15 4LZ, England.	v.thoma@uel.ac.uk	Thoma, Volker/H-8519-2019	Thoma, Volker/0000-0001-7766-4233	UEL's School of Psychology	UEL's School of Psychology	One co-author (VS) was a partner in the organisation (Eclipse Energy Group AS) which co-funding part of the research (Study 1, also funded by UEL's School of Psychology). VS was involved in the initial conception, writing and internal revision of the manuscript, but not the data analysis. Neither Eclipse Energy Group nor VS had any commercial interests linked to the research.	Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Ayal S, 2012, SYNTHESE, V189, P717, DOI 10.1007/s11229-012-0156-1; Barber B.M., 2000, FINANC ANAL J, V70, P17, DOI [DOI 10.2469/FAJ.V56.N1.2326, https://doi.org/10.2469/faj.v56.n1.2326]; Baron J, 1994, THINKING AND DECIDIN; Betsch T, 2001, PERS SOC PSYCHOL B, V27, P242, DOI 10.1177/0146167201272009; Biais B, 2009, MANAGE SCI, V55, P1018, DOI 10.1287/mnsc.1090.1000; Bjorklund F, 2008, SCAND J PSYCHOL, V49, P439, DOI 10.1111/j.1467-9450.2008.00652.x; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; Campitelli G, 2010, JUDGM DECIS MAK, V5, P182; Chase VM, 1998, TRENDS COGN SCI, V2, P206, DOI 10.1016/S1364-6613(98)01179-6; Chen GM, 2007, J BEHAV DECIS MAKING, V20, P425, DOI 10.1002/bdm.561; Colman AM, 1997, PSYCHOL REP, V80, P355, DOI 10.2466/pr0.1997.80.2.355; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; Dhar R, 2006, MANAGE SCI, V52, P726, DOI 10.1287/mnsc.1040.0473; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JSBT, 2009, IN TWO MINDS DUAL PR; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Garling Tommy, 2009, Psychol Sci Public Interest, V10, P1, DOI 10.1177/1529100610378437; Gervais S, 2001, REV FINANC STUD, V14, P1, DOI 10.1093/rfs/14.1.1; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; Gigerenzer G, 2008, PERSPECT PSYCHOL SCI, V3, P20, DOI 10.1111/j.1745-6916.2008.00058.x; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Hensman A, 2011, EUR MANAG J, V29, P51, DOI 10.1016/j.emj.2010.08.006; Hilton D.J., 2001, J PSYCHOL FINANCIAL, V2, P37, DOI [10.1207/S15327760JPFM0201_4, DOI 10.1207/S15327760JPFM0201_4]; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2011, THINKING FAST AND SL; Keren G, 2009, PERSPECT PSYCHOL SCI, V4, P533, DOI 10.1111/j.1745-6924.2009.01164.x; Kirchler E, 2002, J RISK UNCERTAINTY, V25, P65, DOI 10.1023/A:1016319430881; KIRKPATRICK LA, 1992, J PERS SOC PSYCHOL, V63, P534, DOI 10.1037/0022-3514.63.4.534; Klein G, 2008, HUM FACTORS, V50, P456, DOI 10.1518/001872008X288385; Liberali JM, 2012, J BEHAV DECIS MAKING, V25, P361, DOI 10.1002/bdm.752; Lipshitz R, 2007, J COGN ENG DECIS MAK, V1, P212, DOI 10.1518/155534307X232857; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Milkman KL, 2009, PERSPECT PSYCHOL SCI, V4, P379, DOI 10.1111/j.1745-6924.2009.01142.x; Nicholson N, 2005, J RISK RES, V8, P157, DOI 10.1080/1366987032000123856; Nicholson N., 2005, TRADERS RISKS DECISI; Odean T, 1999, AM ECON REV, V89, P1279, DOI 10.1257/aer.89.5.1279; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Parikh J, 1994, INTUITION THE NEW FR; Reyna VF, 2008, MED DECIS MAKING, V28, P829, DOI 10.1177/0272989X08327069; Reyna VF, 2006, J EXP PSYCHOL-APPL, V12, P179, DOI 10.1037/1076-898X.12.3.179; Rindermann H, 2008, INTELLIGENCE, V36, P127, DOI 10.1016/j.intell.2007.02.002; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; Shapira Z, 2001, J BANK FINANC, V25, P1573, DOI 10.1016/S0378-4266(00)00139-4; Shapiro S., 1997, BUS HORIZONS, V40, P63, DOI [10.1016/S0007-6813(97)90027-6, DOI 10.1016/S0007-6813(97)90027-6]; Shefrin H, 2002, BEYOND GREED AND FEA; Shiloh S, 2002, PERS INDIV DIFFER, V32, P415, DOI 10.1016/S0191-8869(01)00034-4; Shleifer A., 2000, INEFFICIENT MARKETS; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; SLOVIC P, 1979, ENVIRONMENT, V21, P14, DOI 10.1080/00139157.1979.9933091; Stanovich KE, 1999, COGNITIVE PSYCHOL, V38, P349, DOI 10.1006/cogp.1998.0700; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Sternberg R. J., 2003, ATHEORY WISDOM INTEL; Taleb N, 2008, THE BLACK SWAN THE I; Thoma V, 2011, NEUROIMAGE, V57, P513, DOI 10.1016/j.neuroimage.2011.04.035; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Waters AJ, 2002, BRIT J PSYCHOL, V93, P557, DOI 10.1348/000712602761381402; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Witteman C, 2009, EUR J PSYCHOL ASSESS, V25, P39, DOI 10.1027/1015-5759.25.1.39	73	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123202	10.1371/journal.pone.0123202	http://dx.doi.org/10.1371/journal.pone.0123202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875674	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100149
J	Vanneste, D; Mello, JD; Macq, J; Van Audenhove, C; Declercq, A				Vanneste, Dirk; Mello, Johanna De Almeida; Macq, Jean; Van Audenhove, Chantal; Declercq, Anja			Incomplete Assessments: Towards a Better Understanding of Causes and Solutions. The Case of the interRAI Home Care Instrument in Belgium	PLOS ONE			English	Article							RESIDENT ASSESSMENT INSTRUMENT; NURSING-HOMES; TRANSITIONAL CARE; ASSESSMENT PROTOCOLS; HEALTH-CARE; SYSTEM; RELIABILITY; QUALITY; SUITE	The chronic diseases, comorbidities and rapidly changing needs of frail older persons increase the complexity of caregiving. A comprehensive, systematic and structured collection of data on the status of the frail older person is presumed to be essential in facilitating decision-making and thus improving the quality of care provided. However, the way in which an assessment is completed has a substantial impact on the quality and value of the results. This study examines the online completion of interRAI Home Care assessments, the possible causes for incomplete assessments and the consequences of these factors with respect to the quality of care received. Our findings indicate high nurse engagement and poor physician participation. We also observed the poor completion of items in predominantly medically-oriented sections characterized by, first, the fact that the assessors felt incapable of answering certain questions, second, the absence of required data or of a competent person to fill out the data, and third, the lack of tools necessary for essential measurements. The incompleteness of assessments has a clear negative influence on outcome generation. Moreover, without the added value of support outcomes, the improvement of care quality can be impeded and information technology can easily be seen as burdensome by the assessors. We have observed that multidisciplinary cooperation is an important prerequisite to establishing high-quality assessments aimed at improving the quality of care.	[Vanneste, Dirk; Mello, Johanna De Almeida; Van Audenhove, Chantal; Declercq, Anja] Katholieke Univ Leuven, Ctr Care Res & Consultancy, Lucas, Leuven, Belgium; [Macq, Jean] Catholic Univ Louvain, Inst Rech Sante & Soc, Ecole Sante Publ, B-1200 Brussels, Belgium	KU Leuven; Universite Catholique Louvain	Declercq, A (corresponding author), Katholieke Univ Leuven, Ctr Care Res & Consultancy, Lucas, Leuven, Belgium.	anja.declercq@med.kuleuven.be	Declercq, Anja G./G-8014-2011; Declercq, Anja/AGS-7441-2022	Declercq, Anja G./0000-0003-3136-124X; Declercq, Anja/0000-0003-3136-124X; De Almeida Mello, Johanna/0000-0002-1262-318X; Van Audenhove, Chantal/0000-0002-5504-5439	Belgian National Institute for Health and Disability Insurance (NIHDI)	Belgian National Institute for Health and Disability Insurance (NIHDI)	This study has been funded by the Belgian National Institute for Health and Disability Insurance (NIHDI). The funding of the research is external and non-commercial. The NIHDI is a federal institution that organizes, manages and supervises the correct application of compulsory health insurance in Belgium. This institution is supervised by the Belgian Ministry of Social affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GERONTOLOGIE SOC, V27, P15, DOI [10.3917/gs.109.0015., DOI 10.3917/GS.109.0015]; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bernabei R, 2008, J GERONTOL A-BIOL, V63, P308, DOI 10.1093/gerona/63.3.308; Bernabei R, 2010, J AM GERIATR SOC, V58, P1202, DOI 10.1111/j.1532-5415.2010.02884.x; Bjorkgren MA, 2000, CANADIAN J AGING, V19; Carpenter GI, 2006, AGE AGEING, V35, P327, DOI 10.1093/ageing/afl038; Carpenter I, 2012, DELSA HEA PARIS, V33, P1, DOI [10.1007/s10840-011-9619-4, DOI 10.1007/S10840-011-9619-4]; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Declercq A., 2008, ACTIEPROJECT BELRAI; Declercq A, 2010, BELRAI; Declercq A., 2007, ACTIE ONDERZOEK NAAR; Declercq A., 2009, ACTIEPROJECT BELRAI; Declercq A, 2011, BELRAI; Declercq A., 2010, BELRAI STAND ZAKEN 2; Dosa D, 2006, J AM GERIATR SOC, V54, P659, DOI 10.1111/j.1532-5415.2006.00654.x; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Fries BE, 1997, J AM GERIATR SOC, V45, P994, DOI 10.1111/j.1532-5415.1997.tb02972.x; Fries BE, 2001, GERONTOLOGIST, V41, P173, DOI 10.1093/geront/41.2.173; Fries BE, 2007, J AM GERIATR SOC, V55, P1139, DOI 10.1111/j.1532-5415.2007.01207.x; Gray L., 2006, GUIDE USE INTERRAI A; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Haux R, 2002, INT J MED INFORM, V66, P3, DOI 10.1016/S1386-5056(02)00030-8; Hawes C, 1997, AGE AGEING, V26, P19, DOI 10.1093/ageing/26.suppl_2.19; Hirdes JP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-9; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Kane RL, 2000, ANNU REV PUBL HEALTH, V21, P659, DOI 10.1146/annurev.publhealth.21.1.659; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; LaMantia MA, 2010, J AM GERIATR SOC, V58, P777, DOI 10.1111/j.1532-5415.2010.02776.x; Mann Eva, 2004, BMC Geriatr, V4, P4, DOI 10.1186/1471-2318-4-4; Mello JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-615; Milisen K., 2008, BEPALEN OPPORTUNITEI; Milisen K., 2010, WETENSCHAPPELIJK OND; Morris J. N., 2006, USERS GUIDE INTERRAI; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN., 2008, INTERRAI CLIN ASSESS; Morris JN, 2006, GUIDE USE INTERRAI L; Morris JN, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-128; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5; Poss J, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-67; Rubenstein LZ, 2004, J GERONTOL A-BIOL, V59, P473; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Vanneste D, 2014, ACHIEVING EFFECTIVE INTEGRATED E-CARE BEYOND THE SILOS, P202, DOI 10.4018/978-1-4666-6138-7.ch010; Vanneste D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-129	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123760	10.1371/journal.pone.0123760	http://dx.doi.org/10.1371/journal.pone.0123760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875281	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100210
J	Krammer, EM; Vu, GT; Homble, F; Prevost, M				Krammer, Eva-Maria; Giang Thi Vu; Homble, Fabrice; Prevost, Martine			Dual Mechanism of Ion Permeation through VDAC Revealed with Inorganic Phosphate Ions and Phosphate Metabolites	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; MOLECULAR-DYNAMICS; MITOCHONDRIAL CHANNEL; OUTER-MEMBRANE; ATP TRANSPORT; SELECTIVE CHANNEL; ALPHA-HEMOLYSIN; BINDING-SITES; PROTEIN; PERMEABILITY	In the exchange of metabolites and ions between the mitochondrion and the cytosol, the voltage-dependent anion channel (VDAC) is a key element, as it forms the major transport pathway for these compounds through the mitochondrial outer membrane. Numerous experimental studies have promoted the idea that VDAC acts as a regulator of essential mitochondrial functions. In this study, using a combination of molecular dynamics simulations, free-energy calculations, and electrophysiological measurements, we investigated the transport of ions through VDAC, with a focus on phosphate ions and metabolites. We showed that selectivity of VDAC towards small anions including monovalent phosphates arises from short-lived interactions with positively charged residues scattered throughout the pore. In dramatic contrast, permeation of divalent phosphate ions and phosphate metabolites (AMP and ATP) involves binding sites along a specific translocation pathway. This permeation mechanism offers an explanation for the decrease in VDAC conductance measured in the presence of ATP or AMP at physiological salt concentration. The binding sites occur at similar locations for the divalent phosphate ions, AMP and ATP, and contain identical basic residues. ATP features a marked affinity for a central region of the pore lined by two lysines and one arginine of the N-terminal helix. This cluster of residues together with a few other basic amino acids forms a "charged brush" which facilitates the passage of the anionic metabolites through the pore. All of this reveals that VDAC controls the transport of the inorganic phosphates and phosphate metabolites studied here through two different mechanisms.	[Krammer, Eva-Maria; Giang Thi Vu; Homble, Fabrice; Prevost, Martine] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, Struct & Fonct Membranes Biol, Brussels, Belgium	Universite Libre de Bruxelles	Prevost, M (corresponding author), Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, Struct & Fonct Membranes Biol, Brussels, Belgium.	mprevost@ulb.ac.be	Krammer, Eva-Maria/H-2543-2013	Krammer, Eva-Maria/0000-0002-4821-2550	ARC grant from the Federation Wallonie-Bruxelles [AUWB 2010-15-2, 20052]; Fonds de la Recherche Scientifique; Universite Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB)	ARC grant from the Federation Wallonie-Bruxelles; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB)	The funders of this study are the ARC grant (AUWB 2010-15-2) from the Federation Wallonie-Bruxelles (grant number 20052), and the Fonds de la Recherche Scientifique (http://www1.frs-fnrs.be/). FH is a Research Director, MP is a Senior Research Associate, and EMK is a Postdoctoral Researcher at the Fonds de la Recherche Scientifique (F.R.S.-FNRS) (Belgium). Computational resources were provided by the Computing Centre HPC cluster, co-funded by the Universite Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB), the Consortium des Equipments de Calcul Intensif (CECI), and the Fonds de la Recherche Scientifique de Belgique (F.R.S.-F.N.R.S.) under convention 2.5020.11, together with the supercomputing facilities of the Universite catholique de Louvain (CISM/UCL) and the ULB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrecht H, 2000, PLANT PHYSIOL, V124, P1181, DOI 10.1104/pp.124.3.1181; Abrecht H, 2000, J BIOL CHEM, V275, P40992, DOI 10.1074/jbc.M006437200; Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Aksimentiev A, 2004, BIOPHYS J, V87, P2086, DOI 10.1529/biophysj.104.042960; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Choudhary OP, 2014, NAT STRUCT MOL BIOL, V21, P626, DOI 10.1038/nsmb.2841; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; COHN M, 1962, J BIOL CHEM, V237, P176; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Corry B, 2005, EUR BIOPHYS J BIOPHY, V34, P208, DOI 10.1007/s00249-004-0442-z; Crozier PS, 2001, BIOPHYS J, V81, P3077, DOI 10.1016/S0006-3495(01)75946-2; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Gumbart J, 2012, BBA-BIOMEMBRANES, V1818, P294, DOI 10.1016/j.bbamem.2011.09.030; GUO XW, 1993, BIOPHYS J, V64, P545, DOI 10.1016/S0006-3495(93)81399-7; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Homble F., 2010, MEMBRANE ACTIVE PEPT, V1st ed., P273; Homble F, 2012, BBA-BIOMEMBRANES, V1818, P1486, DOI 10.1016/j.bbamem.2011.11.028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krammer E- M, 2014, MITOCHONDRION, V2014, DOI [10. 1016/ j. mito. 2014. 04. 003, DOI 10.1016/J.MIT0.2014.04.003]; Krammer EM, 2013, BBA-BIOMEMBRANES, V1828, P1284, DOI 10.1016/j.bbamem.2012.12.018; Krammer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027994; Lackey SWK, 2014, J BIOL CHEM, V289, P21640, DOI 10.1074/jbc.M114.578765; Lee AC, 1996, J BIOL CHEM, V271, P26724, DOI 10.1074/jbc.271.43.26724; Lee K, 2011, BIOPHYS J, V100, p156a, DOI [10. 1016/ j. bpj. 2010. 12. 1068, DOI 10.1016/J.BPJ.2010.12.1068]; Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Luo Y, 2010, J PHYS CHEM B, V114, P952, DOI 10.1021/jp906790f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Modi N, 2012, NANOSCALE, V4, P6166, DOI 10.1039/c2nr31024d; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pongprayoon P, 2012, J PHYS CHEM B, V116, P462, DOI 10.1021/jp206754w; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; Rostovtseva TK, 2002, J MEMBRANE BIOL, V187, P147, DOI 10.1007/s00232-001-0159-1; Roux B, 2004, Q REV BIOPHYS, V37, P15, DOI 10.1017/S0033583504003968; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; STORER AC, 1976, BIOCHEM J, V159, P1; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Villinger S, 2014, J BIOL CHEM, V289, P13397, DOI 10.1074/jbc.M113.524173; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; Wells DB, 2010, J CHEM PHYS, V127, P1, DOI [10. 1063/ 1. 2770738. Exploring, DOI 10.1063/1.2770738.EXPL0RING]; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; ZIZI M, 1994, J BIOL CHEM, V269, P1614	77	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121746	10.1371/journal.pone.0121746	http://dx.doi.org/10.1371/journal.pone.0121746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860993	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300030
J	Wang, Q; Zheng, W; Wang, ZC; Yang, JW; Hussein, S; Tang, JF; Chen, XZ				Wang, Qian; Zheng, Wang; Wang, Zuocheng; Yang, JungWoo; Hussein, Shaimaa; Tang, Jingfeng; Chen, Xing-Zhen			Filamin-A Increases the Stability and Plasma Membrane Expression of Polycystin-2	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; KIDNEY-DISEASE; CHANNEL; RECEPTOR; GENE; PKD2; PROLIFERATION; CYTOSKELETON; DEGRADATION; INTERACTS	Polycystin-2 (PC2), encoded by the PKD2 gene, is mutated in similar to 15% of autosomal dominant polycystic kidney disease. Filamins are actin-binding proteins implicated in scaffolding and membrane stabilization. Here we studied the effects of filamin on PC2 stability using filamindeficient human melanoma M2, filamin-A (FLNA)-replete A7, HEK293 and IMCD cells together with FLNA siRNA/shRNA knockdown (KD). We found that the presence of FLNA is associated with higher total and plasma membrane PC2 protein expression. Western blotting analysis in combination with FLNA KD showed that FLNA in A7 cells represses PC2 degradation, prolonging the half-life from 2.3 to 4.4 hours. By co-immunoprecipitation and Far Western blotting we found that the FLNA C-terminus (FLNAC) reduces the FLNA-PC2 binding and PC2 expression, presumably through competing with FLNA for binding PC2. We further found that FLNA mediates PC2 binding with actin through forming complex PC2-FLNA-actin. FLNAC acted as a blocking peptide and disrupted the link of PC2 with actin through disrupting the PC2-FLNA-actin complex. Finally, we demonstrated that the physical interaction of PC2-FLNA is Ca-dependent. Taken together, our current study indicates that FLNA anchors PC2 to the actin cytoskeleton through complex PC2-FLNA-actin to reduce degradation and increase stability, and possibly regulate PC2 function in a Ca-dependent manner.	[Wang, Qian; Zheng, Wang; Wang, Zuocheng; Yang, JungWoo; Hussein, Shaimaa; Tang, Jingfeng; Chen, Xing-Zhen] Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Membrane Prot Dis & Canc Res Ctr, Wuhan, Peoples R China	University of Alberta; Hubei University of Technology	Tang, JF (corresponding author), Hubei Univ Technol, Membrane Prot Dis & Canc Res Ctr, Wuhan, Peoples R China.	jingfeng@whu.edu.cn; xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Tang, jingfeng/0000-0002-5524-4518; Hussein, Shaimaa/0000-0003-0849-9670	Canadian Institutes of Health Research [MOP 89977]; Kidney Foundation of Canada [KFOC090004]; Alberta Innovates [201200922] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Alberta Innovates	This work was supported by grants from the Canadian Institutes of Health Research [MOP 89977] http://www.cihr-irsc.gc.ca/e/193.html and Kidney Foundation of Canada [KFOC090004] http://www.kidney.ca/page.aspx?pid=183 to XZC. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; de Wit MCY, 2009, J NEUROL NEUROSUR PS, V80, P426, DOI 10.1136/jnnp.2008.149419; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Ibraghimov-Beskrovnaya Oxana, 2006, Nephrol Ther, V2 Suppl 2, pS109; Kim EJ, 2007, BIOCHEM BIOPH RES CO, V362, P1101, DOI 10.1016/j.bbrc.2007.08.148; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lanoix J, 1996, ONCOGENE, V13, P1153; Lantinga-van Leeuwen IS, 2005, EUR J HUM GENET, V13, P649, DOI 10.1038/sj.ejhg.5201392; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Miyakawa A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-34; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montalbetti N, 2005, PFLUG ARCH EUR J PHY, V451, P294, DOI 10.1007/s00424-005-1458-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Obermuller N, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018402.33620.C7; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; PERRONE RD, 1985, J CLIN INVEST, V76, P1688, DOI 10.1172/JCI112155; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Prasad S, 2009, AM J PATHOL, V175, P1493, DOI 10.2353/ajpath.2009.090227; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wang Q, 2013, J BIOL CHEM, V288, P264, DOI 10.1074/jbc.M112.396408; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040448; WILSON PD, 1986, KIDNEY INT, V30, P371, DOI 10.1038/ki.1986.194; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Yuan YH, 2009, CIRC RES, V105, P1177, DOI 10.1161/CIRCRESAHA.109.204669; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhao Y, 2002, NEPHROL DIAL TRANSPL, V17, P2138, DOI 10.1093/ndt/17.12.2138; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	57	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123018	10.1371/journal.pone.0123018	http://dx.doi.org/10.1371/journal.pone.0123018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861040	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300073
J	Witteveen, A; Kwast, ABG; Sonke, GS; IJzerman, MJ; Siesling, S				Witteveen, Annemieke; Kwast, Annemiek B. G.; Sonke, Gabe S.; IJzerman, Maarten J.; Siesling, Sabine			Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; LOCAL RECURRENCE; CONSERVING THERAPY; CONSERVATIVE SURGERY; TUMOR RECURRENCE; RISK-FACTORS; RELEVANCE; WOMEN	The association between the disease-free interval (DFI) and survival after a locoregional recurrence (LRR) or second primary (SP) breast cancer remains uncertain. The objective of this study is to clarify this association to obtain more information on expected prognosis. Women first diagnosed with early breast cancer between 2003-2006 were selected from the Netherlands Cancer Registry. LRRs and SP tumours within five years of first diagnosis were examined. The five-year period was subsequently divided into three equal intervals. Prognostic significance of the DFI on survival after a LRR or SP tumour was determined using Kaplan-Meier estimates and multivariable Cox regression analysis. Follow-up was complete until January 1, 2014. A total of 37,278 women was included in the analysis. LRRs or SP tumours were diagnosed in 890 (2,4%) and 897 (2,4%) respectively. Longer DFI was strongly and independently related to an improved survival after a LRR (long versus short: HR 0.65, 95% CI 0.48-0.88; medium versus short HR 0.81, 95% CI 0.65-1.01). Other factors related to improved survival after LRR were younger age (<70 years) and surgical removal of the recurrence. No significant association was found between DFI and survival after SP tumours. This is the first study to explore the association between the DFI and survival after recurrence in a nationwide population-based cancer registry. The DFI before a LRR is an independent prognostic factor for survival, with a longer DFI predicting better prognosis.	[Witteveen, Annemieke; IJzerman, Maarten J.; Siesling, Sabine] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, NL-7500 AE Enschede, Netherlands; [Kwast, Annemiek B. G.; Siesling, Sabine] Comprehens Canc Ctr Netherlands IKNL, Dept Registrat & Res, Utrecht, Netherlands; [Sonke, Gabe S.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	University of Twente; Netherlands Cancer Institute	Witteveen, A (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, POB 217, NL-7500 AE Enschede, Netherlands.	a.witteveen@utwente.nl	IJzerman, Maarten/AAB-6894-2020; IJzerman, Maarten J/Q-8963-2016	IJzerman, Maarten/0000-0001-5788-5805; IJzerman, Maarten J/0000-0001-5788-5805; Witteveen, Annemieke/0000-0001-5581-6478; Sonke, Gabe/0000-0001-8088-9628				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Bantema-Joppe EJ, 2013, BREAST CANCER RES TR, V140, P577, DOI 10.1007/s10549-013-2650-7; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies E., 2013, SURGERY, V31, P41; Dawood S, 2010, ANN ONCOL, V21, P2169, DOI 10.1093/annonc/mdq220; Doyle T, 2001, INT J RADIAT ONCOL, V51, P74, DOI 10.1016/S0360-3016(01)01625-X; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fredriksson I, 2002, EUR J CANCER, V38, P1860, DOI 10.1016/S0959-8049(02)00219-8; Grillo IM, 2005, CLIN ONCOL-UK, V17, P111, DOI 10.1016/j.clon.2004.10.005; Hastings J, 2013, AM J CLIN ONCOL-CANC, P1; Holzel D, 2011, CANCER METAST REV, V30, P161, DOI 10.1007/s10555-011-9275-2; Komoike Y, 2006, CANCER-AM CANCER SOC, V106, P35, DOI 10.1002/cncr.21551; Kwast A, 2014, BREAST CANCER RES TR; Kwast ABG, 2012, BREAST CANCER RES TR, V135, P271, DOI 10.1007/s10549-012-2160-z; Li HR, 2013, ACTA PHARMACOL SIN, V34, P870, DOI 10.1038/aps.2013.35; Livi L, 2012, CANCER-AM CANCER SOC, V118, P3236, DOI 10.1002/cncr.26647; Lu WL, 2009, BREAST CANCER RES TR, V114, P403, DOI 10.1007/s10549-008-0023-4; Min SY, 2011, INT J RADIAT ONCOL, V81, pE697, DOI 10.1016/j.ijrobp.2010.10.014; Nederlandse Kankerregistratie, 2013, CODEERHANDLEIDING NE; Neri A, 2007, WORLD J SURG, V31, P36, DOI 10.1007/s00268-006-0097-2; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Panet-Raymond V, 2011, INT J RADIAT ONCOL, V81, P409, DOI 10.1016/j.ijrobp.2010.05.063; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Tanis E, 2012, EUR J CANCER, V48, P1751, DOI 10.1016/j.ejca.2012.02.051; van der Sangen MJC, 2006, EJSO-EUR J SURG ONC, V32, P34, DOI 10.1016/j.ejso.2005.10.005; van Laar C, 2013, EUR J CANCER, V49, P3093, DOI 10.1016/j.ejca.2013.05.030; van Tienhoven G, 1999, EUR J CANCER, V35, P32, DOI 10.1016/S0959-8049(98)00301-3; Vichapat V, 2011, BREAST CANCER RES TR, V130, P609, DOI 10.1007/s10549-011-1618-8; Voogd AC, 2005, EUR J CANCER, V41, P2637, DOI 10.1016/j.ejca.2005.04.040; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yadav BS, 2008, RADIOTHER ONCOL, V86, P171, DOI 10.1016/j.radonc.2007.10.002	35	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120832	10.1371/journal.pone.0120832	http://dx.doi.org/10.1371/journal.pone.0120832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861031	Green Published, gold			2022-12-27	WOS:000352590300017
J	Barbaro, D; Di Bari, L; Gandin, V; Evangelisti, C; Vitulli, G; Schiavi, E; Marzano, C; Ferretti, AM; Salvadori, P				Barbaro, Daniele; Di Bari, Lorenzo; Gandin, Valentina; Evangelisti, Claudio; Vitulli, Giovanni; Schiavi, Eleonora; Marzano, Cristina; Ferretti, Anna M.; Salvadori, Piero			Glucose-Coated Superparamagnetic Iron Oxide Nanoparticles Prepared by Metal Vapour Synthesis Are Electively Internalized in a Pancreatic Adenocarcinoma Cell Line Expressing GLUT1 Transporter	PLOS ONE			English	Article							MAGNETIC NANOPARTICLES; THERMOTHERAPY; FEASIBILITY; HYPERTHERMIA; PARTICLES	Iron oxide nanoparticles (IONP) can have a variety of biomedical applications due to their visualization properties through Magnetic Resonance Imaging (MRI) and heating with radio frequency or alternating magnetic fields. In the oncological field, coating IONP with organic compounds to provide specific features and to achieve the ability of binding specific molecular targets appears to be very promising. To take advantage of the high avidity of tumor cells for glucose, we report the development of very small glucose-coated IONP (glc-IONP) by employing an innovative technique, Metal Vapor Synthesis (MVS). Moreover, we tested the internalization of our gl-IONP on a tumor line, BxPC3, over-expressing GLUT 1 transporter. Both glc-IONP and polyvinylpyrrolidone-IONP (PVP-IONP), as control, were prepared with MVS and were tested on BxPC3 at various concentrations. To evaluate the role of GLUT-1 transporter, we also investigated the effect of adding a polyclonal anti-GLUT1 antibody. After proper treatment, the iron value was assessed by atomic absorption spectrometer, reported in mcg/L and expressed in mg of protein. Our IONP prepared with MVS were very small and homogeneously distributed in a narrow range (1.75-3.75 nm) with an average size of 2.7 nm and were super-paramagnetic. Glc-IONP were internalized by BxPC3 cells in a larger amount than PVP-IONP. After 6h of treatment with 50 mcg/mL of IONPs, the content of Fe was 1.5 times higher in glc-IONP-treated cells compared with PVP-IONP-treated cells. After 1h pre-treatment with anti-GLUT1, a reduction of 41% cellular accumulation of glc-IONP was observed. Conversely, the uptake of PVP-IONPs was reduced only by 14% with antibody pretreatment. In conclusion, MVS allowed us to prepare small, homogeneous, super-paramagnetic glc-IONP, which are electively internalized by a tumor line over-expressing GLUT1. Our glc-IONP appear to have many requisites for in vivo use.	[Barbaro, Daniele] Gen Hosp, Endocrinol Sect, I-57100 Livorno, Italy; [Di Bari, Lorenzo] Univ Pisa, Dept Chem & Ind Chem, I-56124 Pisa, Italy; [Gandin, Valentina; Marzano, Cristina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35100 Padua, Italy; [Evangelisti, Claudio; Ferretti, Anna M.] CNR, Inst Mol Sci & Technol, I-20138 Milan, Italy; [Vitulli, Giovanni; Schiavi, Eleonora; Salvadori, Piero] ErreDue SpA, I-57121 Livorno, Italy	University of Pisa; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR)	Barbaro, D (corresponding author), Gen Hosp, Endocrinol Sect, Viale Alfieri 36, I-57100 Livorno, Italy.	danielebarbaro@katamail.com; lorenzo.dibari@unipi.it; valentina.gandin@unipd.it	Evangelisti, Claudio/L-4815-2015; Salvadori, Piero A/B-2342-2012; Ferretti, Anna Maria/E-6861-2010; Di Bari, Lorenzo/H-4804-2015	Evangelisti, Claudio/0000-0002-8855-2592; Salvadori, Piero A/0000-0001-6114-1059; Ferretti, Anna Maria/0000-0002-7373-7965; Di Bari, Lorenzo/0000-0003-2347-2150; GANDIN, VALENTINA/0000-0003-0442-0670				Branca RT, 2010, P NATL ACAD SCI USA, V107, P3693, DOI 10.1073/pnas.1000386107; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Dudeck O, 2006, INVEST RADIOL, V41, P527, DOI 10.1097/01.rli.0000209601.15533.5a; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23; Hassan S, 2014, J NANOSCI NANOTECHNO, V14, P402, DOI 10.1166/jnn.2014.8747; Hayashi K, 2013, THERANOSTICS, V3, P366, DOI 10.7150/thno.5860; Jin RR, 2014, CURR OPIN PHARMACOL, V18, P18, DOI 10.1016/j.coph.2014.08.002; Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360; Johannsen M, 2007, EUR UROL, V52, P1653, DOI 10.1016/j.eururo.2006.11.023; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Jordan A, 1996, INT J HYPERTHER, V12, P705, DOI 10.3109/02656739609027678; Jordan A., 2006, HYPERTHERMIA CANC TR, P1; Kalambur VS, 2007, LANGMUIR, V23, P12329, DOI 10.1021/la701100r; Kim JW, 2006, CANCER RES, V99, P8027; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Klabunde K.J., 1994, FREE ATOMS CLUSTERS; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Laurent S, 2014, EXPERT OPIN DRUG DEL, V11, P1449, DOI 10.1517/17425247.2014.924501; Lin GG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/625095; Maier-Hauff K, 2007, J NEURO-ONCOL, V81, P53, DOI 10.1007/s11060-006-9195-0; Plotkin M, 2006, INT J HYPERTHER, V22, P319, DOI 10.1080/02656730600734128; Schmid G., 1994, CLUSTERS COLLOIDS TH, P459, DOI DOI 10.1002/9783527616077.CH6; Selvi RB, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-35; Shan XH, 2012, EUR J RADIOL, V81, P95, DOI 10.1016/j.ejrad.2011.03.013; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Urban C, 2013, TRANSL CANCER RES, V2, P292, DOI 10.3978/j.issn.2218-676X.2013.08.05; Vitulli G, 2008, METAL NANOCLUSTERS IN CATALYSIS AND MATERIALS SCIENCE: THE ISSUE OF SIZE CONTROL, P437, DOI 10.1016/B978-044453057-8.50034-9; Wust P, 2006, INT J HYPERTHER, V22, P673, DOI 10.1080/02656730601106037; Xiong F, 2012, PHARM RES-DORDR, V29, P1087, DOI 10.1007/s11095-011-0653-9	32	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123159	10.1371/journal.pone.0123159	http://dx.doi.org/10.1371/journal.pone.0123159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874906	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800087
J	Ding, ZJ; Chen, X; Tang, XX; Wang, X; Song, YL; Chen, XD; Mi, WJ; Wang, J; Lin, Y; Chen, FQ; Qiu, JH				Ding, Zhong-Jia; Chen, Xin; Tang, Xiao-Xu; Wang, Xi; Song, Yong-Li; Chen, Xiao-Dong; Mi, Wen-Juan; Wang, Jian; Lin, Ying; Chen, Fu-Quan; Qiu, Jian-Hua			Calpain Inhibitor PD150606 Attenuates Glutamate Induced Spiral Ganglion Neuron Apoptosis through Apoptosis Inducing Factor Pathway In Vitro	PLOS ONE			English	Article							HAIR CELL-DEATH; FACTOR AIF; SENSORY CELLS; ACTIVATION; TRANSLOCATION; MITOCHONDRIA; RELEASE; CA2+	Objective This research aimed to investigate whether glutamate induced spiral ganglion neurons (SGNs) apoptosis through apoptosis inducing factor (AIF) pathway. And verify whether PD150606, a calpain inhibitor could prevent apoptosis by inhibiting cleaving and releasing AIF in mitochondrion. Methods SGNs of postnatal days 0-3 were harvested and cultured in dishes. 20 mM Glu, the caspase inhibitor Z-VAD-FMK and calpain inhibitor PD150606 were added into cultured dishes separately. We used optical microscope and immunofluoresence staining to observe cell morphology and AIF distribution, RT-PCR and Westernblot to analyse AIF and calpain expression in SGNs. TUNEL assay was used to test cell apoptosis. Results Cell morphology and nuclear translocation of AIF were altered in SGNs by 20 mM Glu treated in vitro. The axon of SGN shortened, more apoptosis SGN were observed and the expression of AIF and calpain were up-regulated in Glu-treated group than the normal one (P<0.05). The same experiments were conducted in 20 mM+PD150606 treated group and 20 mM+Z-VAD-FMK group. Obviously AIF were located from cytoplasm to the nuclear and the expressions of AIF and calpain were down-regulated by PD150606 (P<0.05). Positive cells in TUNEL staining decreased after PD150606 treating. However, Z-VAD-FMK had no influence on AIF, calpain expression or cell apoptosis. Conclusion The AIF-related apoptosis pathway is involved in the process of Glu-induced SGN injury. Furthermore, the inhibition of calpain can prevent AIF from releasing the nuclear or inducing SGN apoptosis.	[Ding, Zhong-Jia; Chen, Xin; Wang, Xi; Song, Yong-Li; Chen, Xiao-Dong; Mi, Wen-Juan; Wang, Jian; Lin, Ying; Chen, Fu-Quan; Qiu, Jian-Hua] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China; [Tang, Xiao-Xu] Logist Acad, Outpatient Dept, Beijing, Peoples R China	Air Force Military Medical University	Chen, FQ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China.	Chenfq2@yahoo.com; qiujh@fmmu.edu.cn	chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; Chen, Fuquan/AAL-2322-2021	Chen, Fuquan/0000-0002-4625-073X	Major State Basic Research Development Program of China [2011CB504505]; National Natural Science Foundation of China [81120108008, 30930098, 81100715, 81271069]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Major State Basic Research Development Program of China No. 2011CB504505 and National Natural Science Foundation of China Nos. 81120108008, 30930098, 81100715 and 81271069 provided support to design the research, purchase reagents, and help publish the manuscript.	Chen Hao, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P329; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Han WJ, 2006, HEARING RES, V211, P85, DOI 10.1016/j.heares.2005.10.004; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Kwon CH, 2009, TOXICOLOGY, V257, P1, DOI 10.1016/j.tox.2008.11.019; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Liu WW, 2012, NEUROL RES, V34, P915, DOI 10.1179/1743132812Y.0000000098; Lu HT, 2010, ACTA OTO-LARYNGOL, V130, P1316, DOI 10.3109/00016489.2010.495133; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Steiger-Barraissoul S, 2009, APOPTOSIS, V14, P1274, DOI 10.1007/s10495-009-0396-9; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang DG, 2012, ORL-J OTO-RHIN-LARYN, V74, P1, DOI 10.1159/000333251; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49	19	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123130	10.1371/journal.pone.0123130	http://dx.doi.org/10.1371/journal.pone.0123130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874633	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800086
J	Kopova, I; Lavrentiev, V; Vacik, J; Bacakova, L				Kopova, Ivana; Lavrentiev, Vasily; Vacik, Jiri; Bacakova, Lucie			Growth and Potential Damage of Human Bone-Derived Cells Cultured on Fresh and Aged C-60/Ti Films	PLOS ONE			English	Article							OSTEOBLAST-LIKE; FULLERENE C-60; SURFACE-TREATMENT; OXIDATIVE STRESS; ADHESION; C60; MECHANISMS; DIFFERENTIATION; DEXAMETHASONE; COMPOSITES	Thin films of binary C-60/Ti composites, with various concentrations of Ti ranging from similar to 25% to similar to 70%, were deposited on microscopic glass coverslips and were tested for their potential use in bone tissue engineering as substrates for the adhesion and growth of bone cells. The novelty of this approach lies in the combination of Ti atoms (i.e., widely used biocompatible material for the construction of stomatological and orthopedic implants) with atoms of fullerene C-60, which can act as very efficient radical scavengers. However, fullerenes and their derivatives are able to generate harmful reactive oxygen species and to have cytotoxic effects. In order to stabilize C-60 molecules and to prevent their possible cytotoxic effects, deposition in the compact form of Ti/C-60 composites (with various Ti concentrations) was chosen. The reactivity of C-60/Ti composites may change in time due to the physicochemical changes of molecules in an air atmosphere. In this study, we therefore tested the dependence between the age of C-60/Ti films (from one week to one year) and the adhesion, morphology, proliferation, viability, metabolic activity and potential DNA damage to human osteosarcoma cells (lines MG-63 and U-2 OS). After 7 days of cultivation, we did not observe any negative influence of fresh or aged C-60/Ti layers on cell behavior, including the DNA damage response. The presence of Ti atoms resulted in improved properties of the C-60 layers, which became more suitable for cell cultivation.	[Kopova, Ivana; Bacakova, Lucie] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Krc, Czech Republic; [Lavrentiev, Vasily; Vacik, Jiri] Acad Sci Czech Republ, Inst Nucl Phys, CZ-25068 Rez, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences	Kopova, I (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Krc, Czech Republic.	ivana.kopova@biomed.cas.cz	Nemcakova, Ivana/R-2531-2016; Lavrentiev, Vasily/G-9510-2014; Vacik, Jiri/G-9263-2014; Bacakova, Lucie/C-2664-2012	Nemcakova, Ivana/0000-0001-9725-8048; Vacik, Jiri/0000-0002-1875-4914; Bacakova, Lucie/0000-0002-1818-9484; Lavrentiev, Vasily/0000-0001-8344-080X	Grant Agency of the Czech Republic [P107/11/1856, P108/12/1168]; CANAM infrastructure (NPI ASCR Rez)	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); CANAM infrastructure (NPI ASCR Rez)	This research was supported by the Grant Agency of the Czech Republic (grants No. P107/11/1856 and P108/12/1168) and CANAM infrastructure (NPI ASCR Rez).	Bacakova L, 2001, J BIOMED MATER RES, V54, P567; Bacakova L., 2008, NANOPARTICLES NEW RE, P39; Bacakova L, 2011, ADVANCES IN DIVERSE INDUSTRIAL APPLICATIONS OF NANOCOMPOSITES, P399; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Dwivedi N, 2011, ACS APPL MATER INTER, V3, P4268, DOI 10.1021/am200939j; Gao J, 2010, TOXICOL APPL PHARM, V244, P130, DOI 10.1016/j.taap.2009.12.025; Grausova L, 2008, J OPTOELECTRON ADV M, V10, P2071; Grinevich A, 2009, J BIOMED MATER RES A, V88A, P952, DOI 10.1002/jbm.a.31918; Harcuba P, 2012, J MECH BEHAV BIOMED, V7, P96, DOI 10.1016/j.jmbbm.2011.07.001; Honma M, 2012, MUTAT RES-GEN TOX EN, V749, P97, DOI 10.1016/j.mrgentox.2012.08.006; Jain S, 2013, J BIOMED MATER RES B, V101B, P520, DOI 10.1002/jbm.b.32852; Jirka I, 2013, MAT SCI ENG C-MATER, V33, P1636, DOI 10.1016/j.msec.2012.12.073; Johnston HJ, 2010, TOXICOL SCI, V114, P162, DOI 10.1093/toxsci/kfp265; Joska L., 2014, BIOMATTER, V4; Ko WB, 2006, ULTRASONICS, V44, pE363, DOI 10.1016/j.ultras.2006.05.003; Kopova I, 2013, INT J MOL SCI, V14, P9182, DOI 10.3390/ijms14059182; Liu HJ, 2012, J ORTHOP RES, V30, P1051, DOI 10.1002/jor.22054; Liu X, 2005, SOL ENERG MAT SOL C, V87, P5, DOI 10.1016/j.solmat.2004.09.011; Lucafo M, 2013, TOXICOLOGY, V314, P183, DOI 10.1016/j.tox.2013.10.001; Moller P, 2012, CURR MOL MED, V12, P732, DOI 10.2174/156652412800792624; Mrdanovic J, 2009, MUTAT RES-GEN TOX EN, V680, P25, DOI 10.1016/j.mrgentox.2009.08.008; Murakami M, 2013, PHOTODERMATOL PHOTO, V29, P196, DOI 10.1111/phpp.12050; Popa AC, 2013, J MATER SCI-MATER M, V24, P2695, DOI 10.1007/s10856-013-5026-y; Rebecca M, 2009, TOXICOL APPL PHARM, V234, P58, DOI 10.1016/j.taap.2008.08.021; Ferreira JLR, 2014, AQUAT TOXICOL, V147, P76, DOI 10.1016/j.aquatox.2013.12.007; Rouse JG, 2006, TOXICOL IN VITRO, V20, P1313, DOI 10.1016/j.tiv.2006.04.004; Shinohara N, 2009, TOXICOL LETT, V191, P289, DOI 10.1016/j.toxlet.2009.09.012; Strasky J, 2013, APPL SURF SCI, V281, P73, DOI 10.1016/j.apsusc.2013.02.053; Talyzin AV, 2003, THIN SOLID FILMS, V429, P96, DOI 10.1016/S0040-6090(03)00278-5; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Tsai PC, 2008, J NANOSCI NANOTECHNO, V8, P2516, DOI 10.1166/jnn.2008.600; Vacik J, 2004, NUCL INSTRUM METH B, V219, P862, DOI 10.1016/j.nimb.2004.01.177; Vacik J, 2010, NUCL INSTRUM METH B, V268, P1976, DOI 10.1016/j.nimb.2010.02.112; Vacik J, 2010, DIAM RELAT MATER, V19, P242, DOI 10.1016/j.diamond.2009.10.016; Vacik J, 2009, J ALLOY COMPD, V483, P374, DOI 10.1016/j.jallcom.2008.08.112; Vacik J, 2011, J ALLOY COMPD, V509, pS380, DOI 10.1016/j.jallcom.2011.04.107; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Vandrovcova M, 2008, PHYS STATUS SOLIDI A, V205, P2252, DOI 10.1002/pssa.200879730; Vandrovcova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100475; Vesterdal LK, 2014, TOXICOL APPL PHARM, V274, P350, DOI 10.1016/j.taap.2013.10.001; Xu X, 2012, NUCLEIC ACIDS RES, V40, P7622, DOI 10.1093/nar/gks517; Yudoh K, 2007, ARTHRITIS RHEUM-US, V56, P3307, DOI 10.1002/art.22917; Yudoh K, 2009, INT J NANOMED, V4, P233; Zhang Y, 2013, ACS APPL MATER INTER, V5, P5291, DOI 10.1021/am401153k; Zhao XC, 2005, BIOPHYS J, V89, P3856, DOI 10.1529/biophysj.105.064410	45	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123680	10.1371/journal.pone.0123680	http://dx.doi.org/10.1371/journal.pone.0123680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875338	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800110
J	Qin, JY; Wang, XW; Wang, LD; Zhu, BB; Zhang, XH; Yao, QS; Xu, P				Qin, Jiayang; Wang, Xiuwen; Wang, Landong; Zhu, Beibei; Zhang, Xiaohua; Yao, Qingshou; Xu, Ping			Comparative Transcriptome Analysis Reveals Different Molecular Mechanisms of Bacillus coagulans 2-6 Response to Sodium Lactate and Calcium Lactate during Lactic Acid Production	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LONGITUDINAL TWIN; ADHD SYMPTOMS; GENETIC INFLUENCES; CHILDHOOD; IQ; INTELLIGENCE; PERFORMANCE; CHILDREN	Lactate production is enhanced by adding calcium carbonate or sodium hydroxide during fermentation. However, Bacillus coagulans 2-6 can produce more than 180 g/L L-lactic acid when calcium lactate is accumulated, but less than 120 g/L L-lactic acid when sodium lactate is formed. The molecular mechanisms by which B. coagulans responds to calcium lactate and sodium lactate remain unclear. In this study, comparative transcriptomic methods based on high-throughput RNA sequencing were applied to study gene expression changes in B. coagulans 2-6 cultured in non-stress, sodium lactate stress and calcium lactate stress conditions. Gene expression profiling identified 712 and 1213 significantly regulated genes in response to calcium lactate stress and sodium lactate stress, respectively. Gene ontology assignments of the differentially expressed genes were performed. KEGG pathway enrichment analysis revealed that 'ATP-binding cassette transporters' were significantly affected by calcium lactate stress, and 'amino sugar and nucleotide sugar metabolism' was significantly affected by sodium lactate stress. It was also found that lactate fermentation was less affected by calcium lactate stress than by sodium lactate stress. Sodium lactate stress had negative effect on the expression of 'glycolysis/gluconeogenesis' genes but positive effect on the expression of 'citrate cycle (TCA cycle)' genes. However, calcium lactate stress had positive influence on the expression of 'glycolysis/gluconeogenesis' genes and had minor influence on 'citrate cycle (TCA cycle)' genes. Thus, our findings offer new insights into the responses of B. coagulans to different lactate stresses. Notably, our RNA-seq dataset constitute a robust database for investigating the functions of genes induced by lactate stress in the future and identify potential targets for genetic engineering to further improve L-lactic acid production by B. coagulans.	[Qin, Jiayang; Wang, Xiuwen; Wang, Landong; Zhu, Beibei; Zhang, Xiaohua; Yao, Qingshou] Binzhou Med Univ, Coll Pharm, Yantai, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Binzhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qin, JY (corresponding author), Binzhou Med Univ, Coll Pharm, Yantai, Peoples R China.	qinjy@bzmc.edu.cn			National Natural Science Foundation of China [31200078]; Shandong Provincial Natural Science Foundation, China [ZR2001CQ025]; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences [KLIM-201302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (31200078), the Shandong Provincial Natural Science Foundation, China (ZR2001CQ025), and the CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences (KLIM-201302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2013, J PEDIATR-US, V163, P890, DOI 10.1016/j.jpeds.2013.02.043; Aman MG, 2003, J CHILD ADOL PSYCHOP, V13, P29, DOI 10.1089/104454603321666171; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Burt SA, 2005, DEV PSYCHOPATHOL, V17, P145, DOI 10.1017/S095457940505008X; Chang Z, 2013, JAMA PSYCHIAT, V70, P311, DOI 10.1001/jamapsychiatry.2013.287; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Firkowska-Mankiewicz A, 2011, J POLICY PRACT INTEL, V8, P1, DOI 10.1111/j.1741-1130.2011.00281.x; Fox MC, 2013, J EXP PSYCHOL GEN, V142, P979, DOI 10.1037/a0030155; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Greven CU, 2014, J CHILD PSYCHOL PSYC, V55, P39, DOI 10.1111/jcpp.12090; Greven CU, 2012, J CHILD PSYCHOL PSYC, V53, P234, DOI 10.1111/j.1469-7610.2011.02445.x; Greven CU, 2011, J ABNORM CHILD PSYCH, V39, P623, DOI 10.1007/s10802-011-9513-7; Grizenko N, 2012, J CAN ACAD CHILD ADO, V21, P282; Hallett V, 2010, AM J PSYCHIAT, V167, P809, DOI 10.1176/appi.ajp.2009.09070990; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Hinshaw SP, 2007, J PEDIATR PSYCHOL, V32, P664, DOI 10.1093/jpepsy/jsl055; Hoekstra RA, 2007, LEARN INDIVID DIFFER, V17, P97, DOI 10.1016/j.lindif.2007.05.005; Kuntsi J, 2005, BIOL PSYCHIAT, V57, P647, DOI 10.1016/j.biopsych.2004.12.032; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Larsson JO, 2004, J AM ACAD CHILD PSY, V43, P1267, DOI 10.1097/01.chi.0000135622.05219.bf; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Neale MC, 1992, METHODOLOGY GENETIC; Nikolas MA, 2010, J ABNORM PSYCHOL, V119, P1, DOI 10.1037/a0018010; Oner O, 2005, SCHIZOPHR RES, V76, P293, DOI 10.1016/j.schres.2005.01.005; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; Paloyelis Y, 2010, J ABNORM CHILD PSYCH, V38, P1083, DOI 10.1007/s10802-010-9429-7; Polderman TJC, 2006, ACTA NEUROL BELG, V106, P191; Rasmussen P, 2000, J AM ACAD CHILD PSY, V39, P1424, DOI 10.1097/00004583-200011000-00017; Raven JC, 1996, MANUAL FOR RAVENS PR, DOI [10.1038/nmeth.2939, DOI 10.1038/NMETH.2939]; Rommelse NNJ, 2008, PSYCHOL MED, V38, P1595, DOI 10.1017/S0033291708002869; Scholtens S, 2013, SCAND J PSYCHOL, V54, P205, DOI 10.1111/sjop.12042; Sternberg RJ, 2012, WIRES COGN SCI, V3, P501, DOI 10.1002/wcs.1193; Trzaskowski M, 2014, MOL PSYCHIATR, V19, P380, DOI 10.1038/mp.2012.191; van der Oord S, 2008, EUR CHILD ADOLES PSY, V17, P73, DOI 10.1007/s00787-007-0638-8; van Soelen ILC, 2011, TWIN RES HUM GENET, V14, P119, DOI 10.1375/twin.14.2.119; Walker AJ, 2009, AUST PSYCHOL, V44, P216, DOI 10.1080/00050060902833469; Washbrook E, 2013, BRIT J PSYCHIAT, V203, P265, DOI 10.1192/bjp.bp.112.123562; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X	44	18	19	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124316	10.1371/journal.pone.0124316	http://dx.doi.org/10.1371/journal.pone.0124316			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875592	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800138
J	Underwood, CJ; Johanson, Z; Welten, M; Metscher, B; Rasch, LJ; Fraser, GJ; Smith, MM				Underwood, Charlie J.; Johanson, Zerina; Welten, Monique; Metscher, Brian; Rasch, Liam J.; Fraser, Gareth J.; Smith, Moya Meredith			Development and Evolution of Dentition Pattern and Tooth Order in the Skates And Rays (Batoidea; Chondrichthyes)	PLOS ONE			English	Article							PHYLOGENY; JAWS	Shark and ray (elasmobranch) dentitions are well known for their multiple generations of teeth, with isolated teeth being common in the fossil record. However, how the diverse dentitions characteristic of elasmobranchs form is still poorly understood. Data on the development and maintenance of the dental patterning in this major vertebrate group will allow comparisons to other morphologically diverse taxa, including the bony fishes, in order to identify shared pattern characters for the vertebrate dentition as a whole. Data is especially lacking from the Batoidea (skates and rays), hence our objective is to compile data on embryonic and adult batoid tooth development contributing to ordering of the dentition, from cleared and stained specimens and micro-CT scans, with 3D rendered models. We selected species (adult and embryonic) spanning phylogenetically significant batoid clades, such that our observations may raise questions about relationships within the batoids, particularly with respect to current molecular-based analyses. We include developmental data from embryos of recent model organisms Leucoraja erinacea and Raja clavata to evaluate the earliest establishment of the dentition. Characters of the batoid dentition investigated include alternate addition of teeth as offset successional tooth rows (versus single separate files), presence of a symphyseal initiator region (symphyseal tooth present, or absent, but with two parasymphyseal teeth) and a restriction to tooth addition along each jaw reducing the number of tooth families, relative to addition of successor teeth within each family. Our ultimate aim is to understand the shared characters of the batoids, and whether or not these dental characters are shared more broadly within elasmobranchs, by comparing these to dentitions in shark outgroups. These developmental morphological analyses will provide a solid basis to better understand dental evolution in these important vertebrate groups as well as the general plesiomorphic vertebrate dental condition.	[Underwood, Charlie J.] Univ London, Dept Earth & Planetary Sci, London WC1E 7HX, England; [Johanson, Zerina; Welten, Monique; Smith, Moya Meredith] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Rasch, Liam J.; Fraser, Gareth J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Smith, Moya Meredith] Kings Coll London, Inst Dent, Craniofacial Dev, London SE1 9RT, England; [Metscher, Brian] Univ Vienna, Dept Theoret Biol, A-1090 Vienna, Austria	University of London; Natural History Museum London; University of Sheffield; University of London; King's College London; University of Vienna	Underwood, CJ (corresponding author), Univ London, Dept Earth & Planetary Sci, Malet St, London WC1E 7HX, England.	c.underwood@bbk.ac.uk	Metscher, Brian/I-1238-2019; Welten, Monique/ABC-2988-2020; Fraser, Gareth/I-3457-2019	Metscher, Brian/0000-0002-6514-4406; Fraser, Gareth/0000-0002-7376-0962; Welten, Monique/0000-0001-8675-5700; Johanson, Zerina/0000-0002-8444-6776; Meredith Smith, Moya/0000-0002-3397-873X	Natural Environmental Research Council [NE/K01434X1, NE/K014595/1, NE/K0122071/1]; Natural Environment Research Council [NE/K01434X/1, NE/K014595/1, NE/K014293/1] Funding Source: researchfish; NERC [NE/K014595/1, NE/K01434X/1, NE/K014293/1] Funding Source: UKRI	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Natural Environmental Research Council; NE/K01434X1 (ZJ); NE/K014595/1 (GJF); NE/K0122071/1 (MMS) www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschliman NC, 2012, MOL PHYLOGENET EVOL, V63, P28, DOI 10.1016/j.ympev.2011.12.012; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Capetta H, 2012, HDB PALEOICHTHYOLOGY, V3E, P1; Geniz JLC, 2007, ZOOTAXA, P1; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; Fraser GJ, 2013, DEV BIOL, V377, P399, DOI 10.1016/j.ydbio.2013.02.007; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Kajiura SM, 1996, J EXP BIOL, V199, P2297; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; McEachran JD, 2004, CRC MAR BIOL SER, P79; McEachran John D., 1996, P63, DOI 10.1016/B978-012670950-6/50005-9; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Naylor Gavin J.P., 2005, P1; Owen R, 1840, ODONTOGRAPHY, P1; Pavan-Kumar A, 2014, MOL BIOL REP, V41, P447, DOI 10.1007/s11033-013-2879-6; Peyer B., 1968, COMP ODONTOLOGY, P1; Reif W.-E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V157, P107; REIF WE, 1982, EVOL BIOL, V15, P287; Rocco L, 2007, GENE, V389, P80, DOI 10.1016/j.gene.2006.09.024; Shirai Shigeru, 1996, P9, DOI 10.1016/B978-012670950-6/50003-5; Smith BG, 1937, ARCHAIC FISHES, P333; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 2009, P ROY SOC B-BIOL SCI, V276, P1225, DOI 10.1098/rspb.2008.1526; Smith MM, 2013, HIST BIOL, V25, P127, DOI 10.1080/08912963.2012.662228; TAYLOR W R, 1985, Cybium, V9, P107; Underwood CJ, 2004, PALAEONTOLOGY, V47, P447, DOI 10.1111/j.0031-0239.2004.00386.x; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617	30	43	44	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122553	10.1371/journal.pone.0122553	http://dx.doi.org/10.1371/journal.pone.0122553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874547	Green Accepted, Green Published, gold			2022-12-27	WOS:000353015800064
J	Leitner, G; Blum, SE; Rivas, AL				Leitner, Gabriel; Blum, Shlomo E.; Rivas, Ariel L.			Visualizing the Indefinable: Three-Dimensional Complexity of 'Infectious Diseases'	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMS BIOLOGY; SUBCLINICAL MASTITIS; MILK-COMPOSITION; TIME; IDENTIFICATION; CHALLENGES; CYTOKINES; MODELS; CELLS	Background The words 'infection' and 'inflammation' lack specific definitions. Here, such words are not defined. Instead, the ability to visualize host-microbial interactions was explored. Methods Leukocyte differential counts and four bacterial species (Staphylococcus aureus, Streptococcus dysgalactiae, Staphylococcus chromogenes, and Escherichia coli) were determined or isolated in a cross-sectional and randomized study conducted with 611 bovine milk samples. Two paradigms were evaluated: (i) the classic one, which measures nonstructured (count or percent) data; and (ii) a method that, using complex data structures, detects and differentiates three-dimensional (3D) interactions among lymphocytes (L), macrophages (M), and neutrophils (N). Results Classic analyses failed to differentiate bacterial-positive (B+) from -negative (B-) observations: B-and B+ data overlapped, even when statistical significance was achieved. In contrast, the alternative approach showed distinct patterns, such as perpendicular data inflections, which discriminated microbial-negative/mononuclear cell-predominating (MCP) from microbial-positive/ phagocyte-predominating (PP) subsets. Two PP subcategories were distinguished, as well as PP/culture-negative (false-negative) and MCP/culture-positive (false-positive) observations. In 3D space, MCP and PP subsets were perpendicular to one another, displaying >= 91% specificity or sensitivity. Findings supported five inferences: (i) disease is not always ruled out by negative bacterial tests; (ii) low total cell counts can coexist with high phagocyte percents; (iii) neither positive bacterial isolation nor high cell counts always coincide with PP profiles; (iv) statistical significance is not synonymous with discrimination; and (v) hidden relationships cannot be detected when simple (non-structured) data formats are used and statistical analyses are performed before data subsets are identified, but can be uncovered when complexity is investigated. Conclusions Pattern recognition-based assessments can detect host-microbial interactions usually unobserved. Such cutoff-free, confidence interval-free, gold standard-free approaches provide interpretable information on complex entities, such as 'infection' and 'inflammation', even without definitions. To investigate disease dynamics, combinations of observational and experimental longitudinal studies, on human and non-human infections, are recommended.	[Leitner, Gabriel; Blum, Shlomo E.] Kimron Vet Inst, Natl Mastitis Reference Ctr, IL-50250 Bet Dagan, Israel; [Rivas, Ariel L.] Univ New Mexico, Hlth Sci Ctr, Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Rivas, Ariel L.] N Carolina State Univ, Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	Kimron Veterinary Institute; University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; North Carolina State University	Leitner, G (corresponding author), Kimron Vet Inst, Natl Mastitis Reference Ctr, IL-50250 Bet Dagan, Israel.	leitnerg@moag.gov.il						Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Becker JM, 2013, MIS QUART, V37, P665, DOI 10.25300/MISQ/2013/37.3.01; Blum S, 2010, J VET DIAGN INVEST, V22, P995, DOI 10.1177/104063871002200627; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Bose B, 2013, PROG BIOPHYS MOL BIO, V113, P358, DOI 10.1016/j.pbiomolbio.2013.07.001; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cook NR, 2007, CIRCULATION, V116, pE134, DOI 10.1161/CIRCULATIONAHA.107.715359; Crofts AR, 2007, COMPLEXITY, V13, P14, DOI 10.1002/cplx.20180; Deirmengian C, 2005, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000185756.17401.32; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Evans MR, 2013, TRENDS ECOL EVOL, V28, P578, DOI 10.1016/j.tree.2013.05.022; Fair JM, 2015, TRANSBOUND EMERG DIS, V62, P437, DOI 10.1111/tbed.12162; French GL, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.03092.x; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Huneman P, 2012, SYNTHESE, V185, P195, DOI 10.1007/s11229-010-9721-7; Klinke DJ, 2009, ANN BIOMED ENG, V37, P1886, DOI 10.1007/s10439-009-9733-y; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Koskinen MT, 2009, J DAIRY SCI, V92, P952, DOI 10.3168/jds.2008-1549; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Leitner G, 2006, INT DAIRY J, V16, P648, DOI 10.1016/j.idairyj.2005.10.020; Leitner G, 2004, J DAIRY SCI, V87, P1719, DOI 10.3168/jds.S0022-0302(04)73325-1; Leitner G, 2003, J VET MED B, V50, P45, DOI 10.1046/j.1439-0450.2003.00602.x; Leitner G, 2007, J DAIRY RES, V74, P186, DOI 10.1017/S0022029906002299; Ludewig B, 2012, EUR J IMMUNOL, V42, P3116, DOI 10.1002/eji.201242508; Merin U, 2008, DAIRY SCI TECHNOL, V88, P407, DOI 10.1051/dst:2008022; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Noble D, 2012, INTERFACE FOCUS, V2, P55, DOI 10.1098/rsfs.2011.0067; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Owens, 2004, MICROBIOLOGICAL PROC, V4th ed.; Pinsky MR, 2010, CRIT CARE MED, V38, pS649, DOI 10.1097/CCM.0b013e3181f24484; Pitkala A, 2005, J DAIRY SCI, V88, P553, DOI 10.3168/jds.S0022-0302(05)72717-X; Rivas AL, 2001, J VET DIAGN INVEST, V13, P399, DOI 10.1177/104063870101300506; Rivas AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053984; San Miguel M, 2012, EUR PHYS J-SPEC TOP, V214, P245, DOI 10.1140/epjst/e2012-01694-y; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Segre JA, 2013, J INVEST DERMATOL, V133, P2141, DOI 10.1038/jid.2013.260; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Stephan A, 2006, SYNTHESE, V151, P485, DOI 10.1007/s11229-006-9019-y; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008	51	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123674	10.1371/journal.pone.0123674	http://dx.doi.org/10.1371/journal.pone.0123674			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875169	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700036
J	Okuda, H; Kiuchi, H; Takao, T; Miyagawa, Y; Tsujimura, A; Nonomura, N; Miyata, H; Okabe, M; Ikawa, M; Kawakami, Y; Goshima, N; Wada, M; Tanaka, H				Okuda, Hidenobu; Kiuchi, Hiroshi; Takao, Tetsuya; Miyagawa, Yasushi; Tsujimura, Akira; Nonomura, Norio; Miyata, Haruhiko; Okabe, Masaru; Ikawa, Masahito; Kawakami, Yoshitaka; Goshima, Naoki; Wada, Morimasa; Tanaka, Hiromitsu			A Novel Transcriptional Factor Nkapl Is a Germ Cell-Specific Suppressor of Notch Signaling and Is Indispensable for Spermatogenesis	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; SELF-RENEWAL; STEM-CELLS; MOUSE; GENE; EXPRESSION; ACTIVATION; DEFECTS; COMPLEX; DIFFERENTIATION	Spermatogenesis is an elaborately regulated system dedicated to the continuous production of spermatozoa via the genesis of spermatogonia. In this process, a variety of genes are expressed that are relevant to the differentiation of germ cells at each stage. Although Notch signaling plays a critical role in germ cell development in Drosophila and Caenorhabditis elegans, its function and importance for spermatogenesis in mammals is controversial. We report that Nkapl is a novel germ cell-specific transcriptional suppressor in Notch signaling. It is also associated with several molecules of the Notch corepressor complex such as CIR, HDAC3, and CSL. It was expressed robustly in spermatogonia and early spermatocytes after the age of 3 weeks. Nkapl-deleted mice showed complete arrest at the level of pachytene spermatocytes. In addition, apoptosis was observed in this cell type. Overexpression of NKAPL in germline stem cells demonstrated that Nkapl induced changes in spermatogonial stem cell (SSC) markers and the reduction of differentiation factors through the Notch signaling pathway, whereas testes with Nkapl deleted showed inverse changes in those markers and factors. Therefore, Nkapl is indispensable because aberrantly elevated Notch signaling has negative effects on spermatogenesis, affecting SSC maintenance and differentiation factors. Notch signaling should be properly regulated through the transcriptional factor Nkapl.	[Okuda, Hidenobu; Kiuchi, Hiroshi; Takao, Tetsuya; Miyagawa, Yasushi; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Tsujimura, Akira] Juntendo Univ Hosp, Dept Urol, Tokyo, Japan; [Miyata, Haruhiko; Okabe, Masaru; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Anim Resource Ctr Infect Dis, Osaka, Japan; [Kawakami, Yoshitaka; Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Wada, Morimasa; Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Div Mol Biol, Nagasaki, Japan	Osaka University; Juntendo University; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); Nagasaki International University	Tanaka, H (corresponding author), Nagasaki Int Univ, Fac Pharmaceut Sci, Div Mol Biol, Nagasaki, Japan.	h-tanaka@niu.ac.jp	ikawa, masahito/A-5315-2009	ikawa, masahito/0000-0001-9859-6217; Miyata, Haruhiko/0000-0003-4758-5803	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24659713]; Japan Society for the Promotion of Science (JSPS) [11021]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan 24659713, (http://www.mext.go.jp/english/), the Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (JSPS), 11021 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Huang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071213; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; McCright B, 2001, DEVELOPMENT, V128, P491; Michie AM, 2007, INT IMMUNOL, V19, P1421, DOI 10.1093/intimm/dxm113; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morichika K, 2010, DEV GROWTH DIFFER, V52, P235, DOI 10.1111/j.1440-169X.2009.01164.x; Murta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072767; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Okuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035195; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Pereira LAVD, 1998, INT J ANDROL, V21, P34; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; SEARLE AG, 1983, CYTOGENET CELL GENET, V36, P617, DOI 10.1159/000131985; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanaka H, 1997, INT J ANDROL, V20, P361; Tanaka H, 2003, INT J ANDROL, V26, P52, DOI 10.1046/j.1365-2605.2003.00389.x; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tsuchida J, 1998, DEV BIOL, V197, P67, DOI 10.1006/dbio.1998.8885; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	60	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124293	10.1371/journal.pone.0124293	http://dx.doi.org/10.1371/journal.pone.0124293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875095	Green Published, gold			2022-12-27	WOS:000353014700064
J	Brabrand, M; Lassen, AT; Knudsen, T; Hallas, J				Brabrand, Mikkel; Lassen, Annmarie Touborg; Knudsen, Torben; Hallas, Jesper			Seven-Day Mortality Can Be Predicted in Medical Patients by Blood Pressure, Age, Respiratory Rate, Loss of Independence, and Peripheral Oxygen Saturation (the PARIS Score): A Prospective Cohort Study with External Validation	PLOS ONE			English	Article							INTENSIVE-CARE; ADMISSION; CONSCIOUSNESS; TEMPERATURE; DERIVATION; EVENTS; MODELS; TRENDS; LEVEL	Background Most existing risk stratification systems predicting mortality in emergency departments or admission units are complex in clinical use or have not been validated to a level where use is considered appropriate. We aimed to develop and validate a simple system that predicts seven-day mortality of acutely admitted medical patients using routinely collected variables obtained within the first minutes after arrival. Methods and Findings This observational prospective cohort study used three independent cohorts at the medical admission units at a regional teaching hospital and a tertiary university hospital and included all adult (>= 15 years) patients. Multivariable logistic regression analysis was used to identify the clinical variables that best predicted the endpoint. From this, we developed a simplified model that can be calculated without specialized tools or loss of predictive ability. The outcome was defined as seven-day all-cause mortality. 76 patients (2.5%) met the endpoint in the development cohort, 57 (2.0%) in the first validation cohort, and 111 (4.3%) in the second. Systolic blood Pressure, Age, Respiratory rate, loss of Independence, and peripheral oxygen Saturation were associated with the endpoint (full model). Based on this, we developed a simple score (range 0-5), ie, the PARIS score, by dichotomizing the variables. The ability to identify patients at increased risk (discriminatory power and calibration) was excellent for all three cohorts using both models. For patients with a PARIS score >= 3, sensitivity was 62.5-74.0%, specificity 85.9-91.1%, positive predictive value 11.2-17.5%, and negative predictive value 98.3-99.3%. Patients with a score <= 1 had a low mortality (<= 1%); with 2, intermediate mortality (2-5%); and >= 3, high mortality (>= 10%). Conclusions Seven-day mortality can be predicted upon admission with high sensitivity and specificity and excellent negative predictive values.	[Brabrand, Mikkel; Knudsen, Torben] Sydvestjysk Sygehus, Dept Med, Esbjerg, Denmark; [Brabrand, Mikkel; Knudsen, Torben] Univ Southern Denmark, Ctr South Western Denmark, Inst Reg Hlth Res, Esbjerg, Denmark; [Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark; [Hallas, Jesper] Univ South Denmark, Res Unit Clin Pharmacol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Brabrand, M (corresponding author), Sydvestjysk Sygehus, Dept Med, Esbjerg, Denmark.	mbrabrand@health.sdu.dk	Knudsen, Torben/V-6176-2018; Lassen, Annmarie/AAA-5816-2019; Brabrand, Mikkel/F-7276-2011	Knudsen, Torben/0000-0003-0726-0115; Lassen, Annmarie/0000-0003-4942-6152; Brabrand, Mikkel/0000-0002-3340-8251	Sydvestjysk Sygehus; University of Southern Denmark; Danish Society for Internal Medicine (The AB Foundation); Karola Jorgensen Research Foundation; Edith and Vagn Hedegaard Jensens Foundation; Johs. M. Klein and Wife Scholarship	Sydvestjysk Sygehus; University of Southern Denmark; Danish Society for Internal Medicine (The AB Foundation); Karola Jorgensen Research Foundation; Edith and Vagn Hedegaard Jensens Foundation; Johs. M. Klein and Wife Scholarship	This study was supported by unrestricted grants from Sydvestjysk Sygehus, University of Southern Denmark, Danish Society for Internal Medicine (The AB Foundation), The Karola Jorgensen Research Foundation, The Edith and Vagn Hedegaard Jensens Foundation, and The Johs. M. Klein and Wife Scholarship. The funders have had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Brabrand M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-8; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 1997, SOC SCI MED, V44, P301, DOI 10.1016/S0277-9536(96)00100-1; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Danis M, 1997, CRIT CARE MED, V25, P887; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer D. W., APPL LOGISTIC REGRES; Kellett J, 2006, QJM-INT J MED, V99, P771, DOI 10.1093/qjmed/hcl112; Kellett J, 2008, RESUSCITATION, V78, P52, DOI 10.1016/j.resuscitation.2008.02.011; Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Lowthian JA, 2011, EMERG MED J, V28, P373, DOI 10.1136/emj.2010.099226; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; McGloin H, 1999, J ROY COLL PHYS LOND, V33, P255; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; Pandharipande PP, 2009, CRIT CARE MED, V37, P1317, DOI 10.1097/CCM.0b013e31819cefa9; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pitts SR, 2012, ANN EMERG MED, V60, P679, DOI 10.1016/j.annemergmed.2012.05.014; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sener S, 2012, EUR J EMERG MED, V19, P252, DOI 10.1097/MEJ.0b013e32834c5841; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; TERES D, 1994, CRIT CARE CLIN, V10, P93, DOI 10.1016/S0749-0704(18)30147-7; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wai AKC, 2009, INT J EMERG MED, V2, P141, DOI 10.1007/s12245-009-0098-7; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x; Zollo M B, 1996, Am J Crit Care, V5, P147	36	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122480	10.1371/journal.pone.0122480	http://dx.doi.org/10.1371/journal.pone.0122480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867881	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100075
J	Guo, SX; Jin, YY; Fang, Q; You, CG; Wang, XG; Hu, XL; Han, CM				Guo, Song Xue; Jin, Yun Yun; Fang, Quan; You, Chuan Gang; Wang, Xin Gang; Hu, Xin Lei; Han, Chun-Mao			Beneficial Effects of Hydrogen-Rich Saline on Early Burn-Wound Progression in Rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; DUAL ROLES; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; MOLECULAR-HYDROGEN; AUTOPHAGY; APOPTOSIS; PROTECTS; SKIN	Introduction Deep burn wounds undergo a dynamic process known as wound progression that results in a deepening and extension of the initial burn area. The zone of stasis is more likely to develop more severe during wound progression in the presence of hypoperfusion. Hydrogen has been reported to alleviate injury triggered by ischaemia/reperfusion and burns in various organs by selectively quenching oxygen free radicals. The aim of this study was to investigate the possible protective effects of hydrogen against early burn-wound progression. Methods Deep-burn models were established through contact with a boiled, rectangular, brass comb for 20 s. Fifty-six Sprague-Dawley rats were randomly divided into sham, burn plus saline, and burn plus hydrogen-rich saline (HS) groups with sacrifice and analysis at various time windows (6 h, 24 h, 48 h) post burn. Indexes of oxidative stress, apoptosis and autophagy were measured in each group. The zone of stasis was evaluated using immunofluorescence staining, ELISA, and Western blot to explore the underlying effects and mechanisms post burn. Results The burn-induced increase in malondialdehyde was markedly reduced with HS, while the activities of endogenous antioxidant enzymes were significantly increased. Moreover, HS treatment attenuated increases in apoptosis and autophagy postburn in wounds, according to the TUNEL staining results and the expression analysis of Bax, Bcl-2, caspase-3, Beclin-1 and Atg-5 proteins. Additionally, HS lowered the level of myeloperoxidase and expression of TNF-alpha, IL-1 beta, and IL-6 in the zone of stasis while augmenting IL-10. The elevated levels of Akt phosphorylation and NF-kappa B p65 expression post burn were also downregulated by HS management. Conclusion Hydrogen can attenuate early wound progression following deep burn injury. The beneficial effect of hydrogen was mediated by attenuating oxidative stress, which inhibited apoptosis and inflammation, and the Akt/NF-kappa B signalling pathway may be involved in regulating the release of inflammatory cytokines.	[Guo, Song Xue; Jin, Yun Yun; You, Chuan Gang; Wang, Xin Gang; Han, Chun-Mao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Burns, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Quan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xin Lei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Han, CM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Burns, Hangzhou 310003, Zhejiang, Peoples R China.	hanchunmao1@163.com	jin, yun/GQZ-6618-2022					Al-Jawad F H, 2008, Ann Burns Fire Disasters, V21, P186; Arturson G, 1996, BURNS, V22, P255, DOI 10.1016/0305-4179(95)00153-0; Aw TY, 2012, SEMIN CELL DEV BIOL, V23, P721, DOI 10.1016/j.semcdb.2012.08.002; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Dalboni MA, 2013, CLIN EXP IMMUNOL, V173, P242, DOI 10.1111/cei.12100; Eckermann JM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-7; Eski M, 2012, BURNS, V38, P283, DOI 10.1016/j.burns.2011.08.008; Fang Y, 2011, J BURN CARE RES, V32, pE82, DOI 10.1097/BCR.0b013e318217f84f; Feng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054593; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Giles N, 2008, WOUND REPAIR REGEN, V16, P58, DOI 10.1111/j.1524-475X.2007.00331.x; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gravante G, 2007, J SURG RES, V141, P141, DOI 10.1016/j.jss.2006.07.031; Guo Z, 2012, J BIOMED RES, V26, P365, DOI 10.7555/JBR.26.20110037; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hong Y, 2012, J NEUROSCI RES, V90, P1670, DOI 10.1002/jnr.22739; Ipaktchi K, 2007, SURGERY, V142, P86, DOI 10.1016/j.surg.2007.02.007; Iseri SO, 2008, BURNS, V34, P361, DOI 10.1016/j.burns.2007.03.022; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; Jia G, 2014, BIOCH BIOPHYSICA ACT; Johnson R Michael, 2003, Adv Skin Wound Care, V16, P178, DOI 10.1097/00129334-200307000-00010; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kaminskyy VO, 2014, ANTIOXID REDOX SIGN, V21, P86, DOI 10.1089/ars.2013.5746; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Lanier ST, 2011, WOUND REPAIR REGEN, V19, P622, DOI 10.1111/j.1524-475X.2011.00725.x; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu W, 2013, WORLD J GASTROENTERO, V19, P492, DOI 10.3748/wjg.v19.i4.492; Mei Y, 2014, BIOCH BIOPHYSICA ACT; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nagane N S, 2003, Indian J Med Sci, V57, P7; Nilsson P, 2014, BIOESSAYS, V36, P570, DOI 10.1002/bies.201400002; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; REGAS FC, 1992, J TRAUMA, V32, P557, DOI 10.1097/00005373-199205000-00004; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Scheibye-Knudsen M, 2014, AUTOPHAGY, V10, P1468, DOI 10.4161/auto.29321; Schwacha MG, 2010, J SURG RES, V158, P112, DOI 10.1016/j.jss.2008.07.034; Sener G, 2007, BURNS, V33, P587, DOI 10.1016/j.burns.2006.10.381; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shupp JW, 2010, J BURN CARE RES, V31, P849, DOI 10.1097/BCR.0b013e3181f93571; Singer AJ, 2008, ACAD EMERG MED, V15, P549, DOI 10.1111/j.1553-2712.2008.00115.x; Singh V, 2007, ANN PLAS SURG, V59, P109, DOI 10.1097/01.sap.0000252065.90759.e6; Sun YX, 2013, J SURG RES, V185, P477, DOI 10.1016/j.jss.2013.06.039; Tan JQ, 2013, BURNS, V39, P1551, DOI 10.1016/j.burns.2013.04.018; Tian R, 2014, SCI WORLD J, DOI 10.1155/2014/780616; Viry E, 2014, BIOCHEMICAL PHARMACO; Wu Tianfu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P145; Xiao MJ, 2014, ACAD EMERG MED, V21, P383, DOI 10.1111/acem.12352; Xie K, 2013, BRIT J ANAESTH, V110, P148; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xie KL, 2012, SHOCK, V37, P548, DOI 10.1097/SHK.0b013e31824ddc81; Yu P, 2011, BIOCHEM BIOPH RES CO, V409, P350, DOI 10.1016/j.bbrc.2011.05.024; Zhao L, 2013, J ZHEJIANG UNIV-SC B, V14, P382, DOI 10.1631/jzus.B1200317; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	65	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124897	10.1371/journal.pone.0124897	http://dx.doi.org/10.1371/journal.pone.0124897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874619	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100282
J	Kim, M; McKinnon, D; MacCarthy, T; Rosati, B; McKinnon, D				Kim, Min; McKinnon, Don; MacCarthy, Thomas; Rosati, Barbara; McKinnon, David			Regulatory Evolution and Voltage-Gated Ion Channel Expression in Squid Axon: Selection-Mutation Balance and Fitness Cliffs	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; ACTION-POTENTIALS; GENE-EXPRESSION; CONDUCTION-VELOCITY; LOLIGO-OPALESCENS; SODIUM-CHANNELS; METABOLIC COST; GIANT; EXCITABILITY; ESCAPE	It has been suggested that optimization of either axonal conduction velocity or the energy efficiency of action potential conduction predominates in the selection of voltage-gated sodium conductance levels in the squid axon. A population genetics model of channel gene regulatory function was used to examine the role of these and other evolutionary forces on the selection of both sodium and potassium channel expression levels. In this model, the accumulating effects ofmutations result in degradation of gene regulatory function, causing channel gene expression to fall to near-zero in the absence of positive selection. In the presence of positive selection, channel expression levels fall to the lowest values consistent with the selection criteria, thereby establishing a selection-mutation balance. Within the parameter space of sodium and potassium conductance values, the physiological performance of the squid axon model showed marked discontinuities associated with conduction failure and excitability. These discontinuities in physiological functionmay produce fitness cliffs. A fitness cliff associated with conduction failure, combined with the effects of phenotypic noise, can account for the selection of sodium conductance levels, without considering either conduction velocity or metabolic cost. A fitness cliff associated with a transition in axonal excitability, combined with phenotypic noise, can explain the selection of potassium channel expression levels. The results suggest that voltage-gated ion channel expression will fall to low levels, consistent with key functional constraints, even in the absence of positive selection for energy efficiency. Channel expression levels and individual variation in channel expression within the population can be explained by regulatory evolution in combination with genetic variation in regulatory function and phenotypic noise, without resorting to more complexmechanisms, such as activity-dependent homeostasis. Only a relatively small region of the large, nominally isofunctional parameter space for channel expression will normally be occupied, because of the effects of mutation.	[Kim, Min; McKinnon, David] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [McKinnon, Don; Rosati, Barbara; McKinnon, David] SUNY Stony Brook, Inst Mol Cardiol, Stony Brook, NY 11794 USA; [MacCarthy, Thomas] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rosati, Barbara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [McKinnon, David] Vet Affairs Med Ctr, Dept Res, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McKinnon, D (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	dmckinnon@notes.cc.sunysb.edu			VA Merit Review Grant	VA Merit Review Grant(US Department of Veterans Affairs)	The project was supported by a VA Merit Review Grant to D.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; ADRIAN RH, 1975, PROC R SOC SER B-BIO, V189, P81, DOI 10.1098/rspb.1975.0043; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; Bezzina CR, 2006, CIRCULATION, V113, P338, DOI 10.1161/CIRCULATIONAHA.105.580811; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; Clay JR, 1998, J NEUROPHYSIOL, V80, P903, DOI 10.1152/jn.1998.80.2.903; Crotty P, 2006, J NEUROPHYSIOL, V96, P1237, DOI 10.1152/jn.01204.2005; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; DIAMOND JM, 1992, NATURE, V355, P204, DOI 10.1038/355204a0; Dong M, 2006, AM J PHYSIOL-HEART C, V291, pH631, DOI 10.1152/ajpheart.00084.2006; DUDLEY R, 1991, PHYSIOL ZOOL, V64, P627, DOI 10.1086/physzool.64.3.30158197; Ewens W. J, 2004, MATHEMATICAL POPULAT, VI; Feder ME, 2000, ANNU REV ECOL SYST, V31, P315, DOI 10.1146/annurev.ecolsys.31.1.315; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Gilly WF, 1996, BIOL BULL, V191, P337, DOI 10.2307/1543006; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hartl DL, 2007, PRINCIPLES OF POPULA; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu Z, 1998, J NEUROSCI, V18, P2309; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Meng XY, 2012, DISCRETE CONT DYN-A, V32, P2729, DOI 10.3934/dcds.2012.32.2729; Neumeister H, 2000, J EXP BIOL, V203, P547; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; OTIS TS, 1990, P NATL ACAD SCI USA, V87, P2911, DOI 10.1073/pnas.87.8.2911; PACKARD A, 1969, NATURE, V221, P875, DOI 10.1038/221875a0; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Preuss T, 2000, J EXP BIOL, V203, P559; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Rosati B, 2009, EVOL DEV, V11, P610, DOI 10.1111/j.1525-142X.2009.00367.x; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Rosenthal JJC, 2000, BIOL BULL, V199, P135, DOI 10.2307/1542873; Rosenthal JJC, 2002, J EXP BIOL, V205, P1819; Sanchez P, 2008, HYDROBIOLOGIA, V612, P91, DOI 10.1007/s10750-008-9487-9; Sangrey TD, 2004, J NEUROPHYSIOL, V91, P2541, DOI 10.1152/jn.00646.2003; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sengupta B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000840; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Valavanis VD, 2002, B MAR SCI, V71, P867; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yan QH, 2012, P NATL ACAD SCI USA, V109, P1601, DOI 10.1073/pnas.1114516109	62	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120785	10.1371/journal.pone.0120785	http://dx.doi.org/10.1371/journal.pone.0120785			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875483	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100027
J	Li, LY; Yoshitomi, H; Wei, Y; Qin, LL; Zhou, JX; Xu, TH; Wu, XL; Zhou, T; Sun, W; Guo, XY; Wu, LL; Wang, HY; Zhang, Y; Li, CN; Liu, T; Gao, M				Li, Linyi; Yoshitomi, Hisae; Wei, Ying; Qin, Lingling; Zhou, Jingxin; Xu, Tunhai; Wu, Xinli; Zhou, Tian; Sun, Wen; Guo, Xiangyu; Wu, Lili; Wang, Haiyan; Zhang, Yan; Li, Chunna; Liu, Tonghua; Gao, Ming			Tang-Nai-Kang Alleviates Pre-diabetes and Metabolic Disorders and Induces a Gene Expression Switch toward Fatty Acid Oxidation in SHR.Cg-Leprcp/NDmcr Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MITOCHONDRIAL-FUNCTION; ENERGY HOMEOSTASIS; RECEPTOR-ALPHA; DIABETIC-RATS; LIFE-STYLE; SIRT1	Increased energy intake and reduced physical activity can lead to obesity, diabetes and metabolic syndrome. Transcriptional modulation of metabolic networks has become a focus of current drug discovery research into the prevention and treatment of metabolic disorders associated with energy surplus and obesity. Tang-Nai-Kang (TNK), a mixture of five herbal plant extracts, has been shown to improve abnormal glucose metabolism in patients with prediabetes. Here, we report the metabolic phenotype of SHR.Cg-Leprcp/NDmcr (SHR/cp) rats treated with TNK. Pre-diabetic SHR/cp rats were randomly divided into control, TNK low-dose (1.67 g/kg) and TNK high-dose (3.24 g/kg) groups. After high-dose treatment for 2 weeks, the serum triglycerides and free fatty acids in SHR/cp rats were markedly reduced compared to controls. After 3 weeks of administration, the high dose of TNK significantly reduced the body weight and fat mass of SHR/cp rats without affecting food consumption. Serum fasting glucose and insulin levels in the TNK-treated groups decreased after 6 weeks of treatment. Furthermore, TNK-treated rats exhibited obvious improvements in glucose intolerance and insulin resistance. The improved glucose metabolism may be caused by the substantial reduction in serum lipids and body weight observed in SHR/cp rats starting at 3 weeks of TNK treatment. The mRNA expression of NAD+-dependent deacetylase sirtuin 1 (SIRT1) and genes related to fatty acid oxidation was markedly up-regulated in the muscle, liver and adipose tissue after TNK treatment. Furthermore, TNK promoted the deacetylation of two well-established SIRT1 targets, PPAR. coactivator 1 alpha (PGC1 alpha) and forkhead transcription factor 1 (FOXO1), and induced the phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) in different tissues. These observations suggested that TNK may be an alternative treatment for pre-diabetes and metabolic syndrome by inducing a gene expression switch toward fat oxidation through the activation of SIRT1 and AMPK signaling.	[Li, Linyi; Wei, Ying; Qin, Lingling; Xu, Tunhai; Wu, Xinli; Sun, Wen; Wu, Lili; Wang, Haiyan; Zhang, Yan; Li, Chunna; Liu, Tonghua] Beijing Univ Chinese Med, Hlth Cultivat Lab, Minist Educ, Beijing, Peoples R China; [Yoshitomi, Hisae; Gao, Ming] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Zhou, Jingxin] Beijing Univ Chinese Med, Dongzhimen Hosp Eastern, Beijing, Peoples R China; [Zhou, Tian; Guo, Xiangyu] Beijing Univ Chinese Med, Dongfang Hosp, Beijing, Peoples R China	Beijing University of Chinese Medicine; Mukogawa Women's University; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Liu, T (corresponding author), Beijing Univ Chinese Med, Hlth Cultivat Lab, Minist Educ, Beijing, Peoples R China.	thliu@vip.163.com; gaoming@mukogawa-u.ac.jp		Zhou, Jingxin/0000-0003-0471-1961	International Scientific and Technological Coorperation Program of China [2010DFB33260]; key project of Chinese Ministry of Education [311011]; Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University [2011-CXTD-19]	International Scientific and Technological Coorperation Program of China; key project of Chinese Ministry of Education(Ministry of Education, China); Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University	Support was provided by: 1) The International Scientific and Technological Coorperation Program of China (2010DFB33260). Source: Ministry of Science and Technology of the People's Republic of China to author TX [http://www.istcp.org.cn/]; 2) The key project of Chinese Ministry of Education (311011). Source: Ministry of Education of the People's Republic of China to author TL [http://www.moe.gov.cn/]; 3) The Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University (2011-CXTD-19). Source: Beijing University of Chinese Medicine to author TX [http://kjc.bucm.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson LL, 2002, J BIOL CHEM, V277, P29424, DOI 10.1074/jbc.M203813200; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chiolero A, 2012, LANCET, V380, P1225, DOI 10.1016/S0140-6736(12)61704-8; Deedwania P, 2012, LANCET, V380, P1225, DOI 10.1016/S0140-6736(12)61705-X; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Florez H, 2014, DIABETES OBES METAB, V16, P326, DOI 10.1111/dom.12220; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Grant SJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-104; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guo Xiang-Yu, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P535, DOI 10.3736/jcim20100605; Guo XY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-52; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hwang SM, 2012, AM J CHINESE MED, V40, P937, DOI 10.1142/S0192415X12500693; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kawai K, 2012, EXP TOXICOL PATHOL, V64, P333, DOI 10.1016/j.etp.2010.09.006; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li JB, 2013, J HUAZHONG U SCI-MED, V33, P877, DOI 10.1007/s11596-013-1215-7; Li LY, 2013, BIOL TRACE ELEM RES, V153, P329, DOI 10.1007/s12011-013-9689-5; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu TH, 2011, CHINA SCI TECHNOLOGY, V12, P79; Liu TH, 2004, PR China Patent, Patent No. [CN02153751.8, 021537518]; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menendez-Gutierrez MP, 2012, CURR TOP MED CHEM, V12, P548; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shishtar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107391; Smith Dl Jr, 2009, Int J Body Compos Res, V7, P21; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang HJ, 2012, FOOD FUNCT, V3, P1161, DOI 10.1039/c2fo30139c; Wang L, 2013, INT J BIOCHEM CELL B, V45, P1155, DOI 10.1016/j.biocel.2013.03.007; Wang LS, 2009, J ETHNOPHARMACOL, V126, P487, DOI 10.1016/j.jep.2009.09.009; Wang Y, 2012, PHARMACOL THERAPEUT, V136, P305, DOI 10.1016/j.pharmthera.2012.08.009; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xia JN, 2013, J ETHNOPHARMACOL, V150, P692, DOI 10.1016/j.jep.2013.09.038; Yuan HD, 2012, J GINSENG RES, V36, P27, DOI 10.5142/jgr.2012.36.1.27; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	60	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122024	10.1371/journal.pone.0122024	http://dx.doi.org/10.1371/journal.pone.0122024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874615	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100056
J	Maricato, JT; Furtado, MN; Takenaka, MC; Nunes, ERM; Fincatti, P; Meliso, FM; da Silva, IDCG; Jasiulionis, MG; Sucupira, MCD; Diaz, RS; Janini, LMR				Maricato, Juliana T.; Furtado, Maria N.; Takenaka, Maisa C.; Nunes, Edsel R. M.; Fincatti, Patricia; Meliso, Fabiana M.; da Silva, Ismael D. C. G.; Jasiulionis, Miriam G.; de Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Janini, Luiz M. R.			Epigenetic Modulations in Activated Cells Early after HIV-1 Infection and Their Possible Functional Consequences	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; TYPE-1 REVERSE TRANSCRIPTION; RSK2 GENE RPS6KA3; CD4(+) T-CELLS; OXIDATIVE STRESS; DNA METHYLATION; EXPRESSION; REACTIVATION; REPLICATION	Epigenetic modifications refer to a number of biological processes which alter the structure of chromatin and its transcriptional activity such as DNA methylation and histone post-translational processing. Studies have tried to elucidate how the viral genome and its products are affected by epigenetic modifications imposed by cell machinery and how it affects the ability of the virus to either, replicate and produce a viable progeny or be driven to latency. The purpose of this study was to evaluate epigenetic modifications in PBMCs and CD4(+) cells after HIV-1 infection analyzing three approaches: (i) global DNA-methylation; (ii) qPCR array and (iii) western blot. HIV-1 infection led to methylation increases in the cellular DNA regardless the activation status of PBMCs. The analysis of H3K9me3 and H3K27me3 suggested a trend towards transcriptional repression in activated cells after HIV-1 infection. Using a qPCR array, we detected genes related to epigenetic processes highly modulated in activated HIV-1 infected cells. SETDB2 and RSK2 transcripts showed highest up-regulation levels. SETDB2 signaling is related to transcriptional silencing while RSK2 is related to either silencing or activation of gene expression depending on the signaling pathway triggered down-stream. In addition, activated cells infected by HIV-1 showed lower CD69 expression and a decrease of IL-2, IFN-gamma and metabolism-related factors transcripts indicating a possible functional consequence towards global transcriptional repression found in HIV-1 infected cells. Conversely, based on epigenetic markers studied here, non-stimulated cells infected by HIV-1, showed signs of global transcriptional activation. Our results suggest that HIV-1 infection exerts epigenetic modulations in activated cells that may lead these cells to transcriptional repression with important functional consequences. Moreover, non-stimulated cells seem to increase gene transcription after HIV-1 infection. Based on these observations, it is possible to speculate that the outcome of viral infections may be influenced by the cellular activation status at the moment of infection.	[Maricato, Juliana T.; Takenaka, Maisa C.; Janini, Luiz M. R.] Univ Fed Sao Paulo, Paulista Med Sch, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Meliso, Fabiana M.; Jasiulionis, Miriam G.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Furtado, Maria N.; Nunes, Edsel R. M.; Fincatti, Patricia; da Silva, Ismael D. C. G.; de Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Janini, Luiz M. R.] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Maricato, JT (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	julianamaricato@hotmail.com	Furtado, Maria/GLR-6287-2022; Jasiulionis, Miriam/G-2207-2012; Maricato, Juliana/F-1608-2012	Jasiulionis, Miriam/0000-0002-4135-0440; Janini, Luiz Mario/0000-0002-6186-6284	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed EA, 2014, JAIDS-J ACQ IMM DEF, V65, P19, DOI 10.1097/QAI.0b013e3182a1bca4; [Anonymous], 2010, PROFILER PCR ARRAY S, P5; Arikawa E, 2010, RT2 PROFILER PCR ARR; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Delaunoy JP, 2006, CLIN GENET, V70, P161, DOI 10.1111/j.1399-0004.2006.00660.x; Delaunoy JP, 2001, HUM MUTAT, V17, P103, DOI 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e; Grant PA, 2001, GENOME BIOL, V2; Guimiot F, 2004, GENE EXPR PATTERNS, V4, P111, DOI 10.1016/j.modgep.2003.06.001; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jost S, 2014, J VIROL, V88, P8349, DOI 10.1128/JVI.00924-14; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Liu XF, 2013, VIRUSES-BASEL, V5, P1325, DOI 10.3390/v5051325; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Niller HH, 2009, SEMIN CANCER BIOL, V19, P158, DOI 10.1016/j.semcancer.2009.02.012; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; PARKER MI, 1986, J BIOL CHEM, V261, P2786; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vatakis DN, 2009, J VIROL, V83, P3374, DOI 10.1128/JVI.02161-08; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Westby M, 1998, CLIN EXP IMMUNOL, V111, P257; Willemsen NM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-92; Woellmer A, 2013, CURR OPIN VIROL, V3, P260, DOI 10.1016/j.coviro.2013.03.005; Wu YL, 2013, FREE RADICAL BIO MED, V65, P632, DOI 10.1016/j.freeradbiomed.2013.07.037; Yedavalli VRK, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-9; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37; Zeniou M, 2004, NUCLEIC ACIDS RES, V32, P1214, DOI 10.1093/nar/gkh272; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	44	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119234	10.1371/journal.pone.0119234	http://dx.doi.org/10.1371/journal.pone.0119234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875202	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100012
J	Odhiambo, C; Oyaro, B; Odipo, R; Otieno, F; Alemnji, G; Williamson, J; Zeh, C				Odhiambo, Collins; Oyaro, Boaz; Odipo, Richard; Otieno, Fredrick; Alemnji, George; Williamson, John; Zeh, Clement			Evaluation of Locally Established Reference Intervals for Hematology and Biochemistry Parameters in Western Kenya	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; IMMUNOLOGICAL REFERENCE VALUES; HEALTHY-ADULTS; POPULATION; TOXICITY; INFANTS; AFRICA; TRIALS	Background Important differences have been demonstrated in laboratory parameters from healthy persons in different geographical regions and populations, mostly driven by a combination of genetic, demographic, nutritional, and environmental factors. Despite this, European and North American derived laboratory reference intervals are used in African countries for patient management, clinical trial eligibility, and toxicity determination; which can result in mis-classification of healthy persons as having laboratory abnormalities. Methods An observational prospective cohort study known as the Kisumu Incidence Cohort Study (KICoS) was conducted to estimate the incidence of HIV seroconversion and identify determinants of successful recruitment and retention in preparation for an HIV vaccine/prevention trial among young adults and adolescents in western Kenya. Laboratory values generated from the KICoS were compared to published region-specific reference intervals and the 2004 NIH DAIDS toxicity tables used for the trial. Results About 1106 participants were screened for the KICoS between January 2007 and June 2010. Nine hundred and fifty-three participants aged 16 to 34 years, HIV-seronegative, clinically healthy, and non-pregnant were selected for this analysis. Median and 95% reference intervals were calculated for hematological and biochemistry parameters. When compared with both published region-specific reference values and the 2004 NIH DAIDS toxicity table, it was shown that the use of locally established reference intervals would have resulted in fewer participants classified as having abnormal hematological or biochemistry values compared to US derived reference intervals from DAIDS (10% classified as abnormal by local parameters vs. >40% by US DAIDS). Blood urea nitrogen was most often out of range if US based intervals were used: <10% abnormal by local intervals compared to >83% by US based reference intervals. Conclusion Differences in reference intervals for hematological and biochemical parameters between western and African populations highlight importance of developing local reference intervals for clinical care and trials in Africa.	[Odhiambo, Collins; Oyaro, Boaz; Odipo, Richard; Otieno, Fredrick] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Alemnji, George] US Ctr Dis Control & Prevent CDC, Bridgetown, Barbados; [Williamson, John; Zeh, Clement] US Ctr Dis Control & Prevent CDC, Kisumu, Kenya	Kenya Medical Research Institute	Zeh, C (corresponding author), US Ctr Dis Control & Prevent CDC, Kisumu, Kenya.	czeh@ke.cdc.gov		odhiambo, collins/0000-0002-5534-8720; Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention	Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemnji GA, 2010, AFR J HLTH SCI, V17, P75; [Anonymous], 2008, GUID HIV TEST COUNS; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; Central Bureau of Statistics. Ministry of Planning and National Development, 1999, POP DISTR ADM AR URB, V1; DAIDS, 2004, DIV AIDS TABL GRAD S; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Esparza J, 2003, CURR MOL MED, V3, P183, DOI 10.2174/1566524033479825; Excler JL, 2006, EXPERT REV VACCINES, V5, P167, DOI 10.1586/14760584.5.2.167; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Kueviakoe IM, 2011, ISRN HEMATOL, pe3919; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lubega IR, 2010, JAIDS-J ACQ IMM DEF, V55, P58, DOI 10.1097/QAI.0b013e3181db059d; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; National AIDS and STI Control Programme Ministry of Health Kenya, 2008, AIDS IND SURV 2007 P; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; PEPFAR, 2011, C PEPFAR; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Tefferi A, 2003, MAYO CLIN PROC, V78, P1274, DOI 10.4065/78.10.1274; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; *UNAIDS, 2010, REP GLOB AIDS EP; Wells J, 2006, JAIDS-J ACQ IMM DEF, V42, P460, DOI 10.1097/01.qai.0000224975.45091.a5; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	26	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123140	10.1371/journal.pone.0123140	http://dx.doi.org/10.1371/journal.pone.0123140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874714	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100139
J	Tolea, MI; Morris, JC; Galvin, JE				Tolea, Magdalena I.; Morris, John C.; Galvin, James E.			Longitudinal Associations between Physical and Cognitive Performance among Community-Dwelling Older Adults	PLOS ONE			English	Article							FUNCTIONAL LIMITATIONS; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; DECLINE; IMPAIRMENT; DEMENTIA; HEALTH; RISK; DISABILITY; DIAGNOSIS	To assess the directionality of the association between physical and cognitive decline in later life, we compared patterns of decline in performance across groups defined by baseline presence of cognitive and/or physical impairment [none (n = 217); physical only (n = 169); cognitive only (n = 158), or both (n = 220)] in a large sample of participants in a cognitive aging study at the Knight Alzheimer's Disease Research Center at Washington University in St. Louis who were followed for up to 8 years (3,079 observations). Rates of decline reached 20% for physical performance and varied across cognitive tests (global, memory, speed, executive function, and visuospatial skills). We found that physical decline was better predicted by baseline cognitive impairment (slope = -1.22, p<0.001), with baseline physical impairment not contributing to further decline in physical performance (slope = -0.25, p = 0.294). In turn, baseline physical impairment was only marginally associated with rate of cognitive decline across various cognitive domains. The cognitive-functional association is likely to operate in the direction of cognitive impairment to physical decline although physical impairment may also play a role in cognitive decline/dementia. Interventions to prevent further functional decline and development of disability and complete dependence may benefit if targeted to individuals with cognitive impairment who are at increased risk.	[Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10012 USA; [Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Dept Psychiat, Alzheimers Dis Res Ctr, New York, NY USA; [Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Dept Populat Hlth, Alzheimers Dis Res Ctr, New York, NY USA; [Morris, John C.] Washington Univ, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO USA	New York University; New York University; New York University; Washington University (WUSTL)	Tolea, MI (corresponding author), NYU, Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10012 USA.	Magdalena.Tolea@nyumc.org	Galvin, James/AAM-7492-2021		NIH [P01 AG03991, P50 AG05681, R01 AG040211, P30 AG008051]; Morris and Alma Schapiro Fund; New York State Department of Health [DOH-2011-1004010353]; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991, R01AG040211, P30AG008051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris and Alma Schapiro Fund; New York State Department of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection was supported by grants from NIH (P01 AG03991 and P50 AG05681) to JCM. Data Analysis was supported by grants from the NIH (R01 AG040211 and P30 AG008051), Morris and Alma Schapiro Fund, and the New York State Department of Health (DOH-2011-1004010353) to JEG. The authors take responsibility for the integrity of the data and accuracy of the data analysis and have the right to publish any and all data, separate and apart from the guidance of any sponsor.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Alzheimer's Association, 2013, ALZH DEM FACTS FIG; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Bherer L., 2013, J AGING RES, V2013, DOI [10.1155/2013/657508., 10.1155/2013/657508]; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM428, DOI 10.1093/gerona/54.8.M428; Blankevoort CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070799; Boelens C, 2013, TECHNOL HEALTH CARE, V21, P521, DOI 10.3233/THC-130748; Chodosh J, 2010, J AM GERIATR SOC, V58, P2350, DOI 10.1111/j.1532-5415.2010.03171.x; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; De Buyser SL, 2013, EUR J CLIN INVEST, V43, P379, DOI 10.1111/eci.12056; Elovainio M, 2009, J EPIDEMIOL COMMUN H, V63, P468, DOI 10.1136/jech.2008.081505; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fillenbaum GG, 2008, ALZHEIMERS DEMENT, V4, P96, DOI 10.1016/j.jalz.2007.08.005; Ford K, 2008, COGNITIVE FUNCTIONIN, DOI [10.1159/000247132, DOI 10.1159/000247132]; Giuliani CA, 2008, GERONTOLOGIST, V48, P203, DOI 10.1093/geront/48.2.203; Greiner PA, 1996, AM J PUBLIC HEALTH, V86, P62, DOI 10.2105/AJPH.86.1.62; Gure TR, 2013, J GERIATR PSYCH NEUR, V26, P78, DOI 10.1177/0891988713481264; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Ishizaki T, 2006, ARCH GERONTOL GERIAT, V42, P47, DOI 10.1016/j.archger.2005.06.001; Iwasa H, 2008, ARCH GERONTOL GERIAT, V47, P139, DOI 10.1016/j.archger.2007.07.008; Kanne SM, 1998, NEUROLOGY, V50, P979, DOI 10.1212/WNL.50.4.979; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; Magouirk-Bettcher B, 2011, AGING HLTH, V7, P505; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nagi SZ, 1965, SOCIOLOGY REHABILITA, P100; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005; Rajan KB, 2012, J GERONTOL A-BIOL, V67, P1419, DOI 10.1093/gerona/gls098; REUBEN DB, 1990, J AM GERIATR SOC, V38, P1105, DOI 10.1111/j.1532-5415.1990.tb01373.x; Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Wilkins CH, 2013, J AM GERIATR SOC, V61, P1055, DOI 10.1111/jgs.12255; Wilkins CH, 2010, ARCH GERONTOL GERIAT, V50, P96, DOI 10.1016/j.archger.2009.02.006; Yaffe K, 2009, ARCH NEUROL-CHICAGO, V66, P324, DOI 10.1001/archneurol.2008.566; Zahodne LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073645	40	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122878	10.1371/journal.pone.0122878	http://dx.doi.org/10.1371/journal.pone.0122878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875165	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100114
J	Walseng, E; Walchli, S; Fallang, LE; Yang, WW; Vefferstad, A; Areffard, A; Olweus, J				Walseng, Even; Walchli, Sebastien; Fallang, Lars-Egil; Yang, Weiwen; Vefferstad, Anette; Areffard, Ali; Olweus, Johanna			Soluble T-Cell Receptors Produced in Human Cells for Targeted Delivery	PLOS ONE			English	Article							IN-VITRO; DIRECTED EVOLUTION; HIGH-AFFINITY; PEPTIDE-MHC; SINGLE; RECOGNITION; SPECIFICITY; MOLECULES; PROTEINS; DISPLAY	Recently, technology has become available to generate soluble T-cell receptors (sTCRs) that contain the antigen recognition part. In contrast to antibodies, sTCRs recognize intracellular in addition to extracellular epitopes, potentially increasing the number of applications as reagents for target detection and immunotherapy. Moreover, recent data show that they can be used for identification of their natural peptide ligands in disease. Here we describe a new and simplified expression method for sTCRs in human cells and show that these sTCRs can be used for antigen-specific labeling and elimination of human target cells. Four different TCRs were solubilized by expression of constructs encoding the TCR alpha (alpha) and beta (beta) chains lacking the transmembrane and intracellular domains, linked by a ribosomal skipping 2A sequence that facilitates equimolar production of the chains. Cell supernatants containing sTCRs labeled target cells directly in a peptide (p)-human leukocyte antigen (HLA)-specific manner. We demonstrated that a MART-1p/HLA-A*02:01-specific sTCR fused to a fluorescent protein, or multimerized onto magnetic nanoparticles, could be internalized. Moreover, we showed that this sTCR and two sTCRs recognizing CD20p/HLA-A*02:01 could mediate selective elimination of target cells expressing the relevant pHLA complex when tetramerized to streptavidin-conjugated toxin, demonstrating the potential for specific delivery of cargo. This simple and efficient method can be utilized to generate a wide range of minimally modified sTCRs from the naturally occurring TCR repertoire for antigen-specific detection and targeting.	[Walseng, Even; Walchli, Sebastien; Fallang, Lars-Egil; Yang, Weiwen; Vefferstad, Anette; Areffard, Ali; Olweus, Johanna] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Walchli, Sebastien] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Cell Therapy, Oslo, Norway; [Yang, Weiwen; Vefferstad, Anette; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway; [Yang, Weiwen; Vefferstad, Anette; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Inflammat Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Walchli, S (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Cell Therapy, Oslo, Norway.	sebastien.walchli@rr-research.no; johanna.olweus@medisin.uio.no	Olweus, Johanna/G-8008-2015	Olweus, Johanna/0000-0002-1898-3100; Walchli, Sebastien/0000-0001-5869-1746	Research Council of Norway; Regional Health Authorities South-Eastern Norway; Oslo University Hospital Radiumhospitalet; Norwegian Cancer Association; K. G. Jebsen Foundation	Research Council of Norway(Research Council of Norway); Regional Health Authorities South-Eastern Norway; Oslo University Hospital Radiumhospitalet; Norwegian Cancer Association; K. G. Jebsen Foundation	This study was financed by the Research Council of Norway (EW, LEF), the Regional Health Authorities South-Eastern Norway (AA), Oslo University Hospital Radiumhospitalet (SW, AV, WY), the Norwegian Cancer Association and the K. G. Jebsen Foundation (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen IW, 2010, LEUKEMIA, V24, P1901, DOI 10.1038/leu.2010.186; Adler MJ, 2012, HEMATOL ONCOL CLIN N, V26, P447, DOI 10.1016/j.hoc.2012.02.013; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Card KF, 2004, CANCER IMMUNOL IMMUN, V53, P345, DOI 10.1007/s00262-003-0450-3; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; CHUNG S, 1994, P NATL ACAD SCI USA, V91, P12654, DOI 10.1073/pnas.91.26.12654; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Epel M, 2002, CANCER IMMUNOL IMMUN, V51, P565, DOI 10.1007/s00262-002-0312-4; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Irving M, 2012, J BIOL CHEM; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Moll R, 2001, Nurse Educ, V26, P122, DOI 10.1097/00006223-200105000-00012; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Mosquera LA, 2005, J IMMUNOL, V174, P4381, DOI 10.4049/jimmunol.174.7.4381; Ng TB, 2010, CURR PROTEIN PEPT SC, V11, P37, DOI 10.2174/138920310790274662; Pecorari F, 1999, J MOL BIOL, V285, P1831, DOI 10.1006/jmbi.1998.2422; Richman SA, 2007, BIOMOL ENG, V24, P361, DOI 10.1016/j.bioeng.2007.02.009; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Stone JD, 2012, METHOD ENZYMOL, V503, P189, DOI 10.1016/B978-0-12-396962-0.00008-2; Stronen E, 2009, SCAND J IMMUNOL, V69, P319, DOI 10.1111/j.1365-3083.2008.02223.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Valmori D, 1998, J IMMUNOL, V160, P1750; van Boxel GI, 2009, J IMMUNOL METHODS, V350, P14, DOI 10.1016/j.jim.2009.08.008; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Walchli B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027930; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	48	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119559	10.1371/journal.pone.0119559	http://dx.doi.org/10.1371/journal.pone.0119559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875651	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100016
J	Zhang, T; Guo, R; Gao, S; Guo, JX; Sun, W				Zhang, Tao; Guo, Rui; Gao, Song; Guo, Jixun; Sun, Wei			Responses of Plant Community Composition and Biomass Production to Warming and Nitrogen Deposition in a Temperate Meadow Ecosystem	PLOS ONE			English	Article							SPECIES RICHNESS; TALLGRASS PRAIRIE; ELEVATED CO2; TERRESTRIAL ECOSYSTEMS; BIODIVERSITY LOSS; CLIMATE-CHANGE; N-DEPOSITION; DIVERSITY; STEPPE; CHINA	Climate change has profound influences on plant community composition and ecosystem functions. However, its effects on plant community composition and biomass production are not well understood. A four-year field experiment was conducted to examine the effects of warming, nitrogen (N) addition, and their interactions on plant community composition and biomass production in a temperate meadow ecosystem in northeast China. Experimental warming had no significant effect on plant species richness, evenness, and diversity, while N addition highly reduced the species richness and diversity. Warming tended to reduce the importance value of graminoid species but increased the value of forbs, while N addition had the opposite effect. Warming tended to increase the belowground biomass, but had an opposite tendency to decrease the aboveground biomass. The influences of warming on aboveground production were dependent upon precipitation. Experimental warming had little effect on aboveground biomass in the years with higher precipitation, but significantly suppressed aboveground biomass in dry years. Our results suggest that warming had indirect effects on plant production via its effect on the water availability. Nitrogen addition significantly increased above-and below-ground production, suggesting that N is one of the most important limiting factors determining plant productivity in the studied meadow steppe. Significant interactive effects of warming plus N addition on belowground biomass were also detected. Our observations revealed that environmental changes (warming and N deposition) play significant roles in regulating plant community composition and biomass production in temperate meadow steppe ecosystem in northeast China.	[Zhang, Tao; Gao, Song; Guo, Jixun; Sun, Wei] NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Key Lab Dryland Agr, Minist Agr, Beijing 100193, Peoples R China; [Zhang, Tao] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Guo, JX (corresponding author), NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China.	gjixun@nenu.edu.cn; sunwei@nenu.edu.cn			National Natural Science Foundation of China [31170303, 31300097, 31100322, 31270445]; Program for New Century Excellent Talents in University [NCET-12-0814]; State Key Laboratory of Desert and Oasis Ecology; Xinjiang Institute of Ecology and Geography; Chinese Academy of Sciences; Fundamental Research Funds for the Central Universities [12QNJJ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Desert and Oasis Ecology; Xinjiang Institute of Ecology and Geography; Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (31170303, 31300097, 31100322 and 31270445), Program for New Century Excellent Talents in University (NCET-12-0814), State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences and Fundamental Research Funds for the Central Universities (No. 12QNJJ017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2001, BIOGEOCHEMISTRY, V54, P1, DOI 10.1023/A:1010653913530; Baer SG, 2004, OECOLOGIA, V139, P617, DOI 10.1007/s00442-004-1541-3; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bowman WD, 2006, ECOL APPL, V16, P1183, DOI 10.1890/1051-0761(2006)016[1183:NCLFAV]2.0.CO;2; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cook C.W., 1986, RANGE RES BASIC PROB; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Fay PA, 2011, BIOGEOSCIENCES, V8, P3053, DOI 10.5194/bg-8-3053-2011; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Gill RA, 2014, PLANT SOIL, V374, P197, DOI 10.1007/s11104-013-1868-9; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Harmens H, 2004, GRASS FORAGE SCI, V59, P144, DOI 10.1111/j.1365-2494.2004.00414.x; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Huberty LE, 1998, J ECOL, V86, P794, DOI 10.1046/j.1365-2745.1998.8650794.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060441; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027645; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Payne RJ, 2013, P NATL ACAD SCI USA, V110, P984, DOI 10.1073/pnas.1214299109; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Rull V, 2006, GLOBAL CHANGE BIOL, V12, P1, DOI 10.1111/j.1365-2486.2005.001080.x; Sardans J, 2008, APPL SOIL ECOL, V39, P223, DOI 10.1016/j.apsoil.2007.12.011; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Song L, 2011, BIOGEOSCIENCES, V8, P2341, DOI 10.5194/bg-8-2341-2011; Song L, 2012, J ARID LAND, V4, P3, DOI 10.3724/SP.J.1227.2012.00003; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; van den Berg LJL, 2011, GLOBAL CHANGE BIOL, V17, P1871, DOI 10.1111/j.1365-2486.2010.02345.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhang NY, 2013, SOIL BIOL BIOCHEM, V65, P96, DOI 10.1016/j.soilbio.2013.05.015; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015	58	33	34	19	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123160	10.1371/journal.pone.0123160	http://dx.doi.org/10.1371/journal.pone.0123160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874975	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100142
J	Zhu, M; Wang, HY; Zhu, A; Niu, KJ; Wang, GL				Zhu, Min; Wang, Haiyun; Zhu, Ai; Niu, Kaijun; Wang, Guolin			Meta-Analysis of Dexmedetomidine on Emergence Agitation and Recovery Profiles in Children after Sevoflurane Anesthesia: Different Administration and Different Dosage	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; POSTOPERATIVE ANALGESIA; REDUCES AGITATION; GREATER INCIDENCE; DELIRIUM; TONSILLECTOMY; HALOTHANE; PAIN; MIDAZOLAM; FENTANYL	The objective of this article is to evaluate the effect of dexmedetomidine on emergence agitation (EA) and recovery profiles in children after sevoflurane anesthesia and its pharmacological mechanisms. Standard bibliographic databases, including MEDLINE, EMBASE, PsycINFP, Springer and ISI Web of Knowledge, were artificially searched to identify all randomized controlled trials (RCTs) comparing the impact of dexmedetomidine with placebo, fentanyl and midazolam on EA and recovery profiles after sevoflurane anesthesia in post-anesthesia care unit (PACU). Two authors assessed the quality of each study independently in accordance with strict inclusion criteria and extracted data. RevMan 5.0 software was applied for performing statistic analysis. The outcomes analyzed included: 1) incidence of EA, 2) emergence time, 3) time to extubation, 4) incidence of post-operation nausea and vomiting, 5) number of patients requiring an analgesic, and 6) time to discharge from PACU. A total of 1364 patients (696 in the dexmedetomidine group and 668 in the placebo, fentanyl and midazolam group) from 20 prospective RCTs were included in the meta-analysis. Compared with placebo, dexmedetomidine decreased the incidence of EA (risk ratio [RR] 0.37; 95% CI 0.30 to 0.46), incidence of nausea and vomiting (RR 0.57; 95% CI 0.38 to 0.85) and number of patients requiring an analgesic (RR 0.43; 95% CI 0.31 to 0.59). However, dexmedetomidine had a significantly delayed effect on the emergence time (weighted mean differences [WMD] 1.16; 95% CI 0.72 to 1.60), time to extubation (WMD 0.61; 95% CI 0.27 to 0.95), and time to discharge from recovery room (WMD 2.67; 95% CI 0.95 to 4.39). Compared with fentanyl (RR 1.39; 95% CI 0.78 to 2.48) and midazolam (RR 1.12; 95% CI 0.54 to 2.35), dexmedetomidine has no significantly difference on the incidence of EA. However, the analgesia effect of dexmedetomidine on postoperation pain has no significantly statistical differences compared with fentanyl (RR 1.12; 95% CI 0.66 to 1.91), which implied that its analgesia effect might play an important role in decreasing the incident of EA. No evidence of publication bias was observed.	[Zhu, Min; Wang, Haiyun; Zhu, Ai; Wang, Guolin] Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol, Tianjin 300052, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol, Tianjin 300052, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, HY (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol, Tianjin 300052, Peoples R China.	wanghy819@hotmail.com		Niu, Kaijun/0000-0002-8772-2481	Natural Science Foundation of China [81071059, 81100984]; Science and Technology Supported Key Project of Tianjin [12ZCZDSY03000]; Scientific Grant from Tianjin Health Bureau [09KZ106]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Supported Key Project of Tianjin; Scientific Grant from Tianjin Health Bureau	This work was supported by Natural Science Foundation of China (81071059, 81100984), Science and Technology Supported Key Project of Tianjin (12ZCZDSY03000), Scientific Grant from Tianjin Health Bureau (09KZ106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin A, 2012, PEDIATR ANESTH, V22, P871, DOI 10.1111/j.1460-9592.2012.03802.x; Ali Monaz Abdulrahman, 2013, Saudi J Anaesth, V7, P296, DOI 10.4103/1658-354X.115363; Aono J, 1997, ANESTHESIOLOGY, V87, P1298, DOI 10.1097/00000542-199712000-00006; Arain SR, 2004, ANESTH ANALG, V98, P153, DOI 10.1213/01.ANE.0000093225.39866.75; Asaad OM, 2011, EGYPT J ANAESTH, V27, P233, DOI [10.1016/j.egja.2011.07.006, 10.1016/j.egja.2010.12.005]; Bock M, 2002, BRIT J ANAESTH, V88, P790, DOI 10.1093/bja/88.6.790; Chen JY, 2013, CAN J ANESTH, V60, P385, DOI 10.1007/s12630-013-9886-x; Cohen IT, 2002, ANESTH ANALG, V94, P1178, DOI 10.1097/00000539-200205000-00023; Cohen IT, 2002, PAEDIATR ANAESTH, V12, P604, DOI 10.1046/j.1460-9592.2002.00903.x; Cohen IT, 2003, PAEDIATR ANAESTH, V13, P63, DOI 10.1046/j.1460-9592.2003.00948.x; Coursin D B, 2001, Curr Opin Crit Care, V7, P221, DOI 10.1097/00075198-200108000-00002; Cravero J, 2000, PAEDIATR ANAESTH, V10, P419, DOI 10.1046/j.1460-9592.2000.00560.x; Cravero JP, 2000, J CLIN ANESTH, V12, P397, DOI 10.1016/S0952-8180(00)00180-X; Cravero JP, 2003, ANESTH ANALG, V97, P364, DOI 10.1213/01.ANE.0000070227.78670.43; Dahmani S, 2014, CURR OPIN ANESTHESIO, V27, P309, DOI 10.1097/ACO.0000000000000076; DYCK JB, 1993, ANESTHESIOLOGY, V78, P813, DOI 10.1097/00000542-199305000-00002; El-Rahmawy GF, 2013, EGYPT J ANAESTH, V29, P137, DOI 10.1016/j.egja.2012.10.005; Erdil F, 2009, ANAESTH INTENS CARE, V37, P571, DOI 10.1177/0310057X0903700405; Galinkin JL, 2000, ANESTHESIOLOGY, V93, P1378, DOI 10.1097/00000542-200012000-00006; Gerlach AT, 2007, ANN PHARMACOTHER, V41, P245, DOI 10.1345/aph.1H314; Goa K L, 1999, Paediatr Drugs, V1, P127, DOI 10.2165/00128072-199901020-00005; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guler G, 2005, PEDIATR ANESTH, V15, P762, DOI 10.1111/j.1460-9592.2004.01541.x; Gupta N, 2013, J NEUROSURG ANESTH, V25, P271, DOI 10.1097/ANA.0b013e31828cb6c0; Hamunen K, 2005, PAIN, V117, P40, DOI 10.1016/j.pain.2005.05.012; HANNALLAH RS, 1987, ANESTHESIOLOGY, V66, P832, DOI 10.1097/00000542-198706000-00023; Hatch DJ, 1999, BRIT J ANAESTH, V83, P42, DOI 10.1093/bja/83.1.42; He L, 2013, ANAESTH INTENS CARE, V41, P328, DOI 10.1177/0310057X1304100309; Ibacache ME, 2004, ANESTH ANALG, V98, P60, DOI 10.1213/01.ANE.0000094947.20838.8E; Ihmsen H, 2012, ANAESTHESIST, V61, P1059, DOI 10.1007/s00101-012-2114-1; Isik B, 2006, PEDIATR ANESTH, V16, P748, DOI 10.1111/j.1460-9592.2006.01845.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jurgens S, 2003, ANAESTHESIA, V58, P296, DOI 10.1046/j.1365-2044.2003.307226.x; Keaney A, 2004, PEDIATR ANESTH, V14, P866, DOI 10.1111/j.1460-9592.2004.01310.x; Kim NY, 2014, YONSEI MED J, V55, P209, DOI 10.3349/ymj.2014.55.1.209; Koruk S, 2010, J ANESTH, V24, P858, DOI 10.1007/s00540-010-1023-1; Kuratani N, 2008, ANESTHESIOLOGY, V109, P225, DOI 10.1097/ALN.0b013e31817f5c18; Lalicevic S, 2004, CURR THER RES CLIN E, V65, P360, DOI 10.1016/j.curtheres.2004.07.002; Meng QT, 2012, INT J PEDIATR OTORHI, V76, P1036, DOI 10.1016/j.ijporl.2012.03.028; Moir MS, 2000, LARYNGOSCOPE, V110, P1824, DOI 10.1097/00005537-200011000-00011; Mountain Brian W, 2011, AANA J, V79, P219; Ozcengiz D, 2011, J ANESTH, V25, P184, DOI 10.1007/s00540-011-1099-2; Patel A, 2010, ANESTH ANALG, V111, P1004, DOI 10.1213/ANE.0b013e3181ee82fa; Pestieau SR, 2011, PEDIATR ANESTH, V21, P1128, DOI 10.1111/j.1460-9592.2011.03615.x; Phan Hanna, 2008, Paediatr Drugs, V10, P49, DOI 10.2165/00148581-200810010-00006; Saadawy I, 2009, ACTA ANAESTH SCAND, V53, P251, DOI 10.1111/j.1399-6576.2008.01818.x; Sato M, 2010, J ANESTH, V24, P675, DOI 10.1007/s00540-010-0976-4; Shukry M, 2005, PEDIATR ANESTH, V15, P1098, DOI 10.1111/j.1460-9592.2005.01660.x; Sikich N, 2004, ANESTHESIOLOGY, V100, P1138, DOI 10.1097/00000542-200405000-00015; Sun L, 2014, ACTA ANAESTH SCAND, V58, P642, DOI 10.1111/aas.12292; Tobias JD, 2004, SOUTH MED J, V97, P451, DOI 10.1097/00007611-200405000-00007; Tobias JD, 2002, PAEDIATR ANAESTH, V12, P171, DOI 10.1046/j.1460-9592.2002.00805.x; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; TWERSKY RS, 1993, J CLIN ANESTH, V5, pS57; Uysal HY, 2011, J CLIN ANESTH, V23, P53, DOI 10.1016/j.jclinane.2010.07.001; Viitanen H, 1999, ANESTH ANALG, V89, P75, DOI 10.1097/00000539-199907000-00014; Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8; Voepel-Lewis T, 2003, ANESTH ANALG, V96, P1625, DOI 10.1213/01.ANE.0000062522.21048.61; Voepel-Lewis Terri, 2005, J Perianesth Nurs, V20, P239, DOI 10.1016/j.jopan.2005.05.006; WATCHA MF, 1992, CAN J ANAESTH, V39, P649, DOI 10.1007/BF03008224; Weldon BC, 2004, ANESTH ANALG, V98, P321, DOI 10.1213/01.ANE.0000096004.96603.08; Xu LL, 2012, J ANESTH, V26, P556, DOI 10.1007/s00540-012-1354-1; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099718	63	63	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123728	10.1371/journal.pone.0123728	http://dx.doi.org/10.1371/journal.pone.0123728			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874562	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100203
J	Chen, ZQ; Wu, B; Zhai, X; Bai, YS; Zhu, XD; Luo, B; Chen, X; Li, C; Yang, MY; Xu, KL; Liu, CC; Wang, CF; Zhao, YC; Wei, XZ; Chen, K; Yang, W; Ta, D; Li, M				Chen, Ziqiang; Wu, Bing; Zhai, Xiao; Bai, Yushu; Zhu, Xiaodong; Luo, Beier; Chen, Xiao; Li, Chao; Yang, Mingyuan; Xu, Kailiang; Liu, Chengcheng; Wang, Chuanfeng; Zhao, Yingchuan; Wei, Xianzhao; Chen, Kai; Yang, Wu; Ta, Dean; Li, Ming			Basic Study for Ultrasound-Based Navigation for Pedicle Screw Insertion Using Transmission and Backscattered Methods	PLOS ONE			English	Article							CANCELLOUS BONE; INTRAOSSEOUS ULTRASOUND; X-RAY; PROPAGATION; PLACEMENT; WAVES; COEFFICIENT; ATTENUATION; DEPENDENCE; MARROW	The purpose of this study was to understand the acoustic properties of human vertebral cancellous bone and to study the feasibility of ultrasound-based navigation for posterior pedicle screw fixation in spinal fusion surgery. Fourteen human vertebral specimens were disarticulated from seven un-embalmed cadavers (four males, three females, 73.14 +/- 9.87 years, two specimens from each cadaver). Seven specimens were used to measure the transmission, including tests of attenuation and phase velocity, while the other seven specimens were used for backscattered measurements to inspect the depth of penetration and A-Mode signals. Five pairs of unfocused broadband ultrasonic transducers were used for the detection, with center frequencies of 0.5 MHz, 1 MHz, 1.5 MHz, 2.25 MHz, and 3.5 MHz. As a result, good and stable results were documented. With increased frequency, the attenuation increased (P<0.05), stability of the speed of sound improved (P<0.05), and penetration distance decreased (P>0.05). At about 0.6 cm away from the cortical bone, warning signals were easily observed from the backscattered measurements. In conclusion, the ultrasonic system proved to be an effective, moveable, and real-time imaging navigation system. However, how ultrasonic navigation will benefit pedicle screw insertion in spinal surgery needs to be determined. Therefore, ultrasound-guided pedicle screw implantation is theoretically effective and promising.	[Chen, Ziqiang; Bai, Yushu; Zhu, Xiaodong; Luo, Beier; Chen, Xiao; Li, Chao; Yang, Mingyuan; Xu, Kailiang; Wang, Chuanfeng; Zhao, Yingchuan; Wei, Xianzhao; Chen, Kai; Yang, Wu; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Wu, Bing] 401st Hosp Ctr, Dept Orthoped, Qingdao, Shandong, Peoples R China; [Zhai, Xiao] Second Mil Med Univ, Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Liu, Chengcheng; Ta, Dean] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Ta, D (corresponding author), Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China.	jsjyzx8@qq.com; tda@fudan.edu.cn	Xu, Kailiang/HDM-0051-2022; Xu, Kailiang/AGN-4164-2022	Xu, Kailiang/0000-0002-1819-4101; Ta, Dean/0000-0001-6651-4491	National Natural Science Foundation of China [81101396, 11327405]; Biomedical Key Subject Foundation of Shanghai [12411950800]; Science and Technology Support Program of Shanghai [13441901900]; Creativity and Innovation Training Program of Second Military Medical University [ZD2013005]; Natural Science Foundation of Shanghai [15ZR1412700]; Fund of the Second Military Medical University [2014QN15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biomedical Key Subject Foundation of Shanghai; Science and Technology Support Program of Shanghai; Creativity and Innovation Training Program of Second Military Medical University; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Fund of the Second Military Medical University	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81101396 and 11327405; http://www.nsfc.gov.cn/), Biomedical Key Subject Foundation of Shanghai (Grant No. 12411950800; http://www.shanghai.gov.cn/shanghai/node2314/node2319/node12344/u26ai38195.html), the Science and Technology Support Program of Shanghai (Grant No. 13441901900; http://www.shanghai.gov.cn/shanghai/node2314/node2319/node12344/u26ai38195.html), the Creativity and Innovation Training Program of Second Military Medical University (Grant No. ZD2013005), the Natural Science Foundation of Shanghai (Grant No. 15ZR1412700), and the Fund of the Second Military Medical University (Grant No. 2014QN15).	Allam Y, 2013, EUR SPINE J, V22, P648, DOI 10.1007/s00586-012-2505-7; Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Bakhsh WR, 2013, SPINE, V38, pE1166, DOI 10.1097/BRS.0b013e31829d43a5; Belmont PJ, 2001, SPINE, V26, P2340, DOI 10.1097/00007632-200111010-00010; Chaynes P, 2001, SURG RADIOL ANAT, V23, P85, DOI 10.1007/s00276-001-0085-z; Diakov G, 2010, HNO, V58, P1067, DOI 10.1007/s00106-010-2171-1; Federspil PA, 2009, HNO, V57, P983, DOI 10.1007/s00106-009-1986-0; Goodwin M, 2005, INTRAOSTEAL ULTRASOU; Hoffmeister BK, 2002, PHYS MED BIOL, V47, P3419, DOI 10.1088/0031-9155/47/18/310; Hughes ER, 1999, ULTRASOUND MED BIOL, V25, P811, DOI 10.1016/S0301-5629(99)00034-4; Kantelhardt SR, 2009, SPINE, V34, P400, DOI 10.1097/BRS.0b013e31819286ca; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P655, DOI 10.1007/s00701-009-0447-6; Kondoh T, 2014, APPL OPTICS, V53, P2602, DOI 10.1364/AO.53.002602; Langton C M, 1984, Eng Med, V13, P89, DOI 10.1243/EMED_JOUR_1984_013_022_02; Laugier P, 2011, ONE QUANTITATIVE ULT; Li G, 2010, EUR SPINE J, V19, P1576, DOI 10.1007/s00586-010-1316-y; LI HP, 1985, J BONE JOINT SURG AM, V67A, P1202, DOI 10.2106/00004623-198567080-00009; Manbachi A, 2014, SPINE J, V14, P165, DOI 10.1016/j.spinee.2013.03.029; Micali S, 2011, UROLOG J, V78, P52, DOI 10.5301/RU.2011.6438; Michler Ralf Peter, 2013, Tidsskr Nor Laegeforen, V133, P306, DOI 10.4045/tidsskr.11.1542; Mujagic M, 2008, IEEE T ULTRASON FERR, V55, P1267, DOI 10.1109/TUFFC.2008.789; Nelson EM, 2014, SPINE J, V14, P2985, DOI 10.1016/j.spinee.2014.06.003; Nicholson PHF, 1996, PHYS MED BIOL, V41, P2421, DOI 10.1088/0031-9155/41/11/013; NICHOLSON PHF, 1994, PHYS MED BIOL, V39, P1013, DOI 10.1088/0031-9155/39/6/007; Nicholson PHF, 2002, ULTRASOUND MED BIOL, V28, P369, DOI 10.1016/S0301-5629(01)00508-7; Raphael DT, 2010, SPINE J, V10, P422, DOI 10.1016/j.spinee.2010.02.008; Sproul M, 2004, ULTRASONIC CANNULA S; Strelitzki R., 1996, EUR J ULTRASOUND, V4, P205; Ta DA, 2005, P ANN INT IEEE EMBS, P1131; Ta D, 2008, J ACOUST SOC AM, V124, P4083, DOI 10.1121/1.3001705; Tsiklauri D, 2002, J ACOUST SOC AM, V112, P843, DOI 10.1121/1.1499134; Wear KA, 2001, IEEE T ULTRASON FERR, V48, P602, DOI 10.1109/58.911743; Wear KA, 2008, IEEE T ULTRASON FERR, V55, P1432, DOI 10.1109/TUFFC.2008.818; Xu KL, 2014, ULTRASONICS, V54, P1210, DOI 10.1016/j.ultras.2013.09.015; Xu KL, 2014, ULTRASONICS, V54, P395, DOI 10.1016/j.ultras.2013.07.011; Zhang C, 2011, J ACOUST SOC AM, V129, P3317, DOI 10.1121/1.3562560; Zhang HL, 2014, ULTRASONICS, V54, P1203, DOI 10.1016/j.ultras.2013.10.020	37	7	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122392	10.1371/journal.pone.0122392	http://dx.doi.org/10.1371/journal.pone.0122392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861053	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300045
J	Lee, H; Boot, WR; Baniqued, PL; Voss, MW; Prakash, RS; Basak, C; Kramer, AF				Lee, Hyunkyu; Boot, Walter R.; Baniqued, Pauline L.; Voss, Michelle W.; Prakash, Ruchika Shaurya; Basak, Chandramallika; Kramer, Arthur F.			The Relationship between Intelligence and Training Gains Is Moderated by Training Strategy	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BRAIN; MAGNIFICATION; PERFORMANCE; YOUNG	We examined the relationship between training regimen and fluid intelligence in the learning of a complex video game. Fifty non-game-playing young adults were trained on a game called Space Fortress for 30 hours with one of two training regimens: 1) Hybrid Variable-Priority Training (HVT), with part-task training and a focus on improving specific skills and managing task priorities, and 2) Full Emphasis Training (FET) in which participants practiced the whole game to obtain the highest overall score. Fluid intelligence was measured with the Raven's Progressive Matrix task before training. With FET, fluid intelligence was positively associated with learning, suggesting that intellectual ability played a substantial role in determining individual differences in training success. In contrast, with HVT, fluid intelligence was not associated with learning, suggesting that individual differences in fluid intelligence do not factor into training success in a regimen that emphasizes component tasks and flexible task coordination. By analyzing training effects in terms of individual differences and training regimens, the current study offers a training approach that minimizes the potentially limiting effect of individual differences.	[Lee, Hyunkyu] Brain Plast Inst, Posit Sci, San Francisco, CA 94108 USA; [Boot, Walter R.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Boot, Walter R.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Prakash, Ruchika Shaurya] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Basak, Chandramallika] Univ Texas Dallas, Ctr Vital Longev, Richardson, TX 75083 USA	State University System of Florida; Florida State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University System of Ohio; Ohio State University; University of Texas System; University of Texas Dallas	Lee, H (corresponding author), Brain Plast Inst, Posit Sci, 77 Geary St,Suite 303, San Francisco, CA 94108 USA.	psykyu@gmail.com	Basak, Chandramallika/AAB-2081-2020; Kramer, Arthur/AAB-2937-2019; Prakash, Ruchika S/K-2030-2013	Kramer, Arthur/0000-0001-5870-2724	Office of Naval Research [N000140710903]	Office of Naval Research(Office of Naval Research)	The Office of Naval Research supported this study (grant no. N000140710903). The Office of Naval Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LS, 1991, MULTIPLE REGRESSION, pxi; Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Buitenweg JIV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00183; COX BD, 1994, J GENET PSYCHOL, V155, P423, DOI 10.1080/00221325.1994.9914792; DONCHIN E, 1989, ACTA PSYCHOL, V71, P1, DOI 10.1016/0001-6918(89)90002-4; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Feng J, 2007, LECT NOTES ARTIF INT, V4562, P279; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FREDERIKSEN JR, 1989, ACTA PSYCHOL, V71, P89, DOI 10.1016/0001-6918(89)90006-1; Garrett DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00101; Gaultney JF, 1996, J EXP CHILD PSYCHOL, V61, P43, DOI 10.1006/jecp.1996.0002; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; KLIEGL R, 1990, DEV PSYCHOL, V26, P894, DOI 10.1037/0012-1649.26.6.894; Kwon YJ, 2000, J RES SCI TEACH, V37, P44, DOI 10.1002/(SICI)1098-2736(200001)37:1<44::AID-TEA4>3.0.CO;2-J; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Lovden M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00141; Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810; Raine LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072666; Raven J., 2004, MANUAL RAVENS PROGR; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164	21	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123259	10.1371/journal.pone.0123259	http://dx.doi.org/10.1371/journal.pone.0123259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860978	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300086
J	Peng, X; Qi, W; Huang, RL; Su, RX; He, ZM				Peng, Xin; Qi, Wei; Huang, Renliang; Su, Rongxin; He, Zhimin			Elucidating the Influence of Gold Nanoparticles on the Binding of Salvianolic Acid B and Rosmarinic Acid to Bovine Serum Albumin	PLOS ONE			English	Article							FLUORESCENCE; FLAVONOIDS; CHEMISTRY; PROTECTS; BIOLOGY; PLASMA; BRAIN; SIZE	Salvianolic acid B and rosmarinic acid are two main water-soluble active ingredients from Salvia miltiorrhiza with important pharmacological activities and clinical applications. The interactions between salvianolic acid B (or rosmarinic acid) and bovine serum albumin (BSA) in the presence and absence of gold nanoparticles (Au NPs) with three different sizes were investigated by using biophysical methods for the first time. Experimental results proved that two components quenched the fluorescence of BSA mainly through a static mechanism irrespective of the absence or presence of Au NPs. The presence of Au NPs decreased the binding constants of salvianolic acid B with BSA from 27.82% to 10.08%, while Au NPs increased the affinities of rosmarinic acid for BSA from 0.4% to 14.32%. The conformational change of BSA in the presence of Au NPs (caused by a noncompetitive binding between Au NPs and drugs at different albumin sites) induced changeable affinity and binding distance between drugs and BSA compared with no Au NPs. The competitive experiments revealed that the site I (subdomain IIA) of BSA was the primary binding site for salvianolic acid B and rosmarinic acid. Additionally, two compounds may induce conformational and micro-environmental changes of BSA. The results would provide valuable binding information between salvianolic acid B (or rosmarinic acid) and BSA, and also indicated that the Au NPs could alter the interaction mechanism and binding capability of drugs to BSA, which might be beneficial to understanding the pharmacokinetics and biological activities of the two drugs.	[Peng, Xin] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Peng, Xin; Qi, Wei; Su, Rongxin; He, Zhimin] Tianjin Univ, Sch Chem Engn & Technol, Chem Engn Res Ctr, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin; He, Zhimin] Tianjin Univ, State Key Lab Chem Engn, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin] Tianjin Univ, Tianjin Key Lab Membrane Sci & Desalinat Technol, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Huang, Renliang] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University; Tianjin University; Tianjin University; Tianjin University	Qi, W (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Chem Engn Res Ctr, Tianjin 300072, Peoples R China.	qiwei@tju.edu.cn	Su, Rongxin/AAA-7967-2021; Su, Rongxin/B-6634-2014; Qi, Wei/I-2550-2018; Huang, Renliang/C-2037-2013	Su, Rongxin/0000-0001-9778-9113; Su, Rongxin/0000-0001-9778-9113; Peng, Xin/0000-0003-1654-2130; Huang, Renliang/0000-0003-0797-3473	Natural Science Foundation of China [21476165, 51173128, 21306134]; 863 Program of China [2013AA102204]; Ministry of Science and Technology of China [2012YQ090194]; Ministry of Education [20130032120029]; Beiyang Young Scholar of Tianjin University; Program of Introducing Talents of Discipline to Universities of China [B06006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; Beiyang Young Scholar of Tianjin University; Program of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	This work was supported by the Natural Science Foundation of China (Nos. 21476165, 51173128, 21306134), the 863 Program of China (No. 2013AA102204), the Ministry of Science and Technology of China (No. 2012YQ090194), the Ministry of Education (No. 20130032120029), the Beiyang Young Scholar of Tianjin University (2012) and the Program of Introducing Talents of Discipline to Universities of China (No. B06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin S, 2014, J LUMIN, V151, P219, DOI 10.1016/j.jlumin.2014.02.028; Barreca D, 2013, BIOCHIMIE, V95, P2042, DOI 10.1016/j.biochi.2013.07.014; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Cheng ZJ, 2013, J SOLUTION CHEM, V42, P1238, DOI 10.1007/s10953-013-0022-x; Chi ZX, 2010, J AGR FOOD CHEM, V58, P10262, DOI 10.1021/jf101417w; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ding F, 2009, J LUMIN, V129, P650, DOI 10.1016/j.jlumin.2009.01.011; Dominguez-Medina S, 2012, LANGMUIR, V28, P9131, DOI 10.1021/la3005213; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Feroz SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076067; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Garg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063805; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hemmateenejad B, 2012, J PHARMACEUT BIOMED, V67-68, P201, DOI 10.1016/j.jpba.2012.04.012; Ibrahim N, 2010, BIOMACROMOLECULES, V11, P3341, DOI 10.1021/bm100814n; Jiang Baohong, 2010, BMC Pharmacology, V10, P10, DOI 10.1186/1471-2210-10-10; Kamtekar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053499; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lay IS, 2003, J SURG RES, V115, P279, DOI 10.1016/S0022-4804(03)00226-9; Lee HJ, 2013, J MED FOOD, V16, P239, DOI 10.1089/jmf.2012.2456; Lee J, 2008, J DERMATOL, V35, P768, DOI 10.1111/j.1346-8138.2008.00565.x; Liu BS, 2012, J LUMIN, V132, P1133, DOI 10.1016/j.jlumin.2011.12.082; Liu Y, 2013, FOOD CHEM TOXICOL, V58, P264, DOI 10.1016/j.fct.2013.04.048; Lu DW, 2011, FOOD CHEM TOXICOL, V49, P3158, DOI 10.1016/j.fct.2011.09.011; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Mandal S, 2005, CURR APPL PHYS, V5, P118, DOI 10.1016/j.cap.2004.06.006; Ozturk M, 2010, FOOD CHEM, V123, P1352, DOI 10.1016/j.foodchem.2010.06.021; Pan XR, 2011, J AGR FOOD CHEM, V59, P6650, DOI 10.1021/jf200907x; Peng X, 2014, J SOLUTION CHEM, V43, P585, DOI 10.1007/s10953-014-0146-7; Psotova J, 2006, J PHOTOCH PHOTOBIO B, V84, P167, DOI 10.1016/j.jphotobiol.2006.02.012; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Tang JH, 2013, J SOLUTION CHEM, V42, P226, DOI 10.1007/s10953-012-9938-9; Tewtrakul S, 2003, PHYTOTHER RES, V17, P232, DOI 10.1002/ptr.1111; Thakor AS, 2011, NANO LETT, V11, P4029, DOI 10.1021/nl202559p; Tian FF, 2012, RSC ADV, V2, P501, DOI 10.1039/c1ra00521a; Toneatto J, 2011, J INORG BIOCHEM, V105, P645, DOI 10.1016/j.jinorgbio.2010.10.018; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang YQ, 2011, INORG CHEM, V50, P12661, DOI 10.1021/ic201712e; Xiao JB, 2012, ANALYST, V137, P195, DOI 10.1039/c1an15457e; Xiao JB, 2011, NANOMED-NANOTECHNOL, V7, P850, DOI 10.1016/j.nano.2011.02.003; Xiao JB, 2010, J INORG BIOCHEM, V104, P1148, DOI 10.1016/j.jinorgbio.2010.07.003; Xu Y. Y., 2007, ASIAN J PHARMACODYN, V7, P99; Yeh YC, 2012, NANOSCALE, V4, P1871, DOI 10.1039/c1nr11188d; Zhang GW, 2012, J AGR FOOD CHEM, V60, P2721, DOI 10.1021/jf205260g; Zhang J, 2011, J AGR FOOD CHEM, V59, P7506, DOI 10.1021/jf2005194; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059106; Zhang YP, 2011, J INORG BIOCHEM, V105, P1529, DOI 10.1016/j.jinorgbio.2011.08.007; Zhang YP, 2011, J AGR FOOD CHEM, V59, P8499, DOI 10.1021/jf201796x; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	58	29	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0118274	10.1371/journal.pone.0118274	http://dx.doi.org/10.1371/journal.pone.0118274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861047	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300003
J	Benson, CL; Magee, CL				Benson, Christopher L.; Magee, Christopher L.			Quantitative Determination of Technological Improvement from Patent Data	PLOS ONE			English	Article							FUNCTIONAL-APPROACH; PROGRESS; DISCONTINUITIES; INDICATORS; EXPERIENCE; INNOVATION; CITATIONS; NETWORKS; MODEL	The results in this paper establish that information contained in patents in a technological domain is strongly correlated with the rate of technological progress in that domain. The importance of patents in a domain, the recency of patents in a domain and the immediacy of patents in a domain are all strongly correlated with increases in the rate of performance improvement in the domain of interest. A patent metric that combines both importance and immediacy is not only highly correlated (r = 0.76, p = 2.6*10(-6)) with the performance improvement rate but the correlation is also very robust to domain selection and appears to have good predictive power for more than ten years into the future. Linear regressions with all three causal concepts indicate realistic value in practical use to estimate the important performance improvement rate of a technological domain.	[Benson, Christopher L.; Magee, Christopher L.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Benson, CL (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	cbenson@mit.edu	Magee, Christopher L./E-4021-2012		Singapore University of Technology and Design	Singapore University of Technology and Design	This work was funded by the Singapore University of Technology and Design through their support of the authors at the MIT International Design Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2002, MANAGE SCI, V48, P44, DOI 10.1287/mnsc.48.1.44.14279; Alcacer J, 2007, MANAGE SCI, V53, P760, DOI 10.1287/mnsc.1060.0637; Alcacer J, 2006, REV ECON STAT, V88, P774, DOI 10.1162/rest.88.4.774; ALCHIAN A, 1963, ECONOMETRICA, V31, P679, DOI 10.2307/1909166; ANDERSON P, 1990, ADMIN SCI QUART, V35, P604, DOI 10.2307/2393511; [Anonymous], 2001, 8498 NBER; ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952; Arthur WB, 2007, RES POLICY, V36, P274, DOI 10.1016/j.respol.2006.11.005; Arts S, 2013, SCIENTOMETRICS, V97, P397, DOI 10.1007/s11192-013-1045-1; AYRES RU, 1992, TECHNOVATION, V12, P465, DOI 10.1016/0166-4972(92)90052-J; Balconi M, 2010, RES POLICY, V39, P1, DOI 10.1016/j.respol.2009.09.013; Benson CL, 2014, RENEW ENERG, V68, P745, DOI 10.1016/j.renene.2014.03.002; Benson CL, 2013, SCIENTOMETRICS, V96, P69, DOI 10.1007/s11192-012-0930-3; Benson CL, 2012, ENG MANAGEMENT RES, V1, P2, DOI [10.5539/emr.v1n1p2, DOI 10.5539/EMR.V1N1P2]; Benson CL, 2014, TECHNOLOGY STRUCTURA, DOI [10.1007/s11192-014-1493-2, DOI 10.1007/S11192-014-1493-2]; Benson CL, 2014, THESIS MIT; BRESNAHAN TF, 1995, J ECONOMETRICS, V65, P83, DOI 10.1016/0304-4076(94)01598-T; Bush V., 1945, SCI ENDLESS FRONTIER; Christensen C. M., 2001, INNOVATORS DILEMMA N; Christensen C.M., 1992, PROD OPER MANAG, V1, P334; Ethiraj SK, 2007, STRATEGIC MANAGE J, V28, P563, DOI 10.1002/smj.622; Fischer T, 2014, RES POLICY, V43, P519, DOI 10.1016/j.respol.2013.07.013; Fleming L, 2004, STRATEGIC MANAGE J, V25, P909, DOI 10.1002/smj.384; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; FOSTER RN, 1985, TECHNOL SOC, V7, P127, DOI 10.1016/0160-791X(85)90022-3; Freeman C, 1996, TECHNOL FORECAST SOC, V53, P27, DOI 10.1016/0040-1625(96)00060-1; Fu K, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4023484; Funk JL, 2013, EXPONENTIAL CHANGE W; Funk P, 1993, DIRECTION TECHNOLOGI, V393; Girifalco L. A., 1991, DYNAMICS TECHNOLOGIC; Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865; Griliches Z., 1992, SCAND J ECON, V94, pS29, DOI DOI 10.2307/3440244; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Henderson R, 1998, REV ECON STAT, V80, P119, DOI 10.1162/003465398557221; Jaffe A. B., 2006, CAPITALISM SOC, V1, P1; KLEVORICK AK, 1995, RES POLICY, V24, P185, DOI 10.1016/0048-7333(93)00762-I; Koh H, 2008, TECHNOL FORECAST SOC, V75, P735, DOI 10.1016/j.techfore.2007.05.007; Koh H, 2006, TECHNOL FORECAST SOC, V73, P1061, DOI 10.1016/j.techfore.2006.06.001; LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783; Lundberg E, 1961, PRODUKTIVITET RDNTAB; Magee CL, 2014, ESDWP201422 MIT; Margolis RM, 1999, SCIENCE, V285, P690, DOI 10.1126/science.285.5428.690; MARTINO J, 1971, TECHNOL FORECAST SOC, V2, P247, DOI 10.1016/0040-1625(71)90003-5; Mcnerney J, 2011, P NATL ACAD SCI USA, DOI [10.1073/pnas.1017298108/-/DCSupplemental, DOI 10.1073/PNAS.1017298108/-/DCSUPPLEMENTAL]; Mones E, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/05/P05023; Moore G., 1965, ELECT MAGAZINE, V38; Murray F, 2004, RES POLICY, V33, P643, DOI 10.1016/j.respol.2004.01.013; Murray F, 2002, RES POLICY, V31, P1389, DOI 10.1016/S0048-7333(02)00070-7; Nagy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052669; Nagy B, 2011, TECHNOL FORECAST SOC, V78, P1356, DOI 10.1016/j.techfore.2011.07.006; Nelson R, 1971, J POLITICAL EC, V67, P297; NELSON RR, 1982, AM ECON REV, V72, P114; Nemet GF, 2012, RES POLICY, V41, P190, DOI 10.1016/j.respol.2011.08.009; Nerkar A, 2003, MANAGE SCI, V49, P211, DOI 10.1287/mnsc.49.2.211.12747; Nordhaus W. D., 2009, ENERGY J, V35, P1; Nordhaus WD, 2007, J ECON HIST, V67, P128, DOI 10.1017/S0022050707000058; OECD (Organisation for Economic Co-operationand Development), 2005, OSL MAN GUID COLL IN, DOI [10.1787/9789264013100-en, DOI 10.1787/9789264013100-EN]; Organisation for Economic Co-operation and Development, 2002, FRASC MAN 2002 PROP; PRICE DJD, 1965, SCIENCE, V149, P510; PRICE DJD, 1965, TECHNOL CULT, V6, P553; Rosenberg Nathan, 1982, INSIDE BLACKBOX TECH; Rothaermel FT, 2007, RES POLICY, V36, P832, DOI 10.1016/j.respol.2007.02.008; Ruttan V., 2001, TECHNOLOGY GROWTH DE; SAHAL D, 1979, AIIE T, V11, P23, DOI 10.1080/05695557908974396; Sahal D., 1981, PATTERNS TECHNOLOGIC; Schoenmakers W, 2010, RES POLICY, V39, P1051, DOI 10.1016/j.respol.2010.05.013; Schumpeter JA, 1928, EC J, V38; Sinclair G, 2000, MANAGE SCI, V46, P28, DOI 10.1287/mnsc.46.1.28.15133; Sood A, 2005, J MARKETING, V69, P152, DOI 10.1509/jmkg.69.3.152.66361; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; TRAJTENBERG M, 1989, J POLIT ECON, V97, P444, DOI 10.1086/261611; Trajtenberg M., 1997, ECON INNOV NEW TECH, VVolume 5, P19, DOI [10.1080/10438599700000006, DOI 10.1080/10438599700000006]; TUSHMAN ML, 1986, ADMIN SCI QUART, V31, P439, DOI 10.2307/2392832; Valentini G, 2012, STRATEGIC MANAGE J, V33, P336, DOI 10.1002/smj.946; Wright T, 1936, J AERONAUT SCI, V3	75	38	38	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121635	10.1371/journal.pone.0121635	http://dx.doi.org/10.1371/journal.pone.0121635			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874447	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800026
J	Fischer, MJM; Soller, KJ; Sauer, SK; Kalucka, J; Veglia, G; Reeh, PW				Fischer, Michael J. M.; Soller, Kailey J.; Sauer, Susanne K.; Kalucka, Joanna; Veglia, Gianluigi; Reeh, Peter W.			Formalin Evokes Calcium Transients from the Endoplasmatic Reticulum	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; TRPA1; ACTIVATION; RECEPTOR; EXCITABILITY; CONTRIBUTES; NEURONS; COLD	The formalin test is the most widely used behavioral screening test for analgesic compounds. The cellular mechanism of action of formaldehyde, inducing a typically biphasic pain-related behavior in rodents is addressed in this study. The chemoreceptor channel TRPA1 was suggested as primary transducer, but the high concentrations used in the formalin test elicit a similar response in TRPA1 wildtype and knockout animals. Here we show that formaldehyde evokes a dose-dependent calcium release from intracellular stores in mouse sensory neurons and primary keratinocytes as well as in non-neuronal cell lines, and independent of TRPA1. The source of calcium is the endoplasmatic reticulum and inhibition of the sarco/endoplasmic reticulum calcium-ATPase has a major contribution. This TRPA1-independent mechanism may underlie formaldehyde-induced pan-neuronal excitation and subsequent inflammation.	[Fischer, Michael J. M.; Sauer, Susanne K.; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Soller, Kailey J.; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Kalucka, Joanna] Katholieke Univ Leuven, VIB Vesalius Res Ctr, Leuven, Belgium; [Veglia, Gianluigi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Erlangen Nuremberg; University of Minnesota System; University of Minnesota Twin Cities; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Minnesota System; University of Minnesota Twin Cities	Fischer, MJM (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany.	fischer@physiologie1.uni-erlangen.de	Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Reeh, Peter W./0000-0002-4367-094X; Fischer, Michael J.M./0000-0002-3811-7066; Sauer, Susanne Katharina/0000-0002-9734-885X; Kalucka, Joanna/0000-0003-4887-7672	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; National Institutes of Health [GM 64742]; AHA [13PRE16950023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064742] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. GV is supported by National Institutes of Health GM 64742 and KS is supported by AHA 13PRE16950023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; Drion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041806; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; Gover T D, 2009, Handb Exp Pharmacol, P563, DOI 10.1007/978-3-540-79090-7_16; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jain A, 2011, PAIN, V152, P2765, DOI 10.1016/j.pain.2011.08.025; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kalucka J, 2013, MOL CELL BIOL, V33, P3426, DOI 10.1128/MCB.00609-13; Kosugi M, 2007, J NEUROSCI, V27, P4443, DOI 10.1523/JNEUROSCI.0557-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee B, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-5; Lirk P, 2008, ANESTH ANALG, V107, P673, DOI 10.1213/ane.0b013e31817b7a73; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MADDEN TD, 1979, NATURE, V279, P538, DOI 10.1038/279538a0; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mizumoto N, 2003, J INVEST DERMATOL, V121, P1066, DOI 10.1046/j.1523-1747.2003.12558.x; Qin FZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00084.2014; Radtke C, 2010, PAIN, V148, P94, DOI 10.1016/j.pain.2009.10.014; Raoux M, 2013, TOXICOL IN VITRO, V27, P402, DOI 10.1016/j.tiv.2012.08.010; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Roussel C, 2006, CELL CALCIUM, V39, P455, DOI 10.1016/j.ceca.2006.01.004; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123762	10.1371/journal.pone.0123762	http://dx.doi.org/10.1371/journal.pone.0123762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875358	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800115
J	Kim, SJ; Kim, K; Park, SB; Hong, DJ; Jhun, BW				Kim, Se Jin; Kim, Kang; Park, Sung Bum; Hong, Duck Jin; Jhun, Byung Woo			Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; IMMUNOCOMPETENT ADULTS; COMPUTATIONAL ANALYSIS; INFECTIONS	The benefits of treatment with antiviral therapy for severe adenovirus (AdV) pneumonia are not well established. We described the clinical characteristics and treatment outcomes of early cidofovir treatment of severe AdV pneumonia in non-immunocompromised patients. We retrospectively reviewed the medical records of all patients diagnosed with severe AdV pneumonia between 2012 and 2014. A total of seven non-immunocompromised patients with severe AdV pneumonia were identified, and all isolates typed (n = 6) were human AdV-B55. All patients had progressive respiratory failure with lobar consolidation with or without patchy ground glass opacity. Three patients required vasopressors and mechanical ventilation. All patients had abnormal laboratory findings including: leukopenia, thrombocytopenia, or elevated liver enzymes. After admission, all patients received antiviral therapy with cidofovir, and the median time from admission to cidofovir administration was 48 h and median the time from onset of symptoms to cidofovir administration was 7.1 days. After cidofovir administration, complete symptomatic improvement occurred after a median of 12 days and radiographic resolution occurred after a median of 21 days. Consequently, all patients completely improved without complications. Our data suggest that early administration of cidofovir in the course of treatment for respiratory failure as a result of AdV pneumonia in non-immunocompromised patients could be a treatment strategy worth considering, especially in cases of HAdV-55 infection.	[Kim, Se Jin; Kim, Kang; Park, Sung Bum; Jhun, Byung Woo] Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, Gyeonggi Provin, South Korea; [Hong, Duck Jin] Armed Forces Capital Hosp, Dept Lab Med, Songnam, Gyeonggi Provin, South Korea		Jhun, BW (corresponding author), Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, Gyeonggi Provin, South Korea.	byungwoo.jhun@gmail.com						Barker JH, 2003, CLIN INFECT DIS, V37, pE142, DOI 10.1086/379127; Brosch L, 2009, MIL MED, V174, P1295, DOI 10.7205/MILMED-D-03-0208; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Carballal Guadalupe, 2002, BMC Pediatr, V2, P6, DOI 10.1186/1471-2431-2-6; Claas ECJ, 2005, J CLIN MICROBIOL, V43, P1738, DOI 10.1128/JCM.43.4.1738-1744.2005; Clark Tristan W, 2011, J Med Case Rep, V5, P259, DOI 10.1186/1752-1947-5-259; Damen M, 2008, J CLIN MICROBIOL, V46, P3997, DOI 10.1128/JCM.00563-08; Doan ML, 2007, J HEART LUNG TRANSPL, V26, P883, DOI 10.1016/j.healun.2007.06.009; DUDDING BA, 1972, NEW ENGL J MED, V286, P1289, DOI 10.1056/NEJM197206152862403; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Hakim FA, 2008, EUR J CLIN MICROBIOL, V27, P153, DOI 10.1007/s10096-007-0416-z; Heo JY, 2014, EMERG INFECT DIS, V20, P875, DOI 10.3201/eid2005.131692; Hijikata N, 2012, J INFECT CHEMOTHER; Hindiyeh M, 2000, Semin Respir Infect, V15, P101; Jeon K, 2007, EUR J CLIN MICROBIOL, V26, P481, DOI 10.1007/s10096-007-0312-6; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Klinger JR, 1998, AM J RESP CRIT CARE, V157, P645, DOI 10.1164/ajrccm.157.2.9608057; LEVIN S, 1967, J AMER MED ASSOC, V201, P975; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Matsushima Y, 2012, EMERG INFECT DIS, V18, P846, DOI 10.3201/eid1805.111584; Mayeur N, 2012, HEART LUNG, V41, P401, DOI 10.1016/j.hrtlng.2011.09.006; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robinson CM, 2009, J VIROL, V83, P8980, DOI 10.1128/JVI.00786-09; Ryu JS, 2003, YONSEI MED J, V44, P732, DOI 10.3349/ymj.2003.44.4.732; Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b; Simsir A, 1998, TRANSPLANTATION, V65, P592, DOI 10.1097/00007890-199802270-00027; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Trei JS, 2010, EMERG INFECT DIS, V16, P769, DOI 10.3201/eid1605.091633; Vento TJ, 2011, J INFECT DIS, V203, P1388, DOI 10.1093/infdis/jir040; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Yang ZH, 2009, J CLIN MICROBIOL, V47, P3082, DOI 10.1128/JCM.00282-09	35	33	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122642	10.1371/journal.pone.0122642	http://dx.doi.org/10.1371/journal.pone.0122642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875735	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800069
J	Sankaranarayanan, P; Schomay, TE; Aiello, KA; Alter, O				Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly			Tensor GSVD of Patient- and Platform-Matched Tumor and Normal DNA Copy-Number Profiles Uncovers Chromosome Arm-Wide Patterns of Tumor-Exclusive Platform-Consistent Alterations Encoding for Cell Transformation and Predicting Ovarian Cancer Survival	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; PROGNOSTIC-FACTOR; EXPRESSION; APOPTOSIS; IDENTIFICATION; GLIOBLASTOMA; CHEMOTHERAPY; PROTEINS; SUBTYPE; TOOL	The number of large-scale high-dimensional datasets recording different aspects of a single disease is growing, accompanied by a need for frameworks that can create one coherent model from multiple tensors of matched columns, e.g., patients and platforms, but independent rows, e.g., probes. We define and prove the mathematical properties of a novel tensor generalized singular value decomposition (GSVD), which can simultaneously find the similarities and dissimilarities, i.e., patterns of varying relative significance, between any two such tensors. We demonstrate the tensor GSVD in comparative modeling of patient-and platform-matched but probe-independent ovarian serous cystadenocarcinoma (OV) tumor, mostly high-grade, and normal DNA copy-number profiles, across each chromosome arm, and combination of two arms, separately. The modeling uncovers previously unrecognized patterns of tumor-exclusive platform-consistent co-occurring copy-number alterations (CNAs). We find, first, and validate that each of the patterns across only 7p and Xq, and the combination of 6p+12p, is correlated with a patient's prognosis, is independent of the tumor's stage, the best predictor of OV survival to date, and together with stage makes a better predictor than stage alone. Second, these patterns include most known OV-associated CNAs that map to these chromosome arms, as well as several previously unreported, yet frequent focal CNAs. Third, differential mRNA, microRNA, and protein expression consistently map to the DNA CNAs. A coherent picture emerges for each pattern, suggesting roles for the CNAs in OV pathogenesis and personalized therapy. In 6p+12p, deletion of the p21-encoding CDKN1A and p38-encoding MAPK14 and amplification of RAD51AP1 and KRAS encode for human cell transformation, and are correlated with a cell's immortality, and a patient's shorter survival time. In 7p, RPA3 deletion and POLD2 amplification are correlated with DNA stability, and a longer survival. In Xq, PABPC5 deletion and BCAP31 amplification are correlated with a cellular immune response, and a longer survival.	[Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA; [Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Alter, O (corresponding author), Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA.	orly@sci.utah.edu		Alter, Orly/0000-0002-0418-1078	Utah Science, Technology, and Research (USTAR) Initiative; National Human Genome Research Institute (NHGRI) [HG-004302]; National Science Foundation (NSF) CAREER [DMS-0847173]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0847173] Funding Source: National Science Foundation	Utah Science, Technology, and Research (USTAR) Initiative; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the Utah Science, Technology, and Research (USTAR) Initiative, National Human Genome Research Institute (NHGRI) R01 Grant HG-004302 and National Science Foundation (NSF) CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed J, 2011, NUCLEIC ACIDS RES, V39, pD960, DOI 10.1093/nar/gkq910; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; BAI ZJ, 1993, SIAM J SCI COMPUT, V14, P1464, DOI 10.1137/0914085; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanco P, 2001, GENOMICS, V74, P1, DOI 10.1006/geno.2001.6530; Bourdon V, 2002, CANCER RES, V62, P6218; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; COX DR, 1972, J R STAT SOC B, V34, P187; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Duncan TJ, 2010, INT J GYNECOL PATHOL, V29, P8, DOI 10.1097/PGP.0b013e3181b64ec3; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Friedland S, 2005, SIAM J MATRIX ANAL A, V27, P434, DOI 10.1137/S0895479804439791; Golub G. H., 2012, MATRIX COMPUTATIONS; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn R. A., 2012, MATRIX ANAL; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; Kwon YH, 2003, J BIOL CHEM, V278, P30348, DOI 10.1074/jbc.M300996200; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; Lee LA, 2005, DEV CELL, V8, P435, DOI 10.1016/j.devcel.2004.12.008; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264; Ponnapalli SP, 2006, RES WORKSH ALG MOD M; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Prisco MG, 2012, HUM PATHOL, V43, P282, DOI 10.1016/j.humpath.2011.05.002; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Sibley CR, 2012, NUCLEIC ACIDS RES, V40, P438, DOI 10.1093/nar/gkr722; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Vandewalle J., 2003, P ECCTD 03 EUR C CIR, P389; VANLOAN C, 1985, NUMER MATH, V46, P479, DOI 10.1007/BF01389653; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; WALDMAN T, 1995, CANCER RES, V55, P5187; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020	61	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121396	10.1371/journal.pone.0121396	http://dx.doi.org/10.1371/journal.pone.0121396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875127	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800019
J	Saygin, ZM; Osher, DE; Koldewyn, K; Martin, RE; Finn, A; Saxe, R; Gabrieli, JDE; Sheridan, M				Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Martin, Rebecca E.; Finn, Amy; Saxe, Rebecca; Gabrieli, John D. E.; Sheridan, Margaret			Structural Connectivity of the Developing Human Amygdala	PLOS ONE			English	Article							PROBABILISTIC DIFFUSION TRACTOGRAPHY; STATE FUNCTIONAL CONNECTIVITY; INFANT RHESUS-MONKEYS; HUMAN CEREBRAL-CORTEX; HUMAN BRAIN; IN-VIVO; BASOLATERAL AMYGDALA; NEONATAL DEVELOPMENT; THALAMIC STRUCTURES; FACIAL EXPRESSIONS	A large corpus of research suggests that there are changes in the manner and degree to which the amygdala supports cognitive and emotional function across development. One possible basis for these developmental differences could be the maturation of amygdalar connections with the rest of the brain. Recent functional connectivity studies support this conclusion, but the structural connectivity of the developing amygdala and its different nuclei remains largely unstudied. We examined age related changes in the DWI connectivity fingerprints of the amygdala to the rest of the brain in 166 individuals of ages 5-30. We also developed a model to predict age based on individual-subject amygdala connectivity, and identified the connections that were most predictive of age. Finally, we segmented the amygdala into its four main nucleus groups, and examined the developmental changes in connectivity for each nucleus. We observed that with age, amygdalar connectivity becomes increasingly sparse and localized. Age related changes were largely localized to the subregions of the amygdala that are implicated in social inference and contextual memory (the basal and lateral nuclei). The central nucleus' connectivity also showed differences with age but these differences affected fewer target regions than the basal and lateral nuclei. The medial nucleus did not exhibit any age related changes. These findings demonstrate increasing specificity in the connectivity patterns of amygdalar nuclei across age.	[Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Martin, Rebecca E.; Finn, Amy; Saxe, Rebecca; Gabrieli, John D. E.; Sheridan, Margaret] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Osher, David E.] Boston Univ, Psychol & Brain Sci, Boston, MA 02215 USA; [Martin, Rebecca E.; Sheridan, Margaret] Boston Childrens Hosp, Labs Cognit Neurosci, Boston, MA USA; [Koldewyn, Kami] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Boston Children's Hospital; Bangor University	Saygin, ZM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zsaygin@mit.edu	Saygin, Zeynep M./AAV-4951-2020; Koldewyn, Kami/Q-6108-2019; Gabrieli, John/AAJ-2869-2020	Koldewyn, Kami/0000-0003-3588-6449; Sheridan, Margaret/0000-0002-8909-7501	Robert Wood Johnson Health and Society Scholars Program; Ellison Medical Foundation; Simons Foundation; Simons Center for the Social Brain at MIT; Poitras Center for Affective Disorders Research	Robert Wood Johnson Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Simons Foundation; Simons Center for the Social Brain at MIT; Poitras Center for Affective Disorders Research	This work was supported by funds from the Robert Wood Johnson Health and Society Scholars Program, the Ellison Medical Foundation, Simons Foundation and Simons Center for the Social Brain at MIT, and the Poitras Center for Affective Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bach DR, 2011, J NEUROSCI, V31, P618, DOI 10.1523/JNEUROSCI.2744-10.2011; BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bian XL, 2008, J NEUROPHYSIOL, V99, P77, DOI 10.1152/jn.00902.2007; Bouwmeester H, 2002, J COMP NEUROL, V450, P241, DOI 10.1002/cne.10321; Bouwmeester H, 2002, J COMP NEUROL, V442, P239, DOI 10.1002/cne.10084; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chareyron LJ, 2012, J COMP NEUROL, V520, P3745, DOI 10.1002/cne.23132; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freese J. L., 2009, HUMAN AMYGDALA, P3; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gloor P, 1997, THE TEMPORAL LOBE AN; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Jbabdi S, 2014, IMAGING STRUCTURE FU, P585; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; KALIN NH, 1991, CHILD DEV, V62, P1175, DOI 10.1111/j.1467-8624.1991.tb01598.x; Killgore WDS, 2006, NEUROREPORT, V17, P167, DOI 10.1097/01.wnr.0000198951.30939.73; Kirby E, 2012, MOL PSYCHIAT; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lonigan CJ, 2001, TEMPERAMENTAL INFLUE; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Malkova L, 2010, BEHAV NEUROSCI, V124, P742, DOI 10.1037/a0021622; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; O'Leary D D, 1992, Curr Opin Neurobiol, V2, P70, DOI 10.1016/0959-4388(92)90165-H; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Pine DS, 2007, J CHILD PSYCHOL PSYC, V48, P631, DOI 10.1111/j.1469-7610.2007.01751.x; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Qin S, 2012, PNAS; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; RODMAN HR, 1994, CEREB CORTEX, V4, P484, DOI 10.1093/cercor/4.5.484; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Scherf KS, 2013, HORM BEHAV, V64, P298, DOI 10.1016/j.yhbeh.2013.05.011; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shen K, 2012, J NEUROSCI, V32, P17465, DOI 10.1523/JNEUROSCI.2709-12.2012; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Sporns O, 2014, HUMAN CONNECTOME LIN, VSecond, P401; Swartz JR, 2014, NEUROIMAGE, V86, P212, DOI 10.1016/j.neuroimage.2013.08.018; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; THOMPSON CI, 1969, PHYSIOL BEHAV, V4, P249, DOI 10.1016/0031-9384(69)90088-2; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Essen D. C., 2014, DIFFUSION MRI, P337, DOI DOI 10.1016/B978-0-12-396460-1.00016-0; Vapnik V.N., 1995, NATURE STAT LEARNING; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WEBSTER MJ, 1991, J NEUROSCI, V11, P1095; Webster MJ, 1991, NEUROREPORT INT J RA; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	73	26	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125170	10.1371/journal.pone.0125170	http://dx.doi.org/10.1371/journal.pone.0125170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875758	Green Published, gold			2022-12-27	WOS:000353015800156
J	Jiang, YD; Thakran, S; Bheemreddy, R; Coppess, W; Walker, RJ; Steinle, JJ				Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Coppess, William; Walker, Robert J.; Steinle, Jena J.			Sodium Salicylate Reduced Insulin Resistance in the Retina of a Type 2 Diabetic Rat Model	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TNF-ALPHA; INDUCED APOPTOSIS; ADIPOSE-TISSUE; IKK-BETA; INHIBIT; SOCS-3; CELLS	Sodium salicylate has been reported to reduce markers of diabetic retinopathy in a type 1 rat model. Because rates of type 2 diabetes are on the rise, we wanted to determine whether salicylate could improve insulin resistance in a type 2 rat model, as well as improve retinal function. We treated lean and obese BBZDR/Wor type 2 diabetic rats with salicylate in their chow for 2 months. Prior to salicylate treatment, rats underwent an electroretinogram to measure retinal function. After 2 months of treatment, rats underwent an additional electroretinogram prior to sacrifice. In addition to the animal model, we also treated retinal endothelial cells (REC) and rat Muller cells with salicylate and performed the same analyses as done for the rat retinal lysates. To investigate the role of salicylate in insulin signaling, we measured TNF alpha and caspase 3 levels by ELISA, as well as performed Western blotting for insulin receptor substrate 1, insulin receptor, SOCS3, and pro- and anti-apoptotic markers. Data demonstrated that salicylate significantly improved retinal function, as well as reduced TNF alpha and SOCS3-induced insulin resistance in all samples. Overall, results suggest that salicylate is effective in reducing insulin resistance in the retina of type 2 diabetic rat models.	[Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Steinle, Jena J.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA; [Thakran, Shalini; Bheemreddy, Rajini; Coppess, William; Walker, Robert J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Jiang, Youde; Steinle, Jena J.] VA Med Ctr, Memphis, TN USA; [Walker, Robert J.] Philder Smith Coll, Little Rock, AR USA	Wayne State University; Wayne State University; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Steinle, JJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA.	jsteinle@med.wayne.edu		Steinle, Jena/0000-0002-7539-2892	National Eye Institute [R01EY022330]; VA Merit Award [IBX001585A, P30EY04068]; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); VA Merit Award(US Department of Veterans Affairs); Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Eye Institute (R01EY022330 to JJS); VA Merit Award IBX001585A (JJS), P30EY04068 (PI: Hazlett) and an Unrestricted Grant to the Department of Ophthalmology from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V43, P48, DOI 10.1016/j.freeradbiomed.2007.03.014; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feng H, 2010, NEUROSCI LETT, V479, P34, DOI 10.1016/j.neulet.2010.05.023; He B, 2010, DIABETES RES CLIN PR, V89, P150, DOI 10.1016/j.diabres.2010.04.004; Hu SS, 2014, INFLAMMATION, V37, P365, DOI 10.1007/s10753-013-9748-2; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Ismail WIW, 2013, J CELL BIOCHEM, V114, P1729, DOI 10.1002/jcb.24513; Ito I, 2006, INVEST OPHTH VIS SCI, V47, P683, DOI 10.1167/iovs.05-1012; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Jiang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070555; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2009, MOL VIS, V15, P1418; Klampfer L, 1999, BLOOD, V93, P2386, DOI 10.1182/blood.V93.7.2386.407k15_2386_2394; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lee EJ, 2003, INT J ONCOL, V23, P503; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Liu K, 2012, ATHEROSCLEROSIS, V223, P350, DOI 10.1016/j.atherosclerosis.2012.06.012; Madathil SK, 2013, SYNAPSE, V67, P502, DOI 10.1002/syn.21658; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Park E, 2007, J ENDOCRINOL, V195, P323, DOI 10.1677/JOE-07-0005; Park S, 2013, ARCH PHARM RES, V36, P880, DOI 10.1007/s12272-013-0116-4; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Thakur P, 2013, NEUROSCIENCE, V231, P420, DOI 10.1016/j.neuroscience.2012.11.006; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Walker RJ, 2012, MOL VIS, V18, P271; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P3052, DOI 10.1167/iovs.12-11533; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125505	10.1371/journal.pone.0125505	http://dx.doi.org/10.1371/journal.pone.0125505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874611	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700076
J	Murphy, K; O' Shea, CA; Ryan, CA; Dempsey, EM; O' Toole, PW; Stanton, C; Ross, RP				Murphy, Kiera; O' Shea, Carol Anne; Ryan, C. Anthony; Dempsey, Eugene M.; O' Toole, Paul W.; Stanton, Catherine; Ross, R. Paul			The Gut Microbiota Composition in Dichorionic Triplet Sets Suggests a Role for Host Genetic Factors	PLOS ONE			English	Article							EARLY-LIFE; ANTIBIOTICS; ASTHMA; GENERATION; DIVERSITY; EXPOSURE; HEALTH; RISK; TOOL	Monozygotic and dizygotic twin studies investigating the relative roles of host genetics and environmental factors in shaping gut microbiota composition have produced conflicting results. In this study, we investigated the gut microbiota composition of a healthy dichorionic triplet set. The dichorionic triplet set contained a pair of monozygotic twins and a fraternal sibling, with similar pre- and post-natal environmental conditions including feeding regime. V4 16S rRNA and rpoB amplicon pyrosequencing was employed to investigate microbiota composition, and the species and strain diversity of the culturable bifidobacterial population was also examined. At month 1, the monozygotic pair shared a similar microbiota distinct to the fraternal sibling. By month 12 however, the profile was more uniform between the three infants. Principal coordinate analysis (PCoA) of the microbiota composition revealed strong clustering of the monozygotic pair at month 1 and a separation of the fraternal infant. At months 2 and 3 the phylogenetic distance between the monozygotic pair and the fraternal sibling has greatly reduced and by month 12 the monozygotic pair no longer clustered separately from the fraternal infant. Pulse field gel electrophoresis (PFGE) analysis of the bifidobacterial population revealed a lack of strain diversity, with identical strains identified in all three infants at month 1 and 12. The microbiota of two antibiotic-treated dichorionic triplet sets was also investigated. Not surprisingly, in both triplet sets early life antibiotic administration appeared to be a major determinant of microbiota composition at month 1, irrespective of zygosity. By month 12, early antibiotic administration appeared to no longer exert such a strong influence on gut microbiota composition. We hypothesize that initially host genetics play a significant role in the composition of an individual's gut microbiota, unless an antibiotic intervention is given, but by month 12 environmental factors are the major determinant.	[Murphy, Kiera; Stanton, Catherine] Teagasc Food Res Ctr, Food Biosci Dept, Fermoy, Co Cork, Ireland; [Murphy, Kiera; O' Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O' Shea, Carol Anne; Ryan, C. Anthony; Dempsey, Eugene M.] Cork Univ, Dept Neonatol, Matern Hosp, Cork, Ireland; [O' Shea, Carol Anne; Ryan, C. Anthony; O' Toole, Paul W.; Stanton, Catherine; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Dempsey, Eugene M.] Natl Univ Ireland Univ Coll Cork, Infant Ctr, Cork, Ireland; [Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Coll Sci Engn & Food Sci, Cork, Ireland	Teagasc; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Ross, RP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	p.ross@ucc.ie	Dempsey, Eugene/AAG-3037-2021; Ross, Paul/A-7584-2015; O'Toole, Paul W/G-1593-2012; Stanton, Catherine/A-9549-2015; Dempsey, Eugene Michael/H-8051-2015	Ross, Paul/0000-0003-4876-8839; O'Toole, Paul W/0000-0001-5377-0824; Stanton, Catherine/0000-0002-6724-7011; Dempsey, Eugene Michael/0000-0002-6266-3462; Murphy, Kiera/0000-0002-6543-5158	INFANTMET project [10/RD/Infantmet/MFRC/705]; Government of Ireland's Department of Agriculture Fisheries; Alimentary Pharmabiotic Centre; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [02/CE/B124, 07/CE/B1368]	INFANTMET project; Government of Ireland's Department of Agriculture Fisheries; Alimentary Pharmabiotic Centre(Science Foundation Ireland); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This study was performed as part of the INFANTMET project (10/RD/Infantmet/MFRC/705) and was funded by the Government of Ireland's Department of Agriculture Fisheries and in part by Alimentary Pharmabiotic Centre. KM is a Teagasc Walsh Fellow. CS, RPR and PWOT are members of The Alimentary Pharmabiotic Centre, which is a Centre for Science and Technology (CSET) funded by the Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant no. 02/CE/B124 and 07/CE/B1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI [10.1126/scitranslmed.3008639, DOI 10.1126/SCITRANSLMED.3008639]; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121; Barrett E, 2014, ARCH DIS CHILD FETAL; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kim BJ, 2010, INT J SYST EVOL MICR, V60, P2697, DOI 10.1099/ijs.0.020339-0; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Lakshminarayanan B, 2013, J MED MICROBIOL, V62, P457, DOI 10.1099/jmm.0.052258-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marques TM, 2014, INNOV FOOD SCI EMERG, V22, P239, DOI 10.1016/j.ifset.2013.10.016; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Muc M, 2013, ADV EXP MED BIOL, V788, P393, DOI 10.1007/978-94-007-6627-3_53; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rodriguez JM, 2014, MICROBIAL ECOLOGY HL; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stewart CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073465; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2001, MICROBIAL ECOLOGY IN, V13	41	25	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122561	10.1371/journal.pone.0122561	http://dx.doi.org/10.1371/journal.pone.0122561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874766	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700020
J	Xu, CY; Zhu, SL; Xing, C; Li, DG; Zhu, NF; Zhou, HD				Xu, Changyan; Zhu, Sailing; Xing, Cheng; Li, Dagang; Zhu, Nanfeng; Zhou, Handong			Isolation and Properties of Cellulose Nanofibrils from Coconut Palm Petioles by Different Mechanical Process	PLOS ONE			English	Article							WHEAT-STRAW; EXTRACTION; FIBERS; NANOCRYSTALS; REINFORCEMENT; BEHAVIOR; RESIDUE	In this study, cellulose nanofibrils (CNFs) were successfully isolated from coconut palm petiole residues falling off naturally with chemical pretreatments and mechanical treatments by a grinder and a homogenizor. FTIR spectra analysis showed that most of hemicellulose and lignin were removed from the fiber after chemical pretreatments. The compositions of CNFS indicated that high purity of nanofibrils with cellulose contain more than 95% was obtained. X-ray diffractogram demonstrated that chemical pretreatments significantly increased the crystallinity of CNFs from 38.00% to 70.36%; however, 10-15 times of grinding operation followed by homogenizing treatment after the chemical pretreatments did not significantly improve the crystallinity of CNFs. On the contrary, further grinding operation could destroy crystalline regions of the cellulose. SEM image indicated that high quality of CNFs could be isolated from coconut palm petiole residues with chemical treatments in combination of 15 times of grinding followed by 10 times of homogenization and the aspect ratio of the obtained CNFs ranged from 320 to 640. The result of TGA-DTG revealed that the chemical-mechanical treatments improved thermal stability of fiber samples, and the CNFs with 15 grinding passing times had the best thermal stability. This work suggests that the CNFs can be successfully extracted from coconut palm petiole residues and it may be a potential feed-stock for nanofiber reinforced composites due to its high aspect ratio and crystallinity.	[Xu, Changyan; Zhu, Sailing; Li, Dagang; Zhu, Nanfeng; Zhou, Handong] Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China; [Xing, Cheng] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA	Nanjing Forestry University; Michigan State University	Zhou, HD (corresponding author), Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China.	changyanxu1999@163.com		Zhu, Sailing/0000-0002-9197-5641; Xu, Changyan/0000-0003-4370-9784	Education Department of Jiangsu Province; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents; National Natural Science Foundation of China [31300483]; Natural Science Foundation of Jiangsu Province of China [BK20130971]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD);  [2013102980182]	Education Department of Jiangsu Province; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 	The project name is Fabrication of Functional packaging nano materials from Coconut Palm Petioles, and the Project No. is 2013102980182 (http://www.ec.js.edu.cn/art/2013/9/25/art-4266-131624.html). CYX received funding from the Education Department of Jiangsu Province. This work was also financially supported by "Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents", "National Natural Science Foundation of China (Grant No. 31300483)", "Natural Science Foundation of Jiangsu Province of China (Grant No. BK20130971)" and "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9; Abraham E, 2013, CARBOHYD POLYM, V92, P1477, DOI 10.1016/j.carbpol.2012.10.056; Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029; Ashori A, 2006, POLYM-PLAST TECHNOL, V45, P131, DOI 10.1080/03602550500373782; Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864; Bledzki AK, 2010, COMPOS SCI TECHNOL, V70, P840, DOI 10.1016/j.compscitech.2010.01.022; Chirayil CJ, 2014, IND CROP PROD, V59, P27, DOI 10.1016/j.indcrop.2014.04.020; Dai DS, 2013, IND CROP PROD, V44, P192, DOI 10.1016/j.indcrop.2012.11.010; Fan YM, 2009, CARBOHYD POLYM, V77, P832, DOI 10.1016/j.carbpol.2009.03.008; Fengel D, 1984, WOOD CHEM ULTRASTRUC, V42, P314; Neto WPF, 2013, IND CROP PROD, V42, P480, DOI 10.1016/j.indcrop.2012.06.041; Hult EL, 2000, CELLULOSE, V7, P35, DOI 10.1023/A:1009236932134; Hult EL, 2001, POLYMER, V42, P3309, DOI 10.1016/S0032-3861(00)00774-6; Iwamoto S, 2007, APPL PHYS A-MATER, V89, P461, DOI 10.1007/s00339-007-4175-6; Johar N, 2012, IND CROP PROD, V37, P93, DOI 10.1016/j.indcrop.2011.12.016; Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018; Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078; Li Y, 2009, IND CROP PROD, V29, P420, DOI 10.1016/j.indcrop.2008.08.005; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; Maheswari CU, 2012, BIOMASS BIOENERG, V46, P555, DOI 10.1016/j.biombioe.2012.06.039; Manfredi LB, 2006, POLYM DEGRAD STABIL, V91, P255, DOI 10.1016/j.polymdegradstab.2005.05.003; Costa LMM, 2013, IND CROP PROD, V41, P198, DOI 10.1016/j.indcrop.2012.04.025; Monteiro SN, 2008, POLYM TEST, V27, P591, DOI 10.1016/j.polymertesting.2008.03.003; Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9; Mwaikambo LY, 2006, J MATER SCI, V41, P2483, DOI 10.1007/s10853-006-5098-x; NGUYEN T, 1981, J MACROMOL SCI R M C, VC20, P1; Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022; Ray D, 2002, J APPL POLYM SCI, V85, P2594, DOI 10.1002/app.10934; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Sabri M, 2013, ADV MATER RES-SWITZ, V795, P313, DOI 10.4028/www.scientific.net/AMR.795.313; Sain M, 2006, IND CROP PROD, V23, P1, DOI 10.1016/j.indcrop.2005.01.006; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Silva GG, 2000, J APPL POLYM SCI, V76, P1197, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1197::AID-APP23>3.0.CO;2-G; Silverio HA, 2013, IND CROP PROD, V44, P427, DOI 10.1016/j.indcrop.2012.10.014; Sun XF, 2005, CARBOHYD RES, V340, P97, DOI 10.1016/j.carres.2004.10.022; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Zhu SL, 2014, PACKAGING ENG, V35, P10; Zobel B, 1996, TAPPI J, V49, P383	39	47	49	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122123	10.1371/journal.pone.0122123	http://dx.doi.org/10.1371/journal.pone.0122123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875280	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700012
J	Ben Messaoud, N; Yue, JC; Valent, D; Katzarova, I; Lopez, JM				Ben Messaoud, Nabil; Yue, Jicheng; Valent, Daniel; Katzarova, Ilina; Lopez, Jose M.			Osmostress-Induced Apoptosis in Xenopus Oocytes: Role of Stress Protein Kinases, Calpains and Smac/DIABLO	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; CYTOCHROME-C; MITOCHONDRIAL RELEASE; HYPEROSMOTIC STRESS; NEURONAL APOPTOSIS; POTASSIUM CHANNELS; CELL-DEATH; ACTIVATION; INHIBITOR	Hyperosmotic shock induces cytochrome c release and capase-3 activation in Xenopus oo-cytes, but the regulators and signaling pathways involved are not well characterized. Here we show that hyperosmotic shock induces rapid calpain activation and high levels of Smac/DIABLO release from the mitochondria before significant amounts of cytochrome c are released to promote caspase-3 activation. Calpain inhibitors or EGTA microinjection delays osmostress-induced apoptosis, and blockage of Smac/DIABLO with antibodies markedly reduces cytochrome c release and caspase-3 activation. Hyperosmotic shock also activates the p38 and JNK signaling pathways very quickly. Simultaneous inhibition of both p38 and JNK pathways reduces osmostress-induced apoptosis, while sustained activation of these kinases accelerates the release of cytochrome c and caspase-3 activation. Therefore, at least four different pathways early induced by osmostress converge on the mitochondria to trigger apoptosis. Deciphering the mechanisms of hyperosmotic shock-induced apoptosis gives insight for potential treatments of human diseases that are caused by perturbations in fluid osmolarity.	[Ben Messaoud, Nabil; Yue, Jicheng; Valent, Daniel; Katzarova, Ilina; Lopez, Jose M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose/AAF-3798-2020; Lopez, Jose M/D-1654-2011	Lopez, Jose/0000-0002-4104-6262; Lopez, Jose M/0000-0002-4104-6262; Valent, Daniel/0000-0001-6927-3099	Spanish Ministerio de Economia y Competitividad [BFU2009-10765, BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (grant numbers BFU2009-10765 and BFU2010-15978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Brocker Chad, 2012, Biomol Concepts, V3, P345; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cortese JD, 1998, BIOCHEMISTRY-US, V37, P6402, DOI 10.1021/bi9730543; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DASCALU A, 1995, J PHYSIOL-LONDON, V486, P97, DOI 10.1113/jphysiol.1995.sp020793; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Erickson GR, 2001, J BIOMECH, V34, P1527, DOI 10.1016/S0021-9290(01)00156-7; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gorbenko GP, 1999, BBA-BIOMEMBRANES, V1420, P1, DOI 10.1016/S0005-2736(99)00082-6; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lang KS, 2004, CELL DEATH DIFFER, V11, P231, DOI 10.1038/sj.cdd.4401311; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Rudy A, 2008, CELL DEATH DIFFER, V15, P1930, DOI 10.1038/cdd.2008.125; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; Thomas D, 2001, J PHARMACOL EXP THER, V297, P753; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9	52	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124482	10.1371/journal.pone.0124482	http://dx.doi.org/10.1371/journal.pone.0124482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866890	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100262
J	Birle, A; Nebe, CT; Hill, S; Hartmann, K; Poeschl, J; Koch, L				Birle, Alexandra; Nebe, C. Thomas; Hill, Sandra; Hartmann, Karin; Poeschl, Johannes; Koch, Lutz			Neutrophil Chemotaxis in Cord Blood of Term and Preterm Neonates Is Reduced in Preterm Neonates and Influenced by the Mode of Delivery and Anaesthesia	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTE FUNCTION; LOCAL-ANESTHETICS; NEWBORN-INFANTS; SHAPE CHANGE; IN-VITRO; MIGRATION; ADHESION; CHEMOKINES; LIDOCAINE; INFECTION	Bacterial infections, even without any perinatal risk factors, are common in newborns, especially in preterm neonates. The aim of this study was to evaluate possible impairment of neutrophil chemotaxis in term and preterm neonates compared with adults as well as neonates with different modes of delivery and anaesthesia. We analysed the expression of the adhesion molecule L-Selectin as well as shape change, spontaneous and N-formylmethionyl-leucyl-phenylalanine (fMLP)-induced transmigration of neutrophils in a flow cytometric assay of chemotaxis after spontaneous delivery with Cesarian Section (CS) under spinal anaesthesia (mepivacaine, sufentanil), epidural anaesthesia (ropivacaine or bupivacaine, sufentanil) or general anaesthesia (ketamine, thiopental, succinylcholine). Chemokinesis was higher (p=0.008) in cord blood neutrophils than in the adult ones, whereas those could be more stimulated by fMLP (p=0.02). After vaginal delivery neutrophils showed a higher spontaneous and fMLP-stimulated chemotactic response compared to neonates after CS without labor. Comparing different types of anaesthesia for CS, spinal anaesthesia resulted in less impairment on chemotaxis than general anaesthesia or epidural anaesthesia. The new flow cytometric assay of neutrophil chemotaxis is an appropriate and objective method to analyse functional differences even in very small volumes of blood, essential in neonatology. Term neonates do not show reduced chemotaxis compared to adults. Preterm neonates present with reduced chemotaxis and chemokinesis, confirming the well known deficits in their neutrophil function. The side effects of maternal drugs on the neonatal immune system have to be considered especially when the immune response is already impaired, as in preterm infants.	[Birle, Alexandra; Hill, Sandra; Poeschl, Johannes; Koch, Lutz] Univ Childrens Hosp, Sch Med, Dept Neonatol, Heidelberg, Germany; [Nebe, C. Thomas; Hartmann, Karin] Hamatol Lab Mannheim, Mannheim, Germany; [Koch, Lutz] Catholic Childrens Hosp Wilhelmstift, Dept Neonatol, Hamburg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Birle, A (corresponding author), Univ Childrens Hosp, Sch Med, Dept Neonatol, Heidelberg, Germany.	alexandra.birle@gmail.com			Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1981, J CLIN INVEST, V68, P863, DOI 10.1172/JCI110341; Andrews WW, 2000, AM J PERINAT, V17, P357, DOI 10.1055/s-2000-13448; Baggiolini M, 1995, Clin Exp Immunol, V101 Suppl 1, P5; BEKTAS S, 1990, ACTA PAEDIATR SCAND, V79, P1031, DOI 10.1111/j.1651-2227.1990.tb11379.x; BUHRER C, 1994, PEDIATR RES, V36, P799; CARR R, 1992, ARCH DIS CHILD-FETAL, V67, P813, DOI 10.1136/adc.67.7_Spec_No.813; Cazzola G A, 1990, Pediatr Med Chir, V12, P25; Chen Wu-Yuan, 1996, Kaohsiung Journal of Medical Sciences, V12, P83; COLE AT, 1995, CLIN SCI, V89, P549, DOI 10.1042/cs0890549; De Amici D, 1990, MINERVA ANESTESIOL, V6, P175; Fischer LG, 2001, ANESTH ANALG, V92, P1041; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; FUENFER MM, 1987, PEDIATR RES, V22, P150, DOI 10.1203/00006450-198708000-00009; Gasparoni A, 1998, J CLIN IMMUNOL, V18, P210, DOI 10.1023/A:1020583022614; GASPARONI A, 1991, EUR J PEDIATR, V150, P481, DOI 10.1007/BF01958427; Gessler P, 1996, INTENS CARE MED, V22, P252, DOI 10.1007/BF01712246; HERSON VC, 1992, AM J PERINAT, V9, P285, DOI 10.1055/s-2007-994791; HILL HR, 1987, PEDIATR RES, V22, P375, DOI 10.1203/00006450-198710000-00001; HOGG N, 1992, IMMUNOL TODAY, V13, P113, DOI 10.1016/0167-5699(92)90103-E; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; KRAUSE PJ, 1989, PEDIATR RES, V25, P519, DOI 10.1203/00006450-198905000-00019; Mikawa K, 2003, EUR J ANAESTH, V20, P104, DOI 10.1097/00003643-200302000-00004; Nicholson GC, 2007, PULM PHARMACOL THER, V20, P52, DOI 10.1016/j.pupt.2005.11.009; SASAGAWA S, 1991, IMMUNOPHARM IMMUNOT, V13, P607, DOI 10.3109/08923979109019726; USMANI SS, 1991, PEDIATRICS, V87, P675; USMANI SS, 1993, PEDIATR RES, V33, P466, DOI 10.1203/00006450-199305000-00009; Yektaei-Karin E, 2007, PEDIAT ALLERG IMM-UK, V18, P643, DOI 10.1111/j.1399-3038.2007.00578.x; Zentay Z, 1999, PEDIATR RES, V46, P406, DOI 10.1203/00006450-199910000-00008	28	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120341	10.1371/journal.pone.0120341	http://dx.doi.org/10.1371/journal.pone.0120341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867529	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100022
J	Bussotti, S; Di Franco, A; Francour, P; Guidetti, P				Bussotti, Simona; Di Franco, Antonio; Francour, Patrice; Guidetti, Paolo			Fish Assemblages of Mediterranean Marine Caves	PLOS ONE			English	Article							DIDOGOBIUS-SPLECHTNAI; SOUTHERN APULIA; SUBMARINE CAVES; VISUAL CENSUS; ADRIATIC SEA; 1ST RECORDS; GOBIIDAE; PATTERNS; ECOLOGY	Fish assemblages associated with 14 marine caves and adjacent external rocky reefs were investigated at four Marine Protected Areas (MPAs) along the coasts of Italy. Within the caves sampling was carried out in different sub-habitats: walls, ceilings, bottoms and ends of caves. On the whole, 38 species were recorded inside the 14 caves investigated. Eighteen species were exclusively found inside the caves: they were mainly represented by speleophilic (i.e. species preferentially or exclusively inhabiting caves) gobids (e.g. Didogobius splechtnai) and nocturnal species (e.g. Conger conger). Forty-one species were censused outside, 20 of which were shared with cave habitats. Apogon imberbis was the most common fish found in all 14 caves investigated, followed by Thorogobius ephippiatus (recorded in 13 caves), and Diplodus vulgaris and Scorpaena notata (both censused in 12 caves). Distinct fish assemblages were found between external rocky reefs and the different cave subhabitats. New data on the distribution of some speleophilic gobids were collected, showing the existence of a pool of species shared by marine caves on a large scale (i.e. hundreds of km). Considering the uniqueness of cave fishes (18 exclusive species and different assemblage structures), the inclusion of marine caves among the habitats routinely investigated for fish biodiversity monitoring could facilitate the achievement of more comprehensive inventories. Due to their contribution to local species diversity and the shelter they provide to species valuable for conservation, marine caves should be prioritized for their inclusion not only within future MPAs through the Mediterranean Sea, but also into larger management spatial planning.	[Bussotti, Simona; Di Franco, Antonio; Francour, Patrice; Guidetti, Paolo] Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France; [Bussotti, Simona; Di Franco, Antonio; Guidetti, Paolo] CoNISMa Natl Interuniv Consortium Marine Sci, Rome, Italy	UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa	Bussotti, S (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France.	simonabussotti@libero.it	Di Franco, Antonio/A-8796-2010	Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy) [codice Habitat 8330]; TOTAL Foundation (France)	'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy); TOTAL Foundation (France)	The study was funded by the 'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy) in the framework of the project 'Studio degli ambienti di grotte marine sommerse (codice Habitat 8330) nelle Aree Marine Protette di Pelagie, Plemmirio e Capo Caccia' and by TOTAL Foundation (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; Abdulla A., 2008, STATUS MARINE PROTEC; Abel E. F., 1959, Pubblicazioni della Stazione Zoologica di Napoli Suppl, V30, P519; Ahnelt H., 2004, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V105B, P5; Ahnelt H, 1998, CYBIUM, V22, P183; Ahnelt H., 1996, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V98, P529; Ahnelt Harald, 1994, Cybium, V18, P169; Anderson M.J., 2008, GUIDE SOFTWARE STAT; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arko-Pijevac Milvana, 2001, Natura Croatica, V10, P163; Azzurro E, 2007, MAR BIOL, V151, P2245, DOI 10.1007/s00227-007-0661-9; Azzurro E, 2015, BIOL INVASIONS, V17, P815, DOI 10.1007/s10530-014-0836-5; Ballesteros E, 2007, PARQUE NACL ARCHIPIE, P140; BIANCHI CN, 1996, B MUS I BIOL U GEN, V60, P41; Bilecenoglu Murat, 1999, Zoology in the Middle East, V17, P67; BORI C, 1985, Miscellania Zoologica (Barcelona), V9, P401; Bussotti S, 2003, ITAL J ZOOL, V70, P153, DOI 10.1080/11250000309356509; Bussotti S, 2009, ESTUAR COAST SHELF S, V81, P65, DOI 10.1016/j.ecss.2008.09.023; Bussotti S, 2002, MAR ECOL-P S Z N I, V23, P11, DOI 10.1111/j.1439-0485.2002.tb00004.x; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Cicogna F., 2003, GROTTE MARINE CINQUA; Connell JH, 1961, ECOLOGY, V42, P315; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Di Franco A, 2010, ICES J MAR SCI, V67, P871, DOI 10.1093/icesjms/fsq007; Ferrari G, 2005, THAL SAL S, V29, P117; Francour Patrice, 2007, Rapport du Congress de la CIESM, V38, P478; Francour P, 2008, ACTA ICHTHYOL PISCAT, V38, P139, DOI 10.3750/AIP2008.38.2.09; Gerovasileiou V, 2013, MAR ECOL PROG SER, V486, P13, DOI 10.3354/meps10374; Gerovasileiou V., 2014, P 1 MED S CONS DARK, P45; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Giangrande A, 2004, BIODIVERS CONSERV, V13, P1633, DOI 10.1023/B:BIOC.0000029327.63397.6b; Gorley C.K., 2006, GETTING STARTED PRIM; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Guidetti P, 2014, VIE MILIEU, V64, P1; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti Paolo, 2006, Thalassia Salentina, V29, P41; HARMELIN JG, 1985, TETHYS, V11, P214; Harmelin JG, 2003, SCI REP PORT CROS NA, V19, P117; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Herler J, 1999, MAR ECOL-P S Z N I, V20, P49, DOI 10.1046/j.1439-0485.1999.00062.x; Herler J, 2002, CYBIUM, V26, P153; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KOTRSCHAL K, 1983, PUBBLICAZIONI STAZIO, V4, P275; Kovacic M, 1999, NAT CROAT, V6, P1; Kovacic Marcelo, 1997, Natura Croatica, V6, P423; La Mesa G, 2013, ITAL J ZOOL, V80, P90, DOI 10.1080/11250003.2012.686523; Leonardi R., 1994, B SEDUTE ACCADEMIA G, V27, P599; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Muths D, 2015, J SEA RES, V95, P70, DOI 10.1016/j.seares.2014.10.009; Oertel A, 2007, MAR ECOL-EVOL PERSP, V28, P60, DOI 10.1111/j.1439-0485.2007.00169.x; Otero M., 2013, MONITORING MARINE IN; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Patzner RA, 1999, ENVIRON BIOL FISH, V55, P207, DOI 10.1023/A:1007535808710; RIEDL R, 1966, BIOL MEERESHOHLEN; Scsepka Sonja, 1999, Senckenbergiana Biologica, V79, P71; Stefanni S, 1999, CYBIUM, V23, P105; Suric M, 2010, ENVIRON EARTH SCI, V61, P1473, DOI 10.1007/s12665-010-0463-0; Todaro MA, 2006, MAR BIOL, V149, P1079, DOI 10.1007/s00227-006-0299-z; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, P524; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zander C.D., 1990, MEMORIES BIOSPEOLOGI, V17, P17	64	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122632	10.1371/journal.pone.0122632	http://dx.doi.org/10.1371/journal.pone.0122632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875504	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100089
J	Gao, Y; Su, QD; Yi, Y; Jia, ZY; Wang, H; Lu, XX; Qiu, F; Bi, SL				Gao, Yan; Su, Qiudong; Yi, Yao; Jia, Zhiyuan; Wang, Hao; Lu, Xuexin; Qiu, Feng; Bi, Shengli			Enhanced Mucosal Immune Responses Induced by a Combined Candidate Mucosal Vaccine Based on Hepatitis A Virus and Hepatitis E Virus Structural Proteins Linked to Tuftsin	PLOS ONE			English	Article							B VACCINE; IMMUNOGENICITY; EXPRESSION; OLIGODEOXYNUCLEOTIDE	Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are the most common causes of infectious hepatitis. These viruses are spread largely by the fecal-oral route and lead to clinically important disease in developing countries. To evaluate the potential of targeting hepatitis A and E infection simultaneously, a combined mucosal candidate vaccine was developed with the partial open reading frame 2 (ORF2) sequence (aa 368-607) of HEV (HE-ORF2) and partial virus protein 1 (VP1) sequence (aa 1-198) of HAV (HA-VP1), which included the viral neutralization epitopes. Tuftsin is an immunostimulatory peptide which can enhance the immunogenicity of a protein by targeting it to macrophages and dendritic cells. Here, we developed a novel combined protein vaccine by conjugating tuftsin to HE-ORF2 and HA-VP1 and used synthetic CpG oligodeoxynucleotides (ODNs) as the adjuvant. Subsequent experiments in BALB/c mice demonstrated that tuftsin enhanced the serum-specific IgG and IgA antibodies against HEV and HAV at the intestinal, vaginal and pulmonary interface when delivered intranasally. Moreover, mice from the intranasally immunized tuftsin group (HE-ORF2-tuftsin + HA-VP1-tuftsin + CpG) showed higher levels of IFN-gamma-secreting splenocytes (Th1 response) and ratio of CD4(+)/CD8(+) T cells than those of the no-tuftsin group (HE-ORF2 + HA-VP1 + CpG). Thus, the tuftsin group generated stronger humoral and cellular immune responses compared with the no-tuftsin group. Moreover, enhanced responses to the combined protein vaccine were obtained by intranasal immunization compared with intramuscular injection. By integrating HE-ORF2, HA-VP1 and tuftsin in a vaccine, this study validated an important concept for further development of a combined mucosal vaccine against hepatitis A and E infection.	[Gao, Yan; Su, Qiudong; Yi, Yao; Jia, Zhiyuan; Wang, Hao; Lu, Xuexin; Qiu, Feng; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shengli_bi@163.com		Wang, Hao/0000-0001-9425-4666; Bi, Shengli/0000-0002-0380-5790	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention [2012ZX10002-001]	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention	This study was supported by a grant from the Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention (2012ZX10002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, HEPATOL INT, V2, P308, DOI 10.1007/s12072-008-9071-4; Beloeil L, 2003, J IMMUNOL, V171, P2995, DOI 10.4049/jimmunol.171.6.2995; CANTOR H, 1976, COLD SPRING HARB SYM, V41, P23; Demicheli V, 2003, VACCINE, V21, P2242, DOI 10.1016/S0264-410X(03)00135-X; Du L N, 1998, Sheng Li Xue Bao, V50, P636; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Gokulan K, 1999, DNA CELL BIOL, V18, P623, DOI 10.1089/104454999315033; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165; Kolomin T, 2014, MOL IMMUNOL, V58, P50, DOI 10.1016/j.molimm.2013.11.002; Kui X, 2009, VIRAL IMMUNOL, V22, P49, DOI 10.1089/vim.2008.0068; Lee JM, 2009, BIOTECHNOL APPL BIOC, V53, P101, DOI 10.1042/BA20080019; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Liu XY, 2012, VACCINE, V30, P6527, DOI 10.1016/j.vaccine.2012.08.054; Mezo G, 2004, BIOPOLYMERS, V73, P645, DOI 10.1002/bip.20024; MILLER MJ, 1993, CLIN INFECT DIS, V16, P612, DOI 10.1093/clind/16.5.612; Mitchell LA, 2006, VACCINE, V24, P5300, DOI 10.1016/j.vaccine.2006.04.015; NISHIOKA K, 1973, BIOCHIM BIOPHYS ACTA, V310, P230, DOI 10.1016/0005-2795(73)90025-1; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Roberton D, 2005, VACCINE, V23, P5099, DOI 10.1016/j.vaccine.2005.06.003; Lay LDLAR, 2008, J MED VIROL, V80, P798, DOI 10.1002/jmv.21147; Siemion IZ, 1999, PEPTIDES, V20, P645, DOI 10.1016/S0196-9781(99)00019-4; STAPLETON JT, 1991, J INFECT DIS, V163, P7, DOI 10.1093/infdis/163.1.7; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Warren TL, 2000, J IMMUNOL, V165, P6244, DOI 10.4049/jimmunol.165.11.6244; Wolters B, 2003, VACCINE, V21, P3623, DOI 10.1016/S0264-410X(03)00399-2; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	30	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123400	10.1371/journal.pone.0123400	http://dx.doi.org/10.1371/journal.pone.0123400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875115	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100174
J	Guaraldi, G; Zona, S; Brothers, TD; Carli, F; Stentarelli, C; Dolci, G; Santoro, A; Beghetto, B; Menozzi, M; Mussini, C; Falutz, J				Guaraldi, Giovanni; Zona, Stefano; Brothers, Thomas D.; Carli, Federica; Stentarelli, Chiara; Dolci, Giovanni; Santoro, Antonella; Beghetto, Barbara; Menozzi, Marianna; Mussini, Cristina; Falutz, Julian			Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles	PLOS ONE			English	Article							IMPROVEMENT GROUP INTERVENTION; INFECTED PERSONS; LIFE EXPECTANCY; ADULTS; PREVALENCE; PEOPLE; RISK; MEN; ERA	Objective People aging with HIV might have different health conditions compared with people who seroconverted at older ages. The study objective was to assess the prevalence of, and risk factors for, individual co-morbidities and multimorbidity (MM) between HIV-positive patients with a longer duration of HIV infection, and patients who seroconverted at an older age. We compared estimates across both groups to a matched community-based cohort sampled from the general population. Methods We performed a case-control study including antiretroviral therapy (ART)-experienced patients who were HIV seropositive for >= 20.6 years ("HIV-Aging"), or who were seropositive for < 11.3 years ("HIV-Aged") having access in 2013 at the Modena HIV Metabolic Clinic. Patients were matched in a 1:3 ratio with controls from the CINECA ARNO database. MM was defined as the concurrent presence of >2 NICM. Logistic regression models were constructed to evaluate associated predictors of NICM and MM. Results We analysed 404 HIV-Aging and 404 HIV-Aged participants in comparison to 2424 controls. The mean age was 46.7 +/- 6.2 years, 28.9% were women. Prevalence of HIV co-morbidities and MM were significantly higher in the HIV-positive groups compared to the general population (p<0.001) and a trend towards higher rates of MM was found in aging vs aged group. This difference turned to be significant in patients above the age of 45 years old (p<0.001). Conclusions People aging with HIV display heterogeneous health conditions. Host factors and duration of HIV infection are associated with increased risk of MM compared to the general population.	[Guaraldi, Giovanni; Zona, Stefano; Carli, Federica; Stentarelli, Chiara; Dolci, Giovanni; Santoro, Antonella; Beghetto, Barbara; Menozzi, Marianna; Mussini, Cristina] Univ Modena & Reggio Emilia, Modena, Italy; [Brothers, Thomas D.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Falutz, Julian] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Universita di Modena e Reggio Emilia; Dalhousie University; McGill University	Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Modena, Italy.	g.guaraldi@unimo.it	Guaraldi, Giovanni/J-9467-2018; Mussini, Cristina/K-8672-2016; Brothers, Thomas/ABH-5700-2020	Mussini, Cristina/0000-0002-6615-4198; Brothers, Thomas/0000-0002-5570-5556; Guaraldi, Giovanni/0000-0002-5724-3914; Dolci, Giovanni/0000-0001-9948-652X; Zona, Stefano/0000-0003-3451-2744; Santoro, Antonella/0000-0002-2345-9135	Canadian Institutes of Health Research Summer Research Studentship; European Union [305522]	Canadian Institutes of Health Research Summer Research Studentship(Canadian Institutes of Health Research (CIHR)); European Union(European Commission)	Thomas Brothers was supported by Canadian Institutes of Health Research Summer Research Studentship. Giovanni Guaraldi was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Centers for Disease Control and Prevention (CDC), 2008, HIV AIDS PERS AG 50; Chambers LA, 2014, AIDS BEHAV, V18, P661, DOI 10.1007/s10461-013-0627-5; Cooperman NA, 2007, AIDS EDUC PREV, V19, P321, DOI 10.1521/aeap.2007.19.4.321; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Guaraldi G, 2006, HIV CLIN TRIALS, V7, P97, DOI 10.1310/EYWJ-8B5K-X7VQ-9CPE; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2014, JAIDS-J ACQ IMM DEF, V65, P175, DOI 10.1097/QAI.0000000000000018; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Heckman TG, 2001, AIDS CARE, V13, P129, DOI 10.1080/09540120020018233; Heckman TG, 2006, ANN BEHAV MED, V32, P27, DOI 10.1207/s15324796abm3201_4; Heckman TG, 2011, J BEHAV MED, V34, P102, DOI 10.1007/s10865-010-9292-6; Krentz HB, 2015, HIV MED, V16, P38, DOI 10.1111/hiv.12176; Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x; Levett T, 2014, REV CLIN GERONTOL, V24, P10, DOI 10.1017/S0959259813000208; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Neundorfer M. M., 2004, Journal of HIV/AIDS & Social Services, V3, P79, DOI 10.1300/J187v03n01_07; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701	24	67	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118531	10.1371/journal.pone.0118531	http://dx.doi.org/10.1371/journal.pone.0118531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874806	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100008
J	Guo, Y; Yan, KP; Qu, Q; Qu, J; Chen, ZG; Song, T; Luo, XY; Sun, ZY; Bi, CL; Liu, JF				Guo, Yong; Yan, Kui Po; Qu, Qiang; Qu, Jian; Chen, Zi Gui; Song, Tao; Luo, Xiang-Ying; Sun, Zhong-Yi; Bi, Chang-Long; Liu, Jin-Fang			Common Variants of KCNJ10 Are Associated with Susceptibility and Anti-Epileptic Drug Resistance in Chinese Genetic Generalized Epilepsies	PLOS ONE			English	Article							RECTIFYING K+ CHANNEL; SENSORINEURAL DEAFNESS; SEIZURE SUSCEPTIBILITY; POLYMORPHISMS; ATAXIA; TUBULOPATHY; MUTATIONS; KIR4.1; ABCC2	To explore genetic mechanism of genetic generalized epilepsies (GGEs) is challenging because of their complex heritance pattern and genetic heterogeneity. KCNJ10 gene encodes Kir4.1 channels and plays a major role in modulating resting membrane potentials in excitable cells. It may cause GGEs if mutated. The purpose of this study was to investigate the possible association between KCNJ10 common variants and the susceptibility and drug resistance of GGEs in Chinese population. The allele-specific MALDI-TOF mass spectrometry method was used to assess 8 single nucleotide polymorphisms (SNPs) of KCNJ10 in 284 healthy controls and 483 Chinese GGEs patients including 279 anti-epileptic drug responsive patients and 204 drug resistant patients. We found the rs6690889 TC+TT genotypes were lower frequency in the GGEs group than that in the healthy controls (6.7% vs 9.5%, p = 0.01, OR = 0.50[0.29-0.86]). The frequency of rs1053074 G allele was lower in the childhood absence epilepsy (CAE) group than that in the healthy controls (28.4% vs 36.2%, p = 0.01, OR = 0.70[0.53-0.93]). The frequency of rs12729701 G allele and AG+GG genotypes was lower in the CAE group than that in the healthy controls (21.2% vs 28.4%, p = 0.01, OR = 0.74[0.59-0.94] and 36.3% vs 48.1%, p = 0.01, OR = 0.83[0.72-0.96], respectively). The frequency of rs12402969 C allele and the CC+CT genotypes were higher in the GGEs drug responsive patients than that in the drug resistant patients (9.3% vs 5.6%, OR = 1.73[1.06-2.85], p = 0.026 and 36.3% vs 48.1%, p = 0.01, OR = 0.83[0.72-0.96], respectively). This study identifies potential SNPs of KCNJ10 gene that may contribute to seizure susceptibility and anti-epileptic drug resistance.	[Guo, Yong; Chen, Zi Gui; Song, Tao; Luo, Xiang-Ying; Sun, Zhong-Yi; Bi, Chang-Long; Liu, Jin-Fang] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China; [Yan, Kui Po] Henan Collede TCM, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450008, Peoples R China; [Qu, Qiang] Cent South Univ, Xiangya Hosp, Dept Pharmacol, Changsha 410008, Hunan, Peoples R China; [Qu, Jian] Cent South Univ, Inst Clin Pharmacol, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University	Liu, JF (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China.	1612455489@qq.com			Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C [CX2011B056]; Hunan Provincial Innovation Foundation for Postgraduates [CX2013B102]	Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C; Hunan Provincial Innovation Foundation for Postgraduates	This study was supported by grants from the Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C (CX2011B056) and the Hunan Provincial Innovation Foundation for Postgraduates (CX2013B102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Dai AI, 2014, J CHILD NEUROLOGY; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Greenberg DA, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02734.x; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Kwan P, 2011, PHARMACOGENOMICS, V12, P319, DOI [10.2217/pgs.10.183, 10.2217/PGS.10.183]; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Lucarini N, 2007, PEDIATR NEUROL, V37, P157, DOI 10.1016/j.pediatrneurol.2007.06.001; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nagao Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00104; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Phani NM, 2014, GENE, V536, P247, DOI 10.1016/j.gene.2013.12.026; Qu J, 2012, CNS NEUROSCI THER, V18, P647, DOI 10.1111/j.1755-5949.2012.00336.x; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Shang LJ, 2005, MOL BRAIN RES, V139, P178, DOI 10.1016/j.molbrainres.2005.05.003; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; Tan NCK, 2010, EPILEPSIA, V51, P686, DOI 10.1111/j.1528-1167.2009.02423.x; Weber YG, 2008, DEV MED CHILD NEUROL, V50, P648, DOI 10.1111/j.1469-8749.2008.03058.x	31	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124896	10.1371/journal.pone.0124896	http://dx.doi.org/10.1371/journal.pone.0124896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874548	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100281
J	Lee, MJ; Chen, CJ; Lee, KT; Shi, HY				Lee, Ming-Jang; Chen, Chao-Ju; Lee, King-Teh; Shi, Hon-Yi			Trend Analysis and Outcome Prediction in Mechanically Ventilated Patients: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE	Objective To investigate the relationship between changes in patient attributes and hospital attributes over time and to explore predictors of medical utilization and mortality rates in mechanical ventilation (MV) patients in Taiwan. Background Providing effective medical care for MV patients is challenging and requires good planning and effective clinical decision making policies. Most studies of MV, however, have only analyzed a single regional ventilator weaning center or respiratory care unit, high-quality population-based studies of MV trends and outcomes are scarce. Methods This population-based cohort study retrospectively analyzed 213,945 MV patients treated during 2004-2009. Results During the study period, the percentages of MV patients with the following characteristics significantly increased: age. 65 years, treatment at a medical center, and treatment by a high-volume physician. In contrast, the percentages of MV patients treated at local hospitals and by low-volume physicians significantly decreased (P<0.001). Age, gender, Deyo-Charlson co-morbidity index, teaching hospital, hospital level, hospital volume, and physician volume were significantly associated with MV outcome (P<0.001). Over the 6-year period analyzed in this study, the estimated mean hospital treatment cost increased 48.8% whereas mean length of stay decreased 13.9%. The estimated mean overall survival time for MV patients was 16.4 months (SD 0.4 months), and the overall in-hospital 1-, 3-, and 5year survival rates were 61.0%, 36.7%, 17.3%, and 9.6%, respectively. Conclusions These population-based data revealed increases in the percentages of MV patients treated at medical centers and by high-volume physicians, especially in younger patients. Notably, although LOS for MV patients decreased, hospital treatment costs increased. Healthcare providers and patients should recognize that attributes of both the patient and the hospital may affect outcomes.	[Lee, Ming-Jang] Madou Sin Lau Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Chao-Ju] Madou Sin Lau Hosp, Dept Resp Therepy, Tainan, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Pancreat Surg, Kaohsiung, Taiwan; [Lee, King-Teh; Shi, Hon-Yi] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	hshi@kmu.edu.tw						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Batzlaff CM, 2014, MAYO CLIN PROC, V89, P638, DOI 10.1016/j.mayocp.2013.12.004; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Chao CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050675; Chen CJ, 2013, AM J CRIT CARE, V22, P506, DOI 10.4037/ajcc2013950; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fieselmann JF, 1999, CRIT CARE, V3, P23, DOI 10.1186/cc303; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hung TC, 2013, RESP CARE, V58, P669, DOI 10.4187/respcare.01519; Ko HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083298; Lai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073743; Leyenaar JK, 2014, JAMA PEDIATR, V168, P829, DOI 10.1001/jamapediatrics.2014.339; Limsuwat C, 2014, QUAL MANAG HEALTH CA, V23, P86, DOI 10.1097/QMH.0000000000000024; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190; O'Connor H, 2014, J INTENSIVE CARE MED, V29, P218, DOI 10.1177/0885066613486738; Reineck LA, 2014, CRIT CARE MED, V42, P1055, DOI 10.1097/CCM.0000000000000132; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122618	10.1371/journal.pone.0122618	http://dx.doi.org/10.1371/journal.pone.0122618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875442	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100088
J	Sapmak, A; Boyce, KJ; Andrianopoulos, A; Vanittanakom, N				Sapmak, Ariya; Boyce, Kylie J.; Andrianopoulos, Alex; Vanittanakom, Nongnuch			The pbrB Gene Encodes a Laccase Required for DHN-Melanin Synthesis in Conidia of Talaromyces (Penicillium) marneffei	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BIOSYNTHESIS; OXIDASE; TRICYCLAZOLE; INFECTION; PATHWAY; DOPA	Talaromyces marneffei (Basionym: Penicillium marneffei) is a significant opportunistic fungal pathogen in patients infected with human immunodeficiency virus in Southeast Asia. T. marneffei cells have been shown to become melanized in vivo. Melanins are pigment biopolymers which act as a non-specific protectant against various stressors and which play an important role during virulence in fungi. The synthesis of the two most commonly found melanins in fungi, the eumelanin DOPA-melanin and the allomelanin DHN-melanin, requires the action of laccase enzymes. The T. marneffei genome encodes a number of lac-cases and this study describes the characterization of one of these, pbrB, during growth and development. A strain carrying a PbrB-GFP fusion shows that pbrB is expressed at high levels during asexual development (conidiation) but not in cells growing vegetatively. The pbrB gene is required for the synthesis of DHN-melanin in conidia and when deleted results in brown pigmented conidia, in contrast to the green conidia of the wild type.	[Sapmak, Ariya; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Boyce, Kylie J.; Andrianopoulos, Alex] Univ Melbourne, Fac Sci, Dept Genet, Melbourne, Vic 3010, Australia	Chiang Mai University; University of Melbourne	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	drnongnuch@gmail.com		Boyce, Kylie J./0000-0002-7167-5414	Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund [PHD/0024/2549]; National Research University Project of the Thai Ministry of Education; National Health and Medical Research Council of Australia [566926]	Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund; National Research University Project of the Thai Ministry of Education; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund (Grant no. PHD/0024/2549; http://www.trf.or.th/), the National Research University Project of the Thai Ministry of Education (http://www.inter.mua.go.th/main2/index.php), and the National Health and Medical Research Council of Australia (Grant no. 566926; http://www.nhmrc.gov.au/). All funders supported in the study design, experiments, and publication.	Andrianopoulos A, 2002, INT J MED MICROBIOL, V292, P331, DOI 10.1078/1438-4221-00217; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Borneman AR, 2002, MOL MICROBIOL, V44, P621, DOI 10.1046/j.1365-2958.2002.02906.x; Borneman AR, 2001, GENETICS, V157, P1003; Boyce KJ, 2012, FUNGAL GENET REP, V59, P1, DOI DOI 10.4148/1941-4765.1009; Bugeja HE, 2012, FUNGAL BIOL-UK, V116, P145, DOI 10.1016/j.funbio.2011.10.009; Canovas D, 2011, EUKARYOT CELL, V10, P302, DOI 10.1128/EC.00201-10; Cooper CR, 2008, FUTURE MICROBIOL, V3, P43, DOI 10.2217/17460913.3.1.43; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Kanjanahaluethai A, 2007, VIROLOGY, V361, P391, DOI 10.1016/j.virol.2006.12.009; Kawamura C, 1997, MOL PLANT MICROBE IN, V10, P446, DOI 10.1094/MPMI.1997.10.4.446; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Kurahashi Y, 2001, MOL BIOL REP, V37, P3583, DOI [10.1007/s11033-010-0007-4, DOI 10.1007/S11033-010-0007-4]; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lee JK, 2003, APPL ENVIRON MICROB, V69, P3427, DOI 10.1128/AEM.69.6.3427-3434.2003; Lee PPW, 2012, CLIN INFECT DIS, V54, pe8, DOI 10.1093/cid/cir754; Liu DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092610; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; MAYORGA ME, 1990, GENETICS, V126, P73; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; OHARA EB, 1989, GENETICS, V121, P249; Pal AK, 2014, MED MYCOL, V52, P10, DOI 10.3109/13693786.2013.826879; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Sugareva V, 2006, ARCH MICROBIOL, V186, P345, DOI 10.1007/s00203-006-0144-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thirach S., 2008, Journal of Infectious Diseases and Antimicrobial Agents, V25, P81; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; TOKOUSBALIDES MC, 1979, PESTIC BIOCHEM PHYS, V11, P64, DOI 10.1016/0048-3575(79)90048-8; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom N, 2002, J CLIN MICROBIOL, V40, P1739, DOI 10.1128/JCM.40.5.1739-1742.2002; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; WHEELER MH, 1995, PESTIC BIOCHEM PHYS, V52, P125, DOI 10.1006/pest.1995.1037; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0	50	26	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122728	10.1371/journal.pone.0122728	http://dx.doi.org/10.1371/journal.pone.0122728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866870	gold, Green Published			2022-12-27	WOS:000352845100096
J	Vukic, M; Neme, A; Seuter, S; Saksa, N; de Mello, VDF; Nurmi, T; Uusitupa, M; Tuomainen, TP; Virtanen, JK; Carlberg, C				Vukic, Maja; Neme, Antonio; Seuter, Sabine; Saksa, Noora; de Mello, Vanessa D. F.; Nurmi, Tarja; Uusitupa, Matti; Tuomainen, Tomi-Pekka; Virtanen, Jyrki K.; Carlberg, Carsten			Relevance of Vitamin D Receptor Target Genes for Monitoring the Vitamin D Responsiveness of Primary Human Cells	PLOS ONE			English	Article							25-HYDROXYVITAMIN-D; D-3	Vitamin D-3 has transcriptome- and genome-wide effects and activates, via the binding of its metabolite 1 alpha, 25-dihydroxyvitamin D-3 to the transcription factor vitamin D receptor (VDR), several hundred target genes. Using samples from a 5-month vitamin D-3 intervention study (VitDmet), we recently reported that the expression of 12 VDR target genes in peripheral blood mononuclear cells (PBMCs) as well as 12 biochemical and clinical parameters of the study participants are significantly triggered by vitamin D-3. In this study, we performed a more focused selection of further 12 VDR target genes and demonstrated that changes of their mRNA expression in PBMCs of VitDmet subjects significantly correlate with alterations of 25-hydroxyvitamin D-3 serum levels. Network and self-organizing map analysis of these datasets together with that of the other 24 parameters was followed by relevance calculations and identified changes in parathyroid hormone serum levels and the expression of the newly selected genes STS, BCL6, ITGAM, LRRC25, LPGAT1 and TREM1 as well as of the previously reported genes DUSP10 and CD14 as the most relevant parameters for describing vitamin D responsiveness in vivo. Moreover, parameter relevance ranking allowed the segregation of study subjects into high and low responders. Due to the long intervention period the vitamin D response was not too prominent on the level of transcriptional activation. Therefore, we performed in the separate VitDbol trial a short-term but high dose stimulation with a vitamin D-3 bolus. In PBMCs of VitDbol subjects we observed direct transcriptional effects on the selected VDR target genes, such as an up to 2.1-fold increase already one day after supplementation onset. In conclusion, both long-term and short-term vitamin D-3 supplementation studies allow monitoring the vitamin D responsiveness of human individuals and represent new types of human in vivo vitamin D-3 investigations.	[Vukic, Maja; Neme, Antonio; Seuter, Sabine; Saksa, Noora; Carlberg, Carsten] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland; [de Mello, Vanessa D. F.; Nurmi, Tarja; Uusitupa, Matti; Tuomainen, Tomi-Pekka; Virtanen, Jyrki K.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland.	carsten.carlberg@uef.fi	Carlberg, Carsten/C-9075-2011; Virtanen, Jyrki/G-5149-2013; Virtanen, Jyrki/AAC-8945-2020; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Neme, Antonio/A-8999-2018	Carlberg, Carsten/0000-0003-2633-0684; Virtanen, Jyrki/0000-0002-0648-999X; Virtanen, Jyrki/0000-0002-0648-999X; Neme, Antonio/0000-0002-9952-1943; de Mello, Vanessa/0000-0003-3414-6983	Academy of Finland [267067, 137826]; Juselius Foundation; Diabetes Research Foundation	Academy of Finland(Academy of Finland); Juselius Foundation; Diabetes Research Foundation	This work was supported by the Academy of Finland (grant No. 267067 to C.C. and 137826 for the VitDmet study), the Juselius Foundation, and the Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Campbell MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00181; Carlberg C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00167; Carlberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071042; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nurmi T, 2013, ANAL BIOCHEM, V435, P1, DOI 10.1016/j.ab.2012.12.010; Nurminen V, 2014, BIOCH BIOPHYS ACTA; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Saksa N, 2014, J STEROID BIOCH MOL; Seuter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096184; Seuter S, 2013, BBA-GENE REGUL MECH, V1829, P1266, DOI 10.1016/j.bbagrm.2013.10.003; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TUOMAINEN TP, 2014, GLUCOSE METABO UNPUB; Tuoresmaki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096105; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilfinger J, 2014, J NUTR BIOCHEM, V25, P875, DOI 10.1016/j.jnutbio.2014.04.002	36	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124339	10.1371/journal.pone.0124339	http://dx.doi.org/10.1371/journal.pone.0124339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875760	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100250
J	Beeden, R; Maynard, J; Puotinen, M; Marshall, P; Dryden, J; Goldberg, J; Williams, G				Beeden, Roger; Maynard, Jeffrey; Puotinen, Marjetta; Marshall, Paul; Dryden, Jen; Goldberg, Jeremy; Williams, Gareth			Impacts and Recovery from Severe Tropical Cyclone Yasi on the Great Barrier Reef	PLOS ONE			English	Article							CORAL-REEFS; PHASE-SHIFTS; DISTURBANCE; HURRICANES; RECRUITMENT; RESILIENCE; FREQUENCY; DECLINE; SPACE; MODEL	Full recovery of coral reefs from tropical cyclone (TC) damage can take decades, making cyclones a major driver of habitat condition where they occur regularly. Since 1985, 44 TCs generated gale force winds (>= 17 metres/second) within the Great Barrier Reef Marine Park (GBRMP). Of the hurricane strength TCs (>= H1-Saffir Simpson scale; >= category 3 Australian scale), TC Yasi (February, 2011) was the largest. In the weeks after TC Yasi crossed the GBRMP, participating researchers, managers and rangers assessed the extent and severity of reef damage via 841 Reef Health and Impact Surveys at 70 reefs. Records were scaled into five damage levels representing increasingly widespread colony-level damage (1, 2, 3) and reef structural damage (4, 5). Average damage severity was significantly affected by direction (north vs south of the cyclone track), reef shelf position (mid-shelf vs outershelf) and habitat type. More outer-shelf reefs suffered structural damage than mid-shelf reefs within 150 km of the track. Structural damage spanned a greater latitudinal range for mid-shelf reefs than outer-shelf reefs (400 vs 300 km). Structural damage was patchily distributed at all distances, but more so as distance from the track increased. Damage extended much further from the track than during other recent intense cyclones that had smaller circulation sizes. Just over 15% (3,834 km(2)) of the total reef area of the GBRMP is estimated to have sustained some level of coral damage, with >= 4% (949 km(2)) sustaining a degree of structural damage. TC Yasi likely caused the greatest loss of coral cover on the GBR in a 24-hour period since 1985. Severely impacted reefs have started to recover; coral cover increased an average of 4% between 2011 and 2013 at re-surveyed reefs. The in situ assessment of impacts described here is the largest in scale ever conducted on the Great Barrier Reef following a reef health disturbance.	[Beeden, Roger; Dryden, Jen] Great Barrier Reef Marine Pk Author, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Business, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Law & Governance, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4810, Australia; [Maynard, Jeffrey] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Maynard, Jeffrey] CRIOBE, USR CNRS EPHE 3278, Labs Excellence CORAIL, Papetoai, Moorea, France; [Puotinen, Marjetta] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Puotinen, Marjetta] Australian Inst Marine Sci, Perth, WA 6009, Australia; [Marshall, Paul] Reef Ecol, Alligator Creek, Qld 4814, Australia; [Goldberg, Jeremy] CSIRO Land & Water Flagship, Townsville, Qld 4811, Australia; [Williams, Gareth] Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92037 USA	James Cook University; James Cook University; James Cook University; Cornell University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Wollongong; Australian Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California San Diego; Scripps Institution of Oceanography	Beeden, R (corresponding author), Great Barrier Reef Marine Pk Author, Townsville, Qld 4810, Australia.	roger.beeden@gbrmpa.gov.au		Williams, Dr Gareth J./0000-0001-7837-1619; Maynard, Dr Jeffrey/0000-0002-6444-6373; Puotinen, Marji/0000-0002-1383-697X	Great Barrier Reef Marine Park Authority; Queensland Parks and Wildlife Service; Scripps Institution of Oceanography; EPHE/CNRS AMP; CRIOBE of Paris, France; French Polynesia	Great Barrier Reef Marine Park Authority; Queensland Parks and Wildlife Service; Scripps Institution of Oceanography(University of California System); EPHE/CNRS AMP; CRIOBE of Paris, France; French Polynesia	Fieldwork, data analysis and manuscript preparation were all supported by the Great Barrier Reef Marine Park Authority, Queensland Parks and Wildlife Service, Scripps Institution of Oceanography, and EPHE/CNRS & CRIOBE of Paris, France and French Polynesia using departmental funding and not grants. The lead author works for the GBRMPA and his role at the Authority facilitated the authors' team being able to complete the described assessments of impacts and recovery following tropical cyclone Yasi. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbs D, 2011, 11 CSIRO; Australian Bureau of Meteorology, 2011, SEV TROP CYCL YAS; Beeden RJ, 2014, ENVIRON MONIT ASSESS, V186, P8527, DOI 10.1007/s10661-014-4022-0; Carrigan AD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049722; Coles SL, 2007, CORAL REEFS, V26, P705, DOI 10.1007/s00338-007-0257-3; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CSIRO-Australian Bureau of Meteorology, 2007, CLIM CHANG AUSTR TEC; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hayne M, 2001, PALAEOGEOGR PALAEOCL, V168, P207, DOI 10.1016/S0031-0182(00)00217-0; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knaff JA, 2014, J CLIMATE, V27, P455, DOI 10.1175/JCLI-D-13-00096.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Leslie LM, 2007, METEOROL ATMOS PHYS, V97, P171, DOI 10.1007/s00703-006-0250-3; Lukoschek V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065363; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; McClanahan TR, 2002, RESILIENCE BEHAV LAR; MERRILL RT, 1984, MON WEATHER REV, V112, P1408, DOI 10.1175/1520-0493(1984)112<1408:ACOLAS>2.0.CO;2; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nott J, 2001, NATURE, V413, P508, DOI 10.1038/35097055; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Perry CT, 2014, GEOMORPHOLOGY, V222, P92, DOI 10.1016/j.geomorph.2014.03.012; Powell MD, 2007, B AM METEOROL SOC, V88, P513, DOI 10.1175/BAMS-88-4-513; Puotinen ML, 2007, INT J GEOGR INF SCI, V21, P97, DOI 10.1080/1365SS10600852230; Puotinen ML, 1997, 19 CRC REEF RES CTR; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; Uychiaoco AJ, 2005, BIODIVERS CONSERV, V14, P2775, DOI 10.1007/s10531-005-8414-x; Walsh KJE, 2004, CLIM DYNAM, V22, P47, DOI 10.1007/s00382-003-0362-0; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Young IR, 2003, MAR STRUCT, V16, P201, DOI 10.1016/S0951-8339(02)00054-0; YOUNG IR, 1993, CORAL REEFS, V12, P85, DOI 10.1007/BF00302108	47	53	54	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121272	10.1371/journal.pone.0121272	http://dx.doi.org/10.1371/journal.pone.0121272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874718	Green Published, Green Accepted, gold			2022-12-27	WOS:000353015800016
J	Leach, K; Kelly, R; Cameron, A; Montgomery, WI; Reid, N				Leach, Katie; Kelly, Ruth; Cameron, Alison; Montgomery, W. Ian; Reid, Neil			Expertly Validated Models and Phylogenetically-Controlled Analysis Suggests Responses to Climate Change Are Related to Species Traits in the Order Lagomorpha	PLOS ONE			English	Article							ACTIVITY PATTERNS; EXTINCTION RISK; DISTRIBUTIONS; CONSERVATION; FUTURE; PIKAS; CONSEQUENCES; PREDICTION; DISPERSAL; IMPACTS	Climate change during the past five decades has impacted significantly on natural ecosystems, and the rate of current climate change is of great concern among conservation biologists. Species Distribution Models (SDMs) have been used widely to project changes in species' bioclimatic envelopes under future climate scenarios. Here, we aimed to advance this technique by assessing future changes in the bioclimatic envelopes of an entire mammalian order, the Lagomorpha, using a novel framework for model validation based jointly on subjective expert evaluation and objective model evaluation statistics. SDMs were built using climatic, topographical, and habitat variables for all 87 lagomorph species under past and current climate scenarios. Expert evaluation and Kappa values were used to validate past and current models and only those deemed 'modellable' within our framework were projected under future climate scenarios (58 species). Phylogenetically-controlled regressions were used to test whether species traits correlated with predicted responses to climate change. Climate change is likely to impact more than two-thirds of lagomorph species, with leporids (rabbits, hares, and jackrabbits) likely to undertake poleward shifts with little overall change in range extent, whilst pikas are likely to show extreme shifts to higher altitudes associated with marked range declines, including the likely extinction of Kozlov's Pika (Ochotona koslowi). Smaller-bodied species were more likely to exhibit range contractions and elevational increases, but showing little poleward movement, and fecund species were more likely to shift latitudinally and elevationally. Our results suggest that species traits may be important indicators of future climate change and we believe multi-species approaches, as demonstrated here, are likely to lead to more effective mitigation measures and conservation management. We strongly advocate studies minimising data gaps in our knowledge of the Order, specifically collecting more specimens for biodiversity archives and targeting data deficient geographic regions.	[Leach, Katie; Kelly, Ruth; Montgomery, W. Ian] Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland; [Cameron, Alison; Reid, Neil] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Cameron, Alison; Reid, Neil] Queens Univ Belfast, IGFS, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Leach, K (corresponding author), Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland.	kleach01@qub.ac.uk	Reid, Neil/D-1896-2010; Reid, Neil/M-8517-2019; Kelly, Ruth/J-4012-2015; Cameron, Alison/D-3911-2009	Reid, Neil/0000-0001-8951-8292; Reid, Neil/0000-0001-8951-8292; Kelly, Ruth/0000-0001-7982-5993; Cameron, Alison/0000-0001-8236-7954; Leach, Katie/0000-0003-0915-1158	Queen's University Belfast	Queen's University Belfast	This project was funded by Queen's University Belfast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Altman DG., 1999, PRACTICAL STAT MED R; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Barton K., 2013, MUMIN MULTI MODEL IN; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bland LM, 2015, CONSERV BIOL, V29, P250, DOI 10.1111/cobi.12372; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chapman JA., 2008, LAGOMORPH BIOL EVOLU; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CONNER DA, 1983, CAN J ZOOL, V61, P411, DOI 10.1139/z83-054; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; DAWSON T, 1966, J CELL PHYSIOL, V67, P463, DOI 10.1002/jcp.1040670311; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Estes LD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1007, DOI 10.1111/geb.12034; Fleiss J.L., 2013, STAT METHODS RATES P; Fordham DA, 2013, ECOGRAPHY, V36, P956, DOI 10.1111/j.1600-0587.2013.00147.x; Franken RJ, 2004, INTEGR COMP BIOL, V44, P186, DOI 10.1093/icb/44.2.186; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Ge DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059668; Grange WB, 1932, ALLEN J MAMMAL, V13, P99, DOI [10.2307/1374046, DOI 10.2307/1374046]; Henry P, 2013, ECOL EVOL, V3, P3906, DOI 10.1002/ece3.776; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Jannett FJ, 2007, AM MIDL NAT, V158, P168, DOI 10.1674/0003-0031(2007)158[168:NREOMS]2.0.CO;2; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larrucea ES, 2008, J ARID ENVIRON, V72, P1636, DOI 10.1016/j.jaridenv.2008.04.002; LIVERMAN DM, 1991, GLOBAL ENVIRON CHANG, V1, P351, DOI 10.1016/0959-3780(91)90002-B; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Mccain CM, 2014, GLOBAL CHANGE BIOL, V20, P1760, DOI 10.1111/gcb.12499; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nowak RM, 1991, WALKERS MAMMALS WORL; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pike DA, 2013, ANIM CONSERV, V16, P694, DOI 10.1111/acv.12049; Pinheiro J, 2020, R PACKAGE VERSION 31; Reid N, 2010, BIOL CONSERV, V143, P1701, DOI 10.1016/j.biocon.2010.03.041; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Schai-Braun SC, 2012, MAMM BIOL, V77, P434, DOI 10.1016/j.mambio.2012.07.004; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Smith AT., 2008, LAGOMORPH BIOL EVOLU; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; VanDerWal J, 2012, SDMTOOLS SPECIES DIS; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	67	33	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122267	10.1371/journal.pone.0122267	http://dx.doi.org/10.1371/journal.pone.0122267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874407	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800048
J	Wu, GY; Suo, ST; Lu, Q; Zhang, J; Zhu, WQ; Xu, JR				Wu, Guang-yu; Suo, Shi-teng; Lu, Qing; Zhang, Jin; Zhu, Wan-qiu; Xu, Jian-rong			The Value of Blood Oxygenation Level-Dependent (BOLD) MR Imaging in Differentiation of Renal Solid Mass and Grading of Renal Cell Carcinoma (RCC): Analysis Based on the Largest Cross-Sectional Area versus the Entire Whole Tumour	PLOS ONE			English	Article							SUBTYPE DIFFERENTIATION; RADIOFREQUENCY ABLATION; EXPERIENCE; NEPHRECTOMY; ANGIOGENESIS; MANAGEMENT; SURGERY; LESIONS; STAGE	Objectives To study the value of assessing renal masses using different methods in parameter approaches and to determine whether BOLD MRI is helpful in differentiating RCC from benign renal masses, differentiating clear-cell RCC from renal masses other than clear-cell RCC and determining the tumour grade. Methods Ninety-five patients with 139 renal masses (93 malignant and 46 benign) who underwent abdominal BOLD MRI were enrolled. R2* values were derived from the largest cross-section (R2* largest) and from the whole tumour (R2*(whole)). Intra-observer and inter-observer agreements were analysed based on two measurements by the same observer and the first measurement from each observer, respectively, and these agreements are reported with intraclass correlation coefficients and 95% confidence intervals. The diagnostic value of the R2* value in the evaluation was assessed with receiver-operating characteristic analysis. Results The intra-observer agreement was very good for R2*(largest) and R2*(whole) (all > 0.8). The inter-observer agreement of R2*(whole) (0.75, 95% confidence interval: 0.69 similar to 0.79) was good and was significantly improved compared with the R2*(largest) (0.61, 95% confidence interval: 0.52 similar to 0.68), as there was no overlap in the 95% confidence interval of the intra-class correlation coefficients. The diagnostic value in differentiating renal cell carcinoma from benign lesions with R2*(whole) (AUC=0.79/0.78[observer1/observer2]) and R2*(largest) (AUC=0.75[observer1]) was good and significantly higher (p= 0.01 for R2*(largest)[observer2] vs R2*(whole)[observer2], p < 0.01 for R2* (whole)[observer1] vs R2*(largest)[observer2]) than R2*(largest) for observer2 (AUC=0.64). For the grading of clear-cell RCC, both R2*(whole) and R2*(largest) were good (all > 0.7) and were not significantly different (p=0.89/0.93 for R2*largest vs R2*whole[observer1/observer2], 0.96 for R2*whole[observer1] vs R2*largest[observer2] and 0.96 for R2* whole [observer2] vs R2* largest[observer1]). Conclusions BOLD MRI could provide a feasible parameter for differentiating renal cell carcinoma from benign renal masses and for predicting clear-cell renal cell carcinoma grading. Compared with the largest cross-section, assessing the whole tumour provides better inter-observer agreement in parameter measurement for differentiating renal cell carcinoma from benign renal masses.	[Wu, Guang-yu; Suo, Shi-teng; Lu, Qing; Zhu, Wan-qiu; Xu, Jian-rong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Zhang, Jin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, JR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	renjixujr@163.com			National Natural Science Foundation of China [81371622]; National Basic Research Program of China/973 Program [2012CB932600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China/973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81371622) and National Basic Research Program of China/973 Program (2012CB932600).	Abdellaoui A, 2008, FUTURE ONCOL, V4, P103, DOI 10.2217/14796694.4.1.103; Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1007/BF02524349; Breen DJ, 2007, CARDIOVASC INTER RAD, V30, P936, DOI 10.1007/s00270-007-9090-x; Chen DYT, 2009, J NATL COMPR CANC NE, V7, P635, DOI 10.6004/jnccn.2009.0044; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Choi YA, 2014, AM J ROENTGENOL, V203, pW78, DOI 10.2214/AJR.13.11551; Fenner Annette, 2013, Nat Rev Urol, V10, P310, DOI 10.1038/nrurol.2013.102; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kinouchi T, 2003, UROLOGY, V62, P765, DOI 10.1016/S0090-4295(03)00512-0; Liu M, 2013, EUR RADIOL, V23, P3221, DOI 10.1007/s00330-013-2937-4; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Min JH, 2011, AM J ROENTGENOL, V197, pW489, DOI 10.2214/AJR.10.6319; Moczko Jerzya A, 2013, Przegl Lek, V70, P875; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Padhani A, 2010, RADIOLOGY, V254, P1, DOI 10.1148/radiol.091669; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Park HJ, 2014, ABDOM IMAGING, V39, P142, DOI 10.1007/s00261-013-0044-2; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Pedrosa I, 2008, RADIOGRAPHICS, V28, P985, DOI 10.1148/rg.284065018; Prasad PV, 2006, NEPHRON CLIN PRACT, V103, pC58, DOI 10.1159/000090610; Sadowski EA, 2005, RADIOLOGY, V236, P911, DOI 10.1148/radiol.2363041080; Snyder ME, 2006, J UROLOGY, V176, P2391, DOI 10.1016/j.juro.2006.08.013; Song TR, 2012, UROL ANNALS, V4, P24, DOI 10.4103/0974-7796.91617; Thomsen HS, 2006, EUR RADIOL, V16, P1835, DOI 10.1007/s00330-006-0223-4; Wang HY, 2010, RADIOLOGY, V257, P135, DOI 10.1148/radiol.10092396	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123431	10.1371/journal.pone.0123431	http://dx.doi.org/10.1371/journal.pone.0123431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875306	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800097
J	Yebyo, H; Alemayehu, M; Kahsay, A				Yebyo, Henock; Alemayehu, Mussie; Kahsay, Alemayehu			Why Do Women Deliver at Home? Multilevel Modeling of Ethiopian National Demographic and Health Survey Data	PLOS ONE			English	Article							INSTITUTIONAL DELIVERY; BIRTH ATTENDANTS; CHILDBIRTH; FACILITIES; SERVICES; PRADESH; STATE	Background Despite of the existing intensive efforts to improve maternal health in Ethiopia, the proportion of birth delivered at home remains high and is still the top priority among the national health threats. Objective The study aimed to examine effects of individual women and community-level factors of women's decision on place of delivery in Ethiopia. Methods Data were obtained from the nationally representative 2011 Ethiopian Demographic and Health Survey (EDHS) which used a two-stage cluster sampling design with rural-urban and regions as strata. The EDHS collected data from a big sample size but our study focused on a sample of 7,908 women whose most recent birth was within five years preceding 2011 and 576 communities in which the women were living in. The data were analyzed using a two-level mixed-effects logistic regression to determine fixed-effects of individual- and community-level factors and random-intercept of between-cluster characteristics. Results In the current study, 6980 out of 7908 deliveries (88.3%) took place at home. Lower educational levels (OR=2.74, 95%CI:1.84,4.70; p<0.0001), making no or only a limited number of ANC visits (OR=3.72,95% CI:2.85, 4.83; p<0.0001), non-exposure to media (OR=1.51, 95% CI 1.13, 2.01; p=0.004), higher parity (OR=2.68, 95%CI:1.96,3.68; p<0.0001), and perceived distance problem to reach health facilities (OR=1.29, 95%CI:1.03,1.62; p=0.022) were positively associated with home delivery. About 75% of the total variance in the odds of giving birth at home was accounted for the between-community differences of characteristics (ICC=0.75, p<0.0001). With regard to community-level characteristics, rural communities (OR=4.67, 95%CI:3.06,7.11; p<0.0001), pastoralist communities (OR=4.53, 95%CI:2.81,7.28; p<0.0001), communities with higher poverty levels (OR=1.49 95%CI:1.08,2.22; p=0.048), with lower levels of ANC utilization (OR=2.01, 95%CI:1.42,2.85; p<0.0001) and problem of distance to a health facility (OR=1.29, 95%CI:1.03,1.62; p=0.004) had a positive influence on women to give birth at home. Conclusions Not only individual characteristics of women, but also community-level factors determine women's decision to deliver at home.	[Yebyo, Henock; Alemayehu, Mussie; Kahsay, Alemayehu] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Yebyo, H (corresponding author), Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	henok.yebyo@mu.edu.et	Alemayehu, Mussie/AAH-3016-2019; PAN, ZEQIANG/X-6341-2018	Alemayehu, Mussie/0000-0002-0035-631X; Yebyo, Henock/0000-0001-5400-2448	United States Agency for International Development (USAID); ICF International	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); ICF International	The authors would like to thank United States Agency for International Development (USAID) and ICF International for their technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu S, 2012, BMC PREGNANCY CHILDB, V12, P47, DOI [10.1186/1471-2393-12-47, DOI 10.1186/1471-2393-12-47]; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; [Anonymous], J FAM WELFARE; Aremu O, 2012, INT J PREVENTIVE MED, V3, P278; Asmeret M., 2013, LEVELS DETERMINANTS, P83; Begum H. A., 2012, Journal of Family and Reproductive Health, V6, P49; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; CSA ICF, 2012, ETH DEM HLTH SURV 20; Faye A, 2011, ACTA OBSTET GYNECOLO, V4; Fikre AA, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-33; FMoH, 2015, DIS PREV CONTR; FMOH, 2010, HLTH SECT DEV PROGR; Friberg I, 2010, PLOS MED, V21, P7; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gebrehiwot T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-137; Gedefaw A., 2013, ETHIOPIA SCI J PUBLI, V1, P18; Idris S. H., 2006, Annals of African Medicine, V5, P68; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Johnson FA, 2009, J COMMUN HEALTH, V34, P64, DOI 10.1007/s10900-008-9120-x; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Lwelamira J, 2012, ASIAN J MED SCI, V4, P105; Mekonnen Medhanit Getachew, 2012, Pan Afr Med J, V13 Suppl 1, P17; Moore B., 2011, J MED MED SCI, V2, P864; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mulumebet A, 2011, J HEALTH SCI, V21, P95; Nair M, 2012, RURAL REMOTE HEALTH, V12; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Rockers PC, 2009, MATERN CHILD HLTH J, V13, P879, DOI 10.1007/s10995-008-0412-7; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; Tura G, 2008, ETHIOP J HLTH SCI, V17, P213; Utomo B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-47; Wahed T, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-50; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	38	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124718	10.1371/journal.pone.0124718	http://dx.doi.org/10.1371/journal.pone.0124718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874886	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800149
J	Mutai, H; Miya, F; Fujii, M; Tsunoda, T; Matsunaga, T				Mutai, Hideki; Miya, Fuyuki; Fujii, Masato; Tsunoda, Tatsuhiko; Matsunaga, Tatsuo			Attenuation of Progressive Hearing Loss in DBA/2J Mice by Reagents that Affect Epigenetic Modifications Is Associated with Up-Regulation of the Zinc Importer Zip4	PLOS ONE			English	Article							GENE-EXPRESSION; INNER-EAR; CONTROLLED-TRIAL; C57BL/6J MICE; COCHLEA; TINNITUS; MODEL; TRANSPORTERS; MAINTENANCE; METHYLATION	Various factors that are important for proper hearing have been identified, including serum levels of zinc. Here we investigated whether epigenetic regulatory pathways, which can be modified by environmental factors, could modulate hearing. RT-PCR detected expression of genes encoding DNA methyltransferase and histone deacetylase (Hdac) in the postnatal as well as adult mouse auditory epithelium. DBA/2J mice, which are a model for progressive hearing loss, were injected subcutaneously with one or a combination of the following reagents: <smallcaps> L</smallcaps>-methionine as a methyl donor, valproic acid as a pan-Hdac inhibitor, and folic acid and vitamin B12 as putative factors involved in age-related hearing loss. The mice were treated from ages 4 to 12 weeks (N >= 5), and auditory brain-stem response (ABR) thresholds were measured at 8, 16, and 32 kHz. Treatment of the mice with a combination of <smallcaps> L</smallcaps>-methionine and valproic acid (M+V) significantly reduced the increase in the ABR threshold at 32 kHz. Treatment with any of these reagents individually produced no such effect. Microarray analyses detected 299 gene probes that were significantly up-or down-regulated in the cochleae of mice treated with M+V compared with the control vehicle-treated mice. Quantitative RT-PCR confirmed significant up-regulation of a zinc importer gene, Zip4, in the cochleae of mice treated with M+V. Immunohistochemistry demonstrated an intense Zip4 signal in cochlear tissues such as the lateral wall, organ of Corti, and spiral ganglion. Finally, mice treated with the Zip4 inducer (-)-epigallocatechin-3-O-gallate showed a significant reduction in the increase of the ABR threshold at 32 kHz and up-regulation of Zip4 expression in the cochlea. This study suggests that epigenetic regulatory pathways can modify auditory function and that zinc intake in the cochlea via Zip4 mediates maintenance of mammalian hearing.	[Mutai, Hideki; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Lab Auditory Disorders,Meguro Ku, Tokyo, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Fujii, Masato] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Meguro Ku, Tokyo, Japan	RIKEN	Mutai, H (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Lab Auditory Disorders,Meguro Ku, Tokyo, Japan.	mutaihideki@kankakuki.go.jp	Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Miya, Fuyuki/0000-0001-6758-2015; matsunaga, tatsuo/0000-0001-9647-1496	Japan Society for the Promotion of Science KAKENHI [21791659, 24592573, 24390391]; Grants-in-Aid for Scientific Research [24592573] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this work came from Japan Society for the Promotion of Science KAKENHI (http://www.jsps.go.jp/j-grantsinaid/) grant numbers 21791659 and 24592573 to HM and 24390391 to TM. Grant numbers 21791659 and 24592573 supported study design, data collection, analysis, and preparation of the manuscript. Grant 24390391 supported data analysis.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkiten G, 2015, AM J OTOLARYNG, V36, P230, DOI 10.1016/j.amjoto.2014.11.001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; D'Souza M, 2008, J NEUROSCI METH, V171, P279, DOI 10.1016/j.jneumeth.2008.02.022; De Silva MG, 2006, ACTA OTO-LARYNGOL, V126, P1148, DOI 10.1080/00016480600702118; Drottar M, 2006, LARYNGOSCOPE, V116, P292, DOI 10.1097/01.mlg.0000197630.85208.36; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Fujinami Y, 2012, J PHARMACOL SCI, V118, P363, DOI 10.1254/jphs.11227FP; GERSDORFF M, 1987, ARCH OTO-RHINO-LARYN, V244, P190, DOI 10.1007/BF00464266; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; HOEVE LJ, 1990, EUR ARCH OTO-RHINO-L, V247, P267, DOI 10.1007/BF00176533; Houston DK, 1999, AM J CLIN NUTR, V69, P564; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; ICHIMIYA I, 1994, ACTA OTO-LARYNGOL, V114, P167, DOI 10.3109/00016489409126037; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kang WS, 2012, NEUROREPORT, V23, P201, DOI 10.1097/WNR.0b013e328350235f; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P826, DOI 10.1016/j.otohns.2010.08.031; Marano RJ, 2012, AGING CLIN EXP RES, V24, P603, DOI 10.3275/8590; Mikaelian D, 1965, ACTA OTO-LARYNGOL, V59, P451, DOI DOI 10.3109/00016486509124579; Mikuriya T, 2008, BRAIN RES, V1212, P9, DOI 10.1016/j.brainres.2008.03.031; Morsli H, 1999, DEVELOPMENT, V126, P2335; Mutai H, 2009, NEUROSCIENCE, V163, P1255, DOI 10.1016/j.neuroscience.2009.07.059; Mutai H, 2009, DEV NEUROBIOL, V69, P913, DOI 10.1002/dneu.20746; Nicholas S, 1999, J Am Acad Audiol, V10, P436; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ochi K, 1997, OTOLARYNGOL JPN, V100, P915; PAASKE PB, 1991, ANN OTO RHINOL LARYN, V100, P647, DOI 10.1177/000348949110000809; Pillion JP, 2000, AUDIOLOGY, V39, P80; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Quesada IM, 2011, J NUTR BIOCHEM, V22, P153, DOI 10.1016/j.jnutbio.2009.12.009; Rarey KE, 1996, ACTA OTO-LARYNGOL, V116, P833, DOI 10.3109/00016489609137935; Reser D, 1999, NEUROTOXICOLOGY, V20, P731; SHAMBAUGH GE, 1989, AM J OTOL, V10, P156; SHAMBAUGH GE, 1985, AM J OTOL, V6, P116; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tremolizzo L, 2005, BIOL PSYCHIAT, V57, P500, DOI 10.1016/j.biopsych.2004.11.046; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Waldhaus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036066; Willott JF, 1998, HEARING RES, V119, P27, DOI 10.1016/S0378-5955(98)00029-X; Yang CH, 2011, LARYNGOSCOPE, V121, P617, DOI 10.1002/lary.21291; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	55	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124301	10.1371/journal.pone.0124301	http://dx.doi.org/10.1371/journal.pone.0124301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875282	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700065
J	Dey, T; Gogoi, K; Unni, B; Bharadwaz, M; Kalita, M; Ozah, D; Kalita, M; Kalita, J; Baruah, PK; Bora, T				Dey, Tapan; Gogoi, Kabita; Unni, Balagopalan; Bharadwaz, Moonmee; Kalita, Munmi; Ozah, Dibyajyoti; Kalita, Manoj; Kalita, Jatin; Baruah, Pranab Kumar; Bora, Thaneswar			Role of Environmental Pollutants in Liver Physiology: Special References to Peoples Living in the Oil Drilling Sites of Assam	PLOS ONE			English	Article							NITROGEN-DIOXIDE; AIR-POLLUTION; RESPIRATORY SYMPTOMS; PARTICULATE MATTER; EXPOSURE; OZONE; RESPONSIVENESS; MORTALITY; EXERCISE; ASTHMA	The populations residing near polluted sites are more prone to various types of diseases. The important causes of air pollution are the suspended particulate matter, respirable suspended particulate matter, sulfur dioxide and nitrogen dioxide. As limited information is available enumerating the effect of these pollutants on liver physiology of the population living near the polluted sites; in the present study, we tried to investigate their effect on liver of the population residing near the oil drilling sites since birth. In this study, a randomly selected 105 subjects (46 subjects from oil drilling site and 61 subjects from control site) aged above 30 years were taken under consideration. The particulate matter as well as the gaseous pollutants, sulfur dioxide and nitrogen dioxide, were analyzed through a respirable dust sampler. The level of alkaline phosphatase, alanine transaminase and aspartate transaminase enzymes in serum were measured by spectrophotometer. The generalized regression model studies suggests a higher concentration of respirable suspended particulate matter, suspended particulate matter and nitrogen dioxide lowers the alkaline phosphatase level (p<0.0001) by 3.5 times (95% CI 3.1-3.9), 1.5 times (95% CI 1.4 - 1.6) and 12 times (95% CI 10.74 - 13.804), respectively in the exposed group. The higher concentration of respirable suspended particulate matter and nitrogen dioxide in air was associated with increase in alanine transaminase level (p<0.0001) by 0.8 times (95% CI 0.589-1.049) and by 2.8 times (95% CI 2.067-3.681) respectively in the exposed group. The increase in nitrogen dioxide level was also associated with increase in aspartate transaminase level (p<0.0001) by 2.5 times (95% CI 1.862 - 3.313) in the exposed group as compared to control group. Thus, the study reveals that long-term exposure to the environmental pollutants may lead to liver abnormality or injury of populations living in polluted sites.	[Dey, Tapan; Gogoi, Kabita; Unni, Balagopalan; Bharadwaz, Moonmee; Kalita, Munmi; Ozah, Dibyajyoti; Kalita, Manoj; Kalita, Jatin; Baruah, Pranab Kumar; Bora, Thaneswar] CSIR, North East Inst Sci & Technol, Div Biotechnol, Jorhat, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Unni, B (corresponding author), CSIR, North East Inst Sci & Technol, Div Biotechnol, Jorhat, Assam, India.	bgunni@yahoo.com	Kalita, Jatin/HCH-1167-2022; Dey, Tapan/M-7856-2019	Dey, Tapan/0000-0003-3497-8624; Kalita, Jatin/0000-0002-1369-2005	Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India	Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India	The project was entirely funded by Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WC, 1987, J APPL PHYSIOL, V62, P1698, DOI 10.1152/jappl.1987.62.4.1698; AMDUR MO, 1953, LANCET, V265, P758; Bai JY, 2004, ZHONGHUA BING LI XUE, V33, P155; BAUER MA, 1986, AM REV RESPIR DIS, V134, P1203; Belanger K, 2013, EPIDEMIOLOGY, V24, P320, DOI 10.1097/EDE.0b013e318280e2ac; Bhattacharjee M., 2011, International Journal for Biotechnology and Molecular Biology Research, V2, P195, DOI 10.5897/IJBMBR11.051; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cave M, 2010, ENVIRON HEALTH PERSP, V118, P1735, DOI 10.1289/ehp.1002720; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Das Chutia A, 2011, RES J CHEM ENVIRON, V15, P91; Deng Q, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-30; DERITIS F, 1965, B WORLD HEALTH ORGAN, V32, P59; Dey T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096739; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Filho MAP, 2008, BRAZ J MED BIOL RES, V41, P526, DOI 10.1590/S0100-879X2008005000020; FOLINSBEE LJ, 1981, AM IND HYG ASSOC J, V42, P534, DOI 10.1080/15298668191420206; Goldstein BD, 2011, NEW ENGL J MED, V364, P1334, DOI 10.1056/NEJMra1007197; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Kan HD, 2010, ENVIRON RES, V110, P258, DOI 10.1016/j.envres.2010.01.006; Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC; KOENIG JQ, 1988, TOXICOL IND HEALTH, V4, P521, DOI 10.1177/074823378800400410; Krier M, 2009, CLIN LIVER DIS, V13, P167, DOI 10.1016/j.cld.2009.02.001; Lepeule J, 2010, ENVIRON HEALTH PERSP, V118, P1483, DOI 10.1289/ehp.0901509; Loscalzo J., 2011, HARRISONS PRINCIPLES, V18th; Minuk GY, 1998, CAN J GASTROENTEROL, V12, P417, DOI 10.1155/1998/943498; Modig L, 2006, EUR RESPIR J, V28, P75, DOI 10.1183/09031936.06.00071505; OSTERMAN JW, 1989, BRIT J IND MED, V46, P629; Raaschou-Nielsen O, 2001, AM J EPIDEMIOL, V153, P433, DOI 10.1093/aje/153.5.433; ROGER LJ, 1990, TOXICOL IND HEALTH, V6, P155, DOI 10.1177/074823379000600110; SCHWARTZ J, 1992, AM REV RESPIR DIS, V145, P600, DOI 10.1164/ajrccm/145.3.600; Smargiassi A, 2009, ENVIRON HEALTH PERSP, V117, P653, DOI 10.1289/ehp.0800010; TAKAHASHI Y, 1986, ENVIRON RES, V41, P184, DOI 10.1016/S0013-9351(86)80180-3; Tan HH, 2009, J IMMUNOTOXICOL, V6, P266, DOI [10.3109/15476910903241704, 10.1080/15476910903241704]; Tao YB, 2012, ENVIRON HEALTH PERSP, V120, P393, DOI 10.1289/ehp.1103715; Tseng CY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-4; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Williams R, 2012, INT J ENVIRON HEAL R, V22, P71, DOI 10.1080/09603123.2011.588437; WROBLEWSKI F, 1959, AM J MED, V27, P911, DOI 10.1016/0002-9343(59)90175-5; Zock JP, 2014, ENVIRON INT, V62, P72, DOI 10.1016/j.envint.2013.09.020	41	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123370	10.1371/journal.pone.0123370	http://dx.doi.org/10.1371/journal.pone.0123370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874634	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100166
J	Fattebert, J; Balme, G; Dickerson, T; Slotow, R; Hunter, L				Fattebert, Julien; Balme, Guy; Dickerson, Tristan; Slotow, Rob; Hunter, Luke			Density-Dependent Natal Dispersal Patterns in a Leopard Population Recovering from Over-Harvest	PLOS ONE			English	Article							SPATIAL STRUCTURE; IBERIAN LYNX; DYNAMICS; HABITAT; METAPOPULATION; SELECTION	Natal dispersal enables population connectivity, gene flow and metapopulation dynamics. In polygynous mammals, dispersal is typically male-biased. Classically, the 'mate competition', 'resource competition' and 'resident fitness' hypotheses predict density-dependent dispersal patterns, while the 'inbreeding avoidance' hypothesis posits density-independent dispersal. In a leopard (Panthera pardus) population recovering from over-harvest, we investigated the effect of sex, population density and prey biomass, on age of natal dispersal, distance dispersed, probability of emigration and dispersal success. Over an 11-year period, we tracked 35 subadult leopards using VHF and GPS telemetry. Subadult leopards initiated dispersal at 13.6 +/- 0.4 months. Age at commencement of dispersal was positively density-dependent. Although males (11.0 +/- 2.5 km) generally dispersed further than females (2.7 +/- 0.4 km), some males exhibited opportunistic philopatry when the population was below capacity. All 13 females were philopatric, while 12 of 22 males emigrated. Male dispersal distance and emigration probability followed a quadratic relationship with population density, whereas female dispersal distance was inversely density-dependent. Eight of 12 known-fate females and 5 of 12 known-fate male leopards were successful in settling. Dispersal success did not vary with population density, prey biomass, and for males, neither between dispersal strategies (philopatry vs. emigration). Females formed matrilineal kin clusters, supporting the resident fitness hypothesis. Conversely, mate competition appeared the main driver for male leopard dispersal. We demonstrate that dispersal patterns changed over time, i.e. as the leopard population density increased. We conclude that conservation interventions that facilitated local demographic recovery in the study area also restored dispersal patterns disrupted by unsustainable harvesting, and that this indirectly improved connectivity among leopard populations over a larger landscape.	[Fattebert, Julien; Balme, Guy; Dickerson, Tristan; Hunter, Luke] Panthera, New York, NY 10018 USA; [Fattebert, Julien; Slotow, Rob; Hunter, Luke] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Balme, Guy] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Slotow, Rob] UCL, Dept Genet Evolut & Environm, London, England	University of Kwazulu Natal; University of Cape Town; University of London; University College London	Fattebert, J (corresponding author), Panthera, New York, NY 10018 USA.	julien.fattebert@gmail.com	Fattebert, Julien/I-8126-2019; Hunter, Luke T.B./H-3324-2019; Slotow, Rob/AAM-9053-2020	Fattebert, Julien/0000-0001-5510-6804; Hunter, Luke T.B./0000-0001-9653-6544; Slotow, Rob/0000-0001-9469-1508	Panthera; Albert and Didy Hartog; Stichting Timbo Foundation; National Research Foundation [FA 2004050400038]; University of KwaZulu-Natal Gay Langmuir Bursary	Panthera; Albert and Didy Hartog; Stichting Timbo Foundation; National Research Foundation; University of KwaZulu-Natal Gay Langmuir Bursary	The work was funded by Panthera (http://www.panthera.org), Albert and Didy Hartog, the Stichting Timbo Foundation (http://www.stichting-timbo.nl), the National Research Foundation (FA 2004050400038 to GB), and the University of KwaZulu-Natal Gay Langmuir Bursary (to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P.K, 1989, DISPERSAL RODENTS RE; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2013, ANIM BEHAV, V86, P791, DOI 10.1016/j.anbehav.2013.07.019; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Barton K., 2013, MUMIN MULTIMODEL INF; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beyer H. L, 2012, GEOSPATIAL MODELLING; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; COCKBURN A, 1985, OIKOS, V44, P367, DOI 10.2307/3544715; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Elliot NB, 2014, OIKOS, V123, P1049, DOI 10.1111/oik.01266; Fattebert J., 2014, THESIS U KWAZULU NAT; Fattebert J, 2015, ECOL APPL, V25, P1911, DOI 10.1890/14-1631.1; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Fieberg J, 2008, J WILDLIFE MANAGE, V72, P837, DOI 10.2193/2007-329; Gandon Sylvain, 2001, P155; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Gour DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066956; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gundersen G, 2001, ECOL LETT, V4, P14, DOI 10.1046/j.1461-0248.2001.00182.x; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; HOWARD WALTER E., 1960, AMER MIDLAND NAT, V63, P152, DOI 10.2307/2422936; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Lambin Xavier, 2001, P110; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Long RA, 2008, J WILDLIFE MANAGE, V72, P1133, DOI 10.2193/2007-337; Maehr DS, 2002, BIOL CONSERV, V106, P187, DOI 10.1016/S0006-3207(01)00245-2; Newby JR, 2013, BIOL CONSERV, V159, P230, DOI 10.1016/j.biocon.2012.10.018; Onorato D, 2011, J WILDLIFE MANAGE, V75, P378, DOI 10.1002/jwmg.43; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Perrin Nicolas, 2001, P123; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Skinner J.D., 2005, MAMMALS SO AFRICA SU, V3rd; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Sutherland LJ, 2002, DISPERSAL ECOLOGY, P134; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Waser PM, 2001, CONSERV BIOL SER, V5, P484; Whitlock Michael C., 2001, P273; Wiens John A., 2001, P96; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WOLFF JO, 1994, OIKOS, V71, P349, DOI 10.2307/3546284; Zimmermann F, 2005, J ZOOL, V267, P381, DOI 10.1017/S0952836905007545	55	43	43	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122355	10.1371/journal.pone.0122355	http://dx.doi.org/10.1371/journal.pone.0122355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875293	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100066
J	Kumari, A; Kumar, J; Kumar, A; Chaudhury, A; Singh, SP				Kumari, Anita; Kumar, Jitendra; Kumar, Anil; Chaudhury, Ashok; Singh, Sudhir P.			Grafting Triggers Differential Responses between Scion and Rootstock	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FLORAL ORGAN; POSITIVE REGULATOR; WATER-DEFICIT; PROTEIN; STRESS; IDENTIFICATION; BIOSYNTHESIS	Grafting is a well-established practice to facilitate asexual propagation in horticultural and agricultural crops. It has become a method for studying molecular aspects of root-to-shoot and/or shoot-to-root signaling events. The objective of this study was to investigate differences in gene expression between the organs of the scion and rootstock of a homograft (Arabidopsis thaliana). MapMan and Gene Ontology enrichment analysis revealed differentially expressed genes from numerous functional categories related to stress responses in the developing flower buds and leaves of scion and rootstock. Meta-analysis suggested induction of drought-type responses in flower buds and leaves of the scion. The flower buds of scion showed over-representation of the transcription factor genes, such as Homeobox, NAC, MYB, bHLH, B3, C3HC4, PLATZ etc. The scion leaves exhibited higher accumulation of the regulatory genes for flower development, such as SEPALLATA 1-4, Jumonji C and AHL16. Differential transcription of genes related to ethylene, gibberellic acid and other stimuli was observed between scion and rootstock. The study is useful in understanding the molecular basis of grafting and acclimation of scion on rootstock.	[Kumari, Anita; Kumar, Jitendra; Kumar, Anil; Singh, Sudhir P.] Natl Agrifood Biotechnol Inst, Mohali, Punjab, India; [Kumari, Anita; Chaudhury, Ashok] Guru Jambheshwar Univ Sci & Technol, Hisar, Haryana, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Guru Jambheshwar University of Science & Technology	Singh, SP (corresponding author), Natl Agrifood Biotechnol Inst, Mohali, Punjab, India.	pratapsudhir17@gmail.com	Singh, Sudhir/AAE-5413-2019; Kumar, Jitendra/AAP-5018-2020	Kumar, Anil/0000-0002-3835-4280; chaudhury, ashok/0000-0002-0383-1497; Singh, Sudhir/0000-0001-5437-4292	Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/FT/LS-88/2011]	Science and Engineering Research Board, Department of Science and Technology, Government of India	This work was supported by Science and Engineering Research Board (SR/FT/LS-88/2011), Department of Science and Technology, Government of India.	Aloni B, 2010, SCI HORTIC-AMSTERDAM, V127, P119, DOI 10.1016/j.scienta.2010.09.003; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Baxter CEL, 2007, PLANT J, V52, P105, DOI 10.1111/j.1365-313X.2007.03222.x; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Binder BYK, 2009, BIOTECHNOL PROGR, V25, P861, DOI 10.1002/btpr.97; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-147; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ebel RC, 2000, J PLANT NUTR, V23, P1179, DOI 10.1080/01904160009382091; El-Sharkawy I, 2012, J EXP BOT, V63, P1225, DOI 10.1093/jxb/err345; Etehadnia M, 2008, J PLANT GROWTH REGUL, V27, P125, DOI 10.1007/s00344-008-9039-6; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Groszmann M, 2011, PLANT J, V68, P816, DOI 10.1111/j.1365-313X.2011.04732.x; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Howing T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00058; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Jain M, 2008, PLANT SIGNAL BEHAV, V3, P1024, DOI 10.4161/psb.6770; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Jimenez S, 2007, SCI HORTIC-AMSTERDAM, V112, P73, DOI 10.1016/j.scienta.2006.12.010; Jones ML, 2005, J EXP BOT, V56, P2733, DOI 10.1093/jxb/eri266; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Kato M, 2002, POSTHARVEST BIOL TEC, V24, P69, DOI 10.1016/S0925-5214(01)00111-9; Kirik V, 2005, DEVELOPMENT, V132, P1477, DOI 10.1242/dev.01708; Koprivova A, 2014, FEBS LETT, V588, P1116, DOI 10.1016/j.febslet.2014.02.031; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Lewandowska M, 2010, MOL PLANT, V3, P347, DOI 10.1093/mp/ssq007; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mu RL, 2009, CELL RES, V19, P1291, DOI 10.1038/cr.2009.83; Mudge K., 2009, HIST GRAFTING; Nisar N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-50; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Prassinos C, 2009, TREE PHYSIOL, V29, P927, DOI 10.1093/treephys/tpp027; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Shao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049861; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Singh AP, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt030; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Son O, 2005, BIOCHEM BIOPH RES CO, V326, P203, DOI 10.1016/j.bbrc.2004.11.014; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Sorce C., 2007, Advances in Horticultural Science, V21, P68; Stearns JC, 2003, BIOTECHNOL ADV, V21, P193, DOI 10.1016/S0734-9750(03)00024-7; Sun XL, 2012, J PLANT RES, V125, P429, DOI 10.1007/s10265-011-0448-4; Takahashi Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003760; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; TSUKAYA H, 1993, MOL GEN GENET, V237, P26, DOI 10.1007/BF00282780; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Wang L, 2012, PLANT BIOLOGY, V14, P745, DOI 10.1111/j.1438-8677.2011.00555.x; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; Xu YF, 2013, CURR BIOL, V23, P345, DOI 10.1016/j.cub.2013.01.030; Yang CJ, 2014, MOL PLANT, V7, P841, DOI 10.1093/mp/ssu013; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0; Zhang WN, 2014, PLANT J, V80, P106, DOI 10.1111/tpj.12622; Zhao PS, 2011, MOL BIOL+, V45, P785, DOI 10.1134/S0026893311050165; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	81	22	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124438	10.1371/journal.pone.0124438	http://dx.doi.org/10.1371/journal.pone.0124438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874958	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100258
J	Yu, SF; Huang, HC; Deng, G; Xie, ZT; Ye, YC; Guo, RD; Cai, XJ; Hong, JY; Qian, DL; Zhou, XJ; Tao, ZH; Chen, BL; Li, Q				Yu, Shifang; Huang, Huicong; Deng, Gang; Xie, Zuoting; Ye, Yincai; Guo, Ruide; Cai, Xuejiao; Hong, Junying; Qian, Dingliang; Zhou, Xiangjing; Tao, Zhihua; Chen, Bile; Li, Qiang			miR-326 Targets Antiapoptotic Bcl-xL and Mediates Apoptosis in Human Platelets	PLOS ONE			English	Article							CYTOCHROME-C; CELL-DEATH; MICRORNA; MICROARRAY; EXPRESSION; MARKERS; STORAGE; FAMILY	Platelets play crucial roles in hemostasis, thrombosis, wound healing, inflammation, angiogenesis, and tumor metastases. Because they are anucleated blood cells, platelets lack nuclear DNA, but they do contain mitochondrial DNA, which plays a key role in regulating apoptosis. Recent evidence has suggested that miRNAs are also involved in regulating gene expression and apoptosis in platelets. Our previous study showed that the expression of miR-326 increased visibly when apheresis platelets were stored in vitro. The antiapoptotic Bcl-2 family regulator Bcl-xL has been identified as a putative target of miR-326. In the present study, dual reporter luciferase assays were used to characterize the function of miR-326 in the regulation of the apoptosis of platelet cells. These assays demonstrated that miR-326 bound to the 30-translated region of Bcl-xL. To directly assess the functional effects of miR-326 expression, levels of Bcl-xL and the apoptotic status of stored apheresis platelets were measured after transfection of miR-326 mimic or inhibitor. Results indicated that miR-326 inhibited Bcl-xL expression and induced apoptosis in stored platelets. Additionally, miR-326 inhibited Bcl-2 protein expression and enhanced Bak expression, possibly through an indirect mechanism, though there was no effect on the expression of Bax. The effect of miR-326 appeared to be limited to apoptosis, with no significant effect on platelet activation. These results provide new insight into the molecular mechanisms affecting differential platelet gene regulation, which may increase understanding of the role of platelet apoptosis in multiple diseases.	[Yu, Shifang; Tao, Zhihua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Transfus Med, Hangzhou 310027, Zhejiang, Peoples R China; [Yu, Shifang; Xie, Zuoting; Ye, Yincai; Guo, Ruide; Cai, Xuejiao; Hong, Junying; Zhou, Xiangjing; Chen, Bile] Wenzhou Med Univ, Affiliated Hosp 1, Dept Transfus Med, Wenzhou, Peoples R China; [Huang, Huicong] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou, Peoples R China; [Deng, Gang] Ningbo Cent Blood Stn, Ningbo, Zhejiang, Peoples R China; [Qian, Dingliang; Li, Qiang] Wenzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Ruian, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Li, Q (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Ruian, Peoples R China.	zrtzh@zju.edu.cn; wswzyjs@126.com		li, qiang/0000-0003-0096-7679	Zhejiang Provincial Natural Science Foundation [LQ12H20001]; Social Development Research Project Foundation of Wenzhou Science and Technology Bureau [2011S0106, Y20110079]; Project of Ningbo Medical Science and Technology Plans [2013A25, 2011A01]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Social Development Research Project Foundation of Wenzhou Science and Technology Bureau; Project of Ningbo Medical Science and Technology Plans	This work was supported by grants from: Zhejiang Provincial Natural Science Foundation (NO. LQ12H20001); The Social Development Research Project Foundation of Wenzhou Science and Technology Bureau (NO. 2011S0106; Y20110079); The Project of Ningbo Medical Science and Technology Plans (No. 2013A25; 2011A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Gnatenko Dmitri V., 2009, V496, P245, DOI 10.1007/978-1-59745-553-4_16; Gyulkhandanyan AV, 2012, J THROMB THROMBOLYS, V33, P397, DOI 10.1007/s11239-012-0688-8; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Josefsson EC, 2012, METHODS MOL BIOL, V788, P59, DOI 10.1007/978-1-61779-307-3_5; Kannan M, 2009, TRANSFUSION, V49, P1443, DOI 10.1111/j.1537-2995.2009.02140.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kodama T, 2012, CELL DEATH DIFFER, V19, P1856, DOI 10.1038/cdd.2012.88; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Qi B, 2007, CELL, V128, P1035, DOI 10.1016/j.cell.2007.03.002; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shi R, 2013, THROMB RES, V131, P508, DOI 10.1016/j.thromres.2013.02.015; Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu SF, 2014, BLOOD TRANSFUS-ITALY, V12, P541, DOI 10.2450/2014.0291-13; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	34	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122784	10.1371/journal.pone.0122784	http://dx.doi.org/10.1371/journal.pone.0122784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875481	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100099
J	Zayats, T; Athanasiu, L; Sonderby, I; Djurovic, S; Westlye, LT; Tamnes, CK; Fladby, T; Aase, H; Zeiner, P; Reichborn-Kjennerud, T; Knappskog, PM; Knudsen, GP; Andreassen, OA; Johansson, S; Haavik, J				Zayats, Tetyana; Athanasiu, Lavinia; Sonderby, Ida; Djurovic, Srdjan; Westlye, Lars T.; Tamnes, Christian K.; Fladby, Tormod; Aase, Heidi; Zeiner, Pal; Reichborn-Kjennerud, Ted; Knappskog, Per M.; Knudsen, Gun Peggy; Andreassen, Ole A.; Johansson, Stefan; Haavik, Jan			Genome-Wide Analysis of Attention Deficit Hyperactivity Disorder in Norway	PLOS ONE			English	Article							ASSOCIATION SCAN; ADULT ADHD; MOLECULAR-GENETICS; CANDIDATE GENE; VARIANTS; CHILDREN; COMMON; PLZF; DRD4; DAT1	Background Attention deficit hyperactivity disorder (ADHD) is a highly heritable neuropsychiatric condition, but it has been difficult to identify genes underlying this disorder. This study aimed to explore genetics of ADHD in an ethnically homogeneous Norwegian population by means of a genome-wide association (GWA) analysis followed by examination of candidate loci. Materials and Methods Participants were recruited through Norwegian medical and birth registries as well as the general population. Presence of ADHD was defined according to DSM-IV criteria. Genotyping was performed using Illumina Human OmniExpress-12v1 microarrays. Statistical analyses were divided into several steps: (1) genome-wide association in the form of logistic regression in PLINK and follow-up pathway analyses performed in DAPPLE and INRICH softwares, (2) SNP-heritability calculated using genome-wide complex trait analysis (GCTA) tool, (3) gene-based association tests carried out in JAG software, and (4) evaluation of previously reported genome-wide signals and candidate genes of ADHD. Results In total, 1.358 individuals (478 cases and 880 controls) and 598.384 autosomal SNPs were subjected to GWA analysis. No single polymorphism reached genome-wide significance. The strongest signal was observed at rs9949006 in the ENSG00000263745 gene (OR=1.51, 95% CI 1.28-1.79, p= 1.38E-06). Pathway analyses of the top SNPs implicated genes involved in the regulation of gene expression, cell adhesion and inflammation. Among previously identified ADHD candidate genes, prominent association signals were observed for SLC9A9 (rs1393072, OR=1.46, 95% CI = 1.21-1.77, p= 9.95E-05) and TPH2 (rs17110690, OR = 1.38, 95% CI = 1.14-1.66, p= 8.31E-04). Conclusion This study confirms the complexity and heterogeneity of ADHD etiology. Taken together with previous findings, our results point to a spectrum of biological mechanisms underlying the symptoms of ADHD, providing targets for further genetic exploration of this complex disorder.	[Zayats, Tetyana; Haavik, Jan] Univ Bergen, Dept Biomed, KG Jebsen Ctr Neuropsychiat Disorders, Bergen, Norway; [Athanasiu, Lavinia; Sonderby, Ida; Westlye, Lars T.; Andreassen, Ole A.] Oslo Univ Hosp, NORMENT, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, Oslo, Norway; [Athanasiu, Lavinia; Sonderby, Ida; Westlye, Lars T.; Fladby, Tormod; Reichborn-Kjennerud, Ted; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Tamnes, Christian K.] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway; [Fladby, Tormod] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Aase, Heidi; Reichborn-Kjennerud, Ted; Knudsen, Gun Peggy] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway; [Zeiner, Pal] Oslo Univ Hosp, Child & Adolescent Mental Hlth Res Unit, Oslo, Norway; [Knappskog, Per M.; Johansson, Stefan] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Neuropsychiat Disorders, Bergen, Norway; [Knappskog, Per M.; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Haavik, Jan] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway	University of Bergen; University of Oslo; University of Oslo; University of Bergen; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Zayats, T (corresponding author), Univ Bergen, Dept Biomed, KG Jebsen Ctr Neuropsychiat Disorders, Bergen, Norway.	tetyana.zayats@biomed.uib.no	Johansson, Stefan/C-4394-2011; Haavik, Jan/AAI-3974-2020; Andreassen, Ole A./AAY-7531-2020; Haavik, Jan/ABE-1535-2020	Johansson, Stefan/0000-0002-2298-7008; Haavik, Jan/0000-0001-7865-2808; Westlye, Lars T./0000-0001-8644-956X; Djurovic, Srdjan/0000-0002-8140-8061; Fladby, Tormod/0000-0002-9984-9797	European Community's Seventh Framework Programme (FP7) [602805]; K.G. Jebsen foundation; Research Council of Norway [213837, 223273]; South-East Norway Health Authority [2013-123]; Norwegian Ministry of Health, The Norwegian Health Directorate, The South Eastern Health Region, G AMP; PJ Sorensen Fund for Scientific Research; Norwegian Resource Centre for ADHD, Tourettes Syndrome and Narcolepsy; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS [NO-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme (FP7); K.G. Jebsen foundation; Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; Norwegian Ministry of Health, The Norwegian Health Directorate, The South Eastern Health Region, G AMP; PJ Sorensen Fund for Scientific Research; Norwegian Resource Centre for ADHD, Tourettes Syndrome and Narcolepsy; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602805, from K.G. Jebsen foundation, from Research Council of Norway (#213837, #223273) and from South-East Norway Health Authority (#2013-123). The Norwegian Longitudinal ADHD Study was supported by funds and grants from the Norwegian Ministry of Health, The Norwegian Health Directorate, The South Eastern Health Region, G & PJ Sorensen Fund for Scientific Research, and from The Norwegian Resource Centre for ADHD, Tourettes Syndrome and Narcolepsy. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no NO-ES-75558), NIH/NINDS (Grant No. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (Grant No. 151918/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addamo PK, 2007, BRAIN RES REV, V54, P189, DOI 10.1016/j.brainresrev.2007.01.004; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashmore K, 2013, CLINICAL AND EXPERIM, V3, P119; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Baird AL, 2012, MOL PSYCHIATR, V17, P988, DOI 10.1038/mp.2011.149; Barkley RA, 2006, AM J MED GENET B, V141B, P487, DOI 10.1002/ajmg.b.30326; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Egger HL, 2006, J AM ACAD CHILD PSY, V45, P538, DOI 10.1097/01.chi.0000205705.71194.b8; Elia Josephine, 2007, Curr Psychiatry Rep, V9, P434, DOI 10.1007/s11920-007-0057-z; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Faraone Stephen V, 2005, J Atten Disord, V9, P384, DOI 10.1177/1087054705281478; Faraone SV, 2010, PSYCHIAT CLIN N AM, V33, P159, DOI 10.1016/j.psc.2009.12.004; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fasmer OB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-128; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI 10.1002/ajmg.b.30861; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P311, DOI 10.1007/s00787-010-0097-5; Gabbay V, 2009, J AFFECT DISORDERS, V115, P177, DOI 10.1016/j.jad.2008.07.022; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Haavik J, 2010, EXPERT REV NEUROTHER, V10, P1569, DOI [10.1586/ern.10.149, 10.1586/ERN.10.149]; Halmoy A, 2009, J ATTEN DISORD, V13, P175, DOI 10.1177/1087054708329777; Hammerschlag AR, 2014, GENES-BASEL, V5, P604, DOI 10.3390/genes5030604; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Johansson S, 2008, AM J MED GENET B, V147B, P1470, DOI 10.1002/ajmg.b.30662; Johansson S, 2010, AM J MED GENET B, V153B, P1008, DOI 10.1002/ajmg.b.31067; Kebir O, 2009, J PSYCHIATR NEUROSCI, V34, P88; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kitamura K, 2003, J BIOL CHEM, V278, P44417, DOI 10.1074/jbc.M304306200; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1355, DOI 10.1002/ajmg.b.30869; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lenartowski R, 2011, INT J DEV NEUROSCI, V29, P873, DOI 10.1016/j.ijdevneu.2011.07.006; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Matza LS, 2005, COST EFF RESOUR ALLO; Mavroconstanti T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071445; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKinney J, 2008, MOL PSYCHIATR, V13, P365, DOI 10.1038/sj.mp.4002152; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Miyajima N, 2009, BIOCHEM BIOPH RES CO, V381, P383, DOI 10.1016/j.bbrc.2009.02.059; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Ning SW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-152; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAO ML, 1994, BIOL PSYCHIAT, V35, P151, DOI 10.1016/0006-3223(94)91147-9; Rohrer-Baumgartner N, 2016, J ATTEN DISORD, V20, P867, DOI 10.1177/1087054713497253; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1536, DOI 10.1002/ajmg.b.30848; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; SWEDO SE, 1994, PEDIATRICS, V93, P323; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; vanGent T, 1997, J CHILD PSYCHOL PSYC, V38, P337; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; WARREN RP, 1995, SCIENCE, V268, P786, DOI 10.1126/science.7605493; Weiss G, 1993, HYPERACTIVE CHILDREN; Weng J, 2009, ALCOHOL CLIN EXP RES, V33, P1409, DOI 10.1111/j.1530-0277.2009.00971.x; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang L, 2013, AM J MED GENET B, V162B, P419, DOI 10.1002/ajmg.b.32169; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yoshigai E, 2009, BIOCHEM BIOPH RES CO, V378, P428, DOI 10.1016/j.bbrc.2008.11.069	81	58	59	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122501	10.1371/journal.pone.0122501	http://dx.doi.org/10.1371/journal.pone.0122501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875332	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100078
J	Egli, A; Tschudin-Sutter, S; Oberle, M; Goldenberger, D; Frei, R; Widmer, AF				Egli, Adrian; Tschudin-Sutter, Sarah; Oberle, Michael; Goldenberger, Daniel; Frei, Reno; Widmer, Andreas F.			Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass-Spectrometry (MALDI-TOF MS) Based Typing of Extended-Spectrum beta-Lactamase Producing E. coli - A Novel Tool for Real-Time Outbreak Investigation	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; DESORPTION IONIZATION-TIME; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IDENTIFICATION	Epidemiologically linked clusters are confirmed by typing strains with molecular typing such as pulsed-field gel electrophoresis (PFGE). We compared six extended-spectrum beta-lactamase producing E. coli of a PFGE-related cluster with Matrix-assisted laser desorption/ionization-time of flight mass-spectrometry based typing that confirmed relatedness faster and more cost-effective, but as reliable as PFGE.	[Egli, Adrian; Goldenberger, Daniel; Frei, Reno] Univ Basel Hosp, Div Clin Microbiol, CH-4031 Basel, Switzerland; [Egli, Adrian] Univ Basel, Infect Biol Lab, Dept Biomed, Basel, Switzerland; [Tschudin-Sutter, Sarah; Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Oberle, Michael] Cantonal Hosp Aarau, Clin Microbiol, Aarau, Switzerland	University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA)	Egli, A (corresponding author), Univ Basel Hosp, Div Clin Microbiol, CH-4031 Basel, Switzerland.	a.egli@usb.ch	Tschudin-Sutter, Sarah/K-2212-2019; Goldenberger, Daniel/S-8952-2019	Tschudin-Sutter, Sarah/0000-0003-4875-5368; 	University of Basel "Nachwuchsforderung"	University of Basel "Nachwuchsforderung"	A.E. research was supported by a grant from the University of Basel "Nachwuchsforderung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babouee B, 2011, J CLIN MICROBIOL, V49, P1549, DOI 10.1128/JCM.02254-10; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Lasch P, 2014, J MICROBIOL METH, V100, P58, DOI 10.1016/j.mimet.2014.02.015; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Stranden A, 2003, J CLIN MICROBIOL, V41, P3181, DOI 10.1128/JCM.41.7.3181-3186.2003; Suarez S, 2013, J MICROBIOL METH, V94, P390, DOI 10.1016/j.mimet.2013.07.021; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tschudin-Sutter S, 2010, EMERG INFECT DIS, V16, P1758, DOI 10.3201/eid1611.100366; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xiao D, 2014, J PROTEOMICS, V98, P112, DOI 10.1016/j.jprot.2013.11.021	14	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120624	10.1371/journal.pone.0120624	http://dx.doi.org/10.1371/journal.pone.0120624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860943	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300015
J	Bulbert, MW; Page, RA; Bernal, XE				Bulbert, Matthew W.; Page, Rachel A.; Bernal, Ximena E.			Danger Comes from All Fronts: Predator-Dependent Escape Tactics of Tungara Frogs	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; ANTIPREDATOR BEHAVIOR; TURNING BEHAVIOR; EVASIVE BEHAVIOR; BAT PREDATION; PREY; STRATEGIES; ANURA; PERFORMANCE; RESPONSES	The escape response of an organism is generally its last line of defense against a predator. Because the effectiveness of an escape varies with the approach behaviour of the predator, it should be advantageous for prey to alter their escape trajectories depending on the mode of predator attack. To test this hypothesis we examined the escape responses of a single prey species, the ground-dwelling tungara frog (Engystomops pustulosus), to disparate predators approaching from different spatial planes: a terrestrial predator (snake) and an aerial predator (bat). Tungara frogs showed consistently distinct escape responses when attacked by terrestrial versus aerial predators. The frogs fled away from the snake models (Median: 131 degrees). In stark contrast, the frogs moved toward the bat models (Median: 27 degrees); effectively undercutting the bat's flight path. Our results reveal that prey escape trajectories reflect the specificity of their predators' attacks. This study emphasizes the flexibility of strategies performed by prey to outcompete predators with diverse modes of attack.	[Bulbert, Matthew W.] Macquarie Univ, Dept Biol, Behav Ecol Grp, N Ryde, NSW 2109, Australia; [Bulbert, Matthew W.; Page, Rachel A.; Bernal, Ximena E.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Bernal, Ximena E.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Macquarie University; Smithsonian Institution; Smithsonian Tropical Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bulbert, MW (corresponding author), Macquarie Univ, Dept Biol, Behav Ecol Grp, N Ryde, NSW 2109, Australia.	matthew.bulbert@mq.edu.au	Page, Rachel/AAE-4816-2021; Page, Rachel A/GQQ-2818-2022	Page, Rachel A/0000-0001-7072-0669; Bulbert, Matthew/0000-0002-7313-2536	Texas Tech University	Texas Tech University	This work was partially supported by Texas Tech University funding to XEB. This research received no additional funding from any public, commercial or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2010, R PACKAGE CIRCULAR C; Batschelet E, 1981, CIRCULAR STAT BIOL; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; CAMHI JM, 1989, J COMP PHYSIOL A, V165, P83, DOI 10.1007/BF00613802; COMER CM, 1987, J COMP PHYSIOL A, V160, P571, DOI 10.1007/BF00611930; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 2008, J HERPETOL, V42, P493, DOI 10.1670/07-066.1; Cooper WE, 2008, BEHAVIOUR, V145, P25, DOI 10.1163/156853908782687250; Cooper WE, 2007, ETHOLOGY, V113, P661, DOI 10.1111/j.1439-0310.2007.01363.x; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; William EC, 2006, ETHOLOGY, V112, P858, DOI 10.1111/j.1439-0310.2006.01240.x; Cooper WE, 2009, BEHAVIOUR, V146, P325, DOI 10.1163/156853909X410946; Dawkins R., 1982, pi; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Domenici Paolo, 2009, Communicative & Integrative Biology, V2, P497; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; ELLARD CG, 1988, EXP BRAIN RES, V71, P307; Endler JA, 2006, P R SOC B, V273, P2425, DOI 10.1098/rspb.2006.3650; ERLINGE S, 1974, Fauna och Flora Naturhistoriska Riksmuseet, V69, P203; Gomes FR, 2002, COPEIA, P994, DOI 10.1643/0045-8511(2002)002[0994:EAPFIA]2.0.CO;2; Gray HM, 1999, PREDATION HERPETOL R, V30, P93; HAYES F E, 1990, Bulletin of the Maryland Herpetological Society, V26, P81; HAYES FE, 1989, COPEIA, P1011, DOI 10.2307/1445987; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Ilany A, 2008, BEHAV ECOL SOCIOBIOL, V62, P923, DOI 10.1007/s00265-007-0516-x; INGLE DJ, 1990, BIOSCIENCE, V40, P284, DOI 10.2307/1311265; JAEGER RG, 1976, COPEIA, P833; King C.M., 1985, Symposia of the Zoological Society of London, P219; King JR, 1996, J COMP PHYSIOL A, V178, P293; Kullberg C, 1998, P ROY SOC B-BIOL SCI, V265, P1659, DOI 10.1098/rspb.1998.0485; Kullberg C, 2007, BEHAV ECOL SOCIOBIOL, V61, P1555, DOI 10.1007/s00265-007-0387-1; Lagos PA, 2014, ANIM BEHAV, V97, P221, DOI 10.1016/j.anbehav.2014.09.019; Langerhans R. Brian, 2007, P177, DOI 10.1007/978-3-540-46046-6_10; Lind J, 2002, NATURWISSENSCHAFTEN, V89, P420, DOI 10.1007/s00114-002-0345-8; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; MARCHISIN A, 1978, J HERPETOL, V12, P151, DOI 10.2307/1563401; Martin J, 1996, J COMP PSYCHOL, V110, P187; Nakagawa H, 2010, STUD COMPUT INTELL, V266, P109; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Page RA, 2008, ANIM BEHAV, V76, P761, DOI 10.1016/j.anbehav.2008.05.006; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PENNYCUICK CJ, 1994, J AVIAN BIOL, V25, P39, DOI 10.2307/3677292; Pewsey A, 2013, CIRCULAR STAT R; Poulin B, 2001, J TROP ECOL, V17, P21, DOI 10.1017/S026646740100102X; Rao JS., 2001, TOPICS CIRCULAR STAT; Rose A.B., 1997, Australian Bird Watcher, V17, P25; Royan A, 2010, CAN J ZOOL, V88, P922, DOI 10.1139/Z10-059; Ryan M. J., 1985, TUNGARA FROG STUDY S; RYAN MJ, 1981, BEHAV ECOL SOCIOBIOL, V8, P273, DOI 10.1007/BF00299526; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Schnitzler Hans-Ulrich, 1998, P183; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Tucker VA, 1998, J EXP BIOL, V201, P403; TUTTLE MD, 1982, ANIM BEHAV, V30, P393, DOI 10.1016/S0003-3472(82)80050-X; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; TUTTLE MD, 1981, BIOTROPICA, V13, P233, DOI 10.2307/2388132; Warrick DR, 1998, CAN J ZOOL, V76, P1063, DOI 10.1139/cjz-76-6-1063	62	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120546	10.1371/journal.pone.0120546	http://dx.doi.org/10.1371/journal.pone.0120546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874798	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800011
J	Cizauskas, CA; Turner, WC; Pitts, N; Getz, WM				Cizauskas, Carrie A.; Turner, Wendy C.; Pitts, Neville; Getz, Wayne M.			Seasonal Patterns of Hormones, Macroparasites, and Microparasites in Wild African Ungulates: The Interplay among Stress, Reproduction, and Disease	PLOS ONE			English	Article							ETOSHA-NATIONAL-PARK; TRICHOSTRONGYLUS-COLUBRIFORMIS; HAEMONCHUS-CONTORTUS; CORTISOL METABOLITES; PHYSIOLOGICAL STRESS; IMMUNE-RESPONSES; FOOD USE; PARASITES; SPRINGBOK; RESISTANCE	Sex hormones, reproductive status, and pathogen load all affect stress. Together with stress, these factors can modulate the immune system and affect disease incidence. Thus, it is important to concurrently measure these factors, along with their seasonal fluctuations, to better understand their complex interactions. Using steroid hormone metabolites from fecal samples, we examined seasonal correlations among zebra and springbok stress, reproduction, gastrointestinal (GI) parasite infections, and anthrax infection signatures in zebra and springbok in Etosha National Park (ENP), Namibia, and found strong seasonal effects. Infection intensities of all three GI macroparasites examined (strongyle helminths, Strongyloides helminths, and Eimeria coccidia) were highest in the wet season, concurrent with the timing of anthrax outbreaks. Parasites also declined with increased acquired immune responses. We found hormonal evidence that both mares and ewes are overwhelmingly seasonal breeders in ENP, and that reproductive hormones are correlated with immunosuppression and higher susceptibility to GI parasite infections. Stress hormones largely peak in the dry season, particularly in zebra, when parasite infection intensities are lowest, and are most strongly correlated with host mid-gestation rather than with parasite infection intensity. Given the evidence that GI parasites can cause host pathology, immunomodulation, and immunosuppression, their persistence in ENP hosts without inducing chronic stress responses supports the hypothesis that hosts are tolerant of their parasites. Such tolerance would help to explain the ubiquity of these organisms in ENP herbivores, even in the face of their potential immunomodulatory trade-offs with anti-anthrax immunity.	[Cizauskas, Carrie A.; Turner, Wendy C.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Cizauskas, Carrie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Turner, Wendy C.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Pitts, Neville] Univ Witwatersrand, Sch Physiol, Johannesburg, South Africa; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of California System; University of California Berkeley; Princeton University; University of Oslo; University of Witwatersrand; University of Kwazulu Natal	Cizauskas, CA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	cizauskas@gmail.com	; Getz, Wayne/I-4521-2013	Pitts, Neville/0000-0001-6432-6112; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health Ecology and Evolution of Infectious Diseases [GM83863]; Andrew and Mary Thompson Rocca Scholarships; University of California, Berkeley, Department of Environmental Science, Policy, and Management; University of California, Berkeley, Graduate Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health Ecology and Evolution of Infectious Diseases; Andrew and Mary Thompson Rocca Scholarships; University of California, Berkeley, Department of Environmental Science, Policy, and Management(University of California System); University of California, Berkeley, Graduate Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Ecology and Evolution of Infectious Diseases grant #GM83863 to WMG (http://www.fic.nih.gov/programs/Pages/ecology-infectiousdiseases.aspx); Andrew and Mary Thompson Rocca Scholarships to CAC (http://africa.berkeley.edu/fellowships/Rocca.php); University of California, Berkeley, Department of Environmental Science, Policy, and Management block grants and continuing fellowships to CAC (http://ourenvironment.berkeley.edu/current-graduate-students/funding/); and University of California, Berkeley, Graduate Division Summer Grants to CAC (http://grad.berkeley.edu/news/egrad/february-2013/summer-grant-2013/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Archie EA, 2012, P NATL ACAD SCI USA, V109, P9017, DOI 10.1073/pnas.1206391109; Asa CS, 2001, ZOO BIOL, V20, P185, DOI 10.1002/zoo.1019; Auer C., 1997, Madoqua, V20, P121; BANKS DJD, 1990, INT J PARASITOL, V20, P155, DOI 10.1016/0020-7519(90)90095-5; Barnier F, 2012, ACTA OECOL, V42, P11, DOI 10.1016/j.actao.2011.11.007; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beasley AM, 2010, VET PARASITOL, V168, P60, DOI 10.1016/j.vetpar.2009.08.028; Bellan SE, 2013, METHODS ECOL EVOL, V4, P361, DOI 10.1111/2041-210x.12021; BIGGS HC, 1984, ONDERSTEPOORT J VET, V51, P175; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bowman DD, 2014, GEORGIS PARASITOLOGY, V10th; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; Cizauskas CA, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0027-3; Cizauskas CA, 2014, J ANIM ECOL, V83, P1078, DOI 10.1111/1365-2656.12207; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cornell SJ, 2008, P ROY SOC B-BIOL SCI, V275, P511, DOI 10.1098/rspb.2007.1415; Daugschies A, 2005, J VET MED B, V52, P417, DOI 10.1111/j.1439-0450.2005.00894.x; DELGIUDICE GD, 1992, CAN J ZOOL, V70, P974, DOI 10.1139/z92-139; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Engert S., 1997, Madoqua, V20, P115; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Ezenwa VO, 2012, FUNCT ECOL, V26, P123, DOI 10.1111/j.1365-2435.2011.01919.x; Foerster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050108; Fox J., 2019, R COMPANION APPL REG, V.; Gasaway WC, 1996, CAN J ZOOL, V74, P1556, DOI 10.1139/z96-170; Gibbons LM, 2005, MCMASTER EGG COUNTIN; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Grear DA, 2009, ECOL LETT, V12, P528, DOI 10.1111/j.1461-0248.2009.01306.x; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HOLM S, 1979, SCAND J STAT, V6, P65; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P253; Kamath PL, 2014, P R SOC B, V281, P1; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Khansari D, 1999, IMMUNOL TODAY, V11, P170; Leggett HC, 2013, TRENDS ECOL EVOL, V28, P592, DOI 10.1016/j.tree.2013.07.002; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; Linklater WL, 2010, ANIM CONSERV, V13, P104, DOI 10.1111/j.1469-1795.2009.00308.x; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Little SF, 1997, INFECT IMMUN, V65, P5171, DOI 10.1128/IAI.65.12.5171-5175.1997; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Martinaud G, 2009, INT J PARASITOL, V39, P735, DOI 10.1016/j.ijpara.2008.11.006; Martinez-de la Puente J, 2011, NATURWISSENSCHAFTEN, V98, P99, DOI 10.1007/s00114-010-0746-z; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Monello RJ, 2010, J ZOOL, V282, P100, DOI 10.1111/j.1469-7998.2010.00717.x; Monfort SL, 1997, ZOO BIOL, V16, P533, DOI 10.1002/(SICI)1098-2361(1997)16:6<533::AID-ZOO6>3.0.CO;2-B; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; NAGY KA, 1994, J MAMMAL, V75, P860, DOI 10.2307/1382468; NAGY KA, 1994, AUST J ZOOL, V42, P55, DOI 10.1071/ZO9940055; Ncube H, 2011, GEN COMP ENDOCR, V172, P358, DOI 10.1016/j.ygcen.2011.03.027; Nielsen MK, 2007, VET J, V174, P23, DOI 10.1016/j.tvjl.2006.05.009; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Olleova M, 2012, J ZOOL, V288, P127, DOI 10.1111/j.1469-7998.2012.00930.x; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pickering AK, 2004, INFECT IMMUN, V72, P3069, DOI 10.1128/IAI.72.5.3069-3072.2004; Pilosof S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041487; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rowe A, 2008, VET PARASITOL, V153, P285, DOI 10.1016/j.vetpar.2008.01.040; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; SALTZ D, 1991, J WILDLIFE MANAGE, V55, P1, DOI 10.2307/3809235; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Skinner DC, 2002, REPRODUCTION, V124, P509, DOI 10.1530/rep.0.1240509; Skinner DC, 2001, BIOL REPROD, V64, P1176, DOI 10.1095/biolreprod64.4.1176; SMUTS G L, 1974, Journal of the Southern African Wildlife Management Association, V4, P103; Team R, 2013, R LANG ENV STAT COMP; Turner WC, 2009, ECOLOGY ORALLY INGES; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; Turner WC, 2012, J ANIM ECOL, V81, P58, DOI 10.1111/j.1365-2656.2011.01892.x; Turner WC, 2010, J WILDLIFE DIS, V46, P1108, DOI 10.7589/0090-3558-46.4.1108; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Venables WN., 2002, MODERN APPL STAT S 4; Vera F, 2013, J ZOOL, V289, P111, DOI 10.1111/j.1469-7998.2012.00967.x; Vergouw D, 2012, J MANIP PHYSIOL THER, V35, P464, DOI 10.1016/j.jmpt.2012.07.002; Villanua D, 2006, PARASITOLOGY, V133, P251, DOI 10.1017/S003118200600031X; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Voyles J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035374; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Yun CH, 2000, DEV COMP IMMUNOL, V24, P303, DOI 10.1016/S0145-305X(99)00080-4; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	101	45	45	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120800	10.1371/journal.pone.0120800	http://dx.doi.org/10.1371/journal.pone.0120800			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875647	Green Published, gold			2022-12-27	WOS:000353015800015
J	Han, LM; Haron, Z; Yahya, K; Abu Bakar, S; Dimon, MN				Han, Lim Ming; Haron, Zaiton; Yahya, Khairulzan; Abu Bakar, Suhaimi; Dimon, Mohamad Ngasri			A Stochastic Simulation Framework for the Prediction of Strategic Noise Mapping and Occupational Noise Exposure Using the Random Walk Approach	PLOS ONE			English	Article							CONSTRUCTION EQUIPMENT; ENVIRONMENTAL NOISE; IMPACT ASSESSMENT; HEARING-LOSS; WORKERS; POLLUTION; METROPOLIS; MODELS; SITES; MAP	Strategic noise mapping provides important information for noise impact assessment and noise abatement. However, producing reliable strategic noise mapping in a dynamic, complex working environment is difficult. This study proposes the implementation of the random walk approach as a new stochastic technique to simulate noise mapping and to predict the noise exposure level in a workplace. A stochastic simulation framework and software, namely RW-eNMS, were developed to facilitate the random walk approach in noise mapping prediction. This framework considers the randomness and complexity of machinery operation and noise emission levels. Also, it assesses the impact of noise on the workers and the surrounding environment. For data validation, three case studies were conducted to check the accuracy of the prediction data and to determine the efficiency and effectiveness of this approach. The results showed high accuracy of prediction results together with a majority of absolute differences of less than 2 dBA; also, the predicted noise doses were mostly in the range of measurement. Therefore, the random walk approach was effective in dealing with environmental noises. It could predict strategic noise mapping to facilitate noise monitoring and noise control in the workplaces.	[Han, Lim Ming; Haron, Zaiton; Yahya, Khairulzan; Abu Bakar, Suhaimi] Univ Teknol Malaysia, Fac Civil Engn, Skudai, Malaysia; [Dimon, Mohamad Ngasri] Univ Teknol Malaysia, Fac Elect Engn, Skudai, Malaysia	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Haron, Z (corresponding author), Univ Teknol Malaysia, Fac Civil Engn, Skudai, Malaysia.	zaitonharon@utm.my	haron, zaiton/O-3067-2013; Abu Bakar, Suhaimi/N-1149-2017; Yahya, Khairulzan/K-6831-2012	haron, zaiton/0000-0002-3622-3375; Yahya, Khairulzan/0000-0002-4089-4438; MING HAN, LIM/0000-0003-4196-3201	Malaysian Ministry of Higher Education [GUP, QJ13000.2522.03H43]	Malaysian Ministry of Higher Education	The author ZH received the funding from the Malaysian Ministry of Higher Education (grant number: GUP Vot no. QJ13000.2522.03H43 [http://jpt.mohe.gov.my/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghonamy AI, 2010, J ENV SCI TECHNOLOGY, P1; [Anonymous], 2009, 52281 BSI; [Anonymous], 2008, 6393 BS ISO; [Anonymous], 2002, 616721 IEC; [Anonymous], 2010, 3744 EN ISO BSI; Arezes PM, 2006, INT J IND ERGONOM, V36, P1037, DOI 10.1016/j.ergon.2006.09.005; Armah FA, 2010, ENVIRON HAZARDS-UK, V9, P358, DOI 10.3763/ehaz.2010.0003; Asensio C, 2011, APPL ACOUST, V72, P599, DOI 10.1016/j.apacoust.2010.12.007; Barber M., 1970, RANDOM RESTRICTED WA; Barkokebas B, 2012, WORK, V41, P2982, DOI 10.3233/WOR-2012-0553-2982; BECHARA W, 1994, AIAA J, V32, P455, DOI 10.2514/3.12008; Bite P, 2005, BUDAPEST NOISE MAPPI, P981; BORG E, 1983, HEARING RES, V9, P247, DOI 10.1016/0378-5955(83)90029-1; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Cardoso Antonio Paes, 2006, Rev Port Pneumol, V12, P45; Chevalier S, 1999, J HYDROL, V222, P129, DOI 10.1016/S0022-1694(99)00108-0; Crocker MJ, 2007, HDB NOISE VIBRATION, P19; Cvetkovic V, 2012, ADV WATER RESOUR, V36, P98, DOI 10.1016/j.advwatres.2011.06.008; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; Dearden A, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1440; Department of Environment, 2007, PLANN GUID ENV NOIS; Dowling JL, 2012, BEHAV ECOL, V23, P201, DOI 10.1093/beheco/arr176; Doygun H, 2008, ENVIRON MONIT ASSESS, V142, P65, DOI 10.1007/s10661-007-9908-7; Dshalalow JH, 2006, MATH COMPUT MODEL, V44, P931, DOI 10.1016/j.mcm.2006.02.022; Edwards CG, 2006, AM J EPIDEMIOL, V163, P327, DOI 10.1093/aje/kwj044; Eldien HH, 2009, CIE: 2009 INTERNATIONAL CONFERENCE ON COMPUTERS AND INDUSTRIAL ENGINEERING, VOLS 1-3, P1722, DOI 10.1109/ICCIE.2009.5223696; Eleftheriou PC, 2002, APPL ACOUST, V63, P35, DOI 10.1016/S0003-682X(01)00022-6; Erguler K, 2008, MATH BIOSCI, V216, P90, DOI 10.1016/j.mbs.2008.08.012; European Commission, 2016, EV DIR 2002 49 EC RE, DOI 10.2779/171432; Fernandez MD, 2009, APPL ACOUST, V70, P753, DOI 10.1016/j.apacoust.2008.07.014; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Hamoda MF, 2008, J CONSTR DEV CTRIES, V13, P79; Haron Z., 2008, MALAYSIAN J CIVIL EN, V20, P58; Haron Z, 2005, P I ACOUSTICS, V27, P4; Haron Z, 2004, J RECENT RES DEV SOU, V2, P213; Haron Z, 2012, ENER EDUC SCI TECH-A, V29, P989; Haron Z, 2009, J ASIAN ARCHIT BUILD, V8, P571, DOI 10.3130/jaabe.8.571; Hola B, 2010, AUTOMAT CONSTR, V19, P570, DOI 10.1016/j.autcon.2010.02.004; Hothersall DC, 2000, J SOUND VIB, V234, P207, DOI 10.1006/jsvi.1999.2886; Merchan CI, 2013, SCI TOTAL ENVIRON, V449, P115, DOI 10.1016/j.scitotenv.2013.01.063; Inoue M, 2010, ARCH ENV OCCUPATIONA, V60, P106; Ballesteros MJ, 2010, BUILD ENVIRON, V45, P711, DOI 10.1016/j.buildenv.2009.08.011; Karamalis A, 2012, MED IMAGE ANAL, V16, P1101, DOI 10.1016/j.media.2012.07.005; Kim Y, 2010, ASIAN NURS RES, V4, P10, DOI 10.1016/S1976-1317(10)60002-3; Knighton J, 2014, ECOL INFORM, V19, P1, DOI 10.1016/j.ecoinf.2013.11.001; Ko JH, 2011, APPL ACOUST, V72, P544, DOI 10.1016/j.apacoust.2010.09.002; Kock S, 2012, OCCUPATIONAL ENV MED, V61, P838; Kujala T, 2009, BIOL PSYCHOL, V81, P135, DOI 10.1016/j.biopsycho.2009.03.010; Kumicak J, 2004, NATO SCI SER II-MATH, V151, P61; Lee SW, 2008, APPL ACOUST, V69, P704, DOI 10.1016/j.apacoust.2007.02.009; Legris M, 1998, AM IND HYG ASSOC J, V59, P774, DOI 10.1202/0002-8894(1998)059<0774:NEPAHE>2.0.CO;2; Leonard ML, 2008, BEHAV ECOL, V19, P502, DOI 10.1093/beheco/arm161; LI H, 1995, BUILD RES INF, V23, P205, DOI 10.1080/09613219508727460; Lima EJA, 2004, APPL ECON LETT, V11, P255, DOI 10.1080/13504850410001674911; Manatakis E, 2002, APPL ACOUST, V63, P759, DOI 10.1016/S0003-682X(01)00073-1; Miyakita T, 1997, J SOUND VIB, V205, P441, DOI 10.1006/jsvi.1997.1010; Moudon AV, 2009, AM J PREV MED, V37, P167, DOI 10.1016/j.amepre.2009.03.019; Murphy E, 2011, APPL ACOUST, V72, P487, DOI 10.1016/j.apacoust.2010.10.006; Murphy E, 2006, 8 INT S TRANSP NOIS; Nanthavanij S, 1999, INT J IND ERGONOM, V23, P123; Nanthavanij S, 1999, INT J PROD ECON, V60-1, P319, DOI 10.1016/S0925-5273(98)00190-X; Neitzel R, 1999, AM IND HYG ASSOC J, V60, P807; Nelson J, 2004, COORDIN CHEM REV, V248, P1181, DOI 10.1016/j.ccr.2004.04.001; Oliver C, 2009, MARKOV PROCESSES STO; Oyedepo Sunday Olayinka, 2013, International Journal of Environmental Studies, V70, P503, DOI 10.1080/00207233.2013.813716; Paton D, 2012, LANDSCAPE URBAN PLAN, V104, P1, DOI 10.1016/j.landurbplan.2011.09.002; Pradhananga N, 2013, AUTOMAT CONSTR, V29, P107, DOI 10.1016/j.autcon.2012.09.004; Rachiotis G, 2006, AURIS NASUS LARYNX, V33, P381, DOI 10.1016/j.anl.2006.03.008; Ramirez A, 2012, APPLIED ACO IN PRESS; Rylander R, 2004, J SOUND VIB, V277, P471, DOI 10.1016/j.jsv.2004.03.008; Schreier AL, 2010, ANIM BEHAV, V80, P75, DOI 10.1016/j.anbehav.2010.04.002; Seixas NS, 2005, OCCUP ENVIRON MED, V62, P309, DOI 10.1136/oem.2004.018143; Seixas NS, 2001, AIHAJ, V62, P615; Smith SD, 1999, J CONSTR ENG M ASCE, V125, P133, DOI 10.1061/(ASCE)0733-9364(1999)125:3(133); Spitzer F, 1975, PRINCIPLES RANDOM WA; Tak S, 2009, AM J IND MED, V52, P358, DOI 10.1002/ajim.20690; Thurston FE, 2012, AM J IND MED, P1; Zannin PHT, 2011, APPL ACOUST, V72, P479, DOI 10.1016/j.apacoust.2010.09.014; Tsai KT, 2009, APPL ACOUST, V70, P964, DOI 10.1016/j.apacoust.2008.11.001; Verma A, 2014, COMPUTERS O IN PRESS; Vogiatzis K, 2014, SCI TOTAL ENVIRON, V482, P420, DOI 10.1016/j.scitotenv.2013.07.098; Yang JL, 2003, AUTOMAT CONSTR, V12, P725, DOI 10.1016/S0926-5805(03)00056-6; Zannin PHT, 2012, CITIES IN PRESS; Zhang H, 2014, J CLEAN PROD, V76, P85, DOI 10.1016/j.jclepro.2014.04.021; Zolfagharian Samaneh, 2012, Proceedings of the 2012 Construction Research Congress, P1750; [No title captured]	86	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120667	10.1371/journal.pone.0120667	http://dx.doi.org/10.1371/journal.pone.0120667			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875019	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800012
J	Maestri, R; Fornel, R; Galiano, D; de Freitas, TRO				Maestri, Renan; Fornel, Rodrigo; Galiano, Daniel; de Freitas, Thales R. O.			Niche Suitability Affects Development: Skull Asymmetry Increases in Less Suitable Areas	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; SPECIES DISTRIBUTION; PRIORITY AREAS; SPATIAL AUTOCORRELATION; POTENTIAL DISTRIBUTION; ECOLOGICAL THEORY; CONSERVATION; POPULATIONS; PATTERNS; RODENTIA	For conservation purposes, it is important to take into account the suitability of a species to particular habitats; this information may predict the long-term survival of a species. In this sense, morphological measures of developmental stress, such as fluctuating asymmetry, can be proxies for an individual's performance in different regions. In this study, we conducted tests to determine whether areas with different levels of suitability for a species (generated by ecological niche models) were congruent with morphological markers that reflect environmental stress and morphological variance. We generated a Maxent niche model and compared the suitability assessments of several areas with the skull morphology data (fluctuating asymmetry and morphological disparity) of populations of the Atlantic forest endemic to Brazil rodent Akodon cursor. Our analyses showed a significant negative relationship between suitability levels and fluctuating asymmetry levels, which indicates that in less suitable areas, the individuals experience numerous disturbances during skull ontogeny. We have not found an association between morphological variance and environmental suitability. As expected, these results suggest that in environments with a lower suitability, developmental stress is increased. Such information is helpful in the understanding of the species evolution and in the selection of priority areas for the conservation of species.	[Maestri, Renan] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil; [Fornel, Rodrigo] Univ Reg Integrada Alto Uruguai & Missoes, Programa Posgrad Ecol, Erechim, RS, Brazil; [Galiano, Daniel] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [de Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Maestri, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil.	renanmaestri@gmail.com	Maestri, Renan/L-2637-2015; Galiano, Daniel/O-1671-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012; Fornel, Rodrigo/D-7538-2017; Galiano, Daniel/ABV-4574-2022	Maestri, Renan/0000-0001-9134-2943; Galiano, Daniel/0000-0003-1428-8634; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; 	Coordenadoria de Aperfeicoamento Pessoal (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq; CAPES; Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs)	Coordenadoria de Aperfeicoamento Pessoal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	RM and DG received student fellowships from the Coordenadoria de Aperfeicoamento Pessoal (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), respectively. TROF received financial support from CNPq, CAPES, and Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alvarado-Serrano DF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-160; Aparicio JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P273, DOI 10.1007/s002650000302; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Begon M., 2009, ECOLOGY INDIVIDUALS; Bergstrom CA, 2000, BEHAVIOUR, V137, P1097, DOI 10.1163/156853900502457; Bernardo-Silva J, 2012, NAT CONSERVACAO, V10, P207, DOI 10.4322/natcon.2012.026; Bonn A, 1996, OECOLOGIA, V108, P596, DOI 10.1007/BF00329031; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Butler DW, 2009, BIOL CONSERV, V142, P2202, DOI 10.1016/j.biocon.2009.04.023; Cadee N, 2000, J EVOLUTION BIOL, V13, P359; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; Christoff AU, 2000, J MAMMAL, V81, P838, DOI 10.1644/1545-1542(2000)081<0838:DOANSO>2.3.CO;2; Christoff AU, 2008, IUCN 2014 IUCN RED L; Cooley JR, 2004, ETHOLOGY, V110, P745, DOI 10.1111/j.1439-0310.2004.00993.x; Culumber ZW, 2013, NATURWISSENSCHAFTEN, V100, P801, DOI 10.1007/s00114-013-1072-z; DeLeon VB, 2007, AM J PHYS ANTHROPOL, V132, P520, DOI 10.1002/ajpa.20549; Diniz J, 2009, TREE GENET GENOMES, V5, P617, DOI 10.1007/s11295-009-0214-0; Doko T., 2008, ISPRS 2008, P267; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Ducarme Frederic, 2013, BIOSCIENCES MASTER R, P1, DOI DOI 10.1080/08927936.2015.1052279; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Galeotti P, 2005, EVOL ECOL, V19, P405, DOI 10.1007/s10682-005-8309-z; Galiano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097301; Galiano D, 2013, MAMMALIA, V77, P173, DOI 10.1515/mammalia-2011-0128; Gangestad SW, 1999, J EVOLUTION BIOL, V12, P402, DOI 10.1046/j.1420-9101.1999.00039.x; Gaubert P, 2006, BIOL CONSERV, V130, P106, DOI 10.1016/j.biocon.2005.12.006; Geise Lena, 2012, Mammalian Species, P33, DOI 10.1644/893.1; Gkaraveli A, 2004, BIOL CONSERV, V115, P395, DOI 10.1016/S0006-3207(03)00155-1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Klingenberg CP, 2010, ALCOHOL, V44, P649, DOI 10.1016/j.alcohol.2009.10.016; Klingenberg Christian Peter, 2003, P427; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Maestri R, 2014, ACTA THERIOL, V59, P427, DOI 10.1007/s13364-014-0177-x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Martinez JJ, 2014, BIOL J LINN SOC, V112, P180, DOI 10.1111/bij.12268; May SE, 2011, BIOL CONSERV, V144, P1441, DOI 10.1016/j.biocon.2011.01.013; Meloro C, 2014, EVOL BIOL, V41, P38, DOI 10.1007/s11692-013-9244-5; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nori J, 2013, BIOL CONSERV, V159, P507, DOI 10.1016/j.biocon.2012.11.020; OWEN RD, 1990, TEX J SCI, V42, P319; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pearson R. G., 2007, SYNTHESIS AM MUSEUM, V50; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Polak M, 2008, EVOL BIOL, V35, P208, DOI 10.1007/s11692-008-9032-9; Prieto MH, 2005, EVOL ECOL, V19, P517, DOI 10.1007/s10682-005-0883-6; R Core Team, 2014, R LANG STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Rohlf, 2010, TPSDIG2 VERSION 216; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; WARD RE, 1991, J CRAN GENET DEV BIO, V11, P156; Willmore KE, 2005, EVOLUTION, V59, P898; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	75	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122412	10.1371/journal.pone.0122412	http://dx.doi.org/10.1371/journal.pone.0122412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874364	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800056
J	Nishimura, S; Bilguvar, K; Ishigame, K; Sestan, N; Gunel, M; Louvi, A				Nishimura, Sayoko; Bilguevar, Kaya; Ishigame, Keiko; Sestan, Nenad; Guenel, Murat; Louvi, Angeliki			Functional Synergy between Cholecystokinin Receptors CCKAR and CCKBR in Mammalian Brain Development	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; CINGULATE PIONEERING AXONS; GENE KNOCKOUT MICE; CORPUS-CALLOSUM; CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; NMDA RECEPTORS; FOOD-INTAKE; IN-VIVO; SPECIES-DIFFERENCES	Cholecystokinin (CCK), a peptide hormone and one of the most abundant neuropeptides in vertebrate brain, mediates its actions via two G-protein coupled receptors, CCKAR and CCKBR, respectively active in peripheral organs and the central nervous system. Here, we demonstrate that the CCK receptors have a dynamic and largely reciprocal expression in embryonic and postnatal brain. Using compound homozygous mutant mice lacking the activity of both CCK receptors, we uncover their additive, functionally synergistic effects in brain development and demonstrate that CCK receptor loss leads to abnormalities of cortical development, including defects in the formation of the midline and corpus callosum, and cortical interneuron migration. Using comparative transcriptome analysis of embryonic neocortex, we define the molecular mechanisms underlying these defects. Thus we demonstrate a developmental, hitherto unappreciated, role of the two CCK receptors in mammalian neocortical development.	[Nishimura, Sayoko; Ishigame, Keiko; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Bilguevar, Kaya; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Yale Program Neurogenet, New Haven, CT USA; [Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bilguevar, Kaya] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Sestan, Nenad; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Louvi, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angeliki.louvi@yale.edu	Nishimura, Sayoko/F-4648-2015		Yale Program on Neurogenetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Yale Program on Neurogenetics.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alcantara S, 1998, J NEUROSCI, V18, P7779; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; BURGUNDER JM, 1990, J COMP NEUROL, V300, P26, DOI 10.1002/cne.903000104; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Campos CA, 2013, ENDOCRINOLOGY, V154, P2613, DOI 10.1210/en.2013-1062; Campos CA, 2012, ENDOCRINOLOGY, V153, P2633, DOI 10.1210/en.2012-1025; Cariboni A, 2007, J NEUROSCI, V27, P2387, DOI 10.1523/JNEUROSCI.5075-06.2007; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Caronia-Brown G, 2011, CEREB CORTEX, V21, P748, DOI 10.1093/cercor/bhq142; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chen QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015999; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Edwards TJ, 2014, BRAIN J NEUROLOGY; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; GAUDREAU P, 1983, PEPTIDES, V4, P755, DOI 10.1016/0196-9781(83)90032-3; Giacobini P, 2004, J NEUROSCI, V24, P4737, DOI 10.1523/JNEUROSCI.0649-04.2004; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HILL DR, 1987, J NEUROSCI, V7, P2967; HILL DR, 1987, NEUROSCI LETT, V79, P286, DOI 10.1016/0304-3940(87)90445-9; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; Horinouchi Y, 2004, EUR NEUROPSYCHOPHARM, V14, P157, DOI 10.1016/S0924-977X(03)00103-2; Hu ZL, 2003, J NEUROSCI, V23, P10963; INGRAM SM, 1989, J COMP NEUROL, V287, P260, DOI 10.1002/cne.902870209; Ivy AC, 1928, AM J PHYSIOL, V86, P599, DOI 10.1152/ajplegacy.1928.86.3.599; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KOESTER SE, 1994, J NEUROSCI, V14, P6608; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; Kubota Y, 1997, BRAIN RES, V752, P175, DOI 10.1016/S0006-8993(96)01446-1; Lacourse KA, 1999, AM J PHYSIOL-GASTR L, V276, pG1302, DOI 10.1152/ajpgi.1999.276.5.G1302; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SY, 2011, DEV NEUROBIOL, V71, P83, DOI 10.1002/dneu.20815; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Liapi A, 2008, DEV NEUROSCI-BASEL, V30, P117, DOI 10.1159/000109857; Lo CMC, 2012, ENDOCRINOLOGY, V153, P5857, DOI 10.1210/en.2012-1427; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Matta JA, 2013, NAT NEUROSCI, V16, P1032, DOI 10.1038/nn.3459; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; MICELI MO, 1989, EUR J PHARMACOL, V169, P215, DOI 10.1016/0014-2999(89)90018-6; Miyasaka K, 1999, PANCREAS, V19, P114, DOI 10.1097/00006676-199908000-00002; Miyasaka K, 2004, J GASTROENTEROL, V39, P319, DOI 10.1007/s00535-003-1297-2; Miyasaka K, 2002, J NUTR, V132, P739, DOI 10.1093/jn/132.4.739; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Mohammad S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416214; MORAN TH, 1986, BRAIN RES, V362, P175, DOI 10.1016/0006-8993(86)91413-7; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Morozov YM, 2009, CEREB CORTEX, V19, pI78, DOI 10.1093/cercor/bhp028; Nagata A, 1996, P NATL ACAD SCI USA, V93, P11825, DOI 10.1073/pnas.93.21.11825; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Noble F, 2002, NEUROPEPTIDES, V36, P157, DOI 10.1054/npep.2002.0904; Noble F., 2006, HDB NEUROCHEMISTRY M, P545; NUNZI MG, 1985, J COMP NEUROL, V237, P485, DOI 10.1002/cne.902370406; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Rehfeld JF, 2007, CURR TOP MED CHEM, V7, P1154; Rehfeld JF, 2006, J MOL MED-JMM, V84, P544, DOI 10.1007/s00109-006-0055-3; Rindi G, 1998, YALE J BIOL MED, V71, P347; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Sanchez-Camacho C, 2011, DEV NEUROBIOL, V71, P337, DOI 10.1002/dneu.20865; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Schwarting GA, 2006, J NEUROSCI, V26, P6834, DOI 10.1523/JNEUROSCI.1728-06.2006; SEKIGUCHI R, 1986, BRAIN RES, V399, P271, DOI 10.1016/0006-8993(86)91517-9; Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Silver J, 1993, Perspect Dev Neurobiol, V1, P227; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; Stanic D, 2008, P NATL ACAD SCI USA, V105, P3610, DOI 10.1073/pnas.0712303105; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sui Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00013; Sui Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031549; Tanriover G, 2008, NEUROSURGERY, V62, P930, DOI 10.1227/01.neu.0000318179.02912.ca; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; VANDERHAEGHEN JJ, 1975, NATURE, V257, P604, DOI 10.1038/257604a0; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wahlsten D, 2006, GENES BRAIN BEHAV, V5, P170, DOI 10.1111/j.1601-183X.2005.00153.x; WAHLSTEN D, 1982, BRAIN RES, V239, P329, DOI 10.1016/0006-8993(82)90513-3; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Watakabe A, 2012, J COMP NEUROL, V520, P3553, DOI 10.1002/cne.23160; WILLIAMS JA, 1986, PEPTIDES, V7, P293, DOI 10.1016/0196-9781(86)90228-7; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Xiao ZY, 2012, HIPPOCAMPUS, V22, P1438, DOI 10.1002/hipo.20984; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zwanzger P, 2012, DEPRESS ANXIETY, V29, P762, DOI 10.1002/da.21919	133	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124295	10.1371/journal.pone.0124295	http://dx.doi.org/10.1371/journal.pone.0124295			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875176	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800136
J	Omodaka, K; Horii, T; Takahashi, S; Kikawa, T; Matsumoto, A; Shiga, Y; Maruyama, K; Yuasa, T; Akiba, M; Nakazawa, T				Omodaka, Kazuko; Horii, Takaaki; Takahashi, Seri; Kikawa, Tsutomu; Matsumoto, Akiko; Shiga, Yukihiro; Maruyama, Kazuichi; Yuasa, Tetsuya; Akiba, Masahiro; Nakazawa, Toru			3D Evaluation of the Lamina Cribrosa with Swept-Source Optical Coherence Tomography in Normal Tension Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; REGIONAL DIFFERENCES; THICKNESS; EYES; REPRODUCIBILITY; APOPTOSIS; HEALTHY; HEAD; OCT	Purpose Although the lamina cribrosa (LC) is the primary site of axonal damage in glaucoma, adequate methods to image and measure it are currently lacking. Here, we describe a noninvasive, in vivo method of evaluating the LC, based on swept-source optical coherence tomography (SS-OCT), and determine this method's ability to quantify LC thickness. Methods This study comprised 54 eyes, including normal (n = 18), preperimetric glaucoma (PPG; n = 18), and normal tension glaucoma (NTG; n = 18) eyes. We used SS-OCT to obtain 3 x 3 mm cube scans of an area centered on the optic disc, and then synchronized reconstructed Band en-face images from this data. We identified the LC in these B-scan images by marking the visible borders of the LC pores. We marked points on the anterior and posterior borders of the LC in 12 B-scan images in order to create a skeleton model of the LC. Finally, we used B-spline interpolation to form a 3D model of the LC, including only reliably measured scan areas. We calculated the average LC thickness (avgLCT) in this model and used Spearman's rank correlation coefficient to compare it with circumpapillary retinal nerve fiber layer thickness (cpRNFLT). Results We found that the correlation coefficient of avgLCT and cpRNFLT was 0.64 (p < 0.01). The coefficient of variation for avgLCT was 5.1%. AvgLCT differed significantly in the groups (normal: 282.6 +/- 20.6 mu m, PPG: 261.4 +/- 15.8 mu m, NTG: 232.6 +/- 33.3 mu m). The normal, PPG and NTG groups did not significantly differ in age, sex, refractive error or intraocular pressure (IOP), although the normal and NTG groups differed significantly in cpRNFLT and Humphrey field analyzer measurements of mean deviation. Conclusion Thus, our results indicate that the parameters of our newly developed method of measuring LC thickness with SS-OCT may provide useful and important data for glaucoma diagnosis and research.	[Omodaka, Kazuko; Takahashi, Seri; Shiga, Yukihiro; Maruyama, Kazuichi; Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Horii, Takaaki; Yuasa, Tetsuya] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Kikawa, Tsutomu; Matsumoto, Akiko; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Yamagata University; Topcon Corporation; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	JST grant from JSPS KAKENHI [T.N. 26293372, T.N. 26670751]; JST Center for Revitalization Promotion	JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion	This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372) and for Exploratory Research (T.N. 26670751), and by the JST Center for Revitalization Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Anderson DR., 1999, AUTOMATED STATIC PER; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, pO290; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P7576, DOI 10.1167/iovs.12-10305; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Mardin CY, 2001, CURR OPIN OPHTHALMOL, V12, P100, DOI 10.1097/00055735-200104000-00004; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Naithani P, 2007, INVEST OPHTH VIS SCI, V48, P3138, DOI 10.1167/iovs.06-1407; Okisaka S, 1997, JPN J OPHTHALMOL, V41, P84, DOI 10.1016/S0021-5155(97)00013-0; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P765; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park HY Lopilly, 2013, AM J OPHTHALMOL; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Pollet-Villard F, 2014, INVEST OPHTH VIS SCI, V55, P2953, DOI 10.1167/iovs.13-13482; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tatton NA, 2001, SURV OPHTHALMOL, V45, pS268, DOI 10.1016/S0039-6257(01)00204-1; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138	37	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122347	10.1371/journal.pone.0122347	http://dx.doi.org/10.1371/journal.pone.0122347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875096	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800052
J	Tria, F; Servedio, VDP; Mufwene, SS; Loreto, V				Tria, Francesca; Servedio, Vito D. P.; Mufwene, Salikoko S.; Loreto, Vittorio			Modeling the Emergence of Contact Languages	PLOS ONE			English	Article								Contact languages are born out of the non-trivial interaction of two (or more) parent languages. Nowadays, the enhanced possibility of mobility and communication allows for a strong mixing of languages and cultures, thus raising the issue of whether there are any pure languages or cultures that are unaffected by contact with others. As with bacteria or viruses in biological evolution, the evolution of languages is marked by horizontal transmission; but to date no reliable quantitative tools to investigate these phenomena have been available. An interesting and well documented example of contact language is the emergence of creole languages, which originated in the contacts of European colonists and slaves during the 17th and 18th centuries in exogenous plantation colonies of especially the Atlantic and Indian Ocean. Here, we focus on the emergence of creole languages to demonstrate a dynamical process that mimics the process of creole formation in American and Caribbean plantation ecologies. Inspired by the Naming Game (NG), our modeling scheme incorporates demographic information about the colonial population in the framework of a non-trivial interaction network including three populations: Europeans, Mulattos/Creoles, and Bozal slaves. We show how this sole information makes it possible to discriminate territories that produced modern creoles from those that did not, with a surprising accuracy. The generality of our approach provides valuable insights for further studies on the emergence of languages in contact ecologies as well as to test specific hypotheses about the peopling and the population structures of the relevant territories. We submit that these tools could be relevant to addressing problems related to contact phenomena in many cultural domains: e.g., emergence of dialects, language competition and hybridization, globalization phenomena.	[Tria, Francesca; Loreto, Vittorio] ISI, I-10126 Turin, Italy; [Servedio, Vito D. P.] CNR, ISC, I-00185 Rome, Italy; [Servedio, Vito D. P.; Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Mufwene, Salikoko S.] Univ Chicago, Dept Linguist, Chicago, IL 60637 USA; [Loreto, Vittorio] SONY CSL, F-75005 Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; University of Chicago	Tria, F (corresponding author), ISI, Via Alassio 11C, I-10126 Turin, Italy.	tria@isi.it	Servedio, Vito D. P./P-4965-2015	Servedio, Vito D. P./0000-0003-3221-5973	KREYON project - Templeton Foundation [51663]; EuroUnderstanding Collaborative Research Projects DRUST - European Science Foundation; EU [611272]; CNR PNR Project "CRISIS Lab"	KREYON project - Templeton Foundation; EuroUnderstanding Collaborative Research Projects DRUST - European Science Foundation; EU(European Commission); CNR PNR Project "CRISIS Lab"(Consiglio Nazionale delle Ricerche (CNR))	The authors acknowledge support from the KREYON project funded by the Templeton Foundation under contract n. 51663 and the EuroUnderstanding Collaborative Research Projects DRUST funded by the European Science Foundation. VDPS acknowledges the EU FP7 Grant 611272 (project GROWTHCOM) and CNR PNR Project "CRISIS Lab" for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker P, 2013, LANGUAGE CONTACT BIL; Bakker P, 2011, J PIDGIN CREOLE LANG, V26, P5, DOI 10.1075/jpcl.26.1.02bak; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chaudenson Robert, 2001, CREOLIZATION LANGUAG; Daval-Markussen Aymeric, 2012, EACL 2012; DeGraff M, 2003, LANGUAGE, V79, P391, DOI 10.1353/lan.2003.0114; Emberts Zachary, 2020, EVOLUTION, V74, P897, DOI [10.1111/evo.13948, DOI 10.1111/EVO.13580]; Holm, 2000, INTRO PIDGINS CREOLE; Holm J, 2009, CONTACT LANGUAGES CR; Lalla B, 1990, LANGUAGES EXILE 300; Loreto V, 2007, NAT PHYS, V3, P758, DOI 10.1038/nphys770; Loreto V, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/04/P04006; Mufwene Salikoko S., 2008, LANGUAGE EVOLUTION C; Mufwene Salikoko S., 2005, CREOLES ECOLOGIE SOC; Perkins Edwin J., 1988, EC COLONIAL AM; Pucci L, 2014, LECT NOTES COMPUT SC, V8221, P78, DOI 10.1007/978-3-642-54140-7_7; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Reinecke J, 1975, OCEANIC LINGUISTICS; Sandler W, 2005, P NATL ACAD SCI USA, V102, P2661, DOI 10.1073/pnas.0405448102; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Thomason Sarah G., 2001, LANGUAGE CONTACT; Thomason Sarah G., 2001, LANGUAGE CONTACT INT; Thomason SG, 1988, LANGUAGES CONTACT CR; Tria F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037744; Turner LorenzoDow., 1949, AFRICANISMS GULLAH D; Weinreich Uriel, 1963, LANGUAGES CONTACT FI	27	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120771	10.1371/journal.pone.0120771	http://dx.doi.org/10.1371/journal.pone.0120771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CG1EL	25875371	Green Published, gold			2022-12-27	WOS:000353015800014
J	Xisto, MIDS; Bittencourt, VCB; Liporagi-Lopes, LC; Haido, RMT; Mendonca, MSA; Sassaki, G; Figueiredo, RT; Romanos, MTV; Barreto-Bergter, E				Xisto, Mariana I. D. S.; Bittencourt, Vera C. B.; Liporagi-Lopes, Livia Cristina; Haido, Rosa M. T.; Mendonca, Morena S. A.; Sassaki, Guilherme; Figueiredo, Rodrigo T.; Romanos, Maria Teresa V.; Barreto-Bergter, Eliana			O-Glycosylation in Cell Wall Proteins in Scedosporium prolificans Is Critical for Phagocytosis and Inflammatory Cytokines Production by Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PSEUDALLESCHERIA-BOYDII; CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; LINKED OLIGOSACCHARIDES; SPOROTHRIX-SCHENCKII; MURINE MACROPHAGES; RECOGNITION; POLYSACCHARIDES; DIFFERENTIATION	In this study, we analyze the importance of O-linked oligosaccharides present in peptidorhamnomannan ( PRM) from the cell wall of the fungus Scedosporium prolificans for recognition and phagocytosis of conidia by macrophages. Adding PRM led to a dose-dependent inhibition of conidia phagocytosis, whereas de-O-glycosylated PRM did not show any effect. PRM induced the release of macrophage-derived antimicrobial compounds. However, O-linked oligosaccharides do not appear to be required for such induction. The effect of PRM on conidia-induced macrophage killing was examined using latex beads coated with PRM or de-O-glycosylated PRM. A decrease in macrophage viability similar to that caused by conidia was detected. However, macrophage killing was unaffected when beads coated with de-O-glycosylated PRM were used, indicating the toxic effect of O-linked oligosaccharides on macrophages. In addition, PRM triggered TNF-alpha release by macrophages. Chemical removal of O-linked oligosaccharides from PRM abolished cytokine induction, suggesting that the O-linked oligosaccharidic chains are important moieties involved in inflammatory responses through the induction of TNF-alpha secretion. In summary, we show that O-glycosylation plays a role in the recognition and uptake of Scedosporium prolificans by macrophages, killing of macrophages and production of pro-inflammatory cytokines.	[Xisto, Mariana I. D. S.; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Rio de Janeiro, Brazil; [Bittencourt, Vera C. B.; Haido, Rosa M. T.] Univ Fed Estado Rio de Janeiro, Inst Biomed, Dept Microbiol & Parasitol, Rio de Janeiro, Brazil; [Liporagi-Lopes, Livia Cristina] Univ Fed Rio de Janeiro, Fac Farm, Dept Anal Clin & Toxicol, Rio de Janeiro, Brazil; [Mendonca, Morena S. A.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Sassaki, Guilherme] UFRP, Dept Bioquim & Biol Mol, Curitiba, Parana, Brazil; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Romanos, Maria Teresa V.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Barreto-Bergter, E (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Rio de Janeiro, Brazil.	eliana.bergter@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Sassaki, Guilherme/AAM-1112-2020; Bittencourt, Vera CB/A-7921-2019; Figueiredo, Rodrigo/F-5176-2016	Sassaki, Guilherme/0000-0001-7420-168X; Figueiredo, Rodrigo/0000-0002-7551-8782; bittencourt, vera/0000-0002-7403-9747; Xisto, Mariana Ingrid/0000-0002-1803-6381	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX); FAPERJ; CNPq; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Conselho de Pesquisa da UFRJ, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Programa de Nucleos de Excelencia (PRONEX). LCLL and EBB are supported by FAPERJ, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffeto-Bergter E, 2008, INT J BIOL MACROMOL, V42, P93, DOI 10.1016/j.ijbiomac.2007.09.015; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Barreto-Bergter E, 2011, CARBOHYD POLYM, V85, P349, DOI 10.1016/j.carbpol.2011.02.033; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Figueiredo RT, 2010, J BIOL CHEM, V285, P40714, DOI 10.1074/jbc.M110.181255; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Gil-Lamaignere C, 2001, MED MYCOL, V39, P169, DOI 10.1080/714031013; Gorin PAJ, 2010, CARBOHYD POLYM, V79, P927, DOI 10.1016/j.carbpol.2009.10.015; Haido RMT, 1998, MED MYCOL, V36, P313, DOI 10.1080/02681219880000491; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hung CY, 2007, ANN NY ACAD SCI, V1111, P225, DOI 10.1196/annals.1406.020; Husain S, 2005, CLIN INFECT DIS, V40, P89, DOI 10.1086/426445; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Kudeken N, 1998, CLIN EXP IMMUNOL, V112, P287; Lackner M, 2014, ANTIMICROB AGENTS CH, V58, P5877, DOI 10.1128/AAC.03211-14; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; LLOYD KO, 1971, J IMMUNOL, V107, P663; Lopes LCL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000853; Lopes LCL, 2011, MYCOSES, V54, P28, DOI 10.1111/j.1439-0507.2011.02105.x; Mahmoud Yehia A-G, 2011, Mycobiology, V39, P40, DOI 10.4489/MYCO.2011.39.1.040; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; MENDONCA L, 1976, BIOCHEMISTRY-US, V15, P2423, DOI 10.1021/bi00656a028; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nyberg K, 1996, J MED VET MYCOL, V34, P11; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Pinto MR, 2005, GLYCOBIOLOGY, V15, P895, DOI 10.1093/glycob/cwi084; Pinto MR, 2004, MICROBES INFECT, V6, P1259, DOI 10.1016/j.micinf.2004.07.006; Pinto MR, 2001, MICROBIOL-SGM, V147, P1499, DOI 10.1099/00221287-147-6-1499; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Rocco NM, 2011, INFECT IMMUN, V79, P2385, DOI 10.1128/IAI.01249-10; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roilides E, 2009, MED MYCOL, V47, P433, DOI 10.1080/13693780902738006; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; Sheth CC, 2011, MED MYCOL, V49, P513, DOI 10.3109/13693786.2010.551425; Smiderle FR, 2013, CARBOHYD POLYM, V97, P74, DOI 10.1016/j.carbpol.2013.04.049; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; WOLF JE, 1989, INFECT IMMUN, V57, P513, DOI 10.1128/IAI.57.2.513-519.1989; Zhu ZY, 2013, J PROTEOME RES, V12, P2375, DOI 10.1021/pr300447k	44	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123189	10.1371/journal.pone.0123189	http://dx.doi.org/10.1371/journal.pone.0123189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875427	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700027
J	Abbott, MJ; Battaglia, LL				Abbott, Matthew J.; Battaglia, Loretta L.			Purple Pitcher Plant (Sarracenia rosea) Dieback and Partial Community Disassembly following Experimental Storm Surge in a Coastal Pitcher Plant Bog	PLOS ONE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; MULTIVARIATE-ANALYSIS; HURRICANES KATRINA; NORTH-CAROLINA; UNITED-STATES; WEEKS BAY; DISTURBANCE; IMPACT; MISSISSIPPI	Sea-level rise and frequent intense hurricanes associated with climate change will result in recurrent flooding of inland systems such as Gulf Coastal pitcher plant bogs by storm surges. These surges can transport salt water and sediment to freshwater bogs, greatly affecting their biological integrity. Purple pitcher plants (Sarracenia rosea) are Gulf Coast pitcher plant bog inhabitants that could be at a disadvantage under this scenario because their pitcher morphology may leave them prone to collection of saline water and sediment after a surge. We investigated the effects of storm surge water salinity and sediment type on S. rosea vitality, plant community structure, and bog soil-water conductivity. Plots (containing >= 1 ramet of S. rosea) were experimentally flooded with fresh or saline water crossed with one of three sediment types (local, foreign, or no sediment). There were no treatment effects on soil-water conductivity; nevertheless, direct exposure to saline water resulted in significantly lower S. rosea cover until the following season when a prescribed fire and regional drought contributed to the decline of all the S. rosea to near zero percent cover. There were also significant differences in plant community structure between treatments over time, reflecting how numerous species increased in abundance and a few species decreased in abundance. However, in contrast to S. rosea, most of the other species in the community appeared resilient to the effects of storm surge. Thus, although the community may be somewhat affected by storm surge, those few species that are particularly sensitive to the storm surge disturbance will likely drop out of the community and be replaced by more resilient species. Depending on the longevity of these biological legacies, Gulf Coastal pitcher plant bogs may be incapable of fully recovering if they become exposed to storm surge more frequently due to climate change.	[Abbott, Matthew J.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; So Illinois Univ, Ctr Ecol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Abbott, MJ (corresponding author), So Illinois Univ, Dept Plant Biol, Mail Code 6509, Carbondale, IL 62901 USA.	mabbott259@gmail.com			United States Department of Defense's SERDP program	United States Department of Defense's SERDP program	This project was funded by a grant from the United States Department of Defense's SERDP program (http://www.serdp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Battaglia LL, 2012, WETLAND HABITATS OF NORTH AMERICA: ECOLOGY AND CONSERVATION CONCERNS, P75; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Brewer JS, 2011, J ECOL, V99, P1219, DOI 10.1111/j.1365-2745.2011.01846.x; CHRISTENSEN NL, 1977, OECOLOGIA, V31, P27, DOI 10.1007/BF00348706; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Clarke KR, 1999, ENVIRON TOXICOL CHEM, V18, P118, DOI 10.1002/etc.5620180205; Clewell A., 1985, GUIDE VASCULAR PLANT; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; FOLKERTS GW, 1982, AM SCI, V70, P260; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Goddard J, 2007, P ENTOMOL SOC WASH, V109, P684; Griffiths ME, 2006, J COASTAL RES, V22, P1417, DOI 10.2112/03-0032.1; Grinsted A, 2013, P NATL ACAD SCI USA, V110, P5369, DOI 10.1073/pnas.1209980110; Hanson PJ, 2000, SCI TOTAL ENVIRON, V262, P205, DOI 10.1016/S0048-9697(00)00523-4; Hook D.D., 1991, J COASTAL RES, P291; IPCC, 2007, PHYS SCI BAS; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Lam NSN, 2011, J COASTAL RES, P1707; Mckee KL, 2009, WETLANDS, V29, P2, DOI 10.1672/08-32.1; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Middleton BA, 2009, WETLANDS, V29, P54, DOI 10.1672/08-18.1; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Naczi Robert F. C., 1999, SIDA Contributions to Botany, V18, P1183; NOAA, 2012, NOWDATA WEATH AV 192; Peet R. K., 1993, P TALL TIMB FIR EC C, P45; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REED DJ, 1989, ESTUARIES, V12, P222, DOI 10.2307/1351901; Rhoades JD., 1996, METHODS SOIL ANAL 3, V5, P417; Rodgers JC, 2009, ESTUAR COAST, V32, P496, DOI 10.1007/s12237-009-9138-z; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Simkin SM, 2001, J TORREY BOT SOC, V128, P208, DOI 10.2307/3088712; Tate AS, 2013, J VEG SCI, V24, P46, DOI 10.1111/j.1654-1103.2012.01447.x; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; Wang H, 2010, J HYDROMETEOROL, V11, P1007, DOI 10.1175/2010JHM1229.1; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	41	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125475	10.1371/journal.pone.0125475	http://dx.doi.org/10.1371/journal.pone.0125475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874369	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100296
J	Basu, S; Thorat, R; Dalal, SN				Basu, Srikanta; Thorat, Rahul; Dalal, Sorab N.			MMP7 Is Required to Mediate Cell Invasion and Tumor Formation upon Plakophilin3 Loss	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-7 EXPRESSION; HUMAN COLORECTAL-CANCER; MESSENGER-RNA; GENE-FUNCTION; HUMAN COLON; MATRILYSIN; LOCALIZATION; OVEREXPRESSION; PURIFICATION; METASTASIS	Plakophilin3 (PKP3) loss results in increased transformation in multiple cell lines in vitro and increased tumor formation in vivo. A microarray analysis performed in the PKP3 knockdown clones, identified an inflammation associated gene signature in cell lines derived from stratified epithelia as opposed to cell lines derived from simple epithelia. However, in contrast to the inflammation associated gene signature, the expression of MMP7 was increased upon PKP3 knockdown in all the cell lines tested. Using vector driven RNA interference, it was demonstrated that MMP7 was required for in-vitro cell migration and invasion and tumor formation in vivo. The increase in MMP7 levels was due to the increase in levels of the Phosphatase of Regenerating Liver3 (PRL3), which is observed upon PKP3 loss. The results suggest that MMP7 over-expression may be one of the mechanisms by which PKP3 loss leads to increased cell invasion and tumor formation.	[Basu, Srikanta; Thorat, Rahul; Dalal, Sorab N.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Dalal, SN (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	sdalal@actrec.gov.in	BASU, SRIKANTA/V-5586-2019	BASU, SRIKANTA/0000-0002-0461-3731	Department of Science and Technology (DST), Government of India [SR/SO/HS-011/2009]; ACTREC; Council for Scientific and Industrial Research (CSIR) Govt. of India [09/513(0074)/2009-EMR-I]	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); ACTREC; Council for Scientific and Industrial Research (CSIR) Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Science and Technology (DST), Government of India to SND. The grant number is SR/SO/HS-011/2009. The work was also supported by intra-mural funds from ACTREC. SB was supported by a fellowship from the Council for Scientific and Industrial Research (CSIR) Govt. of India. The fellowship number is 09/513(0074)/2009-EMR-I. The funders had no role in study design, data	Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; ALBINI A, 1987, CANCER RES, V47, P3239; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Demirag GG, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-1; Desai BV, 2009, J CELL SCI, V122, P4401, DOI 10.1242/jcs.037457; Fingleton B, 2007, HYBRIDOMA, V26, P22, DOI 10.1089/hyb.2006.028; Fischer-Keso R., 2014, MOL CELL BIOL; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Jheon AH, 2011, J CELL SCI, V124, P745, DOI 10.1242/jcs.078071; Jiang QH, 2014, SCI WORLD J, DOI 10.1155/2014/340271; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Kivisaari AK, 2008, BRIT J DERMATOL, V158, P778, DOI 10.1111/j.1365-2133.2008.08466.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Kleinman H K, 2001, Curr Protoc Cell Biol, VChapter 12, DOI 10.1002/0471143030.cb1202s00; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Lee SK, 2012, INT J CANCER, V131, pE190, DOI 10.1002/ijc.27381; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MORI M, 1995, CANCER, V75, P1516, DOI 10.1002/1097-0142(19950315)75:6+<1516::AID-CNCR2820751522>3.0.CO;2-7; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Polistena A, 2014, IN VIVO, V28, P105; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sehgal L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021975; Sklyarova T, 2008, J INVEST DERMATOL, V128, P1375, DOI 10.1038/sj.jid.5701189; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Takahashi H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.049; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; WITTY JP, 1994, CANCER RES, V54, P4805; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yamamoto H, 2001, J CLIN ONCOL, V19, P1118, DOI 10.1200/JCO.2001.19.4.1118; Yamashita K, 2000, CLIN CANCER RES, V6, P1169; Yamashita K, 1998, INT J CANCER, V79, P187; YOSHIMOTO M, 1993, INT J CANCER, V54, P614, DOI 10.1002/ijc.2910540415; ZENG ZS, 1995, BRIT J CANCER, V72, P575, DOI 10.1038/bjc.1995.376; Zeng ZS, 2002, CLIN CANCER RES, V8, P144	50	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123979	10.1371/journal.pone.0123979	http://dx.doi.org/10.1371/journal.pone.0123979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875355	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100229
J	Beck, IM; Van Crombruggen, K; Holtappels, G; Daubeuf, F; Frossard, N; Bachert, C; De Bosscher, K				Beck, Ilse M.; Van Crombruggen, Koen; Holtappels, Gabriele; Daubeuf, Francois; Frossard, Nelly; Bachert, Claus; De Bosscher, Karolien			Differential Cytokine Profiles upon Comparing Selective versus Classic Glucocorticoid Receptor Modulation in Human Peripheral Blood Mononuclear Cells and Inferior Turbinate Tissue	PLOS ONE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; INFLAMMATORY MEDIATORS; ENTEROTOXIN-B; PLANT-ORIGIN; NASAL POLYPS; MOUSE MODEL; LIGAND; COMPOUND; DEXAMETHASONE	Background Glucocorticoid Receptor agonists, particularly classic glucocorticoids, are the mainstay among treatment protocols for various chronic inflammatory disorders, including nasal disease. To steer away from steroid-induced side effects, novel GR modulators exhibiting a more favorable therapeutic profile remain actively sought after. Currently, the impact of 2( 4-acetoxyphenyl)-2-chloro-N-methylethylammonium chloride a plant-derived selective glucocorticoid receptor modulator named compound A, on cytokine production in ex vivo human immune cells and tissue has scarcely been evaluated. Methods and Results The current study aimed to investigate the effect of a classic glucocorticoid versus compound A on cytokine and inflammatory mediator production after stimulation with Staphylococcus aureus-derived enterotoxin B protein in peripheral blood mononuclear cells (PBMCs) as well as in inferior nasal turbinate tissue. To this end, tissue fragments were stimulated with RPMI (negative control) or Staphylococcus aureus-derived enterotoxin B protein for 24 hours, in presence of solvent, or the glucocorticoid methylprednisolone or compound A at various concentrations. Supernatants were measured via multiplex for pro-inflammatory cytokines (IL-1 beta, TNF alpha) and T-cell-and subset-related cytokines (IFN-gamma, IL-2, IL-5, IL-6, IL-10, and IL-17). In concordance with the previously described stimulatory role of superantigens in the development of nasal polyposis, a 24h Staphylococcus aureus-derived enterotoxin B protein stimulation induced a significant increase of IL-2, IL-1 beta, TNF-alpha, and IL-17 in PBMCs and in inferior turbinates and of IL-5 and IFN-gamma in PBMCs. Conclusion Notwithstanding some differences in amplitude, the overall cytokine responses to methylprednisolone and compound A were relatively similar, pointing to a conserved and common mechanism in cytokine transrepression and anti-inflammatory actions of these GR modulators. Furthermore, these results provide evidence that selective glucocorticoid receptor modulator-mediated manipulation of the glucocorticoid receptor in human tissues, supports its anti-inflammatory potential.	[Beck, Ilse M.] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, LECR, B-9000 Ghent, Belgium; [Van Crombruggen, Koen; Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium; [Daubeuf, Francois; Frossard, Nelly] Univ Strasbourg, CNRS, Fac Pharm, Lab Innovat Therapeut,UMR 7200, Illkirch Graffenstaden, France; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Stockholm, Sweden; [De Bosscher, Karolien] Univ Ghent, VIB Dept Med Prot Res, NRL, Receptor Res Labs, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Karolinska Institutet; Flanders Institute for Biotechnology (VIB); Ghent University	De Bosscher, K (corresponding author), Univ Ghent, VIB Dept Med Prot Res, NRL, Receptor Res Labs, B-9000 Ghent, Belgium.	Karolien.DeBosscher@vib-ugent.be	Bachert, Claus/J-8825-2012; Frossard, Nelly/F-8301-2013	De Bosscher, Karolien/0000-0001-5059-9718	Research Foundation-Flanders (FWO) [1.2.405.10.N.00]; FWO [1.2.546.07.N.01, 1.5.107.09.N.00]	Research Foundation-Flanders (FWO)(FWO); FWO(FWO)	IMB is a postdoctoral fellow of the Research Foundation-Flanders (FWO), grant number 1.2.405.10.N.00 (www.fwo.be). KDB was also supported as a postdoctoral fellow of the FWO (grant number 1.2.546.07.N.01) during the initial stages of this project. The work was funded by a Research Grant of the FWO to KDB (grant number 1.5.107.09.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2006, ALLERGY, V61, P693, DOI 10.1111/j.1398-9995.2006.01054.x; Bachert C, 2003, ALLERGY, V58, P176, DOI 10.1034/j.1398-9995.2003.02172.x; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Barnes PJ, 1998, PHARMACOL REV, V50, P515; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Beck IM, 2013, EUR J PHARMACOL, V715, P1, DOI 10.1016/j.ejphar.2013.06.032; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bhatt D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00071; BIGSBY RM, 1993, J STEROID BIOCHEM, V46, P253, DOI 10.1016/0960-0760(93)90301-C; Bousquet J, 2008, ALLERGY, V63, P1, DOI 10.1111/j.1398-9995.2007.01594.x; Creed TJ, 2009, J IMMUNOL, V183, P164, DOI 10.4049/jimmunol.0801998; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2014, CELL MOL LIFE SCI, V71, P143, DOI 10.1007/s00018-013-1367-4; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; Dejager L, 2014, CYTOKINE GROWTH F R, V25, P21, DOI 10.1016/j.cytogfr.2013.12.006; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Drebert Z, 2015, J STEROID BIOCH MOL; Fokkens Wytske, 2007, Clin Allergy Immunol, V20, P241; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; GOMPEL A, 1986, J CLIN ENDOCR METAB, V63, P1174, DOI 10.1210/jcem-63-5-1174; Gossye V, 2009, ARTHRITIS RHEUM-US, V60, P3241, DOI 10.1002/art.24963; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; KRAKAUER T, 1995, J LEUKOCYTE BIOL, V57, P450, DOI 10.1002/jlb.57.3.450; Lesovaya EA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1242, DOI 10.1134/S000629791111006X; Liberman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035155; Liberman AC, 2009, ANN NY ACAD SCI, V1153, P6, DOI 10.1111/j.1749-6632.2008.03958.x; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Moon IJ, 2012, ACTA OTO-LARYNGOL, V132, pS6, DOI 10.3109/00016489.2012.661074; Novo CAP, 2010, CLIN EXP ALLERGY, V40, P1323, DOI 10.1111/j.1365-2222.2010.03577.x; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Pedersen S, 1999, ALLERGY, V54, P42, DOI 10.1111/j.1398-9995.1999.tb04387.x; Pujols L, 2004, ALLERGY, V59, P1042, DOI 10.1111/j.1398-9995.2004.00635.x; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Rauner M, 2013, ENDOCRINOLOGY, V154, P3719, DOI 10.1210/en.2012-2221; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Schulz M, 2002, J BIOL CHEM, V277, P26238, DOI 10.1074/jbc.M203268200; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Totino PRR, 2006, CELL BIOL INT, V30, P133, DOI 10.1016/j.cellbi.2005.09.002; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Villa E, 2011, EXPERT OPIN PHARMACO, V12, P2107, DOI 10.1517/14656566.2011.600688; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093754; Zhang N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/673145; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123068	10.1371/journal.pone.0123068	http://dx.doi.org/10.1371/journal.pone.0123068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875480	Green Published, gold			2022-12-27	WOS:000352845100131
J	Kamba, K; Nagata, T; Katahira, M				Kamba, Keisuke; Nagata, Takashi; Katahira, Masato			Catalytic Analysis of APOBEC3G Involving Real-Time NMR Spectroscopy Reveals Nucleic Acid Determinants for Deamination	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; CYTIDINE DEAMINASE; HIV-1 DNA; RESTRICTION; HYPERMUTATION; VIF; METHYLATION; SPECIFICITY; MECHANISM; DYNAMICS	APOBEC3G (A3G) is a single-stranded DNA-specific cytidine deaminase that preferentially converts cytidine to uridine at the third position of triplet cytosine (CCC) hotspots. A3G restricts the infectivity of viruses, such as HIV-1, by targeting CCC hotspots scattered through minus DNA strands, reverse-transcribed from genomic RNA. Previously, we developed a real-time NMR method and elucidated the origin of the 3'-> 5' polarity of deamination of DNA by the C-terminal domain of A3G (CD2), which is a phenomenon by which a hotspot located closer to the 5'-end is deaminated more effectively than one less close to the 5'-end, through quantitative analysis involving nonspecific binding to and sliding along DNA. In the present study we applied the real-time NMR method to analyze the catalytic activity of CD2 toward DNA oligonucleotides containing a nucleotide analog at a single or multiple positions. Analyses revealed the importance of the sugar and base moieties throughout the consecutive 5 nucleotides, the CCC hotspot being positioned at the center. It was also shown that the sugar or base moieties of the nucleotides outside this 5 nucleotide recognition sequence are also relevant as to CD2's activity. Analyses involving DNA oligonucleotides having two CCC hotspots linked by a long sequence of either deoxyribonucleotides, ribonucleotides or abasic deoxyribonucleotides suggested that the phosphate backbone is required for CD2 to slide along the DNA strand and to exert the 3'-> 5' polarity. Examination of the effects of different salt concentrations on the 3'-> 5' polarity indicated that the higher the salt concentration, the less prominent the 3'-> 5' polarity. This is most likely the result of alleviation of sliding due to a decrease in the affinity of CD2 with the phosphate backbone at high salt concentrations. We also investigated the reactivity of substrates containing 5-methylcytidine (5mC) or 5-hydroxymethylcytidine, and found that A3G exhibited low activity toward 5mC.	[Kamba, Keisuke; Nagata, Takashi; Katahira, Masato] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Nagata, Takashi; Katahira, Masato] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan	Kyoto University; Kyoto University	Nagata, T (corresponding author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan.	nagata.takashi.6w@kyoto-u.ac.jp; katahira.masato.6u@kyoto-u.ac.jp	Nagata, Takashi/D-4547-2018	Nagata, Takashi/0000-0002-3733-2709	Ministry of Education, Science, Sports and Culture of Japan [23570146, 26440026, 25115507, 25291013, 26104520, 26650014]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Science, Sports and Culture of Japan with Grants-in-Aid for Scientific Research (23570146 and 26440026 to TN; 25115507, 25291013, 26104520, and 26650014 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furukawa A, 2014, ANGEW CHEM INT EDIT, V53, P2349, DOI 10.1002/anie.201309940; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goddard T. D., 2006, SPARKY 3; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Harris RS, 2003, NAT IMMUNOL, V4, P641, DOI 10.1038/ni0703-641; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KewalRamani VN, 2003, SCIENCE, V301, P923, DOI 10.1126/science.1088965; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nabel CS, 2013, P NATL ACAD SCI USA, V110, P14225, DOI 10.1073/pnas.1306345110; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	41	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124142	10.1371/journal.pone.0124142	http://dx.doi.org/10.1371/journal.pone.0124142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875164	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100241
J	Ota, H; Takehara, N; Aonuma, T; Kabara, M; Matsuki, M; Yamauchi, A; Takeuchi, T; Kawabe, J; Hasebe, N				Ota, Hisanobu; Takehara, Naofumi; Aonuma, Tatsuya; Kabara, Maki; Matsuki, Motoki; Yamauchi, Atsushi; Takeuchi, Toshiharu; Kawabe, Jun-ichi; Hasebe, Naoyuki			Association between Microalbuminuria Predicting In-Stent Restenosis after Myocardial Infarction and Cellular Senescence of Endothelial Progenitor Cells	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR-DISEASE; ALBUMIN EXCRETION; VASCULAR REPAIR; ARTERY-DISEASE; HEART-DISEASE; DNA-DAMAGE; MOBILIZATION; RISK; DYSFUNCTION	Objective Relationship between microalbuminuria and worse outcome of coronary artery disease patients is discussed, but its underlying pathophysiological mechanism remains unclear. We investigated the role of microalbuminuria to the function of endothelial progenitor cells (EPCs), that might affect to outcome of acute myocardial infarction (AMI) patients. Methods Forty-five AMI patients were divided into two groups according to their urinary albumin excretion: normal (n = 24) and microalbuminuria (>30 mg/day, n = 21). At day-2 and day-7 after AMI onset, circulating-EPCs (CD34(+)Flk1(+)) were quantified by flow cytometry. The number of lectin-acLDL-positive cultured-EPCs immobilized on fibronectin was determined. To assess the cellular senescence of cultured-EPCs, the expression level of sirtuin-1 mRNA and the number of SA-beta-gal positive cell were evaluated. Angiographic late in-stent loss after percutaneous coronary intervention (PCI) was evaluated at a six-month follow-up. Results No significant differences in coronary risk and the extent of myocardial damage were observed between the two groups. Late in-stent loss at the six-month follow-up was significantly higher in the microalbuminuria group (normal : microalbuminuria = 0.76 +/- 0.34 : 1.18 +/- 0.57 mm, p=0.021). The number of circulating-EPCs was significantly increased in microalbuminuria group at day-7, however, improved adhesion of EPCs was observed in normal group but not in microalbuminuria group from baseline to day-7 (+3.1 +/- 8.3 : -1.3 +/- 4.4 %: p<0.05). On the other hand, in microalbuminuria group at day-7, the level of sirtuin-1 mRNA expression of cultured-EPCs was significantly decreased (7.1 +/- 8.9 : 2.5 +/- 3.7 fold, p<0.05), which was based on the negative correlation between the level of sirtuin-1 mRNA expression and the extent of microalbuminuria. The ratio of SA-beta-gal-positive cells in microalbuminuria group was increased compared to that of normal group. Conclusions Microalbuminuria in AMI patients is closely associated with functional disorder of EPCs via cellular senescence, that predicts the aggravation of coronary remodeling after PCI.	[Ota, Hisanobu; Aonuma, Tatsuya; Matsuki, Motoki; Yamauchi, Atsushi; Takeuchi, Toshiharu; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan; [Takehara, Naofumi; Kabara, Maki; Kawabe, Jun-ichi] Asahikawa Med Univ, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College	Takehara, N (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan.	takenao1@mac.com		Aonuma, Tatsuya/0000-0002-6838-2813	Grants-in-Aid for Scientific Research [26461052] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Berton G, 2008, AM HEART J, V156, P760, DOI 10.1016/j.ahj.2008.05.021; Berton G, 2010, CLIN CARDIOL, V33, P508, DOI 10.1002/clc.20792; Bonello L, 2012, J THROMB HAEMOST, V10, P1906, DOI 10.1111/j.1538-7836.2012.04854.x; De Winter RJ, 2010, JACC-CARDIOVASC INTE, V3, P87, DOI 10.1016/j.jcin.2009.11.006; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Heper G, 2002, ANGIOLOGY, V53, P287, DOI 10.1177/000331970205300306; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Koulouris S, 2005, AM HEART J, V149, P840, DOI 10.1016/j.ahj.2004.07.031; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Leor J, 2006, J AM COLL CARDIOL, V48, P1588, DOI 10.1016/j.jacc.2006.07.032; Ling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050739; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Ota H, 2013, J CARDIOL, V62, P277, DOI 10.1016/j.jjcc.2013.05.002; Padfield GJ, 2013, HEART, V99, P791, DOI 10.1136/heartjnl-2012-302949; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Perticone F, 2007, J NEPHROL, V20, pS56; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Schiele F, 2009, AM HEART J, V157, P327, DOI 10.1016/j.ahj.2008.09.018; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Schober A, 2005, AM J CARDIOL, V96, P1116, DOI 10.1016/j.amjcard.2005.06.042; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; Wang P, 2014, CARDIOVASC RES, V104, P477, DOI 10.1093/cvr/cvu220	30	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123733	10.1371/journal.pone.0123733	http://dx.doi.org/10.1371/journal.pone.0123733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874702	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100205
J	Rouhi, J; Mamat, MH; Ooi, CHR; Mahmud, S; Mahmood, MR				Rouhi, Jalal; Mamat, Mohamad Hafiz; Ooi, C. H. Raymond; Mahmud, Shahrom; Mahmood, Mohamad Rusop			High-Performance Dye-Sensitized Solar Cells Based on Morphology-Controllable Synthesis of ZnO-ZnS Heterostructure Nanocone Photoanodes	PLOS ONE			English	Article							OPTICAL-PROPERTIES; NANOWIRE ARRAYS; AQUEOUS-SOLUTION; FIELD-EMISSION; NANOSTRUCTURES; GROWTH; FABRICATION; NANORODS; PHOTOVOLTAICS; DEPOSITION	High-density and well-aligned ZnO-ZnS core-shell nanocone arrays were synthesized on fluorine-doped tin oxide glass substrate using a facile and cost-effective two-step approach. In this synthetic process, the ZnO nanocones act as the template and provide Zn2+ ions for the ZnS shell formation. The photoluminescence spectrum indicates remarkably enhanced luminescence intensity and a small redshift in the UV region, which can be associated with the strain caused by the lattice mismatch between ZnO and ZnS. The obtained diffuse reflectance spectra show that the nanocone-based heterostructure reduces the light reflection in a broad spectral range and is much more effective than the bare ZnO nanocone and nanorod structures. Dye-sensitized solar cells based on the heterostructure ZnO-ZnS nanocones are assembled, and high conversion efficiency (eta) of approximately 4.07% is obtained. The. improvement can be attributed primarily to the morphology effect of ZnO nanocones on light-trapping and effectively passivating the interface surface recombination sites of ZnO nanocones by coating with a ZnS shell layer.	[Rouhi, Jalal; Mahmood, Mohamad Rusop] Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Ctr Nanosci & Nanotechnol, Shah Alam 40450, Selangor, Malaysia; [Rouhi, Jalal; Mamat, Mohamad Hafiz; Mahmood, Mohamad Rusop] Univ Teknol MARA, Fac Elect Engn, NANO ElectT Ctr, Shah Alam 40450, Selangor, Malaysia; [Ooi, C. H. Raymond] Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia; [Mahmud, Shahrom] Univ Sains Malaysia, Sch Phys, Nanooptoelect Res NOR Lab, George Town 11800, Pinang, Malaysia	Universiti Teknologi MARA; Universiti Teknologi MARA; Universiti Malaya; Universiti Sains Malaysia	Rouhi, J (corresponding author), Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Ctr Nanosci & Nanotechnol, Shah Alam 40450, Selangor, Malaysia.	jalal.rouhi@gmail.com	Rouhi, Jalal/AAJ-8076-2021; Mahmud, Shahrom/L-3316-2013; Mahmood, Mahmood/AAK-8215-2020; Mahmud, Shahrom/A-7754-2011; Bin Mahmood, Mohamad Rusop/N-4237-2017; Mamat, Mohamad Hafiz/P-9026-2015; Ooi, C. H. Raymond/B-9461-2010	Mahmud, Shahrom/0000-0002-1455-283X; Bin Mahmood, Mohamad Rusop/0000-0002-5842-627X; Mamat, Mohamad Hafiz/0000-0002-6640-2366; Ooi, C. H. Raymond/0000-0003-1084-5501	Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production grant [600-RMI/LRGS 5/3]; NANO-SciTech Centre in Universiti Teknologi MARA; High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/CHAN/04]	Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production grant; NANO-SciTech Centre in Universiti Teknologi MARA; High Impact Research MoE Grant from the Ministry of Education Malaysia	The authors gratefully acknowledge that this work was supported by Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production (600-RMI/LRGS 5/3 (3/2013)) grant, by the NANO-SciTech Centre in Universiti Teknologi MARA, and by the High Impact Research MoE Grant No. UM.C/625/1/HIR/MoE/CHAN/04 from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anta JA, 2012, J PHYS CHEM C, V116, P11413, DOI 10.1021/jp3010025; Chang J, 2013, J PHYS CHEM C, V117, P13836, DOI 10.1021/jp402742n; Chao HY, 2010, SUPERLATTICE MICROST, V47, P160, DOI 10.1016/j.spmi.2009.07.005; Chaoui R, 2008, PHYS STATUS SOLIDI A, V205, P1724, DOI 10.1002/pssa.200723598; Datta A, 2007, J PHYS CHEM C, V111, P17260, DOI 10.1021/jp076093p; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461; Han JB, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/40/405203; Hua GM, 2008, MATER LETT, V62, P4109, DOI 10.1016/j.matlet.2008.06.018; Jensen LL, 2008, J PHYS CHEM C, V112, P3439, DOI 10.1021/jp073554y; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jiu JT, 2006, J PHYS CHEM B, V110, P2087, DOI 10.1021/jp055824n; Jothi NSN, 2013, MATER CHEM PHYS, V138, P186, DOI 10.1016/j.matchemphys.2012.11.042; Kao MC, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-260; Keis K, 2002, J PHOTOCH PHOTOBIO A, V148, P57, DOI 10.1016/S1010-6030(02)00039-4; Ku CH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2778454; Ku CH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505706; Lan Z, 2007, J POWER SOURCES, V164, P921, DOI 10.1016/j.jpowsour.2006.11.011; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Law M, 2006, J PHYS CHEM B, V110, P22652, DOI 10.1021/jp0648644; Lee YJ, 2008, NANO LETT, V8, P1501, DOI 10.1021/nl080659j; Li JH, 2006, J PHYS CHEM B, V110, P14685, DOI [10.1021/jp061563l, 10.1021/jp0615631]; Liu W, 2010, APPL PHYS LETT, V97; Liu X, 2004, J APPL PHYS, V95, P3141, DOI 10.1063/1.1646440; Lo SS, 2011, ADV MATER, V23, P180, DOI 10.1002/adma.201002290; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2014, KONA POWDER PART J, P92; O'Brien PG, 2008, ADV MATER, V20, P1577, DOI 10.1002/adma.200702219; Pawar RC, 2011, MATER LETT, V65, P2235, DOI 10.1016/j.matlet.2011.04.045; Pawar RC, 2013, SENSOR ACTUAT B-CHEM, V187, P323, DOI 10.1016/j.snb.2012.11.100; Pawar RC, 2013, SCRIPTA MATER, V68, P142, DOI 10.1016/j.scriptamat.2012.10.003; Rouhi J, 2014, MATER LETT, V125, P147, DOI 10.1016/j.matlet.2014.03.183; Rouhi J, 2014, CERAM INT, V40, P11193, DOI 10.1016/j.ceramint.2014.03.157; Sagawa T, 2010, J PHYS CHEM LETT, V1, P1020, DOI 10.1021/jz100065u; Schrier J, 2007, NANO LETT, V7, P2377, DOI 10.1021/nl071027k; Sepulveda-Guzman S, 2009, MATER CHEM PHYS, V115, P172, DOI 10.1016/j.matchemphys.2008.11.030; Song J, 2007, J PHYS CHEM C, V111, P596, DOI 10.1021/jp0655017; Thavasi V, 2009, MAT SCI ENG R, V63, P81, DOI 10.1016/j.mser.2008.09.001; Wang HX, 2009, J PHYS CHEM C, V113, P18125, DOI 10.1021/jp906629t; Wang K, 2008, ADV MATER, V20, P3248, DOI 10.1002/adma.200800145; Wang XN, 2010, ACS NANO, V4, P3302, DOI 10.1021/nn1001547; Xu F, 2011, ENERG ENVIRON SCI, V4, P818, DOI 10.1039/c0ee00448k; Yan CL, 2006, J PHYS CHEM B, V110, P25850, DOI 10.1021/jp0659296; Yoo YZ, 2002, APPL PHYS LETT, V81, P3798, DOI 10.1063/1.1521577; Zhu J, 2009, NANO LETT, V9, P279, DOI 10.1021/nl802886y	46	39	39	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123433	10.1371/journal.pone.0123433	http://dx.doi.org/10.1371/journal.pone.0123433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875377	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100176
J	Voges, C; Helmchen, C; Heide, W; Sprenger, A				Voges, Caroline; Helmchen, Christoph; Heide, Wolfgang; Sprenger, Andreas			Ganzfeld Stimulation or Sleep Enhance Long Term Motor Memory Consolidation Compared to Normal Viewing in Saccadic Adaptation Paradigm	PLOS ONE			English	Article							RAPID EYE-MOVEMENTS; PARIETAL CORTEX; GAIN ADAPTATION; VISUAL SPACE; REM-SLEEP; ACTIVATION; PROPRIOCEPTION; REPRESENTATION; ACQUISITION; PERFORMANCE	Adaptation of saccade amplitude in response to intra-saccadic target displacement is a type of implicit motor learning which is required to compensate for physiological changes in saccade performance. Once established trials without intra-saccadic target displacement lead to de-adaptation or extinction, which has been attributed either to extra-retinal mechanisms of spatial constancy or to the influence of the stable visual surroundings. Therefore we investigated whether visual deprivation ("Ganzfeld"-stimulation or sleep) can partially maintain this motor learning compared to free viewing of the natural surroundings. Thirty-five healthy volunteers performed two adaptation blocks of 100 inward adaptation trials -interspersed by an extinction block -which were followed by a two-hour break with or without visual deprivation (VD). Using additional adaptation and extinction blocks short and long (4 weeks) term memory of this implicit motor learning were tested. In the short term, motor memory tested immediately after free viewing was superior to adaptation performance after VD. In the long run, however, effects were opposite: motor memory and relearning of adaptation was superior in the VD conditions. This could imply independent mechanisms that underlie the short-term ability of retrieving learned saccadic gain and its long term consolidation. We suggest that subjects mainly rely on visual cues (i.e., retinal error) in the free viewing condition which makes them prone to changes of the visual stimulus in the extinction block. This indicates the role of a stable visual array for resetting adapted saccade amplitudes. In contrast, visual deprivation (GS and sleep), might train subjects to rely on extra-retinal cues, e.g., efference copy or prediction to remap their internal representations of saccade targets, thus leading to better consolidation of saccadic adaptation.	[Voges, Caroline; Helmchen, Christoph; Sprenger, Andreas] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Heide, Wolfgang] Gen Hosp Celle, Dept Neurol, Celle, Germany; [Sprenger, Andreas] Univ Lubeck, Inst Psychol 2, Lubeck, Germany	University of Lubeck; University of Lubeck	Sprenger, A (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.	Andreas.Sprenger@neuro.uni-luebeck.de	Sprenger, Andreas/C-7612-2009	Sprenger, Andreas/0000-0001-9255-7911	Deutsche Forschungsgemeinschaft DFG [SFB 654]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft DFG (SFB 654, http://www.sfb654.uni-luebeck.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabyane N, 2004, INVEST OPHTH VIS SCI, V45, P123, DOI 10.1167/iovs.03-0570; Alahyane N, 2005, LEARN MEMORY, V12, P433, DOI 10.1101/lm.96405; Alahyane N, 2005, ANN NY ACAD SCI, V1039, P558, DOI 10.1196/annals.1325.067; Arnulf I, 2011, ARCH ITAL BIOL, V149, P367, DOI 10.4449/aib.v149i4.1246; Balslev D, 2012, J NEUROSCI, V32, P8569, DOI 10.1523/JNEUROSCI.1488-12.2012; BUISSERET P, 1995, PHYSIOL REV, V75, P323, DOI 10.1152/physrev.1995.75.2.323; Chaturvedi V, 1997, VISION RES, V37, P1367, DOI 10.1016/S0042-6989(96)00266-0; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; Criscimagna-Hemminger SE, 2008, J NEUROSCI, V28, P9610, DOI 10.1523/JNEUROSCI.3071-08.2008; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Follet B, 2011, I-PERCEPTION, V2, P592, DOI 10.1068/i0414; Gais S, 2008, NEUROBIOL LEARN MEM, V90, P610, DOI 10.1016/j.nlm.2008.07.016; Gaveau V, 2005, EXP BRAIN RES, V162, P526, DOI 10.1007/s00221-005-2224-y; Havermann K, 2011, J NEUROPHYSIOL, V106, P2536, DOI 10.1152/jn.00023.2011; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; Heide W, 2001, EUR J NEUROSCI, V13, P1177, DOI 10.1046/j.0953-816x.2001.01472.x; Herman JP, 2009, J NEUROPHYSIOL, V101, P1713, DOI 10.1152/jn.91076.2008; Hobson JA, 2012, PROG NEUROBIOL, V98, P82, DOI 10.1016/j.pneurobio.2012.05.003; Hong CCH, 2009, HUM BRAIN MAPP, V30, P1705, DOI 10.1002/hbm.20635; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Horii K, 2006, JAPANESE J ERGONOMIC, V42, P234; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Kojima Y, 2011, BRAIN RES, V1401, P30, DOI 10.1016/j.brainres.2011.05.027; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Leclair-Visonneau L, 2010, BRAIN, V133, P1737, DOI 10.1093/brain/awq110; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Leigh R. J., 1999, NEUROLOGY EYE MOVEME, P108; Liem EIML, 2013, CEREBELLUM, V12, P224, DOI 10.1007/s12311-012-0417-z; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Medendorp WP, 2011, PHILOS T R SOC B, V366, P476, DOI 10.1098/rstb.2010.0089; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Metzger W, 1930, PSYCHOL FORSCH, V13, P6, DOI 10.1007/BF00406757; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Noto CT, 1999, J NEUROPHYSIOL, V81, P2798, DOI 10.1152/jn.1999.81.6.2798; Pannasch S, 2008, J EYE MOVEMENT RES, V2, DOI 10.16910/jemr.2.2.4; Panouilleres M, 2013, EXP BRAIN RES; Panouilleres M, 2014, CEREB CORTEX, V24, P304, DOI 10.1093/cercor/bhs312; Panouilleres M, 2012, HUM BRAIN MAPP, V33, P1512, DOI 10.1002/hbm.21301; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; Rambold H, 2004, EXP BRAIN RES, V156, P314, DOI 10.1007/s00221-003-1791-z; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; Seeberger T, 2002, BRAIN RES, V956, P374, DOI 10.1016/S0006-8993(02)03577-1; Shelhamer M, 2002, NEUROSCI LETT, V332, P200, DOI 10.1016/S0304-3940(02)00951-5; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Sprenger A, 2010, NEUROREPORT, V21, P45, DOI 10.1097/WNR.0b013e32833370b2; Steenrod SC, 2013, J NEUROPHYSIOL, V109, P2596, DOI 10.1152/jn.00349.2012; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Sylvester R, 2006, NEUROIMAGE, V30, P214, DOI 10.1016/j.neuroimage.2005.09.014; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker R, 2006, VISION RES, V46, P2082, DOI 10.1016/j.visres.2005.12.009; Wang J, 2012, BRAIN RES, V1489, P56, DOI 10.1016/j.brainres.2012.10.018; Zils E, 2005, SLEEP, V28, P1109, DOI 10.1093/sleep/28.9.1109; Zimmermann E, 2013, J NEUROPHYSIOL, V109, P1815, DOI 10.1152/jn.00743.2012	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123831	10.1371/journal.pone.0123831	http://dx.doi.org/10.1371/journal.pone.0123831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867186	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100217
J	Zimmermann, B; Tkalcec, Z; Mesic, A; Kohler, A				Zimmermann, Boris; Tkalcec, Zdenko; Mesic, Armin; Kohler, Achim			Characterizing Aeroallergens by Infrared Spectroscopy of Fungal Spores and Pollen	PLOS ONE			English	Article							ALLERGIC RHINITIS; IDENTIFICATION; CLASSIFICATION; DIVERSITY; MICROSPECTROSCOPY; DISCRIMINATION; MOISTURE; ASTHMA; URBAN; TOOL	Background Fungal spores and plant pollen cause respiratory diseases in susceptible individuals, such as asthma, allergic rhinitis and hypersensitivity pneumonitis. Aeroallergen monitoring networks are an important part of treatment strategies, but unfortunately traditional analysis is time consuming and expensive. We have explored the use of infrared spectroscopy of pollen and spores for an inexpensive and rapid characterization of aeroallergens. Methodology The study is based on measurement of spore and pollen samples by single reflectance attenuated total reflectance Fourier transform infrared spectroscopy (SR-ATR FTIR). The experimental set includes 71 spore (Basidiomycota) and 121 pollen (Pinales, Fagales and Poales) samples. Along with fresh basidiospores, the study has been conducted on the archived samples collected within the last 50 years. Results The spectroscopic-based methodology enables clear spectral differentiation between pollen and spores, as well as the separation of confamiliar and congeneric species. In addition, the analysis of the scattering signals inherent in the infrared spectra indicates that the FTIR methodology offers indirect estimation of morphology of pollen and spores. The analysis of fresh and archived spores shows that chemical composition of spores is well preserved even after decades of storage, including the characteristic taxonomy-related signals. Therefore, biochemical analysis of fungal spores by FTIR could provide economical, reliable and timely methodologies for improving fungal taxonomy, as well as for fungal identification and monitoring. This proof of principle study shows the potential for using FTIR as a rapid tool in aeroallergen studies. In addition, the presented method is ready to be immediately implemented in biological and ecological studies for direct measurement of pollen and spores from flowers and sporocarps.	[Zimmermann, Boris; Kohler, Achim] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Tkalcec, Zdenko; Mesic, Armin] Ru Er Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia	Norwegian University of Life Sciences	Zimmermann, B (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.	boris.zimmermann@nmbu.no	Tkalčec, Zdenko/ABF-2269-2020; Zimmermann, Boris/N-8297-2014; Mešić, Armin/AAJ-1858-2020; Zimmermann, Boris/GVS-6235-2022	Zimmermann, Boris/0000-0001-5046-520X; Mešić, Armin/0000-0002-4479-600X; Zimmermann, Boris/0000-0001-5046-520X; Kohler, Achim/0000-0001-5759-1989; Tkalcec, Zdenko/0000-0002-1148-9425	European Commission [328289]; Ministry of Education, Sciences and Sports of the Republic of Croatia [098-0982904-2927, 098-0982934-2719]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Sciences and Sports of the Republic of Croatia	The European Commission through the Seventh Framework Programme, project No. 328289 (BZ AK); The Ministry of Education, Sciences and Sports of the Republic of Croatia, projects No. 098-0982904-2927 (BZ) and No. 098-0982934-2719 (AM ZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; [Anonymous], [No title captured]; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Atkinson RW, 2006, OCCUP ENVIRON MED, V63, P580, DOI 10.1136/oem.2005.024448; Besancenot JP, 2012, REV MAL RESPIR, V29, P1238, DOI 10.1016/j.rmr.2012.07.007; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Carinanos P, 1999, AEROBIOLOGIA, V15, P177, DOI DOI 10.1023/A:1007590023585; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; D'Amato G, 2002, ALLERGY, V57, P30, DOI 10.1034/j.1398-9995.57.s72.5.x; De Gussem K, 2007, ANAL BIOANAL CHEM, V387, P2823, DOI 10.1007/s00216-007-1150-1; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Douhan GW, 2011, FUNGAL BIOL-UK, V115, P569, DOI 10.1016/j.funbio.2011.03.005; Flannigan B, 1997, J AEROSOL SCI, V28, P381, DOI 10.1016/S0021-8502(96)00441-7; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Ghosal S, 2012, ENVIRON SCI TECHNOL, V46, P6088, DOI 10.1021/es203782j; Gottardini E, 2007, AEROBIOLOGIA, V23, P211, DOI 10.1007/s10453-007-9065-z; Hassett C. C., 2008, Allergy and allergic diseases. Volume 1: the scientific basis of allergy, P963; Trejo FH, 2013, ANN AGR ENV MED, V20, P657; Hong TD, 1997, ANN BOT-LONDON, V79, P121, DOI 10.1006/anbo.1996.0316; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Mularczyk-Oliwa M, 2012, SPECTROCHIM ACTA A, V97, P246, DOI 10.1016/j.saa.2012.05.063; Oliveira M, 2009, AEROBIOLOGIA, V25, P85, DOI 10.1007/s10453-009-9112-z; Pappas CS, 2003, APPL SPECTROSC, V57, P23, DOI 10.1366/000370203321165160; Parnmen S, 2012, PLOS ONE, V7; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Rivera-Mariani FE, 2012, AEROBIOLOGIA, V28, P83, DOI 10.1007/s10453-011-9234-y; Rivera-Mariani FE, 2011, INT ARCH ALLERGY IMM, V155, P322, DOI 10.1159/000321610; Schoenwetter WF, 2000, ALLERGY ASTHMA PROC, V21, P1, DOI 10.2500/108854100778248971; Schulte F, 2009, ANAL CHEM, V81, P8426, DOI 10.1021/ac901389p; Schulte F, 2008, ANAL CHEM, V80, P9551, DOI 10.1021/ac801791a; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Zervakis GI, 2012, FUNGAL BIOL-UK, V116, P715, DOI 10.1016/j.funbio.2012.04.006; Zhao RL, 2008, J ZHEJIANG UNIV-SC B, V9, P779, DOI 10.1631/jzus.B0860012; Zimmermann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095417; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664	41	32	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124240	10.1371/journal.pone.0124240	http://dx.doi.org/10.1371/journal.pone.0124240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867755	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352845100249
J	Feng, WQ; Guo, JJ; Huang, HY; Xia, B; Liu, HY; Li, J; Lin, SL; Li, TY; Liu, JJ; Li, H				Feng, Wenqiang; Guo, Juanjuan; Huang, Haiyan; Xia, Bo; Liu, Hongya; Li, Jie; Lin, Shaolin; Li, Tiyuan; Liu, Jianjun; Li, Hui			Human Normal Bronchial Epithelial Cells: A Novel In Vitro Cell Model for Toxicity Evaluation	PLOS ONE			English	Article							EXPRESSION; RESPONSES; ALVEOLAR; DIOXIDE; INDUCE; FATE	Human normal cell-based systems are needed for drug discovery and toxicity evaluation. hTERT or viral genes transduced human cells are currently widely used for these studies, while these cells exhibited abnormal differentiation potential or response to biological and chemical signals. In this study, we established human normal bronchial epithelial cells (HNBEC) using a defined primary epithelial cell culture medium without transduction of exogenous genes. This system may involve decreased IL-1 signaling and enhanced Wnt signaling in cells. Our data demonstrated that HNBEC exhibited a normal diploid karyotype. They formed well-defined spheres in matrigel 3D culture while cancer cells (HeLa) formed disorganized aggregates. HNBEC cells possessed a normal cellular response to DNA damage and did not induce tumor formation in vivo by xenograft assays. Importantly, we assessed the potential of these cells in toxicity evaluation of the common occupational toxicants that may affect human respiratory system. Our results demonstrated that HNBEC cells are more sensitive to exposure of 10 similar to 20 nm-sized SiO2, Cr(VI) and B(a)P compared to 16HBE cells (a SV40-immortalized human bronchial epithelial cells). This study provides a novel in vitro human cells-based model for toxicity evaluation, may also be facilitating studies in basic cell biology, cancer biology and drug discovery.	[Feng, Wenqiang; Guo, Juanjuan; Li, Hui] Wuhan Univ, Sch Basic Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Feng, Wenqiang; Guo, Juanjuan; Liu, Hongya; Li, Hui] Wuhan Univ, Shenzhen R&D Ctr State Key Lab Virol, Shenzhen, Guangdong, Peoples R China; [Huang, Haiyan; Xia, Bo; Li, Jie; Liu, Jianjun] Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Lin, Shaolin; Li, Tiyuan] Shenzhen Peoples Hosp, Shenzhen, Guangdong, Peoples R China	Wuhan University; Wuhan University; Shenzhen Center for Disease Control & Prevention (SZCDC); Jinan University	Li, H (corresponding author), Wuhan Univ, Sch Basic Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	somhli@whu.edu.cn	GUO, JUAN/HIK-2220-2022	Xia, Bo/0000-0002-0628-1910	Science and Technology Program of Shenzhen [GJHZ20130417155931486, JCYJ20140419141154244, CXZZ20140902162618036]	Science and Technology Program of Shenzhen	This work was supported by the Science and Technology Program of Shenzhen (No. GJHZ20130417155931486; JCYJ20140419141154244; CXZZ20140902162618036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen Y, 2004, TOXICOL IND HEALTH, V20, P21, DOI 10.1191/0748233704th190oa; Chen Z, 2008, ENVIRON SCI TECHNOL, V42, P8985, DOI 10.1021/es800975u; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ding X, 2014, TOXICOL LETT, V228, P25, DOI 10.1016/j.toxlet.2014.04.010; Fessart D, 2013, EUR RESPIR J, V42, P1345, DOI 10.1183/09031936.00118812; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gilbert B, 2012, ACS NANO, V6, P4921, DOI 10.1021/nn300425a; Gong CM, 2012, TOXICOL LETT, V209, P264, DOI 10.1016/j.toxlet.2012.01.007; Hamouchene H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-333; Huang HY, 2012, EXP CELL RES, V318, P682, DOI 10.1016/j.yexcr.2012.01.007; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kondo M, 2013, BIOMATERIALS, V34, P121, DOI 10.1016/j.biomaterials.2012.09.036; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; McCullough SD, 2014, AM J RESP CELL MOL, V51, P426, DOI 10.1165/rcmb.2013-0515OC; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Sergent JA, 2012, ANN OCCUP HYG, V56, P622, DOI 10.1093/annhyg/mes005; Umannova L, 2011, TOXICOL LETT, V206, P121, DOI 10.1016/j.toxlet.2011.06.029; Ursini CL, 2014, J APPL TOXICOL, V34, P1209, DOI 10.1002/jat.3038; Xia B, 2011, TOXICOL LETT, V205, P140, DOI 10.1016/j.toxlet.2011.05.1032; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1	27	63	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123520	10.1371/journal.pone.0123520	http://dx.doi.org/10.1371/journal.pone.0123520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861018	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300101
J	Bertolini, G; Wicki, A; Baumann, CR; Straumann, D; Palla, A				Bertolini, Giovanni; Wicki, Andrea; Baumann, Christian R.; Straumann, Dominik; Palla, Antonella			Impaired Tilt Perception in Parkinson's Disease: A Central Vestibular Integration Failure	PLOS ONE			English	Article							PEDUNCULOPONTINE NUCLEUS; VESTIBULOOCULAR REFLEX; SYSTEM; STIMULATION; PROJECTIONS; DYSFUNCTION; DISTURBANCE; CEREBELLUM; DISORDERS; RESPONSES	Introduction Impaired balance control is a hallmark symptom in Parkinson's disease (PD). Altered sensory-motor integration contributes to the deficiency. We aimed to determine whether impaired vestibular signal processing added to the disorder. We exposed patients (N = 11; 68+/-6y) and age-matched healthy subjects (hS: N = 19; 65+/-11y) on a motion platform in complete darkness to two consecutive forward tilt movements (12 series; N = 24; overall 288 trials) and asked them to indicate which tilt was perceived larger. By combing tilt movements with translations we manipulated vestibular sensory input in order to investigate whether putative impairment resulted from a deficiency of the sensory organs (semicircular canals in 'single-SCC-cue-condition', otoliths in 'single-OT-cue-condition') themselves or to a sensory integration failure ('multi-cue-condition'). Results Tilt discrimination in the multi-cue-condition was inferior in patients compared to hS (p = 0.02). No significant differences between the two groups were found for both single-cueconditions. Comparison of multi-cue-condition with a prediction resulting from the combination of both single-cue-conditions by optimal observer theory revealed that patients (p = 0.04), in contrast to hS, failed to efficiently combine SCC and OT information to improve tilt perception. Conclusion We found that PD patients distinguished forward tilts less precise than hS, suggesting impaired vestibular perception. Tilt discrimination in patients, moreover, did not improve as much as in hS in conditions where both SCC and OT information was available compared to conditions where only SCC or OT cues were activated. The latter provides evidence that tilt misperception in PD most likely results from an integration failure of vestibular signals.	[Bertolini, Giovanni; Wicki, Andrea; Baumann, Christian R.; Straumann, Dominik; Palla, Antonella] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Bertolini, G (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	giovanni.bertolini@usz.ch	Bertolini, Giovanni/H-3510-2016; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Bertolini, Giovanni/0000-0003-2428-9454; Baumann, Christian/0000-0003-3417-1978	Swiss National Science Foundation; Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation, Betty and David Koetser Foundation for Brain Research, Baasch Medicus Foundation, Zurich Center for Integrative Human Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2009, ANN NY ACAD SCI, V1164, P19, DOI 10.1111/j.1749-6632.2009.03939.x; Aravamuthan BR, 2012, NEUROSCIENCE, V223, P183, DOI 10.1016/j.neuroscience.2012.07.054; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Brock JW, 1996, PSYCHOPHARMACOLOGY, V123, P199, DOI 10.1007/BF02246178; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; De Nunzio AM, 2005, EXP BRAIN RES, V165, P261, DOI 10.1007/s00221-005-2297-7; Delfini C, 2000, EXP BRAIN RES, V135, P285, DOI 10.1007/s002210000516; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Ehrenstein WH, 1999, MODERN TECHNIQUES NE, P1211, DOI DOI 10.1007/978-3-642-58552-4_43; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; FLAHERTY AW, 1991, J NEUROPHYSIOL, V66, P1249; Giardino L, 1996, BRAIN RES, V736, P111, DOI 10.1016/S0006-8993(96)00692-0; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Joyal CC, 2001, BEHAV BRAIN RES, V122, P131, DOI 10.1016/S0166-4328(00)00390-9; Meng H, 2014, J PHYSIOL-LONDON, V592, P171, DOI 10.1113/jphysiol.2013.259614; Mergner T, 1997, J VESTIBUL RES-EQUIL, V7, P347, DOI 10.1016/S0957-4271(96)00176-0; PASTOR MA, 1993, BRAIN, V116, P1177, DOI 10.1093/brain/116.5.1177; Pollak L, 2009, NEUROPHYSIOL CLIN, V39, P235, DOI 10.1016/j.neucli.2009.07.001; RASCOL O, 1995, MOVEMENT DISORD, V10, P163, DOI 10.1002/mds.870100206; REICHERT WH, 1982, NEUROLOGY, V32, P1133, DOI 10.1212/WNL.32.10.1133; Romanelli P, 2005, BRAIN RES REV, V48, P112, DOI 10.1016/j.brainresrev.2004.09.008; Soto E, 2010, CURR NEUROPHARMACOL, V8, P26, DOI 10.2174/157015910790909511; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Stiles L, 2012, BEHAV BRAIN RES, V227, P150, DOI 10.1016/j.bbr.2011.11.006; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Vitale C, 2011, MOVEMENT DISORD, V26, P1458, DOI 10.1002/mds.23657; von Saldern S, 2013, J NEUROSCI, V33, P8841, DOI 10.1523/JNEUROSCI.3020-12.2013; WEST M O, 1987, P27; WHITE OB, 1983, BRAIN, V106, P555, DOI 10.1093/brain/106.3.555; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wright WG, 2010, EXP NEUROL, V225, P202, DOI 10.1016/j.expneurol.2010.06.016; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Zanetti D, 2004, Acta Otorhinolaryngol Ital, V24, P49	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124253	10.1371/journal.pone.0124253	http://dx.doi.org/10.1371/journal.pone.0124253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874868	Green Published, gold, Green Accepted			2022-12-27	WOS:000353015800135
J	Halang, P; Vorburger, T; Steuber, J				Halang, Petra; Vorburger, Thomas; Steuber, Julia			Serine 26 in the PomB Subunit of the Flagellar Motor Is Essential for Hypermotility of Vibrio cholerae	PLOS ONE			English	Article							CONSERVED CHARGED RESIDUES; NADH-QUINONE OXIDOREDUCTASE; NA+-DRIVEN; ESCHERICHIA-COLI; TORQUE GENERATION; TRANSMEMBRANE SEGMENT; CONFORMATIONAL-CHANGE; PERIPLASMIC REGION; CYTOPLASMIC LOOP; POLAR FLAGELLUM	Vibrio cholerae is motile by means of its single polar flagellum which is driven by the sodium-motive force. In the motor driving rotation of the flagellar filament, a stator complex consisting of subunits PomA and PomB converts the electrochemical sodium ion gradient into torque. Charged or polar residues within the membrane part of PomB could act as ligands for Na+, or stabilize a hydrogen bond network by interacting with water within the putative channel between PomA and PomB. By analyzing a large data set of individual tracks of swimming cells, we show that S26 located within the transmembrane helix of PomB is required to promote very fast swimming of V. cholerae. Loss of hypermotility was observed with the S26T variant of PomB at pH 7.0, but fast swimming was restored by decreasing the H+ concentration of the external medium. Our study identifies S26 as a second important residue besides D23 in the PomB channel. It is proposed that S26, together with D23 located in close proximity, is important to perturb the hydration shell of Na+ before its passage through a constriction within the stator channel.	[Halang, Petra; Vorburger, Thomas; Steuber, Julia] Univ Hohenheim, Inst Microbiol, Stuttgart, Germany	University Hohenheim	Vorburger, T (corresponding author), Univ Hohenheim, Inst Microbiol, Stuttgart, Germany.	T.Vorburger@uni-hohenheim.de; julia.steuber@uni-hohenheim.de			Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", Zurich, Switzerland	Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", Zurich, Switzerland	This work was supported by a grant from the Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", 8001 Zurich, Switzerland (to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Asai Y, 2003, J MOL BIOL, V327, P453, DOI 10.1016/S0022-2836(03)00096-2; Asai Y, 1997, J BACTERIOL, V179, P5104, DOI 10.1128/jb.179.16.5104-5110.1997; Asai Y, 1999, J BACTERIOL, V181, P6332, DOI 10.1128/JB.181.20.6332-6338.1999; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1974, NATURE, V249, P77, DOI 10.1038/249077a0; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Che YS, 2008, J BACTERIOL, V190, P6660, DOI 10.1128/JB.00503-08; Fukuoka H, 2009, MOL MICROBIOL, V71, P825, DOI 10.1111/j.1365-2958.2008.06569.x; GLAGOLEV AN, 1978, NATURE, V272, P280, DOI 10.1038/272280a0; Gosink KK, 2000, J BACTERIOL, V182, P4234, DOI 10.1128/JB.182.15.4234-4240.2000; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Griffitt KJ, 2013, MICROB ECOL, V65, P578, DOI 10.1007/s00248-013-0203-6; Halang P, 2013, J BACTERIOL, V195, P4888, DOI 10.1128/JB.00353-13; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Li N, 2011, J BACTERIOL, V193, P3773, DOI 10.1128/JB.00113-11; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lo CJ, 2013, P NATL ACAD SCI USA, V110, pE2544, DOI 10.1073/pnas.1301664110; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; Minato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097083; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto YV, 2010, FEBS LETT, V584, P1268, DOI 10.1016/j.febslet.2010.02.051; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Sato K, 2000, J BIOL CHEM, V275, P5718, DOI 10.1074/jbc.275.8.5718; Sato K, 2000, J BIOL CHEM, V275, P20223, DOI 10.1074/jbc.M002236200; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; STOLZ B, 1991, J BACTERIOL, V173, P7033, DOI 10.1128/jb.173.21.7033-7037.1991; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P11699, DOI 10.1021/bi901517n; Takekawa N, 2014, J BACTERIOL, V196, P1377, DOI 10.1128/JB.01392-13; Takekawa N, 2013, J BIOCHEM, V153, P441, DOI 10.1093/jb/mvt011; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Terahara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046248; Terashima H, 2010, J MOL BIOL, V397, P689, DOI 10.1016/j.jmb.2010.01.050; Terauchi T, 2011, MICROBIOL-SGM, V157, P2422, DOI 10.1099/mic.0.048488-0; Thormann KM, 2010, MICROBIOL-SGM, V156, P1275, DOI 10.1099/mic.0.029595-0; Underwood SA, 2004, APPL ENVIRON MICROB, V70, P2734, DOI 10.1128/AEM.70.5.2734-2740.2004; Van Way SM, 2000, J MOL BIOL, V297, P7, DOI 10.1006/jmbi.2000.3548; Vorburger T, 2009, BBA-BIOENERGETICS, V1787, P1198, DOI 10.1016/j.bbabio.2009.05.015; WILSON ML, 1990, J BACTERIOL, V172, P3932, DOI 10.1128/jb.172.7.3932-3939.1990; Yakushi T, 2004, J BACTERIOL, V186, P5281, DOI 10.1128/JB.186.16.5281-5291.2004; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Yorimitsu T, 1999, J BACTERIOL, V181, P5103, DOI 10.1128/JB.181.16.5103-5106.1999; Yorimitsu T, 2002, J MOL BIOL, V320, P403, DOI 10.1016/S0022-2836(02)00426-6; Zhou JD, 1997, J MOL BIOL, V273, P428, DOI 10.1006/jmbi.1997.1316; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhu SW, 2014, P NATL ACAD SCI USA, V111, P13523, DOI 10.1073/pnas.1324201111; Zhu SW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00410	72	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123518	10.1371/journal.pone.0123518	http://dx.doi.org/10.1371/journal.pone.0123518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874792	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800102
J	Lu, HB; Zheng, C; Wang, ZW; Chen, C; Chen, HB; Hu, JZ				Lu, Hongbin; Zheng, Cheng; Wang, Zhanwen; Chen, Can; Chen, Huabin; Hu, Jianzhong			Effects of Low-Intensity Pulsed Ultrasound on New Trabecular Bone during Bone-Tendon Junction Healing in a Rabbit Model: A Synchrotron Radiation Micro-CT Study	PLOS ONE			English	Article							FEMUR FRACTURE MODEL; PARTIAL PATELLECTOMY; MICROCOMPUTED TOMOGRAPHY; DISTRACTION OSTEOGENESIS; COMPUTED-TOMOGRAPHY; PATELLAR TENDON; RAT MODEL; MU-CT; REPAIR; OSTEOPOROSIS	This study was designed to evaluate the effects of low-intensity pulsed ultrasound on bone regeneration during the bone-tendon junction healing process and to explore the application of synchrotron radiation micro computed tomography in three dimensional visualization of the bone-tendon junction to evaluate the microarchitecture of new trabecular bone. Twenty four mature New Zealand rabbits underwent partial patellectomy to establish a bone-tendon junction injury model at the patella-patellar tendon complex. Animals were then divided into low-intensity pulsed ultrasound treatment (20 min/day, 7 times/week) and placebo control groups, and were euthanized at week 8 and 16 postoperatively (n = 6 for each group and time point). The patella-patellar tendon specimens were harvested for radiographic, histological and synchrotron radiation micro computed tomography detection. The area of the newly formed bone in the ultrasound group was significantly greater than that of control group at postoperative week 8 and 16. The high resolution three dimensional visualization images of the bone-tendon junction were acquired by synchrotron radiation micro computed tomography. Low-intensity pulsed ultrasound treatment promoted dense and irregular woven bone formation at week 8 with greater bone volume fraction, number and thickness of new trabecular bone but with lower separation. At week 16, ultrasound group specimens contained mature lamellar bone with higher bone volume fraction and thicker trabeculae than that of control group; however, there was no significant difference in separation and number of the new trabecular bone. This study confirms that low-intensity pulsed ultrasound treatment is able to promot bone formation and remodeling of new trabecular bone during the bone-tendon junction healing process in a rabbit model, and the synchrotron radiation micro computed tomography could be applied for three dimensional visualization to quantitatively evaluate the microarchitecture of new bone in bone-tendon junction.	[Lu, Hongbin; Zheng, Cheng; Wang, Zhanwen; Chen, Can; Chen, Huabin] Cent S Univ, Xiangya Hosp, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China; [Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Res Ctr Sports Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, JZ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, Res Ctr Sports Med, Changsha, Hunan, Peoples R China.	jianzhonghu@hotmail.com	Zheng, Cheng/AIA-7877-2022	Zheng, Cheng/0000-0003-1726-0258	National Natural Science Foundation of China [81171699, 84172072]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110162110068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 81171699 and No. 84172072) and Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110162110068). HL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Bachl N, 2008, CLIN SPORT MED, V27, P87, DOI 10.1016/j.csm.2007.10.006; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9; Chappard C, 2006, OSTEOARTHR CARTILAGE, V14, P215, DOI 10.1016/j.joca.2005.09.008; Chappard C, 2006, MED PHYS, V33, P3568, DOI 10.1118/1.2256069; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731; Chen SH, 2014, J MED BIOL ENG, V34, P197, DOI 10.5405/jmbe.1346; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; Fazzalari NL, 2011, OSTEOPOROSIS INT, V22, P2003, DOI 10.1007/s00198-011-1611-4; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; Hung L K, 1993, J Orthop Trauma, V7, P252, DOI 10.1097/00005131-199306000-00010; Ito M, 2003, J BONE MINER METAB, V21, P287, DOI 10.1007/s00774-003-0422-x; Kalfas I H, 2001, Neurosurg Focus, V10, pE1; Katano M, 2011, EXP ANIM TOKYO, V60, P385, DOI 10.1538/expanim.60.385; Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981; Kuhn G, 2007, HOMO, V58, P97, DOI 10.1016/j.jchb.2006.11.002; Larrue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021297; Leung KS, 2002, CLIN BIOMECH, V17, P594, DOI 10.1016/S0268-0033(02)00075-X; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111939; Lu H, 2008, ULTRASOUND MED BIOL, V34, P1248, DOI 10.1016/j.ultrasmedbio.2008.01.009; Lu H, 2008, CLIN J SPORT MED, V18, P62, DOI 10.1097/JSM.0b013e31815c24ba; Lu HB, 2006, AM J SPORT MED, V34, P1287, DOI 10.1177/0363546506286788; Lu HB, 2011, J ORTHOP RES, V29, P672, DOI 10.1002/jor.21292; Lui PPY, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-59; MARDER RA, 1993, J BONE JOINT SURG AM, V75A, P35, DOI 10.2106/00004623-199301000-00006; Nogueira LP, 2010, MICRON, V41, P990, DOI 10.1016/j.micron.2010.06.013; Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012; Okazaki N, 2014, BONE, V64, P82, DOI 10.1016/j.bone.2014.03.039; Qin L, 1999, MED SCI SPORT EXER, V31, P502, DOI 10.1097/00005768-199904000-00002; Qin L, 2006, ULTRASOUND MED BIOL, V32, P1905, DOI 10.1016/j.ultrasmedbio.2006.06.028; RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009; Salem KH, 2014, INT ORTHOP, V38, P1477, DOI 10.1007/s00264-013-2254-1; Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736; SALTZMAN CL, 1990, J BONE JOINT SURG AM, V72A, P1279, DOI 10.2106/00004623-199072090-00001; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schofer M. D., 2010, BIOMEDICAL CENTRAL M, V11, P229, DOI DOI 10.1186/1471-2474-11-229; Sone T, 2004, BONE, V35, P432, DOI 10.1016/j.bone.2004.05.011; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Waseem Z, 2010, PM&R, V2, P159, DOI 10.1016/j.pmrj.2009.11.008; Wu SL, 2009, PATHOBIOLOGY, V76, P99, DOI 10.1159/000209387; Xie LK, 2011, INT J ORAL MAX SURG, V40, P730, DOI 10.1016/j.ijom.2011.03.016; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Zehbe R, 2012, MICRON, V43, P1060, DOI 10.1016/j.micron.2012.05.001; Zuluaga MA, 2014, PHYS MED BIOL, V59, P2155, DOI 10.1088/0031-9155/59/9/2155	48	19	20	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124724	10.1371/journal.pone.0124724	http://dx.doi.org/10.1371/journal.pone.0124724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874957	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800150
J	Serra, F; Spoto, A; Ghisi, M; Vidotto, G				Serra, Francesca; Spoto, Andrea; Ghisi, Marta; Vidotto, Giulio			Formal Psychological Assessment in Evaluating Depression: A New Methodology to Build Exhaustive and Irredundant Adaptive Questionnaires	PLOS ONE			English	Article							COGNITIVE THERAPY; RATING-SCALE; PREVALENCE; DISORDERS; SUICIDE; ANXIETY; APATHY; RELEVANCE; SYMPTOM; STATE	Psychological Assessment can be defined as a complex procedure of information collection, analysis and processing. Formal Psychological Assessment (FPA) tries to improve this procedure by providing a formal framework to build assessment tools. In this paper, FPA is applied to depression. Seven questionnaires widely used for the self-evaluation of depression were selected. Diagnostic criteria for major depressive disorder were derived from the DSM-5, literature and Seligman's and Beck's theories. A Boolean matrix was built, including 266 items from the questionnaires in the rows and 20 selected attributes, obtained through diagnostic criteria decomposition, in the columns. In the matrix, a 1 in a cell meant that the corresponding item investigated the specific attribute. It was thus possible to analyze the relationships between items and attributes and among items. While none of the considered questionnaires could alone cover all the criteria for the evaluation of depressive symptoms, we observed that a set of 30 items contained the same information that was obtained redundantly with 266 items. Another result highlighted by the matrix regards the relations among items. FPA allows in-depth analysis of currently used questionnaires based on the presence/absence of clinical elements. FPA allows for going beyond the mere score by differentiating the patients according to symptomatology. Furthermore, it allows for computerized-adaptive assessment.	[Serra, Francesca; Spoto, Andrea; Ghisi, Marta; Vidotto, Giulio] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Vidotto, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giulio.vidotto@unipd.it	Ghisi, Marta/G-3941-2017; Vidotto, Giulio/B-9314-2009	Ghisi, Marta/0000-0002-6904-7259; Vidotto, Giulio/0000-0002-3854-5087; Spoto, Andrea/0000-0002-7580-544X; Serra, Francesca/0000-0003-4758-7585				ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; ALLOY LB, 1984, J PERS SOC PSYCHOL, V46, P681, DOI 10.1037/0022-3514.46.3.681; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2012, LANCET, V380, P1203, DOI 10.1016/S0140-6736(12)61694-8; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Baxter AJ, 2014, DEPRESS ANXIETY, V31, P506, DOI 10.1002/da.22230; BECK A T, 1976, P356; Beck AT, 2005, ARCH GEN PSYCHIAT, V62, P953, DOI 10.1001/archpsyc.62.9.953; BECK AT, 1991, AM PSYCHOL, V46, P368, DOI 10.1037/0003-066X.46.4.368; Beck AT, 1996, MANUAL BECK INVENTOR; Bocquier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080797; Bottesi G, 2015, J PERS ASSESS, V97, P252, DOI 10.1080/00223891.2014.958846; Bracht T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052238; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Cassano GB, 1982, CONDIZIONE DEPRESSIV, P457; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; DOIGNON JP, 1985, INT J MAN MACH STUD, V23, P175, DOI 10.1016/S0020-7373(85)80031-6; Eaton W. W., 2004, USE PSYCHOL TESTING, V3, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Falmagne JC, 2011, LEARNING SPACES: INTERDISCIPLINARY APPLIED MATHEMATICS, P1, DOI 10.1007/978-3-642-01039-2; Fava M, 2014, DEPRESS ANXIETY, V31, P250, DOI 10.1002/da.22199; Ferentinos P, 2011, AMYOTROPH LATERAL SC, V12, P297, DOI 10.3109/17482968.2011.556744; Fried EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090311; Gaillard R, 2013, ENCEPHALE, V39, P296, DOI 10.1016/j.encep.2013.07.001; Ganter B., 1999, FORMAL CONCEPT ANAL; Gaudiano BA, 2008, COMPR PSYCHIAT, V49, P421, DOI 10.1016/j.comppsych.2008.02.007; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Groth-Marnat G, 2009, HDB PSYCHOL ASSESSME; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamoen ABH, 2014, DEPRESS ANXIETY, V31, P662, DOI 10.1002/da.22258; Henderson Sarah E, 2013, Front Psychiatry, V4, P152, DOI 10.3389/fpsyt.2013.00152; Hybels CF, 2012, INT J GERIATR PSYCH, V27, P601, DOI 10.1002/gps.2759; Joormann J, 2014, DEPRESS ANXIETY, V31, P308, DOI 10.1002/da.22264; Knapp P, 2008, REV BRAS PSIQUIATR, V30, pS54, DOI 10.1590/S1516-44462008000600002; Koukopoulos A, 2007, ACTA PSYCHIAT SCAND, V115, P50, DOI 10.1111/j.1600-0447.2007.00963.x; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lee S, 2010, J AFFECT DISORDERS, V126, P125, DOI 10.1016/j.jad.2010.03.007; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Motohashi Y, 2012, LANCET, V379, P1282, DOI 10.1016/S0140-6736(11)61130-6; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Olin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048002; Otto Y, 2014, PRAX KINDERPSYCHOL K, V63, P154, DOI 10.13109/prkk.2014.63.3.154; Pancheri P, 1982, RIV PSICHIATR, V17, P121; Pedrelli P, 2013, J NERV MENT DIS, V201, P953, DOI 10.1097/NMD.0000000000000038; PLUTCHIK R, 1987, PSYCHIAT RES, V22, P243, DOI 10.1016/0165-1781(87)90039-4; Potvin O, 2014, INT J GERIATR PSYCH, V29, P1262, DOI 10.1002/gps.4106; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reeves A, 2013, LANCET, V381, P722, DOI 10.1016/S0140-6736(13)60574-7; Reeves A, 2012, LANCET, V380, P1813, DOI 10.1016/S0140-6736(12)61910-2; Rothschild AJ, 2014, COMPR PSYCHIAT, V55, P1, DOI 10.1016/j.comppsych.2013.08.008; RUSH AJ, 1978, AM J PSYCHOTHER, V32, P201, DOI 10.1176/appi.psychotherapy.1978.32.2.201; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; SELIGMAN MEP, 1978, J ABNORM PSYCHOL, V87, P165, DOI 10.1037/0021-843X.87.1.165; SELIGMAN MEP, 1980, BEHAV RES THER, V18, P462, DOI 10.1016/0005-7967(80)90012-1; Singh SM, 2013, ASIAN J PSYCHIATR, V6, P622, DOI 10.1016/j.ajp.2013.05.010; Spoto A, 2013, PSYCHOTHER PSYCHOSOM, V82, P197, DOI 10.1159/000345317; Spoto A, 2010, BEHAV RES METHODS, V42, P342, DOI 10.3758/BRM.42.1.342; van Zaane J, 2012, DRUG ALCOHOL DEPEN, V124, P235, DOI 10.1016/j.drugalcdep.2012.01.018; Wille R., 1982, ORDERED SETS, V83, P445, DOI [DOI 10.1007/978-94-009-7798-3_15, 10.1007/978-94-009-7798-3_15]; Zimmerman M, 2008, PSYCHOL MED, V38, P199, DOI 10.1017/S0033291707001717; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	62	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122131	10.1371/journal.pone.0122131	http://dx.doi.org/10.1371/journal.pone.0122131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875359	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800041
J	Sinnott, M; Kinsley, BT; Jackson, AD; Walsh, C; O'Grady, T; Nolan, JJ; Gaffney, P; Boran, G; Kelleher, C; Carr, B				Sinnott, Margaret; Kinsley, Brendan T.; Jackson, Abaigeal D.; Walsh, Cathal; O'Grady, Tony; Nolan, John J.; Gaffney, Peter; Boran, Gerard; Kelleher, Cecily; Carr, Bernadette			Fasting Plasma Glucose as Initial Screening for Diabetes and Prediabetes in Irish Adults: The Diabetes Mellitus and Vascular Health Initiative (DMVhi)	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; PREVALENCE; POPULATION; BEHAVIORS; AUSTRALIA; OBESITY	Objective Type 2 diabetes has a long pre clinical asymptomatic phase. Early detection may delay or arrest disease progression. The Diabetes Mellitus and Vascular health initiative (DMVhi) was initiated as a prospective longitudinal cohort study on the prevalence of undiagnosed Type 2 diabetes and prediabetes, diabetes risk and cardiovascular risk in a cohort of Irish adults aged 45-75 years. Research Design and Methods Members of the largest Irish private health insurance provider aged 45 to 75 years were invited to participate in the study. Exclusion criteria: already diagnosed with diabetes or taking oral hypoglycaemic agents. Participants completed a detailed medical questionnaire, had weight, height, waist and hip circumference and blood pressure measured. Fasting blood samples were taken for fasting plasma glucose (FPG). Those with FPG in the impaired fasting glucose (IFG) range had a 75gm oral glucose tolerance test performed. Results 122,531 subjects were invited to participate. 29,144 (24%) completed the study. The prevalence of undiagnosed diabetes was 1.8%, of impaired fasting glucose (IFG) was 7.1% and of impaired glucose tolerance (IGT) was 2.9%. Dysglycaemia increased among those aged 45-54, 55-64 and 65-75 years in both males (10.6%, 18.5%, 21.7% respectively) and females (4.3%, 8.6%, 10.9% respectively). Undiagnosed T2D, IFG and IGT were all associated with gender, age, blood pressure, BMI, abdominal obesity, family history of diabetes and triglyceride levels. Using FPG as initial screening may underestimate the prevalence of T2D in the study population. Conclusions This study is the largest screening study for diabetes and prediabetes in the Irish population. Follow up of this cohort will provide data on progression to diabetes and on cardiovascular outcomes.	[Sinnott, Margaret; Jackson, Abaigeal D.; O'Grady, Tony; Carr, Bernadette] Vhi Healthcare Ltd, Dublin, Ireland; [Kinsley, Brendan T.] Mater Misericordiae Univ Hosp, Dublin, Ireland; [Walsh, Cathal] Univ Dublin Trinity Coll, Dept Stat, Dublin 2, Ireland; [Nolan, John J.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Gaffney, Peter; Boran, Gerard] Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin, Ireland; [Kelleher, Cecily; Carr, Bernadette] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	Mater Misericordiae University Hospital; University College Dublin; Trinity College Dublin; Steno Diabetes Center; Trinity College Dublin; University College Dublin	Carr, B (corresponding author), Vhi Healthcare Ltd, Dublin, Ireland.	bernadette.carr@vhi.ie	kelleher, cecily c/A-4233-2013	kelleher, cecily c/0000-0001-9548-4914; Jackson, Abaigeal/0000-0002-9030-0036; Walsh, Cathal/0000-0001-6599-9562	Vhi Healthcare; EU; Vhi Healthcare Ltd.	Vhi Healthcare; EU(European Commission); Vhi Healthcare Ltd.	The DMVhi research project was funded by Vhi Healthcare. Part funding was received for the project through the EU-funded DEXLIFE ressearch program. Vhi Healthcare Ltd., provided support in the form of salaries for authors MS, ADJ, TOG & BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Creagh D, 2002, Ir Med J, V95, P298; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Simmons RK, 2010, DIABETES OBES METAB, V12, P838, DOI 10.1111/j.1463-1326.2010.01244.x; Smith SM, 2003, DIABETIC MED, V20, P717, DOI 10.1046/j.1464-5491.2003.00998.x; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaccaro O, 2005, DIABETES CARE, V28, P1786, DOI 10.2337/diacare.28.7.1786; von Eckardstein A, 2013, JALA-J LAB AUTOM, V18, P306, DOI 10.1177/2211068212472183; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	26	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122704	10.1371/journal.pone.0122704	http://dx.doi.org/10.1371/journal.pone.0122704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874867	Green Published, gold			2022-12-27	WOS:000353015800072
J	Wilhelm-Buchstab, T; Buchstab, BM; Leitzen, C; Garbe, S; Mudder, T; Oberste-Beulmann, S; Sprinkart, AM; Simon, B; Nelles, M; Block, W; Schoroth, F; Schild, HH; Schuller, H				Wilhelm-Buchstab, Timo; Buchstab, Barbara Myrthe; Leitzen, Christina; Garbe, Stephan; Muedder, Thomas; Oberste-Beulmann, Susanne; Sprinkart, Alois Martin; Simon, Birgit; Nelles, Michael; Block, Wolfgang; Schoroth, Felix; Schild, Hans Heinz; Schueller, Heinrich			Extraretinal Induced Visual Sensations during IMRT of the Brain	PLOS ONE			English	Article							IONIZING-RADIATION; RAY; ASTRONAUTS; PHOSPHENE; ORBIT	Background We observed visual sensations (VSs) in patients undergoing intensity modulated radiotherapy (IMRT) of the brain without the beam passing through ocular structures. We analyzed this phenomenon especially with regards to reproducibility, and origin. Methods and Findings Analyzed were ten consecutive patients (aged 41-71 years) with glioblastoma multiforme who received pulsed IMRT (total dose 60Gy) with helical tomotherapy (TT). A megavolt-CT (MVCT) was performed daily before treatment. VSs were reported and recorded using a triggered event recorder. The frequency of VSs was calculated and VSs were correlated with beam direction and couch position. Subjective patient perception was plotted on an 8x8 visual field (VF) matrix. Distance to the orbital roof (OR) from the first beam causing a VS was calculated from the Dicom radiation therapy data and MVCT data. During 175 treatment sessions (average 17.5 per patient) 5959 VSs were recorded and analyzed. VSs occurred only during the treatment session not during the MVCTs. Plotting events over time revealed patient-specific patterns. The average cranio-caudad extension of VS-inducing area was 63.4mm (range 43.24-92.1mm). The maximum distance between the first VS and the OR was 56.1mm so that direct interaction with the retina is unlikely. Data on subjective visual perception showed that VSs occurred mainly in the upper right and left quadrants of the VF. Within the visual pathways the highest probability for origin of VSs was seen in the optic chiasm and the optic tract (22%). Conclusions There is clear evidence that interaction of photon irradiation with neuronal structures distant from the eye can lead to VSs.	[Wilhelm-Buchstab, Timo; Buchstab, Barbara Myrthe; Leitzen, Christina; Garbe, Stephan; Muedder, Thomas; Oberste-Beulmann, Susanne; Sprinkart, Alois Martin; Simon, Birgit; Nelles, Michael; Block, Wolfgang; Schoroth, Felix; Schild, Hans Heinz; Schueller, Heinrich] Univ Bonn, Dept Radiol, Radiooncol, D-53105 Bonn, Germany	University of Bonn	Wilhelm-Buchstab, T (corresponding author), Univ Bonn, Dept Radiol, Radiooncol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Timo.Buchstab@ukb.uni-bonn.de	Wilhelm-Buchstab, Timo/AAE-3112-2020; Sprinkart, Alois Martin/T-5033-2019	Sprinkart, Alois Martin/0000-0002-1435-9562				BACHOFER CS, 1963, RADIAT RES, V18, P246, DOI 10.2307/3571445; Bokkon I, 2008, BIOSYSTEMS, V92, P168, DOI 10.1016/j.biosystems.2008.02.002; Brandes G, 1897, WIEDEMANNS ANN PHYS, V60, P478; Chapman P, 1972, P NAT S NAT MANM RAD, P1102; CHARMAN WN, 1971, NATURE, V232, P574, DOI 10.1038/232574a0; CHARMAN WN, 1971, NATURE, V230, P522, DOI 10.1038/230522a0; Cherenkov P, 1964, NOBEL LECT PHYS 1942, V3, P426; Chiang CS, 1991, BRAIN RES, V566, P256; Clatworthy AL, 1999, NEUROSCI LETT, V268, P45, DOI 10.1016/S0304-3940(99)00069-5; DARCY FJ, 1962, NATURE, V196, P1013, DOI 10.1038/1961013a0; De Vries KD, 2011, REV LETT, V2011; Edison TA, 1896, ELECTRON ENG, V22, P520; Fazzio GG, 1970, NATURE, V228, P260; Fuglesang C, 2006, AVIAT SPACE ENVIR MD, V77, P449; GANGLOFF H., 1965, ADVANCE BIOL MED PHYS, V10, P1; Jenrow KA, 2001, EXP NEUROL, V169, P96, DOI 10.1006/exnr.2000.7616; Jeraj R, 2004, MED PHYS, V31, P396, DOI 10.1118/1.1639148; Kramer M, 2012, GSI BIOPHYS; Lipetz J, 1955, BR J OPHTALMOL, V39, P577; MCNULTY PJ, 1972, SCIENCE, V178, P160, DOI 10.1126/science.178.4057.160; Newman F, 2008, MED PHYS, V35, P77, DOI 10.1118/1.2815358; PINSKY LS, 1974, SCIENCE, V183, P957, DOI 10.1126/science.183.4128.957; Sannita WG, 2006, VISION RES, V46, P2159, DOI 10.1016/j.visres.2005.12.002; Schardt D, 2013, BRAIN STIMUL, V6, P416, DOI 10.1016/j.brs.2012.08.003; SCHOBER H, 1964, VISION RES, V4, P251, DOI 10.1016/0042-6989(64)90007-0; STEIDLEY KD, 1990, VISION RES, V30, P1139, DOI 10.1016/0042-6989(90)90171-G; STEIDLEY KD, 1989, INT J RADIAT ONCOL, V17, P685, DOI 10.1016/0360-3016(89)90125-9; TOBIAS CA, 1971, NATURE, V230, P596, DOI 10.1038/230596a0; Tobias CA, 1970, OBSERVATIONS HUMAN S, P16; Wilhelm-Buchstab T, 2013, 30 JAHR OST GES RAD, V65	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123440	10.1371/journal.pone.0123440	http://dx.doi.org/10.1371/journal.pone.0123440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875609	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800099
J	Eller, J; Zarnadze, S; Bauerle, P; Dugladze, T; Gloveli, T				Eller, Joanna; Zarnadze, Shota; Bauerle, Peter; Dugladze, Tamar; Gloveli, Tengis			Cell Type-Specific Separation of Subicular Principal Neurons during Network Activities	PLOS ONE			English	Article							ELECTROPHYSIOLOGICALLY-DEFINED CLASSES; TEMPORAL-LOBE EPILEPSY; RAT VENTRAL SUBICULUM; LIMBIC GAMMA RHYTHMS; IN-VITRO; PYRAMIDAL NEURONS; INTRINSIC-PROPERTIES; REGULAR-SPIKING; HIPPOCAMPUS; OSCILLATIONS	The hippocampal output structure, the subiculum, expresses two major memory relevant network rhythms, sharp wave ripple and gamma frequency oscillations. To this date, it remains unclear how the two distinct types of subicular principal cells, intrinsically bursting and regular spiking neurons, participate in these two network rhythms. Using concomitant local field potential and intracellular recordings in an in vitro mouse model that allows the investigation of both network rhythms, we found a cell type-specific segregation of principal neurons into participating intrinsically bursting and non-participating regular spiking cells. However, if regular spiking cells were kept at a more depolarized level, they did participate in a specific manner, suggesting a potential bimodal working model dependent on the level of excitation. Furthermore, intrinsically bursting and regular spiking cells exhibited divergent intrinsic membrane and synaptic properties in the active network. Thus, our results suggest a cell-type-specific segregation of principal cells into two separate groups during network activities, supporting the idea of two parallel streams of information processing within the subiculum.	[Eller, Joanna; Zarnadze, Shota; Bauerle, Peter; Dugladze, Tamar; Gloveli, Tengis] Charite, Inst Neurophysiol, Cellular & Network Physiol Grp, D-13353 Berlin, Germany; [Dugladze, Tamar] Cluster Excellence NeuroCure, Berlin, Germany; [Gloveli, Tengis] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gloveli, T (corresponding author), Charite, Inst Neurophysiol, Cellular & Network Physiol Grp, D-13353 Berlin, Germany.	tengis.gloveli@charite.de		Bauerle, Peter/0000-0002-1675-6553; Dugladze, Tamar/0000-0002-4946-3984; Gloveli, Tengis/0000-0002-2209-375X	DFG [GL 254/5-2]; BMBF (BCCN II) and Einstein Foundation Berlin [A-2013-176]; Cluster Neurocure (Female PostDoc project)	DFG(German Research Foundation (DFG)); BMBF (BCCN II) and Einstein Foundation Berlin(Federal Ministry of Education & Research (BMBF)); Cluster Neurocure (Female PostDoc project)	This study was supported by the DFG (GL 254/5-2), BMBF (BCCN II) and Einstein Foundation Berlin (A-2013-176) to TG, and Cluster Neurocure (Female PostDoc project) to TD. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Behr J, 1996, NEUROSCI LETT, V220, P41, DOI 10.1016/S0304-3940(96)13242-0; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Colgin LL, 2010, PHYSIOLOGY, V25, P319, DOI 10.1152/physiol.00021.2010; Colling SB, 1998, J NEUROPHYSIOL, V80, P155, DOI 10.1152/jn.1998.80.1.155; D'Antuono M, 2001, J NEUROPHYSIOL, V86, P1164, DOI 10.1152/jn.2001.86.3.1164; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; FINCH DM, 1983, BRAIN RES, V271, P201, DOI 10.1016/0006-8993(83)90283-4; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Greene JRT, 1997, J COMP NEUROL, V380, P395, DOI 10.1002/(SICI)1096-9861(19970414)380:3<395::AID-CNE8>3.0.CO;2-Y; Greene JRT, 1996, J NEUROPHYSIOL, V76, P1657, DOI 10.1152/jn.1996.76.3.1657; Greene JRT, 1997, NEUROSCIENCE, V80, P95, DOI 10.1016/S0306-4522(97)00073-0; HABLITZ JJ, 1981, CELL MOL NEUROBIOL, V1, P325, DOI 10.1007/BF00716267; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; Jung HY, 2001, J NEUROSCI, V21, P3312, DOI 10.1523/JNEUROSCI.21-10-03312.2001; Kawasaki H, 1999, J NEUROPHYSIOL, V82, P2590, DOI 10.1152/jn.1999.82.5.2590; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Kintscher M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045039; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MASON A, 1993, BRAIN RES, V600, P174, DOI 10.1016/0006-8993(93)90418-M; MATTIA D, 1993, J NEUROPHYSIOL, V70, P1244, DOI 10.1152/jn.1993.70.3.1244; Naber PA, 1998, J COMP NEUROL, V393, P284; Norimoto H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02696; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Panuccio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050241; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Stanford IM, 1998, J NEUROPHYSIOL, V80, P162, DOI 10.1152/jn.1998.80.1.162; Stewart M, 1997, BRAIN RES, V769, P71, DOI 10.1016/S0006-8993(97)00690-2; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; SWANSON LW, 1975, SCIENCE, V189, P303, DOI 10.1126/science.49928; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wu CP, 2006, J PHYSIOL-LONDON, V576, P457, DOI 10.1113/jphysiol.2006.114918; Zylla MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080718	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123636	10.1371/journal.pone.0123636	http://dx.doi.org/10.1371/journal.pone.0123636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874555	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700034
J	Ovalle-Rivera, O; Laderach, P; Bunn, C; Obersteiner, M; Schroth, G				Ovalle-Rivera, Oriana; Laederach, Peter; Bunn, Christian; Obersteiner, Michael; Schroth, Gotz			Projected Shifts in Coffea arabica Suitability among Major Global Producing Regions Due to Climate Change	PLOS ONE			English	Article							IMPACT; TREE	Regional studies have shown that climate change will affect climatic suitability for Arabica coffee (Coffea arabica) within current regions of production. Increases in temperature and changes in precipitation patterns will decrease yield, reduce quality and increase pest and disease pressure. This is the first global study on the impact of climate change on suitability to grow Arabica coffee. We modeled the global distribution of Arabica coffee under changes in climatic suitability by 2050s as projected by 21 global circulation models. The results suggest decreased areas suitable for Arabica coffee in Mesoamerica at lower altitudes. In South America close to the equator higher elevations could benefit, but higher latitudes lose suitability. Coffee regions in Ethiopia and Kenya are projected to become more suitable but those in India and Vietnam to become less suitable. Globally, we predict decreases in climatic suitability at lower altitudes and high latitudes, which may shift production among the major regions that produce Arabica coffee.	[Ovalle-Rivera, Oriana; Laederach, Peter] Ctr Int Agr Trop, DAPA Program, Cali, Colombia; [Bunn, Christian] Humboldt Univ, Fac Agr & Hort, D-10099 Berlin, Germany; [Obersteiner, Michael] Int Inst Appl Syst Anal, ESM Program, A-2361 Laxenburg, Austria	Alliance; International Center for Tropical Agriculture - CIAT; Humboldt University of Berlin; International Institute for Applied Systems Analysis (IIASA)	Laderach, P (corresponding author), Ctr Int Agr Trop, DAPA Program, Apartado Aereo 6713, Cali, Colombia.	p.laderach@cgiar.org	Bunn, Christian/AAE-9504-2019	Bunn, Christian/0000-0003-2175-8745; Laderach, Peter/0000-0001-8708-6318	Climate Change, Agriculture and Food Security (CCAFS)	Climate Change, Agriculture and Food Security (CCAFS)	This study has been funded by the CGIAR program on Climate Change, Agriculture and Food Security (CCAFS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088463; Bunn C, 2012, INTEGRATED CLIMATE C, p611ff; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; ECOCROP (Food And Agriculture Organization of the United Nations US), COFF AR EC 2000; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fandohan B, 2013, BIOTECHNOL AGRON SOC, V17, P450; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fischlin A, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P211; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Haggar J, 2011, DESK STUDY IMPACTS C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ICO (International Coffee Organization England), HIST DAT COFF PROD 2; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Laderach P, 2009, MANAGEMENT INTRINSIC; Laderach P, 2010, PUBLICACION CATIE, V99, P54; Laderach P, 2010, MESOAMERICAN COFFEE; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Morales M, 2012, CATIE 2012; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rahn E, 2014, MITIG ADAPT STRAT GL, V19, P1119, DOI 10.1007/s11027-013-9467-x; Ramirez J, 2010, DECISION POLICY ANAL; Ramirez-Villegas J, 2012, AGR FOREST METEOROL, V161, P26, DOI 10.1016/j.agrformet.2012.03.015; Schroth G, 2014, REGIONAL ENV CHANGE, P1; Schroth G, 2014, AGRON SUSTAIN DEV, V34, P139, DOI 10.1007/s13593-013-0175-4; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; USDA (United States Departament of agriculture USA), 2011, COFF WORLD MARK TRAD; Villers L, 2009, INTERCIENCIA, V34, P322; WALLER J.M, 2007, COFFEE PESTS DIS THE; Waller JM, 2007, WORLD COFFEE PRODUCT, P17; Zullo J, 2011, CLIMATIC CHANGE, V109, P535, DOI 10.1007/s10584-011-0058-0	34	144	149	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124155	10.1371/journal.pone.0124155	http://dx.doi.org/10.1371/journal.pone.0124155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875230	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353014700056
J	Varga, A; Gyulavari, P; Greff, Z; Futosi, K; Nemeth, T; Simon-Szabo, L; Kerekes, K; Szantai-Kis, C; Brauswetter, D; Kokas, M; Borbely, G; Erdei, A; Mocsai, A; Keri, G; Vantus, T				Varga, Attila; Gyulavari, Pal; Greff, Zoltan; Futosi, Krisztina; Nemeth, Tamas; Simon-Szabo, Laura; Kerekes, Krisztina; Szantai-Kis, Csaba; Brauswetter, Diana; Kokas, Marton; Borbely, Gabor; Erdei, Anna; Mocsai, Attila; Keri, Gyorgy; Vantus, Tibor			Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; PERMANENT CELL-LINE; MAST-CELLS; MOLECULAR-CLONING; DRUG DISCOVERY; D ACTIVATION; PHOSPHORYLATION; NEUTROPHILS; FAMILY; VIVO	Emerging evidence suggests that the vascular endothelial growth factor receptor 2 (VEGFR2) and protein kinase D1 (PKD1) signaling axis plays a critical role in normal and pathological angiogenesis and inflammation related processes. Despite all efforts, the currently available therapeutic interventions are limited. Prior studies have also proved that a multiple target inhibitor can be more efficient compared to a single target one. Therefore, development of novel inflammatory pathway-specific inhibitors would be of great value. To test this possibility, we screened our molecular library using recombinant kinase assays and identified the previously described compound VCC251801 with strong inhibitory effect on both VEGFR2 and PKD1. We further analyzed the effect of VCC251801 in the endothelium- derived EA.hy926 cell line and in different inflammatory cell types. In EA.hy926 cells, VCC251801 potently inhibited the intracellular activation and signaling of VEGFR2 and PKD1 which inhibition eventually resulted in diminished cell proliferation. In this model, our compound was also an efficient inhibitor of in vitro angiogenesis by interfering with endothelial cell migration and tube formation processes. Our results from functional assays in inflammatory cellular models such as neutrophils and mast cells suggested an anti-inflammatory effect of VCC251801. The neutrophil study showed that VCC251801 specifically blocked the immobilized immune-complex and the adhesion dependent TNF-alpha-fibrinogen stimulated neutrophil activation. Furthermore, similar results were found in mast cell degranulation assay where VCC251801 caused significant reduction of mast cell response. In summary, we described a novel function of a multiple kinase inhibitor which strongly inhibits the VEGFR2-PKD1 signaling and might be a novel inhibitor of pathological inflammatory pathways.	[Varga, Attila; Gyulavari, Pal; Borbely, Gabor; Keri, Gyorgy] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, H-1085 Budapest, Hungary; [Greff, Zoltan; Szantai-Kis, Csaba; Keri, Gyorgy] Vichem Chem Res Ltd, Budapest, Hungary; [Futosi, Krisztina; Nemeth, Tamas; Mocsai, Attila] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary; [Simon-Szabo, Laura; Kerekes, Krisztina; Erdei, Anna] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Brauswetter, Diana; Kokas, Marton; Keri, Gyorgy; Vantus, Tibor] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Vichem Chemie Research Ltd.; Semmelweis University; Eotvos Lorand University; Semmelweis University	Vantus, T (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	vantus.tibor@med.semmelweis-univ.hu	Németh, Tamás/O-1968-2017	Németh, Tamás/0000-0001-6854-4301; Erdei, Anna/0000-0002-3622-6680; Futosi, Krisztina/0000-0002-1661-4635; Szantai-Kis, Csaba/0000-0002-5240-845X	Anyos Jedlik [NKFP-A1-0069/2006]; National Office for Research and Technology (Hungary) [KMR-12-1-2012-0074]; National Development Agency (Hungary); European Community [HEALTH-F4-2011-282095]	Anyos Jedlik; National Office for Research and Technology (Hungary)(National Office for Research and Technology); National Development Agency (Hungary); European Community(European Commission)	This study was supported by Anyos Jedlik award number NKFP-A1-0069/2006 to AM, GK and TV by National Office for Research and Technology (Hungary), supporting experimental work, focusing on drug screening and neutrophil studies; KMR-12-1-2012-0074 to GK by National Development Agency (Hungary), supporting experimental work in cell culture; The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement no HEALTH-F4-2011-282095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Aranda E, 2009, BIOL RES, V42, P377, DOI [/S0716-97602009000300012, 10.4067/S0716-97602009000300012]; Barvian M, 2000, J MED CHEM, V43, P4606, DOI 10.1021/jm000271k; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Davidson-Moncada JK, 2002, BIOCHEM J, V363, P95, DOI 10.1042/0264-6021:3630095; de Paulis A, 2006, J IMMUNOL, V177, P7322, DOI 10.4049/jimmunol.177.10.7322; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; ERDEI A, 1995, INT IMMUNOL, V7, P1433, DOI 10.1093/intimm/7.9.1433; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Evans IM, 2011, IUBMB LIFE, V63, P258, DOI 10.1002/iub.456; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Guo JX, 2013, CANCER CHEMOTH PHARM, V71, P331, DOI 10.1007/s00280-012-2010-z; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ittner A, 2012, J EXP MED, V209, P2229, DOI 10.1084/jem.20120677; Keri G, 2005, ASSAY DRUG DEV TECHN, V3, P543, DOI 10.1089/adt.2005.3.543; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kovacs M, 2014, J EXP MED, V211, P1993, DOI 10.1084/jem.20132496; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Murphy TR, 2007, J IMMUNOL, V179, P7876, DOI 10.4049/jimmunol.179.11.7876; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785, DOI 10.1248/bpb.34.1785; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Verzoni E, 2014, PHARMACOGEN PERS MED, V7, P107, DOI 10.2147/PGPM.S37098; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yamashita K, 2010, INT IMMUNOPHARMACOL, V10, P277, DOI 10.1016/j.intimp.2009.11.011	56	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124234	10.1371/journal.pone.0124234	http://dx.doi.org/10.1371/journal.pone.0124234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874616	Green Published, gold			2022-12-27	WOS:000353014700060
J	Deleyrolle, L; Sabourin, JC; Rothhut, B; Fujita, H; Guichet, PO; Teigell, M; Ripoll, C; Chauvet, N; Perrin, F; Mamaeva, D; Noda, T; Mori, K; Yoshihara, Y; Hugnot, JP				Deleyrolle, Loic; Sabourin, Jean-Charles; Rothhut, Bernard; Fujita, Hiroko; Guichet, Pierre-Olivier; Teigell, Marisa; Ripoll, Chantal; Chauvet, Norbert; Perrin, Florence; Mamaeva, Daria; Noda, Tetsuo; Mori, Kensaku; Yoshihara, Yoshihiro; Hugnot, Jean-Philippe			OCAM Regulates Embryonic Spinal Cord Stem Cell Proliferation by Modulating ErbB2 Receptor	PLOS ONE			English	Article							ADHESION MOLECULE NCAM; OLFACTORY GLOMERULI; PROGENITOR CELLS; PRECURSOR CELLS; NEURAL STEM; DIFFERENTIATION; MOUSE; TRAFFICKING; BINDING; FAMILY	The proliferation and differentiation of neural stem cells are tightly controlled by intrinsic and extrinsic cues. Cell adhesion molecules are increasingly recognized as regulators of these processes. Here we report the expression of the olfactory cell adhesion molecule (OCAM/NCAM2/RNCAM) during mouse spinal cord development and in neural stem cells cultured as neurospheres. OCAM is also weakly expressed in the dormant adult stem cell niche around the central canal and is overexpressed after spinal cord injury. Both transmembrane (TM) and glycosylphosphatidylinositol (GPI)-linked isoforms are present in neurospheres. Electron microscopy and internalisation experiments revealed a dynamic trafficking of OCAM between the membrane and intracellular compartments. After differentiation, OCAM remains in neurons and oligodendrocytes whereas no expression is detected in astrocytes. Using OCAM knockout (KO) mice, we found that mutant spinal cord stem cells showed an increased proliferation and self-renewal rates although no effect on differentiation was observed. This effect was reversed by lentivirus-mediated re-introduction of OCAM. Mechanistically, we identified the ErbB2/Neu/HER2 protein as being implicated in the enhanced proliferation of mutant cells. ErbB2 protein expression and phosphorylation level were significantly increased in KO cells whereas no difference was observed at the mRNA level. Overexpression of ErbB2 in wild-type and mutant cells also increased their growth while reintroduction of OCAM in mutant cells reduced the level of phosphorylated ErbB2. These results indicate that OCAM exerts a posttranscriptional control on the ErbB2 signalling in spinal cord stem cells. This study adds further support for considering cell adhesion molecules as regulators of the ErbB signalling.	[Deleyrolle, Loic] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Sabourin, Jean-Charles; Rothhut, Bernard; Guichet, Pierre-Olivier; Teigell, Marisa; Ripoll, Chantal; Perrin, Florence; Mamaeva, Daria; Hugnot, Jean-Philippe] Hop St Eloi, INSERM, Inst Neurosci, U1051, Montpellier, France; [Fujita, Hiroko] RIKEN, Brain Sci Inst, Saitama, Japan; [Chauvet, Norbert] INSERM, Inst Funct Gen, Dept Endocrinol, U661, Montpellier, France; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Hugnot, Jean-Philippe] Univ Montpellier 2, Montpellier, France	State University System of Florida; University of Florida; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Japanese Foundation for Cancer Research; University of Tokyo; Universite de Montpellier	Rothhut, B (corresponding author), Hop St Eloi, INSERM, Inst Neurosci, U1051, Montpellier, France.	bernard.rothhut@inserm.fr	PERRIN, Florence/AAY-6815-2021; Chauvet, Norbert/D-7333-2016; Yoshihara, Yoshihiro/N-6481-2015; Noda, Tetsuo/B-1667-2016	Chauvet, Norbert/0000-0003-4388-6422; Yoshihara, Yoshihiro/0000-0002-0319-7166; Rothhut, Bernard/0000-0001-6467-8134; Mori, Kensaku/0000-0001-7853-9370; PERRIN, Florence/0000-0002-7630-0515; Guichet, Pierre-Olivier/0000-0003-0115-2199	AFM (French association against myopathy); ARSEP (association Francaise contre la sclerose en plaque); Grants-in-Aid for Scientific Research [25115005] Funding Source: KAKEN	AFM (French association against myopathy); ARSEP (association Francaise contre la sclerose en plaque); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the AFM (French association against myopathy). A scholarship was granted to LD by ARSEP (association Francaise contre la sclerose en plaque). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenius M, 2003, DEVELOPMENT, V130, P917, DOI 10.1242/dev.00317; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Bian S., 2013, NEURAL STEM CELLS NE; Borisovska M, 2011, J PHYSIOL-LONDON, V589, P1927, DOI 10.1113/jphysiol.2011.206276; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Chan SA, 2005, J NEUROPHYSIOL, V94, P1037, DOI 10.1152/jn.01213.2004; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Dihne M, 2003, J NEUROSCI, V23, P6638; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Gibson NJ, 2011, CELL ADHES MIGR, V5, P48, DOI 10.4161/cam.5.1.13639; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Klapper LN, 2000, CANCER RES, V60, P3384; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Mao YL, 2009, DEVELOPMENT, V136, P473, DOI 10.1242/dev.026054; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Secher T, 2010, ADV EXP MED BIOL, V663, P227, DOI 10.1007/978-1-4419-1170-4_15; SHIN MH, 2002, EXP MOL MED, V34, P401; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Winther M, 2012, INT J BIOCHEM CELL B, V44, P441, DOI 10.1016/j.biocel.2011.11.020; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	41	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122337	10.1371/journal.pone.0122337	http://dx.doi.org/10.1371/journal.pone.0122337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875008	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100063
J	Eulenburg, C; Mahner, S; Woelber, L; Wegscheider, K				Eulenburg, Christine; Mahner, Sven; Woelber, Linn; Wegscheider, Karl			A Systematic Model Specification Procedure for an Illness-Death Model without Recovery	PLOS ONE			English	Article							PROPORTIONAL HAZARDS REGRESSION; MULTISTATE MODELS; SURVIVAL ANALYSIS; PREDICTION ERROR; COMPETING RISKS; OVARIAN-CANCER; PROBABILITIES; INFERENCE; MORTALITY; PACKAGE	Multi-state models are a flexible tool for analyzing complex time-to-event problems with multiple endpoints. Compared to the Cox regression model with a single endpoint or a summarizing composite endpoint, they can provide a more detailed insight into the disease process. Furthermore, prognosis can be improved by including information from intermediate events occurring during the course of the disease. Different model variants, options and additional assumptions provide many possibilities, but at the same time complicate the implementation of multi-state techniques. So far, no guiding literature is available to specify a multi-state model systematically. The objective of this work was to set up a general specification procedure for an illness-death model that optimizes the model fit and predictive accuracy by stepwise reduction of the model. As an application example, we reanalyzed data from an observational study of 434 ovarian cancer patients with progression as intermediate and death as absorbing state. The technique is described in general terms and can be applied to other illness-death models without recovery. The clock-reset approach was used, implicating that the time was reset to zero after progression. The non-homogeneous semi-Markov characteristic stated that the present time as well as the time between surgery and progression influenced survival after progression. Covariate effects on transitions were estimated and proportionality of transition baseline hazards was tested. The finally developed model optimized the accuracy of predictions for two simulated patients. This stepwise procedure yields parsimonious but targeted multi-state models with well interpretable coefficients and optimized predictive ability, even for smaller data sets.	[Eulenburg, Christine; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Mahner, Sven; Woelber, Linn] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Eulenburg, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany.	C.Eulenburg@uke.de						Andersen PK, 2008, LIFETIME DATA ANAL, V14, P405, DOI 10.1007/s10985-008-9097-x; Andersen PK, 2000, STAT MED, V19, P587, DOI 10.1002/(SICI)1097-0258(20000229)19:4<587::AID-SIM358>3.0.CO;2-0; ANDERSEN PK, 1985, SCAND J STAT, V12, P97; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; [Anonymous], 1991, Hepatology, V14, P1016; Bast RC, 2007, GYNECOL ONCOL, V107, P173, DOI 10.1016/j.ygyno.2007.08.092; Bhattacharyya M, 2005, MATH BIOSCI, V194, P37, DOI 10.1016/j.mbs.2004.07.005; Commenges D, 2004, STAT MED, V23, P199, DOI 10.1002/sim.1709; Commenges D, 2002, STAT METHODS MED RES, V11, P167, DOI 10.1191/0962280202sm279ra; Commenges D, 1999, LIFETIME DATA ANAL, V5, P315, DOI 10.1023/A:1009636125294; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; COX DR, 1972, J R STAT SOC B, V34, P187; Bock GH, 2009, BREAST CANCER RES TR, V117, P401, DOI 10.1007/s10549-008-0300-2; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Farewell VT, 2014, LIFETIME DATA ANAL, V20, P51, DOI 10.1007/s10985-012-9236-2; Fiocco M, 2008, STAT MED, V27, P4340, DOI 10.1002/sim.3305; Gerds TA, 2014, PREDICTION ERROR CUR; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Gillam MH, 2012, ACTA ORTHOP, V83, P220, DOI 10.3109/17453674.2012.684140; Graf E, 1999, STAT MED, V18, P2529; Gunnes N, 2007, LIFETIME DATA ANAL, V13, P211, DOI 10.1007/s10985-007-9034-4; Hougaard P, 1999, LIFETIME DATA ANAL, V5, P239, DOI 10.1023/A:1009672031531; Hougaard P., 2000, ANALYSIS OF MULTIVAR; Iacobelli S, 2013, STAT MED, V32, P5315, DOI 10.1002/sim.5976; Jackson C., 2014, MSM MULTI STATE MARK; Jackson CH, 2011, J STAT SOFTW, V38, P1; Keiding N, 2001, STAT MED, V20, P1871, DOI 10.1002/sim.810; KLEIN JP, 1993, STAT MED, V12, P2315, DOI 10.1002/sim.4780122408; Klein JP, 2002, STAT METHODS MED RES, V11, P117, DOI 10.1191/0962280202sm277ra; Markman M, 2007, GYNECOL ONCOL, V106, P279, DOI 10.1016/j.ygyno.2007.06.005; Meier-Hirmer C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-80; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Mogensen UB, 2012, J STAT SOFTW, V50, P1; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Putter H, 2006, BIOMETRICAL J, V48, P366, DOI 10.1002/bimj.200510218; Rodriguez-Girondo M, 2012, STAT MED, V31, P4416, DOI 10.1002/sim.5619; Shu YY, 2007, LIFETIME DATA ANAL, V13, P91, DOI 10.1007/s10985-006-9018-9; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; THALL PF, 1986, STAT MED, V5, P73, DOI 10.1002/sim.4780050110; The R Foundation for Statistical Computing, 2012, R VERSION 2 15 2 COM; Woelber L, 2010, EJSO-EUR J SURG ONC, V36, P583, DOI 10.1016/j.ejso.2010.04.012	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123489	10.1371/journal.pone.0123489	http://dx.doi.org/10.1371/journal.pone.0123489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874628	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100182
J	Huang, LN; Jun, SH; Drubach, N; Dahan, MH				Huang, Lina N.; Jun, Sunny H.; Drubach, Nathalie; Dahan, Michael H.			Predictors of In Vitro Fertilization Outcomes in Women with Highest Follicle-Stimulating Hormone Levels >= 12 IU/L: A Prospective Cohort Study	PLOS ONE			English	Article							IVF; AGE; PATIENT; EMBRYOS; DECLINE; FSH	Objective The purpose of this study is to evaluate factors predictive of outcomes in women with highest follicle-stimulating hormone (FSH) levels >= 12 IU/L on basal testing, undergoing in vitro fertilization (IVF). Methods A prospective cohort study was conducted at Stanford University Hospital in the Reproductive Endocrinology and Infertility Center for 12 months. Women age 21 to 43 undergoing IVF with highest FSH levels on baseline testing were included. Donor/Recipient and frozen embryo cycles were excluded from this study. Prognostic factors evaluated in association with clinical pregnancy rates were type of infertility diagnosis and IVF stimulation parameters. Results The current study found that factors associated with clinical pregnancy were: increased number of mature follicles on the day of triggering, number of oocytes retrieved, number of Metaphase II oocytes if intracytoplasmic sperm injection was done, and number of embryos developed 24 hours after retrieval. Conclusions Our findings suggest that it would be beneficial for women with increased FSH levels to attempt a cycle of IVF. Results of ovarian stimulation, especially embryo quantity appear to be the best predictors of IVF outcomes and those can only be obtained from a cycle of IVF. Therefore, increased basal FSH levels should not discourage women from attempting a cycle of IVF.	[Huang, Lina N.; Dahan, Michael H.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Jun, Sunny H.; Drubach, Nathalie] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA	McGill University; Stanford University	Dahan, MH (corresponding author), McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada.	dahanhaim@hotmail.com	Dahan, Michael/K-2116-2015	Dahan, Michael/0000-0002-8121-7708	Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH) [5 K12 HD01249]	Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH)	This research was supported by: Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH), 5 K12 HD01249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2004, HUM REPROD, V19, P893, DOI 10.1093/humrep/deh141; Banerjee P, 2010, P NATL ACAD SCI USA, V107, P13570, DOI 10.1073/pnas.1002296107; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Check JH, 1998, GYNECOL OBSTET INVES, V45, P217, DOI 10.1159/000009970; Choi B, 2013, FERTIL STERIL, V99, P1905, DOI 10.1016/j.fertnstert.2013.02.016; Cooper AR, 2011, FERTIL STERIL, V95, P1890, DOI 10.1016/j.fertnstert.2010.01.016; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Griesinger G, 2010, SEMIN REPROD MED, V28, P493, DOI 10.1055/s-0030-1265676; Huang LN, 2015, REPROD BIOMED ONLINE, V30, P128, DOI 10.1016/j.rbmo.2014.10.004; Hull MGR, 1996, FERTIL STERIL, V65, P783, DOI 10.1016/S0015-0282(16)58214-4; Kornafel KL, 2007, FERTIL STERIL, V87, P1253, DOI 10.1016/j.fertnstert.2006.11.056; Levi AJ, 2001, FERTIL STERIL, V76, P666, DOI 10.1016/S0015-0282(01)02017-9; Nasseri A, 1999, FERTIL STERIL, V71, P715, DOI 10.1016/S0015-0282(98)00525-1; Nayot D, 2013, J ASSIST REPROD GEN, V30, P1439, DOI 10.1007/s10815-013-0079-x; Practice Comm Amer Soc Reprod Med, 2015, FERTIL STERIL, V103, pE9, DOI [10.1016/j.fertnstert.2014.12.093, 10.1016/j.fertnstert.2012.09.036]; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Sabatin L, 2008, REPROD BIOMED ONLINE, V17, P10, DOI 10.1016/S1472-6483(10)60287-8; SCOTT RT, 1989, FERTIL STERIL, V51, P651; Sharif K, 1998, BRIT J OBSTET GYNAEC, V105, P107, DOI 10.1111/j.1471-0528.1998.tb09360.x; SPEROFF L, 1994, CURR OPIN OBSTET GYN, V6, P115; Thum MY, 2009, J ASSIST REPROD GEN, V26, P313, DOI 10.1007/s10815-009-9313-y; TONER JP, 1991, FERTIL STERIL, V55, P784; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; Venetis CA, 2010, ANN NY ACAD SCI, V1205, P199, DOI 10.1111/j.1749-6632.2010.05665.x; Weinerman R, 2012, SEMIN REPROD MED, V30, P77, DOI 10.1055/s-0032-1307415	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124789	10.1371/journal.pone.0124789	http://dx.doi.org/10.1371/journal.pone.0124789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867175	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100272
J	Diaz-Hernandez, JI; Sebastian-Serrano, A; Gomez-Villafuertes, R; Diaz-Hernandez, M; Miras-Portugal, MT				Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara			Age-Related Nuclear Translocation of P2X6 Subunit Modifies Splicing Activity Interacting with Splicing Factor 3A1	PLOS ONE			English	Article							P2X(6) RECEPTORS; ATP; SENESCENCE; IDENTIFICATION; SPLICEOSOME; INHIBITION; EXPRESSION; SPECKLES; PROTEINS; COMPLEX	P2X receptors are ligand-gated ion channels sensitive to extracellular nucleotides formed by the assembling of three equal or different P2X subunits. In this work we report, for the first time, the accumulation of the P2X6 subunit inside the nucleus of hippocampal neurons in an age-dependent way. This location is favored by its anchorage to endoplasmic reticulum through its N-terminal domain. The extracellular domain of P2X6 subunit is the key to reach the nucleus, where it presents a speckled distribution pattern and is retained by interaction with the nuclear envelope protein spectrin alpha 2. The in vivo results showed that, once inside the nucleus, P2X6 subunit interacts with the splicing factor 3A1, which ultimately results in a reduction of the mRNA splicing activity. Our data provide new insights into post-transcriptional regulation of mRNA splicing, describing a novel mechanism that could explain why this process is sensitive to changes that occur with age.	[Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara] Univ Complutense Madrid, Sch Vet, Dept Biochem & Mol Biol, Madrid, Spain; [Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara] Hosp Clin San Carlos, Inst Invest Sanitaria, IdISSC, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos	Diaz-Hernandez, M (corresponding author), Univ Complutense Madrid, Sch Vet, Dept Biochem & Mol Biol, Madrid, Spain.	migueldiaz@vet.ucm.es	Díaz-Hernandez, Juan Ignacio/L-6973-2014; Gomez-Villafuertes, Rosa/L-7181-2014; Sebastian-Serrano, Alvaro/Q-5982-2018	Díaz-Hernandez, Juan Ignacio/0000-0003-2507-5888; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Fundacion Marcelino Botin; Ministerio de Ciencia e Innovacion [BFU2011-24743, BFU-2012-31195]; Spanish Ion Channel Initiative [CSD2008-00005]	Fundacion Marcelino Botin; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ion Channel Initiative	This work has been supported by research from Fundacion Marcelino Botin (MTM), Ministerio de Ciencia e Innovacion (BFU2011-24743 (MTM) and BFU-2012-31195 (MDH)) and the Spanish Ion Channel Initiative (CSD2008-00005) (MTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson L, 2002, NATURE, V420, P42, DOI 10.1038/420042a; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Collo G, 1996, J NEUROSCI, V16, P2495; da Silva RL, 2007, EXP PHYSIOL, V92, P139, DOI 10.1113/expphysiol.2006.035543; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Geng YQ, 2010, BIOCHEM BIOPH RES CO, V396, P866, DOI 10.1016/j.bbrc.2010.05.011; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Sebastian-Serrano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031590; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Sridharan DM, 2006, CELL BIOL INT, V30, P866, DOI 10.1016/j.cellbi.2006.06.005; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123121	10.1371/journal.pone.0123121	http://dx.doi.org/10.1371/journal.pone.0123121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874565	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100138
J	Juhlen, R; Idkowiak, J; Taylor, AE; Kind, B; Arlt, W; Huebner, A; Koehler, K				Juehlen, Ramona; Idkowiak, Jan; Taylor, Angela E.; Kind, Barbara; Arlt, Wiebke; Huebner, Angela; Koehler, Katrin			Role of ALADIN in Human Adrenocortical Cells for Oxidative Stress Response and Steroidogenesis	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; WD-REPEAT PROTEIN; TRIPLE-A-SYNDROME; GLUCOCORTICOID DEFICIENCY; GENE-EXPRESSION; FERRITIN; APRATAXIN; TRANSLOCATION; PUBLICATION; AAAS	Triple A syndrome is caused by mutations in AAASencoding the protein ALADIN. We investigated the role of ALADIN in the human adrenocortical cell line NCI-H295R1 by either overexpression or down-regulation of ALADIN. Our findings indicate that AAAS knock-down induces a down-regulation of genes coding for type II microsomal cytochrome P450 hydroxylases CYP17A1 and CYP21A2 and their electron donor enzyme cytochrome P450 oxidoreductase, thereby decreasing biosynthesis of precursor metabolites required for glucocorticoid and androgen production. Furthermore we demonstrate that ALADIN deficiency leads to increased susceptibility to oxidative stress and alteration in redox homeostasis after paraquat treatment. Finally, we show significantly impaired nuclear import of DNA ligase 1, aprataxin and ferritin heavy chain 1 in ALADIN knock-down cells. We conclude that down-regulating ALADIN results in decreased oxidative stress response leading to alteration in steroidogenesis, highlighting our knock-down cell model as an important in-vitro tool for studying the adrenal phenotype in triple A syndrome.	[Juehlen, Ramona; Kind, Barbara; Huebner, Angela; Koehler, Katrin] Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Kinder & Jugendmed, Dresden, Germany; [Idkowiak, Jan; Taylor, Angela E.; Arlt, Wiebke] Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Birmingham	Juhlen, R (corresponding author), Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Kinder & Jugendmed, Dresden, Germany.	ramona.juehlen@uniklinikum-dresden.de	Idkowiak, Jan/R-9990-2019; Arlt, Wiebke/B-6310-2009	Arlt, Wiebke/0000-0001-5106-9719; Huebner, Angela/0000-0003-1338-5192; Taylor, Angela, E/0000-0002-5835-5643; Koehler, Katrin/0000-0002-9407-1410; Idkowiak, Jan/0000-0001-9181-3995; Juhlen, Ramona/0000-0002-5689-9030	Deutsche Forschungsgemeinschaft [HU 895/5-1]; Visiting Scholarship of the European Society for Paediatric Endocrinology awarded; Medical Research Council UK [0900567, G1001964]; Cancer Research UK [15622] Funding Source: researchfish; Medical Research Council [G116/172, G1001964, G0900567] Funding Source: researchfish; MRC [G0900567, G1001964] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Visiting Scholarship of the European Society for Paediatric Endocrinology awarded; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Deutsche Forschungsgemeinschaft grant HU 895/5-1 (Clinical Research Unit 252) to AH, a Visiting Scholarship of the European Society for Paediatric Endocrinology awarded to RJ and the Medical Research Council UK (Program Grant 0900567, to WA; Research Training Fellowship G1001964, to JI, http://www.dfg.de/, http://www.eurospe.org/, http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Alesci S, 2002, P NATL ACAD SCI USA, V99, P7484, DOI 10.1073/pnas.062170099; Alkhateeb AA, 2010, BBA-GEN SUBJECTS, V1800, P793, DOI 10.1016/j.bbagen.2010.03.017; ALLGROVE J, 1978, LANCET, V1, P1284; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai C, 2008, DEV DYNAM, V237, P2676, DOI 10.1002/dvdy.21494; Cai CX, 2001, J CELL SCI, V114, P2327; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Haring R, 2013, J MOL ENDOCRINOL, V50, P73, DOI 10.1530/JME-12-0185; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Huebner A, 2006, MOL CELL BIOL, V26, P1879, DOI 10.1128/MCB.26.5.1879-1887.2006; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; Kind B, 2010, J MOL MED, V88, P1233, DOI 10.1007/s00109-010-0661-y; Kind B, 2009, BIOCHEM BIOPH RES CO, V390, P205, DOI 10.1016/j.bbrc.2009.09.080; Koehler K, 2013, HORM METAB RES, V45, P102, DOI 10.1055/s-0032-1331196; Koehler K, 2008, EUR J HUM GENET, V16, P1499, DOI 10.1038/ejhg.2008.132; Krumbholz M, 2006, BIOCHEM CELL BIOL, V84, P243, DOI 10.1139/O05-198; Matkovic U, 2009, J CELL PHYSIOL, V220, P45, DOI 10.1002/jcp.21727; Milenkovic T, 2010, EUR J PEDIATR, V169, P1323, DOI 10.1007/s00431-010-1222-7; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; Nogueira EF, 2009, J MOL ENDOCRINOL, V42, P319, DOI 10.1677/JME-08-0112; Prasad R, 2013, ENDOCRINOLOGY, V154, P3209, DOI 10.1210/en.2013-1241; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Storr HL, 2009, MOL ENDOCRINOL, V23, P2086, DOI 10.1210/me.2009-0056; Thompson KJ, 2002, J CELL SCI, V115, P2165; Tsigos C, 1999, ARCH MED RES, V30, P475, DOI 10.1016/S0188-0128(99)00057-3; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang T, 2012, HORM METAB RES, V44, P245, DOI 10.1055/s-0031-1298019; Yamazumi Y, 2009, BIOCHEM BIOPH RES CO, V389, P100, DOI 10.1016/j.bbrc.2009.08.096	40	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124582	10.1371/journal.pone.0124582	http://dx.doi.org/10.1371/journal.pone.0124582			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867024	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100267
J	Levi, L; Toyooka, T; Patarroyo, M; Frisan, T				Levi, Laura; Toyooka, Tatsushi; Patarroyo, Manuel; Frisan, Teresa			Bacterial Genotoxins Promote Inside-Out Integrin beta 1 Activation, Formation of Focal Adhesion Complexes and Cell Spreading	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; DOUBLE-STRAND BREAKS; CYCLE ARREST; DNA-DAMAGE; GENOMIC INSTABILITY; ALPHA-5-BETA-1; CARCINOMA; MIGRATION; INVASION; EXPRESSION	Integrins are membrane bound receptors that regulate several cellular processes, such as cell adhesion, migration, survival and proliferation, and may contribute to tumor initiation/progression in cells exposed to genotoxic stress. The extent of integrin activation and its role in cell survival upon intoxication with bacterial genotoxins are still poorly characterized. These toxins induce DNA strand breaks in the target cells and activate the DNA damage response (DDR), coordinated by the Ataxia Telangectasia Mutated (ATM) kinase. In the present study, we demonstrate that induction of DNA damage by two bacterial genotoxins promotes activation of integrin beta 1, leading to enhanced assembly of focal adhesions and cell spreading on fibronectin, but not on vitronectin. This phenotype is mediated by an ATM-dependent inside-out integrin signaling, and requires the actin cytoskeleton remodeler NET1. The toxin-mediated cell spreading and anchorage-independent survival further relies on ALIX and TSG101, two components of the endosomal sorting complex required for transport (ESCRT), known to regulate integrin intracellular trafficking. These data reveal a novel aspect of the cellular response to bacterial genotoxins, and provide new tools to understand the carcinogenic potential of these effectors in the context of chronic intoxication and infection.	[Levi, Laura; Toyooka, Tatsushi; Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Frisan, T (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Toyooka, Tatsushi/AFW-4023-2022; Frisan, Teresa/H-8444-2019; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Frisan, Teresa/0000-0002-1209-0942; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040	Swedish Research Council; Swedish Cancer Society; Karolinska Institutet doctoral funding (KID)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet doctoral funding (KID)	This work was supported by grants awarded by Swedish Research Council and the Swedish Cancer Society to TF and MP. LL is supported by the Karolinska Institutet doctoral funding (KID). TF is a fellow of the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eke I, 2014, SEMIN CANC BIOL; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Escalas N, 2000, EXP CELL RES, V257, P206, DOI 10.1006/excr.2000.4878; Fedor Y, 2013, CELL MICROBIOL, V15, P1, DOI 10.1111/cmi.12028; Feng MX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-226; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Frisan T, 2012, FASEB J, V26, P5060, DOI 10.1096/fj.12-211946; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Guerra L, 2011, FEBS J, V278, P4577, DOI 10.1111/j.1742-4658.2011.08125.x; Guerra L, 2011, J CELL SCI, V124, P2735, DOI 10.1242/jcs.085845; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Guidi R, 2013, CELL MICROBIOL, V15, P2034, DOI 10.1111/cmi.12172; Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Hassane DC, 2001, INFECT IMMUN, V69, P5752, DOI 10.1128/IAI.69.9.5752-5759.2001; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Lobert VH, 2012, J CELL SCI, V125, P29, DOI 10.1242/jcs.088310; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Moncharmont C., 2014, CRIT REV ONCOL HEMAT; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nam JM, 2009, INT J RADIAT BIOL, V85, P923, DOI 10.3109/09553000903232876; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Onodera Y, 2013, PHARMACOL THERAPEUT, V140, P1, DOI 10.1016/j.pharmthera.2013.05.007; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Sato T, 2002, INFECT IMMUN, V70, P528, DOI 10.1128/IAI.70.2.528-534.2002; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Stuffers S, 2009, EXP CELL RES, V315, P1619, DOI 10.1016/j.yexcr.2008.10.013; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x; Yang CQ, 2003, CANCER RES, V63, P8312	56	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124119	10.1371/journal.pone.0124119	http://dx.doi.org/10.1371/journal.pone.0124119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874996	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100240
J	Li, JL; Chen, X; Kang, B; Liu, M				Li, Jianlong; Chen, Xiao; Kang, Bin; Liu, Min			Mitochondrial DNA Genomes Organization and Phylogenetic Relationships Analysis of Eight Anemonefishes (Pomacentridae: Amphiprioninae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DAMSELFISHES TELEOSTEI; EVOLUTION; REGION; MODEL; RADIATION; SEQUENCE; PROGRAM; ORIGIN; SERINE	Anemonefishes (Pomacentridae Amphiprioninae) are a group of 30 valid coral reef fish species with their phylogenetic relationships still under debate. The eight available mitogenomes of anemonefishes were used to reconstruct the molecular phylogenetic tree; six were obtained from this study (Amphiprion clarkii, A. frenatus, A. percula, A. perideraion, A. polymnus and Premnas biaculeatus) and two from GenBank (A. bicinctus and A. ocellaris). The seven Amphiprion species represent all four subgenera and P. biaculeatus is the only species from Premnas. The eight mitogenomes of anemonefishes encoded 13 protein-coding genes, two rRNA genes, 22 tRNA genes and two main non-coding regions, with the gene arrangement and translation direction basically identical to other typical vertebrate mitogenomes. Among the 13 protein-coding genes, A. ocellaris (AP006017) and A. percula (KJ174497) had the same length in ND5 with 1,866 bp, which were three nucleotides less than the other six anemonefishes. Both structures of ND5, however, could translate to amino acid successfully. Only four mitogenomes had the tandem repeats in D-loop; the tandem repeats were located in downstream after Conserved Sequence Block rather than the upstream and repeated in a simply way. The phylogenetic utility was tested with Bayesian and Maximum Likelihood methods using all 13 protein-coding genes. The results strongly supported that the subfamily Amphiprioninae was monophyletic and P. biaculeatus should be assigned to the genus Amphiprion. Premnas biaculeatus with the percula complex were revealed to be the ancient anemonefish species. The tree forms of ND1, COIII, ND4, Cytb, Cytb+ 12S rRNA, Cytb+ and Cytb+ COI+ 12S rRNA were similar to that 13 protein-coding genes, therefore, we suggested that the suitable single mitochondrial gene for phylogenetic analysis of anemonefishes maybe Cytb. Additional mitogenomes of anemonefishes with a combination of nuclear markers will be useful to substantiate these conclusions in future studies.	[Li, Jianlong; Liu, Min] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Chen, Xiao] Guangxi Acad Sci, Guangxi Mangrove Res Ctr, Guangxi Key Lab Mangrove Conservat & Utilizat, Beihai, Guangxi, Peoples R China; [Kang, Bin] Jimei Univ, Coll Fisheries, Xiamen, Fujian, Peoples R China	Xiamen University; Jimei University	Liu, M (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	minliuxm@xmu.edu.cn		Li, Jianlong/0000-0002-0302-0061	Xiamen Southern Oceanographic Center of China;  [13GZY001NF12];  [14GZY019NF19]	Xiamen Southern Oceanographic Center of China; ; 	This research was supported by Xiamen Southern Oceanographic Center of China (www.hyj.xm.gov.cn/Ocean/WorkInfoList.aspx) to ML. The grant numbers are 13GZY001NF12 and 14GZY019NF19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G., 1975, DAMSELFISHES S SEAS; Allen G.R., 1972, P1; Allen Gerald R., 2010, Aqua, V16, P129; Allen Gerald R., 2008, Aqua (Miradolo Terme), V14, P105; Allen Gerald R., 1991, P1; Allen GR, 1975, ANEMONEFISHES THEIR; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CHENG S, 1994, NATURE, V369, P684, DOI 10.1038/369684a0; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Elliott JK, 1999, P ROY SOC B-BIOL SCI, V266, P677, DOI 10.1098/rspb.1999.0689; FAUTIN DG, 1991, SYMBIOSIS, V10, P23; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Guo XH, 2003, AQUACULTURE, V224, P25, DOI 10.1016/S0044-8486(03)00168-6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Jang-Liaw NH, 2002, MOL PHYLOGENET EVOL, V25, P445, DOI 10.1016/S1055-7903(02)00278-6; Jin Xiao-Xiao, 2013, Yichuan, V35, P1391, DOI 10.3724/SP.J.1005.2013.01391; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JOHANSEN S, 1990, NUCLEIC ACIDS RES, V18, P411, DOI 10.1093/nar/18.3.411; Kawahara R, 2008, MOL PHYLOGENET EVOL, V46, P224, DOI 10.1016/j.ympev.2007.07.009; Litsios G, 2014, P ROY SOC LOND B BIO, V281, P2013; Litsios G, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-212; Liu M, 2013, J FISH BIOL, V82, P1684, DOI 10.1111/jfb.12112; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MARISCAL RN, 1970, MAR BIOL, V6, P58, DOI 10.1007/BF00352608; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OSAWA S, 1989, J MOL EVOL, V29, P202, DOI 10.1007/BF02100203; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santini S, 2006, GENE, V385, P19, DOI 10.1016/j.gene.2006.03.028; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stepien Carol A., 1997, P1, DOI 10.1016/B978-012417540-2/50002-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang KL, 2001, COPEIA, P591, DOI 10.1643/0045-8511(2001)001[0591:PRADTP]2.0.CO;2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Zhuang X, 2007, THESIS XIAMEN U; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561	50	18	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123894	10.1371/journal.pone.0123894	http://dx.doi.org/10.1371/journal.pone.0123894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875768	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100220
J	Lim, KC; Lim, PE; Chong, VC; Loh, KH				Lim, Kean Chong; Lim, Phaik-Eem; Chong, Ving Ching; Loh, Kar-Hoe			Molecular and Morphological Analyses Reveal Phylogenetic Relationships of Stingrays Focusing on the Family Dasyatidae (Myliobatiformes)	PLOS ONE			English	Article							HIMANTURA; ELASMOBRANCHII; RAY	Elucidating the phylogenetic relationships of the current but problematic Dasyatidae (Order Myliobatiformes) was the first priority of the current study. Here, we studied three molecular gene markers of 43 species (COI gene), 33 species (ND2 gene) and 34 species (RAG1 gene) of stingrays to draft out the phylogenetic tree of the order. Nine character states were identified and used to confirm the molecularly constructed phylogenetic trees. Eight or more clades (at different hierarchical level) were identified for COI, ND2 and RAG1 genes in the Myliobatiformes including four clades containing members of the present Dasyatidae, thus rendering the latter non-monophyletic. The uncorrected p-distance between these four 'Dasytidae' clades when compared to the distance between formally known families confirmed that these four clades should be elevated to four separate families. We suggest a revision of the present classification, retaining the Dasyatidae (Dasyatis and Taeniurops species) but adding three new families namely, Neotrygonidae (Neotrygon and Taeniura species), Himanturidae (Himantura species) and Pastinachidae (Pastinachus species). Our result indicated the need to further review the classification of Dasyatis microps. By resolving the non-monophyletic problem, the suite of nine character states enables the natural classification of the Myliobatiformes into at least thirteen families based on morphology.	[Lim, Kean Chong; Lim, Phaik-Eem; Chong, Ving Ching] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem; Chong, Ving Ching; Loh, Kar-Hoe] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chong, VC (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	chong@um.edu.my	CHONG, VING/B-4645-2009; Loh, Kar-Hoe/A-1750-2012; LIM, Phaik Eem/B-5331-2010	CHONG, VING/0000-0003-0331-768X; Loh, Kar-Hoe/0000-0001-8406-6485; LIM, Phaik Eem/0000-0001-9186-1487	Japan International Centre for Agricultural Sciences (JIRCAS) [57-02-03-1005]; UM Research Grant (UMRG) [RG191-121SUS]; UM IPPP Grant [PG103-2012B]	Japan International Centre for Agricultural Sciences (JIRCAS); UM Research Grant (UMRG); UM IPPP Grant	We thank Japan International Centre for Agricultural Sciences (JIRCAS) 57-02-03-1005, UM Research Grant (UMRG) RG191-121SUS and UM IPPP Grant-PG103-2012B for the financial support of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschliman NC, 2011, THESIS FLORIDA STATE; Aschliman NC, 2012, CRC MAR BIOL SER, P57; Carpenter K. E., 1999, LIVING MARINE RESOUR, V3, P1397; Carpenter KE, 2002, FAO SPECIES IDENTIFI, V5, P1; Cerutti-Pereyra F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036479; COMPAGNO LJV, 1982, ENVIRON BIOL FISH, V7, P321, DOI 10.1007/BF00005567; Silva João Paulo C.B. da, 2011, Pap. Avulsos Zool. (São Paulo), V51, P139, DOI 10.1590/S0031-10492011000800001; Daley RK, 2002, FIELD GUIDE AUSTR SH; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Last P. R., 2010, DESCRIPTIONS NEW SHA; Last P.R., 2008, DESCRIPTIONS NEW AUS; Last P.R., 2010, SHARKS RAYS BORNEO; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Last Peter R., 2010, Aqua, V16, P37; Manjaji-Matsumoto BM, 2006, ICHTHYOL RES, V53, P290, DOI 10.1007/s10228-006-0350-6; McEachran JD, 2004, CRC MAR BIOL SER, P79; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor Gavin J.P., 2005, P1; NISHIDA K, 1988, JPN J ICHTHYOL, V35, P115; Nishida K, 1990, ELASMOBRANCHS LIVING, P327; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ruhfel BR, 2013, INT J PLANT SCI, V174, P910, DOI 10.1086/670668; Ruocco NL, 2012, ZOOL STUD, V51, P862; Serena F., 2005, FIELD IDENTIFICATION, P97; Serra-Pereira B, 2011, ZOOL SCR, V40, P76, DOI 10.1111/j.1463-6409.2010.00461.x; StatSoft Inc, 1997, EL STAT TXB; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vidthayanon Chavalit, 2005, Natural History Bulletin of the Siam Society, V53, P123; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; White W.T., 2006, EC IMPORTANT SHARKS; Yano K, 2005, SHARKS RAYS MALAYSIA; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120518	10.1371/journal.pone.0120518	http://dx.doi.org/10.1371/journal.pone.0120518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867639	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100023
J	Luo, LY; Jiang, SS; Huang, DQ; Lu, NH; Luo, ZJ				Luo, Lingyu; Jiang, Shanshan; Huang, Deqiang; Lu, Nonghua; Luo, Zhijun			MLK3 Phophorylates AMPK Independently of LKB1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER-CELLS; A TARGET; APOPTOSIS; INFLAMMATION; PATHWAYS; GROWTH; DRUGS; JNK	Emerging evidence has shown that cellular energy metabolism is regulated by the AMPK and MLK3-JNK signaling pathways, but the functional link between them remains to be determined. The present study aimed to explore the crosstalk between MLK3 and AMPK. We found that both JNK and AMPK were phosphorylated at their activation sites by TNF-alpha, Anisomycin, H2O2 and sorbitol. Interestingly, sorbitol stimulated phosphorylation of AMPK at T172 in LKB1-deficient cells. Following the screening of more than 100 kinases, we identified that MLK3 induced phosphorylation of AMPK at T172. Our in vitro analysis further revealed that MLK3-mediated phosphorylation of AMPK at T172 was independent of AMP, but addition of AMP caused a mobility shift of AMPK, an indication of autophosphorylation, suggesting that AMP binding and phosphorylation of T172 leads to maximal activation of AMPK. GST-pull down assays showed a direct interaction between AMPK alpha 1 subunit and MLK3. Altogether, our results indicate that MLK3 serves as a common upstream kinase of AMPK and JNK and functions as a direct upstream kinase for AMPK independent of LKB1.	[Luo, Lingyu; Huang, Deqiang; Lu, Nonghua] Nanchang Univ, Affiliated Hosp 1, Res Inst Digest Dis, Nanchang 330006, Jiangxi, Peoples R China; [Jiang, Shanshan] Nanchang Univ, Jiangxi Med Coll, Grad Program, Nanchang 330006, Jiangxi, Peoples R China; [Luo, Zhijun] Nanchang Univ, Inst Basic Med Sci, Nanchang 330006, Jiangxi, Peoples R China; [Luo, Zhijun] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Nanchang University; Nanchang University; Nanchang University; Boston University	Huang, DQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Res Inst Digest Dis, Nanchang 330006, Jiangxi, Peoples R China.	hdq0515@163.com; zluo559914@gmail.com	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289	National Science foundation of China [81171952, 81272926, 31460304, 81460374]; Jiangxi provincial Department Science and Technology [20133BBG70061]; NATIONAL EYE INSTITUTE [R21EY024388] Funding Source: NIH RePORTER	National Science foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi provincial Department Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by grants from The National Science foundation of China (No. 81171952, No. 81272926, No. 31460304, and No. 81460374) and a grant from Jiangxi provincial Department Science and Technology (20133BBG70061).	Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x; Chadee DN, 2013, CAN J PHYSIOL PHARM, V91, P268, DOI 10.1139/cjpp-2012-0258; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Koul Hari K, 2013, Genes Cancer, V4, P342, DOI 10.1177/1947601913507951; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Luo LY, 2013, CANCER LETT, V328, P114, DOI 10.1016/j.canlet.2012.08.034; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Maki CG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038706, DOI 10.1371/JOURNAL.PONE.0038706]; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Sarvas Jessica L, 2013, J Diabetes Metab, VSuppl 13, DOI 10.4172/2155-6156.S13-003; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	19	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123927	10.1371/journal.pone.0123927	http://dx.doi.org/10.1371/journal.pone.0123927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874865	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100224
J	Passos, MT; Nishida, SK; Camara, NOS; Shimizu, MH; Mastroianni-Kirsztajn, G				Passos, Michelle T.; Nishida, Sonia K.; Camara, Niels O. S.; Shimizu, Maria Heloisa; Mastroianni-Kirsztajn, Gianna			Iohexol Clearance for Determination of Glomerular Filtration Rate in Rats Induced to Acute Renal Failure	PLOS ONE			English	Article							PLASMA-CLEARANCE; CREATININE CLEARANCE; SERUM; DOGS; KIDNEY; SAMPLE; INULIN; CATS	Introduction The glomerular filtration rate (GFR) is considered an especially important tool for the measurement of renal function. Inulin clearance (InCl) is the classic reference method for this purpose, although it is associated with a number of disadvantages; thus, other markers have been proposed, including iohexol. Determination of iohexol clearance (IoCl) has been established for clinical use; however, its application as a GFR marker in experimental rat models has not been reported. Objectives This study aims to standardize a methodology for the measurement of iohexol clearance and to evaluate its applicability as a marker of GFR in rats with induced toxic acute renal failure (ARF), using InCl as the gold standard. Materials and Methods Twenty-six Wistar male rats (200-300 g) were divided into the following two groups: a control group (n=7) and an ARF group (n=19). ARF was induced by the subcutaneous administration of cisplatin (5 mg/kg); IoCl and InCl were determined simultaneously, and plasma creatinine (pCreat) dosage was measured colorimetrically. Results The pCreat, InCl and IoCl levels were consistent with the expected values for the renal function ranges of the evaluated animals, and the IoCl and InCl levels were significantly correlated (r=0.792). An inverse moderate linear correlation between the IoCl and pCreat measurements (r=-0.587) and between the InCl and pCreat measurements (r=-0.722) were observed. Conclusion These results confirm a correlation between IoCl and the gold standard of GFR, InCl measurement. IoCl offers a relevant advantage over InCl because determination of the former allows the animal to live after the procedure.	[Passos, Michelle T.; Nishida, Sonia K.; Camara, Niels O. S.; Mastroianni-Kirsztajn, Gianna] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, SP, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, SP, Brazil; [Shimizu, Maria Heloisa] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Mastroianni-Kirsztajn, G (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, SP, Brazil.	gm.kirsztajn@unifesp.br	Camara, Niels OS/G-8336-2011; Shimizu, Maria/B-7887-2013; Mastroianni Kirsztajn, Gianna/D-9596-2013; camara, niels olsen saraiva/AAX-3269-2020	Camara, Niels OS/0000-0001-5436-1248; Mastroianni Kirsztajn, Gianna/0000-0003-1317-4109; camara, niels olsen saraiva/0000-0001-5436-1248	CNPq (National Council for Research and Development), Brazil	CNPq (National Council for Research and Development), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.T.P. and G.M.-K. are partially supported by CNPq (National Council for Research and Development), Brazil.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Bailey DB, 2009, AM J VET RES, V70, P1135, DOI 10.2460/ajvr.70.9.1135; BARBOUR GL, 1976, J NUCL MED, V17, P317; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Bussab W., 2006, ESTATISTICA BASICA; Caglar Y., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P443; Filler G, 2014, PEDIATR NEPHROL, V29, P183, DOI 10.1007/s00467-013-2426-7; Finco DR, 2001, J VET INTERN MED, V15, P368, DOI 10.1892/0891-6640(2001)015&lt;0368:RBPICA&gt;2.3.CO;2; Fischer PA, 2000, KIDNEY INT, V58, P1336, DOI 10.1046/j.1523-1755.2000.00290.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frennby B, 1996, ACAD RADIOL, V3, P651, DOI 10.1016/S1076-6332(96)80191-7; Frennby B, 1996, ACAD RADIOL, V3, P145, DOI 10.1016/S1076-6332(05)80382-4; Friedman AN, 2014, AM J NEPHROL, V39, P8, DOI 10.1159/000357231; Gaspari F, 1996, J AM SOC NEPHROL, V7, P2689; Gleadhill A, 1996, RES VET SCI, V60, P117, DOI 10.1016/S0034-5288(96)90004-1; Heiene R, 2010, AM J VET RES, V71, P1100, DOI 10.2460/ajvr.71.9.1100; Margolick JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086311; Masereeuw R, 1996, BRIT J PHARMACOL, V119, P57, DOI 10.1111/j.1476-5381.1996.tb15677.x; Miyamoto K, 2001, J FELINE MED SURG, V3, P143, DOI 10.1053/jfms.2001.0125; Miyamoto K, 2001, AM J VET RES, V62, P572, DOI 10.2460/ajvr.2001.62.572; MOE L, 1995, RES VET SCI, V58, P138, DOI 10.1016/0034-5288(95)90067-5; Nesje M, 1997, VET RES COMMUN, V21, P29, DOI 10.1023/B:VERC.0000009698.28252.d1; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Schwartz GJ, 2007, PEDIATR NEPHROL, V22, P1839, DOI 10.1007/s00467-006-0358-1; SHIHABI ZK, 1992, CLIN CHEM, V38, P2117; Wilson KE, 2009, AM J VET RES, V70, P1545, DOI 10.2460/ajvr.70.12.1545; Zanocco JA, 2012, NEPHRON EXTRA, V2, P293, DOI 10.1159/000343899	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123753	10.1371/journal.pone.0123753	http://dx.doi.org/10.1371/journal.pone.0123753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875005	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100208
J	Song, JJ; Vanneste, S; De Ridder, D				Song, Jae Jin; Vanneste, Sven; De Ridder, Dirk			Dysfunctional Noise Cancelling of the Rostral Anterior Cingulate Cortex in Tinnitus Patients	PLOS ONE			English	Article							NEURAL MECHANISMS; AUDITORY-CORTEX; BRAIN ACTIVITY; ACTIVATION; HEARING; DISTRESS; PAIN; DISSOCIATION; OSCILLATIONS; METAANALYSIS	Background Peripheral auditory deafferentation and central compensation have been regarded as the main culprits of tinnitus generation. However, patient-to-patient discrepancy in the range of the percentage of daytime in which tinnitus is perceived (tinnitus awareness percentage, 0 - 100%), is not fully explicable only by peripheral deafferentation, considering that the deafferentation is a stable persisting phenomenon but tinnitus is intermittently perceived in most patients. Consequently, the involvement of a dysfunctional noise cancellation mechanism has recently been suggested with regard to the individual differences in reported tinnitus awareness. By correlating the tinnitus awareness percentage with resting-state source-localized electroencephalography findings, we may be able to retrieve the cortical area that is negatively correlated with tinnitus awareness percentage, and then the area may be regarded as the core of the noise cancelling system that is defective in patients with tinnitus. Methods and Findings Using resting-state cortical oscillation, we investigated 80 tinnitus patients by correlating the tinnitus awareness percentage with their source-localized cortical oscillatory activity and functional connectivity. The activity of bilateral rostral anterior cingulate cortices (ACCs), left dorsal-and pregenual ACCs for the delta band, bilateral rostral/pregenual/subgenual ACCs for the theta band, and left rostral/pregenual ACC for the beta 1 band displayed significantly negative correlations with tinnitus awareness percentage. Also, the connectivity between the left primary auditory cortex (A1) and the rostral ACC, as well as between the left A1 and the subgenual ACC for the beta 1 band, were negatively correlated with tinnitus awareness percentage. Conclusions These results may designate the role of the rostral ACC as the core of the descending noise cancellation system, and thus dysfunction of the rostral ACC may result in perception of tinnitus. The present study also opens a possibility of tinnitus modulation by neuromodulatory approaches targeting the rostral ACC.	[Song, Jae Jin] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Vanneste, Sven] Univ Antwerp, Fac Med, Dept Translat Neurosci, Edegem, Belgium; [Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Lab Auditory & Integrat Neurosci, Dallas, TX 75230 USA; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Unit Neurosurg, Dept Surg Sci, Dunedin, New Zealand; [De Ridder, Dirk] Sint Augustinus Hosp, BRAI2N, Antwerp, Belgium	Seoul National University (SNU); University of Antwerp; University of Texas System; University of Texas Dallas; University of Otago	Song, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.	jjsong96@gmail.com	Song, Jae-Jin/E-4633-2017	Song, Jae-Jin/0000-0002-6631-3232; Vanneste, Sven/0000-0003-1513-5752	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2014002619]; Seoul National University Bundang Hospital Research Fund [14-2014-019]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Seoul National University Bundang Hospital Research Fund	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014002619) (http://www.nrf.re.kr/nrf_eng_cms/) and the Seoul National University Bundang Hospital Research Fund 14-2014-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Buchel C, 1999, J NEUROSCI, V19, P10869; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Ridder D, 2012, J NEUROSURG SCI, V56, P323; De Ridder D, 2012, NEUROSCI BIOBEHAV RE; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Feng YM, 2011, J LARYNGOL OTOL, V125, P741, DOI 10.1017/S0022215111000934; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Frot M, 2008, J NEUROSCI, V28, P944, DOI 10.1523/JNEUROSCI.2934-07.2008; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Marshall AF, 2008, HEARING RES, V244, P35, DOI 10.1016/j.heares.2008.07.001; Meeus O, 2007, B-ENT, P11; Melcher JR, 2013, HEARING RES, V295, P79, DOI 10.1016/j.heares.2012.03.013; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Moller AR, 2006, PROG BRAIN RES, V157, P365, DOI 10.1016/S0079-6123(06)57022-0; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2012, HEAR RES; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Saldana E, 2007, J NEUROSCI, V27, P13108, DOI 10.1523/JNEUROSCI.1892-07.2007; Schaette R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035238; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seydell-Greenwald A, 2012, BRAIN RES, V1485, P22, DOI 10.1016/j.brainres.2012.08.052; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sherlin L, 2005, NEUROSCI LETT, V387, P72, DOI 10.1016/j.neulet.2005.06.069; Siepmann M, 2002, NEUROPSYCHOBIOLOGY, V45, P161, DOI 10.1159/000054958; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Song JJ, 2015, BRAIN STRUCT FUNCT, V220, P571, DOI 10.1007/s00429-013-0648-x; Song JJ, 2014, OTOL NEUROTOL, V35, P1780, DOI 10.1097/MAO.0000000000000560; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Song JJ, 2013, HEARING RES, V299, P1, DOI 10.1016/j.heares.2013.02.001; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; Song JJ, 2012, OTOL NEUROTOL, V33, P137, DOI 10.1097/MAO.0b013e318241c27a; Tanibuchi I, 2003, J NEUROPHYSIOL, V89, P1067, DOI 10.1152/jn.00207.2002; Vanneste S, 2013, NEUROIMAGE, V82, P373, DOI 10.1016/j.neuroimage.2013.05.107; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Zeng FG, 2012, HEAR RES	78	47	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123538	10.1371/journal.pone.0123538	http://dx.doi.org/10.1371/journal.pone.0123538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875099	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100184
J	Wan, YL; Xie, WJ; Gu, GF; Jiang, ZQ; Chen, W; Xiong, X; Zhang, W; Zhou, WX				Wan, Yu-Lei; Xie, Wen-Jie; Gu, Gao-Feng; Jiang, Zhi-Qiang; Chen, Wei; Xiong, Xiong; Zhang, Wei; Zhou, Wei-Xing			Statistical Properties and Pre-Hit Dynamics of Price Limit Hits in the Chinese Stock Markets	PLOS ONE			English	Article							VOLATILITY; IMPACT	Price limit trading rules are adopted in some stock markets (especially emerging markets) trying to cool off traders' short-term trading mania on individual stocks and increase market efficiency. Under such a microstructure, stocks may hit their up-limits and down-limits from time to time. However, the behaviors of price limit hits are not well studied partially due to the fact that main stock markets such as the US markets and most European markets do not set price limits. Here, we perform detailed analyses of the high-frequency data of all A-share common stocks traded on the Shanghai Stock Exchange and the Shenzhen Stock Exchange from 2000 to 2011 to investigate the statistical properties of price limit hits and the dynamical evolution of several important financial variables before stock price hits its limits. We compare the properties of up-limit hits and down-limit hits. We also divide the whole period into three bullish periods and three bearish periods to unveil possible differences during bullish and bearish market states. To uncover the impacts of stock capitalization on price limit hits, we partition all stocks into six portfolios according to their capitalizations on different trading days. We find that the price limit trading rule has a cooling-off effect (object to the magnet effect), indicating that the rule takes effect in the Chinese stock markets. We find that price continuation is much more likely to occur than price reversal on the next trading day after a limit-hitting day, especially for down-limit hits, which has potential practical values for market practitioners.	[Wan, Yu-Lei; Zhou, Wei-Xing] E China Univ Sci & Technol, Sch Sci, Dept Math, Shanghai 200237, Peoples R China; [Wan, Yu-Lei; Xie, Wen-Jie; Gu, Gao-Feng; Jiang, Zhi-Qiang; Zhou, Wei-Xing] E China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China; [Xie, Wen-Jie; Gu, Gao-Feng; Jiang, Zhi-Qiang; Zhou, Wei-Xing] E China Univ Sci & Technol, Sch Business, Dept Finance, Shanghai 200237, Peoples R China; [Xie, Wen-Jie] E China Univ Sci & Technol, Sch Social & Publ Adm, Postdoctoral Res Stn, Shanghai 200237, Peoples R China; [Chen, Wei] Shenzhen Stock Exchange, Shenzhen 518010, Peoples R China; [Xiong, Xiong; Zhang, Wei] Tianjin Univ, Coll Management & Econ, Tianjin 300072, Peoples R China; [Xiong, Xiong; Zhang, Wei] Tianjin Univ, China Ctr Social Comp & Analyt, Tianjin 300072, Peoples R China	East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; Shenzhen Stock Exchange (SZSE); Tianjin University; Tianjin University	Xiong, X (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin 300072, Peoples R China.	xxpeter@tju.edu.cn; wxzhou@ecust.edu.cn	GU, Fao-Feng/G-3301-2016; XIE, Wen-Jie/ABC-4603-2021; Jiang, Zhi-Qiang/B-5746-2008; XIE, Wen Jie/H-5534-2016; Zhou, Wei-Xing/B-1250-2008	GU, Fao-Feng/0000-0002-7726-6232; XIE, Wen-Jie/0000-0001-6602-5057; Jiang, Zhi-Qiang/0000-0003-4013-1753; XIE, Wen Jie/0000-0001-6602-5057; Zhou, Wei-Xing/0000-0002-8952-8228	National Natural Science Foundation of China [11075054, 71072007, 71101052, 71131007]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1028]; Shanghai "Chen Guang" Project [2012CG34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai "Chen Guang" Project	Funding was provided by the National Natural Science Foundation of China, grant No. 11075054 (WXZ), grant No. 71072007 (WC), grant No. 71101052 (GFG), and grant No. 71131007 (XX WZ), http://www.nsfc.gov.cn/; Program for Changjiang Scholars and Innovative Research Team in University under grant No. IRT1028 (XX WZ), http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_263/index.html; and Shanghai "Chen Guang" Project under grant No. 2012CG34 (ZQJ), http://www.shmec.gov.cn/web/xxgk/rows_list.php?node_code=41212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shenzhen Stock Exchange provided support in the form of salary for author WC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Arak M, 1997, J FINANC SERV RES, V12, P5, DOI 10.1023/A:1007955909944; Berkman H, 1998, J FUTURES MARKETS, V18, P265, DOI 10.1002/(SICI)1096-9934(199805)18:3<265::AID-FUT2>3.0.CO;2-I; BRENNAN MJ, 1986, J FINANC ECON, V16, P213, DOI 10.1016/0304-405X(86)90061-9; Cho D.D., 2003, J EMPIR FINANC, V10, P133, DOI [10.1016/S0927-5398(02)00024-5, DOI 10.1016/S0927-5398(02)00024-5]; Du Y, 2005, WORKING PAPER; [方园 FANG Yuan], 2007, [系统工程, Systems Engineering], V25, P48; Gu GF, 2008, PHYSICA A, V387, P5182, DOI 10.1016/j.physa.2008.05.008; Hsieh PH, 2009, J EMPIR FINANC, V16, P830, DOI 10.1016/j.jempfin.2009.06.002; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; Johansen A, 2000, EUR PHYS J B, V17, P319, DOI 10.1007/s100510070147; Li C, 2005, J CENTRAL U FINAN EC, V9, P30; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; Lim M, 2005, QUANT FINANC, V5, P365, DOI 10.1080/14697680500151400; MA CK, 1989, J FINANC SERV RES, V3, P165, DOI 10.1007/BF00122800; Meng WD, 2008, TECHNOL EC, V27, P99; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Randall JO, 1980, ECONOMETRICA, V48, P1099, DOI [10.2307/1912173, DOI 10.2307/1912173]; Sornette D., 2002, Quantitative Finance, V2, P468, DOI 10.1088/1469-7688/2/6/306; SUBRAHMANYAM A, 1994, J FINANC, V49, P237; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; TELSER LG, 1981, J FUTURES MARKETS, V1, P225, DOI 10.1002/fut.3990010213; Wong WK, 2009, CHINA ECON REV, V20, P91, DOI 10.1016/j.chieco.2008.09.002; [曾江洪 ZENG Jianghong], 2007, [数理统计与管理, Application of Statistics and Management], V26, P697; Zhang XT, 2014, J CHONG QING U TECHN, V28, P123; Zhou WX, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023055; Zhou WX, 2012, QUANT FINANC, V12, P1253, DOI 10.1080/14697688.2010.504733; Zhou WX, 2004, PHYSICA A, V337, P243, DOI 10.1016/j.physa.2004.01.051	29	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120312	10.1371/journal.pone.0120312	http://dx.doi.org/10.1371/journal.pone.0120312			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874716	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100021
J	Ple, C; Fan, Y; Yahia, SA; Vorng, H; Everaere, L; Chenivesse, C; Balsamelli, J; Azzaoui, I; de Nadai, P; Wallaert, B; Lazennec, G; Tsicopoulos, A				Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Lazennec, Gwendal; Tsicopoulos, Anne			Polycyclic Aromatic Hydrocarbons Reciprocally Regulate IL-22 and IL-17 Cytokines in Peripheral Blood Mononuclear Cells from Both Healthy and Asthmatic Subjects	PLOS ONE			English	Article							CD4(+) T-CELLS; AIRWAY INFLAMMATION; IMMUNE-RESPONSES; RECEPTOR; DIESEL; DIFFERENTIATION; ACTIVATION; CHEMOKINE; HYPERRESPONSIVENESS; RECRUITMENT	Pollution, including polycyclic aromatic hydrocarbons (PAH), may contribute to increased prevalence of asthma. PAH can bind to the Aryl hydrocarbon Receptor (AhR), a transcription factor involved in Th17/Th22 type polarization. These cells produce IL17A and IL-22, which allow neutrophil recruitment, airway smooth muscle proliferation and tissue repair and remodeling. Increased IL-17 and IL-22 productions have been associated with asthma. We hypothesized that PAH might affect, through their effects on AhR, IL-17 and IL-22 production in allergic asthmatics. Activated peripheral blood mononuclear cells (PBMCs) from 16 nonallergic nonasthmatic (NA) and 16 intermittent allergic asthmatic (AA) subjects were incubated with PAH, and IL-17 and IL-22 productions were assessed. At baseline, activated PBMCs from AA exhibited an increased IL-17/IL-22 profile compared with NA subjects. Diesel exhaust particle (DEP)-PAH and Benzo[a]Pyrene (B[a]P) stimulation further increased IL-22 but decreased IL-17A production in both groups. The PAH-induced IL-22 levels in asthmatic patients were significantly higher than in healthy subjects. Among PBMCs, PAH-induced IL-22 expression originated principally from single IL-22-but not from IL-17-expressing CD4 T cells. The Th17 transcription factors RORA and RORC were down regulated, whereas AhR target gene CYP1A1 was upregulated. IL-22 induction by DEP-PAH was mainly dependent upon AhR whereas IL-22 induction by B[a] P was dependent upon activation of PI3K and JNK. Altogether, these data suggest that DEP-PAH and B[a]P may contribute to increased IL22 production in both healthy and asthmatic subjects through mechanisms involving both AhR-dependent and -independent pathways.	[Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] INSERM, U1019, F-59019 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] CNRS, UMR 8204, F-59000 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] Univ Lille Nord France, F-59000 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Clin Malad Resp, F-59037 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Ctr Hosp, F-59037 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Univ Lille, F-59037 Lille, France; [Lazennec, Gwendal] CNRS SysDiag, UMR3145 Cap Delta, F-34184 Montpellier 4, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Tsicopoulos, A (corresponding author), INSERM, U1019, F-59019 Lille, France.	anne.tsicopoulos@pasteur-lille.fr	SALIHA, AIT YAHIA/B-8269-2018; Tsicopoulos, Anne/C-2260-2019	SALIHA, AIT YAHIA/0000-0003-1108-4222; Tsicopoulos, Anne/0000-0002-1579-2763; de NADAI, Patricia/0000-0001-6084-7447; Azzaoui, Imane/0000-0001-5603-6780; Lazennec, Gwendal/0000-0002-8522-1763	Agence Nationale de la Recherche (ANR CES); Region Nord Pas de Calais (IRENI); FEDER; Santelys	Agence Nationale de la Recherche (ANR CES)(French National Research Agency (ANR)); Region Nord Pas de Calais (IRENI)(Region Hauts-de-France); FEDER(European Commission); Santelys	This study was supported by research grants from Agence Nationale de la Recherche (ANR CES), Region Nord Pas de Calais (IRENI), FEDER and Santelys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Azzaoui I, 2011, BLOOD, V118, P3549, DOI 10.1182/blood-2011-02-338780; Bayram H, 2006, EUR RESPIR J, V27, P705, DOI 10.1183/09031936.06.00012805; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Chang Y, 2010, FASEB J, V24, P5063, DOI 10.1096/fj.10-162560; Chenivesse C, 2012, J IMMUNOL, V189, P128, DOI 10.4049/jimmunol.1003616; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fahy O, 2002, J IMMUNOL, V168, P5912, DOI 10.4049/jimmunol.168.11.5912; Farfariello V, 2011, PEDIAT ALLERG IMM-UK, V22, P419, DOI 10.1111/j.1399-3038.2010.01116.x; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Heo Y, 2001, TOXICOLOGY, V159, P143, DOI 10.1016/S0300-483X(00)00418-2; Hiyoshi K, 2005, CLIN EXP ALLERGY, V35, P1243, DOI 10.1111/j.1365-2222.2005.02297.x; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; IMADA M, 1995, INT IMMUNOL, V7, P229, DOI 10.1093/intimm/7.2.229; Johnson JR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-118; Kadkhoda K, 2005, TOXICOL LETT, V157, P31, DOI 10.1016/j.toxlet.2005.01.002; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Larsen M, 2011, EUR J IMMUNOL, V41, P2596, DOI 10.1002/eji.201041131; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li Y, 1998, J IMMUNOL, V161, P7007; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Senechal S, 2003, AM J RESP CRIT CARE, V168, P215, DOI 10.1164/rccm.200211-1289OC; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	52	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122372	10.1371/journal.pone.0122372	http://dx.doi.org/10.1371/journal.pone.0122372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860963	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300043
J	Kim, D; Deerinck, TJ; Sigal, YM; Babcock, HP; Ellisman, MH; Zhuang, X				Kim, Doory; Deerinck, Thomas J.; Sigal, Yaron M.; Babcock, Hazen P.; Ellisman, Mark H.; Zhuang, Xiaowei			Correlative Stochastic Optical Reconstruction Microscopy and Electron Microscopy	PLOS ONE			English	Article							PHOTOACTIVATED LOCALIZATION MICROSCOPY; SUPERRESOLUTION FLUORESCENCE; RESOLUTION; CELLS; LIGHT; IMMUNOCYTOCHEMISTRY; ARCHITECTURE; TOMOGRAPHY; MULTICOLOR; PROTEIN	Correlative fluorescence light microscopy and electron microscopy allows the imaging of spatial distributions of specific biomolecules in the context of cellular ultrastructure. Recent development of super-resolution fluorescence microscopy allows the location of molecules to be determined with nanometer-scale spatial resolution. However, correlative super-resolution fluorescence microscopy and electron microscopy (EM) still remains challenging because the optimal specimen preparation and imaging conditions for super-resolution fluorescence microscopy and EM are often not compatible. Here, we have developed several experiment protocols for correlative stochastic optical reconstruction microscopy (STORM) and EM methods, both for un-embedded samples by applying EM-specific sample preparations after STORM imaging and for embedded and sectioned samples by optimizing the fluorescence under EM fixation, staining and embedding conditions. We demonstrated these methods using a variety of cellular targets.	[Kim, Doory; Sigal, Yaron M.; Zhuang, Xiaowei] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Kim, Doory; Sigal, Yaron M.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Babcock, Hazen P.; Zhuang, Xiaowei] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Diego; Harvard University; Harvard University	Zhuang, X (corresponding author), Howard Hughes Med Inst, Cambridge, MA 02139 USA.	zhuang@chemistry.harvard.edu		Kim, Doory/0000-0002-2675-106X; Babcock, Hazen/0000-0003-4835-3692	National Science Foundation under NSF award [ECS-0335765]; National Institutes of Health, National Center for Microscopy and Imaging Research (NCMIR) at UCSD [GM068518, P41GM103412]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM068518] Funding Source: NIH RePORTER	National Science Foundation under NSF award(National Science Foundation (NSF)); National Institutes of Health, National Center for Microscopy and Imaging Research (NCMIR) at UCSD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the EM imaging experiments were performed using EM instrument in the Harvard Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. This project is in part supported by the National Institutes of Health GM068518 to X. Z. and P41GM103412 to M.H.E., which funds the National Center for Microscopy and Imaging Research (NCMIR) at UCSD. X.Z. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown E, 2010, PROTOPLASMA, V244, P91, DOI 10.1007/s00709-010-0165-1; Chang YW, 2014, NAT METHODS, V11, P737, DOI [10.1038/NMETH.2961, 10.1038/nmeth.2961]; Clancy B, 1998, J NEUROSCI METH, V83, P97, DOI 10.1016/S0165-0270(98)00066-1; Coleman RA, 2006, J HISTOCHEM CYTOCHEM, V54, P817, DOI 10.1369/jhc.6A6929.2006; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gaietta Guido M, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5547; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; HARRIS LG, 1999, SCANNING MICROSCOPY, V13, P71; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Kopek BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077209; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Loschberger A, 2014, J CELL SCI, V127, P4351, DOI 10.1242/jcs.156620; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Perkovic M, 2014, J STRUCT BIOL, V186, P205, DOI 10.1016/j.jsb.2014.03.018; Powell RD, 1998, MICROSC RES TECHNIQ, V42, P2, DOI 10.1002/(SICI)1097-0029(19980701)42:1<2::AID-JEMT2>3.0.CO;2-Y; Robinson JM, 2000, J MICROSC-OXFORD, V199, P163, DOI 10.1046/j.1365-2818.2000.00734.x; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Sengupta P, 2014, CHEM REV, V114, P3189, DOI 10.1021/cr400614m; Shibata T, 2009, J VIROL METHODS, V156, P162, DOI 10.1016/j.jviromet.2008.10.020; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sochacki KA, 2014, NAT METHODS, V11, P305, DOI 10.1038/nmeth.2816; Suleiman H, 2013, ELIFE, V2, DOI 10.7554/eLife.01149; Takizawa T, 2000, J HISTOCHEM CYTOCHEM, V48, P481, DOI 10.1177/002215540004800405; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Watanabe S, 2014, METHODS MOL BIOL, V1117, P503, DOI 10.1007/978-1-62703-776-1_22; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	43	58	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124581	10.1371/journal.pone.0124581	http://dx.doi.org/10.1371/journal.pone.0124581			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874453	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800146
J	Lankinen, MA; Hanhineva, K; Kolehmainen, M; Lehtonen, M; Auriola, S; Mykkanen, H; Poutanen, K; Schwab, U; Uusitupa, M				Lankinen, Maria A.; Hanhineva, Kati; Kolehmainen, Marjukka; Lehtonen, Marko; Auriola, Seppo; Mykkanen, Hannu; Poutanen, Kaisa; Schwab, Ursula; Uusitupa, Matti			CMPF Does Not Associate with Impaired Glucose Metabolism in Individuals with Features of Metabolic Syndrome	PLOS ONE			English	Article							FISH; RISK; ACID	Objective 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) is a metabolite produced endogenously from dietary sources of furan fatty acids. The richest source of furan fatty acids in human diet is fish. CMPF was recently shown to be elevated in fasting plasma in individuals with gestational diabetes and type 2 diabetes, and mechanistically high level of CMPF was linked to beta cell dysfunction. Here we aimed to study the association between plasma CMPF level and glucose metabolism in persons with impaired glucose metabolism. Methods Plasma CMPF concentration was measured from plasma samples of the study participants in an earlier controlled dietary intervention. All of them had impaired glucose metabolism and two other characteristics of the metabolic syndrome. Altogether 106 men and women were randomized into three groups for 12 weeks with different fish consumption (either three fatty fish meals per week, habitual fish consumption or maximum of one fish meal per week). Associations between concentration of CMPF and various glucose metabolism parameters at an oral glucose tolerance test at baseline and at the end of the study were studied. Results Fasting plasma CMPF concentration was significantly increased after a 12-week consumption of fatty fish three times per week, but the concentration remained much lower compared to concentrations reported in diabetic patients. Increases of plasma CMPF concentrations mostly due to increased fish consumption were not associated with impaired glucose metabolism in this study. Instead, elevated plasma CMPF concentration was associated with decreased 2-hour insulin concentration in OGTT. Conclusions Moderately elevated concentration of CMPF in plasma resulting from increased intake of fish is not harmful to glucose metabolism. Further studies are needed to fully explore the role of CMPF in the pathogenesis of impaired glucose metabolism.	[Lankinen, Maria A.; Hanhineva, Kati; Kolehmainen, Marjukka; Mykkanen, Hannu; Poutanen, Kaisa; Schwab, Ursula; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Lehtonen, Marko; Auriola, Seppo] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Schwab, Ursula] Kuopio Univ Hosp, Internal Med, Inst Clin Med, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Lankinen, MA (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland.	maria.lankinen@uef.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Hanhineva, Kati/AAH-1699-2019	Lehtonen, Marko/0000-0002-5611-0466; /0000-0002-9158-283X; Hanhineva, Kati/0000-0001-6834-7375	Academy of Finland [117844, 118590, 131460, 130469]; Nordic Centre of Excellence on the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN [FOOD-CT-2005-514008]; Nordic Centre of Excellence on HELGA-Nordic health-whole grain food; Biocenter Finland Infrastructure; Tekes -the Finnish Funding Agency for Technology and Innovation [40361/05]; Finnish Cultural Foundation; Paavo Nurmi Foundation	Academy of Finland(Academy of Finland); Nordic Centre of Excellence on the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN; Nordic Centre of Excellence on HELGA-Nordic health-whole grain food; Biocenter Finland Infrastructure; Tekes -the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paavo Nurmi Foundation	This study was supported by: the Academy of Finland (grant numbers 117844 and 118590 to M.U., 131460 to K.P., 130469 to H.M.), The Nordic Centre of Excellence on the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008 to H.M. and K.P.), Nordic Centre of Excellence on HELGA-Nordic health-whole grain food (to H.M., K.H.), Biocenter Finland Infrastructure networks & technology funding (to K.H.), Tekes -the Finnish Funding Agency for Technology and Innovation (No. 40361/05 to R.T. and M.K.), Finnish Cultural Foundation, North Savo Regional Fund (to M.A.L.), and Paavo Nurmi Foundation (to M.A.L.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boelaert J, 2013, ANAL BIOANAL CHEM, V405, P1937, DOI 10.1007/s00216-012-6636-9; de Mello VDF, 2011, DIABETOLOGIA, V54, P2755, DOI 10.1007/s00125-011-2285-3; Hanhineva K, 2015, J NUTR, V145, P1, DOI [10.3945/jn.114.194324, DOI 10.3945/JN.114.194324]; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Lankinen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022646; Niwa T, 2013, BLOOD PURIFICAT, V35, P20, DOI 10.1159/000350843; Nkondjock A, 2003, DIABETES METAB, V29, P635, DOI 10.1016/S1262-3636(07)70080-0; Patel PS, 2009, DIABETES CARE, V32, P1857, DOI 10.2337/dc09-0116; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rylander C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089845; Spiteller G, 2005, LIPIDS, V40, P755, DOI 10.1007/s11745-005-1438-5; van Woudenbergh GJ, 2009, DIABETES CARE, V32, P2021, DOI 10.2337/dc09-1042; Vetter W., 2013, Lipid Technology, V25, P7, DOI 10.1002/lite.201300247; WAHL HG, 1992, HRC-J HIGH RES CHROM, V15, P815; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577; Zhang M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/501015	17	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124379	10.1371/journal.pone.0124379	http://dx.doi.org/10.1371/journal.pone.0124379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874636	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800140
J	Neves, RC; Reichert, H				Neves, Ricardo Cardoso; Reichert, Heinrich			Microanatomy and Development of the Dwarf Male of Symbion pandora (Phylum Cycliophora): New Insights from Ultrastructural Investigation Based on Serial Section Electron Microscopy	PLOS ONE			English	Article							CRYPTIC SPECIATION; AMERICANUS; MORPHOLOGY; LARVA	Cycliophorans have a complex life cycle that involves several sexual and asexual stages. One of the sexual stages is the 40 mu m-long dwarf male, which is among the smallest free-living metazoans. Although the dwarf male has a highly complex body plan, this minute organism is composed of a very low number of somatic cells (similar to 50). The developmental processes that give rise to this unique phenotype are largely unknown. Here we use high resolution serial block face-scanning electron microscopy to analyze the anatomy and morphogenesis of three cycliophoran dwarf males at different developmental stages ranging from internal bud to mature male. The anatomical and morphological features of the mature dwarf male stage reported here largely correspond to those reported in earlier studies. Interestingly, the organs that typically characterize the anatomy of the mature dwarf male, e.g., muscles, brain, testis and glands, are already formed in the young male. However, there are striking differences between the mature male and young male stages at the level of cellular architecture. Thus, while the young male stage, like the internal bud stage, possesses approximately 200 nucleated cells, the mature male stage comprises only around 50 nucleated cells; muscle and epidermal cells of the mature male lack nuclei. Moreover, the total body volume of the mature male is only 63% of the body of the young male implying that the maturation of the young male into a mature male involves a marked reduction of internal body volume, mainly by massive nuclei loss. Our comparative analysis of these dwarf male specimens reveals unprecedented insight into the striking morphological and developmental differences that characterize these highly miniaturized male stages both at the level of body organization and at the level of cellular ultrastructure.	[Neves, Ricardo Cardoso; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Neves, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.	ricardo.neves@unibas.ch	Neves, Ricardo Cardoso/J-9822-2014	Neves, Ricardo Cardoso/0000-0002-9219-9066	EU [227799]	EU(European Commission)	This study was partially funded by EU FP7 ASSEMBLE (grant agreement no. 227799; http://www.assemblemarine.org) for financial support for traveling and sampling in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current funding sources for this study.	Baker JM, 2007, MAR BIOL, V151, P2183, DOI 10.1007/s00227-007-0654-8; Baker JM, 2007, ZOOL SCR, V36, P353, DOI 10.1111/j.1463-6409.2006.00288.x; Deerinck T. J., 2010, MICROSCOPY-JPN, V1, P6; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Franzen A, 2000, INVERTEBR REPROD DEV, V37, P129, DOI 10.1080/07924259.2000.9652411; Funch P, 1996, J MORPHOL, V230, P231, DOI 10.1002/(SICI)1097-4687(199612)230:3<231::AID-JMOR1>3.0.CO;2-H; FUNCH P, 1995, NATURE, V378, P711, DOI 10.1038/378711a0; Funch P., 1999, ENCY REPROD, V1, P800; Funch Peter, 1997, P409; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Kim HY, 2013, DEVELOPMENT, V140, P3146, DOI 10.1242/dev.093682; Neves RC, 2010, J MORPHOL, V271, P596, DOI 10.1002/jmor.10819; Neves RC, 2014, ORG DIVERS EVOL, V14, P363, DOI 10.1007/s13127-014-0179-1; Neves RC, 2012, J MORPHOL, V273, P850, DOI 10.1002/jmor.20025; Neves RC, 2010, HELGOLAND MAR RES, V64, P257, DOI 10.1007/s10152-010-0204-5; Neves RC, 2010, ZOOL ANZ, V249, P1, DOI 10.1016/j.jcz.2010.02.002; Neves RC, 2009, BIOL BULL-US, V217, P2, DOI 10.1086/BBLv217n1p2; Neves RC, 2009, J MORPHOL, V270, P257, DOI 10.1002/jmor.10681; Nielsen Claus, 1997, P13; Obst M, 2006, MAR BIOL, V148, P945, DOI 10.1007/s00227-005-0131-1; Obst M, 2005, MOL ECOL, V14, P4427, DOI 10.1111/j.1365-294X.2005.02752.x; Obst M, 2003, J MORPHOL, V255, P261, DOI 10.1002/jmor.10040; Obst M, 2006, ORG DIVERS EVOL, V6, P83, DOI 10.1016/j.ode.2005.05.001; Polilov AA, 2012, ARTHROPOD STRUCT DEV, V41, P29, DOI 10.1016/j.asd.2011.09.001	24	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122364	10.1371/journal.pone.0122364	http://dx.doi.org/10.1371/journal.pone.0122364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875482	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800053
J	Pollom, RA; Rose, GA				Pollom, Riley A.; Rose, George A.			Size-Based Hydroacoustic Measures of Within-Season Fish Abundance in a Boreal Freshwater Ecosystem	PLOS ONE			English	Article							BODY-SIZE; SPECTRA; ASSEMBLAGES; INDICATORS; ACOUSTICS	Eleven sequential size-based hydroacoustic surveys conducted with a 200 kHz split-beam transducer during the summers of 2011 and 2012 were used to quantify seasonal declines in fish abundance in a boreal reservoir in Manitoba, Canada. Fish densities were sufficiently low to enable single target resolution and tracking. Target strengths converted to log(2)-based size-classes indicated that smaller fish were consistently more abundant than larger fish by a factor of approximately 3 for each halving of length. For all size classes, in both years, abundance (natural log) declined linearly over the summer at rates that varied from -0.067.day(-1) for the smallest fish to -0.016.day(-1) for the largest (R-2 = 0.24-0.97). Inter-annual comparisons of size-based abundance suggested that for larger fish (>16 cm), mean winter decline rates were an order of magnitude lower (-0.001. day(-1)) and overall survival higher (71%) than in the main summer fishing season (mean loss rate -0.038.day(-1); survival 33%). We conclude that size-based acoustic survey methods have the potential to assess within-season fish abundance dynamics, and may prove useful in long-term monitoring of productivity and hence management of boreal aquatic ecosystems.	[Pollom, Riley A.; Rose, George A.] Mem Univ Newfoundland, Fisheries & Marine Inst, Ctr Fisheries Ecosyst Res, St John, NF, Canada	Memorial University Newfoundland	Pollom, RA (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V5Z 1M9, Canada.	r.pollom@fisheries.ubc.ca		Pollom, Riley/0000-0001-8260-4614	National Sciences and Engineering Research Council HydroNet Research Network; Memorial University of Newfoundland Graduate Studentship	National Sciences and Engineering Research Council HydroNet Research Network; Memorial University of Newfoundland Graduate Studentship	This work was supported by the National Sciences and Engineering Research Council HydroNet Research Network to GR and Memorial University of Newfoundland Graduate Studentship to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 1998, CAN J FISH AQUAT SCI, V55, P1854, DOI 10.1139/cjfas-55-8-1854; Beamesderfer R.C., 1988, North American Journal of Fisheries Management, V8, P505, DOI 10.1577/1548-8675(1988)008<0505:SSABIE>2.3.CO;2; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; CHOPIN FS, 1995, FISH RES, V21, P315, DOI 10.1016/0165-7836(94)00301-C; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; DICKIE LM, 1987, ECOL MONOGR, V57, P233, DOI 10.2307/2937082; Elton C., 1927, ANIMAL ECOLOGY; Emmrich M, 2012, FRESHWATER BIOL, DOI 10.111/fwb.12022; Foote K, 1987, 144 ICES; Gislason H, 1998, ICES J MAR SCI, V55, P362, DOI 10.1006/jmsc.1997.0323; Graham NAJ, 2005, CORAL REEFS, V24, P118, DOI 10.1007/s00338-004-0466-y; Guillard J, 2007, INT REV HYDROBIOL, V92, P605, DOI 10.1002/iroh.200710948; Irwin BJ, 2008, ESTIMATING WALLEYE S; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; Kerr S. R., 2001, COM ECO SYS; Koslow JA, 2009, ICES J MAR SCI, V66, P966, DOI 10.1093/icesjms/fsp082; Lazarus P, 2012, PROFESSIONAL BOATBUI; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; LOVE RH, 1971, J ACOUST SOC AM, V49, P816, DOI 10.1121/1.1912422; Patel R, 2009, J ACOUST SOC AM, V125, P698, DOI 10.1121/1.3050325; Persaud AD, 2012, AQUAT SCI, V74, P203, DOI 10.1007/s00027-011-0212-9; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Sawada K., 1993, J MARINE ACOUSTICAL, V20, P73, DOI [DOI 10.3135/JMASJ.20.73, 10.3135/jmasj.20.73]; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; STEWART KW, 2004, FRESHWATER FISHES MA; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; Wheeland LJ, 2015, ECOL FRESHW FISH, V24, P67, DOI 10.1111/eff.12126	33	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124799	10.1371/journal.pone.0124799	http://dx.doi.org/10.1371/journal.pone.0124799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875467	gold, Green Published, Green Accepted			2022-12-27	WOS:000353015800153
J	Numasawa, Y; Kohsaka, S; Miyata, H; Kawamura, A; Noma, S; Suzuki, M; Nakagawa, S; Momiyama, Y; Naito, K; Fukuda, K				Numasawa, Yohei; Kohsaka, Shun; Miyata, Hiroaki; Kawamura, Akio; Noma, Shigetaka; Suzuki, Masahiro; Nakagawa, Susumu; Momiyama, Yukihiko; Naito, Kotaro; Fukuda, Keiichi			Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry	PLOS ONE			English	Article							LONG-TERM OUTCOMES; OBESITY PARADOX; ARTERY-DISEASE; BLEEDING COMPLICATIONS; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; HEART-FAILURE; MORTALITY; RISK	Background Obesity is associated with advanced cardiovascular disease. However, some studies have reported the "obesity paradox" after percutaneous coronary intervention (PCI). The relationship between body mass index (BMI) and clinical outcomes after PCI has not been thoroughly investigated, especially in Asian populations. Methods We studied 10,142 patients who underwent PCI at 15 Japanese hospitals participating in the JCD-KICS registry from September 2008 to April 2013. Patients were divided into four groups according to BMI: underweight, BMI <18.5 (n=462); normal, BMI >= 18.5 and <25.0 (n= 5,945); overweight, BMI >= 25.0 and <30.0 (n=3,100); and obese, BMI >= 30.0 (n= 635). Results Patients with a high BMI were significantly younger (p<0.001) and had a higher incidence of coronary risk factors such as hypertension (p<0.001), hyperlipidemia (p<0.001), diabetes mellitus (p<0.001), and current smoking (p<0.001), than those with a low BMI. Importantly, patients in the underweight group had the worst in-hospital outcomes, including overall complications (underweight, normal, overweight, and obese groups: 20.4%, 11.5%, 8.4%, and 10.2%, p<0.001), in-hospital mortality (5.8%, 2.1%, 1.2%, and 2.7%, p<0.001), cardiogenic shock (3.5%, 2.0%, 1.5%, and 1.6%, p=0.018), bleeding complications (10.0%, 4.5%, 2.6%, and 2.8%, p<0.001), and receiving blood transfusion (7.6%, 2.7%, 1.6%, and 1.7%, p<0.001). BMI was inversely associated with bleeding complications after adjustment by multivariate logistic regression analysis (odds ratio, 0.95; 95% confidence interval, 0.92-0.98; p=0.002). In subgroup multivariate analysis of patients without cardiogenic shock, BMI was inversely associated with overall complications (OR, 0.98; 95% CI, 0.95-0.99; p=0.033) and bleeding complications (OR, 0.95; 95% CI, 0.91-0.98; p=0.006). Furthermore, there was a trend that BMI was moderately associated with in-hospital mortality (OR, 0.94; 95% CI, 0.88-1.01; p=0.091). Conclusions Lean patients, rather than obese patients are at greater risk for in-hospital complications during and after PCI, particularly for bleeding complications.	[Numasawa, Yohei] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan; [Kohsaka, Shun; Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Miyata, Hiroaki] Univ Tokyo, Healthcare Qual Assessment, Tokyo, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Suzuki, Masahiro] Saitama Natl Hosp, Natl Hosp Org, Dept Cardiol, Saitama, Japan; [Nakagawa, Susumu] Saiseikai Cent Hosp, Dept Cardiol, Tokyo, Japan; [Momiyama, Yukihiko] Tokyo Med Ctr, Natl Hosp Org, Dept Cardiol, Tokyo, Japan; [Naito, Kotaro] Keiyu Hosp, Dept Cardiol, Kanagawa, Japan	Keio University; University of Tokyo; Tokyo Saiseikai Central Hospital	Numasawa, Y (corresponding author), Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan.	numasawa@cpnet.med.keio.ac.jp	MOMIYAMA, YUKIHIKO/GHR-6526-2022; Fukuda, Keiichi/L-3777-2013; Numasawa, Yohei/AAC-9604-2020	MOMIYAMA, YUKIHIKO/0000-0002-7710-1446; Numasawa, Yohei/0000-0002-1739-2800; Kohsaka, Shun/0000-0003-3779-2972	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI) [21790751]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 21790751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Benderly M, 2010, AM J CARDIOL, V106, P297, DOI 10.1016/j.amjcard.2010.03.078; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Byrne J, 2009, AM J CARDIOL, V103, P507, DOI 10.1016/j.amjcard.2008.10.027; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Cox N, 2004, AM J CARDIOL, V94, P1174, DOI 10.1016/j.amjcard.2004.07.088; Das SR, 2011, J AM COLL CARDIOL, V58, P2642, DOI 10.1016/j.jacc.2011.09.030; Daugherty SL, 2013, J AM COLL CARDIOL, V61, P2070, DOI 10.1016/j.jacc.2013.02.030; Delhaye C, 2010, AM HEART J, V159, P1139, DOI 10.1016/j.ahj.2010.03.011; Diercks DB, 2006, AM HEART J, V152, P140, DOI 10.1016/j.ahj.2005.09.024; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6; Herrmann J, 2014, AM J CARDIOL, V114, P9, DOI 10.1016/j.amjcard.2014.03.057; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kaneko H, 2013, J CARDIOL, V62, P18, DOI 10.1016/j.jjcc.2013.02.009; Kang SJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI [10.1161/CIRCINTERVENTIONS.114.002079, DOI 10.1161/CIRCINTERVENTI0NS.114.002079]; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Kosuge M, 2008, CIRC J, V72, P521; Kuno T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072672; Lancefield T, 2010, JACC-CARDIOVASC INTE, V3, P660, DOI 10.1016/j.jcin.2010.03.018; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mak KH, 2009, EUR HEART J, V30, P857, DOI 10.1093/eurheartj/ehp037; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Mobeirek AF, 2014, ANN SAUDI MED, V34, P38, DOI 10.5144/0256-4947.2014.38; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Ndrepepa G, 2015, AM J CARDIOL, V115, P434, DOI 10.1016/j.amjcard.2014.11.022; Niraj A, 2007, CLIN CARDIOL, V30, P391, DOI 10.1002/clc.20113; Numasawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116496; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P242, DOI 10.1007/s12928-013-0162-3; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P148, DOI 10.1007/s12928-012-0138-8; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Payvar S, 2013, J AM COLL CARDIOL, V62, P692, DOI 10.1016/j.jacc.2013.05.058; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sarno G, 2011, AM J CARDIOL, V108, P195, DOI 10.1016/j.amjcard.2011.03.023; Sarno G, 2010, AM J CARDIOL, V105, P475, DOI 10.1016/j.amjcard.2009.09.055; Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Wang TY, 2007, AM J CARDIOL, V100, P391, DOI 10.1016/j.amjcard.2007.03.035; Wang ZJ, 2009, HEART, V95, P1587, DOI 10.1136/hrt.2009.172395; Witassek F, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13986	47	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124399	10.1371/journal.pone.0124399	http://dx.doi.org/10.1371/journal.pone.0124399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874887	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700068
J	Qanadli, SD; Jouannic, AM; Dehmeshki, J; Lu, TL				Qanadli, Salah D.; Jouannic, Anne-Marie; Dehmeshki, Jamshid; Lu, Tri-Linh			CT Attenuation Values of Blood and Myocardium: Rationale for Accurate Coronary Artery Calcifications Detection with Multi-Detector CT	PLOS ONE			English	Article							ELECTRON-BEAM CT; IMPROVED REPRODUCIBILITY; CALCIUM; QUANTIFICATION; SCANNER; DISEASE	Objectives To determine inter-session and intra/inter-individual variations of the attenuations of aortic blood/myocardium with MDCT in the context of calcium scoring. To evaluate whether these variations are dependent on patients' characteristics. Methods Fifty-four volunteers were evaluated with calcium scoring non-enhanced CT. We measured attenuations (inter-individual variation) and standard deviations (SD, intra-individual variation) of the blood in the ascending aorta and of the myocardium of left ventricle. Every volunteer was examined twice to study the inter-session variation. The fat pad thickness at the sternum and noise (SD of air) were measured too. These values were correlated with the measured aortic/ventricular attenuations and their SDs (Pearson). Historically fixed thresholds (90 and 130 HU) were tested against different models based on attenuations of blood/ventricle. Results The mean attenuation was 46HU (range, 17-84HU) with mean SD 23HU for the blood, and 39HU (10-82HU) with mean SD 18 HU for the myocardium. The attenuation/SD of the blood were significantly higher than those of the myocardium (p<0.01). The inter-session variation was not significant. There was a poor correlation between SD of aortic blood/ventricle with fat thickness/noise. Based on existing models, 90 HU threshold offers a confidence interval of approximately 95% and 130 HU more than 99%. Conclusions Historical thresholds offer high confidence intervals for exclusion of aortic blood/myocardium and by the way for detecting calcifications. Nevertheless, considering the large variations of blood/myocardium CT values and the influence of patient's characteristics, a better approach might be an adaptive threshold.	[Qanadli, Salah D.; Jouannic, Anne-Marie; Lu, Tri-Linh] Univ Lausanne Hosp, Dept Radiol, CH-1011 Lausanne, Switzerland; [Qanadli, Salah D.; Dehmeshki, Jamshid] Univ Kingston, Fac Comp Informat Syst & Math, Digital Imaging Res Ctr, Quantitat Med Imaging Int Inst, London, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kingston University	Qanadli, SD (corresponding author), Univ Lausanne Hosp, Dept Radiol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	salah.qanadli@chuv.ch	Dr. Tri-Linh Christian Lu, FMH EBIR/AAB-5432-2021	QANADLI, Salah Dine/0000-0003-1330-660X				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; Broderick LS, 2006, AM J ROENTGENOL, V167, P439; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Groen JM, 2009, MED PHYS, V36, P438, DOI 10.1118/1.3049590; Hong C, 2003, RADIOLOGY, V227, P795, DOI 10.1148/radiol.2273020369; Hong C, 2002, RADIOLOGY, V223, P474, DOI 10.1148/radiol.2232010919; Moselewski F, 2006, EUR J RADIOL, V57, P390, DOI 10.1016/j.ejrad.2005.12.026; Muhlenbruch G, 2007, EUR RADIOL, V17, P321, DOI 10.1007/s00330-006-0332-0; Nelson JC, 2005, RADIOLOGY, V235, P403, DOI 10.1148/radiol.2352040515; Oudkerk M, 2008, INT J CARDIOVAS IMAG, V24, P907, DOI [10.1007/s10554-008-9350-0, DOI 10.1007/S10554-008-9350-0]; Qanadli SD, 2001, J COMPUT ASSIST TOMO, V25, P278, DOI 10.1097/00004728-200103000-00023; Raggi P, 2002, AM J ROENTGENOL, V178, P497, DOI 10.2214/ajr.178.2.1780497; Schmermund A, 2002, AM J CARDIOL, V90, p12L, DOI 10.1016/S0002-9149(02)02955-7	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124175	10.1371/journal.pone.0124175	http://dx.doi.org/10.1371/journal.pone.0124175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875629	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700058
J	Ratsitorahina, M; Rahelinirina, S; Michault, A; Rajerison, M; Rajatonirina, S; Richard, V				Ratsitorahina, Maherisoa; Rahelinirina, Soanandrasana; Michault, Alain; Rajerison, Minoarisoa; Rajatonirina, Soatiana; Richard, Vincent		2011 Surveillance Workshop Grp	Has Madagascar Lost Its Exceptional Leptospirosis Free-Like Status?	PLOS ONE			English	Article							INDIAN-OCEAN; HUMANS; UNION	Background Leptospirosis is a widespread but underreported cause of morbidity and mortality. It has rarely been reported in either humans or animals in Madagascar. Methods We conducted a cross-sectional survey of the inhabitants in Moramanga, Madagascar, in June 2011, to estimate the prevalence of human infection using the microscopic agglutination test (MAT). This activity was carried out as part of a workshop implemented by the Pasteur Institute of Madagascar, focusing on surveillance with a one week field study and targeting the health staff of the district level. Results In total, we sampled 678 inhabitants from 263 households. The sex ratio (M/F) was 0.65 and the mean age 26.7 years. We obtained a value of 2.9% for the first recorded seroprevalence of this disease in the human community of Moramanga. Questionnaire responses revealed frequent contacts between humans and rodents in Moramanga. However, activities involving cattle were identified as a risk factor significantly associated with seropositivity (OR=3). Conclusion Leptospirosis remains a neglected disease in Madagascar. This study highlights the need to quantify the public health impact of this neglected disease in a more large scale, in all the country and to establish point-of-care laboratories in remote areas.	[Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Rahelinirina, Soanandrasana; Rajerison, Minoarisoa] Inst Pasteur Madagascar, Plague Unit, Antananarivo, Madagascar; [Michault, Alain] Ctr Hosp Univ CHU Sud, Biol Unit, St Pierre, Reunion, France; [Michault, Alain] Ctr Hosp Univ CHU Sud, Virol Unit, St Pierre, Reunion, France; [Michault, Alain] Ctr Hosp Univ CHU Sud, Parasitol Unit, St Pierre, Reunion, France; [Richard, Vincent] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; CHU Reunion; CHU Reunion; CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Richard, V (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, BP 1274, Antananarivo, Madagascar.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Pasteur Institute of Madagascar	Pasteur Institute of Madagascar	This network was supported by the Pasteur Institute of Madagascar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BRYGOO E R, 1956, Bull Soc Pathol Exot Filiales, V49, P686; BUCK G, 1956, Bull Soc Pathol Exot Filiales, V49, P681; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Duplantier J, 2004, NATURAL HIST MADAGAS, P158; DUVAL G, 1991, REV EPIDEMIOL SANTE, V39, P135; Faine S, 1984, 67 WHO; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Gomard Y, 2014, EMERG INFECT DIS, V20, P720, DOI 10.3201/eid2004.131207; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LHUILLIER M, 1978, Archives de l'Institut Pasteur de Madagascar, V46, P429; Paganin F, 2007, INTENS CARE MED, V33, P1959, DOI 10.1007/s00134-007-0776-y; R Development Core Team, 2010, LANG ENV STAT COMP; Rahelinirina S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014111; Ralaiarijaona R. L., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P34; SILVERIE R, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P346; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933	20	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122683	10.1371/journal.pone.0122683	http://dx.doi.org/10.1371/journal.pone.0122683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874381	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700021
J	Sun, XJ; Li, XQ; Wang, XL; Tan, WF; Wang, JK				Sun, Xi Jia; Li, Xiao Qian; Wang, Xiao Long; Tan, Wen Fei; Wang, Jun Ke			Sevoflurane Inhibits Nuclear Factor-kappa B Activation in Lipopolysaccharide-Induced Acute Inflammatory Lung Injury via Toll-Like Receptor 4 Signaling	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; TLR4 PATHWAY; ISOFLURANE; MICE; EXPRESSION; BINDING; LPS	Background Infection is a common cause of acute lung injury (ALI). This study was aimed to explore whether Toll-like receptors 4 (TLR4) of airway smooth muscle cells (ASMCs) play a role in lipopolysaccharide (LPS)-induced airway hyperresponsiveness and potential mechanisms. Methods In vivo: A sensitizing dose of LPS (50 mu g) was administered i.p. to female mice before anesthesia with either 3% sevoflurane or phenobarbital i.p. After stabilization, the mice were challenged with 5 mu g of intratracheal LPS to mimic inflammatory attack. The effects of sevoflurane were assessed by measurement of airway responsiveness to methacholine, histological examination, and IL-1, IL-6, TNF-alpha levels in bronchoalveolar lavage fluid (BALF). Protein and gene expression of TLR4 and NF-kappa B were also assessed. In vitro: After pre- sensitization of ASMCs and ASM segments for 24h, levels of TLR4 and NF-kappa B proteins in cultured ASMCs were measured after continuous LPS exposure for 1, 3, 5, 12 and 24h in presence or absence of sevoflurane. Constrictor and relaxant responsiveness of ASM was measured 24 h afterwards. Results The mRNA and protein levels of NF-kappa B and TLR4 in ASM were increased and maintained at high level after LPS challenge throughout 24h observation period, both in vivo and in vitro. Sevoflurane reduced LPS-induced airway hyperresponsiveness, lung inflammatory cell infiltration and proinflammatory cytokines release in BALF as well as maximal isometric contractile force of ASM segments to acetylcholine, but it increased maximal relaxation response to isoproterenol. Treatment with specific NF-kappa B inhibitor produced similar protections as sevoflurane, including decreased expressions of TLR4 and NF-kappa B in cultured ASMCs and improved pharmacodynamic responsiveness of ASM to ACh and isoproterenol. Conclusions This study demonstrates the crucial role of TLR4 activation in ASMCs during ALI in response to LPS. Sevoflurane exerts direct relaxant and anti-inflammatory effects in vivo and in vitro via inhibition of TLR4/NF-kappa B pathway.	[Sun, Xi Jia; Li, Xiao Qian; Wang, Xiao Long; Tan, Wen Fei; Wang, Jun Ke] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Wang, JK (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China.	junke45@yahoo.com			National Natural Science Foundation of China [30371376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this project was provided by National Natural Science Foundation of China, No. 30371376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XD, 2000, ANESTH ANALG, V91, P996, DOI 10.1097/00000539-200010000-00042; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Duran A, 2014, INVEST CLIN, V55, P61; Go H, 2014, RESP MED, V108, P783, DOI 10.1016/j.rmed.2013.12.007; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Howarth Peter H, 2004, J Allergy Clin Immunol, V114, pS32, DOI 10.1016/j.jaci.2004.04.041; Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873; Joh EH, 2012, BIOCHEM PHARMACOL, V84, P331, DOI 10.1016/j.bcp.2012.04.020; Kalimeris K, 2014, MINERVA ANESTESIOL, V80, P635; Kojima A, 2013, ANESTHESIOLOGY, V119, P606, DOI 10.1097/ALN.0b013e318292ee52; Kuzemtseva L, 2014, VET IMMUNOL IMMUNOP, V158, P189, DOI 10.1016/j.vetimm.2014.01.009; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; Li QF, 2009, ANESTH ANALG, V109, P1591, DOI 10.1213/ANE.0b013e3181baf506; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-28; Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62; Mansson A, 2009, J LEUKOCYTE BIOL, V85, P719, DOI 10.1189/jlb.0808494; Myers CF, 2011, CAN J ANESTH, V58, P1007, DOI 10.1007/s12630-011-9578-3; Ni JQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/476856; Pang YL, 2012, J ANESTH, V26, P822, DOI 10.1007/s00540-012-1456-9; Qiao SG, 2013, J ANESTH, V27, P251, DOI 10.1007/s00540-012-1494-3; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Rodgers A, 2000, BMJ-BRIT MED J, V16, P321; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Wang Hailian, 2011, Front Biosci (Elite Ed), V3, P604; Wei D, 2014, INFLAMMATION, V37, P1307, DOI 10.1007/s10753-014-9858-5; Xia ZY, 2009, ANESTHESIOLOGY, V111, P924, DOI 10.1097/ALN.0b013e3181b64c38; Xu XB, 2008, ANESTHESIOLOGY, V108, P643, DOI 10.1097/ALN.0b013e318167aeb4; Yang QZ, 2011, ANESTH ANALG, V112, P931, DOI 10.1213/ANE.0b013e31820bcfa4; Zhao SP, 2014, MOL MED REP, V9, P2435, DOI 10.3892/mmr.2014.2094	38	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122752	10.1371/journal.pone.0122752	http://dx.doi.org/10.1371/journal.pone.0122752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875290	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700024
J	Gallo, A; Tosti, E				Gallo, Alessandra; Tosti, Elisabetta			Reprotoxicity of the Antifoulant Chlorothalonil in Ascidians: An Ecological Risk Assessment	PLOS ONE			English	Article								Chlorothalonil is a widely used biocide in antifouling paint formulation that replaces tin-based compounds after their definitive ban. Although chlorothalonil inputs into the marine environment have significantly increased in recent years, little is known about its effect on marine animals and in particular on their reproductive processes. In this line, the aim of the present study was to investigate the effects of chlorothalonil exposure on the gamete physiology, fertilization rate and transmissible damage to offspring in the marine invertebrate Ciona intestinalis (ascidians). To identify a possible mechanism of action of chlorothalonil, electrophysiological techniques were used to study the impact on oocyte membrane excitability and on the electrical events occurring at fertilization. The pre-exposure of spermatozoa and oocytes to chlorothalonil did not affect the fertilization rate but caused damage to the offspring by inducing larval malformation. The highest toxicity was observed when fertilization was performed in chlorothalonil solutions with the lowest EC50 value. In particular, it was observed that low chlorothalonil concentrations interfered with embryo development and led to abnormal larvae, whereas high concentrations arrested embryo formation. In mature oocytes, a decrease in the amplitudes of the sodium and fertilization currents was observed, suggesting an involvement of plasma membrane ion currents in the teratogenic mechanism of chlorothalonil action. The risk estimation confirmed that the predicted no-effect concentration (PNEC) exceeded the predicted effect concentration (PEC), thus indicating that chlorothalonil may pose a risk to aquatic species.	[Gallo, Alessandra; Tosti, Elisabetta] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Tosti, E (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.	tosti@szn.it	Gallo, Alessandra/AAA-3132-2022	Gallo, Alessandra/0000-0002-2558-4722	Stazione Zoologica Anton Dohrn institutional funds; Stazione Zoologica Anton Dohrn PhD fellowship	Stazione Zoologica Anton Dohrn institutional funds; Stazione Zoologica Anton Dohrn PhD fellowship	This work has been supported by Stazione Zoologica Anton Dohrn institutional funds. A.G. has been supported by a Stazione Zoologica Anton Dohrn PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcha F, 2012, AQUAT TOXICOL, V106, P104, DOI 10.1016/j.aquatox.2011.10.018; Alzieu C, 2000, ECOTOXICOLOGY, V9, P71, DOI 10.1023/A:1008968229409; Bao VWW, 2011, MAR POLLUT BULL, V62, P1147, DOI 10.1016/j.marpolbul.2011.02.041; Bellas J, 2005, BIOFOULING, V21, P289, DOI 10.1080/08927010500456589; Bellas J, 2001, WATER RES, V35, P2905, DOI 10.1016/S0043-1354(01)00004-5; Bellas J, 2007, AQUAT TOXICOL, V83, P52, DOI 10.1016/j.aquatox.2007.03.011; Bellas J, 2006, SCI TOTAL ENVIRON, V367, P573, DOI 10.1016/j.scitotenv.2006.01.028; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Cuomo A, 2006, MOL REPROD DEV, V73, P501, DOI 10.1002/mrd.20404; DALE B, 1984, DEV BIOL, V101, P235, DOI 10.1016/0012-1606(84)90135-0; Dale Brian, 1994, Zygote, V2, P373; De Simone ML, 1998, ZYGOTE, V6, P11, DOI 10.1017/S0967199400005037; DeLorenzo ME, 2012, MAR POLLUT BULL, V64, P1291, DOI 10.1016/j.marpolbul.2012.05.011; Emmens C. W., 1948, PRINCIPLES BIOL ASSA; ERNST W, 1991, ARCH ENVIRON CON TOX, V21, P1, DOI 10.1007/BF01055550; European Commission, 2003, EUR20418EN2 JOINT RE; Evans SM, 2000, MAR POLLUT BULL, V40, P204, DOI 10.1016/S0025-326X(99)00248-9; Franchet C, 1999, AQUAT TOXICOL, V44, P213; Gallo A, 2013, MAR DRUGS, V11, P3554, DOI 10.3390/md11093554; Gallo A, 2011, MAR ECOL-EVOL PERSP, V32, P222, DOI 10.1111/j.1439-0485.2011.00433.x; GIANAROLI L, 1994, MOL REPROD DEV, V38, P209, DOI 10.1002/mrd.1080380212; Glahn D, 2003, DEV GROWTH DIFFER, V45, P187; Harino H, 2004, COAST MAR SCI, V29, P28; Key PB, 2003, J ENVIRON SCI HEAL B, V38, P539, DOI 10.1081/PFC-120023512; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Koutsaftis A, 2007, SCI TOTAL ENVIRON, V387, P166, DOI 10.1016/j.scitotenv.2007.07.023; Lee S, 2011, J HAZARD MATER, V185, P1318, DOI 10.1016/j.jhazmat.2010.10.048; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Mai H, 2013, MAR ENVIRON RES, V89, P1, DOI [10.1016/j.marenvres.2013.04.003, 10.1016/j.envres.2013.02.006]; Manzo S, 2006, ARCH ENVIRON CON TOX, V51, P61, DOI 10.1007/s00244-004-0167-0; Onduka T, 2012, FISHERIES SCI, V78, P1301, DOI 10.1007/s12562-012-0562-9; Readman JW, 2006, HANDB ENVIRON CHEM, V50, P1; Sakkas VA, 2002, CHEMOSPHERE, V48, P939, DOI 10.1016/S0045-6535(02)00121-2; Silvestre F, 2009, MOL REPROD DEV, V76, P1084, DOI 10.1002/mrd.21073; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Tosti E, 2002, REPRODUCTION, V124, P835, DOI 10.1530/reprod/124.6.835; Tosti E, 2011, MOL REPROD DEV, V78, P854, DOI 10.1002/mrd.21316; Voulvoulis N, 2000, MAR POLLUT BULL, V40, P938, DOI 10.1016/S0025-326X(00)00034-5; Voulvoulis N, 1999, APPL ORGANOMET CHEM, V13, P135, DOI 10.1002/(SICI)1099-0739(199903)13:3<135::AID-AOC831>3.0.CO;2-G; Voulvoulis N., ANTIFOULING PAINT BI; Wang H, 2011, ENVIRON TOXICOL CHEM, V30, P692, DOI 10.1002/etc.440; Yamada Hisashi, 2007, Bulletin of Fisheries Research Agency, P31; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Zega G, 2009, ISJ-INVERT SURVIV J, V6, pS29	45	98	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123074	10.1371/journal.pone.0123074	http://dx.doi.org/10.1371/journal.pone.0123074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VE8EG	25875759	Green Submitted, Green Published, gold			2022-12-27	WOS:000440564500001
J	Hebar, A; Koller, C; Seifert, JM; Chabicovsky, M; Bodenteich, A; Bernkop-Schnurch, A; Grassauer, A; Prieschl-Grassauer, E				Hebar, Alexandra; Koller, Christiane; Seifert, Jan-Marcus; Chabicovsky, Monika; Bodenteich, Angelika; Bernkop-Schnuerch, Andreas; Grassauer, Andreas; Prieschl-Grassauer, Eva			Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan	PLOS ONE			English	Article							SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; DENGUE VIRUS; NASAL SPRAY; TNF-ALPHA; COMMON; INDUCTION; EFFICACY; POTENT	Carrageenan has been widely used as food additive for decades and therefore, an extended oral data set is available in the public domain. Less data are available for other routes of administration, especially intranasal administration. The current publication describes the nonclinical safety and toxicity of native (non-degraded) iota-carrageenan when applied intranasally or via inhalation. Intranasally applied iota-carrageenan is a topically applied, locally acting compound with no need of systemic bioavailability for the drug's action. Animal experiments included repeated dose local tolerance and toxicity studies with intranasally applied 0.12% iota-carrageenan for 7 or 28 days in New Zealand White rabbits and nebulized 0.12% iota-carrageenan administered to F344 rats for 7 days. Permeation studies revealed no penetration of iota-carrageenan across nasal mucosa, demonstrating that iota-carrageenan does not reach the blood stream. Consistent with this, no relevant toxic or secondary pharmacological effects due to systemic exposure were observed in the rabbit or rat repeated dose toxicity studies. Data do not provide any evidence for local intolerance or toxicity, when carrageenan is applied intranasally or by inhalation. No signs for immunogenicity or immunotoxicity have been observed in the in vivo studies. This is substantiated by in vitro assays showing no stimulation of a panel of pro-inflammatory cytokines by iota-carrageenan. In conclusion, 0.12% iota-carrageenan is safe for clinical use via intranasal application.	[Hebar, Alexandra; Chabicovsky, Monika] MC Toxicol Consulting GmbH, Vienna, Austria; [Koller, Christiane; Seifert, Jan-Marcus; Bodenteich, Angelika; Grassauer, Andreas; Prieschl-Grassauer, Eva] Marinomed Biotechnol GmbH, Vienna, Austria; [Bernkop-Schnuerch, Andreas] ThioMatriX, Innsbruck, Austria		Chabicovsky, M (corresponding author), MC Toxicol Consulting GmbH, Vienna, Austria.	MC@toxicology.cc	Bernkop-Schnürch, Andreas/HCH-3150-2022	Bernkop-Schnürch, Andreas/0000-0003-4187-8277	Marinomed Biotechnologie GmbH	Marinomed Biotechnologie GmbH	This work was supported by Marinomed Biotechnologie GmbH. Marinomed Biotechnologie GmbH (AG, EPG, AB, CK, JMS) had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and is financing the processing charge of the manuscript. MC Toxicology Consulting GmbH (MC, AH), as nonclinical consultant to Marinomed Biotechnologie GmbH, had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. MC Toxicology Consulting's work was financed by Marinomed Biotechnologie GmbH. ThioMatriX (ABS), as contract research organization to Marinomed Biotechnologie GmbH, had a role in study design, data collection and analysis and decision to publish. ThioMatrix's work was financed by Marinomed Biotechnologie GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Batista JA, 2014, CARBOHYD POLYM, V99, P59, DOI 10.1016/j.carbpol.2013.08.071; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Carlucci MJ, 1999, ANTIVIR RES, V43, P93, DOI 10.1016/S0166-3542(99)00038-8; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Csonga R, 1998, J IMMUNOL, V160, P273; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; IUCLID, 2000, IUCLID DAT CARR SUBS; JECFA, 2001, WHO TECHN REP SER, V891; JEFCA, 1974, WHO TECHN REP SER, V539; Li L, 2014, CARBOHYD POLYM, V103, P1, DOI 10.1016/j.carbpol.2013.12.008; Ludwig M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-124; Marino DJ, 2012, J TOXICOL ENV HEAL A, V75, P1484, DOI 10.1080/15287394.2012.722520; Mckim JM, 2014, CRIT REV TOXICOL, V44, P211, DOI 10.3109/10408444.2013.861797; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED; Paulsen FP, 2002, INVEST OPHTH VIS SCI, V43, P3137; Prieschl EE, 1996, J IMMUNOL, V157, P2645; Rowe R.C., 2009, HDB PHARM EXCIPIENTS, VSixth; SCF (Scientific Committee for Food), 2003, SCFCSADDEMU199; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; TARLO SM, 1995, J ALLERGY CLIN IMMUN, V95, P933, DOI 10.1016/S0091-6749(95)70091-9; Tobacman JK, 2001, MED HYPOTHESES, V56, P589, DOI 10.1054/mehy.2000.1208; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Wang W, 2012, MAR DRUGS, V10, P2795, DOI 10.3390/md10122795; WEINER ML, 1991, AGENTS ACTIONS, V32, P46, DOI 10.1007/BF01983307; Weiner ML, 2014, CRIT REV TOXICOL, V44, P244, DOI 10.3109/10408444.2013.861798	32	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122911	10.1371/journal.pone.0122911	http://dx.doi.org/10.1371/journal.pone.0122911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875737	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100117
J	Ito, M; Bentley, KH; Oe, Y; Nakajima, S; Fujisato, H; Kato, N; Miyamae, M; Kanie, A; Horikoshi, M; Barlow, DH				Ito, Masaya; Bentley, Kate H.; Oe, Yuki; Nakajima, Shun; Fujisato, Hiroko; Kato, Noriko; Miyamae, Mitsuhiro; Kanie, Ayako; Horikoshi, Masaru; Barlow, David H.			Assessing Depression Related Severity and Functional Impairment: The Overall Depression Severity and Impairment Scale (ODSIS)	PLOS ONE			English	Article							MENTAL-HEALTH; LIKELIHOOD RATIOS; ANXIETY SEVERITY; SCREENING SCALES; VALIDATION; PERFORMANCE; INVENTORY; VERSION; K10; K6	Background The Overall Depression Severity and Impairment Scale (ODSIS) is a brief, five-item measure for assessing the frequency and intensity of depressive symptoms, as well as functional impairments in pleasurable activities, work or school, and interpersonal relationships due to depression. Although this scale is expected to be useful in various psychiatric and mental health settings, the reliability, validity, and interpretability have not yet been fully examined. This study was designed to examine the reliability, factorial, convergent, and discriminant validity of a Japanese version of the ODSIS, as well as its ability to distinguish between individuals with and without a major depressive disorder diagnosis. Methods From a pool of registrants at an internet survey company, 2830 non-clinical and clinical participants were selected randomly (619 with major depressive disorder, 619 with panic disorder, 576 with social anxiety disorder, 645 with obsessive-compulsive disorder, and 371 non-clinical panelists). Participants were asked to respond to the ODSIS and conventional measures of depression, functional impairment, anxiety, neuroticism, satisfaction with life, and emotion regulation. Results Exploratory and confirmatory factor analysis of three split subsamples indicated the unidimensional factor structure of ODSIS. Multi-group confirmatory factor analysis showed invariance of factor loadings between non-clinical and clinical subsamples. The ODSIS also showed excellent internal consistency and test-retest intraclass correlation coefficients. Convergence and discriminance of the ODSIS with various measures were in line with our expectations. Receiver operating characteristic curve analyses showed that the ODSIS was able to detect a major depressive syndrome accurately. Conclusions This study supports the reliability and validity of ODSIS in a non-western population, which can be interpreted as demonstrating cross-cultural validity.	[Ito, Masaya; Kato, Noriko; Miyamae, Mitsuhiro; Horikoshi, Masaru] Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, Kodaira, Tokyo, Japan; [Bentley, Kate H.; Barlow, David H.] Boston Univ, Boston, MA 02215 USA; [Oe, Yuki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo, Japan; [Nakajima, Shun] Tokyo Med Univ, Tokyo 1608402, Japan; [Fujisato, Hiroko; Miyamae, Mitsuhiro] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Kanie, Ayako] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Boston University; National Center for Neurology & Psychiatry - Japan; Tokyo Medical University; University of Tsukuba; National Center for Neurology & Psychiatry - Japan	Ito, M (corresponding author), Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, Kodaira, Tokyo, Japan.	masayait@ncnp.go.jp	Barlow, David/F-8738-2011		Japan Society for the Promotion of Science [24830127]; National Center of Neurology and Psychiatry Intramural Research Grant [24-4]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center of Neurology and Psychiatry Intramural Research Grant	This study was supported by a Grant-in-Aid for Research Activity start-up (24830127, http://www.jsps.go.jp/english/e-grants/index.html) awarded to MI from the Japan Society for the Promotion of Science, National Center of Neurology and Psychiatry Intramural Research Grant (24-4, http://www.ncnp.go.jp/guide/cost.html) for Neurological and Psychiatric Disorders. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN IV TE; American Psychiatric Association, 2013, DIAGN STAT MAN 5; Andrews D, 2003, INT J HUM-COMPUT INT, V16, P185, DOI 10.1207/S15327590IJHC1602_04; [Anonymous], CONFIRMATORY FACTOR; Barlow D. H., 2018, UNIFIED PROTOCOL TRA, V2nd; Beck AT, 1996, BECK DEPRESSION INVE; Bentley KH, 2014, PSYCHOL ASSESSMENT, V26, P815, DOI 10.1037/a0036216; Blais M, 2010, CURR CLIN PSYCHIAT, P1, DOI 10.1007/978-1-59745-387-5_1; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kline R.B., 2011, PRINCIPLES PRACTICE; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Matthey S, 2002, PSYCHOL ASSESSMENT, V14, P146, DOI 10.1037//1040-3590.14.2.146; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; PEIRCE JC, 1993, MED DECIS MAKING, V13, P141, DOI 10.1177/0272989X9301300208; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Schmitz N, 2000, SOC PSYCH PSYCH EPID, V35, P375, DOI 10.1007/s001270050253; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Yoshizu J., 2013, JPN J RES EMOT, V20, P56, DOI DOI 10.4092/JSRE.20.56	35	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122969	10.1371/journal.pone.0122969	http://dx.doi.org/10.1371/journal.pone.0122969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874558	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100122
J	Ciesielska, A; Sharma, N; Beyer, J; Forsayeth, J; Bankiewicz, K				Ciesielska, Agnieszka; Sharma, Nitasha; Beyer, Janine; Forsayeth, John; Bankiewicz, Krystof			Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; PARKINSONS-DISEASE; L-DOPA; AAV-HAADC; LEVODOPA; STRIATUM; PLASMA; METABOLISM; PRIMATES; MONKEYS	Progressively blunted response to L-DOPA in Parkinson's disease (PD) is a critical factor that complicates long-term pharmacotherapy in view of the central importance of this drug in management of the PD-related motor disturbance. This phenomenon is likely due to progressive loss of one of the key enzymes involved in the biosynthetic pathway for dopamine in the basal ganglia: aromatic L-amino acid decarboxylase (AADC). We have developed a gene therapy based on an adeno-associated virus encoding human AADC (AAV2-hAADC) infused into the Parkinsonian striatum. Although no adverse clinical effects of the AAV2-hAADC gene therapy have been observed so far, the ability to more precisely regulate transgene expression or transgene product activity could be an important long-term safety feature. The present study was designed to define pharmacological regulation of the functional activity of AAV2-hAADC transgene product by manipulating L-DOPA and carbidopa (AADC inhibitor) administration in hemi-parkinsonian rats. Thirty days after unilateral striatal infusion of AAV2-hAADC, animals displayed circling behavior and acceleration of dopamine metabolism in the lesioned striatum after administration of a low dose of L-DOPA (5 mg/kg) co-administered with 1.25 mg/kg of carbidopa. This phenomenon was not observed in control AAV2-GFP-treated rats. Withdrawal of carbidopa from a daily L-DOPA regimen decreased the peripheral L-DOPA pool, resulting in almost total loss of L-DOPA-induced behavioral response in AAV2-hAADC rats and a significant decline in striatal dopamine turnover. The serum L-DOPA level correlated with the magnitude of circling behavior in AAV2-hAADC rats. Additionally, AADC activity in homogenates of lesioned striata transduced by AAV2-AADC was 10-fold higher when compared with AAV2-GFP-treated control striata, confirming functional transduction. Our data suggests that the pharmacological regulation of circulating L-DOPA might be effective in the controlling of function of AAV2-hAADC transgene product in PD gene therapy.	[Ciesielska, Agnieszka; Sharma, Nitasha; Beyer, Janine; Forsayeth, John; Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bankiewicz, K (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	Krystof.Bankiewicz@ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073940] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS073940] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGID Y, 1989, MOVEMENT DISORD, V4, pS126, DOI 10.1002/mds.870040514; Bankiewicz KS, 2006, EXP NEUROL, V197, P363, DOI 10.1016/j.expneurol.2005.10.022; Bankiewicz KS, MOL THER, V14, P564; CHASE TN, 1993, ADV NEUROL, V60, P181; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Ciesielska A, 2013, MOL THER, V21, P158, DOI 10.1038/mt.2012.167; DeJesus OT, 1997, J NUCL MED, V38, P630; Deleu D, 2002, CLIN PHARMACOKINET, V41, P261, DOI 10.2165/00003088-200241040-00003; Doudet DJ, 1999, J CEREBR BLOOD F MET, V19, P278, DOI 10.1097/00004647-199903000-00006; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; ELLENBERG JH, 1991, NEUROLOGY, V41, P14, DOI 10.1212/WNL.41.5_Suppl_2.14; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; GANCHER ST, 1987, NEUROLOGY, V37, P940, DOI 10.1212/WNL.37.6.940; HEFTI F, 1981, J PHARMACOL EXP THER, V217, P189; Hornykiewicz O, 1966, PHARMACOL REV, V18, P925; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Jonkers N, 2001, J NEURAL TRANSM, V108, P559, DOI 10.1007/s007020170056; Jordan S, 1997, BRAIN RES, V750, P264, DOI 10.1016/S0006-8993(96)01366-2; Manfredi G, 2011, METHODS MOL BIOL, Vxv, P1; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; NAGATSU T, 1979, ANAL BIOCHEM, V100, P160, DOI 10.1016/0003-2697(79)90126-X; Okereke CS, 2002, J PHARM PHARM SCI, V5, P146; Paxinos G., 2004, J CHEM INF MODEL, V5th; PEPPE A, 1995, NEUROLOGY, V45, P1144, DOI 10.1212/WNL.45.6.1144; Pilling JB, 1975, J NEUROL NEUROSUR PS, V38, P135; Rainero I, 1988, ITAL J NEUROL SCI, P225; ROSE S, 1988, MOVEMENT DISORD, V3, P117, DOI 10.1002/mds.870030203; ROSSOR MN, 1980, J NEUROL SCI, V46, P385, DOI 10.1016/0022-510X(80)90063-5; Sanchez-Pernaute R, 2001, MOL THER, V4, P324, DOI 10.1006/mthe.2001.0466; SCARR E, 1994, NEUROCHEM RES, V19, P153, DOI 10.1007/BF00966810; Tayarani-Binazir KA, 2010, EUR J PHARMACOL, V635, P109, DOI 10.1016/j.ejphar.2010.03.006; TOLOSA ES, 1975, NEUROLOGY, V25, P177, DOI 10.1212/WNL.25.2.177; Westerink BHC, 2000, J CHROMATOGR B, V747, P21, DOI 10.1016/S0378-4347(00)00338-8	33	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122708	10.1371/journal.pone.0122708	http://dx.doi.org/10.1371/journal.pone.0122708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860990	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300058
J	Bermejo-Nogales, A; Calduch-Giner, JA; Perez-Sanchez, J				Bermejo-Nogales, Azucena; Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume			Unraveling the Molecular Signatures of Oxidative Phosphorylation to Cope with the Nutritionally Changing Metabolic Capabilities of Liver and Muscle Tissues in Farmed Fish	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; GENE-EXPRESSION PROFILE; SPARUS-AURATA L.; MITOCHONDRIAL-FUNCTION; NUTRIENT AVAILABILITY; ASSEMBLY FACTORS; PROTEIN COMPLEX; ATP SYNTHASE; NUCLEAR; EVOLUTION	Mitochondrial oxidative phosphorylation provides over 90% of the energy produced by aerobic organisms, therefore the regulation of mitochondrial activity is a major issue for coping with the changing environment and energy needs. In fish, there is a large body of evidence of adaptive changes in enzymatic activities of the OXPHOS pathway, but less is known at the transcriptional level and the first aim of the present study was to define the molecular identity of the actively transcribed subunits of the mitochondrial respiratory chain of a livestock animal, using gilthead sea bream as a model of farmed fish with a high added value for European aquaculture. Extensive BLAST searches in our transcriptomic database (www.nutrigroup-iats.org/seabreamdb) yielded 97 new sequences with a high coverage of catalytic, regulatory and assembly factors of Complex I to V. This was the basis for the development of a PCR array for the simultaneous profiling of 88 selected genes. This new genomic resource allowed the differential gene expression of liver and muscle tissues in a model of 10 fasting days. A consistent down-regulated response involving 72 genes was made by the liver, whereas an up-regulated response with 29 and 10 differentially expressed genes was found in white skeletal muscle and heart, respectively. This differential regulation was mostly mediated by nuclear-encoded genes (skeletal muscle) or both mitochondrial-and nuclear-encoded genes (liver, heart), which is indicative of a complex and differential regulation of mitochondrial and nuclear genomes, according to the changes in the lipogenic activity of liver and the oxidative capacity of glycolytic and highly oxidative muscle tissues. These insights contribute to the identification of the most responsive elements of OXPHOS in each tissue, which is of relevance for the appropriate gene targeting of nutritional and/or environmental metabolic disturbances in livestock animals.	[Bermejo-Nogales, Azucena; Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume] Inst Aquaculture Torre de la Sal CSIC IATS, Nutrigen & Fish Growth Endocrinol Grp, Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Perez-Sanchez, J (corresponding author), Inst Aquaculture Torre de la Sal CSIC IATS, Nutrigen & Fish Growth Endocrinol Grp, Ribera De Cabanes, Castellon, Spain.	jaime.perez.sanchez@csic.es	Sánchez, Jaume Pérez/AAJ-6628-2021; sanchez, jaume perez/K-3231-2014; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Bermejo-Nogales, Azucena/K-7855-2014	Sánchez, Jaume Pérez/0000-0003-2506-1523; sanchez, jaume perez/0000-0003-2506-1523; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Bermejo-Nogales, Azucena/0000-0002-7163-7338	EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7) [262336]; Generalitat Valenciana [PROMETEOII/2014/085]; Spanish Government through AQUAGENOMICS (Ingenio Programme)	EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Government through AQUAGENOMICS (Ingenio Programme)	This work was funded by the EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7/2007/2013; grant agreement No. 262336; www.aquaexcel.eu) project. Additional funding was received by Generalitat Valenciana (PROMETEOII/2014/085; www.iats.csic.es/nisaam) and from the Spanish Government through AQUAGENOMICS (Ingenio-2010 Programme; www.aquagenomics.es) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Anttila K, 2010, J COMP PHYSIOL B, V180, P707, DOI 10.1007/s00360-010-0446-1; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Barbour JA, 2014, INT J CELL BIOL; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Benedito-Palos L, 2014, GENE, V547, P34, DOI 10.1016/j.gene.2014.05.073; Bermejo-Nogales A, 2008, COMP BIOCHEM PHYS B, V149, P428, DOI 10.1016/j.cbpb.2007.11.003; Bermejo-Nogales A, 2014, GEN COMP ENDOCR, V205, P305, DOI 10.1016/j.ygcen.2014.04.016; Bermejo-Nogales A, 2014, FISH PHYSIOL BIOCHEM, V40, P751, DOI 10.1007/s10695-013-9882-7; Bermejo-Nogales A, 2011, COMP BIOCHEM PHYS A, V159, P296, DOI 10.1016/j.cbpa.2011.03.024; Bremer K, 2011, J EXP BIOL, V214, P1888, DOI 10.1242/jeb.053330; Calduch-Giner JA, 2014, MAR BIOTECHNOL, V16, P423, DOI 10.1007/s10126-014-9562-3; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Coulibaly I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-203; da Costa N, 2004, J NUTR, V134, P2191, DOI 10.1093/jn/134.9.2191; Davies R, 2012, PHYSIOL BIOCHEM ZOOL, V85, P321, DOI 10.1086/666058; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Everett MV, 2012, J EXP ZOOL PART A, V317A, P9, DOI 10.1002/jez.717; Eya JC, 2012, COMP BIOCHEM PHYS B, V163, P211, DOI 10.1016/j.cbpb.2012.05.019; Eya JC, 2011, AQUACULTURE, V321, P71, DOI 10.1016/j.aquaculture.2011.08.037; Frick NT, 2010, AM J PHYSIOL-REG I, V298, pR608, DOI 10.1152/ajpregu.90815.2008; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Lam SH, 2013, BBA-GEN SUBJECTS, V1830, P4778, DOI 10.1016/j.bbagen.2013.06.008; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; LINDER D, 1995, COMP BIOCHEM PHYS B, V112, P461, DOI 10.1016/0305-0491(95)00093-3; Little AG, 2010, PHYSIOL GENOMICS, V42, P76, DOI 10.1152/physiolgenomics.00015.2010; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Miller KM, 2009, COMP BIOCHEM PHYS D, V4, P75, DOI 10.1016/j.cbd.2008.11.002; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; O'Dowd C, 2009, RADIAT RES, V171, P464, DOI 10.1667/RR1484.1; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Orczewska JI, 2010, AM J PHYSIOL-REG I, V299, pR352, DOI 10.1152/ajpregu.00189.2010; Parsons WJ, 1996, AM J PHYSIOL-HEART C, V270, pH567, DOI 10.1152/ajpheart.1996.270.2.H567; Perez-Sanchez J, 2013, COMP BIOCHEM PHYS D, V8, P123, DOI 10.1016/j.cbd.2013.02.001; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pujolar JM, 2013, AQUAT TOXICOL, V132, P157, DOI 10.1016/j.aquatox.2013.02.012; Pujolar JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-507; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Soares SS, 2007, AQUAT TOXICOL, V83, P1, DOI 10.1016/j.aquatox.2007.03.005; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129	63	42	42	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122889	10.1371/journal.pone.0122889	http://dx.doi.org/10.1371/journal.pone.0122889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875231	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800080
J	Chow, S; Okazaki, M; Watanabe, T; Segawa, K; Yamamoto, T; Kurogi, H; Tanaka, H; Ai, K; Kawai, M; Yamamoto, S; Mochioka, N; Manabe, R; Miyake, Y				Chow, Seinen; Okazaki, Makoto; Watanabe, Tomowo; Segawa, Kyohei; Yamamoto, Toshihiro; Kurogi, Hiroaki; Tanaka, Hideki; Ai, Ken-ichiro; Kawai, Miho; Yamamoto, Shin-ichi; Mochioka, Noritaka; Manabe, Ryotaro; Miyake, Yoichi			Light-Sensitive Vertical Migration of the Japanese Eel Anguilla japonica Revealed by Real-Time Tracking and Its Utilization for Geolocation	PLOS ONE			English	Article							FRESH-WATER EELS; EUROPEAN EEL; BLUEFIN TUNA; SWIM BLADDER; DEPTH; DIEFFENBACHII; BEHAVIOR; MATURATION; DISCOVERY; CAPTIVITY	Short-time tracking (one to eight days) of the Japanese eel (Anguilla japonica) using ultrasonic transmitter was performed in the tropical-subtropical area adjacent to the spawning area and temperate area off the Japanese Archipelago. Of 16 eels (11 wild and five farmed) used, 10 wild eels displayed clear diel vertical migration (DVM) from the beginning, while the other five farmed eels tracked for 19 to 66 hours did not. During daytime, a significantly positive correlation between migration depth and light intensity recorded on the vessel was observed in the 10 wild eels, indicating that the eels were sensitive to sunlight even at the middle to lower mesopelagic zone (500 to 800 m). During nighttime, the eel migration depth was observed to be associated with the phase, rising and setting of the moon, indicating that the eels were sensitive to moonlight at the upper mesopelagic zone (<300 m). Two of 10 wild eels were in the yellow stage but shared similar DVM with the silver stage eels. Swimbladders of three silver stage eels were punctured before releasing, but very little effect on DVM was observed. The eels very punctually initiated descent upon nautical dawn and ascent upon sunset, enabling us to determine local times for sunrise and sunset, and hence this behavior may be used for geolocating eels. In fact, estimated positions of eels based on the depth trajectory data were comparable or even better than those obtained by light-based archival tag in other fish species.	[Chow, Seinen; Okazaki, Makoto; Watanabe, Tomowo; Segawa, Kyohei] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Yamamoto, Toshihiro; Kurogi, Hiroaki] Natl Res Inst Aquaculture, Yokosuka Lab, Yokosuka, Kanagawa, Japan; [Tanaka, Hideki] Natl Res Inst Aquaculture, Nakatsuhamaura, Mie, Japan; [Ai, Ken-ichiro; Kawai, Miho] Chiba Prefectural Fisheries Res Ctr Freshwater St, Sakura, Chiba, Japan; [Yamamoto, Shin-ichi] Kagoshima Prefectural Fisheries Technol & Dev Ctr, Ibusuki, Kagoshima, Japan; [Mochioka, Noritaka] Kyushu Univ, Fukuoka 812, Japan; [Manabe, Ryotaro] Nihon Univ, Fujisawa, Kanagawa, Japan; [Miyake, Yoichi] Univ Tokyo, Kashiwa, Chiba, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Kyushu University; Nihon University; University of Tokyo	Chow, S (corresponding author), Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan.	chow@affrc.go.jp	Miyake, Yoichi/I-5796-2017	Miyake, Yoichi/0000-0003-2799-7827; Chow, Seinen/0000-0001-9552-2669	Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF); Fisheries Agency of Japan; Fisheries Research Agency (FRA)	Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Fisheries Agency of Japan; Fisheries Research Agency (FRA)	This research was financially supported by the Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF), the Fisheries Agency of Japan, and the Fisheries Research Agency (FRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Aoyama J, 1999, MAR ECOL PROG SER, V186, P265, DOI 10.3354/meps186265; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Chow S, 2010, MAR ECOL PROG SER, V402, P233, DOI 10.3354/meps08448; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; Itoh T, 2003, FISH B-NOAA, V101, P514; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; KLECKNER RC, 1980, COMP BIOCHEM PHYS A, V65, P351, DOI 10.1016/0300-9629(80)90041-9; KLECKNER RC, 1980, SCIENCE, V208, P1481, DOI 10.1126/science.7384792; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Okamura A, 2007, ENVIRON BIOL FISH, V80, P77, DOI 10.1007/s10641-006-9121-5; Pelster Bernd, 1997, P195; Reimer LW, 2003, EEL, P307; SADLER K, 1979, J FISH BIOL, V15, P499, DOI 10.1111/j.1095-8649.1979.tb03633.x; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Sebert Philippe, 2009, V30, P99; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Tesch F.-W., 1989, Aquatic Living Resources, V2, P9, DOI 10.1051/alr:1989002; TESCH F-W, 1978, Environmental Biology of Fishes, V3, P203, DOI 10.1007/BF00691944; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; VOLLESTAD LA, 1986, CAN J FISH AQUAT SCI, V43, P1909, DOI 10.1139/f86-236; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Westerberg H, 2014, MAR ECOL PROG SER, V496, P145, DOI 10.3354/meps10646; Wysujack K, 2014, J COAST CONSERV, V18, P121, DOI 10.1007/s11852-013-0274-z; Yamada Y, 2001, J FISH BIOL, V58, P804, DOI 10.1111/j.1095-8649.2001.tb00532.x	32	29	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121801	10.1371/journal.pone.0121801	http://dx.doi.org/10.1371/journal.pone.0121801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875179	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800031
J	Liu, W; Liu, JJ; Yin, DX; Zhao, XW				Liu, Wei; Liu, Jianjun; Yin, Dongxue; Zhao, Xiaowen			Influence of Ecological Factors on the Production of Active Substances in the Anti-Cancer Plant Sinopodophyllum hexandrum (Royle) TS Ying	PLOS ONE			English	Article							PODOPHYLLUM-HEXANDRUM; GENETIC DIVERSITY; SECONDARY METABOLITES; SICHUAN PROVINCE; LIGNANS; CONSERVATION; GLYCOSIDES; ETOPOSIDE; PELTATUM; LEAVES	The quality of traditional Chinese herbal medicine, which plays a very important role in the health system of China, is determined by the active substances produced by the plants. The type, content, and proportion of these substances may vary depending on ecological factors in areas where the plants are grown. Sinopodophyllum hexandrum (Royle) T.S. Ying, an endangered plant species with great medical value, was investigated in eight production locations representative of its natural geographical distribution range in China. The correlation between the contents of the active ingredients extracted from the roots and rhizomes of S. hexandrum and the ecological factors were evaluated step-by-step using a series of computational biology methodologies. The results showed that ecological factors had significant effects on the contents but not on the types of the active ingredients in eight production locations. The primary ecological factors influencing the active substances included the annual average precipitation, July mean temperature, frost-free period, sunshine duration, soil pH, soil organic matter, and rapidly available potassium in the soil. The annual average precipitation was the most important determinant factor and was significantly and negatively correlated with the active ingredient contents (P < 0.001). In contrast, organic matter was the most important limiting factor and was significantly and positively correlated with the active substances. These ecological factors caused 98.13% of the total geographical variation of the active ingredient contents. The climate factors contributed more to the active ingredient contents than did the soil factors. It was concluded that from the view of the contents of the secondary metabolites and ecological factors of each growing location, in Jingyuan, Ningxia Province, and Yongdeng, Gansu Province, conditions were favorable to the production of podophyllotoxin and lignans, whereas in Shangri-La, Yunnan Province, and Nyingchi, Tibet, conditions were favorable to the production of quercetin and kaempferol.	[Liu, Wei; Liu, Jianjun; Yin, Dongxue; Zhao, Xiaowen] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Liu, JJ (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	ljj@nwsuaf.edu.cn			Forestry Research Foundation for the Public Service Industry of China [200904004]	Forestry Research Foundation for the Public Service Industry of China	This work was supported by the program from the Forestry Research Foundation for the Public Service Industry of China (Grant numbers: 200904004; http://english.forestry.gov.cn/web/index.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2008, AFR J BIOTECHNOL, V7, P1028; Alam MA, 2009, INDIAN J BIOTECHNOL, V8, P391; AYRES DC, 1976, J CHEM SOC PERK T 1, P832, DOI 10.1039/p19760000832; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cai M, 2006, J CHROMATOGR B, V844, P301, DOI 10.1016/j.jchromb.2006.07.043; Canel C, 2001, PLANTA MED, V67, P97, DOI 10.1055/s-2001-10636; Cao GH, 1998, J NUTR, V128, P2383, DOI 10.1093/jn/128.12.2383; Carollo C, 2007, ANGIOLOGY, V58, P92, DOI 10.1177/0003319706295478; Chattopadhyay S, 2004, NAT PROD RES, V18, P51, DOI 10.1080/1057563031000122095; Chen WL, 2007, CHIN OPT LETT, V5, P706; Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), 2007, COP14 PROP, V27, P1; Dong JE, 2011, IND CROP PROD, V34, P1607, DOI 10.1016/j.indcrop.2011.06.007; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Editorial committee of Flora of China, 2011, FLORA CHINA, V19; FAY DA, 1985, J LIQ CHROMATOGR, V8, P1501, DOI 10.1080/01483918508067160; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; Garson D., PATH ANAL; Giri A, 2000, CYTOTECHNOLOGY, V34, P17, DOI 10.1023/A:1008138230896; Goel H. C., 1998, Indian Journal of Experimental Biology, V36, P583; HOLTHUIS JJM, 1988, PHARM WEEKBLAD, V10, P101, DOI 10.1007/BF01959294; Hu SL, 1998, GEOAUTHENTHIC TRADIT; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; INAMORI Y, 1986, CHEM PHARM BULL, V34, P3928; KAMIL WM, 1986, PHYTOCHEMISTRY, V25, P2093, DOI 10.1016/0031-9422(86)80072-3; Kong Y, 2010, FITOTERAPIA, V81, P367, DOI 10.1016/j.fitote.2009.11.003; KRESTA JV, 1991, CAN J CHEM ENG, V69, P35, DOI 10.1002/cjce.5450690105; Lata H, 2010, IN VITRO CELL DEV-PL, V46, P22, DOI 10.1007/s11627-009-9243-5; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Lin MC, 2008, J FOOD DRUG ANAL, V16, P29; Liu GS, 2007, WASTE MANAGE, V27, P345, DOI 10.1016/j.wasman.2006.03.010; Liu J, 2002, METEOROLOGY; Liu T. C., 1995, PANAX QUINQUEFOLIUM; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110500; Lu GH, 2005, J CHROMATOGR A, V1073, P383, DOI 10.1016/j.chroma.2004.11.080; [鲁守平 LU Shouping], 2006, [天然产物研究与开发, Natural Product R & D], V18, P1027; MACGREGOR JF, 1994, AICHE J, V40, P826, DOI 10.1002/aic.690400509; Nadeem M, 2000, BIOL CONSERV, V92, P121, DOI 10.1016/S0006-3207(99)00059-2; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; Penuelas J, 1997, J CHEM ECOL, V23, P979, DOI 10.1023/B:JOEC.0000006383.29650.d7; Piovoso M, 1992, AM CONTR C, P2359; Purohit MC, 1999, CURR SCI INDIA, V77, P1078; Reddy PB, 2008, ARCH PHARM, V341, P126, DOI 10.1002/ardp.200700116; Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011; Rickard-Bon SE, 2003, MED AROM PLANTS, V34, P181; Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592; STAHELIN HF, 1991, CANCER RES, V51, P5; Sun YJ, 2011, BIOORG MED CHEM LETT, V21, P3794, DOI 10.1016/j.bmcl.2011.04.036; Svensson B, 2003, SCAND J RHEUMATOL, V32, P83, DOI 10.1080/03009740310000085; TZENG SH, 1991, THROMB RES, V64, P91, DOI 10.1016/0049-3848(91)90208-E; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Wilson KE, 1998, PHOTOCHEM PHOTOBIOL, V67, P547, DOI 10.1111/j.1751-1097.1998.tb09092.x; Wise BM, 1996, J PROCESS CONTR, V6, P329, DOI 10.1016/0959-1524(96)00009-1; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wulff Anu, 1999, Boreal Environment Research, V4, P77; Xiao M, 2006, J INTEGR PLANT BIOL, V48, P1140, DOI 10.1111/j.1744-7909.2006.00304.x; Xiao M, 2006, BIOCHEM GENET, V44, P44, DOI 10.1007/s10528-006-9006-5; Yang LW, 2005, J CHROMATOGR A, V1070, P35, DOI 10.1016/j.chroma.2005.02.081; Yeh YL, 2004, CAN J CIVIL ENG, V31, P56, DOI 10.1139/L03-074; Yin DX, 2014, BIORESOURCE TECHNOL, V166, P373, DOI 10.1016/j.biortech.2014.05.037; Zhao CQ, 2011, CHINESE CHEM LETT, V22, P181, DOI 10.1016/j.cclet.2010.10.013; Zhao CQ, 2001, CHEM PHARM BULL, V49, P1474, DOI 10.1248/cpb.49.1474; Zhou Y, 2008, CHROMATOGRAPHIA, V68, P781, DOI 10.1365/s10337-008-0786-0; Zhu CG, 2004, DRUG EVAL, V1, P306; Zhu R.B., 2001, CHINESE J AGR METEOR, V22, P19; Zidorn C, 2001, TAXON, V50, P115, DOI 10.2307/1224515; Zobayed SMA, 2005, PLANT PHYSIOL BIOCH, V43, P977, DOI 10.1016/j.plaphy.2005.07.013	66	29	33	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122981	10.1371/journal.pone.0122981	http://dx.doi.org/10.1371/journal.pone.0122981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874701	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800085
J	Towle, EK; Enochs, IC; Langdon, C				Towle, Erica K.; Enochs, Ian C.; Langdon, Chris			Threatened Caribbean Coral Is Able to Mitigate the Adverse Effects of Ocean Acidification on Calcification by Increasing Feeding Rate	PLOS ONE			English	Article							2 SCLERACTINIAN CORALS; CO2 PARTIAL-PRESSURE; CLIMATE-CHANGE; ACROPORID CORALS; MORTALITY RISK; FATTY-ACIDS; FLORIDA; REEF; TEMPERATURE; HETEROTROPHY	Global climate change threatens coral growth and reef ecosystem health via ocean warming and ocean acidification (OA). Whereas the negative impacts of these stressors are increasingly well-documented, studies identifying pathways to resilience are still poorly understood. Heterotrophy has been shown to help corals experiencing decreases in growth due to either thermal or OA stress; however, the mechanism by which it mitigates these decreases remains unclear. This study tested the ability of coral heterotrophy to mitigate reductions in growth due to climate change stress in the critically endangered Caribbean coral Acropora cervicornis via changes in feeding rate and lipid content. Corals were either fed or unfed and exposed to elevated temperature (30 degrees C), enriched pCO(2) (800 ppm), or both (30 degrees C/800 ppm) as compared to a control (26 degrees C/390 ppm) for 8 weeks. Feeding rate and lipid content both increased in corals experiencing OA vs. present-day conditions, and were significantly correlated. Fed corals were able to maintain ambient growth rates at both elevated temperature and elevated CO2, while unfed corals experienced significant decreases in growth with respect to fed conspecifics. Our results show for the first time that a threatened coral species can buffer OA-reduced calcification by increasing feeding rates and lipid content.	[Towle, Erica K.; Enochs, Ian C.; Langdon, Chris] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Enochs, Ian C.] NOAA, AOML, Miami, FL 33149 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Towle, EK (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	etowle@rsmas.miami.edu	/AAL-3738-2021; Langdon, Chris/A-1543-2016; Enochs, Ian/B-8051-2014	Langdon, Chris/0000-0002-3043-3806; Enochs, Ian/0000-0002-8867-0361	MOTE Marine Laboratories "Protect Our Reefs" Grant [POR-2012-22]; Mohamed bin Zayed Species Conservation Fund [12054710]	MOTE Marine Laboratories "Protect Our Reefs" Grant; Mohamed bin Zayed Species Conservation Fund	This study was supported by MOTE Marine Laboratories "Protect Our Reefs" Grant (#POR-2012-22) to EKT (http://mote.org/support/protect-our-reefs) and by the Mohamed bin Zayed Species Conservation Fund (#12054710) to EKT (http://www.speciesconservation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Belanger S, 2013, BIOGEOSCIENCES, V10, P4087, DOI 10.5194/bg-10-4087-2013; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; DAVIES PS, 1989, MAR BIOL, V101, P389; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Drenkard EJ, 2013, CORAL REEFS, V32, P727, DOI 10.1007/s00338-013-1021-5; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; Edmunds PJ, 2011, LIMNOL OCEANOGR, V56, P2402, DOI 10.4319/lo.2011.56.6.2402; Enochs IC, 2014, CORAL REEFS, V33, P477, DOI 10.1007/s00338-014-1132-7; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Field CB, 2012, IPCC SUMMARY POLICYM; Gagnon AC, 2012, EARTH PLANET SC LETT, V329, P150, DOI 10.1016/j.epsl.2012.03.005; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Imbs AB, 2010, MAR ECOL PROG SER, V409, P65, DOI 10.3354/meps08622; JACKSON JBC, 1994, SCIENCE, V264, P1412, DOI 10.1126/science.264.5164.1412; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Lewis E., 1998, ORNLCDIAC105; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; McConnaughey T., 1989, ORIGIN EVOLUTION MOD, P57, DOI [10.1007/978-1-4757-6114-6_5, DOI 10.1007/978-1-4757-6114-6_5]; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tambutte E, 2012, P ROY SOC B-BIOL SCI, V279, P19, DOI 10.1098/rspb.2011.0733; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wirt KE, 2013, APPL GEOGR, V39, P118, DOI 10.1016/j.apgeog.2012.12.009	49	83	84	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123394	10.1371/journal.pone.0123394	http://dx.doi.org/10.1371/journal.pone.0123394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874963	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800096
J	Badding, MA; Schwegler-Berry, D; Park, JH; Fix, NR; Cummings, KJ; Leonard, SS				Badding, Melissa A.; Schwegler-Berry, Diane; Park, Ju-Hyeong; Fix, Natalie R.; Cummings, Kristin J.; Leonard, Stephen S.			Sintered Indium-Tin Oxide Particles Induce Pro-Inflammatory Responses In Vitro, in Part through Inflammasome Activation	PLOS ONE			English	Article							NALP3 INFLAMMASOME; PRODUCTION FACILITY; PULMONARY TOXICITY; INHALATION; IL-1-BETA; MONOCYTES; CRYSTALS; RELEASE; CYTOTOXICITY; MACROPHAGES	Indium-tin oxide (ITO) is used to make transparent conductive coatings for touch-screen and liquid crystal display electronics. As the demand for consumer electronics continues to increase, so does the concern for occupational exposures to particles containing these potentially toxic metal oxides. Indium-containing particles have been shown to be cytotoxic in cultured cells and pro-inflammatory in pulmonary animal models. In humans, pulmonary alveolar proteinosis and fibrotic interstitial lung disease have been observed in ITO facility workers. However, which ITO production materials may be the most toxic to workers and how they initiate pulmonary inflammation remain poorly understood. Here we examined four different particle samples collected from an ITO production facility for their ability to induce pro-inflammatory responses in vitro. Tin oxide, sintered ITO (SITO), and ventilation dust particles activated nuclear factor kappa B (NF kappa B) within 3 h of treatment. However, only SITO induced robust cytokine production (IL-1 beta, IL-6, TNF alpha, and IL-8) within 24 h in both RAW 264.7 mouse macrophages and BEAS-2B human bronchial epithelial cells. Our lab and others have previously demonstrated SITO-induced cytotoxicity as well. These findings suggest that SITO particles activate the NLRP3 inflammasome, which has been implicated in several immune-mediated diseases via its ability to induce IL-1 beta release and cause subsequent cell death. Inflammasome activation by SITO was confirmed, but it required the presence of endotoxin. Further, a phagocytosis assay revealed that pre-uptake of SITO or ventilation dust impaired proper macrophage phagocytosis of E. coli. Our results suggest that adverse inflammatory responses to SITO particles by both macrophage and epithelial cells may initiate and propagate indium lung disease. These findings will provide a better understanding of the molecular mechanisms behind an emerging occupational health issue.	[Badding, Melissa A.; Schwegler-Berry, Diane; Fix, Natalie R.; Leonard, Stephen S.] NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA; [Park, Ju-Hyeong; Cummings, Kristin J.] NIOSH, Div Resp Dis Studies, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Badding, MA (corresponding author), NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA.	mbadding@cdc.gov			NIOSH intramural National Occupational Research Agenda (NORA) grant	NIOSH intramural National Occupational Research Agenda (NORA) grant	This work was supported by a NIOSH intramural National Occupational Research Agenda (NORA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badding MA, 2014, J TOXICOL ENV HEAL A, V77, P1193, DOI 10.1080/15287394.2014.920757; Badding MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101310; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas R, 2011, PULM MED, V2011, DOI 10.1155/2011/105707; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chonan T, 2007, EUR RESPIR J, V29, P317, DOI 10.1183/09030936.00020306; Cummings KJ, 2013, AM J IND MED, V56, P300, DOI 10.1002/ajim.22125; Cummings KJ, 2012, CHEST, V141, P1512, DOI 10.1378/chest.11-1880; Cummings KJ, 2010, AM J RESP CRIT CARE, V181, P458, DOI 10.1164/rccm.200907-1022CR; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gilbert Y, 2010, J APPL MICROBIOL, V108, P437, DOI 10.1111/j.1365-2672.2009.04433.x; Gwinn WM, 2013, TOXICOL SCI, V135, P414, DOI 10.1093/toxsci/kft154; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamaguchi T, 2008, OCCUP ENVIRON MED, V65, P51, DOI 10.1136/oem.2006.029124; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Homma T, 2003, J OCCUP HEALTH, V45, P137, DOI 10.1539/joh.45.137; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim BC, 2002, MATER LETT, V52, P114, DOI 10.1016/S0167-577X(01)00377-9; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leonard SS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-32; Lison D, 2009, TOXICOL SCI, V108, P472, DOI 10.1093/toxsci/kfp014; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; MILTON DK, 1992, ENVIRON RES, V57, P212, DOI 10.1016/S0013-9351(05)80081-7; Miyauchi H, 2012, J OCCUP HEALTH, V54, P103, DOI 10.1539/joh.11-0233-OA; Nagano K, 2011, J OCCUP HEALTH, V53, P234, DOI 10.1539/joh.10-0053-BR; Nagano K, 2011, J OCCUP HEALTH, V53, P51, DOI 10.1539/joh.L10128; Nakano M, 2009, J OCCUP HEALTH, V51, P513, DOI 10.1539/joh.L9077; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; NIOSH, 2012, US DEP HLTH HUM SERV, V2012-146; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32; Tanaka A, 2010, J OCCUP HEALTH, V52, P14, DOI 10.1539/joh.L9097; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Udawatte CP, 2001, J AM CERAM SOC, V84, P251, DOI 10.1111/j.1151-2916.2001.tb00645.x	44	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124368	10.1371/journal.pone.0124368	http://dx.doi.org/10.1371/journal.pone.0124368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874458	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100255
J	Fink, E; Heathers, JAJ; de Rosnay, M				Fink, Elian; Heathers, James A. J.; de Rosnay, Marc			Young Children's Affective Responses to Another's Distress: Dynamic and Physiological Features	PLOS ONE			English	Article							PRO-SOCIAL BEHAVIOR; EMOTION REGULATION; INDIVIDUAL-DIFFERENCES; EMPATHY; INFANTS; ANXIETY; DIFFERENTIATION; EXPRESSIONS; STRATEGIES; EXPERIENCE	Two descriptive studies set out a new approach for exploring the dynamic features of children's affective responses (sadness and interest-worry) to another's distress. In two samples (N-study1 = 75; N-study2 = 114), Kindergarten children were shown a video-vignette depicting another child in distress and the temporal pattern of spontaneous expressions were examined across the unfolding vignette. Results showed, in both study 1 and 2, that sadness and interest-worry had distinct patterns of elicitation across the events of the vignette narrative and there was little co-occurrence of these affects within a given child. Temporal heart rate changes (study 2) were closely aligned to the events of the vignette and, furthermore, affective responses corresponded to distinctive physiological response profiles. The implications of distinct temporal patterns of elicitation for the meaning of sadness and interest-worry are discussed within the framework of emotion regulation and empathy.	[Fink, Elian; Heathers, James A. J.; de Rosnay, Marc] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [de Rosnay, Marc] Univ Wollongong, Sch Educ, Wollongong, NSW, Australia	University of Sydney; University of Wollongong	de Rosnay, M (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	marcd@uow.edu.au	de Rosnay, Marc/T-8024-2019; Fink, Elian/ABE-4460-2021	Fink, Elian/0000-0002-0328-9685; de Rosnay, Marc/0000-0001-8333-9541; Heathers, James/0000-0002-0936-026X	Australian Research Council's Discovery Projects funding scheme [DP0881855]	Australian Research Council's Discovery Projects funding scheme(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP0881855) received by MdR. URL: http://www.arc.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou-Hadjicharalambous X, 2007, INFANT CHILD DEV, V16, P237, DOI 10.1002/icd.464; Bandstra NF, 2011, PAIN, V152, P1074, DOI 10.1016/j.pain.2011.01.024; Brooker RJ, 2010, DEV PSYCHOBIOL, V52, P372, DOI 10.1002/dev.20432; CACIOPPO JT, 1978, BIOL PSYCHOL, V6, P181, DOI 10.1016/0301-0511(78)90020-0; CAMPOS JJ, 1975, DEV PSYCHOL, V11, P589, DOI 10.1037/0012-1649.11.5.589; Cole PM, 2004, CHILD DEV, V75, P317, DOI 10.1111/j.1467-8624.2004.00673.x; Cole PM, 1996, J ABNORM PSYCHOL, V105, P518, DOI 10.1037/0021-843X.105.4.518; Conradt E, 2010, INFANT BEHAV DEV, V33, P251, DOI 10.1016/j.infbeh.2010.01.001; Dadds MR, 2009, J CHILD PSYCHOL PSYC, V50, P599, DOI 10.1111/j.1469-7610.2008.02058.x; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Dennis TA, 2009, EMOTION, V9, P520, DOI 10.1037/a0016514; Diener ML, 1999, INFANT BEHAV DEV, V22, P569, DOI 10.1016/S0163-6383(00)00012-6; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; EISENBERG N, 1988, DEV PSYCHOL, V24, P237, DOI 10.1037/0012-1649.24.2.237; EISENBERG N, 1988, PERS SOC PSYCHOL B, V14, P298, DOI 10.1177/0146167288142008; EISENBERG N, 1995, COGNITION EMOTION, V9, P203, DOI 10.1080/02699939508409009; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Eisenberg N., 2000, HDB EMOTIONS, P677; Eisenberg N, 1992, REV PERSONALITY SOCI, P119; Eisenberg N., 2009, SOCIAL NEUROSCIENCE; Ekman P., 2002, FACIAL ACTION CODING; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; FABES RA, 1994, CHILD DEV, V65, P1678, DOI 10.2307/1131287; FABES RA, 1990, DEV PSYCHOL, V26, P639, DOI 10.1037/0012-1649.26.4.639; Fink E, 2012, EMOTION ELICITATION; Goldsmith H. H., 1999, LAB TEMPERAMENT ASSE; Grolnick WS, 1996, CHILD DEV, V67, P928, DOI 10.1111/j.1467-8624.1996.tb01774.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gurthrie IK, 1997, MOTIV EMOTION, V21, P87, DOI 10.1023/A:1024478415317; Hastings PD, 2014, CONTRIB HUM DEV, V26, P13, DOI 10.1159/000354347; Hastings PD, 2009, J CHILD PSYCHOL PSYC, V50, P1348, DOI 10.1111/j.1469-7610.2009.02159.x; Hastings PD, 2000, DEV PSYCHOL, V36, P531, DOI [10.1037/0012-1649.36.5.531, 10.1037//0012-1649.36.5.531]; Heathers JAJ, 2014, DEV PSYCHOBIOLOGY; Hemenover SH, 2003, J PERS SOC PSYCHOL, V85, P121, DOI 10.1037/0022-3514.85.1.121; Hepach R, 2013, DEV PSYCHOL, V49, P1132, DOI 10.1037/a0029501; Izard C. E., 1979, MAXIMALLY DISCRIMINA; Kuppens P, 2009, COGNITION EMOTION, V23, P1249, DOI 10.1080/02699930902985605; Larson CL, 2007, EMOTION, V7, P182, DOI 10.1037/1528-3542.7.1.182; Marsh P, 2008, PSYCHOPHYSIOLOGY, V45, P100, DOI 10.1111/j.1469-8986.2007.00603.x; Mauss IB, 2004, COGNITION EMOTION, V18, P631, DOI 10.1080/02699930341000112; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Miller JG, 2013, BIOL PSYCHOL, V92, P417, DOI 10.1016/j.biopsycho.2012.12.005; Noldus, 2008, OBSERVER PROFESSIONA; Pfeifer JH, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P183; Selvaraj N., 2008, Journal of Medical Engineering & Technology, V32, P479, DOI 10.1080/03091900701781317; Sethi A, 2000, DEV PSYCHOL, V36, P767, DOI 10.1037//0012-1649.36.6.767; Strayer J, 1997, INT J BEHAV DEV, V20, P627, DOI 10.1080/016502597385090; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Thought Technology, 2005, BIOGR PROC 2, V2; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; WATERS E, 1975, CHILD DEV, V46, P348, DOI 10.2307/1128127; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325	52	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121735	10.1371/journal.pone.0121735	http://dx.doi.org/10.1371/journal.pone.0121735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874952	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100047
J	Kawata, K; Iwai, A; Muramatsu, D; Aoki, S; Uchiyama, H; Okabe, M; Hayakawa, S; Takaoka, A; Miyazaki, T				Kawata, Koji; Iwai, Atsushi; Muramatsu, Daisuke; Aoki, Shiho; Uchiyama, Hirofumi; Okabe, Mitsuyasu; Hayakawa, Sumio; Takaoka, Akinori; Miyazaki, Tadaaki			Stimulation of Macrophages with the beta-Glucan Produced by Aureobasidium pullulans Promotes the Secretion of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE ACTIVATION; CELL-DEATH; RECEPTOR; DECTIN-1; MICE; TRANSCRIPTION; ANTITUMOR; STRAIN; FAMILY	A beta-glucan produced by Aureobasidium pullulans (AP-PG) is consisting of a beta-(1,3)-linked main chain with beta-(1,6)-linked glucose side residues. Various beta-glucans consisting of beta-(1,3)-linked main chain including AP-PG are believed to exhibit anti-tumor activities, and actually, anti-tumor activities of AP-PG in mice have been demonstrated. In this study, we demonstrate that stimulation with AP-PG induces TRAIL expression in mouse and human macrophage-like cell lines. TRAIL is known to be a cytokine which specifically induces apoptosis in transformed cells, but not in untransformed cells. The expression of TRAIL mRNA after stimulation with AP-PG was increased in RAW264.7 cells, Mono Mac 6 cells, and macrophage-differentiated THP-1 cells. The mRNA expression of TNF-alpha and FasL is only weakly increased after stimulation with AP-PG. The induction activity of TRAIL by curdlan, a bacterial beta-glucan, was very similar to that by AP-PG in RAW264.7 cells, but weaker in macrophage-differentiated THP-1 cells. Activation of caspases was found in HeLa cells after treatment with the supernatant of cultured medium from AP-PG-stimulated Mono Mac 6 cells, and was inhibited by the anti-TRAIL neutralizing antibody. These findings suggest that the stimulation with AP-PG effectively induces TRAIL in macrophages, and that it may be related to apoptosis induction of tumor cells.	[Kawata, Koji; Iwai, Atsushi; Muramatsu, Daisuke; Aoki, Shiho] Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan; [Kawata, Koji; Iwai, Atsushi] Aureo Co Ltd, Kimitsu, Chiba, Japan; [Hayakawa, Sumio; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Iwai, A (corresponding author), Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan.	iwai-atsushi@aureo.co.jp	Iwai, Atsushi/I-6469-2019	Iwai, Atsushi/0000-0002-1491-4693	Aureo Co., Ltd.; Aureo-Science Co., Ltd.	Aureo Co., Ltd.; Aureo-Science Co., Ltd.	This study was funded by by Aureo Co., Ltd., and Aureo-Science Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Alberts B, 2008, MOL BIOL CELL TXB; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; CHIHARA G, 1970, CANCER RES, V30, P2776; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Cretney E, 2005, IMMUNOL CELL BIOL, V83, P511, DOI 10.1111/j.1440-1711.2005.01358.x; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Hamada N, 2000, BIOSCI BIOTECH BIOCH, V64, P1801, DOI 10.1271/bbb.64.1801; HASHIMOTO K, 1991, INT J IMMUNOPHARMACO, V13, P437, DOI 10.1016/0192-0561(91)90014-X; KATAOKASHIRASUGI N, 1994, BIOSCI BIOTECH BIOCH, V58, P2145, DOI 10.1271/bbb.58.2145; Kimura Y, 2007, INT IMMUNOPHARMACOL, V7, P963, DOI 10.1016/j.intimp.2007.03.003; Kimura Y, 2006, ANTICANCER RES, V26, P4131; Kumar S, 1999, CELL DEATH DIFFER, V6, P1060, DOI 10.1038/sj.cdd.4400600; Li H, 2012, J NEUROIMMUNOL; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; MASHIBA H, 1979, GANN, V70, P687; Moriya N, 2013, BIOTECHNOL BIOPROC E, V18, P1083, DOI 10.1007/s12257-013-0516-9; Muramatsu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041399; Novak M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P67; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; OHHASHI F, 1978, GANN, V69, P255; Ozment TR, 2012, J PHARMACOL EXP THER, V342, P808, DOI 10.1124/jpet.112.196329; RALPH P, 1977, J IMMUNOL, V119, P950; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; SAKURAI T, 1992, INT J IMMUNOPHARMACO, V14, P821, DOI 10.1016/0192-0561(92)90080-5; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Su ZY, 2012, BIOCHEM BIOPH RES CO, V417, P777, DOI 10.1016/j.bbrc.2011.12.034; Tada R, 2011, BIOCHEM BIOPH RES CO, V404, P1105, DOI 10.1016/j.bbrc.2010.12.125; Tada R, 2008, GLYCOCONJUGATE J, V25, P851, DOI 10.1007/s10719-008-9147-3; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xia Y, 1999, J IMMUNOL, V162, P7285; YAMAMOTO T, 1981, Invasion and Metastasis, V1, P71; Yatawara L, 2009, KOREAN J PARASITOL, V47, P345, DOI 10.3347/kjp.2009.47.4.345; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	50	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124809	10.1371/journal.pone.0124809	http://dx.doi.org/10.1371/journal.pone.0124809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875639	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100274
J	Kleinberg, B; Verschuere, B				Kleinberg, Bennett; Verschuere, Bruno			Memory Detection 2.0: The First Web-Based Memory Detection Test	PLOS ONE			English	Article							GUILTY KNOWLEDGE TEST; CONCEALED INFORMATION; SKIN-CONDUCTANCE; MECHANICAL TURK; DATA-COLLECTION; TIME MEASURES; VALIDITY; PSYCHOLOGY; PROBE	There is accumulating evidence that reaction times (RTs) can be used to detect recognition of critical (e.g., crime) information. A limitation of this research base is its reliance upon small samples (average n = 24), and indications of publication bias. To advance RT-based memory detection, we report upon the development of the first web-based memory detection test. Participants in this research (Study1: n = 255; Study2: n = 262) tried to hide 2 high salient (birthday, country of origin) and 2 low salient (favourite colour, favourite animal) autobiographical details. RTs allowed to detect concealed autobiographical information, and this, as predicted, more successfully so than error rates, and for high salient than for low salient items. While much remains to be learned, memory detection 2.0 seems to offer an interesting new platform to efficiently and validly conduct RT-based memory detection research.	[Kleinberg, Bennett; Verschuere, Bruno] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Verschuere, Bruno] Univ Ghent, Dept Psychol, B-9000 Ghent, Belgium; [Verschuere, Bruno] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands	University of Amsterdam; Ghent University; Maastricht University	Verschuere, B (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	b.j.verschuere@uva.nl		VERSCHUERE, BRUNO/0000-0002-6161-4415; Kleinberg, Bennett/0000-0003-1658-9086				Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carmel D, 2003, J EXP PSYCHOL-APPL, V9, P261, DOI 10.1037/1076-898X.9.4.261; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dindo L, 2008, PSYCHOPHYSIOLOGY, V45, P111, DOI 10.1111/j.1469-8986.2007.00604.x; Gamer M, 2010, INT J PSYCHOPHYSIOL, V76, P19, DOI 10.1016/j.ijpsycho.2010.01.009; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Houben K, 2008, BEHAV RES METHODS, V40, P1134, DOI 10.3758/BRM.40.4.1134; Hu XQ, 2013, ACTA PSYCHOL, V142, P278, DOI 10.1016/j.actpsy.2012.12.006; Ipeirotis P, CEDER1001 NEW YORK U; Jokinen A, 2006, INT J PSYCHOPHYSIOL, V62, P175, DOI 10.1016/j.ijpsycho.2006.04.004; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; LIEBLICH I, 1976, J APPL PSYCHOL, V61, P89, DOI 10.1037/0021-9010.61.1.89; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Marszalek JM, 2011, PERCEPT MOTOR SKILL, V112, P331, DOI 10.2466/03.11.PMS.112.2.331-348; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Meijer, 2011, MEMORY DETECTION THE, P293, DOI DOI 10.1007/S10484-014-9244-Y; Meijer EH, 2014, PSYCHOPHYSIOLOGY, V51, P879, DOI 10.1111/psyp.12239; Meijer EH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00068; Nahari G, 2011, PSYCHOPHYSIOLOGY, V48, P733, DOI 10.1111/j.1469-8986.2010.01148.x; Noordraven E, 2013, APPL COGNITIVE PSYCH, V27, P328, DOI 10.1002/acp.2910; Osugi A., 2011, MEMORY DETECTION THE, P253, DOI DOI 10.1017/CBO9780511975196.015; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reimers S, 2015, BEHAV RES METHODS, V47, P309, DOI 10.3758/s13428-014-0471-1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Seymour TL, 2000, J APPL PSYCHOL, V85, P30, DOI 10.1037/0021-9010.85.1.30; Seymour TL, 2008, APPL COGNITIVE PSYCH, V22, P475, DOI 10.1002/acp.1375; Seymour TL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00614; Seymour TL, 2009, APPL PSYCHOPHYS BIOF, V34, P177, DOI 10.1007/s10484-009-9092-3; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Suchotzki K, 2014, METAANALYSIS UNPUB; Suchotzki K, 2013, ACTA PSYCHOL, V144, P224, DOI 10.1016/j.actpsy.2013.06.014; Verschuere B, 2011, MEMORY DETECTION THE, P128, DOI [10.1017/CBO9780511975196.008, DOI 10.1017/CBO9780511975196.008, 10.1017/CBO9780511975196.004]; Verschuere B, 2010, APPL COGNITIVE PSYCH, V23, P1, DOI DOI 10.1002/ACP.1601; Verschuere B., 2014, DECEPTION DETECTION; Verschuere B, 2007, BIOL PSYCHOL, V74, P309, DOI 10.1016/j.biopsycho.2006.08.002; Verschuere B, 2015, J APPL RES MEM COGN, V4, P59, DOI 10.1016/j.jarmac.2015.01.001; Verschuere B, 2014, EUR PSYCHOL, V19, P162, DOI 10.1027/1016-9040/a000194; Visu-Petra G., 2011, INTERDISCIPLINARY J, V14, P19, DOI [DOI 10.1002/ACP.1827, 10.1002/acp.1827]; Visu-Petra G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00146; Visu-Petra G, 2012, APPL COGNITIVE PSYCH, V26, P342, DOI 10.1002/acp.1827; Vrij A, 2012, J APPL RES MEM COGN, V1, P110, DOI 10.1016/j.jarmac.2012.02.004; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	54	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118715	10.1371/journal.pone.0118715	http://dx.doi.org/10.1371/journal.pone.0118715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874966	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100010
J	Lovisa, F; Cozza, G; Cristiani, A; Cuzzolin, A; Albiero, A; Mussolin, L; Pillon, M; Moro, S; Basso, G; Rosolen, A; Bonvini, P				Lovisa, Federica; Cozza, Giorgio; Cristiani, Andrea; Cuzzolin, Alberto; Albiero, Alessandro; Mussolin, Lara; Pillon, Marta; Moro, Stefano; Basso, Giuseppe; Rosolen, Angelo; Bonvini, Paolo			ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							IMATINIB-BASED THERAPY; ACTIVATING MUTATIONS; LUNG-CANCER; DIFFERENTIAL SENSITIVITY; CONFER RESISTANCE; CHRONIC PHASE; CRIZOTINIB; NEUROBLASTOMA; EXPRESSION; MUTANTS	ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymphoma (ALCL) and the opportunity to include ALK inhibitors in first-line therapies is oncoming. However, recent studies suggest that crizotinib-resistance mutations may emerge in ALCL patients. In the present study, we analyzed ALK kinase domain mutational status of 36 paediatric ALCL patients at diagnosis to identify point mutations and gene aberrations that could impact on NPM-ALK gene expression, activity and sensitivity to small-molecule inhibitors. Amplicon ultra-deep sequencing of ALK kinase domain detected 2 single point mutations, R335Q and R291Q, in 2 cases, 2 common deletions of exon 23 and 25 in all the patients, and 7 splicing-related INDELs in a variable number of them. The functional impact of missense mutations and INDELs was evaluated. Point mutations were shown to affect protein kinase activity, signalling output and drug sensitivity. INDELs, instead, generated kinase-dead variants with dominant negative effect on NPM-ALK kinase, in virtue of their capacity of forming non-functional heterocomplexes. Consistently, when co-expressed, INDELs increased crizotinib inhibitory activity on NPM-ALK signal processing, as demonstrated by the significant reduction of STAT3 phosphorylation. Functional changes in ALK kinase activity induced by both point mutations and structural rearrangements were resolved by molecular modelling and dynamic simulation analysis, providing novel insights into ALK kinase domain folding and regulation. Therefore, these data suggest that NPM-ALK pre-therapeutic mutations may be found at low frequency in ALCL patients. These mutations occur randomly within the ALK kinase domain and affect protein activity, while preserving responsiveness to crizotinib.	[Lovisa, Federica; Mussolin, Lara; Pillon, Marta; Basso, Giuseppe; Rosolen, Angelo; Bonvini, Paolo] Univ Padua, Azienda Osped, Clin Oncoematol Pediat Padova, Padua, Italy; [Cozza, Giorgio] Univ Padua, Dipartimento Sci Biomed, Padua, Italy; [Cristiani, Andrea; Cuzzolin, Alberto; Moro, Stefano] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy; [Albiero, Alessandro] Univ Padua, CRIBI, Padua, Italy; [Mussolin, Lara; Bonvini, Paolo] Ist Ric Pediat Citta Speranza, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; University of Padua; Fondazione Citta della Speranza	Lovisa, F (corresponding author), Univ Padua, Azienda Osped, Clin Oncoematol Pediat Padova, Padua, Italy.	federica.lovisa@gmail.com	Pillon, Marta/AAB-9581-2022; MUSSOLIN, LARA/AAA-1931-2019; Moro, Stefano/A-2979-2012; Bonvini, Paolo/J-9877-2018	Pillon, Marta/0000-0002-1190-3198; MUSSOLIN, LARA/0000-0003-4802-1866; Moro, Stefano/0000-0002-7514-3802; Bonvini, Paolo/0000-0003-2889-108X; COZZA, GIORGIO/0000-0002-5155-4682; LOVISA, FEDERICA/0000-0001-9570-6150; BASSO, GIUSEPPE/0000-0002-2634-9302	"Associazione Italiana Leucemie Treviso", Italy; "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy; "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy; University of Padua, Italy; Italian Ministry for University and Research (MIUR), Rome, Italy	"Associazione Italiana Leucemie Treviso", Italy; "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy; "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy; University of Padua, Italy; Italian Ministry for University and Research (MIUR), Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by "Associazione Italiana Leucemie Treviso", Italy (fellowship to FL), "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy, and "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy. The molecular modelling work has been carried out with financial support of the University of Padua, Italy, and the Italian Ministry for University and Research (MIUR), Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Bonvini P, 2004, CANCER RES, V64, P3256, DOI 10.1158/0008-5472.CAN-03-3531; Bonvini P, 2012, LEUKEMIA, V26, P1375, DOI 10.1038/leu.2011.367; Boutterin MC, 2013, CELL SIGNAL, V25, P1505, DOI 10.1016/j.cellsig.2013.02.020; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Carella AM, 2010, LEUKEMIA LYMPHOMA, V51, P275, DOI 10.3109/10428190903503446; Ceccon M, 2013, MOL CANCER RES, V11, P122, DOI 10.1158/1541-7786.MCR-12-0569; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Chung KP, 2012, CLIN CANCER RES, V18, P3470, DOI 10.1158/1078-0432.CCR-11-2353; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; Epstein LF, 2012, J BIOL CHEM, V287, P37447, DOI 10.1074/jbc.M112.391425; Ferreri AJM, 2012, CRIT REV ONCOL HEMAT, V83, P293, DOI 10.1016/j.critrevonc.2012.02.005; Fleuren EDG, 2013, INT J CANCER, V133, P427, DOI 10.1002/ijc.28047; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; He M, 2012, CLIN CANCER RES, V18, P1790, DOI 10.1158/1078-0432.CCR-11-2361; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; La Madrid AM, 2012, TARGET ONCOL, V7, P199, DOI 10.1007/s11523-012-0227-8; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; MURPHY SB, 1989, J CLIN ONCOL, V7, P186, DOI 10.1200/JCO.1989.7.2.186; Mussolin L, 2005, LEUKEMIA, V19, P1643, DOI 10.1038/sj.leu.2403888; Mussolin L, 2013, LEUKEMIA, V27, P416, DOI 10.1038/leu.2012.205; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Passerini CG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt378; Pfeifer H, 2012, LEUKEMIA, V26, P1475, DOI 10.1038/leu.2012.5; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2008, LEUKEMIA, V22, P1184, DOI 10.1038/leu.2008.65; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Soverini S, 2011, HAEMATOL-HEMATOL J, V96, P552, DOI 10.3324/haematol.2010.034173; STEIN H, 1985, BLOOD, V66, P848; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Woessmann W, 2011, J CLIN ONCOL, V29, P3065, DOI 10.1200/JCO.2011.34.8417; Zdzalik D, 2014, J CANCER RES CLIN, V140, P589, DOI 10.1007/s00432-014-1589-3; Zhang S, 2011, CHEM BIOL DRUG DES, V78, P999, DOI 10.1111/j.1747-0285.2011.01239.x	52	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121378	10.1371/journal.pone.0121378	http://dx.doi.org/10.1371/journal.pone.0121378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874976	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100040
J	Morton, SU; Joshi, M; Savic, T; Beggs, AH; Agrawal, PB				Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.			Skeletal Muscle MicroRNA and Messenger RNA Profiling in Cofilin-2 Deficient Mice Reveals Cell Cycle Dysregulation Hindering Muscle Regeneration	PLOS ONE			English	Article							CONGENITAL MYOPATHIES; NEMALINE MYOPATHY; UP-REGULATION; P21; PROLIFERATION; MYOGENESIS; ARREST; GENE; CHOLESTEROL; APOPTOSIS	Congenital myopathies are rare skeletal muscle diseases presenting in early age with hypotonia and weakness often linked to a genetic defect. Mutations in the gene for cofilin-2 (CFL2) have been identified in several families as a cause of congenital myopathy with nemaline bodies and cores. Here we explore the global messenger and microRNA expression patterns in quadriceps muscle samples from cofillin-2-null mice and compare them with sibling-matched wild-type mice to determine the molecular pathways and mechanisms involved. Cell cycle processes are markedly dysregulated, with altered expression of genes involved in mitotic spindle formation, and evidence of loss of cell cycle checkpoint regulation. Importantly, alterations in cell cycle, apoptosis and proliferation pathways are present in both mRNA and miRNA expression patterns. Specifically, p21 transcript levels were increased, and the expression of p21 targets, such as cyclin D and cyclin E, was decreased. We therefore hypothesize that deficiency of cofilin-2 is associated with interruption of the cell cycle at several checkpoints, hindering muscle regeneration. Identification of these pathways is an important step towards developing appropriate therapies against various congenital myopathies.	[Morton, Sarah U.; Joshi, Mugdha; Agrawal, Pankaj B.] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Harvard Univ, Sch Med, Boston, MA USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Boston Childrens Hosp, Dept Med, Div Genet & Genom, Boston, MA USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Agrawal, PB (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	pagrawal@enders.tch.harvard.edu	Agrawal, Pankaj/ABG-8957-2021	Beggs, Alan/0000-0001-8818-0568; Hitt, Talia/0000-0003-4491-3648; Morton, Sarah/0000-0002-7816-2646	National Institutes of Health [T32 HD 007466]; National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH [K08 AR055072]; NIH [R01 AR044345, R01 HD075802, P30 HD018655]; Muscular Dystrophy Association of USA [MDA201302]; AUism Charitable Foundation; A Foundation Building Strength; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466, R01HD075802, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345, K08AR055072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association of USA(Muscular Dystrophy Association); AUism Charitable Foundation; A Foundation Building Strength; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	SUM is supported via an National Institutes of Health T32 HD 007466 and PBA supported by K08 AR055072 from the National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH. This work was also supported by NIH R01 AR044345 and R01 HD075802, the Muscular Dystrophy Association of USA (MDA201302), and generous gifts and grants from the AUism Charitable Foundation and A Foundation Building Strength (AHB). Microarray studies were performed by the IDDRC Molecular Genetics Core Facility at Boston Children's Hospital, supported by NIH P30 HD018655.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Briolay A, 2013, BBA-BIOMEMBRANES, V1828, P602, DOI 10.1016/j.bbamem.2012.10.006; Endesfelder S, 2005, J MOL MED, V83, P64, DOI 10.1007/s00109-004-0607-3; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Hawke TJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1019, DOI 10.1152/ajpcell.00055.2003; Kass EM, 2009, CELL CYCLE, V8, P430, DOI 10.4161/cc.8.3.7624; Kwon B, 2014, HUM MOL GENET, V23, P3681, DOI 10.1093/hmg/ddu077; Li J, 2014, STEM CELLS; Loro E, 2010, CELL DEATH DIFFER, V17, P1315, DOI 10.1038/cdd.2010.33; Moll UM, 2003, MOL CANCER RES, V1, P1001; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; Ockeloen CW, 2012, NEUROMUSCULAR DISORD, V22, P632, DOI 10.1016/j.nmd.2012.03.008; Ong RW, 2014, J NEUROL NEUROSURG P; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; Riechman SE, 2007, J GERONTOL A-BIOL, V62, P1164, DOI 10.1093/gerona/62.10.1164; Sakellariou A, 2011, IEEE T INF TECHNOL B, V15, P349, DOI 10.1109/TITB.2011.2130531; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Sanoudou D, 2004, PHYSIOL GENOMICS, V16, P222, DOI 10.1152/physiolgenomics.00137.2003; Sharma MC, 2009, ACTA NEUROL SCAND, V119, P281, DOI 10.1111/j.1600-0404.2008.01126.x; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Vandamme D, 2009, CELL MOTIL CYTOSKEL, V66, P179, DOI 10.1002/cm.20340; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wattanasirichaigoon D, 2002, NEUROLOGY, V59, P613, DOI 10.1212/WNL.59.4.613; Weise C, 2006, ANAT EMBRYOL, V211, P639, DOI 10.1007/s00429-006-0117-x; Xu HL, 2014, BIOCHEM BIOPH RES CO, V446, P235, DOI 10.1016/j.bbrc.2014.02.105; Yamauchi J, 2013, HUM MOL GENET, V22, P4306, DOI 10.1093/hmg/ddt280; Zhu B, 2014, INT J CANCER, V135, P785, DOI 10.1002/ijc.28721	35	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123829	10.1371/journal.pone.0123829	http://dx.doi.org/10.1371/journal.pone.0123829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874796	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100216
J	Stanley, ML; Simpson, SL; Dagenbach, D; Lyday, RG; Burdette, JH; Laurienti, PJ				Stanley, Matthew L.; Simpson, Sean L.; Dagenbach, Dale; Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.			Changes in Brain Network Efficiency and Working Memory Performance in Aging	PLOS ONE			English	Article							RESTING-STATE NETWORKS; AGE-RELATED-CHANGES; MINI-MENTAL STATE; FUNCTIONAL CONNECTIVITY; DECISION-MAKING; ADULT AGE; ACCURACY; MODEL; ARCHITECTURE; ATTENTION	Working memory is a complex psychological construct referring to the temporary storage and active processing of information. We used functional connectivity brain network metrics quantifying local and global efficiency of information transfer for predicting individual variability in working memory performance on an n- back task in both young (n = 14) and older (n = 15) adults. Individual differences in both local and global efficiency during the working memory task were significant predictors of working memory performance in addition to age (and an interaction between age and global efficiency). Decreases in local efficiency during the working memory task were associated with better working memory performance in both age cohorts. In contrast, increases in global efficiency were associated with much better working performance for young participants; however, increases in global efficiency were associated with a slight decrease in working memory performance for older participants. Individual differences in local and global efficiency during resting-state sessions were not significant predictors of working memory performance. Significant group whole-brain functional network decreases in local efficiency also were observed during the working memory task compared to rest, whereas no significant differences were observed in network global efficiency. These results are discussed in relation to recently developed models of age-related differences in working memory.	[Stanley, Matthew L.; Simpson, Sean L.; Dagenbach, Dale; Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27157 USA; [Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Dagenbach, Dale] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Stanley, ML (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27157 USA.	stanleymattl9@gmail.com			Wake Forest Older Americans Independence Center [P3021332]; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; NIBIB [K25 EB012236-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	Wake Forest Older Americans Independence Center; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by the Wake Forest Older Americans Independence Center (P3021332), the Sticht Center on Aging at Wake Forest School of Medicine, and the Translational Science Center at Wake Forest University. Sean Simpson was supported by NIBIB K25 EB012236-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Botwinick J, 1973, AGING AND BEHAVIOR A; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brinley JF, 1965, BEHAV AGING NERVOUS, P114; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Gilbert B, 2005, NEUROPSYCHOLOGY, V19, P106, DOI 10.1037/0894-4105.19.1.106; Grossman M, 2002, NEUROIMAGE, V15, P302, DOI 10.1006/nimg.2001.0971; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Haatveit BC, 2010, J CLIN EXP NEUROPSYC, V32, P871, DOI 10.1080/13803391003596421; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ishihara S, 1917, TESTS FOR COLOR BLIN; Jolles DD, 2011, DEVELOPMENTAL SCI, V14, P713, DOI 10.1111/j.1467-7687.2010.01016.x; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Macmillan NA, 1997, SPATIAL VISION, V11, P141; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Meunier D, 2014, NEUROIMAGE, V95, P264, DOI 10.1016/j.neuroimage.2014.03.041; Moussa MN, 2014, BRAIN CONNECT, V4, P193, DOI 10.1089/brain.2013.0184; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Pessoa L, 2012, BEHAV BRAIN SCI, V35, P158, DOI 10.1017/S0140525X11001567; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PRADHAN SN, 1980, LIFE SCI, V26, P1643, DOI 10.1016/0024-3205(80)90172-1; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ratcliff R, 2007, PSYCHOL AGING, V22, P56, DOI 10.1037/0882-7974.22.1.56; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rzucidlo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070275; Sala-Llonch R, 2014, NEUROBIOL AGING, V35, P2193, DOI 10.1016/j.neurobiolaging.2014.04.007; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; SALTHOUSE TA, 1979, ERGONOMICS, V22, P811, DOI 10.1080/00140137908924659; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schneider W, 2001, E PRIME USERS GUIDE, DOI [10.3758/s13428-012-0302-1, DOI 10.3758/S13428-012-0302-1]; SMITH GA, 1985, BRIT J PSYCHOL, V76, P199, DOI 10.1111/j.2044-8295.1985.tb01943.x; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stanley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00954; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Stopford CL, 2007, CORTEX, V43, P846, DOI 10.1016/S0010-9452(08)70684-1; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; SWETS JA, 1961, PSYCHOL REV, V68, P301, DOI 10.1037/0033-295X.68.5.301; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Telesford QK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00067; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055347	96	58	58	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123950	10.1371/journal.pone.0123950	http://dx.doi.org/10.1371/journal.pone.0123950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875001	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100226
J	Vanlieferinghen, S; Anselem, O; Le Ray, C; Shen, Y; Marcellin, L; Goffinet, F				Vanlieferinghen, Sarah; Anselem, Olivia; Le Ray, Camille; Shen, Yao; Marcellin, Louis; Goffinet, Francois			Prognostic Value of Umbilical and Cerebral Doppler in Fetal Growth Restriction: Comparison of Dichorionic Twins and Singletons	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREGNANCIES; ULTRASOUND	Objective To compare the prognostic value of fetal Doppler in dichorionic twins and singletons by measuring the interval between diagnosis of an abnormal Doppler flow and birth in fetuses who are small for gestational age (SGA). Design Comparative retrospective study using a prospectively collected database. Setting A level 3 maternity unit in France. Population Fetuses from singleton and dichorionic pregnancies who are SGA (vascular or unexplained), defined by an abdominal circumference (AC) measurement below the 10th percentile and confirmed by a birth weight below the 10th percentile. Methods Fisher's exact and Chi-2 tests were used to compare frequencies, and the Mann-Whitney-Wilcoxon test was used to compare medians in non-Gaussian distributions. Main outcome measures Both neonatal outcomes and intervals between the first Doppler abnormality and birth were compared in the groups of dichorionic twins and singletons. Results Obstetric and neonatal outcome were similar in the 104 SGA dichorionic twins and 170 SGA singletons. Abnormalities of umbilical artery Doppler, regardless of type, appeared at the same frequency in both groups (52.9%) but were identified earlier in twins (25 versus 28 weeks, p = 0.02). Among fetuses with abnormal Doppler flow, the interval between the finding and birth was significantly longer in the twins than the singletons (44 vs 15 days, p<0.01). Conclusions The prognostic value of an abnormal Doppler finding for the course of a pregnancy may be different in dichorionic twins and singletons. The management of women carrying SGA twins and the information provided to them should take these results into account.	[Vanlieferinghen, Sarah; Anselem, Olivia; Le Ray, Camille; Shen, Yao; Marcellin, Louis; Goffinet, Francois] Cochin Broca Hotel Dieu Hosp, AP HP, Dept Obstet & Gynaecol, F-75014 Paris, France; [Anselem, Olivia; Le Ray, Camille; Marcellin, Louis; Goffinet, Francois] PremUP Fdn Sci Cooperat Connect Pregnancy & Prema, F-75014 Paris, France; [Le Ray, Camille; Goffinet, Francois] Sorbonne Paris Cite CRESS, Res Ctr Epidemiol & Biostat, Obstetr Perinatal & Pediat Epidemiol Res Team EPO, French Inst Hlth & Med Res INSERM Unit 1153, Paris, France; [Vanlieferinghen, Sarah; Anselem, Olivia; Le Ray, Camille; Shen, Yao; Marcellin, Louis; Goffinet, Francois] Univ Hosp Dept DHU Risks Pregnancy, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Goffinet, F (corresponding author), Cochin Broca Hotel Dieu Hosp, AP HP, Dept Obstet & Gynaecol, 53 Ave Observ, F-75014 Paris, France.	francois.goffinet@cch.aphp.fr	Marcellin, Louis/O-8787-2017; louis, marcellin/V-4728-2019	louis, marcellin/0000-0003-4482-9710; GOFFINET, Francois/0000-0001-9643-0299; Le Ray, Camille/0000-0003-0891-1063				Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub3; Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P125, DOI 10.1111/j.1471-0528.1994.tb13077.x; Corsello G, 2010, J MATERN-FETAL NEO M, V23, P59, DOI 10.3109/14767058.2010.508218; Crequat J, 2000, Gynecol Obstet Fertil, V28, P435; Cynober E, 1999, REV PRATICIEN GYNECO, V30, P18; Ego A, 2013, J GYNECOL OBST BIO R, V42, P872, DOI 10.1016/j.jgyn.2013.09.012; French College of Gynecologists and Obstetricians (CNGOF), 2013, J GYNECOL OBST BIO R, V42, P1018, DOI [10.1016/j.jgyn.2013.09.023PMID: 24216306, DOI 10.1016/J.JGYN.2013.09.023]; Giles W, 2003, BJOG-INT J OBSTET GY, V110, P593, DOI 10.1016/S1470-0328(03)02966-5; Giles WB, 1998, BAILLIERE CLIN OB GY, V12, P77, DOI 10.1016/S0950-3552(98)80041-2; JOHNSTONE FD, 1993, BRIT J OBSTET GYNAEC, V100, P733, DOI 10.1111/j.1471-0528.1993.tb14264.x; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Martin A, 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 1, pS34, DOI 10.1016/j.jgyn.2007.11.009; NEWNHAM JP, 1991, BRIT J OBSTET GYNAEC, V98, P956, DOI 10.1111/j.1471-0528.1991.tb15332.x; Societe francaise d'anesthesie et de reanimation (Sfar); College national des gynecologues et obstetriciens francais (CNGOF); Societe francaise de medecine perinatale (SFMP); Societe francaise de neonatalogie (SFNN), 2009, ANN FR ANESTH, V28, P275, DOI [10.1016/j.annfar.2009.02.015, DOI 10.1016/J.ANNFAR.2009.02.015]; Vayssiere C, 2011, EUR J OBSTET GYN R B, V156, P12, DOI 10.1016/j.ejogrb.2010.12.045; Victoria A, 2001, OBSTET GYNECOL, V97, P310, DOI 10.1016/S0029-7844(00)01111-X	17	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123067	10.1371/journal.pone.0123067	http://dx.doi.org/10.1371/journal.pone.0123067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875366	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100130
J	Long, YH; Ye, H				Long, Yan-Hua; Ye, Hong			Filled Pause Refinement Based on the Pronunciation Probability for Lecture Speech	PLOS ONE			English	Article							DISFLUENCIES; ERROR	Nowadays, although automatic speech recognition has become quite proficient in recognizing or transcribing well-prepared fluent speech, the transcription of speech that contains many disfluencies remains problematic, such as spontaneous conversational and lecture speech. Filled pauses (FPs) are the most frequently occurring disfluencies in this type of speech. Most recent studies have shown that FPs are widely believed to increase the error rates for state-of-the-art speech transcription, primarily because most FPs are not well annotated or provided in training data transcriptions and because of the similarities in acoustic characteristics between FPs and some common non-content words. To enhance the speech transcription system, we propose a new automatic refinement approach to detect FPs in British English lecture speech transcription. This approach combines the pronunciation probabilities for each word in the dictionary and acoustic language model scores for FP refinement through a modified speech recognition forced-alignment framework. We evaluate the proposed approach on the Reith Lectures speech transcription task, in which only imperfect training transcriptions are available. Successful results are achieved for both the development and evaluation datasets. Acoustic models trained on different styles of speech genres have been investigated with respect to FP refinement. To further validate the effectiveness of the proposed approach, speech transcription performance has also been examined using systems built on training data transcriptions with and without FP refinement.	[Long, Yan-Hua; Ye, Hong] Shanghai Normal Univ, Elect & Informat Engn Dept, Shanghai, Peoples R China	Shanghai Normal University	Long, YH (corresponding author), Shanghai Normal Univ, Elect & Informat Engn Dept, Shanghai, Peoples R China.	yanhua@shnu.edu.cn			Shanghai Science and Technology Development Funds [14YF1409300]; Research Foundation of Young Teachers Program in University of Shanghai [ZZshsf14026]; Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences [2010JDXM024]	Shanghai Science and Technology Development Funds; Research Foundation of Young Teachers Program in University of Shanghai; Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences	This work was partially funded by the Shanghai Science and Technology Development Funds (Grant No. 14YF1409300), the Research Foundation of Young Teachers Program in University of Shanghai (Grant No. ZZshsf14026) and the Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences (Grant No. 2010JDXM024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell J, 2012, SPEECH COMMUN, V54, P459, DOI 10.1016/j.specom.2011.10.010; An GZ, 2013, INTERSPEECH, P178; Audhkhasi K, 2009, INT CONF ACOUST SPEE, P4857, DOI 10.1109/ICASSP.2009.4960719; Bell PJ, 2012, IEEE W SP LANG TECH, P324, DOI 10.1109/SLT.2012.6424244; Benus S., 2012, P 3 IEEE C COGN INF; Bisani M, 2008, SPEECH COMMUN, V50, P434, DOI 10.1016/j.specom.2008.01.002; Braunschweiler N, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2222; Corley M, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00068.x; Dall R, 2014, INTERSPEECH, P51; Dufour R, 2014, SPEECH COMMUN, V56, P1, DOI 10.1016/j.specom.2013.07.007; Fraundorf SH, 2011, J MEM LANG, V65, P161, DOI 10.1016/j.jml.2011.03.004; Georgila Kallirroi, 2009, P HUM LANG TECHN 200, P109; Godfrey J.J., 1997, SWITCHBOARD 1 RELEAS; Goldwater S, 2010, SPEECH COMMUN, V52, P181, DOI 10.1016/j.specom.2009.10.001; Jonathan F, 1998, 1997 ENGLISH BROADCA; KNESER R, 1995, INT CONF ACOUST SPEE, P181, DOI 10.1109/ICASSP.1995.479394; Kumar N., 1997, THESIS J HOPKINS U; Lafferty J, 2001, CONDITIONAL RANDOM F, P282; Lease M, 2006, IEEE T AUDIO SPEECH, V14, P1566, DOI 10.1109/TASL.2006.878269; Long Y, 2013, INTERSPEECH, P2186; Martin A., 1997, P EUR C SPEECH COMM; Medeiros H, 2013, INTERSPEECH, P2628; Moniz H, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P1959; Povey D, 2002, INT CONF ACOUST SPEE, P105; Robinson A., 1996, BRIT ENGLISH EXAMPLE; Shriberg E., 2005, INTERSPEECH 2005, P1781; Shriberg E, 1999, INT C PHON SCI SAN F, P612; Shriberg E, 1996, P INT C SPOK LANG PR, V96, P3; Tranter SE, 2004, P 2004 RICH TRANSCR; Wang D, 2004, P IEEE INT C AC SPEE, pI; Wang W, 2013, HLT NAACL, P703; Young S., 2009, HTK BOOK; Zwarts S, 2011, P 49 ANN M ASS COMP, V1, P703	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123466	10.1371/journal.pone.0123466	http://dx.doi.org/10.1371/journal.pone.0123466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860959	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300100
J	Gil, A; Rodriguez-Escudero, I; Stumpf, M; Molina, M; Cid, VJ; Pulido, R				Gil, Anabel; Rodriguez-Escudero, Isabel; Stumpf, Miriam; Molina, Maria; Cid, Victor J.; Pulido, Rafael			A Functional Dissection of PTEN N-Terminus: Implications in PTEN Subcellular Targeting and Tumor Suppressor Activity	PLOS ONE			English	Article							NUCLEAR PTEN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE ASSOCIATION; PHOSPHATASE-ACTIVITY; BINDING MOTIF; PROTEIN; CANCER; LOCALIZATION; ACTIVATION; CELLS	Spatial regulation of the tumor suppressor PTEN is exerted through alternative plasma membrane, cytoplasmic, and nuclear subcellular locations. The N-terminal region of PTEN is important for the control of PTEN subcellular localization and function. It contains both an active nuclear localization signal (NLS) and an overlapping PIP2-binding motif (PBM) involved in plasma membrane targeting. We report a comprehensive mutational and functional analysis of the PTEN N-terminus, including a panel of tumor-related mutations at this region. Nuclear/cytoplasmic partitioning in mammalian cells and PIP3 phosphatase assays in reconstituted S. cerevisiae defined categories of PTEN N-terminal mutations with distinct PIP3 phosphatase and nuclear accumulation properties. Noticeably, most tumor-related mutations that lost PIP3 phosphatase activity also displayed impaired nuclear localization. Cell proliferation and soft-agar colony formation analysis in mammalian cells of mutations with distinctive nuclear accumulation and catalytic activity patterns suggested a contribution of both properties to PTEN tumor suppressor activity. Our functional dissection of the PTEN N-terminus provides the basis for a systematic analysis of tumor-related and experimentally engineered PTEN mutations.	[Gil, Anabel; Stumpf, Miriam] Ctr Invest Principe Felipe, Valencia, Spain; [Rodriguez-Escudero, Isabel; Molina, Maria; Cid, Victor J.] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Gil, Anabel; Stumpf, Miriam] Inst Ramon & Cajal Invest Sanitarias IRYCIS, Madrid, Spain; [Stumpf, Miriam] Hubrecht Inst, Utrecht, Netherlands; [Pulido, Rafael] BioCruces Hlth Res Inst, Baracaldo, Spain; [Pulido, Rafael] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Prince Felipe Research Center; Complutense University of Madrid; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Basque Foundation for Science	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	vicjcid@ucm.es; rpulidomurillo@gmail.com	Molina, Maria/ABE-7186-2021; Rodríguez, Isabel/I-5955-2017; JIMENEZ CID, VICTOR/ABC-4858-2021; CID, VICTOR JIMENEZ/I-1240-2015	Molina, Maria/0000-0003-0074-3309; Rodríguez, Isabel/0000-0002-1792-1143; JIMENEZ CID, VICTOR/0000-0002-3933-2016; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Pulido, Rafael/0000-0001-9100-248X	Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional) [SAF2009-10226]; Ministerio de Economia y Competitividad (Spain) [SAF2013-48812-R]; Ministerio de Ciencia e Innovacion (Spain) [BIO2010-22369-C02-01]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Instituto de Salud Carlos III (Spain) [CP04/00318]	Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	This work was supported in part by grants SAF2009-10226 from Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional), SAF2013-48812-R from Ministerio de Economia y Competitividad (Spain), BIO2010-22369-C02-01 from Ministerio de Ciencia e Innovacion (Spain), and S2011/BMD-2414 from Comunidad Autonoma de Madrid (Spain). A. Gil has been the recipient of CP04/00318 research contract from Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Pons A, 2005, CANCER LETT, V223, P303, DOI 10.1016/j.canlet.2004.09.047; Andres-Pons A, 2007, CANCER RES, V67, P9731, DOI 10.1158/0008-5472.CAN-07-1278; Andres-Pons A, 2012, CELL SIGNAL, V24, P577, DOI 10.1016/j.cellsig.2011.10.012; Bartholomeusz C, 2012, EXPERT OPIN THER TAR, V16, P121, DOI 10.1517/14728222.2011.644788; Bassi C, 2013, CELL DEATH DIFFER, V20, P1595, DOI 10.1038/cdd.2013.127; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Cid VJ, 2008, ONCOGENE, V27, P5431, DOI 10.1038/onc.2008.240; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Fan C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-98; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Mester J, 2013, AM J MED GENET C, V163C, P114, DOI 10.1002/ajmg.c.31364; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Redfern RE, 2010, PROTEIN SCI, V19, P1948, DOI 10.1002/pro.483; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rodriguez-Escudero I, 2015, METHODS, V77-78, P172, DOI 10.1016/j.ymeth.2014.10.020; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119287	10.1371/journal.pone.0119287	http://dx.doi.org/10.1371/journal.pone.0119287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875300	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000353015800004
J	Hausler, AN; Becker, B; Bartling, M; Weber, B				Haeusler, Alexander Niklas; Becker, Benjamin; Bartling, Marcel; Weber, Bernd			Goal or Gold: Overlapping Reward Processes in Soccer Players upon Scoring and Winning Money	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; POSTERIOR CINGULATE; PREDICTION ERRORS; PREFRONTAL CORTEX; DISSOCIATION; MEMORY; RESPONSES; MEDIATE	Social rewards are important incentives for human behavior. This is especially true in team sports such as the most popular one worldwide: soccer. We investigated reward processing upon scoring a soccer goal in a standard two-versus-one situation and in comparison to winning in a monetary incentive task. The results show a strong overlap in brain activity between the two conditions in established reward regions of the mesolimbic dopaminergic system, including the ventral striatum and ventromedial pre-frontal cortex. The three main components of reward-associated learning i.e. reward probability (RP), reward reception (RR) and reward prediction errors (RPE) showed highly similar activation in both con-texts, with only the RR and RPE components displaying overlapping reward activity. Passing and shooting behavior did not correlate with individual egoism scores, but we observe a positive correlation be-tween egoism and activity in the left middle frontal gyrus upon scoring after a pass versus a direct shot. Our findings suggest that rewards in the context of soccer and monetary incentives are based on similar neural processes.	[Haeusler, Alexander Niklas; Weber, Bernd] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Haeusler, Alexander Niklas; Weber, Bernd] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany; [Haeusler, Alexander Niklas; Bartling, Marcel; Weber, Bernd] Life & Brain Res Ctr, Dept NeuroCognit Imaging, Bonn, Germany; [Becker, Benjamin] Univ Bonn, Dept Psychiat, Bonn, Germany; [Becker, Benjamin] Univ Bonn, Div Med Psychol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Hausler, AN (corresponding author), Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany.	anh@uni-bonn.de	Weber, Bernd/H-5244-2012; Becker, Benjamin/W-4971-2017	Weber, Bernd/0000-0002-7811-9605; Becker, Benjamin/0000-0002-9014-9671; Hausler, Dr. Alexander Niklas/0000-0003-3506-7566	Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [WE 4427(3-1)]	Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG))	BW was supported by a Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)), WE 4427(3-1), http://www.dfg.de/en/research_funding/programmes/individual/heisenberg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Ashton M.C., 2013, INDIVIDUAL DIFFERENC; Ashton MC, 2005, J PERS, V73, P1321, DOI 10.1111/j.1467-6494.2005.00351.x; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Baumgartner T, 2014, SOC COGN AFFECT NEUR, V9, P653, DOI 10.1093/scan/nst023; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Brosch T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00398; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; de Vries RE, 2009, EUR J PERSONALITY, V23, P635, DOI 10.1002/per.733; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Erdeniz B, 2013, FRONTIERS NEUROSCIEN, V7, P1, DOI [10.3389/fnins.2013.00001, DOI 10.3389/FNINS.2013.00001]; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Fliessbach K, 2010, NEUROIMAGE, V50, P1168, DOI 10.1016/j.neuroimage.2010.01.036; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Harris LT, 2007, COGN AFFECT BEHAV NE, V7, P309, DOI 10.3758/CABN.7.4.309; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kohls G, 2013, NEUROPSYCHOLOGIA, V51, P2062, DOI 10.1016/j.neuropsychologia.2013.07.020; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; Lallement JH, 2014, SOC COGN AFFECT NEUR, V9, P342, DOI 10.1093/scan/nss147; Lee K, 2012, H FACTOR OF PERSONALITY: WHY SOME PEOPLE ARE MANIPULATIVE, SELF-ENTITLED, MATERIALISTIC, AND EXPLOITIVE - AND WHY IT MATTERS FOR EVERYONE, P1; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McLean J, 2009, PSYCHIAT RES-NEUROIM, V171, P33, DOI 10.1016/j.pscychresns.2008.02.005; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Prohovnik I, 2004, PSYCHIAT RES-NEUROIM, V132, P239, DOI 10.1016/j.pscychresns.2004.03.005; Race EA, 2010, CEREB CORTEX, V20, P1726, DOI 10.1093/cercor/bhp233; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Rohe T, 2012, EUR J NEUROSCI, V36, P2376, DOI 10.1111/j.1460-9568.2012.08125.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Simon D, 2014, NEUROIMAGE, V99, P1, DOI 10.1016/j.neuroimage.2014.05.071; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Strang S, 2015, SOC COGN AFFECT NEUR, V10, P790, DOI 10.1093/scan/nsu114; Strang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087654; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733	54	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122798	10.1371/journal.pone.0122798	http://dx.doi.org/10.1371/journal.pone.0122798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875594	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800075
J	Liu, G; Huang, TZ; Liu, J; Lv, XG				Liu, Gang; Huang, Ting-Zhu; Liu, Jun; Lv, Xiao-Guang			Total Variation with Overlapping Group Sparsity for Image Deblurring under Impulse Noise	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; AUGMENTED LAGRANGIAN METHOD; PRIMAL-DUAL METHOD; SPLITTING METHOD; RESTORATION; ALGORITHM; MULTIPLIERS; MODELS	The total variation (TV) regularization method is an effective method for image deblurring in preserving edges. However, the TV based solutions usually have some staircase effects. In order to alleviate the staircase effects, we propose a new model for restoring blurred images under impulse noise. The model consists of an l(1)-fidelity term and a TV with overlapping group sparsity (OGS) regularization term. Moreover, we impose a box constraint to the proposed model for getting more accurate solutions. The solving algorithm for our model is under the framework of the alternating direction method of multipliers (ADMM). We use an inner loop which is nested inside the majorization minimization (MM) iteration for the sub-problem of the proposed method. Compared with other TV-based methods, numerical results illustrate that the proposed method can significantly improve the restoration quality, both in terms of peak signal-to-noise ratio (PSNR) and relative error (ReE).	[Liu, Gang; Huang, Ting-Zhu; Liu, Jun] Univ Elect Sci & Technol China, Res Ctr Image & Vis Comp, Sch Math Sci, Chengdu 610054, Sichuan, Peoples R China; [Lv, Xiao-Guang] Huaihai Inst Technol, Sch Sci, Lianyungang, Jiangsu, Peoples R China	University of Electronic Science & Technology of China; Jiangsu Ocean University	Huang, TZ (corresponding author), Univ Elect Sci & Technol China, Res Ctr Image & Vis Comp, Sch Math Sci, Chengdu 610054, Sichuan, Peoples R China.	tingzhuhuang@126.com			China 973 Program [2013CB329404]; NSFC [61370147, 61170311, 61401172]; Sichuan Province Sci. and Tech. Research Project [2012GZX0080]; Nature Science Foundation of Jiangsu Province [BK20131209]	China 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Sichuan Province Sci. and Tech. Research Project; Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The work of GL, TZH and JL is supported by China 973 Program (2013CB329404), NSFC (61370147, 61170311), Sichuan Province Sci. and Tech. Research Project (2012GZX0080). The work of XGL is supported by Nature Science Foundation of Jiangsu Province (BK20131209), NSFC (61401172).	Afonso MV, 2011, IEEE T IMAGE PROCESS, V20, P681, DOI 10.1109/TIP.2010.2076294; ALLINEY S, 1994, IEEE T SIGNAL PROCES, V42, P618, DOI 10.1109/78.277854; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; Cai JF, 2008, INVERSE PROBL IMAG, V2, P187; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Chambolle A, 1997, NUMER MATH, V76, P167, DOI 10.1007/s002110050258; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan RH, 2013, SIAM J IMAGING SCI, V6, P680, DOI 10.1137/110860185; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Chan TF, 1999, SIAM J SCI COMPUT, V20, P1964, DOI 10.1137/S1064827596299767; Chen PY, 2014, SIGNAL PROCESS, V94, P476, DOI 10.1016/j.sigpro.2013.06.011; Clason C, 2010, SIAM J SCI COMPUT, V32, P1484, DOI 10.1137/090768217; Dong YQ, 2009, SIAM J IMAGING SCI, V2, P1168, DOI 10.1137/090758490; ECKSTEIN J, 1992, MATH PROGRAM, V55, P293, DOI 10.1007/BF01581204; Esser E., 2009, CAM REP, P9; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Gabay D., 1976, Computers & Mathematics with Applications, V2, P17, DOI 10.1016/0898-1221(76)90003-1; Glowinski R, 1984, NUMERICAL METHODS NO, P1434; Goldstein T., 2012, FAST ALTERNATING DIR, P12; Guo XX, 2009, SIAM J SCI COMPUT, V31, P2322, DOI 10.1137/080724435; Hansen P.C., 2006, DEBLURRING IMAGES MA; He BS, 1998, OPER RES LETT, V23, P151, DOI 10.1016/S0167-6377(98)00044-3; KARAYIANNIS NB, 1990, IEEE T ACOUST SPEECH, V38, P1155, DOI 10.1109/29.57544; Liu G, 2013, EPRINTS13126813 ARXI; Liu G, 2014, COMPUT MATH APPL, V67, P2015, DOI 10.1016/j.camwa.2014.04.008; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Peyre G, 2011, EUR SIGNAL PR CONF, P303; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Selesnick IW, 2013, INT CONF ACOUST SPEE, P5696, DOI 10.1109/ICASSP.2013.6638755; Steidl G, 2006, COMPUTING, V76, P135, DOI 10.1007/s00607-005-0129-z; Tikhonov A, 1995, NUMERICAL METHODS SO, V328; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wu CL, 2011, INVERSE PROBL IMAG, V5, P237, DOI 10.3934/ipi.2011.5.237; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yan M, 2013, SIAM J IMAGING SCI, V6, P1227, DOI 10.1137/12087178X; Yang JF, 2009, SIAM J IMAGING SCI, V2, P569, DOI 10.1137/080730421; Yang JF, 2009, SIAM J SCI COMPUT, V31, P2842, DOI 10.1137/080732894; Yin W, 2007, MULTISCALE MODEL SIM, V6, P190, DOI 10.1137/060663027	45	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122562	10.1371/journal.pone.0122562	http://dx.doi.org/10.1371/journal.pone.0122562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874860	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800065
J	Rausch, MP; Hastings, KT				Rausch, Matthew P.; Hastings, Karen Taraszka			An Exhaustion-Like Phenotype Constrains the Activity of CD4+T Cells Specific for a Self and Melanoma Antigen	PLOS ONE			English	Article							CD4(+) T-CELLS; UP-REGULATION; PD-1 PATHWAY; TOLERANCE; TYROSINASE; EXPRESSION; AUTOIMMUNITY; LYMPHOCYTES; INDUCTION; RECEPTOR	While the immune system has the capacity to recognize and destroy melanoma, tolerance mechanisms often hinder the development of effective anti-tumor immune responses. Since many melanoma antigens are self proteins expressed in normal melanocytes, self antigen exposure before tumor development can negatively impact the function of T cells specific for these self/tumor antigens. However, the contribution of self tolerance to anti-melanoma T cell dysfunction remains largely unexplored. We have previously described a TCR transgenic (Tg) mouse model in which T cells specific for the self/melanoma antigen, tyrosinase-related protein 1 (TRP1), develop in the presence of endogenous TRP1 expression (Ag+) and diminished antigen presentation due to the absence of gamma-interferoninducible lysosomal thiol reductase (GILT-/-). We show that TRP1-specific T cells from these Ag+ GILT-/-Tg mice do not protect from melanoma tumor growth, fail to induce autoimmune vitiligo, and undergo diminished proliferation compared to T cells from Ag-GILT+/+ Tg mice. Despite an increased frequency of TRP1-specific Treg cells in Ag+ GILT-/-Tg mice compared to Ag-GILT+/+ Tg animals, Treg cell depletion only partially rescues the proliferative capacity of T cells from TRP1-expressing mice, suggesting the involvement of additional suppressive mechanisms. An increased percentage of melanoma-specific T cells from Ag+ GILT-/-Tg animals express PD-1, an inhibitory receptor associated with the maintenance of T cell exhaustion. Antibody blockade of PD-1 partially improves the ability of TRP1-specific T cells from Ag+ GILT-/-Tg mice to produce IL-2. These findings demonstrate that melanoma-specific T cells exposed to a self/melanoma antigen in healthy tissue develop an exhaustion-like phenotype characterized by PD-1-mediated immunosuppression prior to encounter with tumor.	[Rausch, Matthew P.; Hastings, Karen Taraszka] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85021 USA; [Rausch, Matthew P.; Hastings, Karen Taraszka] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Hastings, Karen Taraszka] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ USA	University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Arizona	Hastings, KT (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85021 USA.	khasting@email.arizona.edu	Hastings, Karen Taraszka/AAX-9487-2020	Hastings, Karen Taraszka/0000-0003-1502-8033	National Institutes of Health [K08-AR054388, R03-AR063259, T32-CA09213]; Arizona Biomedical Research Commission; NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063259, K08AR054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Biomedical Research Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants K08-AR054388 (KTH) and R03-AR063259 (KTH) and T32-CA09213 (MPR) and a grant from the Arizona Biomedical Research Commission (KTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Kobayashi H, 1998, CANCER RES, V58, P296; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Parkhurst MR, 2004, J IMMUNOTHER, V27, P79, DOI 10.1097/00002371-200403000-00001; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rausch MP, 2012, J INVEST DERMATOL, V132, P154, DOI 10.1038/jid.2011.236; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Robbins PF, 2002, J IMMUNOL, V169, P6036, DOI 10.4049/jimmunol.169.10.6036; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Topalian SL, 1996, J EXP MED, V183, P1965, DOI 10.1084/jem.183.5.1965; Touloukian CE, 2002, CANCER RES, V62, P5144; Touloukian CE, 2000, J IMMUNOL, V164, P3535, DOI 10.4049/jimmunol.164.7.3535; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	37	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123332	10.1371/journal.pone.0123332	http://dx.doi.org/10.1371/journal.pone.0123332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875653	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800091
J	Vangansbeke, D; Audenaert, J; Nguyen, DT; Verhoeven, R; Gobin, B; Tirry, L; De Clercq, P				Vangansbeke, Dominiek; Audenaert, Joachim; Duc Tung Nguyen; Verhoeven, Ruth; Gobin, Bruno; Tirry, Luc; De Clercq, Patrick			Diurnal Temperature Variations Affect Development of a Herbivorous Arthropod Pest and its Predators	PLOS ONE			English	Article							TETRANYCHUS-URTICAE ACARI; NEOSEIULUS-CALIFORNICUS ACARI; 2-SPOTTED SPIDER-MITES; FLUCTUATING TEMPERATURES; PHYTOSEIULUS-PERSIMILIS; CONSTANT TEMPERATURES; DEPENDENT DEVELOPMENT; CLIMATE-CHANGE; HEAT-SHOCK; JENSENS INEQUALITY	The impact of daily temperature variations on arthropod life history remains woefully understudied compared to the large body of research that has been carried out on the effects of constant temperatures. However, diurnal varying temperature regimes more commonly represent the environment in which most organisms thrive. Such varying temperature regimes have been demonstrated to substantially affect development and reproduction of ectothermic organisms, generally in accordance with Jensen's inequality. In the present study we evaluated the impact of temperature alternations at 4 amplitudes (DTR0, +5, +10 and + 15 degrees C) on the developmental rate of the predatory mites Phytoseiulus persimilis Athias-Henriot and Neoseiulus californicus McGregor (Acari: Phytoseiidae) and their natural prey, the two-spotted spider mite Tetranychus urticae Koch (Acari: Tetranychidae). We have modelled their developmental rates as a function of temperature using both linear and nonlinear models. Diurnally alternating temperatures resulted in a faster development in the lower temperature range as compared to their corresponding mean constant temperatures, whereas the opposite was observed in the higher temperature range. Our results indicate that Jensen's inequality does not suffice to fully explain the differences in developmental rates at constant and alternating temperatures, suggesting additional physiological responses play a role. It is concluded that diurnal temperature range should not be ignored and should be incorporated in predictive models on the phenology of arthropod pests and their natural enemies and their performance in biological control programmes.	[Vangansbeke, Dominiek; Duc Tung Nguyen; Tirry, Luc; De Clercq, Patrick] Univ Ghent, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Audenaert, Joachim; Verhoeven, Ruth; Gobin, Bruno] PCS Ornamental Plant Res, B-9070 Destelbergen, Belgium; [Duc Tung Nguyen] Vietnam Natl Univ Agr, Dept Entomol, Hanoi, Vietnam	Ghent University; Vietnam National University of Agriculture (VNUA)	Vangansbeke, D (corresponding author), Univ Ghent, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium.	dominiek.vangansbeke@Ugent.be	De Clercq, Patrick/B-5721-2015; Nguyen, Duc Tung/P-1316-2017	De Clercq, Patrick/0000-0003-0664-1602; Nguyen, Duc Tung/0000-0002-8954-3604	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [090931]; PCS-Ornamental Plant Research	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); PCS-Ornamental Plant Research	This study was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen http://www.iwt.be/) (Project number 090931). Co-authors Joachim Audenaert, Ruth Verhoeven and Bruno Gobin are employed by PCSOrnamental Plant Research. PCS-Ornamental Plant Research provided support in the form of salaries for authors JA, RV and BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Fenollosa E, 2014, PEST MANAG SCI, V70, P853, DOI 10.1002/ps.3678; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BECK SD, 1983, J INSECT PHYSIOL, V29, P107, DOI 10.1016/0022-1910(83)90113-0; BEHRENS W, 1983, OECOLOGIA, V59, P279, DOI 10.1007/BF00378849; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Bryant SR, 1999, EUR J ENTOMOL, V96, P143; Bryon A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-815; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; DECLERCQ P, 1992, CAN ENTOMOL, V124, P125; Dieleman JA, 2005, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2005.691.3; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; EICHMEIER J, 1960, J ECON ENTOMOL, V53, P661, DOI 10.1093/jee/53.4.661; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Fantinou AA, 2003, ENVIRON ENTOMOL, V32, P1337, DOI 10.1603/0046-225X-32.6.1337; Garcia-Ruiz E, 2011, ENVIRON ENTOMOL, V40, P939, DOI 10.1603/EN11080; Gerson U, 2012, ANNU REV ENTOMOL, V57, P229, DOI 10.1146/annurev-ento-120710-100639; Gotoh T, 2014, EXP APPL ACAROL, V64, P465, DOI 10.1007/s10493-014-9841-8; Greco NM, 2005, EXP APPL ACAROL, V37, P57, DOI 10.1007/s10493-005-0067-7; HAGSTRUM DW, 1991, ANN ENTOMOL SOC AM, V84, P369, DOI 10.1093/aesa/84.4.369; HAGSTRUM DW, 1970, ANN ENTOMOL SOC AM, V63, P1385, DOI 10.1093/aesa/63.5.1385; HONEK A, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P401; Honek Alois, 1999, Entomological Science, V2, P615; Huffaker Carl B., 1944, ANN ENT SOC AMER, V37, P1, DOI 10.1093/aesa/37.1.1; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Korner O, 2003, COMPUT ELECTRON AGR, V39, P39, DOI 10.1016/S0168-1699(03)00006-1; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LEWONTIN RC, 1965, GENETICS COLONIZING; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; Logan JD, 2006, ECOL MODEL, V196, P471, DOI 10.1016/j.ecolmodel.2006.02.034; Maeda T, 2000, EXP APPL ACAROL, V24, P415, DOI 10.1023/A:1006449108245; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Messelink GJ, 2014, BIOCONTROL, V59, P377, DOI 10.1007/s10526-014-9579-6; Moerkens R, 2011, AGR FOREST ENTOMOL, V13, P301, DOI 10.1111/j.1461-9563.2011.00525.x; MORI H, 1966, CAN J ZOOLOG, V44, P483, DOI 10.1139/z66-047; Morrison WR, 2014, PEST MANAG SCI, V70, P1105, DOI 10.1002/ps.3654; MYSTER J, 1995, SCI HORTIC-AMSTERDAM, V62, P205, DOI 10.1016/0304-4238(95)00783-P; Otsuka Y, 1997, GENES GENET SYST, V72, P19, DOI 10.1266/ggs.72.19; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pedigo LP, 1998, ENTOMOLOGY PEST MANA; Ratte H.T., 1985, P33; Rhodes EM, 2006, EXP APPL ACAROL, V39, P213, DOI 10.1007/s10493-006-9005-6; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Smallwood PD, 1996, AM ZOOL, V36, P392; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; TANIGOSHI LK, 1976, ANN ENTOMOL SOC AM, V69, P712, DOI 10.1093/aesa/69.4.712; Tantau HJ, 1998, MATH COMPUT SIMULAT, V48, P93, DOI 10.1016/S0378-4754(98)00145-1; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Vangansbeke D, 2013, EXP APPL ACAROL, V61, P285, DOI 10.1007/s10493-013-9704-8; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Walzer A, 2007, BIOL CONTROL, V41, P42, DOI 10.1016/j.biocontrol.2006.11.012; Weintraub P, 2008, EXP APPL ACAROL, V45, P29, DOI 10.1007/s10493-008-9169-3; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Xu XM, 1996, PLANT PATHOL, V45, P163, DOI 10.1046/j.1365-3059.1996.d01-134.x	65	35	36	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124898	10.1371/journal.pone.0124898	http://dx.doi.org/10.1371/journal.pone.0124898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874697	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800154
J	Drumond, MA; Guimaraes, AQ; da Silva, RHP				Drumond, Maria Auxiliadora; Guimaraes, Artur Queiroz; Pereira da Silva, Raquel Hosken			The Role of Local Knowledge and Traditional Extraction Practices in the Management of Giant Earthworms in Brazil	PLOS ONE			English	Article							ECOLOGICAL KNOWLEDGE; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; INDIGENOUS KNOWLEDGE; AUTOTOMY; MAMMALS; OLIGOCHAETA; PERCEPTIONS; SCIENCE; FAUNA	The giant earthworm, Rhinodrilus alatus (Righi 1971), has been captured in the southeastern Brazilian Cerrado biome for approximately 80 years and used as bait for amateur fishing throughout Brazil. Local knowledge and traditional extraction practices are crucial for the establishment of management strategies for the species because, although its extraction involves conflicts and social and environmental impacts, the species is one of the major sources of income for approximately 3,000 people, especially for members of an Afro-descendant community that has approximately 2,000 inhabitants. Participatory tools, such as seasonal calendar, transect walks and participatory maps, were individually or collectively used with extractors and traders (former extractors), and 129 semi-structured and unstructured interviews were conducted with the same individuals between 2005 and 2012. The capture of Rhinodrilus alatus was observed in different seasons and areas of occurrence of the species in 17 municipalities, where this giant earthworm is the only species extracted for trade. All information obtained was verified by community members in 17 meetings. The extractors have an extensive knowledge of the life history, behavior, distribution, and possible impacts of climate change on the species. Different capture techniques, which have different impacts, are used during the dry and rainy seasons and are passed by the extractors through the generations. Local knowledge contributed to the establishment of agreements for the use of capture techniques that have less impact, to the expansion of scientific knowledge and the reassessment of the conservation status of Rhinodrilus alatus. The present study may serve as an example for management projects for other giant earthworm species in other regions of Brazil and in other countries.	[Drumond, Maria Auxiliadora] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Drumond, Maria Auxiliadora; Guimaraes, Artur Queiroz; Pereira da Silva, Raquel Hosken] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Drumond, MA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	alatus@ufmg.br	Drumond, Maria A/C-9582-2016	Drumond, Maria A/0000-0002-0677-6673	Instituto Estadual de Florestas de Minas Gerais; Pro-Reitoria de Pesquisa; Pro-Reitoria de Extensao of Universidade Federal de Minas Gerais; Ministerio Publico do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conservacao Internacional do Brasil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Instituto Estadual de Florestas de Minas Gerais; Pro-Reitoria de Pesquisa; Pro-Reitoria de Extensao of Universidade Federal de Minas Gerais; Ministerio Publico do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conservacao Internacional do Brasil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Instituto Estadual de Florestas de Minas Gerais (www.ief.mg.gov.br); Pro-Reitoria de Pesquisa (www.ufmg.br/prpq) and Pro-Reitoria de Extensao (www2.ufmg.br/proex) of Universidade Federal de Minas Gerais (www.ufmg.br); Ministerio Publico do Estado de Minas Gerais (www.mpmg.mp.br); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (www.fapemig.br); Conservacao Internacional do Brasil (www.conservacao.org); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvard MS, 1997, CONSERV BIOL, V11, P977, DOI 10.1046/j.1523-1739.1997.96047.x; Alvares F, 2011, INNOVATION-ABINGDON, V24, P313, DOI 10.1080/13511610.2011.592049; Alves RRN, 2011, J ETHNOBIOL ETHNOMED, V7, DOI [10.1186/1746-4269-7-9, 10.1186/1746-4269-7-22]; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI [10.1186/1746-4269-5-1, 10.1186/1746-4269-5-12]; [Anonymous], 1997, FENCES SEEKING SOCIA; Anthwal A, 2010, RESOUR CONSERV RECY, V54, P962, DOI 10.1016/j.resconrec.2010.02.003; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Balamurugan M, 2009, J ETHNOPHARMACOL, V121, P330, DOI 10.1016/j.jep.2008.10.021; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Barbraud C, 2011, J ANIM ECOL, V80, P89, DOI 10.1111/j.1365-2656.2010.01752.x; Bender MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110332; Berkes F., 1998, LINKING SOCIAL ECOLO, P1; Berkes F., 1998, LINKING SOCIAL ECOLO, P98; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bonaldo S. M., 2004, Fitopatologia Brasileira, V29, P128, DOI 10.1590/S0100-41582004000200002; Brown G.G., 2007, MINHOCAS AM LATINA B, P297; Carvalho AM, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-36; Catania KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003472; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; CHAMBERS R, 1994, WORLD DEV, V22, P1437, DOI 10.1016/0305-750X(94)90030-2; Chan KY, 2001, PEDOBIOLOGIA, V45, P272, DOI 10.1078/0031-4056-00084; CHANG YM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEQ079; Charnley S, 2007, FOREST ECOL MANAG, V246, P14, DOI 10.1016/j.foreco.2007.03.047; Cook TC, 2015, MAR POLICY, V51, P573, DOI 10.1016/j.marpol.2014.09.020; Cooper EL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164152; Cooper EL, 2004, ADV EXP MED BIOL, V546, P359; Costa Neto E. M., 2000, HUM ECOL REV, V7, P41; CPRM-Servico Geologico do Brasil, 2014, 1 CPRM; Csuzdi C, 2011, ZOOL ANZ, V250, P2, DOI 10.1016/j.jcz.2010.10.001; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; de Garine-Wichatitsky M, 2013, COMP IMMUNOL MICROB, V36, P321, DOI 10.1016/j.cimid.2012.10.007; de Souza JB, 2014, TROP CONSERV SCI, V7, P145, DOI 10.1177/194008291400700105; Diaz-Guisado D, 2006, J EXP MAR BIOL ECOL, V338, P73, DOI 10.1016/j.jembe.2006.06.037; Dominguez J, 2004, SOIL ZOOLOGY SUSTAIN, P369; Drumond MA, 2014, BRAZ J BIOL, V73, P699, DOI 10.1590/S1519-69842013000400004; Drumond M. A., 2012, BIODIVERS BRAS, V2, P134; Drumond M. A., 2009, TECNICAS FERRAMENTAS, V2; Drumond Maria Auxiliadora, 2008, MG Biota, V1, P5; EISNER T, 1983, P NATL ACAD SCI-BIOL, V80, P3382, DOI 10.1073/pnas.80.11.3382; Fernandes-Ferreira H, 2012, BIODIVERS CONSERV, V21, P221, DOI 10.1007/s10531-011-0179-9; Lopez-Arevalo HF, 2011, BIOL CONSERV, V144, P1451, DOI 10.1016/j.biocon.2011.01.014; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; GADGIL M, 1993, AMBIO, V22, P151; Gilchrist G, 2007, ECOL SOC, V12; Grech A, 2014, BIODIVERS CONSERV, V23, P3319, DOI 10.1007/s10531-014-0783-6; Hanazaki N, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-36; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Holling CS, 2009, LINKING SOCIAL ECOLO, P342; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; James SW, 2006, SOIL BIODIVERSITY IN AMAZONIAN AND OTHER BRAZILIAN ECOSYSTEMS, P56, DOI 10.1079/9781845930325.0056; Alonso-Castro AJ, 2014, J ETHNOPHARMACOL, V152, P53, DOI 10.1016/j.jep.2014.01.005; KASTER JL, 1979, T AM MICROSC SOC, V98, P473, DOI 10.2307/3225736; Lee K.N., 1999, CONSERV ECOL, V3, P3, DOI DOI 10.5751/ES-00131-030203; Lynam T, 2007, ECOL SOC, V12; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MAIORANA VC, 1977, NATURE, V265, P533, DOI 10.1038/265533a0; Mantilla J, 1996, REV FORESTAL CENTROA, V14, P15; MARENGO J. A., 2010, NOVA ACTA LEOPOLDINA, V112, P1; Maxwell J.A., 2013, QUALITATIVE RES DESI, V3rd; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Mitchell T., 2012, RESILIENCE RISK MANA; Mitra O, 2009, BIOL LETTERS, V5, P16, DOI 10.1098/rsbl.2008.0456; Mittermeier Russell A., 2004, P1; Moreno AG, 2004, CAN J ZOOL, V82, P1000, DOI 10.1139/Z04-056; Mosleh YY, 2005, ECOTOXICOLOGY, V14, P559; Newmaster AF, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-37; Alves RRN, 2012, ETHNOBIOL CONSERV, V1, DOI [10.15451/ec2012-8-1.2-1-69, 10.15451/ec2012-8-1.7-1-21, 10.15451/ec2012-8-1.1-1-03]; Alves RRN, 2012, ENVIRON MONIT ASSESS, V184, P6877, DOI 10.1007/s10661-011-2465-0; Nyberg B., 1999, INTRO GUIDE ADAPTIVE; O'Donnell KP, 2010, ANIM CONSERV, V13, P526, DOI 10.1111/j.1469-1795.2010.00377.x; Padmanaba M, 2013, ENVIRON MANAGE, V52, P348, DOI 10.1007/s00267-013-0051-7; Pahl-Wostl C., 2007, Ecology and Society, V12, P30; Paoletti MG, 2000, P ROY SOC B-BIOL SCI, V267, P2247, DOI 10.1098/rspb.2000.1275; Paoletti MG, 2003, P ROY SOC B-BIOL SCI, V270, P249, DOI 10.1098/rspb.2002.2141; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pezzuti J.C.B., 2004, JANELAS BIODIVERSIDA, P213; Pitt AL, 2012, BIODIVERS CONSERV, V21, P51, DOI 10.1007/s10531-011-0160-7; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; RAW F, 1959, NATURE, V184, P1661, DOI 10.1038/1841661a0; Reynolds J.W., 1972, American Journal of Nursing, V72, P1273; Righi G, 1998, LIVRO VERMELHO ESPEC, P579; Rocha-Mendes F, 2005, REV BRAS ZOOL, V22, P991, DOI 10.1590/S0101-81752005000400027; Russell IC, 2012, ICES J MAR SCI, V69, P1563, DOI 10.1093/icesjms/fsr208; Scarlett L, 2013, ECOL SOC, V18, DOI 10.5751/ES-05762-180326; Shanley P, 2006, ECOL SOC, V11; Sharma S., 2005, J AM SCI, V1, P4; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Steyaert P, 2007, ECOL SOC, V12; TAMPI P. R. S., 1959, JOUR MAR BIOL ASSOC INDIA, V1, P250; Turvey ST, 2014, BIOL CONSERV, V169, P189, DOI 10.1016/j.biocon.2013.11.018; Turvey ST, 2013, BIOL CONSERV, V157, P352, DOI 10.1016/j.biocon.2012.07.016; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Valsecchi Joao, 2009, Uakari, V5, P33; Verdejo ME, 2003, DIAGNOSTICO RURAL PA; Wallace A. R., 1853, VIAGENS PELOS RIOS A; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Younsi M, 2010, MEDITERR MAR SCI, V11, P185, DOI 10.12681/mms.101; ZHANG FX, 1992, SOIL BIOL BIOCHEM, V24, P1247; Ziembicki MR, 2013, BIOL CONSERV, V157, P78, DOI 10.1016/j.biocon.2012.07.004; Zuniga MC, 2013, APPL SOIL ECOL, V69, P61, DOI 10.1016/j.apsoil.2013.03.001	101	7	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123913	10.1371/journal.pone.0123913	http://dx.doi.org/10.1371/journal.pone.0123913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874618	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700052
J	Gao, DF; Hao, GH; Meng, Z; Ning, N; Yang, G; Liu, ZW; Dong, X; Niu, XL				Gao, Dengfeng; Hao, Guanghua; Meng, Zhe; Ning, Ning; Yang, Guang; Liu, Zhongwei; Dong, Xin; Niu, Xiaolin			Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; TRANSCRIPTION FACTOR; INCREASED EXPRESSION; TYPE-1 RECEPTOR; ROSIGLITAZONE; INHIBITION; PATHWAY; KRUPPEL-LIKE-FACTOR-5	Kruppel-like factor (KLF) 5, which initiates vascular smooth muscle cell (VSMC) proliferation, also participates in Angiotensin (Ang) II-induced vascular remodeling. The protective effect of rosiglitazone on vascular remodeling may be due to their impact on VSMC proliferation. However, the underlying mechanisms involved remain unclear. This study was designed to investigate whether the antiproliferation effects of rosiglitazone are mediated by regulating Ang II/KLF5 response. We found that, in aortas of Ang II-infused rats, vascular remodeling and KLF5 expression were markedly increased, and its target gene cyclin D1 was overexpressed. Co-treatment with rosiglitazone diminished these changes. In growth-arrested VSMCs, PPAR-gamma agonists (rosiglitazone and 15d-PGJ2) dose-dependently inhibited Ang II-induced cell proliferation and expression of KLF5 and cyclin D1. Moreover, these effects were attenuated by the PPAR- gamma antagonists GW9662, bisphenol A diglycidyl ether and PPAR- gamma specific siRNA. Furthermore, rosiglitazone inhibited Ang II-induced phosphorylation of protein kinase C (PKC) zeta and extracellular signal-regulated kinase (ERK) 1/2 and activation of early growth response protein (Egr). In conclusion, in Ang II-stimulated VSMCs, rosiglitazone might have an antiproliferative effect through mechanisms that include reducing KLF5 expression, and a crosstalk between PPAR-. and PKC zeta/ERK1/2/ Egr may be involved in. These findings not only provide a previously unrecognized mechanism by which PPAR- gamma agonists inhibit VSMC proliferation, but also document a novel evidence for the beneficial vascular effect of PPAR- gamma activation.	[Gao, Dengfeng; Hao, Guanghua; Meng, Zhe; Yang, Guang; Liu, Zhongwei; Dong, Xin; Niu, Xiaolin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Ning, Ning] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nucl Med, Xian 710004, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Gao, DF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China.	gaomedic@163.com			National Natural Science Foundation of China [30900617]; science and technology project of Shaanxi Province [2014k11-02-01-12]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology project of Shaanxi Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by a grant from National Natural Science Foundation of China (No. 30900617 to DG), the science and technology project of Shaanxi Province (No. 2014k11-02-01-12 to NN), and the Fundamental Research Funds for the Central Universities (to DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafford R, 2006, SURGERY, V140, P289, DOI 10.1016/j.surg.2006.04.004; Bai YP, 2007, BIOCHEM BIOPH RES CO, V360, P20, DOI 10.1016/j.bbrc.2007.05.222; Chang SJ, 2009, MOL BIOL REP, V36, P2165, DOI 10.1007/s11033-008-9430-1; de Oliveira Silva-Junior G, 2009, EXP TOXICOL PATHOL; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gao DF, 2007, BIOCHEM PHARMACOL, V73, P185, DOI 10.1016/j.bcp.2006.09.019; Gao DF, 2006, BIOL PHARM BULL, V29, P2004, DOI 10.1248/bpb.29.2004; Gizard F, 2008, PPAR RES, V2008, DOI 10.1155/2008/429123; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; HAN EKH, 1995, CARCINOGENESIS, V16, P2423, DOI 10.1093/carcin/16.10.2423; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Iglarz M, 2003, ARTERIOSCL THROM VAS, V23, P45, DOI 10.1161/01.ATV.0000047447.67827.CD; Isenovic ER, 2010, ANGIOLOGY, V61, P357, DOI 10.1177/0003319709358693; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Kim JS, 2012, CELL BIOL INT, V36, P305, DOI 10.1042/CBI20100524; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Li Jingjue, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P109; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Lombardi A, 2008, ARTERIOSCL THROM VAS, V28, P718, DOI 10.1161/ATVBAHA.107.160713; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Nagai R, 2003, ADV EXP MED BIOL, V538, P57; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Qin HD, 2009, J CELL PHYSIOL, V221, P387, DOI 10.1002/jcp.21865; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923; Satoh H, 1999, BIOCHEM BIOPH RES CO, V254, P757, DOI 10.1006/bbrc.1998.0126; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Solinil A, 2008, DIABETES-METAB RES, V24, P197, DOI 10.1002/dmrr.781; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Sugawara A, 2001, HYPERTENS RES, V24, P229, DOI 10.1291/hypres.24.229; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Takeda K, 2000, CIRCULATION, V102, P1834; Verrier E, 2004, CIRC RES, V94, P1515, DOI 10.1161/01.RES.0000130527.92537.06; Wakino S, 2001, J BIOL CHEM, V276, P47650, DOI 10.1074/jbc.M108719200; Wan HY, 2012, TRANSL RES, V160, P153, DOI 10.1016/j.trsl.2012.02.003; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574	47	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123724	10.1371/journal.pone.0123724	http://dx.doi.org/10.1371/journal.pone.0123724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874449	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700040
J	Santos, RV; Bastos, JL; Cruz, OG; Longo, LAFD; Flowers, NM; Pereira, NDM				Santos, Ricardo Ventura; Bastos, Joao Luiz; Cruz, Oswaldo Goncalves; Ferreira de Barros Longo, Luciene Aparecida; Flowers, Nancy May; Martins Pereira, Nilza de Oliveira			Parity of Indigenous and Non-Indigenous Women in Brazil: Does the Reported Number of Children Born Depend upon Who Answers National Census Questions?	PLOS ONE			English	Article							LATIN-AMERICA; HEALTH	Taking parity as the main analytic variable, the objective of this study is to investigate whether the patterns of response to national census questions in Brazil differ when Indigenous and non-Indigenous women are compared, taking into consideration whether the information was provided by the women directly or by a proxy respondent (another household member or a non-resident). We use data on children ever born to Indigenous and non-Indigenous women from two Brazilian regions, the Northeast and the North. Data on the number of household members, total household rooms, interviewee's color/race, educational attainment, age, parity, and type of respondent were obtained from the 2010 Brazilian census. The relation between color/race and reported parity, as well as the impact of the type of respondent on this association were assessed with the Zero-inflated Negative Binomial regression, stratified by region (North and Northeast) and urban/rural status. Just over half of census interviewees answered directly the census questions (51.2% in the North and 54.4% in the Northeast). Indigenous women in the North region had the highest percentage of interviews carried out with a non-resident (12.7% total; 15.0% and 3.0% in rural and urban areas, respectively). Regardless of color/race, paritymeans were considerably higher when the question was answered by the woman directly (93.5%-101.4% and 15.6%-21.7% higher, compared co-resident and non-resident based answers, respectively). Parity underreporting was particularly strong in Indigenous women living in the rural North (16.0% less in comparison to White women). Proxy respondents tend to underestimate the count of children, particularly among Indigenous women from the North. The implementation of certain methodological alternatives in the Brazilian national censuses, such as the selection and training of census takers to work specifically in Indigenous territories, might be a productive means to improve data collection.	[Santos, Ricardo Ventura] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Bastos, Joao Luiz] Univ Fed Santa Catarina, Dept Saude Publ, Florianopolis, SC, Brazil; [Cruz, Oswaldo Goncalves] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil; [Ferreira de Barros Longo, Luciene Aparecida] Inst Brasileiro Geog & Estat, Unidade Estadual Minas Gerais, Belo Horizonte, MG, Brazil; [Flowers, Nancy May] CUNY Hunter Coll, New York, NY 10021 USA; [Martins Pereira, Nilza de Oliveira] Inst Brasileiro Geog & Estat, Diretoria Pesquisas, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Santa Catarina (UFSC); Fundacao Oswaldo Cruz; City University of New York (CUNY) System; Hunter College (CUNY)	Santos, RV (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.	santos@ensp.fiocruz.br	Bastos, Joao L/K-8362-2015; Bastos, Joao/AAG-4560-2019	Bastos, Joao L/0000-0002-1816-0745; Bastos, Joao/0000-0002-1816-0745	Brazilian National Research Council (CNPq) [304.358/2014-2]; Research Support Foundation of the State of Rio de Janeiro (FAPERJ) [E-26/102.352/2013]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank the Brazilian National Research Council (CNPq) and the Research Support Foundation of the State of Rio de Janeiro (FAPERJ), which funded the research that resulted in this paper through grants 304.358/2014-2 and E-26/102.352/2013, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CENS DEM 2010 CAR GE; Axelsson P, 2011, INDIGENOUS PEOPLES D, P1; Azevedo MM, 2011, POVOS INDIGENAS BRAS, P25; Cardoso Andrey Moreira, 2005, Cad. Saúde Pública, V21, P1602, DOI 10.1590/S0102-311X2005000500035; Carvalho José Alberto Magno de, 2005, Rev. bras. estud. popul., V22, P351, DOI 10.1590/S0102-30982005000200011; Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52; Coimbra Jr CEA, 2004, LOST PARADISES ETHIC, P89; Cooke Martin, 2007, BMC Int Health Hum Rights, V7, P9, DOI 10.1186/1472-698X-7-9; Del Popolo F, 2011, DERECHO INFORM PUEBL; Del Popolo F, 2008, PUEBLOS INDIGENAS AF; Department of Economic and Social Affairs, 2009, STAT WORLDS IND PEOP; Frutos ND, 2004, ATLAS COMUNIDADES IN; Goldani AM, 2009, COMPLETING FERTILITY, P331; Goncalves JMM, 1995, IBGE RETRATO HIST; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; HEMMING J, 1987, AMAZON FRONTIER DEFE; IBGE, 2012, BRAS 500 AN POV; IBGE, 2010, CENS DEM 2010 NUPC F; IBGE, 2013, MET CENS DEM 2010; IBGE (The Brazilian Institute of Statistics and Geography), 2005, TEND DEM AN IND COM; Incayawar M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-27; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, CENS DEM 2010 MAN RE; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2006, EST SEC 20; Kertzer D.I., 2002, CENSUS IDENTITY POLI; McSweeney K, 2005, LAT AM RES REV, V40, P3, DOI 10.1353/lar.2005.0012; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Morning A, 2008, POPUL RES POLICY REV, V27, P239, DOI 10.1007/s11113-007-9062-5; Nobles M., 2000, SHADES CITIZENSHIP R; Oliveira-Filho JP, 2011, RIO DE JANEIRO CAPA, DOI [10.5603/CJ.a2013.0129, DOI 10.5603/CJ.A2013.0129]; PAGLIARO H, 2005, DEMOGRAFIA POVOS IND; Pan American Health Organization, 2006, HLTH IND PEOPL AM; Perz SG, 2008, LAT AM RES REV, V43, P7, DOI 10.1353/lar.0.0019; Potter JE, 2010, POPUL DEV REV, V36, P283, DOI 10.1111/j.1728-4457.2010.00330.x; Ricardo F., 2011, POVOS INDIGENAS BRAS; Santos RV, 2011, CAD SAUDE PUBLICA, V27, P1049, DOI 10.1590/S0102-311X2011000600001; Skold Peter, 2011, INDIGENOUS PEOPLES D, P295	36	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123826	10.1371/journal.pone.0123826	http://dx.doi.org/10.1371/journal.pone.0123826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874712	Green Published, gold			2022-12-27	WOS:000353014700046
J	Sultana, T; Karim, MN; Ahmed, T; Hossain, MI				Sultana, Tania; Karim, Md. Nazmul; Ahmed, Tahmeed; Hossain, Md. Iqbal			Assessment of Under Nutrition of Bangladeshi Adults Using Anthropometry: Can Body Mass Index Be Replaced by Mid-Upper-Arm-Circumference?	PLOS ONE			English	Article							PROTEIN-ENERGY MALNUTRITION; MALE SLUM DWELLERS; UNDERNUTRITION; DEFICIENCY; MORBIDITY; MORTALITY; SURVIVAL; CHILDREN; KOLKATA; MALES	Background and Objective Body-mass-index (BMI) is widely accepted as an indicator of nutritional status in adults. Mid-upper-arm-circumference (MUAC) is another anthropometric-measure used primarily among children. The present study attempted to evaluate the use of MUAC as a simpler alternative to BMI cut-off <18.5 to detect adult undernutrition, and thus to suggest a suitable cut-off value. Methods A cross-sectional study in 650 adult attendants of the patients of Dhaka-Hospital, of the International Centre for Diarrheal Disease Research, Bangladesh (icddr, b) was conducted during 2012. Height, weight and MUAC of 260 male and 390 female aged 19-60 years were measured. Curve estimation was done to assess the linearity and correlation of BMI and MUAC. Sensitivity and specificity of MUAC against BMI<18.5 was determined. Separate Receiver-operating-characteristic (ROC) analyses were performed for male and female. Area under ROC curve and Youden's index were generated to aid selection of the most suitable cut-off value of MUAC for undernutrition. A value with highest Youden's index was chosen for cut-off. Results Our data shows strong significant positive correlation (linear) between MUAC and BMI, for males r = 0.81, (p<0.001) and for females r = 0.828, (p<0.001). MUAC cut-off <25.1 cm in males (AUC 0.930) and <23.9 cm in females (AUC 0.930) were chosen separately based on highest corresponding Youden's index. These values best correspond with BMI cut-off for under nutrition (BMI <18.5) in either gender. Conclusion MUAC correlates closely with BMI. For the simplicity and easy to remember MUAC <25 cm for male and <24 cm for female may be considered as a simpler alternative to BMI cut-off <18.5 to detect adult undernutrition.	[Sultana, Tania; Ahmed, Tahmeed; Hossain, Md. Iqbal] Int Ctr Diarrheal Dis Res, Ctr Nutr & Food Secur, Bangladesh Icddr B, Dhaka 1212, Bangladesh; [Karim, Md. Nazmul] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Hossain, Md. Iqbal] Dhaka Hosp, Icddr B, Dhaka 1212, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Monash University; International Centre for Diarrhoeal Disease Research (ICDDR)	Hossain, MI (corresponding author), Int Ctr Diarrheal Dis Res, Ctr Nutr & Food Secur, Bangladesh Icddr B, Dhaka 1212, Bangladesh.	ihossain@icddrb.org		Karim, Md Nazmul/0000-0003-2604-9649	core donors; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	core donors; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by core donors who provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr, b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; [Anonymous], 1995, PHYS STAT US INT ANT; Bose K, 2001, Anthropol Anz, V59, P275; Bose K, 1996, J ROY SOC HEALTH, V116, P161, DOI 10.1177/146642409611600307; Bose K, 2006, ANTHROPOL SCI, V114, P65, DOI 10.1537/ase.050306; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; BRIEND A, 1987, LANCET, V2, P725; Chakraborty R, 2009, NUTR DIET RES PROG, P377; Chakraborty R, 2009, ANTHROPOL ANZ, V67, P129, DOI 10.1127/0003-5548/2009/0017; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; GASSULL MA, 1984, HUM NUTR-CLIN NUTR, V38C, P419; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Khongsdier R, 2005, EUR J CLIN NUTR, V59, P1007, DOI 10.1038/sj.ejcn.1602205; Khongsdier R, 2002, EUR J CLIN NUTR, V56, P484, DOI 10.1038/sj.ejcn.1601281; LEITER LA, 1982, JAMA-J AM MED ASSOC, V248, P2306, DOI 10.1001/jama.248.18.2306; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Nieman, 2003, NUTR ASSESSMENT; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; OHLSON M. A., 1956, HUMAN BIOL, V28, P189; OLUKOYA AA, 1990, INT J GYNECOL OBSTET, V31, P231, DOI 10.1016/0020-7292(90)91016-J; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; RODRIGUES VC, 1994, TROP DOCT, V24, P164, DOI 10.1177/004947559402400408; SHAKIR A, 1975, AM J CLIN NUTR, V28, P661, DOI 10.1093/ajcn/28.6.661; Shetty P S, 1994, FAO Food Nutr Pap, V56, P1; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; VELLA V, 1994, EUR J CLIN NUTR, V48, P189; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P135, DOI 10.1093/tropej/29.3.135; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P159, DOI 10.1093/tropej/29.3.159; Vlaming S, 2001, CLIN NUTR, V20, P517, DOI 10.1054/clnu.2001.0486; Wijnhoven HAH, 2010, J GERONTOL A-BIOL, V65, P1107, DOI 10.1093/gerona/glq100	34	48	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0121456	10.1371/journal.pone.0121456	http://dx.doi.org/10.1371/journal.pone.0121456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875397	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700009
J	Xiao, CW; Ji, QA; Wei, Q; Liu, Y; Pan, LJ; Bao, GL				Xiao, Chen-Wen; Ji, Quan-An; Wei, Qiang; Liu, Yan; Pan, Li-Jun; Bao, Guo-Lian			Digital Gene Expression Analysis of Microsporum canis Exposed to Berberine Chloride	PLOS ONE			English	Article							CANDIDA-ALBICANS; SALT-TOLERANCE; ZINC; IDENTIFICATION; APOPTOSIS; GENOME; CELLS	Berberine, a natural isoquinoline alkaloid of many medicinal herbs, has an active function against a variety of microbial infections including Microsporum canis (M. canis). However, the underlying mechanisms are poorly understood. To study the effect of berberine chloride on M. canis infection, a Digital Gene Expression (DGE) tag profiling was constructed and a transcriptome analysis of the M. canis cellular responses upon berberine treatment was performed. Illimina/Hisseq sequencing technique was used to generate the data of gene expression profile, and the following enrichment analysis of Gene Ontology (GO) and Pathway function were conducted based on the data of transcriptome. The results of DGE showed that there were 8476945, 14256722, 7708575, 5669955, 6565513 and 9303468 tags respectively, which was obtained from M. canis incubated with berberine or control DMSO. 8,783 genes were totally mapped, and 1,890 genes have shown significant changes between the two groups. 1,030 genes were up-regulated and 860 genes were down-regulated (P<0.05) in berberine treated group compared to the control group. Besides, twenty-three GO terms were identified by Gene Ontology functional enrichment analysis, such as calcium-transporting ATPase activity, 2-oxoglutarate metabolic process, valine catabolic process, peroxisome and unfolded protein binding. Pathway significant enrichment analysis indicated 6 signaling pathways that are significant, including steroid biosynthesis, steroid hormone biosynthesis, Parkinson's disease, 2,4-Dichlorobenzoate degradation, and tropane, piperidine and Isoquinoline alkaloid biosynthesis. Among these, eleven selected genes were further verified by qRT-PCR. Our findings provide a comprehensive view on the gene expression profile of M. canis upon berberine treatment, and shed light on its complicated effects on M. canis.	[Xiao, Chen-Wen; Ji, Quan-An; Wei, Qiang; Liu, Yan; Pan, Li-Jun; Bao, Guo-Lian] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Bao, GL (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China.	baoguolian@163.com			China agricultural research system [CARS-44-C-2]; Zhejiang Provincial Natural Science Foundation Project [LQ12C18002]	China agricultural research system; Zhejiang Provincial Natural Science Foundation Project	This study was supported by grant from the China agricultural research system (CARS-44-C-2) and Zhejiang Provincial Natural Science Foundation Project (LQ12C18002).	Benjamini Y, 2001, ANN STAT, V29, P1165; Cafarchia C, 2012, VET MICROBIOL, V154, P395, DOI 10.1016/j.vetmic.2011.07.021; Cao YB, 2004, PHARM CARE RES, V1, P22; Chen LH, 2008, TRANSGENIC RES, V17, P121, DOI 10.1007/s11248-007-9085-z; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Fan JJ, 2005, FEMS MICROBIOL LETT, V245, P107, DOI 10.1016/j.femsle.2005.02.031; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Lah L, 2013, FUNGAL GENET BIOL, V50, P72, DOI 10.1016/j.fgb.2012.10.002; Lang C, 2007, AM J PHYSIOL-LUNG C, V292, pL577, DOI 10.1152/ajplung.00280.2006; Liang D, 2012, BIOL TRACE ELEM RES, V148, P420, DOI 10.1007/s12011-012-9387-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; [谭生建 Tan Shengjian], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P546; Thambiayya K, 2012, AM J PHYSIOL-LUNG C, V302, pL1287, DOI 10.1152/ajplung.00385.2011; Thumm M, 2000, MICROSC RES TECHNIQ, V51, P563, DOI 10.1002/1097-0029(20001215)51:6<563::AID-JEMT6>3.0.CO;2-8; Tian J, 2008, CHINESE J MODERN DRU, V15, P21; Wang DC, 2008, FEMS MICROBIOL LETT, V279, P217, DOI 10.1111/j.1574-6968.2007.01031.x; Wang YX, 2012, ACTA PHARM SIN B, V2, P581, DOI 10.1016/j.apsb.2012.10.008; Xiao CW, 2014, PAK VET J, V34, P219; Xu K, 2009, J PLANT BIOL, V52, P453, DOI 10.1007/s12374-009-9058-2; Xue JB, 2002, CHINESE J RABBIT FAR, V4, P9; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XL, 2013, CELL SIGNAL, V25, P999, DOI 10.1016/j.cellsig.2012.12.013	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124265	10.1371/journal.pone.0124265	http://dx.doi.org/10.1371/journal.pone.0124265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874937	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700062
J	Bartolome, N; Segarra, S; Artieda, M; Francino, O; Sanchez, E; Szczypiorska, M; Casellas, J; Tejedor, D; Cerdeira, J; Martnez, A; Velasco, A; Sanchez, A				Bartolome, Nerea; Segarra, Sergi; Artieda, Marta; Francino, Olga; Sanchez, Elisenda; Szczypiorska, Magdalena; Casellas, Joaquim; Tejedor, Diego; Cerdeira, Joaquin; Martnez, Antonio; Velasco, Alfonso; Sanchez, Armand			A Genetic Predictive Model for Canine Hip Dysplasia: Integration of Genome Wide Association Study (GWAS) and Candidate Gene Approaches	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ELBOW DYSPLASIA; OSTEOARTHRITIS; JOINT; SUSCEPTIBILITY; IDENTIFICATION; DISCOVERY; LAXITY; DOGS	Canine hip dysplasia is one of the most prevalent developmental orthopedic diseases in dogs worldwide. Unfortunately, the success of eradication programs against this disease based on radiographic diagnosis is low. Adding the use of diagnostic genetic tools to the current phenotype-based approach might be beneficial. The aim of this study was to develop a genetic prognostic test for early diagnosis of hip dysplasia in Labrador Retrievers. To develop our DNA test, 775 Labrador Retrievers were recruited. For each dog, a blood sample and a ventrodorsal hip radiograph were taken. Dogs were divided into two groups according to their FCI hip score: control (A/B) and case (D/E). C dogs were not included in the sample. Genetic characterization combining a GWAS and a candidate gene strategy using SNPs allowed a case-control population association study. A mathematical model which included 7 SNPs was developed using logistic regression. The model showed a good accuracy (Area under the ROC curve = 0.85) and was validated in an independent population of 114 dogs. This prognostic genetic test represents a useful tool for choosing the most appropriate therapeutic approach once genetic predisposition to hip dysplasia is known. Therefore, it allows a more individualized management of the disease. It is also applicable during genetic selection processes, since breeders can benefit from the information given by this test as soon as a blood sample can be collected, and act accordingly. In the authors' opinion, a shift towards genomic screening might importantly contribute to reducing canine hip dysplasia in the future. In conclusion, based on genetic and radiographic information from Labrador Retrievers with hip dysplasia, we developed an accurate predictive genetic test for early diagnosis of hip dysplasia in Labrador Retrievers. However, further research is warranted in order to evaluate the validity of this genetic test in other dog breeds.	[Bartolome, Nerea; Artieda, Marta; Szczypiorska, Magdalena; Tejedor, Diego; Martnez, Antonio] Progenika Biopharma SA, Grifols Co, Derio, Bizkaia, Spain; [Segarra, Sergi; Velasco, Alfonso] Bioiberica SA, Barcelona, Spain; [Francino, Olga; Sanchez, Elisenda; Casellas, Joaquim; Sanchez, Armand] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Dels Aliments, Serv Vet Genet Mol, E-08193 Barcelona, Spain; [Cerdeira, Joaquin] Ctr Vet Aluche Las Aguilas, Madrid, Spain	Grifols; Bioiberica; Autonomous University of Barcelona	Bartolome, N (corresponding author), Progenika Biopharma SA, Grifols Co, Derio, Bizkaia, Spain.	nerea.bartolome@progenika.grifols.com	Francino, Olga/K-5683-2017; Sanchez, Armand/L-7905-2015	Francino, Olga/0000-0002-9022-3835; Sanchez, Armand/0000-0001-9160-1124; Segarra, Sergi/0000-0002-6680-4146; Casellas, Joaquim/0000-0002-4982-3556	Basque Government [IG-2011/0000745, IG-2012/0000068]; Bioiberica SA	Basque Government(Basque Government); Bioiberica SA	This work has been supported by Grants IG-2011/0000745 and IG-2012/0000068 from the Basque Government and by the corporate sponsor Bioiberica SA. The funder Bioiberica SA provided support in the form of salaries and research materials for authors AV and SS, while Progenika Biopharma SA provided support in the form of salaries for authors NB, MA, MS, DT, and AM, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Balsa A, 2010, RHEUMATOLOGY, V49, P458, DOI 10.1093/rheumatology/kep380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Distl O, 2008, P 14 EUR SOC VET ORT, pS61; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Fels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096618; FLUCKIGER M, 1995, SCHWEIZ ARCH TIERH, V137, P243; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kaneene JB, 2009, VET SURG, V38, P398, DOI 10.1111/j.1532-950X.2008.00475.x; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Leppanen M, 2000, J SMALL ANIM PRACT, V41, P19, DOI 10.1111/j.1748-5827.2000.tb03130.x; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Moonga BS, 1996, CALCIFIED TISSUE INT, V59, P105, DOI 10.1007/s002239900095; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Sanchez-Molano E, 2014, J ANIM BREED GENET, V131, P134, DOI 10.1111/jbg.12056; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Stock KF, 2010, J ANIM BREED GENET, V127, P42, DOI 10.1111/j.1439-0388.2009.00809.x; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	46	21	22	8	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122558	10.1371/journal.pone.0122558	http://dx.doi.org/10.1371/journal.pone.0122558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874693	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100084
J	Beck, H; Titze, SI; Hubner, S; Busch, M; Schlieper, G; Schultheiss, UT; Wanner, C; Kronenberg, F; Krane, V; Eckardt, KU; Kottgen, A				Beck, Hanna; Titze, Stephanie I.; Huebner, Silvia; Busch, Martin; Schlieper, Georg; Schultheiss, Ulla T.; Wanner, Christoph; Kronenberg, Florian; Krane, Vera; Eckardt, Kai-Uwe; Koettgen, Anna		GCKD Investigators	Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MEN BORN; EPIDEMIOLOGY; INSUFFICIENCY; POPULATION; DIAGNOSIS; DEATH; CLASSIFICATION; ASSOCIATION	Background and Aims Chronic kidney disease (CKD) is a risk factor for development and progression of heart failure (HF). CKD and HF share common risk factors, but few data exist on the prevalence, signs and symptoms as well as correlates of HF in populations with CKD of moderate severity. We therefore aimed to examine the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) study, a large observational prospective study. Methods and Results We analyzed data from 5,015 GCKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73m(2) or with an eGFR >= 60 and overt proteinuria (>500 mg/d). We evaluated a definition of HF based on the Gothenburg score, a clinical HF score used in epidemiological studies (Gothenburg HF), and self-reported HF. Factors associated with HF were identified using multivariable adjusted logistic regression. The prevalence of Gothenburg HF was 43% (ranging from 24% in those with eGFR >90 to 59% in those with eGFR<30 ml/min/1.73m2). The corresponding estimate for self-reported HF was 18% (range 5%-24%). Lower eGFR was significantly and independently associated with the Gothenburg definition of HF (p-trend <0.001). Additional significantly associated correlates included older age, female gender, higher BMI, hypertension, diabetes mellitus, valvular heart disease, anemia, sleep apnea, and lower educational status. Conclusions The burden of self-reported and Gothenburg HF among patients with CKD is high. The proportion of patients who meet the criteria for Gothenburg HF in a European cohort of patients with moderate CKD is more than twice as high as the prevalence of self-reported HF. However, because of the shared signs, symptoms and medications of HF and CKD, the Gothenburg score cannot be used to reliably define HF in CKD patients. Our results emphasize the need for early screening for HF in patients with CKD.	[Beck, Hanna; Schultheiss, Ulla T.; Koettgen, Anna] Univ Freiburg, Med Ctr, Div Nephrol, Dept Med, D-79106 Freiburg, Germany; [Titze, Stephanie I.; Huebner, Silvia; Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Busch, Martin] Univ Jena, Dept Internal Med 3, Jena, Germany; [Schlieper, Georg] Rhein Westfal TH Aachen, Fac Med, Div Nephrol & Clin Immunol, Aachen, Germany; [Wanner, Christoph; Krane, Vera] Univ Wurzburg, Div Nephrol, Dept Internal Med 1, Wurzburg, Germany; [Wanner, Christoph; Krane, Vera] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria	University of Freiburg; University of Erlangen Nuremberg; Friedrich Schiller University of Jena; RWTH Aachen University; University of Wurzburg; University of Wurzburg; Medical University of Innsbruck	Kottgen, A (corresponding author), Univ Freiburg, Med Ctr, Div Nephrol, Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	anna.koettgen@uniklinik-freiburg.de	Weissensteiner, Hansi/AAT-1789-2021; Baid-Agrawal, Seema/HGB-9062-2022; Ekici, Arif B/C-3971-2013; Kronenberg, Florian/B-1736-2008	Weissensteiner, Hansi/0000-0002-2871-8669; Baid-Agrawal, Seema/0000-0001-8192-1079; Ekici, Arif B/0000-0001-6099-7066; Kronenberg, Florian/0000-0003-2229-1120; Kielstein, Jan/0000-0001-8110-9064; Gefeller, Olaf/0000-0002-8985-7582; Lorenzen, Johan/0000-0002-9132-948X; Schultheiss, Ulla T/0000-0002-7541-5310; Ganslandt, Thomas/0000-0001-6864-8936	German Ministry of Education and Research (BMBF) [01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821]; KfH Foundation for Preventive Medicine; Emmy Noether Programme of the German Research Foundation (DFG) [KO-3598/2-1]; German Ministry of Education and Research (Comprehensive Heart Failure Center) [01GL0304]; Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin)	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); KfH Foundation for Preventive Medicine; Emmy Noether Programme of the German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (Comprehensive Heart Failure Center); Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin)	The GCKD Study is funded by grants from the German Ministry of Education and Research (BMBF) (www.gesundheitsforschung-bmbf.de/de/2101.php; grant number 01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820 und 01ER 0821) and the KfH Foundation for Preventive Medicine (www.kfh-stiftung-praeventivmedizin.de/stiftung.html). AK was funded by the Emmy Noether Programme of the German Research Foundation (DFG KO-3598/2-1). VK and CW were supported by the German Ministry of Education and Research (project 01GL0304: Comprehensive Heart Failure Center). SH was supported by a grant from the Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bagshaw SM, 2010, NEPHROL DIAL TRANSPL, V25, P1406, DOI 10.1093/ndt/gfq066; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Cerasola G, 2011, J NEPHROL, V24, P1, DOI 10.5301/JN.2010.2030; Chae CU, 2003, AM J CARDIOL, V92, P682, DOI 10.1016/S0002-9149(03)00822-1; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Damman K, 2013, EUR HEART J; Dhingra R, 2011, CIRC-HEART FAIL, V4, P138, DOI 10.1161/CIRCHEARTFAILURE.109.899070; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; ERIKSSON H, 1988, ACTA MED SCAND, V223, P197; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fonseca C, 2004, EUR J HEART FAIL, V6, P813, DOI 10.1016/j.ejheart.2004.08.003; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Kuznik A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-132; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Meyer S, 2013, EUR HEART J, V34, P2538, DOI 10.1093/eurheartj/eht152; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Shlipak MG, 2011, J CARD FAIL, V17, P17, DOI 10.1016/j.cardfail.2010.08.009; van Deursen VM, 2014, EUR J HEART FAIL, V16, P103, DOI 10.1002/ejhf.30; WHO Collaborating Centre for Drug Statistics Methodology, 2012, WHO COLLABORATING CT; WILHELMSEN L, 1989, EUR HEART J, V10, P13, DOI 10.1093/eurheartj/10.suppl_C.13	38	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122552	10.1371/journal.pone.0122552	http://dx.doi.org/10.1371/journal.pone.0122552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874373	Green Published, gold			2022-12-27	WOS:000352845100082
J	Hu, JX; Qian, MR; Zhang, Q; Cui, JL; Yu, CN; Su, XM; Shen, CF; Hashmi, MZ; Shi, JY				Hu, Jinxing; Qian, Mingrong; Zhang, Qian; Cui, Jinglan; Yu, Chunna; Su, Xiaomei; Shen, Chaofeng; Hashmi, Muhammad Z.; Shi, Jiyan			Sphingobium fuliginis HC3: A Novel and Robust Isolated Biphenyl- and Polychlorinated Biphenyls-Degrading Bacterium without Dead-End Intermediates Accumulation	PLOS ONE			English	Article							LOW-CHLORINATED BIPHENYLS; WASTE RECYCLING SITES; MICROBIAL-DEGRADATION; AGRICULTURAL SOILS; STRAIN LB400; TAIZHOU AREA; SP-NOV.; METABOLISM; GENES; IDENTIFICATION	Biphenyl and polychlorinated biphenyls (PCBs) are typical environmental pollutants. However, these pollutants are hard to be totally mineralized by environmental microorganisms. One reason for this is the accumulation of dead-end intermediates during biphenyl and PCBs biodegradation, especially benzoate and chlorobenzoates (CBAs). Until now, only a few microorganisms have been reported to have the ability to completely mineralize biphenyl and PCBs. In this research, a novel bacterium HC3, which could degrade biphenyl and PCBs without dead-end intermediates accumulation, was isolated from PCBs-contaminated soil and identified as Sphingobium fuliginis. Benzoate and 3-chlorobenzoate (3-CBA) transformed from biphenyl and 3-chlorobiphenyl (3-CB) could be rapidly degraded by HC3. This strain has strong degradation ability of biphenyl, lower chlorinated (mono-, di- and tri-) PCBs as well as mono-CBAs, and the biphenyl/PCBs catabolic genes of HC3 are cloned on its plasmid. It could degrade 80.7% of 100 mg L-1 biphenyl within 24 h and its biphenyl degradation ability could be enhanced by adding readily available carbon sources such as tryptone and yeast extract. As far as we know, HC3 is the first reported that can degrade biphenyl and 3-CB without accumulation of benzoate and 3-CBA in the genus Sphingobium, which indicates the bacterium has the potential to totally mineralize biphenyl/PCBs and might be a good candidate for restoring biphenyl/PCBs-polluted environments.	[Hu, Jinxing; Zhang, Qian; Cui, Jinglan; Su, Xiaomei; Shen, Chaofeng; Hashmi, Muhammad Z.; Shi, Jiyan] Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Standard Agr Prod, Hangzhou, Zhejiang, Peoples R China; [Yu, Chunna] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Hangzhou Normal University	Shen, CF (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310027, Zhejiang, Peoples R China.	ysxzt@zju.edu.cn	Hashmi, Muhammad Zaffar/F-3427-2015; Shen, Chaofeng/I-7138-2013	Shen, Chaofeng/0000-0002-6394-7416; qian, mingrong/0000-0001-6011-872X	National High Technology Research and Development Program of China [2012AA06A203]; Zhejiang Provincial Natural Science Foundation of China [LR12D01001]; International Cooperation Project of Zhejiang Academy of Agricultural Sciences; National Risk Assessment on the Quality and Safety of Poultry Products [GJFP2014007]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); International Cooperation Project of Zhejiang Academy of Agricultural Sciences; National Risk Assessment on the Quality and Safety of Poultry Products	This study was supported by the National High Technology Research and Development Program of China (2012AA06A203), Zhejiang Provincial Natural Science Foundation of China (LR12D01001), International Cooperation Project of Zhejiang Academy of Agricultural Sciences 2013 and National Risk Assessment on the Quality and Safety of Poultry Products (GJFP2014007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusoye SA, 2008, CHEMOSPHERE, V70, P656, DOI 10.1016/j.chemosphere.2007.06.079; Adebusoye SA, 2008, WORLD J MICROB BIOT, V24, P1203, DOI 10.1007/s11274-007-9594-1; AMBROSE AM, 1960, FOOD RES, V25, P328; Aoki Y, 2001, ENVIRON RES, V86, P2, DOI 10.1006/enrs.2001.4244; BEDARD DL, 1986, APPL ENVIRON MICROB, V51, P761, DOI 10.1128/AEM.51.4.761-768.1986; BHAT MA, 1994, APPL ENVIRON MICROB, V60, P307, DOI 10.1128/AEM.60.1.307-312.1994; Boehncke A, 1999, 6 WHO CONC INT CHEM; Brul S, 1999, INT J FOOD MICROBIOL, V50, P1, DOI 10.1016/S0168-1605(99)00072-0; Chadhain SMN, 2007, J IND MICROBIOL BIOT, V34, P605, DOI 10.1007/s10295-007-0235-3; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chen YQ, 2005, J IND MICROBIOL BIOT, V32, P561, DOI 10.1007/s10295-005-0039-2; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Di Toro S, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-11; DON RH, 1985, J BACTERIOL, V161, P85, DOI 10.1128/JB.161.1.85-90.1985; EKLUND T, 1985, INT J FOOD MICROBIOL, V2, P159, DOI 10.1016/0168-1605(85)90035-2; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Faroon O, 2000, TOXICOL IND HEALTH, V16, P307, DOI 10.1177/074823370001600708; Fava F, 1998, BIOTECHNOL BIOENG, V58, P345, DOI 10.1002/(SICI)1097-0290(19980520)58:4&lt;345::AID-BIT1&gt;3.0.CO;2-J; FAVA F, 1994, APPL MICROBIOL BIOT, V41, P117, DOI 10.1007/BF00166092; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; Focht DD, 1996, APPL ENVIRON MICROB, V62, P3910, DOI 10.1128/AEM.62.10.3910-3913.1996; FURUKAWA K, 1982, APPL ENVIRON MICROB, V44, P619, DOI 10.1128/AEM.44.3.619-626.1982; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; FURUKAWA K, 1979, APPL ENVIRON MICROB, V38, P301, DOI 10.1128/AEM.38.2.301-310.1979; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Gan S, 2009, J HAZARD MATER, V172, P532, DOI 10.1016/j.jhazmat.2009.07.118; Hawley GG, 1971, CONDENSED CHEM DICT, V8th; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HICKEY WJ, 1993, APPL ENVIRON MICROB, V59, P1194, DOI 10.1128/AEM.59.4.1194-1200.1993; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Hong Q, 2009, INT BIODETER BIODEGR, V63, P365, DOI 10.1016/j.ibiod.2008.10.009; Keshavarz MH, 2012, J HAZARD MATER, V237, P79, DOI 10.1016/j.jhazmat.2012.07.048; KOHLER HPE, 1988, APPL ENVIRON MICROB, V54, P1940, DOI 10.1128/AEM.54.8.1940-1945.1988; Lambo AJ, 2006, J BASIC MICROB, V46, P94, DOI 10.1002/jobm.200510006; Lee K, 2003, J HAZARD MATER, V105, P157, DOI 10.1016/j.jhazmat.2003.08.005; Li A, 2009, APPL BIOCHEM BIOTECH, V159, P687, DOI 10.1007/s12010-008-8513-8; Li A, 2009, J ENVIRON SCI-CHINA, V21, P211, DOI 10.1016/S1001-0742(08)62253-6; Luo W, 2008, CHEMOSPHERE, V70, P364, DOI 10.1016/j.chemosphere.2007.07.022; Man YB, 2011, J HAZARD MATER, V195, P92, DOI 10.1016/j.jhazmat.2011.08.010; Mayes BA, 1998, TOXICOL SCI, V41, P62; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; MONDELLO FJ, 1989, J BACTERIOL, V171, P1725, DOI 10.1128/jb.171.3.1725-1732.1989; Moody JD, 2002, APPL MICROBIOL BIOT, V58, P364, DOI 10.1007/s00253-001-0878-3; Ortega-Calvo JJ, 2013, J HAZARD MATER, V261, P733, DOI 10.1016/j.jhazmat.2013.03.042; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Pinyakong O, 2003, BIOCHEM BIOPH RES CO, V301, P350, DOI 10.1016/S0006-291X(02)03036-X; Potrawfke T, 1998, APPL MICROBIOL BIOT, V50, P440, DOI 10.1007/s002530051318; Prakash O, 2006, INT J SYST EVOL MICR, V56, P2147, DOI 10.1099/ijs.0.64080-0; PROVIDENTI MA, 1993, J IND MICROBIOL, V12, P379, DOI 10.1007/BF01569669; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai M, 2002, J BIOSCI BIOENG, V93, P421, DOI 10.1263/jbb.93.421; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Shen CF, 2008, ENVIRON SCI TECHNOL, V42, P49, DOI 10.1021/es071162z; Shen CF, 2009, ENVIRON INT, V35, P50, DOI 10.1016/j.envint.2008.07.005; Stratford J, 1996, ARCH MICROBIOL, V165, P213, DOI 10.1007/BF01692864; Suenaga H, 2002, J BACTERIOL, V184, P3682, DOI 10.1128/JB.184.13.3682-3688.2002; Taguchi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1136, DOI 10.1271/bbb.60551; TAIRA K, 1992, J BIOL CHEM, V267, P4844; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Toyama T, 2010, APPL ENVIRON MICROB, V76, P6733, DOI 10.1128/AEM.00258-10; Tu C, 2011, J HAZARD MATER, V186, P1438, DOI 10.1016/j.jhazmat.2010.12.008; Ushiba Y, 2003, INT J SYST EVOL MICR, V53, P2045, DOI 10.1099/ijs.0.02581-0; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Watanabe T, 2003, J BACTERIOL, V185, P3575, DOI 10.1128/JB.185.12.3575-3582.2003; Weaver WC, 1979, KIRK OTHMER ENCY CHE, P789; Yang XQ, 2004, J IND MICROBIOL BIOT, V31, P415, DOI 10.1007/s10295-004-0162-5; Yuan SY, 2000, CHEMOSPHERE, V41, P1463, DOI 10.1016/S0045-6535(99)00522-6; ZACHE G, 1989, APPL MICROBIOL BIOT, V30, P426, DOI 10.1007/BF00296635; Zhao LJ, 2010, J HAZARD MATER, V179, P729, DOI 10.1016/j.jhazmat.2010.03.062; Zylstra GJ, 1997, J IND MICROBIOL BIOT, V19, P408, DOI 10.1038/sj.jim.2900475	72	21	24	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122740	10.1371/journal.pone.0122740	http://dx.doi.org/10.1371/journal.pone.0122740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875180	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100097
J	Luallen, RJ; Bakowski, MA; Troemel, ER				Luallen, Robert J.; Bakowski, Malina A.; Troemel, Emily R.			Characterization of Microsporidia-Induced Developmental Arrest and a Transmembrane Leucine-Rich Repeat Protein in Caenorhabditis elegans	PLOS ONE			English	Article							LYSOSOME-RELATED ORGANELLES; C. ELEGANS; RNA INTERFERENCE; GROWTH-FACTOR; BINDING; BIOGENESIS; PATHOGEN; PATHWAY; FAMILY; GENES	Microsporidia comprise a highly diverged phylum of intracellular, eukaryotic pathogens, with some species able to cause life-threatening illnesses in immunocompromised patients. To better understand microsporidian infection in animals, we study infection of the genetic model organism Caenorhabditis elegans and a species of microsporidia, Nematocida parisii, which infects Caenorhabditis nematodes in the wild. We conducted a targeted RNAi screen for host C. elegans genes important for infection and growth of N. parisii, using nematode larval arrest as an assay for infection. Here, we present the results of this RNAi screen, and our analyses on one of the RNAi hits from the screen that was ultimately not corroborated by loss of function mutants. This hit was an RNAi clone against F56A8.3, a conserved gene that encodes a transmembrane protein containing leucine-rich repeats (LRRs), a domain found in numerous pathogen receptors from other systems. This RNAi clone caused C. elegans to be resistant to infection by N. parisii, leading to reduced larval arrest and lower pathogen load. Characterization of the endogenous F56A8.3 protein revealed that it is expressed in the intestine, localized to the membrane around lysosomerelated organelles (LROs), and exists in two different protein isoforms in C. elegans. We used the CRISPR-Cas9 system to edit the F56A8.3 locus and created both a frameshift mutant resulting in a truncated protein and a complete knockout mutant. Neither of these mutants was able to recapitulate the infection phenotypes of the RNAi clone, indicating that the RNAi-mediated phenotypes are due to an off-target effect of the RNAi clone. Nevertheless, this study describes microsporidia-induced developmental arrest in C. elegans, presents results from an RNAi screen for host genes important for microsporidian infection, and characterizes aspects of the conserved F56A8.3 gene and its protein product.	[Luallen, Robert J.; Bakowski, Malina A.; Troemel, Emily R.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Troemel, ER (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	etroemel@ucsd.edu		Luallen, Robert/0000-0001-7657-2791	National Science Foundation Graduate Research Fellowship; National Institutes of Health Cell and Molecular Genetics Training Grant [T32 GM008666]; NIAID [R01 AI087528]; Searle Scholars Program; Packard Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, T32GM007240] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Cell and Molecular Genetics Training Grant; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Searle Scholars Program; Packard Foundation(The David & Lucile Packard Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Graduate Research Fellowship to RJL, (https://www.nsfgrfp.org), the National Institutes of Health Cell and Molecular Genetics Training Grant (T32 GM008666) to RJL, (http://www.nih.gov), by NIAID R01 AI087528 (http://www.niaid.nih.gov/), the Searle Scholars Program (http://www.searlescholars.net/), Packard Foundation (http://www.packard.org/) and Burroughs Wellcome Fund (http://www.bwfund.org/grant-programs/infectious-diseases/investigators-in-pathogenesis-of-infectious-disease) to ERT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P341; Bakowski MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004200; Becnel James J., 1999, P447; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; BRENNER S, 1974, GENETICS, V77, P71; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Delahaye JL, 2014, MOL BIOL CELL, V25, P1073, DOI 10.1091/mbc.E13-09-0521; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier Elizabeth S, 2005, Expert Rev Anti Infect Ther, V3, P419, DOI 10.1586/14787210.3.3.419; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Estes KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002227; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; King SM, 2002, SEMIN CELL DEV BIOL, V13, P293, DOI 10.1016/S1084952102000599; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Ma ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084137; McGhee James D, 2007, WormBook, P1; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; OpenWetWare, 2013, ROUND THE HORN SIT D; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabbitts BM, 2008, GENETICS, V180, P857, DOI 10.1534/genetics.108.093534; Radman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076019; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Szumowski SC, 2014, P NATL ACAD SCI USA, V111, P8215, DOI 10.1073/pnas.1400696111; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Williams BAP, 2009, CELL MICROBIOL, V11, P1551, DOI 10.1111/j.1462-5822.2009.01362.x; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x; Zhou HM, 1998, J NEUROSCI, V18, P10438	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124065	10.1371/journal.pone.0124065	http://dx.doi.org/10.1371/journal.pone.0124065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874557	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100237
J	Strudwick, XL; Lang, DL; Smith, LE; Cowin, AJ				Strudwick, Xanthe L.; Lang, Debbie L.; Smith, Louise E.; Cowin, Allison J.			Combination of Low Calcium with Y-27632 Rock Inhibitor Increases the Proliferative Capacity, Expansion Potential and Lifespan of Primary Human Keratinocytes while Retaining Their Capacity to Differentiate into Stratified Epidermis in a 3D Skin Model	PLOS ONE			English	Article							P53 MUTATIONS; CELL-LINE; CULTURE; HACAT; GROWTH; SUNLIGHT; CANCER; RHO	Human keratinocytes are difficult to isolate and have a limited lifespan. Traditionally, immortalised keratinocyte cell lines are used in vitro due to their ability to bypass senescence and survive indefinitely. However these cells do not fully retain their ability to differentiate in vitro and they are unable to form a normal stratum corneum in organotypic culture. Here we aimed to generate a pool of phenotypically similar keratinocytes from human donors that could be used in monolayer culture, without a fibroblast feeder layer, and in 3D human skin equivalent models. Primary human neonatal epidermal keratinocytes (HEKn) were cultured in low calcium, (0.07mM) media, +/-10 mu M Y-27632 ROCK inhibitor (HEKn-CaY). mRNA and protein was extracted and expression of differentiation markers Keratin 14 (K14), Keratin 10 (K10) and Involucrin (Inv) assessed by qRT-PCR and Western blotting. The differentiation potential of the HEKn-CaY cultures was assessed by increasing calcium levels and removing the Y-27632 for 72hrs prior to assessment of K14, K10 and Inv. The ability of the HEKn-CaY, to form a stratified epithelium was assessed using a human skin equivalent (HSE) model in the absence of Y-27632. Increased proliferative capacity, expansion potential and lifespan of HEKn was observed with the combination of low calcium and 10 mu M ROCK inhibitor Y-27632. The removal of Y-27632 and the addition of high calcium to induce differentiation allowed the cells to behave as primary keratinocytes even after extended serial passaging. Prolonged lifespan HEK-CaYs were capable of forming an organised stratified epidermis in 3D HSE cultures, demonstrating their ability to fully stratify and retain their original, primary characteristics. In conclusion, the use of 0.07mM Calcium and 10 mu M Y-27632 in HEKn monocultures provides the opportunity to culture primary human keratinocytes without a cell feeder layer for extended periods of culture whilst retaining their ability to differentiate and form a stratified epithelium.	[Strudwick, Xanthe L.; Lang, Debbie L.; Smith, Louise E.; Cowin, Allison J.] Univ S Australia, Mawson Inst, Regenerat Med, Mawson Lakes, Australia	University of South Australia	Cowin, AJ (corresponding author), Univ S Australia, Mawson Inst, Regenerat Med, Mawson Lakes, Australia.	allison.cowin@unisa.edu.au	Cowin, Allison/F-4281-2013; Strudwick, Xanthe/C-9708-2013; Smith, Louise E/V-6186-2019; Smith, Louise/C-8855-2011; Cowin, Allison/AAM-3105-2020	Cowin, Allison/0000-0003-2885-2080; Strudwick, Xanthe/0000-0002-8557-3857; Smith, Louise E/0000-0003-0659-0884; Smith, Louise/0000-0003-0659-0884; Cowin, Allison/0000-0003-2885-2080	Wound Management Innovation Cooperative Research Centre - Commonwealth Government of Australia	Wound Management Innovation Cooperative Research Centre - Commonwealth Government of Australia	This study was supported by the Wound Management Innovation Cooperative Research Centre a program funded by the Commonwealth Government of Australia. Regarding the role of the funders in the study: the authors confirm that the funders, the Wound Management Innovation Cooperative Research Centre, did not take any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Chapman S, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt449; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; De Corte P, 2012, CELL TISSUE BANK, V13, P175, DOI 10.1007/s10561-011-9247-3; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Hayflick L, 1973, TISSUE CULTURE METHO, P220, DOI DOI 10.1016/B978-0-12-427150-0.50060-7; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; TENCHINI ML, 1992, BURNS, V18, pS11, DOI 10.1016/0305-4179(92)90104-3; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	21	27	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123651	10.1371/journal.pone.0123651	http://dx.doi.org/10.1371/journal.pone.0123651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874771	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352845100194
J	Wilmut, K; Du, WC; Barnett, AL				Wilmut, Kate; Du, Wenchong; Barnett, Anna L.			How Do I Fit through That Gap? Navigation through Apertures in Adults with and without Developmental Coordination Disorder	PLOS ONE			English	Article							VISUAL GUIDANCE; OLDER-ADULTS; CHILDREN; WALKING; INFORMATION; LOCOMOTION	During everyday life we move around busy environments and encounter a range of obstacles, such as a narrow aperture forcing us to rotate our shoulders in order to pass through. In typically developing individuals the decision to rotate the shoulders is body scaled and this movement adaptation is temporally and spatially tailored to the size of the aperture. This is done effortlessly although it actually involves many complex skills. For individuals with Developmental Coordination Disorder (DCD) moving in a busy environment and negotiating obstacles presents a real challenge which can negatively impact on safety and participation in motor activities in everyday life. However, we have a limited understanding of the nature of the difficulties encountered. Therefore, this current study considered how adults with DCD make action judgements and movement adaptations while navigating apertures. Fifteen adults with DCD and 15 typically developing (TD) controls passed through a series of aperture sizes which were scaled to body size (0.9-2.1 times shoulder width). Spatial and temporal characteristics of movement were collected over the approach phase and while crossing the aperture. The decision to rotate the shoulders was not scaled in the same way for the two groups, with the adults with DCD showing a greater propensity to turn for larger apertures compared to the TD adults when body size alone was accounted for. However, when accounting for degree of lateral trunk movement and variability on the approach, we no longer saw differences between the two groups. In terms of the movement adaptations, the adults with DCD approached an aperture differently when a shoulder rotation was required and then adapted their movement sooner compared to their typical peers. These results point towards an adaptive strategy in adults with DCD which allows them to account for their movement difficulties and avoid collision.	[Wilmut, Kate; Du, Wenchong; Barnett, Anna L.] Oxford Brookes Univ, Percept & Mot Anal Lab, Oxford OX3 0BP, England	Oxford Brookes University	Wilmut, K (corresponding author), Oxford Brookes Univ, Percept & Mot Anal Lab, Oxford OX3 0BP, England.	k.wilmut@brookes.ac.uk		Du, Wenchong/0000-0002-5115-7214	Economic and Social Research Council [ES/J02015X/1]; ESRC [ES/J02015X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work received support from the Economic and Social Research Council- awarded to KW and AB. http://www.esrc.ac.uk/. ES/J02015X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AL, 2015, PHYS OCCUP THER PEDI, V35, P103, DOI 10.3109/01942638.2014.957430; Bruininks RH, 2005, BRUININKS OSERETSKY; Conners CK, 2009, CONNERS ADULT ADHD R, DOI [10.1177/1087054708326109, DOI 10.1177/1087054708326109]; Deconinck FJA, 2006, CHILD CARE HLTH DEV, V32, P711, DOI 10.1111/j.1365-2214.2006.00685.x; Deconinck FJA, 2010, GAIT POSTURE, V32, P327, DOI 10.1016/j.gaitpost.2010.05.018; Deconinck FJA, 2006, MOTOR CONTROL, V10, P125, DOI 10.1123/mcj.10.2.125; Du W, HUMAN MOVEMENT UNPUB; Gentle J, 2015, WALKING PATTERNS IND; Geuze RH, 2007, COORDINATION DEV, P9; Hackney AL, 2013, GAIT POSTURE, V37, P93, DOI 10.1016/j.gaitpost.2012.06.020; Hackney AL, 2011, GAIT POSTURE, V33, P733, DOI 10.1016/j.gaitpost.2011.02.019; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Hyde C, 2011, BRAIN COGNITION, V75, P232, DOI 10.1016/j.bandc.2010.12.004; Kirby A., 2008, ADULT DEV COORDINATI; Kirby A, 2010, RES DEV DISABIL, V31, P131, DOI 10.1016/j.ridd.2009.08.010; Lingam R, 2009, PEDIATRICS, V123, pE693, DOI 10.1542/peds.2008-1770; LOSSE A, 1991, DEV MED CHILD NEUROL, V33, P55, DOI 10.1111/j.1469-8749.1991.tb14785.x; Mandich A, 2003, BRAIN COGNITION, V51, P346, DOI 10.1016/S0278-2626(03)00039-3; Mon-Williams M, 2005, Q J EXP PSYCHOL-A, V58, P1249, DOI 10.1080/02724980443000575; Montagne G, 2002, EXP BRAIN RES, V143, P133, DOI 10.1007/s00221-001-0990-8; Purcell C, 2001, DEVELOPMENTAL SCI, V15, P299; Snapp-Childs W, 2009, EXP BRAIN RES, V198, P527, DOI 10.1007/s00221-009-1944-9; Sugden D., 2006, LEEDS CONSENSUS STAT; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wilmut K, 2008, EXP BRAIN RES, V191, P403, DOI 10.1007/s00221-008-1532-4; Wilmut K, 2013, RES DEV DISABIL, V34, P174, DOI 10.1016/j.ridd.2012.07.020; Wilmut K, 2011, EXP BRAIN RES, V210, P185, DOI 10.1007/s00221-011-2614-2; Wilmut K, 2010, HUM MOVEMENT SCI, V29, P289, DOI 10.1016/j.humov.2010.01.001	30	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124695	10.1371/journal.pone.0124695	http://dx.doi.org/10.1371/journal.pone.0124695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874635	Green Published, Green Accepted, gold			2022-12-27	WOS:000352845100268
J	Chen, Y; Zhang, J; Lu, Y; Wang, LB				Chen, Yan; Zhang, Jin; Lu, Yong; Wang, Libo			Immunosuppression in Early Postnatal Days Induces Persistent and Allergen-Specific Immune Tolerance to Asthma in Adult Mice	PLOS ONE			English	Article							PERIPHERAL TOLERANCE; AIRWAY INFLAMMATION; T-CELLS; INDUCTION; BLOCKADE; THYMUS; TRANSPLANTATION; MECHANISMS; RECEPTOR; CTLA4IG	Bronchial asthma is a chronic airway inflammatory condition with high morbidity, and effective treatments for asthma are limited. Allergen-specific immunotherapy can only induce peripheral immune tolerance and is not sustainable. Exploring new therapeutic strategies is of great clinical importance. Recombinant adenovirus (rAdV) was used as a vector to make cells expressing cytotoxic T lymphocyte-associated antigen-4-immunoglobulin (CTLA4Ig) a soluble CTLA4 immunoglobulin fusion protein. Dendritic cells (DCs) were modified using the rAdVs together with allergens. Then these modified DCs were transplanted to mice before allergen sensitization. The persistence and specificity of immune tolerance were evaluated in mice challenged with asthma allergens at 3 and 7 months. DCs modified by CTLA4Ig showed increased IL-10 secretion, decreased IL-12 secretion, and T cell stimulation in vitro. Mice treated with these DCs in the early neonatal period developed tolerance against the allergens that were used to induce asthma in the adult stage. Asthma symptoms, lung damage, airway reactivity, and inflammatory response all improved. Humoral immunity indices showed that this therapeutic strategy strongly suppressed mice immune responses and was maintained for as long as 7 months. Furthermore, allergen cross-sensitization and challenge experiments demonstrated that this immune tolerance was allergen-specific. Treatment with CTLA4Ig modified DCs in the early neonatal period, inducing persistent and allergen-specific immune tolerance to asthma in adult mice. Our results suggest that it may be possible to develop a vaccine for asthma.	[Chen, Yan; Zhang, Jin; Lu, Yong; Wang, Libo] Fudan Univ, Dept Resp Med, Childrens Hosp, Shanghai 200433, Peoples R China	Fudan University	Chen, Y (corresponding author), Fudan Univ, Dept Resp Med, Childrens Hosp, Shanghai 200433, Peoples R China.	chenyancy@fudan.edu.cn; libowang@fudan.edu.cn			National Natural Science Foundation of China [30600684, 30901623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30600684 and 30901623). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Al-Alawi M, 2014, AM J MED, V127, P370, DOI 10.1016/j.amjmed.2013.12.013; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen Y, 2014, INT J MOL SCI, V15, P15304, DOI 10.3390/ijms150915304; De Leval L, 1998, J VIROL, V72, P5285, DOI 10.1128/JVI.72.6.5285-5290.1998; De Leval L, 1999, IMMUNOLOGY, V98, P630, DOI 10.1046/j.1365-2567.1999.00900.x; Fujita Hiroyuki, 2012, Clin Transl Allergy, V2, P2, DOI 10.1186/2045-7022-2-2; Gaffin JM, 2011, CLIN PEDIATR, V50, P133, DOI 10.1177/0009922810384720; Goldman M, 2009, CLIN EXP IMMUNOL, V156, P185, DOI 10.1111/j.1365-2249.2009.03887.x; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Henry E, 2008, J IMMUNOL, V181, P7230, DOI 10.4049/jimmunol.181.10.7230; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jutel Marek, 2014, Curr Treat Options Allergy, V1, P213; Kimzey SL, 2004, J IMMUNOL, V173, P632, DOI 10.4049/jimmunol.173.1.632; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Reyes-Garcia MG, 2013, BIOMED RES INT, V2013; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sastre B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/645383; Seyfert-Margolis V, 2010, PEDIATR CLIN N AM, V57, P523, DOI 10.1016/j.pcl.2010.01.015; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Sun LN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/206929; Suzuki J, 2010, CELL TRANSPLANT, V19, P253, DOI 10.3727/096368909X480314; Tang AM, 1996, J IMMUNOL, V157, P117; Tang AM, 1997, EUR J IMMUNOL, V27, P3143, DOI 10.1002/eji.1830271210; Tian CR, 2004, J IMMUNOL, V173, P7217, DOI 10.4049/jimmunol.173.12.7217; van Wijk F, 2007, BIOMED PHARMACOTHER, V61, P8, DOI 10.1016/j.biopha.2006.11.003; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; von Bubnoff D, 2001, J ALLERGY CLIN IMMUN, V108, P329, DOI 10.1067/mai.2001.117457; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Ying L, 2011, CLIN EXP IMMUNOL, V165, P130, DOI 10.1111/j.1365-2249.2011.04405.x; Zhang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063775	37	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122990	10.1371/journal.pone.0122990	http://dx.doi.org/10.1371/journal.pone.0122990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860995	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300072
J	Komiyama, T; Hirokawa, T; Sato, K; Oka, A; Kamiguchi, H; Nagata, E; Sakura, H; Otsuka, K; Kobayashi, H				Komiyama, Tomoyoshi; Hirokawa, Takatsugu; Sato, Kyoko; Oka, Akira; Kamiguchi, Hiroshi; Nagata, Eiichiro; Sakura, Hiroshi; Otsuka, Kuniaki; Kobayashi, Hiroyuki			Relationship between Human Evolution and Neurally Mediated Syncope Disclosed by the Polymorphic Sites of the Adrenergic Receptor Gene alpha 2B-AR	PLOS ONE			English	Article							MITOCHONDRIAL GENOME VARIATION; PROTEIN; PREDICTION; DELETION; HISTORY; DIVERSIFICATION	The objective of this study was to clarify the effects of disease on neurally mediated syncope (NMS) during an acute stress reaction. We analyzed the mechanism of the molecular interaction and the polymorphisms of the alpha-2 adrenoreceptor (alpha 2B-AR) gene as the potential psychiatric cause of incentive stress. We focused on the following three genotypes of the repeat polymorphism site at Glu 301-303 in the a2B-AR gene: Glu12/12, Glu12/9, and Glu9/9. On the basis of our clinical research, NMS is likely to occur in people with the Glu12/9 heterotype. To verify this, we assessed this relationship with the interaction of Gi protein and adenylate cyclase by in silico analysis of the Glu12/9 heterotype. By measuring the difference in the dissociation time of the Gi-alpha subunit twice, we found that the Glu12/9 heterotype suppressed the action of adenylate cyclase longer than the Glu homotypes. As this difference in the Glu repeat number effect is thought to be one of the causes of NMS, we investigated the evolutionary significance of the Glu repeat number. Glu8 was originally repeated in simians, while the Glu12 repeats occurred over time during the evolution of bipedalism in humans. Taken with the Glu12 numbers, NMS would likely become a defensive measure to prevent significant blood flow to the human brain.	[Komiyama, Tomoyoshi; Kobayashi, Hiroyuki] Tokai Univ, Dept Clin Pharmacol, Sch Med, Isehara, Kanagawa 2591193, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Koto Ku, Tokyo 1350064, Japan; [Sato, Kyoko; Sakura, Hiroshi; Otsuka, Kuniaki] Tokyo Womens Med Univ, Med Ctr East, Arakawa Ku, Tokyo 1168567, Japan; [Oka, Akira] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan; [Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa 2591193, Japan; [Nagata, Eiichiro] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa 2591193, Japan	Tokai University; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Women's Medical University; Tokai University; Tokai University; Tokai University	Komiyama, T (corresponding author), Tokai Univ, Dept Clin Pharmacol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	komiyama@tokai-u.jp		Komiyama, Tomoyoshi/0000-0003-2138-0084	Ministry of Education, Culture, Sports, Science and Technology [60439685, 22590797]; Auxiliary Plan for Fellowship of Tokai University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Auxiliary Plan for Fellowship of Tokai University	This study was supported in part by a Grant-in-Aid for Scientific Research (C) 60439685 and 22590797 from the Ministry of Education, Culture, Sports, Science and Technology. In addition, this research was supported by the Auxiliary Plan for Fellowship of Tokai University.	Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Blain H-A, 2013, JOURNAL OF HUMAN EVO; BRASS LF, 1986, J BIOL CHEM, V261, P6838; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chiou KL, 2011, MOL PHYLOGENET EVOL, V59, P736, DOI 10.1016/j.ympev.2011.03.025; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Ekokoski E, 2000, EXTRACELLULAR ATP AS; Ensemble, 2010, THE NEANDERTHAL GENO; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jackson EK, 2012, PRIMER AUTONOMIC NER, P215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P558, DOI 10.1007/s00586-011-1939-7; Lei XM, 2012, NEUROPSYCHOPHARMACOL, V37, P1115, DOI 10.1038/npp.2011.266; Matsui Atsushi, 2007, Mammal Study, V32, P7, DOI 10.3106/1348-6160(2007)32[7:DOACLM]2.0.CO;2; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meinkoth JL, 1994, REVERSIBLE PROTEIN P, P179; Mikkelsen TS, 2005, NATURE; Mosqueda-Garcia R, 1995, DISORDERS AUTONOMIC, P25; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Muszkat M, 2005, PHARMACOGENET GENOM, V15, P407, DOI 10.1097/01213011-200506000-00006; Muszkat M, 2010, J HYPERTENS, V28, P278, DOI 10.1097/HJH.0b013e328333d212; NEI M, 1974, AM J HUM GENET, V26, P421; Nguyen K, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-5; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Preuschoft H, 2004, J ANAT, V204, P363, DOI 10.1111/j.0021-8782.2004.00303.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson D, 1995, DISORDERS OF THE AUT; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saltamavros AD, 2007, CLIN AUTON RES, V17, P112, DOI 10.1007/s10286-007-0403-6; Sato K, 2013, THE AUTONOMIC NERVOU, V50, P126; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Snapir A, 2001, J AM COLL CARDIOL, V37, P1516, DOI 10.1016/S0735-1097(01)01201-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tayel SI, 2012, THE APPLICATION OF C, V5, P111, DOI [10.2147/TACG.S33814, DOI 10.2147/TACG.S33814]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno LM, 2006, INT J OBESITY, V30, P214, DOI 10.1038/sj.ijo.0803140; van Dijk JG, 2003, CLIN AUTON RES, V13, P247, DOI 10.1007/s10286-003-0099-1; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xie HG, 2000, CLIN PHARMACOL THER, V67, P670, DOI 10.1067/mcp.2000.106293	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120788	10.1371/journal.pone.0120788	http://dx.doi.org/10.1371/journal.pone.0120788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860977	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300016
J	Sheu, MJ; Hsieh, MJ; Chiang, WL; Yang, SF; Lee, HL; Lee, LM; Yeh, CB				Sheu, Ming-Jen; Hsieh, Ming-Ju; Chiang, Whei-Ling; Yang, Shun-Fa; Lee, Hsiang-Lin; Lee, Liang-Ming; Yeh, Chao-Bin			Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; HUMAN BREAST; PATHOLOGICAL DEVELOPMENT; GENE POLYMORPHISMS; GASTRIC-CANCER; RISK-FACTORS; FGFR4; EXPRESSION; HEPATITIS	Background Fibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated the potential associations of FGFR4 single nucleotide polymorphisms (SNPs) with HCC susceptibility and its clinicopathological characteristics. Methodology/Principal Findings Four SNPs in FGFR4 (rs1966265, rs351855, rs2011077, and rs7708357) were analyzed among 884 participants, including 595 controls and 289 patients with HCC. The samples were further analyzed to clarify the associations between these gene polymorphisms and the risk of HCC, and the impact of these SNPs on the susceptibility and clinicopathological characteristics of HCC. After adjusting for other covariants, HCC patients who carrying at least one A genotype (GA and AA) at rs351855 were observed to have a higher risk of liver cirrhosis compared with those carrying the wild-type genotype (GG) (OR: 2.113, 95% CI: 1.188-3.831). Moreover, the patients with at least one A genotype were particularly showed a high level of alpha-fetoprotein (AFP). Conclusions Our findings suggest that genetic polymorphism in FGFR4 rs351855 may be associated with the risk of HCC coupled with liver cirrhosis and may markedly increase the AFP level in Taiwanese patients with HCC. In addition, this is the first study that evaluated the risk factors associated with FGFR4 polymorphism variants in Taiwanese patients with HCC.	[Sheu, Ming-Jen] Chi Mei Med Ctr, Dept Gastroenterol & Hepatol, Tainan, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Sch Optometry, Taichung, Taiwan; [Hsieh, Ming-Ju; Yang, Shun-Fa; Lee, Hsiang-Lin] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiang, Whei-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Chiang, Whei-Ling; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Lee, Hsiang-Lin] Chung Shan Med Univ Hosp, Dept Surg, Taichung 40201, Taiwan; [Lee, Liang-Ming] Taipei Med Univ, Dept Urol, Wan Fang Hosp, Taipei, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung 40201, Taiwan	Chi Mei Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, CB (corresponding author), Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan.	sky5ff@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234; Yeh, Chao-Bin/0000-0002-3978-5576	Chung Shan Medical University Hospital [CSH-2014-C-019]; Chung Shan Medical University Hospital; Chi-Mei Foundation Medical Center [CSMU-CMMC-103-06]	Chung Shan Medical University Hospital; Chung Shan Medical University Hospital; Chi-Mei Foundation Medical Center	This study was supported by research grants from Chung Shan Medical University Hospital, (CSH-2014-C-019) and Chung Shan Medical University Hospital and Chi-Mei Foundation Medical Center (CSMU-CMMC-103-06). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2014, BRIT J CANCER, V110, P1088, DOI 10.1038/bjc.2013.769; Ansell A, 2009, ORAL ONCOL, V45, P23, DOI 10.1016/j.oraloncology.2008.03.007; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Chen ZX, 2013, INT J MED SCI, V10, P1868, DOI 10.7150/ijms.6868; Chien MH, 2011, J SURG ONCOL, V104, P798, DOI 10.1002/jso.22037; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FitzGerald LM, 2009, PROSTATE CANCER P D, V12, P192, DOI 10.1038/pcan.2008.46; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Gospodarowicz D, 1975, Adv Metab Disord, V8, P301; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Hsieh MC, 2014, J CLIN LAB ANAL, V28, P237, DOI 10.1002/jcla.21672; Huang YW, 2013, CLIN INFECT DIS, V57, P1695, DOI 10.1093/cid/cit603; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; JACQUEMIER J, 1994, INT J CANCER, V59, P373, DOI 10.1002/ijc.2910590314; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Ma ZY, 2008, INT J CANCER, V123, P2574, DOI 10.1002/ijc.23578; Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Rezvani M, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/932356; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Shen YY, 2013, WORLD J GASTROENTERO, V19, P4568, DOI 10.3748/wjg.v19.i28.4568; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; Tiong KH, 2013, APOPTOSIS, V18, P1447, DOI 10.1007/s10495-013-0886-7; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Weinmann A, 2014, J CLIN GASTROENTEROL, V48, P279, DOI 10.1097/MCG.0b013e3182a8a793; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Xu W, 2010, EUR J CANCER, V46, P3332, DOI 10.1016/j.ejca.2010.06.017; Yang Y, 2012, MOL CARCINOGEN, V51, P515, DOI 10.1002/mc.20805; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	39	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122961	10.1371/journal.pone.0122961	http://dx.doi.org/10.1371/journal.pone.0122961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860955	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300071
J	Braun, F; Hamelin, J; Bonnafous, A; Delgenes, N; Steyer, JP; Patureau, D				Braun, Florence; Hamelin, Jerome; Bonnafous, Anais; Delgenes, Nadine; Steyer, Jean-Philippe; Patureau, Dominique			Similar PAH Fate in Anaerobic Digesters Inoculated with Three Microbial Communities Accumulating Either Volatile Fatty Acids or Methane	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; RDNA SEQUENCE-ANALYSIS; ACTIVATED-SLUDGE; DEGRADATION; DIVERSITY; BIODEGRADATION; PCR; PHENANTHRENE; NAPHTHALENE; SEDIMENT	Urban sludge produced on wastewater treatment plants are often contaminated by organic pollutants such as polycyclic aromatic hydrocarbons (PAH). Their removal under methanogenic conditions was already reported, but the factors influencing this removal remain unclear. Here, we determined the influence of microbial communities on PAH removal under controlled physico-chemical conditions. Twelve mesophilic anaerobic digesters were inoculated with three microbial communities extracted from ecosystems with contrasting pollution histories: a PAH contaminated soil, a PCB contaminated sediment and a low contaminated anaerobic sludge. These anaerobic digesters were operated during 100 days in continuous mode. A sterilised activated sludge, spiked with 13 PAH at concentrations usually encountered in full-scale wastewater treatment plants, was used as substrate. The dry matter and volatile solid degradation, the biogas production rate and composition, the volatile fatty acids (VFA) production and the PAH removals were monitored. Bacterial and archaeal communities were compared in abundance (qPCR), in community structure (SSCP fingerprinting) and in dominant microbial species (454-pyrosequencing). The bioreactors inoculated with the community extracted from low contaminated anaerobic sludge showed the greater methane production. The PAH removals ranged from 10% to 30%, respectively, for high and low molecular weight PAH, whatever the inoculums tested, and were highly correlated with the dry matter and volatile solid removals. The microbial community structure and diversity differed with the inoculum source; this difference was maintained after the 100 days of digestion. However, the PAH removal was not correlated to these diverse structures and diversities. We hence obtained three functional stable consortia with two contrasted metabolic activities, and three different pictures of microbial diversity, but similar PAH and matter removals. These results confirm that PAH removal depends on the molecule type and on the solid matter removal. But, as PAH elimination is similar whether the solid substrate is degraded into VFA or into methane, it seems that the fermentative communities are responsible for their elimination.	[Braun, Florence; Hamelin, Jerome; Bonnafous, Anais; Delgenes, Nadine; Steyer, Jean-Philippe; Patureau, Dominique] INRA, UR0050, Lab Biotechnol Environm, F-11100 Narbonne, France; [Braun, Florence] French Environm & Energy Management Agcy, ADEME, F-49004 Angers 01, France	INRAE	Patureau, D (corresponding author), INRA, UR0050, Lab Biotechnol Environm, Ave Etangs, F-11100 Narbonne, France.	dominique.patureau@supagro.inra.fr	Hamelin, Jérôme/F-4981-2013	Hamelin, Jérôme/0000-0003-3601-6349; Steyer, Jean-Philippe/0000-0003-0467-8081	'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME) [0906C0008]; 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE); 'Institut National de la Recherche Agronomique' (INRA)	'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME); 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE); 'Institut National de la Recherche Agronomique' (INRA)	This work was supported by the 'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME), ADEME convention number: 0906C0008, from the 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE), and 'Institut National de la Recherche Agronomique' (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Lara CA, 2008, CHEM ENG PROCESS, V47, P1968, DOI 10.1016/j.cep.2007.12.007; Barret M, 2010, WATER RES, V44, P3797, DOI 10.1016/j.watres.2010.04.031; Berdugo-Clavijo C, 2012, FEMS MICROBIOL ECOL, V81, P124, DOI 10.1111/j.1574-6941.2012.01328.x; Bertin L, 2007, WATER RES, V41, P2407, DOI 10.1016/j.watres.2007.02.046; Blanchard G, 2010, MUTOSS UNIFIED MUTIP; Blanchard M, 2004, ENVIRON RES, V95, P184, DOI 10.1016/j.envres.2003.07.003; Braun F, 2011, APPL ENVIRON MICROB, V77, P8487, DOI 10.1128/AEM.05549-11; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; Cea-Barcia G, 2013, INT J CHEM ENG, V2013, DOI 10.1155/2013/450542; Chang BV, 2008, B ENVIRON CONTAM TOX, V80, P145, DOI 10.1007/s00128-007-9333-1; Chang W, 2006, BIOTECHNOL LETT, V28, P425, DOI 10.1007/s10529-005-6073-3; Chiu PC, 2001, APPL ENVIRON MICROB, V67, P2371, DOI 10.1128/AEM.67.5.2371-2374.2001; Christensen N, 2004, WATER SCI TECHNOL, V50, P237, DOI 10.2166/wst.2004.0580; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2009, MICROB BIOTECHNOL, V2, P566, DOI 10.1111/j.1751-7915.2009.00096.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng J, 2012, ENVIRON SCI POLLUT R, V19, P1097, DOI 10.1007/s11356-011-0620-3; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Haegeman B, 2014, MICROB ECOL, V68, P169, DOI 10.1007/s00248-014-0394-5; Lu XY, 2011, APPL MICROBIOL BIOT, V89, P1357, DOI 10.1007/s00253-010-3072-7; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Mirza R, 2012, WATER AIR SOIL POLL, V223, P189, DOI 10.1007/s11270-011-0850-5; Musat F, 2009, ENVIRON MICROBIOL, V11, P209, DOI 10.1111/j.1462-2920.2008.01756.x; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rockne KJ, 2001, WATER RES, V35, P291, DOI 10.1016/S0043-1354(00)00246-3; Roesch L. F. W., 2007, ISME J, P1, DOI DOI 10.1038/ISMEJ.2007.94; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Sany SBT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094907; Sen B, 2008, J APPL MICROBIOL, V105, P2123, DOI 10.1111/j.1365-2672.2008.03911.x; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Talbot G, 2008, WATER RES, V42, P513, DOI 10.1016/j.watres.2007.08.003; Tarnawski S, 2006, SOIL BIOL BIOCHEM, V38, P1193, DOI 10.1016/j.soilbio.2005.10.003; Team RDC, 2010, R LANG ENV STAT COMP; Thavamani P, 2012, ENVIRON MONIT ASSESS, V184, P3875, DOI 10.1007/s10661-011-2230-4; Trably E, 2004, INT J ENVIRON AN CH, V84, P995, DOI 10.1080/03067310412331298412; Trably E, 2003, WATER SCI TECHNOL, V48, P53, DOI 10.2166/wst.2003.0220; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Yang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086441; Youngsoon Um, 2004, ISOLATION CHARACTERI; Yuan SY, 2007, J ENVIRON SCI HEAL B, V42, P63, DOI 10.1080/03601230601020860; Zhang SY, 2012, BIODEGRADATION, V23, P221, DOI 10.1007/s10532-011-9501-1; Zumstein E, 2000, ENVIRON MICROBIOL, V2, P69, DOI 10.1046/j.1462-2920.2000.00072.x	47	18	18	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125552	10.1371/journal.pone.0125552	http://dx.doi.org/10.1371/journal.pone.0125552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874750	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800158
J	Chen, S; Liu, BQ; Kong, DH; Li, S; Li, C; Wang, HQ; Sun, YX				Chen, Shuang; Liu, Baoqin; Kong, Dehui; Li, Si; Li, Chao; Wang, Huaqin; Sun, Yingxian			Atorvastatin Calcium Inhibits Phenotypic Modulation of PDGF-BB-Induced VSMCs via Down-Regulation the Akt Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; INDUCED PROLIFERATION; MAMMALIAN TARGET; VASCULAR INJURY; IN-VIVO; MIGRATION; ATHEROSCLEROSIS; EXPRESSION; DIFFERENTIATION	Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as alpha-SM actin, SM22 alpha and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGFBB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype.	[Chen, Shuang; Sun, Yingxian] China Med Univ, Hosp 1, Dept Cardiol, Shenyang 110001, Liaoning, Peoples R China; [Liu, Baoqin; Kong, Dehui; Li, Si; Li, Chao; Wang, Huaqin] China Med Univ, Dept Biochem & Mol Biol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University	Sun, YX (corresponding author), China Med Univ, Hosp 1, Dept Cardiol, Shenyang 110001, Liaoning, Peoples R China.	yxsun@mail.cmu.edu.cn						Axel DI, 2000, J CARDIOVASC PHARM, V35, P619, DOI 10.1097/00005344-200004000-00016; Babapulle MN, 2002, CIRCULATION, V106, P2859, DOI 10.1161/01.CIR.0000038984.30279.89; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; BLANK RS, 1990, J CELL PHYSIOL, V142, P635, DOI 10.1002/jcp.1041420325; Bochaton-Piallat ML, 2005, HANDB EXP PHARM, V170, P645; Braun-Dullaeus RC, 2001, ARTERIOSCL THROM VAS, V21, P1152, DOI 10.1161/hq0701.092104; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Coats W D Jr, 1997, Semin Interv Cardiol, V2, P167; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; DiNicolantonio JJ, 2013, POSTGRAD MED, V125, P7, DOI 10.3810/pgm.2013.01.2620; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Heldin CH, 1997, FEBS LETT, V410, P17, DOI 10.1016/S0014-5793(97)00318-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Liu DM, 2014, CELL PHYSIOL BIOCHEM, V33, P129, DOI 10.1159/000356656; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Owens GK, 1997, AGENT ACTION SUPPL, V48, P3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Park ES, 2013, EXP CELL RES, V319, P982, DOI 10.1016/j.yexcr.2012.12.024; Rani PU, 2013, J NUTR BIOCHEM, V24, P1830, DOI 10.1016/j.jnutbio.2013.04.004; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sun L, 2012, MOLECULES, V17, P3333, DOI 10.3390/molecules17033333; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhao Y, 2011, CHINESE MED J-PEKING, V124, P4286, DOI 10.3760/cma.j.issn.0366-6999.2011.24.029; Zhu LH, 2013, MOL CELL BIOCHEM, V373, P53, DOI 10.1007/s11010-012-1474-9	39	69	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122577	10.1371/journal.pone.0122577	http://dx.doi.org/10.1371/journal.pone.0122577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874930	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800066
J	Dhar, G; Sen, S; Chaudhuri, G				Dhar, Gautam; Sen, Suvajit; Chaudhuri, Gautam			Acid Gradient across Plasma Membrane Can Drive Phosphate Bond Synthesis in Cancer Cells: Acidic Tumor Milieu as a Potential Energy Source	PLOS ONE			English	Article							ATP SYNTHASE; INORGANIC-PYROPHOSPHATE; EXTRACELLULAR PH; METABOLISM; MICROENVIRONMENT; PHOSPHORYLATION; GLYCOLYSIS; INHIBITORS; DIFFUSION; ADENOSINE	Aggressive cancers exhibit an efficient conversion of high amounts of glucose to lactate accompanied by acid secretion, a phenomenon popularly known as the Warburg effect. The acidic microenvironment and the alkaline cytosol create a proton-gradient (acid gradient) across the plasma membrane that represents proton-motive energy. Increasing experimental data from physiological relevant models suggest that acid gradient stimulates tumor proliferation, and can also support its energy needs. However, direct biochemical evidence linking extracellular acid gradient to generation of intracellular ATP are missing. In this work, we demonstrate that cancer cells can synthesize significant amounts of phosphate-bonds from phosphate in response to acid gradient across plasma membrane. The noted phenomenon exists in absence of glycolysis and mitochondrial ATP synthesis, and is unique to cancer. Biochemical assays using viable cancer cells, and purified plasma membrane vesicles utilizing radioactive phosphate, confirmed phosphate-bond synthesis from free phosphate (Pi), and also localization of this activity to the plasma membrane. In addition to ATP, predominant formation of pyrophosphate (PPi) from Pi was also observed when plasma membrane vesicles from cancer cells were subjected to trans-membrane acid gradient. Cancer cytosols were found capable of converting PPi to ATP, and also stimulate ATP synthesis from Pi from the vesicles. Acid gradient created through glucose metabolism by cancer cells, as observed in tumors, also proved critical for phosphate-bond synthesis. In brief, these observations reveal a role of acidic tumor milieu as a potential energy source and may offer a novel therapeutic target.	[Dhar, Gautam; Sen, Suvajit; Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sen, Suvajit; Chaudhuri, Gautam] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Dhar, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gdhar99@gmail.com; gchaudhuri@mednet.ucla.edu			Carl and Roberta Deutsch Foundation	Carl and Roberta Deutsch Foundation	This work was supported by grants to GC from the Carl and Roberta Deutsch Foundation and Kelly Day. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; DAVIES JM, 1993, BIOCHIM BIOPHYS ACTA, V1141, P29, DOI 10.1016/0005-2728(93)90185-I; Drose S, 1997, J EXP BIOL, V200, P1; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fitzgerald RC, 1997, J CELL SCI, V110, P663; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Helenius M, 2012, BBA-MOL CELL RES, V1823, P1967, DOI 10.1016/j.bbamcr.2012.08.001; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Lehninger A., 1993, PRINCIPLES BIOCH; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitchell P, 1977, Annu Rev Biochem, V46, P996, DOI 10.1146/annurev.bi.46.070177.005024; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; NG TC, 1989, RADIOLOGY, V170, P875, DOI 10.1148/radiology.170.3.2916046; OBERHAENSLI RD, 1986, LANCET, V2, P8, DOI 10.1016/S0140-6736(86)92558-4; Quillen EE, 2006, J BIOL CHEM, V281, P20728, DOI 10.1074/jbc.M513042200; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; VAUPEL P, 1989, CANCER RES, V49, P6449; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZACHOWSKI A, 1974, BIOCHEM BIOPH RES CO, V57, P787, DOI 10.1016/0006-291X(74)90615-9	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124070	10.1371/journal.pone.0124070	http://dx.doi.org/10.1371/journal.pone.0124070			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874623	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800130
J	Fuzita, FJ; Pinkse, MWH; Patane, JSL; Juliano, MA; Verhaert, PDEM; Lopes, AR				Fuzita, Felipe J.; Pinkse, Martijn W. H.; Patane, Jose S. L.; Juliano, Maria A.; Verhaert, Peter D. E. M.; Lopes, Adriana R.			Biochemical, Transcriptomic and Proteomic Analyses of Digestion in the Scorpion Tityus serrulatus: Insights into Function and Evolution of Digestion in an Ancient Arthropod	PLOS ONE			English	Article							CARCINOGENIC LIVER FLUKE; CATHEPSIN-F; CYSTEINE PROTEASE; MOLECULAR-CLONING; ASPARAGINYL ENDOPEPTIDASE; HARD TICK; ENZYMATIC CHARACTERIZATION; OPISTHORCHIS-VIVERRINI; SUBSTRATE-SPECIFICITY; PERITROPHIC MEMBRANES	Scorpions are among the oldest terrestrial arthropods and they have passed through small morphological changes during their evolutionary history on land. They are efficient predators capable of capturing and consuming large preys and due to envenomation these animals can become a human health challenge. Understanding the physiology of scorpions can not only lead to evolutionary insights but also is a crucial step in the development of control strategies. However, the digestive process in scorpions has been scarcely studied. In this work, we describe the combinatory use of next generation sequencing, proteomic analysis and biochemical assays in order to investigate the digestive process in the yellow scorpion Tityus serrulatus, mainly focusing in the initial protein digestion. The transcriptome generated database allowed the quantitative identification by mass spectrometry of different enzymes and proteins involved in digestion. All the results suggested that cysteine cathepsins play an important role in protein digestion. Two digestive cysteine cathepsins were isolated and characterized presenting acidic characteristics (pH optima and stability), zymogen conversion to the mature form after acidic activation and a cross-class inhibition by pepstatin. A more elucidative picture of the molecular mechanism of digestion in a scorpion was proposed based on our results from Tityus serrulatus. The midgut and midgut glands (MMG) are composed by secretory and digestive cells. In fasting animals, the secretory granules are ready for the next predation event, containing enzymes needed for alkaline extra-oral digestion which will compose the digestive fluid, such as trypsins, astacins and chitinase. The digestive vacuoles are filled with an acidic proteolytic cocktail to the intracellular digestion composed by cathepsins L, B, F, D and legumain. Other proteins as lipases, carbohydrases, ctenitoxins and a chitolectin with a perithrophin domain were also detected. Evolutionarily, a large gene duplication of cathepsin L occurred in Arachnida with the sequences from ticks being completely divergent from other arachnids probably due to the particular selective pressures over this group.	[Fuzita, Felipe J.; Lopes, Adriana R.] Inst Butantan, Biochem & Biophys Lab, Sao Paulo, Brazil; [Fuzita, Felipe J.] Univ Sao Paulo, Biotechnol Program, Sao Paulo, Brazil; [Pinkse, Martijn W. H.; Verhaert, Peter D. E. M.] Delft Univ Technol, Lab Analyt Biotechnol & Innovat Peptide Biol, Delft, Netherlands; [Patane, Jose S. L.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Delft University of Technology; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Lopes, AR (corresponding author), Inst Butantan, Biochem & Biophys Lab, Sao Paulo, Brazil.	adriana.lopes@butantan.gov.br	Lopes, Adriana Rios/Y-9957-2019; Lopes, Adriana/I-9551-2014	Lopes, Adriana Rios/0000-0002-9741-2110; Lopes, Adriana/0000-0002-9741-2110; Fuzita, Felipe/0000-0002-0966-4183; Verhaert, Peter/0000-0002-6921-087X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2005/02486-1, 2006/03474-0]; Conselho Nacional de desenvolvimento cientifico e tecnologico Science [237706/2012-1]; Coordenacao de aperfeicoamento de pessoal de nivel superior; Netherlands Proteomics Centre	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de desenvolvimento cientifico e tecnologico Science(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Netherlands Proteomics Centre	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2005/02486-1) (www.fapesp.br) to ARL, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2006/03474-0 to FJF and ARL, Conselho Nacional de desenvolvimento cientifico e tecnologico Science without Borders 237706/2012-1 to FJF (www.cnpq.br), Coordenacao de aperfeicoamento de pessoal de nivel superior to FJF (www.capes.gov.br), and Netherlands Proteomics Centre to PDEMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Ahn SJ, 2009, COMP BIOCHEM PHYS B, V154, P211, DOI 10.1016/j.cbpb.2009.06.005; ALBERTI G, 1983, ZOOL ANZ, V211, P145; Alexandre D, 2014, COMP BIOCHEM PHYS B, V172, P90, DOI [10.1016/j.cbpb.201404.010, 10.1016/j.cbpb.2014.04.010]; Alim MA, 2008, J INSECT PHYSIOL, V54, P573, DOI 10.1016/j.jinsphys.2007.12.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki H, 2003, J BIOCHEM, V133, P799, DOI 10.1093/jb/mvg102; BECKER A, 1985, ZOOMORPHOLOGY, V105, P326, DOI 10.1007/BF00312064; Beynon R, 2001, PROTEOLYTIC ENZYMES, P340; Brusca RC, 2002, INVERTEBRATES, P895; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chajec L, 2012, INVERTEBR BIOL, V131, P119, DOI 10.1111/j.1744-7410.2012.00264.x; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cristofoletti PT, 2005, INSECT BIOCHEM MOLEC, V35, P883, DOI 10.1016/j.ibmb.2005.03.006; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontanetti Carmem Silvia, 2001, Naturalia (Rio Claro), V26, P35; Foradori MJ, 2006, COMP BIOCHEM PHYS B, V143, P257, DOI 10.1016/j.cbpb.2005.08.012; Franta Z, 2011, INT J PARASITOL, V41, P1253, DOI 10.1016/j.ijpara.2011.06.006; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; GOYFFON M, 1983, CELL TISSUE RES, V228, P661, DOI 10.1007/BF00211482; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Hu KJ, 2004, COMP BIOCHEM PHYS B, V137, P21, DOI 10.1016/j.cbpc.2003.09.010; INOMATA M, 1984, J BIOCHEM-TOKYO, V95, P1661, DOI 10.1093/oxfordjournals.jbchem.a134779; Jensen AG, 2007, BIOCHEM J, V402, P449, DOI 10.1042/BJ20061205; Kang JM, 2010, MOL BIOCHEM PARASIT, V170, P7, DOI 10.1016/j.molbiopara.2009.11.006; Kang TH, 2004, PARASITOLOGY, V128, P195, DOI 10.1017/S0031182003004335; KAVANAGH EJ, 1983, COMP BIOCHEM PHYS B, V74, P365, DOI 10.1016/0305-0491(83)90026-3; Kjellesvig-Waering EN, 1986, RESTUDY FOSSIL SCORP, P287; Laha T, 2008, INT J INFECT DIS, V12, pE49, DOI 10.1016/j.ijid.2008.03.033; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Legros C, 1998, FEBS LETT, V431, P375, DOI 10.1016/S0014-5793(98)00780-7; Liebensteiner MG, 2013, SCIENCE, V340, P85, DOI 10.1126/science.1233957; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu XW, 2010, MOL CELL PROTEOMICS, V9, P2772, DOI 10.1074/mcp.M110.002766; Lopes AR, 2006, INSECT BIOCHEM MOLEC, V36, P130, DOI 10.1016/j.ibmb.2005.11.006; Louati H, 2011, LIPIDS HLTH DIS, V858, P853; Louati H, 2010, J CHROMATOGR B, V878, P853, DOI 10.1016/j.jchromb.2010.01.047; LUDWIG M, 1990, Acta Zoologica Fennica, P255; Martinez R, 2011, AQUACULT INT, V19, P445, DOI 10.1007/s10499-010-9360-5; Melo RL, 2001, ANAL BIOCHEM, V293, P71, DOI 10.1006/abio.2001.5115; Miyaji T, 2010, INSECT BIOCHEM MOLEC, V40, P835, DOI 10.1016/j.ibmb.2010.08.003; Miyoshi T, 2004, J VET MED SCI, V66, P1195, DOI 10.1292/jvms.66.1195; Mohien CU, 2013, MOL CELL PROTEOMICS, V12, P120, DOI 10.1074/mcp.M112.019596; MOMMSEN TP, 1978, J COMP PHYSIOL, V127, P355, DOI 10.1007/BF00738421; MOMMSEN TP, 1978, COMP BIOCHEM PHYS A, V60, P365, DOI 10.1016/0300-9629(78)90001-4; Mulenga A, 1999, JPN J VET RES, V46, P179; Muth T, 2010, PROTEOMICS, V10, P1522, DOI 10.1002/pmic.200900759; Myers J, 2008, J PARASITOL, V94, P659, DOI 10.1645/GE-1410.1; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Oliver EM, 2006, PARASITOLOGY, V133, P237, DOI 10.1017/S0031182006000229; Padilha MHP, 2009, INSECT BIOCHEM MOLEC, V39, P782, DOI 10.1016/j.ibmb.2009.09.003; Pavlovsky EN, 1926, Q J MICROSC SCI, V70, P221; Pinlaor P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000398; Polis GA, 1990, BIOL SCORPIONS, P233; Pough F.H., 2012, VERTEBRATE LIFE; Rates B, 2008, TOXICON, V52, P611, DOI 10.1016/j.toxicon.2008.07.010; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1; Redmond DL, 2006, INT J PARASITOL, V36, P277, DOI 10.1016/j.ijpara.2005.10.011; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Renard G, 2002, INSECT MOL BIOL, V11, P325, DOI 10.1046/j.1365-2583.2002.00342.x; Rojo L, 2010, MAR BIOTECHNOL, V12, P696, DOI 10.1007/s10126-010-9257-3; Said EE, 1958, P EGIPTIAL ACAD SCI, V13, P55; Sarin E, 1922, BIOCHEM Z, V129, P359; SCHMIDT PG, 1982, BIOCHEMISTRY-US, V21, P6710, DOI 10.1021/bi00269a015; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Segel I.H., 1975, ENZYME KINETICS; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; SHUTOV AD, 1982, BIOCHEMISTRY-MOSCOW+, V47, P678; Shutov AD, 2012, J PLANT PHYSIOL, V169, P319, DOI 10.1016/j.jplph.2011.11.005; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sobotnik J, 2008, J MORPHOL, V269, P54, DOI 10.1002/jmor.10573; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Sripa J, 2010, CELL MICROBIOL, V12, P781, DOI 10.1111/j.1462-5822.2010.01433.x; Stephens A, 2012, COMP BIOCHEM PHYS B, V161, P32, DOI 10.1016/j.cbpb.2011.09.004; Strojan P, 2000, CLIN CANCER RES, V6, P1052; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teng L, 2010, BIOSCIENCE REP, V30, P177, DOI 10.1042/BSR20090049; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; Turk B, 1999, EUR J BIOCHEM, V259, P926, DOI 10.1046/j.1432-1327.1999.00145.x; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VANDERBO.O, 1966, NATURE, V210, P751, DOI 10.1038/210751b0; Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000; Yamaji K, 2009, PARASITOL INT, V58, P232, DOI 10.1016/j.parint.2009.05.003; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zouari N, 2005, BBA-GEN SUBJECTS, V1726, P67, DOI 10.1016/j.bbagen.2005.08.005; Zouari N, 2006, BBA-GEN SUBJECTS, V1760, P1386, DOI 10.1016/j.bbagen.2006.02.009	97	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123841	10.1371/journal.pone.0123841	http://dx.doi.org/10.1371/journal.pone.0123841			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875018	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800119
J	Visram, A; Chan, KKW; McGee, P; Boro, J; Hicks, LK; Feld, JJ				Visram, Alissa; Chan, Kelvin K. W.; McGee, Phyllis; Boro, Jordana; Hicks, Lisa K.; Feld, Jordan J.			Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; VIRUS HBV REACTIVATION; CYTOTOXIC CHEMOTHERAPY; RHEUMATOID-ARTHRITIS; COST-EFFECTIVENESS; CANCER-PATIENTS; INFECTION; MANAGEMENT; LAMIVUDINE; LYMPHOMA	Background Reactivation of hepatitis B virus (HBV) during immunosuppressive therapy (IST) can lead to severe and even fatal hepatitis but can be largely prevented with prophylactic antiviral therapy. Screening for HBV prior to starting IST is recommended. Both risk-based and universal screening have been recommended by different societies. For effective risk-based screening, physicians must be aware of risk factors for chronic HBV infection. Methods The HBV screening practices prior to starting IST of rheumatologists, medical and hematological oncologists were evaluated by survey and chart review. Country of origin, the primary risk factor for HBV exposure, was determined in all patients. Results Of 140 rheumatology, 79 medical oncology and 53 hematology patients reviewed, 81%, 11% and 81% were deemed to be at high risk of HBV reactivation by their physicians respectively, however only 27%, 6% and 62% (p<0.0001) were actually screened for HBV prior to starting IST. For patients from HBV-endemic regions, more hematology patients (53%) were correctly identified by their physicians as being at high risk of reactivation than rheumatology patients (2.4%, p=0.0001) or medical oncology patients (15%, p=0.009). However actual screening rates were not increased in patients from endemic regions. A total of 81 patients were screened for HBsAg; 2 were positive. Of the 33 patients screened for anti-HBc, 10 (30%) were positive. Conclusions Hematologists, rheumatologists and medical oncologists had low rates of screening for HBV prior to prescribing IST, largely due to poor identification of those at risk for infection. Risk-based screening strategies are unlikely to be effective and should be replaced by universal screening.	[Visram, Alissa; Feld, Jordan J.] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Hicks, Lisa K.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Chan, Kelvin K. W.; Boro, Jordana] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [McGee, Phyllis] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Visram, A (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada.	avisram@toh.on.ca	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Hicks, Lisa/0000-0003-1858-7420	Canadian Liver Foundation	Canadian Liver Foundation	AV received the Summer Studentship Research Grant from the Canadian Liver Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL is listed below: http://www.liver.ca/liver-education-liver-research/research/grant-programs/Grant_Recipients.aspx.	Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Corporation A, 2014, PROD MON; Corporation I, 2013, PROD MON; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; Day FL, 2011, J CLIN ONCOL, V29, P3270, DOI 10.1200/JCO.2011.35.1635; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; HOOFNAGLE JH, 1982, ANN INTERN MED, V96, P447, DOI 10.7326/0003-4819-96-4-447; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Inc. J. Remicade (infliximab), 2011, PROD MON; Khokhar OS, 2009, CHEMOTHERAPY, V55, P69, DOI 10.1159/000183731; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lee RSM, 2012, J ONCOL PRACT, V8, P325, DOI 10.1200/JOP.2012.000597; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Li YH, 2006, CANCER-AM CANCER SOC, V106, P1320, DOI 10.1002/cncr.21701; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Minuk G Y, 2001, Can J Infect Dis, V12, P351; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Tran TT, 2010, ALIMENT PHARM THER, V31, P240, DOI 10.1111/j.1365-2036.2009.04158.x; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Zurawska U, 2012, J CLIN ONCOL, V30, P3167, DOI 10.1200/JCO.2011.40.7510	35	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120749	10.1371/journal.pone.0120749	http://dx.doi.org/10.1371/journal.pone.0120749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875198	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800013
J	Bernardes, PTT; Rezende, BM; Resende, CB; De Paula, TP; Reis, AC; Goncalves, WA; Vieira, EG; Pinheiro, MVB; Souza, DG; Castor, MGM; Teixeira, MM; Pinho, V				Bernardes, Priscila T. T.; Rezende, Barbara M.; Resende, Carolina B.; De Paula, Talles P.; Reis, Alesandra C.; Goncalves, William A.; Vieira, Elias G.; Pinheiro, Mauricio V. B.; Souza, Danielle G.; Castor, Marina G. M.; Teixeira, Mauro M.; Pinho, Vanessa			Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects	PLOS ONE			English	Article							FULLERENOL C-60(OH)(24); MARROW-TRANSPLANTATION; LEUKOCYTE RECRUITMENT; TISSUE-INJURY; LIFE-SPAN; IN-VIVO; LIVER; RATS; HEPATOTOXICITY; PATHOGENESIS	Graft versus host disease (GVHD) is an immunological disorder triggered by bone marrow transplantation that affects several organs, including the gastrointestinal tract and liver. Fullerenes and their soluble forms, fullerols, are nanocomposites with a closed symmetrical structure with anti-inflammatory and anti-oxidant properties. The present study evaluated the effects of treatment with the fullerol (C60(OH)18-20) in the development and pathogenesis of GVHD in a murine model. Mice with experimental GVHD that were treated with the fullerol showed reduced clinical signs of disease and mortality compared with untreated mice. Treatment with the fullerol decreased the hepatic damage associated with reduced hepatic levels of reactive oxygen species, pro-inflammatory cytokines and chemokines (IFN-gamma TNF-alpha, CCL2, CCL3 and CCL5) and reduced leukocyte accumulation. The amelioration of GVHD after treatment with the fullerol was also associated with reduced intestinal lesions and consequent bacterial translocation to the blood, liver and peritoneal cavity. Moreover, the fullerol treatment alleviated the GVHD while preserving effects of the graft against a leukemia cell line (GFP+P815). In summary, the fullerol was effective in reducing the GVHD inflammatory response in mice and may suggest novel ways to treat this disease.	[Bernardes, Priscila T. T.; Rezende, Barbara M.; Resende, Carolina B.; Reis, Alesandra C.; Goncalves, William A.; Castor, Marina G. M.; Pinho, Vanessa] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil; [De Paula, Talles P.; Souza, Danielle G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Interacao Microorganismo & Hospedeiro, Belo Horizonte, MG, Brazil; [Vieira, Elias G.; Pinheiro, Mauricio V. B.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, Lab Ressonancia Paramagnet, Belo Horizonte, MG, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Pinho, V (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil.	vpinho@icb.ufmg.br	Pinho, Vanessa/GXM-8532-2022; pinho, vanessa/AAC-8437-2020; Gonçalves, William Antonio/AAC-7156-2021; Rezende, BM/G-7071-2018; Pinho, Vanessa/AAR-1686-2021; Teixeira, Mauro M/A-4587-2008; Pinheiro, Maurício Veloso Brant/N-7746-2017	pinho, vanessa/0000-0003-1038-2324; Rezende, BM/0000-0001-7959-7732; Teixeira, Mauro M/0000-0002-6944-3008; Pinheiro, Maurício Veloso Brant/0000-0001-5722-6260; Gomes Miranda e Castor, Marina/0000-0003-4129-8715; Goncalves, William/0000-0001-6960-4337	Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); NANOVALID	Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NANOVALID	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and NANOVALID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves GC, 2006, J BRAZIL CHEM SOC, V17, P1186, DOI 10.1590/S0103-50532006000600017; Amaral SS, 2013, CELL COMMUN SIGNAL, V11, P2, DOI [10.1186/1478-811X-11-2, DOI 10.1186/1478-811X-11-2]; Baati T, 2012, BIOMATERIALS, V33, P4936, DOI 10.1016/j.biomaterials.2012.03.036; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barcelos LS, 2004, INFLAMM RES, V53, P576, DOI 10.1007/s00011-004-1299-4; BEELEN DW, 1992, BLOOD, V80, P2668; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Bouazzaoui A, 2009, GENES IMMUN, V10, P687, DOI 10.1038/gene.2009.49; Britto RS, 2012, AQUAT TOXICOL, V114, P80, DOI 10.1016/j.aquatox.2012.02.018; Castor MGM, 2012, J LEUKOCYTE BIOL, V91, P629, DOI 10.1189/jlb.1111561; Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464; Castor MGM, 2010, J IMMUNOL, V184, P2646, DOI 10.4049/jimmunol.0902614; Choi Jung Hwa, 2011, Immune Netw, V11, P68, DOI 10.4110/in.2011.11.1.68; Choi SW, 2010, IMMUNOL ALLERGY CLIN, V30, P75, DOI 10.1016/j.iac.2009.10.001; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; El-Hayek JM, 2005, J LEUKOCYTE BIOL, V78, P1001, DOI 10.1189/jlb.1204730; Ferrara JLM, 2007, BEST PRACT RES CL HA, V20, P91, DOI 10.1016/j.beha.2006.11.004; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fujii N, 2001, BONE MARROW TRANSPL, V27, P1007, DOI 10.1038/sj.bmt.1702997; Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b; Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o; Injac R, 2008, BIOMATERIALS, V29, P3451, DOI 10.1016/j.biomaterials.2008.04.048; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Irani JL, 2008, ARCH SURG-CHICAGO, V143, P1041, DOI 10.1001/archsurg.143.11.1041; Jacobsohn DA, 2004, CURR PHARM DESIGN, V10, P1195, DOI 10.2174/1381612043452569; Kim BK, 2000, BONE MARROW TRANSPL, V26, P193, DOI 10.1038/sj.bmt.1702453; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183; ordevic A., 2008, ARCH ONCOL, V16, P42, DOI [10.2298/AOO0804042D, DOI 10.2298/AOO0804042D, DOI 10.2298/AOO0804042]; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Rezende BM, 2013, MAR DRUGS, V11, P2595, DOI 10.3390/md11072595; Robb RJ, 2012, BLOOD, V119, P5351, DOI 10.1182/blood-2012-02-368076; Roberts JE, 2008, TOXICOL APPL PHARM, V228, P49, DOI 10.1016/j.taap.2007.12.010; Sardenberg RB, 2011, ACS NANO, V5, P2681, DOI 10.1021/nn102913p; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Serody JS, 2000, BLOOD, V96, P2973; Souza DG, 2002, EUR J PHARMACOL, V440, P61, DOI 10.1016/S0014-2999(02)01313-4; Strasser SI, 2000, HEPATOLOGY, V32, P1265, DOI 10.1053/jhep.2000.20067; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Tuncer HH, 2012, WORLD J GASTROENTERO, V18, P1851, DOI 10.3748/wjg.v18.i16.1851; Vago L, 2012, SEMIN ONCOL, V39, P707, DOI 10.1053/j.seminoncol.2012.09.009; Wysocki CA, 2005, BLOOD, V105, P4191, DOI 10.1182/blood-2004-12-4726; Yudoh K, 2009, INT J NANOMED, V4, P217	46	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123004	10.1371/journal.pone.0123004	http://dx.doi.org/10.1371/journal.pone.0123004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875016	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100126
J	Chen, T; Wang, QQ; Qin, Y; Chen, X; Yang, XX; Lou, W; Zhou, MK; He, GX; Lu, K				Chen, Tao; Wang, Qiqi; Qin, Yu; Chen, Xi; Yang, Xiaoxiong; Lou, Wei; Zhou, Mikang; He, Guangxue; Lu, Kai			Knowledge, Attitudes and Practice of Desalinated Water among Professionals in Health and Water Departments in Shengsi, China: A Qualitative Study	PLOS ONE			English	Article							DRINKING-WATER; CARDIOVASCULAR MORTALITY; MAGNESIUM; CALCIUM; FUTURE; RISK	Desalination has been considered as an essential way to solve water stress all over the world. Most of previous studies focused on its environmental impacts, energy consumption and desalination technologies rather than human health. However, the safety of desalinated water remains unclear. This study was undertaken to investigate the knowledge, attitude and practice (KAP) of the residents in an island county in eastern China to desalinated water. Seventeen people working in medical and water industries were recruited, and focus group discussion and in-depth interview were conducted among them. Our results showed that the majority of people interviewed knew the definition and local supply pattern of desalinated water, while some of them showed some concern about the safety and nutrition of desalinated water. Current drinking water standard has no specific item for desalination, so we strongly suggest issuing a standard for desalinated water.	[Chen, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Qiqi; Qin, Yu; He, Guangxue; Lu, Kai] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Chen, Xi; Yang, Xiaoxiong] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing, Peoples R China; [Yang, Xiaoxiong; Lou, Wei; Zhou, Mikang] Shengsi Cty Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Lu, K (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	lukai263@126.com		Chen, Xi/0000-0002-7775-8210	public science and technology research funds projects of ocean [201305039-6]; research special fund for public welfare industry of health [201302004]	public science and technology research funds projects of ocean; research special fund for public welfare industry of health	This study was supported by: the public science and technology research funds projects of ocean (grant no. 201305039-6) (http://www.soa.gov.cn/); the research special fund for public welfare industry of health (grant no. 201302004) (http://www.nhfpc.gov.cn/qjjys/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUIDELINES FOR DRINK; Chiu HF, 2011, J TOXICOL ENV HEAL A, V74, P62, DOI 10.1080/15287394.2010.514236; Cotruvo J, 2010, DESALINATION TECHNOL; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Kousa A, 2004, J EPIDEMIOL COMMUN H, V58, P136, DOI 10.1136/jech.58.2.136; Marque S, 2003, EUR J EPIDEMIOL, V18, P305, DOI 10.1023/A:1023618728056; Ministry of Health of People's Republic of China Standard for drinking water quality, 2006, GB5749 2006; Ministry of Science and Technology of People's Republic of China & National Development and Reform Commission, 2012, THE 12TH FIVE YEAR P; Nerbrand C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-21; Ni H, 2010, CHINESE J HEALTH LAB, V20, P162; Penate B, 2012, DESALINATION, V284, P1, DOI 10.1016/j.desal.2011.09.010; Service RF, 2006, SCIENCE, V313, P1088, DOI 10.1126/science.313.5790.1088; Tsiourtis NX, 2001, DESALINATION, V141, P223, DOI 10.1016/S0011-9164(01)85001-3; von Medeazza GLM, 2005, DESALINATION, V185, P57, DOI 10.1016/j.desal.2005.03.071; WHO, WHO HSE WSH 11 03 20; WHO, 2009, BORON IN DRINKING WA; Zhang, 2007, CHIN J HLTH LAB TECH, V17, P371, DOI [10.3969/j.issn.1004-8685.2007.02.081, DOI 10.3969/J.ISSN.1004-8685.2007.02.081]; Zhang YongLi, 2012, Journal of Environmental & Occupational Medicine, V29, P681; Zhao HX, 2001, DIABETIC MED, V18, P709, DOI 10.1046/j.1464-5491.2001.00554.x; [赵欣 Zhao Xin], 2013, [环境与健康杂志, Journal of Environment and Health], V30, P335	20	15	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118360	10.1371/journal.pone.0118360	http://dx.doi.org/10.1371/journal.pone.0118360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874459	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100005
J	Corneli, A; Perry, B; Agot, K; Ahmed, K; Malamatsho, F; Van Damme, L				Corneli, Amy; Perry, Brian; Agot, Kawango; Ahmed, Khatija; Malamatsho, Fulufhelo; Van Damme, Lut			Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; TENOFOVIR GEL; ACCEPTABILITY; MICROBICIDE; PARTICIPANTS; INFECTION; MISCONCEPTION; INTERVENTION	Introduction FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of recent pill use. We conducted a follow-up study to identify, among other topics, participants' reasons for taking the study pill. Methods Qualitative, semi-structured interviews (SSIs) were conducted with 88 FEM-PrEP participants. Participants were purposefully selected based on their adherence drug concentrations collected during FEM-PrEP and placed into three adherence interview groups: "high," "moderate," and "none/scarce." Participants in the high and moderate groups described reasons why they adhered most or some of the time, including factors that facilitated their adherence. Participants in all groups described what they believed made it possible for other FEM-PrEP participants to adhere. In addition, 224 FEM-PrEP participants reported on their reasons for taking the study pills through a quantitative, audio computer-assisted self-interview (ACASI). Thematic analysis and descriptive statistics were used to analyze the qualitative and quantitative data, respectively. Results Five themes were identified from the SSIs as facilitating factors of adherence: 1) participants' support for the research, 2) HIV risk reduction, 3) routine formation and use of tools, 4) adherence counseling, and 5) partner awareness and support. Participants described similar facilitators when they spoke about other participants' adherence. Among the 172 participants who reported in ACASI that they had taken a study pill, wanting to help answer the research question was the most frequently stated reason for taking the pills (94%, n = 161). We also found evidence of preventive misconception. Conclusions Adherence was facilitated by personal motivations, such as risk reduction and interest in the research outcome, and by adherence strategies consisting of external cues, reminders, and support. These findings can inform future HIV prevention clinical trials and the rollout of effective antiretroviral-based HIV prevention technologies for women.	[Corneli, Amy; Perry, Brian; Van Damme, Lut] FHI 360, Durham, NC 27701 USA; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ahmed, Khatija; Malamatsho, Fulufhelo] Setshaba Res Ctr, Soshanguve, South Africa	FHI 360	Corneli, A (corresponding author), FHI 360, Durham, NC 27701 USA.	acorneli@fhi360.org		ahmed, khatija/0000-0003-0309-1641; Corneli, Amy/0000-0002-4629-4329; Perry, Brian/0000-0002-4648-7673	United States Agency for International Development (USAID); Contraceptive and Reproductive Health Technologies and Research Utilization Program; Preventive Technologies Agreement [GHO A 00 09 00016-00]; Bill & Melinda Gates Foundation; NIH [P30 AI50410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies and Research Utilization Program; Preventive Technologies Agreement; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	FEM-PrEP was conducted under two grants funded by the United States Agency for International Development (USAID): the Contraceptive and Reproductive Health Technologies and Research Utilization Program, and the Preventive Technologies Agreement No. GHO A 00 09 00016-00. Early support was also provided by the Bill & Melinda Gates Foundation. The drug concentration analyses were performed using equipment provided by the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot K, 2014, AIDS BEHAV; Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bayer AM, 2010, CULT HEALTH SEX, V12, P771, DOI [10.1080/13691058.2010.488299, 10.1080/13691051003728599]; Carballo-Dieguez A, 2007, AIDS CARE, V19, P1026, DOI 10.1080/09540120701294237; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Corneli A, 2014, CONFERENCE ON RETROV; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Corneli AL, 2015, JAIDS-J ACQ IMM DEF, V68, P578, DOI 10.1097/QAI.0000000000000525; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Dellar RC, 2014, AIDS BEHAV, V18, P1746, DOI 10.1007/s10461-014-0771-6; Donnell D, 2014, J ACQUIR IMMUNE DEFI; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2012, APPLIED THEMATIC ANA; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Lanham Michele, 2014, J Int AIDS Soc, V17, P19159, DOI 10.7448/IAS.17.3.19159; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McLellan E., 2003, FIELD METHOD, V15, P63, DOI [DOI 10.1177/1525822X02239573, 10.1177/1525822X02239573]; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Psaros C, 2014, JAIDS-J ACQ IMM DEF, V66, P522, DOI 10.1097/QAI.0000000000000212; QSR International Pty Ltd, 2013, NVIVO QUALITATIVE DA; Simon AE, 2007, AM J PREV MED, V32, P370, DOI 10.1016/j.amepre.2007.01.007; Sugarman J, 2015, AM J BIOETH EMP RESE; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van der Straten A, 2014, AIDS BEHAV; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Woodsong C, 2004, INT FAM PLAN PERSPEC, V30, P94, DOI 10.1363/3009404; Woodsong C, 2012, AIDS BEHAV, V16, P785, DOI 10.1007/s10461-011-0027-7	33	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125458	10.1371/journal.pone.0125458	http://dx.doi.org/10.1371/journal.pone.0125458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867624	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100293
J	Koga, M; Gilbert, M; Li, JJ; Yuki, N				Koga, Michiaki; Gilbert, Michel; Li, Jianjun; Yuki, Nobuhiro			Complex of GM1-and GD1a-Like Lipo-Oligosaccharide Mimics GM1b, Inducing Anti-GM1b Antibodies	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; MOTOR AXONAL NEUROPATHY; CAMPYLOBACTER-JEJUNI; CLINICAL-FEATURES; FISHER-SYNDROME; GANGLIOSIDE; LIPOOLIGOSACCHARIDE; IGG; ANTIGENS; MODEL	Objective Molecular mimicry between Campylobacter jejuni lipo-oligosaccharides (LOSs) and human gangliosides GM1 and GD1a induces the production of anti-GM1 and anti-GD1a antibodies, and the development of Guillain-Barre syndrome. Complexes of two different gangliosides form new molecular shapes capable of enhancing recognition by anti-ganglioside antibodies. To test the hypothesis that the complex of GM1-like and GD1a-like LOSs of C. jejuni induces the development of anti-GM1b antibodies in Guillain-Barre syndrome patients. Methods Mass spectrometry analysis determined the LOS outer core structures, with which mice were immunized. IgG antibodies to single gangliosides and complex of gangliosides were tested in sera from Guillain-Barre syndrome patients from whom C. jejuni LOS had been isolated. Results Two isolates from GBS patients who had anti-GM1b antibodies, but neither anti-GM1 nor -GD1a antibodies, expressed both GM1-like and GD1a-like LOSs, but not GM1b-like LOS. Anti-GM1b antibodies were induced in one of the mice immunized with the C. jejuni bearing GM1-like and GD1a-like LOS. Sera from 20 patients had antibodies to the complex of GM1 and GD1a, all of which carried anti-GM1b reactivity. Five of these sera harbored neither anti-GM1 nor anti-GD1a antibodies. IgG antibodies to the complex were absorbed by GM1b, but by neither GM1 nor GD1a. Conclusions GM1-like and GD1a-like LOSs form a GM1b epitope, inducing the development of anti-GM1b antibodies in patients with Guillain-Barre syndrome subsequent to C. jejuni enteritis. Here, we present a new paradigm that the complex of two different structures forms a new molecular mimicry, inducing the production of autoantibodies.	[Koga, Michiaki; Yuki, Nobuhiro] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Koga, Michiaki] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON, Canada; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Dokkyo Medical University; Yamaguchi University; National Research Council Canada; National University of Singapore; National University of Singapore	Yuki, N (corresponding author), Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan.	mdcyuki@nus.edu.sg	Koga, Michiaki/L-4825-2019	Koga, Michiaki/0000-0002-1356-955X; Li, Jianjun/0000-0002-6531-3687; Gilbert, Michel/0000-0002-0204-4408	Human Frontier Science Program [RGP0038/2003-C]; Singapore National Medical Research Council IRG [10nov086]; Singapore National Medical Research Council [CSA/047/2012]; Grants-in-Aid for Scientific Research [15K08464] Funding Source: KAKEN	Human Frontier Science Program(Human Frontier Science Program); Singapore National Medical Research Council IRG(National Medical Research Council, Singapore); Singapore National Medical Research Council(National Medical Research Council, Singapore); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Human Frontier Science Program RGP0038/2003-C, www.hfsp.org/funding/research-grants; Singapore National Medical Research Council IRG 10nov086, www.nmrc.gov.sg/; Singapore National Medical Research Council CSA/047/2012, www.nmrc.gov.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Funakoshi K, 2009, J NEUROL NEUROSUR PS, V80, P60, DOI 10.1136/jnnp.2008.154351; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Koga M, 2005, J NEUROL NEUROSUR PS, V76, P1736, DOI 10.1136/jnnp.2005.065359; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Koga M, 2002, J NEUROL NEUROSUR PS, V72, P767, DOI 10.1136/jnnp.72.6.767; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuijf ML, 2007, J NEUROIMMUNOL, V188, P69, DOI 10.1016/j.jneuroim.2007.05.014; Kusunoki S, 1996, NEUROLOGY, V47, P237, DOI 10.1212/WNL.47.1.237; Li JJ, 2005, ELECTROPHORESIS, V26, P3360, DOI 10.1002/elps.200500145; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Ogawara K, 2003, J NEUROL SCI, V210, P41, DOI 10.1016/S0022-510X(03)00013-3; Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Yuki N, 1997, J NEUROIMMUNOL, V74, P30, DOI 10.1016/S0165-5728(96)00201-9; Yuki N, 2000, ANN NEUROL, V47, P314, DOI 10.1002/1531-8249(200003)47:3<314::AID-ANA6>3.3.CO;2-3	24	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124004	10.1371/journal.pone.0124004	http://dx.doi.org/10.1371/journal.pone.0124004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867522	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100232
J	Kong, LB; Li, SS; Huang, MJ; Xiong, Y; Zhang, QH; Ye, L; Liu, J; Zhu, XD; Sun, RN; Guo, YL				Kong, Lingbao; Li, Shanshan; Huang, Mingjie; Xiong, Ying; Zhang, Qinghua; Ye, Li; Liu, Jing; Zhu, Xiangdong; Sun, Ruina; Guo, Yunli			The Roles of Endoplasmic Reticulum Overload Response Induced by HCV and NS4B Protein in Human Hepatocyte Viability and Virus Replication	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED APOPTOSIS; EXPRESSION; ACTIVATION; CANCER; CORE; INFLAMMATION; INHIBITION; STRESS; ALPHA	Hepatitis C virus (HCV) replication is associated with endoplasmic reticulum (ER) and its infection triggers ER stress. In response to ER stress, ER overload response (EOR) can be activated, which involves the release of Ca2+ from ER, production of reactive oxygen species (ROS) and activation of nuclear factor kappa B (NF-kappa B). We have previously reported that HCV NS4B expression activates NF-kappa B via EOR-Ca2+-ROS pathway. Here, we showed that NS4B expression and HCV infection activated cancer-related NF-kappa B signaling pathway and induced the expression of cancer-related NF-kappa B target genes via EOR-Ca2+-ROS pathway. Moreover, we found that HCV-activated EOR-Ca2+-ROS pathway had profound effects on host cell viability and HCV replication. HCV infection induced human hepatocyte death by EOR-Ca2+-ROS pathway, whereas activation of EOR-Ca2+-ROS-NF-kappa B pathway increased the cell viability. Meanwhile, EOR-Ca2+-ROS-NF-kappa B pathway inhibited acute HCV replication, which could alleviate the detrimental effect of HCV on cell viability and enhance chronic HCV infection. Together, our findings provide new insights into the functions of EOR-Ca2+-ROS-NF-kappa B pathway in natural HCV replication and pathogenesis.	[Kong, Lingbao; Huang, Mingjie; Zhang, Qinghua; Zhu, Xiangdong; Sun, Ruina; Guo, Yunli] Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang, Jiangxi, Peoples R China; [Li, Shanshan] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Xiong, Ying] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Liu, Jing] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ Lab Combinatorial Biosynthesis & Drug, Wuhan, Hubei, Peoples R China	Jiangxi Agricultural University; Iowa State University; Guangxi Medical University; Wuhan University	Kong, LB (corresponding author), Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang, Jiangxi, Peoples R China.	lingbaok@hotmail.com; shanshanyxl@hotmail.com			National Nature Science Foundation of China [31160034]; China Scholarship Council [201208360008]; Jiangxi Province [20142BAB205067, 2010GZY0059, 20133ACG70005, GJJ12219]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was funded by grants from the National Nature Science Foundation of China (No. 31160034, http://www.nsfc.gov.cn/) to L. Kong, the China Scholarship Council (201208360008, http://www.csc.edu.cn/) to L. Kong, and Jiangxi Province (Nos. 20142BAB205067, 2010GZY0059, 20133ACG70005 and GJJ12219, http://www.jxstc.gov.cn/ and http://www.jxedu.gov.cn/) to L. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Gupta SC, 2013, CLIN CANCER RES, V19, P4465, DOI 10.1158/1078-0432.CCR-13-0080; Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027; Ip PP, 2012, ANTIVIR RES, V96, P36, DOI 10.1016/j.antiviral.2012.07.006; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kong LB, 2007, VIRUS RES, V128, P9, DOI 10.1016/j.virusres.2007.03.020; Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003; Casella ML, 2014, MOL NUTR FOOD RES, V58, P289, DOI 10.1002/mnfr.201300362; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li S., 2013, CRIT REV MICROBIOL, P1, DOI DOI 10.1109/ANTHOLOGY.2013.6784885; Li SS, 2012, CELL MICROBIOL, V14, P994, DOI 10.1111/j.1462-5822.2012.01773.x; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li XY, 2013, THYROID, V23, P209, DOI 10.1089/thy.2012.0237; Li YX, 2012, J VIROL, V86, P12531, DOI 10.1128/JVI.01136-12; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; Mosialos G, 1997, SEMIN CANCER BIOL, V8, P121, DOI 10.1006/scbi.1997.0063; Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Pannem RR, 2014, CARCINOGENESIS, V35, P461, DOI 10.1093/carcin/bgt335; Rance E, 2012, J VIRAL HEPATITIS, V19, pE73, DOI 10.1111/j.1365-2893.2011.01505.x; Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Siavoshian S, 2005, J MED VIROL, V75, P402, DOI 10.1002/jmv.20283; Starkel P, 2010, EUR J CLIN INVEST, V40, P575, DOI 10.1111/j.1365-2362.2010.02295.x; Tai DI, 2000, HEPATOLOGY, V31, P656, DOI 10.1002/hep.510310316; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Victoriano AFB, 2012, AIDS RES HUM RETROV, V28, P125, DOI [10.1089/aid.2011.0263, 10.1089/AID.2011.0263]; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Zhang LM, 2013, VIROLOGY, V438, P28, DOI 10.1016/j.virol.2013.01.015; Zhao P, 2012, VIRUS RES, V169, P1, DOI 10.1016/j.virusres.2012.04.006; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123190	10.1371/journal.pone.0123190	http://dx.doi.org/10.1371/journal.pone.0123190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875501	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100147
J	Liu, Y; Han, J; Liu, DD; Gu, DD; Wang, YP; Liao, YC; Wen, XX				Liu, Yang; Han, Juan; Liu, Didi; Gu, Dandan; Wang, Yongping; Liao, Yuncheng; Wen, Xiaoxia			Effect of Plastic Film Mulching on the Grain Filling and Hormonal Changes of Maize under Different Irrigation Conditions	PLOS ONE			English	Article							WATER-USE EFFICIENCY; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; CYTOKININ CONTENT; LOESS PLATEAU; ABSCISIC-ACID; SOIL; WHEAT; GROWTH; YIELD	Plastic film mulching (PM) is widely utilized for maize production in China. However, the effect of PM on the grain yield of crops has not been established, and the biochemical mechanism underlying the increase or decrease in grain yield under PM is not yet understood. Grain filling markedly affects the grain yield. The objective of this study was to investigate the effects of PM on maize grain filling under different irrigation levels and the relationship of such effects with hormonal changes. In the present study, PM was compared with traditional nonmulching management (TN) under 220 mm, 270 mm and 320 mm irrigation amount, and the grain filling characters of the grains located in various parts of the ear and the hormonal changes in the grains were measured. The results indicated that at 220 mm irrigation, PM significantly increased the grain filling rate of the middle and basal grains and decreased the grain filling rate of the upper grains. At 270 mm irrigation, the PM significantly increased the grain filling rate of the all grains. At 320 mm irrigation, the PM only significantly increased the grain filling rate of the upper grains. The IAA, Z+ZR and ABA content in the grains was positively correlated with the grain weight and grain-filling rates; however, the ETH evolution rate of the grains was negatively correlated with the grain weight and grain-filling rates. These results show that the effect of PM on maize grain filling is related to the irrigation amount and that the grain position on the ear and the grain filling of the upper grains was more sensitive to PM and irrigation than were the other grains. In addition, the PM and irrigation regulated the balance of hormones rather than the content of individual hormones to affect the maize grain filling.	[Liu, Yang; Han, Juan; Liu, Didi; Wang, Yongping; Liao, Yuncheng; Wen, Xiaoxia] Northwest A&F Univ, Coll Agron, Yangling 712100, Peoples R China; [Gu, Dandan] Northwest A&F Univ, Coll Plant Protect, Yangling 712100, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wen, XX (corresponding author), Northwest A&F Univ, Coll Agron, Yangling 712100, Peoples R China.	wenxiaoxia@126.com			National Natural Science Foundation of China [31301260]; Doctor Subject Foundation of the Ministry of Education of China [20120204120020]; Fundamental Research Funds for the Central Universities of China [QN2013003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Subject Foundation of the Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Project No. 31301260), the Doctor Subject Foundation of the Ministry of Education of China (Project No. 20120204120020), and the Fundamental Research Funds for the Central Universities of China (Project No. QN2013003). In this paper, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELTRANO J, 1994, PLANT GROWTH REGUL, V15, P107, DOI 10.1007/BF00024098; Bu LD, 2013, AGR WATER MANAGE, V123, P71, DOI 10.1016/j.agwat.2013.03.015; Cao JS, 2012, J FOOD AGRIC ENVIRON, V10, P519; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; DIETRICH JT, 1995, PLANT PHYSIOL BIOCH, V33, P327; EEUWENS CJ, 1975, J EXP BOT, V26, P1, DOI 10.1093/jxb/26.1.1; Gu XY, 2012, J FOOD AGRIC ENVIRON, V10, P560; Han J, 2014, FIELD CROP RES, V155, P202, DOI 10.1016/j.fcr.2013.09.004; He R.X., 1999, J SHANXI AGR U, V19, P16; KUROGOCHI S, 1979, PLANTA, V146, P185, DOI 10.1007/BF00388230; Li FM, 2004, AGR WATER MANAGE, V67, P77, DOI 10.1016/j.agwat.2004.02.001; Li XY, 2001, AGR WATER MANAGE, V50, P173, DOI 10.1016/S0378-3774(01)00105-6; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Liu CA, 2013, EUR J SOIL BIOL, V57, P9, DOI 10.1016/j.ejsobi.2013.03.007; Liu JL, 2014, AGR ECOSYST ENVIRON, V188, P20, DOI 10.1016/j.agee.2014.02.010; Liu Y, 2013, FIELD CROP RES, V144, P43, DOI 10.1016/j.fcr.2013.01.009; Liu YE, 2010, CROP SCI, V50, P215, DOI 10.2135/cropsci2009.04.0186; MICHAEL G, 1972, CROP SCI, V12, P162, DOI 10.2135/cropsci1972.0011183X001200020002x; MORRIS RO, 1993, AUST J PLANT PHYSIOL, V20, P621, DOI 10.1071/PP9930621; Ren X, 2010, J AGRON CROP SCI, V196, P109, DOI 10.1111/j.1439-037X.2009.00401.x; Ren XiaoLong, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P45; Ren XL, 2008, AGR WATER MANAGE, V95, P1293, DOI 10.1016/j.agwat.2008.05.007; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAHA S, 1986, Canadian Journal of Botany, V64, P2068, DOI 10.1139/b86-271; SETH AK, 1967, J EXP BOT, V18, P65, DOI 10.1093/jxb/18.1.65; SINGH G, 1982, Plant Physiology and Biochemistry, V9, P22; Song G., 2000, J HENAN AGR U, V34, P213; SUZUKI Y, 1981, PLANT CELL PHYSIOL, V22, P1085; [王永平 Wang Yongping], 2014, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V23, P28; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xin N., 1998, AGR ARID REGIONS NO; Xu GW, 2007, FIELD CROP RES, V101, P53, DOI 10.1016/j.fcr.2006.09.008; Xu YunJi, 2013, Acta Agronomica Sinica, V39, P1452, DOI 10.3724/SP.J.1006.2013.01452; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2008, PLANTA, V228, P137, DOI 10.1007/s00425-008-0725-1; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang MF, 1993, MAIZE SCI, V1, P29; Zhang SL, 2013, FIELD CROP RES, V151, P9, DOI 10.1016/j.fcr.2013.07.005; Zhao H, 2014, FIELD CROP RES, V161, P137, DOI 10.1016/j.fcr.2014.02.013; ZHU Q, 1988, Acta Agronomica Sinica, V14, P182	45	12	15	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122791	10.1371/journal.pone.0122791	http://dx.doi.org/10.1371/journal.pone.0122791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867028	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100100
J	Sharei, A; Trifonova, R; Jhunjhunwala, S; Hartoularos, GC; Eyerman, AT; Lytton-Jean, A; Angin, M; Sharma, S; Poceviciute, R; Mao, S; Heimann, M; Liu, S; Talkar, T; Khan, OF; Addo, M; von Andrian, UH; Anderson, DG; Langer, R; Lieberman, J; Jensen, KF				Sharei, Armon; Trifonova, Radiana; Jhunjhunwala, Siddharth; Hartoularos, George C.; Eyerman, Alexandra T.; Lytton-Jean, Abigail; Angin, Mathieu; Sharma, Siddhartha; Poceviciute, Roberta; Mao, Shirley; Heimann, Megan; Liu, Sophia; Talkar, Tanya; Khan, Omar F.; Addo, Marylyn; von Andrian, Ulrich H.; Anderson, Daniel G.; Langer, Robert; Lieberman, Judy; Jensen, Klavs F.			Ex Vivo Cytosolic Delivery of Functional Macromolecules to Immune Cells	PLOS ONE			English	Article							APTAMER-SIRNA CHIMERAS; SMALL INTERFERING RNAS; INTRACELLULAR DELIVERY; DENDRITIC CELLS; T-CELLS; ELECTROPORATION; INFECTION; NANOPARTICLES; PEPTIDES; PROTEINS	Intracellular delivery of biomolecules, such as proteins and siRNAs, into primary immune cells, especially resting lymphocytes, is a challenge. Here we describe the design and testing of microfluidic intracellular delivery systems that cause temporary membrane disruption by rapid mechanical deformation of human and mouse immune cells. Dextran, antibody and siRNA delivery performance is measured in multiple immune cell types and the approach's potential to engineer cell function is demonstrated in HIV infection studies.	[Sharei, Armon; Hartoularos, George C.; Eyerman, Alexandra T.; Poceviciute, Roberta; Mao, Shirley; Heimann, Megan; Liu, Sophia; Talkar, Tanya; Anderson, Daniel G.; Langer, Robert; Jensen, Klavs F.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Angin, Mathieu; Sharma, Siddhartha; Addo, Marylyn; von Andrian, Ulrich H.] MIT, MGH, Ragon Inst, Cambridge, MA 02139 USA; [Angin, Mathieu; Sharma, Siddhartha; Addo, Marylyn; von Andrian, Ulrich H.] Harvard Univ, Cambridge, MA 02138 USA; [Sharei, Armon; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Sharei, Armon; Jhunjhunwala, Siddharth; Lytton-Jean, Abigail; Khan, Omar F.; Anderson, Daniel G.; Langer, Robert] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Trifonova, Radiana; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA.	judy.lieberman@childrens.harvard.edu; kfjensen@mit.edu	Liu, Sophia/GYU-0250-2022; Lieberman, Judy/A-2717-2015; Jensen, Klavs F/F-2462-2012; Addo, Marylyn M./GNP-2548-2022; Jhunjhunwala, Siddharth/K-1526-2013; Khan, Omar/G-6952-2014	Jensen, Klavs F/0000-0001-7192-580X; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Lytton-Jean, Abigail/0000-0002-1582-0066; Angin, Mathieu/0000-0002-6867-4680; Liu, Sophia/0000-0003-3614-9731; Khan, Omar/0000-0003-3811-2369; Addo, Marylyn/0000-0003-2836-9224	National Institutes of Health Grant [R01GM101420-01A1]; Kathy and Curt Marble Cancer Research Fund; Ragon Institute of Harvard/MIT/MGH; National Cancer Institute Cancer Center Support (Core) Grant [P30-CA14051]; Mazumdar-Shaw International Oncology Fellowship; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI112521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101420] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; Ragon Institute of Harvard/MIT/MGH; National Cancer Institute Cancer Center Support (Core) Grant; Mazumdar-Shaw International Oncology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM101420-01A1, the Kathy and Curt Marble Cancer Research Fund, the Ragon Institute of Harvard/MIT/MGH and partially by the National Cancer Institute Cancer Center Support (Core) Grants P30-CA14051. SJ is in receipt of the Mazumdar-Shaw International Oncology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angin M, 2013, JOVE-J VIS EXP, DOI 10.3791/50244; Angin M, 2012, J INFECT DIS, V205, P1495, DOI 10.1093/infdis/jis236; Bonehill A, 2008, MOL THER, V16, P1170, DOI 10.1038/mt.2008.77; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Huang LF, 2013, NAT BIOTECHNOL, V31, P350, DOI 10.1038/nbt.2537; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; LAMBERT H, 1990, BIOCHEM CELL BIOL, V68, P729, DOI 10.1139/o90-105; Lee J, 2012, NANO LETT, V12, P6322, DOI 10.1021/nl303421h; MARRERO MB, 1995, J BIOL CHEM, V270, P15734, DOI 10.1074/jbc.270.26.15734; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schaft N, 2006, CANCER IMMUNOL IMMUN, V55, P1132, DOI 10.1007/s00262-005-0098-2; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Wheeler LA, 2011, J CLIN INVEST, V121, P2401, DOI 10.1172/JCI45876; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	25	36	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118803	10.1371/journal.pone.0118803	http://dx.doi.org/10.1371/journal.pone.0118803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875117	gold, Green Published			2022-12-27	WOS:000352845100011
J	Cai, XR; Zhou, QC; Yu, J; Feng, YZ; Xian, ZH; Yang, WC; Mo, XK				Cai, Xiang-Ran; Zhou, Qing-Chun; Yu, Juan; Feng, You-Zhen; Xian, Zhao-Hui; Yang, Wen-Cai; Mo, Xu-Kai			Assessment of Renal Function in Patients with Unilateral Ureteral Obstruction Using Whole-Organ Perfusion Imaging with 320-Detector Row Computed Tomography	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NONINVASIVE MEASUREMENT; TUBULAR DYNAMICS; MULTIDETECTOR CT; BLOOD-FLOW; HEMODYNAMICS; NEPHROPATHY; ABDOMEN; LIVER; MODEL	Background Obstructed nephropathy is a common complication of several disease processes. Accurate evaluation of the functional status of the obstructed kidney is important to achieve a good outcome. The purpose of this study was to investigate renal cortical and medullary perfusion changes associated with unilateral ureteral obstruction (UUO) using whole-organ perfusion imaging with 320-detector row computed tomography (CT). Methodology/Principle Findings Sixty-four patients with UUO underwent whole-organ CT perfusion imaging. Patients were divided into 3 groups, mild, moderate, and severe, based on hydronephrosis severity. Twenty sex-and age-matched patients without renal disease, who referred to abdominal CT, were chosen as control subjects. Mean cortical and medullary perfusion parameters of obstructed and contralateral kidneys were compared, and mean perfusion ratios between obstructed and contralateral kidneys were calculated and compared. Mean cortical or medullary blood flow (BF) and blood volume (BV) of the obstructed kidneys in the moderate UUO and BF, BV, and clearance (CL) in the severe UUO were significantly lower than those of the contralateral kidneys (p < 0.05). The mean cortical or medullary BF of the obstructed kidney in the moderate UUO, and BF, BV, and CL in the severe UUO were significantly lower than those of the kidneys in control subjects (p < 0.05). Mean cortical or medullary BF of the non-obstructed kidneys in the severe UUO were statistically greater than that of normal kidneys in control subjects (p < 0.05). An inverse correlation was observed between cortical and medullary perfusion ratios and grades of hydronephosis (p < 0.01). Conclusions/Significance Perfusion measurements of the whole kidney can be obtained with 320-detector row CT, and estimated perfusion ratios have potential for quantitatively evaluating UUO renal injury grades.	[Cai, Xiang-Ran; Feng, You-Zhen; Xian, Zhao-Hui; Yang, Wen-Cai; Mo, Xu-Kai] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Qing-Chun] Nanhua Univ, Nanhua Affiliated Hosp, Dept Urol, Hengyang, Hunan, Peoples R China; [Yu, Juan] Shenzhen Second Peoples Hosp, Dept Radiol, Shenzhen, Guangdong, Peoples R China	Jinan University; University of South China; Second People's Hospital of Shenzhen	Cai, XR (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	caixran@163.com						Blomley MJK, 1999, EUR J RADIOL, V30, P214, DOI 10.1016/S0720-048X(99)00014-5; Brix G, 2004, EUR RADIOL, V14, P1275, DOI 10.1007/s00330-004-2267-7; Chang J, 2011, J VET SCI, V12, P393, DOI 10.4142/jvs.2011.12.4.393; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085522; Daghini E, 2007, RADIOLOGY, V243, P405, DOI 10.1148/radiol.2432060655; Dawson P, 2006, EUR J RADIOL, V60, P331, DOI 10.1016/j.ejrad.2006.06.023; ELDER JS, 1995, J UROLOGY, V154, P719, DOI 10.1016/S0022-5347(01)67143-X; Grenier N, 2013, Diagn Interv Imaging, V94, P1313, DOI 10.1016/j.diii.2013.08.018; Hegarty NJ, 2001, KIDNEY INT, V59, P1059, DOI 10.1046/j.1523-1755.2001.00589.x; Itano NB, 2001, J UROLOGY, V166, P2530, DOI 10.1016/S0022-5347(05)65629-7; Kambadakone AR, 2009, RADIOL CLIN N AM, V47, P161, DOI 10.1016/j.rcl.2008.11.003; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Lemoine S, 2011, RADIOLOGY, V260, P414, DOI 10.1148/radiol.11101317; Lerman LO, 1999, J AM SOC NEPHROL, V10, P1455; Liu X, 2009, RADIOLOGY, V253, P98, DOI [10.1148/radiol.2531081677, 10.1148/radiol.2531081677/-/DC1]; LOO MH, 1988, WORLD J UROL, V6, P53, DOI 10.1007/BF00326844; Mazzei MA, 2013, ACTA RADIOL, V54, P805, DOI 10.1177/0284185113484643; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; Moos SI, 2013, EUR J RADIOL, V82, pE387, DOI 10.1016/j.ejrad.2013.04.029; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Ohno Y, 2011, RADIOLOGY, V258, P599, DOI 10.1148/radiol.10100245; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pelaez LI, 2005, NEPHROL DIAL TRANSPL, V20, P83, DOI 10.1093/ndt/gfh556; RAGI I, 1981, International Urology and Nephrology, V13, P237, DOI 10.1007/BF02082421; SATOH N, 1991, Nippon Acta Radiologica, V51, P1346; SHEEHAN SJ, 1994, UROL RES, V22, P279, DOI 10.1007/BF00297195; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Tantawy MN, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-168; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; Yilmaz O, 2009, J PEDIATR SURG, V44, P1977, DOI 10.1016/j.jpedsurg.2009.01.072; Zhong JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074365	33	11	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122454	10.1371/journal.pone.0122454	http://dx.doi.org/10.1371/journal.pone.0122454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874690	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800058
J	Falcone, PH; Tai, CY; Carson, LR; Joy, JM; Mosman, MM; Vogel, RM; McCann, TR; Crona, KP; Griffin, JD; Kim, MP; Moon, JR				Falcone, Paul H.; Tai, Chih Yin; Carson, Laura R.; Joy, Jordan M.; Mosman, Matt M.; Vogel, Roxanne M.; McCann, Tyler R.; Crona, Kevin P.; Griffin, J. Daniel; Kim, Michael P.; Moon, Jordan R.			Subcutaneous and Segmental Fat Loss with and without Supportive Supplements in Conjunction with a Low-Calorie High Protein Diet in Healthy Women	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; BODY-COMPOSITION CHANGES; X-RAY ABSORPTIOMETRY; WEIGHT-LOSS; ENERGY-EXPENDITURE; RANDOMIZED-TRIAL; GREEN TEA; BEHAVIOR-THERAPY; METABOLIC-RATE; ABDOMINAL FAT	Background Weight loss benefits of multi-ingredient supplements in conjunction with a low-calorie, high-protein diet in young women are unknown. Therefore, the purpose of this study was to investigate the effects of a three-week low-calorie diet with and without supplementation on body composition. Methods Thirty-seven recreationally-trained women (n = 37; age = 27.1 +/- 4.2; height = 165.1 +/- 6.4; weight = 68.5 +/- 10.1; BMI = 25.1 +/- 3.4) completed one of the following three-week interventions: no change in diet (CON); a high-protein, low-calorie diet supplemented with a thermogenic, conjugated linoleic acid (CLA), a protein gel, and a multi-vitamin (SUP); or the high-protein diet with isocaloric placebo supplements (PLA). Before and after the three-week intervention, body weight, % Fat via dual X-ray absorptiometry (DXA), segmental fat mass via DXA, % Fat via skinfolds, and skinfold thicknesses at seven sites were measured. Results SUP and PLA significantly decreased body weight (SUP: PRE, 70.47 +/- 8.01 kg to POST, 67.51 +/- 8.10 kg; PLA: PRE, 67.88 +/- 12.28 kg vs. POST, 66.38 +/- 11.94 kg; p +/- 0.05) with a greater (p +/- 0.05) decrease in SUP than PLA or CON. SUP and PLA significantly decreased % Fat according to DXA (SUP: PRE, 34.98 +/- 7.05% to POST, 32.99 +/- 6.89%; PLA: PRE, 34.22 +/- 6.36% vs. POST, 32.69 +/- 5.84%; p <= 0.05), whereas only SUP significantly decreased % Fat according to skinfolds (SUP: PRE, 27.40 +/- 4.09% to POST, 24.08 +/- 4.31%; p <= 0.05). SUP significantly (p <= 0.05) decreased thicknesses at five skinfolds (chest, waist, hip, subscapular, and tricep) compared to PLA, but not at two skinfolds (axilla and thigh). Conclusions The addition of a thermogenic, CLA, protein, and a multi-vitamin to a three-week low-calorie diet improved weight loss, total fat loss and subcutaneous fat loss, compared to diet alone.	[Falcone, Paul H.; Tai, Chih Yin; Carson, Laura R.; Joy, Jordan M.; Mosman, Matt M.; Kim, Michael P.; Moon, Jordan R.] MusclePharm Sports Sci Inst, Denver, CO USA; [Vogel, Roxanne M.] Metropolitan State Univ Denver, Denver, CO USA; [McCann, Tyler R.] Univ Colorado, Boulder, CO 80309 USA; [Crona, Kevin P.] Univ Colorado, Denver, CO 80202 USA; [Griffin, J. Daniel] Widener Univ, Chester, PA 19013 USA; [Moon, Jordan R.] US Sports Acad, Dept Sports Exercise Sci, Daphne, AL USA	Metropolitan State University of Denver; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver; Widener University	Moon, JR (corresponding author), MusclePharm Sports Sci Inst, Denver, CO USA.	jordan@musclepharm.com	Biguzzi, Felipe A/E-4724-2015		MusclePharm Corporation	MusclePharm Corporation	MusclePharm Corporation funded this study. The funder provided support in the form of salaries for authors PHF, CYT, LRC, JMJ, MMM, MPK, TRM and JRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acheson KJ, 2013, EUR J CLIN NUTR, V67, P462, DOI 10.1038/ejcn.2012.194; Alvarez VP, 2007, OBES SURG, V17, P211, DOI 10.1007/s11695-007-9032-3; ANDERSEN T, 1984, NEW ENGL J MED, V310, P352, DOI 10.1056/NEJM198402093100604; Baba NH, 1999, INT J OBESITY, V23, P1202, DOI 10.1038/sj.ijo.0801064; Ball S, 2004, RES Q EXERCISE SPORT, V75, P248, DOI 10.1080/02701367.2004.10609158; Berube-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; Cha YS, 2012, NUTR RES PRACT, V6, P520, DOI 10.4162/nrp.2012.6.6.520; Chen SC, 2012, NUTRITION, V28, P559, DOI 10.1016/j.nut.2011.09.008; Claessens M, 2009, INT J OBESITY, V33, P296, DOI 10.1038/ijo.2008.278; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; Di Pierro F, 2009, ALTERN MED REV, V14, P154; DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Lejeune MPGM, 2005, BRIT J NUTR, V93, P281, DOI 10.1079/BJN20041305; Leung FW, 2014, PROG DRUG RES, V68, P171, DOI 10.1007/978-3-0348-0828-6_7; Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22; Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293; Minderico CS, 2008, BRIT J NUTR, V99, P432, DOI 10.1017/S0007114507815789; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; Najafpanah MJ, 2014, GENE, V543, P253, DOI 10.1016/j.gene.2014.04.006; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25; Pfeuffer M, 2011, J AM COLL NUTR, V30, P19, DOI 10.1080/07315724.2011.10719940; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529; Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848; Sillanpaa E, 2013, EUR J APPL PHYSIOL, V113, P2331, DOI 10.1007/s00421-013-2669-9; Sites CK, 2007, FERTIL STERIL, V88, P1609, DOI 10.1016/j.fertnstert.2007.01.061; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Vasudev Sudha, 2004, J Assoc Physicians India, V52, P877; WADDEN TA, 1990, JAMA-J AM MED ASSOC, V263, P83, DOI 10.1001/jama.263.1.83; WADDEN TA, 1986, J CONSULT CLIN PSYCH, V54, P482, DOI 10.1037/0022-006X.54.4.482; WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wang J, 2002, OBES RES, V10, P885, DOI 10.1038/oby.2002.121; Wang J, 2000, ANN NY ACAD SCI, V904, P317; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	52	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123854	10.1371/journal.pone.0123854	http://dx.doi.org/10.1371/journal.pone.0123854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875200	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800121
J	Hu, FN; Li, H; Liu, XM; Li, S; Ding, WQ; Xu, CY; Li, Y; Zhu, LH				Hu, Feinan; Li, Hang; Liu, Xinmin; Li, Song; Ding, Wuquan; Xu, Chenyang; Li, Yue; Zhu, Longhui			Quantitative Characterization of Non-Classic Polarization of Cations on Clay Aggregate Stability	PLOS ONE			English	Article							EXCHANGEABLE POTASSIUM; HYDRAULIC CONDUCTIVITY; INTERACTION FORCES; HOFMEISTER SERIES; ION SPECIFICITY; ORGANIC-MATTER; DLVO THEORY; WATER; DISPERSION; SALT	Soil particle interactions are strongly influenced by the concentration, valence and ion species and the pH of the bulk solution, which will also affect aggregate stability and particle transport. In this study, we investigated clay aggregate stability in the presence of different alkali ions (Li+, Na+, K+, and Cs+) at concentrations from 10(-5) to 10(-1) mol L-1. Strong specific ion effects on clay aggregate stability were observed, and showed the order Cs+>K+>Na+>Li+. We found that it was not the effects of ion size, hydration, and dispersion forces in the cation-surface interactions but strong non-classic polarization of adsorbed cations that resulted in these specific effects. In this study, the non-classic dipole moments of each cation species resulting from the non-classic polarization were estimated. By comparing non-classic dipole moments with classic values, the observed dipole moments of adsorbed cations were up to 104 times larger than the classic values for the same cation. The observed non-classic dipole moments sharply increased with decreasing electrolyte concentration. We conclude that strong non-classic polarization could significantly suppress the thickness of the diffuse layer, thereby weakening the electric field near the clay surface and resulting in improved clay aggregate stability. Even though we only demonstrated specific ion effects on aggregate stability with several alkali ions, our results indicate that these effects could be universally important in soil aggregate stability.	[Hu, Feinan; Li, Hang; Liu, Xinmin; Li, Song; Ding, Wuquan; Xu, Chenyang; Li, Yue; Zhu, Longhui] Southwest Univ, Chongqing Key Lab Soil Multiscale Interfacial Pro, Coll Resources & Environm, Chongqing, Peoples R China	Southwest University - China	Li, H (corresponding author), Southwest Univ, Chongqing Key Lab Soil Multiscale Interfacial Pro, Coll Resources & Environm, Chongqing, Peoples R China.	lihangswu@163.com			National Natural Science Foundation of China [41371249, 41101223, 41201223]; Fundamental Research Funds for the Central Universities [XDJK2013D025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41371249, 41101223, 41201223)(http://www.nsfc.gov.cn/), and the Fundamental Research Funds for the Central Universities (XDJK2013D025)(http://www.swu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk Z, 1999, ADV COLLOID INTERFAC, V83, P137, DOI 10.1016/S0001-8686(99)00009-3; Amezketa E, 1999, J SUSTAIN AGR, V14, P83, DOI 10.1300/J064v14n02_08; Ao Z, 2011, J PHYS CHEM C, V115, P2284, DOI 10.1021/jp110782g; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Bin G, 2011, CRIT REV ENV SCI TEC, V41, P336, DOI 10.1080/10643380902871464; Borah JM, 2011, LANGMUIR, V27, P8710, DOI 10.1021/la2006277; Bostrom M, 2004, PROG COLL POL SCI S, V123, P110, DOI 10.1007/b11652; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Bostrom M, 2003, J PHYS CHEM B, V107, P2875, DOI 10.1021/jp026804d; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Das MR, 2010, J COLLOID INTERF SCI, V344, P482, DOI 10.1016/j.jcis.2009.12.048; Denef K, 2002, PLANT SOIL, V246, P185, DOI 10.1023/A:1020668013524; Dishon M, 2009, LANGMUIR, V25, P2831, DOI 10.1021/la803022b; Duiker SW, 2003, SOIL SCI SOC AM J, V67, P606, DOI 10.2136/sssaj2003.0606; Flores SC, 2012, J PHYS CHEM C, V116, P5730, DOI 10.1021/jp210791j; FRENKEL H, 1978, SOIL SCI SOC AM J, V42, P32, DOI 10.2136/sssaj1978.03615995004200010008x; Funkner S, 2012, J AM CHEM SOC, V134, P1030, DOI 10.1021/ja207929u; Gao XD, 2014, ACTA PHYS-CHIM SIN, V30, P2272, DOI 10.3866/PKU.WHXB201410231; Hashemi M, 2011, ANAL BIOANAL CHEM, V400, P643, DOI 10.1007/s00216-011-4722-z; Hess B, 2009, P NATL ACAD SCI USA, V106, P14008; Holthusen D, 2010, SOIL TILL RES, V111, P75, DOI 10.1016/j.still.2010.08.002; Hribar B, 2002, J AM CHEM SOC, V124, P12302, DOI 10.1021/ja026014h; Itami K, 2005, COLLOID SURFACE A, V265, P55, DOI 10.1016/j.colsurfa.2004.10.138; Jungwirth P, 2014, NAT CHEM, V6, P261, DOI 10.1038/nchem.1899; Kowacz M, 2008, GEOCHIM COSMOCHIM AC, V72, P4476, DOI 10.1016/j.gca.2008.07.005; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; LEVY GJ, 1995, SOIL SCI, V160, P352, DOI 10.1097/00010694-199511000-00004; LEVY GJ, 1990, SOIL SCI, V149, P69, DOI 10.1097/00010694-199002000-00002; Li H, 2004, J COLLOID INTERF SCI, V275, P172, DOI 10.1016/j.jcis.2003.12.055; Li H, 2011, SOIL SCI SOC AM J, V75, P2128, DOI 10.2136/sssaj2010.0301; Li H, 2009, J PHYS CHEM C, V113, P4419, DOI 10.1021/jp808372r; Li S, 2013, SOIL SCI SOC AM J, V77, P1563, DOI 10.2136/sssaj2013.01.0009; Liang Y, 2007, ADV COLLOID INTERFAC, V134-35, P151, DOI 10.1016/j.cis.2007.04.003; Liu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05047; Liu XM, 2013, J PHYS CHEM C, V117, P6245, DOI 10.1021/jp312682u; Lo Nostro P, 2002, BIOMACROMOLECULES, V3, P1217, DOI 10.1021/bm0255692; Long YC, 2013, LANGMUIR, V29, P3645, DOI 10.1021/la400035e; Lopez-Leon T, 2008, J PHYS CHEM C, V112, P16060, DOI 10.1021/jp803796a; McBride MB, 2002, SOIL SCI SOC AM J, V66, P1207, DOI 10.2136/sssaj2002.1207; MINHAS PS, 1986, IRRIGATION SCI, V7, P159; Ninham BW, 1997, LANGMUIR, V13, P2097, DOI 10.1021/la960974y; Noah-Vanhoucke J, 2009, P NATL ACAD SCI USA, V106, P15125, DOI 10.1073/pnas.0905168106; NocitoGobel J, 1996, COLLOID SURFACE A, V107, P223, DOI 10.1016/0927-7757(95)03340-8; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; Parsons DF, 2010, LANGMUIR, V26, P3323, DOI 10.1021/la903061h; Parsons DF, 2011, PHYS CHEM CHEM PHYS, V13, P12352, DOI 10.1039/c1cp20538b; Parsons DF, 2010, LANGMUIR, V26, P6430, DOI 10.1021/la9041265; Patil S., 2011, Journal of Urban and Environmental Engineering (JUEE), V5, P84, DOI 10.4090/juee.2011.v5n2.084090; Plaza-Bonilla D, 2013, SOIL SCI SOC AM J, V77, P284, DOI 10.2136/sssaj2012.0258; Richter DD, 2009, SCIENCE, V326, P1067, DOI 10.1126/science.1179117; RIESKAUTT MM, 1989, J BIOL CHEM, V264, P745; Ruiz-Agudo E, 2010, GEOCHIM COSMOCHIM AC, V74, P1256, DOI 10.1016/j.gca.2009.11.004; Ruiz-Agudo E, 2011, CHEM GEOL, V281, P364, DOI 10.1016/j.chemgeo.2011.01.003; Santos APd, 2011, PHYS REV LETT, V106; Schwartz CP, 2010, P NATL ACAD SCI USA, V107, P14008, DOI 10.1073/pnas.1006435107; Tian R, 2014, PHYS CHEM CHEM PHYS, V16, P8828, DOI 10.1039/c3cp54813a; TISDALL JM, 1994, PLANT SOIL, V159, P115, DOI 10.1007/BF00000100; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Wang LF, 2013, ENVIRON SCI TECHNOL, V47, P5042, DOI 10.1021/es304993j; Xu CY, 2015, EUROPEAN J IN PRESS; Yang JL, 2009, SOIL TILL RES, V105, P292, DOI 10.1016/j.still.2009.04.003; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P15249, DOI 10.1073/pnas.0907616106	67	27	31	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122460	10.1371/journal.pone.0122460	http://dx.doi.org/10.1371/journal.pone.0122460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874864	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800060
J	Kornej, J; Schmidl, J; Ueberham, L; John, S; Daneschnejad, S; Dinov, B; Hindricks, G; Adams, V; Husser, D; Bollmann, A				Kornej, Jelena; Schmidl, Josephin; Ueberham, Laura; John, Silke; Daneschnejad, Sait; Dinov, Borislav; Hindricks, Gerhard; Adams, Volker; Husser, Daniela; Bollmann, Andreas			Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; INFLAMMATION; BIOMARKERS; MARKERS	Background Galectin-3 (Gal-3) is an emerging biomarker in heart failure that is involved in fibrosis and inflammation. However, its potential value as a prognostic marker in atrial fibrillation (AF) is unknown. The aim of this study was to assess the impact of AF catheter ablation on Gal-3 and evaluate its prognostic impact for predicting rhythm outcome after catheter ablation. Methods Gal-3 was measured at baseline and after 6 months using specific ELISA. AF recurrences were defined as any atrial arrhythmia lasting longer than 30 sec within 6 months after ablation. Results In 105 AF patients (65% males, age 62 +/- 9 years, 52% paroxysmal AF) undergoing catheter ablation, Gal-3 was measured at baseline and after 6 months and compared with an AF-free control cohort (n=14, 50 % males, age 58 +/- 11 years). Gal-3 was higher in AF patients compared with AF-free controls (7.8 +/- 2.9 vs. 5.8 +/- 1.8, ng/mL, p=0.013). However, on multi-variable analysis, BMI (p=0.007) but not AF (p=0.068) was associated with Gal-3. In the AF cohort, on univariable analysis higher Gal-3 levels were associated with female gender (p=0.028), higher BMI (p=0.005) and both CHADS2 (p=0.008) and CHA2DS2-VASC (p=0.016) scores, however, on multivariable analysis only BMI remained significantly associated with baseline Gal-3 (p=0.016). Gal-3 was similar 6 months after AF catheter ablation and was not associated with sinus rhythm maintenance. Conclusions Although galectin-3 levels are higher in AF patients, this is driven by cardiometabolic comorbidities and not heart rhythm. Gal-3 is not useful for predicting rhythm outcome of catheter ablation.	[Kornej, Jelena; Schmidl, Josephin; Ueberham, Laura; John, Silke; Daneschnejad, Sait; Dinov, Borislav; Hindricks, Gerhard; Husser, Daniela; Bollmann, Andreas] Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Adams, Volker] Ctr Heart, Dept Cardiol, Leipzig, Germany	Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kornej, J (corresponding author), Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de						Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008; de Boer Rudolf A, 2010, Curr Heart Fail Rep, V7, P1, DOI 10.1007/s11897-010-0004-x; de Boer RA, 2013, EUR J HEART FAIL, V15, P1095, DOI 10.1093/eurjhf/hft077; den Uijl DW, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.031; Doyama K, 1998, J AM COLL CARDIOL, V32, P1832, DOI 10.1016/S0735-1097(98)00494-X; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Gould PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P18, DOI 10.1161/CIRCEP.108.831586; Gurses KM, 2014, AM J CARDIOL; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Ho JE, 2014, AM HEART J, V167, P729, DOI 10.1016/j.ahj.2014.02.009; Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252; Kornej J, 2014, HAMOSTASEOLOGIE, V34, P9, DOI 10.5482/HAMO-13-09-0051; Kornej J, 2014, CIRC-ARRHYTHMIA ELEC, V7, P281, DOI 10.1161/CIRCEP.113.001182; Kornej J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-49; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Marcus GM, 2008, HEART RHYTHM, V5, P215, DOI 10.1016/j.hrthm.2007.10.007; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; van Kimmenade R, 2006, J AM COLL CARDIOL, V47, P886, DOI 10.1016/j.jacc.2005.11.022; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; Weigert J, 2010, J CLIN ENDOCR METAB, V95, P1404, DOI 10.1210/jc.2009-1619; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168	23	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123574	10.1371/journal.pone.0123574	http://dx.doi.org/10.1371/journal.pone.0123574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875595	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800105
J	Larson, MJ; LeCheminant, JD; Hill, K; Carbine, K; Masterson, T; Christenson, E				Larson, Michael J.; LeCheminant, James D.; Hill, Kyle; Carbine, Kaylie; Masterson, Travis; Christenson, Ed			Cognitive and Typing Outcomes Measured Simultaneously with Slow Treadmill Walking or Sitting: Implications for Treadmill Desks	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; CARDIOVASCULAR-DISEASE; ACUTE EXERCISE; OLDER-ADULTS; PERFORMANCE; HEALTH; ASSOCIATIONS; MEMORY; WORK	Purpose This study compared cognitive (attention, learning, and memory) and typing outcomes during slow treadmill walking or sitting. Seventy-five healthy individuals were randomly assigned to a treadmill walking group (n=37; 23 female) or sitting group (n=38; 17 female). Methods The treadmill walking group completed a series of tests while walking at 1.5 mph. The sitting group performed the same tests while sitting at a standard desk. Tests performed by both groups included: the Rey Auditory Verbal Learning Test and a modified version of the Paced Auditory Serial Attention Test. In addition, typing performance was evaluated. Results Participants in the treadmill walking group performed worse on the Rey Auditory Verbal Learning Test for total learning than the sitting group; the main effect was significant (F(1,73)=4.75, p=0.03, eta(2)(p)=0.06); however, short-and long-delay recall performance did not differ between groups (p>0.05). For the Paced Auditory Serial Attention Test, total number of correct responses was lower in the treadmill walking group relative to the sitting group; the main effect was significant (F(1,73)=4.97, p=0.03, eta(2)(p)=0.06). The performance of both groups followed the same learning slope (Group x Trial interactions were not significant) for the Rey Auditory Verbal Learning Test and Paced Auditory Serial Attention Test. Individuals in the treadmill walking group performed significantly worse for all measures of typing (p<0.05). Conclusion Walking on a treadmill desk may result in a modest difference in total learning and typing outcomes relative to sitting, but those declines may not outweigh the benefit of the physical activity gains from walking on a treadmill.	[Larson, Michael J.; Hill, Kyle; Carbine, Kaylie] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.; Hill, Kyle; Carbine, Kaylie] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [LeCheminant, James D.; Masterson, Travis; Christenson, Ed] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	michael_larson@byu.edu; lecheminant@byu.edu	Larson, Michael J/C-8543-2012; LeCheminant, James/O-9110-2016	Larson, Michael J/0000-0002-8199-8065; Carbine, Kaylie/0000-0003-2696-8880				Albright C, 2006, J WOMENS HEALTH, V15, P271, DOI 10.1089/jwh.2006.15.271; Alderman BL, 2014, J PHYS ACT HEALTH, V11, P752, DOI 10.1123/jpah.2012-0097; Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Blair SN, 1996, MED SCI SPORT EXER, V28, P9, DOI 10.1097/00005768-199601000-00004; Brown HE, 2011, SPORTS MED, V41, P249, DOI 10.2165/11539180-000000000-00000; Chang YK, 2012, ARCH CLIN NEUROPSYCH, V27, P225, DOI 10.1093/arclin/acr094; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper SB, 2011, PHYSIOL BEHAV, V103, P431, DOI 10.1016/j.physbeh.2011.03.018; DEARY IJ, 1991, PERS INDIV DIFFER, V12, P983, DOI 10.1016/0191-8869(91)90027-9; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Funk RE, 2012, PERCEPT MOTOR SKILL, V115, P309, DOI 10.2466/06.23.26.PMS.115.4.309-318; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; GEORGE JD, 1993, MED SCI SPORT EXER, V25, P643; Gomez-Cabello A, 2012, NUTR HOSP, V27, P865, DOI 10.3305/nh.2012.27.3.5668; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Kashihara Koji, 2009, Journal of Physiological Anthropology, V28, P155, DOI 10.2114/jpa2.28.155; Koepp GA, 2013, OBESITY, V21, P705, DOI 10.1002/oby.20121; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; LeCheminant J, 2011, J PHYS ACT HEALTH, V8, P481, DOI 10.1123/jpah.8.4.481; LeCheminant JD, 2012, POPUL HEALTH MANAG, V15, P261, DOI 10.1089/pop.2011.0083; LeCheminant JD, 2011, DIABETES EDUCATOR, V37, P573, DOI 10.1177/0145721711411108; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032755; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ohlinger CM, 2011, J PHYS ACT HEALTH, V8, P119, DOI 10.1123/jpah.8.1.119; Ozdemir PG, 2013, PSYCHIAT RES, V210, P1219, DOI 10.1016/j.psychres.2013.09.022; Paran D, 2009, ANN RHEUM DIS, V68, P812, DOI 10.1136/ard.2008.091538; Pescatello LS, 2000, AGE AGEING, V29, P433, DOI 10.1093/ageing/29.5.433; Plotnikoff R, 2012, ARCH ENVIRON OCCUP H, V67, P125, DOI 10.1080/19338244.2012.697407; Rey A, 1964, LEXAMEN CLINIQUE PSY; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33, DOI DOI 10.1080/13854049108401840; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; Rosti E, 2006, MULT SCLER J, V12, P586, DOI 10.1177/1352458506070624; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; Schmidt M, 1996, REY AUDITORY VERBAL, P1; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Straker L, 2013, APPL ERGON, V44, P517, DOI 10.1016/j.apergo.2012.11.001; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Strauss E, 2006, COMPENDIUM NEUROPSYC, DOI DOI 10.1212/WNL.41.11.1856-A; Thompson WG, 2011, WORK, V40, P473, DOI 10.3233/WOR-2011-1258; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tudor-Locke C, 2014, INT J OBESITY, V38, P755, DOI 10.1038/ijo.2013.223; Vakil E, 2012, CHILD NEUROPSYCHOL, V18, P449, DOI 10.1080/09297049.2011.613816	56	26	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121309	10.1371/journal.pone.0121309	http://dx.doi.org/10.1371/journal.pone.0121309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874910	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800018
J	Lundy, ME; Parrella, MP				Lundy, Mark E.; Parrella, Michael P.			Crickets Are Not a Free Lunch: Protein Capture from Scalable Organic Side-Streams via High-Density Populations of Acheta domesticus	PLOS ONE			English	Article							GROWTH-RATES; FOOD WASTE; FEED; ORTHOPTERA; INSECTS; CONVERSION; NITROGEN; WEIGHT; VALUES; ENERGY	It has been suggested that the ecological impact of crickets as a source of dietary protein is less than conventional forms of livestock due to their comparatively efficient feed conversion and ability to consume organic side-streams. This study measured the biomass output and feed conversion ratios of house crickets (Acheta domesticus) reared on diets that varied in quality, ranging from grain-based to highly cellulosic diets. The measurements were made at a much greater population scale and density than any previously reported in the scientific literature. The biomass accumulation was strongly influenced by the quality of the diet (p<0.001), with the nitrogen (N) content, the ratio of N to acid detergent fiber (ADF) content, and the crude fat (CF) content (y=N/ADF+CF) explaining most of the variability between feed treatments (p=0.02; R-2=0.96). In addition, for populations of crickets that were able to survive to a harvestable size, the feed conversion ratios measured were higher (less efficient) than those reported from studies conducted at smaller scales and lower population densities. Compared to the industrial-scale production of chickens, crickets fed a poultry feed diet showed little improvement in protein conversion efficiency, a key metric in determining the ecological footprint of grain-based livestock protein. Crickets fed the solid filtrate from food waste processed at an industrial scale via enzymatic digestion were able to reach a harvestable size and achieve feed and protein efficiencies similar to that of chickens. However, crickets fed minimally-processed, municipal-scale food waste and diets composed largely of straw experienced >99% mortality without reaching a harvestable size. Therefore, the potential for A. domesticus to sustainably supplement the global protein supply, beyond what is currently produced via grain-fed chickens, will depend on capturing regionally scalable organic side-streams of relatively high-quality that are not currently being used for livestock production.	[Lundy, Mark E.] Univ Calif, Div Agr & Nat Resources, Colusa, CA 95932 USA; [Parrella, Michael P.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Lundy, ME (corresponding author), Univ Calif, Div Agr & Nat Resources, Colusa, CA 95932 USA.	melundy@ucanr.edu		Lundy, Mark/0000-0003-4043-0841	Jastro Fellowship through the Graduate Group in Horticulture and Agronomy; Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA	Jastro Fellowship through the Graduate Group in Horticulture and Agronomy; Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA	Vestergaard Inc. provided partial support for this research by purchasing the materials used in the experiment. The remainder of the experiment was funded via a Jastro Fellowship through the Graduate Group in Horticulture and Agronomy and a Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA (www.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ECONOMIST; AOAC, 2006, OFFICIAL METHODS ANA; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; California Safe Soil, 2014, FERT FOOD H2HT; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; Collavo Alberto, 2005, P519; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dossey AT, 2013, SCIENTIST; Elferink EV, 2008, J CLEAN PROD, V16, P1227, DOI 10.1016/j.jclepro.2007.06.008; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Feddes JJR, 2002, POULTRY SCI, V81, P774, DOI 10.1093/ps/81.6.774; Fiala N, 2008, ECOL ECON, V67, P412, DOI 10.1016/j.ecolecon.2007.12.021; Finnveden G, 2005, J CLEAN PROD, V13, P213, DOI 10.1016/j.jclepro.2004.02.023; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Lyn JC, 2011, AGE, V33, P509, DOI 10.1007/s11357-010-9195-z; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; Offenberg J, 2011, J APPL ENTOMOL, V135, P575, DOI 10.1111/j.1439-0418.2010.01588.x; Oji UI, 2007, SMALL RUMINANT RES, V69, P232, DOI 10.1016/j.smallrumres.2006.01.015; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Peckham M, 2013, UN TIME         0515; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; R Core Team, 2013, R LANG ENV STAT COMP; Ramos-Elorduy J, 2002, J ECON ENTOMOL, V95, P214, DOI 10.1603/0022-0493-95.1.214; Ramos-Elorduy Julieta, 2005, P263; Roy K, 2007, WORLD DEV REPORT 200; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Runyon L., 2014, WILL AM BUY BUG SNAC; Saha UK, 2010, THE UNIVERSITY OF GE, V1367; SLANSKY F, 1985, ENTOMOL EXP APPL, V39, P47, DOI 10.1007/BF00338524; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tiquia SM, 2002, NUTR CYCL AGROECOSYS, V62, P15, DOI 10.1023/A:1015137922816; Van Huis A., 2013, EDIBLE INSECTS FUTUR; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Verheyen L, 1996, MANAGEMENT WASTE ANI; Vogel G, 2010, SCIENCE, V327, P811, DOI 10.1126/science.327.5967.811; White T, 2000, ECOL ECON, V34, P145, DOI 10.1016/S0921-8009(00)00175-0; Zhang RH, 2007, BIORESOURCE TECHNOL, V98, P929, DOI 10.1016/j.biortech.2006.02.039	45	96	97	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0118785	10.1371/journal.pone.0118785	http://dx.doi.org/10.1371/journal.pone.0118785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875026	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800003
J	Marqueze, EC; Vasconcelos, S; Garefelt, J; Skene, DJ; Moreno, CR; Lowden, A				Marqueze, Elaine Cristina; Vasconcelos, Suleima; Garefelt, Johanna; Skene, Debra J.; Moreno, Claudia Roberta; Lowden, Arne			Natural Light Exposure, Sleep and Depression among Day Workers and Shiftworkers at Arctic and Equatorial Latitudes	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; LOW-BACK-PAIN; BRIGHT LIGHT; CIRCADIAN-RHYTHMS; MOOD; PREVALENCE; IMPACT; ASSOCIATION; PHOTOPERIOD; ALERTNESS	Objectives This study aimed to investigate the relationship between individual natural light exposure, sleep need, and depression at two latitudes, one extreme with a few hours of light per day during winter, and the other with equal hours of light and darkness throughout the year. Methods This cross-sectional study included a sample of Brazilian workers (Equatorial, n = 488 workers) and a Swedish sample (Arctic, n = 1,273). Results The reported mean total natural light exposure per 4-week cycle differed significantly between the Equatorial and Arctic regions. However, shiftworkers from both sites reported similar hours of natural light exposure. Short light exposure was a predictor for insufficient sleep. Conclusion Reduced exposure to natural light appears to increase the perception of obtaining insufficient sleep. Arctic workers were more prone to develop depression than Equatorial workers.	[Marqueze, Elaine Cristina; Vasconcelos, Suleima; Moreno, Claudia Roberta] Univ Sao Paulo, Sch Publ Hlth, Dept Environm Hlth, BR-09500900 Sao Paulo, Brazil; [Marqueze, Elaine Cristina; Garefelt, Johanna; Moreno, Claudia Roberta; Lowden, Arne] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Marqueze, Elaine Cristina] Univ Catolica Santos, UNISANTOS, Publ Hlth Grad Program, Epidemiol, Sao Paulo, Brazil; [Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Vasconcelos, Suleima] Univ Fed Acre, UFAC, Dept Hlth Sci, Rio Branco, Acre, Brazil	Universidade de Sao Paulo; Stockholm University; Universidade Catolica de Santos; University of Surrey; Universidade Federal do Acre (UFAC)	Marqueze, EC (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Environm Hlth, BR-09500900 Sao Paulo, Brazil.	elaine.marqueze@unisantos.br	Moreno, Claudia/GRJ-1036-2022; Marqueze, Elaine Cristina/V-3077-2019; de Castro Moreno, Claudia Roberta/I-3298-2012; Lowden, Arne/AAH-5305-2019; Garefelt, Johanna/AAQ-7356-2020	Marqueze, Elaine Cristina/0000-0002-4987-7757; de Castro Moreno, Claudia Roberta/0000-0003-1839-9673; Garefelt, Johanna/0000-0003-3658-6448; PEDROZA VASCONCELOS, SULEIMA/0000-0002-0850-9659; Skene, Debra/0000-0001-8202-6180	FAPESP/Surrey; FAPESP [2011/19563-0, 2014/01514-0]; CNPq [471085/2010-3]; UGPN; Funtac/FDCT [752618171/11]; Swedish Research Council for Health, Working Life and Welfare [2011-0488]; CAPES/STINT Program [18886/12-4]; Royal Society;  [CAPES/STINT-004/12]	FAPESP/Surrey; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UGPN; Funtac/FDCT; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); CAPES/STINT Program; Royal Society(Royal Society of London); 	We would like to acknowledge funding from the CAPES/STINT-004/12 (Mobility funding), FAPESP/Surrey (Mobility funding), FAPESP (Project 2011/19563-0), CNPq (Project 471085/2010-3), UGPN (Mobility funding), Funtac/FDCT (Project 752618171/11) and Swedish Research Council for Health, Working Life and Welfare (2011-0488). E.C.M. was awarded by CAPES/STINT Program-18886/12-4 and C.R.C.M. by FAPESP 2014/01514-0. D.J.S. is a Royal Society Wolfson Research Merit Award holder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, J SLEEP RES, V3, P152, DOI 10.1111/j.1365-2869.1994.tb00122.x; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Alsaadi SM, 2014, CLIN J PAIN, V30, P755, DOI 10.1097/AJP.0000000000000055; [Anonymous], 1997, WORK ABILITY INDEX; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Bech P, 2009, ACTA PSYCHIAT SCAND, V119, P298, DOI 10.1111/j.1600-0447.2008.01289.x; Benedetti F, 2013, BIOL PSYCHIAT, V74, P236, DOI 10.1016/j.biopsych.2013.05.037; Bjorvatn B, 1999, J SLEEP RES, V8, P105, DOI 10.1046/j.1365-2869.1999.00146.x; Borisenkov MF, 2012, CHRONOBIOL INT, V29, P305, DOI 10.3109/07420528.2011.653612; Brancaleoni G, 2009, EPIDEMIOL PSICHIAT S, V18, P336, DOI 10.1017/S1121189X00000312; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Burke TM, 2013, SLEEP, V36, P1617, DOI 10.5665/sleep.3110; Cardinali DP, 2000, NEUROENDOCRINOL LETT, V21, P9; Chapman DP, 2013, PSYCHIAT SERV, V64, P385, DOI 10.1176/appi.ps.201200226; Ciesielczyk Katarzyna, 2004, Psychiatr Pol, V38, P1105; Czeisler C, 2013, NATURE, V497, pS13, DOI 10.1038/497S13a; Dumont M, 2007, SLEEP MED, V8, P557, DOI 10.1016/j.sleep.2006.11.008; Faestel PM, 2013, J CLIN SLEEP MED, V9, P577, DOI 10.5664/jcsm.2754; Fetveit A, 2003, INT J GERIATR PSYCH, V18, P520, DOI 10.1002/gps.852; Friborg O, 2012, J SLEEP RES, V21, P176, DOI 10.1111/j.1365-2869.2011.00982.x; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grandner MA, 2012, J CLIN SLEEP MED, V8, P77, DOI 10.5664/jcsm.1668; Grimaldi S, 2009, NORD J PSYCHIAT, V63, P397, DOI 10.1080/08039480902878729; Guillemette J, 1998, BIOL PSYCHIAT, V44, P622, DOI 10.1016/S0006-3223(97)00543-X; Hanson LLM, 2014, SCAND J WORK ENV HEA, V40, P66, DOI 10.5271/sjweh.3378; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hayashi M, 2003, CLIN NEUROPHYSIOL, V114, P2268, DOI 10.1016/S1388-2457(03)00255-4; Horowitz TS, 2002, IND HEALTH, V40, P223, DOI 10.2486/indhealth.40.223; Juzeniene A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/6/066701; Kakooei H, 2010, INT J OCCUP SAF ERGO, V16, P477, DOI 10.1080/10803548.2010.11076860; Kegel M, 2009, NORD J PSYCHIAT, V63, P331, DOI 10.1080/08039480902799040; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kripke D, 2011, PSYCHOPHARMACOLOGY, V213, P833, DOI 10.1007/s00213-010-2045-y; Kuller R, 2006, ERGONOMICS, V49, P1496, DOI 10.1080/00140130600858142; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Leger D, 2011, J PSYCHOSOM RES, V70, P29, DOI 10.1016/j.jpsychores.2010.09.006; Levitt AJ, 2002, CAN J PSYCHIAT, V47, P361, DOI 10.1177/070674370204700407; Lindblom N, 2002, CHRONOBIOL INT, V19, P441, DOI 10.1081/CBI-120002880; Lowden A, 2004, J SLEEP RES, V13, P37, DOI 10.1046/j.1365-2869.2003.00381.x; Martinez MC, 2009, REV SAUDE PUBL, V43; Martinez-Nicolas A, 2011, CHRONOBIOL INT, V28, P617, DOI 10.3109/07420528.2011.593278; Matos FB, 2011, RENEW SUST ENERG REV, V15, P3196, DOI 10.1016/j.rser.2011.04.012; McLaughlin C, 2008, CHRONOBIOL INT, V25, P455, DOI 10.1080/07420520802118269; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mersch PPA, 1999, J AFFECT DISORDERS, V53, P35, DOI 10.1016/S0165-0327(98)00097-4; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Palinkas L A, 2000, Int J Circumpolar Health, V59, P63; Pallesen S, 2010, SCAND J WORK ENV HEA, V36, P109, DOI 10.5271/sjweh.2886; Park DH, 2007, CHRONOBIOL INT, V24, P905, DOI 10.1080/07420520701669677; Sadeghniiat-Haghighi K, 2011, SCAND J WORK ENV HEA, V37, P77, DOI 10.5271/sjweh.3086; Sivertsen B, 2011, AM J EPIDEMIOL, V174, P147, DOI 10.1093/aje/kwr052; Terao T, 2011, PSYCHOPHARMACOLOGY, V213, P831, DOI 10.1007/s00213-010-2046-x; TUOMI K, 2005, INDICE CAPACIDADE TR; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; Vorcaro CMR, 2001, ACTA PSYCHIAT SCAND, V104, P257, DOI 10.1034/j.1600-0447.2001.00440.x; Waage S, 2013, IND HEALTH, V51, P172; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wheaton A. G., 2011, Morbidity and Mortality Weekly Report, V60, P239; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	62	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122078	10.1371/journal.pone.0122078	http://dx.doi.org/10.1371/journal.pone.0122078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874859	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800037
J	Pickering, BS; Tyler, S; Smith, G; Burton, L; Li, MY; Dallaire, A; Weingartl, H				Pickering, Brad S.; Tyler, Shaun; Smith, Greg; Burton, Lynn; Li, Mingyi; Dallaire, Andre; Weingartl, Hana			Identification of a Novel Afipia Species Isolated from an Indian Flying Fox	PLOS ONE			English	Article							AMOEBAL PATHOGENS; FELIS; BATS; BACTERIAL; GROWTH; AGENTS	An old world fruit bat Pteropus giganteus, held in captivity and suffering from necrosis of its wing digits, failed to respond to antibiotic therapy and succumbed to the infection. Samples submitted to the National Centre for Foreign Animal Disease were tested for viral infection. Vero E6 cells exhibited minor but unique cytopathic effects on second blind passage, and full CPE by passage four. Utilizing an unbiased random amplification technique from cell culture supernatant, we identified a bacterium belonging to the Bradyrhizobiaceae. Purification of cell culture supernatant on TY media revealed a slow growing bacterial isolate. In this study using electron microscopy, 16S rRNA gene analysis and whole genome sequencing, we identify a novel bacterial species associated with the site of infection belonging to the genus Afipia. This genus of bacteria is very diverse, with only a limited number of species characterized. Afipia felis, previously described as the etiological agent to cause cat scratch disease, and Afipia septicemium, most recently shown to cause disease in humans, highlight the potential for members of this genus to form a branch of opportunistic pathogens within the Bradyrhizobiaceae. Increased utilization of next generation sequencing and genomics will aid in classifying additional members of this intriguing bacterial genera.	[Pickering, Brad S.; Smith, Greg; Burton, Lynn; Li, Mingyi; Weingartl, Hana] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Pickering, Brad S.; Weingartl, Hana] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Tyler, Shaun] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Dallaire, Andre] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada	Canadian Food Inspection Agency; University of Manitoba; Public Health Agency of Canada; Universite de Montreal	Pickering, BS (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	Bradley.pickering@inspection.gc.ca			Canadian Food Inspection Agency	Canadian Food Inspection Agency	The authors received technical development funds of the Canadian Food Inspection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BIRKNESS KA, 1992, INFECT IMMUN, V60, P2281, DOI 10.1128/IAI.60.6.2281-2287.1992; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Jerris RC, 1996, ANNU REV MICROBIOL, V50, P707, DOI 10.1146/annurev.micro.50.1.707; Kuzmin IV, 2006, EMERG INFECT DIS, V12, P486, DOI 10.3201/eid1203.050333; La Scola B, 1999, LANCET, V353, P1330, DOI 10.1016/S0140-6736(99)00906-X; La Scola B, 2002, INFECT CONT HOSP EP, V23, P462, DOI 10.1086/502086; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082673; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; Luhrmann A, 2001, P NATL ACAD SCI USA, V98, P7271, DOI 10.1073/pnas.121190398; Marrie TJ, 2001, EMERG INFECT DIS, V7, P1026, DOI 10.3201/eid0706.010619; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Schneider B, 2007, TRAFFIC, V8, P226, DOI 10.1111/j.1600-0854.2006.00525.x; Schueller C, 2007, MICROBES INFECT, V9, P355, DOI 10.1016/j.micinf.2006.12.007; Schueller C, 2010, FEMS MICROBIOL LETT, V302, P203, DOI 10.1111/j.1574-6968.2009.01858.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas V, 2007, SYST APPL MICROBIOL, V30, P572, DOI 10.1016/j.syapm.2007.06.004; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06	32	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121274	10.1371/journal.pone.0121274	http://dx.doi.org/10.1371/journal.pone.0121274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874801	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800017
J	Ramzan, M				Ramzan, Muhammad			Influence of Newtonian Heating on Three Dimensional MHD Flow of Couple Stress Nanofluid with Viscous Dissipation and Joule Heating	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; VERTICAL SURFACE	The present exploration discusses the influence of Newtonian heating on the magnetohy-drodynamic (MHD) three dimensional couple stress nanofluid past a stretching surface. Viscous dissipation and Joule heating effects are also considered. Moreover, the nanofluid model includes the combined effects of thermophoresis and Brownian motion. Using an appropriate transformation, the governing non linear partial differential equations are converted into nonlinear ordinary differential equations. Series solutions using Homotopy Analysis method (HAM) are computed. Plots are presented to portrait the arising parameters in the problem. It is seen that an increase in conjugate heating parameter results in considerable increase in the temperature profile of the stretching wall. Skin friction coefficient, local Nusselt and local Sherwood numbers tabulated and analyzed. Higher values of conjugate parameter, Thermophoresis parameter and Brownian motion parameter result in enhancement of temperature distribution.	Majmaah Univ, Coll Sci, Dept Math, Academic City, Saudi Arabia	Majmaah University	Ramzan, M (corresponding author), Majmaah Univ, Coll Sci, Dept Math, Academic City, Saudi Arabia.	m.ramzan@mu.edu.sa	Ramzan, M./AAH-9959-2020	Ramzan, M./0000-0002-9523-5800	Deanship of Scientific Research (DSR), Al-Majmaah University, Saudi Arabia [36-1-3]; DSR	Deanship of Scientific Research (DSR), Al-Majmaah University, Saudi Arabia; DSR	This project is funded by the Deanship of Scientific Research (DSR), Al-Majmaah University, Saudi Arabia under grant no. 36-1-3. The author therefore acknowledges with thanks DSR for technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Ariel PD, 2007, COMPUT MATH APPL, V54, P920, DOI 10.1016/j.camwa.2006.12.066; Azizian R, 2014, INT J HEAT MASS TRAN, V68, P94, DOI 10.1016/j.ijheatmasstransfer.2013.09.011; Chaudhary RC, 2007, J ENG PHYS THERMOPH+, V80, P954, DOI 10.1007/s10891-007-0127-4; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Dinarvand S, 2010, NONLINEAR ANAL-REAL, V11, P1159, DOI 10.1016/j.nonrwa.2009.02.009; Gorla RSR, 2014, J NANOFLUIDS, V3, P65, DOI 10.1166/jon.2014.1074; Gumgum S, 2014, J COMPUT APPL MATH, V259, P730, DOI 10.1016/j.cam.2013.05.006; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107858; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13158-1; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2375, DOI 10.1016/j.cnsns.2009.09.013; Hayat T, 2014, INT J NUMER METHOD H, V24, P760, DOI 10.1108/HFF-09-2012-0219; Hussain T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103719; Ishak A, 2010, PHYSICA A, V389, P40, DOI 10.1016/j.physa.2009.09.008; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Liao SJ, 2013, HOMOTOPY ANAL METHOD; Liao SJ, 2003, BEYONG PERTURBATION; Makinde OD, 2010, CAN J CHEM ENG, V88, P983, DOI 10.1002/cjce.20369; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Mukhopadhyay S, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/5/054703; Raftari B, 2010, COMPUT MATH APPL, V59, P3328, DOI 10.1016/j.camwa.2010.03.018; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rashidi M. M., 2011, AM J COMPUT MATH, V1, P119, DOI DOI 10.4236/AJCM.2011.12012; Rizvi IH, 2013, HEAT MASS TRANSFER, V49, P595, DOI 10.1007/s00231-013-1117-z; Sahoo B, 2011, COMPUT MATH APPL, V61, P1442, DOI 10.1016/j.camwa.2011.01.017; Seddeek MA, 2009, APPL APPL MATH, V4, P301; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	28	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124699	10.1371/journal.pone.0124699	http://dx.doi.org/10.1371/journal.pone.0124699			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874800	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700071
J	Reddy, PJ; Sinha, S; Ray, S; Sathe, GJ; Chatterjee, A; Prasad, TSK; Dhali, S; Srikanth, R; Panda, D; Srivastava, S				Reddy, Panga Jaipal; Sinha, Sneha; Ray, Sandipan; Sathe, Gajanan J.; Chatterjee, Aditi; Prasad, T. S. Keshava; Dhali, Snigdha; Srikanth, Rapole; Panda, Dulal; Srivastava, Sanjeeva			Comprehensive Analysis of Temporal Alterations in Cellular Proteome of Bacillus subtilis under Curcumin Treatment	PLOS ONE			English	Article							CLP-DEPENDENT PROTEOLYSIS; DIVISION; PROTEINS; GENE; BIOSYNTHESIS; LOCALIZATION; INSTABILITY; SPORULATION; MECHANISM; PATHWAYS	Curcumin is a natural dietary compound with antimicrobial activity against various gram positive and negative bacteria. This study aims to investigate the proteome level alterations in Bacillus subtilis due to curcumin treatment and identification of its molecular/cellular targets to understand the mechanism of action. We have performed a comprehensive proteomic analysis of B. subtilis AH75 strain at different time intervals of curcumin treatment (20, 60 and 120 min after the drug exposure, three replicates) to compare the protein expression profiles using two complementary quantitative proteomic techniques, 2D-DIGE and iTRAQ. To the best of our knowledge, this is the first comprehensive longitudinal investigation describing the effect of curcumin treatment on B. subtilis proteome. The proteomics analysis revealed several interesting targets such UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1, putative septation protein SpoVG and ATP-dependent Clp protease proteolytic subunit. Further, in silico pathway analysis using DAVID and KOBAS has revealed modulation of pathways related to the fatty acid metabolism and cell wall synthesis, which are crucial for cell viability. Our findings revealed that curcumin treatment lead to inhibition of the cell wall and fatty acid synthesis in addition to differential expression of many crucial proteins involved in modulation of bacterial metabolism. Findings obtained from proteomics analysis were further validated using 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) assay for respiratory activity, resazurin assay for metabolic activity and membrane integrity assay by potassium and inorganic phosphate leakage measurement. The gene expression analysis of selected cell wall biosynthesis enzymes has strengthened the proteomics findings and indicated the major effect of curcumin on cell division.	[Reddy, Panga Jaipal; Sinha, Sneha; Ray, Sandipan; Panda, Dulal; Srivastava, Sanjeeva] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Dhali, Snigdha; Srikanth, Rapole] Natl Ctr Cell Sci, Prote Lab, Pune, Maharashtra, India; [Sathe, Gajanan J.; Chatterjee, Aditi; Prasad, T. S. Keshava] Inst Bioinformat, Bangalore, Karnataka, India; [Sathe, Gajanan J.; Chatterjee, Aditi] Manipal Univ, Manipal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Manipal Academy of Higher Education (MAHE)	Srivastava, S (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	sanjeeva@iitb.ac.in	RAY, SANDIPAN/AAQ-4064-2021; panga, jaipalreddy/A-6591-2019; Prasad, Keshava/F-7631-2010	RAY, SANDIPAN/0000-0002-9960-5768; panga, jaipalreddy/0000-0002-4481-3631; Prasad, Keshava/0000-0002-6206-2384; Sathe, Gajanan/0000-0002-6239-5365	IIT Bombay [09IRCC007]; Department of Science and Technology, Government of India	IIT Bombay; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by a start-up grant 09IRCC007 from the IIT Bombay to Sanjeeva Srivastava and grant from Department of Science and Technology, Government of India to Dulal Panda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Chimerel C, 2012, BBA-BIOMEMBRANES, V1818, P1590, DOI 10.1016/j.bbamem.2012.02.022; Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632; D'Aguanno S, 2012, MOL BIOSYST, V8, P1068, DOI 10.1039/c2mb05498a; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Ribeiro APD, 2013, LASER MED SCI, V28, P391, DOI 10.1007/s10103-012-1064-9; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Foss MH, 2013, MEDCHEMCOMM, V4, P112, DOI 10.1039/c2md20127e; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Hegge AB, 2012, J PHARM SCI-US, V101, P1524, DOI 10.1002/jps.23046; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Liebeke M, 2008, MOL MICROBIOL, V69, P1513, DOI 10.1111/j.1365-2958.2008.06382.x; Madden K, 2009, PROSTAG LEUKOTR ESS, V80, P9, DOI 10.1016/j.plefa.2008.10.003; Mariscal A, 2009, APPL MICROBIOL BIOT, V82, P773, DOI 10.1007/s00253-009-1879-x; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; McAuliffe O, 1998, APPL ENVIRON MICROB, V64, P439; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Newman EB, 1998, J BACTERIOL, V180, P3614, DOI 10.1128/JB.180.14.3614-3619.1998; Ogino H, 2004, GENES CELLS, V9, P765, DOI 10.1111/j.1365-2443.2004.00770.x; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Perry MC, 2010, MOL NUTR FOOD RES, V54, P1192, DOI 10.1002/mnfr.200900277; Ragunathan Irulappan, 2007, Journal of Zhejiang University-Science B, V8, P470, DOI 10.1631/jzus.2007.B0470; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Ray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041751; Real G, 2006, J BACTERIOL, V188, P1721, DOI 10.1128/JB.188.5.1721-1732.2006; Reddy PJ, 2013, CURR PROTEOMICS, V10, P298, DOI 10.2174/15701646113106660004; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Thompson LS, 2006, J BACTERIOL, V188, P7677, DOI 10.1128/JB.01072-06; van Baarle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009850; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Wenzel M, 2012, ANTIMICROB AGENTS CH, V56, P5749, DOI 10.1128/AAC.01380-12; Wolff S, 2006, MOL CELL PROTEOMICS, V5, P1183, DOI 10.1074/mcp.M600069-MCP200; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483	59	7	7	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120620	10.1371/journal.pone.0120620	http://dx.doi.org/10.1371/journal.pone.0120620			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874956	Green Published, gold			2022-12-27	WOS:000353014700004
J	Brederoo, SG; Bos, LS; Dragoy, O; Bastiaanse, R; Baggio, G				Brederoo, Sanne Goren; Bos, Laura Simone; Dragoy, Olga; Bastiaanse, Roelien; Baggio, Giosue			Gamma Oscillations as a Neural Signature of Shifting Times in Narrative Language	PLOS ONE			English	Article							SEMANTIC VIOLATION; EEG; RESPONSES; N400; MEG	Verbs and other temporal expressions allow speakers to specify the location of events in time, as well as to move back and forth in time, shifting in a narrative between past, present and future. The referential flexibility of temporal expressions is well understood in linguistics but its neurocognitive bases remain unknown. We aimed at obtaining a neural signature of shifting times in narrative language. We recorded and analyzed event-related brain potentials (ERPs) and oscillatory responses to the adverb 'now' and to the second main verb in Punctual ('An hour ago the boy stole a candy and now he peeled the fruit') and Iterative ('The entire afternoon the boy stole candy and now he peeled the fruit') contexts. 'An hour ago' introduces a time frame that lies entirely in the past, 'now' shifts the narrative to the present, and 'peeled' shifts it back to the past. These two referential shifts in Punctual contexts are expected to leave very similar traces on neural responses. In contrast, 'The entire afternoon' specifies a time frame that may encompass past, present and future, such that both 'now' and 'peeled' are consistent with it. Here, no time shift is required. We found no difference in ERPs between Punctual and Iterative contexts either at 'now' or at the second verb. However, reference shifts modulated oscillatory signals. 'Now' and the second verb in Punctual contexts resulted in similar responses: an increase in gamma power with a left-anterior distribution. Gamma bursts were absent in Iterative contexts. We propose that gamma oscillations here reflect the binding of temporal variables to the values allowed by constraints introduced by temporal expressions in discourse.	[Brederoo, Sanne Goren; Bos, Laura Simone; Dragoy, Olga; Bastiaanse, Roelien] Univ Groningen, Ctr Language & Cognit, Groningen, Netherlands; [Brederoo, Sanne Goren; Bos, Laura Simone] Univ Groningen, Univ Med Ctr Groningen, NeuroImaging Ctr, NL-9713 AV Groningen, Netherlands; [Dragoy, Olga] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Baggio, Giosue] Scuola Int Super Studi Avanzati, Brain & Language Lab, Trieste, Italy; [Baggio, Giosue] Norwegian Univ Sci & Technol, Dept Language & Literature, Language Acquisit & Language Proc Lab, Trondheim, Norway	University of Groningen; University of Groningen; HSE University (National Research University Higher School of Economics); International School for Advanced Studies (SISSA); Norwegian University of Science & Technology (NTNU)	Baggio, G (corresponding author), Scuola Int Super Studi Avanzati, Brain & Language Lab, Trieste, Italy.	giosue.baggio@ntnu.no	Dragoy, Olga/AAD-7823-2019; Bastiaanse, Roelien/I-9209-2017; Dragoy, Olga/A-2365-2014	Bastiaanse, Roelien/0000-0002-4818-0763; Baggio, Giosue/0000-0001-5086-0365; Dragoy, Olga/0000-0002-6777-5164; Brederoo, Sanne/0000-0001-9608-0954	European Masters in Clinical Linguistics; Basic Research Program at the National Research University Higher School of Economics	European Masters in Clinical Linguistics; Basic Research Program at the National Research University Higher School of Economics	The work of Olga Dragoy was supported by a visiting scholar Erasmus Mundus Grant from the European Masters in Clinical Linguistics and the Basic Research Program at the National Research University Higher School of Economics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GRONINGEN DISSERTATI, V42; Baggio G, 2008, J MEM LANG, V59, P36, DOI 10.1016/j.jml.2008.02.005; Baggio G, 2012, HBK PHILOS SCI, P325; Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Baggio G, 2010, J COGNITIVE NEUROSCI, V22, P2131, DOI 10.1162/jocn.2009.21303; Baggio G, 2008, LANG LEARN, V58, P35, DOI 10.1111/j.1467-9922.2008.00460.x; Baggio Giosue, 2012, OXFORD HDB COMPOSITI, P657; Bar-Hillel Y., 1954, MIND, V63, P359, DOI DOI 10.1093/MIND/LXIII.251.359; Bastiaansen M, 2006, PROG BRAIN RES, V159, P179, DOI 10.1016/S0079-6123(06)59012-0; Bos LS, 2013, J NEUROLINGUIST, V26, P283, DOI 10.1016/j.jneuroling.2012.10.001; Braeutigam S, 2001, COGNITIVE BRAIN RES, V10, P365, DOI 10.1016/S0926-6410(00)00055-0; Comrie Bernard, 1985, TENSE, DOI [10.1017/CBO9781139165815, DOI 10.1017/CBO9781139165815]; Corazza E, 2004, SYNTHESE, V138, P289, DOI 10.1023/B:SYNT.0000013244.65400.a0; Dilligham Pierson C, 1901, POND PEOPLE; Dragoy O, 2012, J MEM LANG, V66, P307, DOI 10.1016/j.jml.2011.09.001; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fonseca A, 2015, BRAIN RES, V1604, P1, DOI 10.1016/j.brainres.2015.01.030; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Grossmann A., 1989, WAVELETS TIME FREQUE, DOI DOI 10.1007/978-3-642-97177-8_1; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; Hunter Julie, 2012, Logic, Language and Meaning. 18th Amsterdam Colloquium. Revised Selected Papers, P371, DOI 10.1007/978-3-642-31482-7_38; Hunter J, 2013, J SEMANT, V30, P381, DOI 10.1093/jos/ffs013; KAMP H, 1971, THEORIA, V37, P227; Kamp H, 1993, INTRO MODEL THEORETI; KAPLAN D., 1989, THEMES KAPLAN, P481; Kuperberg GR, 2010, J COGNITIVE NEUROSCI, V22, P2685, DOI 10.1162/jocn.2009.21333; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; NIGAM A, 1992, J COGNITIVE NEUROSCI, V4, P15, DOI 10.1162/jocn.1992.4.1.15; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Paczynski M, 2014, J COGNITIVE NEUROSCI, V26, P1905, DOI 10.1162/jocn_a_00638; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Penolazzi B, 2009, NEUROSCI LETT, V465, P74, DOI 10.1016/j.neulet.2009.08.065; Predelli S, 1998, MIND LANG, V13, P400, DOI 10.1111/1468-0017.00083; Prior Arthur, 1968, NOUS, V2, P101; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Recanati F., 2001, TEXTE, V127, P115; SAG IA, 1984, LINGUIST PHILOS, V7, P325, DOI 10.1007/BF00627709; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sinha C, 2014, ANN NY ACAD SCI, V1326, P72, DOI 10.1111/nyas.12491; SMITH Q, 1989, SYNTHESE, V78, P167, DOI 10.1007/BF00869371; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; VanLambalgen M, 2005, EXPLOR SEMANT, P1, DOI 10.1002/9780470759257; Voltolini A, 2006, SYNTHESE, V153, P23, DOI 10.1007/s11229-006-0001-5; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	52	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121146	10.1371/journal.pone.0121146	http://dx.doi.org/10.1371/journal.pone.0121146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874576	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100036
J	Gonzalez-Miguel, J; Morchon, R; Siles-Lucas, M; Simon, F				Gonzalez-Miguel, Javier; Morchon, Rodrigo; Siles-Lucas, Mar; Simon, Fernando			Fibrinolysis and Proliferative Endarteritis: Two Related Processes in Chronic Infections? The Model of the Blood-Borne Pathogen Dirofilaria immitis	PLOS ONE			English	Article							PLASMINOGEN-BINDING PROTEINS; CELL-SURFACE; EXCRETORY/SECRETORY ANTIGENS; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; DOGS; LESIONS; SYSTEM; IDENTIFICATION; ACTIVATION	The interaction between blood-borne pathogens and fibrinolysis is one of the most important mechanisms that mediate invasion and the establishment of infectious agents in their hosts. However, overproduction of plasmin (final product of the route) has been related in other contexts to proliferation and migration of the arterial wall cells and degradation of the extracellular matrix. We have recently identified fibrinolysis-activating antigens from Dirofilaria immitis, a blood-borne parasite whose key pathological event (proliferative endarteritis) is produced by similar mechanisms to those indicated above. The objective of this work is to study how two of this antigens [actin (ACT) and fructose-bisphosphate aldolase (FBAL)] highly conserved in pathogens, activate fibrinolysis and to establish a relationship between this activation and the development of proliferative endarteritis during cardiopulmonary dirofilariasis. We demonstrate that both proteins bind plasminogen, enhance plasmin generation, stimulate the expression of the fibrinolytic activators tPA and uPA in endothelial cell cultures and are located on the surface of the worm in contact with the host's blood. ELISA, western blot and immunofluorescence techniques were employed for this purpose. Additionally, the implication of lysine residues in this interaction was analyzed by bioinformatics. The involvement of plasmin generated by the ACT/FBAL and plasminogen binding in cell proliferation and migration, and degradation of the extracellular matrix were shown in an "in vitro" model of endothelial and smooth muscle cells in culture. The obtained results indicate that ACT and FBAL from D. immitis activate fibrinolysis, which could be used by the parasite like a survival mechanism to avoid the clot formation. However, long-term overproduction of plasmin can trigger pathological events similar to those described in the emergence of proliferative endarteritis. Due to the high degree of evolutionary conservation of these antigens, similar processes may occur in other blood-borne pathogens.	[Gonzalez-Miguel, Javier; Morchon, Rodrigo; Simon, Fernando] Inst Biomed Res Salamanca IBSAL, Parasitol Lab, Fac Pharm, Salamanca, Spain; [Siles-Lucas, Mar] CSIC, Parasitol Lab, IRNASA, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA)	Gonzalez-Miguel, J (corresponding author), Inst Biomed Res Salamanca IBSAL, Parasitol Lab, Fac Pharm, Salamanca, Spain.	jglez@usal.es	Siles-Lucas, Mar/B-1113-2012; González-Miguel, Javier/A-4922-2019; Morchón, Rodrigo/A-4889-2019; González-Miguel, Javier/AAA-3563-2021; Simón, Fernando/A-4903-2019	Siles-Lucas, Mar/0000-0002-1257-2562; González-Miguel, Javier/0000-0003-4279-4761; Morchón, Rodrigo/0000-0003-2699-1482; González-Miguel, Javier/0000-0003-4279-4761; Simón, Fernando/0000-0002-8177-6083	Agencia de Desarrollo Economico de Castilla y Leon; FEDER; Junta de Castilla y Leon, Spain [SA090/A09]	Agencia de Desarrollo Economico de Castilla y Leon; FEDER(European Commission); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This research was supported by Agencia de Desarrollo Economico de Castilla y Leon (cofinanced with FEDER funds), Junta de Castilla y Leon (grant SA090/A09), Spain.	ADCOCK JL, 1961, AM J VET RES, V22, P655; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATWELL RB, 1986, BRIT J EXP PATHOL, V67, P395; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Dudani AK, 2005, BIOCHEM CELL BIOL, V83, P28, DOI 10.1139/O04-109; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Figuera L, 2013, ACTA TROP, V128, P116, DOI 10.1016/j.actatropica.2013.06.023; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Geary J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-140; Gebbink MFBG, 2011, J THROMB HAEMOST, V9, P174, DOI 10.1111/j.1538-7836.2011.04278.x; Gomez-Arreaza A, 2014, MOL BIOCHEM PARASIT, V193, P75, DOI 10.1016/j.molbiopara.2014.02.005; Gonzalez-Miguel J, 2013, VET PARASITOL, V196, P235, DOI 10.1016/j.vetpar.2013.01.028; Gonzalez-Miguel J, 2012, MOL BIOCHEM PARASIT, V181, P134, DOI 10.1016/j.molbiopara.2011.10.010; Hawley SB, 2000, THROMB HAEMOSTASIS, V84, P882; Hayashi M, 2009, MOL CELL BIOCHEM, V322, P1, DOI 10.1007/s11010-008-9934-y; Hidaka Y, 2004, J VET MED SCI, V66, P1457, DOI 10.1292/jvms.66.1457; Kawabata A, 2008, J VET MED SCI, V70, P301, DOI 10.1292/jvms.70.301; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; LIND SE, 1991, J BIOL CHEM, V266, P17673; Marangoni NR, 2011, PARASITE IMMUNOL, V33, P330, DOI 10.1111/j.1365-3024.2011.01285.x; McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2; Mebius MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003781; Morchon R, 2008, PARASITOL INT, V57, P441, DOI 10.1016/j.parint.2008.05.004; Morchon R, 2010, VET PARASITOL, V170, P331, DOI 10.1016/j.vetpar.2010.02.034; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Ramajo-Hernandez A, 2007, EXP PARASITOL, V115, P83, DOI 10.1016/j.exppara.2006.07.003; Simon F, 2012, CLIN MICROBIOL REV, V25, P507, DOI 10.1128/CMR.00012-12; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Urano T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/208108; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Venco L., 2007, Mappe Parassitologiche, V8, P117; Wang H, 2006, CANCER RES, V66, P7211, DOI 10.1158/0008-5472.CAN-05-4331; Wang JS, 2005, VET PARASITOL, V131, P261, DOI 10.1016/j.vetpar.2005.04.041; Yamaguchi M, 2011, INVEST OPHTH VIS SCI, V52, P679, DOI 10.1167/iovs.10-5555; Yang Z, 2005, J VASC SURG, V42, P532, DOI 10.1016/j.jvs.2005.05.035	47	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124445	10.1371/journal.pone.0124445	http://dx.doi.org/10.1371/journal.pone.0124445			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875022	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100259
J	Graesboll, K; Kirkeby, C; Nielsen, SS; Christiansen, LE				Graesboll, Kaare; Kirkeby, Carsten; Nielsen, Soren Saxmose; Christiansen, Lasse Engbo			Danish Holsteins Favor Bull Offspring: Biased Milk Production as a Function of Fetal Sex, and Calving Difficulty	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; CATTLE; YIELD; COWS; SELECTION; EASE	In a previous study from 2014 it was found that US Holstein cows that gave birth to heifer calves produced more milk than cows having bull calves. We wanted to assess whether this is also true for Danish cattle. Data from 578 Danish Holstein herds were analysed with a mixed effect model and contrary to the findings in the US, we found that cows produced higher volumes of milk if they had a bull calf compared to a heifer calf. We found a significantly higher milk production of 0.28% in the first lactation period for cows giving birth to a bull calf, compared to a heifer calf. This difference was even higher when cows gave birth to another bull calf, so having two bull calves resulted in a difference of 0.52% in milk production compared to any other combination of sex of the offspring. Furthermore, we found that farmer assisted calvings were associated with a higher milk yield. Cows with no farmer assistance or with veterinary assistance during the most recent calving produced less milk. There were also indications that dams would favor a bull fetus by decreasing milk production during the second pregnancy if the calf born in the first parity was a heifer. We hypothesize that size of calves is a confounding factor for milk production. However, calving weight was not available in the present data set to test this hypothesis.	[Graesboll, Kaare; Christiansen, Lasse Engbo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Kirkeby, Carsten] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Nielsen, Soren Saxmose] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Graesboll, K (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	kagr@dtu.dk	Kirkeby, Carsten/GVS-8137-2022	Christiansen, Lasse Engbo/0000-0001-5019-1931; Graesboll, Kaare/0000-0002-6258-8212; Nielsen, Soren/0000-0003-2417-0787; Kirkeby, Carsten/0000-0001-9292-5526	GUDP under the Danish Directorate for Food, Fisheries and Agriculture [34009-13-0596]	GUDP under the Danish Directorate for Food, Fisheries and Agriculture	This study carried out under the iCull project funded by GUDP under the Danish Directorate for Food, Fisheries and Agriculture grant no. 34009-13-0596 (http://naturerhverv.dk/tvaergaaende/gudp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrier AC, 2011, J DAIRY SCI, V94, P1804, DOI 10.3168/jds.2010-3641; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BYERS JA, 1990, BEHAV ECOL SOCIOBIOL, V26, P157; CHEW BP, 1981, J DAIRY SCI, V64, P2401, DOI 10.3168/jds.S0022-0302(81)82863-9; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Eaglen SAE, 2011, J DAIRY SCI, V94, P5413, DOI 10.3168/jds.2010-4040; FORTIN A, 1980, J ANIM SCI, V51, P604, DOI 10.2527/jas1980.513604x; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kertz AF, 1997, J DAIRY SCI, V80, P525, DOI 10.3168/jds.S0022-0302(97)75966-6; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; R Core Team, 2018, R LANG ENV STAT COMP; SIEBER M, 1989, J DAIRY SCI, V72, P2402, DOI 10.3168/jds.S0022-0302(89)79373-5; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WILMINK JBM, 1987, LIVEST PROD SCI, V17, P1, DOI 10.1016/0301-6226(87)90049-2	15	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124051	10.1371/journal.pone.0124051	http://dx.doi.org/10.1371/journal.pone.0124051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874441	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100236
J	Huang, YL; Tse, CS				Huang, Yanli; Tse, Chi-Shing			Re-Examining the Automaticity and Directionality of the Activation of the Spatial-Valence "Good is Up" Metaphoric Association	PLOS ONE			English	Article							WORKING-MEMORY LOAD; POLARITY CORRESPONDENCE; EMOTIONAL VALENCE; SERIAL-RECALL; LOCATION; SPACE; CLASSIFICATION; EMBODIMENT; HYPOTHESIS; SIMILARITY	According to the Conceptual Metaphor Theory, people understand abstract concepts depending on the activation of more concrete concepts, but not vice versa. The present research aims to investigate the role of directionality and automaticity regarding the activation of the conceptual metaphor "good is up". Experiment 1 tested the automaticity of the spatial-to-valence metaphoric congruency effect by having participants judge the valence of a positive or negative word that appeared either at the top or at the bottom of the screen. They performed the task concurrently with a 6-digit verbal rehearsal task in the working-memory-load (WML) blocks and without this task in the non-WML blocks. The spatial-to-valence metaphoric congruency effect occurred for the positive words in the non-WML blocks (i.e., positive words are judged more quickly when they appeared at the top than at the bottom of the screen), but not in the WML blocks, suggesting that this metaphoric association might not be activated automatically. Experiments 2-6 investigated the valence-to-spatial metaphoric association and its automaticity. Participants processed a positive or negative prime, which appeared at the center of the screen, and then identified a letter (p/q) that subsequently appeared at the top or bottom of the screen. The valence-to-spatial metaphoric congruency effect did not occur in the WML (6-digit verbal rehearsal) or non-WML blocks, whether response modality to the prime was key-press or vocal, or whether the prime was a word or a picture. The effect only unexpectedly occurred when the task was simultaneously performed with a 4-dot-position visuo-spatial rehearsal task. Nevertheless, the data collapsed across multiple experiments showed a null valence-to-spatial metaphoric congruency effect, suggesting the absence of the valence-to-spatial metaphoric association in general. The implications of the current findings for the Conceptual Metaphor Theory and its alternatives are discussed.	[Huang, Yanli; Tse, Chi-Shing] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tse, CS (corresponding author), Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China.	cstse@cuhk.edu.hk	huang, yan/GWM-4747-2022; Tse, Chi-Shing/B-3876-2011	Tse, Chi-Shing/0000-0003-3676-8102				[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Boot I, 2010, Q J EXP PSYCHOL, V63, P942, DOI 10.1080/17470210903134351; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chen Z, 2007, PSYCHON B REV, V14, P306, DOI 10.3758/BF03194069; CLARK HH, 1974, MEM COGNITION, V2, P101, DOI 10.3758/BF03197499; CLARK HH, 1975, J EXP PSYCHOL HUMAN, V1, P339, DOI 10.1037/0096-1523.1.4.339; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; Davis LC, 2013, MEMORY, V21, P778, DOI 10.1080/09658211.2012.756037; de la Vega I, 2012, J EXP PSYCHOL HUMAN, V38, P375, DOI 10.1037/a0024979; Dudschig C, 2015, ACTA PSYCHO IN PRESS; Fernandez-Duque D, 1999, COGNITIVE SCI, V23, P83, DOI 10.1016/S0364-0213(99)80053-6; Flumini A., 2013, P 36 ANN C COGN SCI, P2315; Gao QY, 2007, NEW ZEAL J PSYCHOL, V36, P146; Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001; Giessner SR, 2011, MEDIA PSYCHOL, V14, P442, DOI 10.1080/15213269.2011.620541; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hendricks MA, 2013, J EXP PSYCHOL LEARN, V39, P1491, DOI 10.1037/a0032974; Hermans D, 2000, PSYCHOL BELG, V40, P3; Huang YL, 2014, EUR J SOC PSYCHOL, V44, P360, DOI 10.1002/ejsp.2013; Hulme C, 2003, J MEM LANG, V49, P500, DOI 10.1016/S0749-596X(03)00096-2; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kahneman D., 1973, ATTENTION EFFORT; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kroneisen M, 2014, MEMORY, V22, P92, DOI 10.1080/09658211.2013.815217; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lakens D, 2012, J EXP PSYCHOL LEARN, V38, P726, DOI 10.1037/a0024955; Lakens D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00021; Lakoff G, 2008, CAMB HANDB PSYCHOL, P17; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lakoff George, 1993, METAPHOR THOUGHT, V2nd, P202, DOI DOI 10.1017/CBO9781139173865.013; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lebois LA, 2014, COGN SCI IN PRESS; Lee SWS, 2012, J PERS SOC PSYCHOL, V103, P737, DOI 10.1037/a0029708; Lien MC, 2002, PSYCHON B REV, V9, P212, DOI 10.3758/BF03196277; Louwerse M.M., 2007, HDB LATENT SEMANTIC, P107; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Lundholm H, 1921, PSYCHOL REV, V28, P43, DOI 10.1037/h0072647; Lynott D, 2014, PSYCHON B REV, V21, P218, DOI 10.3758/s13423-013-0481-5; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2004, PSYCHOL SCI, V15, P82, DOI 10.1111/j.0963-7214.2004.01502002.x; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Nairne JS, 2008, PSYCHOL SCI, V19, P176, DOI 10.1111/j.1467-9280.2008.02064.x; Neely JH, 2001, SCI CON SER, P69, DOI 10.1037/10394-005; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Piaget J., 1972, PSYCHOL CHILD; Posner M. I., 1975, ATTENTION PERFORM, P669; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Rubichi S, 2006, PSYCHON B REV, V13, P201, DOI 10.3758/BF03193832; Santiago J, 2011, APPL COGN LINGUIST, V18, P39; Santiago J, 2012, COGNITIVE SCI, V36, P1051, DOI 10.1111/j.1551-6709.2012.01240.x; SEYMOUR PHK, 1971, ACTA PSYCHOL, V35, P461, DOI 10.1016/0001-6918(71)90004-7; Tse CS, 2007, MEMORY, V15, P675, DOI 10.1080/09658210701467186; Tse CS, 2011, J EXP PSYCHOL HUMAN, V37, P180, DOI 10.1037/a0019930; Tse CS, 2010, MEM COGNITION, V38, P1110, DOI 10.3758/MC.38.8.1110; Wang SM, 2013, J EXP CHILD PSYCHOL, V115, P188, DOI 10.1016/j.jecp.2012.11.015; WAPNER S, 1957, J PERS, V25, P752, DOI 10.1111/j.1467-6494.1957.tb01563.x; Weger UW, 2007, PSYCHON B REV, V14, P517, DOI 10.3758/BF03194100; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yap MJ, 2009, J MEM LANG, V61, P303, DOI 10.1016/j.jml.2009.07.001; Zhang M, 2012, J CONSUM RES, V38, P1063, DOI 10.1086/661768; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	71	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123371	10.1371/journal.pone.0123371	http://dx.doi.org/10.1371/journal.pone.0123371			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25867748	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100167
J	Kasthurinaidu, SP; Ramasamy, T; Ayyavoo, J; Dave, DK; Adroja, DA				Kasthurinaidu, Senthilkumar Pitchalu; Ramasamy, Thirumurugan; Ayyavoo, Jayachitra; Dave, Dhvani Kirtikumar; Adroja, Divya Anantray			GST M1-T1 null Allele Frequency Patterns in Geographically Assorted Human Populations: A Phylogenetic Approach	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GENETIC POLYMORPHISMS; ESOPHAGEAL CANCER; ORAL-CANCER; NECK-CANCER; CYP1A1; RISK; SUSCEPTIBILITY; GENOTYPE; NAT2	Genetic diversity in drug metabolism and disposition is mainly considered as the outcome of the inter-individual genetic variation in polymorphism of drug-xenobiotic metabolizing enzyme (XME). Among the XMEs, glutathione-S-transferases (GST) gene loci are an important candidate for the investigation of diversity in allele frequency, as the deletion mutations in GST M1 and T1 genotypes are associated with various cancers and genetic disorders of all major Population Affiliations (PAs). Therefore, the present population based phylogenetic study was focused to uncover the frequency distribution pattern in GST M1 and T1 null genotypes among 45 Geographically Assorted Human Populations (GAHPs). The frequency distribution pattern for GST M1 and T1 null alleles have been detected in this study using the data derived from literatures representing 44 populations affiliated to Africa, Asia, Europe, South America and the genome of PA from Gujarat, a region in western India. Allele frequency counting for Gujarat PA and scattered plot analysis for geographical distribution among the PAs were performed in SPSS-21. The GST M1 and GST T1 null allele frequencies patterns of the PAs were computed in Seqboot, Gendist program of Phylip software package (3.69 versions) and Unweighted Pair Group method with Arithmetic Mean in Mega-6 software. Allele frequencies from South African Xhosa tribe, East African Zimbabwe, East African Ethiopia, North African Egypt, Caucasian, South Asian Afghanistan and South Indian Andhra Pradesh have been identified as the probable seven patterns among the 45 GAHPs investigated in this study for GST M1-T1 null genotypes. The patternized null allele frequencies demonstrated in this study for the first time addresses the missing link in GST M1-T1 null allele frequencies among GAHPs.	[Kasthurinaidu, Senthilkumar Pitchalu; Dave, Dhvani Kirtikumar; Adroja, Divya Anantray] Shree M&N Virani Sci Coll, Dept Biotechnol, Rajkot 360005, Gujarat, India; [Kasthurinaidu, Senthilkumar Pitchalu; Ayyavoo, Jayachitra] Madurai Kamaraj Univ, Sch Biotechnol, Dept Plant Biotechnol, Madurai 625021, Tamil Nadu, India; [Ramasamy, Thirumurugan] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli 620024, Tamil Nadu, India	Madurai Kamaraj University; Bharathidasan University	Ramasamy, T (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli 620024, Tamil Nadu, India.	ramthiru72@gmail.com						Abbas A, 2004, WORLD J GASTROENTERO, V10, P3389; Adams CH, 2003, CLIN CHEM LAB MED, V41, P600, DOI 10.1515/CCLM.2003.090; Agusa T, 2010, TOXICOL APPL PHARM, V242, P352, DOI 10.1016/j.taap.2009.11.007; Amtha R, 2009, ASIAN PAC J CANCER P, V10, P21; Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038; ArunKumar G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050269; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Ben Salah G, 2012, GENE, V498, P317, DOI 10.1016/j.gene.2012.01.054; Binkova B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2; Bu H, 2007, ONCOL REP, V17, P859; Buch S, 2001, EUR J CLIN PHARMACOL, V57, P553; Buch SC, 2002, CARCINOGENESIS, V23, P803, DOI 10.1093/carcin/23.5.803; Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030; Dandara C, 2002, CLIN CHEM LAB MED, V40, P952, DOI 10.1515/CCLM.2002.167; Dialyna IA, 2003, ONCOL REP, V10, P1829; Ebeshi BU, 2011, J MED GENET GENOMICS, V3, P56; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Field JS, 2005, J WORLD PREHIST, V19, P1, DOI 10.1007/s10963-005-9000-6; Fujihara Junko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS408, DOI 10.1016/j.legalmed.2009.01.073; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Ghosh T, 2012, MOL BIOL REP, V39, P9383, DOI 10.1007/s11033-012-1802-x; Gra O, 2010, GENET TEST MOL BIOMA, V14, P329, DOI 10.1089/gtmb.2009.0158; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P560, DOI 10.1046/j.1365-2125.2003.01786.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Huang K, 2006, CANCER CAUSE CONTROL, V17, P385, DOI 10.1007/s10552-005-0424-1; Jain M, 2006, CANCER LETT, V242, P60, DOI 10.1016/j.canlet.2005.10.034; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kim WJ, 2002, UROLOGY, V60, P913, DOI 10.1016/S0090-4295(02)01892-7; Konwar R, 2010, ASIAN PAC J CANCER P, V11, P1067; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LEE EJD, 1995, PHARMACOGENETICS, V5, P332, DOI 10.1097/00008571-199510000-00010; Magno LAV, 2009, PHARMACOLOGY, V83, P231, DOI 10.1159/000205823; Mishra Dhruva K, 2004, Asian Pac J Cancer Prev, V5, P362; Naveen AT, 2004, EUR J CLIN PHARMACOL, V60, P403, DOI 10.1007/s00228-004-0779-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; O'Donnell PH, 2009, CLIN CANCER RES, V15, P4806, DOI 10.1158/1078-0432.CCR-09-0344; Piacentini S, 2011, MOL BIOL REP, V38, P1225, DOI 10.1007/s11033-010-0221-0; Polimanti R, 2013, GENE, V512, P102, DOI 10.1016/j.gene.2012.09.113; Rimando MG, 2008, BIOSCIENCE REP, V28, P117, DOI 10.1042/BSR20070010; Rossini Ana, 2002, Genetics and Molecular Research, V1, P233; Saadat M., 2007, International Journal of Cancer Research (USA), V3, P74; Sabitha K, 2008, AFR J BIOTECHNOL, V7, P3853; Saify K, 2012, MOL BIOL REP, V39, P7855, DOI 10.1007/s11033-012-1628-6; Saijo N, 2013, YONSEI MED J, V54, P1, DOI 10.3349/ymj.2013.54.1.1; Senthilkumar KP, 2014, MOL BIOL REP, V41, P5635, DOI 10.1007/s11033-014-3433-x; Shaikh RS, 2010, ENVIRON TOXICOL PHAR, V30, P76, DOI 10.1016/j.etap.2010.04.002; Shukla D, 2012, BIOMED PAP, V156, P253, DOI 10.5507/bp.2012.013; Sikdar Nilabja, 2005, International Journal of Human Genetics, V5, P37; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sreelekha TT, 2001, ORAL ONCOL, V37, P593, DOI 10.1016/S1368-8375(01)00028-8; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Thier R, 2003, INT J HYG ENVIR HEAL, V206, P149, DOI 10.1078/1438-4639-00209; Toncheva DI, 2004, J NEPHROL, V17, P384	61	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118660	10.1371/journal.pone.0118660	http://dx.doi.org/10.1371/journal.pone.0118660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867025	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100009
J	Lo, SL; Chiong, R; Cornforth, D				Lo, Siaw Ling; Chiong, Raymond; Cornforth, David			Using Support Vector Machine Ensembles for Target Audience Classification on Twitter	PLOS ONE			English	Article							PREDICTION; TEXT	The vast amount and diversity of the content shared on social media can pose a challenge for any business wanting to use it to identify potential customers. In this paper, our aim is to investigate the use of both unsupervised and supervised learning methods for target audience classification on Twitter with minimal annotation efforts. Topic domains were automatically discovered from contents shared by followers of an account owner using Twitter Latent Dirichlet Allocation (LDA). A Support Vector Machine (SVM) ensemble was then trained using contents from different account owners of the various topic domains identified by Twitter LDA. Experimental results show that the methods presented are able to successfully identify a target audience with high accuracy. In addition, we show that using a statistical inference approach such as bootstrapping in over-sampling, instead of using random sampling, to construct training datasets can achieve a better classifier in an SVM ensemble. We conclude that such an ensemble system can take advantage of data diversity, which enables real-world applications for differentiating prospective customers from the general audience, leading to business advantage in the crowded social media space.	[Lo, Siaw Ling; Chiong, Raymond; Cornforth, David] Univ Newcastle, Sch Design Commun & Informat Technol, Callaghan, NSW 2308, Australia	University of Newcastle	Lo, SL (corresponding author), Univ Newcastle, Sch Design Commun & Informat Technol, Callaghan, NSW 2308, Australia.	siawling.lo@uon.edu.au		Lo, Siaw Ling/0000-0002-8749-0473				Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cambria E, 2013, IEEE INTELL SYST, V28, P30, DOI 10.1109/MIS.2013.140; Cambria E, 2013, BIOL INSPIR COGN ARC, V4, P41, DOI 10.1016/j.bica.2013.02.003; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; da Silva NFF, 2014, DECIS SUPPORT SYST, V66, P170, DOI 10.1016/j.dss.2014.07.003; Dietterich T. G., 1995, CS9501101 ARXIV; Ding JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511-S11; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Hassan A, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P357, DOI 10.1109/SocialCom.2013.56; HONG L., 2013, P 6 ACM INT C WEB SE, P557, DOI DOI 10.1145/2433396.2433467; Ikeda K, 2013, KNOWL-BASED SYST, V51, P35, DOI 10.1016/j.knosys.2013.06.020; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Kim HC, 2003, PATTERN RECOGN, V36, P2757, DOI 10.1016/S0031-3203(03)00175-4; Li XC, 2008, ENG APPL ARTIF INTEL, V21, P785, DOI 10.1016/j.engappai.2007.07.001; Liu Y, 2006, LECT NOTES ARTIF INT, V3918, P107; Lo SL, 2015, PROCEEDINGS OF THE 18TH ASIA PACIFIC SYMPOSIUM ON INTELLIGENT AND EVOLUTIONARY SYSTEMS, VOL 1, P325, DOI 10.1007/978-3-319-13359-1_26; Lo SL, 2015, PROCEEDINGS OF ELM 2, P417; Mahmud J., 2012, ICWSM, V12, P511; Michelson M., 2010, P 4 WORKSH AN NOIS U, P73, DOI DOI 10.1145/1871840.1871852; Pennacchiotti M., 2011, P 17 ACM SIGKDD INT, P430, DOI DOI 10.1145/2020408.2020477; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Rao Delip, 2010, P 2 INT WORKSH SEARC, P37, DOI DOI 10.1145/1871985.1871993; Ren Ye, 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P917; Shaikh GR, 2013, INT J ENG RES TECHNO, V2, P37; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Tao Yang, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P684; Willett P, 2006, PROGRAM-ELECTRON LIB, V40, P219, DOI 10.1108/00330330610681295; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Yang MC, 2014, EXPERT SYST APPL, V41, P4330, DOI 10.1016/j.eswa.2013.12.051; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	34	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122855	10.1371/journal.pone.0122855	http://dx.doi.org/10.1371/journal.pone.0122855			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874768	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100109
J	Madeleneau, D; Aubelle, MS; Pierron, C; Lopez, E; Patkai, J; Roze, JC; Jarreau, PH; Gascoin, G				Madeleneau, Doriane; Aubelle, Marie-Stephanie; Pierron, Charlotte; Lopez, Emmanuel; Patkai, Juliana; Roze, Jean-Christophe; Jarreau, Pierre-Henri; Gascoin, Geraldine			Efficacy of a First Course of Ibuprofen for Patent Ductus Arteriosus Closure in Extremely Preterm Newborns According to Their Gestational Age-Specific Z-Score for Birth Weight	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; PREMATURE-INFANTS; DOUBLE-BLIND; INDOMETHACIN	Objective Therapeutic strategies for patent ductus arteriosus (PDA) in very preterm infants remain controversial. To identify infants likely to benefit from treatment, we analysed the efficacy of a first course of ibuprofen in small-for-gestational age (SGA) newborns. Study design This single-centre retrospective study included 185 infants born at 24+0-27+6 weeks of gestation with haemodynamically significant PDA, who were treated by intravenous ibuprofen (Pedea): 10 mg/kg on day one and 5 mg/kg on days two and three. Birth weight and gestational age (GA) were analysed with reference to the standard deviations from the Olsen growth curve to define GA-specific Z-scores for birth weights. The efficacy of treatment was evaluated by echocardiography 48 hours after the last dose of ibuprofen. The primary outcome was failure of the first course of ibuprofen associated in a composite criterion with the most severe outcomes. Results The risk of treatment failure increased according to a continuous gradient in SGA neonates. A higher risk was observed on multiple regression analysis (crude OR: 3.8; 95% CI [1.2-12.3] p = 0.02; adjusted OR: 12.8; 95% CI [2.3-70.5] p=0.003). Conclusion There is a linear relationship between infant birth weight and PDA treatment: the failure rate of a first course of ibuprofen increases with increasing degree of growth restriction.	[Madeleneau, Doriane; Aubelle, Marie-Stephanie; Pierron, Charlotte; Lopez, Emmanuel; Patkai, Juliana; Jarreau, Pierre-Henri] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Dept Neonatal Med Port Royal, Paris, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Gascoin, G (corresponding author), Angers Univ Hosp, Dept Neonatal Med, Angers, France.	gegascoin@chu-angers.fr	Rozé, Jean-Christophe/AAS-1314-2021; Gascoin, Geraldine/ABE-4950-2020	Roze, Jean-Christophe/0000-0003-3367-512X				Aranda JV, 2009, AM J PERINAT, V26, P235, DOI 10.1055/s-0028-1103515; Clyman RI, 2000, NEW ENGL J MED, V343, P728, DOI 10.1056/NEJM200009073431009; Coceani F, 2012, SEMIN PERINATOL, V36, P92, DOI 10.1053/j.semperi.2011.09.018; Dani C, 2012, CLIN PHARMACOL THER, V91, P590, DOI 10.1038/clpt.2011.284; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; Guellec I, 2011, PEDIATRICS, V127, pE883, DOI 10.1542/peds.2010-2442; Hirt D, 2008, BRIT J CLIN PHARMACO, V65, P629, DOI 10.1111/j.1365-2125.2008.03118.x; Koch J, 2006, PEDIATRICS, V117, P1113, DOI 10.1542/peds.2005-1528; MAHONY L, 1985, J PEDIATR-US, V106, P801, DOI 10.1016/S0022-3476(85)80361-9; Malviya MN, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003951.pub3; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub5; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Rakza T, 2007, J PEDIATR-US, V151, P624, DOI 10.1016/j.jpeds.2007.04.058; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Robel-Tillig E, 2003, EARLY HUM DEV, V72, P123, DOI 10.1016/S0378-3782(03)00045-8; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001; Van Overmeire B, 2004, LANCET, V364, P1945, DOI 10.1016/S0140-6736(04)17477-1; Van Overmeire B, 2001, CLIN PHARMACOL THER, V70, P336, DOI 10.1067/mcp.2001.118453; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	19	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124804	10.1371/journal.pone.0124804	http://dx.doi.org/10.1371/journal.pone.0124804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875583	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100273
J	Mardones-Toledo, DA; Montory, JA; Joyce, A; Thompson, RJ; Diederich, CM; Pechenik, JA; Mardones, ML; Chaparro, OR				Mardones-Toledo, Daniela A.; Montory, Jaime A.; Joyce, Alyssa; Thompson, Raymond J.; Diederich, Casey M.; Pechenik, Jan A.; Mardones, Maria L.; Chaparro, Oscar R.			Brooding in the Chilean Oyster Ostrea chilensis: Unexpected Complexity in the Movements of Brooded Offspring within the Mantle Cavity	PLOS ONE			English	Article							GASTROPOD CREPIPATELLA-DILATATA; PARTICLE-TRANSPORT; NEW-ZEALAND; PLACOPECTEN-MAGELLANICUS; CAPSULE WALLS; GILL FUNCTION; BIVALVES; MOLLUSKS; PHILIPPI; MUSSEL	Brooding in invertebrates serves to protect embryos from stressful external conditions by retaining progeny inside the female body, effectively reducing the risk of pelagic stages being exposed to predation or other environmental stressors, but with accompanying changes in pallial fluid characteristics, including reduced oxygen availability. Brooded embryos are usually immobile and often encapsulated, but in some Ostrea species the embryos move freely inside the female pallial cavity in close association with the mother's gills for as long as eight weeks. We used endoscopic techniques to characterize the circulation pattern of embryos brooded by females of the oyster, Ostrea chilensis. Progeny at embryonic and veliger stages typically circulated in established patterns that included the use of dorsal and ventral food grooves (DFG, VFG) to move anteriorly on the gills. Both embryos and veligers accumulated around the mother's palps, and remained there until an active maternal countercurrent moved them to the gill inhalant area. Both food grooves were able to move embryos, veligers, and food-particle aggregates anteriorly, but the DFG was more important in progeny transport; early embryos were moved more rapidly than veligers in the DFG. A microcirculation pattern of embryos was apparent when they were moved by gill lamellae: when they were close to the VFG, most embryos lost gill contact and "fell" down to the DFG. Those that actually reached the DFG moved anteriorly, but others came into contact with the base of the lamellae and again moved towards the VFG. The circulation pattern of the progeny appears well-suited for both cleaning them and directing them posteriorly to an area where there is more oxygen and food than in the palp region. This process for actively circulating progeny involves the feeding structures (gill and palps) and appears to be energetically costly for the female. It also interferes with feeding, which could explain the poor energy balance previously documented for brooding females of this species.	[Mardones-Toledo, Daniela A.; Montory, Jaime A.; Mardones, Maria L.; Chaparro, Oscar R.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Joyce, Alyssa] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Thompson, Raymond J.] Mem Univ Newfoundland, NFLD, Ctr Ocean Sci, St John, NF, Canada; [Diederich, Casey M.; Pechenik, Jan A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Universidad Austral de Chile; University of Gothenburg; Memorial University Newfoundland; Tufts University	Chaparro, OR (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	ochaparr@uach.cl	Montory, Jaime/E-6077-2010; Chaparro, Oscar R/A-5070-2009; Montory, Jaime/AAL-5187-2020	Montory, Jaime/0000-0003-3383-7467; Montory, Jaime/0000-0003-3383-7467	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile [1141052]	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile grant 1141052 to ORC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2000, BIOL BULL, V199, P116, DOI 10.2307/1542871; Ben-Ami F, 2005, J MORPHOL, V263, P322, DOI 10.1002/jmor.10307; BENINGER PG, 1993, MAR ECOL PROG SER, V98, P275, DOI 10.3354/meps098275; Beninger PG, 1997, MAR ECOL PROG SER, V150, P157, DOI 10.3354/meps150157; BENINGER PG, 1992, MAR BIOL, V114, P281, DOI 10.1007/BF00349531; BUROKER NE, 1985, J EXP MAR BIOL ECOL, V90, P233, DOI 10.1016/0022-0981(85)90169-8; BYRNE RA, 1994, AM ZOOL, V34, P194; CASTRO NF, 1988, J MAR BIOL ASSOC UK, V68, P399, DOI 10.1017/S0025315400043290; CHANLEY P, 1980, NEW ZEAL J MAR FRESH, V14, P103, DOI 10.1080/00288330.1980.9515851; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V365, P38, DOI 10.1016/j.jembe.2008.07.038; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V359, P18, DOI 10.1016/j.jembe.2008.02.008; CHAPARRO OR, 1993, BIOL BULL-US, V185, P365, DOI 10.2307/1542477; Chaparro OR, 1999, BIOL BULL, V197, P104, DOI 10.2307/1543001; Chaparro OR, 1998, MAR ECOL PROG SER, V171, P151, DOI 10.3354/meps171151; Chaparro OR, 2001, MAR BIOL, V138, P199, DOI 10.1007/s002270000447; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; CRANFIELD HJ, 1989, NEW ZEAL J MAR FRESH, V23, P51, DOI 10.1080/00288330.1989.9516340; DIX T G, 1976, Journal of the Malacological Society of Australia, V3, P209; Garrido MV, 2012, MAR BIOL, V159, P987, DOI 10.1007/s00227-012-1879-8; Gillespie JM, 2007, J EXP MAR BIOL ECOL, V342, P191, DOI 10.1016/j.jembe.2006.10.055; Hopkins AE, 1936, ECOLOGY, V17, P551, DOI 10.2307/1932760; Ituarte C, 2009, INVERTEBR BIOL, V128, P243, DOI 10.1111/j.1744-7410.2009.00171.x; Joyce A, J SHELLF RE IN PRESS; KIORBOE T, 1981, MAR ECOL PROG SER, V5, P291, DOI 10.3354/meps005291; MILLAR RH, 1963, NATURE, V197, P512, DOI 10.1038/197512b0; MORRICONI E, 1980, REV INVEST DESARROLL, V2, P57; Navarro JM, 2011, J MAR BIOL ASSOC UK, V91, P1607, DOI 10.1017/S0025315410000925; NELSON TC, 1946, ANAT REC, V94, P355; Ojeda JA, 2004, MAR BIOL, V144, P263, DOI 10.1007/s00227-003-1194-5; PECHENIK JA, 1986, AM MALACOL BULL, V4, P165; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Richoux NB, 2001, J EXP MAR BIOL ECOL, V260, P199, DOI 10.1016/S0022-0981(01)00254-4; Segura CJ, 2010, J EXP MAR BIOL ECOL, V390, P49, DOI 10.1016/j.jembe.2010.04.007; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; TANKERSLEY RA, 1992, BIOL BULL, V182, P145, DOI 10.2307/1542189; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Toro JE, 1990, CULTIVO MOLUSCOS AM; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VANCE RR, 1973, AM NAT, V107, P339, DOI 10.1086/282838; Walne R., 1964, J MAR BIOL ASSOC UK, V44, P293; Ward JE, 1996, INVERTEBR BIOL, V115, P218, DOI 10.2307/3226932; Ward JE, 2003, J EXP MAR BIOL ECOL, V293, P129, DOI 10.1016/S0022-0981(03)00218-1; WARD JE, 1991, MAR BIOL, V111, P287, DOI 10.1007/BF01319711; Ward JE, 1998, MAR BIOL, V131, P283, DOI 10.1007/s002270050321	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122859	10.1371/journal.pone.0122859	http://dx.doi.org/10.1371/journal.pone.0122859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874932	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100111
J	Soril, LJJ; Leggett, LE; Lorenzetti, DL; Noseworthy, TW; Clement, FM				Soril, Lesley J. J.; Leggett, Laura E.; Lorenzetti, Diane L.; Noseworthy, Tom W.; Clement, Fiona M.			Reducing Frequent Visits to the Emergency Department: A Systematic Review of Interventions	PLOS ONE			English	Article							CLINICAL CASE-MANAGEMENT; INAPPROPRIATE ATTENDERS; USERS; CARE; ACCIDENT; PROGRAM; ACCESS	Objective The objective of this study was to establish the effectiveness of interventions to reduce frequent emergency department (ED) use among a general adult high ED-use population. Methods Systematic review of the literature from 1950-January 2015. Studies were included if they: had a control group (controlled trials or comparative cohort studies), were set in an ED or acute care facility, and examined the impact of an intervention to reduce frequent ED use in a general adult population. Studies reporting non-original data or focused on a specific patient population were excluded. Study design, patient population, intervention, the frequency of ED visits, and costs of frequent ED use and/or interventions were extracted and narratively synthesized. Results Among 17 included articles, three intervention categories were identified: case management (n = 12), individualized care plans (n = 3), and information sharing (n = 2). Ten studies examining case management reported reductions in mean (-0.66 to -37) or median (-0.1 to -20) number of ED visits after 12-months; one study reported an increase in mean ED visits (+2.79); and one reported no change. Of these, 6 studies also reported reduced hospital costs. Only 1 study evaluating individualized care plans examined ED utilization and found no change in median ED visits post-intervention. Costs following individualized care plans were also only evaluated in 1 study, which reported savings in hospital costs of $742/patient. Evidence was mixed regarding information sharing: 1 study reported no change in mean ED visits and did not examine costs; whereas the other reported a decrease in mean ED visits (-16.9) and ED cost savings of $15,513/patient. Conclusions The impact of all three frequent-user interventions was modest. Case management had the most rigorous evidence base, yielded moderate cost savings, but with variable reductions in ED use. Future studies evaluating non-traditional interventions, tailoring to patient subgroups or socio-cultural contexts, are warranted.	[Soril, Lesley J. J.; Leggett, Laura E.; Lorenzetti, Diane L.; Noseworthy, Tom W.; Clement, Fiona M.] Dept Community Hlth Sci, Calgary, AB, Canada; [Soril, Lesley J. J.; Leggett, Laura E.; Noseworthy, Tom W.; Clement, Fiona M.] Inst Publ Hlth, Calgary, AB, Canada; [Lorenzetti, Diane L.] Inst Hlth Econ, Edmonton, AB, Canada		Clement, FM (corresponding author), Dept Community Hlth Sci, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB, Canada.	fclement@ucalgary.ca		Lorenzetti, Diane L./0000-0001-8423-3458	Harkness/Canadian Foundation for Healthcare Improvement Fellowship in Health Care Policy and Practice	Harkness/Canadian Foundation for Healthcare Improvement Fellowship in Health Care Policy and Practice	Dr. Clement is supported by a Harkness/Canadian Foundation for Healthcare Improvement Fellowship in Health Care Policy and Practice. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JG, 2003, ACAD EMERG MED, V10, P271, DOI 10.1197/aemj.10.3.271; Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Bieler G, 2012, ACAD EMERG MED, V19, P63, DOI 10.1111/j.1553-2712.2011.01246.x; Blank FSJ, 2005, J EMERG NURS, V31, P139, DOI 10.1016/j.jen.2005.02.008; Chiang CY, 2014, HONG KONG J EMERG ME, V21, P161, DOI 10.1177/102490791402100305; Crane S, 2012, J AM BOARD FAM MED, V25, P184, DOI 10.3122/jabfm.2012.02.110156; DeHaven M, 2012, J PUBLIC HEALTH-UK, V34, P577, DOI 10.1093/pubmed/fds027; Doupe MB, 2012, ANN EMERG MED, V60, P24, DOI 10.1016/j.annemergmed.2011.11.036; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Grimmer-Somers K, 2010, AUST NZ J PUBL HEAL, V34, P609, DOI 10.1111/j.1753-6405.2010.00616.x; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Hansagi H, 2008, EUR J EMERG MED, V15, P34, DOI 10.1097/MEJ.0b013e3282aa4115; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horton C, 2013, CURR CARDIOL REP, V15, P1; Huang J-A, 2003, J FORMOS MED ASSOC, V102; Kennedy D, 2004, NZ MED J, V117, pU871; Kumar GS, 2013, J EMERG MED, V44, P717, DOI 10.1016/j.jemermed.2012.08.035; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Lee KH, 2006, HEALTH CARE MANAG, V25, P155, DOI 10.1097/00126450-200604000-00008; Les Vertesi MD., 2009, CJEM, V11; Markham D, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-21; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murphy AW, 1998, FAM PRACT, V15, P33, DOI 10.1093/fampra/15.1.33; Murphy AW, 1998, FAM PRACT, V15, P23, DOI 10.1093/fampra/15.1.23; Murphy SM, 2014, J EMERG MED, V47, P223, DOI 10.1016/j.jemermed.2013.11.073; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Peddie S, 2011, NEW ZEAL MED J, V124, P61; Phillips GA, 2006, MED J AUSTRALIA, V184, P602, DOI 10.5694/j.1326-5377.2006.tb00412.x; Pines JM, 2011, ACAD EMERG MED, V18, P655, DOI 10.1111/j.1553-2712.2011.01085.x; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Raven MC, 2011, ANN EMERG MED, V58, P53, DOI 10.1016/j.annemergmed.2011.04.009; Reinius P, 2013, EUR J EMERG MED, V20, P327, DOI 10.1097/MEJ.0b013e328358bf5a; Schull Michael J, 2002, CJEM, V4, P76; Shah R, 2011, MED CARE, V49, P166, DOI 10.1097/MLR.0b013e3182028e81; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Skinner J, 2009, EMERG MED J, V26, P103, DOI 10.1136/emj.2008.063081; Spillane LL, 1997, ACAD EMERG MED, V4, P574, DOI 10.1111/j.1553-2712.1997.tb03581.x; Stokes-Buzzelli S, 2010, WEST J EMERG MED, V11, P348; Weintraub NL, 2010, CIRCULATION, V122, P1975, DOI 10.1161/CIR.0b013e3181f9a223	40	123	126	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123660	10.1371/journal.pone.0123660	http://dx.doi.org/10.1371/journal.pone.0123660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874866	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100195
J	Tirani, M; Meregaglia, M; Melegaro, A				Tirani, Marcello; Meregaglia, Michela; Melegaro, Alessia			Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; MULTICOMPONENT VACCINE; NEW-ZEALAND; BACTERICIDAL ANTIBODY; COST-EFFECTIVENESS; CONJUGATE VACCINE; 4CMENB VACCINE; DISEASE; IMMUNOGENICITY; MENINGITIS	Introduction In January 2013 a novel type of multicomponent protein-based vaccine against group B meningococcal disease was licensed by the European Medicines Agency. With the widespread use of the meningococcal serogroup C conjugate vaccines, serogroup B remains now the major cause of bacterial meningitis and septicaemia in young children in Europe. The aim of this study is to investigate the health and the economic outcomes of MenB vaccine introduction into the Italian routine mass vaccination programme. Methods The present work is structured in two main parts. Firstly, we assess the epidemiological burden of group B meningococcal disease using official hospitalisation and notification data from two of the most populated Italian regions (Lombardia and Piemonte) during a 6-year study period (2007-2012). Secondly, we evaluate the cost-effectiveness of the immunisation programme in Italy from the public health payer perspective under base case parameters assumptions and performing a comprehensive sensitivity analysis to assess the robustness and the uncertainty of our model results. Results MenB serotype is responsible for 59% of the 341 cases of Invasive Meningococcal Disease in Lombardia and Piemonte. Incidence rate for MenB infection is estimated to be 0.21/100,000/y resulting at the highest level in children <= 4 years of age. Although the new MenB vaccine can potentially prevent about one third of the disease cases in the Italian population, model results show this strategy is unlikely to be cost-effective (ICER value over (sic)350,000/QALY) with a vaccine that prevents disease only. These results are robust under most of the sensitivity scenarios except when allowing for lower discount rates. Discussion The introduction of the novel vaccine into the routine immunisation schedule needs to be carefully evaluated. The new MenB vaccine has the potential to reduce the disease burden at the population level. However, from the Italian Health Service perspective, the immunisation programme is unlikely to be cost-effective at the current incidence levels and vaccine price.	[Tirani, Marcello] Univ Milan, Dept Biomed Sci Hlth, Postgrad Sch Publ Hlth, Milan, Italy; [Meregaglia, Michela] Bocconi Univ, Ctr Res Hlth & Social Care Management, CeRGAS, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dept Policy Anal & Publ Management, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy	University of Milan; Bocconi University; Bocconi University; Bocconi University	Tirani, M (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Postgrad Sch Publ Hlth, Milan, Italy.	marcello.tirani@unimi.it	Tirani, Marcello/H-9433-2017; Tirani, Marcello/GZK-5114-2022; Meregaglia, Michela/K-1178-2018	Tirani, Marcello/0000-0002-7512-9162; Tirani, Marcello/0000-0002-7512-9162; Melegaro, Alessia/0000-0003-2221-8898; Meregaglia, Michela/0000-0003-0092-5970				Ahmed F, 2011, VACCINE, V29, P9171, DOI 10.1016/j.vaccine.2011.08.005; Andrews SM, 2014, LANCET INFECT DIS, V14, P426, DOI 10.1016/S1473-3099(13)70341-4; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], 2010, RIC OSP SIST TAR REG; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; Bos JM, 2001, VACCINE, V20, P202, DOI 10.1016/S0264-410X(01)00254-7; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII62, DOI 10.1093/heapol/czr049; Caban-Martinez AJ, 2011, AM J PUBLIC HEALTH, V101, P1729, DOI 10.2105/AJPH.2011.300173; Capri S, 2001, DRUG INF J, V35, P189, DOI 10.1177/009286150103500122; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Committee on Immunisation Programmes and Registries, 2013, CRIT ASS CHANG IMM P; Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111/j.1365-3156.2007.01929.x; di Pietro ML, 2013, ITALIAN J PUBLIC HLT, V2; Donev D, 2010, MEASURING BURDEN DIS; ECDC, 2011, SURV INV BACT DIS EU; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Santolaya ME, 2013, HUM VACC IMMUNOTHER, V9, P2304, DOI 10.4161/hv.25505; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; EU-IBIS Network, 2006, INV NEISS MEN EUR 20; European Centre for Disease Prevention and Control, 2009, SURV INV BACT DIS EU; European Centre for Disease Prevention and Control, 2013, EUR INV BACT DIS SUR; European Medicines Agency, 2013, BEXS SUMM PROD CHAR; Fattore G., 2009, PHARMACOECONOMICS, V11, P83, DOI [10.1007/BF03320660, DOI 10.1007/BF03320660]; Feavers I, 2012, BIOLOGICALS, V40, P507, DOI 10.1016/j.biologicals.2012.09.008; FINNE J, 1987, J IMMUNOL, V138, P4402; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Ginsberg L, 2004, J NEUROL NEUROSUR PS, V75, pI16, DOI 10.1136/jnnp.2003.034272; Giorgi-Rossi P, 2009, HEALTH POLICY, V89, P225, DOI 10.1016/j.healthpol.2008.05.016; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Gottfredsson M, 2011, CLIN INFECT DIS, V53, pE117, DOI 10.1093/cid/cir500; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Health Council (GezondheidsRaad; GR), 2007, FUT NAT IMM PROGR PR; HILLMAN AL, 1995, PHARMACOECONOMICS, V7, P198, DOI 10.2165/00019053-199507030-00003; Hong AT, 2013, 35 ANN M SOC MED DEC; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Hutubessy R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-55; Istituto Nazionale di Statistica, 2013, DEM CIFR; Istituto Superiore di Sanita-Gruppo di Lavoro del CNESPS, 2014, DAT EV DISP INTR VAC; Joint Committee on Vaccination and Immunisation, 2014, JCVI INT POS STAT US; Joint Committee on Vaccination and Immunisation, 2013, JCVI INT POS STAT US; Kelly C, 2007, AM J EPIDEMIOL, V166, P817, DOI 10.1093/aje/kwm147; Kinlin LM, 2009, VACCINE, V27, P1735, DOI 10.1016/j.vaccine.2009.01.026; Krabbe PFM, 2000, INT J TECHNOL ASSESS, V16, P864, DOI 10.1017/S0266462300102132; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Le Haut Conseil de la sante publique, 2013, VACC INF INV MEN B P; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Lucioni C, 2005, PHARMACOECONOMICS IT, V7, P177, DOI DOI 10.1007/BF03320548; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; Meyerhoff AS, 2005, PREV MED, V41, P540, DOI 10.1016/j.ypmed.2004.12.001; Ministero della Salute, 2014, SCHED DIM OSP SDO; Ministero della Salute, 2013, SIST DRG; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; Oostenbrink R, 2002, J CLIN EPIDEMIOL, V55, P791, DOI 10.1016/S0895-4356(02)00448-1; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Oster P, 2007, VACCINE, V25, P3075, DOI 10.1016/j.vaccine.2007.01.023; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Piso B, 2009, VACCINE, V27, P5923, DOI 10.1016/j.vaccine.2009.07.105; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pollard AJ, 2007, ARCH DIS CHILD, V92, P283, DOI 10.1136/adc.2006.102384; Pouwels KB, 2013, HUM VACC IMMUNOTHER, V9, P1129, DOI 10.4161/hv.23888; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Read RC, 2013, 31 ANN M EUR SOC PAE; Rossi PG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-13; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Severens JL, 2004, VALUE HEALTH, V7, P397, DOI 10.1111/j.1524-4733.2004.74002.x; Snape MD, 2013, PEDIATR INFECT DIS J, V32, P1116, DOI 10.1097/INF.0b013e31829cfff2; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tasset A, 1999, VACCINE, V17, pS75, DOI 10.1016/S0264-410X(99)00298-4; Thein HH, 2010, QUAL LIFE RES, V19, P81, DOI 10.1007/s11136-009-9563-2; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; U.S. Food and Drug Administration, 2015, VACC BLOOD BIOL TRUM; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Visintin Cristina, 2010, BMJ, V340, pc3209, DOI 10.1136/bmj.c3209; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; WHO, 2005, VACC INTR GUID ADD V; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Xu RF, 2011, QUAL LIFE RES, V20, P601, DOI 10.1007/s11136-010-9783-5; Yfantopoulos J., 2001, ARCH HELL MED, V18, P114	93	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123383	10.1371/journal.pone.0123383	http://dx.doi.org/10.1371/journal.pone.0123383			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874805	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100169
J	Wan, DL; Wan, YQ; Hou, XY; Ren, WB; Ding, Y; Sa, RL				Wan, Dongli; Wan, Yongqing; Hou, Xiangyang; Ren, Weibo; Ding, Yong; Sa, Rula			De novo Assembly and Transcriptomic Profiling of the Grazing Response in Stipa grandis	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; ABSCISIC-ACID BIOSYNTHESIS; INNER-MONGOLIA; GENE-EXPRESSION; DISEASE RESISTANCE; JASMONIC ACID; PSEUDOMONAS-SYRINGAE; DROUGHT TOLERANCE; RNA-SEQ; 9-CIS-EPOXYCAROTENOID DIOXYGENASE	Background Stipa grandis (Poaceae) is one of the dominant species in a typical steppe of the Inner Mongolian Plateau. However, primarily due to heavy grazing, the grasslands have become seriously degraded, and S. grandis has developed a special growth-inhibition phenotype against the stressful habitat. Because of the lack of transcriptomic and genomic information, the understanding of the molecular mechanisms underlying the grazing response of S. grandis has been prohibited. Results Using the Illumina HiSeq 2000 platform, two libraries prepared from non-grazing (FS) and overgrazing samples (OS) were sequenced. De novo assembly produced 94,674 unigenes, of which 65,047 unigenes had BLAST hits in the National Center for Biotechnology Information (NCBI) non-redundant (nr) database (E-value < 10(-5)). In total, 47,747, 26,156 and 40,842 unigenes were assigned to the Gene Ontology (GO), Clusters of Orthologous Group (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. A total of 13,221 unigenes showed significant differences in expression under the overgrazing condition, with a threshold false discovery rate <= 0.001 and an absolute value of log(2)Ratio >= 1. These differentially expressed genes (DEGs) were assigned to 43,257 GO terms and were significantly enriched in 32 KEGG pathways (q-value <= 0.05). The alterations in the wound-, drought-and defense-related genes indicate that stressors have an additive effect on the growth inhibition of this species. Conclusions This first large-scale transcriptome study will provide important information for further gene expression and functional genomics studies, and it facilitated our investigation of the molecular mechanisms of the S. grandis grazing response and the associated morphological and physiological characteristics.	[Wan, Dongli; Hou, Xiangyang; Ren, Weibo; Ding, Yong; Sa, Rula] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Wan, Yongqing] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia Agricultural University	Hou, XY (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China.	Houxy16@126.com			National Basic Research Program of China ("973") [2014CB138804]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2014BS0330]; Fundamental Research Funds for Central nonprofit research institutes [1610332014027]	National Basic Research Program of China ("973")(National Basic Research Program of China); Natural Science Foundation of Inner Mongolia Autonomous Region of China; Fundamental Research Funds for Central nonprofit research institutes	This work was supported by the National Basic Research Program of China ("973", 2014CB138804), the Natural Science Foundation of Inner Mongolia Autonomous Region of China (2014BS0330) and the Fundamental Research Funds for Central nonprofit research institutes (1610332014027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chouinard A, 2005, ECOSCIENCE, V12, P506, DOI 10.2980/i1195-6860-12-4-506.1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Holmstrom KO, 1996, NATURE, V379, P683, DOI 10.1038/379683a0; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Kawamura K, 2005, AGR ECOSYST ENVIRON, V107, P83, DOI 10.1016/j.agee.2004.09.008; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li XX, 2014, ACTA PHYSIOL PLANT, V36, P1251, DOI 10.1007/s11738-014-1505-0; Liang C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-146; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishiuchi T, 1997, PLANT CELL, V9, P1701, DOI 10.1105/tpc.9.10.1701; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schiborra A, 2009, AGR ECOSYST ENVIRON, V132, P82, DOI 10.1016/j.agee.2009.03.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su M, 2013, PLANT MOL BIOL REP, V31, P1184, DOI 10.1007/s11105-013-0582-3; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang XT, 2014, CHINESE SCI BULL, V59, P1405, DOI 10.1007/s11434-014-0142-8; Wu JB, 2010, BIOCHEM SYST ECOL, V38, P471, DOI 10.1016/j.bse.2010.04.008; Wu JB, 2010, RANGELAND J, V32, P427, DOI 10.1071/RJ09038; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin XR, 2000, CHINESE J PLANT ECOL, V34, P39; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhang TH, 2004, NEW ZEAL J AGR RES, V47, P307, DOI 10.1080/00288233.2004.9513599; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zhao NX, 2008, BIOCHEM SYST ECOL, V36, P1, DOI 10.1016/j.bse.2007.08.004; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0	78	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122641	10.1371/journal.pone.0122641	http://dx.doi.org/10.1371/journal.pone.0122641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875617	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100090
J	Xu, L; Xu, WS; Jiang, Y; Hu, F; Li, HX				Xu, Li; Xu, Wensi; Jiang, Ying; Hu, Feng; Li, Huixin			Effects of Interactions of Auxin-Producing Bacteria and Bacterial-Feeding Nematodes on Regulation of Peanut Growths	PLOS ONE			English	Article							IAA-PRODUCING BACTERIA; PLANT-GROWTH; NITROGEN MINERALIZATION; ARABIDOPSIS-THALIANA; ROOT-GROWTH; SOIL; BACILLUS; PROTOZOA; RHIZOSPHERE; DIVERSITY	The influences of an IAA (indole-3-acetic acid)-producing bacterium (Bacillus megaterium) and two bacterial-feeding nematodes (Cephalobus sp. or Mesorhabditis sp.) on the growth of peanut (Arachis hypogaea L. cv. Haihua 1) after various durations of time were investigated in natural soils. The addition of bacteria and nematodes and incubation time all significantly affected plant growth, plant root growth, plant nutrient concentrations, soil nutrient concentrations, soil microorganisms and soil auxin concentration. The addition of nematodes caused greater increases in these indices than those of bacteria, while the addition of the combination of bacteria and nematodes caused further increases. After 42-day growth, the increases in soil respiration differed between the additions of two kinds of nematodes because of differences in their life strategies. The effects of the bacteria and nematodes on the nutrient and hormone concentrations were responsible for the increases in plant growth. These results indicate the potential for promoting plant growth via the addition of nematodes and bacteria to soil.	[Xu, Li; Xu, Wensi; Jiang, Ying; Hu, Feng; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing, Jiangsu, Peoples R China.	huixinli@njau.edu.cn	Li, huixin/H-5573-2011		National Foundation of Sciences in China [30970537]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Foundation of Sciences in China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Foundation of Sciences in China (grant 30970537) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphei J, 1996, OECOLOGIA, V106, P111, DOI 10.1007/BF00334413; Armada E, 2014, MICROB ECOL, V67, P410, DOI 10.1007/s00248-013-0326-9; Bjornlund L, 2012, EUR J SOIL BIOL, V50, P28, DOI 10.1016/j.ejsobi.2011.11.012; Blanc C, 2006, EUR J SOIL BIOL, V42, pS70, DOI 10.1016/j.ejsobi.2006.06.003; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Buchan D, 2013, SOIL BIOL BIOCHEM, V60, P142, DOI 10.1016/j.soilbio.2013.01.022; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; Cheng YH, 2011, NEMATOLOGY, V13, P369, DOI 10.1163/138855410X528253; Diaz SA, 2014, APPL ENVIRON MICROB, V80, P5411, DOI 10.1128/AEM.01037-14; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; Egamberdieva D, 2009, ACTA PHYSIOL PLANT, V31, P861, DOI 10.1007/s11738-009-0297-0; Etesami H, 2014, J PLANT GROWTH REGUL, V33, P654, DOI 10.1007/s00344-014-9415-3; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Frankenberger JWT, 1995, PHYTOHORMONES SOILS, P35; Goodfriend WL, 2000, PLANT SOIL, V223, P23, DOI 10.1023/A:1004756832367; Grewal PS, 2006, BIOL CONTROL, V38, P54, DOI 10.1016/j.biocontrol.2005.09.004; GRIFFITHS BS, 1994, PLANT SOIL, V164, P25, DOI 10.1007/BF00010107; Hu P, 2001, CHINESE J ANAL LAB, V20, P8, DOI DOI 10.3969/J.ISSN.1000-0720.2001.06.003; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Koberl M, 2013, FEMS MICROBIOL LETT, V342, P168, DOI 10.1111/1574-6968.12089; Kumar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106041; Ladygina N, 2009, FEMS MICROBIOL ECOL, V69, P53, DOI 10.1111/j.1574-6941.2009.00687.x; Liu ZZ, 2013, APPL MICROBIOL BIOT, V97, P10081, DOI 10.1007/s00253-013-5247-5; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Mao XF, 2007, SOIL BIOL BIOCHEM, V39, P1816, DOI 10.1016/j.soilbio.2007.01.027; Mao XF, 2006, SOIL BIOL BIOCHEM, V38, P1615, DOI 10.1016/j.soilbio.2005.12.002; Moens T, 1999, MAR ECOL PROG SER, V176, P165, DOI 10.3354/meps176165; Moghaddam MR, 2014, BIOCONTROL SCI TECHN, V24, P279, DOI 10.1080/09583157.2013.858100; Neher DA, 2001, J NEMATOL, V33, P161; Nykyri J, 2014, PLANT PATHOL, V63, P747, DOI 10.1111/ppa.12159; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Porcel R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-36; Salinas KA, 2007, PEDOBIOLOGIA, V51, P55, DOI 10.1016/j.pedobi.2006.12.003; Sebastian W, 2013, NEMATOLOGY, V15, P291; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; Standing D, 2006, MICROB ECOL, V52, P444, DOI 10.1007/s00248-006-9119-8; Zhou DM, 2014, BIOCONTROL SCI TECHN, V24, P1451, DOI 10.1080/09583157.2014.945899	39	71	72	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124361	10.1371/journal.pone.0124361	http://dx.doi.org/10.1371/journal.pone.0124361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867954	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100253
J	Zanette, DL; Lorenzi, JCC; Panepucci, RA; Palma, PVB; dos Santos, DF; Prata, KL; Silva, WA				Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.			Simvastatin Modulates Mesenchymal Stromal Cell Proliferation and Gene Expression	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; IN-VITRO; STATINS; GROWTH; FIBROBLASTS; DIFFERENTIATION; APOPTOSIS; DISEASE; PROGRESSION	Statins are widely used hypocholesterolemic drugs that block the mevalonate pathway, responsible for the biosysnthesis of cholesterol. However, statins also have pleiotropic effects that interfere with several signaling pathways. Mesenchymal stromal cells (MSC) are a heterogeneous mixture of cells that can be isolated from a variety of tissues and are identified by the expression of a panel of surface markers and by their ability to differentiate in vitro into osteocytes, adipocytes and chondrocytes. MSC were isolated from amniotic membranes and bone marrows and characterized based on ISCT (International Society for Cell Therapy) minimal criteria. Simvastatin-treated cells and controls were directly assayed by CFSE (Carboxyfluorescein diacetate succinimidyl ester) staining to assess their cell proliferation and their RNA was used for microarray analyses and quantitative PCR (qPCR). These MSC were also evaluated for their ability to inhibit PBMC (peripheral blood mononuclear cells) proliferation. We show here that simvastatin negatively modulates MSC proliferation in a dose-dependent way and regulates the expression of proliferation-related genes. Importantly, we observed that simvastatin increased the percentage of a subset of smaller MSC, which also were actively proliferating. The association of MSC decreased size with increased pluripotency and the accumulating evidence that statins may prevent cellular senescence led us to hypothesize that simvastatin induces a smaller subpopulation that may have increased ability to maintain the entire pool of MSC and also to protect them from cellular senescence induced by long-term cultures/passages in vitro. These results may be important to better understand the pleiotropic effects of statins and its effects on the biology of cells with regenerative potential.	[Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Silva, Wilson Arajo, Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Reg Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Ctr Cell Based Therapy CEPID FAPESP, Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Zanette, DL (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.	zanettedl@gmail.com	ZANETTE, DALILA/Q-3541-2016; Prata, Karen/I-4568-2013; Lorenzi, Julio/S-2394-2019; Panepucci, Rodrigo A/C-2365-2012; Silva Jr, Wilson Araújo/E-9487-2011; CTC USP, CEPID 13 18/J-8951-2014	Lorenzi, Julio/0000-0003-2492-3961; Panepucci, Rodrigo A/0000-0002-1119-4352; Silva Jr, Wilson Araújo/0000-0001-9364-2886; zanette, dalila l./0000-0001-9397-4127; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2009/09443-2, 2013/08135-2]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support for this work was provided by grants 2009/09443-2 and 2013/08135-2, Sao Paulo Research Foundation (FAPESP) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccardi V, 2013, FASEB J, V27, P3879, DOI 10.1096/fj.13-232066; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Du J, 2013, AM J PHYSL CELL PHYS; El-Karim EA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-89; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567; Gong M, 2013, INT J BIOCHEM CELL B, V45, P866, DOI 10.1016/j.biocel.2013.01.002; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Kim YW, 2010, CANCER RES TREAT, V42, P82, DOI 10.4143/crt.2010.42.2.82; Kok SH, 2013, ARTHRITIS RHEUM-US, V65, P639, DOI 10.1002/art.37807; Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Liu SW, 2009, MOL CELL BIOCHEM, V331, P173, DOI 10.1007/s11010-009-0155-9; Liu YJ, 2010, HYPERTENSION, V56, P445, DOI 10.1161/HYPERTENSIONAHA.110.150102; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; Martens JWM, 2003, THROMB HAEMOSTASIS, V89, P393; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Olivieri F, 2012, CURR VASC PHARMACOL, V10, P216, DOI 10.2174/157016112799305076; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Poggi A, 2011, CURR MED CHEM, V18, P5196, DOI 10.2174/092986711798184244; Rasmusson I, 2005, EXP CELL RES, V305, P33, DOI 10.1016/j.yexcr.2004.12.013; Sala SG, 2008, J PHARMACOL EXP THER, V324, P352, DOI 10.1124/jpet.107.128959; Sassano A, 2009, MOL CANCER THER, V8, P615, DOI 10.1158/1535-7163.MCT-08-1196; Saulnier N, 2011, CYTOTHERAPY, V13, P329, DOI 10.3109/14653249.2010.515576; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Shi YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045354; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sokalska A, 2013, J CLIN ENDOCR METAB, V98, pE463, DOI 10.1210/jc.2012-3402; Spampanato C, 2012, INT J ONCOL, V40, P935, DOI 10.3892/ijo.2011.1273; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi S, 2008, AM J PHYSIOL-LUNG C, V294, pL882, DOI 10.1152/ajplung.00238.2007; Takeda I, 2007, CANCER SCI, V98, P890, DOI 10.1111/j.1349-7006.2007.00471.x; Tu YS, 2011, EUR J PHARMACOL, V670, P356, DOI 10.1016/j.ejphar.2011.09.031; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; van de Donk NWCJ, 2002, LEUKEMIA, V16, P1362, DOI 10.1038/sj.leu.2402501; Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004; Wood WG, 2013, MOL NEUROBIOL, V48, P308, DOI 10.1007/s12035-013-8496-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang YC, 2008, CHEMOTHERAPY, V54, P438, DOI 10.1159/000158663	46	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120137	10.1371/journal.pone.0120137	http://dx.doi.org/10.1371/journal.pone.0120137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874574	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100020
J	De Niz, M; Helm, S; Horstmann, S; Annoura, T; del Portillo, HA; Khan, SM; Heussler, VT				De Niz, Mariana; Helm, Susanne; Horstmann, Sebastian; Annoura, Takeshi; del Portillo, Hernando A.; Khan, Shahid M.; Heussler, Volker T.			In Vivo and In Vitro Characterization of a Plasmodium Liver Stage-Specific Promoter	PLOS ONE			English	Article							FIREFLY LUCIFERASE; EXOERYTHROCYTIC SCHIZONTS; DNA-BINDING; BIOLUMINESCENCE; ANTIGEN; LOCALIZATION; INHIBITION; DISCOVERY; PARASITES; PROTEINS	Little is known about stage-specific gene regulation in Plasmodium parasites, in particular the liver stage of development. We have previously described in the Plasmodium berghei rodent model, a liver stage-specific (lisp2) gene promoter region, in vitro. Using a dual luminescence system, we now confirm the stage specificity of this promoter region also in vivo. Furthermore, by substitution and deletion analyses we have extended our in vitro characterization of important elements within the promoter region. Importantly, the dual luminescence system allows analyzing promoter constructs avoiding mouse-consuming cloning procedures of transgenic parasites. This makes extensive mutation and deletion studies a reasonable approach also in the malaria mouse model. Stage-specific expression constructs and parasite lines are extremely valuable tools for research on Plasmodium liver stage biology. Such reporter lines offer a promising opportunity for assessment of liver stage drugs, characterization of genetically attenuated parasites and liver stage-specific vaccines both in vivo and in vitro, and may be key for the generation of inducible systems.	[De Niz, Mariana; Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Helm, Susanne; Horstmann, Sebastian] Bernhard Nocht Inst Trop Med, Mol Parasitol, D-20359 Hamburg, Germany; [Annoura, Takeshi; Khan, Shahid M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands; [Annoura, Takeshi] NIID, Dept Parasitol, Tokyo, Japan; [del Portillo, Hernando A.] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [del Portillo, Hernando A.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	University of Bern; Bernhard Nocht Institut fur Tropenmedizin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institute of Infectious Diseases (NIID); ISGlobal; CRESIB; ICREA	De Niz, M (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	mariana.denizhidalgo@izb.unibe.ch	Heussler, Volker/H-9322-2019; Annoura, Takeshi/AAS-7911-2021; del Portillo Obando, Hernando A/L-2131-2014	Heussler, Volker/0000-0001-8028-9825; Khan, Shahid/0000-0002-0533-4670; De Niz, Mariana/0000-0001-6987-6789; del Portillo Obando, Hernando A/0000-0002-5278-3452	Swiss National Foundation [310030_140691/1]; Swiss SystemsX Consortium; European Union [242095]; ICREA Funding Source: Custom	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss SystemsX Consortium; European Union(European Commission); ICREA(ICREA)	This work was supported by the Swiss National Foundation grant to VH (310030_140691/1), the Swiss SystemsX Consortium and European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095: EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Annoura Takeshi, 2013, Methods Mol Biol, V923, P429; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; ATKINSON CT, 1989, AM J TROP MED HYG, V40, P131, DOI 10.4269/ajtmh.1989.40.131; ATKINSON CT, 1992, AM J TROP MED HYG, V46, P533, DOI 10.4269/ajtmh.1992.46.533; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-42; Helm S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013653; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Kimura T, 2010, J GENE MED, V12, P528, DOI 10.1002/jgm.1463; Lin Jing-Wen, 2013, Methods Mol Biol, V923, P507; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; McNabb DS, 2005, EUKARYOT CELL, V4, P1539, DOI 10.1128/EC.4.9.1539-1549.2005; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Mwakingwe A, 2009, J INFECT DIS, V200, P1470, DOI 10.1086/606115; Nagel A, 2013, INT J PARASITOL, V43, P503, DOI 10.1016/j.ijpara.2013.01.010; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Nganou-Makamdop K, 2012, PARASITE IMMUNOLOGY; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Orito Y, 2013, MOL MICROBIOL, V87, P66, DOI 10.1111/mmi.12083; Ploemen I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-350; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; Vilalta M, 2009, BIOMATERIALS, V30, P4986, DOI 10.1016/j.biomaterials.2009.05.056; Wendt MK, 2011, JOVE-J VIS EXP, DOI 10.3791/3245; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	51	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123473	10.1371/journal.pone.0123473	http://dx.doi.org/10.1371/journal.pone.0123473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874388	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800101
J	Dziak, RP; Bohnenstiehl, DR; Stafford, KM; Matsumoto, H; Park, M; Lee, WS; Fowler, MJ; Lau, TK; Haxel, JH; Mellinger, DK				Dziak, Robert P.; Bohnenstiehl, DelWayne R.; Stafford, Kathleen M.; Matsumoto, Haruyoshi; Park, Minkyu; Lee, Won Sang; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.			Sources and Levels of Ambient Ocean Sound near the Antarctic Peninsula	PLOS ONE			English	Article							MARINE MAMMALS; ICE-SHELF; SEA; NOISE; BLUE; PACIFIC; ICEBERGS; RETREAT; WATERS; RANGE	Arrays of hydrophones were deployed within the Bransfield Strait and Scotia Sea (Antarctic Peninsula region) from 2005 to 2009 to record ambient ocean sound at frequencies of up to 125 and 500 Hz. Icequakes, which are broadband, short duration signals derived from fracturing of large free-floating icebergs, are a prominent feature of the ocean soundscape. Ice quake activity peaks during austral summer and is minimum during winter, likely following freeze-thaw cycles. Iceberg grounding and rapid disintegration also releases significant acoustic energy, equivalent to large-scale geophysical events. Overall ambient sound levels can be as much as similar to 10-20 dB higher in the open, deep ocean of the Scotia Sea compared to the relatively shallow Bransfield Strait. Noise levels become lowest during the austral winter, as sea-ice cover suppresses wind and wave noise. Ambient noise levels are highest during austral spring and summer, as surface noise, ice cracking and biological activity intensifies. Vocalizations of blue (Balaenoptera musculus) and fin (B. physalus) whales also dominate the long-term spectra records in the 15-28 and 89 Hz bands. Blue whale call energy is a maximum during austral summer-fall in the Drake Passage and Bransfield Strait when ambient noise levels are a maximum and sea-ice cover is a minimum. Fin whale vocalizations were also most common during austral summer-early fall months in both the Bransfield Strait and Scotia Sea. The hydrophone data overall do not show sustained anthropogenic sources (ships and airguns), likely due to low coastal traffic and the typically rough weather and sea conditions of the Southern Ocean.	[Dziak, Robert P.; Matsumoto, Haruyoshi; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Dziak, Robert P.; Matsumoto, Haruyoshi; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.] NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Bohnenstiehl, DelWayne R.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Park, Minkyu; Lee, Won Sang] Korea Polar Res Inst, Polar Environm Res Div, Inchon 406840, South Korea	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; North Carolina State University; University of Washington; University of Washington Seattle; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Dziak, RP (corresponding author), Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	robert.p.dziak@noaa.gov	Dziak, Robert/AAC-6107-2020; Matsumoto, Haru/J-6812-2017	Matsumoto, Haru/0000-0002-0202-4060; Lee, Won Sang/0000-0002-1074-7672	Department of Energy [09NA28654]; NOAA Ocean Exploration and Research Program; Korea Ocean and Polar Research Institute [08NA28654, PE13050, PM12020, PM14020]	Department of Energy(United States Department of Energy (DOE)); NOAA Ocean Exploration and Research Program; Korea Ocean and Polar Research Institute	This work was sponsored by the Department of Energy contract number 09NA28654, NOAA Ocean Exploration and Research Program and the Korea Ocean and Polar Research Institute, projects number 08NA28654, PE13050, PM12020 and PM14020, respectively. The research analysis was performed at the NOAA/Pacific Marine Environmental Laboratory, PMEL contribution number 4162.	Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Berzin Alfred A., 2008, U S National Marine Fisheries Service Marine Fisheries Review, V70, P4; Bevington PR., 2002, DATA REDUCTION ERROR; Bliss A, 2013, ANN GLACIOL, V54, P191, DOI 10.3189/2013AoG63A377; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P251; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; CATO DH, 1976, J ACOUST SOC AM, V60, P320, DOI 10.1121/1.381109; Cavalieri D. J., 2004, AMSR E AQUA DAILY L3; Chapp E, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000889; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Curtis KR, 1999, J ACOUST SOC AM, V106, P3189, DOI 10.1121/1.428173; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; Dowdeswell JA, 2007, MAR GEOL, V243, P120, DOI 10.1016/j.margeo.2007.04.008; Dziak RP, 2013, OCEANOGRAPHY, V26, P10, DOI 10.5670/oceanog.2013.20; Dziak RP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006295; Dziak RP, 2001, GEOPHYS RES LETT, V28, P2537, DOI 10.1029/2001GL012939; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Jansen D, 2008, GEOPH RES ABSTR, V10; Jansen D, 2007, REMOTE SENS ENVIRON, V111, P195, DOI 10.1016/j.rse.2007.03.022; Klinck H, 2012, J ACOUST SOC AM, V132, pEL176, DOI 10.1121/1.4740226; MacAyeal DR, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001005; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; Matsumoto H, 2012, SCI COMM ANT RES ANT; Matsumoto H, 2011, USE AUTONOMOUS HYDRO; Matsumoto K, 2001, J GEODETIC SOC JPN, V47, P243, DOI DOI 10.11366/SOKUCHI1954.47.243; Maurice SDR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002416; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Miksis-Olds JL, 2013, PROG OCEANOGR, V111, P38, DOI 10.1016/j.pocean.2012.10.010; Miksis-Olds JL, 2012, ADV EXP MED BIOL, V730, P597, DOI 10.1007/978-1-4419-7311-5_135; Muller C, 2005, SCIENCE, V310, P1299, DOI 10.1126/science.1117145; National Aeronautic and Space Administration Earth Observatory, 2008, LARG TERR MODIS IM; Pelayo AM, 1989, SEISMOTECTONICS RELA; PRITCHARD RS, 1990, J ACOUST SOC AM, V88, P2830, DOI 10.1121/1.399687; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Romero MCR, 2004, THESIS NM I MIN TECH; Roth EH, 2012, J ACOUST SOC AM, V131, P104, DOI 10.1121/1.3664096; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; Scambos T, 2008, J GLACIOL, V54, P579, DOI 10.3189/002214308786570836; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Slack PD, 1999, J GEOPHYS RES-SOL EA, V104, P13061, DOI 10.1029/1999JB900112; Stein PJ, 2000, J GEOPHYS RES-OCEANS, V105, P8813, DOI 10.1029/2000JC900009; Talandier J, 2002, EARTH PLANET SC LETT, V203, P519, DOI 10.1016/S0012-821X(02)00867-1; Urick R. J., 1975, PRINCIPLES UNDERWATE; Warren K, 2011, THESIS N CAROLINA ST; Wilcock WSD, 2014, ANNU REV MAR SCI, V6, P117, DOI 10.1146/annurev-marine-121211-172423	51	20	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123425	10.1371/journal.pone.0123425	http://dx.doi.org/10.1371/journal.pone.0123425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875205	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700031
J	Chang, IJ; Kang, CJ; Yueh, CY; Fang, KH; Yeh, RM; Tsai, YT				Chang, I. Jen; Kang, Chung Jan; Yueh, Chen Yu; Fang, Ku Hao; Yeh, Re Ming; Tsai, Yao Te			The Relationship between Serum Lipids and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; DIABETES-MELLITUS	Background Sudden sensorineural hearing loss (SSNHL) is a relatively common condition that is usually of unknown etiology. A number of individual studies have investigated the association between various serum lipids and SSNHL; however, the findings have been inconsistent. In an attempt to obtain more definitive information on the relationship between serum lipids and SSNHL, we carried out a systematic review and meta-analysis. Methods Medline, the Cochrane Library, and EMBASE were searched using the following key words: lipid, cholesterol, triglyceride, fat, serum, blood, sudden hearing loss, hearing loss, hearing disorders. Randomized controlled trials, prospective cohort studies, and retrospective case-control studies involving patients with SSNHL and healthy controls that examined the relationship (reported as odds ratios [OR]) between lipid profiles and SSNHL were included. Primary outcomes were total cholesterol and low-density lipoprotein cholesterol (LDL-C) concentrations. Secondary outcomes were triglyceride, high-density lipoprotein cholesterol, and lipoprotein(a) concentrations. Results A total of 6 case-control studies were included in this systematic review/meta-analysis. The total number of participants ranged from 30 to 250 in the case group and from 43 to 271 in the control group. Meta-analysis revealed no significant difference in total cholesterol levels between the case and control groups (pooled OR = 1.79, 95% confidence interval [CI] = 0.98 to 3.26, P = 0.057). Likewise, meta-analysis revealed no significant difference in LDLC concentrations between the case and control groups (pooled OR = 1.15, 95% CI = 0.64 to 2.07, P = 0.639). Since there were an insufficient number of studies reporting data for the secondary outcomes, meta-analysis was not possible. Conclusions Our results do not provide evidence for serum lipids being associated with SSNHL, nor do they definitively rule out such an association. Additional studies are needed to ascertain the relationship, or lack thereof, between serum lipids and SSNHL.	[Chang, I. Jen; Yueh, Chen Yu] Chang Gung Mem Hosp, Dept Family Med, Chiayi, Taiwan; [Kang, Chung Jan; Fang, Ku Hao] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Yeh, Re Ming; Tsai, Yao Te] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsai, YT (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Chiayi, Taiwan.	yaote1215@gmail.com		Fang, Ku-Hao/0000-0002-1458-5041				Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Cadoni G, 2007, OTOL NEUROTOL, V28, P878; Cadoni G, 2010, ANN OTO RHINOL LARYN, V119, P82, DOI 10.1177/000348941011900203; Capaccio P, 2007, LARYNGOSCOPE, V117, P547, DOI 10.1097/MLG.0b013e31802f3c6a; Chang SL, 2014, EAR HEARING, V35, P256, DOI 10.1097/AUD.0b013e3182a76637; Chau JK, 2010, LARYNGOSCOPE, V120, P1011, DOI 10.1002/lary.20873; Kuhn M, 2011, TRENDS AMPLIF, V15, P91, DOI 10.1177/1084713811408349; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Lu YY, 2008, ACTA OTO-LARYNGOL, V128, P1168, DOI 10.1080/00016480801901626; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; MATTOX DE, 1977, ANN OTO RHINOL LARYN, V86, P463, DOI 10.1177/000348947708600406; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; Nagaoka J, 2010, BRAZ J OTORHINOLAR, V76, P363, DOI 10.1590/S1808-86942010000300015; Nakashima T, 2000, OTOLARYNG HEAD NECK, V123, P593, DOI 10.1067/mhn.2000.109486; Oreskovic Z, 2011, J LARYNGOL OTOL, V125, P258, DOI 10.1017/S0022215110002252; Orita S, 2007, EUR ARCH OTO-RHINO-L, V264, P359, DOI 10.1007/s00405-006-0196-6; Quaranta N, 2008, OTOL NEUROTOL, V29, P470, DOI 10.1097/MAO.0b013e318170b650; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; Stew BT, 2012, BRIT J HOSP MED, V73, P86, DOI 10.12968/hmed.2012.73.2.86; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; ULLRICH D, 1992, EUR ARCH OTO-RHINO-L, V249, P273, DOI 10.1007/BF00714491; Weng TW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-95; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772	24	19	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121025	10.1371/journal.pone.0121025	http://dx.doi.org/10.1371/journal.pone.0121025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866869	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100032
J	Chang, PC; Wo, HT; Lee, HL; Lin, SF; Wen, MS; Chu, Y; Yeh, SJ; Chou, CC				Chang, Po-Cheng; Wo, Hung-Ta; Lee, Hui-Ling; Lin, Shien-Fong; Wen, Ming-Shien; Chu, Yen; Yeh, San-Jou; Chou, Chung-Chuan			Role of Sarcoplasmic Reticulum Calcium in Development of Secondary Calcium Rise and Early Afterdepolarizations in Long QT Syndrome Rabbit Model	PLOS ONE			English	Article							TORSADE-DE-POINTES; INTRACELLULAR CALCIUM; INTERVAL PROLONGATION; VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; REPOLARIZATION; AMIODARONE; MECHANISMS; ALTERNANS; HEART	Background L-type calcium current reactivation plays an important role in development of early afterdepolarizations (EADs) and torsades de pointes (TdP). Secondary intracellular calcium (Ca-i) rise is associated with initiation of EADs. Objective To test whether inhibition of sarcoplasmic reticulum (SR) Ca2+ cycling suppresses secondary Ca-i rise and genesis of EADs. Methods Langendorff perfusion and dual voltage and Cai optical mapping were conducted in 10 rabbit hearts. Atrioventricular block (AVB) was created by radiofrequency ablation. After baseline studies, E4031, SR Ca2+ cycling inhibitors (ryanodine plus thapsigargin) and nifedipine were then administrated subsequently, and the protocols were repeated. Results At baseline, there was no spontaneous or pacing-induced TdP. After E4031 administration, action potential duration (APD) was significantly prolonged and the amplitude of secondary Cai rise was enhanced, and 7 (70%) rabbits developed spontaneous or pacing-induced TdP. In the presence of ryanodine plus thapsigargin, TdP inducibility was significantly reduced (2 hearts, 20%, p = 0.03). Although APD was significantly prolonged (from 298 +/- 30 ms to 457 +/- 75 ms at pacing cycle length of 1000 m, p = 0.007) by ryanodine plus thapsigargin, the secondary Ca-i rise was suppressed ( from 8.8 +/- 2.6% to 1.2 +/- 0.9%, p = 0.02). Nifedipine inhibited TdP inducibility in all rabbit hearts. Conclusion In this AVB and long QT rabbit model, inhibition of SR Ca2+ cycyling reduces the inducibility of TdP. The mechanism might be suppression of secondary Ca-i rise and genesis of EADs.	[Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Yeh, San-Jou; Chou, Chung-Chuan] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan; [Chang, Po-Cheng; Wen, Ming-Shien; Chu, Yen; Yeh, San-Jou; Chou, Chung-Chuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Hui-Ling] Chang Gung Mem Hosp, Dept Anesthesia, Taipei 10591, Taiwan; [Lin, Shien-Fong; Chu, Yen] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Chu, Yen] Chang Gung Mem Hosp, Div Thorac Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Chou, CC (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.	2867@cgmh.org.tw	Lin, Shien-fong/AAQ-1608-2020; Chou, Chung-Chuan/AAZ-9776-2021; Chang, Po-Cheng/ABA-4979-2020	Lin, Shien-fong/0000-0003-1270-3961; Chang, Po-Cheng/0000-0002-6901-5951; Chu, Yen/0000-0002-7712-8331	Taiwan National Science Council [NSC 102-2314-B-182A-038-MY2]; Chang Gung Memorial Hospital [CMRPG3C1651]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Taiwan National Science Council Grant (NSC 102-2314-B-182A-038-MY2) to PCC and by Chang Gung Memorial Hospital Medical Research Programs (CMRPG3C1651) to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev SA, 2002, B EXP BIOL MED+, V133, P205, DOI 10.1023/A:1015832710818; Asano Y, 1997, J AM COLL CARDIOL, V29, P831, DOI 10.1016/S0735-1097(96)00588-8; Chang PC, 2014, J CARDIOL; Chang PC, 2013, HEART RHYTHM, V10, P1516, DOI 10.1016/j.hrthm.2013.07.003; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Chou CC, 2013, PACE, V36, P596, DOI 10.1111/pace.12091; Driessen HE, 2014, NETH HEART J, V22, P198, DOI 10.1007/s12471-014-0549-5; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Hancox JC, 1997, GEN PHARMACOL, V29, P429, DOI 10.1016/S0306-3623(96)00465-X; Hoffmann Peter, 2006, Journal of Pharmacological and Toxicological Methods, V53, P87, DOI 10.1016/j.vascn.2005.07.003; Lacampagne A, 1996, BIOPHYS J, V70, P370, DOI 10.1016/S0006-3495(96)79580-2; Maruyama M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P103, DOI 10.1161/CIRCEP.110.959064; Milberg P, 2012, BRIT J PHARMACOL, V166, P557, DOI 10.1111/j.1476-5381.2011.01721.x; Moss AJ, 2003, JAMA-J AM MED ASSOC, V289, P2041, DOI 10.1001/jama.289.16.2041; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Qu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043587; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Takamatsu H, 2003, J PHYSIOL-LONDON, V552, P415, DOI 10.1113/jphysiol.2003.050823; Terentyev D, 2014, CIRC RES, V115, P919, DOI 10.1161/CIRCRESAHA.115.305146; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123868	10.1371/journal.pone.0123868	http://dx.doi.org/10.1371/journal.pone.0123868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875599	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100219
J	Goldfarb, JW; Hasan, U				Goldfarb, James W.; Hasan, Usama			Imaging of Reperfused Intramyocardial Hemorrhage with Cardiovascular Magnetic Resonance Susceptibility Weighted Imaging (SWI)	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MICROVASCULAR OBSTRUCTION; CORONARY REPERFUSION; MR; CONTRAST; INJURY; DETERMINANTS; COMPONENTS; EDEMA; HEART	Purpose To report initial experience with TE-averaged susceptibility weighted imaging (SWI) in normal subjects and acute myocardial infarction (AMI) patients for the detection of intramyocardial hemorrhage (IMH). Materials and Methods 15 healthy control and 11 AMI subjects were studied at 1.5T before contrast agent administration with a dark blood double inversion recovery multiple spoiled gradient-echo sequence. Magnitude, susceptibility weighted and TE-averaged images were reconstructed from raw data. Contrast and signal-difference-to-noise were measured and compared between methods for IMH detection. Results There were six patients with microvascular obstruction (MVO) and four patients with IMH detected by TE-averaged SWI imaging. All patients with IMH on SWI scans had MVO on late gadolinium-enhanced (LGE) imaging. There was a three-fold increase in IMH contrast with SWI compared to magnitude images. IMH contrast decreased and signal-to-noise increased with increased TE averages. Conclusions TE-averaged SWI imaging is a promising method for myocardial tissue characterization in the setting of AMI for the detection of IMH. Along with gray-scale colormap inversion, it combines not only magnitude and phase information, but also images across TEs to provide a single image sensitive to IMH with characteristics similar to LGE imaging.	[Goldfarb, James W.; Hasan, Usama] St Francis Hosp, Dept Res & Educ, Roslyn, NY 11576 USA; [Goldfarb, James W.] SUNY Stony Brook, Biomed Engn Program, Stony Brook, NY 11794 USA; [Hasan, Usama] New York Coll Osteopath Med, Old Westbury, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York Institute Technology	Goldfarb, JW (corresponding author), St Francis Hosp, Dept Res & Educ, Roslyn, NY 11576 USA.	James.Goldfarb.PhD@gmail.com			American Heart Association Scientist Development Grant [0635029N]	American Heart Association Scientist Development Grant(American Heart Association)	This work was supported by American Heart Association Scientist Development Grant, 0635029N.	Abdel-Aty H, 2007, J MAGN RESON IMAGING, V26, P452, DOI 10.1002/jmri.21028; Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Asanuma T, 1997, CIRCULATION, V96, P448; Basso C, 2006, HEART, V92, P1559, DOI 10.1136/hrt.2005.086959; Basso C, 2007, AM J CARDIOL, V100, P1322, DOI 10.1016/j.amjcard.2007.05.062; Beek AM, 2010, INT J CARDIOVAS IMAG, V26, P49, DOI 10.1007/s10554-009-9499-1; Brainovich V, 2009, MAGN RESON IMAGING, V27, P23, DOI 10.1016/j.mri.2008.05.006; Cannan C, 2010, JACC-CARDIOVASC IMAG, V3, P665, DOI 10.1016/j.jcmg.2009.12.019; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Croisille P, 2012, RADIOLOGY, V265, P12, DOI 10.1148/radiol.12111769; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Edelman RR, 2004, RADIOLOGY, V232, P653, DOI 10.1148/radiol.2323031558; Eitel I, 2011, CIRC-CARDIOVASC IMAG, V4, P354, DOI 10.1161/CIRCIMAGING.110.960500; El Aidi H, 2014, J AM COLL CARDIOL, V63, P1031, DOI 10.1016/j.jacc.2013.11.048; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Foltz WD, 2006, MAGN RESON MED, V56, P1311, DOI 10.1002/mrm.21079; Francone M, 2011, RADIOL MED, V116, P32, DOI 10.1007/s11547-010-0594-0; Ganame J, 2009, EUR HEART J, V30, P1440, DOI 10.1093/eurheartj/ehp093; GARCIADORADO D, 1990, AM J PATHOL, V137, P301; Gilbert G, 2012, MAGN RESON IMAGING, V30, P722, DOI 10.1016/j.mri.2012.02.008; Goldfarb JW, 2007, RADIOLOGY, V245, P245, DOI 10.1148/radiol.2451061590; Goldfarb JW, 2007, MAGN RESON MED, V57, P828, DOI 10.1002/mrm.21207; Goldfarb JW, 2014, MAGN RESON MED, V71, P1210, DOI 10.1002/mrm.24747; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Huber AM, 2005, RADIOLOGY, V237, P854, DOI 10.1148/radiol.2373041483; Jackowski C, 2006, EUR HEART J, V27, P2459, DOI 10.1093/eurheartj/ehl255; Kali A, 2013, RADIOLOGY, V269, P386, DOI 10.1148/radiol.13122397; Kumar A, 2011, JACC-CARDIOVASC IMAG, V4, P1274, DOI 10.1016/j.jcmg.2011.08.016; LOTAN CS, 1990, CATHETER CARDIO DIAG, V20, P205, DOI 10.1002/ccd.1810200313; LOTAN CS, 1992, CIRCULATION, V86, P1018, DOI 10.1161/01.CIR.86.3.1018; Marra MP, 2011, EUR HEART J, V32, P284, DOI 10.1093/eurheartj/ehq409; Mather AN, 2011, HEART, V97, P453, DOI 10.1136/hrt.2010.202028; Mikami Y, 2009, AM J ROENTGENOL, V193, pW321, DOI 10.2214/AJR.09.2335; O'Regan DP, 2010, HEART, V96, P1885, DOI 10.1136/hrt.2010.200634; O'Regan DP, 2009, RADIOLOGY, V250, P916, DOI 10.1148/radiol.2503081154; Ochiai K, 1999, J CARDIOV MAGN RESON, V1, P247, DOI 10.3109/10976649909088337; Pedersen SF, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-59; Porto I, 2011, AM HEART J, V162, P372, DOI 10.1016/j.ahj.2011.04.014; Quinn MP, 2013, AJNR AM J NEURORADIO; Rajiah P, 2013, RADIOGRAPHICS, V33, P1383, DOI 10.1148/rg.335125722; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Saeed M, 2010, WORLD J RADIOL, V2, P1, DOI 10.4329/wjr.v2.i1.1; Saeed M, 2010, ACTA RADIOL, V51, P1093, DOI 10.3109/02841851.2010.520025; Salerno M, 2013, JACC-CARDIOVASC IMAG, V6, P806, DOI 10.1016/j.jcmg.2013.05.005; Schwartz RS, 2005, CATHETER CARDIO INTE, V66, P170, DOI 10.1002/ccd.20510; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Vargas-Barron J, 2014, REV INVEST CLIN, V66, P107; Wolff SD, 1997, RADIOLOGY, V202, P25, DOI 10.1148/radiology.202.1.8988186; Wu KC, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-68; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Zia MI, 2012, CIRC-CARDIOVASC IMAG, V5, P566, DOI 10.1161/CIRCIMAGING.112.973222	55	1	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123560	10.1371/journal.pone.0123560	http://dx.doi.org/10.1371/journal.pone.0123560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875478	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100188
J	Hoellig, A; Weinandy, A; Nolte, K; Clusmann, H; Rossaint, R; Coburn, M				Hoellig, Anke; Weinandy, Agnieszka; Nolte, Kay; Clusmann, Hans; Rossaint, Rolf; Coburn, Mark			Experimental Subarachnoid Hemorrhage in Rats: Comparison of Two Endovascular Perforation Techniques with Respect to Success Rate, Confounding Pathologies and Early Hippocampal Tissue Lesion Pattern	PLOS ONE			English	Article							EARLY BRAIN-INJURY; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; CEREBRAL VASOSPASM; PERFUSION-PRESSURE; CASE-FATALITY; BLOOD-FLOW; MODEL; EPIDEMIOLOGY; APOPTOSIS	Recently aside from the "classic" endovascular monofilament perforation technique to induce experimental subarachnoid hemorrhage (SAH) a modification using a tungsten wire advanced through a guide tube has been described. We aim to assess both techniques for their success rate (induction of SAH without confounding pathologies) as primary endpoint. Further, the early tissue lesion pattern as evidence for early brain injury will be analyzed as secondary endpoint. Sprague Dawley rats (n=39) were randomly assigned to receive either Sham surgery (n=4), SAH using the "classic" technique (n= 18) or using a modified technique (n= 17). Course of intracranial pressure (ICP) and regional cerebral blood flow (rCBF) was analyzed; subsequent pathologies were documented either 6 or 24 h after SAH. Hippocampal tissue samples were analyzed via immunohistochemistry and western blotting. SAH-induction, regardless of confounding pathologies, was independent from type of technique (p=0.679). There was no significant difference concerning case fatality rate (classic: 40%; modified: 20%; p=0.213). Successful induction of SAH without collateral ICH or SDH was possible in 40% with the classic and in 86.7% with the modified technique (p=0.008). Peak ICP levels differed significantly between the two groups (classic: 94 +/- 23 mmHg; modified: 68 +/- 19 mmHg; p=0.003). Evidence of early cellular stress response and activation of apoptotic pathways 6 h after SAH was demonstrated. The extent of stress response is not dependent on type of technique. Both tested techniques successfully produce SAH including activation of an early stress response and apoptotic pathways in the hippocampal tissue. However, the induction of SAH with less confounding pathologies was more frequently achieved with the modified tungsten wire technique.	[Hoellig, Anke; Weinandy, Agnieszka; Clusmann, Hans] Univ RWTH Aachen, Dept Neurosurg, Aachen, Germany; [Hoellig, Anke; Rossaint, Rolf; Coburn, Mark] Univ RWTH Aachen, Dept Anesthesiol, Aachen, Germany; [Weinandy, Agnieszka; Nolte, Kay] Univ RWTH Aachen, Dept Neuropathol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Coburn, M (corresponding author), Univ RWTH Aachen, Dept Anesthesiol, Aachen, Germany.	mcoburn@ukaachen.de		Coburn, Mark/0000-0002-7930-0270	Start Program, RWTH Aachen	Start Program, RWTH Aachen(Austrian Science Fund (FWF))	The study was funded by Start Program, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KJ, 1998, NEUROSURG CLIN N AM, V9, P435; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bleilevens C, 2013, EXP BRAIN RES, V224, P155, DOI 10.1007/s00221-012-3296-0; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chaitanya GV, 2009, CELL MOL NEUROBIOL, V29, P563, DOI 10.1007/s10571-009-9348-8; DELGADO TJ, 1985, STROKE, V16, P595, DOI 10.1161/01.STR.16.4.595; Dodel R, 2010, STROKE, V41, P2918, DOI 10.1161/STROKEAHA.110.586826; Dong YS, 2013, BRAIN RES, V1517, P114, DOI 10.1016/j.brainres.2013.04.024; Dreier A, 2012, TUMOR BIOL, V33, P85, DOI 10.1007/s13277-011-0248-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; Greenhalgh AD, 2012, TRANSL STROKE RES, V3, P164, DOI 10.1007/s12975-011-0124-y; Hockel Konstantin, 2012, Exp Transl Stroke Med, V4, P5, DOI 10.1186/2040-7378-4-5; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Kaptain GJ, 2000, DRUG AGING, V17, P183, DOI 10.2165/00002512-200017030-00003; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Leonardo Christopher C, 2012, Front Neurol, V3, P85, DOI 10.3389/fneur.2012.00085; MacLellan CL, 2012, J CEREBR BLOOD F MET, V32, P612, DOI 10.1038/jcbfm.2012.8; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Meguro T, 2001, NEUROL RES, V23, P761, DOI 10.1179/016164101101199144; Meguro T, 2001, J NEUROCHEM, V77, P1128, DOI 10.1046/j.1471-4159.2001.00313.x; Ogihara K, 2000, ACT NEUR S, V76, P507; Ogihara K, 2001, BRAIN RES, V889, P89, DOI 10.1016/S0006-8993(00)03120-6; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Park IS, 2008, J NEUROSCI METH, V172, P195, DOI 10.1016/j.jneumeth.2008.04.027; Paxinos G., 2004, RAT NERVOUS SYSTEM, Vxvii; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Rivero-Arias Oliver, 2010, Cost Eff Resour Alloc, V8, P6, DOI 10.1186/1478-7547-8-6; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Satoh M, 2001, STROKE, V32, P225, DOI 10.1161/01.STR.32.1.225; Schwartz AY, 2000, J NEUROSCI METH, V96, P161, DOI 10.1016/S0165-0270(00)00156-4; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VEELKEN JA, 1995, STROKE, V26, P1279, DOI 10.1161/01.STR.26.7.1279; Wu C, 2013, BIOCHEM BIOPH RES CO, V437, P469, DOI 10.1016/j.bbrc.2013.06.107; Zhou CM, 2004, J CEREBR BLOOD F MET, V24, P419, DOI 10.1097/00004647-200404000-00007	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123398	10.1371/journal.pone.0123398	http://dx.doi.org/10.1371/journal.pone.0123398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867893	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100172
J	Ivonin, L; Chang, HM; Diaz, M; Catala, A; Chen, W; Rauterberg, M				Ivonin, Leonid; Chang, Huang-Ming; Diaz, Marta; Catala, Andreu; Chen, Wei; Rauterberg, Matthias			Traces of Unconscious Mental Processes in Introspective Reports and Physiological Responses	PLOS ONE			English	Article							EMOTION; MODEL	Unconscious mental processes have recently started gaining attention in a number of scientific disciplines. One of the theoretical frameworks for describing unconscious processes was introduced by Jung as a part of his model of the psyche. This framework uses the concept of archetypes that represent prototypical experiences associated with objects, people, and situations. Although the validity of Jungian model remains an open question, this framework is convenient from the practical point of view. Moreover, archetypes found numerous applications in the areas of psychology and marketing. Therefore, observation of both conscious and unconscious traces related to archetypal experiences seems to be an interesting research endeavor. In a study with 36 subjects, we examined the effects of experiencing conglomerations of unconscious emotions associated with various archetypes on the participants' introspective reports and patterns of physiological activations. Our hypothesis for this experiment was that physiological data may predict archetypes more precisely than introspective reports due to the implicit nature of archetypal experiences. Introspective reports were collected using the Self-Assessment Manikin (SAM) technique. Physiological measures included cardiovascular, electrodermal, respiratory responses and skin temperature of the subjects. The subjects were stimulated to feel four archetypal experiences and four explicit emotions by means of film clips. The data related to the explicit emotions served as a reference in analysis of archetypal experiences. Our findings indicated that while prediction models trained on the collected physiological data could recognize the archetypal experiences with accuracy of 55 percent, similar models built based on the SAM data demonstrated performance of only 33 percent. Statistical tests enabled us to confirm that physiological observations are better suited for observation of implicit psychological constructs like archetypes than introspective reports.	[Ivonin, Leonid; Chang, Huang-Ming; Chen, Wei; Rauterberg, Matthias] Eindhoven Univ Technol, Dept Ind Design, Designed Intelligence Grp, NL-5612 AZ Eindhoven, Netherlands; [Ivonin, Leonid; Chang, Huang-Ming; Diaz, Marta; Catala, Andreu] Univ Politecn Cataluna, Vilanova I La Geltru Bar 08800, Spain	Eindhoven University of Technology; Universitat Politecnica de Catalunya	Ivonin, L (corresponding author), Eindhoven Univ Technol, Dept Ind Design, Designed Intelligence Grp, Den Dolech 2, NL-5612 AZ Eindhoven, Netherlands.	leonid.ivonin@gmail.com	Díaz-Boladeras, Marta/AAX-7954-2020; CATALA, Andreu/G-4038-2015; Rauterberg, G. W. Matthias/M-4466-2014	Rauterberg, G. W. Matthias/0000-0002-2596-395X; Diaz-Boladeras, Marta/0000-0001-8215-0499; Catala, Andreu/0000-0001-8775-1955	Erasmus Mundus Joint Doctorate (EMJD) in Interactive and Cognitive Environments (ICE); Erasmus Mundus under the FPA [2010-2012]	Erasmus Mundus Joint Doctorate (EMJD) in Interactive and Cognitive Environments (ICE); Erasmus Mundus under the FPA	This work was supported in part by the Erasmus Mundus Joint Doctorate (EMJD) in Interactive and Cognitive Environments (ICE), which is funded by Erasmus Mundus under the FPA no. 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; Allers Roger, 1994, THE LION KING; Aronofsky Darren, 2010, BLACK SWAN; Atkinson R, 1990, BEAN; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boiten FA, 1998, BIOL PSYCHOL, V49, P29, DOI 10.1016/S0301-0511(98)00025-8; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bradley MM, 1999, INT AFFECTIVE DIGITI; Brunel FF, 2004, J CONSUM PSYCHOL, V14, P385, DOI 10.1207/s15327663jcp1404_8; Burns A, 2010, IEEE ENG MED BIO, P3759, DOI 10.1109/IEMBS.2010.5627535; CACIOPPO JT, 1990, AM PSYCHOL, V45, P16, DOI 10.1037/0003-066X.45.1.16; Caldwell M, 2010, QUAL MARK RES, V13, P84, DOI 10.1108/13522751011013990; Camm AJ, 1996, CIRCULATION, V93, P1043; Campbell J., 2008, HERO 1000 FACES; Chang HM, 2011, LECT NOTES COMPUT SC, V6972, P411, DOI 10.1007/978-3-642-24500-8_54; Chartrand TL, 2011, J CONSUM PSYCHOL, V21, P1, DOI 10.1016/j.jcps.2010.12.001; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Demme Jonathan, 1991, SILENCE LAMBS; Eich E., 2007, HDB EMOTION ELICITAT, P124, DOI DOI 10.1016/J.ENCEP.2006.08.003; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Faber MA, 2009, J RES PERS, V43, P307, DOI 10.1016/j.jrp.2008.11.003; Fairclough SH, 2006, BIOL PSYCHOL, V71, P100, DOI 10.1016/j.biopsycho.2005.03.007; Figner B., 2011, HDB PROCESS TRACING, P163, DOI DOI 10.4324/9780203875292-18/USING-SKIN-CONDUCTANCE-JUDGMENT-DECISION-MAKING-RESEARCH-MICHAEL-SCHULTE-MECKLENBECK-ANTON-KUEHBERGER-JOSEPH-JOHNSON-JOSEPH-JOHNSON; Fincher D., 1999, FIGHT CLUB; Geurts P., 2001, EUR C PRINC DAT MIN, P115, DOI DOI 10.1073/pnas.1311874111; Gibson Mel, 1995, BRAVEHEART; Gronning T, 2007, VIS RESOUR, V23, P245, DOI 10.1080/01973760701450983; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gunes Hatice, 2010, International Journal of Strategic Synthetic Emotions, V1, P68, DOI 10.4018/jse.2010101605; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Healey J, 2011, LECT NOTES COMPUT SC, V6974, P107, DOI 10.1007/978-3-642-24600-5_14; Ivonin Leonid, 2013, Human Factors in Computing and Informatics. Proceedings of the First International Conference (SouthCHI 2013): LNCS 7946, P16, DOI 10.1007/978-3-642-39062-3_2; Ivonin L, 2014, DATA SETS; Ivonin L, 2012, LECT NOTES INFORM TE, P337; Ivonin L, 2015, BEHAV INFORM TECHNOL, V34, P220, DOI 10.1080/0144929X.2014.912353; Ivonin L, 2013, PERS UBIQUIT COMPUT, V17, P663, DOI 10.1007/s00779-012-0514-5; Jung C., 1968, MAN HIS SYMBOLS; Jung Carl Gustav., 1980, ARCHETYPES COLLECTIV, V2nd; Kadous MW, 2005, MACH LEARN, V58, P179, DOI 10.1007/s10994-005-5826-5; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; Kim KH, 2004, MED BIOL ENG COMPUT, V42, P419, DOI 10.1007/BF02344719; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Maloney A, 1999, J ANAL PSYCHOL, V44, P101, DOI 10.1111/1465-5922.00070; McLoone H. E., 2010, P HUMAN FACTORS ERGO, V54, P1771, DOI [10.1177/154193121005402006, DOI 10.1177/154193121005402006]; Megehee CM, 2012, J BUS RES, V65, P1434, DOI 10.1016/j.jbusres.2011.10.009; Mendes Sam, 1999, AM BEAUTY; Moran-Ellis J, 2006, QUAL RES, V6, P45, DOI [10.1177/1468794106058870, DOI 10.1177/1468794106058870]; Nakatsu R, 2006, MULTIMEDIA SYST, V11, P304, DOI 10.1007/s00530-005-0006-9; Nakatsu R., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P281, DOI 10.1109/ICSMC.1999.812414; Neuman MR, 2010, IEEE PULSE, V1, P51, DOI 10.1109/MPUL.2010.939179; NISBETT R, 1977, PSYCHOL REV, V84, P1977, DOI DOI 10.1037/0033-295X.84.3.231; Novak D, 2012, INTERACT COMPUT, V24, P154, DOI 10.1016/j.intcom.2012.04.003; Nunn C. M. H., 1998, J CONSCIOUSNESS STUD, V5, P344; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Peter C, 2006, INTERACT COMPUT, V18, P139, DOI 10.1016/j.intcom.2005.10.006; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Piferi RL, 2000, INT J PSYCHOPHYSIOL, V37, P207, DOI 10.1016/S0167-8760(00)00102-1; Ramshur J.T., 2010, THESIS U MEMPHIS MEM; Rauterberg M, 2010, LECT NOTES COMPUT SC, V6243, P205, DOI 10.1007/978-3-642-15399-0_19; REINGOLD EM, 1990, MIND LANG, V5, P9, DOI DOI 10.1111/J.1468-0017.1990.TB00150.X; Robinson MD, 2010, SELF IDENTITY, V9, P87, DOI 10.1080/15298860902728274; ROSEN DH, 1991, J ANAL PSYCHOL, V36, P211, DOI 10.1111/j.1465-5922.1991.00211.x; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saariluoma P, 2009, FUTURE INTERACTION D, P69; Sakr GE, 2010, IEEE T AFFECT COMPUT, V1, P98, DOI 10.1109/T-AFFC.2010.2; Schmitt B, 2012, J CONSUM PSYCHOL, V22, P7, DOI 10.1016/j.jcps.2011.09.005; Soleymani M, 2012, IEEE T AFFECT COMPUT, V3, P211, DOI 10.1109/T-AFFC.2011.37; van Gaal S, 2012, NEUROSCIENTIST, V18, P287, DOI 10.1177/1073858411404079; Walle AlfH., 1986, J CONSUM MARK, V3, P21, DOI DOI 10.1108/EB008176; WALTERS S, 1994, J SOC EVOL SYST, V17, P287, DOI 10.1016/1061-7361(94)90013-2; West B. T., 2006, LINEAR MIXED MODELS, P180; Woodside AG, 2006, PSYCHOL MARKET, V23, P257, DOI [10.1002/mar.20099, 10.1002/mar.20034]; Woodside AG, 2012, J BUS RES, V65, P594, DOI 10.1016/j.jbusres.2011.02.016; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478; Zaltman Gerald, 2003, HOW CUSTOMERS THINK; Zemeckis R., 1994, FORREST GUMP	82	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124519	10.1371/journal.pone.0124519	http://dx.doi.org/10.1371/journal.pone.0124519			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875608	gold, Green Published			2022-12-27	WOS:000352845100264
J	Mester, D; Ronin, Y; Schnable, P; Aluru, S; Korol, A				Mester, David; Ronin, Yefim; Schnable, Patrick; Aluru, Srinivas; Korol, Abraham			Fast and Accurate Construction of Ultra-Dense Consensus Genetic Maps Using Evolution Strategy Optimization	PLOS ONE			English	Article							ALGORITHMS	Our aim was to develop a fast and accurate algorithm for constructing consensus genetic maps for chip-based SNP genotyping data with a high proportion of shared markers between mapping populations. Chip-based genotyping of SNP markers allows producing high-density genetic maps with a relatively standardized set of marker loci for different mapping populations. The availability of a standard high-throughput mapping platform simplifies consensus analysis by ignoring unique markers at the stage of consensus mapping thereby reducing mathematical complicity of the problem and in turn analyzing bigger size mapping data using global optimization criteria instead of local ones. Our three-phase analytical scheme includes automatic selection of similar to 100-300 of the most informative (resolvable by recombination) markers per linkage group, building a stable skeletal marker order for each data set and its verification using jackknife re-sampling, and consensus mapping analysis based on global optimization criterion. A novel Evolution Strategy optimization algorithm with a global optimization criterion presented in this paper is able to generate high quality, ultra-dense consensus maps, with many thousands of markers per genome. This algorithm utilizes "potentially good orders" in the initial solution and in the new mutation procedures that generate trial solutions, enabling to obtain a consensus order in reasonable time. The developed algorithm, tested on a wide range of simulated data and real world data (Arabidopsis), outperformed two tested state-of-the-art algorithms by mapping accuracy and computation time.	[Mester, David; Ronin, Yefim; Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Schnable, Patrick] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Aluru, Srinivas] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA USA	University of Haifa; Iowa State University; Iowa State University	Mester, D (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	dmester@research.haifa.ac.il; korol@research.haifa.ac.il		Schnable, Patrick/0000-0001-9169-5204				Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Chen X, 2010, J COMPUT BIOL, V17, P1561, DOI 10.1089/cmb.2009.0268; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-407; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; FLOOD MM, 1956, OPER RES, V4, P61, DOI 10.1287/opre.4.1.61; Jackson BN, 2008, IEEE ACM T COMPUT BI, V5, P161, DOI 10.1109/TCBB.2007.70221; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; Kwitek AE, 2001, GENOME RES, V11, P1935, DOI 10.1101/gr.173701; Mester D, 2003, GENETICS, V165, P2269; Mester D, 2010, GEN-RES ISSUES, P1; Mester DI, 2006, COMPUT BIOL CHEM, V30, P12, DOI 10.1016/j.compbiolchem.2005.09.007; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Or I., 1976, THESIS N W U US; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Ronin Y, 2012, G3-GENES GENOM GENET, V2, P537, DOI 10.1534/g3.112.002428; Ronin Y, 2015, P 12 IWGS IN PRESS; Salome PA, 2012, HEREDITY, V108, P447, DOI 10.1038/hdy.2011.95; Sewell MM, 1999, GENETICS, V151, P321; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Williams R.W., 2001, GENOME BIOL, V2; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Wu Y, 2008, PLOS GENET, V10, DOI [10.1371/journal.pgen.1000212e, DOI 10.1371/JOURNAL.PGEN.1000212E]; Wu Y, 2008, P LSS COMP SYST BIOI, P285; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Yap IV, 2003, GENETICS, V165, P2235	28	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122485	10.1371/journal.pone.0122485	http://dx.doi.org/10.1371/journal.pone.0122485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867943	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100076
J	Wagner, EYN; Wagner, JT; Glaus, J; Vandeleur, CL; Castelao, E; Strippoli, MPF; Vollenweider, P; Preisig, M; von Kanel, R				Wagner, En-Young N.; Wagner, Jan T.; Glaus, Jennifer; Vandeleur, Caroline L.; Castelao, Enrique; Strippoli, Marie-Pierre F.; Vollenweider, Peter; Preisig, Martin; von Kaenel, Roland			Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; POSTTRAUMATIC-STRESS-DISORDER; TEST-RETEST RELIABILITY; GENETIC-STUDIES DIGS; DIAGNOSTIC INTERVIEW; ANXIETY DISORDERS; PREVALENCE; RISK; INTERRATER	Background Anxiety disorders have been linked to an increased risk of incident coronary heart disease in which inflammation plays a key pathogenic role. To date, no studies have looked at the association between proinflammatory markers and agoraphobia. Methods In a random Swiss population sample of 2890 persons (35-67 years, 53% women), we diagnosed a total of 124 individuals (4.3%) with agoraphobia using a validated semi-structured psychiatric interview. We also assessed socioeconomic status, traditional cardiovascular risk factors (i.e., body mass index, hypertension, blood glucose levels, total cholesterol/ high-density lipoprotein-cholesterol ratio), and health behaviors (i.e., smoking, alcohol consumption, and physical activity), and other major psychiatric diseases (other anxiety disorders, major depressive disorder, drug dependence) which were treated as covariates in linear regression models. Circulating levels of inflammatory markers, statistically controlled for the baseline demographic and health-related measures, were determined at a mean follow-up of 5.5 +/- 0.4 years (range 4.7 -8.5). Results Individuals with agoraphobia had significantly higher follow-up levels of C-reactive protein (p = 0.007) and tumor-necrosis-factor-alpha (p = 0.042) as well as lower levels of the cardioprotective marker adiponectin (p = 0.032) than their non-agoraphobic counterparts. Follow-up levels of interleukin (IL)-1 beta and IL-6 did not significantly differ between the two groups. Conclusions Our results suggest an increase in chronic low-grade inflammation in agoraphobia over time. Such a mechanism might link agoraphobia with an increased risk of atherosclerosis and coronary heart disease, and needs to be tested in longitudinal studies.	[Wagner, En-Young N.] Univ Hosp Bern, Inselspital, Div Psychosomat Med, CH-3010 Bern, Switzerland; [Wagner, En-Young N.; von Kaenel, Roland] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Wagner, Jan T.] Swissmed, Div Clin Review, Bern, Switzerland; [Glaus, Jennifer; Vandeleur, Caroline L.; Castelao, Enrique; Strippoli, Marie-Pierre F.; Preisig, Martin] Univ Lausanne Hosp, Ctr Res Psychiat Epidemiol & Psychopathol, Dept Psychiat, Prilly, Switzerland; [Vollenweider, Peter] Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland; [von Kaenel, Roland] Clin Barmelweid, Dept Psychosomat Med, Barmelweid, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wagner, EYN (corresponding author), Univ Hosp Bern, Inselspital, Div Psychosomat Med, CH-3010 Bern, Switzerland.	en-young.wagner@insel.ch	Glaus, Jennifer/C-7887-2017; von Känel, Roland/B-1811-2019; Strippoli, Marie-Pierre F/K-8164-2013; Colaus, PsyColaus/K-6607-2013	Glaus, Jennifer/0000-0001-8883-9473; von Känel, Roland/0000-0002-8929-5129; Strippoli, Marie-Pierre F/0000-0003-3053-484X; Castelao, Enrique/0000-0003-1966-3683; Preisig, Martin/0000-0001-5689-4259; Vandeleur, Caroline/0000-0001-9092-6648	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Peter Vollenweider, Gerard Waeber and Martin Preisig received two unrestricted grants from GlaxoSmithKline to build the cohort and to complete the physical and psychiatric baseline investigations. The CoLaus|PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). The funders had no role in the study design, in the collection, management, analysis or interpretation of the data, in the preparation, review or approval of the manuscript, and the decision to submit the manuscript for publication.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Berney A, 2002, DRUG ALCOHOL DEPEN, V65, P149, DOI 10.1016/S0376-8716(01)00156-9; Bettschart W, 1996, EVALUATION CLIN STAN, VI; Buist-Bouwman MA, 2006, ACTA PSYCHIAT SCAND, V113, P492, DOI 10.1111/j.1600-0447.2005.00684.x; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Emmelkamp PMG, 2009, STRESS-INDUCED AND FEAR CIRCUITRY DISORDERS: ADVANCING THE RESEARCH AGENDA FOR DSM-V, P77; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Flower L, 2000, CYTOKINE, V12, P1712, DOI 10.1006/cyto.2000.0764; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hamer M, 2006, BRAIN BEHAV IMMUN, V20, P456, DOI 10.1016/j.bbi.2006.01.001; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Leboyer M., 1995, INTERVIEW DIAGNOSTIQ; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P642, DOI 10.1016/j.bbi.2012.02.003; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pervanidou P, 2007, PSYCHONEUROENDOCRINO, V32, P991, DOI 10.1016/j.psyneuen.2007.07.001; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rothman K J, 1990, Epidemiology, V1, P232, DOI 10.1097/00001648-199005000-00009; Rougemont-Buecking A, 2008, PSYCHIAT RES, V157, P211, DOI 10.1016/j.psychres.2006.04.022; Skeppholm M, 2008, CLIN CHEM LAB MED, V46, P1175, DOI 10.1515/CCLM.2008.219; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; SURMAN OS, 1986, BIOL PSYCHIAT, V21, P768, DOI 10.1016/0006-3223(86)90242-8; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; van Zuiden M, 2013, BRAIN BEHAV IMMUN, V30, P12, DOI 10.1016/j.bbi.2012.08.015; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; von Kanel R, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13502; Wittchen HU, 2010, DEPRESS ANXIETY, V27, P113, DOI 10.1002/da.20646; World Health Organization, 2000, WHO TECH REP SER, V894, pi	51	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123757	10.1371/journal.pone.0123757	http://dx.doi.org/10.1371/journal.pone.0123757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875094	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100209
J	Seferian, AM; Moraux, A; Canal, A; Decostre, V; Diebate, O; Le Moing, AG; Gidaro, T; Deconinck, N; Van Parys, F; Vereecke, W; Wittevrongel, S; Annoussamy, M; Mayer, M; Maincent, K; Cuisset, JM; Tiffreau, V; Denis, S; Jousten, V; Quijano-Roy, S; Voit, T; Hogrel, JY; Servais, L				Seferian, Andreea Mihaela; Moraux, Amelie; Canal, Aurelie; Decostre, Valerie; Diebate, Oumar; Le Moing, Anne Gaelle; Gidaro, Teresa; Deconinck, Nicolas; Van Parys, Frauke; Vereecke, Wendy; Wittevrongel, Sylvia; Annoussamy, Melanie; Mayer, Michele; Maincent, Kim; Cuisset, Jean-Marie; Tiffreau, Vincent; Denis, Severine; Jousten, Virginie; Quijano-Roy, Susana; Voit, Thomas; Hogrel, Jean-Yves; Servais, Laurent			Upper Limb Evaluation and One-Year Follow Up of Non-Ambulant Patients with Spinal Muscular Atrophy: An Observational Multicenter Trial	PLOS ONE			English	Article							FUNCTIONAL MOTOR SCALE; MUSCLE STRENGTH; NATURAL-HISTORY; SMA; DYSTROPHY; RELIABILITY; CAPACITY	Assessment of the upper limb strength in non-ambulant neuromuscular patients remains challenging. Although potential outcome measures have been reported, longitudinal data demonstrating sensitivity to clinical evolution in spinal muscular atrophy patients are critically lacking. Our study recruited 23 non-ambulant patients, 16 patients (males/females = 6/10; median age 15.4 years with a range from 10.7 to 31.1 years) with spinal muscular atrophy type II and 7 patients (males/females = 2/5; median age 19.9 years with a range from 8.3 to 29.9 years) with type III. The Brooke functional score was on median 3 with a range from 2 to 6. The average total vital capacity was 46%, and seven patients required non-invasive ventilation at night. Patients were assessed at baseline, 6 months, and 1 year using the Motor Function Measure and innovative devices MyoGrip, MyoPinch, and MoviPlate, which assess handgrip strength, key pinch strength, and hand/finger extension-flexion function, respectively. The study demonstrated the feasibility and reliability of these measures for all patients, and sensitivity to negative changes after the age of 14 years. The younger patients showed an increase of the distal force in the follow-up period. The distal force measurements and function were correlated to different functional scales. These data represent an important step in the process of validating these devices as potential outcome measures for future clinical trials.	[Seferian, Andreea Mihaela; Moraux, Amelie; Canal, Aurelie; Decostre, Valerie; Diebate, Oumar; Le Moing, Anne Gaelle; Gidaro, Teresa; Annoussamy, Melanie; Voit, Thomas; Hogrel, Jean-Yves; Servais, Laurent] Inst Myol, Paris, France; [Le Moing, Anne Gaelle] Ctr Hosp Univ Amiens Picardie, Dept Child Neurol, Amiens, France; [Deconinck, Nicolas; Van Parys, Frauke; Vereecke, Wendy; Wittevrongel, Sylvia] Univ Ziekenhuis Gent, Neuromuscular Reference Ctr, Div Pediat Neurol & Metab, Dept Pediat, Ghent, Belgium; [Mayer, Michele; Maincent, Kim] Hop Trousseau, AP HP, Reference Ctr Neuromuscular Dis, F-75571 Paris, France; [Cuisset, Jean-Marie] CHRU Lille, Hop Roger Salengro, Dept Pediat, F-59037 Lille, France; [Tiffreau, Vincent] CHRU Lille, Hop Pierre Swynghedauw, Dept Phys Med & Rehabil, F-59037 Lille, France; [Denis, Severine; Jousten, Virginie; Servais, Laurent] Ctr Hosp Reg La Citadelle, Reference Ctr Neuromuscular Dis, Liege, Belgium; [Quijano-Roy, Susana] Ctr References Malad Neuromusculaires Garches Nec, Dept Pediat, Garches, France; [Quijano-Roy, Susana] Univ Versailles St Quentin En Yvelines, Hop Raymond Poincare, AP HP, Endicap INSERM U1179, Garches, France; [Voit, Thomas] Univ Paris 06, Format Rech Evolut 3617, Assoc Inst Myol,Unite Mixte Rech S 974, CNRS,Therapie Malad Muscle Strie Inst Myol,INSERM, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Ghent University; Ghent University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Servais, L (corresponding author), Inst Myol, Paris, France.	l.servais@institut-myologie.org	Quijano-Roy, Susana/GRF-6829-2022; Servais, Laurent/AAL-7384-2020	Hogrel, Jean-Yves/0000-0003-0045-7505; Servais, Laurent/0000-0001-9270-4061	ADNA (Advanced Diagnostics for New Therapeutic Approaches); French public agency, OSEO	ADNA (Advanced Diagnostics for New Therapeutic Approaches); French public agency, OSEO	ULENAP study was funded by ADNA (Advanced Diagnostics for New Therapeutic Approaches, http://www.institut-merieux.com/projetssante_adna.php), a program dedicated to personalized medicine, coordinated by Institut Merieux and supported by research and innovation aid from the French public agency, OSEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach Y, 2012, NEUROMUSCULAR DISORD, V22, P980, DOI 10.1016/j.nmd.2012.05.004; Andrich D, 2011, EXPERT REV PHARM OUT, V11, P571, DOI [10.1586/ERP.11.59, 10.1586/erp.11.59]; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; CARTER CT, 1995, AM J PHYS MED REHAB, V74, pS150, DOI 10.1097/00002060-199509001-00009; Chow S-C, 2008, SAMPLE SIZE CALCULAT; Farrar MA, 2013, J PEDIATR-US, V162, P155, DOI 10.1016/j.jpeds.2012.05.067; Febrer A, 2010, J REHABIL MED, V42, P228, DOI 10.2340/16501977-0507; Iannaccone ST, 2009, NEUROMUSCULAR DISORD, V19, P805, DOI 10.1016/j.nmd.2009.09.009; Ioos C, 2004, CHEST, V126, P831, DOI 10.1378/chest.126.3.831; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P93, DOI 10.1016/j.nmd.2005.11.010; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Merlini L, 2004, MUSCLE NERVE, V29, P548, DOI 10.1002/mus.20018; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Nelson L, 2006, NEUROMUSCULAR DISORD, V16, P374, DOI 10.1016/j.nmd.2006.03.005; Rudnik-Schoneborn S, 2001, EUR NEUROL, V45, P174, DOI 10.1159/000052118; RUSSMAN BS, 1990, MUSCLE NERVE, V13, pS13, DOI 10.1002/mus.880131306; Russman BS, 1996, NEUROLOGY, V47, P973, DOI 10.1212/WNL.47.4.973; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Sleigh James N, 2013, Neuromuscul Disord, V23, P96, DOI 10.1016/j.nmd.2012.08.008; Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221; Steffensen BF, 2002, DEV MED CHILD NEUROL, V44, P623; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Vuillerot C, 2013, ARCH PHYS MED REHAB, V94, P1555, DOI 10.1016/j.apmr.2013.01.014; Werlauff U, 2012, NEUROMUSCULAR DISORD, V22, P1069, DOI 10.1016/j.nmd.2012.06.352	34	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121799	10.1371/journal.pone.0121799	http://dx.doi.org/10.1371/journal.pone.0121799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861036	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300031
J	Cui, H; Wang, L; Gong, PH; Zhao, CC; Zhang, SD; Zhang, K; Zhou, RP; Zhao, ZJ; Fan, H				Cui, He; Wang, Ling; Gong, Pihai; Zhao, Chengcheng; Zhang, Shaodan; Zhang, Kun; Zhou, Rongping; Zhao, Zhujiang; Fan, Hong			Deregulation between miR-29b/c and DNMT3A Is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASE PROTEINS; CLINICAL-SIGNIFICANCE; MICRORNA; EXPRESSION; METHYLATION; FAMILY; HYPERMETHYLATION; INVOLVEMENT; PROMOTER; RISK	The de-regulation of the miR-29 family and DNA methyltransferase 3A (DNMT3A) is associated with gastric cancer (GC). While increasing evidence indicates miR-29b/c could regulate DNA methylation by targeting DNMT3A, it is currently unknown if epigenetic silencing of miR-29b/c via promoter hypermethylation in GC is caused by abnormal expression of DNMT3A. Thus, we aimed to evaluate whether cross-talk regulation exists between miR-29b/c and DNMT3A and whether it is associated with a malignant phenotype in GC. First, wound healing and Transwell assays revealed that miR-29b/c suppresses tumor metastasis in GC. A luciferase reporter assay demonstrated that DNMT3A is a direct target of miR-29b/c. We used bisulfite genomic sequencing to analyze the DNA methylation status of miR-29b/c. The percentage of methylated CpGs was significantly decreased in DNMT3A-depleted cells compared to the controls. Furthermore, the involvement of DNMT3A in promoting GC cell migration was associated with the promoter methylation-mediated repression of CDH1. In 50 paired clinical GC tissue specimens, decreased miR-29b/c was significantly correlated with the degree of differentiation and invasion of the cells and was negatively correlated with DNMT3A expression. Together, our preliminary results suggest that the following process may be involved in GC tumorigenesis. miR-29b/c suppresses the downstream gene DNMT3A, and in turn, miR-29b/c is suppressed by DNMT3A in a DNA methylation-dependent manner. The de-regulation of both of miR-29b/c and DNMT3A leads to the epigenetic silencing of CDH1 and contributes to the metastasis phenotype in GC. This finding reveals that DNA methylation-associated silencing of miR-29b/c is critical for GC development and thus may be a therapeutic target.	[Cui, He; Wang, Ling; Gong, Pihai; Zhao, Chengcheng; Zhang, Shaodan; Zhao, Zhujiang; Fan, Hong] Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China; [Zhang, Kun] Harbin Med Univ, Affiliated Hosp 3, Canc Hosp, Harbin 150081, Peoples R China; [Zhou, Rongping] Nanjing Med Univ, Affiliated Jiangning Hosp, Nanjing 210000, Jiangsu, Peoples R China	Southeast University - China; Harbin Medical University; Nanjing Medical University	Fan, H (corresponding author), Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China.	fanh@seu.edu.cn			National Natural Science Foundation of China [81171915, 91229107, 81472548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81171915, No. 91229107 and No. 81472548), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao XY, 2014, WORLD J GASTROENTERO, V20, P8201, DOI 10.3748/wjg.v20.i25.8201; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fesler A, 2014, ONCOTARGETS THER, V7, P7, DOI 10.2147/OTT.S65548; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gong JA, 2014, CARCINOGENESIS, V35, P497, DOI 10.1093/carcin/bgt337; Han L, 2007, CANCER BIOL THER, V6, P1284; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lang Nan, 2010, Chin J Cancer, V29, P603; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MAEHARA Y, 1991, SURGERY, V110, P820; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Weissmann-Brenner A, 2012, INT J ONCOL, V40, P2097, DOI 10.3892/ijo.2012.1403; Xia JZ, 2014, J CANCER RES CLIN, V140, P1451, DOI 10.1007/s00432-014-1649-8; Yang J, 2011, MOL MED REP, V4, P1139, DOI 10.3892/mmr.2011.578; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhao Z, 2010, J BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/737535, DOI 10.1155/2010/73753]	36	54	57	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123926	10.1371/journal.pone.0123926	http://dx.doi.org/10.1371/journal.pone.0123926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874772	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800125
J	Dominianni, C; Sinha, R; Goedert, JJ; Pei, ZH; Yang, LY; Hayes, RB; Ahn, JY				Dominianni, Christine; Sinha, Rashmi; Goedert, James J.; Pei, Zhiheng; Yang, Liying; Hayes, Richard B.; Ahn, Jiyoung			Sex, Body Mass Index, and Dietary Fiber Intake Influence the Human Gut Microbiome	PLOS ONE			English	Article							FECAL MICROBIOTA; INTESTINAL MICROBIOME; COLORECTAL-CANCER; OBESITY; DIVERSITY; BUTYRATE; ECOLOGY; GENDER; BIFIDOBACTERIA; DETERMINANTS	Increasing evidence suggests that the composition of the human gut microbiome is important in the etiology of human diseases; however, the personal factors that influence the gut microbiome composition are poorly characterized. Animal models point to sex hormone-related differentials in microbiome composition. In this study, we investigated the relationship of sex, body mass index (BMI) and dietary fiber intake with the gut microbiome in 82 humans. We sequenced fecal 16S rRNA genes by 454 FLX technology, then clustered and classified the reads to microbial genomes using the QIIME pipeline. Relationships of sex, BMI, and fiber intake with overall gut microbiome composition and specific taxon abundances were assessed by permutational MANOVA and multivariate logistic regression, respectively. We found that sex was associated with the gut microbiome composition overall (p=0.001). The gut microbiome in women was characterized by a lower abundance of Bacteroidetes (p=0.03). BMI (>25 kg/m(2) vs. <25 kg/m(2)) was associated with the gut microbiome composition overall (p=0.05), and this relationship was strong in women (p=0.03) but not in men (p=0.29). Fiber from beans and from fruits and vegetables were associated, respectively, with greater abundance of Actinobacteria (p=0.006 and false discovery rate adjusted q=0.05) and Clostridia (p=0.009 and false discovery rate adjusted q=0.09). Our findings suggest that sex, BMI, and dietary fiber contribute to shaping the gut microbiome in humans. Better understanding of these relationships may have significant implications for gastrointestinal health and disease prevention.	[Dominianni, Christine; Hayes, Richard B.; Ahn, Jiyoung] NYU, Sch Med, Dept Populat Hlth, New York, NY 11201 USA; [Pei, Zhiheng; Hayes, Richard B.; Ahn, Jiyoung] NYU, Perlmutter Canc Ctr, New York, NY USA; [Sinha, Rashmi; Goedert, James J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pei, Zhiheng] New York Vet Affairs Med Ctr, Dept Pathol & Lab Med, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Pei, Zhiheng; Yang, Liying] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; New York University	Ahn, JY (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 11201 USA.	Jiyoung.Ahn@nyumc.org	Sinha, Rashmi/G-7446-2015	Sinha, Rashmi/0000-0002-2466-7462; Hayes, Richard/0000-0002-0918-661X; Yang, Liying/0000-0003-1442-4915; Ahn, Jiyoung/0000-0002-2900-2304; Pei, Zhiheng/0000-0001-8570-6747	National Cancer Institute [R03CA159414, R21CA183887, R01CA159036, UH3CA140233]; National Institutes of Health Human Microbiome Project; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA159036, ZIACP010214, R21CA183887, P30CA016087, UH3CA140233, R03CA159414] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Human Microbiome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants R03CA159414, R21CA183887, R01CA159036 and UH3CA140233 from the National Cancer Institute (http://www.cancer.gov/researchandfunding) (JA) and National Institutes of Health Human Microbiome Project (http://grants.nih.gov/grants/oer.htm) and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (http://www.research.va.gov/) (ZP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benus RFJ, 2010, BRIT J NUTR, V104, P693, DOI 10.1017/S0007114510001030; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; Classification BMI, 2006, CLASSIFICATION BMI G; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LAMPE JW, 1993, GUT, V34, P531, DOI 10.1136/gut.34.4.531; Landa-Habana L, 2004, PLANT FOOD HUM NUTR, V59, P133, DOI 10.1007/s11130-004-4307-5; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lewis SJ, 1997, GUT, V41, P245, DOI 10.1136/gut.41.2.245; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Nielsen DS, 2014, FEBS LETT; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; PROBERT CSJ, 1995, QJM-MON J ASSOC PHYS, V88, P311; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; SCHIFFMAN MH, 1989, CANCER RES, V49, P1322; SCHIFFMAN MH, 1989, CANCER RES, V49, P3420; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Stipanuk M, 2013, BIOCH PHYSL MOL ASPE; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Versini M, 2014, AUTOIMMUNITY REV; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Whelan K, 2005, J NUTR, V135, P1896, DOI 10.1093/jn/135.8.1896; Willett W., 2012, NUTR EPIDEMIOLOGY; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yadav BS, 2009, INT J FOOD SCI NUTR, V60, P258, DOI 10.1080/09637480902970975; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	58	232	245	10	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124599	10.1371/journal.pone.0124599	http://dx.doi.org/10.1371/journal.pone.0124599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874569	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800147
J	Endres, RG				Endres, Robert G.			Bistability: Requirements on Cell-Volume, Protein Diffusion, and Thermodynamics	PLOS ONE			English	Article							SINGLE-MOLECULE EVENT; ESCHERICHIA-COLI; STOCHASTIC SIMULATION; CHEMICAL-REACTIONS; BACTERIAL-CELL; FLUCTUATION THEOREM; ENTROPY PRODUCTION; PHASE-TRANSITIONS; HYSTERESIS; SYSTEMS	Bistability is considered wide-spread among bacteria and eukaryotic cells, useful e.g. for enzyme induction, bet hedging, and epigenetic switching. However, this phenomenon has mostly been described with deterministic dynamic or well-mixed stochastic models. Here, we map known biological bistable systems onto the well-characterized biochemical Schlogl model, using analytical calculations and stochastic spatiotemporal simulations. In addition to network architecture and strong thermodynamic driving away from equilibrium, we show that bistability requires fine-tuning towards small cell volumes (or compartments) and fast protein diffusion (well mixing). Bistability is thus fragile and hence may be restricted to small bacteria and eukaryotic nuclei, with switching triggered by volume changes during the cell cycle. For large volumes, single cells generally loose their ability for bistable switching and instead undergo a first-order phase transition.	[Endres, Robert G.] Dept Life Sci, London, England; [Endres, Robert G.] Ctr Integrat Syst Biol & Bioinformat, London, England		Endres, RG (corresponding author), Dept Life Sci, London, England.	r.endres@imperial.ac.uk			Leverhulme- Trust [RPG-181]; European Research Council [280492-PPHPI]	Leverhulme- Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	Work was funded by Leverhulme- Trust Grant N. RPG-181 (http://www.leverhulme.ac.uk/) and European Research Council Starting-Grant N. 280492-PPHPI (http://erc.europa.eu/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ANDRESEN B, 1984, J CHEM PHYS, V81, P4676, DOI 10.1063/1.447402; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Botello E, 1998, J BACTERIOL, V180, P6364; Boulineau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061686; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Choi PJ, 2010, J MOL BIOL, V396, P230, DOI 10.1016/j.jmb.2009.11.035; Dewar RC, 2005, J PHYS A-MATH GEN, V38, pL371, DOI 10.1088/0305-4470/38/21/L01; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DYKMAN MI, 1994, J CHEM PHYS, V100, P5735, DOI 10.1063/1.467139; EBELING W, 1979, PHYSICA A, V98, P587, DOI 10.1016/0378-4371(79)90157-2; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaspard P, 2004, J CHEM PHYS, V120, P8898, DOI 10.1063/1.1688758; Ge H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glansdorf P, 1971, THERMODYNAMIC THEORY; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; HANGGI P, 1984, PHYS REV A, V29, P371, DOI 10.1103/PhysRevA.29.371; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; Hoffmann M, 2014, SOFT MATTER, V10, P2388, DOI 10.1039/c3sm52251b; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Kaizu K, 2014, BIOPHYS J, V106, P976, DOI 10.1016/j.bpj.2013.12.030; Kalwarczyk T, 2012, BIOINFORMATICS, V28, P2971, DOI 10.1093/bioinformatics/bts537; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; KURTZ TG, 1971, J APPL PROBAB, V8, P344, DOI 10.2307/3211904; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; LUO JL, 1984, Z PHYS B CON MAT, V56, P165, DOI 10.1007/BF01469698; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; NICOLIS G, 1977, PHYS LETT A, V62, P469, DOI 10.1016/0375-9601(77)90069-X; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; SAWADA Y, 1981, PROG THEOR PHYS, V66, P68, DOI 10.1143/PTP.66.68; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Schrodinger E, 1944, MALIA KOUKIA; Shimizu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023953; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Tanase-Nicola S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.040103; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Vellela M, 2007, B MATH BIOL, V69, P1727, DOI 10.1007/s11538-006-9188-3; Vellela M, 2009, J R SOC INTERFACE, V6, P925, DOI 10.1098/rsif.2008.0476; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zaritsky A, 2011, MICROBIOL-SGM, V157, P1876, DOI 10.1099/mic.0.049403-0; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96; Zuk PJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055002	64	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121681	10.1371/journal.pone.0121681	http://dx.doi.org/10.1371/journal.pone.0121681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874711	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800028
J	Shimizu, M; Li, J; Inoue, J; Sato, R				Shimizu, Makoto; Li, Juan; Inoue, Jun; Sato, Ryuichiro			Quercetin Represses Apolipoprotein B Expression by Inhibiting the Transcriptional Activity of C/EBP beta	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; GENE PROMOTER; RECEPTOR EXPRESSION; HEPG2 CELLS; ABSORPTION; SECRETION; ELEMENT; PLASMA; KINASE; BIND	Quercetin is one of the most abundant polyphenolic flavonoids found in fruits and vegetables and has anti-oxidative and anti-obesity effects. Because the small intestine is a major absorptive organ of dietary nutrients, it is likely that highly concentrated food constituents, including polyphenols, are present in the small intestinal epithelial cells, suggesting that food factors may have a profound effect in this tissue. To identify novel targets of quercetin in the intestinal enterocytes, mRNA profiling using human intestinal epithelial Caco-2 cells was performed. We found that mRNA levels of some apolipoproteins, particularly apolipoprotein B (apoB), are downregulated in the presence of quercetin. On the exposure of Caco-2 cells to quercetin, both mRNA and protein levels of apoB were decreased. Promoter analysis of the human apoB revealed that quercetin response element is localized at the 5'-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. We found that quercetin reduces the promoter activity of apoB, driven by the enforced expression of C/EBP beta. Quercetin had no effect on either mRNA or protein levels of C/EBP beta. In contrast, we found that quercetin inhibits the transcriptional activity of C/EBP beta but not its recruitment to the apoB promoter. On the exposure of Caco-2 cells to quercetin 3-O-glucuronide, which is in a cell-impermeable form, no notable change in apoB mRNA was observed, suggesting an intracellular action of quercetin. In vitro interaction experiments using quercetin-conjugated beads revealed that quercetin binds to C/EBP beta. Our results describe a novel regulatory mechanism of transcription of apolipoprotein genes by quercetin in the intestinal enterocytes.	[Shimizu, Makoto; Li, Juan; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sato, R (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Ministry of Agriculture, Forestry and Fisheries; Nestle Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) [14533567]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Nestle Research Foundation(Nestle SA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP)	This study was supported by grants for project research from the Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods), Nestle Research Foundation, and research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Dimple, 2005, BMC Cardiovasc Disord, V5, P30, DOI 10.1186/1471-2261-5-30; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Alam MM, 2014, LIFE SCI, V109, P8, DOI 10.1016/j.lfs.2014.06.005; Antes TJ, 2000, J BIOL CHEM, V275, P26637, DOI 10.1074/jbc.M003025200; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; CARLSSON P, 1990, GENE, V94, P295, DOI 10.1016/0378-1119(90)90401-C; Casaschi A, 2002, LIPIDS, V37, P647, DOI 10.1007/s11745-002-0945-8; de Vries JHM, 1998, AM J CLIN NUTR, V68, P60, DOI 10.1093/ajcn/68.1.60; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Inoue J, 2011, FEBS J, V278, P2739, DOI 10.1111/j.1742-4658.2011.08204.x; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Kanazawa K, 2006, ARCH BIOCHEM BIOPHYS, V455, P197, DOI 10.1016/j.abb.2006.09.003; KARDASSIS D, 1992, J BIOL CHEM, V267, P2622; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Luchoomun J, 1997, ARTERIOSCL THROM VAS, V17, P2955, DOI 10.1161/01.ATV.17.11.2955; METZGER S, 1990, J BIOL CHEM, V265, P9978; METZGER S, 1993, J BIOL CHEM, V268, P16831; Moon JH, 2000, AM J PHYSIOL-REG I, V279, pR461, DOI 10.1152/ajpregu.2000.279.2.R461; Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809; Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123; Pal S, 2003, J NUTR, V133, P700, DOI 10.1093/jn/133.3.700; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Takahashi M, 2008, BIOCHEM BIOPH RES CO, V372, P395, DOI 10.1016/j.bbrc.2008.04.136; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis	35	11	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121784	10.1371/journal.pone.0121784	http://dx.doi.org/10.1371/journal.pone.0121784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875015	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800029
J	Nguyen, NUN; Wang, HV				Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven			Dual Roles of Palladin Protein in In Vitro Myogenesis: Inhibition of Early Induction but Promotion of Myotube Maturation	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; ACTIN-ASSOCIATED PROTEIN; MOLECULAR REGULATION; PROGENITOR CELLS; ALPHA-ACTININ; MYOSTATIN; EXPRESSION; ORGANIZATION; CYTOSKELETON; MIGRATION	Palladin is a microfilament-associated phosphoprotein whose function in skeletal muscle has rarely been studied. Therefore, we investigate whether myogenesis is influenced by the depletion of palladin expression known to interfere with the actin cytoskeleton dynamic required for skeletal muscle differentiation. The inhibition of palladin in C2C12 myoblasts leads to precocious myogenic differentiation with a concomitant reduction in cell apoptosis. This premature myogenesis is caused, in part, by an accelerated induction of p21, myogenin, and myosin heavy chain, suggesting that palladin acts as a negative regulator in early differentiation phases. Paradoxically, palladin-knockdown myoblasts are unable to differentiate terminally, despite their ability to perform some initial steps of differentiation. Cells with attenuated palladin expression form thinner myotubes with fewer myonuclei compared to those of the control. It is noteworthy that a negative regulator of myogenesis, myostatin, is activated in palladin-deficient myotubes, suggesting the palladin- mediated impairment of late-stage myogenesis. Additionally, overexpression of 140-kDa palladin inhibits myoblast differentiation while 200-kDa and 90-kDa palladin-overexpressed cells display an enhanced differentiation rate. Together, our data suggest that palladin might have both positive and negative roles in maintaining the proper skeletal myogenic differentiation in vitro.	[Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Wang, Hao-Ven] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven] Natl Cheng Kung Univ, Ctr Cell Dynam, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, HV (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	hvwang@mail.ncku.edu.tw		Nguyen, Ngoc Uyen Nhi/0000-0003-0694-3176; Wang, Hao-Ven/0000-0001-7523-087X	Ministry of Sciences and Technology (MOST) [1022320-B-006-036]; National Cheng Kung University's Aim for the Top University Project	Ministry of Sciences and Technology (MOST); National Cheng Kung University's Aim for the Top University Project	This work was supported by grants from the Ministry of Sciences and Technology (MOST 1022320-B-006-036) and National Cheng Kung University's Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029338; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Beck MR, 2011, J MOL BIOL, V413, P712, DOI 10.1016/j.jmb.2011.08.059; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; DIAS P, 1994, SEMIN DIAGN PATHOL, V11, P3; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Johnston APW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015212; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Nguyen NUN, 2014, BIOCHEM BIOPH RES CO, V452, P728, DOI 10.1016/j.bbrc.2014.08.143; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; PATERSON B, 1972, DEV BIOL, V29, P113, DOI 10.1016/0012-1606(72)90050-4; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255; Zhang YJ, 2005, PROG BIOCHEM BIOPHYS, V32, P607; Zhou W, 2011, BIOCHEM BIOPH RES CO, V411, P768, DOI 10.1016/j.bbrc.2011.07.022	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124762	10.1371/journal.pone.0124762	http://dx.doi.org/10.1371/journal.pone.0124762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875253	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700072
J	Agrawal, P; Miryala, S; Varshney, U				Agrawal, Priyanka; Miryala, Sandeep; Varshney, Umesh			Use of Mycobacterium smegmatis Deficient in ADP-Ribosyltransferase as Surrogate for Mycobacterium tuberculosis in Drug Testing and Mutation Analysis	PLOS ONE			English	Article							DNA-DAMAGING AGENTS; RNA-POLYMERASE; RESISTANT TUBERCULOSIS; RIFAMPICIN; PROTECTION; MUTANTS; REPAIR; RIBOSYLATION; INHIBITION; EMERGENCE	Rifampicin (Rif) is a first line drug used for tuberculosis treatment. However, the emergence of drug resistant strains has necessitated synthesis and testing of newer analogs of Rif. Mycobacterium smegmatis is often used as a surrogate for M. tuberculosis. However, the presence of an ADP ribosyltransferase (Arr) in M. smegmatis inactivates Rif, rendering it impractical for screening of Rif analogs or other compounds when used in conjunction with them (Rif/Rif analogs). Rifampicin is also used in studying the role of various DNA repair enzymes by analyzing mutations in RpoB (a subunit of RNA polymerase) causing Rif resistance. These analyses use high concentrations of Rif when M. smegmatis is used as model. Here, we have generated M. smegmatis strains by deleting arr (Delta arr). The M. smegmatis Delta arr strains show minimum inhibitory concentration (MIC) for Rif which is similar to that for M. tuberculosis. The MICs for isoniazid, pyrazinamide, ethambutol, ciprofloxacin and streptomycin were essentially unaltered for M. smegmatis Delta arr. The growth profiles and mutation spectrum of Delta arr and, Delta arr combined with Delta udgB (udgB encodes a DNA repair enzyme that excises uracil) strains were similar to their counterparts wild-type for arr. However, the mutation spectrum of Delta fpg Delta arr strain differed somewhat from that of the Delta fpg strain (fpg encodes a DNA repair enzyme that excises 8-oxo-G). Our studies suggest M. smegmatis Delta arr strain as an ideal model system in drug testing and mutation spectrum determination in DNA repair studies.	[Agrawal, Priyanka; Miryala, Sandeep; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Varshney, Umesh/Q-6914-2019		Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (UV) (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007, DOI 10.1128/AAC.39.4.1007; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Dey A, 2010, MICROBIOL-SGM, V156, P873, DOI 10.1099/mic.0.033670-0; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Jain R, 2007, DNA REPAIR, V6, P1774, DOI 10.1016/j.dnarep.2007.06.009; Kurthkoti K, 2008, MICROBIOL-SGM, V154, P2776, DOI 10.1099/mic.0.2008/019638-0; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Kurthkoti K, 2010, MICROBIOL-SGM, V156, P88, DOI 10.1099/mic.0.033621-0; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Malshetty V, 2010, MICROBIOL-SGM, V156, P1565, DOI 10.1099/mic.0.036970-0; Malshetty VS, 2010, MICROBIOL-SGM, V156, P940, DOI 10.1099/mic.0.034363-0; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Mohammad A., 2013, WORLD J ORGANIC CHEM, V1, P14; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nigam A, 2014, J BIOL CHEM, V289, P21142, DOI 10.1074/jbc.M114.572636; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Sambrook J, 1989, MOL CLONING; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shiloh MU, 2010, CURR OPIN MICROBIOL, V13, P86, DOI 10.1016/j.mib.2009.11.006; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEHRLI W, 1971, BACTERIOL REV, V35, P290, DOI 10.1128/MMBR.35.3.290-309.1971	32	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122076	10.1371/journal.pone.0122076	http://dx.doi.org/10.1371/journal.pone.0122076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874691	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000352845100057
J	Bewley, KD; Dey, M; Bjork, RE; Mitra, S; Chobot, SE; Drennan, CL; Elliott, SJ				Bewley, Kathryn D.; Dey, Mishtu; Bjork, Rebekah E.; Mitra, Sangha; Chobot, Sarah E.; Drennan, Catherine L.; Elliott, Sean J.			Rheostat Re-Wired: Alternative Hypotheses for the Control of Thioredoxin Reduction Potentials	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; ESCHERICHIA-COLI THIOREDOXIN; SITE CYSTEINE RESIDUES; ACTIVE-SITE; REDOX PROPERTIES; DESTABILIZING DISULFIDE; REDUCED FORM; DSBA; BOND; IONIZATION	Thioredoxins are small soluble proteins that contain a redox-active disulfide (CXXC). These disulfides are tuned to oxidizing or reducing potentials depending on the function of the thioredoxin within the cell. The mechanism by which the potential is tuned has been controversial, with two main hypotheses: first, that redox potential (Em) is specifically governed by a molecular 'rheostat'-the XX amino acids, which influence the Cys pK(a) values, and thereby, Em; and second, the overall thermodynamics of protein folding stability regulates the potential. Here, we use protein film voltammetry (PFV) to measure the pH dependence of the redox potentials of a series of wild-type and mutant archaeal Trxs, PFV and glutathionine-equilibrium to corroborate the measured potentials, the fluorescence probe BADAN to measure pKa values, guanidinium-based denaturation to measure protein unfolding, and X-ray crystallography to provide a structural basis for our functional analyses. We find that when these archaeal thioredoxins are probed directly using PFV, both the high and low potential thioredoxins display consistent 2H(+):2e-coupling over a physiological pH range, in conflict with the conventional 'rheostat' model. Instead, folding measurements reveals an excellent correlation to reduction potentials, supporting the second hypothesis and revealing the molecular mechanism of reduction potential control in the ubiquitous Trx family.	[Bewley, Kathryn D.; Mitra, Sangha; Chobot, Sarah E.; Elliott, Sean J.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Dey, Mishtu; Bjork, Rebekah E.; Drennan, Catherine L.] Howard Hughes Med Inst, Cambridge, MA USA; [Dey, Mishtu; Bjork, Rebekah E.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA USA	Boston University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Elliott, SJ (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	elliott@bu.edu		Hokanson, Sarah Chobot/0000-0002-7348-4312; Elliott, Sean/0000-0003-0096-9551	National Science Foundation [MCB 1122977]; Smith Family New Investigator Award; Boston University Undergraduate Research Opportunities Program; Direct For Biological Sciences [1122977] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smith Family New Investigator Award; Boston University Undergraduate Research Opportunities Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (MCB 1122977), a Smith Family New Investigator Award (SJE) and the Boston University Undergraduate Research Opportunities Program (SEC). CLD is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chobot S. E., 2007, ANGEW CHEM INT EDIT, V119, P4223; Clark W. M., 1960, OXIDATION REDUCTION; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Dawson RMC., 1989, DATA BIOCH RES; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Hamill MJ, 2008, BIOCHEMISTRY-US, V47, P9738, DOI 10.1021/bi800676g; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Hiniker A, 2003, BIOCHEMISTRY-US, V42, P1179, DOI 10.1021/bi027141t; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jacobi A, 1997, J BIOL CHEM, V272, P21692, DOI 10.1074/jbc.272.35.21692; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122466	10.1371/journal.pone.0122466	http://dx.doi.org/10.1371/journal.pone.0122466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874934	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100074
J	Da Guan, W; Gong, XY; Mok, CKP; Chen, TT; Wu, SG; Pan, SH; Cowling, BJ; Yang, ZF; Chen, DH				Da Guan, Wen; Gong, Xiao Yan; Mok, Chris Ka Pun; Chen, Ting Ting; Wu, Shi Guan; Pan, Si Hua; Cowling, Benjamin John; Yang, Zi Feng; Chen, De Hui			Surveillance for Seasonal Influenza Virus Prevalence in Hospitalized Children with Lower Respiratory Tract Infection in Guangzhou, China during the Post-Pandemic Era	PLOS ONE			English	Article							PNEUMONIA; H1N1	Background Influenza A(H1N1)pdm09, A(H3N2) and B viruses have co-circulated in the human population since the swine-origin human H1N1 pandemic in 2009. While infections of these subtypes generally cause mild illnesses, lower respiratory tract infection (LRTI) occurs in a portion of children and required hospitalization. The aim of our study was to estimate the prevalence of these three subtypes and compare the clinical manifestations in hospitalized children with LRTI in Guangzhou, China during the post-pandemic period. Methods Children hospitalized with LRTI from January 2010 to December 2012 were tested for influenza A/B virus infection from their throat swab specimens using real-time PCR and the clinical features of the positive cases were analyzed. Results Of 3637 hospitalized children, 216 (5.9%) were identified as influenza A or B positive. Infection of influenza virus peaked around March in Guangzhou each year from 2010 to 2012, and there were distinct epidemics of each subtype. Influenza A(H3N2) infection was more frequently detected than A(H1N1)pdm09 and B, overall. The mean age of children with influenza A virus (H1N1/H3N2) infection was younger than those with influenza B (34.4 months/32.5 months versus 45 months old; p < 0.005). Co-infections of influenza A/B with mycoplasma pneumoniae were found in 44/216 (20.3%) children. Conclusions This study contributes the understanding to the prevalence of seasonal influenza viruses in hospitalized children with LRTI in Guangzhou, China during the post pandemic period. High rate of mycoplasma pneumoniae co-infection with influenza viruses might contribute to severe disease in the hospitalized children.	[Da Guan, Wen; Chen, Ting Ting; Wu, Shi Guan; Pan, Si Hua; Yang, Zi Feng; Chen, De Hui] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Gong, Xiao Yan; Chen, De Hui] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Mok, Chris Ka Pun] Univ Hong Kong, HKU Li Ka Shing Fac Med, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Mok, Chris Ka Pun] Univ Hong Kong, HKU Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin John] Univ Hong Kong, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, ZF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	jeffyah@163.com; cdh84@126.com	Cowling, Benjamin John/C-4263-2009; Mok, Chris Ka Pun/ABD-2667-2021	Cowling, Benjamin John/0000-0002-6297-7154; Mok, Chris Ka Pun/0000-0002-0525-6772	Municipal Science and Technology Bureau Foundation of Guangzhou [2014Y2-00031]; Emergency Response Project of Ministry of Science and Technology of China [KJYJ-2013-01-05]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX10004006]; University Grants Committee, Hong Kong [AoE/M-12/06]	Municipal Science and Technology Bureau Foundation of Guangzhou; Emergency Response Project of Ministry of Science and Technology of China; National Science and Technology Major Project of the Ministry of Science and Technology of China; University Grants Committee, Hong Kong	This study was financially supported by Municipal Science and Technology Bureau Foundation of Guangzhou (Grant no. Grant no. 2014Y2-00031), Emergency Response Project of Ministry of Science and Technology of China (Grant no. KJYJ-2013-01-05), National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant no. 2014ZX10004006). CKPM and BC were supported by funding by grant AoE/M-12/06 from the University Grants Committee, Hong Kong.	Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Centers for Disease Control and Prevention (CDC), 2009, CDC PROT REAL TIM RT; Chiu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021837; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cowling BJ, 2014, VACCINE; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Dangi T, 2014, INDIAN J MED RES, V139, P418; Dhanoa A, 2009, VIROL J, V8, P1; Eurosurveillance Editorial Team, 2010, EURO SURVEILL, V15; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; Kashyap S, 2010, LUNG INDIA, V27, P75, DOI 10.4103/0970-2113.63611; Lin JY, 2013, J THORAC DIS, V5, pS109, DOI 10.3978/j.issn.2072-1439.2013.08.09; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Liu CL, 2010, CHINESE MED J-PEKING, V123, P3444, DOI 10.3760/cma.j.issn.0366-6999.2010.23.013; Le MN, 2014, INFLUENZA OTHER RESP, V8, P389, DOI 10.1111/irv.12244; Peltola V, 2003, CLIN INFECT DIS, V36, P299, DOI 10.1086/345909; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Shen CF, 2008, J MICROBIOL IMMUNOL, V41, P294; Stripeli F, 2013, PAEDIAT INT CHILD HL; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; Wong JY, 2013, EPIDEMIOLOGY, V24, P830, DOI 10.1097/EDE.0b013e3182a67448; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205	24	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120983	10.1371/journal.pone.0120983	http://dx.doi.org/10.1371/journal.pone.0120983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867910	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100030
J	Kim, HL; Jin, KN; Seo, JB; Choi, YH; Chung, WY; Kim, SH; Kim, MA; Zo, JH				Kim, Hack-Lyoung; Jin, Kwang Nam; Seo, Jae-Bin; Choi, Young Ho; Chung, Woo-Young; Kim, Sang-Hyun; Kim, Myung-A; Zo, Joo-Hee			The Association of Brachial-Ankle Pulse Wave Velocity with Coronary Artery Disease Evaluated by Coronary Computed Tomography Angiography	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR EVENTS; INDEPENDENT PREDICTOR; PROGNOSTIC VALUE; CT ANGIOGRAPHY; STIFFNESS; PLAQUE; SEVERITY; CALCIUM; INDEX	The aim of this study was to investigate whether brachial-ankle pulse wave velocity (baPWV) is associated with the severity of coronary artery disease (CAD) assessed by coronary computed tomography angiography (CCTA), and to evaluate baPWV as a predictor of obstructive CAD on CCTA. A total of 470 patients who underwent both baPWV and CCTA were included. We evaluated stenosis degree and plaque characteristics on CCTA. To estimate the severity of CAD, we calculated the number of segment with plaque (segment involvement score; SIS), stenosis degree-weighted plaque score (segment stenosis score; SSS), and coronary artery calcium score (CACS). The mean baPWV was 1,485 +/- 315 cm/s (range, 935-3,175 cm/s). Non-obstructive (stenosis < 50%) and obstructive (stenosis >= 50%) CAD was found in 129 patients (27.4%) and 144 (30.6%), respectively. baPWV in patients with obstructive CAD was higher than that of patients with non-obstructive (1,680 +/- 396 cm/s versus 1,477 +/- 244 cm/s, P < 0.001) or no CAD (1,680 +/- 396 cm/s versus +/- 196 1,389 cm/s, P < 0.001). baPWV showed significant correlation with SSS (r = 0.429, P < 0.001), SIS (r = 0.395, P < 0.001), CACS (r 0.346, P < 0.001), and the number of segment with non-calcified plaque (r 0.092, P = 0.047), mixed plaque (r = 0.267, P < 0.001), and calcified plaque (r = 0.348, P < 0.001), respectively. The optimal baPWV cut-off value for the detection of obstructive CAD was 1,547 cm/s. baPWV >= 1,547 cm/s was independent predictor for the obstructive CAD. In conclusion, baPWV is well correlated with the severity of CAD evaluated by CCTA. baPWV has the potential to predict severity of coronary artery atherosclerosis.	[Kim, Hack-Lyoung; Seo, Jae-Bin; Chung, Woo-Young; Kim, Sang-Hyun; Kim, Myung-A; Zo, Joo-Hee] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Jin, Kwang Nam; Choi, Young Ho] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Zo, JH (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea.	jooheezo@hanmail.net	Kim, Hack-Lyoung/AAL-5038-2020; Stefanadis, Christodoulos/ABH-2232-2020	Kim, Hack-Lyoung/0000-0002-6703-1472; Stefanadis, Christodoulos/0000-0001-5974-6454; Kim, Sang-Hyun/0000-0001-8026-1582				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Austen W G, 1975, Circulation, V51, P5; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cecelja M, 2011, J AM COLL CARDIOL, V57, P1480, DOI 10.1016/j.jacc.2010.09.079; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; FARRAR DJ, 1991, CIRCULATION, V83, P1754, DOI 10.1161/01.CIR.83.5.1754; Gao DF, 2011, ATHEROSCLEROSIS, V219, P603, DOI 10.1016/j.atherosclerosis.2011.08.022; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hoffmann U, 2006, CIRCULATION, V114, P2251, DOI 10.1161/CIRCULATIONAHA.106.634808; Hope SA, 2007, J HYPERTENS, V25, P2105, DOI 10.1097/HJH.0b013e3282a9be41; Imanishi R, 2004, HYPERTENS RES, V27, P71, DOI 10.1291/hypres.27.71; Kim HL, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-2; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Leung MCH, 2006, AM J PHYSIOL-HEART C, V290, pH624, DOI 10.1152/ajpheart.00380.2005; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126; Nakazato R, 2012, ATHEROSCLEROSIS, V225, P148, DOI 10.1016/j.atherosclerosis.2012.08.002; Nam HJ, 2012, INT J CARDIOL, V157, P227, DOI 10.1016/j.ijcard.2011.01.045; Nance JW, 2012, RADIOLOGY, V264, P679, DOI 10.1148/radiol.12112350; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Pundziute G, 2008, JACC-CARDIOVASC INTE, V1, P176, DOI 10.1016/j.jcin.2008.01.007; Schroeder S, 2001, J AM COLL CARDIOL, V37, P1430, DOI 10.1016/S0735-1097(01)01115-9; Seo Won-Woo, 2010, Korean Circ J, V40, P224, DOI 10.4070/kcj.2010.40.5.224; Shmilovich H, 2011, ATHEROSCLEROSIS, V219, P588, DOI 10.1016/j.atherosclerosis.2011.07.128; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Waddell TK, 2001, HYPERTENSION, V38, P927, DOI 10.1161/hy1001.096107; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1; Xiong ZJ, 2012, J ATHEROSCLER THROMB, V19, P970, DOI 10.5551/jat.13326; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Zureik M, 2003, HYPERTENSION, V41, P519, DOI 10.1161/01.HYP.0000054978.86286.92; 한승환, 2004, Korean Circulation Journal, V34, P468	45	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123164	10.1371/journal.pone.0123164	http://dx.doi.org/10.1371/journal.pone.0123164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875036	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100143
J	Laurent, A; Calabrese, M; Warnatz, HJ; Yaspo, ML; Tkachuk, V; Torres, M; Blasi, F; Penkov, D				Laurent, Audrey; Calabrese, Manuela; Warnatz, Hans-Joerg; Yaspo, Marie-Laure; Tkachuk, Vsevolod; Torres, Miguel; Blasi, Francesco; Penkov, Dmitry			ChIP-Seq and RNA-Seq Analyses Identify Components of the Wnt and Fgf Signaling Pathways as Prep1 Target Genes in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; HOX PROTEIN; PBX; DNA; COMPLEX; PKNOX1; DIFFERENTIATION; EMBRYOGENESIS; PLURIPOTENT; EXPRESSION	The Prep1 (Pknox1) homeodomain transcription factor is essential at multiple stages of embryo development. In the E11.5 embryo trunk, we previously estimated that Prep1 binds about 3,300 genomic sites at a highly specific decameric consensus sequence, mainly governing basal cellular functions. We now show that in embryonic stem (ES) cells Prep1 binding pattern only partly overlaps that of the embryo trunk, with about 2,000 novel sites. Moreover, in ES cells Prep1 still binds mostly to promoters, as in total embryo trunk but, among the peaks bound exclusively in ES cells, the percentage of enhancers was threefold higher. RNA-seq identifies about 1800 genes down-regulated in Prep1(-/-) ES cells which belong to gene ontology categories not enriched in the E11.5 Prep1(i/i) differentiated embryo, including in particular essential components of the Wnt and Fgf pathways. These data agree with aberrant Wnt and Fgf expression levels in the Prep1(-/-) ES cells with a deficient embryoid bodies (EBs) formation and differentiation. Re-establishment of the Prep1 level rescues the phenotype.	[Laurent, Audrey; Calabrese, Manuela; Blasi, Francesco; Penkov, Dmitry] IFOM FIRC Inst Mol Oncol, Milan, Italy; [Warnatz, Hans-Joerg; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Tkachuk, Vsevolod] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia; [Torres, Miguel] CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Penkov, Dmitry] Russian Cardiol Res & Prod Complex, Dept Expt Cardiol, Moscow, Russia	IFOM - FIRC Institute of Molecular Oncology; Max Planck Society; Lomonosov Moscow State University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); National Medical Research Center of Cardiology	Blasi, F (corresponding author), IFOM FIRC Inst Mol Oncol, IFOM IEO Campus, Milan, Italy.	francesco.blasi@ifom.eu; dmitry.penkov@ifom.eu	Torres, Miguel/CAG-0003-2022; Tkachuk, Vsevolod/AAE-1136-2022; Torres, Miguel/A-7388-2013; Tkachuk, Vsevolod A/J-9357-2012	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767; Warnatz, Hans-Jorg/0000-0002-0327-9209; Blasi, Francesco/0000-0001-9406-1784; LAURENT, Audrey/0000-0002-7643-6017	FUV (Fondazione Umberto Veronesi); AIRC (Italian Association for Cancer Research) [BM0805]; Cariplo Foundation; Italian Ministry of Health; Max Planck Society (Munich, Germany); European Commission (FP6, grant AnEUploidy) [LSHG-CT-2006-037627]; Spanish Ministerio de Economia y Competitividad [BFU2012-31086]; Russian Foundation for Basic Research [12-04-01659-a]; Russian Research Foundation Grant [14-24-00086]	FUV (Fondazione Umberto Veronesi)(Fondazione Umberto Veronesi); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Max Planck Society (Munich, Germany)(Max Planck Society); European Commission (FP6, grant AnEUploidy); Spanish Ministerio de Economia y Competitividad(Spanish Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Research Foundation Grant	Without the support of COST BM0805 action and the ensuing inter-laboratory exchanges, this work would have not been possible. AL was supported by a fellowship of FUV (Fondazione Umberto Veronesi). FB was supported by AIRC (Italian Association for Cancer Research, grant n. BM0805), Cariplo Foundation and Italian Ministry of Health. JIW and MLY were supported by the Max Planck Society (Munich, Germany) and the European Commission under its sixth Framework Programme (FP6, grant AnEUploidy [LSHG-CT-2006-037627]). Work in MT laboratory was supported by grant BFU2012-31086 from the Spanish Ministerio de Economia y Competitividad. DP was funded from the Russian Foundation for Basic Research (12-04-01659-a); VT was supported by Russian Research Foundation Grant (project 14-24-00086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chen CCG, 2013, DEVELOPMENT, V140, P719, DOI 10.1242/dev.083741; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Longobardi E, 2003, J BIOL CHEM, V278, P39235, DOI 10.1074/jbc.M304704200; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modica L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107916; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122518	10.1371/journal.pone.0122518	http://dx.doi.org/10.1371/journal.pone.0122518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875616	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100080
J	Li, C; Wu, AC; Go, RM; Malouf, J; Turner, MS; Malde, AK; Mark, AE; Gilbert, RG				Li, Cheng; Wu, Alex Chi; Go, Rob Marc; Malouf, Jacob; Turner, Mark S.; Malde, Alpeshkumar K.; Mark, Alan E.; Gilbert, Robert G.			The Characterization of Modified Starch Branching Enzymes: Toward the Control of Starch Chain-Length Distributions	PLOS ONE			English	Article							SLOWLY DIGESTIBLE STARCH; ALPHA-AMYLASE; CRYSTAL-STRUCTURE; CYCLODEXTRIN GLYCOSYLTRANSFERASE; I BEI; RICE; AMYLOSE; ENDOSPERM; GLYCOGEN; BIOSYNTHESIS	Starch is a complex branched glucose polymer whose branch molecular weight distribution (the chain-length distribution, CLD) influences nutritionally important properties such as digestion rate. Chain-stopping in starch biosynthesis is by starch branching enzyme (SBE). Site-directed mutagenesis was used to modify SBEIIa from Zea mays (mSBEIIa) to produce mutants, each differing in a single conserved amino-acid residue. Products at different times from in vitro branching were debranched and the time evolution of the CLD measured by size-exclusion chromatography. The results confirm that Tyr352, Glu513, and Ser349 are important for mSBEIIa activity while Arg456 is important for determining the position at which the linear glucan is cut. The mutant mSBEIIa enzymes have different activities and suggest the length of the transferred chain can be varied by mutation. The work shows analysis of the molecular weight distribution can yield information regarding the enzyme branching sites useful for development of plants yielding starch with improved functionality.	[Li, Cheng; Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Li, Cheng; Wu, Alex Chi; Go, Rob Marc; Malouf, Jacob; Turner, Mark S.; Gilbert, Robert G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Turner, Mark S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Malde, Alpeshkumar K.; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	Huazhong University of Science & Technology; University of Queensland; University of Queensland; University of Queensland	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China.	b.gilbert@uq.edu.au	MALDE, Alpesh/A-5341-2010; Mark, Alan E/A-8799-2011; Wu, Alex/C-3513-2017; Gilbert, Robert G/C-5660-2009	MALDE, Alpesh/0000-0002-8181-1619; Mark, Alan E/0000-0001-5880-4798; Wu, Alex/0000-0002-6612-7691; Gilbert, Robert G/0000-0001-6988-114X; Turner, Mark/0000-0003-2770-852X	1000-Talents Program of the Chinese Foreign Experts Bureau; Australian Research Council [DP130102153]	1000-Talents Program of the Chinese Foreign Experts Bureau; Australian Research Council(Australian Research Council)	This work was supported by the 1000-Talents Program of the Chinese Foreign Experts Bureau (www.1000plan.org) to RGG and the Australian Research Council (www.arc.gov.au) DP130102153 to AEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; BYRNES SE, 1995, J NUTR, V125, P1430; Cao HP, 1996, J PROTEIN CHEM, V15, P291, DOI 10.1007/BF01887118; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Castro J, 2005, LAT TRADE, V13, P6; Cave RA, 2009, BIOMACROMOLECULES, V10, P2245, DOI 10.1021/bm900426n; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; DEDECKERE EAM, 1995, BRIT J NUTR, V73, P287, DOI 10.1079/BJN19950030; Ferguson LR, 2000, NUTR CANCER, V36, P230, DOI 10.1207/S15327914NC3602_13; Flipse E, 1996, PLANTA, V198, P340, DOI 10.1007/BF00620049; Gilbert RG, 2011, ANAL BIOANAL CHEM, V399, P1425, DOI 10.1007/s00216-010-4435-8; Goncalves P, 2013, CURR DRUG METAB, V14, P994; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hasjim J, 2010, BIOMACROMOLECULES, V11, P3600, DOI 10.1021/bm101053y; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Hernandez JM, 2008, BIOMACROMOLECULES, V9, P954, DOI 10.1021/bm701213p; Jenkins DJA, 1998, J AM COLL NUTR, V17, P609, DOI 10.1080/07315724.1998.10718810; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Johnston KL, 2010, DIABETIC MED, V27, P391, DOI 10.1111/j.1464-5491.2010.02923.x; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar V, 2010, CARBOHYD RES, V345, P893, DOI 10.1016/j.carres.2010.02.007; Kuriki T, 1996, J PROTEIN CHEM, V15, P305, DOI 10.1007/BF01887119; Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999; Lehmann U, 2007, TRENDS FOOD SCI TECH, V18, P346, DOI 10.1016/j.tifs.2007.02.009; Libessart N, 1998, ARCH BIOCHEM BIOPHYS, V360, P135, DOI 10.1006/abbi.1998.0960; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mikkelsen R, 2001, ARCH BIOCHEM BIOPHYS, V385, P372, DOI 10.1006/abbi.2000.2164; Nakamura Y., 2011, Journal of Applied Glycoscience, V58, P119, DOI 10.5458/jag.jag.JAG-2010_015; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Regina A, 2010, J EXP BOT, V61, P1469, DOI 10.1093/jxb/erq011; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schrodinger L.L.C., 2009, PYMOL MOL GRAPHICS S; Sestili F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-144; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vilaplana F, 2010, J SEP SCI, V33, P3537, DOI 10.1002/jssc.201000525; Witt T, 2010, J AGR FOOD CHEM, V58, P8444, DOI 10.1021/jf101063m; Wu AC, 2014, CARBOHYD POLYM, V114, P36, DOI 10.1016/j.carbpol.2014.08.001; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang G, 2008, J AGR FOOD CHEM, V56, P4686, DOI 10.1021/jf072822m	69	27	28	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125507	10.1371/journal.pone.0125507	http://dx.doi.org/10.1371/journal.pone.0125507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874689	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100298
J	Maki, K; Nagai, K; Suzuki, M; Inomata, T; Yoshida, T; Nishimura, M				Maki, Kanako; Nagai, Katsura; Suzuki, Masaru; Inomata, Takashi; Yoshida, Takayuki; Nishimura, Masaharu			Temporal Changes in Glutaredoxin 1 and Protein S-Glutathionylation in Allergic Airway Inflammation	PLOS ONE			English	Article							FACTOR-KAPPA-B; QUANTITATIVE-DETERMINATION; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; REDOX CONTROL; MOUSE MODEL; MODULATION; ACTIVATION; MICE	Introduction Asthma is a chronic inflammatory disorder of the airways, involving oxidative stress. Upon oxidative stress, glutathione covalently binds to protein thiols to protect them against irreversible oxidation. This posttranslational modification, known as protein S-glutathionylation, can be reversed by glutaredoxin 1 (Glrx1) under physiological condition. Glrx1 is known to increase in the lung tissues of a murine model of allergic airway inflammation. However, the temporal relationship between levels of Glrx1, protein S-glutathionylation, and glutathione in the lungs with allergic airway inflammation is not clearly understood. Methods BALB/c mice received 3 aerosol challenges with ovalbumin (OVA) following sensitization to OVA. They were sacrificed at 6, 24, 48, or 72 h, or 8 days (5 mice per group), and the levels of Glrx1, protein S-glutathionylation, glutathione, and 25 cytokines/chemokines were evaluated in bronchoalveolar lavage fluid (BALF) and/or lung tissue. Results Levels of Glrx1 in BALF were significantly elevated in the OVA 6 h (final challenge) group compared to those in the control, with concurrent increases in protein S-glutathionylation levels in the lungs, as well as total glutathione (reduced and oxidized) and oxidized glutathione in BALF. Protein S-glutathionylation levels were attenuated at 24 h, with significant increases in Glrx1 levels in lung tissues at 48 and 72 h. Glrx1 in alveolar macrophages was induced after 6 h. Glrx1 levels concomitantly increased with Th2/NF-kappa B-related cytokines and chemokines in BALF. Conclusions The temporal relationships of Glrx1 with protein S-glutathionylation, glutathione, and cytokines/chemokines were observed as dynamic changes in lungs with allergic airway inflammation, suggesting that Glrx1 and protein-SSG redox status may play important roles in the development of allergic airway inflammation.	[Maki, Kanako; Nagai, Katsura; Suzuki, Masaru; Inomata, Takashi; Yoshida, Takayuki; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan	Hokkaido University	Nagai, K (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan.	katnagai@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012; Nishimura, Masaharu/A-4062-2012	Suzuki, Masaru/0000-0002-2124-6793; Nishimura, Masaharu/0000-0002-6456-4361	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461181]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A scientific research grant was obtained from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25461181) http://www.mext.go.jp/english/.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; Aesif SW, 2009, AM J PATHOL, V175, P36, DOI 10.2353/ajpath.2009.080736; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Fitzpatrick AM, 2012, ANTIOXID REDOX SIGN, V17, P375, DOI 10.1089/ars.2011.4198; Hoffman SM, 2012, AM J PHYSIOL-LUNG C, V303, pL528, DOI 10.1152/ajplung.00167.2012; Ito W, 2008, INT ARCH ALLERGY IMM, V145, P324, DOI 10.1159/000110891; Kanda M, 2006, J BIOL CHEM, V281, P28518, DOI 10.1074/jbc.M604359200; Kuipers I, 2013, EUR RESPIR J, V41, P469, DOI 10.1183/09031936.00115212; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Park CS, 2009, ANN ALLERG ASTHMA IM, V103, P238, DOI 10.1016/S1081-1206(10)60188-3; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Reynaert NL, 2011, BBA-GEN SUBJECTS, V1810, P1045, DOI 10.1016/j.bbagen.2011.01.010; Reynaert NL, 2006, BBA-GEN SUBJECTS, V1760, P380, DOI 10.1016/j.bbagen.2006.01.006; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Shimizu K, 2012, CLIN EXP ALLERGY, V42, P1273, DOI 10.1111/j.1365-2222.2012.04007.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122986	10.1371/journal.pone.0122986	http://dx.doi.org/10.1371/journal.pone.0122986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874776	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100123
J	Schnoor, T; Bruun, HH; Olsson, PA				Schnoor, Tim; Bruun, Hans Henrik; Olsson, Pal Axel			Soil Disturbance as a Grassland Restoration Measure-Effects on Plant Species Composition and Plant Functional Traits	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; LAND-USE; DIVERSITY; COMMUNITIES; CONSERVATION; BIODIVERSITY; RICHNESS; CONVERGENCE; DIVERGENCE; MANAGEMENT	Soil disturbance is recognized as an important driver of biodiversity in dry grasslands, and can therefore be implemented as a restoration measure. However, because community re-assembly following disturbance includes stochastic processes, a focus only on species richness or establishment success of particular species will not inform on how plant communities respond ecologically to disturbance. We therefore evaluated vegetation development following disturbance by quantifying species richness, species composition and functional trait composition. Degraded calcareous sandy grassland was subjected to experimental disturbance treatments (ploughing or rotavation), and the vegetation was surveyed during four subsequent years of succession. Treated plots were compared with control plots representing untreated grassland, as well as nearby plots characterized by plant communities representing the restoration target. Species richness and functional diversity both increased in response to soil disturbance, and rotavation, but not ploughing, had a persistent positive effect on the occurrence of specialist species of calcareous sandy grassland. However, no type of soil disturbance caused the plant species composition to develop towards the target vegetation. The disturbance had an immediate and large impact on the vegetation, but the vegetation developed rapidly back towards the control sites. Plant functional composition analysis indicated that the treatments created habitats different both from control sites and target sites. Community-weighted mean Ellenberg indicator values suggested that the observed plant community response was at least partially due to an increase in nitrogen and water availability following disturbance. This study shows that a mild type of disturbance, such as rotavation, may be most successful in promoting specialist species in calcareous sandy grassland, but that further treatments are needed to reduce nutrient availability. We conclude that a functional trait based analysis provides additional information of the vegetation response and the abiotic conditions created, complementing the information from the species composition.	[Schnoor, Tim; Olsson, Pal Axel] Lund Univ, Dept Biol, Biodivers, SE-22362 Lund, Sweden; [Bruun, Hans Henrik] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark	Lund University; University of Copenhagen	Olsson, PA (corresponding author), Lund Univ, Dept Biol, Biodivers, Ecol Bldg, SE-22362 Lund, Sweden.	pal_axel.olsson@biol.lu.se	Bruun, Hans Henrik/C-4476-2008	Bruun, Hans Henrik/0000-0003-0674-2577	Swedish research council FORMAS; Swedish Research Council	Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish research council FORMAS and The Swedish Research Council. HHB thanks the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON O., 1950, Botaniska Notiser, P145; Ansquer P, 2009, ANN BOT-LONDON, V103, P117, DOI 10.1093/aob/mcn215; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bossuyt B, 2006, J ENVIRON MANAGE, V79, P364, DOI 10.1016/j.jenvman.2005.08.005; Brown GG, 2009, PESQUI AGROPECU BRAS, V44, pI, DOI 10.1590/S0100-204X2009000800001; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; Callaway JC, 2003, ECOL APPL, V13, P1626, DOI 10.1890/02-5144; Cingolani AM, 2007, J VEG SCI, V18, P911, DOI 10.1111/j.1654-1103.2007.tb02607.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Dupre C, 2001, ECOGRAPHY, V24, P275, DOI 10.1034/j.1600-0587.2001.240305.x; Eichberg C, 2010, APPL VEG SCI, V13, P425, DOI 10.1111/j.1654-109X.2010.01082.x; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Ellenberg H., 1991, SCRIPTA GEOBOT, V18; Emanuelsson U., 2002, SKANSKA KULTURLANDSK; Faust C, 2011, FLORA, V206, P611, DOI 10.1016/j.flora.2010.09.013; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardenfors U., 2010, RED LIST SWEDISH SPE; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; Hill M, 1999, ECOFACT RES REPORT B, V2b; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Johansson LJ, 2008, LANDSCAPE URBAN PLAN, V84, P200, DOI 10.1016/j.landurbplan.2007.08.001; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Kent Martin, 2003, Botanical Journal of Scotland, V55, P161; Kew Royal Botanic Gardens, 2008, SEED INFORM DATABASE; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kleyer M, 1999, J VEG SCI, V10, P697, DOI 10.2307/3237084; Knevel I.C., 2005, LEDA TRAITBASE COLLE; Laliberte E, 2010, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lansstyrelsen Skane, 2005, CONS PLAN RINK SKJ N; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Martensson LM, 2010, PLANT ECOL, V206, P127, DOI 10.1007/s11258-009-9629-9; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Murray BR, 1999, ECOLOGY, V80, P1806, DOI 10.1890/0012-9658(1999)080[1806:SITTOR]2.0.CO;2; Odman AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090998; Odman AM, 2012, BIODIVERS CONSERV, V21, P1921, DOI 10.1007/s10531-012-0292-4; Odman AM, 2011, BIODIVERS CONSERV, V20, P3039, DOI 10.1007/s10531-011-0108-y; Olsson K-A, 1994, LUNDS BOT FORENING M, V2, P4; Olsson PA, 2014, J INSECT CONSERV, V18, P827, DOI 10.1007/s10841-014-9689-6; Olsson PA, 2014, RESTOR ECOL, V22, P49, DOI 10.1111/rec.12024; Olsson PA, 2009, APPL VEG SCI, V12, P350, DOI 10.1111/j.1654-109X.2009.01029.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Pokorny ML, 2005, RESTOR ECOL, V13, P448, DOI 10.1111/j.1526-100X.2005.00056.x; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Raunkiaer C., 1905, OVERSIGT KONGELIGE D, V1905, P347; Rehounkova K, 2008, RESTOR ECOL, V16, P305, DOI 10.1111/j.1526-100X.2007.00316.x; Rodwell JS, 2002, DVERSITY EUROPEAN VE; Romermann C, 2009, J VEG SCI, V20, P1086, DOI 10.1111/j.1654-1103.2009.01106.x; Sasaki T, 2009, ECOLOGY, V90, P2598, DOI 10.1890/08-1850.1; Schnoor TK, 2010, AGR ECOSYST ENVIRON, V139, P714, DOI 10.1016/j.agee.2010.10.018; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonnier G, 2010, J VEG SCI, V21, P1014, DOI 10.1111/j.1654-1103.2010.01210.x; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Tyler Torbjorn, 2003, Botaniska Notiser, V136, P1; Tyler Torbjorn, 2005, Lindbergia, V30, P11; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITTAKER R H, 1975, P385; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	74	15	18	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123698	10.1371/journal.pone.0123698	http://dx.doi.org/10.1371/journal.pone.0123698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875745	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100200
J	Zhornitsky, S; Greenfield, J; Koch, MW; Patten, SB; Harris, C; Wall, W; Alikhani, K; Burton, J; Busche, K; Costello, F; Davenport, JW; Jarvis, SE; Lavarato, D; Parpal, H; Patry, DG; Yeung, M; Metz, LM				Zhornitsky, Simon; Greenfield, Jamie; Koch, Marcus W.; Patten, Scott B.; Harris, Colleen; Wall, Winona; Alikhani, Katayoun; Burton, Jodie; Busche, Kevin; Costello, Fiona; Davenport, Jeptha W.; Jarvis, Scott E.; Lavarato, Dina; Parpal, Helene; Patry, David G.; Yeung, Michael; Metz, Luanne M.			Long-Term Persistence with Injectable Therapy in Relapsing-Remitting Multiple Sclerosis: An 18-Year Observational Cohort Study	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; INTERFERON-BETA THERAPY; RRMS PATIENTS; ADHERENCE; DATABASE; STATIN; DRUGS	Disease modifying therapies (DMTs) reduce the frequency of relapses and accumulation of disability in multiple sclerosis (MS). Long-term persistence with treatment is important to optimize treatment benefit. This long-term, cohort study was conducted at the Calgary MS Clinic. All consenting adults with relapsing-remitting MS who started either glatiramer acetate (GA) or interferon-beta 1a/1b (IFN-beta) between January 1st, 1996 and July 1st, 2011 were included. Follow-up continued to February 1st, 2014. Time-to-discontinuation of the initial and subsequently-prescribed DMTs (switches) was analysed using Kaplan-Meier survival analyses. Group differences were compared using log-rank tests and multivariable Cox regression models. Analysis included 1471 participants; 906 were initially prescribed GA and 565 were initially prescribed IFN-beta. Follow-up information was available for 87%; 29 (2%) were lost to follow-up and 160 (11%) moved from Southern Alberta while still using DMT. Median time-to-discontinuation of all injectable DMTs was 11.1 years. Participants with greater disability at treatment initiation, those who started treatment before age 30, and those who started between 2006 and 2011 were more likely to discontinue use of all injectable DMTs. Median time-to-discontinuation of the initial DMT was 8.6 years. Those initially prescribed GA remained on treatment longer. Of 610 participants who discontinued injectable DMT, 331 (54%) started an oral DMT, or a second-line DMT, or resumed injectable DMT after 90 days. Persistence with injectable DMTs was high in this long-term population-based study. Most participants who discontinued injectable DMT did not remain untreated. Further research is required to understand treatment outcomes and outcomes after stopping DMT.	[Zhornitsky, Simon; Greenfield, Jamie; Koch, Marcus W.; Harris, Colleen; Wall, Winona; Alikhani, Katayoun; Burton, Jodie; Busche, Kevin; Costello, Fiona; Davenport, Jeptha W.; Jarvis, Scott E.; Parpal, Helene; Patry, David G.; Yeung, Michael; Metz, Luanne M.] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada; [Patten, Scott B.; Lavarato, Dina] Univ Calgary, Fac Med, Dept Psychiat, Calgary, AB, Canada; [Zhornitsky, Simon; Greenfield, Jamie; Koch, Marcus W.; Patten, Scott B.; Harris, Colleen; Wall, Winona; Alikhani, Katayoun; Burton, Jodie; Busche, Kevin; Costello, Fiona; Davenport, Jeptha W.; Jarvis, Scott E.; Lavarato, Dina; Parpal, Helene; Patry, David G.; Yeung, Michael; Metz, Luanne M.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Metz, LM (corresponding author), Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada.	lmetz@ucalgary.ca	Koch, Marcus/L-9346-2019; Patten, Scott/B-4434-2011	Koch, Marcus/0000-0001-9972-5092; Patten, Scott/0000-0001-9871-4041				Agius M, 2014, CNS NEUROSCI THER, V20, P446, DOI 10.1111/cns.12235; Brixner DI, 2009, AM J HEALTH-SYST PH, V66, P2171, DOI 10.2146/ajhp080711; Broder MS, 2009, ALLERGY ASTHMA PROC, V30, P148, DOI 10.2500/aap.2009.30.3190; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Buysman E, 2011, CURR MED RES OPIN, V27, P1709, DOI 10.1185/03007995.2011.598500; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Cooke CE, 2010, CURR MED RES OPIN, V26, P231, DOI 10.1185/03007990903421994; Cunningham A, 2010, ACTA NEUROL SCAND, V121, P154, DOI 10.1111/j.1600-0404.2009.01285.x; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Evans C, 2012, CLIN THER, V34, P341, DOI 10.1016/j.clinthera.2012.01.006; Filippi M, 2001, NEUROLOGY, V56, P422, DOI 10.1212/WNL.56.3.422; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; Helin-Salmivaara A, 2010, AM J MANAG CARE, V16, P116; Iqbal SU, 2008, J CLIN PHARM THER, V33, P251, DOI 10.1111/j.1365-2710.2008.00912.x; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Jokubaitis VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059694; Jordan LB, 2012, J CLIN PHARM THER, V37, P173, DOI 10.1111/j.1365-2710.2011.01276.x; Juday T, 2011, AIDS CARE, V23, P1154, DOI 10.1080/09540121.2010.543884; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Margolis JM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-122; Mesaros S, 2012, CLIN NEUROL NEUROSUR, V114, P1145, DOI 10.1016/j.clineuro.2012.02.043; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Oleen-Burkey M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-11; Patti F, 2010, PATIENT PREFER ADHER, V4, P1; Pechlivanoglou P, 2010, CLIN THER, V32, P108, DOI 10.1016/j.clinthera.2010.01.008; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Wheeler Amanda, 2012, Clin Schizophr Relat Psychoses, V6, P61, DOI 10.3371/CSRP.6.2.3; Wong J, 2011, CAN J NEUROL SCI, V38, P429, DOI 10.1017/S0317167100011823; World Health Organisation, 2003, ADHERENCE LONG TERM; Xie L, 2011, ADV THER, V28, P1000, DOI 10.1007/s12325-011-0074-5	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123824	10.1371/journal.pone.0123824	http://dx.doi.org/10.1371/journal.pone.0123824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867095	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100215
J	Guigue, N; Lardeux, S; Alanio, A; Hamane, S; Tabouret, M; Bretagne, S				Guigue, Nicolas; Lardeux, Samuel; Alanio, Alexandre; Hamane, Samia; Tabouret, Marc; Bretagne, Stephane			Importance of Operational Factors in the Reproducibility of Aspergillus Galactomannan Enzyme Immune Assay	PLOS ONE			English	Article							LONG-TERM STABILITY; INTRA-LABORATORY REPRODUCIBILITY; INVASIVE ASPERGILLOSIS; INSUFFICIENT DEMONSTRATION; CIRCULATING GALACTOMANNAN; SERUM GALACTOMANNAN; IMMUNOASSAY TEST; DIAGNOSIS; STORAGE	Background The Platelia Aspergillus Ag assay (Bio-Rad) is designed for detecting Aspergillus galactomannan (GM) and is widely used for diagnosing invasive aspergillosis but is hampered by variable occurrences of unreproducible positive results. Frequency and origin of these unreproducible results have not been formally studied. Methods Different technicians simultaneously performed four tests on 550 consecutive sera from adult patients (Test#1-Test#2 for extraction#1 and Test#3-Test#4 for extraction#2). The samples were classified as confirmed negative [all tests with GM optical density index (GM-ODI) <0.5], confirmed positive (all tests with GM-ODI >= 0.5), extraction unreproducible positive (Test#1 and Test#2 ODIs >= 0.5, and Test#3 and Test#4 GM-ODIs <0.5, or conversely), and ELISA unreproducible positive (only one test with GM-ODI >= 0.5). The samples with positive and negative GM-ODIs within the assay coefficient of variation values were classified as non-conclusive. Four similar additional tests were performed after <= 72h storage at 4 degrees C and a new GM test after 8 months at -20 degrees C. Results Five-hundred-twenty sera (94.5%) were confirmed negative, 15 (2.7%) confirmed positive, 4 (0.7%) extraction unreproducible positive, 6 (1.1%) ELISA unreproducible positive, and 5 (0.9%) non-conclusive. Upon retesting, the unreproducible positive results turned negative except for one which turned non-conclusive. The confirmed positive and non-conclusive had similar GM-ODIs (p>0.4) upon retesting after storage <= 72h at 4 degrees C (n = 20) or eight months at -20 degrees C (n = 17). Conclusions Operational unreproducible positives represent 33% of the GM-positive results and a second sample evaluation appears mandatory to avoid useless investigations or treatments. When operational artifacts are excluded, GM remains stable at standard storage conditions.	[Guigue, Nicolas; Alanio, Alexandre; Hamane, Samia; Bretagne, Stephane] Grp Hosp Lariboisiere St Louis, AP HP, Lab Parasitol Mycol, Paris, France; [Guigue, Nicolas; Alanio, Alexandre; Bretagne, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Lardeux, Samuel; Tabouret, Marc] Biorad Labs, Steenvoorde, France; [Alanio, Alexandre; Bretagne, Stephane] CNRS, URA3012, Paris, France; [Alanio, Alexandre; Bretagne, Stephane] Ctr Natl Reference Mycoses Invas & Antifong, Inst Pasteur, Unite Mycol Mol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bretagne, S (corresponding author), Grp Hosp Lariboisiere St Louis, AP HP, Lab Parasitol Mycol, Paris, France.	stephane.bretagne@sls.aphp.fr	Alanio, Alexandre/N-8472-2016; BRETAGNE, Stephane/H-6655-2019; BRETAGNE, Stephane/GLT-8879-2022	Alanio, Alexandre/0000-0001-9726-3082; BRETAGNE, Stephane/0000-0001-6870-3800; TABOURET, Marc/0000-0003-0499-2804				Barton RC, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/459405; Bergeron A, 2012, J CLIN MICROBIOL, V50, P823, DOI 10.1128/JCM.00750-11; Bizzini A, 2012, TRANSPL INFECT DIS, V14, P218, DOI 10.1111/j.1399-3062.2011.00707.x; Bretagne S, 1997, J INFECTION, V35, P7, DOI 10.1016/S0163-4453(97)90833-1; Chai LYA, 2012, J CLIN MICROBIOL, V50, P2330, DOI 10.1128/JCM.06513-11; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dufresne SF, 2014, J CLIN MICROBIOL; Furfaro E, 2012, TRANSPL INFECT DIS, V14, pE38, DOI 10.1111/j.1399-3062.2012.00733.x; Guigue N, 2013, NEW ENGL J MED, V369, P97, DOI 10.1056/NEJMc1210430; Johnson GL, 2014, J CLIN MICROBIOL, V52, P4118, DOI 10.1128/JCM.02342-14; Johnson GL, 2013, INT J MOL SCI, V14, P12970, DOI 10.3390/ijms140712970; Kimpton G, 2014, MED MYCOL, V52, P618, DOI 10.1093/mmy/myu014; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Mikulska M, 2012, J ANTIMICROB CHEMOTH, V67, P1746, DOI 10.1093/jac/dks111; Oren I, 2012, TRANSPL INFECT DIS, V14, P107, DOI 10.1111/j.1399-3062.2011.00663.x; Pedroza KCMC, 2013, MYCOPATHOLOGIA, V176, P295, DOI 10.1007/s11046-013-9670-z; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Sulahian A, 1996, EUR J CLIN MICROBIOL, V15, P139, DOI 10.1007/BF01591487; Upton A, 2005, J CLIN MICROBIOL, V43, P4796, DOI 10.1128/JCM.43.9.4796-4800.2005; Wheat LJ, 2014, J CLIN MICROBIOL, V52, P4119, DOI 10.1128/JCM.02433-14; Wheat LJ, 2014, J CLIN MICROBIOL, V52, P2108, DOI 10.1128/JCM.03500-13	25	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124044	10.1371/journal.pone.0124044	http://dx.doi.org/10.1371/journal.pone.0124044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860967	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300128
J	Linzen, U; Lilischkis, R; Pandithage, R; Schilling, B; Ullius, A; Luscher-Firzlaff, J; Kremmer, E; Luscher, B; Vervoorts, J				Linzen, Ulrike; Lilischkis, Richard; Pandithage, Ruwin; Schilling, Britta; Ullius, Andrea; Luescher-Firzlaff, Juliane; Kremmer, Elisabeth; Luescher, Bernhard; Vervoorts, Joerg			ING5 Is Phosphorylated by CDK2 and Controls Cell Proliferation Independently of p53	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; GENE FAMILY; EXPRESSION; CANCER; ACETYLATION; PROTEIN; TRANSCRIPTION; RECOGNITION; GROWTH	Inhibitor of growth (ING) proteins have multiple functions in the control of cell proliferation, mainly by regulating processes associated with chromatin regulation and gene expression. ING5 has been described to regulate aspects of gene transcription and replication. Moreover deregulation of ING5 is observed in different tumors, potentially functioning as a tumor suppressor. Gene transcription in late G1 and in S phase and replication is regulated by cyclin- dependent kinase 2 (CDK2) in complex with cyclin E or cyclin A. CDK2 complexes phosphorylate and regulate several substrate proteins relevant for overcoming the restriction point and promoting S phase. We have identified ING5 as a novel CDK2 substrate. ING5 is phosphorylated at a single site, threonine 152, by cyclin E/CDK2 and cyclin A/CDK2 in vitro. This site is also phosphorylated in cells in a cell cycle dependent manner, consistent with it being a CDK2 substrate. Furthermore overexpression of cyclin E/CDK2 stimulates while the CDK2 inhibitor p27(KIP1) represses phosphorylation at threonine 152. This site is located in a bipartite nuclear localization sequence but its phosphorylation was not sufficient to deregulate the subcellular localization of ING5. Although ING5 interacts with the tumor suppressor p53, we could not establish p53-dependent regulation of cell proliferation by ING5 and by phospho-site mutants. Instead we observed that the knockdown of ING5 resulted in a strong reduction of proliferation in different tumor cell lines, irrespective of the p53 status. This inhibition of proliferation was at least in part due to the induction of apoptosis. In summary we identified a phosphorylation site at threonine 152 of ING5 that is cell cycle regulated and we observed that ING5 is necessary for tumor cell proliferation, without any apparent dependency on the tumor suppressor p53.	[Linzen, Ulrike; Lilischkis, Richard; Pandithage, Ruwin; Schilling, Britta; Ullius, Andrea; Luescher-Firzlaff, Juliane; Luescher, Bernhard; Vervoorts, Joerg] Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, D-52057 Aachen, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	RWTH Aachen University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Luscher, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, Pauwelsstr 30, D-52057 Aachen, Germany.	luescher@rwth-aachen.de; jvervoorts-weber@ukaachen.de	; Luscher, Bernhard/A-7330-2011	Vervoorts, Jorg/0000-0002-3251-6496; Luscher, Bernhard/0000-0002-9622-8709	Deutsche Forschungsgemeinschaft DFG [LU466/14-1]; Deutsche Krebshilfe/German Cancer Aid [109061]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutsche Krebshilfe/German Cancer Aid(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (LU466/14-1) and the Deutsche Krebshilfe/German Cancer Aid (109061) to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borkosky SS, 2010, ONCOL RES, V18, P509, DOI 10.3727/096504010X12704916124864; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Cengiz B, 2010, INT J CANCER, V127, P2088, DOI 10.1002/ijc.25224; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Copeland NA, 2010, J CELL SCI, V123, P1108, DOI 10.1242/jcs.059345; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Federico M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-208; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Garate M, 2007, FASEB J, V21, P3705, DOI 10.1096/fj.07-8069com; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gong W, 2006, MOL CELLULAR BIOL, V26; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Kataoka H, 2003, CANCER RES, V63, P5785; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Li XH, 2010, J CANCER RES CLIN, V136, P1573, DOI 10.1007/s00432-010-0815-x; Liu MH, 2013, PANCREAS, V42, P1169, DOI 10.1097/MPA.0b013e3182962acb; Liu NS, 2013, CANCER RES, V73, P3749, DOI 10.1158/0008-5472.CAN-12-3684; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park SH, 2014, NUCLEIC ACIDS RES, V42, P6196, DOI 10.1093/nar/gku263; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; PRICE BD, 1995, ONCOGENE, V11, P73; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 2000, CANCER RES, V60, P3689; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shiseki M, 2003, CANCER RES, V63, P2373; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Thalappilly S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021065; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Xing YN, 2011, HUM PATHOL, V42, P25, DOI 10.1016/j.humpath.2010.05.024; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021505; Zhang H, 2007, MOL CELL, V25, P175, DOI 10.1016/j.molcel.2007.01.008; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng HC, 2011, HUM PATHOL, V42, P424, DOI 10.1016/j.humpath.2009.12.018	78	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123736	10.1371/journal.pone.0123736	http://dx.doi.org/10.1371/journal.pone.0123736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860957	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300113
J	Wang, SY; Liu, LC; Lu, MC; Koo, M				Wang, Shu Yi; Liu, Liang Chun; Lu, Ming Chi; Koo, Malcolm			Comparisons of Musculoskeletal Disorders among Ten Different Medical Professions in Taiwan: A Nationwide, Population-Based Study	PLOS ONE			English	Article							LOW-BACK-PAIN; RISK-FACTORS; PHYSICAL-THERAPISTS; PREVALENCE; NURSES; COMPLAINTS; SEVERITY; INJURIES	Objective Medical personnel are at risk of musculoskeletal disorders but little is known whether the risk of musculoskeletal disorders were different among various medical professions. Therefore, this study compared the risk of musculoskeletal disorders among personnel of 10 different medical professions in Taiwan using a nationwide health claims database. Methods Data from the 2000-2010 Taiwan National Health Insurance Research Database were used to identify personnel of 10 different medical professions. Diagnoses based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) were used to identify eight different musculoskeletal disorders that occurred after the license issuance date. Cox proportional hazards model was used to compare the risk of eight musculoskeletal disorders among the 10 different medical professions using dentists as the reference category. Results A total of 7,820 medical personnel were included in the analysis. Using dentists as the reference category, physical therapists showed a significantly higher risk of all eight musculoskeletal disorders (ranging from 1.59 [p = 0.032] in sprains and strains of other and unspecified parts of back to 2.93 [p < 0.001] in spondylosis and allied disorders). Conclusions Compared with dentists, a profession that already known to suffer from high rates of work-related musculoskeletal disorders, physical therapists, registered nurses, and doctors of Chinese medicine showed an even higher risk of musculoskeletal disorders.	[Wang, Shu Yi; Liu, Liang Chun] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Rehabil, Chiayi, Taiwan; [Lu, Ming Chi] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming Chi] Tzu Chi Univ, Sch Med, Chiayi, Taiwan; [Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Koo, M (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan.	m.koo@utoronto.ca	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Alexopoulos EC, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-16; Alperovitch-Najenson D, 2014, ARCH ENVIRON OCCUP H, V69, P33, DOI 10.1080/19338244.2012.719555; Bos E, 2007, INT ARCH OCC ENV HEA, V80, P198, DOI 10.1007/s00420-006-0121-8; CHIOU WK, 1994, INT J NURS STUD, V31, P361, DOI 10.1016/0020-7489(94)90076-0; Chung YC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-144; Cromie JE, 2000, PHYS THER, V80, P336, DOI 10.1093/ptj/80.4.336; Darragh AR, 2009, AM J OCCUP THER, V63, P351, DOI 10.5014/ajot.63.3.351; Directorate General of Budget Accounting and Statistics Republic of China: Statistical Yearbook of Republic of China, 2011, REP CHIN STAT YB REP; Feng CK, 2005, J OCCUPATIONAL SAFET, V13, P205; Harcombe H, 2014, OCCUP MED-OXFORD, V64, P601, DOI 10.1093/occmed/kqu117; Hayes MJ, 2009, INT J DENT HYG, V7, P159, DOI 10.1111/j.1601-5037.2009.00395.x; Hayes Melanie J, 2013, BMC Res Notes, V6, P250, DOI 10.1186/1756-0500-6-250; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ijzelenberg W, 2005, SPINE, V30, P1550, DOI 10.1097/01.brs.0000167533.83154.28; Karahan A, 2009, J ADV NURS, V65, P516, DOI 10.1111/j.1365-2648.2008.04905.x; Liu SH, 2009, TOHOKU J EXP MED, V219, P207, DOI 10.1620/tjem.219.207; McDonald M, 2011, J OCCUP ENVIRON MED, V53, P765, DOI 10.1097/JOM.0b013e318222af81; Morse T, 2010, WORK, V35, P419, DOI 10.3233/WOR-2010-0979; National Health Research Institute, 2015, NAT HLTH INS RES DAT; Occhionero V, 2014, ERGONOMICS, V57, P1166, DOI 10.1080/00140139.2014.917205; Pompeii LA, 2009, AM J IND MED, V52, P571, DOI 10.1002/ajim.20704; Barros ARR, 2009, REV LAT-AM ENFERM, V17, P1015, DOI 10.1590/S0104-11692009000600014; Smith DR, 2006, J SAFETY RES, V37, P195, DOI 10.1016/j.jsr.2006.01.004; Wang R, 2015, PUBLIC HEALTH, P237; Yasobant Sandul, 2014, Indian J Occup Environ Med, V18, P75, DOI 10.4103/0019-5278.146896; Yassi A, 2013, INT J OCCUP ENV HEAL, V19, P223, DOI 10.1179/2049396713Y.0000000027; Yip YB, 2001, J ADV NURS, V36, P794, DOI 10.1046/j.1365-2648.2001.02037.x	27	21	21	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123750	10.1371/journal.pone.0123750	http://dx.doi.org/10.1371/journal.pone.0123750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25861017	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300114
J	Li, YX; Wu, P; Liang, FR; Huang, WH				Li, Yongxin; Wu, Ping; Liang, Fanrong; Huang, Wenhua			The Microstructural Status of the Corpus Callosum Is Associated with the Degree of Motor Function and Neurological Deficit in Stroke Patients	PLOS ONE			English	Article							SUBJECT DIFFUSION DATA; WHITE-MATTER ANATOMY; SUBCORTICAL STROKE; STRUCTURAL CONNECTIVITY; WALLERIAN DEGENERATION; SPATIAL STATISTICS; VOXELWISE ANALYSIS; TRACT INTEGRITY; TENSOR; RECOVERY	Human neuroimaging studies and animal models have suggested that white matter damage from ischemic stroke leads to the functional and structural reorganization of perilesional and remote brain regions. However, the quantitative relationship between the transcallosal tract integrity and clinical motor performance score after stroke remains unexplored. The current study employed a tract-based spatial statistics (TBSS) analysis on diffusion tensor imaging (DTI) to investigate the relationship between white matter diffusivity changes and the clinical scores in stroke patients. Probabilistic fiber tracking was also used to identify structural connectivity patterns in the patients. Thirteen ischemic stroke patients and fifteen healthy control subjects participated in this study. TBSS analyses showed that the corpus callosum (CC) and bilateral corticospinal tracts (CST) in the stroke patients exhibited significantly decreased fractional anisotropy and increased axial and radial diffusivity compared with those of the controls. Correlation analyses revealed that the motor and neurological deficit scores in the stroke patients were associated with the value of diffusivity indices in the CC. Compared with the healthy control group, probabilistic fiber tracking analyses revealed that significant changes in the inter-hemispheric fiber connections between the left and right motor cortex in the stroke patients were primarily located in the genu and body of the CC, left anterior thalamic radiation and inferior fronto-occipital fasciculus, bilateral CST, anterior/superior corona radiate, cingulum and superior longitudinal fasciculus, strongly suggesting that ischemic induces inter-hemispheric network disturbances and disrupts the white matter fibers connecting motor regions. In conclusion, the results of the present study show that DTI-derived measures in the CC can be used to predict the severity of motor skill and neurological deficit in stroke patients. Changes in structural connectivity pattern tracking between the left and right motor areas, particularly in the body of the CC, might reflect functional reorganization and behavioral deficit.	[Li, Yongxin; Huang, Wenhua] Southern Med Univ, Sch Basic Med Sci, Inst Clin Anat, Guangzhou, Guangdong, Peoples R China; [Wu, Ping; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China	Southern Medical University - China; Chengdu University of Traditional Chinese Medicine	Liang, FR (corresponding author), Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China.	0001170@cdutcm.edu.cn; huangwenhua2009@139.com	huang, wenhua/AAO-5990-2020	huang, wenhua/0000-0003-2382-9180; Liang, Fanrong/0000-0003-2210-2027	Natural Science Foundation of China [81072864]; Specialized Research Fund for the Doctoral Program of Higher Education [20134433110012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	PW, FRL, the Natural Science Foundation of China (No. 81072864), http://www.nsfc.gov.cn/. WHH, Specialized Research Fund for the Doctoral Program of Higher Education (No. 20134433110012), http://www.cutech.edu.cn/cn/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048079; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen JL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00178; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jayaram G, 2012, CLIN NEUROPHYSIOL, V123, P2422, DOI 10.1016/j.clinph.2012.04.026; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mori S, 2002, ANN NEUROL, V51, P377, DOI 10.1002/ana.10137; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Radlinska BA, 2012, J CEREBR BLOOD F MET, V32, P1515, DOI 10.1038/jcbfm.2012.37; Righini A, 2010, NEURORADIOLOGY, V52, P1025, DOI 10.1007/s00234-010-0745-y; Saini J, 2012, NEURORADIOLOGY, V54, P771, DOI 10.1007/s00234-011-0983-7; Schaechter JD, 2008, NEUROIMAGE, V39, P1370, DOI 10.1016/j.neuroimage.2007.09.071; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schmahmann J.D., 2009, FIBER PATHWAYS BRAIN; Serbruyns L, 2013, BRAIN STRUCTURE FUNC, P1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takenobu Y, 2014, NEUROIMAGE-CLIN, V4, P201, DOI 10.1016/j.nicl.2013.12.003; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; van Eimeren L, 2010, NEUROIMAGE, V52, P358, DOI 10.1016/j.neuroimage.2010.04.001; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wang CH, 2014, J CEREBR BLOOD F MET, V34, P597, DOI 10.1038/jcbfm.2013.238; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhu D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00167; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	64	41	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122615	10.1371/journal.pone.0122615	http://dx.doi.org/10.1371/journal.pone.0122615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875333	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800068
J	Wanner, J; Romashko, D; Werner, DS; May, EW; Peng, Y; Schulz, R; Foreman, KW; Russo, S; Arnold, LD; Pingle, M; Bergstrom, DE; Barany, F; Thomson, S				Wanner, Jutta; Romashko, Darlene; Werner, Douglas S.; May, Earl W.; Peng, Yue; Schulz, Ryan; Foreman, Kenneth W.; Russo, Suzanne; Arnold, Lee D.; Pingle, Maneesh; Bergstrom, Donald E.; Barany, Francis; Thomson, Stuart			Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines	PLOS ONE			English	Article							C-MYC; BORONIC ESTERS; MUTATIONS; BINDING; INACTIVATION; ONCOPROTEIN; DISRUPTION; LANDSCAPE; STABILITY; LYMPHOMA	We describe the successful application of a novel approach for generating dimeric Myc inhibitors by modifying and reversibly linking two previously described small molecules. We synthesized two directed libraries of monomers, each comprised of a ligand, a connector, and a bioorthogonal linker element, to identify the optimal dimer configuration required to inhibit Myc. We identified combinations of monomers, termed self-assembling dimeric inhibitors, which displayed synergistic inhibition of Myc-dependent cell growth. We confirmed that these dimeric inhibitors directly bind to Myc blocking its interaction with Max and affect transcription of MYC dependent genes. Control combinations that are unable to form a dimer do not show any synergistic effects in these assays. Collectively, these data validate our new approach to generate more potent and selective inhibitors of Myc by self-assembly from smaller, lower affinity components. This approach provides an opportunity for developing novel therapeutics against Myc and other challenging protein: protein interaction (PPI) target classes.	[Wanner, Jutta; Romashko, Darlene; Werner, Douglas S.; May, Earl W.; Peng, Yue; Schulz, Ryan; Foreman, Kenneth W.; Russo, Suzanne; Arnold, Lee D.; Pingle, Maneesh; Thomson, Stuart] Coferon Inc, Stony Brook, NY 11790 USA; [Bergstrom, Donald E.] Purdue Univ, W Lafayette, IN 47907 USA; [Barany, Francis] Weill Cornell Med Coll, Dept Microbiol, New York, NY USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University	Thomson, S (corresponding author), Coferon Inc, 25 Hlth Sci Dr, Stony Brook, NY 11790 USA.	sthomson@coferon.com	Foreman, Kenneth/AAI-2249-2020		Coferon, Inc.	Coferon, Inc.	Coferon, Inc. provided support in the form of salaries for authors JW, DR, DSW, EWM, YP, RS, KWF, SR, MP and ST, and LDA at the time of the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Barany F, 2009, WO, Patent No. [2009126290 A3, 2009126290]; Bernardini R, 2009, CHEM LETT, V38, P750, DOI 10.1246/cl.2009.750; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Chauhan J, 2014, CHEMMEDCHEM, V9, P2274, DOI 10.1002/cmdc.201402189; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Demetriades M, 2012, ANGEW CHEM INT EDIT, V51, P6672, DOI 10.1002/anie.201202000; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Metallo S, 2012, WO, Patent No. [2010083404 A2, 2010083404]; Muller I, 2014, PLOS, V9, P1; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Roy CD, 2007, J ORGANOMET CHEM, V692, P784, DOI 10.1016/j.jorganchem.2006.10.013; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shin SBY, 2010, CHEM BIOL, V17, P1171, DOI 10.1016/j.chembiol.2010.09.008; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Tansey WP, 2014, NEW J SCI, DOI DOI 10.1155/2014/757534; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang HB, 2013, ONCOTARGET, V4, P936, DOI 10.18632/oncotarget.1108; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Yap JL, 2013, BIOORG MED CHEM LETT, V23, P370, DOI 10.1016/j.bmcl.2012.10.013; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	37	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121793	10.1371/journal.pone.0121793	http://dx.doi.org/10.1371/journal.pone.0121793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875098	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800030
J	Yasuda, Y; Fujita, M; Koike, E; Obata, K; Shiota, M; Kotani, Y; Musha, T; Tsuji-Kawahara, S; Satou, T; Masuda, S; Okano, J; Yamasaki, H; Okumoto, K; Uesugi, T; Nakao, S; Hoshiai, H; Mandai, M				Yasuda, Yoshiko; Fujita, Mitsugu; Koike, Eiji; Obata, Koshiro; Shiota, Mitsuru; Kotani, Yasushi; Musha, Terunaga; Tsuji-Kawahara, Sachiyo; Satou, Takao; Masuda, Seiji; Okano, Junko; Yamasaki, Harufumi; Okumoto, Katsumi; Uesugi, Tadao; Nakao, Shinichi; Hoshiai, Hiroshi; Mandai, Masaki			Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction	PLOS ONE			English	Article							NITRIC-OXIDE; UTERINE CERVIX; EXPRESSION; CANCER; INDUCTION; MYOGLOBIN; HYPOXIA; CARCINOMA; GROWTH; IDENTIFICATION	The aim of this study is to explore a cause-oriented therapy for patients with uterine cervical cancer that expresses erythropoietin (Epo) and its receptor (EpoR). Epo, by binding to EpoR, stimulates the proliferation and differentiation of erythroid progenitor cells into hemoglobin-containing red blood cells. In this study, we report that the HeLa cells in the xenografts expressed epsilon,gamma, and a globins as well as myoglobin (Mb) to produce tetrameric alpha 2 epsilon 2 and alpha 2 gamma 2 and monomeric Mb, most of which were significantly suppressed with an EpoR antagonist EMP9. Western blotting revealed that the EMP9 treatment inhibited the AKT-pAKT, MAPKs-pMAPKs, and STAT5-pSTAT5 signaling pathways. Moreover, the treatment induced apoptosis and suppression of the growth and inhibited the survival through disruption of the harmonized hemoprotein syntheses in the tumor cells concomitant with destruction of vascular nets in the xenografts. Furthermore, macrophages and natural killer (NK) cells with intense HIF-1 alpha expression recruited significantly more in the degenerating foci of the xenografts. These findings were associated with the enhanced expressions of nNOS in the tumor cells and iNOS in macrophages and NK cells in the tumor sites. The treated tumor cells exhibited a substantial number of perforations on the cell surface, which indicates that the tumors were damaged by both the nNOS-induced nitric oxide (NO) production in the tumor cells as well as the iNOS-induced NO production in the innate immune cells. Taken together, these data suggest that HeLa cells constitutively acquire e,. and Mb synthetic capacity for their survival. Therefore, EMP9 treatment might be a cause-oriented and effective therapy for patients with squamous cell carcinoma of the uterine cervix.	[Yasuda, Yoshiko; Koike, Eiji; Kotani, Yasushi; Yamasaki, Harufumi; Hoshiai, Hiroshi; Mandai, Masaki] Kinki Univ Fac Med, Dept Obstet, Osaka, Japan; [Yasuda, Yoshiko; Koike, Eiji; Kotani, Yasushi; Yamasaki, Harufumi; Hoshiai, Hiroshi; Mandai, Masaki] Kinki Univ Fac Med, Dept Gynecol, Osaka, Japan; [Fujita, Mitsugu] Kinki Univ Fac Med, Dept Microbiol, Osaka, Japan; [Obata, Koshiro] Nara Hosp Kinki Univ Fac Med, Dept Obstet & Gynecol, Nara, Japan; [Shiota, Mitsuru] Kawasaki Med Sch, Dept Gynecol Oncol, Kurashiki, Okayama, Japan; [Musha, Terunaga] Medicalcourt Hachinohe West Hosp, Dept Gynecol, Hachinohe, Aomori, Japan; [Tsuji-Kawahara, Sachiyo] Kinki Univ Fac Med, Dept Immunol, Osaka, Japan; [Satou, Takao; Uesugi, Tadao] Kinki Univ Fac Med, Dept Pathol, Osaka, Japan; [Masuda, Seiji] Kyoto Univ, Grad Sch Biostudies, Lab Mol Biol Bioresponse, Kyoto 6068502, Japan; [Okano, Junko] Shiga Univ Med Sci, Div Anat & Cell Biol, Otsu, Shiga 52021, Japan; [Okumoto, Katsumi] Kinki Univ Fac Med, Lifesci Inst, Osaka, Japan; [Nakao, Shinichi] Kinki Univ Fac Med, Dept Anesthesiol, Osaka, Japan	Kawasaki Medical School; Kyoto University; Shiga University of Medical Science	Yasuda, Y (corresponding author), Kinki Univ Fac Med, Dept Obstet, Osaka, Japan.	y1126yas@med.kindai.ac.jp	Fujita, Mitsugu/A-6690-2009	Fujita, Mitsugu/0000-0002-0000-9879	Promotion and Mutual Aid-Co-operation for Private Schools of Japan; Japan Society for the Promotion of Science [24700998]; University Research Grant from Kinki University [SR08]; Grants-in-Aid for Scientific Research [25660295] Funding Source: KAKEN	Promotion and Mutual Aid-Co-operation for Private Schools of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University Research Grant from Kinki University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the following grants: Promotion and Mutual Aid-Co-operation for Private Schools of Japan (YY); Grants-in-Aid for Young Scientist (B) (MF: No. 24700998) from the Japan Society for the Promotion of Science; and the University Research Grant (MF: No. SR08) from Kinki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Blackwell KL, 2003, CANCER RES, V63, P6162; Brookes M, 1998, CLIN EMBRYOLOGY COLO, P142; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; da Silva CS, 2010, CLINICS, V65, P575, DOI 10.1590/S1807-59322010000600003; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eggen T, 2011, ANTICANCER RES, V31, P2319; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gadducci A, 2010, ONCOL LETT, V1, P3, DOI 10.3892/ol_00000001; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson DL, 1998, BIOCHEMISTRY-US, V37, P3699, DOI 10.1021/bi971956y; Katsumura KR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015412; KRANTZ S B, 1991, Blood, V77, P419; Leo C, 2006, CLIN CANCER RES, V12, P6894, DOI 10.1158/1078-0432.CCR-06-1285; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; Lopez TV, 2011, INT J CANCER, V129, P2566, DOI 10.1002/ijc.25935; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moore MAS, 1997, STEM CELLS, V15, P239, DOI 10.1002/stem.5530150832; NIJHOF W, 1987, EXP HEMATOL, V15, P779; Nishio N, 2012, J IMMUNOTHER, V35, P598, DOI 10.1097/CJI.0b013e31826a745a; Ohba N, 2004, NEUROSCI LETT, V359, P159, DOI 10.1016/j.neulet.2004.02.029; Shenouda G, 2006, INT J GYNECOL CANCER, V16, P752, DOI 10.1111/j.1525-1438.2006.00357.x; Shiota M, 2013, CONGENIT ANOM, V53, P18, DOI 10.1111/j.1741-4520.2012.00382.x; Wunderlich C, 2003, CIRC RES, V92, P1352, DOI 10.1161/01.RES.0000079026.70629.E5; Xu W M, 1998, Cell Res, V8, P251; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yasuda M, 2007, INT J CLIN ONCOL, V12, P455, DOI 10.1007/s10147-007-0714-6; YASUDA Y, 1993, DEV GROWTH DIFFER, V35, P711; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yasuda Y, 2002, CARCINOGENESIS, V23, P1797, DOI 10.1093/carcin/23.11.1797; Yasuda Y, 2001, MARC MALPIG SYMP SER, V8, P215; Yasuda Y, 2001, BRIT J CANCER, V84, P836, DOI 10.1054/bjoc.2000.1666; Yasuda Y, 2011, J CANC THER, V2, P40; Yasuda Y, 2010, ANAT SCI INT, V85, P204, DOI 10.1007/s12565-010-0081-7; Yasuda Y, 2010, REC ADV BIOL BIOMED, P337; Yasuda Yoshiko, 2007, Congenital Anomalies, V47, P22, DOI 10.1111/j.1741-4520.2006.00137.x	54	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122458	10.1371/journal.pone.0122458	http://dx.doi.org/10.1371/journal.pone.0122458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874769	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800059
J	Buckner, CA; Buckner, AL; Koren, SA; Persinger, MA; Lafrenie, RM				Buckner, Carly A.; Buckner, Alison L.; Koren, Stan A.; Persinger, Michael A.; Lafrenie, Robert M.			Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels	PLOS ONE			English	Article							MAGNETIC-FIELDS; MELANOMA-CELLS; WEAK; PROLIFERATION; CYCLE; DIFFERENTIATION; ACTIVATION; EXPRESSION; INDUCTION; CARCINOMA	Electromagnetic field (EMF) exposures affect many biological systems. The reproducibility of these effects is related to the intensity, duration, frequency, and pattern of the EMF. We have shown that exposure to a specific time-varying EMF can inhibit the growth of malignant cells. Thomas-EMF is a low-intensity, frequency-modulated (25-6 Hz) EMF pattern. Daily, 1 h, exposures to Thomas-EMF inhibited the growth of malignant cell lines including B16-BL6, MDA-MB-231, MCF-7, and HeLa cells but did not affect the growth of non-malignant cells. Thomas-EMF also inhibited B16-BL6 cell proliferation in vivo. B16-BL6 cells implanted in syngeneic C57b mice and exposed daily to Thomas-EMF produced smaller tumours than in sham-treated controls. In vitro studies showed that exposure of malignant cells to Thomas-EMF for > 15 min promoted Ca2+ influx which could be blocked by inhibitors of voltage-gated T-type Ca2+ channels. Blocking Ca2+ uptake also blocked Thomas-EMF-dependent inhibition of cell proliferation. Exposure to Thomas-EMF delayed cell cycle progression and altered cyclin expression consistent with the decrease in cell proliferation. Non-malignant cells did not show any EMF-dependent changes in Ca2+ influx or cell growth. These data confirm that exposure to a specific EMF pattern can affect cellular processes and that exposure to Thomas-EMF may provide a potential anti-cancer therapy.	[Buckner, Carly A.; Buckner, Alison L.; Persinger, Michael A.; Lafrenie, Robert M.] Laurentian Univ, Dept Biomol Sci, Sudbury, ON P3E 2C6, Canada; [Buckner, Carly A.; Buckner, Alison L.; Lafrenie, Robert M.] Hlth Sci North, Reg Canc Program, Sudbury, ON, Canada; [Koren, Stan A.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci, Sudbury, ON P3E 2C6, Canada; [Lafrenie, Robert M.] Northern Ontario Sch Med, Sudbury, ON, Canada	Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Laurentian University; Northern Ontario School of Medicine	Lafrenie, RM (corresponding author), Laurentian Univ, Dept Biomol Sci, Sudbury, ON P3E 2C6, Canada.	rlafrenie@amric.ca		Lafrenie, Robert/0000-0001-9981-997X	Northern Cancer Foundation, Sudbury, Ontario; Natural Sciences and Engineering Research Council, Canada	Northern Cancer Foundation, Sudbury, Ontario; Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Northern Cancer Foundation, Sudbury, Ontario and Natural Sciences and Engineering Research Council, Canada (MAP, primary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS MJ, 1990, AM J PATHOL, V136, P593; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; BIANCHI S, 1994, BIOCHEM BIOPH RES CO, V204, P691, DOI 10.1006/bbrc.1994.2515; BLANCHARD JP, 1994, BIOELECTROMAGNETICS, V15, P217, DOI 10.1002/bem.2250150306; Blank Martin, 2009, Pathophysiology, V16, P71, DOI 10.1016/j.pathophys.2009.01.006; Brizhik L, 1998, J BIOL PHYS, V24, P19, DOI 10.1023/A:1005096714234; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Cifra M, 2011, PROG BIOPHYS MOL BIO, V105, P223, DOI 10.1016/j.pbiomolbio.2010.07.003; CONTI P, 1986, FEBS LETT, V199, P130, DOI 10.1016/0014-5793(86)81238-8; Costa FP, 2011, BRIT J CANCER, V105, P640, DOI 10.1038/bjc.2011.292; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Cui YJ, 2014, CELL CALCIUM, V55, P48, DOI 10.1016/j.ceca.2013.11.002; FIDLER IJ, 1975, CANCER RES, V35, P218; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; GAFFNEY EV, 1982, CELL TISSUE RES, V227, P563, DOI 10.1007/BF00204786; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GERDES J, 1984, J IMMUNOL, V133, P1710; Guo BQ, 2005, EUR J CELL BIOL, V84, P927, DOI 10.1016/j.ejcb.2005.09.016; Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775; Hirooka K, 2002, J NEUROPHYSIOL, V88, P196, DOI 10.1152/jn.2002.88.1.196; Hu JH, 2010, INT J RADIAT BIOL, V86, P79, DOI 10.3109/09553000903419932; Iftinca M C, 2011, J Med Life, V4, P126; Lam K, 2005, J CELL PHYSIOL, V203, P353, DOI 10.1002/jcp.20247; Lange S, 2004, CELL PROLIFERAT, V37, P337, DOI 10.1111/j.1365-2184.2004.00317.x; Li XP, 2012, ELECTROMAGN BIOL MED, V31, P356, DOI 10.3109/15368378.2012.662194; Lin H, 2001, J CELL BIOCHEM, V81, P143, DOI 10.1002/1097-4644(20010401)81:1<143::AID-JCB1030>3.0.CO;2-4; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Martin LJ, 2004, PHARMACOL BIOCHEM BE, V78, P217, DOI 10.1016/j.pbb.2004.03.016; Nie K, 2003, J CELL BIOCHEM, V90, P1197, DOI 10.1002/jcb.10704; Nie YZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-582; Novikov VV, 2009, BIOELECTROMAGNETICS, V30, P343, DOI 10.1002/bem.20487; Ohkubo T, 2012, INT J ONCOL, V41, P267, DOI 10.3892/ijo.2012.1422; Pall ML, 2013, J CELL MOL MED, V17, P958, DOI 10.1111/jcmm.12088; Panagopoulos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062663; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Sadeghipour R, 2012, ELECTROMAGN BIOL MED, V31, P425, DOI 10.3109/15368378.2012.683844; Saliev Timur, 2014, Front Biosci (Elite Ed), V6, P175; Schimmelpfeng J, 1997, BIOELECTROMAGNETICS, V18, P177, DOI 10.1002/(SICI)1521-186X(1997)18:2<177::AID-BEM11>3.0.CO;2-O; Schimmelpfeng J, 1995, BIOELECTROMAGNETICS, V16, P381, DOI 10.1002/bem.2250160606; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Shupak NM, 2004, NEUROSCI LETT, V363, P157, DOI 10.1016/j.neulet.2004.03.069; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Stratton D, 2013, BIOCHEM BIOPH RES CO, V430, P470, DOI 10.1016/j.bbrc.2012.12.012; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Thumm S, 1999, RADIAT ENVIRON BIOPH, V38, P195, DOI 10.1007/s004110050155; Tokalov SV, 2004, ENVIRON RES, V94, P145, DOI 10.1016/S0013-9351(03)00088-4; Tomitsch J, 2015, BIOELECTROMAGNETICS, V36, P77, DOI 10.1002/bem.21887; Ushiyama A, 2004, IN VIVO, V18, P125; Vijayalaxmi, 2009, INT J RADIAT BIOL, V85, P196, DOI 10.1080/09553000902748575; Wang TT, 2011, BIOELECTROMAGNETICS, V32, P443, DOI 10.1002/bem.20654; Weaver JC, 1999, BIOPHYS J, V76, P3026, DOI 10.1016/S0006-3495(99)77455-2; Whissell PD, 2007, CURR NEUROPHARMACOL, V5, P278, DOI 10.2174/157015907782793603; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yamaguchi S, 2006, BIOELECTROMAGNETICS, V27, P64, DOI 10.1002/bem.20177; Yan JH, 2010, ELECTROMAGN BIOL MED, V29, P165, DOI 10.3109/01676830.2010.505490; Zahradnikova A, 2007, J PHARMACOL EXP THER, V322, P638, DOI 10.1124/jpet.107.122176; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523	62	45	46	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124136	10.1371/journal.pone.0124136	http://dx.doi.org/10.1371/journal.pone.0124136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875081	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700055
J	Bai, H; Wang, ZX; Hu, R; Kan, TT; Li, Y; Zhang, XS; Zhang, JL; Lian, L; Han, HB; Lian, ZX				Bai, Hai; Wang, Zhixian; Hu, Rui; Kan, Tongtong; Li, Yan; Zhang, Xiaosheng; Zhang, Jinlong; Lian, Ling; Han, Hongbing; Lian, Zhengxing			A 90-Day Toxicology Study of Meat from Genetically Modified Sheep Overexpressing TLR4 in Sprague-Dawley Rats	PLOS ONE			English	Article							SAFETY ASSESSMENT; LIPOPOLYSACCHARIDE; PROTEIN; ANIMALS; CATTLE	Genetic modification offers alternative strategies to traditional animal breeding. However, the food safety of genetically modified (GM) animals has attracted increasing levels of concern. In this study, we produced GM sheep overexpressing TLR4, and the transgene-positive off springs (F1) were confirmed using the polymerase chain reaction (PCR) and Southern blot. The expression of TLR4 was 2.5-fold compared with that of the wild-type (WT) sheep samples. During the 90-day safety study, Sprague-Dawley rats were fed with three different dietary concentrations (3.75%, 7.5%, and 15% wt/wt) of GM sheep meat, WT sheep meat or a commercial diet (CD). Blood samples from the rats were collected and analyzed for hematological and biochemical parameters, and then compared with hematological and biochemical reference ranges. Despite a few significant differences among the three groups in some parameters, all other values remained within the normal reference intervals and thus were not considered to be affected by the treatment. No adverse diet-related differences in body weights or relative organ weights were observed. Furthermore, no differences were observed in the gross necropsy findings or microscopic pathology of the rats whose diets contained the GM sheep meat compared with rats whose diets contained the WT sheep meat. Therefore, the present 90-day rat feeding study suggested that the meat of GM sheep overexpressing TLR4 had no adverse effect on Sprague-Dawley rats in comparison with WT sheep meat. These results provide valuable information regarding the safety assessment of meat derived from GM animals.	[Bai, Hai; Wang, Zhixian; Hu, Rui; Kan, Tongtong; Li, Yan; Lian, Ling; Han, Hongbing; Lian, Zhengxing] China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing 100094, Peoples R China; [Bai, Hai] Shanxi Datong Univ, Sch Life Sci, Datong, Shanxi, Peoples R China; [Zhang, Xiaosheng; Zhang, Jinlong] Tianjin Inst Anim Sci, Tianjin, Peoples R China	China Agricultural University; Shanxi Datong University	Han, HB (corresponding author), China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing 100094, Peoples R China.	hanhongbing@cau.edu.cn; lianzhx@cau.edu.cn			Chinese Universities Scientific Fund [2014JD016]; National Transgenic Creature Breeding Grand Project [2013ZX08008-005]	Chinese Universities Scientific Fund; National Transgenic Creature Breeding Grand Project	This work was supported by grants from Chinese Universities Scientific Fund (2014JD016) and National Transgenic Creature Breeding Grand Project (2013ZX08008-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2501; Bihl F, 2003, J IMMUNOL, V170, P6141, DOI 10.4049/jimmunol.170.12.6141; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLEMENTS JE, 1994, VIROLOGY, V200, P370, DOI 10.1006/viro.1994.1201; Deng SL, 2013, THERIOGENOLOGY, V80, P50, DOI 10.1016/j.theriogenology.2013.03.008; Deng SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047118; EC, 2013, OJEU, VL157, P1; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang Jikun, 2003, 195 IDS; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; Kampfmann I, 2012, VET CLIN PATH, V41, P228, DOI 10.1111/j.1939-165X.2012.00427.x; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; MULLER M, 1994, REPROD FERT DEVELOP, V6, P605, DOI 10.1071/RD9940605; MURRAY JD, 1989, REPROD FERT DEVELOP, V1, P147, DOI 10.1071/RD9890147; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richards HA, 2003, J NUTR, V133, P1909, DOI 10.1093/jn/133.6.1909; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sengupta P, 2012, BIOMED, V2, P81; Swanson KS, 2004, J ANIM SCI, V82, P1713; Tang MX, 2012, TRANSGENIC RES, V21, P499, DOI 10.1007/s11248-011-9550-6; Tang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052507; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Whitelaw CBA, 2005, REV SCI TECH OIE, V24, P275, DOI 10.20506/rst.24.1.1569; Williams P, 2007, NUTR DIET, V64, pS113, DOI 10.1111/j.1747-0080.2007.00197.x; Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029; Yang XZ, 2007, P NATL ACAD SCI USA, V104, P13859, DOI 10.1073/pnas.0706163104; Zhou GH, 2012, MEAT SCI, V92, P188, DOI 10.1016/j.meatsci.2012.04.016	34	11	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121636	10.1371/journal.pone.0121636	http://dx.doi.org/10.1371/journal.pone.0121636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874566	Green Published, gold			2022-12-27	WOS:000352845100044
J	Benavides, MV; Sonstegard, TS; Kemp, S; Mugambi, JM; Gibson, JP; Baker, RL; Hanotte, O; Marshall, K; Van Tassell, C				Benavides, Magda Vieira; Sonstegard, Tad S.; Kemp, Stephen; Mugambi, John M.; Gibson, John P.; Baker, Robert Leyden; Hanotte, Olivier; Marshall, Karen; Van Tassell, Curtis			Identification of Novel Loci Associated with Gastrointestinal Parasite Resistance in a Red Maasai x Dorper Backcross Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; HAEMONCHUS-CONTORTUS; NEMATODE PARASITES; MERINO SHEEP; TRICHOSTRONGYLUS-COLUBRIFORMIS; GENE-EXPRESSION; BODY-WEIGHT; MUCUS; LAMBS	Gastrointestinal (GI) parasitic infection is the main health constraint for small ruminant production, causing loss of weight and/or death. Red Maasai sheep have adapted to a tropical environment where extreme parasite exposure is a constant, especially with highly pathogenic Haemonchus contortus. This breed has been reported to be resistant to gastrointestinal parasite infection, hence it is considered an invaluable resource to study associations between host genetics and resistance. The aim of this study was to identify polymorphisms strongly associated with host resistance in a double backcross population derived from Red Maasai and Dorper sheep using a SNP-based GWAS analysis. The animals that were genotyped represented the most resistant and susceptible individuals based on the tails of phenotypic distribution (10% each) for average faecal egg counts (AVFEC). AVFEC, packed cell volume (AVPCV), and live weight (AVLWT) were adjusted for fixed effects and co-variables, and an association analysis was run using EMMAX. Revised significance levels were calculated using 100,000 permutation tests. The top five significant SNP markers with - log10 p-values >3.794 were observed on five different chromosomes for AVFEC, and BLUPPf90/PostGSf90 results confirmed EMMAX significant regions for this trait. One of these regions included a cluster of significant SNP on chromosome (Chr) 6 not in linkage disequilibrium to each other. This genomic location contains annotated genes involved in cytokine signalling, haemostasis and mucus biosynthesis. Only one association detected on Chr 7 was significant for both AVPCV and AVLWT. The results generated here reveal candidate immune variants for genes involved in differential response to infection and provide additional SNP marker information that has potential to aid selection of resistance to gastrointestinal parasites in sheep of a similar genetic background to the double backcross population.	[Benavides, Magda Vieira] EMBRAPA, LabEx USA, Brasilia, DF, Brazil; [Sonstegard, Tad S.; Van Tassell, Curtis] USDA ARS, Beltsville Agr Res Ctr, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA; [Kemp, Stephen; Marshall, Karen] ILRI, Anim Biosci, Nairobi, Kenya; [Mugambi, John M.] KARI, Natl Vet Res Ctr, Muguga, Kenya; [Gibson, John P.] Univ New England, Ctr Genet Anal & Applicat, Armidale, NSW, Australia; [Baker, Robert Leyden] Whangamata, Waikato, New Zealand; [Hanotte, Olivier] Univ Nottingham, Med & Hlth Sci, Nottingham NG7 2RD, England	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA); CGIAR; International Livestock Research Institute (ILRI); University of New England; University of Nottingham	Benavides, MV (corresponding author), EMBRAPA, LabEx USA, Brasilia, DF, Brazil.	magda.benavides@embrapa.br	Benavides, M/F-6643-2015; Van Tassell, Curtis P./O-4247-2019	Benavides, M/0000-0002-0219-3163; Van Tassell, Curtis P./0000-0002-8416-2087; Gibson, John/0000-0003-0371-2401; Hanotte, Olivier/0000-0002-2877-4767; kemp, stephen/0000-0003-4041-1720	Embrapa; USDA Agricultural Research Service [1265-31000-093-00D]	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Embrapa funded DNA genotyping and data analysis, and supported MB at the Embrapa LabEx programme; Research project 1265-31000-093-00D (AGIL) from the USDA Agricultural Research Service funded CVT and TSS; CVT will cover PLOS ONE submission fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; ALBERS GAA, 1989, AUST J AGR RES, V40, P419, DOI 10.1071/AR9890419; Araujo RN, 2009, VET PARASITOL, V162, P106, DOI 10.1016/j.vetpar.2008.12.017; Arranz JJ, 2004, 12 REUN NAC MEJ GEN, P4; Baker RL, 2004, ANIM SCI, V79, P343, DOI 10.1017/S1357729800090214; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; Beh KJ, 2002, ANIM GENET, V33, P97, DOI 10.1046/j.1365-2052.2002.00829.x; BELL AE, 1984, INT J BIOL MACROMOL, V6, P309, DOI 10.1016/0141-8130(84)90015-1; Beraldi D, 2007, INT J PARASITOL, V37, P121, DOI 10.1016/j.ijpara.2006.09.007; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; Biffa Demelash, 2006, Animal Health Research Reviews, V7, P107, DOI 10.1017/S1466252307001132; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 2004, ANIM SCI, V78, P185, DOI 10.1017/S1357729800053972; Bisset SA, 1996, VET PARASITOL, V61, P249, DOI 10.1016/0304-4017(95)00836-5; Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; Bouix J, 1998, INT J PARASITOL, V28, P1797, DOI 10.1016/S0020-7519(98)00147-7; CHURCHILL GA, 1994, GENETICS, V138, P963; Diez-Tascon C, 2002, 7 WORLD C GEN APPL L, P4; Dominik S, 2005, GENET SEL EVOL, V37, pS83, DOI 10.1051/gse:2004027; DOUCH PGC, 1983, INT J PARASITOL, V13, P207, DOI 10.1016/0020-7519(83)90014-0; DOUCH PGC, 1995, LIVEST PROD SCI, V41, P121, DOI 10.1016/0301-6226(94)00046-A; Eady SJ, 1998, AUST J AGR RES, V49, P1201, DOI 10.1071/A98069; Eady SJ, 1996, AUST J AGR RES, V47, P895, DOI 10.1071/AR9960895; Ellis NA, 2009, P ASS ADV ANIMAL BRE, V18, P4; Else KJ, 1998, INT J PARASITOL, V28, P1145, DOI 10.1016/S0020-7519(98)00087-3; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Ge T, 2012, NEUROIMAGE, V63, P858, DOI 10.1016/j.neuroimage.2012.07.012; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Guo YF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-429; Gururaja TL, 1999, BBA-PROTEIN STRUCT M, V1431, P107, DOI 10.1016/S0167-4838(99)00034-5; Gutierrez-Gil B, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-46; Hadjipavlou G, 2009, ANIM GENET, V40, P165, DOI 10.1111/j.1365-2052.2008.01814.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; KELLY EAB, 1991, J IMMUNOL, V147, P306; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Louie K, 2007, INT J PARASITOL, V37, P233, DOI 10.1016/j.ijpara.2006.09.013; Maizels RM, 1998, CURR BIOL, V8, pR711, DOI 10.1016/S0960-9822(98)70455-5; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marshall K, 2013, ANIM GENET, V44, P285, DOI 10.1111/j.1365-2052.2012.02401.x; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Matika O, 2011, ANIM GENET, V42, P172, DOI 10.1111/j.1365-2052.2010.02121.x; McEwan J., 1995, P AUSTR ASS AN BREED, P4; McEwan JC, 1992, P NZ SOC ANIMAL PROD, P4; McKay DM, 2003, J PARASITOL, V89, P188, DOI 10.1645/0022-3395(2003)089[0188:SIAARF]2.0.CO;2; McRae AF, 2005, ANIM SCI, V80, P135, DOI 10.1079/ASC41040135; MILLER HRP, 1987, PARASITOLOGY, V94, pS77, DOI 10.1017/S0031182000085838; MILLER HRP, 1981, IMMUNOLOGY, V44, P419; Miller J E, 2006, J Anim Sci, V84 Suppl, pE124; Morris C. A, 1998, WORLD C GEN APPL LIV, P295; Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625; Morris CA, 1995, BREEDING RESISTANCE, P22; Mugambi JM, 2005, SMALL RUMINANT RES, V56, P239, DOI 10.1016/j.smallrumres.2004.06.003; Mugambi JM, 1996, RES VET SCI, V61, P218, DOI 10.1016/S0034-5288(96)90066-1; Mugambi JM, 1997, VET PARASITOL, V69, P265, DOI 10.1016/S0304-4017(96)01128-4; Nde PN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00337; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; Riggio V, 2013, HEREDITY, V110, P420, DOI 10.1038/hdy.2012.90; Robertson JO, 2009, THROMB RES, V123, P644, DOI 10.1016/j.thromres.2008.07.003; Rowe A, 2008, VET PARASITOL, V154, P71, DOI 10.1016/j.vetpar.2008.02.014; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Silva MVB, 2012, ANIM GENET, V43, P63, DOI 10.1111/j.1365-2052.2011.02202.x; Sykes AR, 2003, AUST J EXP AGR, V43, P1393, DOI 10.1071/EA02228; Woolaston RR, 1996, ANIM SCI, V62, P451, DOI 10.1017/S1357729800014995; Woolaston RR, 1996, INT J PARASITOL, V26, P845, DOI 10.1016/S0020-7519(96)80054-3	71	59	64	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122797	10.1371/journal.pone.0122797	http://dx.doi.org/10.1371/journal.pone.0122797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867089	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100101
J	Dugat-Bony, E; Straub, C; Teissandier, A; Onesime, D; Loux, V; Monnet, C; Irlinger, F; Landaud, S; Leclercq-Perlat, MN; Bento, P; Fraud, S; Gibrat, JF; Aubert, J; Fer, F; Guedon, E; Pons, N; Kennedy, S; Beckerich, JM; Swennen, D; Bonnarme, P				Dugat-Bony, Eric; Straub, Cecile; Teissandier, Aurelle; Onesime, Djamila; Loux, Valentin; Monnet, Christophe; Irlinger, Francoise; Landaud, Sophie; Leclercq-Perlat, Marie-Noelle; Bento, Pascal; Fraud, Sebastien; Gibrat, Jean-Francois; Aubert, Julie; Fer, Frederic; Guedon, Eric; Pons, Nicolas; Kennedy, Sean; Beckerich, Jean-Marie; Swennen, Dominique; Bonnarme, Pascal			Overview of a Surface-Ripened Cheese Community Functioning by Meta-Omics Analyses	PLOS ONE			English	Article							GEOTRICHUM-CANDIDUM; DEBARYOMYCES-HANSENII; GENE-EXPRESSION; PENICILLIUM-CAMEMBERTI; METABOLIC-ACTIVITY; GENOME SEQUENCE; AMINO-ACIDS; YEAST; BACTERIA; PROTEIN	Cheese ripening is a complex biochemical process driven by microbial communities composed of both eukaryotes and prokaryotes. Surface-ripened cheeses are widely consumed all over the world and are appreciated for their characteristic flavor. Microbial community composition has been studied for a long time on surface-ripened cheeses, but only limited knowledge has been acquired about its in situ metabolic activities. We applied metagenomic, metatranscriptomic and biochemical analyses to an experimental surface-ripened cheese composed of nine microbial species during four weeks of ripening. By combining all of the data, we were able to obtain an overview of the cheese maturation process and to better understand the metabolic activities of the different community members and their possible interactions. Furthermore, differential expression analysis was used to select a set of biomarker genes, providing a valuable tool that can be used to monitor the cheese-making process.	[Dugat-Bony, Eric; Straub, Cecile; Monnet, Christophe; Irlinger, Francoise; Landaud, Sophie; Leclercq-Perlat, Marie-Noelle; Fer, Frederic; Beckerich, Jean-Marie; Swennen, Dominique; Bonnarme, Pascal] INRA, UMR Genie & Microbiol Proc Alimentaires 782, F-78850 Thiverval Grignon, France; [Dugat-Bony, Eric; Straub, Cecile; Monnet, Christophe; Irlinger, Francoise; Landaud, Sophie; Leclercq-Perlat, Marie-Noelle; Fer, Frederic; Beckerich, Jean-Marie; Swennen, Dominique; Bonnarme, Pascal] AgroParisTech, UMR Genie & Microbiol Proc Alimentaires 782, F-78850 Thiverval Grignon, France; [Teissandier, Aurelle; Aubert, Julie; Fer, Frederic] AgroParisTech, UMR Math & Informat Appl 518, F-75231 Paris, France; [Teissandier, Aurelle; Aubert, Julie; Fer, Frederic] INRA, UMR Math & Informat Appl 518, F-75231 Paris, France; [Onesime, Djamila; Guedon, Eric] INRA, Inst Micalis, F-78352 Jouy En Josas, France; [Onesime, Djamila; Guedon, Eric] AgroParisTech, Inst Micalis, F-78352 Jouy En Josas, France; [Bento, Pascal; Gibrat, Jean-Francois] INRA, Math & Informat Appl Genome & Environm UR1404, F-78352 Jouy En Josas, France; [Fraud, Sebastien] Actalia, F-74801 La Roche Sur Foron, France; [Pons, Nicolas; Kennedy, Sean] INRA, US Metagenopolis 1367, F-78352 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bonnarme, P (corresponding author), INRA, UMR Genie & Microbiol Proc Alimentaires 782, F-78850 Thiverval Grignon, France.	Pascal.Bonnarme@grignon.inra.fr	AUBERT, Julie/D-9120-2011; AUBERT, Julie/AAJ-8960-2021; GUEDON, Eric/N-8624-2019; Dugat-Bony, Eric/K-2455-2014; Guedon, Eric/S-5635-2016; Guédon, Eric/AAP-4143-2021; Swennen, Dominique/T-4544-2017	AUBERT, Julie/0000-0001-5203-5748; GUEDON, Eric/0000-0002-0901-4447; Dugat-Bony, Eric/0000-0002-5182-0063; Guedon, Eric/0000-0002-0901-4447; aurelie, teissandier/0000-0002-9836-9089; Swennen, Dominique/0000-0002-9370-5717; IRLINGER, Francoise/0000-0001-7883-7589; Loux, Valentin/0000-0002-8268-915X; Kennedy, Sean/0000-0002-3932-8922	ExEco program - French National Research Agency (ANR) [ANR-09-ALIA-012-01]	ExEco program - French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the ExEco program (a joint metatranscriptomic and biochemical approach to the cheese ecosystem: for an improved monitoring of the expression of a complex food ecosystem) (ANR-09-ALIA-012-01), funded by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrzak-Piekarczyk T., 2013, LACTIC ACID BACTERIA; Almeida M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1101; Arfi K, 2004, LAIT, V84, P435, DOI 10.1051/lait:2004016; Baruzzi F, 2005, J RAPID METH AUT MIC, V13, P177, DOI 10.1111/j.1745-4581.2005.00018.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaiseau PL, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P265; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P5214, DOI 10.1128/AEM.00934-13; Bonaiti C, 2005, J DAIRY SCI, V88, P1671, DOI 10.3168/jds.S0022-0302(05)72839-3; Boutrou R, 2005, INT J FOOD MICROBIOL, V102, P1, DOI 10.1016/j.ijfoodmicro.2004.12.028; Boutrou R, 2006, INT DAIRY J, V16, P775, DOI 10.1016/j.idairyj.2005.07.007; Carvalho AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068470; Castellote J, 2015, INT J FOOD MICROBIOL, V194, P54, DOI 10.1016/j.ijfoodmicro.2014.11.009; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Cholet O, 2007, APPL ENVIRON MICROB, V73, P2561, DOI 10.1128/AEM.02720-06; Collins YF, 2003, INT DAIRY J, V13, P841, DOI 10.1016/S0958-6946(03)00109-2; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cretenet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1054; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; Delcenserie V, 2014, J DAIRY SCI, V97, P6046, DOI 10.3168/jds.2014-8225; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Falentin H, 2012, FOOD MICROBIOL, V29, P132, DOI 10.1016/j.fm.2011.09.009; Falentin H, 2010, INT J FOOD MICROBIOL, V144, P10, DOI 10.1016/j.ijfoodmicro.2010.06.003; Gagny B, 2000, J CELL SCI, V113, P3309; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gori K, 2007, J DAIRY SCI, V90, P5032, DOI 10.3168/jds.2006-750; Hickey DK, 2006, J AGR FOOD CHEM, V54, P8229, DOI 10.1021/jf060819h; Irlinger F, 2012, J BACTERIOL, V194, P5141, DOI 10.1128/JB.01038-12; Irlinger F, 2009, CURR OPIN BIOTECH, V20, P142, DOI 10.1016/j.copbio.2009.02.016; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kumura H, 2002, BIOSCI BIOTECH BIOCH, V66, P1370, DOI 10.1271/bbb.66.1370; Lamarque M, 2004, J BACTERIOL, V186, P6492, DOI 10.1128/JB.186.19.6492-6500.2004; Landaud S, 2008, APPL MICROBIOL BIOT, V77, P1191, DOI 10.1007/s00253-007-1288-y; LANDER E S, 1988, Genomics, V2, P231; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larpin S, 2006, FEMS YEAST RES, V6, P1243, DOI 10.1111/j.1567-1364.2006.00127.x; Larpin-Laborde S, 2011, CAN J MICROBIOL, V57, P651, DOI [10.1139/W11-050, 10.1139/w11-050]; Leclercq-Perlat MN, 2013, J DAIRY SCI, V96, P4031, DOI 10.3168/jds.2012-6372; Leclercq-Perlat MN, 1999, J DAIRY RES, V66, P271, DOI 10.1017/S0022029999003362; Leclercq-Perlat MN, 2000, J DAIRY SCI, V83, P1674, DOI 10.3168/jds.S0022-0302(00)75036-3; Lessard MH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-235; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lodi T, 1999, MOL GEN GENET, V262, P623, DOI 10.1007/s004380051125; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Mansour S, 2009, PROTEOMICS, V9, P4714, DOI 10.1002/pmic.200900161; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; Miethke M, 2013, METALLOMICS, V5, P15, DOI 10.1039/c2mt20193c; Milesi MM, 2008, J DAIRY SCI, V91, P3277, DOI 10.3168/jds.2008-1197; Molimard P, 1996, J DAIRY SCI, V79, P169, DOI 10.3168/jds.S0022-0302(96)76348-8; Monnet C, 2013, APPL ENVIRON MICROB, V79, P469, DOI 10.1128/AEM.02360-12; Monnet C, 2012, APPL ENVIRON MICROB, V78, P3185, DOI 10.1128/AEM.00085-12; Monnet C, 2012, J BACTERIOL, V194, P738, DOI 10.1128/JB.06496-11; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Mor H, 1990, Biol Met, V2, P209, DOI 10.1007/BF01141361; MOUILLET L, 1981, LAIT, V61, P171, DOI 10.1051/lait:1981603-60411; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Rodicio R, 2013, YEAST, V30, P165, DOI 10.1002/yea.2954; Rossi F, 2011, APPL ENVIRON MICROB, V77, P2817, DOI 10.1128/AEM.02531-10; Savijoki K, 2006, APPL MICROBIOL BIOT, V71, P394, DOI 10.1007/s00253-006-0427-1; Sourabie AM, 2012, APPL MICROBIOL BIOT, V93, P1673, DOI 10.1007/s00253-011-3500-3; Sousa MJ, 2001, INT DAIRY J, V11, P327, DOI 10.1016/S0958-6946(01)00062-0; van Hijum SAFT, 2013, CURR OPIN BIOTECH, V24, P178, DOI 10.1016/j.copbio.2012.08.004; Vegarud GE, 2000, BRIT J NUTR, V84, pS91; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Wilkinson D, 2011, BIOCHEM SOC T, V39, P1502, DOI 10.1042/BST0391502; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041; Yvon M, 2001, INT DAIRY J, V11, P185, DOI 10.1016/S0958-6946(01)00049-8	76	82	89	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124360	10.1371/journal.pone.0124360	http://dx.doi.org/10.1371/journal.pone.0124360			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867897	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100252
J	Guo, LL; Liu, W; Lu, TT; Guo, WJ; Gao, J; Luo, Q; Wu, XF; Sun, Y; Wu, XD; Shen, Y; Xu, Q				Guo, Lele; Liu, Wen; Lu, Tingting; Guo, Wenjie; Gao, Jian; Luo, Qiong; Wu, Xuefeng; Sun, Yang; Wu, Xudong; Shen, Yan; Xu, Qiang			Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid Astilbin	PLOS ONE			English	Article							TARGETED THERAPIES; IMMUNOSUPPRESSIVE ACTIVITY; DENDRITIC CELLS; TNF-ALPHA; ERYTHEMATOSUS; DAMAGE; COSTIMULATION; LYMPHOCYTES; DYSFUNCTION; METABOLITE	Treatment of systemic lupus erythematosus (SLE), a chronic inflammatory disease, involves the long-term use of immunosuppressive agents with significant side effects. New therapeutic approaches are being explored to find better treatment possibilities. In this study, age-matched female MRL/lpr mice were treated orally with a natural flavonoid astilbin. Astilbin administration started either at week 8 or week 12 of age though week 20. In the early treatment regimen, the treatment with astilbin reduced splenomegaly/lymphomegaly, autoantibody production and ameliorated lupus nephitis. Several serum cytokines were significantly decreased upon treatment including IFN-g, IL-17A, IL-1b, TNF-a and IL-6. Both spleen CD44(hi)CD62L(lo) activated T cells and CD138(+)B220(-) plasma cells greatly declined. Furthermore, astilbin treatment resulted in decreased mitochondrial membrane potential in activated T cells and downregulated expression of the co-stimulatory molecules CD80 and CD86 on LPS stimulated B cells. Similar but less profound effectiveness was observed in the mice with established disease in the late treatment regimen. These results indicate that the natural product astilbin can mitigate disease development in lupus-prone mice by decreasing functional activated T and B cells.	[Guo, Lele; Liu, Wen; Lu, Tingting; Guo, Wenjie; Gao, Jian; Luo, Qiong; Wu, Xuefeng; Sun, Yang; Wu, Xudong; Shen, Yan; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Shen, Y (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	shenyan@nju.edu.cn; molpharm@163.com	Guo, Wenjie/AAQ-7553-2020; Gao, Jian/AAU-8293-2021	Gao, Jian/0000-0002-2722-7067	National Natural Science Foundation of China [81330079, 31370900, 81373466]; Natural Science Foundation of Jiangsu Province [BK20131282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Nos. 81330079, 31370900, 81373466) and the Natural Science Foundation of Jiangsu Province (No. BK20131282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Cai Y, 2003, INFLAMM RES, V52, P334, DOI 10.1007/s00011-003-1179-3; Chen T, 1999, PLANTA MED, V65, P56, DOI 10.1055/s-1999-13963; Chen T H, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P382; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Ding YB, 2014, BIOCHEM BIOPH RES CO, V446, P529, DOI 10.1016/j.bbrc.2014.02.136; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; Giltiay NV, 2013, J IMMUNOL, V191, P2155, DOI 10.4049/jimmunol.1300152; Grech P, 2013, LUPUS, V22, P978, DOI 10.1177/0961203313499417; Guo JM, 2007, CLIN CHEM, V53, P465, DOI 10.1373/clinchem.2006.077297; Haraguchi H, 1996, BIOSCI BIOTECH BIOCH, V60, P945, DOI 10.1271/bbb.60.945; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Ichinose K, 2011, ARTHRITIS RHEUM-US, V63, P523, DOI 10.1002/art.30085; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Liang BL, 2000, J IMMUNOL, V165, P3436, DOI 10.4049/jimmunol.165.6.3436; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Lu LD, 2011, J IMMUNOL, V187, P3840, DOI 10.4049/jimmunol.1101228; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Mok CC, 2014, EXPERT OPIN EMERG DR, V19, P303, DOI 10.1517/14728214.2014.894018; Mok CC, 2014, EXPERT OPIN BIOL TH, V14, P773, DOI 10.1517/14712598.2014.895810; Mosca M, 2013, CLIN EXP RHEUMATOL, V31, pS82; Nagy G, 2005, CRIT REV IMMUNOL, V25, P123, DOI 10.1615/CritRevImmunol.v25.i2.30; Robak E, 2012, CURR MED CHEM, V19, P438, DOI 10.2174/092986712803414312; Roth R, 1996, J IMMUNOL, V157, P2924; Tang JY, 2013, J CHROMATOGR B, V929, P56, DOI 10.1016/j.jchromb.2013.04.018; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Wang J, 2004, J PHARM PHARMACOL, V56, P495, DOI 10.1211/0022357023033; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Xu Q, 1999, EUR J PHARMACOL, V377, P93, DOI 10.1016/S0014-2999(99)00401-X; Yan R, 2001, PHARMACOL RES, V44, P135, DOI 10.1006/phrs.2001.0838; Yi HW, 2008, INT IMMUNOPHARMACOL, V8, P1467, DOI 10.1016/j.intimp.2008.06.006; Zou S, 2010, TRANSPL P, V42, P3798, DOI 10.1016/j.transproceed.2010.06.031	36	69	73	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124002	10.1371/journal.pone.0124002	http://dx.doi.org/10.1371/journal.pone.0124002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867237	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100231
J	Liu, XL; Gheno, T; Lindahl, BB; Lindwall, G; Gleeson, B; Liu, ZK				Liu, Xuan L.; Gheno, Thomas; Lindahl, Bonnie B.; Lindwall, Greta; Gleeson, Brian; Liu, Zi-Kui			First-Principles Calculations, Experimental Study, and Thermodynamic Modeling of the Al-Co-Cr System	PLOS ONE			English	Article							PHASE-EQUILIBRIA; TERNARY-SYSTEM; TEMPERATURE; STABILITY; ALLOYS; NI; TECHNOLOGY; COATINGS; PROGRESS; TI	The phase relations and thermodynamic properties of the condensed Al-Co-Cr ternary alloy system are investigated using first-principles calculations based on density functional theory (DFT) and phase-equilibria experiments that led to X-ray diffraction (XRD) and electron probe micro-analysis (EPMA) measurements. A thermodynamic description is developed by means of the calculations of phase diagrams (CALPHAD) method using experimental and computational data from the present work and the literature. Emphasis is placed on modeling the bcc-A2, B2, fcc-gamma, and tetragonal-sigma phases in the temperature range of 1173 to 1623 K. Liquid, bcc-A2 and fcc-gamma phases are modeled using substitutional solution descriptions. First-principles special quasirandom structures (SQS) calculations predict a large bcc-A2 (disordered)/B2 (ordered) miscibility gap, in agreement with experiments. A partitioning model is then used for the A2/B2 phase to effectively describe the order-disorder transitions. The critically assessed thermodynamic description describes all phase equilibria data well. A2/B2 transitions are also shown to agree well with previous experimental findings.	[Liu, Xuan L.; Lindwall, Greta; Liu, Zi-Kui] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Gheno, Thomas; Gleeson, Brian] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA; [Lindahl, Bonnie B.] KTH Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Institute of Technology	Liu, XL (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	xul119@psu.edu	Gheno, Thomas/AAI-5552-2020; Liu, Zi-Kui/A-8196-2009	Liu, Zi-Kui/0000-0003-3346-3696; Lindwall, Greta/0000-0003-4221-8510; Gheno, Thomas/0000-0002-9343-8559; Gleeson, Brian/0000-0001-5531-7337; Hagen, Bonnie/0000-0001-9010-525X	NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD) [IIP-1034965, IIP-1034968]; Office of Naval Research (ONR) - the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL) [N0014-07-1-0638]; Department of Energy [DE-FE0007271]; European Research Fund for Coal and Steel (RFCS) [RFSR-CT-2010-00018]; National Science Foundation [ACI-1053575]	NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD); Office of Naval Research (ONR) - the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL); Department of Energy(United States Department of Energy (DOE)); European Research Fund for Coal and Steel (RFCS); National Science Foundation(National Science Foundation (NSF))	XLL, GL, and ZKL acknowledges that the computational aspects of this work were financially supported by the NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD, http://www.ccmd.psu.edu/), including dues contributions of CCMD members, through grants IIP-1034965 (Penn State) and IIP-1034968 (Georgia Tech) and the Office of Naval Research (ONR, http://www.onr.navy.mil/) with the contract number N0014-07-1-0638 managed by David Shifler. TG and BG acknowledges that the experimental aspects of this work were partly supported by the Department of Energy under grant number DE-FE0007271 through the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL, http://www.netl.doe.gov/), with Dr. Seth Lawson being the Project Manager. One of the authors, BL, acknowledges funding from the European Research Fund for Coal and Steel (RFCS, http://cordis.europa.eu/coal-steel-rtd/) project "Precipitation in High Manganese Steels" under the grant agreement no. RFSR-CT-2010-00018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Computing clusters LION and Cyberstar are provided by the Materials Simulation Center and the Research Computing and Cyberinfrastructure Group at the Pennsylvania State University. Additionally, this work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. We would like to also thank Dr. Yi Wang and Richard Otis for stimulating discussions about the computational aspects of this work.	Achar DRG, 2004, SURF COAT TECH, V187, P272, DOI [10.1016/j.surfcoat.2004.02.018, 10.1016/j.surfocat.2004.02.018]; Alers G.A., 1965, PHYS ACOUSTICS, VIII, P1; Andersson JO, 2002, CALPHAD, V26, P273, DOI 10.1016/S0364-5916(02)00037-8; Ansara I., 1998, COST 507 DEFINITION, V2; Bell H. B., 1973, Metal Science Journal, V7, P185; BIRCH F, 1947, PHYS REV AM PHYS SOC, P71; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chen Q, 2001, ACTA MATER, V49, P947, DOI 10.1016/S1359-6454(01)00002-7; Clarke DR, 2003, ANNU REV MATER RES, V33, P383, DOI 10.1146/annurev.matsci.33.011403.113718; Darolia R, 2013, INT MATER REV, V58, P315, DOI 10.1179/1743280413Y.0000000019; DICKINS GJ, 1956, ACTA CRYSTALLOGR, V9, P297, DOI 10.1107/S0365110X56000826; DINSDALE AT, 1991, CALPHAD, V15, P317, DOI 10.1016/0364-5916(91)90030-N; DOWNIE DB, 1983, J CHEM THERMODYN, V15, P645, DOI 10.1016/0021-9614(83)90078-2; Dupin N, 2001, CALPHAD, V25, P279, DOI 10.1016/S0364-5916(01)00049-9; Dupin N, 1998, REV METALL-PARIS, V95, P1121, DOI 10.1051/metal/199895091121; Dupin N, 1999, Z METALLKD, V90, P76; Dupin N, 1995, THESIS INP GRENOBLE; Evans AG, 2001, PROG MATER SCI, V46, P505, DOI 10.1016/S0079-6425(00)00020-7; Goward GW, 1998, SURF COAT TECH, V108, P73, DOI 10.1016/S0257-8972(98)00667-7; Hafner R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184432; Hammer L, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075413; Havrankova J, 1999, KOVOVE MATER, V37, P34; Helander T, 1999, J PHASE EQUILIB, V20, P57, DOI 10.1361/105497199770335947; Hillert M, 2001, J ALLOY COMPD, V320, P161, DOI 10.1016/S0925-8388(00)01481-X; HILLERT M, 1978, CALPHAD, V2, P227, DOI 10.1016/0364-5916(78)90011-1; INDEN G, 1981, PHYSICA B & C, V103, P82, DOI 10.1016/0378-4363(81)91004-4; Ishikawa K, 1998, BER BUNSEN PHYS CHEM, V102, P1206, DOI 10.1002/bbpc.19981020924; JANSSON B, 1984, TRITAMAC0234; Jiang C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214202; Jiang C, 2005, ACTA MATER, V53, P2643, DOI 10.1016/j.actamat.2005.02.026; Jiang C, 2009, ACTA MATER, V57, P4716, DOI 10.1016/j.actamat.2009.06.026; Joubert JM, 2008, PROG MATER SCI, V53, P528, DOI 10.1016/j.pmatsci.2007.04.001; KAMM GN, 1964, J APPL PHYS, V35, P327, DOI 10.1063/1.1713309; KATTNER UR, 2002, CONSTRUCTION THERMOD; KITTEL C, 1995, INTRO SOLID STATE PH; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G., 2013, VASP GUIDE; Lieser AC, 2012, CALPHAD, V38, P92, DOI 10.1016/j.calphad.2012.04.005; Liu XL, 2015, COMP MATER SCI, V98, P34, DOI 10.1016/j.commatsci.2014.10.056; Liu XL, 2013, CALPHAD, V41, P119, DOI 10.1016/j.calphad.2013.02.006; Liu ZK, 2009, J PHASE EQUILIB DIFF, V30, P517, DOI 10.1007/s11669-009-9570-6; Lu XG, 2007, ACTA MATER, V55, P1215, DOI 10.1016/j.actamat.2006.05.054; MEHL MJ, 1990, PHYS REV B, V41, P10311, DOI 10.1103/PhysRevB.41.10311; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; MORI N, 1988, PHYSICA B & C, V149, P226, DOI 10.1016/0378-4363(88)90246-X; MORUZZI VL, 1990, PHYS REV B, V42, P8361, DOI 10.1103/PhysRevB.42.8361; MOSKVITINA ES, 1992, VESTN MOSK U KHIM+, V33, P373; Nicholls JR, 2000, JOM-J MIN MET MAT S, V52, P28, DOI 10.1007/s11837-000-0112-2; Oikawa K, 2002, ACTA MATER, V50, P2223, DOI 10.1016/S1359-6454(01)00433-5; Pavlu J, 2010, INTERMETALLICS, V18, P212, DOI 10.1016/j.intermet.2009.07.018; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; REDLICH O, 1948, IND ENG CHEM, V40, P345, DOI 10.1021/ie50458a036; Reed R.C., 2006, SUPERALLOYS; Shang S., 2007, APPL PHYS LETT, V90; Shang SL, 2010, COMP MATER SCI, V48, P813, DOI 10.1016/j.commatsci.2010.03.041; Shang SL, 2010, COMP MATER SCI, V47, P1040, DOI 10.1016/j.commatsci.2009.12.006; Stein F, 2013, INTERMETALLICS, V39, P58, DOI 10.1016/j.intermet.2013.03.011; Sundman B, 2009, ACTA MATER, V57, P2896, DOI 10.1016/j.actamat.2009.02.046; Toscano J, 2007, SURF COAT TECH, V202, P603, DOI 10.1016/j.surfcoat.2007.06.044; Wang Y, 2004, CALPHAD, V28, P79, DOI 10.1016/j.calphad.2004.05.002; Wang Y, 2004, ACTA MATER, V52, P2665, DOI 10.1016/j.actamat.2004.02.014; WOOD JH, 1987, SUPERALLOYS, V2; Wright IG, 2007, INT J HYDROGEN ENERG, V32, P3610, DOI 10.1016/j.ijhydene.2006.08.049; Yang SY, 2012, RARE METALS, V31, P75, DOI 10.1007/s12598-012-0466-y; Zacherl CL, 2012, CALPHAD, V38, P71, DOI 10.1016/j.calphad.2012.05.001; ZUNGER A, 1990, PHYS REV LETT, V65, P353, DOI 10.1103/PhysRevLett.65.353	68	13	13	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121386	10.1371/journal.pone.0121386	http://dx.doi.org/10.1371/journal.pone.0121386			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875037	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000352845100312
J	Peugnet, P; Robles, M; Mendoza, L; Wimel, L; Dubois, C; Dahirel, M; Guillaume, D; Camous, S; Berthelot, V; Toquet, MP; Richard, E; Sandersen, C; Chaffaux, S; Lejeune, JP; Tarrade, A; Serteyn, D; Chavatte-Palmer, P				Peugnet, Pauline; Robles, Morgane; Mendoza, Luis; Wimel, Laurence; Dubois, Cedric; Dahirel, Michele; Guillaume, Daniel; Camous, Sylvaine; Berthelot, Valerie; Toquet, Marie-Pierre; Richard, Eric; Sandersen, Charlotte; Chaffaux, Stephane; Lejeune, Jean-Philippe; Tarrade, Anne; Serteyn, Didier; Chavatte-Palmer, Pascale			Effects of Moderate Amounts of Barley in Late Pregnancy on Growth, Glucose Metabolism and Osteoarticular Status of Pre-Weaning Horses	PLOS ONE			English	Article							INSULIN-SECRETION; POSTNATAL-GROWTH; EMBRYO-TRANSFER; BODY CONDITION; MATERNAL SIZE; YOUNG HORSES; FETAL-GROWTH; RESPONSES; MARES; FOALS	In stud management, broodmares are commonly fed concentrates in late pregnancy. This practice, however, was shown to correlate with an increased incidence of osteochondrosis in foals, which may be related to insulin sensitivity. We hypothesized that supplementation of the mare with barley in the last trimester of pregnancy alters the pre-weaning foal growth, glucose metabolism and osteoarticular status. Here, pregnant multiparous saddlebred mares were fed forage only (group F, n=13) or both forage and cracked barley (group B, n=12) from the 7th month of pregnancy until term, as calculated to cover nutritional needs of broodmares. Diets were given in two daily meals. All mares and foals returned to pasture after parturition. Post-natal growth, glucose metabolism and osteoarticular status were investigated in pre-weaning foals. B mares maintained an optimal body condition score (>3.5), whereas that of F mares decreased and remained low (<2.5) up to 3 months of lactation, with a significantly lower bodyweight (-7%) than B mares throughout the last 2 months of pregnancy. B mares had increased plasma glucose and insulin after the first meal and after the second meal to a lesser extent, which was not observed in F mares. B mares also had increased insulin secretion during an intravenous glucose tolerance test (IVGTT). Plasma NEFA and leptin were only temporarily affected by diet in mares during pregnancy or in early lactation. Neonatal B foals had increased serum osteocalcin and slightly increased glucose increments and clearance after glucose injection, but these effects had vanished at weaning. Body measurements, plasma IGF-1, T4, T3, NEFA and leptin concentrations, insulin secretion during IVGTT, as well as glucose metabolism rate during euglycemic hyperinsulinemic clamps after weaning, did not differ between groups. Radiographic examination of joints indicated increased osteochondrosis relative risk in B foals, but this was not significant. These data demonstrate that B or F maternal nutrition has very few effects on foal growth, endocrinology and glucose homeostasis until weaning, but may induce cartilage lesions.	[Peugnet, Pauline; Robles, Morgane; Dahirel, Michele; Camous, Sylvaine; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France; [Wimel, Laurence; Dubois, Cedric] IFCE, Stn Expt Valade, F-19370 Chamberet, France; [Guillaume, Daniel] INRA, CNRS, Physiol Reprod & Comportements, UMR85,UMR7247, F-37380 Nouzilly, France; [Guillaume, Daniel] Univ Tours, F-37000 Tours, France; [Berthelot, Valerie] AgroParis Tech, F-75005 Paris 5, France; [Toquet, Marie-Pierre; Richard, Eric] Normandie Univ, UNICAEN, ICORE LABEO Frank Duncombe Lab SF4206, F-14000 Caen, France; [Mendoza, Luis; Sandersen, Charlotte; Lejeune, Jean-Philippe; Serteyn, Didier] Univ Liege, Equine Clin, Fac Med Vet, B-4000 Liege, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; AgroParisTech; Universite de Caen Normandie; University of Liege	Peugnet, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France.	peugnetpauline@gmail.com	Richard, Eric A./T-9257-2017; Robles, Morgane/AAA-4407-2020; Chavatte-Palmer, Pascale/K-7349-2012	Richard, Eric A./0000-0002-5890-8658; Robles, Morgane/0000-0003-4821-4684; Chavatte-Palmer, Pascale/0000-0002-4581-6092; TOQUET, MARIE-PIERRE/0000-0001-6510-3957; Couturier-Tarrade, Anne/0000-0003-1559-5476; Sandersen, charlotte/0000-0002-3404-2757	"Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM"; "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems"	"Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM"; "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems"	This work was funded through a grant from the "Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM" and through funding from the "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2004, REPRODUCTION, V127, P67, DOI 10.1530/rep.1.00024; Allen WR, 2002, J ENDOCRINOL, V172, P237, DOI 10.1677/joe.0.1720237; Anderson ST, 2012, AUSTR EQ SCI S GOLD; Anderson ST, 2014, AUSTR EQ SCI S GOLD; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Arnaud G, 2000, NOTATION ETAT CORPOR; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Cavinder C. A., 2012, Professional Animal Scientist, V28, P344; Denoix J. M., 1990, Pratique Veterinaire Equine, V22, P14; DEPEW CL, 1994, J ANIM SCI, V72, P1530, DOI 10.2527/1994.7261530x; Dobbs TN, 2012, AUSTR EQ SCI S GOLD; DOREAU M, 1994, LAIT, V74, P401, DOI 10.1051/lait:1994633; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; FOWDEN AL, 1984, EQUINE VET J, V16, P239, DOI 10.1111/j.2042-3306.1984.tb01919.x; Gentry LR, 2002, J ANIM SCI, V80, P2695; George LA, 2009, DOMEST ANIM ENDOCRIN, V37, P23, DOI 10.1016/j.domaniend.2009.01.003; Giussani DA, 2003, J PHYSIOL-LONDON, V547, P67, DOI 10.1113/jphysiol.2002.027409; Glade M. J., 1986, Journal of Equine Veterinary Science, V6, P151, DOI 10.1016/S0737-0806(86)80066-1; GLADE MJ, 1984, GROWTH, V48, P473; GLADE MJ, 1984, J ANIM SCI, V59, P658, DOI 10.2527/jas1984.593658x; GLADE MJ, 1985, J ENDOCRINOL, V104, P93, DOI 10.1677/joe.0.1040093; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Henson FMD, 1997, EQUINE VET J, V29, P441, DOI 10.1111/j.2042-3306.1997.tb03156.x; JAESCHKE G, 1975, ZBL VET MED A, V22, P89; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Martin-Rosset W, 2012, NUTR ALIMENTATION CH, P624; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ousey JC, 2008, EQUINE VET J, V40, P673, DOI 10.2746/042516408X322175; Pagan JD, 2001, RELATIONSHIP GLYCEMI; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Peugnet P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102044; Ralston SL, 1996, PFERDEHEILKUNDE, V12, P320; Salazar-Ortiz J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-130; Savage C., 1993, EQUINE VET J S, V25, P74; Song X, 2014, AUSTR EQ SCI S GOLD; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; STICKER LS, 1995, J ANIM SCI, V73, P136; STULL CL, 1988, J NUTR, V118, P206, DOI 10.1093/jn/118.2.206; Thorson JF, 2010, J ANIM SCI, V88, P982, DOI 10.2527/jas.2008-1646; Valette J. P., 2007, Equine and Comparative Exercise Physiology, V4, P23, DOI 10.1017/S1478061507747758; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Weeren P. R. van, 2006, Clinical Techniques in Equine Practice, V5, P248, DOI 10.1053/j.ctep.2006.08.002; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887	44	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122596	10.1371/journal.pone.0122596	http://dx.doi.org/10.1371/journal.pone.0122596			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875166	Green Published, gold			2022-12-27	WOS:000352845100086
J	Sapio, MR; Vessaz, M; Thomas, P; Genton, P; Fricker, LD; Salzmann, A				Sapio, Matthew R.; Vessaz, Monique; Thomas, Pierre; Genton, Pierre; Fricker, Lloyd D.; Salzmann, Annick			Novel Carboxypeptidase A6 (CPA6) Mutations Identified in Patients with Juvenile Myoclonic and Generalized Epilepsy	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; EXTRACELLULAR-MATRIX; FEBRILE SEIZURES; GENE; EFHC1; SUSCEPTIBILITY; ASSOCIATION; PROTEIN; EPIDEMIOLOGY; PURIFICATION	Carboxypeptidase A6 (CPA6) is a peptidase that removes C-terminal hydrophobic amino acids from peptides and proteins. The CPA6 gene is expressed in the brains of humans and animals, with high levels of expression during development. It is translated with a prodomain (as proCPA6), which is removed before secretion. The active form of CPA6 binds tightly to the extracellular matrix (ECM) where it is thought to function in the processing of peptides and proteins. Mutations in the CPA6 gene have been identified in patients with temporal lobe epilepsy and febrile seizures. In the present study, we screened for CPA6 mutations in patients with juvenile myoclonic epilepsy and identified two novel missense mutations: Arg36His and Asn271Ser. Patients harboring these mutations also presented with generalized epilepsy. Neither of the novel mutations was found in a control population. Asn271 is highly conserved in CPA6 and other related metallocarboxypeptidases. Arg36 is present in the prodomain and is not highly conserved. To assess structural consequences of the amino acid substitutions, both mutants were modeled within the predicted structure of the enzyme. To examine the effects of these mutations on enzyme expression and activity, we expressed the mutated enzymes in human embryonic kidney 293T cells. These analyses revealed that Asn271Ser abolished enzymatic activity, while Arg36His led to a similar to 50% reduction in CPA6 levels in the ECM. Pulse-chase using radio-labeled amino acids was performed to follow secretion. Newly-synthesized CPA6 appeared in the ECM with peak levels between 2-8 hours. There was no major difference in time course between wild-type and mutant forms, although the amount of radiolabeled CPA6 in the ECM was lower for the mutants. Our experiments demonstrate that these mutations in CPA6 are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of epilepsy.	[Sapio, Matthew R.; Fricker, Lloyd D.] Albert Einstein Coll, Dept Neurosci, Bronx, NY 10461 USA; [Vessaz, Monique] Univ Hosp Geneva, Dept Genet Med & Lab, Geneva, Switzerland; [Thomas, Pierre] Univ Hosp, Dept Neurol, Nice, France; [Genton, Pierre] Hop Henri Gastaut, Ctr St Paul, Marseille, France; [Fricker, Lloyd D.] Albert Einstein Coll, Dept Mol Pharmacol, Bronx, NY USA; [Salzmann, Annick] Univ Geneva, Dept Psychiat, Geneva, Switzerland	Yeshiva University; Albert Einstein College of Medicine; University of Geneva; CHU Nice; Yeshiva University; Albert Einstein College of Medicine; University of Geneva	Fricker, LD (corresponding author), Albert Einstein Coll, Dept Neurosci, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu; annick.salzmann@hcuge.ch	Sapio, Matthew R/J-5096-2016	Sapio, Matthew R/0000-0002-8855-5419; Salzmann, Annick/0000-0003-0571-251X	National Institutes of Health [1R01 DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes of Health grant 1R01 DA-004494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, EPILEPSIA, V30, P389; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Belhedi N, 2014, EPILEPSY RES, V108, P144, DOI 10.1016/j.eplepsyres.2013.10.007; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berg Anne T, 2013, Continuum (Minneap Minn), V19, P571, DOI 10.1212/01.CON.0000431377.44312.9e; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Camfield CS, 2013, EPILEPSY BEHAV, V28, pS15, DOI 10.1016/j.yebeh.2012.06.024; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; de Nijs L, 2013, EPILEPSY BEHAV, V28, pS58, DOI 10.1016/j.yebeh.2012.06.034; Delgado-Escueta Antonio V, 2007, Epilepsy Curr, V7, P61, DOI 10.1111/j.1535-7511.2007.00171.x; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fialka F, 2008, ORAL ONCOL, V44, P941, DOI 10.1016/j.oraloncology.2007.10.011; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Gardiner M, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00310.x; Genton P, 2013, EPILEPSY BEHAV, V28, pS8, DOI 10.1016/j.yebeh.2012.10.034; Greenberg DA, 2005, AM J HUM GENET, V76, P139, DOI 10.1086/426735; Grisar T, 2012, JASPERS BASIC MECH E; Guipponi M, 1997, AM J MED GENET, V74, P150, DOI 10.1002/(SICI)1096-8628(19970418)74:2<150::AID-AJMG6>3.3.CO;2-H; Helbig I, 2013, EPILEPSY BEHAV, V28, pS66, DOI 10.1016/j.yebeh.2012.07.005; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Katano M, 2012, CELL CALCIUM, V51, P179, DOI 10.1016/j.ceca.2011.12.011; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Lyons PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012967; Mas C, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017954; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Novikova EG, 2000, J BIOL CHEM, V275, P4865, DOI 10.1074/jbc.275.7.4865; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rodriguez de la Vega Otazo M., 2012, FASEB J; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rossetto MG, 2011, HUM MOL GENET, V20, P4248, DOI 10.1093/hmg/ddr352; Salzmann A, 2012, HUM MUTAT, V33, P124, DOI 10.1002/humu.21613; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Sapio MR, 2012, J BIOL CHEM, V287, P42900, DOI 10.1074/jbc.M112.414094; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Song LX, 1997, BIOCHEM J, V323, P265, DOI 10.1042/bj3230265; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Stogmann E, 2006, NEUROLOGY, V67, P2029, DOI 10.1212/01.wnl.0000250254.67042.1b; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Tanco S, 2013, MOL CELL PROTEOMICS, V12, P2096, DOI 10.1074/mcp.M112.023234; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Trenite DGAKN, 2013, EPILEPSY BEHAV, V28, pS87, DOI 10.1016/j.yebeh.2012.11.051; Varlamov O, 1996, J BIOL CHEM, V271, P13981, DOI 10.1074/jbc.271.24.13981; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	57	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123180	10.1371/journal.pone.0123180	http://dx.doi.org/10.1371/journal.pone.0123180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875328	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100146
J	Schock, SN; Young, JA; He, TH; Sun, YF; Winoto, A				Schock, Suruchi N.; Young, Jennifer A.; He, Tina H.; Sun, Yuefang; Winoto, Astar			Deletion of FADD in Macrophages and Granulocytes Results in RIP3-and MyD88-Dependent Systemic Inflammation	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; DENDRITIC CELLS; PROGRAMMED NECROSIS; NLRP3 INFLAMMASOME; T-CELLS; DEATH; APOPTOSIS; KINASE; NECROPTOSIS; ACTIVATION	Myeloid cells, which include monocytes, macrophages, and granulocytes, are important innate immune cells, but the mechanism and downstream effect of their cell death on the immune system is not completely clear. Necroptosis is an alternate form of cell death that can be triggered when death receptor-mediated apoptosis is blocked, for example, in stimulated Fas-associated Death Domain (FADD) deficient cells. We report here that mice deficient for FADD in myeloid cells (mFADD(-/-)) exhibit systemic inflammation with elevated inflammatory cytokines and increased levels of myeloid and B cell populations while their dendritic and T cell numbers are normal. These phenotypes were abolished when RIP3 deficiency was introduced, suggesting that systemic inflammation is caused by RIP3-dependent necroptotic and/or inflammatory activity. We further found that loss of MyD88 can rescue the systemic inflammation observed in these mice. These phenotypes are surprisingly similar to that of dendritic cell (DC)-specific FADD deficient mice with the exception that DC numbers are normal in mFADD(-/-)mice. Together these data support the notion that innate immune cells are constantly being stimulated through the MyD88-dependent pathway and aberrations in their cell death machinery can result in systemic effects on the immune system.	[Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu			National Institutes of Health [R01 AI095299, T32 AI100829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095299, T32AI100829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01 AI095299 and T32 AI100829). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FK, 2015, ANNU REV IMMUNOL, V33, P41; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hochweller K, 2009, BLOOD, V114, P4411, DOI 10.1182/blood-2008-11-188045; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Young JA, 2013, CELL REP, V3, P1932, DOI 10.1016/j.celrep.2013.04.033; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	52	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124391	10.1371/journal.pone.0124391	http://dx.doi.org/10.1371/journal.pone.0124391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874713	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100257
J	Sprehn, CG; Blum, MJ; Quinn, TP; Heins, DC				Sprehn, C. Grace; Blum, Michael J.; Quinn, Thomas P.; Heins, David C.			Landscape Genetics of Schistocephalus solidus Parasites in Threespine Stickleback (Gasterosteus aculeatus) from Alaska	PLOS ONE			English	Article							3-SPINED STICKLEBACKS; NATURAL-POPULATIONS; GAVIA-IMMER; HOST-SPECIFICITY; LOCAL ADAPTATION; FLOW; DIFFERENTIATION; DISPERSAL; SOFTWARE; HISTORY	The nature of gene flow in parasites with complex life cycles is poorly understood, particularly when intermediate and definitive hosts have contrasting movement potential. We examined whether the fine-scale population genetic structure of the diphyllobothriidean cestode Schistocephalus solidus reflects the habits of intermediate threespine stickleback hosts or those of its definitive hosts, semi-aquatic piscivorous birds, to better understand complex host-parasite interactions. Seventeen lakes in the Cook Inlet region of south-central Alaska were sampled, including ten in the Matanuska-Susitna Valley, five on the Kenai Peninsula, and two in the Bristol Bay drainage. We analyzed sequence variation across a 759 bp region of the mitochondrial DNA (mtDNA) cytochrome oxidase I region for 1,026 S. solidus individuals sampled from 2009-2012. We also analyzed allelic variation at 8 microsatellite loci for 1,243 individuals. Analysis of mtDNA haplotype and microsatellite genotype variation recovered evidence of significant population genetic structure within S. solidus. Host, location, and year were factors in structuring observed genetic variation. Pair-wise measures revealed significant differentiation among lakes, including a pattern of isolation-by-distance. Bayesian analysis identified three distinct genotypic clusters in the study region, little admixture within hosts and lakes, and a shift in genotype frequencies over time. Evidence of fine-scale population structure in S. solidus indicates that movement of its vagile, definitive avian hosts has less influence on gene flow than expected based solely on movement potential. Observed patterns of genetic variation may reflect genetic drift, behaviors of definitive hosts that constrain dispersal, life history of intermediate hosts, and adaptive specificity of S. solidusto intermediate host genotype.	[Sprehn, C. Grace; Blum, Michael J.; Heins, David C.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Blum, Michael J.] Tulane Univ, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70118 USA; [Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Tulane University; Tulane University; Xavier University of Louisiana; University of Washington; University of Washington Seattle	Sprehn, CG (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	csprehn@tulane.edu		Sprehn, Charlotte/0000-0002-4164-4246	Newcomb College Institute at Tulane University	Newcomb College Institute at Tulane University	Laboratory funding was provided by the Newcomb College Institute at Tulane University (http://tulane.edu/newcomb/).	Barber I, 2010, PARASITOLOGY, V137, P411, DOI 10.1017/S0031182009991466; Barr JF, 1996, HYDROBIOLOGIA, V321, P119, DOI 10.1007/BF00023169; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Bartolome C, 2011, ORG DIVERS EVOL, V11, P307, DOI 10.1007/s13127-011-0052-4; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Binz T, 2000, MOL ECOL, V9, P1926, DOI 10.1046/j.1365-294x.2000.01073-5.x; Blasco-Costa I, 2012, MOL ECOL, V21, P207, DOI 10.1111/j.1365-294X.2011.05374.x; BLOUIN MS, 1992, EVOLUTION, V46, P470, DOI 10.1111/j.1558-5646.1992.tb02052.x; BLOUIN MS, 1995, GENETICS, V141, P1007; Bouzid W, 2008, INT J PARASITOL, V38, P1465, DOI 10.1016/j.ijpara.2008.03.008; BRATEN T, 1966, PARASITOLOGY, V56, pP5, DOI 10.1017/S0031182000071687; Caldera EJ, 2008, EVOL ECOL RES, V10, P575; Copp GH, 2003, ANN ZOOL FENN, V40, P341; Criscione CD, 2008, PARASITE, V15, P439, DOI 10.1051/parasite/2008153439; Criscione CD, 2006, EVOLUTION, V60, P553, DOI 10.1111/j.0014-3820.2006.tb01136.x; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Criscione CD, 2004, EVOLUTION, V58, P198, DOI 10.1111/j.0014-3820.2004.tb01587.x; Davies CM, 1999, PARASITOLOGY, V119, P295, DOI 10.1017/S0031182099004722; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.1111/j.1558-5646.1996.tb03615.x, 10.2307/2410696]; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Franke F, 2014, FISH SHELLFISH IMMUN, V36, P130, DOI 10.1016/j.fsi.2013.10.019; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; HAFNER JC, 1983, SYST ZOOL, V32, P1, DOI 10.2307/2413215; Hafner MS, 2003, COPHYLOGENY POCKET G, P350; Heins DC, 2010, PARASITOLOGY, V137, P1681, DOI 10.1017/S003118201000048X; Heins DC, 2008, BEHAVIOUR, V145, P625, DOI 10.1163/156853908792451412; Heins DC, 2010, BIOL J LINN SOC, V100, P835, DOI 10.1111/j.1095-8312.2010.01486.x; Hendry AP, 2004, EVOLUTION, V58, P2319; Henrich T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-33; HILBURN LR, 1986, HEREDITY, V57, P67, DOI 10.1038/hdy.1986.88; HILBURN LR, 1986, HEREDITY, V57, P113, DOI 10.1038/hdy.1986.94; Humple DL, 2009, GENETIC STRUCTURE DE; Jarne P, 2001, PARASITOLOGY, V123, pS27, DOI 10.1017/S0031182001007715; Johnson LS, 2004, J BIOGEOGR, V31, P1073, DOI 10.1111/j.1365-2699.2004.01078.x; Johnson S.G., 1997, EXS, V82, P263; Kenow KP, 2002, WATERBIRDS, V25, P449, DOI 10.1675/1524-4695(2002)025[0449:UOSTTI]2.0.CO;2; Lamphere BA, 2012, ECOL FRESHW FISH, V21, P75, DOI 10.1111/j.1600-0633.2011.00525.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MCMANUS DP, 1985, J HELMINTHOL, V59, P323, DOI 10.1017/S0022149X00025906; Moore JS, 2009, PHILOS T R SOC B, V364, P1533, DOI 10.1098/rstb.2009.0007; NADLER SA, 1995, J PARASITOL, V81, P395, DOI 10.2307/3283821; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Nishimura N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022505; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PENNYCUICK L, 1971, PARASITOLOGY, V63, P389, DOI 10.1017/S0031182000079920; Piper W, 2011, AM SCI, V99, P220, DOI 10.1511/2011.90.220; Piper WH, 1997, J WILDLIFE MANAGE, V61, P1253, DOI 10.2307/3802124; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Price P. W., 1980, EVOLUTIONARY BIOL PA; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, EVOLUTION, V59, P296, DOI 10.1111/j.0014-3820.2005.tb00990.x; REIMCHEN TE, 1980, CAN FIELD NAT, V94, P398; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggles AK, 1991, HABITAT SELECTION CO; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smyth J., 1962, INTRO ANIMAL PARASIT; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Thomas L. J., 1947, Journal of Parasitology Lancaster, V33, P10; Todd CD, 2004, CAN J FISH AQUAT SCI, V61, P1176, DOI 10.1139/F04-069; Ward AJW, 2013, BEHAVIOUR, V150, P1689, DOI 10.1163/1568539X-00003115; Wedekind C, 1997, PARASITOLOGY, V115, P317, DOI 10.1017/S0031182097001406	68	25	25	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122307	10.1371/journal.pone.0122307	http://dx.doi.org/10.1371/journal.pone.0122307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874710	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100061
J	Diaz-Cabrera, M; Ferrer, MA; Morales, A				Diaz-Cabrera, Moises; Ferrer, Miguel A.; Morales, Aythami			Modeling the Lexical Morphology of Western Handwritten Signatures	PLOS ONE			English	Article							RAPID HUMAN MOVEMENTS; STROKE RISK-FACTORS; KINEMATIC THEORY; VERIFICATION; TIME; DYSGRAPHIA; DISEASE; PATIENT	A handwritten signature is the final response to a complex cognitive and neuromuscular process which is the result of the learning process. Because of the many factors involved in signing, it is possible to study the signature from many points of view: graphologists, forensic experts, neurologists and computer vision experts have all examined them. Researchers study written signatures for psychiatric, penal, health and automatic verification purposes. As a potentially useful, multi-purpose study, this paper is focused on the lexical morphology of handwritten signatures. This we understand to mean the identification, analysis, and description of the signature structures of a given signer. In this work we analyze different public datasets involving 1533 signers from different Western geographical areas. Some relevant characteristics of signature lexical morphology have been selected, examined in terms of their probability distribution functions and modeled through a General Extreme Value distribution. This study suggests some useful models for multi-disciplinary sciences which depend on handwriting signatures.	[Diaz-Cabrera, Moises; Ferrer, Miguel A.; Morales, Aythami] Univ Las Palmas Gran Canaria, Inst Univ Desarrollo Tecnol & Innovac Comunicac, Las Palmas Gran Canaria 35017, Spain	Universidad de Las Palmas de Gran Canaria	Diaz-Cabrera, M (corresponding author), Univ Las Palmas Gran Canaria, Inst Univ Desarrollo Tecnol & Innovac Comunicac, Las Palmas Gran Canaria 35017, Spain.	mdiaz@idetic.eu	Moreno, Aythami/ABF-8166-2021; Ferrer, Miguel/AFU-8286-2022; Diaz, Moises/L-3637-2013; Morales, Aythami/L-2529-2013; Ferrer, Miguel A A/L-3863-2013	Diaz, Moises/0000-0003-3878-3867; Morales, Aythami/0000-0002-7268-4785; Ferrer, Miguel A A/0000-0002-2924-1225	Spanish government's Ministry of Economy and Competitiveness research project [TEC2012-38630-C04-02]	Spanish government's Ministry of Economy and Competitiveness research project	This study was funded by the Spanish government's Ministry of Economy and Competitiveness research project, whose reference is: TEC2012-38630-C04-02 http://www.idi.mineco.gob.es/stfls/eSede/Ficheros/2012/PRESEL_TEC_TMC_112928_25643305.pdf. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse LC, 2009, P 14 BIENN C INT GRA, P6; Balint T, 2013, INT REV SOCIAL SCI H, V4, P43; Bird C, 2010, FORENSIC SCI INT, V195, P103, DOI 10.1016/j.forsciint.2009.12.001; Bishop Christopher M., 2006, PATTERN RECOGNITION; Blankers Vivian L., 2009, 2009 10th International Conference on Document Analysis and Recognition (ICDAR), P1403, DOI 10.1109/ICDAR.2009.216; Bromby MC, 2010, INT REV LAW COMPUTER, V24, P133, DOI [10.1080/13600861003644541, DOI 10.1080/13600861003644541]; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Diaz-Cabrera M, 2014, INT CONF FRONT HAND, P482, DOI 10.1109/ICFHR.2014.87; Diaz-Cabrera M, 2014, INT CONF FRONT HAND, P61, DOI 10.1109/ICFHR.2014.18; Djioua M, 2009, IEEE T PATTERN ANAL, V31, P2060, DOI 10.1109/TPAMI.2008.264; Eichhorn TE, 1996, MOVEMENT DISORD, V11, P289, DOI 10.1002/mds.870110313; Ferrara Matteo, 2014, PHYTOCHEM REV, P1, DOI DOI 10.1163/9789004269347_002; Ferrer MA, 2013, 6 IAPR INT C BIOM IC, P1, DOI DOI 10.1109/ICB.2013.6612969; Ferrer MA, 2013, P IEEE INT CARN C SE; Ferrer MA, 2012, IEEE T INF FOREN SEC, V7, P966, DOI 10.1109/TIFS.2012.2190281; Fierrez-Aguilar J, 2004, LECT NOTES COMPUT SC, V3087, P295; Forbes KE, 2004, BRAIN RES BULL, V63, P19, DOI 10.1016/j.brainresbull.2003.11.005; Galbally Javier, 2009, 2009 10th International Conference on Document Analysis and Recognition (ICDAR), P1295, DOI 10.1109/ICDAR.2009.38; Galbally J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069897; Galbally J, 2012, PATTERN RECOGN, V45, P2622, DOI 10.1016/j.patcog.2011.12.007; Galbally J, 2012, PATTERN RECOGN, V45, P2610, DOI 10.1016/j.patcog.2011.12.011; Ghali B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063216; Ginestroni A, 2012, HUM BRAIN MAPP, V33, P1780, DOI 10.1002/hbm.21319; Kettle KL, 2011, J CONSUM RES, V38, P474, DOI 10.1086/659753; Kholmatov A, 2009, PATTERN ANAL APPL, V12, P227, DOI 10.1007/s10044-008-0118-x; Kotz S., 2000, EXTREME VALUE DISTRI; Leedham CG, 1994, IEEE C HANDWR PEN BA, P1; Linderman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006791; Llados J, 2007, PROC INT CONF DOC, P362; Marcelli A, 2013, LECT NOTES COMPUT SC, V8157, P673, DOI 10.1007/978-3-642-41184-7_68; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807; Neils-Strunjas J, 2006, J SPEECH LANG HEAR R, V49, P1313, DOI 10.1044/1092-4388(2006/094); O'Reilly C., 2012, 2012 11th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA), P787, DOI 10.1109/ISSPA.2012.6310660; O'Reilly Christian, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1864, DOI 10.1109/ICPR.2010.460; O'Reilly C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00150; O'Reilly C, 2011, HUM MOVEMENT SCI, V30, P792, DOI 10.1016/j.humov.2010.07.010; Oliveira L, 2005, 12 C INT GRAPH SOC, P178; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Pirlo G, 2013, IEEE T HUM-MACH SYST, V43, P499, DOI 10.1109/THMS.2013.2279008; PLAMONDON R, 1995, BIOL CYBERN, V72, P295, DOI 10.1007/BF00202785; PLAMONDON R, 1995, BIOL CYBERN, V72, P309, DOI 10.1007/BF00202786; Plamondon R, 1998, BIOL CYBERN, V78, P119, DOI 10.1007/s004220050419; Plamondon R, 2003, BIOL CYBERN, V89, P126, DOI 10.1007/s00422-003-0407-9; Plamondon Rejean, 2007, Frontiers of Computer Science in China, V1, P106, DOI 10.1007/s11704-007-0009-0; Plamondon R, 1998, BIOL CYBERN, V78, P133, DOI 10.1007/s004220050420; Plamondon R, 2014, PATTERN RECOGN, V47, P929, DOI 10.1016/j.patcog.2013.05.004; Plamondon R, 2013, HUM MOVEMENT SCI, V32, P1026, DOI 10.1016/j.humov.2012.07.006; Plamondon R, 2014, PATTERN RECOGN LETT, V35, P225, DOI 10.1016/j.patrec.2012.06.004; Ploog H, 2013, HANDWRITING PSYCHOL; Poizner A, 2011, SEMIOTICA, V185, P113, DOI 10.1515/semi.2011.035; Rabasse C, 2008, IEEE T SYST MAN CY B, V38, P691, DOI 10.1109/TSMCB.2008.918575; Roy P. P., 2012, Proceedings of the 10th IAPR International Workshop on Document Analysis Systems (DAS 2012), P150, DOI 10.1109/DAS.2012.17; Rub U, 2003, BRAIN, V126, P2257, DOI 10.1093/brain/awg234; Rupasov Valery I, 2012, PLoS One, V7, pe43945, DOI 10.1371/journal.pone.0043945; Rupasov VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034759; Taroni F., 2010, DATA ANAL FORENSIC S; van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x; Venkatesh A, 2013, COMMUN COMPUT PHYS, V361, P199; Wing AM, 2000, CURR BIOL, V10, pR245, DOI 10.1016/S0960-9822(00)00375-4; Woch A, 2011, HUM MOVEMENT SCI, V30, P1, DOI 10.1016/j.humov.2009.10.006; Yeung DY, 2004, LECT NOTES COMPUT SC, V3072, P16; Zhang YH, 2005, MOVEMENT DISORD, V20, P819, DOI 10.1002/mds.20408	64	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123254	10.1371/journal.pone.0123254	http://dx.doi.org/10.1371/journal.pone.0123254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860942	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300085
J	Drew, JC; Oli, MW; Rice, KC; Ardissone, AN; Galindo-Gonzalez, S; Sacasa, PR; Belmont, HJ; Wysocki, AF; Rieger, M; Triplett, EW				Drew, Jennifer C.; Oli, Monika W.; Rice, Kelly C.; Ardissone, Alexandria N.; Galindo-Gonzalez, Sebastian; Sacasa, Pablo R.; Belmont, Heather J.; Wysocki, Allen F.; Rieger, Mark; Triplett, Eric W.			Development of a Distance Education Program by a Land-Grant University Augments the 2-Year to 4-Year STEM Pipeline and Increases Diversity in STEM	PLOS ONE			English	Article							COMMUNITY-COLLEGES	Although initial interest in science, technology, engineering and mathematics (STEM) is high, recruitment and retention remains a challenge, and some populations are disproportionately underrepresented in STEM fields. To address these challenges, the Microbiology and Cell Science Department in the College of Agricultural and Life Sciences at the University of Florida has developed an innovative 2+2 degree program. Typical 2+2 programs begin with a student earning an associate's degree at a local community college and then transferring to a 4-year institution to complete a bachelor's degree. However, many universities in the United States, particularly land-grant universities, are located in rural regions that are distantly located from their respective states' highly populated urban centers. This geographical and cultural distance could be an impediment to recruiting otherwise highly qualified and diverse students. Here, a new model of a 2+2 program is described that uses distance education as the vehicle to bring a research-intensive university's life sciences curriculum to students rather than the oft-tried model of a university attempting to recruit underrepresented minority students to its location. In this paradigm, community college graduates transfer into the Microbiology and Cell Science program as distance education students to complete their Bachelor of Science degree. The distance education students' experiences are similar to the on-campus students' experiences in that both groups of students take the same department courses taught by the same instructors, take required laboratory courses in a face-to-face format, take only proctored exams, and have the same availability to instructors. Data suggests that a hybrid online transfer program may be a viable approach to increasing STEM participation (as defined by enrollment) and diversity. This approach is particularly compelling as the distance education cohort has comparable grade point averages and retention rates compared to the corresponding on-campus transfer cohort.	[Drew, Jennifer C.; Oli, Monika W.; Rice, Kelly C.; Ardissone, Alexandria N.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Microbiol & Cell Sci Dept, Gainesville, FL 32611 USA; [Galindo-Gonzalez, Sebastian] Univ Florida, Inst Food & Agr Sci, Agr Educ & Commun Dept, Gainesville, FL 32611 USA; [Sacasa, Pablo R.] Miami Dade Coll, Miami, FL USA; [Belmont, Heather J.] Miami Dade Coll, Sch Sci, Miami, FL USA; [Wysocki, Allen F.; Rieger, Mark] Univ Florida, Inst Food & Agr Sci, Coll Agr & Life Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Triplett, EW (corresponding author), Univ Florida, Inst Food & Agr Sci, Microbiol & Cell Sci Dept, Gainesville, FL 32611 USA.	ewt@ufl.edu	Galindo, Sebastian/W-1870-2019	Galindo, Sebastian/0000-0002-4061-773X; Ardissone, Alexandria/0000-0003-3608-6486; Drew, Jennifer/0000-0002-4037-108X	National Science Foundation, Division of Undergraduate Education [DUE-0920151]; Science and Technology Expansion Program (STEP) [DUE-1161177]	National Science Foundation, Division of Undergraduate Education(National Science Foundation (NSF)); Science and Technology Expansion Program (STEP)	This research was generously supported by grants from the National Science Foundation, Division of Undergraduate Education (http://www.nsf.gov/div/index.jsp?div=DUE): Course, Curriculum and Laboratory Instruction CCLI Phase 2 (DUE-0920151 to EWT) and the Science and Technology Expansion Program (STEP) (DUE-1161177 to EWT). The authors also thank the Provost's Office at the University of Florida and the College of Agricultural and Life Sciences for providing seed money to initiate this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisauskas R., 2007, FOCUS MICROBIOL ED, V13, P13; Allen I. E., 2014, GRADE CHANGE TRACKIN; Antonio AL, 2004, PSYCHOL SCI, V15, P507, DOI 10.1111/j.0956-7976.2004.00710.x; Bernard RM, 2004, REV EDUC RES, V74, P379, DOI 10.3102/00346543074003379; Bidwell Allie, 2014, US NEWS WORLD REPORT; Dell C.A., 2010, MERLOT J ONLINE LEAR, V6, P30; Federal Science Technology Engineering and Mathematics (STEM), 2013, REP COMM STEM ED; Fletcher LA, 2010, CBE-LIFE SCI EDUC, V9, P382, DOI 10.1187/cbe.10-09-0112; Jones LWK, 2010, MICROBE WASH DC, V5, P520; Labov JB, 2012, CBE-LIFE SCI EDUC, V11, P121, DOI 10.1187/cbe.12-03-0031; Lack K.A., 2013, ITHAKA R ZULETZT GEP, V3, P2013; Maltese AV, 2011, SCI EDUC, V95, P877, DOI 10.1002/sce.20441; Meyer KA, 2009, J ASYNCHRONOUS LEARN, V13, P129; Moore J. C., 2009, J ASYNCHRONOUS LEARN, V13, P85; National Academy of Sciences, 2010, RIS GATH STORM REV R, V5; [National Academy of Sciences National Academy of Engineering Institute of Medicine], 2011, EXP UND MIN PART AM; National Research Council, 2009, RIS GATH STORM 2 YEA; National Research Council and National Academy of Engineering, 2012, COMM COLL EV STEM ED; National Science Board, 2014, SCI ENG IND; National Student Clearinghouse Research Center, 2012, SNAPSH REP DEGR ATT; Nuez A.-M., 2013, PERSPECTIVAS ISSUES, V2; Nunez A-M, 2011, J HISPANIC HIGH ED, V8, P322; Office of Planning Evaluation and Policy Development, 2009, EVALUATION EVIDENCE; Olson S., 2012, ENGAGE EXCEL PRODUCI; Page SE, 2007, DIFFERENCE POWER DIV; Perez P.A., 2008, J HISPANIC HIGHER ED, V7, P249, DOI [https://doi.org/10.1177/1538192708317620, DOI 10.1177/1538192708317620, 10.1177/1538192708317620]; Pontes MCF, 2012, ONLINE LEARNING FORM, V16, P79; Radford AW, 2010, 201111 NCES US DEP E; Rovai AP, 2010, INTERNET HIGH EDUC, V13, P141, DOI 10.1016/j.iheduc.2009.07.001; Tsapogas, 2004, ROLE COMMUNITY COLL; Warren L.L., 2005, J INSTR PSYCHOL, V32, P148; Wasik John F., 2014, NY TIMES; Weber J., 2007, J ED ONLINE, V4, P1, DOI DOI 10.9743/JEO.2007.2.2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	34	15	15	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119548	10.1371/journal.pone.0119548	http://dx.doi.org/10.1371/journal.pone.0119548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875606	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800006
J	Kamilar, JM; Beaudrot, L; Reed, KE				Kamilar, Jason M.; Beaudrot, Lydia; Reed, Kaye E.			Climate and Species Richness Predict the Phylogenetic Structure of African Mammal Communities	PLOS ONE			English	Article							PRIMATE COMMUNITIES; FUNCTIONAL TRAIT; EVOLUTION; COOCCURRENCE; PATTERNS; ECOLOGY; SCALE; DIET; CONSERVATISM; DIVERSITY	We have little knowledge of how climatic variation (and by proxy, habitat variation) influences the phylogenetic structure of tropical communities. Here, we quantified the phylogenetic structure of mammal communities in Africa to investigate how community structure varies with respect to climate and species richness variation across the continent. In addition, we investigated how phylogenetic patterns vary across carnivores, primates, and ungulates. We predicted that climate would differentially affect the structure of communities from different clades due to between-clade biological variation. We examined 203 communities using two metrics, the net relatedness (NRI) and nearest taxon (NTI) indices. We used simultaneous autoregressive models to predict community phylogenetic structure from climate variables and species richness. We found that most individual communities exhibited a phylogenetic structure consistent with a null model, but both climate and species richness significantly predicted variation in community phylogenetic metrics. Using NTI, species rich communities were composed of more distantly related taxa for all mammal communities, as well as for communities of carnivorans or ungulates. Temperature seasonality predicted the phylogenetic structure of mammal, carnivoran, and ungulate communities, and annual rainfall predicted primate community structure. Additional climate variables related to temperature and rainfall also predicted the phylogenetic structure of ungulate communities. We suggest that both past interspecific competition and habitat filtering have shaped variation in tropical mammal communities. The significant effect of climatic factors on community structure has important implications for the diversity of mammal communities given current models of future climate change.	[Kamilar, Jason M.; Reed, Kaye E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Kamilar, Jason M.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ USA; [Beaudrot, Lydia] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Beaudrot, Lydia] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Midwestern University; University of California System; University of California Davis; University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe	Kamilar, JM (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	jason.kamilar@asu.edu	; Beaudrot, L./M-6936-2017	Kamilar, Jason/0000-0001-6082-9396; Beaudrot, L./0000-0001-8135-7519	UC Davis Open Access Fund; Midwestern University	UC Davis Open Access Fund; Midwestern University	We thank Jillian DeBenney and Joshua Kohn for African mammal data compilation. In addition, we appreciate the helpful comments provided by two anonymous reviewers and the academic editor, Karen Samonds. We are thankful to the UC Davis Open Access Fund and Midwestern University for assisting with publication fees.	Algar AC, 2011, ECOLOGY, V92, P903, DOI 10.1890/10-0606.1; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Beaudrot LH, 2011, J ANIM ECOL, V80, P332, DOI 10.1111/j.1365-2656.2010.01777.x; Belmaker J, 2013, AM NAT, V181, P464, DOI 10.1086/669906; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blair ME, 2013, J EVOLUTION BIOL, V26, P1790, DOI 10.1111/jeb.12179; Cantalapiedra JL, 2014, ECOGRAPHY, V37, P1, DOI 10.1111/j.1600-0587.2013.00236.x; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Cardillo M, 2011, PHILOS T R SOC B, V366, P2545, DOI 10.1098/rstb.2011.0021; Cardillo M, 2010, GLOBAL ECOL BIOGEOGR, V19, P465, DOI 10.1111/j.1466-8238.2010.00537.x; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Davies TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1096, DOI 10.1111/j.1466-8238.2012.00759.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gavilanez MM, 2013, GLOBAL ECOL BIOGEOGR, V22, P607, DOI 10.1111/geb.12011; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gouveia SF, J ANIM ECOL IN PRESS; Graham CH, 2012, ECOLOGY, V93, pS99, DOI 10.1890/11-0493.1; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hothorn T, 2013, COIN CONDITIONAL INF; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jones KE, 2011, PHILOS T R SOC B, V366, P2451, DOI 10.1098/rstb.2011.0090; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kamilar JM, 2014, INT J PRIMATOL, V35, P1105, DOI 10.1007/s10764-014-9784-2; Kamilar JM, 2013, EVOL ANTHROPOL, V22, P174, DOI 10.1002/evan.21361; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kamilar JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011073; Kamilar JM, 2010, J BIOGEOGR, V37, P801, DOI 10.1111/j.1365-2699.2009.02267.x; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Pointer MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-103; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Qian H, ECOGRAPHY IN PRESS; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Razafindratsima O. H., 2012, ECOGRAPHY, V35, P1; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Thibault K. M., 2011, ECOLOGY, V92, P2316, DOI DOI 10.1890/11-0262.1; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; WHITTAKER R H, 1975, P385; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	74	32	32	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121808	10.1371/journal.pone.0121808	http://dx.doi.org/10.1371/journal.pone.0121808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875361	Green Published, gold			2022-12-27	WOS:000353015800033
J	Reed, SJ; Plourde, G				Reed, Sean J.; Plourde, Gilles			Attenuation of High-Frequency (50-200 Hz) Thalamocortical EEG Rhythms by Propofol in Rats Is More Pronounced for the Thalamus than for the Cortex	PLOS ONE			English	Article							IN-VITRO TOXICITY; OXIDATIVE STRESS; DNA-DAMAGE; POLYSTYRENE NANOPARTICLES; SILVER NANOPARTICLES; RESAZURIN METABOLISM; SURFACE-CHEMISTRY; HUMAN MACROPHAGES; CELLS; PARTICLES	Background Thalamocortical EEG rhythms in gamma (30-80 Hz) and high-gamma (80-200 Hz) ranges have been linked to arousal and conscious processes. To test the hypothesis that general anesthetics attenuate these rhythms, we characterized the concentration-effect relationship of propofol on the spectral power of these rhythms. In view of the ongoing debate about cortex versus thalamus as the primary site of anesthetic action for unconsciousness, we also compared the relative sensitivity of cortex and thalamus to this effect propofol. Methods Adult male Long-Evans rats were chronically implanted with electrodes in somatosensory (barrel) cortex and ventroposteromedial thalamus. Propofol was delivered by a computer-controlled infusion using real-time pharmacokinetic modeling to obtain the desired plasma concentration. Spectral power was assessed during baseline, at four stable propofol plasma-concentrations (0, 3,6,9,12 mu g/ml) and during recovery over four frequency ranges (3050, 51-75, 76-125, 126-200 Hz). Unconsciousness was defined as complete loss of righting reflex. Multiple regression was used to model the change of power (after logarithmic transformation) as a function of propofol concentration and recording site. Results Unconsciousness occurred at the 9 mu g/ml concentration in all animals. Propofol caused a robust linear concentration-dependent attenuation of cortical power in the 76-200 Hz range and of thalamic power in the 51-200 Hz range. In all instances the concentration-effect slope for the thalamus was markedly steeper than for the cortex. Furthermore the lowest concentration causing unconsciousness significantly reduced cortical power in the 126-200 Hz range and thalamic power in the 51-200 Hz range. Conclusions Propofol causes a concentration-dependent attenuation of the power of thalamocortical rhythms in the 51-200 Hz range and this effect is far more pronounced for the thalamus, where the attenuation provides a robust correlate of the hypnotic action of propofol.	[Reed, Sean J.] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Plourde, Gilles] McGill Univ, Dept Anesthesia, Montreal, PQ, Canada	McGill University; McGill University	Plourde, G (corresponding author), McGill Univ, Dept Anesthesia, Montreal, PQ, Canada.	gilles.plourde@mcgill.ca			Canadian Anesthesiologists Society; Fondation d'Anesthesiologie et Reanimation du Quebec; McGill University from Le Fonds de la Recherche du Quebec	Canadian Anesthesiologists Society; Fondation d'Anesthesiologie et Reanimation du Quebec; McGill University from Le Fonds de la Recherche du Quebec	This work was supported by grants from the Canadian Anesthesiologists Society and from the Fondation d'Anesthesiologie et Reanimation du Quebec to GP and by a studentships from McGill University from Le Fonds de la Recherche du Quebec to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Anguissola S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108025; Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/NNANO.2009.313, 10.1038/nnano.2009.313]; Bhattacharjee S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-25; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; Dekali S, 2013, NANOTOXICOLOGY, V7, P1302, DOI 10.3109/17435390.2012.735269; Donaldson Ken, 2012, Swiss Med Wkly, V142, pw13547, DOI 10.4414/smw.2012.13547; Donaldson K, 2010, NANOTOXICOLOGY, V4, P414, DOI 10.3109/17435390.2010.482751; Frohlich E, 2013, TOXICOL IN VITRO, V27, P409, DOI 10.1016/j.tiv.2012.08.008; Frohlich E, 2012, NANOTOXICOLOGY, V6, P424, DOI 10.3109/17435390.2011.586478; Frohlich E, 2009, J TOXICOL SCI, V34, P363; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Geys J, 2007, TOXICOL IN VITRO, V21, P1215, DOI 10.1016/j.tiv.2007.05.012; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; ISO, 2008, 276872008 ISOTS, P7; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Karlsson HL, 2010, ANAL BIOANAL CHEM, V398, P651, DOI 10.1007/s00216-010-3977-0; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JA, 2013, ACS NANO, V7, P7483, DOI 10.1021/nn403126e; Klein SG, 2011, TOXICOL IN VITRO, V25, P1516, DOI 10.1016/j.tiv.2011.09.006; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Lehmann AD, 2011, EUR J PHARM BIOPHARM, V77, P398, DOI 10.1016/j.ejpb.2010.10.014; Lewis DJ, 2010, NANOMEDICINE-UK, V5, P1547, DOI [10.2217/nnm.10.96, 10.2217/NNM.10.96]; Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Matthews JB, 2001, J MATER SCI-MATER M, V12, P249, DOI 10.1023/A:1008967200706; McCarthy J, 2011, INT J NANOMED, V6, P1343, DOI 10.2147/IJN.S21145; Mukhopadhyay A, 2012, APPL BIOCHEM BIOTECH, V167, P327, DOI 10.1007/s12010-012-9666-z; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650; Osseni RA, 1999, TOXICOL IN VITRO, V13, P683, DOI 10.1016/S0887-2333(99)00050-8; Paget V, 2014, NANOTOXICOLOGY, V8, P46, DOI 10.3109/17435390.2013.855828; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Perrot S, 2003, TOXICOL SCI, V72, P122, DOI 10.1093/toxsci/kfg014; Perrot SB, 2003, CYTOM PART A, V55A, P7, DOI 10.1002/cyto.a.10067; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Ruenraroengsak P, 2012, NANOTOXICOLOGY, V6, P94, DOI 10.3109/17435390.2011.558643; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Stentebjerg-Andersen A, 2011, EUR J PHARM BIOPHARM, V78, P19, DOI 10.1016/j.ejpb.2010.12.030; Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975; Team RDC, 2005, R LANG ENV STAT COMP; Tetley TD, 2007, BIOCHEM SOC T, V35, P527, DOI 10.1042/BST0350527; Thubagere A, 2010, ACS NANO, V4, P3611, DOI 10.1021/nn100389a; Tsamou M, 2012, MUTAGENESIS, V27, P645, DOI 10.1093/mutage/ges030; Wang FJ, 2013, NANOSCALE, V5, P10868, DOI 10.1039/c3nr03249c; Wang XZ, 2014, NANOTOXICOLOGY, V8, P465, DOI 10.3109/17435390.2013.796534; Warheit David B, 2009, Inhal Toxicol, V21 Suppl 1, P61, DOI 10.1080/08958370902942640; Wottrich R, 2004, INT J HYG ENVIR HEAL, V207, P353, DOI 10.1078/1438-4639-00300; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xie H, 2010, REV ENV HLTH, V26, P251; Zaqout Mazen S. K., 2012, Environmental Health and Preventive Medicine, V17, P341, DOI 10.1007/s12199-011-0245-7; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zhu MT, 2009, TOXICOL SCI, V107, P342, DOI 10.1093/toxsci/kfn245; Zucker RM, 2010, CYTOM PART A, V77A, P677, DOI 10.1002/cyto.a.20927	64	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123287	10.1371/journal.pone.0123287	http://dx.doi.org/10.1371/journal.pone.0123287			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875024	gold, Green Published			2022-12-27	WOS:000353015800090
J	Chen, JJ; Huang, NS; Xue, JY; Quan, CL; Tan, YL; Liu, GY; Shao, ZM; Wu, J				Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Quan, Chen-lian; Tan, Yu-long; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong			Surgical Management for Early-Stage Bilateral Breast Cancer Patients in China	PLOS ONE			English	Article							SENTINEL LYMPH-NODE; PARADIGM SHIFT; RECONSTRUCTION; MASTECTOMY	Background The aim of this study was to investigate the current surgical management strategy for bilateral breast cancer (BBC) patients and to assess the changes in this strategy in China. Methods This is a retrospective review of all patients with early-stage BBC who underwent surgical treatment at the Fudan University Shanghai Cancer Center between June 2007 and June 2014. Results A total of 15,337 patients with primary breast cancer were identified. Of these patients, 218 (1.5%) suffered from synchronous bilateral breast cancer (sBBC), and 296 (2.0%) suffered from metachronous bilateral breast cancer (mBBC). Patients with a lobular carcinoma component, those with estrogen receptor-positive cancer, and those with an accompanying sclerosing adenosis in the affected breast tended to develop BBC. The rates of bilateral mastectomy, breast conserving therapy, reconstruction, and combined surgeries were 86.2%, 6.4%, 3.7%, and 3.7%, respectively, for patients with sBBC and 81.1%, 4.4%, 3.0%, and 11.5%, respectively, for patients with mBBC. The interval between bilateral cancers, age at first diagnosis of breast cancer, histopathological type, and stage have significant impacts on the choice of surgery for patients with BBC. Conclusions Bilateral mastectomy was the dominant surgical management for patients with BBC in China, despite the increased application of breast reconstruction surgery observed in recent years. Bilateral prosthetic breast reconstruction was the ideal choice for patients with sBBC. Chinese surgeons should take responsibility for patient education and inform their patients about their surgical options.	[Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Quan, Chen-lian; Tan, Yu-long; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	wujiong1122@vip.sina.com		CHEN, Jiajian/0000-0001-9202-404X	Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau [20124Y067]; National Natural Science Foundation of China [81302297]	Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau (No.20124Y067), and the National Natural Science Foundation of China (No.81302297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, EJSO-EUR J SURG ONC, V39, P320, DOI 10.1016/j.ejso.2012.12.015; Albornoz CR, 2013, PLAST RECONSTR SURG, V131, P15, DOI 10.1097/PRS.0b013e3182729cde; Black DM, 2013, GLAND SURG, V2, P120, DOI 10.3978/j.issn.2227-684X.2013.06.01; Cemal Y, 2013, PLAST RECONSTR SURG, V131, p320E, DOI 10.1097/PRS.0b013e31827cf576; Chen JJ, 2009, EJSO-EUR J SURG ONC, V35, P921, DOI 10.1016/j.ejso.2009.01.009; Chen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095185; Chen JJ, 2011, CRIT REV ONCOL HEMAT, V79, P293, DOI 10.1016/j.critrevonc.2010.06.008; Cotlar Alvin M, 2003, Curr Surg, V60, P329, DOI 10.1016/S0149-7944(02)00777-8; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Jagsi R, 2014, J CLIN ONCOL, V32, P919, DOI 10.1200/JCO.2013.52.2284; Kayar R, 2011, BREAST CANCER-BASIC, V5, P43, DOI 10.4137/BCBCR.S6128; Li J, 2008, J COMMUN NETW-S KOR, V10, P10, DOI 10.1109/JCN.2008.6388323; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Qiao Q, 1997, AESTHET PLAST SURG, V21, P362, DOI 10.1007/s002669900139; Roostaeian J, 2011, CURR OPIN OBSTET GYN, V23, P44, DOI 10.1097/GCO.0b013e328340e18a; Schubart JR, 2014, ANN SURG ONCOLOGY; Sinno S, 2014, PLASTIC SURGICAL NUR, V34, P6; Sinno Sammy, 2014, Plast Surg Nurs, V34, P141, DOI 10.1097/PSN.0000000000000048; Tan BK, 2014, ARCH PLAST SURG-APS, V41, P366, DOI 10.5999/aps.2014.41.4.366; Zhang L, 2012, PSYCHO-ONCOLOGY, V21, P488, DOI 10.1002/pon.1922; Zhong T, 2014, J CLIN ONCOL, V32, P2133, DOI 10.1200/JCO.2013.53.0774	22	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122692	10.1371/journal.pone.0122692	http://dx.doi.org/10.1371/journal.pone.0122692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874699	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100095
J	Chou, ML; Bailey, A; Avory, T; Tanimoto, J; Burnouf, T				Chou, Ming Li; Bailey, Andy; Avory, Tiffany; Tanimoto, Junji; Burnouf, Thierry			Removal of Transmissible Spongiform Encephalopathy Prion from Large Volumes of Cell Culture Media Supplemented with Fetal Bovine Serum by Using Hollow Fiber Anion-Exchange Membrane Chromatography	PLOS ONE			English	Article							BLOOD COMPONENTS; PLASMA; AGENT; INFECTIVITY; PROTEIN; MANUFACTURE	Cases of variant Creutzfeldt-Jakob disease in people who had consumed contaminated meat products from cattle with bovine spongiform encephalopathy emphasize the need for measures aimed at preventing the transmission of the pathogenic prion protein (PrPSc) from materials derived from cattle. Highly stringent scrutiny is required for fetal bovine serum (FBS), a growth-medium supplement used in the production of parenteral vaccines and therapeutic recombinant proteins and in the ex vivo expansion of stem cells for transplantation. One such approach is the implementation of manufacturing steps dedicated to removing PrPSc from materials containing FBS. We evaluated the use of the QyuSpeed D (QSD) adsorbent hollow-fiber anion-exchange chromatographic column (Asahi Kasei Medical, Tokyo, Japan) for the removal of PrPSc from cell culture media supplemented with FBS. We first established that QSD filtration had no adverse effect on the chemical composition of various types of culture media supplemented with 10% FBS or the growth and viability characteristics of human embryonic kidney (HEK293) cells, baby hamster kidney (BHK-21) cells, African green monkey kidney (Vero) cells, and Chinese hamster ovary (CHO-k1) cells propagated in the various culture-medium filtrates. We used a 0.6-mL QSD column for removing PrPSc from up to 1000 mL of Dulbecco's modified Eagle's medium containing 10% FBS previously spiked with the 263K strain of hamster-adapted scrapie. The Western blot analysis, validated alongside an infectivity assay, revealed that the level of PrPSc in the initial 200mL flow-through was reduced by 2.5 to > 3 log(10), compared with that of the starting material. These results indicate that QSD filtration removes PrPSc from cell culture media containing 10% FBS, and demonstrate the ease with which QSD filtration can be implemented in at industrial-scale to improve the safety of vaccines, therapeutic recombinant proteins, and ex vivo expanded stem cells produced using growth media supplemented with FBS.	[Chou, Ming Li] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Bailey, Andy; Avory, Tiffany] ViruSure, A-1220 Vienna, Austria; [Tanimoto, Junji] Asahi Kasei Med Co Ltd, Tokyo, Japan; [Burnouf, Thierry] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan	Taipei Medical University; Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243	Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through Taipei Medical University; ViruSure; Asahi Kasei Medical	Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through Taipei Medical University; ViruSure; Asahi Kasei Medical	This study was funded by Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through a research contract agreement with Taipei Medical University. Asahi Kasei Medical provided support in the form of salaries for author JT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the author contributions section. ViruSure provided support in the form of salaries for authors AB and TA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agency EM, 1996, CPMPBWP26895 AG EM; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; [Anonymous], 2011, OFFICIAL J EUROPEAN; [Anonymous], 2010, TAS33059 LTD AKMC; [Anonymous], 1998, OECD SERIES PRINCIPL, P17; Avgoustiniatos ES, 2012, CELL TRANSPLANT, V21, P2805, DOI 10.3727/096368912X653138; Bailey AC, 1999, IDRUGS INVESTIGATION; Brockbank KGM, 2011, CELLS TISSUES ORGANS, V193, P264, DOI 10.1159/000321166; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Burnouf T, 2006, TRANSFUS CLIN BIOL, V13, P320, DOI 10.1016/j.tracli.2006.11.001; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094020; CPMP, 2003, CPMPBWP513603; Foster PR, 2004, VOX SANG, V86, P92, DOI 10.1111/j.0042-9007.2004.00403.x; Foster PR, 2000, VOX SANG, V78, P86, DOI 10.1159/000031156; Foster PR, 1999, TRANSFUSION MED, V9, P3; Gstraunthaler G, 2013, CYTOTECHNOLOGY, V65, P791, DOI 10.1007/s10616-013-9633-8; Jochems CEA, 2002, ATLA-ALTERN LAB ANIM, V30, P219, DOI 10.1177/026119290203000208; Lee DC, 2001, TRANSFUSION, V41, P449, DOI 10.1046/j.1537-2995.2001.41040449.x; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; MILLSON GC, 1971, J COMP PATHOL, V81, P255, DOI 10.1016/0021-9975(71)90100-9; Neisser-Svae A, 2009, VOX SANG, V97, P226, DOI 10.1111/j.1423-0410.2009.01206.x; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Reichl HE, 2002, VOX SANG, V83, P137, DOI 10.1046/j.1423-0410.2002.00211.x; Robinson MM, 1996, DEV BIOL STAND, V88, P237; Shih DT, 2014, N BIOTECHNOL; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Van Holten RW, 2003, VOX SANG, V85, P20, DOI 10.1046/j.1423-0410.2003.00312.x; Vey M, 2002, BIOLOGICALS, V30, P187, DOI 10.1006/biol.2002.0327; WHO, 2006, WHO GUID TISS INF DI	32	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122300	10.1371/journal.pone.0122300	http://dx.doi.org/10.1371/journal.pone.0122300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874629	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100060
J	Feng, W; Cui, XQ; Liu, B; Liu, CY; Xiao, Y; Lu, W; Guo, H; He, MA; Zhang, XM; Yuan, J; Chen, WH; Wu, TC				Feng, Wei; Cui, Xiuqing; Liu, Bing; Liu, Chuanyao; Xiao, Yang; Lu, Wei; Guo, Huan; He, Meian; Zhang, Xiaomin; Yuan, Jing; Chen, Weihong; Wu, Tangchun			Association of Urinary Metal Profiles with Altered Glucose Levels and Diabetes Risk: A Population-Based Study in China	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; ARSENIC EXPOSURE; NATIONAL-HEALTH; BIOLOGICAL SAMPLES; TRACE-ELEMENTS; BLOOD-GLUCOSE; MELLITUS; INSULIN	Background Elevated heavy metals and fasting plasma glucose (FPG) levels were both associated with increased risk of cardiovascular diseases. However, studies on the associations of heavy metals and essential elements with altered FPG and diabetes risk were limited or conflicting. The objective of this study was to evaluate the potential associations of heavy metals and essential trace elements with FPG and diabetes risk among general Chinese population. Methods We conducted a cross-sectional study to investigate the associations of urinary concentrations of 23 metals with FPG, impaired fasting glucose (IFG) and diabetes among 2242 community-based Chinese adults in Wuhan. We used the false discovery rate (FDR) method to correct for multiple hypothesis tests. Results After adjusting for potential confounders, urinary aluminum, titanium, cobalt, nickel, copper, zinc, selenium, rubidium, strontium, molybdenum, cadmium, antimony, barium, tungsten and lead were associated with altered FPG, IFG or diabetes risk (all P < 0.05); arsenic was only dose-dependently related to diabetes (P < 0.05). After additional adjustment for multiple testing, titanium, copper, zinc, selenium, rubidium, tungsten and lead were still significantly associated with one or more outcomes (all FDR-adjusted P < 0.05). Conclusions Our results suggest that multiple metals in urine are associated with FPG, IFG or diabetes risk. Because the cross-sectional design precludes inferences about causality, further prospective studies are warranted to validate our findings.	[Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubat, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018; XIAO, YANG/GPW-5529-2022		National Key Basic Research and Development Program (973 project) [2011CB503804, 2011CB503806, 2011CB512102]	National Key Basic Research and Development Program (973 project)(National Basic Research Program of China)	This study is supported by the funds from the National Key Basic Research and Development Program (973 project, grant No. 2011CB503804, 2011CB503806, and 2011CB512102) (Dr. T. Wu, W. Chen and J. Yuan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2008, DIABETES RES CLIN PR, V80, P280, DOI 10.1016/j.diabres.2007.12.021; Agarwal S, 2011, ANGIOLOGY, V62, P422, DOI 10.1177/0003319710395562; Aguilar V, 2007, ANN NUTR METAB, V51, P402, DOI 10.1159/000108108; Akbaraly TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-21; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; BELL RR, 1990, TOXICOL LETT, V54, P199, DOI 10.1016/0378-4274(90)90184-N; Brandao-Neto J, 2001, BIOMETALS, V14, P75, DOI 10.1023/A:1016662324626; BROOKS AP, 1980, LANCET, V2, P141; CARTANA J, 1992, TOXICOLOGY, V71, P181, DOI 10.1016/0300-483X(92)90065-M; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Eskandari MR, 2015, ENVIRON TOXICOL, V30, P232, DOI 10.1002/tox.21900; Feng W, 2015, ENVIRON HEALTH PERSP, V123, P217, DOI 10.1289/ehp.1307563; Ferdousi S, 2012, Mymensingh Med J, V21, P475; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fukui Y, 1999, INT ARCH OCC ENV HEA, V72, P516, DOI 10.1007/s004200050409; Gallieni M, 1996, NEPHROL DIAL TRANSPL, V11, P1232, DOI 10.1093/ndt/11.7.1232; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hegde KR, 2005, FREE RADICAL RES, V39, P513, DOI 10.1080/10715760400013755; Heitland P, 2006, CLIN CHIM ACTA, V365, P310, DOI 10.1016/j.cca.2005.09.013; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; KOENIG RJ, 1976, DIABETES, V25, P230, DOI 10.2337/diabetes.25.3.230; Kumar V, 2014, NEUROTOXICOLOGY, V41, P154, DOI 10.1016/j.neuro.2014.02.004; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lilley TM, 2013, COMP BIOCHEM PHYS C, V157, P298, DOI 10.1016/j.cbpc.2013.01.003; Linsinger T, 2005, 1 ERM; MAHAFFEY K R, 1974, Environmental Health Perspectives, V7, P107, DOI 10.2307/3428003; Masad A, 2007, FEBS LETT, V581, P3489, DOI 10.1016/j.febslet.2007.06.061; Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547; Molgat ASD, 2014, CIRCULATION, V130, pS70, DOI 10.1161/CIRCULATIONAHA.113.007908; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Nakhaee A, 2010, BIOL TRACE ELEM RES, V136, P221, DOI 10.1007/s12011-009-8537-0; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Navas-Acien A, 2009, EPIDEMIOLOGY, V20, P816, DOI 10.1097/EDE.0b013e3181afef88; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Purdey M, 2004, MED HYPOTHESES, V62, P746, DOI 10.1016/j.mehy.2003.12.034; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Serdar MA, 2009, INT J DIABETES DEV C, V29, P35, DOI 10.4103/0973-3930.50713; Sha BY, 2013, FOOD CHEM TOXICOL, V58, P280, DOI 10.1016/j.fct.2013.04.050; Shan ZL, 2014, DIABETES, V63, P1796, DOI 10.2337/db13-0606; Siddiqui K, 2014, THESCIENTIFICWORLDJO, V2014, DOI [10.1155/2014/461591, DOI 10.1155/2014/461591]; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Swaddiwudhipong W, 2010, ENVIRON RES, V110, P612, DOI 10.1016/j.envres.2010.06.002; Thompson KH, 2004, J INORG BIOCHEM, V98, P683, DOI 10.1016/j.jinorgbio.2004.01.006; Vicente-Vicente L, 2010, TOXICOL SCI, V118, P324, DOI 10.1093/toxsci/kfq178; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; World Health Organization (WHO), 1996, BIOL MON CHEM EXP WO, P1; Wu FC, 2011, SCI TOTAL ENVIRON, V409, P3344, DOI 10.1016/j.scitotenv.2011.05.033; Xu M, 2010, EXP CLIN ENDOCR DIAB, V118, P459, DOI 10.1055/s-0030-1248325; Yang CY, 2012, CLIN NUTR, V31, P630, DOI 10.1016/j.clnu.2012.02.008; YARAT A, 1992, BIOL TRACE ELEM RES, V35, P273, DOI 10.1007/BF02783771; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeng Q, 2013, REPROD TOXICOL, V41, P109, DOI 10.1016/j.reprotox.2013.06.062; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	66	64	70	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123742	10.1371/journal.pone.0123742	http://dx.doi.org/10.1371/journal.pone.0123742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874871	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100207
J	Jiang, JY; Wen, W; Brown, DA; Crawford, J; Thalamuthu, A; Smith, E; Breit, SN; Liu, T; Zhu, WL; Brodaty, H; Baune, BT; Trollor, JN; Sachdev, PS				Jiang, Jiyang; Wen, Wei; Brown, David A.; Crawford, John; Thalamuthu, Anbupalam; Smith, Evelyn; Breit, Samuel N.; Liu, Tao; Zhu, Wanlin; Brodaty, Henry; Baune, Bernhard T.; Trollor, Julian N.; Sachdev, Perminder S.			The Relationship of Serum Macrophage Inhibitory Cytokine-1 Levels with Gray Matter Volumes in Community-Dwelling Older Individuals	PLOS ONE			English	Article							ACTIVATED GENE NAG-1; INFLAMMATORY RESPONSE; BRAIN ATROPHY; EXPRESSION; MIC-1/GDF15; MIC-1; INTERLEUKIN-6; HIPPOCAMPAL; NEURONS; MEMORY	Using circulating inflammatory markers and magnetic resonance imaging (MRI), recent studies have associated inflammation with brain volumetric measures. Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) is a divergent transforming growth factor - beta (TGF-beta) superfamily cytokine. To uncover the underlying mechanisms of the previous finding of a negative association between MIC-1/GDF15 serum levels and cognition, the present study aimed to examine the relationship of circulating MIC-1/GDF15 levels with human brain gray matter (GM) volumes, in a community-dwelling sample aged 70-90 years over two years (Wave 1: n = 506, Wave 2: n = 327), of which the age-related brain atrophy had been previously well defined. T1-weighted MRI scans were obtained at both waves and analyzed using the FMRIB Software Library and FreeSurfer. The results showed significantly negative associations between MIC-1/GDF15 serum levels and both subcortical and cortical GM volumes. GM volumes of the whole brain, cortex, temporal lobe, thalamus and accumbens showed significant mediating effects on the associations between MIC-1/GDF15 serum levels and global cognition scores. Increases in MIC-1/GDF15 serum levels were associated with decreases in cortical and subcortical GM volume over two years. In conclusion, MIC-1/GDF15 serum levels were inversely associated with GM volumes both cross-sectionally and longitudinally.	[Jiang, Jiyang; Wen, Wei; Crawford, John; Thalamuthu, Anbupalam; Smith, Evelyn; Brodaty, Henry; Trollor, Julian N.; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, CHeBA, Randwick, NSW, Australia; [Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW 2031, Australia; [Brown, David A.; Breit, Samuel N.] St Vincents Hosp, Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia; [Brown, David A.; Breit, Samuel N.] Univ New S Wales, Darlinghurst, NSW, Australia; [Liu, Tao] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China; [Zhu, Wanlin] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Brodaty, Henry] Prince Wales Hosp, Aged Care Psychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Baune, Bernhard T.] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA, Australia; [Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Beihang University; Beijing Normal University; University of New South Wales Sydney; University of Adelaide; University of New South Wales Sydney	Wen, W (corresponding author), Univ New S Wales, Sch Psychiat, CHeBA, Randwick, NSW, Australia.	w.wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Jiang, Jiyang/AAD-6296-2019; Thalamuthu, Anbupalam/Z-5545-2019	Sachdev, Perminder/0000-0002-9595-3220; Jiang, Jiyang/0000-0002-2147-6302; Thalamuthu, Anbupalam/0000-0002-7114-1260; Liu, Tao/0000-0002-7783-3073; Wen, Wei/0000-0003-2753-3870; Brown, David/0000-0003-1382-9419; Trollor, Julian/0000-0002-7685-2977; Smith, Evelyn/0000-0002-9142-986X	National Health and Medical Research Council (NHMRC) [350833, 510175, 510124]; Australian Research Council [DP0774213, DP0773584, LP0669645]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This research was supported by the National Health and Medical Research Council (NHMRC, https://www.nhmrc.gov.au/, NHMRC Program Grant ID 350833, NHMRC Project Grant ID 510175 and NHMRC Project Grant ID 510124), and the Australian Research Council (http://www.arc.gov.au/, DP0774213, DP0773584 and LP0669645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2012, ONCOGENE, V31, P4139, DOI 10.1038/onc.2011.572; [Anonymous], 1981, WAIS R MANUAL; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baune BT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-125; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Benton AL, 1996, DER BENTON TEST; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Di Napoli M, 2001, THROMB RES, V103, P261, DOI 10.1016/S0049-3848(01)00290-0; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Ferrari N, 2005, CLIN CANCER RES, V11, P4610, DOI 10.1158/1078-0432.CCR-04-2210; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116; Hamdani N, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0387-y; Huh SJ, 2010, AM J PATHOL, V176, P2948, DOI 10.2353/ajpath.2010.090963; Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Johnen H, 2012, CARDIOVASC PATHOL, V21, P499, DOI 10.1016/j.carpath.2012.02.003; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Kaplan E., 2001, THE BOSTON NAMING TE; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Lindahl B, 2013, CLIN CHEM, V59, P1550, DOI 10.1373/clinchem.2013.212811; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Muller N, 2012, ADV PROTEIN CHEM STR, V88, P49, DOI 10.1016/B978-0-12-398314-5.00003-9; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Strauss E, 2006, COMPENDIUM OF NEUROP; Strelau J, 2000, J NEUROSCI, V20, P8597; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Taki Y, 2013, HUM BRAIN MAPP, V34, P2418, DOI 10.1002/hbm.22073; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Willette AA, 2013, AGE, V35, P2215, DOI 10.1007/s11357-013-9518-y	62	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123399	10.1371/journal.pone.0123399	http://dx.doi.org/10.1371/journal.pone.0123399			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867953	gold, Green Published			2022-12-27	WOS:000352845100173
J	Lee, J; Martinez, N; West, K; Kornfeld, H				Lee, Jinhee; Martinez, Nuria; West, Kim; Kornfeld, Hardy			Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production	PLOS ONE			English	Article							T-CELL PROLIFERATION; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; INNATE IMMUNITY; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; PROSTAGLANDIN E-2; VACCINE ADJUVANT; LYMPHOCYTES-T; IFN-GAMMA	Activation of different pattern recognition receptors causes distinct profiles of innate immune responses, which in turn dictate the adaptive immune response. We found that mice had higher CD4(+) T cell expansion to an immunogen, ovalbumin, when coadministered with CpG than with CL097 in vivo. To account for this differential adjuvanticity, we assessed the activities of CpG and CL097 on antigen-specific CD4(+) T cell expansion in vitro using an OT-II CD4(+) T cell/bone marrow-derived dendritic cell (DC) co-culture system. Unexpectedly, oval-bumin-stimulated expansion of OT-II CD4(+) T cells in vitro was potently suppressed by both TLR agonists, with CL097 being stronger than CpG. The suppression was synergistically reversed by co-inhibition of cyclooxygenases 1 and 2, and inducible nitric oxide (NO) synthase. In addition, stimulation of OT-II CD4(+) T cell/DC cultures with CL097 induced higher levels of CD4(+) T cell death than stimulation with CpG, and this CD4(+) T cell turnover was reversed by NO and PGE2 inhibition. Consistently, the co-cultures stimulated with CL097 produced higher levels of prostaglandin E-2 (PGE(2)) and NO than stimulation with CpG. CL097 induced higher PGE(2) production in DC cultures and higher IFN-gamma in the OT-II CD4(+) T cell/DC cultures, accounting for the high levels of PGE(2) and NO. This study demonstrates that the adjuvant activities of immunostimulatory molecules may be determined by differential induction of negative regulators, including NO and PGE(2) suppressing clonal expansion and promoting cell death of CD4(+) T cells.	[Lee, Jinhee; Martinez, Nuria; West, Kim; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Lee, J (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.	Jinhee.lee@umassmed.edu	Kornfeld, Hardy/AAS-2903-2021		American Thoracic Society [ATS-06-099]; Grand Challenge Explore [OPP1007703]; National Institutes of Health [1R21AI094074-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094074] Funding Source: NIH RePORTER	American Thoracic Society; Grand Challenge Explore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by American Thoracic Society ATS-06-099 [http://www.thoracic.org/] (JL, PI); Grand Challenge Explore OPP1007703 [http://www.grandchallenges.org/explorations/Pages/introduction.aspx] (JL, PI); and National Institutes of Health grant 1R21AI094074-01A1 [http://www.nih.gov/] (JL, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1991, J IMMUNOL, V147, P144; BAKER PE, 1981, CELL IMMUNOL, V61, P52, DOI 10.1016/0008-8749(81)90353-1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Bauer H, 1997, IMMUNOLOGY, V90, P205, DOI 10.1046/j.1365-2567.1997.00161.x; Beharka AA, 1997, MECH AGEING DEV, V93, P59, DOI 10.1016/S0047-6374(96)01819-2; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Beutner KR, 1998, J AM ACAD DERMATOL, V38, P230, DOI 10.1016/S0190-9622(98)70243-9; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; CHOUDHRY MA, 1995, INFECT IMMUN, V63, P3101, DOI 10.1128/IAI.63.8.3101-3105.1995; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Fiorucci S, 2004, J IMMUNOL, V173, P874, DOI 10.4049/jimmunol.173.2.874; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; GOODWIN JS, 1978, J CLIN INVEST, V62, P753, DOI 10.1172/JCI109186; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Harrison CJ, 2001, VACCINE, V19, P1820, DOI 10.1016/S0264-410X(00)00387-X; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hilkens C M, 1996, Eur Respir J Suppl, V22, p90s; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Johnston D, 2007, CANCER IMMUNOL IMMUN, V56, P1133, DOI 10.1007/s00262-006-0262-3; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LERNER A, 1988, J IMMUNOL, V140, P936; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; LIANG S, 1989, INT J IMMUNOPHARMACO, V11, P809, DOI 10.1016/0192-0561(89)90135-5; MacFarlane AS, 1999, INFECT IMMUN, V67, P891, DOI 10.1128/IAI.67.2.891-898.1999; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Moser M, 2010, VACCINE, V28, pC2, DOI 10.1016/j.vaccine.2010.07.022; NARISAWA T, 1981, CANCER RES, V41, P1954; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; RAPPAPORT RS, 1982, J EXP MED, V155, P943, DOI 10.1084/jem.155.3.943; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sriskandan S, 1996, J IMMUNOL, V156, P2430; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TETSUKA T, 1994, P NATL ACAD SCI USA, V91, P12168, DOI 10.1073/pnas.91.25.12168; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; VERCAMMEN C, 1987, CELL IMMUNOL, V104, P24, DOI 10.1016/0008-8749(87)90003-7; Zech B, 2003, BIOCHEM J, V371, P1055, DOI 10.1042/BJ20021720; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zuber AK, 2004, VACCINE, V22, P1791, DOI 10.1016/j.vaccine.2003.10.051	70	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123165	10.1371/journal.pone.0123165	http://dx.doi.org/10.1371/journal.pone.0123165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875128	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100144
J	Moualeu-Ngangue, DP; Roblitz, S; Ehrig, R; Deuflhard, P				Moualeu-Ngangue, Dany Pascal; Roeblitz, Susanna; Ehrig, Rainald; Deuflhard, Peter			Parameter Identification in a Tuberculosis Model for Cameroon	PLOS ONE			English	Article							DISEASE; TRANSMISSION; HIV; EPIDEMICS; THERAPY; NUMBERS; IMPACT; TB	A deterministic model of tuberculosis in Cameroon is designed and analyzed with respect to its transmission dynamics. The model includes lack of access to treatment and weak diagnosis capacity as well as both frequency-and density-dependent transmissions. It is shown that the model is mathematically well-posed and epidemiologically reasonable. Solutions are non-negative and bounded whenever the initial values are non-negative. A sensitivity analysis of model parameters is performed and the most sensitive ones are identified by means of a state-of-the-art Gauss-Newton method. In particular, parameters representing the proportion of individuals having access to medical facilities are seen to have a large impact on the dynamics of the disease. The model predicts that a gradual increase of these parameters could significantly reduce the disease burden on the population within the next 15 years.	[Moualeu-Ngangue, Dany Pascal] Leibniz Univ Hannover, Inst Hort Prod Syst, Hannover, Germany; [Roeblitz, Susanna; Ehrig, Rainald; Deuflhard, Peter] Zuse Inst Berlin, Dept Numer Math, Berlin, Germany; [Deuflhard, Peter] Beijing Univ Technol, Beijing Ctr Sci & Engn Comp, Beijing, Peoples R China	Leibniz University Hannover; Zuse Institute Berlin; Beijing University of Technology	Roblitz, S (corresponding author), Zuse Inst Berlin, Dept Numer Math, Berlin, Germany.	susanna.roeblitz@zib.de	Röblitz, Susanna/AAB-8447-2021; Moualeu-Ngangue, Dany/C-6608-2018	Moualeu-Ngangue, Dany/0000-0003-3356-7209; Roblitz, Susanna/0000-0002-2735-0030	IMU Berlin Einstein Foundation Program	IMU Berlin Einstein Foundation Program	D.M. received funding from the IMU Berlin Einstein Foundation Program (http://www.math-berlin.de/efp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aparicio JP, 2002, J THEOR BIOL, V215, P227, DOI 10.1006/jtbi.2001.2489; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Balabanova Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-276; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Bhunu CP, 2008, B MATH BIOL, V70, P1163, DOI 10.1007/s11538-008-9295-4; Blower SM, 2002, LANCET INFECT DIS, V2, P374, DOI 10.1016/S1473-3099(02)00292-X; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Blower SM, 1999, MATHEMATICAL MODELS; CastilloChavez C, 1997, J MATH BIOL, V35, P629, DOI 10.1007/s002850050069; Chaulk CP, 2000, INT J TUBERC LUNG D, V4, P201; Chintu C, 1999, LANCET, V353, P997, DOI 10.1016/S0140-6736(99)01141-1; DEUFLHARD P, 1980, LINEAR ALGEBRA APPL, V29, P91, DOI 10.1016/0024-3795(80)90232-3; Deuflhard P, 2004, SPRINGER SERIES IN C, V35; Deuflhard P, 2003, NUMERICAL ANALYSIS I; Dierkes T, 2013, ARXIV 1303 4928; Feng ZL, 2000, THEOR POPUL BIOL, V57, P235, DOI 10.1006/tpbi.2000.1451; Ferebee SH, 1967, B NATL TUBERCULO JAN, V53, P4; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Iggidr A., 2007, DISCRETE CONT DYN-S, V2007, P506; Kamgang JC, 2008, MATH BIOSCI, V213, P1, DOI 10.1016/j.mbs.2008.02.005; Kumar V, 2007, ROBBINS BASIC PATHOL; Ministere de la Sante Publique`, 1995, CADR CONC DISTR SANT; Moualeu DP, 2012, MATH MODEL NAT PHENO, V7, P117, DOI 10.1051/mmnp/20127309; Moualeu DP, 2011, J BIOL SYST, V19, P683, DOI 10.1142/S0218339011004159; Moualeu Dany Pascal, 2011, Journal of Applied Mathematics and Informatics, V29, P1097; Murphy BM, 2003, J THEOR BIOL, V223, P391, DOI 10.1016/S0022-5193(03)00038-9; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Mushayabasa S, 2013, J BIOL PHYS, V39, P723, DOI 10.1007/s10867-013-9328-6; National Institute of Statistics Bureau Central des Recensements et des Etudes de Popu lation, 2010, RAPPORT SUR LA PRESE; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Okuonghae D, 2007, MATH MODEL NAT PHENO, V2, P113, DOI 10.1051/mmnp:2008013; REVELLE CS, 1967, AM REV RESPIR DIS, V96, P893; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tewa JJ, 2009, CHAOS SOLITON FRACT, V39, P936, DOI 10.1016/j.chaos.2007.01.069; Thieme H, 2003, MATHEMATICS IN POPUL; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WAALER H, 1962, AM J PUBLIC HEALTH N, V56, P1002; Waaler HT, 1968, TUBERCLE           S, V49, P2, DOI [10.1016/S0041-3879(68)80031-5, DOI 10.1016/S0041-3879(68)80031-5]; WHO, 2012, TECHNICAL REPORT; WHO, 2006, THE STOP TB STRATEGY; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2008, TECHNICAL REPORT	44	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120607	10.1371/journal.pone.0120607	http://dx.doi.org/10.1371/journal.pone.0120607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874885	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100025
J	Narayanaswamy, R; Iyer, V; Khare, P; Bodziak, ML; Badgett, D; Zivadinov, R; Weinstock-Guttman, B; Rideout, TC; Ramanathan, M; Browne, RW				Narayanaswamy, Rohini; Iyer, Vignesh; Khare, Prachi; Bodziak, Mary Lou; Badgett, Darlene; Zivadinov, Robert; Weinstock-Guttman, Bianca; Rideout, Todd C.; Ramanathan, Murali; Browne, Richard W.			Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; VITAMIN-D; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; LIPID PROFILES; BRAIN; SERUM; 24S-HYDROXYCHOLESTEROL; PRECURSORS; QUANTIFICATION	Background Oxysterols are promising biomarkers of neurodegenerative diseases that are linked with cholesterol and vitamin D metabolism. There is an unmet need for methods capable of sensitive, and simultaneous quantitation of multiple oxysterols, vitamin D and cholesterol pathway biomarkers. Methods A method for simultaneous determination of 5 major oxysterols, 25-hydroxy vitamin D3 and cholesterol in human plasma was developed. Total oxysterols were prepared by room temperature saponification followed by solid phase extraction from plasma spiked with deuterated internal standards. Oxysterols were resolved by reverse phase HPLC using a methanol/water/0.1% formic acid gradient. Oxysterols and 25-hydroxy vitamin D3 were detected with atmospheric pressure chemical ionization mass spectrometry in positive ion mode; in-series photodiode array detection at 204nm was used for cholesterol. Method validation studies were performed. Oxysterol levels in 220 plasma samples from healthy control subjects, multiple sclerosis and other neurological disorders patients were quantitated. Results Our method quantitated 5 oxysterols, cholesterol and 25-hydroxy vitamin D3 from 200 mu L plasma in 35 minutes. Recoveries were >85% for all analytes and internal standards. The limits of detection were 3-10 ng/mL for oxysterols and 25-hydroxy vitamin D3 and 1 mu g/mL for simultaneous detection of cholesterol. Analytical imprecision was < 10 %CV for 24(S)-, 25-, 27-, 7 alpha-hydroxycholesterol (HC) and cholesterol and <= 15% for 7-keto-cholesterol. Multiple Sclerosis and other neurological disorder patients had lower 27-hydroxycholesterol levels compared to controls whereas 7 alpha-hydroxycholesterol was lower specifically in Multiple Sclerosis. Conclusion The method is suitable for measuring plasma oxysterols levels in human health and disease. Analysis of human plasma indicates that the oxysterol, bile acid precursors 7 alpha-hydroxycholesterol and 27-hydroxycholesterol are lower in Multiple Sclerosis and may serve as potential biomarkers of disease.	[Narayanaswamy, Rohini; Iyer, Vignesh; Khare, Prachi; Bodziak, Mary Lou; Browne, Richard W.] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Rideout, Todd C.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Badgett, Darlene; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Zivadinov, Robert; Weinstock-Guttman, Bianca; Ramanathan, Murali] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Browne, RW (corresponding author), SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA.	rwbrowne@buffalo.edu	Zivadinov, Robert/Q-2054-2019; IYER, VIGNESH/AAK-6751-2021; Weinstock-Guttman, Bianca/AAI-4694-2021	Zivadinov, Robert/0000-0002-7799-1485; IYER, VIGNESH/0000-0002-5874-4964; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Rideout, Todd C/0000-0002-1834-7083	National Multiple Sclerosis Society [RG4836-A-5]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	Funding provided by National Multiple Sclerosis Society, Grant # RG4836-A-5 to MR; http://www.nationalmssociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; [Anonymous], 2001, GUIDANCE IND BIOANAL; Bjorkhem I, 2006, ACTA NEUROL SCAND, V114, P43, DOI 10.1111/j.1600-0404.2006.00684.x; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Boenzi S, 2014, CLIN CHIM ACTA, V437, P93, DOI 10.1016/j.cca.2014.07.010; Brown AJ, 1996, J LIPID RES, V37, P320; Browne RW, 2014, J STEROID BIOCHEM, V143, P424, DOI 10.1016/j.jsbmb.2014.06.007; Duan XT, 2010, ANAL CHEM, V82, P2488, DOI 10.1021/ac902869y; Gosselet F, 2014, BIOCHEM BIOPH RES CO, V446, P687, DOI 10.1016/j.bbrc.2013.11.059; Griffiths WJ, 2013, BIOCHEM PHARMACOL, V86, P3, DOI 10.1016/j.bcp.2013.01.027; Griffiths WJ, 2011, BBA-MOL CELL BIOL L, V1811, P784, DOI 10.1016/j.bbalip.2011.05.012; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Kantarci O, 2006, CURR OPIN NEUROL, V19, P248, DOI 10.1097/01.wco.0000227033.47458.82; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Marwarha G, 2015, EXP GERONTOL, V68, P13, DOI 10.1016/j.exger.2014.09.013; Matysik S, 2012, CLIN CHEM, V58, P1557, DOI 10.1373/clinchem.2012.189605; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Olkkonen VM, 2004, ANN MED, V36, P562, DOI 10.1080/07853890410018907; Ponsonby A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1267, DOI 10.1562/2005-02-15-IR-441; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; van de Kraats C, 2014, MULT SCLER J, V20, P412, DOI 10.1177/1352458513499421; van de Merbel NC, 2008, TRAC-TREND ANAL CHEM, V27, P924, DOI 10.1016/j.trac.2008.09.002; Weinstock-Guttman B, 2013, J NEUROL NEUROSUR PS, V84, P1186, DOI 10.1136/jnnp-2012-304740; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Weinstock-Guttman B, 2011, J NEUROL SCI, V311, P86, DOI 10.1016/j.jns.2011.07.024; Wong J, 2007, J NEUROCHEM, V103, P1764, DOI 10.1111/j.1471-4159.2007.04913.x	30	23	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123771	10.1371/journal.pone.0123771	http://dx.doi.org/10.1371/journal.pone.0123771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875771	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100212
J	Ramaprasad, A; Mourier, T; Naeem, R; Malas, TB; Moussa, E; Panigrahi, A; Vermont, SJ; Otto, TD; Wastling, J; Pain, A				Ramaprasad, Abhinay; Mourier, Tobias; Naeem, Raeece; Malas, Tareq B.; Moussa, Ehab; Panigrahi, Aswini; Vermont, Sarah J.; Otto, Thomas D.; Wastling, Jonathan; Pain, Arnab			Comprehensive Evaluation of Toxoplasma gondii VEG and Neospora caninum LIV Genomes with Tachyzoite Stage Transcriptome and Proteome Defines Novel Transcript Features	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; LONG NONCODING RNAS; ANTISENSE TRANSCRIPTS; GENE PREDICTION; TRANSLATION; INTEGRATION; WIDESPREAD; EXPRESSION; ARTEMIS	Toxoplasma gondii is an important protozoan parasite that infects all warm-blooded animals and causes opportunistic infections in immuno-compromised humans. Its closest relative, Neospora caninum, is an important veterinary pathogen that causes spontaneous abortion in livestock. Comparative genomics of these two closely related coccidians has been of particular interest to identify genes that contribute to varied host cell specificity and disease. Here, we describe a manual evaluation of these genomes based on strand-specific RNA sequencing and shotgun proteomics from the invasive tachyzoite stages of these two parasites. We have corrected predicted structures of over one third of the previously annotated gene models and have annotated untranslated regions (UTRs) in over half of the predicted protein-coding genes. We observe distinctly long UTRs in both the organisms, almost four times longer than other model eukaryotes. We have also identified a putative set of cis-natural antisense transcripts (cis-NATs) and long intergenic non-coding RNAs (lincRNAs). We have significantly improved the annotation quality in these genomes that would serve as a manually curated dataset for Toxoplasma and Neospora research communities.	[Ramaprasad, Abhinay; Naeem, Raeece; Malas, Tareq B.; Moussa, Ehab; Pain, Arnab] King Abdullah Univ Sci & Technol, Pathogen Genom Lab, Biol & Environm Sci & Engn BESE Div, Jeddah, Saudi Arabia; [Mourier, Tobias] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Panigrahi, Aswini] King Abdullah Univ Sci & Technol, Biosci Core Lab, Jeddah, Saudi Arabia; [Vermont, Sarah J.; Wastling, Jonathan] Univ Liverpool, Inst Infect & Global Hlth, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Vermont, Sarah J.; Wastling, Jonathan] Univ Liverpool, Sch Vet Sci, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Otto, Thomas D.] Wellcome Trust Sanger Inst, Parasite Genom Grp, Cambridge, England	King Abdullah University of Science & Technology; University of Copenhagen; King Abdullah University of Science & Technology; University of Liverpool; University of Liverpool; Wellcome Trust Sanger Institute	Pain, A (corresponding author), King Abdullah Univ Sci & Technol, Pathogen Genom Lab, Biol & Environm Sci & Engn BESE Div, Jeddah, Saudi Arabia.	arnab.pain@kaust.edu.sa	Otto, Thomas/ABE-7632-2020; Ramaprasad, Abhinay/X-1235-2019; Ramaprasad, Abhinay/D-1181-2013; Pain, Arnab/L-5766-2015	Ramaprasad, Abhinay/0000-0001-9372-5526; Ramaprasad, Abhinay/0000-0001-9372-5526; Pain, Arnab/0000-0002-1755-2819; Otto, Thomas/0000-0002-1246-7404	KAUST Faculty Base Research Funding (BRF); KAUST-Cambridge Academic Excellence Alliance (AEA) [7000000080]	KAUST Faculty Base Research Funding (BRF); KAUST-Cambridge Academic Excellence Alliance (AEA)	This project was supported by KAUST Faculty Base Research Funding (BRF) and KAUST-Cambridge Academic Excellence Alliance (AEA) Grant (7000000080) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2005, BIOINFORMATICS, V21, P3596, DOI 10.1093/bioinformatics/bti609; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Caro F., 2014, eLife, pe04106; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cohen AM, 2002, INT J PARASITOL, V32, P39, DOI 10.1016/S0020-7519(01)00308-3; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; Dumas C, 2006, EUKARYOT CELL, V5, P2033, DOI 10.1128/EC.00147-06; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gastens MH, 2002, INT J PARASITOL, V32, P1225, DOI 10.1016/S0020-7519(02)00096-6; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hassan MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-696; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jung S, 2011, NUCLEIC ACIDS RES, V39, P7529, DOI 10.1093/nar/gkr501; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Siegel TN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-150; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trees AJ, 1999, INT J PARASITOL, V29, P1195, DOI 10.1016/S0020-7519(99)00093-4; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Yamagishi J, 2012, J PARASITOL, V98, P445, DOI 10.1645/GE-2864.1; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	44	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124473	10.1371/journal.pone.0124473	http://dx.doi.org/10.1371/journal.pone.0124473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875305	Green Published, gold, Green Accepted			2022-12-27	WOS:000352845100260
J	Wang, Y; Liu, ZY; Sun, MS				Wang, Yan; Liu, Zhiyuan; Sun, Maosong			Incorporating Linguistic Knowledge for Learning Distributed Word Representations	PLOS ONE			English	Article								Combined with neural language models, distributed word representations achieve significant advantages in computational linguistics and text mining. Most existing models estimate distributed word vectors from large-scale data in an unsupervised fashion, which, however, do not take rich linguistic knowledge into consideration. Linguistic knowledge can be represented as either link-based knowledge or preference-based knowledge, and we propose knowledge regularized word representation models (KRWR) to incorporate these prior knowledge for learning distributed word representations. Experiment results demonstrate that our estimated word representation achieves better performance in task of semantic relatedness ranking. This indicates that our methods can efficiently encode both prior knowledge from knowledge bases and statistical knowledge from large-scale text corpora into a unified word representation model, which will benefit many tasks in text mining.	[Wang, Yan; Liu, Zhiyuan; Sun, Maosong] Tsinghua Univ, Dept Comp Sci & Technol, Tsinghua Natl Lab Informat Sci & Technol, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China; [Sun, Maosong] Jiangsu Collaborat Innovat Ctr Language Competenc, Nanjing, Jiangsu, Peoples R China	Tsinghua University	Liu, ZY (corresponding author), Tsinghua Univ, Dept Comp Sci & Technol, Tsinghua Natl Lab Informat Sci & Technol, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China.	liuzy@tsinghua.edu.cn	Liu, Zhiyuan/I-2233-2014; Liu, Zhiyuan/L-9243-2019	Liu, Zhiyuan/0000-0002-7709-2543	National Key Basic Research Program of China (973 Program) [2014CB340500]; National Natural Science Foundation of China [NSFC 61133012, 61202140]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Key Basic Research Program of China (973 Program 2014CB340500) and National Natural Science Foundation of China (NSFC 61133012, 61202140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre Eneko, 2009, P HUMAN LANGUAGE TEC, P19; Andrzejewski David, 2009, Proc Int Conf Mach Learn, V382, P25; Baroni M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P238; Bengio Y, 2006, STUD FUZZ SOFT COMP, V194, P137; Bordes A., 2013, P NEUR INF PROC SYST, V2, P2787, DOI DOI 10.5555/2999792.2999923; Brown P. F., 1992, Computational Linguistics, V18, P467; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Collobert R., 2008, P 25 INT C MACH LEAR, P160, DOI DOI 10.1145/1390156.1390177; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Finkelstein L., 2001, P 10 INT C WORLD WID, P406, DOI DOI 10.1145/371920.372094; Fu RJ, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1199; Gabrilovich E, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1606; Ganitkevitch Juri, 2013, P NAACL HLT, P758; Guo J., 2014, P 2014 C EMP METH NA, P110, DOI DOI 10.3115/V1/D14-1012; Honkela T., 1995, ICANN '95. International Conference on Artificial Neural Networks. Neuronimes '95 Scientific Conference, P3; Honkela T, 1997, THESIS HELSINKI U TE; Huang E. H., 2008, P 50 ANN M ASS COMP, P873; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Li H., 2011, SYNTHESIS LECT HUMAN, DOI [10.2200/S00348ED1V01Y201104HLT012, DOI 10.2200/S00348ED1V01Y201104HLT012]; Lin Y., 2015, P AAAI; Manning C. D., 2008, INTRO INFORM RETRIEV, V1; Mei Q., 2008, P 17 INT C WORLD WID, P101, DOI DOI 10.1145/1367497.1367512; Mei SK, 2014, PR MACH LEARN RES, V32; Mikolov Tomas, 2013, P ICLR; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mnih A., 2008, P 21 INT C NEURAL IN, P1081; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Reisinger Joseph, 2010, P 2010 C EMP METH NA, P1; RITTER H, 1989, BIOL CYBERN, V61, P241, DOI 10.1007/BF00203171; Socher R, 2011, INT C MACHINE LEARNI; Socher R, 2013, P ACL; Tie-Yan Liu, 2009, Foundations and Trends in Information Retrieval, V3, P225, DOI 10.1561/1500000016; Turian J, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P384; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934	35	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118437	10.1371/journal.pone.0118437	http://dx.doi.org/10.1371/journal.pone.0118437			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874581	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100006
J	Zhang, ZW; Tang, XQ; Wang, D; Zhang, Q; Li, PW; Ding, XX				Zhang, Zhaowei; Tang, Xiaoqian; Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia			Rapid On-Site Sensing Aflatoxin B-1 in Food and Feed via a Chromatographic Time-Resolved Fluoroimmunoassay	PLOS ONE			English	Article							IMMUNOSENSOR; FLUORESCENCE	Aflatoxin B-1 poses grave threats to food and feed safety due to its strong carcinogenesis and toxicity, thus requiring ultrasensitive rapid on-site determination. Herein, a portable immunosensor based on chromatographic time-resolved fluoroimmunoassay was developed for sensitive and on-site determination of aflatoxin B-1 in food and feed samples. Chromatographic time-resolved fluoroimmunoassay offered a magnified positive signal and low signal-to-noise ratio in time-resolved mode due to the absence of noise interference caused by excitation light sources. Compared with the immunosensing performance in previous studies, this platform demonstrated a wider dynamic range of 0.2-60 mu g/kg, lower limit of detection from 0.06 to 0.12 mu g/kg, and considerable recovery from 80.5% to 116.7% for different food and feed sample matrices. It was found to be little cross-reactivity with other aflatoxins (B-2, G(1), G(2), and M-1). In the case of determination of aflatoxin B-1 in peanuts, corn, soy sauce, vegetable oil, and mouse feed, excellent agreement was found when compared with aflatoxin B-1 determination via the conversational high-performance liquid chromatography method. The chromatographic time-resolved fluoroimmunoassay affords a powerful alternative for rapid on-site determination of aflatoxin B1 and holds a promise for food safety in consideration of practical food safety and environmental monitoring.	[Zhang, Zhaowei; Tang, Xiaoqian; Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Peoples R China; [Zhang, Zhaowei; Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China; [Tang, Xiaoqian; Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Detect Mycotoxins, Wuhan 430062, Peoples R China; [Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan 430062, Peoples R China; [Ding, Xiaoxia] Minist Agr, Qual Inspect & Test Ctr Oilseeds Prod, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Zhang, ZW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	zwzhang@whu.edu.cn; zhangqi01@caas.cn; peiwuli@oilcrops.cn		, Zhaowei/0000-0002-6686-2995	Project of National Science & Technology Pillar Plan [2012BAB19B09]; Special Fund for Agro-scientific Research in the Public Interest [201203094-4]; National Natural Science Foundation of China [31101299]	Project of National Science & Technology Pillar Plan; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Project of National Science & Technology Pillar Plan to PL (Grant: 2012BAB19B09) (URL: http://www.most.gov.cn/), Special Fund for Agro-scientific Research in the Public Interest to ZZ(Grant: 201203094-4) (URL: http://www.moa.gov.cn/), National Natural Science Foundation of China to ZZ (Grant: 31101299) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanyi N, 2007, BIOSENS BIOELECTRON, V22, P797, DOI 10.1016/j.bios.2006.02.015; Bunzli JCG, 2005, CHEM SOC REV, V34, P1048, DOI 10.1039/b406082m; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gehring AG, 2011, ANNU REV ANAL CHEM, V4, P151, DOI 10.1146/annurev-anchem-061010-114010; Hu H, 2013, IEEE SENS J, V13, P1835, DOI 10.1109/JSEN.2013.2242057; Hu WH, 2013, BIOSENS BIOELECTRON, V50, P338, DOI 10.1016/j.bios.2013.06.037; Li PW, 2013, MASS SPECTROM REV, V32, P420, DOI 10.1002/mas.21377; Li PW, 2012, ELECTROPHORESIS, V33, P2253, DOI 10.1002/elps.201200050; Loock HP, 2012, SENSOR ACTUAT B-CHEM, V173, P157, DOI 10.1016/j.snb.2012.06.071; Park JH, 2014, FOOD CONTROL, V36, P183, DOI 10.1016/j.foodcont.2013.08.038; Tang DP, 2013, ANAL CHEM, V85, P10589, DOI 10.1021/ac402713a; Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1081/AL-100103209; Weissman SI, 1942, J CHEM PHYS, V10, P214, DOI 10.1063/1.1723709; Xu W, 2014, BIOSENS BIOELECTRON, V56, P144, DOI 10.1016/j.bios.2014.01.007; Xu X, 2013, BIOSENS BIOELECTRON, V47, P361, DOI 10.1016/j.bios.2013.03.048; Zhang DH, 2011, TALANTA, V85, P736, DOI 10.1016/j.talanta.2011.04.061; Zhang DH, 2011, BIOSENS BIOELECTRON, V26, P2877, DOI 10.1016/j.bios.2010.11.031; Zhang DH, 2009, ANAL CHIM ACTA, V636, P63, DOI 10.1016/j.aca.2009.01.010; Zhang ZW, 2014, ELECTROPHORESIS, V35, P1547, DOI 10.1002/elps.201300570; Zhang ZW, 2012, SENSORS-BASEL, V12, P9234, DOI 10.3390/s120709234	20	26	28	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123266	10.1371/journal.pone.0123266	http://dx.doi.org/10.1371/journal.pone.0123266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874803	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100157
J	Brenner, S; De Allegri, M; Gabrysch, S; Chinkhumba, J; Sarker, M; Muula, AS				Brenner, Stephan; De Allegri, Manuela; Gabrysch, Sabine; Chinkhumba, Jobiba; Sarker, Malabika; Muula, Adamson S.			The Quality of Clinical Maternal and Neonatal Healthcare - A Strategy for Identifying 'Routine Care Signal Functions'	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; LOW-RESOURCE SETTINGS; OVERCOME CHALLENGES; MEDICAL-CARE; 3 DISTRICTS; SURVIVAL 1; INDICATORS; ATTENDANTS; COUNTRIES; SERVICES	Background A variety of clinical process indicators exists to measure the quality of care provided by maternal and neonatal health (MNH) programs. To allow comparison across MNH programs in low-and middle-income countries (LMICs), a core set of essential process indicators is needed. Although such a core set is available for emergency obstetric care (EmOC), the 'EmOC signal functions', a similar approach is currently missing for MNH routine care evaluation. We describe a strategy for identifying core process indicators for routine care and illustrate their usefulness in a field example. Methods We first developed an indicator selection strategy by combining epidemiological and programmatic aspects relevant to MNH in LMICs. We then identified routine care process indicators meeting our selection criteria by reviewing existing quality of care assessment protocols. We grouped these indicators into three categories based on their main function in addressing risk factors of maternal or neonatal complications. We then tested this indicator set in a study assessing MNH quality of clinical care in 33 health facilities in Malawi. Results Our strategy identified 51 routine care processes: 23 related to initial patient risk assessment, 17 to risk monitoring, 11 to risk prevention. During the clinical performance assessment a total of 82 cases were observed. Birth attendants' adherence to clinical standards was lowest in relation to risk monitoring processes. In relation to major complications, routine care processes addressing fetal and newborn distress were performed relatively consistently, but there were major gaps in the performance of routine care processes addressing bleeding, infection, and pre-eclampsia risks. Conclusion The identified set of process indicators could identify major gaps in the quality of obstetric and neonatal care provided during the intra-and immediate postpartum period. We hope our suggested indicators for essential routine care processes will contribute to streamlining MNH program evaluations in LMICs.	[Brenner, Stephan; De Allegri, Manuela; Gabrysch, Sabine; Sarker, Malabika] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Chinkhumba, Jobiba; Muula, Adamson S.] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi	Ruprecht Karls University Heidelberg; University of Malawi	Brenner, S (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.	stephan.brenner@uni-heidelberg.de	Muula, Adamson/AAF-1153-2020; Gabrysch, Sabine/A-3503-2013	Gabrysch, Sabine/0000-0002-7081-0506; Sarker, Malabika/0000-0001-7293-8805	United States Agency for International Development (USAID) [GHS-A-00-09-00015-00]; Norwegian Ministry of Foreign Affairs [MWI 12/0010]; Malawi College of Medicine	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Ministry of Foreign Affairs; Malawi College of Medicine	This research project is made possible through Translating Research into Action, TRAction, and is funded by United States Agency for International Development (USAID) under cooperative agreement number GHS-A-00-09-00015-00. The project team includes prime recipient, University Research Co., LLC (URC), Harvard University School of Public Health (HSPH), and sub-recipient research organization, University of Heidelberg. This research project is co-funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MAL STAND TREATM GUI; [Anonymous], 2005, MAL NAT ROAD MAP ACC; [Anonymous], 2009, INT MAN PREGN CHILDB, DOI [10.1186/1471-2393-9-20, DOI 10.1186/1471-2393-9-20]; [Anonymous], 2006, MAL NAT REPR HLTH SE; [Anonymous], 2010, COUNTD 2015 DEC REP, DOI [10.1016/S0140-6736(10)60678-2, DOI 10.1016/S0140-6736(10)60678-2]; [Anonymous], 2010, CLIN MAN HIV CHILDR; [Anonymous], 2010, NAT INT INF PREV REP; Ashebir Getachew, 2011, QUALITY CARE PREVENT; Bates I, 2008, BJOG-INT J OBSTET GY, V115, P1331, DOI 10.1111/j.1471-0528.2008.01866.x; Bayley O, 2013, MALAWI MED J, V25, P105; Betran Ana P., 2006, MONITORING EVALUATIO; Brenner S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-180; Chin MH, 2003, PERSPECT BIOL MED, V46, P5, DOI 10.1353/pbm.2003.0002; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Diana B, 2010, EXPLORING EVIDENCE D; Edmond K., 2006, OPTIMAL FEEDING LOW; Fidele Ngabo, 2012, QUALITY CARE PREVENT; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Hermida J, 1999, INT J QUAL HEALTH C, V11, P429, DOI 10.1093/intqhc/11.5.429; Hirshon JM, 2013, B WORLD HEALTH ORGAN, V91, P386, DOI 10.2471/BLT.12.112664; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hussein J, 2005, HEALTH POLICY, V73, P294, DOI 10.1016/j.healthpol.2004.11.021; Ith P, 2013, MIDWIFERY, V29, P300, DOI 10.1016/j.midw.2012.01.010; Kagema F, 2011, QUALITY CARE PREVENT; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lidia Chongo, 2013, QUALITY HUMANIZATION; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Makaula P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-328; Marya Plotkin, 2011, QUALITY CARE PREVENT; Marya Plotkin, 2012, QUALITY MATERNAL NEW; Ministry of Health Malawi, 2011, MAL HLTH SECT STRAT; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Ranjalahy Justin, 2011, QUALITY CARE PREVENT; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Samuel Rigbe, 2005, Afr Health Sci, V5, P4; Tawfik Y, 2010, FINDING COMMON GROUN; The Partnership for Maternal Newborn and Child Health, 2011, MAT NEWB CHILD HLTH; United Nations Children's Fund (UNICEF), STAT WORLDS CHILDR R; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2011, IMCI INS TRAIN; WHO UNICEF UNFPA The World Bank United Nations Population Division., 2014, WHO TRENDS MAT MORT; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2010, PACK INT FAM PLANN S; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7	62	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123968	10.1371/journal.pone.0123968	http://dx.doi.org/10.1371/journal.pone.0123968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875252	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353015800126
J	Chabot, D; Craik, SR; Bird, DM				Chabot, Dominique; Craik, Shawn R.; Bird, David M.			Population Census of a Large Common Tern Colony with a Small Unmanned Aircraft	PLOS ONE			English	Article							INVESTIGATOR-DISTURBANCE; AERIAL VEHICLES; WATERBIRDS; MANAGEMENT; ACCURACY; SEABIRDS; ECOLOGY; SUCCESS; SYSTEMS; COUNTS	Small unmanned aircraft systems (UAS) may be useful for conducting high-precision, low-disturbance waterbird surveys, but limited data exist on their effectiveness. We evaluated the capacity of a small UAS to census a large (>6,000 nests) coastal Common tern (Sterna hirundo) colony of which ground surveys are particularly disruptive and time-consuming. We compared aerial photographic tern counts to ground nest counts in 45 plots (5-m radius) throughout the colony at three intervals over a nine-day period in order to identify sources of variation and establish a coefficient to estimate nest numbers from UAS surveys. We also compared a full colony ground count to full counts from two UAS surveys conducted the following day. Finally, we compared colony disturbance levels over the course of UAS flights to matched control periods. Linear regressions between aerial and ground counts in plots had very strong correlations in all three comparison periods (R-2 = 0.972-0.989, P < 0.001) and regression coefficients ranged from 0.928-0.977 terns/nest. Full colony aerial counts were 93.6% and 94.0%, respectively, of the ground count. Varying visibility of terns with ground cover, weather conditions and image quality, and changing nest attendance rates throughout incubation were likely sources of variation in aerial detection rates. Optimally timed UAS surveys of Common tern colonies following our method should yield population estimates in the 93-96% range of ground counts. Although the terns were initially disturbed by the UAS flying overhead, they rapidly habituated to it. Overall, we found no evidence of sustained disturbance to the colony by the UAS. We encourage colonial waterbird researchers and managers to consider taking advantage of this burgeoning technology.	[Chabot, Dominique] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Craik, Shawn R.] Univ St Anne, Dept Sci, Pointe De Leglise, NS, Canada; [Chabot, Dominique; Bird, David M.] McGill Univ, Avian Sci & Conservat Ctr, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	Chabot, D (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	dominique.chabot@mail.mcgill.ca		Chiaradia, Andre/0000-0002-6178-4211	Kenneth M. Molson Foundation; New Brunswick Wildlife Trust Fund [W202-002]; Canadian Wildlife Federation; Fonds Quebecois de la Recherche sur la Nature et les Technologies [135289]	Kenneth M. Molson Foundation; New Brunswick Wildlife Trust Fund; Canadian Wildlife Federation; Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	Funds for this research were provided by the Kenneth M. Molson Foundation (www.kennethmolsonfoundation.ca), the New Brunswick Wildlife Trust Fund (www.nbwtf.ca; grant #W202-002), the Canadian Wildlife Federation (www.cwf-fcf.org), and the Fonds Quebecois de la Recherche sur la Nature et les Technologies (www.frqnt.gouv.qc.ca; scholarship #135289). In-kind contributions were provided by Parks Canada (www.pc.gc.ca), Aerial Insight (www.aerialinsight.co.uk), and MicroPilot (www.micropilot.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elrahman A, 2005, SURVEYING LAND INFOR, V65, P37; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bechet A, 2004, J WILDLIFE MANAGE, V68, P639, DOI 10.2193/0022-541X(2004)068[0639:ETSOTG]2.0.CO;2; Blackmer AL, 2004, BIOL CONSERV, V116, P141, DOI 10.1016/S0006-3207(03)00185-X; BOLLINGER PB, 1990, AUK, V107, P696, DOI 10.2307/4088000; Boyd WS, 2000, J FIELD ORNITHOL, V71, P686, DOI 10.1648/0273-8570-71.4.686; Boyne AW, 2002, TECHNICAL REPORT SER, V999; Burger J., 1991, COMMON TERN ITS BREE; Carey MJ, 2009, NEW ZEAL J ZOOL, V36, P367, DOI 10.1080/03014220909510161; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Chabot D, 2013, J UNMANNED VEH SYST, V1, P15, DOI 10.1139/juvs-2013-0014; Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Cordts SD, 2002, WILDLIFE SOC B, V30, P317; COURTNEY P, 1979, IBIS, V121, P207, DOI 10.1111/j.1474-919X.1979.tb04964.x; Craik SR, 2009, WATERBIRDS, V32, P282, DOI 10.1675/063.032.0208; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Frederick PC, 1996, CONDOR, V98, P837, DOI 10.2307/1369865; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kingsford RT, 2009, WILDLIFE RES, V36, P29, DOI 10.1071/WR08034; Kingsford RT, 1999, FRESHWATER BIOL, V41, P425, DOI 10.1046/j.1365-2427.1999.00440.x; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; KUSHLAN JA, 1993, COLON WATERBIRD, V16, P223, DOI 10.2307/1521444; Laursen K, 2008, WILDLIFE BIOL, V14, P165, DOI 10.2981/0909-6396(2008)14[165:AOTCOW]2.0.CO;2; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; MORRIS RD, 1986, WILSON BULL, V98, P101; Mulac BL, 2011, GEOCARTO INT, V26, P71, DOI 10.1080/10106049.2010.537786; Nisbet ICT, 2000, WATERBIRDS, V23, P312; PARNELL JF, 1988, COLON WATERBIRD, V11, P129, DOI 10.2307/1520996; Rango A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3474649; Rodgers JA, 2005, WATERBIRDS, V28, P230, DOI 10.1675/1524-4695(2005)028[0230:AOASOW]2.0.CO;2; Rodway MS, 1996, BIOL CONSERV, V76, P311, DOI 10.1016/0006-3207(94)00118-9; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Vertigan C, 2012, ANIM WELFARE, V21, P101, DOI 10.7120/096272812799129493; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; [No title captured]	36	92	97	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122588	10.1371/journal.pone.0122588	http://dx.doi.org/10.1371/journal.pone.0122588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874997	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800067
J	Watanabe, T; Takeuchi, T; Handa, O; Sakata, Y; Tanigawa, T; Shiba, M; Naito, Y; Higuchi, K; Fujimoto, K; Yoshikawa, T; Arakawa, T				Watanabe, Toshio; Takeuchi, Toshihisa; Handa, Osamu; Sakata, Yasuhisa; Tanigawa, Tetsuya; Shiba, Masatsugu; Naito, Yuji; Higuchi, Kazuhide; Fujimoto, Kazuma; Yoshikawa, Toshikazu; Arakawa, Tetsuo			A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage	PLOS ONE			English	Article							INJURY POSSIBLE INVOLVEMENT; SMALL-BOWEL INJURY; PRIMARY PREVENTION; DRUG; MISOPROSTOL; DELAY	Background Low-dose aspirin (LDA) frequently causes small bowel injury. While some drugs have been reported to be effective in treating LDA-induced small intestinal damage, most studies did not exclude patients with mild damage thought to be clinically insignificant. Aim We conducted a multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy of a high dose of rebamipide, a gastroprotective drug, for LDA-induced moderate- to-severe enteropathy. Methods We enrolled patients who received 100 mg of enteric-coated aspirin daily for more than 3 months and were found to have more than 3 mucosal breaks (i.e., erosions or ulcers) in the small intestine by capsule endoscopy. Eligible patients were assigned to receive either rebamipide 300 mg (triple dose) 3 times daily or placebo for 8 weeks in a 2: 1 ratio. Capsule endoscopy was then repeated. The primary endpoint was the change in the number of mucosal breaks from baseline to 8 weeks. Secondary endpoints included the complete healing of mucosal breaks at 8 weeks and the change in Lewis score (an endoscopic score assessing damage severity) from baseline to 8 weeks. Results The study was completed by 38 patients (rebamipide group: n = 25, placebo group: n = 13). After 8 weeks of treatment, rebamipide, but not placebo, significantly decreased the number of mucosal breaks (p = 0.046). While the difference was not significant (p = 0.13), the rate of complete mucosal break healing in the rebamipide group (32%, 8 of 25) tended to be higher than that in the placebo group (7.7%, 1 of 13). Rebamipide treatment significantly improved intestinal damage severity as assessed by the Lewis score (p = 0.02), whereas placebo did not. The triple dose of rebamipide was well tolerated. Conclusions High-dose rebamipide is effective for the treatment of LDA-induced moderate-tosevere enteropathy.	[Watanabe, Toshio; Tanigawa, Tetsuya; Shiba, Masatsugu; Arakawa, Tetsuo] Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Takeuchi, Toshihisa; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 569, Japan; [Handa, Osamu; Naito, Yuji; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Sakata, Yasuhisa; Fujimoto, Kazuma] Saga Med Sch, Dept Internal Med & Gastroenterol, Saga, Japan	Osaka Metropolitan University; Osaka Medical College; Kyoto Prefectural University of Medicine; Saga University	Watanabe, T (corresponding author), Osaka City Univ Grad Sch Med, Dept Gastroenterol, Osaka, Japan.	watanabet@med.osaka-cu.ac.jp	半田, 修/GQA-9627-2022; Tanigawa, Tetsuya/J-6131-2019; Handa, Osamu/AEW-4869-2022	Tanigawa, Tetsuya/0000-0002-9305-1637; Handa, Osamu/0000-0003-2228-0405	Eisai Co., Ltd.; Otsuka Pharmaceutical Co., Ltd; Takeda Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.	Eisai Co., Ltd.(Eisai Co Ltd); Otsuka Pharmaceutical Co., Ltd(Otsuka Pharmaceutical); Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	YN has received research grants from Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd and Takeda Pharmaceutical Co., Ltd. KH has received research grants and speaker's fee from Otsuka Pharmaceutical Co., Ltd. TA has received research grants from Eisai Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. Otsuka Pharmaceutical Co., Ltd provided rebamipide and identical placebo. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aihara M, 1998, DIGEST DIS SCI, V43, p160S; Akamatsu T, 2002, DIGEST DIS SCI, V47, P1399, DOI 10.1023/A:1015347219999; Arakawa T, 2005, DIGEST DIS SCI, V50, pS3, DOI 10.1007/s10620-005-2800-9; Arakawa T, 2012, CURR MED CHEM, V19, P77, DOI 10.2174/092986712803414105; Endo H, 2011, J GASTROENTEROL, V46, P894, DOI 10.1007/s00535-011-0410-1; Gralnev IM, 2008, ALIMENT PHARM THERAP, V27, P146, DOI 10.1111/j.1365-2036.2007.03556.x; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Imaeda H, 2012, DIGESTION, V86, P250, DOI 10.1159/000341508; Mizukami K, 2011, WORLD J GASTROENTERO, V17, P5117, DOI 10.3748/wjg.v17.i46.5117; Nadatani Y, 2013, SCAND J GASTROENTERO, V48, P320, DOI 10.3109/00365521.2012.758771; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Nagano Y, 2005, DIGEST DIS SCI, V50, pS76, DOI 10.1007/s10620-005-2810-7; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Niwa Y, 2008, J GASTROENTEROL, V43, P270, DOI 10.1007/s00535-007-2155-4; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Park SH, 2007, J CLIN BIOCHEM NUTR, V40, P148, DOI 10.3164/jcbn.40.148; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Sun WH, 2000, J PHARMACOL EXP THER, V295, P447; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Tanigawa T, 2011, J CLIN BIOCHEM NUTR, V48, P149, DOI 10.3164/jcbn.10-75; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2005, DIGEST DIS SCI, V50, pS63, DOI 10.1007/s10620-005-2808-1; Watanabe T, 2002, DIGEST DIS SCI, V47, P1582, DOI 10.1023/A:1015879421739; Watanabe T, 2014, GUT, V63, P409, DOI 10.1136/gutjnl-2013-304713; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; Watari I, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-108; Xie ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090286; YOSHIKAWA T, 1993, ARZNEIMITTEL-FORSCH, V43-1, P363	30	30	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122330	10.1371/journal.pone.0122330	http://dx.doi.org/10.1371/journal.pone.0122330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874951	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800051
J	Alvarez-Filip, L; Paddack, MJ; Ben Collen; Robertson, DR; Cote, IM				Alvarez-Filip, Lorenzo; Paddack, Michelle J.; Ben Collen; Robertson, D. Ross; Cote, Isabelle M.			Simplification of Caribbean Reef-Fish Assemblages over Decades of Coral Reef Degradation	PLOS ONE			English	Article							REGION-WIDE DECLINES; MONITORING CHANGE; SPARISOMA-VIRIDE; ADULT ABUNDANCE; BIODIVERSITY; POPULATION; RISK; HOMOGENIZATION; SPECIALIZATION; DAMSELFISHES	Caribbean coral reefs are becoming structurally simpler, largely due to human impacts. The consequences of this trend for reef-associated communities are currently unclear, but expected to be profound. Here, we assess whether changes in fish assemblages have been non-random over several decades of declining reef structure. More specifically, we predicted that species that depend exclusively on coral reef habitat (i.e., habitat specialists) should be at a disadvantage compared to those that use a broader array of habitats (i.e., habitat generalists). Analysing 3727 abundance trends of 161 Caribbean reef-fishes, surveyed between 1980 and 2006, we found that the trends of habitat-generalists and habitat-specialists differed markedly. The abundance of specialists started to decline in the mid-1980s, reaching a low of similar to 60% of the 1980 baseline by the mid-1990s. Both the average and the variation in abundance of specialists have increased since the early 2000s, although the average is still well below the baseline level of 1980. This modest recovery occurred despite no clear evidence of a regional recovery in coral reef habitat quality in the Caribbean during the 2000s. In contrast, the abundance of generalist fishes remained relatively stable over the same three decades. Few specialist species are fished, thus their population declines are most likely linked to habitat degradation. These results mirror the observed trends of replacement of specialists by generalists, observed in terrestrial taxa across the globe. A significant challenge that arises from our findings is now to investigate if, and how, such community-level changes in fish populations affect ecosystem function.	[Alvarez-Filip, Lorenzo] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico; [Alvarez-Filip, Lorenzo; Paddack, Michelle J.; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol, Santa Barbara, CA 93109 USA; [Ben Collen] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England; [Robertson, D. Ross] Smithsonian Trop Res Inst, Balboa, Panama	Universidad Nacional Autonoma de Mexico; Simon Fraser University; University of London; University College London; Smithsonian Institution; Smithsonian Tropical Research Institute	Alvarez-Filip, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico.	lorenzo@cmarl.unam.mx.com	Collen, Ben/F-2543-2016; Cote, Isabelle/ABD-5898-2021; Alvarez-Filip, Lorenzo/C-9552-2011	Collen, Ben/0000-0003-2564-4243; Alvarez-Filip, Lorenzo/0000-0002-5726-7238	UK's Natural Environment Resource Council [NE/C004442/1]; Mexican Council of Science and Technology (CONACYT) [160230]; Natural Sciences and Engineering Council of Canada (NSERC); Rufford Foundation; NSERC; Smithsonian Tropical Research Institute; Natural Environment Research Council [NE/C004442/1] Funding Source: researchfish; NERC [NE/C004442/1] Funding Source: UKRI	UK's Natural Environment Resource Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rufford Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Compilation of the original database by MJP was funded by the UK's Natural Environment Resource Council, NE/C004442/1. LA-F was supported by the Mexican Council of Science and Technology (CONACYT; 160230), and by the Natural Sciences and Engineering Council of Canada (NSERC). BC is supported by the Rufford Foundation, IMC is funded by a Discovery Grant from NSERC, and DRR is supported by the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bruckner A.W., 2003, P CAR ACR WORKSH POT; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Collen B, 2014, SCIENCE, V346, P166, DOI 10.1126/science.1255772; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Froese R, FISHBASE; Galewski T, 2011, BIOL CONSERV, V144, P1392, DOI 10.1016/j.biocon.2010.10.030; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Haughton EO, 2004, ANN P GULF CARIBB FI, V54, P188; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Lirman D, 1999, B MAR SCI, V65, P235; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Luiz OJ, 2012, P ROY SOC B-BIOL SCI, V279, P1033, DOI 10.1098/rspb.2011.1525; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; McClenachan Loren, 2009, Endangered Species Research, V7, P175, DOI 10.3354/esr00167; McManus E, 2005, FISHERIES REGULATION; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Paddack MJ, 2008, MAR ECOL PROG SER, V369, P205, DOI 10.3354/meps07632; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; ROBERTSON DR, 1984, ECOLOGY, V65, P1121, DOI 10.2307/1938320; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Tolimieri N, 1998, B MAR SCI, V62, P253; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	54	41	42	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0126004	10.1371/journal.pone.0126004	http://dx.doi.org/10.1371/journal.pone.0126004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875218	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700078
J	Song, N; Choi, JY; Sung, H; Jeon, S; Chung, S; Song, M; Park, SK; Han, W; Lee, JW; Kim, MK; Yoo, KY; Ahn, SH; Noh, DY; Kang, D				Song, Nan; Choi, Ji-Yeob; Sung, Hyuna; Jeon, Sujee; Chung, Seokang; Song, Minkyo; Park, Sue K.; Han, Wonshik; Lee, Jong Won; Kim, Mi Kyung; Yoo, Keun-Young; Ahn, Sei-Hyun; Noh, Dong-Young; Kang, Daehee			Tumor Subtype-Specific Associations of Hormone-Related Reproductive Factors on Breast Cancer Survival	PLOS ONE			English	Article							RISK-FACTORS; PROGNOSTIC FACTOR; RECEPTOR STATUS; YOUNG-WOMEN; LAST BIRTH; SHORT-TERM; PARITY; MORTALITY; PROLACTIN; DIAGNOSIS	Purpose It is inconclusive whether reproductive factors, which are known as risk factors of breast cancer, also influence survival. We investigated overall and subtype-specific associations between reproductive factors and breast cancer survival. Methods Among 3,430 incident breast cancer patients who enrolled in the Seoul Breast Cancer Study, 269 patients (7.8%) died and 528 patients (15.4%) recurred. The overall and subtype-specific associations of reproductive factors including age at menarche and menopause, duration of estrogen exposure, menstrual cycle, parity, age at first full-term pregnancy, number of children, age at last birth, time since the last birth, and duration of breastfeeding, on overall and disease-free survival (OS and DFS) were estimated by hazard ratios (HRs) and 95% confidence intervals (95% CIs) using a multivariate Cox proportional hazard model. Results An older age at menarche (HR for OS=1.10, 95% CI=1.03-1.19), a greater number of children (>= 4 vs. 2, HR for DFS=1.58, 95% CI=1.11-2.26), and a shorter time since last birth (<5 vs. >= 20 years, HR for DFS=1.67, 95% CI=1.07-2.62) were associated with worse survival while longer duration of estrogen exposure with better survival (HR for DFS=0.97, 95% CI=0.96-0.99). In the stratified analyses by subtypes, those associations were more pronounced among women with hormone receptor and human epidermal growth factor 2 positive (HR+ HER2+) tumors. Conclusions It is suggested that reproductive factors, specifically age at menarche, number of children, time since last birth, and duration of estrogen exposure, could influence breast tumor progression, especially in the HR+ HER2+ subtype.	[Song, Nan; Choi, Ji-Yeob; Park, Sue K.; Han, Wonshik; Noh, Dong-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Ji-Yeob; Sung, Hyuna; Chung, Seokang; Song, Minkyo; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Choi, Ji-Yeob; Jeon, Sujee; Song, Minkyo; Park, Sue K.; Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Sung, Hyuna] NCI, Div Epidemiol & Genet, Rockville, MD USA; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won; Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won] ASAN Med Ctr, Seoul, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Management, Goyang Si, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); University of Ulsan; National Cancer Center - Korea (NCC)	Choi, JY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	jiyeob.choi@gmail.com	Song, Minkyo/AAE-9095-2020; Han, Wonshik/B-3699-2008; Song, Nan/F-5774-2019	Song, Minkyo/0000-0002-9412-2871; Han, Wonshik/0000-0001-7310-0764; Song, Nan/0000-0002-9182-1060; Kang, Daehee/0000-0003-4031-5878	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2010-0028631]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaker MDK, 2013, INT J CANCER, V132, P174, DOI 10.1002/ijc.27593; Andersen SW, 2011, BREAST CANCER RES TR, V130, P975, DOI 10.1007/s10549-011-1666-0; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Baglin T, 2010, J THROMB HAEMOST, V8, P228, DOI 10.1111/j.1538-7836.2009.03702.x; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bhatavdekar J M, 1993, Eur J Surg Oncol, V19, P409; BLACK MM, 1983, JNCI-J NATL CANCER I, V70, P27; Bladstrom Anna, 2003, Clin Breast Cancer, V4, P280, DOI 10.3816/CBC.2003.n.033; Bonnier P, 1997, INT J CANCER, V72, P720, DOI 10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Butt S, 2009, EJSO-EUR J SURG ONC, V35, P702, DOI 10.1016/j.ejso.2008.03.017; Choi HK, 2014, NAT REV RHEUMATOL, V10, P403, DOI 10.1038/nrrheum.2014.36; Chung S, 2013, BREAST CANCER RES TR, V140, P557, DOI 10.1007/s10549-013-2645-4; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Conroy SM, 2011, BREAST CANCER RES TR, V129, P565, DOI 10.1007/s10549-011-1468-4; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046; GUINEE VF, 1994, LANCET, V343, P1587; Harlow BL, 2000, MATURITAS, V35, P3, DOI 10.1016/S0378-5122(00)00092-X; Jaffe DH, 2009, EUR J EPIDEMIOL, V24, P9, DOI 10.1007/s10654-008-9310-y; JURET P, 1976, EUR J CANCER, V12, P701, DOI 10.1016/0014-2964(76)90019-0; KORZENIOWSKI S, 1994, CANCER, V74, P1591, DOI 10.1002/1097-0142(19940901)74:5<1591::AID-CNCR2820740515>3.0.CO;2-#; Kroman N, 2003, BREAST, V12, P516, DOI 10.1016/S0960-9776(03)00159-0; Kroman N, 1997, BRIT MED J, V315, P851, DOI 10.1136/bmj.315.7112.851; Kroman N, 1998, BRIT J CANCER, V78, P1529, DOI 10.1038/bjc.1998.718; Kwan ML, 2014, AM J EPIDEMIOL, V179, P95, DOI 10.1093/aje/kwt233; Largent JA, 2005, BREAST CANCER RES, V7, pR541, DOI 10.1186/bcr1198; LEES AW, 1989, BREAST CANCER RES TR, V13, P143, DOI 10.1007/BF01806526; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; MOHLEBOETANI JC, 1988, PREV MED, V17, P634, DOI 10.1016/0091-7435(88)90056-4; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Niraula S, 2012, BREAST CANCER RES TR, V134, P769, DOI 10.1007/s10549-012-2073-x; Olson SH, 1998, EPIDEMIOLOGY, V9, P669, DOI 10.1097/00001648-199811000-00019; Orgeas CC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2212; PAPATESTAS AE, 1980, CANCER, V45, P191, DOI 10.1002/1097-0142(19800101)45:1<191::AID-CNCR2820450130>3.0.CO;2-6; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Phillips KA, 2004, J CLIN ONCOL, V22, P699, DOI 10.1200/JCO.2004.07.062; Phillips KA, 2009, CANCER EPIDEM BIOMAR, V18, P1792, DOI 10.1158/1055-9965.EPI-08-1014; Reeves GK, 2000, INT J CANCER, V89, P293, DOI 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R; Rich JD, 2010, J AM COLL CARDIOL, V56, P1376, DOI 10.1016/j.jacc.2010.06.028; Rosenberg L, 2004, INT J CANCER, V111, P772, DOI 10.1002/ijc.20323; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Schouten LJ, 1997, BREAST CANCER RES TR, V43, P217, DOI 10.1023/A:1005790531122; Song N, 2014, INT J CANCER, V135, P669, DOI 10.1002/ijc.28685; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spitale A, 2009, ANN ONCOL, V20, P628, DOI 10.1093/annonc/mdn675; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Trivers KF, 2007, BREAST CANCER RES TR, V103, P93, DOI 10.1007/s10549-006-9346-1; WANG DY, 1995, J CLIN EPIDEMIOL, V48, P959, DOI 10.1016/0895-4356(94)00201-Z; WANG DY, 1985, INT J CANCER, V36, P427, DOI 10.1002/ijc.2910360403; Whiteman MK, 2004, OBSTET GYNECOL, V104, P146, DOI 10.1097/01.AOG.0000128173.01611.ff; Yamauchi T, 2000, J BIOL CHEM, V275, P33937, DOI 10.1074/jbc.M000743200	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123994	10.1371/journal.pone.0123994	http://dx.doi.org/10.1371/journal.pone.0123994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875532	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700053
J	van der Werf, IM; Kooy, RF; Vandeweyer, G				van der Werf, Ilse M.; Kooy, R. Frank; Vandeweyer, Geert			A Robust Protocol to Increase NimbleGen SeqCap EZ Multiplexing Capacity to 96 Samples	PLOS ONE			English	Article							GENERATION; DIAGNOSIS; FRAMEWORK	Contemporary genetic studies frequently involve sequencing of a targeted gene panel, for instance consisting of a set of genes associated with a specific disease. The NimbleGen SeqCap EZ Choice kit is commonly used for the targeted enrichment of sequencing libraries comprising a target size up to 7 Mb. A major drawback of this commercially available method is the exclusive use of single-indexing, meaning that at most 24 samples can be multiplexed in a single reaction. In case of relatively small target sizes, this will lead to excessive amounts of data per sample. We present an extended version of the NimbleGen SeqCap EZ protocol which allows to robustly multiplex up to 96 samples. We achieved this by incorporating Illumina dual-indexing based custom adapters into the original protocol. To further extend the optimization of cost-efficient sequencing of custom target panels, we studied the effect of higher pre-enrichment pooling factors and show that pre-enrichment pooling of up to 12 samples does not affect the quality of the data. To facilitate evaluation of capture efficiency in custom design panels, we also provide a detailed reporting tool.	[van der Werf, Ilse M.; Kooy, R. Frank; Vandeweyer, Geert] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	University of Antwerp	van der Werf, IM (corresponding author), Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.	Geert.Vandeweyer@uantwerpen.be	Kooy, Frank/F-5276-2014	Kooy, Frank/0000-0003-2024-0485; Vandeweyer, Geert/0000-0002-6262-6522	Belgian National Fund for Scientific Research-Flanders (FWO); Special Research Fund of the University of Antwerp [Bijzonder Onderzoeksfonds (BOF-IWT)]	Belgian National Fund for Scientific Research-Flanders (FWO)(Fonds de la Recherche Scientifique - FNRSFWO); Special Research Fund of the University of Antwerp [Bijzonder Onderzoeksfonds (BOF-IWT)]	This work was funded by the Belgian National Fund for Scientific Research-Flanders (FWO) to GV and RFK and the Special Research Fund of the University of Antwerp [Bijzonder Onderzoeksfonds (BOF-IWT)] to IMvdW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparisi MJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0168-7; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Helsmoortel C, 2015, CLIN GENET, V88, P140, DOI 10.1111/cge.12470; Illumina, 2014, TECHNICAL NOTE ESTIM; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johansen CT, 2014, J LIPID RES, V55, P765, DOI 10.1194/jlr.D045963; KAPABiosystems, 2013, KAPA LIBRARY PREPARA; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakano E, 2015, DIGEST DIS SCI, V60, P1297, DOI 10.1007/s10620-014-3476-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Vandeweyer G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0074-6; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123872	10.1371/journal.pone.0123872	http://dx.doi.org/10.1371/journal.pone.0123872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875648	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700050
J	Cavalcanti, AS; Ribeiro-Alves, M; Pereira, LDR; Mestre, GL; Ferreira, ABR; Morgado, FN; Boite, MC; Cupolillo, E; Moraes, MO; Porrozzi, R				Cavalcanti, Amanda S.; Ribeiro-Alves, Marcelo; Pereira, Luiza de O. R.; Mestre, Gustavo Leandro; Robottom Ferreira, Anna Beatriz; Morgado, Fernanda N.; Boite, Mariana C.; Cupolillo, Elisa; Moraes, Milton O.; Porrozzi, Renato			Parasite Load Induces Progressive Spleen Architecture Breakage and Impairs Cytokine mRNA Expression in Leishmania infantum-Naturally Infected Dogs	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CANINE VISCERAL LEISHMANIASIS; T-CELL EXHAUSTION; IMMUNE-RESPONSES; FACTOR-ALPHA; TNF-ALPHA; MURINE MACROPHAGES; LYMPH-NODES; CHAGASI; TISSUE	Canine Visceral Leishmaniasis (CVL) shares many aspects with the human disease and dogs are considered the main urban reservoir of L. infantum in zoonotic VL. Infected dogs develop progressive disease with a large clinical spectrum. A complex balance between the parasite and the genetic/immunological background of the host are decisive for infection evolution and clinical outcome. This study comprised 92 Leishmania infected mongrel dogs of various ages from Mato Grosso, Brazil. Spleen samples were collected for determining parasite load, humoral response, cytokine mRNA expression and histopathology alterations. By real-time PCR for the ssrRNA Leishmania gene, two groups were defined; a low (lowP, n = 46) and a high parasite load groups (highP, n = 42). When comparing these groups, results show variable individual humoral immune response with higher specific IgG production in infected animals but with a notable difference in CVL rapid test optical densities (DPP) between highP and lowP groups. Splenic architecture disruption was characterized by disorganization of white pulp, more evident in animals with high parasitism. All cytokine transcripts in spleen were less expressed in highP than lowP groups with a large heterogeneous variation in response. Individual correlation analysis between cytokine expression and parasite load revealed a negative correlation for both pro-inflammatory cytokines: IFN gamma, IL-12, IL-6; and anti-inflammatory cytokines: IL-10 and TGF beta. TNF showed the best negative correlation (r(2) = 0.231; p<0.001). Herein we describe impairment on mRNA cytokine expression in leishmania infected dogs with high parasite load associated with a structural modification in the splenic lymphoid micro-architecture. We also discuss the possible mechanism responsible for the uncontrolled parasite growth and clinical outcome.	[Cavalcanti, Amanda S.; Morgado, Fernanda N.; Boite, Mariana C.; Cupolillo, Elisa; Porrozzi, Renato] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, BR-21045900 Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST AIDS, BR-21045900 Rio De Janeiro, Brazil; [Pereira, Luiza de O. R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil; [Mestre, Gustavo Leandro] Secretaria Municipal Saude, Ctr Controle Zoonoses, Cuiaba, Brazil; [Robottom Ferreira, Anna Beatriz; Moraes, Milton O.] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Cavalcanti, AS (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, BR-21045900 Rio De Janeiro, Brazil.	amandacavalcanti.ac@gmail.com	Moraes, Milton/AFF-1842-2022; Porrozzi, Renato/U-2059-2019; Porrozzi, Renato/U-2166-2019; Morgado, Fernanda/O-3577-2017; Cupolillo, Elisa/U-1667-2019; Morgado, Fernanda/AAV-4435-2021; Pereira, Luiza O R/P-7606-2018; Boité, Mariana C/F-8784-2012; Morgado, Fernanda N/K-2527-2013; Moraes, Milton Ozório/G-9753-2011	Porrozzi, Renato/0000-0003-2167-316X; Morgado, Fernanda/0000-0002-7188-251X; Cupolillo, Elisa/0000-0002-0620-3250; Morgado, Fernanda/0000-0002-7188-251X; Pereira, Luiza O R/0000-0002-8132-1724; Morgado, Fernanda N/0000-0002-7188-251X; Moraes, Milton Ozório/0000-0003-2653-0037; Robottom Ferreira, Anna Beatriz/0000-0003-3553-1744; Ribeiro-Alves, Marcelo/0000-0002-8663-3364; Cavalcanti, Amanda/0000-0002-8792-7524	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ASC was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748; Almeida MAO, 2005, VET IMMUNOL IMMUNOP, V106, P151, DOI 10.1016/j.vetimm.2004.08.024; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Association AVM, 2013, AVMA GUID EUTH AN; Bhadra R, 2012, J INFECT DIS, V206, P125, DOI 10.1093/infdis/jis304; Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029; CGaL Lara Saraiva, 2012, J TROPICALMEDICINE, V2012, P9, DOI [10.1186/1687-9856-2012-9, DOI 10.1186/1687-9856-2012-9]; CHIOFALO MS, 1992, MICROB PATHOGENESIS, V12, P9, DOI 10.1016/0882-4010(92)90061-R; Costa DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060535; Costa JD, 2007, EXP PARASITOL, V117, P390, DOI 10.1016/j.exppara.2007.05.015; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; De Leonardis F, 2009, CLIN EXP RHEUMATOL, V27, P503; DYE C, 1988, PARASITOLOGY, V96, P19, DOI 10.1017/S0031182000081622; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; Ferrer L, 1999, P INT CAN LEISHM FOR; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Correa APFL, 2007, VET PARASITOL, V143, P267, DOI 10.1016/j.vetpar.2006.08.023; Maia C, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/541571; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; McLachlan G., 2000, WILEY SER PROB STAT; Melo GD, 2011, VET J, V188, P243, DOI 10.1016/j.tvjl.2010.03.017; Mendez-Samperio P, 2010, INT J INFECT DIS, V14, pE366, DOI 10.1016/j.ijid.2009.06.022; Menezes-Souza D, 2011, VET PARASITOL, V177, P39, DOI 10.1016/j.vetpar.2010.11.025; Michelin AD, 2011, ANN TROP MED PARASIT, V105, P373, DOI 10.1179/1364859411Y.0000000027; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640; Nascimento MSL, 2013, VET IMMUNOL IMMUNOP, V153, P202, DOI 10.1016/j.vetimm.2013.02.015; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Osnes LT, 2013, AUTOIMMUN REV, V12, P967, DOI 10.1016/j.autrev.2013.02.003; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Panaro MA, 2009, PARASITOLOGY, V136, P823, DOI 10.1017/S0031182009006155; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Prieto-Perez R, 2013, PHARMACOGENOMICS J, V13, P297, DOI 10.1038/tpj.2012.53; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Quinnell RJ, 2001, J INFECT DIS, V183, P1421, DOI 10.1086/319869; Raeymaeckers S, 2012, EUR J RADIOL, V81, P2550, DOI 10.1016/j.ejrad.2011.11.021; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Santos-Gomes GM, 2002, VET IMMUNOL IMMUNOP, V88, P21, DOI 10.1016/S0165-2427(02)00134-4; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Saxena AK, 2011, INDIAN J PEDIATR, V78, P753, DOI 10.1007/s12098-010-0333-5; Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103; Silva LC, 2013, INT J EXP PATHOL; Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000158; Strauss-Ayali D, 2007, VET RES, V38, P547, DOI 10.1051/vetres:2007015; Team RDC, 2009, R LANG ENV STAT COMP; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERESS B, 1977, IMMUNOLOGY, V33, P605; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHO, 2010, WHO TECH REP SER, V949, P1; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	65	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123009	10.1371/journal.pone.0123009	http://dx.doi.org/10.1371/journal.pone.0123009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875101	gold, Green Published			2022-12-27	WOS:000352845100127
J	Huang, P; Zhang, YY; Lu, XM; Xu, Y; Wang, J; Zhang, Y; Yu, RB; Su, J				Huang, Peng; Zhang, Yuanyuan; Lu, Xiaomei; Xu, Yin; Wang, Jie; Zhang, Yun; Yu, Rongbin; Su, Jing			Association of Polymorphisms in HLA Antigen Presentation-Related Genes with the Outcomes of HCV Infection	PLOS ONE			English	Article							MHC CLASS-I; TAPASIN; VIRUS; IMMUNOLOGY; EXPRESSION; PEPTIDE; TAP; MAP	Antigen-presentation genes play a vital role in the pathogenesis of HCV infection. However, the relationship of variants of these genes with spontaneous outcomes of HCV infection has not been fully investigated. To explore novel loci in the Chinese population, 34 tagging-SNPs in 9 candidate genes were genotyped for their associations with the outcomes of HCV infection. The distributions of different genotypes and haplotypes were compared among 773 HCV-negative controls, 246 subjects with HCV natural clearance, and 218 HCV persistent carriers recruited from hemodialysis patients and intravenous drug users. Our study implicated that TAP2, HLA-DOA, HLA-DOB, and tapasin loci were novel candidate regions for susceptibility to HCV infection and viral clearance in the Chinese population. Logistic regression analyses showed that TAP2 rs1800454 A (OR = 1.48, P = 0.002) and HLA-DOB rs2071469 G (OR = 1.23, P = 0.048) were significantly associated with increased susceptibility to establishment of HCV infection. However, high-risk behavior exposure and age were stronger predictors of HCV infection. Mutation of tapasin rs9277972 T (OR = 1.57, P = 0.043) increased the risk of HCV chronicity, and HLA-DOA rs3128935 C (OR = 0.62, P = 0.019) increased the chance of viral resolution. With regards to the effect of rs3128925, interactions were found with high-risk behavior (P = 0.013) and age (P = 0.035). The risk effect of rs3128925 T for persistent HCV infection was higher in injecting drug users (vs. dialysis patients) and in subjects >= 40 years old (vs. <40 years old).	[Huang, Peng; Zhang, Yuanyuan; Lu, Xiaomei; Xu, Yin; Yu, Rongbin; Su, Jing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostatist, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Nanjing Med Univ, Kangda Coll, Dept Gen Practice, Nanjing, Jiangsu, Peoples R China; [Zhang, Yun] Med Inst Nanjing Army, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yu, RB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostatist, Nanjing, Jiangsu, Peoples R China.	rongbinyu@njmu.edu.cn; sujing@njmu.edu.cn			National Natural Science Foundation of China [81102164, 81102165, 81273146]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (Grant No. 81102164 to JS, No. 81102165 to JS, and No. 81273146 to YZ), http://www.nsfc.gov.cn/. The work was also supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (to Nanjing Medical University, major of public health and preventive medicine), http://english.jsjyt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Ashraf S, 2013, HEPATOLOGY, V58, P881, DOI 10.1002/hep.26415; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Chen RH, 2006, J CLIN LAB ANAL, V20, P93, DOI 10.1002/jcla.20107; Cui Q, 2010, J BIOMED RES, V24, P374, DOI 10.1016/S1674-8301(10)60050-4; Cui Q, 2011, INFECT GENET EVOL, V11, P1682, DOI 10.1016/j.meegid.2011.06.016; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Inglis TJJ, 2003, MICROBIOLOGY INFECT, P19; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Penfornis A, 2002, HUM IMMUNOL, V63, P61, DOI 10.1016/S0198-8859(01)00365-2; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Sugimoto Y, 2002, J VIRAL HEPATITIS, V9, P377, DOI 10.1046/j.1365-2893.2002.00365.x; Yu MC, 2004, CLIN RHEUMATOL, V23, P35, DOI 10.1007/s10067-003-0769-3	24	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123513	10.1371/journal.pone.0123513	http://dx.doi.org/10.1371/journal.pone.0123513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874709	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100183
J	Huber, MB; Wacker, ME; Vogelmeier, CF; Leidl, R				Huber, Manuel B.; Wacker, Margarethe E.; Vogelmeier, Claus F.; Leidl, Reiner			Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; BETA-BLOCKER USE; NETWORK MEDICINE; INHALED CORTICOSTEROIDS; CO-MORBIDITY; OLDER-ADULTS; INFLAMMATION; MULTIMORBIDITY; EPIDEMIOLOGY; CANCER	Background Chronic obstructive pulmonary disease ( COPD) is a leading cause of morbidity and mortality worldwide. Comorbidities are often reported in patients with COPD and may influence the cost of care. Yet, the extent by which comorbidities affect costs remains to be determined. Objectives To review, quantify and evaluate excess costs of comorbidities in COPD. Methods Using a systematic review approach, Pubmed and Embase were searched for studies analyzing excess costs of comorbidities in COPD. Resulting studies were evaluated according to study characteristics, comorbidity measurement and cost indicators. Mark-up factors were calculated for respective excess costs. Furthermore, a checklist of quality criteria was applied. Results Twelve studies were included. Nine evaluated comorbidity specific costs; three examined index-based results. Pneumonia, cardiovascular disease and diabetes were associated with the highest excess costs. The mark-up factors for respective excess costs ranged between 1.5 and 2.5 in the majority of cases. On average the factors constituted a doubling of respective costs in the comorbid case. The main cost driver, among all studies, was inpatient cost. Indirect costs were not accounted for by the majority of studies. Study heterogeneity was high. Conclusions The reviewed studies clearly show that comorbidities are associated with significant excess costs in COPD. The inclusion of comorbid costs and effects in future health economic evaluations of preventive or therapeutic COPD interventions seems highly advisable.	[Huber, Manuel B.; Wacker, Margarethe E.; Leidl, Reiner] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr Munich CPC M, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Vogelmeier, Claus F.] Univ Marburg, Univ Med Ctr Giessen & Marburg UGMLC, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Leidl, Reiner] Univ Munich, Munich Ctr Hlth Sci, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; University of Munich	Huber, MB (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr Munich CPC M, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	manuel.huber@helmholtz-muenchen.de	Leidl, Reiner M/B-7209-2009; Leidl, Reiner/GQY-7389-2022	Leidl, Reiner M/0000-0002-7115-7510; 	German Center for Lung Research (DZL, BMBF)	German Center for Lung Research (DZL, BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support for this study by the German Center for Lung Research (DZL, BMBF) is gratefully acknowledged. Funding received by RL; (http://www.dzl.de/index.php/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Aydemir Y, 2014, INT J CHRONIC OBSTR, V9, P1045, DOI 10.2147/COPD.S70620; Babu KS, 2014, BRIT J CLIN PHARMACO, V78, P282, DOI 10.1111/bcp.12334; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baty F, 2013, PLOS ONE, V8; BENSON MK, 1978, BRIT J CLIN PHARMACO, V5, P415, DOI 10.1111/j.1365-2125.1978.tb01647.x; Black-Shinn JL, 2014, COPD; Boros PW, 2012, POL ARCH MED WEWN, V122, P73, DOI 10.20452/pamw.1177; Bureau of Labor Statistics, 2014, CPI INFL CALC; Capobianco E, 2013, TRENDS MOL MED, V19, P515, DOI 10.1016/j.molmed.2013.07.004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choudhury G, 2014, CLIN CHEST MED, V35, P101, DOI 10.1016/j.ccm.2013.10.007; Dahl M, 2002, ANN INTERN MED, V136, P270, DOI 10.7326/0003-4819-136-4-200202190-00006; Dal Negro R, 2003, RESP MED, V97, pS43, DOI 10.1016/S0954-6111(03)80024-0; Dalal AA, 2011, RESP MED, V105, P1516, DOI 10.1016/j.rmed.2011.04.005; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; de Miguel-Diez J, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-8; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Divo MJ, 2014, EUR RESPIR J, V44, P1055, DOI 10.1183/09031936.00059814; Egred M, 2005, QJM-INT J MED, V98, P493, DOI 10.1093/qjmed/hci080; Faner R, 2014, EUR RESPIR J, V44, P775, DOI 10.1183/09031936.00078714; Finney L, 2014, LANCET RESP MED 0917; Fu JJ, 2014, ALLERGY ASTHMA IMMUN, V6, P316, DOI 10.4168/aair.2014.6.4.316; Garcia-Nunez M, 2014, J CLIN MICROBIOL; Geppert T, 2014, DRUG DEVELOP RES, V75, P271, DOI 10.1002/ddr.21207; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; GOLD, 2011, GLOB STRAT DIAGN MAN; Grosdidier S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0111-4; Halpern MT, 2006, COST EFFECTIVENESS R, V4; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Husereau D, 2013, PHARMACOECONOMICS, V31, P361, DOI 10.1007/s40273-013-0032-y; Jansson SA, 2014, COPD; Kargin F, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-8; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Lee DSH, 2014, MED CARE, V52, pS45, DOI 10.1097/MLR.0000000000000035; Lehnert T, 2012, BUNDESGESUNDHEITSBLA, V55, P685, DOI 10.1007/s00103-012-1475-6; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Levinson AD, 2010, SCIENCE, V328, P137, DOI 10.1126/science.1189749; Lin JJ, 2014, CLINICOECONOMIC OUTC, V6, P349, DOI 10.2147/CEOR.S65824; Lin PJ, 2010, RESP MED, V104, P697, DOI 10.1016/j.rmed.2009.11.009; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Maclay JD, 2007, RESPIROLOGY, V12, P634, DOI 10.1111/j.1440-1843.2007.01136.x; McKeage K, 2008, PHARMACOECONOMICS, V26, P699, DOI 10.2165/00019053-200826080-00006; Menn P, 2012, RESP MED, V106, P540, DOI 10.1016/j.rmed.2011.10.013; Miller J, 2013, RESP MED, V107, P1376, DOI 10.1016/j.rmed.2013.05.001; Minor DS, 2013, J CLIN HYPERTENS, V15, P925, DOI 10.1111/jch.12204; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Molinier L, 2008, VALUE HEALTH, V11, P878, DOI 10.1111/j.1524-4733.2008.00327.x; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Organisation for Economic Co-operation and Development, 2014, PURCH POW PAR; Organisation for Economic Co-operation and Development, 2014, CONS PRIC IND MEI; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109710; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Patel JG, 2014, INT J CHRONIC OBSTR, V9, P289, DOI 10.2147/COPD.S57157; Polsky D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-379; Puente-Maestu L, 2014, RESP MED, V108, P737, DOI 10.1016/j.rmed.2014.02.009; Putcha N, 2013, COPD, V10, P324, DOI 10.3109/15412555.2012.744963; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Rizzo JA, 2014, J MED ECON, P1; Roukos DH, 2014, WIRES SYST BIOL MED, V6, P201, DOI 10.1002/wsbm.1254; Ryan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075887; Sevenoaks MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-70; Shaya FT, 2009, SLEEP BREATH, V13, P317, DOI 10.1007/s11325-009-0266-2; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Simon-Tuval T, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-7; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Snider JT, 2012, CURR MED RES OPIN, V28, P1959, DOI 10.1185/03007995.2012.743459; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Sze MA, 2014, INT J CHRONIC OBSTR, V9, P229, DOI 10.2147/COPD.S38932; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Welte R, 2004, PHARMACOECONOMICS, V22, P857, DOI 10.2165/00019053-200422130-00004; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548; World Health Organization, 2014, TOP 10 CAUS DEATH; Zeng LH, 2013, CLIN INTERV AGING, V8, P1157, DOI 10.2147/CIA.S49644	83	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123292	10.1371/journal.pone.0123292	http://dx.doi.org/10.1371/journal.pone.0123292			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875204	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100161
J	Ismail, S; Dadrasnia, A				Ismail, Salmah; Dadrasnia, Arezoo			Biotechnological Potential of Bacillus salmalaya 139SI: A Novel Strain for Remediating Water Polluted with Crude Oil Waste	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOSURFACTANT; BIODEGRADATION; BIOREMEDIATION	Environmental contamination by petroleum hydrocarbons, mainly crude oil waste from refineries, is becoming prevalent worldwide. This study investigates the bioremediation of water contaminated with crude oil waste. Bacillus salamalaya 139SI, a bacterium isolated from a private farm soil in the Kuala Selangor in Malaysia, was found to be a potential degrader of crude oil waste. When a microbial population of 10(8) CFU ml(-1) was used, the 139SI strain degraded 79% and 88% of the total petroleum hydrocarbons after 42 days of incubation in mineral salt media containing 2% and 1% of crude oil waste, respectively, under optimum conditions. In the uninoculated medium containing 1% crude oil waste, 6% was degraded. Relative to the control, the degradation was significantly greater when a bacteria count of 99 x 10(8) CFU ml(-1) was added to the treatments polluted with 1% oil. Thus, this isolated strain is useful for enhancing the biotreatment of oil in wastewater.	[Ismail, Salmah; Dadrasnia, Arezoo] Univ Malaya, Fac Sci, Inst Biol Sci, Dept Biohlth Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Dept Biohlth Sci, Kuala Lumpur, Malaysia.	salmah_r@um.edu.my	Dadrasnia, Arezoo/A-8413-2012; Ismail, Salmah/A-6504-2016; ISMAIL, SALMAH/B-9680-2010	Dadrasnia, Arezoo/0000-0002-0160-6333; ISMAIL, SALMAH/0000-0001-5595-8222	University Malaya [A-21010-DA674, A-21010-DA677]; University of Malaya Research Program (UMRP) [RP023A-14AFR]	University Malaya(Universiti Malaya); University of Malaya Research Program (UMRP)	The authors would like to acknowledge the support of chancellery of University Malaya with special grants numbered A-21010-DA674 and A-21010-DA677. Also, the authors would like to acknowledge the support of the University of Malaya Research Program (UMRP) with grant number RP023A-14AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J KOREAN SOC APPL BI, V57, P5; Bao MT, 2014, ENVIRON SCI-PROC IMP, V16, P897, DOI 10.1039/c3em00600j; Bento FM, 2005, BIORESOURCE TECHNOL, V96, P1049, DOI 10.1016/j.biortech.2004.09.008; Carrillo PG, 1996, WORLD J MICROB BIOT, V12, P82, DOI 10.1007/BF00327807; Chand Raza A, 2010, BIOLOGIA, V56, P77; Dadrasnia A, 2015, PETROL SCI TECHNOL, V33, P1030, DOI 10.1080/10916466.2014.925920; Dadrasnia A., 2014, INT J ENV SCI, V4, P241; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Eddouaouda K, 2012, J BASIC MICROB, V52, P408, DOI 10.1002/jobm.201100268; Hassanshahian M, 2014, MAR ENVIRON RES, V95, P28, DOI 10.1016/j.marenvres.2013.12.010; Ismail S, 2012, BIOLOGIA, V67, P1031, DOI 10.2478/s11756-012-0117-7; Joo MH, 2013, J KOREAN SOC APPL BI, V56, P193, DOI 10.1007/s13765-012-3269-9; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kumari B, 2012, PROCESS BIOCHEM, V47, P2463, DOI 10.1016/j.procbio.2012.10.010; Makkar RS, 2003, ENVIRON TOXICOL CHEM, V22, P2280, DOI 10.1897/02-472; Maliji D., 2013, International Journal of Current Microbiology and Applied Sciences, V2, P1; Moghadam MS, 2014, IRAN J BIOTECHNOL, V12, DOI 10.5812/ijb.15392; Norman RS, 2002, APPL ENVIRON MICROB, V68, P5096, DOI 10.1128/AEM.68.10.5096-5103.2002; Rufino RD, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.006; Sharma D, 2014, INT J MICROBIOL, V7; Xu YH, 2010, J HAZARD MATER, V183, P395, DOI 10.1016/j.jhazmat.2010.07.038	21	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120931	10.1371/journal.pone.0120931	http://dx.doi.org/10.1371/journal.pone.0120931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875763	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100028
J	Martinez-Garcia, PM; Ramos, C; Rodriguez-Palenzuela, P				Manuel Martinez-Garcia, Pedro; Ramos, Cayo; Rodriguez-Palenzuela, Pablo			T346Hunter: A Novel Web-Based Tool for the Prediction of Type III, Type IV and Type VI Secretion Systems in Bacterial Genomes	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; PROTEIN; GENE; IDENTIFICATION; MELIOIDOSIS	T346Hunter (Type Three, Four and Six secretion system Hunter) is a web-based tool for the identification and localisation of type III, type IV and type VI secretion systems (T3SS, T4SS and T6SS, respectively) clusters in bacterial genomes. Non-flagellar T3SS (NF-T3SS) and T6SS are complex molecular machines that deliver effector proteins from bacterial cells into the environment or into other eukaryotic or prokaryotic cells, with significant implications for pathogenesis of the strains encoding them. Meanwhile, T4SS is a more functionally diverse system, which is involved in not only effector translocation but also conjugation and DNA uptake/release. Development of control strategies against bacterial-mediated diseases requires genomic identification of the virulence arsenal of pathogenic bacteria, with T3SS, T4SS and T6SS being major determinants in this regard. Therefore, computational methods for systematic identification of these specialised machines are of particular interest. With the aim of facilitating this task, T346Hunter provides a user-friendly web-based tool for the prediction of T3SS, T4SS and T6SS clusters in newly sequenced bacterial genomes. After inspection of the available scientific literature, we constructed a database of hidden Markov model (HMM) protein profiles and sequences representing the various components of T3SS, T4SS and T6SS. T346Hunter performs searches of such a database against user-supplied bacterial sequences and localises enriched regions in any of these three types of secretion systems. Moreover, through the T346Hunter server, users can visualise the predicted clusters obtained for approximately 1700 bacterial chromosomes and plasmids. T346Hunter offers great help to researchers in advancing their understanding of the biological mechanisms in which these sophisticated molecular machines are involved. T346Hunter is freely available at http://bacterial-virulence-factors.cbgp.upm.es/T346Hunter.	[Manuel Martinez-Garcia, Pedro; Ramos, Cayo] Univ Malaga, IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Area Genet,Fac Ciencias, E-29071 Malaga, Spain; [Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Rodriguez-Palenzuela, P (corresponding author), Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Biotecnol & Genom Plantas, Parque Cient & Tecnol,Campus Montegancedo, Madrid 28223, Spain.	pablo.rpalenzuela@upm.es	RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; RAMOS, CAYO/G-3818-2011	RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; RAMOS, CAYO/0000-0002-2362-5041; Martinez Garcia, Pedro Manuel/0000-0002-2119-2465	Ministerio de Economia y Competitividad, Spain [AGL2011-30343-C02-01]; Campus de Excelencia Internacional Andalucia Tech	Ministerio de Economia y Competitividad, Spain; Campus de Excelencia Internacional Andalucia Tech	This research has been supported by project grant AGL2011-30343-C02-01 from the Ministerio de Economia y Competitividad, Spain (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en). PMMG was supported by the Campus de Excelencia Internacional Andalucia Tech (http://www.andaluciatech.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bi DX, 2013, NUCLEIC ACIDS RES, V41, pD660, DOI 10.1093/nar/gks1248; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; D'Cruze T, 2011, INFECT IMMUN, V79, P3659, DOI 10.1128/IAI.01351-10; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li PL, 1998, J BACTERIOL, V180, P6164; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Nandi T, 2014, GENOME RES; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pundhir S, 2011, BIOINFORMATION, V6, P380, DOI 10.6026/97320630006380; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Souza RC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-172; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Wandersman C, 2013, RES MICROBIOL, V164, P683, DOI 10.1016/j.resmic.2013.03.008; Wang YJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-66; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	41	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119317	10.1371/journal.pone.0119317	http://dx.doi.org/10.1371/journal.pone.0119317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867189	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100014
J	Ouedraogo, O; Chetelat, J; Amyot, M				Ouedraogo, Ousseni; Chetelat, John; Amyot, Marc			Bioaccumulation and Trophic Transfer of Mercury and Selenium in African Sub-Tropical Fluvial Reservoirs Food Webs (Burkina Faso)	PLOS ONE			English	Article							STABLE-ISOTOPES; LAKE VICTORIA; CHAIN STRUCTURE; WINAM GULFS; BIOMAGNIFICATION; FISH; POSITION; WATER; DELTA-N-15; METHYLMERCURY	The bioaccumulation and biomagnification of mercury (Hg) and selenium (Se) were investigated in sub-tropical freshwater food webs from Burkina Faso, West Africa, a region where very few ecosystem studies on contaminants have been performed. During the 2010 rainy season, samples of water, sediment, fish, zooplankton, and mollusks were collected from three water reservoirs and analysed for total Hg (THg), methylmercury (MeHg), and total Se (TSe). Ratios of delta C-13 and delta N-15 were measured to determine food web structures and patterns of contaminant accumulation and transfer to fish. Food chain lengths (FCLs) were calculated using mean delta N-15 of all primary consumer taxa collected as the site-specific baseline. We report relatively low concentrations of THg and TSe in most fish. We also found in all studied reservoirs short food chain lengths, ranging from 3.3 to 3.7, with most fish relying on a mixture of pelagic and littoral sources for their diet. Mercury was biomagnified in fish food webs with an enrichment factor ranging from 2.9 to 6.5 for THg and from 2.9 to 6.6 for MeHg. However, there was no evidence of selenium biomagnification in these food webs. An inverse relationship was observed between adjusted delta N-15 and log-transformed Se: Hg ratios, indicating that Se has a lesser protective effect in top predators, which are also the most contaminated animals with respect to MeHg. Trophic position, carbon source, and fish total length were the factors best explaining Hg concentration in fish. In a broader comparison of our study sites with literature data for other African lakes, the THg biomagnification rate was positively correlated with FCL. We conclude that these reservoir systems from tropical Western Africa have low Hg biomagnification associated with short food chains. This finding may partly explain low concentrations of Hg commonly reported in fish from this area.	[Ouedraogo, Ousseni; Amyot, Marc] Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ H3C 3J7, Canada; [Chetelat, John] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada	Universite de Montreal; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Amyot, M (corresponding author), Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, CP 6128, Montreal, PQ H3C 3J7, Canada.	m.amyot@umontreal.ca	Chételat, John/AAE-4711-2020; Amyot, Marc/A-7182-2008	Chételat, John/0000-0002-9380-7203; Amyot, Marc/0000-0002-0340-3249	Natural Sciences and Engineering Research Council of Canada [217099]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MA received funds from the Natural Sciences and Engineering Research Council of Canada (Discovery; 217099; www.crsng-nserc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2007, J N AM BENTHOL SOC, V26, P273, DOI 10.1899/0887-3593(2007)26[273:ETTPOA]2.0.CO;2; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Belzile N, 2006, CAN J FISH AQUAT SCI, V63, P1, DOI 10.1139/F05-202; Black FJ, 2011, SCI TOTAL ENVIRON, V409, P1967, DOI 10.1016/j.scitotenv.2010.11.027; Boelee E, 2009, HLTH IMPACTS SMALL R; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CABANA G, 1994, CAN J FISH AQUAT SCI, V51, P381, DOI 10.1139/f94-039; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Campbell L, 2008, SCI TOTAL ENVIRON, V402, P184, DOI 10.1016/j.scitotenv.2008.04.017; Campbell LM, 2003, J GREAT LAKES RES, V29, P267, DOI 10.1016/S0380-1330(03)70554-1; Campbell LM, 2003, J GREAT LAKES RES, V29, P243, DOI 10.1016/S0380-1330(03)70552-8; Campbell LM, 2003, J TOXICOL ENV HEAL B, V6, P325, DOI 10.1080/10937400306474; Chen CY, 2000, LIMNOL OCEANOGR, V45, P1525, DOI 10.4319/lo.2000.45.7.1525; Chen YW, 2001, LIMNOL OCEANOGR, V46, P1814, DOI 10.4319/lo.2001.46.7.1814; Chetelat J, 2015, SCI TOTAL ENVIRON, V509, P41, DOI 10.1016/j.scitotenv.2014.05.151; Chetelat J, 2011, ENVIRON POLLUT, V159, P10, DOI 10.1016/j.envpol.2010.09.034; Clayden MG, 2013, ENVIRON SCI TECHNOL, V47, P12047, DOI 10.1021/es4022975; CORNS WT, 1993, J ANAL ATOM SPECTROM, V8, P71, DOI 10.1039/ja9930800071; Cossa D, 2012, ENVIRON SCI TECHNOL, V46, P4885, DOI 10.1021/es204269w; Dang F, 2011, ENVIRON SCI TECHNOL, V45, P3116, DOI 10.1021/es103705a; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Desta Z, 2008, J FISH BIOL, V73, P477, DOI 10.1111/j.1095-8649.2008.01920.x; Desta Z, 2006, ECOL FRESHW FISH, V15, P532, DOI 10.1111/j.1600-0633.2006.00193.x; Desta Z, 2007, SCI TOTAL ENVIRON, V376, P134, DOI 10.1016/j.scitotenv.2007.01.091; Donkor AK, 2006, SCI TOTAL ENVIRON, V368, P164, DOI 10.1016/j.scitotenv.2005.09.046; FAO/WHO, 2004, SAF EV CERT ADD CONT; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Gailer J, 2007, COORDIN CHEM REV, V251, P234, DOI 10.1016/j.ccr.2006.07.018; Gorski PR, 2003, SCI TOTAL ENVIRON, V304, P327, DOI 10.1016/S0048-9697(02)00579-X; Hallanger IG, 2011, ENVIRON TOXICOL CHEM, V30, P1026, DOI 10.1002/etc.488; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hong YS, 2013, ENVIRON TOXICOL CHEM, V32, P1143, DOI 10.1002/etc.2169; Ikemoto T, 2008, ARCH ENVIRON CON TOX, V54, P504, DOI 10.1007/s00244-007-9058-5; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; Jardine TD, 2012, SCI TOTAL ENVIRON, V416, P385, DOI 10.1016/j.scitotenv.2011.11.022; Jardine TD, 2011, SCI TOTAL ENVIRON, V409, P785, DOI 10.1016/j.scitotenv.2010.11.013; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Karimi R, 2013, PLOS ONE, V8; Kidd K., 2012, ENV CHEM TOXICOLOGY, P455; KIDD KA, 1995, SCI TOTAL ENVIRON, V160-61, P381, DOI 10.1016/0048-9697(95)04371-7; KIDD KA, 1995, WATER AIR SOIL POLL, V80, P1011, DOI 10.1007/BF01189756; Kidd KA, 2003, J GREAT LAKES RES, V29, P258, DOI 10.1016/S0380-1330(03)70553-X; Kidd KA, 2004, B ENVIRON CONTAM TOX, V73, P249, DOI 10.1007/s00128-004-0420-2; Kidd KA, 2012, SCI TOTAL ENVIRON, V438, P135, DOI 10.1016/j.scitotenv.2012.08.057; Lavoie RA, 2013, ENVIRON SCI TECHNOL, V47, P13385, DOI 10.1021/es403103t; Lemly AD, 2004, ECOTOX ENVIRON SAFE, V59, P44, DOI 10.1016/S0147-6513(03)00095-2; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; N'guessan Sylvain Yao, 2010, European Journal of Scientific Research, V46, P275; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Orr PL, 2006, ECOTOX ENVIRON SAFE, V63, P175, DOI 10.1016/j.ecoenv.2005.09.004; Oueda A, 2009, THESIS U QUAGADOUGOU; Oueda Adama, 2008, Journal of Fisheries and Aquatic Sciences, V3, P240; Ouedraogo O, 2013, THESIS U MONTREAL; Ouedraogo O, 2013, SCI TOTAL ENVIRON, V444, P243, DOI 10.1016/j.scitotenv.2012.11.095; PARIZEK J, 1967, EXPERIENTIA, V23, P142, DOI 10.1007/BF02135970; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson SA, 2009, ENVIRON SCI TECHNOL, V43, P3919, DOI 10.1021/es803203g; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Poste AE, 2015, SCI TOTAL ENVIRON, V506, P126, DOI 10.1016/j.scitotenv.2014.10.094; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Ralston NVC, 2006, NEUROTOXICOLOGY, V27, P1172; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Razavi NR, 2014, ECOTOXICOLOGY, V23, P133, DOI 10.1007/s10646-013-1158-6; Simmons DBD, 2005, ENVIRON TOXICOL CHEM, V24, P1331, DOI 10.1897/04-176R.1; Swanson HK, 2010, ENVIRON SCI TECHNOL, V44, P3286, DOI 10.1021/es100439t; Tadiso TM, 2011, ECOTOX ENVIRON SAFE, V74, P953, DOI 10.1016/j.ecoenv.2011.01.005; U.S. E.P.A, 1996, 1669 US EPA; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Verburg P, 2014, SCI TOTAL ENVIRON, V493, P342, DOI 10.1016/j.scitotenv.2014.05.097; Yang DY, 2008, ENVIRON REV, V16, P71, DOI 10.1139/A08-001; Yang DY, 2010, SCI TOTAL ENVIRON, V408, P1676, DOI 10.1016/j.scitotenv.2009.11.049	78	39	40	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123048	10.1371/journal.pone.0123048	http://dx.doi.org/10.1371/journal.pone.0123048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875292	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100129
J	Spindler, KLG; Pallisgaard, N; Andersen, RF; Brandslund, I; Jakobsen, A				Spindler, Karen Lise Garm; Pallisgaard, Niels; Andersen, Rikke Fredslund; Brandslund, Ivan; Jakobsen, Anders			Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer	PLOS ONE			English	Article							K-RAS MUTATIONS; ACQUIRED-RESISTANCE; PERIPHERAL-BLOOD; KRAS MUTATIONS; PHASE-II; PLASMA; SERUM; CETUXIMAB; COMBINATION; IRINOTECAN	Background Circulating cell-free DNA (cfDNA) in plasma has shown potential as biomarker in various cancers and could become an importance source for tumour mutation detection. The objectives of our study were to establish a normal range of cfDNA in a cohort of healthy individuals and to compare this with four cohorts of metastatic colorectal cancer (mCRC) patients. We also investigated the prognostic value of cfDNA and analysed the tumour-specific KRAS mutations in the plasma. Methods The study was a prospective biomarker evaluation in four consecutive Phase II trials, including 229 patients with chemotherapy refractory mCRC and 100 healthy individuals. Plasma was obtained from an EDTA blood-sample, and the total number of DNA alleles and KRAS mutated alleles were assessed using an in-house ARMS-qPCR as previously described. Results Median cfDNA levels were higher in mCRC compared to controls (p < 0.0001). ROC analysis revealed an AUC of 0.9486 (p < 0.00001). Data showed impaired OS with increasing levels of baseline cfDNA both when categorising patients by quartiles of cfDNA and into low or high cfDNA groups based on the upper normal range of the control group (Median OS 10.2 (8.3-11.7) and 5.2 (4.6-5.9) months, respectively, HR 1.78, p = 0.0006). Multivariate analysis confirmed an independent prognostic value of cfDNA (HR 1.5 (95% CI 1.3-1.7) for each increase in the cfDNA quartile). The overall concordance of KRAS mutations in plasma and tissue was high (85%). Conclusions These data confirm the prognostic value of cfDNA measurement in plasma and utility for mutation detection with the method presented.	[Spindler, Karen Lise Garm; Jakobsen, Anders] Vejle Hosp, Dept Oncol, Vejle, Denmark; [Pallisgaard, Niels; Andersen, Rikke Fredslund; Brandslund, Ivan] Vejle Hosp, Dept Biochem, Vejle, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital	Spindler, KLG (corresponding author), Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark.	k.g.spindler@rm.dk	Andersen, Rikke/GRS-3064-2022	Jakobsen, Anders/0000-0003-2110-2615; Andersen, Rikke Fredslund/0000-0002-5894-7745; Brandslund, Ivan/0000-0002-4203-5442	Research Counsil Vejle Hospital; Tryg fonden; Novo Nordisk Fonden [NNF14OC0009297] Funding Source: researchfish	Research Counsil Vejle Hospital; Tryg fonden; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by the Research Counsil Vejle Hospital and Tryg fonden. The funders had no role in study design, data Collection and analysis, desicion to publish, or preparation of the manuscript.	Agostini M, 2011, ANN SURG ONCOL, V18, P2461, DOI 10.1245/s10434-011-1638-y; Benesova L, 2013, ANAL BIOCHEM, V433, P227, DOI 10.1016/j.ab.2012.06.018; Boni L, 2007, SURG ONCOL, V16, pS29, DOI 10.1016/j.suronc.2007.10.004; Danese E, 2010, CLIN CHEM LAB MED, V48; Dawson SJ, 2013, N ENGL J MED; De Mattos-Arruda L, 2011, FUTURE ONCOL, V7, P1385, DOI [10.2217/fon.11.122, 10.2217/FON.11.122]; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Flamini E, 2006, CLIN CANCER RES, V12, P6985, DOI 10.1158/1078-0432.CCR-06-1931; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Jahr S, 2001, CANCER RES, V61, P1659; Kopreski MS, 2000, J NATL CANCER I, V92, P918, DOI 10.1093/jnci/92.11.918; LEON SA, 1977, CANCER RES, V37, P646; Mandel P., 1948, CR SOC BIOL, V142, P241; Marchese R, 2006, PANCREAS, V32, P171, DOI 10.1097/01.mpa.0000202938.63084.e3; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mora J, 2006, CLIN CHEM, V52, P1448, DOI 10.1373/clinchem.2006.067140; Nygaard AD, 2014, BRIT J CANCER, V110, P363, DOI 10.1038/bjc.2013.705; Perkins G, 2012, PLOS ONE, V7; Qi J, 2013, CLIN BIOCH; Qiu LX, 2010, EUR J CANCER, V46, P2781, DOI 10.1016/j.ejca.2010.05.022; Spindler K, 2013, J CANC THER, V4, P44; Spindler KLG, 2009, ANN ONCOL, V20, P879, DOI 10.1093/annonc/mdn712; Spindler KLG, 2014, ANTICANCER RES, V34, P845; Spindler KLG, 2013, ACTA ONCOL, V52, P963, DOI 10.3109/0284186X.2013.776175; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1592, DOI 10.1097/IGC.0b013e31822a0f6b; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Su YH, 2008, ANN NY ACAD SCI, V1137, P197, DOI 10.1196/annals.1448.027; van der Vaart M, 2010, CLIN BIOCHEM, V43, P26, DOI 10.1016/j.clinbiochem.2009.08.027; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179	32	93	100	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0108247	10.1371/journal.pone.0108247	http://dx.doi.org/10.1371/journal.pone.0108247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875772	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100001
J	Zhao, YJ; Zeng, C; Massiah, MA				Zhao, Yunjie; Zeng, Chen; Massiah, Michael A.			Molecular Dynamics Simulation Reveals Insights into the Mechanism of Unfolding by the A130T/V Mutations within the MID1 Zinc-Binding Bbox1 Domain	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; OPITZ G/BBB SYNDROME; SERINE/THREONINE PHOSPHATASES; UBIQUITIN LIGASE; PP2A; ALPHA4; DEGRADATION; RING; KEY	The zinc-binding Bbox1 domain in protein MID1, a member of the TRIM family of proteins, facilitates the ubiquitination of the catalytic subunit of protein phosphatase 2A and alpha4, a protein regulator of PP2A. The natural mutation of residue A130 to a valine or threonine disrupts substrate recognition and catalysis. While NMR data revealed the A130T mutant Bbox1 domain failed to coordinate both structurally essential zinc ions and resulted in an unfolded structure, the unfolding mechanism is unknown. Principle component analysis revealed that residue A130 served as a hinge point between the structured beta-strand-turn-beta-strand (beta-turn-beta) and the lasso-like loop sub-structures that constitute loop1 of the beta beta alpha-RING fold that the Bbox1 domain adopts. Backbone RMSD data indicate significant flexibility and departure from the native structure within the first 5 ns of the molecular dynamics (MD) simulation for the A130V mutant (> 6 angstrom) and after 30 ns for A130T mutant (> 6 angstrom). Overall RMSF values were higher for the mutant structures and showed increased flexibility around residues 125 and 155, regions with zinc-coordinating residues. Simulated pKa values of the sulfhydryl group of C142 located near A130 suggested an increased in value to similar to 9.0, paralleling the increase in the apparent dielectric constants for the small cavity near residue A130. Protonation of the sulfhydryl group would disrupt zinc-coordination, directly contributing to unfolding of the Bbox1. Together, the increased motion of residues of loop 1, which contains four of the six zinc-binding cysteine residues, and the increased pKa of C142 could destabilize the structure of the zinc-coordinating residues and contribute to the unfolding.	[Zhao, Yunjie; Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Zeng, Chen] Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Peoples R China; [Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University; Huazhong University of Science & Technology; George Washington University	Zeng, C (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	chenz@gwu.edu; massiah@gwu.edu			National Science Foundation (US) [1052520, 0941228]	National Science Foundation (US)(National Science Foundation (NSF))	The work was supported by funds from the National Science Foundation (US): 1052520 (MAM) and 0941228 (CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109154; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Du HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107428; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kerrigan John E, 2013, Methods Mol Biol, V993, P95, DOI 10.1007/978-1-62703-342-8_7; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Winter J, 2003, HUM GENET, V112, P249, DOI 10.1007/s00439-002-0901-5; Wright KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107537; Xu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01895; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhao YJ, 2013, TRANSCR-AUSTIN, V4, P227, DOI 10.4161/trns.27368; Zhao YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00734	42	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124377	10.1371/journal.pone.0124377	http://dx.doi.org/10.1371/journal.pone.0124377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874572	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100256
J	Wang, D; Li, TT; Ye, GT; Shen, ZY; Hu, YF; Mou, TY; Yu, J; Li, SH; Liu, H; Li, GX				Wang, Da; Li, Tingting; Ye, Gengtai; Shen, Zhiyong; Hu, Yanfeng; Mou, Tingyu; Yu, Jiang; Li, Sihao; Liu, Hao; Li, Guoxin			Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Associated with Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							END-PRODUCTS RAGE; TARGETING RECEPTOR; SOLUBLE RECEPTOR; TUMOR-GROWTH; EXPRESSION; RISK; ANGIOGENESIS; AMPHOTERIN; BLOCKADE; LIGAND	Background The receptor for advanced glycation endproducts (RAGE) is an oncogenic multidisciplinary trans-membranous receptor, which is overexpressed in multiple human cancers. Recently, it has been shown that RAGE is also involved in carcinogenesis and tumor invasion. In this study, we investigated the expression levels and prognostic value of RAGE in primary gastric cancers (GC). Methods We investigated RAGE expression in primary GC and paired normal gastric tissue by real-time quantitative RT-PCR (n = 30) and Western blotting analysis (n = 30). Additionally, we performed immunohistochemistry on 180 paraffin-embedded GC specimens, 69 matched normal specimens. Results RAGE was overexpressed in GC compared with the adjacent noncancerous tissues (P<0.001), and higher RAGE expression significantly correlated with the histological grade (P = 0.002), nodal status(P = 0.025), metastasis status(P = 0.002), and American Joint Committee on Cancer stage (P = 0.020). Furthermore, upregulation of RAGE expression is an independent prognostic factor in multivariate analysis using the Cox regression model (P = 0.001). Conclusions RAGE Overexpression may be a useful marker to predict GC progression and poor prognosis.	[Wang, Da; Li, Tingting; Ye, Gengtai; Shen, Zhiyong; Hu, Yanfeng; Mou, Tingyu; Yu, Jiang; Li, Sihao; Liu, Hao; Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Li, Sihao] SCNU, Affiliated High Sch, Int Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; South China Normal University	Liu, H (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	wonder0618.dw@gmail.com	Liu, Hao/I-9884-2019; Shen, Zhiyong/AAD-7957-2019	Liu, Hao/0000-0003-1227-2954; Shen, Zhiyong/0000-0003-4950-2434	Program of the National Key Clinical Medical Specialty; Research Fund of Public welfare in Health Industry [201402015]; Major Program of Science and Technology Program of Guangzhou [201300000087]; National Key Technology RD Program [2013BAI05B00]	Program of the National Key Clinical Medical Specialty; Research Fund of Public welfare in Health Industry; Major Program of Science and Technology Program of Guangzhou; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by The Program of the National Key Clinical Medical Specialty, the Research Fund of Public welfare in Health Industry (No. 201402015), the Major Program of Science and Technology Program of Guangzhou (No. 201300000087), and The National Key Technology R&D Program (No. 2013BAI05B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; DiNorcia J, 2012, J GASTROINTEST SURG, V16, P104, DOI 10.1007/s11605-011-1754-9; Elangovan I, 2012, BIOCHEM BIOPH RES CO, V417, P1133, DOI 10.1016/j.bbrc.2011.12.060; Gu HJ, 2008, CLIN CANCER RES, V14, P3627, DOI 10.1158/1078-0432.CCR-07-4808; Heijmans J, 2013, ONCOGENE, V32, P1202, DOI 10.1038/onc.2012.119; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Ito R, 2014, J SURG RES, V192, P503, DOI 10.1016/j.jss.2014.06.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Liang HS, 2011, CANCER LETT, V313, P91, DOI 10.1016/j.canlet.2011.08.028; Liu DN, 2013, GASTRIC CANCER, V16, P498, DOI 10.1007/s10120-013-0232-3; Moy KA, 2013, HEPATOLOGY, V57, P2338, DOI 10.1002/hep.26264; Radia AM, 2013, INT J MOL SCI, V14, P7959, DOI 10.3390/ijms14047959; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Sasahira T, 2007, VIRCHOWS ARCH, V450, P287, DOI 10.1007/s00428-006-0359-2; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Xu XC, 2013, EUR J HISTOCHEM, V57, P240, DOI 10.4081/ejh.2013.e36; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045	26	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122697	10.1371/journal.pone.0122697	http://dx.doi.org/10.1371/journal.pone.0122697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860956	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300057
J	Aibar, A; Chanal, J				Aibar, Alberto; Chanal, Julien			Physical Education: The Effect of Epoch Lengths on Children's Physical Activity in a Structured Context	PLOS ONE			English	Article							ACCELEROMETERS; CALIBRATION	Background Despite a consensus emerging that affirms that shorter epochs should be used in youth to correctly register physical activity levels in free-living conditions, little is known about its effect on children's physical activity conducted in structured periods of time. This study analyzed the effect that epoch length (1, 2, 3, 5, 10, 15, 30 and 60s) may have on different physical activity intensities in physical education lessons. Methods A sample of 1912 individualmeasures of physical education lessons were measured with a GT3X accelerometer. Data were collected from 1227 Swiss Elementary school students recruited in 17 elementary schools. PE lessons lasted from 45 minutes to one and a half hours. Data, originally collected in 1-s epoch, were then reintegrated into 2s, -3s -5s -10s -15s 30s -60s epochs. Results Longer epochs were associated with higher levels of light (F = 8197.6, p < .001), moderate (F = 2708.17, p < .001), and moderate-to-vigorous physical activity (F = 888.08, p < .001). However, longer epochs showed lower levels of sedentary activity (F = 31714.33, p < .001) and vigorous physical activity (F = 1910.97, p < .001). Bias increased in all PA intensities when shorter epochs were compared with longer epochs. There were statistically significant differences in compliance with physical education guidelines (chi(2) = 989.27, p < .001), showing higher levels with longer epochs. Conclusion PA context may have some influence on the effects that epoch length have on PA estimates, more specifically on MVPA. Nevertheless, the use of a high-frequency sampling interval should be used to more accurately assess children's PA.	[Aibar, Alberto; Chanal, Julien] Univ Geneva, Geneva, Switzerland; [Chanal, Julien] Distance Learning Univ, Brig, Switzerland	University of Geneva	Aibar, A (corresponding author), Univ Geneva, Geneva, Switzerland.	aibar@unizar.es	Solana, Alberto Aibar/R-1123-2018	Solana, Alberto Aibar/0000-0001-9126-5976	Swiss National Science Foundation [SNF 100014_132010 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by a research grant from the Swiss National Science Foundation (SNF 100014_132010 / 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar A, 2014, J SPORT MED PHYS FIT, V54, P326; Ayabe Makoto, 2013, BMC Res Notes, V6, P20, DOI 10.1186/1756-0500-6-20; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Berman N, 1998, AM J HUM BIOL, V10, P289, DOI 10.1002/(SICI)1520-6300(1998)10:3<289::AID-AJHB4>3.0.CO;2-E; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough S., 2002, EUR PHYS EDUC REV, V8, P69, DOI DOI 10.1177/1356336X020081005; Gabriel Kelley Pettee, 2010, Int J Behav Nutr Phys Act, V7, P53, DOI 10.1186/1479-5868-7-53; Garriguet D, 2014, HEALTH REP, V25, P3; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Orme M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-34; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridgers ND, 2011, EUR J SPORT SCI, V11, P205, DOI 10.1080/17461391.2010.501116; SALLIS JF, 1991, RES Q EXERCISE SPORT, V62, P124, DOI 10.1080/02701367.1991.10608701; Sanders T, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084323, 10.1371/journal.pone.0092040]; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	26	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121238	10.1371/journal.pone.0121238	http://dx.doi.org/10.1371/journal.pone.0121238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874641	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100038
J	Garrido, P; Ribeiro, S; Fernandes, J; Vala, H; Bronze-Da-Rocha, E; Rocha-Pereira, P; Belo, L; Costa, E; Santos-Silva, A; Reis, F				Garrido, Patrcia; Ribeiro, Sandra; Fernandes, Joao; Vala, Helena; Bronze-da-Rocha, Elsa; Rocha-Pereira, Petronila; Belo, Luis; Costa, Elisio; Santos-Silva, Alice; Reis, Flavio			Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; REGULATORY PEPTIDE HEPCIDIN; GENE-EXPRESSION; TUBULOINTERSTITIAL HYPOXIA; DISEASE PATIENTS; FAILURE; HEALTH; ACCUMULATION; CONSEQUENCE; VARIABILITY	Anemia is a common complication of chronic kidney disease (CKD) that develops early and its severity increases as renal function declines. It is mainly due to a reduced production of erythropoietin (EPO) by the kidneys; however, there are evidences that iron metabolism disturbances increase as CKD progresses. Our aim was to study the mechanisms underlying the development of anemia of CKD, as well as renal damage, in the remnant kidney rat model of CKD induced by 5/6 nephrectomy. This model of CKD presented a sustained degree of renal dysfunction, with mild and advanced glomerular and tubulointerstitial lesions. Anemia developed 3 weeks after nephrectomy and persisted throughout the protocol. The remnant kidney was still able to produce EPO and the liver showed an increased EPO gene expression. In spite of the increased EPO blood levels, anemia persisted and was linked to low serum iron and transferrin levels, while serum interleukin (IL)-6 and high sensitivity C-reactive protein (hsCRP) levels showed the absence of systemic inflammation. The increased expression of duodenal ferroportin favours iron absorption; however, serum iron is reduced which might be due to iron leakage through advanced kidney lesions, as showed by tubular iron accumulation. Our data suggest that the persistence of anemia may result from disturbances in iron metabolism and by an altered activity/function of EPO as a result of kidney cell damage and a local inflammatory milieu, as showed by the increased gene expression of different inflammatory proteins in the remnant kidney. In addition, this anemia and the associated kidney hypoxia favour the development of fibrosis, angiogenesis and inflammation that may underlie a resistance to EPO stimuli and reduced iron availability. These findings might contribute to open new windows to identify putative therapeutic targets for this condition, as well as for recombinant human EPO (rHuEPO) resistance, which occurs in a considerable percentage of CKD patients.	[Garrido, Patrcia; Fernandes, Joao; Reis, Flavio] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Lab Pharmacol & Expt Therapeut, Coimbra, Portugal; [Garrido, Patrcia; Fernandes, Joao; Reis, Flavio] Univ Coimbra, Inst Biomed Imaging & Life Sci CNC IBILI, Res Unit, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ribeiro, Sandra; Bronze-da-Rocha, Elsa; Belo, Luis; Costa, Elisio; Santos-Silva, Alice] Univ Porto, Fac Pharm, Biochem Lab, Res Unit Appl Mol Biosci UCIBIO,REQUIMTE,Dept Bio, P-4100 Porto, Portugal; [Vala, Helena] Polytech Inst Viseu, Agrarian Sch Viseu, Ctr Studies Educ Technol & Hlth CI&DETS, Viseu, Portugal; [Rocha-Pereira, Petronila] Univ Beira Interior, Res Ctr Hlth Sci, Covilha, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Instituto Politecnico de Viseu; Universidade da Beira Interior	Reis, F (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Lab Pharmacol & Expt Therapeut, Coimbra, Portugal.	freis@fmed.uc.pt	Fernandes, Joao C/AAF-2091-2019; Bronze-da-Rocha, Elsa M R/K-2723-2013; Santos-Silva, Alice/K-2326-2013; Costa, Elisio MS/K-1990-2013; Belo, Luís FBA/K-5878-2013; Santos-Silva, Alice/AAC-7082-2020; Reis, Flávio/E-7077-2016; Rocha-Pereira, Petronila/K-3102-2013	Fernandes, Joao C/0000-0003-1556-1698; Bronze-da-Rocha, Elsa M R/0000-0002-3571-2513; Santos-Silva, Alice/0000-0002-2565-3169; Costa, Elisio MS/0000-0003-1158-1480; Belo, Luís FBA/0000-0002-3941-6850; Santos-Silva, Alice/0000-0002-2565-3169; Reis, Flávio/0000-0003-3401-9554; Rocha-Pereira, Petronila/0000-0002-7985-1494; Vala, Helena/0000-0001-6829-4867; Ribeiro, Sandra/0000-0003-3505-1310; Garrido, Patricia/0000-0002-0457-6790	Portuguese Foundation for Science and Technology (FCT); COMPETE-FEDER;  [POPH/FSE: PTDC/SAU-TOX/114253/2009];  [SFRH/BD/61020/2009];  [SFRH/BD/79875/2011];  [SFRH/BPD/81968/2011];  [PEst-C/SAU/UI3282/2011];  [PEst-C/SAU/UI3282/2013];  [PEst-OE/CED/UI4016/2014 (CIDETS)];  [UID/NEU/04539/2013 (CNC.IBILI)]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); COMPETE-FEDER; ; ; ; ; ; ; ; 	This work was supported by the Portuguese Foundation for Science and Technology (FCT), COMPETE-FEDER and POPH/FSE: PTDC/SAU-TOX/114253/2009, SFRH/BD/61020/2009, SFRH/BD/79875/2011, SFRH/BPD/81968/2011, PEst-C/SAU/UI3282/2011 and 2013, PEst-OE/CED/UI4016/2014 (CI&DETS) and UID/NEU/04539/2013 (CNC.IBILI). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; ALFREY AC, 1989, KIDNEY INT, V36, P753, DOI 10.1038/ki.1989.259; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Beaumont C, 2004, M S-MED SCI, V20, P68, DOI 10.1051/medsci/200420168; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; BRENNER BM, 1992, J CARDIOVASC PHARM, V19, pS1, DOI 10.1097/00005344-199219006-00002; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Collins AJ, 2002, KIDNEY INT, V61, pS44, DOI 10.1046/j.1523-1755.61.s80.9.x; Costa E, 2008, ACTA HAEMATOL-BASEL, V120, P11, DOI 10.1159/000149496; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Egrie JC, 2002, ONCOLOGY-NY, V16, P13; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fernandez-Fresnedo G, 2006, J AM SOC NEPHROL, V17, pS246, DOI 10.1681/ASN.2006080921; FINE LG, 1986, KIDNEY INT, V29, P619, DOI 10.1038/ki.1986.45; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Garrido P, 2009, RENAL FAILURE, V31, P833, DOI 10.3109/08860220903151435; Garrido P, 2013, FRONTIERS IN DRUG DI, P89; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hamada Y, 2008, NEPHROL DIAL TRANSPL, V23, P1886, DOI 10.1093/ndt/gfm900; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Jairam A, 2010, Indian J Nephrol, V20, P125, DOI 10.4103/0971-4065.70840; Jelkmann W, 2007, METHOD ENZYMOL, V435, P179, DOI 10.1016/S0076-6879(07)35010-6; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Liu Jiannong, 2009, Ther Clin Risk Manag, V5, P319; Liu ZC, 2003, RENAL FAILURE, V25, P935, DOI 10.1081/JDI-120026028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P288, DOI 10.1093/ndt/gfg489; MALT RA, 1969, NEW ENGL J MED, V280, P1446, DOI 10.1056/NEJM196906262802606; Malyszko J, 2007, KIDNEY BLOOD PRESS R, V30, P15, DOI 10.1159/000098522; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; PETERS G, 1978, YALE J BIOL MED, V51, P235; Peyssonnaux C, 2008, CELL CYCLE, V7, P28, DOI 10.4161/cc.7.1.5145; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; REMUZZI A, 1991, KIDNEY INT, V39, P647, DOI 10.1038/ki.1991.77; Remuzzi G, 2002, ANN INTERN MED, V136, P604, DOI 10.7326/0003-4819-136-8-200204160-00010; Robinson BM, 2005, KIDNEY INT, V68, P2323, DOI 10.1111/j.1523-1755.2005.00693.x; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; SILVERBERG D, 2003, NEPHROL DIAL TRAN S8, V18, P7, DOI DOI 10.1093/ndt//gfg1084; Staples AO, 2009, CLIN J AM SOC NEPHRO, V4, P48, DOI 10.2215/CJN.05301107; Sun CC, 2013, NEPHROL DIAL TRANSPL, V28, P1733, DOI 10.1093/ndt/gfs584; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; Teixeira M, 2012, J PHARM BIOALLIED SC, V4, P76, DOI 10.4103/0975-7406.92743; Volke M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007875; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Weisbord SD, 2008, HEMODIAL INT, V12, P6, DOI 10.1111/j.1542-4758.2008.00233.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wexler D, 2005, NEPHROL DIAL TRAN S7, V20, DOI [10.1093/ndt/gfh1101, DOI 10.1093/NDT/GFH1101]; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058	70	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124048	10.1371/journal.pone.0124048	http://dx.doi.org/10.1371/journal.pone.0124048			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867633	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100235
J	Ishikawa, T; Kobayashi, M; Yanagi, S; Kato, C; Takashima, R; Kobayashi, E; Hagiwara, K; Ochiya, T				Ishikawa, Tetsuya; Kobayashi, Momoko; Yanagi, Satoshi; Kato, Chika; Takashima, Ryokichi; Kobayashi, Eiji; Hagiwara, Keitaro; Ochiya, Takahiro			Human Induced Hepatic Lineage-Oriented Stem Cells: Autonomous Specification of Human iPS Cells toward Hepatocyte-Like Cells without Any Exogenous Differentiation Factors	PLOS ONE			English	Article							LONG-TERM CULTURE; GENERATION; EFFICIENT; EXPRESSION; INDUCTION; MOUSE; LIVER; EXPANSION	Preparing targeted cells for medical applications from human induced pluripotent stem cells (hiPSCs) using growth factors, compounds, or gene transfer has been challenging. Here, we report that human induced hepatic lineage-oriented stem cells (hiHSCs) were generated and expanded as a new type of hiPSC under non-typical coculture with feeder cells in a chemically defined hiPSC medium at a very high density. Self-renewing hiHSCs expressed markers of both human embryonic stem cells (hESCs) and hepatocytes. Those cells were highly expandable, markedly enhancing gene expression of serum hepatic proteins and cytochrome P450 enzymes with the omission of FGF-2 from an undefined hiPSC medium. The hepatic specification of hiHSCs was not attributable to the genetic and epigenetic backgrounds of the starting cells, as they were established from distinct donors and different types of cells. Approximately 90% of hiHSCs autonomously differentiated to hepatocyte-like cells, even in a defined minimum medium without any of the exogenous growth factors necessary for hepatic specification. After 12 days of this culture, the differentiated cells significantly enhanced gene expression of serum hepatic proteins (ALB, SERPINA1, TTR, TF, FABP1, FGG, AGT, RBP4, and AHSG), conjugating enzymes (UGT2B4, UGT2B7, UGT2B10, GSTA2, and GSTA5), transporters (SULT2A1, SLC13A5, and SLCO2B1), and urea cycle-related enzymes (ARG1 and CPS1). In addition, the hepatocyte-like cells performed key functions of urea synthesis, albumin secretion, glycogen storage, indocyanine green uptake, and low-density lipoprotein uptake. The autonomous hepatic specification of hiHSCs was due to their culture conditions (coculture with feeder cells in a defined hiPSC medium at a very high density) in self-renewal rather than in differentiation. These results suggest the feasibility of preparing large quantities of hepatocytes as a convenient and inexpensive hiPSC differentiation. Our study also suggests the necessity of optimizing culture conditions to generate other specific lineage-oriented hiPSCs, allowing for a very simple differentiation.	[Ishikawa, Tetsuya; Kobayashi, Momoko] Natl Canc Ctr, Res Inst, Chuo Ku, Core Facil Res & Innovat Med, Tokyo 104, Japan; [Yanagi, Satoshi; Kato, Chika; Takashima, Ryokichi; Kobayashi, Eiji] Takara Bio Inc, Otsu, Shiga, Japan; [Hagiwara, Keitaro; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Chuo Ku, Div Mol & Cellular Med, Tokyo 104, Japan	National Cancer Center - Japan; Takara Bio Inc.; National Cancer Center - Japan	Ishikawa, T (corresponding author), Natl Canc Ctr, Res Inst, Chuo Ku, Core Facil Res & Innovat Med, Tokyo 104, Japan.	teishika@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Health, Labor, and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Takara Bio, Inc.	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Takara Bio, Inc.	T.O. was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan. T.I. was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takara Bio, Inc., provided support in the form of salaries for authors SY, CK, RT, and EK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Gerbal-Chaloin S, 2014, AM J PATHOL, V184, P332, DOI 10.1016/j.ajpath.2013.09.026; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Ishikawa T, 2012, METHODS MOL BIOL, V826, P103, DOI 10.1007/978-1-61779-468-1_9; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Lubberstedt M, 2011, J PHARMACOL TOX MET, V63, P59, DOI 10.1016/j.vascn.2010.04.013; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Matsunaga T, 2012, DRUG METAB PHARMACOK, V27, P653, DOI 10.2133/dmpk.DMPK-12-NT-018; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohnuki Mari, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a02s9; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; STOCKERT RJ, 1983, HEPATOLOGY, V3, P750; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vosough M, 2013, STEM CELLS DEV, V22, P2693, DOI 10.1089/scd.2013.0088; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamazoe T, 2013, J CELL SCI, V126, P5391, DOI 10.1242/jcs.129767; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123193	10.1371/journal.pone.0123193	http://dx.doi.org/10.1371/journal.pone.0123193			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875613	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100148
J	Marquez-Rodas, I; Gonzalez, MM; Nagore, E; Gomez-Fernandez, C; Aviles-Izquierdo, JA; Maldonado-Seral, C; Soriano, V; Majem-Tarruella, M; Palomar, V; Maseda, R; Martin-Carnicero, A; Puertolas, T; Godoy, E; Cerezuela, P; de Olza, MO; Campos, B; Perez-Ruiz, E; Soria, A; Gil-Arnaiz, I; Gonzalez-Cao, M; Galvez, E; Arance, A; Belon, J; de la Cruz-Merino, L; Martin-Algarra, S				Marquez-Rodas, Ivan; Gonzalez, Manuel Martin; Nagore, Eduardo; Gomez-Fernandez, Cristina; Antonio Aviles-Izquierdo, Jose; Maldonado-Seral, Cayetana; Soriano, Virtudes; Majem-Tarruella, Margarita; Palomar, Virginia; Maseda, Rocio; Martin-Carnicero, Alfonso; Puertolas, Teresa; Godoy, Elena; Cerezuela, Pablo; de Olza, Maria Ochoa; Campos, Begona; Perez-Ruiz, Elisabeth; Soria, Ainara; Gil-Arnaiz, Irene; Gonzalez-Cao, Maria; Galvez, Elisa; Arance, Ana; Belon, Joaquin; de la Cruz-Merino, Luis; Martin-Algarra, Salvador		Spanish Multidisciplinary Grp Mela	Frequency and Characteristics of Familial Melanoma in Spain: The FAM-GEM-1 Study	PLOS ONE			English	Article							MULTIPLE PRIMARY MELANOMAS; CUTANEOUS MELANOMA; RISK; ADHERENCE; CARRIERS; CANCERS; MEMBERS	Introduction Familial history of melanoma is a well-known risk factor for the disease, and 7% melanoma patients were reported to have a family history of melanoma. Data relating to the frequency and clinical and pathological characteristics of both familial and non-familial melanoma in Spain have been published, but these only include patients from specific areas of Spain and do not represent the data for the whole of Spain. Patients and methods An observational study conducted by the Spanish Group of Melanoma (GEM) analyzed the family history of patients diagnosed with melanoma between 2011 and 2013 in the dermatology and oncology departments. Results In all, 1047 patients were analyzed, and 69 (6.6%) fulfilled criteria for classical familial melanoma (two or more first-degree relatives diagnosed with melanoma). Taking into account other risk factors for familial melanoma, such as multiple melanoma, pancreatic cancer in the family or second-degree relatives with melanoma, the number of patients fulfilling the criteria increased to 165 (15.8%). Using a univariate analysis, we determined that a Breslow index of less than 1 mm, negative mitosis, multiple melanoma, and a history of sunburns in childhood were more frequent in familial melanoma patients, but a multivariate analysis revealed no differences in any pathological or clinical factor between the two groups. Conclusions Similar to that observed in other countries, familial melanoma accounts for 6.6% of melanoma diagnoses in Spain. Although no differences in the multivariate analysis were found, some better prognosis factors, such as Breslow index, seem more frequent in familial melanoma, which reflect a better early detection marker and/or a different biological behavior.	[Marquez-Rodas, Ivan] Inst Invest Sanitaria Gregorio Maranon, Med Oncol Serv, Madrid, Spain; [Gonzalez, Manuel Martin] Hosp Ramon & Cajal, Serv Dermatol, E-28034 Madrid, Spain; [Nagore, Eduardo] Inst Valenciano Oncol, Serv Dermatol, Valencia, Spain; [Gomez-Fernandez, Cristina; Maseda, Rocio] Hosp La Paz, Serv Dermatol, Madrid, Spain; [Antonio Aviles-Izquierdo, Jose] Inst Invest Sanitaria Gregorio Maranon, Serv Dermatol, Madrid, Spain; [Maldonado-Seral, Cayetana] Hosp Univ Cent Asturias, Serv Dermatol, Oviedo, Spain; [Soriano, Virtudes] Inst Valenciano Oncol, Med Oncol Serv, Valencia, Spain; [Majem-Tarruella, Margarita] Hosp Santa Creu & Sant Pau, Med Oncol Serv, Barcelona, Spain; [Palomar, Virginia] Hosp Gen Valencia, Med Oncol Serv, Valencia, Spain; [Martin-Carnicero, Alfonso] Hosp San Pedro, Med Oncol Serv, Logrono, Spain; [Puertolas, Teresa] Hosp Univ Miguel Servet, Serv Oncol, Zaragoza, Spain; [Godoy, Elena] Hosp Cabuenes, Serv Dermatol, Gijon, Spain; [Cerezuela, Pablo] Hosp Gen Univ St Lucia, Med Oncol Serv, Cartagena, Spain; [de Olza, Maria Ochoa] Inst Catalan Oncol, Med Oncol Serv, Hosp, Barcelona, Spain; [Campos, Begona] Hosp Lucus Augusti, Med Oncol Serv, Lugo, Spain; [Perez-Ruiz, Elisabeth] Hosp Costa Sol, Med Oncol Serv, Marbella, Spain; [Soria, Ainara] Hosp Ramon & Cajal, Med Oncol Serv, E-28034 Madrid, Spain; [Gil-Arnaiz, Irene] Hosp Reina Sofia, Med Oncol Serv, Tudela, Spain; [Gonzalez-Cao, Maria] Inst Dexeus, Med Oncol Serv, Barcelona, Spain; [Galvez, Elisa] Hosp Elda, Med Oncol Serv, Alicante, Spain; [Arance, Ana] Hosp Clin Barcelona, Med Oncol Serv, Barcelona, Spain; [Belon, Joaquin] Clin Oncogranada, Med Oncol Serv, Granada, Spain; [de la Cruz-Merino, Luis] Hosp Virgen Macarena, Med Oncol Serv, Seville, Spain; [Martin-Algarra, Salvador] Univ Navarra Clin, Dept Oncol, Pamplona, Spain	Hospital Universitario Ramon y Cajal; Instituto Valenciano De Oncologia; Hospital Universitario La Paz; Central University Hospital Asturias; Instituto Valenciano De Oncologia; Hospital of Santa Creu i Sant Pau; Miguel Servet University Hospital; Hospital de Cabuenes; Catalan Institute of Oncology; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Ramon y Cajal; Servicio Navarro de Salud - Osasunbidea; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Virgen Macarena; University of Navarra	Marquez-Rodas, I (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Med Oncol Serv, Madrid, Spain.	ivanpantic@hotmail.com	Valdivia Bautista, Javier/ABD-4463-2021; Soria, Angèle/B-6070-2017; Nagore, Eduardo/Z-2126-2019; Martín-Broto, Javier/AAI-2313-2019; Berciano-Berciano, Miguel-Ángel/AAV-2120-2021; REDONDO, PEDRO/H-7989-2017; Marti, Rosa/A-2256-2010; Marquez-Rodas, Ivan/ABD-5532-2021; Idoate, Miguel-Ángel/D-8502-2019; Ruiz, Elísabeth Pérez/ABI-5900-2020; Martín-Algarra, Salvador/CAF-3626-2022; de la Cruz-Merino, Luis/K-8633-2017; Perez-Gracia, Jose Luis/I-8372-2017; IBIS, BIOMARCADORES/P-3515-2015; CARRERA, CRISTINA/N-1887-2019; Vaqué, José P/H-8413-2015; Gonzalez Larriba, Jose Luis/G-6177-2016	Valdivia Bautista, Javier/0000-0002-3738-0655; Nagore, Eduardo/0000-0003-3433-8707; Berciano-Berciano, Miguel-Ángel/0000-0002-5437-5196; REDONDO, PEDRO/0000-0001-7899-2511; Marti, Rosa/0000-0001-6866-6114; Marquez-Rodas, Ivan/0000-0002-2476-668X; Idoate, Miguel-Ángel/0000-0002-1596-1192; Ruiz, Elísabeth Pérez/0000-0001-7204-0800; Martín-Algarra, Salvador/0000-0002-3109-8026; de la Cruz-Merino, Luis/0000-0002-5333-0535; Perez-Gracia, Jose Luis/0000-0003-4941-9075; CARRERA, CRISTINA/0000-0003-1608-8820; Vaqué, José P/0000-0002-3913-2495; Martin-Broto, Javier/0000-0001-7350-6916; Gonzalez Larriba, Jose Luis/0000-0003-2631-0309; Martin Carnicero, Alfonso/0000-0002-8564-2875; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Arance, Ana/0000-0003-2896-1957; Aya, Francisco/0000-0002-3452-7607; Palomar Coloma, Virginia/0000-0002-1628-7224; Rubio-Casadevall, Jordi/0000-0002-3516-6970; Boada, Aram/0000-0001-9809-5308; Olier-Garate, Clara/0000-0002-5403-5300; Caminal, JM/0000-0001-9563-0344; GUILLEN PONCE, CARMEN/0000-0002-3594-1084; Blazquez Sanchez, Nuria/0000-0003-4055-4174; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153				Aspinwall LG, 2014, GENET MED, V16, P846, DOI 10.1038/gim.2014.37; Aspinwall LG, 2013, CANCER EPIDEM BIOMAR, V22, P1687, DOI 10.1158/1055-9965.EPI-13-0422; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Badenas C, 2012, DERMATOL THER, V25, P397, DOI 10.1111/j.1529-8019.2012.01499.x; Chen TH, 2014, EUR J CANCER, V50, P2659, DOI 10.1016/j.ejca.2014.07.007; Debniak Tadeusz, 2004, Hered Cancer Clin Pract, V2, P123, DOI 10.1186/1897-4287-2-3-123; Fuster V, 2003, AM J HUM BIOL, V15, P709, DOI 10.1002/ajhb.10198; Glanz K, 2013, CANCER EPIDEM BIOMAR, V22, P607, DOI 10.1158/1055-9965.EPI-12-1174; Hansson J, 2010, ADV EXP MED BIOL, V685, P134; Helgadottir H, 2014, J MED GENET, V51, P545, DOI 10.1136/jmedgenet-2014-102320; Mukherjee B, 2012, JNCI-J NATL CANCER I, V104, P953, DOI 10.1093/jnci/djs221; Nagore E, 2008, J EUR ACAD DERMATOL, V22, P931, DOI 10.1111/j.1468-3083.2008.02682.x; Olsen CM, 2010, CANCER EPIDEM BIOMAR, V19, P65, DOI 10.1158/1055-9965.EPI-09-0928; Pollio A, 2014, MELANOMA RES, V24, P267, DOI 10.1097/CMR.0000000000000057; Potrony M, 2014, J AM ACAD DERMATOL, V71, P888, DOI 10.1016/j.jaad.2014.06.036; Puig S, 2005, J CLIN ONCOL, V23, P3043, DOI 10.1200/JCO.2005.08.034; Slominski RM, 2015, EXP DERMATOL, V24, P258, DOI 10.1111/exd.12618	17	5	5	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124239	10.1371/journal.pone.0124239	http://dx.doi.org/10.1371/journal.pone.0124239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874698	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100248
J	Ruan, RQ; Zou, LL; Sun, SJ; Liu, J; Wen, LP; Gao, DY; Ding, WP				Ruan, Renquan; Zou, Lili; Sun, Sijie; Liu, Jing; Wen, Longping; Gao, Dayong; Ding, Weiping			Cell Blebbing upon Addition of Cryoprotectants: A Self-Protection Mechanism	PLOS ONE			English	Article							AUTOPHAGY; STRESS; BLEBS; 33258-HOECHST; ACTIVATION; APOPTOSIS; MIGRATION; POLARITY; SHAPE	In this work, the mechanism of cell bleb formation upon the addition of cryoprotectants (CPAs) was investigated, and the role of cell blebs in protecting cells was determined. The results show that after adding CPAs, the hyperosmotic stress results in the breakage of the cortical cytoskeleton and the detachment of the cell membrane from the cortical cytoskeleton, causing the formation of cell blebs. Multiple blebs decrease the intracellular hydrostatic pressure induced by the extracellular hyperosmotic shock and alleviate the osmotic damage to cells, which reduces the cell mortality rate. In the presence of a low concentration of CPAs, cell blebs can effectively protect cells. In contrast, in the presence of a high concentration of CPAs, the protective effect is limited because of severe disruption in the cortical cytoskeleton. To determine the relationship between blebs and the mortality rate of cells, we defined a bleb index and found that the bleb index of 0.065 can be regarded as a reference value for the safe addition of DMSO to HeLa cells. The bleb index can also explain why the stepwise addition of CPAs is better than the single-step addition of CPAs. Moreover, the mechanism of the autophagy of cells induced by the hyperosmotic stress was studied, and the protective effect associated with the autophagy was compared with the effect of the blebbing. The findings reported here elucidate a self-protection mechanism of cells experiencing the hyperosmotic stress in the presence of CPAs, and they provide significant evidence for cell tolerance in the field of cryopreservation.	[Ruan, Renquan; Zou, Lili; Liu, Jing; Ding, Weiping] Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230027, Anhui, Peoples R China; [Ruan, Renquan; Zou, Lili; Liu, Jing; Ding, Weiping] Univ Sci & Technol China, Dept Elect Sci & Technol, Hefei 230027, Anhui, Peoples R China; [Sun, Sijie] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wen, Longping] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle	Ding, WP (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230027, Anhui, Peoples R China.	wpdings@ustc.edu.cn	Ding, Weiping/K-5292-2012	Ding, Weiping/0000-0002-3331-1011; Wen, Longping/0000-0003-0384-4578	Fundamental Research Funds for the Central Universities of China [WK2100000001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133402120033]; Natural Science Foundation of Anhui Province [1408085ME96]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was supported by the Fundamental Research Funds for the Central Universities of China (WK2100000001), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133402120033), and the Natural Science Foundation of Anhui Province (1408085ME96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cooper RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033528; Copp J, 2005, AM J PHYSIOL-CELL PH, V288, pC403, DOI 10.1152/ajpcell.00095.2004; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Fedier A, 1997, CELL MOTIL CYTOSKEL, V37, P326; Fessard V., 1994, Natural Toxins, V2, P322, DOI 10.1002/nt.2620020512; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Guan N, 2012, CRYOBIOLOGY, V65, P179, DOI 10.1016/j.cryobiol.2012.05.011; Guthe HJT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031332; Heo YS, 2011, LAB CHIP, V11, P3530, DOI 10.1039/c1lc20377k; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hotamisligil S, 1996, BIOL REPROD, V55, P161, DOI 10.1095/biolreprod55.1.161; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lai KP, 2013, INT J BIOCHEM CELL B, V45, P1921, DOI 10.1016/j.biocel.2013.05.023; LATT SA, 1975, J HISTOCHEM CYTOCHEM, V23, P493, DOI 10.1177/23.7.1095650; LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; McFarland AJ, 2012, ARCH TOXICOL, V86, P275, DOI 10.1007/s00204-011-0755-5; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Nunes P, 2013, AUTOPHAGY, V9, P550, DOI 10.4161/auto.23662; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sam R, 2012, AM J NEPHROL, V36, P97, DOI 10.1159/000339625; Sharma P, 2013, INTEGR BIOL-UK, V5, P1036, DOI 10.1039/c3ib40073e; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; Song YS, 2009, LAB CHIP, V9, P1874, DOI 10.1039/b823062e; Spangler EJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051906; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wei PF, 2014, BIOMATERIALS, V35, P899, DOI 10.1016/j.biomaterials.2013.10.024; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	46	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125746	10.1371/journal.pone.0125746	http://dx.doi.org/10.1371/journal.pone.0125746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875076	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100301
J	Wei, HX; Chiba, S; Moriwaki, C; Kitamura, H; Ina, K; Aosa, T; Tomonari, K; Gotoh, K; Masaki, T; Katsuragi, I; Noguchi, H; Kakuma, T; Hamaguchi, K; Shimada, T; Fujikura, Y; Shibata, H				Wei, Huixing; Chiba, Seiichi; Moriwaki, Chinatsu; Kitamura, Hirokazu; Ina, Keisuke; Aosa, Taishi; Tomonari, Kenichiro; Gotoh, Koro; Masaki, Takayuki; Katsuragi, Isao; Noguchi, Hitoshi; Kakuma, Tetsuya; Hamaguchi, Kazuyuki; Shimada, Tatsuo; Fujikura, Yoshihisa; Shibata, Hirotaka			A Clinical Approach to Brown Adipose Tissue in the Para-Aortic Area of the Human Thorax	PLOS ONE			English	Article							UNCOUPLING PROTEIN-1; F-18-FDG UPTAKE; FAT; MUSCLE; ADIPOCYTES; EXPRESSION; OBESITY; MOUSE; PET	Background Human thoracic brown adipose tissue (BAT), composed of several subdivisions, is a well-known target organ of many clinical studies; however, the functional contribution of each part of human thoracic BAT remains unknown. The present study analyzed the significance of each part of human thoracic BAT in the association between regional distribution, cellularity, and factors involved in the functional regulation of thoracic BAT. Methods We analyzed 1550 healthy adults who underwent medical check-ups by positron-emission tomography and computed tomography (PET-CT) imaging, 8 cadavers, and 78 autopsy cases in an observational study. We first characterized the difference between the mediastinum and the supraclavicular areas using counts of BAT detection and conditions based on PET-CT outcomes. The measurable important area was then subjected to systematic anatomical and immunohistochemical analyses using anti-uncoupling protein 1 (UCP1) antibody to characterize the cellularity in association with age and sex. Results In PET-CT scanning, the main site of thoracic BAT was the mediastinum rather than the supraclavicular area (P < 0.05). Systemic macroanatomy revealed that the thumb-sized BAT in the posterior mediastinal descending para-aortic area (paBAT) had feeding vessels from the posterior intercostal arteries and veins and sympathetic/parasympathetic innervation from trunks of the sympathetic and vagus nerves, respectively. Immunohistochemical analysis indicated that the paBAT exhibited immunoreactivity for tyrosine hydroxylase and vesicular acetylcholine transporter located in the pericellular nervous fibers and intracellular UCP1. The brown adipose cells of paBAT showed age-dependent decreases in UCP1 expression (P < 0.05), accompanied by a significant increase in vacuole formation, indicating fat accumulation (P < 0.05), from 10 to 37 years of age (P < 0.01). Conclusions paBAT may be one of the essential sites for clinical application in BAT study because of its visible anatomy with feeding vessels and sympathetic/parasympathetic innervation functionally affected by outer condition and senescence.	[Wei, Huixing; Moriwaki, Chinatsu; Gotoh, Koro; Masaki, Takayuki; Katsuragi, Isao; Kakuma, Tetsuya; Shibata, Hirotaka] Oita Univ, Fac Med, Dept Endocrinol Metab Rheumatol & Nephrol, Yufu, Oita, Japan; [Wei, Huixing; Chiba, Seiichi; Moriwaki, Chinatsu; Kitamura, Hirokazu; Ina, Keisuke; Aosa, Taishi; Fujikura, Yoshihisa] Oita Univ, Fac Med, Dept Mol Anat, Yufu, Oita, Japan; [Tomonari, Kenichiro] Shonin Hosp, Oita Diagnost Imaging Ctr, Bepu, Oita, Japan; [Noguchi, Hitoshi] Noguchi Thyroid Clin & Hosp Fdn, Bepu, Oita, Japan; [Hamaguchi, Kazuyuki; Shimada, Tatsuo] Oita Univ, Sch Nursing, Fac Med, Yufu, Oita, Japan	Oita University; Oita University; Oita University	Chiba, S (corresponding author), Oita Univ, Fac Med, Dept Mol Anat, 1-1 Idaigaoka Hasama, Yufu, Oita, Japan.	schiba@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X	Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [25461397] Funding Source: KAKEN	Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan. The researchers were financed independently from the funding organisations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; Cheung L, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.6; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Giordano A, 2004, J HISTOCHEM CYTOCHEM, V52, P923, DOI 10.1369/jhc.3A6246.2004; Hashimoto Y, 2006, J NUCL MED, V47, P426; HEATON JM, 1972, J ANAT, V112, P35; HORKA J, 1990, Folia Morphologica (Prague), V38, P38; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; KORTELAINEN ML, 1993, J HISTOCHEM CYTOCHEM, V41, P759, DOI 10.1177/41.5.8468458; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perkins AC, 2013, NUCL MED COMMUN, V34, P168, DOI 10.1097/MNM.0b013e32835bbbf0; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092608; Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929; TANUMA Y, 1975, ARCH HISTOL JAPON, V38, P43, DOI 10.1679/aohc1950.38.43; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Vijgen GHEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077221; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeung HWD, 2003, J NUCL MED, V44, P1789; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	43	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122594	10.1371/journal.pone.0122594	http://dx.doi.org/10.1371/journal.pone.0122594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875082	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100085
J	Xiao, D; Wu, KJ; Tan, X; Le, J; Li, HT; Yan, YP; Xu, ZK				Xiao, Dan; Wu, Kejian; Tan, Xin; Le, Jing; Li, Haitao; Yan, Yongping; Xu, Zhikai			Modeling and Predicting Hemorrhagic Fever with Renal Syndrome Trends Based on Meteorological Factors in Hu County, China	PLOS ONE			English	Article							HANTAVIRUS INFECTIONS; RISK-FACTORS; TRANSMISSION; VARIABILITY; EPIDEMIC	Background Hu County is a serious hemorrhagic fever with renal syndrome (HFRS) epidemic area, with notable fluctuation of the HFRS epidemic in recent years. This study aimed to explore the optimal model for HFRS epidemic prediction in Hu. Methods Three models were constructed and compared, including a generalized linear model (GLM), a generalized additive model (GAM), and a principal components regression model (PCRM). The fitting and predictive adjusted R-2 of each model were calculated. Ljung-Box Q tests for fitted and predicted residuals of each model were conducted. The study period was stratified into before (1971-1993) and after (1994-2012) vaccine implementation epochs to avoid the confounding factor of vaccination. Results The autocorrelation of fitted and predicted residuals of the GAM in the two epochs were not significant (Ljung-Box Q test, P>. 05). The adjusted R-2 for the predictive abilities of the GLM, GAM, and PCRM were 0.752, 0.799, and 0.665 in the early epoch, and 0.669, 0.756, and 0.574 in the recent epoch. The adjusted R-2 values of the three models were lower in the early epoch than in the recent epoch. Conclusions GAM is superior to GLM and PCRM for monthly HFRS case number prediction in Hu County. A shift in model reliability coincident with vaccination implementation demonstrates the importance of vaccination in HFRS control and prevention.	[Xiao, Dan; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Wu, Kejian; Li, Haitao] Fourth Mil Med Univ, Sch Biomed & Engn, Dept Math & Phys, Xian 710032, Peoples R China; [Tan, Xin] Hu Cty Ctr Dis Control & Prevent, Xian, Peoples R China; [Le, Jing] Hu Cty Meteorol Bur, Xian, Peoples R China; [Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yanyping@fmmu.edu.cn; zhikaixu@fmmu.edu.cn	Yan, Yongping/K-9634-2019		China Postdoctoral Science Foundation [2012M512104, 2014T07967]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by two foundations: China Postdoctoral Science Foundation (No: 2012M512104 and No: 2014T07967). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erbas B, 2005, INT J ENVIRON HEAL R, V15, P437, DOI 10.1080/09603120500289192; Gunnes N, 2013, EPIDEMIOLOGY, V24, P906, DOI 10.1097/01.ede.0000434435.52506.f5; Han SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-347; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hu W, 2007, EPIDEMIOL INFECT, V135, P245, DOI 10.1017/S0950268806006649; Huang Li-Yong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P685; Knoblauch K, 2008, J VISION, V8, DOI 10.1167/8.16.10; Li CP, 2013, AM J TROP MED HYG, V89, P1006, DOI 10.4269/ajtmh.12-0473; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Ministry of Health of China, 2012, CHIN HLTH STAT YB; Sargianou M, 2012, CRIT REV MICROBIOL, V38, P317, DOI 10.3109/1040841X.2012.673553; Tan X, 2012, CHIN J VECTOR BIOL C, V23, P573; The central people's government of the people's republic of China website, NAT KIDN SYNDR HEM F; Viel JF, 2011, EPIDEMIOL INFECT, V139, P867, DOI 10.1017/S0950268810002062; Wang De-zheng, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P478; Wang L, 2010, FOREIGN MED SCI SECT, V31, P216; Wanka ER, 2014, INT J BIOMETEOROL, V58, P249, DOI 10.1007/s00484-013-0730-3; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Xiao D, 2014, VACCINE, V32, P740, DOI 10.1016/j.vaccine.2013.11.024; Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	27	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123166	10.1371/journal.pone.0123166	http://dx.doi.org/10.1371/journal.pone.0123166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875211	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100145
J	Zhao, L; Li, B; Dian, K; Ying, BW; Lu, XJ; Hu, XJ; An, Q; Chen, CX; Huang, CY; Tan, B; Qin, L				Zhao, Li; Li, Bei; Dian, Ke; Ying, Binwu; Lu, Xiaojun; Hu, Xuejiao; An, Qi; Chen, Chunxia; Huang, Chunyan; Tan, Bin; Qin, Li			Association between the European GWAS-Identified Susceptibility Locus at Chromosome 4p16 and the Risk of Atrial Septal Defect: A Case-Control Study in Southwest China and a Meta-Analysis	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SCHIZOPHRENIA; MUTATIONS; GENE	Atrial septal defect (ASD) is the third most frequent type of congenital heart anomaly, featuring shunting of blood between the two atria. Gene-environment interaction remains to be an acknowledged cause for ASD occurrence. A recent European genome-wide association study (GWAS) of congenital heart disease (CHD) identified 3 susceptibility SNPs at chromosome 4p16 associated with ASD: rs870142, rs16835979 and rs6824295. A Chinese-GWAS of CHD conducted in the corresponding period did not reveal the 3 susceptibility SNPs, but reported 2 different risk SNPs: rs2474937 and rs1531070. Therefore, we aimed to investigate the associations between the 3 European GWAS-identified susceptibility SNPs and ASD risk in the Han population in southwest China. Additionally, to increase the robustness of our current analysis, we conducted a meta-analysis combining published studies and our current case-control study. We performed association, linkage disequilibrium, and haplotype analysis among the 3 SNPs in 190 ASD cases and 225 age-, sex-, and ethnicity-matched healthy controls. Genotype and allele frequencies among the 3 SNPs showed statistically significant differences between the cases and controls. Our study found that individuals carrying the allele T of rs870142, the allele A of rs16835979, and the allele T of rs6824295 had a respective 50.1% (odds ratio (OR) = 1.501, 95% confidence interval (CI) = 1.122-2.009, PFDR-BH = 0.018), 48.5% (OR = 1.485, 95% CI = 1.109-1.987, PFDR-BH = 0.012), and 38.6%(OR = 1.386, 95% CI = 1.042-1.844, PFDR-BH = 0.025) increased risk to develop ASD than wild-type allele carriers in our study cohort. In the haplotype analysis, we identified a disease-risk haplotype (TAT) (OR = 1.540, 95% CI = 1.030-2.380, PFDR-BH = 0.016). Our meta-analysis also showed that the investigated SNP was associated with ASD risk (combined OR (95% CI) = 1.35 (1.24-1.46), P < 0.00001). Our study provides compelling evidence to motivate better understanding of the etiology of ASD.	[Zhao, Li; Li, Bei; Ying, Binwu; Lu, Xiaojun; Hu, Xuejiao; Chen, Chunxia; Huang, Chunyan; Tan, Bin; Qin, Li] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Peoples R China; [Dian, Ke; An, Qi] Sichuan Univ, Dept Cardiothorac Surg, West China Hosp, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Qin, L (corresponding author), Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Peoples R China.	qinli7@126.com	Ying, Binwu/AAB-5934-2022	Ying, Binwu/0000-0001-8077-3908				Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; CHANTHOMAS PS, 1993, DEV DYNAM, V197, P203, DOI 10.1002/aja.1001970305; Chen CX, 2012, DNA CELL BIOL, V31, P988, DOI 10.1089/dna.2011.1471; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Cordell HJ, 2013, NATURE GENETICS; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hinton RB, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000292; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu Z, 2013, NATURE GENETICS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Reamon-Buettner Stella Marie, 2004, Hum Mutat, V24, P104, DOI 10.1002/humu.9255; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Zhao BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107411; Zhou Y, 2010, DNA CELL BIOL, V29, P745, DOI 10.1089/dna.2010.1075	17	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123959	10.1371/journal.pone.0123959	http://dx.doi.org/10.1371/journal.pone.0123959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875170	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100228
J	Kawchuk, GN; Fryer, J; Jaremko, JL; Zeng, HB; Rowe, L; Thompson, R				Kawchuk, Gregory N.; Fryer, Jerome; Jaremko, Jacob L.; Zeng, Hongbo; Rowe, Lindsay; Thompson, Richard			Real-Time Visualization of Joint Cavitation	PLOS ONE			English	Article							VELOCITY THRUST MANIPULATION; SPINAL HIGH-VELOCITY; LOW-BACK-PAIN; ZYGAPOPHYSEAL JOINTS; KNUCKLE CRACKING; AUDIBLE POP; GAS-BUBBLES; INDIVIDUALS	Cracking sounds emitted from human synovial joints have been attributed historically to the sudden collapse of a cavitation bubble formed as articular surfaces are separated. Unfortunately, bubble collapse as the source of joint cracking is inconsistent with many physical phenomena that define the joint cracking phenomenon. Here we present direct evidence from real-time magnetic resonance imaging that the mechanism of joint cracking is related to cavity formation rather than bubble collapse. In this study, ten metacarpophalangeal joints were studied by inserting the finger of interest into a flexible tube tightened around a length of cable used to provide long-axis traction. Before and after traction, static 3D T1-weighted magnetic resonance images were acquired. During traction, rapid cine magnetic resonance images were obtained from the joint midline at a rate of 3.2 frames per second until the cracking event occurred. As traction forces increased, real-time cine magnetic resonance imaging demonstrated rapid cavity inception at the time of joint separation and sound production after which the resulting cavity remained visible. Our results offer direct experimental evidence that joint cracking is associated with cavity inception rather than collapse of a pre-existing bubble. These observations are consistent with tribonucleation, a known process where opposing surfaces resist separation until a critical point where they then separate rapidly creating sustained gas cavities. Observed previously in vitro, this is the first in-vivo macroscopic demonstration of tribonucleation and as such, provides a new theoretical framework to investigate health outcomes associated with joint cracking.	[Kawchuk, Gregory N.] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada; [Jaremko, Jacob L.] Univ Alberta, Fac Med & Dent, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada; [Zeng, Hongbo] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Rowe, Lindsay] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Thompson, Richard] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Newcastle; University of Alberta	Kawchuk, GN (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada.	greg.kawchuk@ualberta.ca	Zeng, Hongbo/C-8491-2011; Fryer, Jerome/AAP-3950-2020	Zeng, Hongbo/0000-0002-1432-5979; Thompson, Richard/0000-0003-3319-4377	Canadian Chiropractic Research Foundation (CCRF); Canada Research Chairs program	Canadian Chiropractic Research Foundation (CCRF); Canada Research Chairs program(Canada Research Chairs)	Imaging costs in the study were funded by an operating grant from the Canadian Chiropractic Research Foundation (CCRF). http://www.canadianchiropracticresearchfoundation.com/. GK is supported by the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljishia S, 1991, WHY DOES HEATING WAT, P628; Barrow MS, 2003, P ROY SOC A-MATH PHY, V459, P2885, DOI 10.1098/rspa.2003.1128; Beffa Roberto, 2004, J Manipulative Physiol Ther, V27, pe2; BENJAMIN TB, 1966, PHILOS TR R SOC S-A, V260, P221, DOI 10.1098/rsta.1966.0046; Bereznick DE, 2008, J MANIP PHYSIOL THER, V31, P199, DOI 10.1016/j.jmpt.2008.02.002; BRODEUR R, 1995, J MANIP PHYSIOL THER, V18, P155; Bronfort G, 2008, SPINE J, V8, P213, DOI 10.1016/j.spinee.2007.10.023; CAMPBELL J, 1968, J PHYS D APPL PHYS, V1, P1085, DOI 10.1088/0022-3727/1/8/421; Cascioli V, 2003, J MANIP PHYSIOL THER, V26, P356, DOI 10.1016/S0161-4754(03)00075-7; CASTELLANOS J, 1990, ANN RHEUM DIS, V49, P308, DOI 10.1136/ard.49.5.308; CHEN YL, 1991, SCIENCE, V252, P1157, DOI 10.1126/science.252.5009.1157; Christen T, 1911, ANAT HEFTE, V43, P379; Cramer GD, 2012, J MANIP PHYSIOL THER, V35, P614, DOI 10.1016/j.jmpt.2012.06.007; Crisco JJ, 2007, J BIOMECH, V40, P2767, DOI 10.1016/j.jbiomech.2006.12.013; Davies MS, 1999, J BONE JOINT SURG BR, V81B, P203, DOI 10.1302/0301-620X.81B2.9084; deWeber K, 2011, J AM BOARD FAM MED, V24, P169, DOI 10.3122/jabfm.2011.02.100156; DiGiorgi D, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-14; Evans DW, 2010, MANUAL THER, V15, P286, DOI 10.1016/j.math.2009.12.009; Evans DW, 2006, J MANIP PHYSIOL THER, V29, P72, DOI 10.1016/j.jmpt.2005.11.011; Evans DW, 2002, J MANIP PHYSIOL THER, V25, P251, DOI 10.1067/mmt.2002.123166; Fick R, 1911, STREIT GELENKDRUCK, V43, P397; Flynn TW, 2003, ARCH PHYS MED REHAB, V84, P1057, DOI 10.1016/S0003-9993(03)00048-0; Flynn TW, 2006, J MANIP PHYSIOL THER, V29, P40, DOI 10.1016/j.jmpt.2005.11.005; Gibbons P., 2001, J MANIP PHYSIOL THER, V5, P110, DOI [10.1054/jbmt.2000.0208, DOI 10.1054/JBMT.2000.0208]; Hung WC, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500498; IKELS KG, 1970, J APPL PHYSIOL, V28, P524, DOI 10.1152/jappl.1970.28.4.524; Knapp R, 1970, CAVITATION, P728; LaFond E, 1997, J AM VET MED ASSOC, V210, P1294; Levick J. R., 1995, Microcirculation (New York), V2, P217, DOI 10.3109/10739689509146768; MEAL GM, 1986, J MANIP PHYSIOL THER, V9, P189; Mierau D, 1988, MANUAL MED, V3, P135; Nordheim Y, 1938, ROFO FORTSCHR RONTG, P57; Protapapas Marina G., 2002, Journal of the American Osteopathic Association, V102, P283; RAMAMURTHY AS, 1979, J FLUID ENG-T ASME, V101, P69, DOI 10.1115/1.3448737; RAMAMURTHY AS, 1991, J FLUID ENG-T ASME, V113, P278, DOI 10.1115/1.2909492; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Reggars J W, 1996, Australas Chiropr Osteopathy, V5, P39; Reggars J W, 1999, Australas Chiropr Osteopathy, V8, P16; ROSTON JB, 1947, J ANAT, V81, P165; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Sandoz R., 1976, ANN SWISS CHIROPR AS, V6, P91; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SWEZEY RL, 1975, WESTERN J MED, V122, P377; TREVENA DH, 1984, J PHYS D APPL PHYS, V17, P2139, DOI 10.1088/0022-3727/17/11/003; UNSWORTH A, 1971, ANN RHEUM DIS, V30, P348, DOI 10.1136/ard.30.4.348; Watson P, 1989, Proc Inst Mech Eng H, V203, P109, DOI 10.1243/PIME_PROC_1989_203_019_01; WATSON P, 1989, CLIN ORTHOP RELAT R, P288; WATSON P, 1990, BRIT J RADIOL, V63, P145, DOI 10.1259/0007-1285-63-746-145; Werner D, 2003, J HAND SURG-AM, V28A, P1044, DOI 10.1016/S0363-5023(03)00425-8; Zeng HB, 2010, MACROMOLECULES, V43, P538, DOI 10.1021/ma901845z	50	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119470	10.1371/journal.pone.0119470	http://dx.doi.org/10.1371/journal.pone.0119470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875374	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800005
J	Khomami, MB; Tehrani, FR; Hashemi, S; Farahmand, M; Azizi, F				Khomami, Mahnaz Bahri; Tehrani, Fahimeh Ramezani; Hashemi, Somayeh; Farahmand, Maryam; Azizi, Fereidoun			Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; HEALTH; PREVALENCE; ASSOCIATION; ADOLESCENTS; POPULATION; CRITERIA	Introduction Polycystic ovary syndrome is a common endocrine disorder affecting women both physically and psychologically and can lead to a poor quality of life compared to their normal counterparts. The aim of the present study was to assess the impact of various clinical features of polycystic ovary syndrome on the health-related quality of life of Iranian women diagnosed with this syndrome. Materials and Methods A total of 796 women diagnosed with polycystic ovary syndrome, aged 15-49 years, completed the questionnaires, interviews, and medical assessments required for this study. A reliable and validated Persian version of the health-related quality of life questionnaire for polycystic ovary syndrome patients was used. Linear regression models were used to assess the association between the symptoms of polycystic ovary syndrome and health-related quality of life. Results The mean age of participants was 28.02 years. 35.4% of the subjects were classified as overweight or obese. Hirsutism, was reported to have the strongest impact on the patients' health-related quality of life, followed in descending order by body mass index, irregular menses and infertility. The relative level of hirsutism was directly proportional to decrease in health-related quality of life score (p<0.001). Conclusions The results of the study found that hirsutism had the strongest impact on the health-related quality of life measures in Iranian women diagnosed with polycystic ovary syndrome. Health care officials need to evaluate in depth the effect of each clinical feature of polycystic ovary syndrome separately and design management strategies, keeping in mind the psychological and physical manifestations.	[Khomami, Mahnaz Bahri; Tehrani, Fahimeh Ramezani; Hashemi, Somayeh; Farahmand, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, 24 Parvaneh,Yaman St,POB 19395-4763, Tehran, Iran.	ramezani@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Tehrani, Fahimeh Ramezani/H-6133-2017; Khomami, Mahnaz Bahri/AAR-4972-2021	Azizi, Fereidoun/0000-0002-6470-2517; Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Khomami, Mahnaz Bahri/0000-0002-5955-1283	Research Institute for Endocrine Sciences [427]	Research Institute for Endocrine Sciences	This study was funded by the Research Institute for Endocrine Sciences (grant number: 427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acmaz G, 2013, SCI WORLD J, DOI 10.1155/2013/851815; Amini L GB, 2011, PAYESH J, V11, P213; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Barnard L, 2007, HUM REPROD, V22, P2279, DOI 10.1093/humrep/dem108; Bazarganipour F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-141; Bazarganipour F, 2012, HUM REPROD, V27, P2729, DOI 10.1093/humrep/des199; Brady C, 2009, DRUG HEALTHC PATIENT, V1, P9; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Clark Charlotte M, 2014, Skinmed, V12, P84; Cronin L, 1998, J CLIN ENDOCR METAB, V83, P1976, DOI 10.1210/jc.83.6.1976; Ekback M, 2009, HEALTH CARE WOMEN IN, V30, P358, DOI 10.1080/07399330902785133; Fauser BCJM, 2012, HUM REPROD, V27, P14, DOI 10.1093/humrep/der396; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hartman EE, 2007, PEDIATRICS, V119, pE374, DOI 10.1542/peds.2006-0212; Hobbs L, 2000, Skin Therapy Lett, V5, P1; Janssen O, 2007, ADROGEN EXCESS DISOR, P343; Jones GL, 2011, JOGNN-J OBST GYN NEO, V40, P577, DOI 10.1111/j.1552-6909.2011.01279.x; Katulski K, 2012, ARCH PERINAT MED, V18, P148; Kumarapeli V, 2008, AM J EPIDEMIOL, V168, P321, DOI 10.1093/aje/kwn137; Kumarapeli VL, 2011, BJOG-INT J OBSTET GY, V118, P319, DOI 10.1111/j.1471-0528.2010.02799.x; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Li YA, 2011, FERTIL STERIL, V96, P452, DOI 10.1016/j.fertnstert.2011.05.072; Lujan ME, 2008, J OBSTET GYNAECOL CA, V30, P671, DOI 10.1016/S1701-2163(16)32915-2; McCook JG, 2005, JOGNN-J OBST GYN NEO, V34, P12, DOI 10.1177/0884217504272945; Merkin SS, 2011, J WOMENS HEALTH, V20, P413, DOI 10.1089/jwh.2010.2303; Moran C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/317241; Musmar S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-47; Pastore LM, 2011, J PSYCHOSOM RES, V71, P270, DOI 10.1016/j.jpsychores.2011.02.005; Qin JZ, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-56; Rayis Duria A, 2010, BMC Res Notes, V3, P327, DOI 10.1186/1756-0500-3-327; Schmid J, 2004, HUM REPROD, V19, P2251, DOI 10.1093/humrep/deh432; Shen WJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003646; Snyder BS, 2006, JOGNN-J OBST GYN NEO, V35, P385, DOI 10.1111/J.1552-6909.2006.00047.x; Spencer James M, 2007, J Drugs Dermatol, V6, P788; Stener-Victorin E, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-131; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-39; Thomson RL, 2010, FERTIL STERIL, V94, P1812, DOI 10.1016/j.fertnstert.2009.11.001; Trent ME, 2002, ARCH PEDIAT ADOL MED, V156, P556, DOI 10.1001/archpedi.156.6.556; Xiang SK, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/173281	42	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123608	10.1371/journal.pone.0123608	http://dx.doi.org/10.1371/journal.pone.0123608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874409	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800108
J	Klein, TA; Kim, HC; Chong, ST; Kim, JA; Lee, SY; Kim, WK; Nunn, PV; Song, JW				Klein, Terry A.; Kim, Heung-Chul; Chong, Sung-Tae; Kim, Jeong-Ah; Lee, Sook-Young; Kim, Won-Keun; Nunn, Peter V.; Song, Jin-Won			Hantaan Virus Surveillance Targeting Small Mammals at Nightmare Range, a High Elevation Military Training Area, Gyeonggi Province, Republic of Korea	PLOS ONE			English	Article							FIRING POINTS 10; HANTAVIRUS INFECTION; ECOLOGICAL SURVEILLANCE; HEMORRHAGIC-FEVER; ETIOLOGIC AGENT; MYODES-REGULUS; PUUMALA VIRUS; MUJU VIRUS; SEOUL; TRANSMISSION	Rodent-borne disease surveillance was conducted at Nightmare Range (NM-R), near the demilitarized zone in northeast Gyeonggi Province, Republic of Korea, to identify hemorrhagic fever with renal syndrome (HFRS) risks for a mountainous high-elevation (500 m) military training site. Monthly surveys were conducted from January 2008-December 2009. A total of 1,720 small mammals were captured belonging to the Orders Rodentia [Families, Sciuridae (1 species) and Muridae (7 species)] and Soricomorpha [Family, Soricidae (1species)]. Apodemus agrarius, the primary reservoir for Hantaan virus (HTNV), accounted for 89.9% (1,546) of all small mammals captured, followed by Myodes regulus (4.0%), Crocidura lasiura (3.9%), Micromys minutus (1.4%), Mus musculus (0.3%), Microtus fortis(0.2%), Apodemus peninsulae (0.2%), Tamias sibiricus (0.1%), and Rattus norvegicus(< 0.1%). Three species were antibody-positive (Ab+) for hantaviruses: A. agrarius (8.2%), M. minutus (4.2%), and C. lasiura (1.5%). HTNV specific RNA was detected in 93/127 Ab+ A. agrarius, while Imjin virus specific RNA was detected in 1/1 Ab+ C. lasiura. Overall, hantavirus Ab+ rates for A. agrariusincreased with weight (age) and were significantly higher among males (10.9%) than females (5.1%) (P<0.0001). High A. agrariusgravid rates during the fall (August-September) were associated with peak numbers of HFRS cases in Korea that followed high gravid rates. From 79 RT-PCR positive A. agrarius, 12 HTNV RNA samples were sequenced and compared phylogenetically based on a 320 nt sequence from the G(C) glycoprotein-encodingM segment. These results demonstrate that the HTNV isolates from NM-R are distinctly separated from HTNV isolated from the People's Republic of China. These studies provide for improved disease risk assessments that identify military activities, rodent HTNV rates, and other factors associated with the transmission of hantaviruses during field training exercises.	[Klein, Terry A.] 65th Med Brigade US Army MEDDAC Korea, Force Hlth Protect & Prevent Med, Unit 15281, APO, AP 96205 USA; [Kim, Heung-Chul; Chong, Sung-Tae; Nunn, Peter V.] 65th Med Brigade, Multifunct Med Battal 168, Med Detachment 5, APO, AP 96205 USA; [Kim, Jeong-Ah; Lee, Sook-Young; Kim, Won-Keun; Song, Jin-Won] Korea Univ, Inst Biomed Sci & Food Safety, Coll Med, Dept Microbiol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Song, JW (corresponding author), Korea Univ, Inst Biomed Sci & Food Safety, Coll Med, Dept Microbiol, 126-1,5-ga Anam Dong, Seoul 136705, South Korea.	jwsong@korea.ac.kr	Song, Jin/HHS-8731-2022		Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD; Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development [UE134020ID]; Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK	Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD; Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development; Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK	Funding for portions of this work was provided by the Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD, the Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development (UE134020ID), and the Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek LJ, 2006, J MED VIROL, V78, P290, DOI 10.1002/jmv.20538; Baek LJ, 2002, J MICROBIOL BIOTECHN, V12, P53; Cho HW, 2002, INTERVIROLOGY, V45, P328, DOI 10.1159/000067925; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hong HK, 1984, THESIS INCHON U, V6, P417; Huggins John W., 1997, P745; KANG S W, 1971, Korean Journal of Zoology, V14, P57; Kim HC, 2011, J VECTOR ECOL, V36, P42, DOI 10.1111/j.1948-7134.2011.00139.x; Kim HC, 2007, MIL MED, V172, P759, DOI 10.7205/MILMED.172.7.759; Klein TA, 2012, VECTOR-BORNE ZOONOT, V12, P674, DOI 10.1089/vbz.2011.0618; Klein TA, 2011, J VECTOR ECOL, V36, P373, DOI 10.1111/j.1948-7134.2011.00178.x; Koichiro T, 2013, MOL BIOL EVOL, V28, P2731; Korean Centers for Disease Control and Prevention (KCDC), DIS WEB STAT SYST DIS WEB STAT SYST; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee HW, 1972, REPT NAT I HLTH KORE, V9, P295; Lee JG, 2014, VIRUSES-BASEL, V6, P1701, DOI 10.3390/v6041701; Mackelprang R, 2001, EMERG INFECT DIS, V7, P480, DOI 10.3201/eid0703.017328; Mills JN, 1995, METHODS TRAPPING SAM, P1; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; O'Guinn ML, 2008, J VECTOR ECOL, V33, P370, DOI 10.3376/1081-1710-33.2.370; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; PON E, 1990, AM J TROP MED HYG, V42, P612, DOI 10.4269/ajtmh.1990.42.612; Sachar DS, 2003, MIL MED, V168, P231, DOI 10.1093/milmed/168.3.231; Sames WJ, 2009, J VECTOR ECOL, V34, P225, DOI [10.1111/j.1948-7134.2009.00030.x, 10.3376/038.034.0208]; Song JW, 2009, EMERG INFECT DIS, V15, P1833, DOI 10.3201/eid1511.090076; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Song JS, 1971, REPT NAT I HLTH KORE, V8, P117; Song JW, 2000, VIRUS GENES, V21, P227, DOI 10.1023/A:1008199800011; Song JW, 1998, J KOREAN SOC VIROL, V28, P287; Song KJ, 2007, J GEN VIROL, V88, P3121, DOI 10.1099/vir.0.83139-0; USFK Reg 40-1, 2000, PREV SURV TREATM HEM; XIAO SY, 1992, J GEN VIROL, V73, P567; XIAO SY, 1994, VIROLOGY, V198, P205, DOI 10.1006/viro.1994.1023	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0118483	10.1371/journal.pone.0118483	http://dx.doi.org/10.1371/journal.pone.0118483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874643	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800002
J	Scheinpflug, K; Krylova, O; Nikolenko, H; Thurm, C; Dathe, M				Scheinpflug, Kathi; Krylova, Oxana; Nikolenko, Heike; Thurm, Charley; Dathe, Margitta			Evidence for a Novel Mechanism of Antimicrobial Action of a Cyclic R-,W-Rich Hexapeptide	PLOS ONE			English	Article							ESCHERICHIA-COLI MEMBRANES; HOST-DEFENSE PEPTIDES; ANIONIC PHOSPHOLIPIDS; TITRATION CALORIMETRY; BACTERIAL-MEMBRANES; BACILLUS-SUBTILIS; ACRIDINE-ORANGE; LIPID DOMAINS; ARGININE-RICH; BUFORIN-II	The development of antimicrobial peptides as new class of antibiotic agents requires structural characterisation and understanding of their diverse mechanisms of action. As the cyclic hexapeptide cWFW(cyclo(RRRWFW)) does not exert its rapid cell killing activity by membrane permeabilisation, in this study we investigated alternative mechanisms of action, such as peptide translocation into the cytoplasm and peptide interaction with components of the phospholipid matrix of the bacterial membrane. Using fluorescence microscopy and an HPLC-based strategy to analyse peptide uptake into the cells we could confirm the cytoplasmic membrane as the major peptide target. However, unexpectedly we observed accumulation of cWFW at distinct sites of the membrane. Further characterisation of peptide-membrane interaction involved live cell imaging to visualise the distribution of the lipid cardiolipin (CL) and isothermal titration calorimetry to determine the binding affinity to model membranes with different bacterial lipid compositions. Our results demonstrate a distribution of the cyclic peptide similar to that of cardiolipin within the membrane and highly preferred affinity of cWFW for CL-rich phosphatidylethanolamine (POPE) matrices. These observations point to a novel mechanism of antimicrobial killing for the cyclic hexapeptide cWFW which is neither based on membrane permeabilisation nor translocation into the cytoplasm but rather on preferred partitioning into particular lipid domains. As the phospholipids POPE/CL play a key role in the dynamic organisation of bacterial membranes we discuss the consequences of this peptide-lipid-interaction and outline the impact on antimicrobial peptide research.	[Scheinpflug, Kathi; Krylova, Oxana; Nikolenko, Heike; Thurm, Charley; Dathe, Margitta] Leibniz Inst Mol Pharmakol FMP, Dept Biol Chem, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Dathe, M (corresponding author), Leibniz Inst Mol Pharmakol FMP, Dept Biol Chem, Berlin, Germany.	dathe@fmp-berlin.de						Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Appelt C, 2008, J PEPT SCI, V14, P524, DOI 10.1002/psc.924; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Bagheri M, 2011, ANTIMICROB AGENTS CH, V55, P788, DOI 10.1128/AAC.01098-10; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bishop RE, 2014, J BACTERIOL, V196, P3209, DOI 10.1128/JB.02043-14; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fleming E, 2008, PROTEINS, V73, P480, DOI 10.1002/prot.22074; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; OEHLKE J, 1994, EUR J PHARM SCI, V2, P365, DOI 10.1016/0928-0987(94)00063-8; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Scheinpflug K, 2013, PHARMACEUTICALS, V6, P1130, DOI 10.3390/ph6091130; SCHUHMANN E, 1969, Z ALLG MIKROBIOL, V9, P297, DOI 10.1002/jobm.3630090407; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Uyterhoeven ET, 2008, FEBS LETT, V582, P1715, DOI 10.1016/j.febslet.2008.04.036; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; Wang JP, 2014, BBA-BIOMEMBRANES, V1838, P2870, DOI 10.1016/j.bbamem.2014.07.002; Wang Q, 2010, J PHYS CHEM B, V114, P13726, DOI 10.1021/jp1069362; Wessolowski A, 2004, J PEPT RES, V64, P159, DOI 10.1111/j.1399-3011.2004.00182.x; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yaroslavov AA, 2007, LANGMUIR, V23, P7539, DOI 10.1021/la700637d; Zhang TH, 2014, J BIOL CHEM, V289, P11584, DOI 10.1074/jbc.M114.554444; Zweytick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090228	56	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125056	10.1371/journal.pone.0125056	http://dx.doi.org/10.1371/journal.pone.0125056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875357	Green Submitted, gold, Green Published			2022-12-27	WOS:000353015800155
J	Stewart, R; Hardy, R; Richards, M				Stewart, Robert; Hardy, Rebecca; Richards, Marcus			Associations between Skeletal Growth in Childhood and Cognitive Function in Mid-Life in a 53-Year Prospective Birth Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEAD CIRCUMFERENCE; EARLY-LIFE; LEG LENGTH; HEIGHT; RISK; DEMENTIA; ABILITY; ENVIRONMENT; EDUCATION	Background Several studies have found that shorter stature (height and limb length) in late life is associated with dementia and cognitive impairment. The extent to which childhood environment and early life cognitive function accounts for these associations is not clear. Methods We investigated associations of adult trunk height and leg length with cognitive function in middle age, analysing data from the MRC National Survey of Health and Development: a cohort followed from birth to age 53, 1677 of whom had data on all covariates. The four cognitive tests measured verbal ability, word list memory, verbal fluency and speed/concentration. Early life environmental measures included parental education, poverty, parental divorce, physical health, cognitive ability at age 15, own education and own adult social class. Results After adjusting for gender, shorter trunk length was associated with lower cognitive function on all four tests and shorter leg length with lower verbal intelligence and word list memory. These associations were only partially attenuated following adjustment for childhood adversity/health but were substantially accounted for by cognitive ability at age 15. Conclusions Shorter stature was associated with lower cognitive function at age 53, the majority of this association being accounted for by cognitive function at age 15. Reduced cognitive reserve may well account for later associations between anthropometric measures and dementia.	[Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Hardy, Rebecca; Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London, England; [Hardy, Rebecca; Richards, Marcus] MRC Natl Survey Hlth & Dev, London, England	University of London; King's College London	Stewart, R (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	r.stewart@iop.kcl.ac.uk	Stewart, Robert/B-1667-2010; Hardy, Rebecca/AFR-1989-2022	Stewart, Robert/0000-0002-4435-6397; Richards, Marcus/0000-0001-9191-2192; Hardy, Rebecca/0000-0001-9949-0799	National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; King's College London; UK Medical Research Council; MRC [MC_UU_12019/3] Funding Source: UKRI; Medical Research Council [MC_UU_12019/3] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. Funding to MR and RH is provided by the UK Medical Research Council. No specific funding was obtained for the analysis presented here and no funding agency had input into its design or execution.	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; [Anonymous], 1970, CLASS OCC; Beeri MS, 2005, AM J GERIAT PSYCHIAT, V13, P116, DOI 10.1097/00019442-200502000-00005; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; Department of Education and Science, 1972, BURNH FURTH ED COMM; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; Gunnell D, 2002, INT J EPIDEMIOL, V31, P390, DOI 10.1093/ije/31.2.390; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Jeong SK, 2005, INT J GERIATR PSYCH, V20, P406, DOI 10.1002/gps.1295; Kim JM, 2008, INT J GERIATR PSYCH, V23, P41, DOI 10.1002/gps.1833; Kim JM, 2003, J NEUROL NEUROSUR PS, V74, P427, DOI 10.1136/jnnp.74.4.427; Mak Z, 2006, INT J GERIATR PSYCH, V21, P266, DOI 10.1002/gps.1458; McGurn B, 2008, NEUROLOGY, V71, P1051, DOI 10.1212/01.wnl.0000319692.20283.10; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Moceri VM, 2001, EPIDEMIOLOGY, V12, P383, DOI 10.1097/00001648-200107000-00007; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; MORTIMER JA, 1993, NEUROLOGY, V43, pS39; Nelson H., 1991, NATL ADULT READING T; Petot GJ, 2007, J ALZHEIMERS DIS, V11, P337; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; SCHOFIELD PW, 1995, ARCH NEUROL-CHICAGO, V52, P95, DOI 10.1001/archneur.1995.00540250103019; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Yano K, 2000, J AM GERIATR SOC, V48, P199, DOI 10.1111/j.1532-5415.2000.tb03912.x; Yliharsila H, 2003, HYPERTENSION, V41, P446, DOI 10.1161/01.HYP.0000055780.21222.96	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124163	10.1371/journal.pone.0124163	http://dx.doi.org/10.1371/journal.pone.0124163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875444	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800133
J	Yin, J; Liu, MF; Ren, WK; Duan, JL; Yang, G; Zhao, YR; Fang, RJ; Chen, LX; Li, TJ; Yin, YL				Yin, Jie; Liu, Mingfeng; Ren, Wenkai; Duan, Jielin; Yang, Guan; Zhao, Yurong; Fang, Rejun; Chen, Lixiang; Li, Tiejun; Yin, Yulong			Effects of Dietary Supplementation with Glutamate and Aspartate on Diquat-Induced Oxidative Stress in Piglets	PLOS ONE			English	Article							GROWTH-PERFORMANCE; INDUCED LIVER; AMINO-ACIDS; EXPRESSION; METABOLISM; SYSTEM	This study aimed to investigate the protective effects of dietary glutamate and aspartate supplementations on diquat-induced oxidative stress in piglets. Diquat injection significantly reduced growth performance, including body weight, average daily weight gain, and feed intake (P<0.05). Meanwhile, diquat administration induced oxidative stress evidenced by the decreased serum nitric oxide (NO) and elevated malondialdeyhde (MDA) concentration (P<0.05). Furthermore, diquat-induced oxidative stress disrupted intestinal absorption system and decreased serum threonine, serine, and glycine levels. Dietary supplementation with glutamate improved final body weight, antioxidant system, and expressions of amino acids transporters and enhanced serum glutamate concentration compared with diquat group (P<0.05). While aspartate failed to alleviate diquat-induced oxidative stress, growth depression, and dysfunction of nutrients absorption except for liver relative weight. In conclusion, dietary supplementation with glutamate confers beneficial effects on diquat-induced oxidative stress in piglets, while aspartate exhibits little effects.	[Yin, Jie; Ren, Wenkai; Duan, Jielin; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock, Minist Agr,Key Lab Agroecol Proc Subtrop Reg,Inst, Changsha 410125, Hunan, Peoples R China; [Yin, Jie; Ren, Wenkai; Duan, Jielin] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Liu, Mingfeng; Zhao, Yurong; Fang, Rejun; Chen, Lixiang] Univ Hunan Agr, Dept Anim Sci, Changsha 410128, Hunan, Peoples R China; [Yang, Guan] Univ Florida, Dept Anim Sci, Gainesville, FL 32610 USA; [Yin, Yulong] Southwest Collaborat Innovat Ctr Swine Qual & Saf, Chengdu, Peoples R China	Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University System of Florida; University of Florida	Li, TJ (corresponding author), Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock, Minist Agr,Key Lab Agroecol Proc Subtrop Reg,Inst, Changsha 410125, Hunan, Peoples R China.	tjli@isa.ac.cn; yinyulong@isa.ac.cn	YIN, Jie/H-3578-2019	YIN, Jie/0000-0003-1852-1042; YANG, Guan/0000-0002-2131-8435	National Natural Science Foundation of China [31330075, 31110103909, 31101729, 31402088, 31201813, 31272463]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 2013RS4065, 12JJ2020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The present work was supported by grants from the National Natural Science Foundation of China (Nos. 31330075, 31110103909, 31101729, 31402088, 31201813, and 31272463) and the Hunan Provincial Natural Science Foundation of China (Nos. 12JJ2014, 2013RS4065, and 12JJ2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrin DG, 2009, AM J CLIN NUTR, V90, p850S, DOI 10.3945/ajcn.2009.27462Y; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Deng Y, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/534705; Duan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112357; Enomoto A, 2012, FREE RADICAL BIO MED, V52, P507, DOI 10.1016/j.freeradbiomed.2011.11.006; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; JOHNSON JL, 1972, BRAIN RES, V37, P1, DOI 10.1016/0006-8993(72)90343-5; LEFLOCH N, 1994, J NUTR, V124, P1987, DOI 10.1093/jn/124.10.1987; Li LL, 2007, ASIAN AUSTRAL J ANIM, V20, P761, DOI 10.5713/ajas.2007.761; Liang Y, 2014, J IMMUNOL, V192, P1277, DOI 10.4049/jimmunol.1203428; Libao-Mercado AJ, 2006, J ANIM SCI, V84, P1351, DOI 10.2527/2006.8461351x; Lu T, 2010, FOOD CHEM TOXICOL, V48, P764, DOI 10.1016/j.fct.2009.12.018; Lv M, 2012, ANIMAL, V6, P928, DOI 10.1017/S1751731111002382; Pi DA, 2014, J NUTR BIOCHEM, V25, P456, DOI 10.1016/j.jnutbio.2013.12.006; Qiang M, 2014, PROTEIN CELL, V5, P484, DOI 10.1007/s13238-014-0052-1; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rogers LK, 2006, TOXICOL APPL PHARM, V217, P289, DOI 10.1016/j.taap.2006.08.012; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Senthilkumar R, 2004, PHARMAZIE, V59, P55; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Watford M, 2008, J NUTR, V138, p2003S, DOI 10.1093/jn/138.10.2003S; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Wu KC, 2012, FREE RADICAL RES, V46, P1220, DOI 10.3109/10715762.2012.700709; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Wu X, 2012, J ANIM SCI, V90, P337, DOI 10.2527/jas.53752; Wu X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-63; Xin W, 2013, BIOL TRACE ELEM RES, V153, P191, DOI 10.1007/s12011-013-9668-x; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2013, FREE RADICAL RES, V47, P643, DOI 10.3109/10715762.2013.812206; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zoerner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064792	38	120	136	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122893	10.1371/journal.pone.0122893	http://dx.doi.org/10.1371/journal.pone.0122893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875335	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800081
J	Li, J; Li, R; You, LM; Xu, AL; Fu, YG; Huang, SF				Li, Jie; Li, Rui; You, Leiming; Xu, Anlong; Fu, Yonggui; Huang, Shengfeng			Evaluation of Two Statistical Methods Provides Insights into the Complex Patterns of Alternative Polyadenylation Site Switching	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; ZEBRAFISH DEVELOPMENT; CLEAVAGE; CANCER; CELLS; MICRORNAS; LANDSCAPE; STABILITY; SELECTION	Switching between different alternative polyadenylation (APA) sites plays an important role in the fine tuning of gene expression. New technologies for the execution of 3'-end enriched RNA-seq allow genome-wide detection of the genes that exhibit significant APA site switching between different samples. Here, we show that the independence test gives better results than the linear trend test in detecting APA site-switching events. Further examination suggests that the discrepancy between these two statistical methods arises from complex APA site-switching events that cannot be represented by a simple change of average 3'-UTR length. In theory, the linear trend test is only effective in detecting these simple changes. We classify the switching events into four switching patterns: two simple patterns (3'-UTR shortening and lengthening) and two complex patterns. By comparing the results of the two statistical methods, we show that complex patterns account for 1/4 of all observed switching events that happen between normal and cancerous human breast cell lines. Because simple and complex switching patterns may convey different biological meanings, they merit separate study. We therefore propose to combine both the independence test and the linear trend test in practice. First, the independence test should be used to detect APA site switching; second, the linear trend test should be invoked to identify simple switching events; and third, those complex switching events that pass independence testing but fail linear trend testing can be identified.	[Li, Jie; Li, Rui; You, Leiming; Xu, Anlong; Fu, Yonggui; Huang, Shengfeng] Sun Yat Sen Univ, Coll Life Sci, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Beijing, Peoples R China	Sun Yat Sen University; Beijing University of Chinese Medicine	Xu, AL (corresponding author), Sun Yat Sen Univ, Coll Life Sci, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn; hshengf2@mail.sysu.edu.cn	Li, Jie/N-5859-2015	Li, Jie/0000-0002-8328-3274; Xu, Anlong/0000-0002-1419-3494; Fu, Yonggui/0000-0001-6469-3430; Huang, Shengfeng/0000-0002-0968-1370; You, Leiming/0000-0002-8120-8916	National Natural Science Foundation of China [31171193]; National Basic Research Program of China (973 Program) [2013CB917800, 2013CB835300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the project (No. 31171193) of the National Natural Science Foundation of China (to SH) and the National Basic Research Program of China (973 Program; No. 2013CB917800 and 2013CB835300) (to AX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEVY JR, 1992, J BIOL CHEM, V267, P25289; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Lopez F, 2006, RNA, V12, P1794, DOI 10.1261/rna.136206; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Sachs A, 1990, CURR OPIN CELL BIOL, V2, P1092, DOI 10.1016/0955-0674(90)90161-7; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Sun Y, 2012, J MOL CELL BIOL, V4, P352, DOI 10.1093/jmcb/mjs041; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2014, BIOINFORMATICS, V30, P2162, DOI 10.1093/bioinformatics/btu189; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, P6370, DOI 10.1093/nar/gkt364; You LM, 2015, NUCLEIC ACIDS RES, V43, pD59, DOI 10.1093/nar/gku1076	35	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124324	10.1371/journal.pone.0124324	http://dx.doi.org/10.1371/journal.pone.0124324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875641	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700067
J	Yang, LR; Xie, LH; Xue, BG; Goodwin, PH; Quan, X; Zheng, CL; Liu, TG; Lei, ZS; Yang, XJ; Chao, Y; Wu, C				Yang, Lirong; Xie, Lihua; Xue, Baoguo; Goodwin, Paul H.; Quan, Xin; Zheng, Chuanlin; Liu, Taiguo; Lei, Zhensheng; Yang, Xiaojie; Chao, Yueen; Wu, Chao			Comparative Transcriptome Profiling of the Early Infection of Wheat Roots by Gaeumannomyces graminis var. tritici	PLOS ONE			English	Article							CELL-WALL; TAKE-ALL; GENE-EXPRESSION; ABC TRANSPORTERS; PROTEIN-KINASES; CA2+ TOLERANCE; RICE PATHOGEN; VIRULENCE; LACCASE; DISEASE	Take-all, which is caused by the fungal pathogen, Gaeumannomyces graminis var. tritici (Ggt), is an important soil-borne root rot disease of wheat occurring worldwide. However, the genetic basis of Ggt pathogenicity remains unclear. In this study, transcriptome sequencing for Ggt in axenic culture and Ggt-infected wheat roots was performed using Illumina paired-end sequencing. Approximately 2.62 and 7.76 Gb of clean reads were obtained, and 87% and 63% of the total reads were mapped to the Ggt genome for RNA extracted from Ggt in culture and infected roots, respectively. A total of 3,258 differentially expressed genes (DEGs) were identified with 2,107 (65%) being 2-fold up-regulated and 1,151 (35%) being 2-fold down-regulated between Ggt in culture and Ggt in infected wheat roots. Annotation of these DEGs revealed that many were associated with possible Ggt pathogenicity factors, such as genes for guanine nucleotide-binding protein alpha-2 subunit, cellulase, pectinase, xylanase, glucosidase, aspartic protease and gentisate 1, 2-dioxygenase. Twelve DEGs were analyzed for expression by qRT-PCR, and could be generally divided into those with high expression only early in infection, only late in infection and those that gradually increasing expression over time as root rot developed. This indicates that these possible pathogenicity factors may play roles during different stages of the interaction, such as signaling, plant cell wall degradation and responses to plant defense compounds. This is the first study to compare the transcriptomes of Ggt growing saprophytically in axenic cultures to it growing parasitically in infected wheat roots. As a result, new candidate pathogenicity factors have been identified, which can be further examined by gene knock-outs and other methods to assess their true role in the ability of Ggt to infect roots.	[Yang, Lirong; Xie, Lihua; Xue, Baoguo; Quan, Xin; Wu, Chao] Henan Acad Agr Sci, Plant Protect Res Inst, Henan Key Lab Control Crop Dis & Insect Pests, IPM Key Lab Southern Part North China,Minist Agr, Zhengzhou, Peoples R China; [Goodwin, Paul H.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Zheng, Chuanlin; Liu, Taiguo] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Lei, Zhensheng; Chao, Yueen] Henan Acad Agr Sci, Res Ctr Wheat, Zhengzhou, Peoples R China; [Yang, Xiaojie] Henan Acad Agr Sci, Econ Crop Res Inst, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; University of Guelph; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences	Xue, BG (corresponding author), Henan Acad Agr Sci, Plant Protect Res Inst, Henan Key Lab Control Crop Dis & Insect Pests, IPM Key Lab Southern Part North China,Minist Agr, Zhengzhou, Peoples R China.	xue@hnaa.org	Liu, Taiguo/EYP-0651-2022; Liu, Tai Guo/GYD-3049-2022	Liu, Tai Guo/0000-0001-7466-1811	National Natural Science Foundation of China [31401815]; Ministry of Science and Technology, "The 12th Five-Year Plan" National Technology Project in Rural Areas [2012BAD19B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, "The 12th Five-Year Plan" National Technology Project in Rural Areas	This work was supported by grants from the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, (No.31401815) to YLR and Ministry of Science and Technology, http://www.most.gov.cn/, "The 12th Five-Year Plan" National Technology Project in Rural Areas (Grant No. 2012BAD19B04) to XBG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Askew C, 2011, MOL MICROBIOL, V79, P940, DOI 10.1111/j.1365-2958.2010.07504.x; Babaeipoor E, 2011, AFR J MICROBIOL RES, V5, P5165, DOI 10.5897/AJMR11.789; Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; BOURBONNAIS R, 1990, FEBS LETT, V267, P99, DOI 10.1016/0014-5793(90)80298-W; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Cook RJ, 2003, PHYSIOL MOL PLANT P, V62, P73, DOI 10.1016/S0885-5765(03)00042-0; Daval S, 2011, MOL PLANT PATHOL, V12, P839, DOI [10.1111/J.1364-3703.2011.00715.X, 10.1111/j.1364-3703.2011.00715.x]; de Wouw APV, 2011, MOL PLANT PATHOL, V12, P507, DOI 10.1111/j.1364-3703.2010.00680.x; deWaard MA, 1997, PESTIC SCI, V51, P271, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;271::AID-PS642&gt;3.0.CO;2-#; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; DORI S, 1995, PHYSIOL MOL PLANT P, V46, P189, DOI 10.1006/pmpp.1995.1015; Edens WA, 1999, APPL ENVIRON MICROB, V65, P3071; Gosme M, 2013, ANN APPL BIOL, V163, P359, DOI 10.1111/aab.12060; Guilleroux M, 2004, MOL PLANT PATHOL, V5, P203, DOI 10.1111/J.1364-3703.2004.00219.X; Gutteridge RJ, 2003, PEST MANAG SCI, V59, P215, DOI 10.1002/ps.574; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang Z, 2000, Z PFLANZENK PFLANZEN, V107, P337; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kmetzsch L, 2013, FEBS J, V280, P4853, DOI 10.1111/febs.12458; Kmetzsch L, 2010, EUKARYOT CELL, V9, P1798, DOI 10.1128/EC.00114-10; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kramer B, 2009, FUNGAL GENET BIOL, V46, P667, DOI 10.1016/j.fgb.2009.06.001; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li W, 2014, CURR GENET, V5, pe1432; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDQVIST T, 1994, STRUCTURE, V2, P937, DOI 10.1016/S0969-2126(94)00095-6; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIEMEYER HM, 1992, HEREDITAS, V116, P295, DOI 10.1111/j.1601-5223.1992.tb00158.x; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; PEARSON V, 1974, T BRIT MYCOL SOC, V63, P199, DOI 10.1016/S0007-1536(74)80157-9; Pinchai N, 2010, EUKARYOT CELL, V9, P472, DOI 10.1128/EC.00378-09; [全鑫 Quan Xin], 2014, [植物病理学报, Acta Phytopathologica Sinica], V44, P139; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schalchli H, 2012, J SOIL SCI PLANT NUT, V12, P329, DOI 10.4067/S0718-95162012000200012; Schoonbeek HJ, 2002, MOL PLANT MICROBE IN, V15, P1165, DOI 10.1094/MPMI.2002.15.11.1165; Stephenson SA, 2005, MICROBIOL RES, V160, P389, DOI 10.1016/j.micres.2005.03.003; Sun J., 2010, J HENAN AGR SCI, V5, P134; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; URBANEK H, 1984, PHYTOPATHOL Z, V110, P261; Valette-Collet O, 2003, MOL PLANT MICROBE IN, V16, P360, DOI 10.1094/MPMI.2003.16.4.360; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Weste G, 1970, J PHYTOPATHOL, V67, P189; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yang LR, 2012, P ANN M CHIN SOC PLA, P555; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu YT, 2010, J PHYTOPATHOL, V158, P344, DOI 10.1111/j.1439-0434.2009.01614.x; Zhang HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017241; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	67	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120691	10.1371/journal.pone.0120691	http://dx.doi.org/10.1371/journal.pone.0120691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875107	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700005
J	Ahn, J; Shin, S; Suh, Y; Park, JY; Hwang, S; Lee, K				Ahn, Jinsoo; Shin, Sangsu; Suh, Yeunsu; Park, Ju Yeon; Hwang, Seongsoo; Lee, Kichoon			Identification of the Avian RBP7 Gene as a New Adipose-Specific Gene and RBP7 Promoter-Driven GFP Expression in Adipose Tissue of Transgenic Quail	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; TRIGLYCERIDE LIPASE; NUTRITIONAL REGULATION; CLONING; FAT; METABOLISM; ENHANCER; ACID	The discovery of an increasing number of new adipose-specific genes has significantly contributed to our understanding of adipose tissue biology and the etiology of obesity and its related diseases. In the present study, comparison of gene expression profiles among various tissues was performed by analysis of chicken microarray data, leading to identification of RBP7 as a novel adipose-specific gene in chicken. Adipose-specific expression of RBP7 in the avian species was further confirmed at the protein and mRNA levels. Examination of the transcription factor binding sites within the chicken RBP7 promoter by Matinspector software revealed potential binding sites for adipogenic transcription factors. This led to the hypothesis that the RBP7 promoter can be utilized to overexpress a transgene in adipose tissue in order to further investigate the function of a transgene in adipose tissue. Several lines of transgenic quail containing a green fluorescent protein (GFP) gene under the control of the RBP7 promoter were generated using lentivirus-mediated gene transfer. The GFP expression in transgenic quail was specific to adipose tissue and increased after adipocyte differentiation. This expression pattern was consistent with endogenous RBP7 expression, suggesting the RBP7 promoter is sufficient to overexpress a gene of interest in adipose tissue at later developmental stages. These findings will lead to the establishment of a novel RBP7 promoter cassette which can be utilized for overexpressing genes of interest in adipose tissue in vivo to study the function of genes in adipose tissue development and lipid metabolism.	[Ahn, Jinsoo; Shin, Sangsu; Suh, Yeunsu; Hwang, Seongsoo; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Ahn, Jinsoo; Lee, Kichoon] Ohio State Univ, Interdisciplinary PhD Program Nutr, Columbus, OH 43210 USA; [Shin, Sangsu] Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang, Gyeongnam, South Korea; [Park, Ju Yeon] Ohio State Univ, Dept Biol Sci, Columbus, OH 43210 USA; [Hwang, Seongsoo] Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, Gyeonggi, South Korea	Ohio State University; Ohio State University; Pusan National University; Ohio State University; National Institute of Animal Science, Republic of Korea	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu			Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2010-65206-20716]; National Research Foundation of Korea Agenda Program [PJ009457]; SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants at The Ohio State University [2014090, 2013-044]	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; National Research Foundation of Korea Agenda Program(National Research Foundation of Korea); SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants at The Ohio State University	This work was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture to KL (http://www.csrees.usda.gov/fo/funding.cfm), the National Research Foundation of Korea Agenda Program no. PJ009457 to KL (http://www.nrf.re.kr/nrf_eng_cms), and by SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants Program no. 2014090 and 2013-044 at The Ohio State University to JA and KL (http://oardc.osu.edu/seeds/t08_pageview/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lee K, 2009, POULTRY SCI, V88, P620, DOI 10.3382/ps.2008-00265; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li X, 2012, J ANIM SCI, V90, P4346, DOI 10.2527/jas.2012-5151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Oh SA, 2011, J ANIM SCI, V89, P367, DOI 10.2527/jas.2010-3339; Piantedosi R, 2005, J BIOL CHEM, V280, P24286, DOI 10.1074/jbc.M503906200; Poynter Greg, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.emo112; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Sato Y, 2013, DEV GROWTH DIFFER, V55, P406, DOI 10.1111/dgd.12058; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Serr J, 2009, POULTRY SCI, V88, P2585, DOI 10.3382/ps.2009-00265; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Shin SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100905; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064483; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Yang SJ, 2013, LIPIDS, V48, P13, DOI 10.1007/s11745-012-3742-6; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	31	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124768	10.1371/journal.pone.0124768	http://dx.doi.org/10.1371/journal.pone.0124768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867079	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100271
J	Eguiluz, VM; Masuda, N; Fernandez-Gracia, J				Eguiluz, Vctor M.; Masuda, Naoki; Fernandez-Gracia, Juan			Bayesian Decision Making in Human Collectives with Binary Choices	PLOS ONE			English	Article							OPINION DYNAMICS; MODEL; WISDOM; CROWD	Here we focus on the description of the mechanisms behind the process of information aggregation and decision making, a basic step to understand emergent phenomena in society, such as trends, information spreading or the wisdom of crowds. In many situations, agents choose between discrete options. We analyze experimental data on binary opinion choices in humans. The data consists of two separate experiments in which humans answer questions with a binary response, where one is correct and the other is incorrect. The questions are answered without and with information on the answers of some previous participants. We find that a Bayesian approach captures the probability of choosing one of the answers. The influence of peers is uncorrelated with the difficulty of the question. The data is inconsistent with Weber's law, which states that the probability of choosing an option depends on the proportion of previous answers choosing that option and not on the total number of those answers. Last, the present Bayesian model fits reasonably well to the data as compared to some other previously proposed functions although the latter sometime perform slightly better than the Bayesian model. The asset of the present model is the simplicity and mechanistic explanation of the behavior.	[Eguiluz, Vctor M.; Fernandez-Gracia, Juan] UIB, CSIC, IFISC, E-07122 Palma de Mallorca, Spain; [Masuda, Naoki] Univ Bristol, Dept Engn Math, Bristol BS8 1UB, Avon, England; [Fernandez-Gracia, Juan] UIB, CSIC, IMEDEA, E-07190 Esporles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Eguiluz, VM (corresponding author), UIB, CSIC, IFISC, E-07122 Palma de Mallorca, Spain.	victor@ifisc.uib-csic.es	Fernández-Gracia, Juan/S-4344-2018; Eguíluz, Víctor M./B-9655-2008	Fernández-Gracia, Juan/0000-0001-9728-7666; Eguíluz, Víctor M./0000-0003-1133-1289; Masuda, Naoki/0000-0003-1567-801X	Ministerio de Economia y Competitividad (Spain) [FIS2011-24785]; FEDER (EU); CREST; Japan Science and Technology Agency; CREST program	Ministerio de Economia y Competitividad (Spain); FEDER (EU)(European Commission); CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); CREST program(Core Research for Evolutional Science and Technology (CREST))	Project (FIS2011-24785) from the Ministerio de Economia y Competitividad (Spain) and FEDER (EU) supprted VME and JFG. CREST, Japan Science and Technology Agency and CREST program supported NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, DYN GAMES APPL, V1, P3, DOI 10.1007/s13235-010-0004-1; Andreoni J, 2012, AM ECON J-MICROECON, V4, P209, DOI 10.1257/mic.4.1.209; Arganda S, 2012, P NATL ACAD SCI USA, V109, P20508, DOI 10.1073/pnas.1210664109; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Binmore K, 2008, RATIONAL DECISIONS; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Helbing D, 2010, P NATL ACAD SCI USA, V107, P5265, DOI 10.1073/pnas.1000140107; Johnson DDP, 2013, TRENDS ECOL EVOL, V28, P474, DOI 10.1016/j.tree.2013.05.014; Kahneman D., 1982, JUDGMENT UNCERTAINTY, P32, DOI [DOI 10.1017/CBO9780511809477.004, DOI 10.1017/CB09780511809477.007]; King AJ, 2012, BIOL LETTERS, V8, P197, DOI 10.1098/rsbl.2011.0795; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Marshall HH, 2013, J ANIM ECOL, V82, P894, DOI 10.1111/1365-2656.12089; Marshall JAR, 2013, TRENDS ECOL EVOL, V28, P469, DOI 10.1016/j.tree.2013.05.013; Martins ACR, 2008, INT J MOD PHYS C, V19, P617, DOI 10.1142/S0129183108012339; Martins ACR, 2009, PHYSICA A, V388, P3225, DOI 10.1016/j.physa.2009.04.007; Mckay R, 2010, EVOL HUM BEHAV, V31, P309, DOI 10.1016/j.evolhumbehav.2010.04.005; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; MILGRAM S, 1969, J PERS SOC PSYCHOL, V13, P79, DOI 10.1037/h0028070; Mori S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.084004; Mori S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026109; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Nishi R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062123; Orlean A, 1995, J ECON BEHAV ORGAN, V28, P257, DOI 10.1016/0167-2681(95)00035-6; Perez-Escudero A, 2013, P NATL ACAD SCI USA, V110, pE3466, DOI 10.1073/pnas.1309867110; Perez-Escudero A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002282; Perna A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002592; Surowiecki J., 2005, WISDOM CROWDS; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Trimmer PC, 2011, ANIM COGN, V14, P465, DOI 10.1007/s10071-011-0387-4; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	42	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121332	10.1371/journal.pone.0121332	http://dx.doi.org/10.1371/journal.pone.0121332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25867176	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100039
J	Enwerem, II; Wu, GW; Yu, YT; Hebert, MD				Enwerem, Isioma I.; Wu, Guowei; Yu, Yi Tao; Hebert, Michael D.			Cajal Body Proteins Differentially Affect the Processing of Box C/D scaRNPs	PLOS ONE			English	Article							MUSCULAR-ATROPHY PROTEIN; SNRNP BIOGENESIS; GENE-PRODUCT; SMN COMPLEX; HELA-CELLS; GUIDE RNAS; IN-VIVO; COILIN; BODIES; LOCALIZATION	Small nuclear ribonucleoproteins (snRNPs), which are required for pre-mRNA splicing, contain extensively modified snRNA. Small Cajal body-specific ribonucleoproteins (scaRNPs) mediate these modifications. It is unknown how the box C/D class of scaRNPs localizes to Cajal Bodies (CBs). The processing of box C/D scaRNA is also unclear. Here, we explore the processing of box C/D scaRNA 2 and 9 by coilin. We also broaden our investigation to include WRAP53 and SMN, which accumulate in CBs, play a role in RNP biogenesis and associate with coilin. These studies demonstrate that the processing of an ectopically expressed scaRNA2 is altered upon the reduction of coilin, WRAP53 or SMN, but the extent and direction of this change varies depending on the protein reduced. We also show that box C/D scaRNP activity is reduced in a cell line derived from coilin knockout mice. Collectively, the findings presented here further implicate coilin as being a direct participant in the formation of box C/D scaRNPs, and demonstrate that WRAP53 and SMN may also play a role, but the activity of these proteins is divergent to coilin.	[Enwerem, Isioma I.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Wu, Guowei; Yu, Yi Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Mississippi; University of Mississippi Medical Center; University of Rochester	Hebert, MD (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu			University of Mississippi Medical Center; National Institute of General Medical Sciences of the National Institutes of Health [R01GM081448, R01GM104077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448, R01GM104077] Funding Source: NIH RePORTER	University of Mississippi Medical Center; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Intramural Research Support Program of the University of Mississippi Medical Center supported this work. This work was also supported by The National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM081448 (MDH) and award number R01GM104077 (YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2013, BIOL OPEN, V2, P407, DOI 10.1242/bio.20133863; Broome HJ, 2013, J MOL BIOL, V425, P713, DOI 10.1016/j.jmb.2012.12.014; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Coady TH, 2011, WIRES RNA, V2, P546, DOI 10.1002/wrna.76; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Enwerem II, 2014, BIOL OPEN, V3, P240, DOI 10.1242/bio.20147443; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gerard MA, 2010, NUCLEIC ACIDS RES, V38, P370, DOI 10.1093/nar/gkp988; Girard C, 2006, NUCLEIC ACIDS RES, V34, P2925, DOI 10.1093/nar/gkl374; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Huang C, 2010, MOL CELL BIOL, V30, P4368, DOI 10.1128/MCB.00384-10; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kishore S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r45; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Machyna M, 2014, MOL CELL, V56, P389, DOI 10.1016/j.molcel.2014.10.004; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Marnef A, 2014, NUCLEIC ACIDS RES, V42, P6616, DOI 10.1093/nar/gku287; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; SPECTOR DL, 1992, MOL BIOL CELL, V3, P555, DOI 10.1091/mbc.3.5.555; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Tycowski KT, 2004, CURR BIOL, V14, P1985, DOI 10.1016/j.cub.2004.11.003; Velma V, 2012, CHROMOSOMA, V121, P629, DOI 10.1007/s00412-012-0387-4; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122348	10.1371/journal.pone.0122348	http://dx.doi.org/10.1371/journal.pone.0122348			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875178	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100065
J	Perez, LM; Bernal, A; de Lucas, B; San Martin, N; Mastrangelo, A; Garcia, A; Barbas, C; Galvez, BG				Perez, Laura M.; Bernal, Aurora; de Lucas, Beatriz; San Martin, Nuria; Mastrangelo, Annalaura; Garcia, Antonia; Barbas, Coral; Galvez, Beatriz G.			Altered Metabolic and Stemness Capacity of Adipose Tissue-Derived Stem Cells from Obese Mouse and Human	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; OCT4; RESPIRATION; ADIPOCYTES; TELOMERASE; FACTOR-1	Adipose stem cells (ASCs) are an appealing source of cells for therapeutic intervention; however, the environment from which ASCs are isolated may impact their usefulness. Using a range of functional assays, we have evaluated whether ASCs isolated from an obese environment are comparable to cells from non-obese adipose tissue. Results showed that ASCs isolated from obese tissue have a reduced proliferative ability and a loss of viability together with changes in telomerase activity and DNA telomere length, suggesting a decreased self-renewal capacity. Metabolic analysis demonstrated that mitochondrial content and function was impaired in obese-derived ASCs resulting in changes in favored oxidative substrates. These findings highlight the impact of obesity on adult stem properties. Hence, caution should be exercised when considering the source of ASCs for cellular therapies since their therapeutic potential may be impaired.	[Perez, Laura M.; Bernal, Aurora; de Lucas, Beatriz; San Martin, Nuria; Galvez, Beatriz G.] CNIC, Madrid, Spain; [Mastrangelo, Annalaura; Garcia, Antonia; Barbas, Coral] Univ San Pablo, CEU, Madrid, Spain; [Galvez, Beatriz G.] UEM, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); San Pablo CEU University; European University of Madrid	Galvez, BG (corresponding author), CNIC, Madrid, Spain.	b.gonzalez@uem.es	de Lucas Moreno, Beatriz/P-1378-2019; Bernal, Aurora/AAG-1926-2019; Garcia, Antonia/C-4296-2008; Gálvez, Beatriz G./H-1644-2015; Barbas, Coral/K-3871-2014; Pérez, Laura M./E-7818-2016	de Lucas Moreno, Beatriz/0000-0002-2852-0118; Bernal, Aurora/0000-0002-5741-7865; Garcia, Antonia/0000-0002-1521-8489; Gálvez, Beatriz G./0000-0002-8082-9323; Barbas, Coral/0000-0003-4722-491X; Pérez, Laura M./0000-0003-0649-7778; Mastrangelo, Annalaura/0000-0003-2650-0444	Spanish Ministry of Science and Innovation (SAF) [2010-15239]; Spanish Ministry of Science and Innovation [RYC2009-04669]; Spanish Ministry of Science and Innovation; Pro-CNIC Foundation; Spanish Ministry; Spanish Ministry of Economy and Competitiveness (MINECO) [CTQ2011-23562]	Spanish Ministry of Science and Innovation (SAF); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; Spanish Ministry(Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government)	This study was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2010-15239) to BGG. BGG also acknowledges support from the "Ramon y Cajal" tenure track programme from the Spanish Ministry of Science and Innovation (RYC2009-04669). The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. LMP and AB are supported by FPI fellowships from the Spanish Ministry. AM is supported by a fellowship from the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2011-23562). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Bernal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053215; Canuto GAB, 2014, ANAL BIOANAL CHEM, V406, P3459, DOI 10.1007/s00216-014-7772-1; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Choi JR, 2014, BIOCHEM BIOPHYS RES; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Covarrubias P, 2013, AESTHET PLAST SURG, V37, P778, DOI 10.1007/s00266-013-0126-0; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Ferrer-Lorente R, 2014, DIABETOLOGIA, V57, P246, DOI 10.1007/s00125-013-3081-z; Frazier TP, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-34; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Holvoet P, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/205027; Insinga A, 2014, BLOOD CELL MOL DIS, V52, P147, DOI 10.1016/j.bcmd.2013.12.005; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Moreno L, 2014, ANTIOXID REDOX SIGN, V20, P1, DOI 10.1089/ars.2012.4752; Onate B, 2012, FASEB J; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Panfilov Ilia Alexander, 2013, Methods Mol Biol, V1036, P207, DOI 10.1007/978-1-62703-511-8_16; Park E, 2010, CELL BIOL INT, V34, P979, DOI 10.1042/CBI20100124; Perez LM, 2013, ARCH PHYSIOL BIOCHEM, V119, P195, DOI 10.3109/13813455.2013.784339; Perez LM, 2013, DIABETES, V62, P2368, DOI 10.2337/db12-1220; Pintus F, 2012, AGING-US, V4, P734, DOI 10.18632/aging.100505; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Roldan M, 2011, FASEB J, V25, P4111, DOI 10.1096/fj.10-171439; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; San Martin Nuria, 2011, Archives of Physiology and Biochemistry, V117, P188, DOI 10.3109/13813455.2011.571700; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Szivek JA, 2014, J BIOMED MATER RES B; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.292; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229; Wu YY, 2013, MOL BIOL REP, V40, P2897, DOI 10.1007/s11033-012-2305-5; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	56	63	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123397	10.1371/journal.pone.0123397	http://dx.doi.org/10.1371/journal.pone.0123397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875023	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100171
J	Tian, FX; Wang, T; Xie, YL; Zhang, J; Hu, JJ				Tian, Fengxia; Wang, Tan; Xie, Yuli; Zhang, Jin; Hu, Jianjun			Genome-Wide Identification, Classification, and Expression Analysis of 14-3-3 Gene Family in Populus	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; TRANSCRIPTOME ANALYSIS; MAXIMUM-LIKELIHOOD; PROTEIN-STRUCTURE; STRESS TOLERANCE; DUPLICATE GENES; ARABIDOPSIS; PLANT	Background In plants, 14-3-3 proteins are encoded by a large multigene family and are involved in signaling pathways to regulate plant development and protection from stress. Although twelve Populus 14-3-3s were identified based on the Populus trichocarpa genome V1.1 in a previous study, no systematic analysis including genome organization, gene structure, duplication relationship, evolutionary analysis and expression compendium has been conducted in Populus based on the latest P. trichocarpa genome V3.0. Principal Findings Here, a comprehensive analysis of Populus 14-3-3 family is presented. Two new 14-3-3 genes were identified based on the latest P. trichocarpa genome. In P. trichocarpa, fourteen 14-3-3 genes were grouped into epsilon and non-epsilon group. Exon-intron organizations of Populus 14-3-3s are highly conserved within the same group. Genomic organization analysis indicated that purifying selection plays a pivotal role in the retention and maintenance of Populus 14-3-3 family. Protein conformational analysis indicated that Populus 14-3-3 consists of a bundle of nine a-helices (alpha 1-alpha 9); the first four are essential for formation of the dimer, while alpha 3, alpha 5, alpha 7, and alpha 9 form a conserved peptide-binding groove. In addition, alpha 1, alpha 3, alpha 5, alpha 7, and alpha 9 were evolving at a lower rate, while alpha 2, alpha 4, and alpha 6 were evolving at a relatively faster rate. Microarray analyses showed that most Populus 14-3-3s are differentially expressed across tissues and upon exposure to various stresses. Conclusions The gene structures and their coding protein structures of Populus 14-3-3s are highly conserved among group members, suggesting that members of the same group might also have conserved functions. Microarray and qRT-PCR analyses showed that most Populus 14-3-3s were differentially expressed in various tissues and were induced by various stresses. Our investigation provided a better understanding of the complexity of the 14-3-3 gene family in poplars.	[Tian, Fengxia; Wang, Tan; Xie, Yuli] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang, Henan, Peoples R China; [Tian, Fengxia; Wang, Tan; Xie, Yuli; Zhang, Jin; Hu, Jianjun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China	Nanyang Normal College; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, J (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	Zhang007jin@163.com; Hujj@caf.ac.cn	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078	National Nonprofit Institute Research Grant of CAF [TGB2013009, CAFYBB2014ZX001-4]; China Postdoctoral Science Foundation [2014M550104]	National Nonprofit Institute Research Grant of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Nonprofit Institute Research Grant of CAF [TGB2013009] and [CAFYBB2014ZX001-4] to JJH and the China Postdoctoral Science Foundation [2014M550104] to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; CHANDLER PM, 1994, ANNU REV PLANT PHYS, V45, P113, DOI 10.1146/annurev.pp.45.060194.000553; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; Cotelle V, 2000, EMBO J, V19, P2869, DOI 10.1093/emboj/19.12.2869; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Ferl RJ, 2002, GENOME BIOL, V3; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fulgosi H, 2002, PLANT MOL BIOL, V50, P1019, DOI 10.1023/A:1021295604109; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Ko JH, 2012, PLANT BIOTECHNOL J, V10, P587, DOI 10.1111/j.1467-7652.2012.00690.x; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Liu YanJing, 2010, Journal of Beijing Forestry University, V32, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU GH, 1992, P NATL ACAD SCI USA, V89, P11490, DOI 10.1073/pnas.89.23.11490; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P661, DOI 10.1016/j.semcdb.2011.09.011; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Pertl H, 2005, PLANT BIOLOGY, V7, P140, DOI 10.1055/s-2005-837583; Pertl H, 2010, PLANT PHYSIOL, V154, P1921, DOI 10.1104/pp.110.165696; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vuttipongchaikij S, 2012, NEW PHYTOL, V195, P585, DOI 10.1111/j.1469-8137.2012.04196.x; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang XH, 2009, PLANT J, V60, P539, DOI 10.1111/j.1365-313X.2009.03978.x; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	70	36	40	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123225	10.1371/journal.pone.0123225	http://dx.doi.org/10.1371/journal.pone.0123225			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867623	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100153
J	van Andel, J; Leijten, F; van Delden, H; van Thiel, G				van Andel, Judith; Leijten, Frans; van Delden, Hans; van Thiel, Ghislaine			What Makes a Good Home-Based Nocturnal Seizure Detector? A Value Sensitive Design	PLOS ONE			English	Article							SUDDEN UNEXPECTED DEATH; EPILEPSY; ETHICS	A device for the in-home detection of nocturnal seizures is currently being developed in the Netherlands, to improve care for patients with severe epilepsy. It is recognized that the design of medical technology is not value neutral: perspectives of users and developers are influential in design, and design choices influence these perspectives. However, during development processes, these influences are generally ignored and value-related choices remain implicit and poorly argued for. In the development process of the seizure detector we aimed to take values of all stakeholders into consideration. Therefore, we performed a parallel ethics study, using "value sensitive design." Analysis of stakeholder communication (in meetings and e-mail messages) identified five important values, namely, health, trust, autonomy, accessibility, and reliability. Stakeholders were then asked to give feedback on the choice of these values and how they should be interpreted. In a next step, the values were related to design choices relevant for the device, and then the consequences (risks and benefits) of these choices were investigated. Currently the process of design and testing of the device is still ongoing. The device will be validated in a trial in which the identified consequences of design choices are measured as secondary endpoints. Value sensitive design methodology is feasible for the development of new medical technology and can help designers substantiate the choices in their design.	[van Andel, Judith; Leijten, Frans] Univ Med Ctr Utrecht, Dept Clin Neurophysiol, Utrecht, Netherlands; [van Delden, Hans; van Thiel, Ghislaine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Andel, J (corresponding author), Univ Med Ctr Utrecht, Dept Clin Neurophysiol, Utrecht, Netherlands.	j.m.vanandel@umcutrecht.nl	Van Thiel, Ghislaine/R-8977-2019	van Thiel, Ghislaine/0000-0003-1799-1894	ZonMW [300040003]	ZonMW(Netherlands Organization for Health Research and Development)	This study was funded by ZonMW, grant number 300040003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Cummings ML, 2006, SCI ENG ETHICS, V12, P701, DOI 10.1007/s11948-006-0065-0; Flanagan M, 2008, HDB INFORM COMPUTER, P69; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Friedman B., 2002, U WAHINGTON TECHNICA; FRIEDMAN B., 2003, HUM FAC ER, P1177; JACKO J. A., 2007, HUMAN COMPUTER INTER; Lamberts RJ, 2012, EPILEPSIA, V53, P253, DOI 10.1111/j.1528-1167.2011.03360.x; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Shankar R, 2013, SEIZURE-EUR J EPILEP, V22, P812, DOI 10.1016/j.seizure.2013.07.014; Timmermans Job, 2011, Nanoethics, V5, P269, DOI 10.1007/s11569-011-0135-x; van Wynsberghe A, 2013, SCI ENG ETHICS, V19, P407, DOI 10.1007/s11948-011-9343-6; Zwart SD, 2006, SCI ENG ETHICS, V12, P663, DOI 10.1007/s11948-006-0063-2	14	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121446	10.1371/journal.pone.0121446	http://dx.doi.org/10.1371/journal.pone.0121446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875320	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100041
J	Zhao, XY; Li, Y; Zheng, M; Bian, XY; Liu, MR; Sun, YS; Jiang, J; Wang, FW; Li, SC; Cui, YH; Liu, GF; Yang, CP				Zhao, Xiyang; Li, Ying; Zheng, Mi; Bian, Xiuyan; Liu, Mengran; Sun, Yanshuang; Jiang, Jing; Wang, Fuwei; Li, Shuchun; Cui, Yonghong; Liu, Guifeng; Yang, Chuanping			Comparative Analysis of Growth and Photosynthetic Characteristics of (Populus simonii x P-nigra) x (P-nigra x P-simonii) Hybrid Clones of Different Ploidides	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; STEM STRAIGHTNESS; GENETIC-VARIATION; ELEVATED CO2; BIOMASS; GENOME; TRICHOCARPA; POLYPLOIDY; EVOLUTION; VIETNAM	To evaluate differences among poplar clones of various ploidies, 12 hybrid poplar clones (Populus simonii x P. nigra) x (P. nigra x P. simonii) with different ploidies were used to study phenotypic variation in growth traits and photosynthetic characteristics. Analysis of variance showed remarkable differences for each of the investigated traits among these clones (P < 0.01). Coefficients of phenotypic variation (PCV) ranged from 2.38% to 56.71%, and repeatability ranged from 0.656 to 0.987. The Pn (photosynthetic rate) photosynthetic photon flux density (PPFD) curves of the 12 clones were S-shaped, but the Pn-ambient CO2 (Ca) curves were shaped like an inverted "V". The stomatal conductance (Gs)-PPFD and transpiration rate (Tr)-PPFD curves had an upward tendency; however, with increasing PFFD, the intercellular CO2 concentration (Ci)-PPFD curves had a downward tendency in all of the clones. The Pn-PPFD and Pn-Ca curves followed the pattern of a quadratic equation. The average light saturation point and light compensation point of the triploid clones were the highest and lowest, respectively, among the three types of clones. For Pn-Ca curves, diploid clones had a higher average CO2 saturation point and average CO2 compensation point compared with triploid and tetraploid clones. Correlation analyses indicated that all investigated traits were strongly correlated with each other. In future studies, molecular methods should be used to analyze poplar clones of different ploidies to improve our understanding of the growth and development mechanisms of polyploidy.	[Zhao, Xiyang; Li, Ying; Zheng, Mi; Bian, Xiuyan; Liu, Mengran; Sun, Yanshuang; Jiang, Jing; Liu, Guifeng; Yang, Chuanping] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Wang, Fuwei; Li, Shuchun] Forestry Dept Jilin Prov, Tree Seedling Management Stn, Changchun 130000, Peoples R China; [Zhao, Xiyang; Cui, Yonghong] Seed Orchard Siping, Siping 136000, Peoples R China	Northeast Forestry University - China	Liu, GF (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	liuguifeng@126.com; yangcp@nefu.edu.cn			Innovation Project of State Key Laboratory of Tree Genetics and Breeding (Northeast Forestry University) [2013B09]; Fundamental Research Funds for the Central Universities [2572014CA16]	Innovation Project of State Key Laboratory of Tree Genetics and Breeding (Northeast Forestry University); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The role of the Innovation Project of State Key Laboratory of Tree Genetics and Breeding (Northeast Forestry University) (No. 2013B09) was data collection, analysis, and the role of Fundamental Research Funds for the Central Universities (2572014CA16) support for the research was decision to publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSMAN JH, 1991, TREE PHYSIOL, V8, P145, DOI 10.1093/treephys/8.2.145; CEULEMANS R, 1987, CAN J FOREST RES, V17, P273, DOI 10.1139/x87-047; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cowley R, 2011, 17 AUSTR RES ASS BRA; DEMMIG B, 1987, PLANTA, V171, P171, DOI 10.1007/BF00391092; DIPPERY JK, 1995, OECOLOGIA, V101, P13, DOI 10.1007/BF00328894; Ewald D, 2009, PLANT CELL TISS ORG, V99, P353, DOI 10.1007/s11240-009-9601-3; Fan Shao-hui, 2010, Forest Research, V23, P71; Fu YaPing, 1999, Chinese Journal of Rice Science, V13, P157; Hai PH, 2008, FOREST ECOL MANAG, V255, P156, DOI 10.1016/j.foreco.2007.09.017; Hansen JK, 1997, SILVAE GENET, V46, P107; [姜静 Jiang Jing], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P669; Jiang ZeHui, 2007, Scientia Silvae Sinicae, V43, P15; Johnsson H, 1940, HEREDITAS, V26, P321; Kang XiangYang, 2003, Journal of Beijing Forestry University, V25, P70; Kien Nguyen Duc, 2008, New Zealand Journal of Forestry Science, V38, P160; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li XuYao, 1998, Journal of Northeast Forestry University, V26, P24; Li ZX, 2013, J BEIJING FORESTRY U, V35, P57; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Maniee M., 2009, Journal of Applied Sciences, V9, P1383, DOI 10.3923/jas.2009.1383.1387; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Nilsson EH, 1936, HEREDITAS, V21, P379; Pliura A, 2007, FOREST ECOL MANAG, V238, P92, DOI 10.1016/j.foreco.2006.09.082; Qi ChuanLei, 2010, Plant Physiology Communications, V46, P917; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Sarvas R., 1958, COMMUN I FOREST FENN, V49, P25; Sixto H, 2011, NEW FOREST, V42, P163, DOI 10.1007/s11056-010-9244-6; Surabhi GK, 2009, ENVIRON EXP BOT, V66, P160, DOI 10.1016/j.envexpbot.2009.02.004; Sylven N., 1943, SVENSK PAPPTIDN, V47, P38; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Buijtenen J. P. van, 1958, TAPPI, V41, P170; Wang Lei, 2009, Plant Physiology Communications, V45, P1160; Wang S, 2011, J NE FORESTRY U, V39, P16; Wang Sui, 2011, Journal of Northeast Forestry University, V39, P5; Ward JK, 1999, TREE PHYSIOL, V19, P211; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xi XJ, 2012, TREE GENET GENOMES, V8, P1237, DOI 10.1007/s11295-012-0510-y; Xing XinTing, 2000, Journal of Beijing Forestry University, V22, P21; Yang ChuanPing, 2001, Scientia Silvae Sinicae, V37, P34; Zhang Jun-E, 2006, Acta Genetica Sinica, V33, P647, DOI 10.1016/S0379-4172(06)60095-4; Zhao Xi-yang, 2011, Xibei Zhiwu Xuebao, V31, P1665; Zhao Xi-yang, 2011, Forest Research, V24, P370; Zhao XY, 2014, NEW FOREST, V45, P21, DOI 10.1007/s11056-013-9389-1; Zhao XiYang, 2012, Journal of Beijing Forestry University, V34, P41; Zheng HQ, 2010, PLANT CELL REP, V29, P449, DOI 10.1007/s00299-010-0834-8; Zhou Yu-mei, 2002, Journal of Forestry Research (Harbin), V13, P209, DOI 10.1007/BF02871699; Zhu ZhiTi, 1995, Scientia Silvae Sinicae, V31, P499	50	20	28	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119259	10.1371/journal.pone.0119259	http://dx.doi.org/10.1371/journal.pone.0119259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867100	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100013
J	Guo, AJ; Cai, JP; Luo, XN; Zhang, SH; Hou, JL; Li, H; Cai, XP				Guo, Aijiang; Cai, Jianping; Luo, Xuenong; Zhang, Shaohua; Hou, Junling; Li, Hui; Cai, Xuepeng			Cloning and Characterization of Three Eimeria tenella Lipid Phosphate Phosphatases	PLOS ONE			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; MIGRATING GERM-CELLS; ACID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; RAT-LIVER; ENDOPLASMIC-RETICULUM; MULTIPLE GENES; SEQUENCE MOTIF; IDENTIFICATION	Although lipid phosphate phosphatases (LPPs) play an important role in cellular signaling in addition to lipid biosynthesis, little is thus far known about parasite LPPs. In this study, we characterized three Eimeria tenella cDNA clones encoding LPP named EtLPP1, EtLPP2 and EtLPP3. Key structural features previously described in LPPs, including the three conserved domains proposed as catalytic sites, a single conserved N-glycosylation site, and putative transmembrane domains were discovered in the three resulting EtLPP amino acid sequences. Expression of His6-tagged EtLPP1, -2, and -3 in HEK293 cells produced immunoreactive proteins with variable molecular sizes, suggesting the presence of multiple forms of each of the three EtLPPs. The two faster-migrating protein bands below each of the three EtLPP proteins were found to be very similar to the porcine 35-kDa LPP enzyme in their molecular size and the extent of their N-glycosylation, suggesting that the three EtLPPs are partially N-glycosylated. Kinetic analyses of the activity of the three enzymes against PA, LPA, C1P and S1P showed that Km values for each of the substrates were (in mu M) 284, 46, 28, and 22 for EtLPP1; 369, 179, 237, and 52 for EtLPP2; and 355, 83, and 260 for EtLPP3. However, EtLPP3 showed negligible activity on S1P. These results confirmed that the three EtLPPs have broad substrate specificity. The results also indicated that despite structural similarities, the three EtLPPs may play distinct functions through their different models of substrate preference. Furthermore, particularly high expression levels of the three EtLPP genes were detected in the sporozoite stage of the E. tenella life cycle (p<0.001), suggesting that their encoded proteins might play an important biological function in the sporozoite stage.	[Guo, Aijiang; Cai, Jianping; Luo, Xuenong; Zhang, Shaohua; Hou, Junling; Li, Hui; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Guo, Aijiang; Luo, Xuenong] Jiangsu Co Innovat Ctr Prevent & Control Importan, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Guo, AJ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	guoaijiang@caas.cn			National Natural Science Foundation of China [30872369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by Grant # 30872369 (http://www.nsfc.gov.cn/) from National Natural Science Foundation of China, to AJG. The funders had no role in study design, data-collection and analysis, decision to publish, or preparation of the manuscript.	Barila D, 1996, J BIOL CHEM, V271, P29928, DOI 10.1074/jbc.271.47.29928; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; FLEMING IN, 1995, BIOCHEM J, V308, P983, DOI 10.1042/bj3080983; Guo AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064236; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; Kai M, 1997, J BIOL CHEM, V272, P24572; KANOH H, 1992, J BIOL CHEM, V267, P25309; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Roberts R, 1998, J BIOL CHEM, V273, P22059; Siess EA, 1996, FEBS LETT, V381, P169, DOI 10.1016/0014-5793(96)00111-1; SIMONS BH, 1995, EUR J BIOCHEM, V229, P566, DOI 10.1111/j.1432-1033.1995.tb20499.x; SMITH SW, 1957, J BIOL CHEM, V228, P915; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Stukey J, 1997, PROTEIN SCI, V6, P469; Sun LY, 2005, MOL CELL BIOCHEM, V272, P91, DOI 10.1007/s11010-005-7640-6; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang N, 2000, GENESIS, V27, P137, DOI 10.1002/1526-968X(200008)27:4<137::AID-GENE10>3.0.CO;2-4; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181; Zhang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3134, DOI 10.1271/bbb.80305	44	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122736	10.1371/journal.pone.0122736	http://dx.doi.org/10.1371/journal.pone.0122736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861032	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300059
J	Xia, H; Hu, C; Zhang, DK; Tang, S; Zhang, Z; Kou, Z; Fan, ZJ; Bente, D; Zeng, CQ; Li, TX				Xia, Han; Hu, Cheng; Zhang, Dake; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Bente, Dennis; Zeng, Changqing; Li, Tianxian			Metagenomic Profile of the Viral Communities in Rhipicephalus spp. Ticks from Yunnan, China	PLOS ONE			English	Article							DISEASE VIRUS; BORNE; DIVERSITY; FEVER; PHLEBOVIRUS; REVEALS; BATS	Besides mosquitoes, ticks are regarded as the primary source of vector-borne infectious diseases. Indeed, a wide variety of severe infectious human diseases, including those involving viruses, are transmitted by ticks in many parts of the world. To date, there are no published reports on the use of next-generation sequencing for studying viral diversity in ticks or discovering new viruses in these arthropods from China. Here, Ion-torrent sequencing was used to investigate the presence of viruses in three Rhipicephalus spp. tick pools (NY-11, NY-13, and MM-13) collected from the Menglian district of Yunnan, China. The sequencing run resulted in 3,641,088, 3,106,733, and 3,871,851 reads in each tick pool after trimming. Reads and assembled contiguous sequences (contigs) were subject to basic local alignment search tool analysis against the GenBank database. Large numbers of reads and contigs related to known viral sequences corresponding to a broad range of viral families were identified. Some of the sequences originated from viruses that have not been described previously in ticks. Our findings will facilitate better understanding of the tick virome, and add to our current knowledge of disease-causing viruses in ticks living under natural conditions.	[Xia, Han; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Li, Tianxian] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Xia, Han; Bente, Dennis] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hu, Cheng] Wuhan Univ, Int Sch Software, Wuhan, Hubei, Peoples R China; [Zhang, Dake; Zeng, Changqing] Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Texas System; University of Texas Medical Branch Galveston; Wuhan University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zeng, CQ (corresponding author), Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, 1 Beichen West Rd, Beijing, Peoples R China.	czeng@big.ac.cn; litx@wh.iov.cn	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Ministry of Science and Technology of China [2013FY113500]; Chinese Academy of Sciences [INFOXXH12504-1-06]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Ministry of Science and Technology of China (grant No. 2013FY113500), Chinese Academy of Sciences (grant Nos. INFOXXH12504-1-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Bzhalava D, 2013, J DATA MIN GENOM PRO, V4, P134; Chen Z, 2008, SICHUAN J ZOOL, V27, P4; Chitimia L, 2009, PARASITOL RES, V105, P907, DOI 10.1007/s00436-009-1474-1; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de la Fuente J, 2008, FRONT BIOSCI, V1, P9; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gibbs A, 1986, THE PLANT VIRUSES, P167; Gong ZD, 2001, CHINA J PEST CO, V2, P3; Havlikova S, 2013, ACTA VIROL, V57, P123, DOI 10.4149/av_2013_02_123; Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Karabatsos N., 1985, INTERNATIONAL CATALO; Kaufman WR, 2003, EXP PARASITOL, V104, P20, DOI 10.1016/S0014-4894(03)00113-9; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Lasecka L, 2014, ARCH VIROL, V159, P1249, DOI 10.1007/s00705-013-1940-z; Liu L, 2012, J BIOMED BIOTECHNOL, V50, P2881; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Nersesov V. A., 2003, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P30; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Tokarz R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-26; Wang JL, 2009, EMERG INFECT DIS, V15, P326, DOI 10.3201/eid1502.080979; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119; Xia H, 2011, INT J INFECT DIS, V15, pE459, DOI 10.1016/j.ijid.2011.03.013; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	39	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121609	10.1371/journal.pone.0121609	http://dx.doi.org/10.1371/journal.pone.0121609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25867946	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300276
J	Ding, CJ; Lu, J; Song, ZQ				Ding, Changjiang; Lu, Jun; Song, Zhiqing			Electrohydrodynamic Drying of Carrot Slices	PLOS ONE			English	Article							EHD; AIR; KINETICS; APPLE; RICE	Carrots have one of the highest levels of carotene, and they are rich in vitamins, fiber and minerals. However, since fresh carrots wilt rapidly after harvest under inappropriate storage conditions, drying has been used to improve their shelf life and retain nutritional quality. Therefore, to further investigate the potential of this method, carrot slices were dried in an EHD system in order to study the effect of different voltages on drying rate. As measures of quality, carotene content and rehydration ratio were, respectively, compared against the conventional oven drying regime. Carotene, the main component of the dried carrot, and rehydration characteristics of the dried product can both indicate quality by physical and chemical changes during the drying process. Mathematical modeling and simulation of drying curves were also performed, using root mean square error, reduced mean square of the deviation and modeling efficiency as the primary criteria to select the equation that best accounts for the variation in the drying curves of the dried samples. Theoretically, the Page model was best suited for describing the drying rate curve of carrot slices at 10kV to 30kV. Experimentally, the drying rate of carrots was notably greater in the EHD system when compared to control, and quality, as determined by carotene content and rehydration ratio, was also improved when compared to oven drying. Therefore, this work presents a facile and effective strategy for experimentally and theoretically determining the drying properties of carrots, and, as a result, it provides deeper insight into the industrial potential of the EHD drying technique.	[Ding, Changjiang; Lu, Jun; Song, Zhiqing] Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China	Inner Mongolia University of Technology	Ding, CJ (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China.	ding9713@163.com	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	National Natural Science Foundations of China [51467015]; Natural Science Foundation of Inner Mongolia Autonomous Region of china [2013MS0106]; Science Foundation of Inner Mongolia of Technology [ZD201311]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of china; Science Foundation of Inner Mongolia of Technology	This work was Supported by National Natural Science Foundations of China(No. 51467015), Natural Science Foundation of Inner Mongolia Autonomous Region of china (No. 2013MS0106) and Science Foundation of Inner Mongolia of Technology (No. ZD201311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemrajabi AA, 2012, DRY TECHNOL, V30, P88, DOI 10.1080/07373937.2011.608913; Bai YX, 2012, J AQUAT FOOD PROD T, V21, P238, DOI 10.1080/10498850.2011.590271; Bai YX, 2011, J FOOD PROCESS PRES, V35, P891, DOI 10.1111/j.1745-4549.2011.00542.x; Bai YX, 2013, LWT-FOOD SCI TECHNOL, V54, P570, DOI 10.1016/j.lwt.2013.06.026; Bai YX, 2011, INT J APPL ELECTROM, V36, P217, DOI 10.3233/JAE-2011-1361; Balcer BE, 2004, DRY TECHNOL, V22, P821, DOI 10.1081/DRT-120034265; Basiry M, 2010, J ELECTROSTAT, V68, P360, DOI 10.1016/j.elstat.2010.05.002; Cao W, 2004, BIOSYST ENG, V87, P445, DOI 10.1016/j.biosystemseng.2003.12.007; Celma AR, 2008, CHEM ENG PROCESS, V47, P1810, DOI 10.1016/j.cep.2007.10.003; Demir V, 2007, BIOSYST ENG, V98, P47, DOI 10.1016/j.biosystemseng.2007.06.011; Dinani ST, 2014, ENERG CONVERS MANAGE, V86, P70, DOI 10.1016/j.enconman.2014.05.010; Dinani ST, 2014, DRY TECHNOL, V32, P597, DOI 10.1080/07373937.2013.851086; Ding CJ, 2014, INT J APPL ELECTROM, V46, P455, DOI 10.3233/JAE-141781; Esehaghbeygi A, 2012, DRY TECHNOL, V30, P1644, DOI 10.1080/07373937.2012.701262; Esehaghbeygi A, 2011, J FOOD ENG, V104, P628, DOI 10.1016/j.jfoodeng.2011.01.032; Hashinaga F, 1999, DRY TECHNOL, V17, P479, DOI 10.1080/07373939908917547; Lai FC, 2002, DRY TECHNOL, V20, P1393, DOI 10.1081/DRT-120005858; Li FD, 2006, J FOOD ENG, V77, P275, DOI 10.1016/j.jfoodeng.2005.06.028; Li FD, 2005, DRY TECHNOL, V23, P565, DOI 10.1081/DRT-200054133; Li ZF, 2010, LWT-FOOD SCI TECHNOL, V43, P291, DOI 10.1016/j.lwt.2009.08.002; Meisami-asl E., 2009, Pakistan Journal of Nutrition, V8, P804; Menges HO, 2006, J FOOD ENG, V77, P119, DOI 10.1016/j.jfoodeng.2005.06.049; Pardeshi IL, 2010, FOOD BIOPROCESS TECH, V3, P415, DOI 10.1007/s11947-008-0100-z; Romano G, 2009, DRY TECHNOL, V27, P574, DOI 10.1080/00304940802716233; Senadeera W, 2003, J FOOD ENG, V58, P277, DOI 10.1016/S0260-8774(02)00386-2; Singh A, 2012, DRY TECHNOL, V30, P1812, DOI 10.1080/07373937.2012.708912; Srikiatden J, 2008, J FOOD ENG, V84, P516, DOI 10.1016/j.jfoodeng.2007.06.009; Wu BG, 2014, J FOOD PROCESS ENG, V37, P111, DOI 10.1111/jfpe.12066; Zhang J, 2000, J INNER MONGOLIA AGR, V21, P121; Zhang Y, 2014, J ELECTROSTAT, V72, P76, DOI 10.1016/j.elstat.2013.11.010	30	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124077	10.1371/journal.pone.0124077	http://dx.doi.org/10.1371/journal.pone.0124077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25835017	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800131
J	Xia, H; Wang, XM; Li, FB; Longuet, C; Vernet, G; Goletti, D; Zhao, YL; Lagrange, PH				Xia, Hui; Wang, Xiaomen; Li, Fabin; Longuet, Christophe; Vernet, Guy; Goletti, Delia; Zhao, Yanlin; Lagrange, Philippe H.			Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; CLINICAL UTILITY; INFECTION; LATENT; BCG; IMMUNODIAGNOSIS	Background Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. Methods/Principal Findings A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). Conclusions/Significance The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB.	[Xia, Hui; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China; [Wang, Xiaomen] TB Control Ctr Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China; [Li, Fabin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Longuet, Christophe; Vernet, Guy] Fdn Merieux, Lyon, France; [Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe H.] Paris VII Denis Diderot Univ, Hop St Louis, AP HP, Microbiol Serv, Paris, France	Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhao, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China.	zhaoyanlin@chinatb.org; plagrange@sfr.fr	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Fondation Merieux	Fondation Merieux	Fondation Merieux funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bass Jr JB, 1993, TUBERCULOSIS A COMPR; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; CHEN ZR, 1982, CHINESE MED J-PEKING, V95, P437; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2008, GUIDELINES FOR IMPLE; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention China TB control program, 2009, SPUTUM SMEAR MICROSC; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Delogu G, 2014, J RHEUMATOL, V41, P11, DOI 10.3899/jrheum.140097; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hu PL, 2014, CHINESE MED J-PEKING, V127, P3744, DOI 10.3760/cma.j.issn.0366-6999.20141004; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Li WM, 2007, SCAND J INFECT DIS, V39, P138, DOI 10.1080/00365540600951234; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health People's Republic of China Joint United Nations Program on HIV/AIDS World Health Organization, 2011, 2011 ESTIMATES FOR T; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Thompson ML, 2003, BIOSTATISTICS, V4, P341, DOI 10.1093/biostatistics/4.3.341; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; World Health Organization [WHO], 2014, WHO REPORT 2013; Zhang M, 2010, INT J TUBERC LUNG D, V14, P1556; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	50	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121021	10.1371/journal.pone.0121021	http://dx.doi.org/10.1371/journal.pone.0121021			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867946	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100031
J	Borner, J; Kis-Katos, K; Hargrave, J; Konig, K				Boerner, Jan; Kis-Katos, Krisztina; Hargrave, Jorge; Koenig, Konstantin			Post-Crackdown Effectiveness of Field-Based Forest Law Enforcement in the Brazilian Amazon	PLOS ONE			English	Article							PROPENSITY SCORE; PROTECTED AREAS; DEFORESTATION; POLICY; ISSUES; FIRE; BEEF	Regulatory enforcement of forest conservation laws is often dismissed as an ineffective approach to reducing tropical forest loss. Yet, effective enforcement is often a precondition for alternative conservation measures, such as payments for environmental services, to achieve desired outcomes. Fair and efficient policies to reducing emissions from deforestation and forest degradation (REDD) will thus crucially depend on understanding the determinants and requirements of enforcement effectiveness. Among potential REDD candidate countries, Brazil is considered to possess the most advanced deforestation monitoring and enforcement infrastructure. This study explores a unique dataset of over 15 thousand point coordinates of enforcement missions in the Brazilian Amazon during 2009 and 2010, after major reductions of deforestation in the region. We study whether local deforestation patterns have been affected by field-based enforcement and to what extent these effects vary across administrative boundaries. Spatial matching and regression techniques are applied at different spatial resolutions. We find that field-based enforcement operations have not been universally effective in deterring deforestation during our observation period. Inspections have been most effective in reducing large-scale deforestation in the states of Mato Grosso and Para, where average conservation effects were 4.0 and 9.9 hectares per inspection, respectively. Despite regional and actor-specific heterogeneity in inspection effectiveness, field-based law enforcement is highly cost-effective on average and might be enhanced by closer collaboration between national and state-level authorities.	[Boerner, Jan] Univ Bonn, Res Dev Ctr, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res, Bogor, Indonesia; [Kis-Katos, Krisztina] Univ Freiburg, Inst Econ Res, D-79106 Freiburg, Germany; [Hargrave, Jorge] Boston Consulting Grp Inc, Sao Paulo, Brazil; [Koenig, Konstantin] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR); University of Freiburg; Boston Consulting Group (BCG); Humboldt University of Berlin	Borner, J (corresponding author), Univ Bonn, Res Dev Ctr, Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation [32.5.8043.0012.0]; European Commission [DCI-ENV/2011/269520]	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Robert Bosch Foundation (Grant: 32.5.8043.0012.0; www.bosch-stiftung.de) and the European Commission (Grant: DCI-ENV/2011/269520; http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assunu║ao JJ., 2013, DETERRING DEFORESTAT; Barretto AGOP, 2013, GLOBAL CHANGE BIOL, V19, P1804, DOI 10.1111/gcb.12174; Bartolini F, 2012, J AGR ECON, V63, P310, DOI 10.1111/j.1477-9552.2012.00339.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J., 2011, REDD STICKS CARROTS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; CEPAL-IPEA-GIZ, 2011, AVALIACAO PLANO ACAO, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; CLARKE HR, 1993, RESOUR ENERGY ECON, V15, P271, DOI 10.1016/0928-7655(93)90009-J; Dalla-Nora EL, 2014, LAND USE POLICY, V39, P403, DOI 10.1016/j.landusepol.2014.02.004; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Godar J, 2014, P NATL ACAD SCI USA; Godar J, 2012, FOREST ECOL MANAG, V267, P58, DOI 10.1016/j.foreco.2011.11.046; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Mitchell Polinsky A., 2000, AM LAW ECON REV, V2, P223, DOI [10.1093/aler/2.2.223, DOI 10.1093/ALER/2.2.223]; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pacheco P, 2012, GEOFORUM, V43, P864, DOI 10.1016/j.geoforum.2012.02.003; Piquero AR, 2011, ANNU REV LAW SOC SCI, V7, P335, DOI 10.1146/annurev-lawsocsci-102510-105404; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Robinson EJZ., 2010, J NAT RES POLICY RES, V2, P25, DOI 10.1080/19390450903350820; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; STIGLER GJ, 1970, J POLIT ECON, V78, P526, DOI 10.1086/259646; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wooldridge JM, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321946930	46	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121544	10.1371/journal.pone.0121544	http://dx.doi.org/10.1371/journal.pone.0121544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875656	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800022
J	Lin, CK; Hung, CC; Peng, CY; Chao, E; Lee, TSH				Lin, Chao-Kuang; Hung, Chia-Chun; Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien			Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis	PLOS ONE			English	Article							HEROIN USERS; MAINTENANCE TREATMENT; DRUG-USERS; FOLLOW-UP; RETENTION; PREDICTORS; MORTALITY; THERAPY; COHORT	This study examined retention rates and associated predictors of methadone maintenance treatment (MMT) duration among 128 newly admitted patients in Taiwan. A semi-structured questionnaire was used to obtain demographic and drug use history. Daily records of methadone taken and test results for HIV, HCV, and morphine toxicology were taken from a computerized medical registry. Cox regression analyses were performed to examine factors associated with MMT duration. MMT retention rates were 80.5%, 68.8%, 53.9%, and 41.4% for 3, 6, 12, and 18 months, respectively. Excluding 38 patients incarcerated during the study period, retention rates were 81.1%, 73.3%, 61.1%, and 48.9% for 3 months, 6 months, 12 months, and 18 months, respectively. No participant seroconverted to HIV and 1 died during the 18-months follow-up. Results showed that being female, imprisonment, a longer distance from house to clinic, having a lower methadone dose after 30 days, being HCV positive, and in the New Taipei city program predicted early patient dropout. The findings suggest favorable MMT outcomes of HIV seroincidence and mortality. Results indicate that the need to minimize travel distance and to provide programs that meet women's requirements justify expansion of MMT clinics in Taiwan.	[Lin, Chao-Kuang] Natl Yang Ming Univ, Educ Ctr Humanities & Social Sci, Taipei 112, Taiwan; [Hung, Chia-Chun] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Taiwan Normal University	Lee, TSH (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	tonylee@ntnu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886	Taiwan Ministry of Health and Welfare [DOH97-NNB-1044, DOH98-NNB-1032, DOH99-FDA-61501]; National Taiwan Normal University (NTNU), Taiwan, ROC	Taiwan Ministry of Health and Welfare; National Taiwan Normal University (NTNU), Taiwan, ROC	This study was funded by the Taiwan Ministry of Health and Welfare (DOH97-NNB-1044, DOH98-NNB-1032 and DOH99-FDA-61501). The funders of the study had no role in study design, data collection, data analysis, data interpretation, and writing of the report. This article was subsidized by the National Taiwan Normal University (NTNU), Taiwan, ROC.	Borisova NN, 2004, J SUBST ABUSE TREAT, V26, P345, DOI 10.1016/S0740-5472(03)00157-0; Deck D, 2005, J BEHAV HEALTH SER R, V32, P43, DOI 10.1007/BF02287327; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Hartel DM, 1999, PUBLIC HEALTH, V113, P107; Hser YI, 2004, PSYCHIAT SERV, V55, P767, DOI 10.1176/appi.ps.55.7.767; Huang YF, 2011, ADDICTION, V106, P1437, DOI 10.1111/j.1360-0443.2011.03443.x; Kelly SM, 2011, DRUG ALCOHOL DEPEN, V117, P170, DOI 10.1016/j.drugalcdep.2011.01.008; Kerr T, 2005, DRUG ALCOHOL DEPEN, V80, P329, DOI 10.1016/j.drugalcdep.2005.05.002; Lee TSH, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-6; Lee TSH, 2006, TAIWAN J PUBLIC HLTH, V25, P214; Liao DL, 2013, J PSYCHIATR RES, V47, P1530, DOI 10.1016/j.jpsychires.2013.07.001; Lin HC, 2013, J ADDICT DIS, V32, P140, DOI 10.1080/10550887.2013.795466; Magura S, 1998, ADDICTION, V93, P51, DOI 10.1046/j.1360-0443.1998.931516.x; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Peles E, 2006, DRUG ALCOHOL DEPEN, V82, P211, DOI 10.1016/j.drugalcdep.2005.09.004; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; UNODC, 2002, COMTEMPORARY DRUG AB; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; World Health Organization, 2012, WHO UNODC UNAIDS TEC, DOI [10.1016/j.drugpo.2007.12.002, DOI 10.1016/J.DRUGPO.2007.12.002]; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang ZW, 2003, ADDICTION, V98, P673, DOI 10.1046/j.1360-0443.2003.00354.x	24	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123687	10.1371/journal.pone.0123687	http://dx.doi.org/10.1371/journal.pone.0123687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EB	25875531	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700038
J	Lin, CS; Popescu, SC; Thomson, G; Tsogt, K; Chang, CI				Lin, Chinsu; Popescu, Sorin C.; Thomson, Gavin; Tsogt, Khongor; Chang, Chein-I			Classification of Tree Species in Overstorey Canopy of Subtropical Forest Using QuickBird Images	PLOS ONE			English	Article							HIGH-RESOLUTION; LIDAR DATA; VEGETATION; KAPPA; IDENTIFICATION; PREVALENCE; ALGORITHMS; DENSITY; SYSTEM; CROWNS	This paper proposes a supervised classification scheme to identify 40 tree species (2 coniferous, 38 broadleaf) belonging to 22 families and 36 genera in high spatial resolution QuickBird multispectral images (HMS). Overall kappa coefficient (OKC) and species conditional kappa coefficients (SCKC) were used to evaluate classification performance in training samples and estimate accuracy and uncertainty in test samples. Baseline classification performance using HMS images and vegetation index (VI) images were evaluated with an OKC value of 0.58 and 0.48 respectively, but performance improved significantly (up to 0.99) when used in combination with an HMS spectral-spatial texture image (SpecTex). One of the 40 species had very high conditional kappa coefficient performance (SCKC >= 0.95) using 4-band HMS and 5-band VIs images, but, only five species had lower performance (0.68 <= SCKC <= 0.94) using the SpecTex images. When SpecTex images were combined with a Visible Atmospherically Resistant Index (VARI), there was a significant improvement in performance in the training samples. The same level of improvement could not be replicated in the test samples indicating that a high degree of uncertainty exists in species classification accuracy which may be due to individual tree crown density, leaf greenness (inter-canopy gaps), and noise in the background environment (intra-canopy gaps). These factors increase uncertainty in the spectral texture features and therefore represent potential problems when using pixel-based classification techniques for multi-species classification.	[Lin, Chinsu; Tsogt, Khongor] Natl Chiayi Univ, Dept Forestry & Nat Resources, Chiayi 60004, Taiwan; [Popescu, Sorin C.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Thomson, Gavin] Natl Formosa Univ, Dept Appl Foreign Languages, Huwei Township 63201, Yunlin, Taiwan; [Chang, Chein-I] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA	National Chiayi University; Texas A&M University System; Texas A&M University College Station; National Formosa University; University System of Maryland; University of Maryland Baltimore County	Lin, CS (corresponding author), Natl Chiayi Univ, Dept Forestry & Nat Resources, 300 Univ Rd, Chiayi 60004, Taiwan.	chinsu@mail.ncyu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081478; Boschetti M, 2007, INT J REMOTE SENS, V28, P1251, DOI 10.1080/01431160600928542; Brandtberg T, 1998, MACH VISION APPL, V11, P64, DOI 10.1007/s001380050091; CHAVEZ PS, 1991, PHOTOGRAMM ENG REM S, V57, P295; Chinsu Lin, 2015, Information Processing in Agriculture, V2, P25, DOI 10.1016/j.inpa.2015.01.003; Chytry M, 2011, APPL VEG SCI, V14, P435, DOI 10.1111/j.1654-109X.2011.01154.x; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; Dwivedi Ravi Shankar, 2009, P73; Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057; Frampton CM, 2001, ENVIRON MONIT ASSESS, V72, P227, DOI 10.1023/A:1012049205475; Franklin SE, 2000, INT J REMOTE SENS, V21, P61, DOI 10.1080/014311600210993; Gaikwad RN, 2006, ISPRS ARCH 4, VXXXVI; Gairola S, 2013, INT J REMOTE SENS, V34, P2006, DOI 10.1080/01431161.2012.730161; Ghiyamat A, 2010, INT J REMOTE SENS, V31, P1837, DOI 10.1080/01431160902926681; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Hantson W, 2012, APPL VEG SCI, V15, P536, DOI 10.1111/j.1654-109X.2012.01194.x; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Hill RA, 2005, INT J REMOTE SENS, V26, P3763, DOI 10.1080/01431160500114706; Hoare D, 2004, APPL VEG SCI, V7, P19, DOI 10.1111/j.1654-109X.2004.tb00591.x; Holmgren J, 2008, INT J REMOTE SENS, V29, P1537, DOI 10.1080/01431160701736471; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Ishihama F, 2012, APPL VEG SCI, V15, P383, DOI 10.1111/j.1654-109X.2012.01184.x; Jensen JR., 2004, INTRO DIGITAL IMAGE, V3; Jones TG, 2010, INT J REMOTE SENS, V31, P1121, DOI 10.1080/01431160903349040; Kang JY, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL III, PROCEEDINGS, P315, DOI 10.1109/IITA.2008.269; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Ke Y, REMOTE SENSING ENV, V114, P1141; Krause K., 2005, RADIOMETRIC USE QUIC; KRUSE FA, 1993, AIP CONF PROC, P192, DOI 10.1016/0034-4257(93)90013-N; Larcher W, 2003, PHYSL PLANT ECOLOGY; Leckie DG, 2005, CAN J REMOTE SENS, V31, P175, DOI 10.5589/m05-004; LEE JS, 1980, IEEE T PATTERN ANAL, V2, P165, DOI 10.1109/TPAMI.1980.4766994; Li CF, 2012, S E AS FLOR ROL FORM; Lin C, 2015, BIOGEOSCIENCES, V12, P49, DOI 10.5194/bg-12-49-2015; Lin C, 2003, J NATL CHIAYI U, V75, P181; Lin C., 2011, J EARTH SCI ENG, V1, P35; Lin C, 2005, Q J CHINESE FORESTRY, V38, P163; Lin C, 2011, P 4 INT C IM SIGN PR, V3, P1633; Lin CS, 2012, J ENVIRON MANAGE, V113, P440, DOI 10.1016/j.jenvman.2012.09.001; Lin CS, 2011, PHOTOGRAMM ENG REM S, V77, P241, DOI 10.14358/PERS.77.3.241; Lin Chinsu, 1999, Taiwan Journal of Forest Science, V14, P289; Lo CS, 2013, IEEE T GEOSCI REMOTE, V51, P2216, DOI 10.1109/TGRS.2012.2211023; Hernandez-Stefanoni JL, 2009, APPL VEG SCI, V12, P398, DOI 10.1111/j.1654-109X.2009.01044.x; McDanold RI, 2007, APPL VEG SCI, V10, P193; Ouyang ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067315; Pu RL, 2009, INT J REMOTE SENS, V30, P2759, DOI 10.1080/01431160802555820; Reitberger J, 2008, INT J REMOTE SENS, V29, P1407, DOI 10.1080/01431160701736448; Richards J.A., 1999, REMOTE SENSING DIGIT, DOI [DOI 10.1007/978-3-642-30062-2, 10.1007/978-3-662-03978-6, DOI 10.1007/978-3-662-03978-6]; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Schowengerdt R. A., 1997, REMOTE SENSING MODEL; Stehman SV, 1996, PHOTOGRAMM ENG REM S, V62, P401; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vach W, 2005, J CLIN EPIDEMIOL, V58, P655, DOI 10.1016/j.jclinepi.2004.02.021; Vina A, 2004, AGRON J, V96, P1139, DOI 10.2134/agronj2004.1139; Wang L, 2009, INT J REMOTE SENS, V30, P1267, DOI 10.1080/01431160802474014; Wu TF, 2004, J MACH LEARN RES, V5, P975	62	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125554	10.1371/journal.pone.0125554	http://dx.doi.org/10.1371/journal.pone.0125554			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25875531	Green Published, Green Submitted, gold			2022-12-27	WOS:000354916100031
J	Zhao, SY; Ding, C; He, JZ				Zhao, Siyan; Ding, Chang; He, Jianzhong			Detoxification of 1,1,2-Trichloroethane to Ethene by Desulfitobacterium and Identification of Its Functional Reductase Gene	PLOS ONE			English	Article							DEHALOCOCCOIDES-ETHENOGENES; SP NOV.; DEHALOGENASE; GROWTH; 1,1,2,2-TETRACHLOROETHANE; DECHLORINATION; SPP.	1,1,2-trichloroethane (1,1,2-TCA) has become a common groundwater pollutant due to historically extensive utilization, improper disposal, as well as from incomplete dechlorination of 1,1,2,2-tetrachloroethane. Currently, limited information is available on microbial detoxification of 1,1,2-TCA. Desulfitobacterium sp. strain PR, which was isolated from an anaerobic bioreactor maintained to dechlorinate chloroethenes/ethanes, exhibited the capacity to dechlorinate 1,1,1-trichloroethane and chloroform. In this study, the dechlorinating ability of strain PR was further explored. Strain PR showed the capability to dechlorinate 1,1,2-TCA (similar to 1.12 mM) predominantly to 1,2-dichloroethane (1,2-DCA) and chloroethane, and to trace amounts of vinyl chloride and ethene within 20 days. Strain PR coupled growth with dechlorination of 1,1,2-TCA to 1,2-DCA, while no cell growth was observed with dechlorination of 1,2-DCA to chloroethane. Later, through transcriptomic and enzymatic analysis, the reductive dehalogenase CtrA, which was previously reported to be responsible for 1,1,1-trichloroethane and chloroform dechlorination, was identified as the 1,1,2-TCA reductive dehalogenase. Since trichloroethene (TCE) is usually co-contaminated with 1,1,2-TCA, a co-culture containing Dehalococcoides mccartyi strain 11a capable of detoxifying TCE and 1,2-DCA and strain PR was established. Interestingly, this co-culture dechlorinated 1,1,2-TCA and TCE to the non-toxic end-product ethene within 48 days without chloroethane production. This novel pathway avoids production of the carcinogenic intermediate dechlorination product vinyl chloride, providing a more environmentally friendly strategy to treat 1,1,2-TCA.	[Zhao, Siyan; Ding, Chang; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore.	jianzhong.he@nus.edu.sg	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]; National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme [NRF-CRP5-2009-05]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme(National Research Foundation, Singapore)	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project no.: 102 101 0025 and the National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme with a project no.: NRF-CRP5-2009-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; ATSDR, 2006, TOX PROF VIN CHLOR; ATSDR, 2010, TOX PROF 1 1 2 TRICH; Aulenta F, 2006, BIODEGRADATION, V17, P193, DOI 10.1007/s10532-005-4218-7; Bowman KS, 2013, INT J SYST EVOL MICR, V63, P1492, DOI 10.1099/ijs.0.045054-0; CASTRO CE, 1994, ENVIRON TOXICOL CHEM, V13, P429, DOI [10.1897/1552-8618(1994)13[429:BRDBMT]2.0.CO;2, 10.1002/etc.5620130310]; Chen C, 1996, ENVIRON SCI TECHNOL, V30, P542, DOI 10.1021/es9502987; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Coons DE, 2000, CHEMICAL OXIDATION AND REACTIVE BARRIERS, P161; De Wildeman S, 2003, APPL ENVIRON MICROB, V69, P5643, DOI 10.1128/AEM.69.9.5643-5647.2003; Ding C, 2014, ENVIRON MICROBIOL, V15, P1462; FATHEPURE BZ, 1994, ENVIRON SCI TECHNOL, V28, P746, DOI 10.1021/es00053a031; Grostern A, 2006, APPL ENVIRON MICROB, V72, P428, DOI 10.1128/AEM.72.1.428-436.2006; He JZ, 2007, APPL ENVIRON MICROB, V73, P2847, DOI 10.1128/AEM.02574-06; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee PKH, 2013, ENVIRON MICROBIOL, V15, P2293, DOI 10.1111/1462-2920.12099; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Maness AD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-54; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Plagentz V, 2006, ENVIRON GEOL, V49, P684, DOI 10.1007/s00254-005-0106-z; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Schiffmann CL, 2014, J PROTEOMICS, V98, P59, DOI 10.1016/j.jprot.2013.12.009	24	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119507	10.1371/journal.pone.0119507	http://dx.doi.org/10.1371/journal.pone.0119507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835017	Green Published, Green Submitted, gold			2022-12-27	WOS:000352139000009
J	Borner, J; Marinho, E; Wunder, S				Boerner, Jan; Marinho, Eduardo; Wunder, Sven			Mixing Carrots and Sticks to Conserve Forests in the Brazilian Amazon: A Spatial Probabilistic Modeling Approach	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; POLICY MIX; DEFORESTATION; PAYMENTS	Annual forest loss in the Brazilian Amazon had in 2012 declined to less than 5,000 sqkm, from over 27,000 in 2004. Mounting empirical evidence suggests that changes in Brazilian law enforcement strategy and the related governance system may account for a large share of the overall success in curbing deforestation rates. At the same time, Brazil is experimenting with alternative approaches to compensate farmers for conservation actions through economic incentives, such as payments for environmental services, at various administrative levels. We develop a spatially explicit simulation model for deforestation decisions in response to policy incentives and disincentives. The model builds on elements of optimal enforcement theory and introduces the notion of imperfect payment contract enforcement in the context of avoided deforestation. We implement the simulations using official deforestation statistics and data collected from field-based forest law enforcement operations in the Amazon region. We show that a large-scale integration of payments with the existing regulatory enforcement strategy involves a tradeoff between the cost-effectiveness of forest conservation and landholder incomes. Introducing payments as a complementary policy measure increases policy implementation cost, reduces income losses for those hit hardest by law enforcement, and can provide additional income to some land users. The magnitude of the tradeoff varies in space, depending on deforestation patterns, conservation opportunity and enforcement costs. Enforcement effectiveness becomes a key determinant of efficiency in the overall policy mix.	[Boerner, Jan] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Boerner, Jan; Marinho, Eduardo; Wunder, Sven] Ctr Int Forestry Res CIFOR, Rio De Janeiro, Brazil	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR)	Borner, J (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Walter Flex Str 3, D-53113 Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation; European Commission [DCI-ENV/2011/269520]; Forest, Trees, and Agroforestry Program	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Forest, Trees, and Agroforestry Program	This work was funded by the Robert Bosch Foundation (www.bosch-stiftung.de), European Commission (http://ec.europa.eu/index_en.htm; Grant number: DCI-ENV/2011/269520), and Forest, Trees, and Agroforestry Program (http://foreststreesagroforestry.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Armsworth PR, 2012, ECOL LETT, V15, P406, DOI 10.1111/j.1461-0248.2012.01747.x; Assuncao J., 2013, DOES CREDIT AFFECT D; Assuncao Juliano., 2012, DEFORESTATION SLOWDO; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2014, TECHINCAL BRIEF; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J, 2010, ECOL ECON, V69, P1272, DOI 10.1016/j.ecolecon.2009.11.003; Borner J., 2013, GOVERNING PROVISION, P21, DOI [10.1007/978-94-007-5176-7_2, DOI 10.1007/978-94-007-5176-7]; Borner J, 2013, COMPENSACAO PORSERVI; Borner J, 2014, GLOBAL ENV IN PRESS; Cattaneo A., 2002, RES REPORT; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Godar J, 2014, P NATL ACAD SCI USA; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lehmann P, 2012, J ECON SURV, V26, P71, DOI 10.1111/j.1467-6419.2010.00628.x; Merger Eduard, 2012, Carbon Balance Manag, V7, P9, DOI 10.1186/1750-0680-7-9; MMA, 2009, BRAZ REDD STRAT DOC; Moxey A, 2014, LAND USE POLICY, V39, P397, DOI 10.1016/j.landusepol.2014.04.008; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Prager K, 2011, LAND DEGRAD DEV, V22, P111, DOI 10.1002/ldr.1038; Sandmo A, 2002, ENVIRON RESOUR ECON, V23, P85, DOI 10.1023/A:1020236324130; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sohngen B, 2004, CAN J FOREST RES, V34, P829, DOI [10.1139/x03-249, 10.1139/X03-249]; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Tinbergen Jan, 1952, THEORY EC POLICY; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2014, EARTHSCAN FOR LIBR, P202; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034	37	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116846	10.1371/journal.pone.0116846	http://dx.doi.org/10.1371/journal.pone.0116846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25875656	Green Published, Green Submitted, gold			2022-12-27	WOS:000349250700007
